PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bertrand, S; Joo, R; Fablet, R				Bertrand, Sophie; Joo, Rocio; Fablet, Ronan			Generalized Pareto for Pattern-Oriented Random Walk Modelling of Organisms' Movements	PLOS ONE			English	Article							FLIGHT SEARCH PATTERNS; STATISTICAL-INFERENCE; SPATIAL-DISTRIBUTION; ANIMAL MOVEMENT; SCALING LAWS; LEVY FLIGHTS; LIKELIHOOD; DISTRIBUTIONS; ECOLOGY	How organisms move and disperse is crucial to understand how population dynamics relates to the spatial heterogeneity of the environment. Random walk (RW) models are typical tools to describe movement patterns. Whether Levy or alternative RW better describes forager movements is keenly debated. We get around this issue using the Generalized Pareto Distribution (GPD). GPD includes as specific cases Normal, exponential and power law distributions, which underlie Brownian, Poisson-like and Levy walks respectively. Whereas previous studies typically confronted a limited set of candidate models, GPD lets the most likely RW model emerge from the data. We illustrate the wide applicability of the method using GPS-tracked seabird foraging movements and fishing vessel movements tracked by Vessel Monitoring System (VMS), both collected in the Peruvian pelagic ecosystem. The two parameters from the fitted GPD, a scale and a shape parameter, provide a synoptic characterization of the observed movement in terms of characteristic scale and diffusive property. They reveal and quantify the variability, among species and individuals, of the spatial strategies selected by predators foraging on a common prey field. The GPD parameters constitute relevant metrics for (1) providing a synthetic and pattern-oriented description of movement, (2) using top predators as ecosystem indicators and (3) studying the variability of spatial behaviour among species or among individuals with different personalities.	[Bertrand, Sophie; Joo, Rocio] Ctr Rech Halieut Mediterraneenne & Trop, IRD, EME UMR212, F-34203 Sete, France; [Joo, Rocio] IMARPE, Lima, Peru; [Fablet, Ronan] Inst TELECOM, F-29238 Brest, France; [Fablet, Ronan] TELECOM Bretagne, F-29238 Brest, France; [Fablet, Ronan] CNRS, UMR Lab STICC 3192, F-29238 Brest, France	Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Instituto del Mar del Peru; IMT - Institut Mines-Telecom; IMT Atlantique; IMT - Institut Mines-Telecom; IMT Atlantique; Centre National de la Recherche Scientifique (CNRS); Universite de Bretagne Occidentale	Bertrand, S (corresponding author), Ctr Rech Halieut Mediterraneenne & Trop, IRD, EME UMR212, Ave Jean Monnet,BP 171, F-34203 Sete, France.	Sophie.Bertrand@ird.fr	fablet, ronan/L-5574-2019; Joo, Rocio/H-8238-2019; bertrand, sophie/F-4161-2012	fablet, ronan/0000-0002-6462-423X; bertrand, sophie/0000-0003-1976-3799				AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; ALLEN PM, 1986, CAN J FISH AQUAT SCI, V43, P1187, DOI 10.1139/f86-148; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Benoit-Bird KJ, 2013, MAR ECOL PROG SER, V479, P283, DOI 10.3354/meps10209; Berkolaiko G, 1996, PHYS REV E, V53, P5774, DOI 10.1103/PhysRevE.53.5774; Bertrand S, 2005, ICES J MAR SCI, V62, P477, DOI 10.1016/j.icesjms.2004.12.002; Bertrand S, 2007, ECOL APPL, V17, P331, DOI 10.1890/06-0303; Bertrand S, 2012, J APPL ECOL, V49, P1168, DOI 10.1111/j.1365-2664.2012.02190.x; Bertrand S, 2008, PROG OCEANOGR, V79, P379, DOI 10.1016/j.pocean.2008.10.009; Boyd C, 2014, ECOL MODEL, V286, P13, DOI 10.1016/j.ecolmodel.2014.03.015; Boyd IL, 2006, CONSERV BIOL SER, P1, DOI 10.2277/ 052161256X; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brown CT, 2007, HUM ECOL, V35, P129, DOI 10.1007/s10745-006-9083-4; BUSH JG, 1983, COMMUN STAT-THEOR M, V12, P2465, DOI 10.1080/03610928308828613; Chaouche A, 2006, COMMUN STAT-THEOR M, V35, P785, DOI 10.1080/03610920500501429; Chavez FP, 2008, PROG OCEANOGR, V79, P95, DOI 10.1016/j.pocean.2008.10.012; Codling EA, 2010, THEORETICAL ECOLOGY, V4, P397; Cote J, 2010, PHILOS T R SOC B, V365, P4065, DOI 10.1098/rstb.2010.0176; DAVISON AC, 1990, J ROY STAT SOC B MET, V52, P393; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Edwards AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045174; Edwards AM, 2011, ECOLOGY, V92, P1247, DOI 10.1890/10-1182.1; Fraser DF, 2001, AM NAT, V158, P124, DOI 10.1086/321307; FreuEn P., 1999, DYNAMICS PELAGIC FIS; Gautestad AO, 2013, OIKOS, V122, P612, DOI 10.1111/j.1600-0706.2012.19998.x; Giuggioli L, 2010, J ANIM ECOL, V79, P906, DOI 10.1111/j.1365-2656.2010.01682.x; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; GRIMSHAW SD, 1993, TECHNOMETRICS, V35, P185, DOI 10.2307/1269663; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Joo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071246; MURPHY R.C., 1936, OCEANIC BIRDS S AM, V2; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Nelson JB, 2005, PELICANS CORMORANTS; Peraltilla S, 2014, FISH RES, V149, P92, DOI 10.1016/j.fishres.2013.09.002; PICKANDS J, 1975, ANN STAT, V3, P119; Plank MJ, 2009, ECOLOGY, V90, P3546, DOI 10.1890/09-0079.1; Reynolds A, 2008, ECOLOGY, V89, P2347, DOI 10.1890/07-1688.1; Scherrer B., 2007, BIOSTATISTIQUE; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; SHLESINGER MF, 1993, NATURE, V363, P31, DOI 10.1038/363031a0; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sokal R. R., 2001, BIOMETRY PRINCIPLES; Turchin Peter, 1998; van Overveld T, 2010, BIOL LETTERS, V6, P187, DOI 10.1098/rsbl.2009.0764; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Weimerskirch H, 2012, MAR ECOL PROG SER, V458, P231, DOI 10.3354/meps09752; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1	51	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132231	10.1371/journal.pone.0132231	http://dx.doi.org/10.1371/journal.pone.0132231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172045	Green Published, gold			2022-12-27	WOS:000358194900037
J	Bustnes, JO; Bourgeon, S; Leat, EHK; Magnusdottir, E; Strom, H; Hanssen, SA; Petersen, A; Olafsdottir, K; Borga, K; Gabrielsen, GW; Furness, RW				Bustnes, Jan O.; Bourgeon, Sophie; Leat, Eliza H. K.; Magnusdottir, Ellen; Strom, Hallvard; Hanssen, Sveinn A.; Petersen, Aevar; Olafsdottir, Kristin; Borga, Katrine; Gabrielsen, Geir W.; Furness, Robert W.			Multiple Stressors in a Top Predator Seabird: Potential Ecological Consequences of Environmental Contaminants, Population Health and Breeding Conditions	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; SKUAS STERCORARIUS-SKUA; EGG-SIZE; ORGANOCHLORINE POLLUTANTS; REPRODUCTIVE-PERFORMANCE; FLAME-RETARDANT; GLAUCOUS GULL; BIRDS; MORTALITY; IMPACTS	Environmental contaminants may have impacts on reproduction and survival in wildlife populations suffering from multiple stressors. This study examined whether adverse effects of persistent organic pollutants (POPs) increased with poor population health and breeding conditions in three colonies (60-74 degrees N) of great skua (Stercorarius skua) in the north-eastern Atlantic (Shetland, Iceland and Bjornoya [Bear Island]). POPs (organochlorines [OCs] and polybrominated diphenyl ethers [BDEs]) were measured in plasma of incubating birds (n = 222), concentrations differing nearly tenfold among colonies: Bjornoya (2009) > Bjornoya (2010) > Iceland (2009) > Shetland (2009). Reproductive success (hatching success and chick survival) showed that breeding conditions were favourable in Shetland and at Bjornoya (2010), but were very poor in Iceland and at Bjornoya (2009). Biomarkers indicated that health was poor in the Shetland population compared to the other populations. Females whose chicks hatched late had high POP concentrations in all colonies except at Bjornoya (2010), and females losing their eggs at Bjornoya (2009) tended to have higher concentrations than those hatching. Moreover, there was a negative relationship between female POP concentrations and chick body condition at hatching in Iceland and at Bjornoya (2010). Supplementary feeding experiments were conducted, and in Iceland where feeding conditions were poor, significant negative relationships were found between female POP concentrations and daily growth-rate in first-hatched chicks of control nests, but not in food supplemented nests. This suggests that negative impacts of POPs were mitigated by improved feeding conditions. For second-chicks, there was a strong negative relationship between the female POP concentrations and growth-rate, but no effects of supplementary feeding. Lowered adult return-rate between breeding seasons with increasing POP loads were found both at Bjornoya (2009) and in Shetland, especially related to BDEs. This indicates stronger fitness consequences of POPs following seasons with very poor breeding conditions and/or high reproductive effort. This study suggests that the impacts of POPs may differ depending on population health and breeding conditions, and that even low concentrations of POPs could have ecological consequences during adverse circumstances. This is important with regard to risk assessment of biomagnifying contaminants in marine ecosystems.	[Bustnes, Jan O.; Bourgeon, Sophie; Hanssen, Sveinn A.] Norwegian Inst Nat Res NINA, Fram Ctr, N-9296 Tromso, Norway; [Bourgeon, Sophie; Strom, Hallvard; Gabrielsen, Geir W.] Norwegian Polar Res Inst, Fram Ctr, N-9296 Tromso, Norway; [Leat, Eliza H. K.; Furness, Robert W.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Magnusdottir, Ellen; Olafsdottir, Kristin] Univ Iceland, Dept Pharmacol & Toxicol, IS-107 Reykjavik, Iceland; [Borga, Katrine] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway	Norwegian Institute Nature Research; Norwegian Polar Institute; University of Glasgow; University of Iceland; University of Oslo	Bustnes, JO (corresponding author), Norwegian Inst Nat Res NINA, Fram Ctr, N-9296 Tromso, Norway.	Jan.O.Bustnes@nina.no	Hanssen, Sveinn Are/C-9989-2009; Olafsdottir, Kristin/L-9430-2015	Hanssen, Sveinn Are/0000-0003-1792-435X; Olafsdottir, Kristin/0000-0002-3241-836X	Norwegian Research Council [184830]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The project was fully funded by the Norwegian Research Council (Grant Number: 184830).	AMAP Assessment, 2002, PERS ORG POLL ARCT; Arnold JM, 2004, J AVIAN BIOL, V35, P33, DOI 10.1111/j.0908-8857.2004.03059.x; Bourgeon S, 2013, ENVIRON SCI TECHNOL, V47, P5963, DOI 10.1021/es400442q; Bourgeon S, 2012, ENVIRON RES, V118, P31, DOI 10.1016/j.envres.2012.08.004; Bustnes JO, 2008, ENVIRON INT, V34, P193, DOI 10.1016/j.envint.2007.07.016; Bustnes JO, 2007, ENVIRON INT, V33, P911, DOI 10.1016/j.envint.2007.04.010; Bustnes JO, 2006, P ROY SOC B-BIOL SCI, V273, P3117, DOI 10.1098/rspb.2006.3687; Bustnes JO, 2008, ENVIRON POLLUT, V156, P417, DOI 10.1016/j.envpol.2008.01.028; Bustnes JO, 2000, ECOTOXICOLOGY, V9, P179, DOI 10.1023/A:1008938603257; Bustnes JO, 2005, ENVIRON POLLUT, V136, P175, DOI 10.1016/j.envpol.2004.09.026; Bustnes JO, 2006, J TOXICOL ENV HEAL A, V68, P1; Carere C, 2010, ANN I SUPER SANITA, V46, P81, DOI 10.4415/ANN_10_01_10; Chen D, 2010, ENVIRON INT, V36, P800, DOI 10.1016/j.envint.2010.05.013; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Danhardt A, 2011, ECOSYSTEMS, V14, P791, DOI 10.1007/s10021-011-9445-7; Eng ML, 2013, ENVIRON POLLUT, V178, P343, DOI 10.1016/j.envpol.2013.03.037; Erikstad KE, 1998, ECOLOGY, V79, P1781; Erikstad KE, 1998, J AVIAN BIOL, V29, P3, DOI 10.2307/3677334; Erikstad KE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1483; Evenset A, 2005, ENVIRON POLLUT, V136, P419, DOI 10.1016/j.envpol.2005.01.018; Fischer BB, 2013, SCI TOTAL ENVIRON, V449, P253, DOI 10.1016/j.scitotenv.2013.01.066; Forbes VE, 2010, ECOL APPL, V20, P1449, DOI 10.1890/09-1063.1; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Furness R. W., 1987, SKUAS; GILBERTSON M, 1991, J TOXICOL ENV HEALTH, V33, P455, DOI 10.1080/15287399109531538; Goldberg M, 2011, ENVIRON RES, V111, P1007, DOI 10.1016/j.envres.2011.08.010; Hamlin HJ, 2010, SYST BIOL REPROD MED, V56, P113, DOI 10.3109/19396360903244598; Henriksen EO, 1998, CHEMOSPHERE, V37, P2627, DOI 10.1016/S0045-6535(98)00162-3; Hipfner JM, 2001, CONDOR, V103, P240, DOI 10.1650/0010-5422(2001)103[0240:FSATCO]2.0.CO;2; Institute SAS, 2011, SAS 9 3 FDN MICR WIN; Kalmbach E, 2004, J AVIAN BIOL, V35, P501, DOI 10.1111/j.0908-8857.2004.03271.x; Kozak K, 2013, TRAC-TREND ANAL CHEM, V50, P107, DOI 10.1016/j.trac.2013.04.016; Leat EHK, 2013, MAR ECOL PROG SER, V491, P277, DOI 10.3354/meps10455; Leat EHK, 2011, ENVIRON POLLUT, V159, P1222, DOI 10.1016/j.envpol.2011.01.036; Letcher RJ, 2010, SCI TOTAL ENVIRON, V408, P2995, DOI 10.1016/j.scitotenv.2009.10.038; Lund-Hansen L.C., 1991, Acta Naturalia Islandica, V34, P1; Mitchell PI, 2004, SEABIRD POPULATIONS; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Ottinger MA, 2011, J TOXICOL ENV HEAL B, V14, P413, DOI 10.1080/10937404.2011.578560; Perrins CM, 1996, IBIS, V138, P2, DOI 10.1111/j.1474-919X.1996.tb04308.x; Ratcliffe N, 1998, J ANIM ECOL, V67, P853, DOI 10.1046/j.1365-2656.1998.6760853.x; Ratcliffe N, 2002, IBIS, V144, P384, DOI 10.1046/j.1474-919X.2002.00066.x; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sih A, 2004, TRENDS ECOL EVOL, V19, P274, DOI 10.1016/j.tree.2004.02.010; Slagsvold T, 2007, ANIM BEHAV, V73, P691, DOI 10.1016/j.anbehav.2006.05.021; Strom H., 2007, SEAPOP STUDIES LOFOT, V249, P50; Van Straalen NM, 2003, ENV SCI TECHNOL A, V325A; Venables WN., 2002, MODERN APPL STAT S 4; Verreault J, 2010, REV ENVIRON CONTAM T, V205, P77, DOI 10.1007/978-1-4419-5623-1_2; Votier SC, 2007, J AVIAN BIOL, V38, P234, DOI 10.1111/j.0908-8857.2007.03893.x; WILLIAMS TD, 1994, BIOL REV, V69, P35, DOI 10.1111/j.1469-185X.1994.tb01485.x; Wingfield JC, 2008, GEN COMP ENDOCR, V157, P207, DOI 10.1016/j.ygcen.2008.04.017; Wingfield JC, 2013, FUNCT ECOL, V27, P37, DOI 10.1111/1365-2435.12039	53	21	21	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131769	10.1371/journal.pone.0131769	http://dx.doi.org/10.1371/journal.pone.0131769			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172383	Green Published, gold, Green Accepted			2022-12-27	WOS:000358194900024
J	Peterson, R; Gundlapalli, AV; Metraux, S; Carter, ME; Palmer, M; Redd, A; Samore, MH; Fargo, JD				Peterson, Rachel; Gundlapalli, Adi V.; Metraux, Stephen; Carter, Marjorie E.; Palmer, Miland; Redd, Andrew; Samore, Matthew H.; Fargo, Jamison D.			Identifying Homelessness among Veterans Using VA Administrative Data: Opportunities to Expand Detection Criteria	PLOS ONE			English	Article							HEALTH; RISK	Researchers at the U.S. Department of Veterans Affairs (VA) have used administrative criteria to identify homelessness among U.S. Veterans. Our objective was to explore the use of these codes in VA health care facilities. We examined VA health records (2002-2012) of Veterans recently separated from the military and identified as homeless using VA conventional identification criteria (ICD-9-CM code V60.0, VA specific codes for homeless services), plus closely allied V60 codes indicating housing instability. Logistic regression analyses examined differences between Veterans who received these codes. Health care services and co-morbidities were analyzed in the 90 days post-identification of homelessness. VA conventional criteria identified 21,021 homeless Veterans from Operations Enduring Freedom, Iraqi Freedom, and New Dawn (rate 2.5%). Adding allied V60 codes increased that to 31,260 (rate 3.3%). While certain demographic differences were noted, Veterans identified as homeless using conventional or allied codes were similar with regards to utilization of homeless, mental health, and substance abuse services, as well as co-morbidities. Differences were noted in the pattern of usage of homelessness-related diagnostic codes in VA facilities nation-wide. Creating an official VA case definition for homelessness, which would include additional ICD-9-CM and other administrative codes for VA homeless services, would likely allow improved identification of homeless and at-risk Veterans. This also presents an opportunity for encouraging uniformity in applying these codes in VA facilities nationwide as well as in other large health care organizations.	[Peterson, Rachel; Gundlapalli, Adi V.; Carter, Marjorie E.; Palmer, Miland; Redd, Andrew; Samore, Matthew H.; Fargo, Jamison D.] VA Salt Lake City Hlth Care Syst, Salt Lake Informat Decis Enhancement & Analyt Sci, Salt Lake City, UT 84108 USA; [Peterson, Rachel; Fargo, Jamison D.] Utah State Univ, Dept Psychol, Logan, UT 84322 USA; [Gundlapalli, Adi V.; Carter, Marjorie E.; Palmer, Miland; Redd, Andrew; Samore, Matthew H.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA; [Metraux, Stephen; Fargo, Jamison D.] Natl Ctr Homelessness Vet, Philadelphia, PA USA; [Metraux, Stephen] Allegheny Univ Hlth Sci, Hlth Policy & Publ Educ, Philadelphia, PA 19102 USA	US Department of Veterans Affairs; Utah System of Higher Education; Utah State University; Utah System of Higher Education; University of Utah; Drexel University	Gundlapalli, AV (corresponding author), VA Salt Lake City Hlth Care Syst, Salt Lake Informat Decis Enhancement & Analyt Sci, Salt Lake City, UT 84108 USA.	adi.gundlapalli@hsc.utah.edu	; Redd, Andrew/F-3210-2015	Metraux, Stephen/0000-0003-4741-1010; Redd, Andrew/0000-0002-6149-2438	United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development Project [HIR 10-002]	United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development Project(US Department of Veterans Affairs)	Funding for this project was provided by United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development Project # HIR 10-002 (PI: AVG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balshem H., 2011, CRITICAL REV LIT REG; Blow F, 2010, 12 US DEP VET AFF; Brown LM, 2013, PSYCHOL SERV, V10, P250, DOI 10.1037/a0031516; Edens EL, 2011, AM J ADDICTION, V20, P412, DOI 10.1111/j.1521-0391.2011.00166.x; ESRI, 2011, ARCGIS DESKT REL 10; Fihn SD, 2014, HEALTH AFFAIR, V33, P1203, DOI 10.1377/hlthaff.2014.0054; Gundlapalli Adi V, 2013, AMIA Annu Symp Proc, V2013, P537; Himelhoch S, 2007, PSYCHIAT SERV, V58, P1165, DOI 10.1176/appi.ps.58.9.1165; IBM Corp, 2013, IBM SPSS STAT WINDOW; Montgomery AE, 2013, AM J PUBLIC HEALTH, V103, pS210, DOI 10.2105/AJPH.2013.301398; Office of the Secretary HHS, 2012, FED REGISTER, V77, P54663; R Core Team, 2021, R LANGUAGE ENV STAT; Redd A, 2014, STUD HLTH TECHNOL IN, V202, P153; U.S. Department of Housing and Urban Development, 2013, 2013 ANN HOM ASS REP; U.S. Department of Veterans Affairs, 2008, STAT PH DOUGH DIR HO; U.S. Department of Veterans Affairs Office of Inspector General, 2012, HOM INC RISK FACT BE; US Department of Veterans Affairs, 2015, VA INF COMP INFR VIN; Venables WN, 2002, MODERN APPL STAT S, Vxi	18	64	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132664	10.1371/journal.pone.0132664	http://dx.doi.org/10.1371/journal.pone.0132664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172386	gold, Green Published			2022-12-27	WOS:000358194900072
J	Hou, LY; Li, YZ; Song, HC; Zhang, ZH; Sun, YP; Zhang, XG; Wu, K				Hou, Liying; Li, Yuze; Song, Huacui; Zhang, Zhihong; Sun, Yanpei; Zhang, Xuguang; Wu, Kun			Protective Macroautophagy Is Involved in Vitamin E Succinate Effects on Human Gastric Carcinoma Cell Line SGC-7901 by Inhibiting mTOR Axis Phosphorylation	PLOS ONE			English	Article							ALPHA-TOCOPHERYL SUCCINATE; BREAST-CANCER CELLS; INDUCED APOPTOSIS; ANTICANCER AGENTS; MAMMALIAN TARGET; E ANALOGS; AUTOPHAGY; KINASE; PROTEIN; DEATH	Vitamin E succinate (VES), a potential cancer therapeutic agent, potently induces apoptosis and inhibits the growth of various cancer cells. Autophagy has been supposed to promote cancer cell survival or trigger cell death, depending on particular cancer types and tumor microenvironments. The role of autophagy in the growth suppressive effect of VES on gastric cancer cell is basically unknown. We aimed to determine whether and how autophagy affected the VES-induced inhibition of SGC-7901 human gastric carcinoma cell growth. SGC-7901 cells were treated with VES or pre-treated with autophagy inhibitor, chloroquine (CQ) and 3-methyladenine (3-MA). Electron microscopy, fluorescence microscopy and Western blot were used to study whether VES induced autophagy reaction in SGC-7901 cells. Western blot evaluated the activities of the mammalian target of rapamycin (mTOR) axis. Then we used 3-(4,5dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium bromide (MTT) and flow cytometry to detect the level of cell viability and apoptosis. Collectively, our data indeed strongly support our hypothesis that VES treatment produced cytological variations that depict autophagy, increased the amount of intracellular green fluorescent protein-microtubule associated protein 1 light chain 3 (GFP-LC3) punctate fluorescence and the number of autophagic vacuoles. It altered the expression of endogenous autophagy marker LC3. VES activated the suppression of mTOR through inhibiting upstream regulators p38 MAPK and Akt. mTOR suppression consequently inhibited the activation of mTOR downstream targets p70S6K and 4E-BP-1. The activation of the upstream mTOR inhibitor AMPK had been up-regulated by VES. The results showed that pre-treatment SGC-7901 with autophagy inhibitors before VES treatment could increase the capacity of VES to reduce cell viability and to provoke apoptosis. In conclusion, VES-induced autophagy participates in SGC-7901 cell protection by inhibitingmTOR axis phosphorylation. Our findings not only strengthen our understanding of the roles of autophagy in cancer biology, but may also be useful for developing new treatments for gastric cancer patients.	[Hou, Liying; Li, Yuze; Song, Huacui; Zhang, Zhihong; Sun, Yanpei; Zhang, Xuguang; Wu, Kun] Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin, Peoples R China; [Li, Yuze] Fourth Hosp Heilongjiang Prov, Dept Internal Med 4, Harbin, Peoples R China; [Zhang, Zhihong] Heilongjiang Acad Agr Sci, Food Proc Inst, Harbin, Peoples R China; [Zhang, Xuguang] Harbin Childrens Hosp, Dept Internal Med Hematol & Oncol, Harbin, Peoples R China	Harbin Medical University; Heilongjiang Academy of Agricultural Sciences	Wu, K (corresponding author), Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin, Peoples R China.	wukun_15000@126.com	zhang, zh/GWV-4677-2022		National Natural Science Foundation of China [81172651]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (no. 81172651) to KW.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Ahn CH, 2007, APMIS, V115, P1344, DOI 10.1111/j.1600-0463.2007.00858.x; Asnaghi L, 2004, PHARMACOL RES, V50, P545, DOI 10.1016/j.phrs.2004.03.007; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bang OS, 2001, BIOCHEM BIOPH RES CO, V288, P789, DOI 10.1006/bbrc.2001.5839; Beljanski V, 2010, J PHARMACOL EXP THER, V333, P454, DOI 10.1124/jpet.109.163337; Bonapace L, 2010, J CLIN INVEST, V120, P1310, DOI 10.1172/JCI39987; Brech A, 2009, MOL ONCOL, V3, P366, DOI 10.1016/j.molonc.2009.05.007; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hu C, 2012, TOXICOL LETT, V210, P78, DOI 10.1016/j.toxlet.2012.01.019; Huang XL, 2010, CANCER LETT, V296, P123, DOI 10.1016/j.canlet.2010.04.002; Israel K, 2000, NUTR CANCER, V36, P90, DOI 10.1207/S15327914NC3601_13; Iwamaru A, 2007, ONCOGENE, V26, P1840, DOI 10.1038/sj.onc.1209992; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karim MR, 2010, BIOCHEM BIOPH RES CO, V394, P981, DOI 10.1016/j.bbrc.2010.03.103; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Liang CY, 2010, CURR OPIN CELL BIOL, V22, P226, DOI 10.1016/j.ceb.2009.11.003; Liang CY, 2012, ONCOL REP, V27, P1079, DOI 10.3892/or.2011.1593; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Mahoney E, 2013, AUTOPHAGY, V9, P434, DOI 10.4161/auto.23027; Mann SS, 1996, J NEUROSCI RES, V43, P535, DOI 10.1002/(SICI)1097-4547(19960301)43:5<535::AID-JNR3>3.0.CO;2-J; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Morselli E, 2009, BBA-MOL CELL RES, V1793, P1524, DOI 10.1016/j.bbamcr.2009.01.006; Neuzil J, 2001, FASEB J, V15, P403, DOI 10.1096/fj.00-0251com; Neuzil J, 2001, BRIT J CANCER, V84, P87, DOI 10.1054/bjoc.2000.1559; Neuzil J, 2007, MOL PHARMACOL, V71, P1185, DOI 10.1124/mol.106.030122; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Prasad KN, 2003, J AM COLL NUTR, V22, P108, DOI 10.1080/07315724.2003.10719283; PRASAD RN, 1987, IMMUNOL CELL BIOL, V65, P211, DOI 10.1038/icb.1987.23; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ren JH, 2010, CANCER BIOTHER RADIO, V25, P75, DOI 10.1089/cbr.2009.0701; SAHU SN, 1988, J AM COLL NUTR, V7, P285, DOI 10.1080/07315724.1988.10720245; Shi Z, 2013, CANCER LETT, V337, P149, DOI 10.1016/j.canlet.2013.06.004; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Turcotte S, 2008, CANCER CELL, V14, P90, DOI 10.1016/j.ccr.2008.06.004; Wang XF, 2006, MOL NUTR FOOD RES, V50, P675, DOI 10.1002/mnfr.200500267; Wu K, 2002, WORLD J GASTROENTERO, V8, P982, DOI 10.3748/wjg.v8.i6.982; Wu K, 2002, WORLD J GASTROENTERO, V8, P26, DOI 10.3748/wjg.v8.i1.26; Wu K, 2004, WORLD J GASTROENTERO, V10, P1110; Wu WKK, 2010, AUTOPHAGY, V6, P228, DOI 10.4161/auto.6.2.11042; Yang L, 2005, CANCER EPIDEM BIOMAR, V14, P243; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yin F, 2003, BIOSENS BIOELECTRON, V19, P297, DOI 10.1016/S0956-5663(03)00197-0; Yoshioka A, 2008, INT J ONCOL, V33, P461, DOI 10.3892/ijo_00000028; Yu WP, 1999, CANCER RES, V59, P953; Zhang XN, 2013, TOXICOL APPL PHARM, V270, P122, DOI 10.1016/j.taap.2013.04.011; Zhang XG, 2011, CANCER LETT, V307, P174, DOI 10.1016/j.canlet.2011.04.001; Zhang Y, 2002, P NATL ACAD SCI USA, V99, P7408, DOI 10.1073/pnas.102014399	58	12	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132829	10.1371/journal.pone.0132829	http://dx.doi.org/10.1371/journal.pone.0132829			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168048	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100086
J	Kittappa, S; Cui, MC; Ramalingam, M; Ibrahim, S; Khim, J; Yoon, Y; Snyder, SA; Jang, M				Kittappa, Shanmuga; Cui, Mingcan; Ramalingam, Malarvili; Ibrahim, Shaliza; Khim, Jeehyeong; Yoon, Yeomin; Snyder, Shane A.; Jang, Min			Synthesis Mechanism and Thermal Optimization of an Economical Mesoporous Material Using Silica: Implications for the Effective Removal or Delivery of Ibuprofen	PLOS ONE			English	Article							DRUG-DELIVERY; ACTIVATED CARBONS; PHARMACEUTICAL COMPOUNDS; SURFACE-CHEMISTRY; MOLECULAR-SIEVES; ADSORPTION; SBA-15; MCM-41; NANOPARTICLES; COPOLYMER	Mesoporous silica materials (MSMs) were synthesized economically using silica (SiO2) as a precursor via a modified alkaline fusion method. The MSM prepared at 500 degrees C (MSM-500) had the highest surface area, pore size, and volume, and the results of isotherms and the kinetics of ibuprofen (IBP) removal indicated that MSM-500 had the highest sorption capacity and fastest removal speed vs. SBA-15 and zeolite. Compared with commercial granular activated carbon (GAC), MSM-500 had a similar to 100 times higher sorption rate at neutral pH. IBP uptake by MSM-500 was thermodynamically favorable at room temperature, which was interpreted as indicating relatively weak bonding because the entropy (Delta(adsS), -0.07 J mol(-1) K-1) was much smaller. Five times recycling tests revealed that MSM-500 had 83-87% recovery efficiencies and slower uptake speeds due to slight deformation of the outer pore structure. In the IBP delivery test, MSM-500 drug loading was 41%, higher than the reported value of SBA-15 (31%). The in vitro release of IBP was faster, almost 100%, reaching equilibrium within a few hours, indicating its effective loading and unloading characteristics. A cost analysis study revealed that the MSM was similar to 10-70 times cheaper than any other mesoporous silica material for the removal or delivery of IBP.	[Kittappa, Shanmuga; Ibrahim, Shaliza; Jang, Min] Univ Malaya, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia; [Cui, Mingcan; Khim, Jeehyeong] Korea Univ, Sch Civil Environm & Architectural Engn, Seoul, South Korea; [Yoon, Yeomin] Univ S Carolina, Dept Civil & Environm Engn, Columbia, SC 29208 USA; [Snyder, Shane A.] Univ Arizona, Dept Chem & Environm Engn, Tucson, AZ USA; [Jang, Min] Univ Malaya, Nanotechnol & Catalysis Res Ctr NANOCAT, Kuala Lumpur, Malaysia	Universiti Malaya; Korea University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Arizona; Universiti Malaya	Jang, M (corresponding author), Univ Malaya, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia.	minjang@um.edu.my	Cui, Mingcan/K-2890-2013; Yoon, Yeomin/C-3331-2012; Ibrahim, Shaliza/A-5854-2010; Park, Jeonghyuk/AAE-3814-2020; Snyder, Shane A/AAE-8252-2021; Jang, Min/M-6690-2018; Snyder, Shane/A-3302-2011	Cui, Mingcan/0000-0001-9619-154X; Ibrahim, Shaliza/0000-0001-9413-957X; Jang, Min/0000-0003-2700-7256; Jang, Min/0000-0002-5900-0991; Snyder, Shane/0000-0003-2709-9840	Malaysian Government Ministry of Higher Education through the High Impact Research Grant [D000062-16001]; National Research Foundation of Korea (NRF) grant - Korea government (MEST) [KRF-2009-0092799]	Malaysian Government Ministry of Higher Education through the High Impact Research Grant; National Research Foundation of Korea (NRF) grant - Korea government (MEST)	This research was funded by the Malaysian Government Ministry of Higher Education through the High Impact Research Grant (D000062-16001), and partly supported by the Basic Science Research Program through a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST, No. KRF-2009-0092799). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khateeb LA, 2014, J IND ENG CHEM, V20, P916, DOI 10.1016/j.jiec.2013.06.023; Alyoshina NA, 2013, J SOLID STATE CHEM, V205, P211, DOI 10.1016/j.jssc.2013.03.044; Andersson J, 2004, CHEM MATER, V16, P4160, DOI 10.1021/cm0401490; Attia TMS, 2013, CHEMOSPHERE, V93, P2076, DOI 10.1016/j.chemosphere.2013.07.046; Babonneau F, 2003, MRS P; Baccar R, 2012, CHEM ENG J, V211, P310, DOI 10.1016/j.cej.2012.09.099; Bui TX, 2009, J HAZARD MATER, V168, P602, DOI 10.1016/j.jhazmat.2009.02.072; Doadrio AL, 2004, J CONTROL RELEASE, V97, P125, DOI 10.1016/j.jconrel.2004.03.005; Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013; Guedidi H, 2013, CARBON, V54, P432, DOI 10.1016/j.carbon.2012.11.059; Jaroniec M., 2006, ACCESS NANOPOROUS MA, V188, P255, DOI [10.1007/0-306-47066-7_17., DOI 10.1007/0-306-47066-7_17]; Kamarudin NHN, 2014, J COLLOID INTERF SCI, V421, P6, DOI 10.1016/j.jcis.2014.01.034; Katiyar A, 2006, J CHROMATOGR A, V1122, P13, DOI 10.1016/j.chroma.2006.04.055; Kim SS, 2001, CHEM COMMUN, P2418, DOI 10.1039/b107896h; Kim Y, 2014, CHEM ENG J, V256, P475, DOI 10.1016/j.cej.2014.06.100; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Kruk M, 1997, LANGMUIR, V13, P6267, DOI 10.1021/la970776m; Kwon M, 2015, CHEM ENG J, V269, P379, DOI 10.1016/j.cej.2015.01.125; Lim MH, 1999, CHEM MATER, V11, P3285, DOI 10.1021/cm990369r; Liu TH, 2013, J RADIOANAL NUCL CH, V297, P119, DOI 10.1007/s10967-012-2316-7; Liu Y, 2008, SEP PURIF TECHNOL, V61, P229, DOI 10.1016/j.seppur.2007.10.002; Margolese D, 2000, CHEM MATER, V12, P2448, DOI 10.1021/cm0010304; Mestre AS, 2007, CARBON, V45, P1979, DOI 10.1016/j.carbon.2007.06.005; Mestre AS, 2014, CHEM ENG J, V253, P408, DOI 10.1016/j.cej.2014.05.051; Mestre AS, 2009, BIORESOURCE TECHNOL, V100, P1720, DOI 10.1016/j.biortech.2008.09.039; Munoz B, 2003, CHEM MATER, V15, P500, DOI 10.1021/cm021217q; NAKASHIMA H, 1994, ARCH TOXICOL, V68, P277, DOI 10.1007/s002040050069; Neng NR, 2011, J CHROMATOGR A, V1218, P6263, DOI 10.1016/j.chroma.2011.07.025; Park J, 2012, J NANOMATER, V2012, DOI 10.1155/2012/528174; Reijenga JC, 1997, J CHROMATOGR A, V792, P371, DOI 10.1016/S0021-9673(97)00644-4; Sadecka J, 2001, J PHARMACEUT BIOMED, V25, P881, DOI 10.1016/S0731-7085(01)00374-0; Slowing II, 2007, ADV FUNCT MATER, V17, P1225, DOI 10.1002/adfm.200601191; Son SJ, 2006, J CONTROL RELEASE, V114, P143, DOI 10.1016/j.jconrel.2006.06.004; Song SW, 2005, LANGMUIR, V21, P9568, DOI 10.1021/la051167e; Thommes M, 2010, CHEM-ING-TECH, V82, P1059, DOI 10.1002/cite.201000064; Vallet-Regi M, 2001, CHEM MATER, V13, P308, DOI 10.1021/cm0011559; Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488; Walas S.M., 1985, PHASE EQUILIBRIA CHE, DOI 10.1016/C2013-0-04304-6; Wang XF, 2011, MICROPOR MESOPOR MAT, V142, P334, DOI 10.1016/j.micromeso.2010.12.018; Yang PP, 2007, INORG CHEM, V46, P3203, DOI 10.1021/ic0622959; Yang PP, 2012, CHEM SOC REV, V41, P3679, DOI 10.1039/c2cs15308d; Zhang L, 2013, SEP PURIF TECHNOL, V116, P145, DOI 10.1016/j.seppur.2013.05.036; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548; Zhao DY, 1998, J AM CHEM SOC, V120, P6024, DOI 10.1021/ja974025i; Zhao XS, 1997, J PHYS CHEM B, V101, P6525, DOI 10.1021/jp971366+; Zhu YF, 2005, MICROPOR MESOPOR MAT, V85, P75, DOI 10.1016/j.micromeso.2005.06.015	46	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130253	10.1371/journal.pone.0130253	http://dx.doi.org/10.1371/journal.pone.0130253			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161510	gold, Green Submitted, Green Published			2022-12-27	WOS:000358162300016
J	Pohjanen, VM; Koivurova, OP; Huhta, H; Helminen, O; Makinen, JM; Karhukorpi, JM; Joensuu, T; Koistinen, PO; Valtonen, JM; Niemela, SE; Karttunen, RA; Karttunen, TJ				Pohjanen, Vesa-Matti; Koivurova, Olli-Pekka; Huhta, Heikki; Helminen, Olli; Makinen, Johanna M.; Karhukorpi, Jari M.; Joensuu, Tapio; Koistinen, Pentti O.; Valtonen, Jarno M.; Niemela, Seppo E.; Karttunen, Riitta A.; Karttunen, Tuomo J.			Toll-Like Receptor 4 Wild Type Homozygozity of Polymorphisms+896 and+1196 Is Associated with High Gastrin Serum Levels and Peptic Ulcer Risk	PLOS ONE			English	Article							GENETIC POLYMORPHISMS; PRECANCEROUS LESIONS; TLR4; DISEASES; CANCER; PATHOGENESIS; SECRETION; CYTOKINE; GENOTYPE	Toll-like receptor 4 is a part of the innate immune system and recognizes Helicobacter pylori lipopolysaccharide. The goal of this study was to analyze the role of Toll-like receptor 4 polymorphisms +896 (rs4986790) and +1196 (rs4986791) in the pathogenesis of Helicobacter pylori related gastroduodenal diseases in relation to gastric secretion and inflammation. Toll-like receptor 4 polymorphisms, serum gastrin-17 and pepsinogen I and II concentrations were determined, and gastroscopies with histopathological analyses were performed to 216 dyspeptic patients. As genotype controls, 179 controls and 61 gastric cancer patients were studied. In our study, the Toll-like receptor 4 +896 and +1196 polymorphisms were in total linkage disequilibrium. The homozygous wild types displayed higher gastrin-17 serum concentrations than the mutants (p = 0.001) and this effect was independent of Helicobacter pylori. The homozygous wild types also displayed an increased risk for peptic ulcers (OR: 4.390). Toll-like receptor 4 genotypes did not show any association with Helicobacter pylori positivity or the features of gastric inflammation. Toll-like receptor 4 expression was seen in gastrin and somatostatin expressing cells of antral mucosa by immunohistochemistry. Our results suggest a role for Toll-like receptor 4 in gastric acid regulation and that the Toll-like receptor 4 +896 and +1196 wild type homozygozity increases peptic ulcer risk via gastrin secretion.	[Pohjanen, Vesa-Matti; Huhta, Heikki; Helminen, Olli; Makinen, Johanna M.; Joensuu, Tapio; Karttunen, Tuomo J.] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Pohjanen, Vesa-Matti; Huhta, Heikki; Helminen, Olli; Makinen, Johanna M.; Joensuu, Tapio; Karttunen, Tuomo J.] Univ Oulu, Oulu, Finland; [Koivurova, Olli-Pekka; Niemela, Seppo E.] Oulu Univ Hosp, Dept Internal Med, Oulu, Finland; [Karhukorpi, Jari M.; Karttunen, Riitta A.] Univ Oulu, Inst Diagnost, Dept Med Microbiol & Immunol, Oulu, Finland; [Karhukorpi, Jari M.] Eastern Finland Lab Ctr Joint Author Enterprise I, Joensuu, Finland; [Joensuu, Tapio] Pietarsaari City Hosp, Dept Internal Med, Pietarsaari, Finland; [Koistinen, Pentti O.; Valtonen, Jarno M.] Oulu City Hosp, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu	Karttunen, TJ (corresponding author), Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.	tuomo.karttunen@oulu.fi	Helminen, Olli/AGO-2713-2022	Karttunen, Tuomo/0000-0002-8843-7957; Helminen, Olli/0000-0001-9544-6475; Pohjanen, Vesa-Matti/0000-0002-4129-4346; Huhta, Heikki/0000-0002-6273-198X				Achyut BR, 2007, HUM IMMUNOL, V68, P901, DOI 10.1016/j.humimm.2007.10.006; Bagheri N, 2014, CLIN RES HEPATOL GAS, V38, P366, DOI 10.1016/j.clinre.2013.12.004; Chen J, 2013, CANCER BIOTHER RADIO, V28, P674, DOI 10.1089/cbr.2012.1395; Chu SJ, 2013, CURR OPIN GASTROEN, V29, P636, DOI 10.1097/MOG.0b013e328365efc7; Eiro N, 2012, DIGEST DIS SCI, V57, P2278, DOI 10.1007/s10620-012-2184-6; El-Omar EM, 2008, ONCOGENE, V27, P244, DOI 10.1038/sj.onc.1210912; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Fukui T, 2006, GUT, V55, P607, DOI 10.1136/gut.2005.077917; Hofner P, 2007, HELICOBACTER, V12, P124, DOI 10.1111/j.1523-5378.2007.00481.x; Karhukorpi J, 2000, EUR J CLIN MICROBIOL, V19, P790, DOI 10.1007/s100960000366; Kato I, 2007, DIGEST DIS SCI, V52, P254, DOI 10.1007/s10620-006-9303-1; Kidd M, 2009, GASTROENTEROLOGY, V137, P231, DOI 10.1053/j.gastro.2009.01.005; Koivurova OP, 2003, SCAND J GASTROENTERO, V38, P1217, DOI 10.1080/00365520310006504; Koskela RM, 2011, SCAND J GASTROENTERO, V46, P567, DOI 10.3109/00365521.2011.551889; Kutikhin AG, 2011, HUM IMMUNOL, V72, P193, DOI 10.1016/j.humimm.2010.11.003; Lorenz E, 2001, BIOTECHNIQUES, V31, P22, DOI 10.2144/01311bm01; McColl KEL, 2000, BEST PRACT RES CL GA, V14, P13, DOI 10.1053/bega.1999.0056; MISIEWICZ JJ, 1991, J GASTROEN HEPATOL, V6, P207, DOI 10.1111/j.1440-1746.1991.tb01467.x; Murphy G, 2009, EUR J GASTROEN HEPAT, V21, P630, DOI 10.1097/MEG.0b013e3283140eea; Peri F, 2013, J MED CHEM REFERENCE; Pohjanen VM, 2013, GENE CHROMOSOME CANC, V52, P976, DOI 10.1002/gcc.22093; Rigoli L, 2010, ANTICANCER RES, V30, P513; Schmausser B, 2004, CLIN EXP IMMUNOL, V136, P521, DOI 10.1111/j.1365-2249.2004.02464.x; Trejo-de la O A, 2008, CLIN IMMUNOL, V129, P333, DOI 10.1016/j.clim.2008.07.009; Wallace JL, 2012, BRIT J PHARMACOL, V165, P67, DOI 10.1111/j.1476-5381.2011.01509.x; Zavros Y, 2005, BIOCHEM PHARMACOL, V69, P365, DOI 10.1016/j.bcp.2004.07.043	26	11	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131553	10.1371/journal.pone.0131553	http://dx.doi.org/10.1371/journal.pone.0131553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161647	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300047
J	Qi, Y; Zhang, F; Zhang, L; Harrison, TJ; Huang, WJ; Zhao, CY; Kong, W; Jiang, CL; Wang, YC				Qi, Ying; Zhang, Feng; Zhang, Li; Harrison, Tim J.; Huang, Weijin; Zhao, Chenyan; Kong, Wei; Jiang, Chunlai; Wang, Youchun			Hepatitis E Virus Produced from Cell Culture Has a Lipid Envelope	PLOS ONE			English	Article							ORF3 PROTEIN; CAPSID PROTEIN; IN-VITRO; HEV; EXPRESSION; PARTICLES; GLYCOSYLATION; HEPATOMA; REVEALS; RELEASE	The absence of a productive cell culture system hampered detailed analysis of the structure and protein composition of the hepatitis E virion. In this study, hepatitis E virus from a robust HEV cell culture system and from the feces of infected monkeys at the peak of virus excretion was purified by ultra-centrifugation. The common feature of the two samples after ultracentrifugation was that the ORF2 protein mainly remained in the top fractions. The ORF2 protein from cell culture system was glycosylated, with an apparent molecular weight of 88 kDa, and was not infectious in PLC/PRF/5 cells. The ORF2 protein in this fraction can bind to and protect HEV RNA from digestion by RNase A. The RNA-ORF2 product has a similar sedimentation coefficient to the virus from feces. The viral RNA in the cell culture supernatant was mainly in the fraction of 1.15g/cm(3) but that from the feces was mainly in the fraction of 1.21 g/cm(3). Both were infectious in PLC/PRF/5 cells. And the fraction in the middle of the gradient (1.06g/cm3) from the cell culture supernatant, but not that from the feces, also has ORF2 protein and HEV RNA but was not infectious in PLC/PRF/5. The infectious RNA-rich fraction from the cell culture contained ORF3 protein and lipid but the corresponding fraction from feces had no lipid and little ORF3 protein. The lipid on the surface of the virus has no effect on its binding to cells but the ORF3 protein interferes with binding. The result suggests that most of the secreted ORF2 protein is not associated with HEV RNA and that hepatitis E virus produced in cell culture differs in structure from the virus found in feces in that it has a lipid envelope.	[Qi, Ying; Kong, Wei; Jiang, Chunlai] Jilin Univ, Natl Engn Lab AIDS Vaccine, Changchun 130012, Peoples R China; [Qi, Ying; Zhang, Feng; Zhang, Li; Huang, Weijin; Zhao, Chenyan; Wang, Youchun] Natl Inst Food & Drug Control, Div HIV AIDS & Sexually Transmitted Virus Vaccine, Beijing 100050, Peoples R China; [Harrison, Tim J.] UCL, Sch Med, Div Med, London WC1E 6BT, England	Jilin University; National Institute of Food & Drug Control - China; University of London; University College London; UCL Medical School	Wang, YC (corresponding author), Natl Inst Food & Drug Control, Div HIV AIDS & Sexually Transmitted Virus Vaccine, Beijing 100050, Peoples R China.	wangyc@nifdc.org.cn	huang, weijin/AAY-5028-2020	huang, weijin/0000-0002-4246-8889	National Natural Science Foundation of China [81171549]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant: 81171549). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2009, J GASTROEN HEPATOL, V24, P1484, DOI 10.1111/j.1440-1746.2009.05933.x; Agrawal S, 2001, VIROLOGY, V282, P87, DOI 10.1006/viro.2000.0819; Emerson SU, 2006, J VIROL, V80, P10457, DOI 10.1128/JVI.00892-06; Emerson SU, 2010, J VIROL, V84, P9059, DOI 10.1128/JVI.00593-10; Feng ZD, 2014, TRENDS MICROBIOL, V22, P59, DOI 10.1016/j.tim.2013.10.005; Graff J, 2008, J VIROL, V82, P1185, DOI 10.1128/JVI.01219-07; Graff J, 2006, J VIROL, V80, P5919, DOI 10.1128/JVI.00046-06; Jameel S, 1996, J VIROL, V70, P207, DOI 10.1128/JVI.70.1.207-216.1996; Khudyakov YE, 1999, J CLIN MICROBIOL, V37, P2863, DOI 10.1128/JCM.37.9.2863-2871.1999; Li TC, 1997, J VIROL, V71, P7207, DOI 10.1128/JVI.71.10.7207-7213.1997; Ma HX, 2011, J MED VIROL, V83, P827, DOI 10.1002/jmv.22032; Ma HX, 2009, J MED VIROL, V81, P1052, DOI 10.1002/jmv.21484; Meng XJ, 2013, SEMIN LIVER DIS, V33, P41, DOI 10.1055/s-0033-1338113; Parvez MK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-159; Robinson RA, 1998, PROTEIN EXPRES PURIF, V12, P75, DOI 10.1006/prep.1997.0817; Shiota T, 2013, J VIROL, V87, P6031, DOI 10.1128/JVI.00444-13; Smith JL, 2001, J FOOD PROTECT, V64, P572, DOI 10.4315/0362-028X-64.4.572; Takahashi M, 2008, ARCH VIROL, V153, P1703, DOI 10.1007/s00705-008-0179-6; Takahashi M, 2010, J CLIN MICROBIOL, V48, P1112, DOI 10.1128/JCM.02002-09; Torresi J, 1997, J VIROL METHODS, V69, P81, DOI 10.1016/S0166-0934(97)00142-0; Torresi J, 1999, J GEN VIROL, V80, P1185, DOI 10.1099/0022-1317-80-5-1185; Touze A, 1998, NUCLEIC ACIDS RES, V26, P1317, DOI 10.1093/nar/26.5.1317; Wang YC, 2000, J GEN VIROL, V81, P1675, DOI 10.1099/0022-1317-81-7-1675; Xing L, 2010, J BIOL CHEM, V285, P33175, DOI 10.1074/jbc.M110.106336; Yamada K, 2009, J GEN VIROL, V90, P1880, DOI 10.1099/vir.0.010561-0; Zafrullah M, 1999, J VIROL, V73, P4074, DOI 10.1128/JVI.73.5.4074-4082.1999; Zhang F, 2006, J MED VIROL, V78, P1441, DOI 10.1002/jmv.20717; Zhao CY, 2007, J MED VIROL, V79, P1966, DOI 10.1002/jmv.21040	28	36	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132503	10.1371/journal.pone.0132503	http://dx.doi.org/10.1371/journal.pone.0132503			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161670	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300143
J	Schofield, PW; Malacova, E; Preen, DB; D'Este, C; Tate, R; Reekie, J; Wand, H; Butler, T				Schofield, Peter W.; Malacova, Eva; Preen, David B.; D'Este, Catherine; Tate, Robyn; Reekie, Joanne; Wand, Handan; Butler, Tony			Does Traumatic Brain Injury Lead to Criminality? A Whole-Population Retrospective Cohort Study Using Linked Data	PLOS ONE			English	Article							HEAD-INJURY; PSYCHIATRIC-ILLNESS; AFGHANISTAN; DISORDERS; PRISONERS; IRAQ; TBI	Background Traumatic brain injury (TBI) may be a risk factor for criminal behaviour however multiple factors potentially confound the association. Methods Record linkage and Cox proportional hazards regression analyses were used to examine the association between hospital-recorded TBI (n = 7,694) and subsequent first criminal conviction in a retrospective cohort matched 1: 3 with 22,905 unaffected community controls and full-sibling controls (n = 2,397). Aboriginality, substance abuse, social disadvantage, and mental illness were included in analyses as potential confounders Results In multivariable models, relative to general population controls, TBI was associated with any conviction (males: Hazard Ratio (HR) = 1.58 (95% CI 1.46 to 1.72); females: HR = 1.52 (95% CI 1.28 to 1.81)); and similar Hazard Ratios were obtained for the sibling analyses in males (HR = 1.68 (95% CI 1.31-2.18)) and females (HR 1.27 (95% CI 0.71-2.29)). TBI was also associated with violent convictions relative to the general population, (males: HR = 1.65 (95% CI 1.42 to 1.92); females HR = 1.73 (95% CI 1.21 to 2.47)), and in analyses with sibling controls in men (HR = 1.89 (95% CI 1.20-3.00)), but not in women (HR 0.73, 95% CI 0.29-1.81)). Conclusion The results support a modest causal link between TBI and criminality after comprehensive adjustment for confounding. Reducing the rate of TBI, a major public health imperative, might have benefits in terms of crime reduction.	[Schofield, Peter W.] Hunter New England Local Hlth Dist, Neuropsychiat Serv, Newcastle, NSW, Australia; [Schofield, Peter W.] Univ Newcastle, Ctr Translat Neurosci & Mental Hlth, Newcastle, NSW 2300, Australia; [Malacova, Eva; Preen, David B.] Univ Western Australia, Sch Populat Hlth, Ctr Hlth Serv Res, Perth, WA 6009, Australia; [D'Este, Catherine] Australian Natl Univ, Natl Ctr Epidemiol & Publ Hlth, Canberra, ACT, Australia; [Tate, Robyn] Univ Sydney, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Reekie, Joanne; Wand, Handan; Butler, Tony] UNSW Australia, Kirby Inst, Sydney, NSW, Australia	University of Newcastle; University of Western Australia; Australian National University; University of Sydney; University of New South Wales Sydney; Kirby Institute	Schofield, PW (corresponding author), Hunter New England Local Hlth Dist, Neuropsychiat Serv, Newcastle, NSW, Australia.	peter.schofield@hnehealth.nsw.gov.au	; Preen, David/H-5663-2014	Butler, Tony/0000-0002-2679-2769; Schofield, Peter/0000-0001-8298-8590; Preen, David/0000-0002-2982-2169	National Health and Medical Research Council [533504]; MRC [MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1] Funding Source: researchfish	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was supplied by the National Health and Medical Research Council (grant # 533504) to TB, PWS, RT, DBP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, AUSTR VERS INT CLASS, V1; [Anonymous], 2010, INT STAT CLASS DIS R; Australian Bureau of Statistics, 2006, SOC IND AR SEIFA TEC; BIJUR PE, 1990, PEDIATRICS, V86, P337; Briffa TG, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-111; Caspi A, 1996, ARCH GEN PSYCHIAT, V53, P1033; Cobb BK, 1995, J ADOLESCENT HEALTH, V17, P381, DOI 10.1016/1054-139X(95)00059-2; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Elbogen EB, 2012, J CONSULT CLIN PSYCH, V80, P1097, DOI 10.1037/a0029967; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Frisell T, 2012, BEHAV GENET, V42, P3, DOI 10.1007/s10519-011-9483-0; Hodgins S, 1996, ARCH GEN PSYCHIAT, V53, P489, DOI 10.1001/archpsyc.1996.01830060031004; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Institute for Digital Research and Education, INTR TO SAS; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Kelman CW, 2002, AUST NZ J PUBL HEAL, V26, P251, DOI 10.1111/j.1467-842X.2002.tb00682.x; Lahey BB, 2010, CURR DIR PSYCHOL SCI, V19, P319, DOI 10.1177/0963721410383977; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mayhew P, 2003, TRENDS ISS CRIME CRI, V247, P1; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Mulder E, 2011, INT J OFFENDER THER, V55, P118, DOI 10.1177/0306624X09356683; Preen D, 2003, AUST EPIDEMIOL, V10, P24; Rowe DC, 1997, CRIMINOLOGY, V35, P177, DOI 10.1111/j.1745-9125.1997.tb00874.x; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Sourander A, 2011, SOC PSYCH PSYCH EPID, V46, P1211, DOI 10.1007/s00127-010-0292-1; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017	37	38	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132558	10.1371/journal.pone.0132558	http://dx.doi.org/10.1371/journal.pone.0132558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26172545	Green Published, gold			2022-12-27	WOS:000358194900058
J	Sigdel, S; Singh, R; Kim, TS; Li, J; Kim, SY; Kim, IW; Jung, WS; Pan, CH; Kang, YC; Lee, JK				Sigdel, Sujan; Singh, Ranjitha; Kim, Tae-Su; Li, Jinglin; Kim, Sang-Yong; Kim, In-Won; Jung, Woo-Suk; Pan, Cheol-Ho; Kang, Yun Chan; Lee, Jung-Kul			Characterization of a Mannose-6-Phosphate Isomerase from Bacillus amyloliquefaciens and Its Application in Fructose-6-Phosphate Production	PLOS ONE			English	Article							D-FRUCTOSE 6-PHOSPHATE; L-ARABINOSE ISOMERASE; PHOSPHOMANNOSE ISOMERASE; CLONING; SUBSTRATE; BINDING; BIOSYNTHESIS; SEQUENCE; ENZYMES; LACCASE	The BaM6PI gene encoding a mannose-6-phosphate isomerase (M6PI, EC 5.3.1.8) was cloned from Bacillus amyloliquefaciens DSM7 and overexpressed in Escherichia coli. The enzyme activity of BaM6PI was optimal at pH and temperature of 7.5 and 70 degrees C, respectively, with a k(cat)/K-m of 13,900 s(-1) mM(-1) for mannose-6-phosphate (M6P). The purified BaM6PI demonstrated the highest catalytic efficiency of all characterized M6PIs. Although M6PIs have been characterized from several other sources, BaM6PI is distinguished from other M6PIs by its wide pH range and high catalytic efficiency for M6P. The binding orientation of the substrate M6P in the active site of BaM6PI shed light on the molecular basis of its unusually high activity. BaM6PI showed 97% substrate conversion from M6P to fructose-6-phosphate demonstrating the potential for using BaM6PI in industrial applications.	[Sigdel, Sujan; Singh, Ranjitha; Kim, Tae-Su; Li, Jinglin; Kim, In-Won; Lee, Jung-Kul] Konkuk Univ, Dept Chem Engn, Seoul 143701, South Korea; [Kim, Sang-Yong] BioNgene Co Ltd, Seoul 110521, South Korea; [Jung, Woo-Suk; Pan, Cheol-Ho] Korea Inst Sci & Technol, Gangneung Inst, Funct Food Ctr, Kangnung 210340, South Korea; [Kang, Yun Chan] Korea Univ, Dept Mat Sci & Engn, Seoul 136713, South Korea	Konkuk University; Korea Institute of Science & Technology (KIST); Korea University	Kang, YC (corresponding author), Korea Univ, Dept Mat Sci & Engn, Seoul 136713, South Korea.	yckang@korea.ac.kr; jkrhee@konkuk.ac.kr	Lee, Jungkukl/D-9104-2011; Ramakrishnan, Ranjitha/K-7554-2019; Ramakrishnan, Ranjitha/D-9087-2011; Kang, Yun Chan/H-2457-2015	Ramakrishnan, Ranjitha/0000-0001-9697-9070; Ramakrishnan, Ranjitha/0000-0001-9697-9070; Kang, Yun Chan/0000-0001-5769-5761	Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP), from the Ministry of Trade, Industry & Energy, Republic of Korea [201320200000420]; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT and Future Planning, Republic of Korea [2011-0031955]	Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP), from the Ministry of Trade, Industry & Energy, Republic of Korea; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT and Future Planning, Republic of Korea	This work was supported by the Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP), granted financial resources from the Ministry of Trade, Industry & Energy, Republic of Korea (201320200000420). This research was also supported by a grant from the Intelligent Synthetic Biology Center of Global Frontier Project (2011-0031955) funded by the Ministry of Science, ICT and Future Planning, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerens K, 2012, J IND MICROBIOL BIOT, V39, P823, DOI 10.1007/s10295-012-1089-x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cleasby A, 1996, NAT STRUCT BIOL, V3, P470, DOI 10.1038/nsb0596-470; COLLINS LV, 1991, GENE, V103, P135, DOI 10.1016/0378-1119(91)90406-2; DISCHE Z, 1951, J BIOL CHEM, V192, P583; Fessner WD, 2012, CATAL SCI TECHNOL, V2, P1596, DOI 10.1039/c2cy20092a; Helanto M, 2007, APPL ENVIRON MICROB, V73, P7083, DOI 10.1128/AEM.01180-07; HICKS KB, 1980, CARBOHYD RES, V82, P393, DOI 10.1016/S0008-6215(00)85716-X; Izumori K, 2002, NATURWISSENSCHAFTEN, V89, P120, DOI 10.1007/s00114-002-0297-z; Jensen SO, 1998, BBA-PROTEIN STRUCT M, V1382, P5, DOI 10.1016/S0167-4838(97)00122-2; Kalam Y, 2012, CLIN TOXICOL, V50, P546, DOI 10.3109/15563650.2012.705847; Kim JH, 2010, APPL MICROBIOL BIOT, V85, P1839, DOI 10.1007/s00253-009-2210-6; Kim NH, 2008, APPL ENVIRON MICROB, V74, P3008, DOI 10.1128/AEM.00249-08; Kim TS, 2015, J MICROBIOL BIOTECHN, V25, P1093, DOI 10.4014/jmb.1503.03023; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee KM, 2012, BIORESOURCE TECHNOL, V123, P636, DOI 10.1016/j.biortech.2012.07.066; Lee SY, 2012, J MICROBIOL BIOTECHN, V22, P571, DOI 10.4014/jmb.1110.10010; Li YJ, 2011, EXTREMOPHILES, V15, P441, DOI 10.1007/s00792-011-0375-2; Marangos P J, 1998, Expert Opin Investig Drugs, V7, P615, DOI 10.1517/13543784.7.4.615; MELDAL M, 1992, CARBOHYD RES, V235, P115, DOI 10.1016/0008-6215(92)80082-C; MILES JS, 1984, NUCLEIC ACIDS RES, V12, P3631, DOI 10.1093/nar/12.8.3631; Narasaki CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025514; Pascual C, 1981, FOLIA MICROBIOL PRAH, V26, P103; Patel SKS, 2014, J MICROBIOL BIOTECHN, V24, P639, DOI 10.4014/jmb.1401.01025; PAYTON MA, 1991, J BACTERIOL, V173, P2006, DOI 10.1128/jb.173.6.2006-2010.1991; Prabhu P, 2008, APPL MICROBIOL BIOT, V81, P283, DOI 10.1007/s00253-008-1652-6; Prabhu P, 2014, FEBS J, V281, P3446, DOI 10.1111/febs.12872; Prabhu P, 2011, APPL MICROBIOL BIOT, V89, P635, DOI 10.1007/s00253-010-2844-4; PROUDFOOT AEI, 1994, EUR J BIOCHEM, V219, P415, DOI 10.1111/j.1432-1033.1994.tb19954.x; Ramachandran P, 2012, PROCESS BIOCHEM, V47, P99, DOI 10.1016/j.procbio.2011.10.015; Roux C, 2011, PROTEINS, V79, P203, DOI 10.1002/prot.22873; Sagurthi SR, 2009, ACTA CRYSTALLOGR D, V65, P724, DOI 10.1107/S0907444909013328; Salonen N, 2013, BIOPROC BIOSYST ENG, V36, P489, DOI 10.1007/s00449-012-0805-2; Sanchez-Moreno I, 2012, ADV SYNTH CATAL, V354, P1725, DOI 10.1002/adsc.201200150; Singh RK, 2013, APPL MICROBIOL BIOT, V97, P7205, DOI 10.1007/s00253-012-4577-z; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; Tiwari M, 2010, J MOL GRAPH MODEL, V28, P707, DOI 10.1016/j.jmgm.2010.01.004; Tiwari MK, 2012, J BIOL CHEM, V287, P19429, DOI 10.1074/jbc.M111.335752; VALLEE BL, 1984, ADV ENZYMOL RAMB, V56, P283; WELLS TNC, 1993, BIOCHEMISTRY-US, V32, P1294, DOI 10.1021/bi00056a014; Widjaja A, 1999, J BIOSCI BIOENG, V87, P611, DOI 10.1016/S1389-1723(99)80123-6; Wu BY, 2002, FEBS LETT, V519, P87, DOI 10.1016/S0014-5793(02)02717-5; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yeom SJ, 2011, BIOCHIMIE, V93, P1659, DOI 10.1016/j.biochi.2011.05.040; Yeom SJ, 2009, APPL ENVIRON MICROB, V75, P4705, DOI 10.1128/AEM.00310-09; Zhang YW, 2012, ENZYME MICROB TECH, V50, P255, DOI 10.1016/j.enzmictec.2012.01.009; Zhang YW, 2010, APPL MICROBIOL BIOT, V87, P1993, DOI 10.1007/s00253-010-2600-9	48	12	12	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131585	10.1371/journal.pone.0131585	http://dx.doi.org/10.1371/journal.pone.0131585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171785	gold, Green Published, Green Submitted			2022-12-27	WOS:000358194900018
J	van Uitert, M; Moerland, PD; Enquobahrie, DA; Laivuori, H; van der Post, JAM; Ris-Stalpers, C; Afink, GB				van Uitert, Miranda; Moerland, Perry D.; Enquobahrie, Daniel A.; Laivuori, Hannele; van der Post, Joris A. M.; Ris-Stalpers, Carrie; Afink, Gijs B.			Meta-Analysis of Placental Transcriptome Data Identifies a Novel Molecular Pathway Related to Preeclampsia	PLOS ONE			English	Article							RUBINSTEIN-TAYBI-SYNDROME; GENE-EXPRESSION; MICROARRAY ANALYSIS; GROWTH; PREGNANCIES; HYPOXIA; RECRUITMENT; ACTIVATION; MUTATIONS; CBP/P300	Studies using the placental transcriptome to identify key molecules relevant for preeclampsia are hampered by a relatively small sample size. In addition, they use a variety of bioinformatics and statistical methods, making comparison of findings challenging. To generate a more robust preeclampsia gene expression signature, we performed a meta-analysis on the original data of 11 placenta RNA microarray experiments, representing 139 normotensive and 116 preeclamptic pregnancies. Microarray data were pre-processed and analyzed using standardized bioinformatics and statistical procedures and the effect sizes were combined using an inverse-variance random-effects model. Interactions between genes in the resulting gene expression signature were identified by pathway analysis (Ingenuity Pathway Analysis, Gene Set Enrichment Analysis, Graphite) and protein-protein associations (STRING). This approach has resulted in a comprehensive list of differentially expressed genes that led to a 388-gene meta-signature of preeclamptic placenta. Pathway analysis highlights the involvement of the previously identified hypoxia/HIF1A pathway in the establishment of the preeclamptic gene expression profile, while analysis of protein interaction networks indicates CREBBP/EP300 as a novel element central to the preeclamptic placental transcriptome. In addition, there is an apparent high incidence of preeclampsia in women carrying a child with a mutation in CREBBP/EP300 (Rubinstein-Taybi Syndrome). The 388-gene preeclampsia meta-signature offers a vital starting point for further studies into the relevance of these genes (in particular CREBBP/EP300) and their concomitant pathways as biomarkers or functional molecules in preeclampsia. This will result in a better understanding of the molecular basis of this disease and opens up the opportunity to develop rational therapies targeting the placental dysfunction causal to preeclampsia.	[van Uitert, Miranda; Ris-Stalpers, Carrie; Afink, Gijs B.] Univ Amsterdam, Acad Med Ctr, Reprod Biol Lab, NL-1105 AZ Amsterdam, Netherlands; [Moerland, Perry D.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, NL-1105 AZ Amsterdam, Netherlands; [Enquobahrie, Daniel A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Laivuori, Hannele] Univ Helsinki, Med Genet & Obstet & Gynaecol, FIN-00014 Helsinki, Finland; [Laivuori, Hannele] Univ Helsinki, Inst Mol Med Finland, FIN-00014 Helsinki, Finland; [Laivuori, Hannele] Univ Helsinki Hosp, Helsinki, Finland; [van der Post, Joris A. M.; Ris-Stalpers, Carrie] Univ Amsterdam, Acad Med Ctr, Womens & Childrens Clin, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Washington; University of Washington Seattle; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Afink, GB (corresponding author), Univ Amsterdam, Acad Med Ctr, Reprod Biol Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	g.b.afink@amc.uva.nl	Moerland, Perry/AAG-1425-2020; van der Post, Joris A M/A-8991-2008; Afink, Gijs/AAB-2832-2021; Afink, Gijs/A-2025-2009; Laivuori, Hannele/F-2953-2011	Moerland, Perry/0000-0002-2357-3659; Afink, Gijs/0000-0002-2155-725X; Laivuori, Hannele/0000-0003-3212-7826; van der Post, Joris/0000-0003-3311-2116	Swedish Research Council; Academy of Finland; Sigrid Juselius Foundation; Finnish Medical Foundation; Helsinki University Central Hospital Research Funds; Helsinki University Research Funds; Paivikki and Sakari Sohlberg Foundation; Uusimaa Regional Fund of the Finnish Cultural Foundation; National Iinstitute of Health [R01HD32562, R01HD055566, K01HL103174]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055566] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032562] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL103174] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Medical Foundation; Helsinki University Central Hospital Research Funds; Helsinki University Research Funds; Paivikki and Sakari Sohlberg Foundation; Uusimaa Regional Fund of the Finnish Cultural Foundation; National Iinstitute of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study has been supported by funds from the Swedish Research Council (www.vr.se), Academy of Finland (http://www.aka.fi), Sigrid Juselius Foundation (http://www.sigridjuselius.fi), Finnish Medical Foundation (http://www.laaketieteensaatio.fi), Helsinki University Central Hospital Research Funds (http://www.med.helsinki.fi), Helsinki University Research Funds (http://www.helsinki.fi), Paivikki and Sakari Sohlberg Foundation (http://www.pss-saatio.fi) and Uusimaa Regional Fund of the Finnish Cultural Foundation (www.skr.fi) (H.L.); National Iinstitute of Health (www.nih.gov) grants R01HD32562, R01HD055566, and K01HL103174 (D.A.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahr A, 2006, Zentralbl Gynakol, V128, P138, DOI 10.1055/s-2006-933377; Andraweera PH, 2012, HUM REPROD UPDATE, V18, P436, DOI 10.1093/humupd/dms011; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bartholdi D, 2007, J MED GENET, V44, P327, DOI 10.1136/jmg.2006.046698; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Centlow M, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/472354; Chigusa Y, 2012, J CLIN ENDOCR METAB, V97, pE1862, DOI 10.1210/jc.2012-1268; Enquobahrie DA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.020; Foley P, 2009, AM J MED GENET A, V149A, P997, DOI 10.1002/ajmg.a.32771; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Guller S, 2008, LAB INVEST, V88, P1057, DOI 10.1038/labinvest.2008.74; Hahn S, 2011, PLACENTA, V32, pS17, DOI 10.1016/j.placenta.2010.06.018; Hennekam RCM, 2006, EUR J HUM GENET, V14, P981, DOI 10.1038/sj.ejhg.5201594; Henson MC, 2006, BIOL REPROD, V74, P218, DOI 10.1095/biolreprod.105.045120; Hoegh AM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/787545; Jarvenpaa J, 2009, J PERINAT MED, V37, P257, DOI 10.1515/JPM.2009.046; Jebbink JM, 2015, PLACENTA, V36, P160, DOI 10.1016/j.placenta.2014.12.001; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kang JH, 2011, J HYPERTENS, V29, P928, DOI 10.1097/HJH.0b013e328344a82c; Kivinen K, 2007, EUR J HUM GENET, V15, P494, DOI 10.1038/sj.ejhg.5201788; Kleinrouweler CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068991; Kweider N, 2014, ANN ANAT, V196, P268, DOI 10.1016/j.aanat.2014.04.002; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee GSR, 2010, ARCH GYNECOL OBSTET, V282, P363, DOI 10.1007/s00404-009-1222-x; Liu YX, 2008, MOL MED, V14, P561, DOI 10.2119/2008-00009.Liu; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; Meng T, 2012, OMICS, V16, P301, DOI 10.1089/omi.2011.0066; Mikheev AM, 2008, REPROD SCI, V15, P866, DOI 10.1177/1933719108322425; Moslehi R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02407; Myatt L, 2014, HYPERTENSION, V63, P1293, DOI 10.1161/HYPERTENSIONAHA.113.02664; Negri G, 2015, CLIN GENET, V87, P148, DOI 10.1111/cge.12348; Nishizawa H, 2007, PLACENTA, V28, P487, DOI 10.1016/j.placenta.2006.05.010; Nishizawa H, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-107; Parsley L, 2011, AM J MED GENET A, V155A, P2766, DOI 10.1002/ajmg.a.34227; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Redman CW, 2014, PLACENTA, V35, pS20, DOI 10.1016/j.placenta.2013.12.008; Roelfsema Jeroen H., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000415; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Sales G, 2013, NUCLEIC ACIDS RES, V41, pW89, DOI 10.1093/nar/gkt386; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tal R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102723; Tsai ACH, 2011, EUR J HUM GENET, V19, P43, DOI 10.1038/ejhg.2010.121; Tsai S, 2011, PLACENTA, V32, P175, DOI 10.1016/j.placenta.2010.11.014; Vaiman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065498; Varkonyi T, 2011, PLACENTA, V32, pS21, DOI 10.1016/j.placenta.2010.04.014; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wang F, 2013, CELL MOL LIFE SCI, V70, P3989, DOI 10.1007/s00018-012-1254-4; Wieczorek D, 2009, AM J MED GENET A, V149A, P2849, DOI 10.1002/ajmg.a.33129; Winn VD, 2009, ENDOCRINOLOGY, V150, P452, DOI 10.1210/en.2008-0990; Zhou RR, 2006, GYNECOL OBSTET INVES, V62, P108, DOI 10.1159/000092857	56	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132468	10.1371/journal.pone.0132468	http://dx.doi.org/10.1371/journal.pone.0132468			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171964	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900052
J	Wiedmann, RT; Nonneman, DJ; Rohrer, GA				Wiedmann, Ralph T.; Nonneman, Dan J.; Rohrer, Gary A.			Genome-Wide Copy Number Variations Using SNP Genotyping in a Mixed Breed Swine Population	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; DOMESTIC PIG; VARIANTS; IDENTIFICATION; EXPRESSION; DISEASE	Copy number variations (CNVs) are increasingly understood to affect phenotypic variation. This study uses SNP genotyping of trios of mixed breed swine to add to the catalog of known genotypic variation in an important agricultural animal. PorcineSNP60 BeadChip genotypes were collected from 1802 pigs that combined to form 1621 trios. These trios were from the crosses of 50 boars with 525 sows producing 1621 piglets. The pigs were part of a population that was a mix of 1/4 Duroc, 1/2 Landrace and 1/4 Yorkshire breeds. Merging the overlapping CNVs that were observed in two or more individuals to form CNV regions (CNVRs) yielded 502 CNVRs across the autosomes. The CNVRs intersected genes, as defined by RefSeq, 84% of the time - 420 out of 502. The results of this study are compared and contrasted to other swine studies using similar and different methods of detecting CNVR. While progress is being made in this field, more work needs to be done to improve consistency and confidence in CNVR results.	[Wiedmann, Ralph T.; Nonneman, Dan J.; Rohrer, Gary A.] ARS, USDA, US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA	United States Department of Agriculture (USDA)	Rohrer, GA (corresponding author), ARS, USDA, US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA.	gary.rohrer@ars.usda.gov	Wiedmann, Ralph T/F-6530-2016	Rohrer, Gary/0000-0002-8252-9308	Agricultural Research Service, a division of the US Department of Agriculture [5438-31000-083-00D]; ARS [ARS-0426415] Funding Source: Federal RePORTER	Agricultural Research Service, a division of the US Department of Agriculture; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by Current Research Information System #5438-31000-083-00D of the Agricultural Research Service, a division of the US Department of Agriculture. The funder did not contribute to the study design, data collation and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Chen CY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-733; Clop A, 2012, ANIM GENET, V43, P503, DOI 10.1111/j.1365-2052.2012.02317.x; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Fadista J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003916; Fernandez AI, 2014, ANIM GENET, V45, P357, DOI 10.1111/age.12137; Fowler KE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-784; Giuffra E, 2002, MAMM GENOME, V13, P569, DOI 10.1007/s00335-002-2184-5; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jiang JC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-593; Li Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-725; Lindholm-Perry AK, 2009, ANIM GENET, V40, P713, DOI 10.1111/j.1365-2052.2009.01903.x; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Marklund S, 1998, GENOME RES, V8, P826, DOI 10.1101/gr.8.8.826; Paudel Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-449; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Ramayo-Caldas Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-593; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Revay T, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1473-9; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Wang JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087571; Wang Jiying, 2013, PLoS One, V8, pe68683, DOI 10.1371/journal.pone.0068683; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074879; Wang YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106780; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	33	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133529	10.1371/journal.pone.0133529	http://dx.doi.org/10.1371/journal.pone.0133529			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172260	gold, Green Published, Green Submitted			2022-12-27	WOS:000358194900151
J	Capellini, I; Nunn, CL; Barton, RA				Capellini, Isabella; Nunn, Charles L.; Barton, Robert A.			Microparasites and Placental Invasiveness in Eutherian Mammals	PLOS ONE			English	Article							VERTICAL TRANSMISSION; PHYLOGENETIC ANALYSIS; HUMAN-PREGNANCY; IMMUNE-SYSTEM; EVOLUTION; INTERFACE; ADAPTATION; ALLOMETRY; INFECTION; PRIMATES	Placental invasiveness-the number of maternal tissue layers separating fetal tissues from maternal blood-is variable across mammalian species. Although this diversity is likely to be functionally important, variation in placental invasiveness remains unexplained. Here we test the hypothesis that increased risk of transplacental transmission of pathogens from the mother to the fetus promotes the evolution of non-invasive placentation, the most likely derived condition in eutherian mammals. Specifically, we predict that non-invasive placentation is associated with increased microparasite species richness relative to more invasive placental types, based on the assumption that higher numbers of microparasites in a population reflects greater risk of transplacental transmission to fetuses. As predicted, higher bacteria species richness is associated with non-invasive placentation. Protozoa species richness, however, shows the opposite pattern. Because invasive placentae facilitate the transfer of maternal antibodies to the fetus, we propose that the ancestral condition of invasive placentation is retained under selection for protection of newborns from higher risk of postnatal protozoan infection. Hence, our findings suggest that a tradeoff exists between protection against bacterial infection prenatally and protozoan infection postnatally. Future studies are needed to investigate how maternal prevalence of infection and the relative preversus postnatal risk of fetal infection by different microparasite groups vary among mammalian hosts in relation to placental invasiveness.	[Capellini, Isabella] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Nunn, Charles L.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA; [Nunn, Charles L.] Duke Univ, Duke Global Hlth Inst Biol Sci, Durham, NC USA; [Barton, Robert A.] Univ Durham, Dept Anthropol, Durham, England	University of Hull; Duke University; Duke University; Durham University	Capellini, I (corresponding author), Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England.	I.Capellini@hull.ac.uk	Capellini, Isabella/H-4813-2013	Capellini, Isabella/0000-0001-8065-2436	Biotechnology and Biological Sciences Research Council (UK); Natural Environment Research Council (UK) [BB/E014593/1]; BBSRC [BB/E014593/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E014593/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was joint grant funded by Biotechnology and Biological Sciences Research Council (UK) and Natural Environment Research Council (UK), Grant N: BB/E014593/1, PI: RAB, Co-I: IC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; [Anonymous], 2014, ADV BIOL; Baintner K, 2007, VET IMMUNOL IMMUNOP, V117, P153, DOI 10.1016/j.vetimm.2007.03.001; Bakardjiev AI, 2004, INFECT IMMUN, V72, P489, DOI 10.1128/IAI.72.1.489-497.2004; Benirschke K, 2012, PATHOLOGY HUMAN PLAC; Bininda-Emonds ORP, 2008, NATURE, V456, P274, DOI 10.1038/nature07347; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Bordes F, 2009, OIKOS, V118, P801, DOI 10.1111/j.1600-0706.2008.17169.x; Capellini I, 2012, PLACENTA, V33, P763, DOI 10.1016/j.placenta.2012.07.004; Capellini I, 2011, AM NAT, V177, P86, DOI 10.1086/657435; Chucri TM, 2010, J REPROD IMMUNOL, V87, P14, DOI 10.1016/j.jri.2010.08.062; Crespi B, 2004, AM NAT, V163, P635, DOI 10.1086/382734; Duaso J, 2010, PLACENTA, V31, P705, DOI 10.1016/j.placenta.2010.05.007; Dubey JP, 2014, VET PARASITOL, V202, P270, DOI 10.1016/j.vetpar.2014.01.006; Elliot MG, 2008, J EVOLUTION BIOL, V21, P1763, DOI 10.1111/j.1420-9101.2008.01590.x; Elliot MG, 2009, PLACENTA, V30, P949, DOI 10.1016/j.placenta.2009.08.004; Erlebacher A, 2010, TRENDS ENDOCRIN MET, V21, P428, DOI 10.1016/j.tem.2010.02.003; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Freyer C, 2009, J EXP ZOOL PART B, V312B, P545, DOI 10.1002/jez.b.21239; Garamszegi LZ, 2011, J EVOLUTION BIOL, V24, P184, DOI 10.1111/j.1420-9101.2010.02156.x; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; HANSEN PJ, 1995, J REPROD FERTIL, P69; Harvey PH, 1998, COMP METHOD EVOLUTIO; Hemberger M, 2013, J REPROD IMMUNOL, V97, P36, DOI 10.1016/j.jri.2012.10.006; KIRKBRIDE CA, 1993, J VET DIAGN INVEST, V5, P64, DOI 10.1177/104063879300500114; Langer P, 2009, J MAMMAL, V90, P332, DOI 10.1644/08-MAMM-A-071.1; Lecuit M, 2004, P NATL ACAD SCI USA, V101, P6152, DOI 10.1073/pnas.0401434101; LEISER R, 1994, EXP CLIN ENDOCRINOL, V102, P122, DOI 10.1055/s-0029-1211275; Lindenfors P, 2007, GLOBAL ECOL BIOGEOGR, V16, P496, DOI 10.1111/j.1466-8238.2006.00301.x; LOKE YW, 1982, ADV PARASIT, V21, P155, DOI 10.1016/S0065-308X(08)60276-6; Meeusen ENT, 2001, AM J REPROD IMMUNOL, V46, P169, DOI 10.1111/j.8755-8920.2001.460208.x; Moffett A, 2015, PHILOS T R SOC B, V370, DOI [10.1093/ije/dyg238, DOI 10.1093/IJE/DYG238]; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Mossman HW, 1987, VERTEBRATE FETAL MEM; Nunn CL, 2005, EVOL ANTHROPOL, V14, P1, DOI 10.1002/evan.20041; Nunn CL, 2001, EVOL ANTHROPOL, V10, P81, DOI 10.1002/evan.1019; Nunn CL, 2006, INFECT DIS PRIMATES; Nunn CL, 2011, COMP APPROACHES EVOL; Oliveira LJ, 2012, REPROD DOMEST ANIM, V47, P384, DOI 10.1111/j.1439-0531.2012.02102.x; Orme C. D. L., 2014, CAPER COMP ANAL PHYL; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Petroff MG, 2005, J REPROD IMMUNOL, V68, P1, DOI 10.1016/j.jri.2005.08.003; Quinn GP, 2003, EXPT DESIGN DATA ANA; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Robbins JR, 2012, INFECT IMMUN, V80, P418, DOI 10.1128/IAI.05899-11; Robbins JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000732; Thellin O, 2003, TOXICOLOGY, V185, P179, DOI 10.1016/S0300-483X(02)00607-8; Vacca P, 2013, J REPROD IMMUNOL, V97, P14, DOI 10.1016/j.jri.2012.10.008; Vogel P, 2005, PLACENTA, V26, P591, DOI 10.1016/j.placenta.2004.11.005; Webster P, 2005, VET PARASITOL, V130, P255, DOI 10.1016/j.vetpar.2005.03.031; Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wooding P., 2008, COMP PLACENTATION ST; Zeldovich VB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002005	60	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132563	10.1371/journal.pone.0132563	http://dx.doi.org/10.1371/journal.pone.0132563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168031	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100055
J	Dessie, Y; Berhane, Y; Worku, A				Dessie, Yadeta; Berhane, Yemane; Worku, Alemayehu			Parent-Adolescent Sexual and Reproductive Health Communication Is Very Limited and Associated with Adolescent Poor Behavioral Beliefs and Subjective Norms: Evidence from a Community Based Cross-Sectional Study in Eastern Ethiopia	PLOS ONE			English	Article							CHILD COMMUNICATION; ATTITUDES; PREDICTORS; STUDENTS	Introduction While parent-adolescent sexual and reproductive health (SRH) communication is one potential source of SRH information for adolescents, it appears to be inadequately practiced in Ethiopia. This study was designed to investigate the factors that limit or improve parent-adolescent SRH communication in Harar, Eastern Ethiopia. Methods A community based cross-sectional study was done on 4,559 adolescents of age 13-18. SRH communication was measured using a nine-item scale whose response ranged from "not at all" to "always." Summated composite score ranging from 0-36 was generated; higher score indicates high SRH communication. A median value of the composite score was 4 out of the possible 36 with an Interquartile Range (IQR) of 7. Respondents were ranked as very poor, poor and satisfactory communicators based on 33rd and 67th percentiles values. Generalized ordered logit model was applied to investigate the factors associated with SRH communication. Results Results showed that the adolescents who were more likely to practice poor-very poor/very poor SRH communication were those who had poor behavioral beliefs on and poor subjective norms of communicating sexual issues with parents and those who perceived their parents' reproductive health (RH) knowledge as poor. Nonetheless, the probability of poor-very poor/very poor SRH communication was less with high adolescent-parent communication quality, television co-viewing and discussions, and self-disclosure. Conclusions Curtailing the adolescents' underlying poor beliefs and norms, and improving adolescent-parent communication quality, self-disclosure, and television co-viewing and discussions are essential to engage the parents in sexual and reproductive health education of the adolescents.	[Dessie, Yadeta] Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia; [Berhane, Yemane; Worku, Alemayehu] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia	Haramaya University; Addis Continental Institute of Public Health; Addis Ababa University	Dessie, Y (corresponding author), Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia.	yad_de2005@yahoo.comm	Berhane, Yemane/ABB-8154-2020; Bacha, Yadeta/AAF-8849-2021	Berhane, Yemane/0000-0002-2527-1339	Haramaya University; STEP UP (Strengthening Evidence for Programming on Unintended Pregnancy) Research Programme Consortium [ADF002]	Haramaya University; STEP UP (Strengthening Evidence for Programming on Unintended Pregnancy) Research Programme Consortium	The research is funded by Haramaya University as a post graduate study project and partially supported through a PhD fellowship by the STEP UP (Strengthening Evidence for Programming on Unintended Pregnancy) Research Programme Consortium through a sub-award grant to the African Population and Health Research Center (APHRC) for the African Doctoral Dissertation Research Fellowships (ADDRF) with grant number ADF002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu-Mireku Samuel, 2003, Afr Health Sci, V3, P7; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; AJZEN I, 1986, J EXP SOC PSYCHOL, V22, P453, DOI 10.1016/0022-1031(86)90045-4; Ayalew M, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-77; Bastien S, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-25; Berg K, 2012, SAHARA J-J SOC ASP H, V9, P95, DOI 10.1080/17290376.2012.683583; Bersamin M, 2008, J MARRIAGE FAM, V70, P97, DOI 10.1111/j.1741-3737.2007.00464.x; Central Statistical Agency, 2012, ETH DEM HLTH SURV; Crichton J, 2012, J ADOLESCENCE, V35, P21, DOI 10.1016/j.adolescence.2011.06.008; CSA, 2007, 2007 POPULATION HOUS; DiClemente RJ, 2001, J PEDIATR-US, V139, P407, DOI 10.1067/mpd.2001.117075; Eisenberg ME, 2006, J YOUTH ADOLESCENCE, V35, P893, DOI 10.1007/s10964-006-9093-y; Federal Democratic Republic of Ethiopia Minstry of Health, 2006, NAT AD YOUTH REPR HL; Feleke SA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-294; FISHER TD, 1987, J YOUTH ADOLESCENCE, V16, P481, DOI 10.1007/BF02202942; Frehiwot Berhane, 2005, Ethiopian Journal of Health Development, V19, P29; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Guo WX, 2011, J CHILD MEDIA, V5, P358, DOI 10.1080/17482798.2011.587141; Harari Region, 2010, HARARI REGIONAL BURE; Jaccard J, 2000, J ADOLESCENT RES, V15, P187, DOI 10.1177/0743558400152001; Jerman P, 2010, J YOUTH ADOLESCENCE, V39, P1164, DOI 10.1007/s10964-010-9546-1; Jewkes R, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000288; Lishner DA, 2008, COGNITION EMOTION, V22, P180, DOI 10.1080/02699930701319139; Melaku YA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-252; MENSCH BS, 2005, CHANGING CONTEXT SEX; Miller KS, 1998, FAM PLANN PERSPECT, V30, P218, DOI 10.2307/2991607; Ministry of Youth Sport and Culture of Ethiopia(MYSC), 2005, YOUTH POL; Musa OI, 2012, AFRJINFECTDIS, V2, P1; Mutema F, 2013, GWERU J EMERGING TRE, V4, P604; Paul-Ebhohimhen VA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-4; Poulsen MN, 2010, AIDS BEHAV, V14, P1083, DOI 10.1007/s10461-009-9612-4; Richter LM, 2006, SCIENCE, V312, P1902, DOI 10.1126/science.1127489; Sales JM, 2008, HEALTH EDUC BEHAV, V35, P332, DOI 10.1177/1090198106293524; Schouten BC, 2007, PATIENT EDUC COUNS, V66, P75, DOI 10.1016/j.pec.2006.10.010; Shiferaw K, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-2; Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210; Steinberg L., 1996, ADOLESCENCE; Taffa N, 1999, ETHIOP J HEALTH DEV, V13, P107; Tebekaw Y, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-326; Tesso DW, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-13; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Wamoyi J, 2010, REPROD HLTH, V7; Whitaker DJ, 2000, J ADOLESCENT RES, V15, P251, DOI 10.1177/0743558400152004; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104; Wilson EK, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-31; World Health Organization, 2013, UNS AB GLOB REG EST; Yadeta TA, 2014, J ENVIRON PUBLIC HEA, V2014, DOI 10.1155/2014/102579; Yesus DG, 2010, ETHIOP J HEALTH DEV, V24, P89; Zhang LY, 2007, EUR J CONTRACEP REPR, V12, P138, DOI 10.1080/13625180701300293	49	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0129941	10.1371/journal.pone.0129941	http://dx.doi.org/10.1371/journal.pone.0129941			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1PW	26167860	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100003
J	Kagohashi, K; Tsurumi, T; Managi, S				Kagohashi, Kazuki; Tsurumi, Tetsuya; Managi, Shunsuke			The Effects of International Trade on Water Use	PLOS ONE			English	Article							VIRTUAL WATER; ENVIRONMENT; INVESTMENT; GROWTH	The growing scarcity of water resources worldwide is conditioned not only by precipitation changes but also by changes to water use patterns; the latter is driven by social contexts such as capital intensity, trade openness, and income. This study explores the determinants of water use by focusing on the effect of trade openness on the degree to which water is withdrawn and consumed. Previous studies have conducted analyses on the determinants of water use but have ignored the endogeneity of trade openness. To deal with this endogeneity problem, we adopt instrumental variable estimation and clarify the determinants of water use. The determinants of water use are divided into scale, technique, and composition effects. Calculating each trade-induced effect, we examine how trade openness affects the degree of water use. Our results show that while trade has a positive effect on water withdrawal/consumption through trade-induced scale effects and direct composition effects, the trade-induced technique and the indirect composition effect, both of which exhibit a negative sign, counteract the scale effect and the direct composition effect, resulting in reduced water withdrawal/consumption. The overall effect induced by trade is calculated as being in the range of -1.00 to -1.52; this means that the overall effect of a 1% increase in the intensity of trade openness reduces the degree of water withdrawal/consumption by roughly 1.0-1.5%, on average. This result indicates that international bilateral trade would promote efficient water use through the diffusion of water-saving technologies and the reformation of industry composition.	[Kagohashi, Kazuki] Kyoto Univ, Grad Sch Econ, Kyoto, Japan; [Tsurumi, Tetsuya] Nanzan Univ, Dept Policy Studies, Nagoya, Aichi 466, Japan; [Managi, Shunsuke] Kyushu Univ, Dept Urban & Environm Engn, Fukuoka 812, Japan; [Managi, Shunsuke] Queensland Univ Technol, QUT Business Sch, Brisbane, Qld 4001, Australia	Kyoto University; Kyushu University; Queensland University of Technology (QUT)	Kagohashi, K (corresponding author), Kyoto Univ, Grad Sch Econ, Kyoto, Japan.	kagohashi@gmail.com	Managi, Shunsuke/G-1740-2013	Managi, Shunsuke/0000-0001-7883-1427; Kagohashi, Kazuki/0000-0001-5428-9637; Scalas, Enrico/0000-0002-1516-9285	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [26000001]; MEXT, Japan [25740068, 26870690]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was funded by a Grant-inAid for Specially Promoted Research (26000001) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and by a Grant-in-Aid for Young Scientists (B) Numbers 25740068 and 26870690, also from MEXT, Japan. The results and conclusions of this paper do not necessarily reflect the views of the funding agency.	Aiyar S, 2005, IMF STAFF PAPERS, V52, P82; Allan JA, 2003, WATER INT, V28, P106, DOI 10.1080/02508060.2003.9724812; Allan T., 1998, MIDDLE E REV INT AFF, V5; Antweiler W, 2001, AM ECON REV, V91, P877, DOI 10.1257/aer.91.4.877; Antweiler W., 1996, ECON SYST RES, V8, P361, DOI DOI 10.1080/09535319600000027; Bank World, 2003, WORLD DEV IND; Barbier EB, 2004, ECON REC, V80, P1, DOI 10.1111/j.1475-4932.2004.00121.x; Caselli F, 2005, HANDB ECON, V22, P679; Cole MA, 2004, APPL ECON LETT, V11, P1, DOI 10.1080/1350485042000187435; Cole MA, 2003, J ENVIRON ECON MANAG, V46, P363, DOI 10.1016/S0095-0696(03)00021-4; COPELAND BR, 1994, Q J ECON, V109, P755, DOI 10.2307/2118421; De Fraiture C, 2004, COMPR ASSESS RES REP, V4, P41; Edwards J, 2005, NAT RESOUR J, V45, P953; Frankel J, 2002, Q J ECON, V117, P437, DOI 10.1162/003355302753650292; Frankel JA, 2005, REV ECON STAT, V87, P85, DOI 10.1162/0034653053327577; Frankel JA, 1999, AM ECON REV, V89, P379, DOI 10.1257/aer.89.3.379; Gleick PH, 1996, WATER INT, V21, P83, DOI 10.1080/02508069608686494; Gleick PH, 2000, WATER INT, V25, P127, DOI 10.1080/02508060008686804; Hall RE, 1999, Q J ECON, V114, P83, DOI 10.1162/003355399555954; Hoehn JP, 2008, LETT SPAT RESOUR SCI, V1, P127, DOI 10.1007/s12076-008-0013-5; Hoekstra AY, 2002, VIRTUAL WATER TRADE, P1; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; Kumar MD, 2005, WATER RESOUR MANAG, V19, P759, DOI 10.1007/s11269-005-3278-0; Managi S, 2009, J ENVIRON ECON MANAG, V58, P346, DOI 10.1016/j.jeem.2009.04.008; Old T., 2003, VALUE WATER RES REPO, V12, P221; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; PSACHAROPOULOS G, 1994, WORLD DEV, V22, P1325, DOI 10.1016/0305-750X(94)90007-8; Reimer JJ, 2012, ECOL ECON, V75, P135, DOI 10.1016/j.ecolecon.2012.01.011; Rosegrant M.W., 2002, INT FOOD POLICY RES; Shiklomanov I. A., 1999, WORLD WATER RESOURCE; Shiklomanov IA, 2000, WATER INT, V25, P11, DOI 10.1080/02508060008686794; Silva JMCS, 2006, REV ECON STAT, V88, P641, DOI 10.1162/rest.88.4.641; Silva JMCS, 2011, ECON LETT, V112, P220, DOI 10.1016/j.econlet.2011.05.008; Todo Y, 2005, BE J MACROECON, V5; Tsurumi T, 2014, ENVIRON ECON POLICY, V16, P305, DOI 10.1007/s10018-012-0051-5; Vose R.S., 1992, GLOBAL HIST CLIMATOL, DOI 10.2172/10178730; WTO, 2010, WORLD TRAD REP 2010; Yang H., 2006, HYDROL EARTH SYST SC, V3, P1, DOI DOI 10.5194/HESSD-3-1-2006; Zimmer D., 2003, VALUE WATER RES REPO, V12, P1	39	16	16	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132133	10.1371/journal.pone.0132133	http://dx.doi.org/10.1371/journal.pone.0132133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1PW	26168045	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100022
J	Reinprecht, Y; Arif, M; Simon, LC; Pauls, KP				Reinprecht, Yarmilla; Arif, Muhammad; Simon, Leonardo C.; Pauls, K. Peter			Genome Regions Associated with Functional Performance of Soybean Stem Fibers in Polypropylene Thermoplastic Composites	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; CINNAMYL-ALCOHOL-DEHYDROGENASE; RECOMBINANT INBRED LINES; GLYCINE-RICH PROTEINS; CELL-WALLS; MECHANICAL-PROPERTIES; CHEMICAL-COMPOSITION; PHYSICAL-PROPERTIES; AGRONOMIC TRAITS; GENETIC-ANALYSIS	Plant fibers can be used to produce composite materials for automobile parts, thus reducing plastic used in their manufacture, overall vehicle weight and fuel consumption when they replace mineral fillers and glass fibers. Soybean stem residues are, potentially, significant sources of inexpensive, renewable and biodegradable natural fibers, but are not curretly used for biocomposite production due to the functional properties of their fibers in composites being unknown. The current study was initiated to investigate the effects of plant genotype on the performance characteristics of soybean stem fibers when incorporated into a polypropylene (PP) matrix using a selective phenotyping approach. Fibers from 50 lines of a recombinant inbred line population (169 RILs) grown in different environments were incorporated into PP at 20% (wt/wt) by extrusion. Test samples were injection molded and characterized for their mechanical properties. The performance of stem fibers in the composites was significantly affected by genotype and environment. Fibers from different genotypes had significantly different chemical compositions, thus composites prepared with these fibers displayed different physical properties. This study demonstrates that thermoplastic composites with soybean stem-derived fibers have mechanical properties that are equivalent or better than wheat straw fiber composites currently being used for manufacturing interior automotive parts. The addition of soybean stem residues improved flexural, tensile and impact properties of the composites. Furthermore, by linkage and in silico mapping we identified genomic regions to which quantitative trait loci (QTL) for compositional and functional properties of soybean stem fibers in thermoplastic composites, as well as genes for cell wall synthesis, were co-localized. These results may lead to the development of high value uses for soybean stem residue.	[Reinprecht, Yarmilla; Arif, Muhammad; Pauls, K. Peter] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada; [Arif, Muhammad; Simon, Leonardo C.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada	University of Guelph; University of Waterloo	Reinprecht, Y (corresponding author), Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada.	yreinpre@uoguelph.ca			Ontario Ministry of Agriculture, Food and Rural Affairs, KPP Ontario Ministry of Research and Innovation, KPP	Ontario Ministry of Agriculture, Food and Rural Affairs, KPP Ontario Ministry of Research and Innovation, KPP	Ontario Ministry of Agriculture, Food and Rural Affairs, KPP Ontario Ministry of Research and Innovation, KPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson M, 2010, PLANT SCI, V178, P61, DOI 10.1016/j.plantsci.2009.11.003; [Anonymous], 2010, D170810 ASTM, DOI [10.1520/D1708-10, DOI 10.1520/D1708-10]; Appenzeller L, 2004, CELLULOSE, V11, P287, DOI 10.1023/B:CELL.0000046417.84715.27; Ashori A, 2009, J APPL POLYM SCI, V111, P1684, DOI 10.1002/app.29189; ASTM INTERNATIONAL, 2010, ANN BOOK ASTM STAND, P1, DOI DOI 10.1520/C0109; Banniza S, 2005, CAN J BOT, V83, P954, DOI [10.1139/B05-044, 10.1139/b05-044]; Barchi L, 2009, THEOR APPL GENET, V118, P1157, DOI 10.1007/s00122-009-0970-0; Barriere Y., 2007, GENES GENOMES GENOMI, V1, P133; Bengtsson M, 2007, COMPOS PART A-APPL S, V38, P1922, DOI 10.1016/j.compositesa.2007.03.004; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Brown RM, 2004, J POLYM SCI POL CHEM, V42, P487, DOI 10.1002/pola.10877; Capron A, 2013, J EXP BOT, V64, P185, DOI 10.1093/jxb/ers319; Cardinal AJ, 2003, THEOR APPL GENET, V106, P866, DOI 10.1007/s00122-002-1136-5; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Chen AP, 2007, J PLANT RES, V120, P337, DOI 10.1007/s10265-006-0058-8; DELMER DP, 1995, PLANT CELL, V7, P987, DOI 10.1105/tpc.7.7.987; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fang DD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-397; Fletcher RS, 2005, J SCI FOOD AGR, V85, P2429, DOI 10.1002/jsfa.2270; Fowler PA, 2006, J SCI FOOD AGR, V86, P1781, DOI 10.1002/jsfa.2558; FREY K. J., 1957, AGRON JOUR, V49, P59; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; Gu Y, 2010, P NATL ACAD SCI USA, V107, P12866, DOI 10.1073/pnas.1007092107; Hallac BB, 2011, BIOFUEL BIOPROD BIOR, V5, P215, DOI 10.1002/bbb.269; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; Jannink JL, 2005, CROP SCI, V45, P901, DOI 10.2135/cropsci2004.0278; Jestin C, 2012, OPEN J GENET CYTOL, V2, P190, DOI DOI 10.4236/0JGEN.2012.24025; Jin CF, 2004, GENETICS, V168, P2285, DOI 10.1534/genetics.104.027524; Johnson JMF, 2007, SOIL SCI SOC AM J, V71, P155, DOI 10.2136/sssaj2005.0419; Julson JL, 2004, J APPL POLYM SCI, V93, P2484, DOI 10.1002/app.20823; Kong EY, 2013, CROP J, V1, P43, DOI 10.1016/j.cj.2013.07.012; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Krakowsky MD, 2005, THEOR APPL GENET, V111, P337, DOI 10.1007/s00122-005-2026-4; Krakowsky MD, 2003, MAYDICA, V48, P283; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lee S, 2006, HOLZ ROH WERKST, V64, P74, DOI 10.1007/s00107-005-0062-z; Lin S, 1997, MOL BREEDING, V3, P219, DOI 10.1023/A:1009637320805; Lorenz AJ, 2010, CROP SCI, V50, P842, DOI 10.2135/cropsci2009.04.0168; Luiz H.C., 2000, NATURAL POLYM AGROFI, P115; Mangeon A, 2010, PLANT SIGNAL BEHAV, V5, P99, DOI 10.4161/psb.5.2.10336; MANSUR LM, 1993, THEOR APPL GENET, V86, P907, DOI 10.1007/BF00211040; Mansur LM, 1996, CROP SCI, V36, P1327, DOI 10.2135/cropsci1996.0011183X003600050042x; Mehdinia M., 2013, World Journal of Agricultural Sciences, V9, P238; Minic Z, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-6; Mittal A, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-41; Mohanty AK, 2002, J POLYM ENVIRON, V10, P19, DOI 10.1023/A:1021013921916; Novaes E, 2009, NEW PHYTOL, V182, P878, DOI 10.1111/j.1469-8137.2009.02785.x; Nutzmann HW, 2014, CURR OPIN BIOTECH, V26, P91, DOI 10.1016/j.copbio.2013.10.009; Orf JH, 1999, CROP SCI, V39, P1642, DOI 10.2135/cropsci1999.3961642x; Peng DL, 2014, FIELD CROP RES, V157, P1, DOI 10.1016/j.fcr.2013.11.015; Penning BW, 2009, PLANT PHYSIOL, V151, P1703, DOI 10.1104/pp.109.136804; Perrin RM, 2001, CURR BIOL, V11, pR213, DOI 10.1016/S0960-9822(01)00108-7; Reddy N, 2005, TRENDS BIOTECHNOL, V23, P22, DOI 10.1016/j.tibtech.2004.11.002; Reddy N, 2009, BIORESOURCE TECHNOL, V100, P3593, DOI 10.1016/j.biortech.2008.09.063; Reinprecht Y, 2006, GENOME, V49, P1510, DOI 10.1139/G06-112; Reinprecht Y, 2011, SOYBEAN - MOLECULAR ASPECTS OF BREEDING, P119; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Rong J, 2007, GENETICS, V176, P2577, DOI 10.1534/genetics.107.074518; Rowell R.M., 1997, LIGNOCELLUL COMPOS, V13, P23; Rowell RM, 1997, J COMPOS, V18, P23; Sachetto-Martins G, 2000, BBA-GENE STRUCT EXPR, V1492, P1, DOI 10.1016/S0167-4781(00)00064-6; Said JI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-776; Sanadi A.R., 1997, PAPER COMPOSITES AGR, P377; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; SAS S., 2009, STAT US GUID VERS 9; Schlueter JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-330; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schuetz M, 2014, PLANT PHYSIOL, V166, P798, DOI 10.1104/pp.114.245597; Shen H, 2009, BIOENERG RES, V2, P217, DOI 10.1007/s12155-009-9047-9; Sibout R, 2005, PLANT CELL, V17, P2059, DOI 10.1105/tpc.105.030767; Sindhu A, 2007, PLANT PHYSIOL, V145, P1444, DOI 10.1104/pp.107.102582; StatSoft Inc, 2009, STAT VERS 9; Stombaugh SK, 2004, CROP SCI, V44, P2101, DOI 10.2135/cropsci2004.2101; Sukumaran K., 1997, MET MATER PROCESS, V13, P121; Sykes R, 2008, WOOD SCI TECHNOL, V42, P649, DOI 10.1007/s00226-008-0199-0; Taylor-Teeples M, 2015, NATURE, V517, P571, DOI 10.1038/nature14099; Thomas S, 2011, CELLULOSE FIBERS: BIO- AND NANO-POLYMER COMPOSITES, P3, DOI 10.1007/978-3-642-17370-7_1; Toriz G, 2002, POLYM COMPOSITE, V23, P806, DOI 10.1002/pc.10478; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Vassilev SV, 2010, FUEL, V89, P913, DOI 10.1016/j.fuel.2009.10.022; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang S, 2012, WINDOWS QTL CARTOGRA; WHETTEN R, 1995, PLANT CELL, V7, P1001, DOI 10.2307/3870053; Xu W, 1996, PLANT J, V9, P879, DOI 10.1046/j.1365-313X.1996.9060879.x; Yokoyama R, 2004, PLANT CELL PHYSIOL, V45, P1111, DOI 10.1093/pcp/pch151; Zhang, 2007, CROP MANAGE, V6, DOI [10.1094/cm-2007-0927-01-rs, DOI 10.1094/CM-2007-0927-01-RS, 10.1094/CM-2007-0927-01-RS]; Zhong RQ, 2007, CURR OPIN PLANT BIOL, V10, P564, DOI 10.1016/j.pbi.2007.09.001; Zhong RQ, 2015, PLANT CELL PHYSIOL, V56, P195, DOI 10.1093/pcp/pcu140	89	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0130371	10.1371/journal.pone.0130371	http://dx.doi.org/10.1371/journal.pone.0130371			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167917	Green Submitted, Green Published, gold			2022-12-27	WOS:000358193100004
J	Florea, OA; Rosca, IC				Florea, Olivia Ana; Rosca, Ileana Constanta			Stokes' Second Problem for a Micropolar Fluid with Slip	PLOS ONE			English	Article							FREE-CONVECTION FLOW; STATE-SPACE APPROACH	In this paper is presented the model of an incompressible micropolar fluid flow with slip using the initial and boundary conditions when the wall velocity is considered depending on the frequency of the vibration. Regarding the boundary conditions of the velocity at the wall, we remark that there is a discontinuity of the velocity at the fluid-wall interface. The solutions for velocity and microrotation with the given conditions are obtained using the method of numerical inversion of Laplace transform.	[Florea, Olivia Ana] Transilvania Univ Brasov, Fac Math & Comp Sci, Brasov, Romania; [Rosca, Ileana Constanta] Transilvania Univ Brasov, Fac Prod Design & Environm, Brasov, Romania	Transylvania University of Brasov; Transylvania University of Brasov	Florea, OA (corresponding author), Transilvania Univ Brasov, Fac Math & Comp Sci, Brasov, Romania.	olivia.florea@unitbv.ro	Rosca, Ileana Constanta G/H-3746-2016		Sectorial Operational Programme Human Resources Development (SOP HRD); European Social Fund; Romanian Government [POSDRU/159/1.5/S/134378]	Sectorial Operational Programme Human Resources Development (SOP HRD); European Social Fund(European Social Fund (ESF)); Romanian Government(Romanian Government)	This paper is supported by the Sectorial Operational Programme Human Resources Development (SOP HRD), financed from the European Social Fund and by the Romanian Government under the project number POSDRU/159/1.5/S/134378.	Devakar M, 2009, APPL MATH MODEL, V33, P924, DOI 10.1016/j.apm.2007.12.016; ERINGEN AC, 1966, J MATH MECH, V16, P1; Florea O, 2014, OSTEOARTHR CARTILAGE, V22, pS109, DOI 10.1016/j.joca.2014.02.204; Helmy KA, 2002, CAN J PHYS, V80, P1661, DOI 10.1139/P02-054; Helmy KA, 2000, ACTA MECH, V140, P41, DOI 10.1007/BF01175979; HONIG G, 1984, J COMPUT APPL MATH, V10, P113, DOI 10.1016/0377-0427(84)90075-X; Ibrahem FS, 2006, APPL MATH COMPUT, V173, P916, DOI 10.1016/j.amc.2005.04.024; Ibrahem FS, 2005, J APPL MECH-T ASME, V72, P468, DOI 10.1115/1.1875412; Lok YY, 2010, MECCANICA, V45, P187, DOI 10.1007/s11012-009-9236-9; Marin M, 2014, AN STI U OVID CO-MAT, V22, P169, DOI 10.2478/auom-2014-0014; Mekheimer K, 2008, ACTA MECH SINICA-PRC, V24, P637, DOI 10.1007/s10409-008-0185-7; Mekheimer KS, 2008, J APPL MATH, DOI 10.1155/2008/570825; PURI P, 1995, ACTA MECH, V112, P1, DOI 10.1007/BF01177474; Schlichting H, 1979, SERIES MECH ENG; Sharma K, 2014, AN STI U OVID CO-MAT, V22, P151, DOI 10.2478/auom-2014-0040	21	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131860	10.1371/journal.pone.0131860	http://dx.doi.org/10.1371/journal.pone.0131860			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161780	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300066
J	Mascotti, ML; Lapadula, WJ; Ayub, MJ				Laura Mascotti, Maria; Jesus Lapadula, Walter; Juri Ayub, Maximiliano			The Origin and Evolution of Baeyer-Villiger Monooxygenases (BVMOs): An Ancestral Family of Flavin Monooxygenases	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; ASPERGILLUS-FUMIGATUS AF293; RHODOCOCCUS-JOSTII RHA1; PRODRUG ACTIVATOR ETAA; FLAVOPROTEIN MONOOXYGENASES; MYCOBACTERIUM-TUBERCULOSIS; SUBSTRATE-SPECIFICITY; EUKARYOTIC EVOLUTION; OXYGEN ACTIVATION; PROTEIN-SEQUENCE	The Baeyer-Villiger Monooxygenases (BVMOs) are enzymes belonging to the "Class B" of flavin monooxygenases and are capable of performing exquisite selective oxidations. These enzymes have been studied from a biotechnological perspective, but their physiological substrates and functional roles are widely unknown. Here, we investigated the origin, taxonomic distribution and evolutionary history of the BVMO genes. By using in silico approaches, 98 BVMO encoding genes were detected in the three domains of life: Archaea, Bacteria and Eukarya. We found evidence for the presence of these genes in Metazoa (Hydra vulgaris, Oikopleura dioica and Adineta vaga) and Haptophyta (Emiliania huxleyi) for the first time. Furthermore, a search for other "Class B" monooxygenases (flavoprotein monooxygenases-FMOs - and N-hydroxylating monooxygenases - NMOs) was conducted. These sequences were also found in the three domains of life. Phylogenetic analyses of all "Class B" monooxygenases revealed that NMOs and BVMOs are monophyletic, whereas FMOs form a paraphyletic group. Based on these results, we propose that BVMO genes were already present in the last universal common ancestor (LUCA) and their current taxonomic distribution is the result of differential duplication and loss of paralogous genes.	[Laura Mascotti, Maria; Jesus Lapadula, Walter; Juri Ayub, Maximiliano] Univ Nacl San Luis, IMIBIO SL CONICET, Fac Quim Bioquim & Farm, San Luis, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Luis	Ayub, MJ (corresponding author), Univ Nacl San Luis, IMIBIO SL CONICET, Fac Quim Bioquim & Farm, San Luis, Argentina.	mjuriayub@hotmail.com	; Mascotti, Maria Laura/H-9501-2017	Lapadula, Walter/0000-0003-4180-9490; Juri Ayub, Maximiliano/0000-0002-5787-0993; Mascotti, Maria Laura/0000-0002-5817-4631	CONICET [PIP 0021]; National Agency for Scientific and Technological Promotion (Agencia Nacional de Promocion Cientifica y Tecnologica); FONCyT [PICT 2010-1468]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Agency for Scientific and Technological Promotion (Agencia Nacional de Promocion Cientifica y Tecnologica); FONCyT(FONCyT)	MJA is a member of the scientific career of the National Council for Research from Argentina (Consejo Nacional de Investigaciones Cientificas y Tecnicas; CONICET). MLM and WJL have postdoctoral and doctoral fellowships, respectively, from CONICET. Grants from CONICET (Grant Code PIP 0021) and the National Agency for Scientific and Technological Promotion (Agencia Nacional de Promocion Cientifica y Tecnologica); FONCyT (Grant Code PICT 2010-1468) to MJA are acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balke K, 2012, ORG BIOMOL CHEM, V10, P6249, DOI 10.1039/c2ob25704a; Beneventi E, 2013, J MOL CATAL B-ENZYM, V98, P145, DOI 10.1016/j.molcatb.2013.10.006; Bisagni S, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0023-1; Bosserman MA, 2013, ACS CHEM BIOL, V8, P2466, DOI 10.1021/cb400399b; Ceccoli RD, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00025; Chen H, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0239-x; Choi IG, 2007, P NATL ACAD SCI USA, V104, P4489, DOI 10.1073/pnas.0611557104; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Diminic J, 2014, J IND MICROBIOL BIOT, V41, P211, DOI 10.1007/s10295-013-1337-8; Ferroni FM, 2014, J MOL CATAL B-ENZYM, V107, P47, DOI 10.1016/j.molcatb.2014.05.015; Fink MJ, 2011, J MOL CATAL B-ENZYM, V73, P9, DOI 10.1016/j.molcatb.2011.07.003; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Forterre P, 2013, ARCHAEA, V2013, DOI 10.1155/2013/372396; Fraaije MW, 2004, J BIOL CHEM, V279, P3354, DOI 10.1074/jbc.M307770200; Fraaije MW, 2002, FEBS LETT, V518, P43, DOI 10.1016/S0014-5793(02)02623-6; Franceschini S, 2012, BIOCHEMISTRY-US, V51, P7043, DOI 10.1021/bi301072w; Frederick RE, 2014, BIOCHEMISTRY-US, V53, P2007, DOI 10.1021/bi401256b; Furnham N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002403; Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860; Gibson M, 2005, J AM CHEM SOC, V127, P17594, DOI 10.1021/ja055750t; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hu YC, 2014, NAT CHEM BIOL, V10, P552, DOI [10.1038/NCHEMBIO.1527, 10.1038/nchembio.1527]; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kamerbeek NM, 2003, APPL ENVIRON MICROB, V69, P419, DOI 10.1128/AEM.69.1.419-426.2003; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Koonin EV, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-64; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Mascotti ML, 2014, BIOCHIMIE, V107, P270, DOI 10.1016/j.biochi.2014.09.005; Laurence M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097876; Leipold F, 2012, APPL MICROBIOL BIOT, V94, P705, DOI 10.1007/s00253-011-3670-z; Leisch H, 2012, APPL ENVIRON MICROB, V78, P2200, DOI 10.1128/AEM.07694-11; Leisch H, 2011, CHEM REV, V111, P4165, DOI 10.1021/cr1003437; Mascotti ML, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-33; MEI BG, 1993, P NATL ACAD SCI USA, V90, P903, DOI 10.1073/pnas.90.3.903; Mihovilovic MD, 2005, ANGEW CHEM INT EDIT, V44, P3609, DOI 10.1002/anie.200462964; Minerdi D, 2012, MICROB BIOTECHNOL, V5, P700, DOI 10.1111/j.1751-7915.2012.00356.x; Nasir A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003452; Noda-Garcia L, 2013, MOL BIOL EVOL, V30, P2024, DOI 10.1093/molbev/mst115; Olucha J, 2011, BIOORG CHEM, V39, P171, DOI 10.1016/j.bioorg.2011.07.006; Orru R, 2010, J BIOL CHEM, V285, P35021, DOI 10.1074/jbc.M110.161372; Pace NR, 2012, P NATL ACAD SCI USA, V109, P1011, DOI 10.1073/pnas.1109716109; Pazmino DET, 2010, CURR OPIN CHEM BIOL, V14, P138, DOI 10.1016/j.cbpa.2009.11.017; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Rebehmed J, 2013, BIOCHIMIE, V95, P1394, DOI 10.1016/j.biochi.2013.03.005; Riebel A, 2012, APPL MICROBIOL BIOT, V95, P1479, DOI 10.1007/s00253-011-3823-0; Riebel A, 2013, J MOL CATAL B-ENZYM, V88, P20, DOI 10.1016/j.molcatb.2012.11.009; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schlaich NL, 2007, TRENDS PLANT SCI, V12, P412, DOI 10.1016/j.tplants.2007.08.009; Schlenk D, 1998, COMP BIOCHEM PHYS C, V121, P185, DOI 10.1016/S0742-8413(98)10060-9; Szolkowy C, 2009, CHEMBIOCHEM, V10, P1208, DOI 10.1002/cbic.200900011; Tang MC, 2013, ACS CATAL, V3, P444, DOI 10.1021/cs300819e; Weiss M, 2012, APPL ENVIRON MICROB, V78, P8254, DOI 10.1128/AEM.02412-12; Wiemann P, 2013, P NATL ACAD SCI USA, V110, P17065, DOI 10.1073/pnas.1313258110; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999	60	33	34	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132689	10.1371/journal.pone.0132689	http://dx.doi.org/10.1371/journal.pone.0132689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161776	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300168
J	Pan, B; Chen, JZ; Lian, JM; Huang, XF; Deng, C				Pan, Bo; Chen, Jiezhong; Lian, Jiamei; Huang, Xu-Feng; Deng, Chao			Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3 beta Signalling Pathways in Rats	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; OLANZAPINE-INDUCED HYPERPHAGIA; GLYCOGEN-SYNTHASE KINASE-3; TYROSINE-HYDROXYLASE; ANTIPSYCHOTIC-DRUGS; CYCLIC-AMP; FUNCTIONAL SELECTIVITY; PARTIAL AGONIST; BETA-CATENIN; MOUSE-BRAIN	Aripiprazole is a wide-used antipsychotic drug with therapeutic effects on both positive and negative symptoms of schizophrenia, and reduced side-effects. Although aripiprazole was developed as a dopamine D-2 receptor (D2R) partial agonist, all other D2R partial agonists that aimed to mimic aripiprazole failed to exert therapeutic effects in clinic. The present in vivo study aimed to investigate the effects of aripiprazole on the D2R downstream cAMP-PKA and Akt-GSK3 beta signalling pathways in comparison with a D2R antagonist - haloperidol and a D2R partial agonist - bifeprunox. Rats were injected once with aripiprazole (0.75mg/kg, i.p.), bifeprunox (0.8mg/kg, i.p.), haloperidol (0.1mg/kg, i.p.) or vehicle. Five brain regions - the prefrontal cortex (PFC), nucleus accumbens (NAc), caudate putamen (CPu), ventral tegmental area (VTA) and substantia nigra (SN) were collected. The protein levels of PKA, Akt and GSK3 beta were measured by Western Blotting; the cAMP levels were examined by ELISA tests. The results showed that aripiprazole presented similar acute effects on PKA expression to haloperidol, but not bifeprunox, in the CPU and VTA. Additionally, aripiprazole was able to increase the phosphorylation of GSK3 beta in the PFC, NAc, CPu and SN, respectively, which cannot be achieved by bifeprunox and haloperidol. These results suggested that acute treatment of aripiprazole had differential effects on the cAMP-PKA and Akt-GSK3 beta signalling pathways from haloperidol and bifeprunox in these brain areas. This study further indicated that, by comparison with bifeprunox, the unique pharmacological profile of aripiprazole may be attributed to the relatively lower intrinsic activity at D2R.	[Pan, Bo; Chen, Jiezhong; Lian, Jiamei; Deng, Chao] Illawarra Hlth & Med Res Inst, Antipsychot Res Lab, Wollongong, NSW, Australia; [Pan, Bo; Lian, Jiamei; Huang, Xu-Feng; Deng, Chao] Univ Wollongong, Sch Med, Ctr Translat Neurosci, Wollongong, NSW, Australia	University of Wollongong; University of Wollongong	Deng, C (corresponding author), Illawarra Hlth & Med Res Inst, Antipsychot Res Lab, Wollongong, NSW, Australia.	chao@uow.edu.au	Huang, Xu-Feng/H-7408-2015; Deng, Chao/F-4417-2016; Pan, Bo/L-9742-2015; Pan, Bo/HHD-1463-2022; Huang, Xu-Feng/D-6053-2013	Huang, Xu-Feng/0000-0002-5895-2253; Deng, Chao/0000-0003-1147-5741; Pan, Bo/0000-0001-8478-5252; Pan, Bo/0000-0001-8478-5252; Huang, Xu-Feng/0000-0002-5895-2253; Lian, Jiamei/0000-0002-8850-2536; Chen, Jiezhong/0000-0003-1977-6143	Australian National Health; Medical Research Council project [APP108473]	Australian National Health(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council project(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Australian National Health and Medical Research Council project grant (APP108473) to Chao Deng. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell A, 2004, NEUROSCI BIOBEHAV R, V28, P415, DOI 10.1016/j.neubiorev.2004.05.001; Alimohamad H, 2005, J NEUROCHEM, V95, P513, DOI 10.1111/j.1471-4159.2005.03388.x; Alimohamad H, 2005, BIOL PSYCHIAT, V57, P533, DOI 10.1016/j.biopsych.2004.11.036; Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Batchelor M, 1998, J NEUROSCI, V18, P10304; Bateup HS, 2008, NAT NEUROSCI, V11, P932, DOI 10.1038/nn.2153; Beasley C, 2001, NEUROSCI LETT, V302, P117, DOI 10.1016/S0304-3940(01)01688-3; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Beaulieu JM, 2007, J NEUROSCI, V27, P881, DOI 10.1523/JNEUROSCI.5074-06.2007; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Boyd KN, 2012, HANDB EXP PHARMACOL, V212, P53, DOI 10.1007/978-3-642-25761-2_3; Burris KD, 2002, J PHARMACOL EXP THER, V302, P381, DOI 10.1124/jpet.102.033175; CADD G, 1989, NEURON, V3, P71, DOI 10.1016/0896-6273(89)90116-5; CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140; Clegg CH, 1996, J BIOL CHEM, V271, P1638, DOI 10.1074/jbc.271.3.1638; CLEGG CH, 1987, J BIOL CHEM, V262, P13111; DeLeon A, 2004, CLIN THER, V26, P649, DOI 10.1016/S0149-2918(04)90066-5; Der-Ghazarian T, 2010, J NEURAL TRANSM, V117, P573, DOI 10.1007/s00702-010-0396-5; Dwivedi Y, 2002, J PHARMACOL EXP THER, V301, P197, DOI 10.1124/jpet.301.1.197; ELMESTIKAWY S, 1986, J NEUROCHEM, V47, P1425; Emamian ES, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00033; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Han M, 2009, NEUROSCIENCE, V164, P1754, DOI 10.1016/j.neuroscience.2009.09.041; Han M, 2009, INT J NEUROPSYCHOPH, V12, P941, DOI 10.1017/S1461145709009948; Harada K, 1996, J NEUROCHEM, V67, P629; He M, 2014, PSYCHONEUROENDOCRINO, V42, P153, DOI 10.1016/j.psyneuen.2014.01.018; Hirose Tsuyoshi, 2005, J Med Invest, V52 Suppl, P284, DOI 10.2152/jmi.52.284; Jope RS, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00016; KANEKO M, 1992, PROSTAG LEUKOTR ESS, V46, P53, DOI 10.1016/0952-3278(92)90059-R; Kang UG, 2004, FEBS LETT, V560, P115, DOI 10.1016/S0014-5793(04)00082-1; Khanna P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006569.pub4; KIKUCHI T, 1995, J PHARMACOL EXP THER, V274, P329; Koros E, 2007, DRUG NEWS PERSPECT, V20, P437, DOI 10.1358/dnp.2007.20.7.1149632; Kozlovsky N, 2001, SCHIZOPHR RES, V52, P101, DOI 10.1016/S0920-9964(00)00174-2; Lawler CP, 1999, NEUROPSYCHOPHARMACOL, V20, P612, DOI 10.1016/S0893-133X(98)00099-2; Li XH, 2007, INT J NEUROPSYCHOPH, V10, P7, DOI 10.1017/S1461145706006547; Lieberman JA, 2004, CNS DRUGS, V18, P251, DOI 10.2165/00023210-200418040-00005; Lovestone S, 2007, TRENDS NEUROSCI, V30, P142, DOI 10.1016/j.tins.2007.02.002; Mailman RB, 2007, TRENDS PHARMACOL SCI, V28, P390, DOI 10.1016/j.tips.2007.06.002; Mailman RB, 2010, CURR PHARM DESIGN, V16, P488, DOI 10.2174/138161210790361461; Malling D, 2007, SCHIZOPHR B; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; MIYAZAKI H, 1986, ARZNEIMITTEL-FORSCH, V36-1, P443; Mizrahi R, 2009, INT J NEUROPSYCHOPH, V12, P715, DOI 10.1017/S1461145709000327; NISSBRANDT H, 1985, J PHARM PHARMACOL, V37, P884, DOI 10.1111/j.2042-7158.1985.tb04994.x; ONALI P, 1992, NEUROCHEM INT, V20, pS89; Page G, 2004, NEUROCHEM INT, V45, P627, DOI 10.1016/j.neuint.2004.04.002; Park SW, 2011, NEUROSCI RES, V71, P335, DOI 10.1016/j.neures.2011.08.010; Paxinos G, 2005, THE RAT BRAIN IN STE; Polter AM, 2012, CELL SIGNAL, V24, P265, DOI 10.1016/j.cellsig.2011.09.009; ROSKOSKI R, 1987, J NEUROCHEM, V48, P236, DOI 10.1111/j.1471-4159.1987.tb13153.x; Seeman Philip, 2010, Clin Schizophr Relat Psychoses, V4, P56, DOI 10.3371/CSRP.4.1.5; Shapiro DA, 2003, NEUROPSYCHOPHARMACOL, V28, P1400, DOI 10.1038/sj.npp.1300203; Shimokawa Y, 2005, J CHROMATOGR B, V821, P8, DOI 10.1016/j.jchromb.2005.03.024; Sibley DR, 1999, ANNU REV PHARMACOL, V39, P313, DOI 10.1146/annurev.pharmtox.39.1.313; Smith GC, 2014, PSYCHOPHARMACOLOGY, V231, P4553, DOI 10.1007/s00213-014-3608-0; Soberg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060935; STRAIT KA, 1986, MOL PHARMACOL, V29, P561; Sutton LP, 2007, J NEUROCHEM, V102, P153, DOI 10.1111/j.1471-4159.2007.04527.x; Svenningsson P, 1998, NEUROSCIENCE, V84, P223, DOI 10.1016/S0306-4522(97)00510-1; SVENSSON K, 1991, N-S ARCH PHARMACOL, V344, P263; Tadori Y, 2008, EUR J PHARMACOL, V597, P27, DOI 10.1016/j.ejphar.2008.09.008; Tadori Y, 2007, EUR J PHARMACOL, V574, P103, DOI 10.1016/j.ejphar.2007.07.031; Tamminga CA, 2002, CNS NEUROL DISORD-DR, V1, P141, DOI 10.2174/1568007024606195; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Thiselton DL, 2008, BIOL PSYCHIAT, V63, P449, DOI 10.1016/j.biopsych.2007.06.005; Turalba AV, 2004, NEUROSCI LETT, V357, P53, DOI 10.1016/j.neulet.2003.11.059; UHLER MD, 1986, J BIOL CHEM, V261, P5360; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Urban JD, 2007, NEUROPSYCHOPHARMACOL, V32, P67, DOI 10.1038/sj.npp.1301071; Urs NM, 2012, P NATL ACAD SCI USA, V109, P20732, DOI 10.1073/pnas.1215489109; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Vernaleken I, 2006, NEUROIMAGE, V30, P1332, DOI 10.1016/j.neuroimage.2005.11.014; WEINER DM, 1991, P NATL ACAD SCI USA, V88, P1859, DOI 10.1073/pnas.88.5.1859; WOLF ME, 1990, ANN NY ACAD SCI, V604, P323, DOI 10.1111/j.1749-6632.1990.tb32003.x; Zhang QS, 2014, INT J NEUROPSYCHOPH, V17, P807, DOI 10.1017/S1461145713001697; Zhang QS, 2014, PROG NEURO-PSYCHOPH, V51, P172, DOI 10.1016/j.pnpbp.2014.02.003	81	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132722	10.1371/journal.pone.0132722	http://dx.doi.org/10.1371/journal.pone.0132722			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162083	Green Submitted, gold, Green Published			2022-12-27	WOS:000358162300171
J	Pandis, N; Fleming, PS; Worthington, H; Salanti, G				Pandis, Nikolaos; Fleming, Padhraig S.; Worthington, Helen; Salanti, Georgia			The Quality of the Evidence According to GRADE Is Predominantly Low or Very Low in Oral Health Systematic Reviews	PLOS ONE			English	Review							REPORTING QUALITY; RECOMMENDATIONS; GUIDELINES; STRENGTH; METAANALYSES; ORTHODONTICS; ABSTRACTS; COCHRANE; JOURNALS	Objectives The main objective was to assess the credibility of the evidence using Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) in oral health systematic reviews on the Cochrane Database of Systematic Reviews (CDSR) and elsewhere. Study Design and Setting Systematic Reviews or meta-analyses (January 2008-December 2013) from 14 high impact general dental and specialty dental journals and the Cochrane Database of Systematic Reviews were screened for meta-analyses. Data was collected at the systematic review, meta-analysis and trial level. Two reviewers applied and agreed on the GRADE rating for the selected meta-analyses. Results From the 510 systematic reviews initially identified 91 reviews (41 Cochrane and 50 non-Cochrane) were eligible for inclusion. The quality of evidence was high in 2% and moderate in 18% of the included meta-analyses with no difference between Cochrane and non-Cochrane reviews, journal impact factor or year of publication. The most common domains prompting downgrading of the evidence were study limitations (risk of bias) and imprecision (risk of play of chance). Conclusion The quality of the evidence in oral health assessed using GRADE is predominantly low or very low suggesting a pressing need for more randomised clinical trials and other studies of higher quality in order to inform clinical decisions thereby reducing the risk of instituting potentially ineffective and/or harmful therapies.	[Pandis, Nikolaos; Salanti, Georgia] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Fleming, Padhraig S.] Queen Mary Univ London, Barts & London Sch Med & Dent, London E12 AD, England; [Worthington, Helen] Univ Manchester, Sch Dent, Cochrane Oral Hlth Grp, Manchester M13 9PL, Lancs, England; [Pandis, Nikolaos] Univ Bern, Fac Med, Sch Dent, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland	University of Ioannina; University of London; Queen Mary University London; University of Manchester; University of Bern; University of Geneva	Pandis, N (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	npandis@yahoo.com	Worthington, Helen/U-8971-2019	Worthington, Helen/0000-0002-4851-7469; Salanti, Georgia/0000-0002-3830-8508	Papavramides Foundation, Bern, Switzerland; European Research Council (ERC Starting Grant) [IMMA 260559]	Papavramides Foundation, Bern, Switzerland; European Research Council (ERC Starting Grant)(European Research Council (ERC))	This study was supported by a grant of the Papavramides Foundation, Bern, Switzerland to the first author. Additionally, Georgia Salanti received funding from the European Research Council (ERC Starting Grant IMMA 260559). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Beller EM, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-36; Brito JP, 2013, J CLIN EPIDEMIOL, V66, P633, DOI 10.1016/j.jclinepi.2013.01.008; Brozek JL, 2009, ALLERGY, V64, P669, DOI 10.1111/j.1398-9995.2009.01973.x; Davey J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-160; De Palma R, 2008, J CLIN ONCOL, V26, P1033, DOI 10.1200/JCO.2007.12.1608; Eberhard J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004622.pub2; Eberhard J, 2008, J CLIN PERIODONTOL, V35, P591, DOI 10.1111/j.1600-051X.2008.01239.x; Faggion CM, 2011, J ORAL REHABIL, V38, P940, DOI 10.1111/j.1365-2842.2011.02230.x; Faggion Clovis Mariano Jr, 2010, J Evid Based Dent Pract, V10, P78, DOI 10.1016/j.jebdp.2010.01.001; Ferreira ML, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5913; Fleming PS, 2014, J CLIN EPIDEMIOL, V67, P754, DOI 10.1016/j.jclinepi.2014.01.002; Fleming PS, 2013, EUR J ORTHODONT, V35, P244, DOI 10.1093/ejo/cjs016; Fleming PS, 2013, J DENT, V41, P265, DOI 10.1016/j.jdent.2012.11.012; Fleming PS, 2013, ANGLE ORTHOD, V83, P158, DOI 10.2319/032612-251.1; Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174; Guyatt G, 2013, J CLIN EPIDEMIOL, V66, P151, DOI 10.1016/j.jclinepi.2012.01.006; Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1303, DOI 10.1016/j.jclinepi.2011.04.014; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P395, DOI 10.1016/j.jclinepi.2010.09.012; Hartling L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034697; Kiriakou J, 2013, J DENT, V41, P1181, DOI 10.1016/j.jdent.2013.09.006; Koletsi D, 2012, EUR J ORTHODONT, V34, P287, DOI 10.1093/ejo/cjr122; Latthe PM, 2008, BJOG-INT J OBSTET GY, V115, P435, DOI 10.1111/j.1471-0528.2007.01629.x; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Martel G, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-14; Murad MH, 2014, J CLIN EPIDEMIOL, V67, P65, DOI 10.1016/j.jclinepi.2013.08.004; Mustafa RA, 2013, J CLIN EPIDEMIOL, V66, P736, DOI 10.1016/j.jclinepi.2013.02.004; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Pandis N, 2013, EUR J ORTHODONT, V35, P783, DOI 10.1093/ejo/cjs108; Pandis N, 2013, EUR J ORTHODONT, V35, P669, DOI 10.1093/ejo/cjs072; Saltaji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074545; Seehra J, 2013, EUR J ORAL SCI, V121, P57, DOI 10.1111/eos.12027; Sterne J.A., 2008, COCHRANE HDB SYSTEMA, DOI [10.1002/9780470712184.ch10, DOI 10.1002/9780470712184.CH10]; Swiglo BA, 2008, J CLIN ENDOCR METAB, V93, P666, DOI 10.1210/jc.2007-1907	41	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131644	10.1371/journal.pone.0131644	http://dx.doi.org/10.1371/journal.pone.0131644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162076	Green Submitted, gold, Green Published			2022-12-27	WOS:000358162300051
J	Salfati, E; Morrison, AC; Boerwinkle, E; Chakravarti, A				Salfati, Elias; Morrison, Alanna C.; Boerwinkle, Eric; Chakravarti, Aravinda			Direct Estimates of the Genomic Contributions to Blood Pressure Heritability within a Population-Based Cohort (ARIC)	PLOS ONE			English	Article							COMMON SNPS EXPLAIN; WIDE ASSOCIATION; GENETIC-VARIATION; DISEASE; SUSCEPTIBILITY; HYPERTENSION; TRAITS; LOCI; IDENTIFICATION; ANNOTATION	Blood pressure (BP) is a heritable trait with multiple environmental and genetic contributions, with current heritability estimates from twin and family studies being similar to 40%. Here, we use genome-wide polymorphism data from the Atherosclerosis Risk in Communities (ARIC) study to estimate BP heritability from genomic relatedness among cohort members. We utilized data on 6,365,596 and 9,578,528 genotyped and imputed common single nucleotide polymorphisms (SNPs), in 8,901 European ancestry (EA) and 2,860 African Ancestry (AA) ARIC participants, respectively, and a mixed linear model for analyses, to make four observations. First, for BP measurements, the heritability is similar to 20%/similar to 50% and similar to 27%/similar to 39% for systolic (SBP)/diastolic (DBP) blood pressure in European and African ancestry individuals, respectively, consistent with prior studies. Second, common variants with allele frequency >10% recapitulate most of the BP heritability in these data. Third, the vast majority of BP heritability varies by chromosome, depending on its length, and is largely concentrated in noncoding genomic regions annotated as DNaseI hypersensitive sites (DHSs). Fourth, the majority of this heritability arises from loci not harboring currently known cardiovascular and renal genes. Recent meta-analyses of large-scale genome-wide association studies (GWASs) and admixture mapping have identified similar to 50 loci associated with BP and hypertension (HTN), and yet they account for only a small fraction (similar to 2%) of the heritability.	[Salfati, Elias; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA; [Salfati, Elias] Univ Paris 05, Sorbonne Paris Cite, F-75005 Paris, France; [Morrison, Alanna C.; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA	Johns Hopkins University; UDICE-French Research Universities; Universite Paris Cite; University of Texas System; University of Texas Health Science Center Houston	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA.	aravinda@jhmi.edu		Morrison, Alanna/0000-0001-6381-4296	National Heart, Lung, and Blood Institute (NHLBI) [HL086694]; NHLBI [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health, a component of the National Institutes of Health [HHSN268200625226C, UL1RR025005]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087641, R01HL086694, R01HL059367] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health, a component of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grant HL086694 from the National Heart, Lung, and Blood Institute (NHLBI) to A.C. The Atherosclerosis Risk in Communities Study was carried out as a collaborative study supported by NHLBI contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research.	ARIC Investigators, 1988, SITT BLOOD PRESS POS; Barkley RA, 2004, HYPERTENSION, V43, P477, DOI 10.1161/01.HYP.0000111585.76299.f7; Cook NR, 2000, STAT MED, V19, P2625, DOI 10.1002/1097-0258(20001015)19:19<2625::AID-SIM536>3.0.CO;2-H; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Ehret GB, 2013, EUR HEART J, V34, P951, DOI 10.1093/eurheartj/ehs455; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Fox ER, 2011, HUM MOL GENET, V20, P2273, DOI 10.1093/hmg/ddr092; Ganesh SK, 2014, AM J HUM GENET, V95, P49, DOI 10.1016/j.ajhg.2014.06.002; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Harvey PR, 2013, J NEPHROL, V26, P94, DOI 10.5301/jn.5000119; Ho JE, 2011, J HYPERTENS, V29, P62, DOI 10.1097/HJH.0b013e3283406927; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Johnson AD, 2011, HYPERTENSION, V57, P903, DOI 10.1161/HYPERTENSIONAHA.110.158667; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Lee SH, 2013, HUM MOL GENET, V22, P832, DOI 10.1093/hmg/dds491; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; LIFTON RP, 1993, J HYPERTENS, V11, P231, DOI 10.1097/00004872-199303000-00002; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Olden M, 2013, AM J KIDNEY DIS, V61, P889, DOI 10.1053/j.ajkd.2012.12.024; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Salvi E, 2012, HYPERTENSION, V59, P248, DOI 10.1161/HYPERTENSIONAHA.111.181990; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Vattikuti S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002637; Vinkhuyzen AAE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.27; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2014, BBA-MOL BASIS DIS, V1842, P1896, DOI 10.1016/j.bbadis.2014.04.024; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; World Health Organization, 2012, WORLD HLTH STAT, V2012, P35; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang SC, 2009, OBESITY, V17, P1581, DOI 10.1038/oby.2009.125; Zhu XF, 2011, HUM MOL GENET, V20, P2285, DOI 10.1093/hmg/ddr113	40	29	30	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0133031	10.1371/journal.pone.0133031	http://dx.doi.org/10.1371/journal.pone.0133031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162070	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300183
J	Fernandes, JDS; Martho, K; Tofik, V; Vallim, MA; Pascon, RC				Santos Fernandes, Joao Daniel; Martho, Kevin; Tofik, Veridiana; Vallim, Marcelo A.; Pascon, Renata C.			The Role of Amino Acid Permeases and Tryptophan Biosynthesis in Cryptococcus neoformans Survival	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; MYCOBACTERIUM-TUBERCULOSIS; GENE-EXPRESSION; COMPLETE GENOME; VIRULENCE; SYNTHASE; MUTANTS; PATHWAY; METABOLISM; INFECTION	Metabolic diversity is an important factor during microbial adaptation to different environments. Among metabolic processes, amino acid biosynthesis has been demonstrated to be relevant for survival for many microbial pathogens, whereas the association between pathogenesis and amino acid uptake and recycling are less well-established. Cryptococcus neoformans is an opportunistic fungal pathogen with many habitats. As a result, it faces frequent metabolic shifts and challenges during its life cycle. Here we studied the C. neoformans tryptophan biosynthetic pathway and found that the pathway is essential. RNAi indicated that interruptions in the biosynthetic pathway render strains inviable. However, auxotroph complementation can be partially achieved by tryptophan uptake when a non preferred nitrogen source and lower growth temperature are applied, suggesting that amino acid permeases may be the target of nitrogen catabolism repression (NCR). We used bioin-formatics to search for amino acid permeases in the C. neoformans and found eight potential global permeases (AAP1 to AAP8). The transcriptional profile of them revealed that they are subjected to regulatory mechanisms which are known to respond to nutritional status in other fungi, such as (i) quality of nitrogen (Nitrogen Catabolism Repression, NCR) and carbon sources (Carbon Catabolism Repression, CCR), (ii) amino acid availability in the extracellular environment (SPS-sensing) and (iii) nutritional deprivation (Global Amino Acid Control, GAAC). This study shows that C. neoformans has fewer amino acid permeases than other model yeasts, and that these proteins may be subjected to complex regulatory mechanisms. Our data suggest that the C. neoformans tryptophan biosynthetic pathway is an excellent pharmacological target. Furthermore, inhibitors of this pathway cause Cryptococcus growth arrest in vitro.	[Santos Fernandes, Joao Daniel; Martho, Kevin; Tofik, Veridiana; Vallim, Marcelo A.; Pascon, Renata C.] Univ Fed Sao Paulo, Dept Ciencias Biol, Inst Ciencias Ambientais Quim & Farmaceut, Lab Interacoes Microbianas,Lab 29, BR-09972270 Diadema, SP, Brazil; [Santos Fernandes, Joao Daniel] Univ Sao Paulo, BR-05508900 Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Pascon, RC (corresponding author), Univ Fed Sao Paulo, Dept Ciencias Biol, Inst Ciencias Ambientais Quim & Farmaceut, Lab Interacoes Microbianas,Lab 29, Campus Diadema,Rua Arthur Ridel 275, BR-09972270 Diadema, SP, Brazil.	renata.pascon@gmail.com	Pascon, Renata/E-1494-2012; Vallim, Marcelo/J-2624-2013	Pascon, Renata/0000-0001-9902-9396; Vallim, Marcelo/0000-0002-6929-0566	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/51298-4, 2007/50536-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2011/51298-4 (RCP) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2007/50536-3 (MAV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 2015, FUNGAL GENET BIOL, V78, P55, DOI 10.1016/j.fgb.2014.09.004; Antinori Spinello, 2013, ISRN AIDS, V2013, P471363, DOI 10.1155/2013/471363; BRAUS GH, 1991, MICROBIOL REV, V55, P349, DOI 10.1128/MMBR.55.3.349-370.1991; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brown SM, 2007, CURR OPIN MICROBIOL, V10, P320, DOI 10.1016/j.mib.2007.05.014; Chittur SV, 2001, BIOCHEMISTRY-US, V40, P876, DOI 10.1021/bi0014047; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Datta K, 2009, EMERG INFECT DIS, V15, P1185, DOI 10.3201/eid1508.081384; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; de Gontijo FA, 2014, FUNGAL GENET BIOL, V70, P12, DOI 10.1016/j.fgb.2014.06.003; Fan WH, 2005, EUKARYOT CELL, V4, P1420, DOI 10.1128/EC.4.8.1420-1433.2005; Fernandez J, 2014, ANNU REV PHYTOPATHOL, V52, P155, DOI 10.1146/annurev-phyto-102313-050135; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Gahan CGM, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00009; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hu GG, 2008, MOL MICROBIOL, V69, P1456, DOI 10.1111/j.1365-2958.2008.06374.x; Jones EW, 2008, YEAST, V25, P41, DOI 10.1002/yea.1552; Jung WH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040045; Jung WH, 2008, CELL MICROBIOL, V10, P277, DOI 10.1111/j.1462-5822.2007.01077.x; Jung WH, 2011, MOL CELLS, V31, P73, DOI 10.1007/s10059-011-0011-0; Jung WH, 2009, EUKARYOT CELL, V8, P1511, DOI 10.1128/EC.00166-09; Kim MS, 2009, BIOCHEM BIOPH RES CO, V390, P983, DOI 10.1016/j.bbrc.2009.10.089; Kingsbury JM, 2004, MICROBIOL-SGM, V150, P1547, DOI 10.1099/mic.0.26928-0; Kingsbury JM, 2004, EUKARYOT CELL, V3, P752, DOI 10.1128/EC.3.3.752-763.2004; Kingsbury JM, 2008, MICROBIOL-SGM, V154, P2767, DOI 10.1099/mic.0.2008/019729-0; Kingsbury JM, 2010, EUKARYOT CELL, V9, P729, DOI 10.1128/EC.00045-10; Kingsbury JM, 2010, MICROBIOL-SGM, V156, P929, DOI 10.1099/mic.0.034348-0; Kmetzsch L, 2011, FUNGAL GENET BIOL, V48, P192, DOI 10.1016/j.fgb.2010.07.011; Kretschmer M, 2014, INFECT IMMUN, V82, P2697, DOI 10.1128/IAI.01607-14; Kronstad J, 2012, EUKARYOT CELL, V11, P109, DOI 10.1128/EC.05273-11; Lee IR, 2013, FEMS MICROBIOL LETT, V345, P77, DOI 10.1111/1574-6968.12181; Lee IR, 2011, GENETICS, V188, P309, DOI 10.1534/genetics.111.128538; Lee IS, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/872142; Li Shu Shun, 2010, Proc Am Thorac Soc, V7, P186, DOI 10.1513/pats.200907-063AL; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; MAURER R, 1971, J BACTERIOL, V106, P331, DOI 10.1128/JB.106.2.331-338.1971; MIOZZARI G, 1977, ARCH MICROBIOL, V115, P307, DOI 10.1007/BF00446457; Moran GP, 2011, EUKARYOT CELL, V10, P34, DOI 10.1128/EC.00242-10; Morya VK, 2011, INT J LATEST TRENDS, V2, P178; Nazi I, 2007, ANTIMICROB AGENTS CH, V51, P1731, DOI 10.1128/AAC.01400-06; Nelissen B, 1995, FEBS LETT, V377, P232, DOI 10.1016/0014-5793(95)01380-6; Nelissen B, 1997, FEMS MICROBIOL REV, V21, P113, DOI 10.1111/j.1574-6976.1997.tb00347.x; Nosanchuk JD, 2001, J INFECT DIS, V183, P1093, DOI 10.1086/319272; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pascon RC, 2004, MICROBIOL-SGM, V150, P3013, DOI 10.1099/mic.0.27235-0; Paulsen IT, 1998, FEBS LETT, V430, P116, DOI 10.1016/S0014-5793(98)00629-2; Payne RJ, 2010, ORG BIOMOL CHEM, V8, P3534, DOI 10.1039/c004062b; Payne RJ, 2009, ORG BIOMOL CHEM, V7, P2421, DOI 10.1039/b901694e; Payne RJ, 2005, ORG BIOMOL CHEM, V3, P3629, DOI 10.1039/b510633h; PERFECT JR, 1992, GENE, V122, P213, DOI 10.1016/0378-1119(92)90053-R; Peter GJ, 2006, J BIOL CHEM, V281, P5546, DOI 10.1074/jbc.M513842200; Raboni S, 2009, CELL MOL LIFE SCI, V66, P2391, DOI 10.1007/s00018-009-0028-0; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Reilly MC, 2009, J BIOL CHEM, V284, P36118, DOI 10.1074/jbc.M109.056226; Sasaki T, 2012, J BIOSCI BIOENG, V113, P726, DOI 10.1016/j.jbiosc.2012.01.012; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Shen HB, 2010, J MICROBIOL, V48, P337, DOI 10.1007/s12275-010-9315-6; Shen HB, 2009, FEBS J, V276, P144, DOI 10.1111/j.1742-4658.2008.06763.x; Skowyra Michael L, 2012, Methods Mol Biol, V845, P165, DOI 10.1007/978-1-61779-539-8_11; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; TILBY MJ, 1976, J GEN MICROBIOL, V93, P126, DOI 10.1099/00221287-93-1-126; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Toyn JH, 2000, YEAST, V16, P553, DOI 10.1002/(SICI)1097-0061(200004)16:6<553::AID-YEA554>3.0.CO;2-7; Webby CJ, 2010, J BIOL CHEM, V285, P30567, DOI 10.1074/jbc.M110.111856; Yang ZH, 2002, MICROBIOL-SGM, V148, P2617, DOI 10.1099/00221287-148-8-2617; Ziebart KT, 2010, J MED CHEM, V53, P3718, DOI 10.1021/jm100158v	70	29	28	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132369	10.1371/journal.pone.0132369	http://dx.doi.org/10.1371/journal.pone.0132369			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162077	gold, Green Submitted, Green Published			2022-12-27	WOS:000358162300123
J	Sithambaram, S; Hilmi, I; Goh, KL				Sithambaram, Suresh; Hilmi, Ida; Goh, Khean-Lee			The Diagnostic Accuracy of the M2 Pyruvate Kinase Quick Stool Test-A Rapid Office Based Assay Test for the Detection of Colorectal Cancer	PLOS ONE			English	Article							OCCULT BLOOD-TEST; SENSITIVE SCREENING TOOL; ISOENZYME TYPE M2; PROSPECTIVE MULTICENTER; TUMOR M2-PK; POPULATION; PERFORMANCE; BIOMARKER; NEOPLASIA; ADENOMAS	Background M2 pyruvate kinase (M2PK) is an oncoprotein secreted by colorectal cancers in stools. This the first report on the accuracy of a rapid stool test in the detection of colorectal cancer (CRC). Objective To determine the sensitivity, specificity and positive and negative predictive value of a rapid, point of care stool test M2 PK-the M2PK Quick. Methods Consecutive cases of endoscopically diagnosed and histological proven CRC were recruited. Stools were collected by patients and tested with the immunochromatographic M2PK Quick Test (Schebo Biotech AC, Giessen, Germany). Controls were consecutively chosen from patients without any significant colorectal or gastrointestinal disease undergoing colonoscopy. CRC was staged according to the AJCC staging manual (7th Edition) and location of tumor defined as proximal or distal. Results The sensitivity, specificity, positive predictive value, negative predictive value and overall accuracy were: 93%, 97.5%, 94.9%, 96.5% and 96.0% respectively. The positive predictive value for proximal tumors was significantly lower compared to distal tumors. No differences were seen between the different stages of the tumor. Conclusions The M2-PK Quick, rapid, point-of-care test is a highly accurate test in the detection of CRC. It is easy and convenient to perform and a useful diagnostic test for the detection of CRC in a clinical practice setting.	[Sithambaram, Suresh; Hilmi, Ida; Goh, Khean-Lee] Univ Malaya, Dept Med, Div Gastroenterol & Hepatol, Kuala Lumpur, Malaysia	Universiti Malaya	Goh, KL (corresponding author), Univ Malaya, Dept Med, Div Gastroenterol & Hepatol, Kuala Lumpur, Malaysia.	klgoh56@gmail.com	Goh, Khean-Lee/B-6404-2009; Hilmi, Ida/AAN-7129-2020	Goh, Khean-Lee/0000-0002-9965-1561; 	Alere Company	Alere Company	The study was funded by Alere Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah Murdhani, 2012, Acta Med Indones, V44, P94; Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; Hardt PD, 2004, BRIT J CANCER, V91, P980, DOI 10.1038/sj.bjc.6602033; Hardt PD, 2003, ANTICANCER RES, V23, P851; Haug U, 2008, BRIT J CANCER, V99, P133, DOI 10.1038/sj.bjc.6604427; Imperiale TF, 2007, ANN INTERN MED, V146, P309, DOI 10.7326/0003-4819-146-4-200702200-00013; Koss K, 2008, COLORECTAL DIS, V10, P244, DOI 10.1111/j.1463-1318.2007.01334.x; Kumar Y, 2007, EUR J GASTROEN HEPAT, V19, P265, DOI 10.1097/MEG.0b013e3280102f78; Leen R, 2014, EUR J GASTROEN HEPAT, V26, P514, DOI 10.1097/MEG.0000000000000025; Levi Z, 2007, ANN INTERN MED, V146, P244, DOI 10.7326/0003-4819-146-4-200702200-00003; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Mulder SA, 2007, EUR J GASTROEN HEPAT, V19, P878, DOI 10.1097/MEG.0b013e3282cfa49c; Naumann M, 2004, DEUT MED WOCHENSCHR, V129, P1806, DOI 10.1055/s-2004-829033; Shastri YM, 2008, AM J GASTROENTEROL, V103, P1496, DOI 10.1111/j.1572-0241.2008.01824.x; Shastri YM, 2006, INT J CANCER, V119, P2651, DOI 10.1002/ijc.22243; Shastri YM, 2008, CLIN LAB, V54, P389; Tonus C, 2006, WORLD J GASTROENTERO, V12, P7007, DOI 10.3748/wjg.v12.i43.7007; Tonus C, 2012, WORLD J GASTROENTERO, V18, P4004, DOI 10.3748/wjg.v18.i30.4004; Vilkin A, 2005, AM J GASTROENTEROL, V100, P2519, DOI 10.1111/j.1572-0241.2005.00231.x; Vogel T, 2005, DEUT MED WOCHENSCHR, V130, P872, DOI 10.1055/s-2005-865100; Walkowiak J, 2005, SCAND J GASTROENTERO, V40, P1493, DOI 10.1080/00365520500319112; Zappa M, 2001, INT J CANCER, V92, P151, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1149>3.3.CO;2-Y	23	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131616	10.1371/journal.pone.0131616	http://dx.doi.org/10.1371/journal.pone.0131616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158845	Green Published, gold, Green Submitted			2022-12-27	WOS:000358161200034
J	Mezyk-Kopec, R; Wyroba, B; Stalinska, K; Prochnicki, T; Wiatrowska, K; Kilarski, WW; Swartz, MA; Bereta, J				Mezyk-Kopec, Renata; Wyroba, Barbara; Stalinska, Krystyna; Prochnicki, Tomasz; Wiatrowska, Karolina; Kilarski, Witold W.; Swartz, Melody A.; Bereta, Joanna			ADAM17 Promotes Motility, Invasion, and Sprouting of Lymphatic Endothelial Cells	PLOS ONE			English	Article							EGFR TRANSACTIVATION; THERAPEUTIC TARGET; TNF-ALPHA; IN-VITRO; MIGRATION; EXPRESSION; INTEGRIN; ADAM-17; PROLIFERATION; REGENERATION	Tumor-associated lymphatic vessels actively participate in tumor progression and dissemination. ADAM17, a sheddase for numerous growth factors, cytokines, receptors, and cell adhesion molecules, is believed to promote tumor development, facilitating both tumor cell proliferation and migration, as well as tumor angiogenesis. In this work we addressed the issue of whether ADAM17 may also promote tumor lymphangiogenesis. First, we found that ADAM17 is important for the migratory potential of immortalized human dermal lymphatic endothelial cells (LEC). When ADAM17 was stably silenced in LEC, their proliferation was not affected, but: (i) single-cell motility, (ii) cell migration through a 3D Matrigel/collagen type I matrix, and (iii) their ability to form sprouts in a 3D matrix were significantly diminished. The differences in the cell motility between ADAM17-proficient and ADAM17-silenced cells were eliminated by inhibitors of EGFR and HER2, indicating that ADAM17-mediated shedding of growth factors accounts for LEC migratory potential. Interestingly, ADAM17 depletion affected the integrin surface expression/functionality in LEC. ADAM17-silenced cells adhered to plastic, type I collagen, and fibronectin faster than their ADAM17-proficient counterparts. The difference in adhesion to fibronectin was abolished by a cyclic RGD peptide, emphasizing the involvement of integrins in the process. Using a soluble receptor array, we identified BIG-H3 among several candidate proteins involved in the phenotypic and behavioral changes of LEC upon ADAM17 silencing. In additional assays, we confirmed the increased expression of BIG-H3, as well as TGF beta 2 in ADAM17-silenced LEC. The antilym-phangiogenic effects of ADAM17 silencing in lymphatic endothelial cells suggest further relevance of ADAM17 as a potential target in cancer therapy.	[Mezyk-Kopec, Renata; Wyroba, Barbara; Stalinska, Krystyna; Prochnicki, Tomasz; Wiatrowska, Karolina; Bereta, Joanna] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biochem, Krakow, Poland; [Mezyk-Kopec, Renata; Kilarski, Witold W.; Swartz, Melody A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland; [Mezyk-Kopec, Renata; Kilarski, Witold W.; Swartz, Melody A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Canc Res ISREC, Lausanne, Switzerland; [Mezyk-Kopec, Renata; Kilarski, Witold W.; Swartz, Melody A.] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA	Jagiellonian University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of Chicago	Bereta, J (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biochem, Krakow, Poland.	joanna.bereta@uj.edu.pl	Kilarski, Witold/AAA-1843-2019; Kilarski, Witold W./G-8673-2012; Swartz, Melody A./F-9563-2011	Kilarski, Witold W./0000-0003-0734-4749; Bereta, Joanna/0000-0001-7930-2770	Polish-Swiss Research Programme [PSPB 057/2010]	Polish-Swiss Research Programme	Funding provided by Polish-Swiss Research Programme, http://www.swiss.opi.org.pl/, grant no. PSPB 057/2010 to MAS and JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas J, 2009, CURR PHARM DESIGN, V15, P2319, DOI 10.2174/138161209788682398; Avraham T, 2010, AM J PATHOL, V177, P3202, DOI 10.2353/ajpath.2010.100594; Avraham T, 2009, PLAST RECONSTR SURG, V124, P438, DOI 10.1097/PRS.0b013e3181adcf4b; Bax DV, 2004, J BIOL CHEM, V279, P22377, DOI 10.1074/jbc.M400180200; Bell JH, 2007, J LEUKOCYTE BIOL, V82, P173, DOI 10.1189/jlb.0307193; Blacher S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097019; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Cells J., 1998, CELL BIOL LAB HDB; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Chen Jie, 2012, Int J Cell Biol, V2012, P853703, DOI 10.1155/2012/853703; Christiansen Ailsa, 2011, Genes Cancer, V2, P1146, DOI 10.1177/1947601911423028; Clavin NW, 2008, AM J PHYSIOL-HEART C, V295, pH2113, DOI 10.1152/ajpheart.00879.2008; Coligan J, 1997, CURRENT PROTOCOLS IN; Das S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050791; Dreymueller D, 2012, EMBO MOL MED, V4, P412, DOI 10.1002/emmm.201200217; Duffy Michael J, 2011, Clin Proteomics, V8, P9, DOI 10.1186/1559-0275-8-9; Ebi M, 2010, BIOCHEM BIOPH RES CO, V402, P449, DOI 10.1016/j.bbrc.2010.09.130; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; Fedak PWM, 2006, CIRCULATION, V113, P238, DOI 10.1161/CIRCULATIONAHA.105.571414; Franovic A, 2006, CANCER RES, V66, P8083, DOI 10.1158/0008-5472.CAN-06-1595; Fukaya S, 2013, LAB INVEST, V93, P72, DOI 10.1038/labinvest.2012.153; Gooz P, 2009, BIOCHEM BIOPH RES CO, V380, P33, DOI 10.1016/j.bbrc.2009.01.013; Goitre L, 2012, J SIGNAL TRANSDUCT, V2012, DOI DOI 10.1155/2012/807682; Goldman J, 2007, FASEB J, V21, P1003, DOI 10.1096/fj.06-6656com; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Hirosue S, 2014, J IMMUNOL, V192, P5002, DOI 10.4049/jimmunol.1302492; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; James JM, 2013, DEVELOPMENT, V140, P3903, DOI 10.1242/dev.095026; Karaman S, 2014, J CLIN INVEST, V124, P922, DOI 10.1172/JCI71606; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Klamer SE, 2013, CELL ADHES MIGR, V7, P434, DOI 10.4161/cam.26596; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; Malapeira J, 2011, ONCOGENE, V30, P1912, DOI 10.1038/onc.2010.565; Maretzky T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1232; McGowan PM, 2013, ANN ONCOL, V24, P362, DOI 10.1093/annonc/mds279; McGowan PM, 2007, CLIN CANCER RES, V13, P2335, DOI 10.1158/1078-0432.CCR-06-2092; Miteva DO, 2010, CIRC RES, V106, P920, DOI 10.1161/CIRCRESAHA.109.207274; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Moreno-Caceres J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.294; Morgan MR, 2013, DEV CELL, V24, P472, DOI 10.1016/j.devcel.2013.01.027; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nam EJ, 2006, ARTHRITIS RHEUM-US, V54, P2734, DOI 10.1002/art.22076; Nees M, 2000, CANCER RES, V60, P4289; Oka M, 2008, BLOOD, V111, P4571, DOI 10.1182/blood-2007-10-120337; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schoppmann SF, 2004, MICROCIRCULATION, V11, P261, DOI 10.1080/10739680490425967; Sroka J, 2007, BIOL CELL, V99, P677, DOI 10.1042/BC20070024; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Tewalt EF, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00305; Tsubota Y, 2013, J IMMUNOL, V190, P4236, DOI 10.4049/jimmunol.1300046; Tumbarello DA, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-36; Uchiyama-Tanaka Y, 2002, KIDNEY INT, V62, P799, DOI 10.1046/j.1523-1755.2002.00537.x; Wang YD, 2010, GENE DEV, V24, P2115, DOI 10.1101/gad.1955910; Weskamp G, 2010, CIRC RES, V106, P932, DOI 10.1161/CIRCRESAHA.109.207415; Wick N, 2008, AM J PATHOL, V173, P1202, DOI 10.2353/ajpath.2008.080101; Yan A, 2011, FUTURE ONCOL, V7, P1457, DOI [10.2217/fon.11.121, 10.2217/FON.11.121]; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141; Yang JW, 2001, NAT BIOTECHNOL, V19, P219, DOI 10.1038/85655; Yoda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054412; Zhang Y, 2009, CANCER RES, V69, P37, DOI 10.1158/0008-5472.CAN-08-1648; Zheng XG, 2012, MOL CARCINOGEN, V51, P150, DOI 10.1002/mc.20772	65	15	15	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132661	10.1371/journal.pone.0132661	http://dx.doi.org/10.1371/journal.pone.0132661			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176220	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600140
J	Akiyama, H; Uchino, K; Hasegawa, Y				Akiyama, Hisanao; Uchino, Kenji; Hasegawa, Yasuhiro			Characteristics of Symptomatic Intracranial Hemorrhage in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulant Therapy	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; INTRACEREBRAL HEMORRHAGE; DABIGATRAN; WARFARIN; RIVAROXABAN; RISK; PREVENTION; APIXABAN; STROKE; COHORT	Objectives The first non-vitamin K antagonist oral anticoagulant (NOAC) introduced to the market in Japan was dabigatran in March 2011, and three more NOACs, rivaroxaban, apixaban, and edoxaban, have since become available. Randomized controlled trials of NOACs have revealed that intracranial hemorrhage (ICH) occurs less frequently with NOACs compared with warfarin. However, the absolute incidence of ICH associated with NOACs has increased with greater use of these anticoagulants, and we wanted to explore the incidence, clinical characteristics, and treatment course of patients with NOACs-associated ICH. Methods We retrospectively analyzed the characteristics of symptomatic ICH patients receiving NOACs between March 2011 and September 2014. Results ICH occurred in 6 patients (5 men, 1 woman; mean +/- SD age, 72.8 +/- 3.2 years). Mean time to onset was 146.2 +/- 111.5 days after starting NOACs. Five patients received rivaroxaban and 1 patient received apixaban. None received dabigatran or edoxaban. Notably, no hematoma expansion was observed within 24 h of onset in the absence of infusion of fresh frozen plasma, activated prothrombin complex concentrate, recombinant activated factor VIIa or hemodialysis. When NOAC therapy was initiated, mean HAS-BLED and PANWARDS scores were 1.5 +/- 0.5 and 39.5 +/- 7.7, respectively. Mean systolic blood pressure was 137.8 +/- 15.9 mmHg within 1 month before spontaneous ICH onset. Conclusion Six symptomatic ICHs occurred early in NOAC therapy but hematoma volume was small and did not expand in the absence of infusion of reversal agents or hemodialysis. The occurrence of ICH during NOAC therapy is possible even when there is acceptable mean systolic blood pressure control (137.8 +/- 15.9 mmHg) and HAS-BLED score <= 2. Even stricter blood pressure lowering and control within the acceptable range may be advisable to prevent ICH during NOAC therapy.	[Akiyama, Hisanao; Uchino, Kenji; Hasegawa, Yasuhiro] St Marianna Univ, Sch Med, Dept Neurol, Kawasaki, Kanagawa, Japan	Saint Marianna University	Akiyama, H (corresponding author), St Marianna Univ, Sch Med, Dept Neurol, Kawasaki, Kanagawa, Japan.	h2akiyama@marianna-u.ac.jp		Akiyama, Hisanao/0000-0003-4491-6064				Arima H, 2012, STROKE, V43, P1675, DOI 10.1161/STROKEAHA.112.651448; Awad AJ, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1323; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Chang DN, 2013, AM J KIDNEY DIS, V61, P487, DOI 10.1053/j.ajkd.2012.08.047; Chatterjee S, 2013, JAMA NEUROL, V70, P1486, DOI 10.1001/jamaneurol.2013.4021; Chen BC, 2012, CLIN TOXICOL, V50, P854, DOI 10.3109/15563650.2012.721888; Ciura VA, 2014, STROKE, V45, P3293, DOI 10.1161/STROKEAHA.114.005570; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; DEBATA A, 2015, JPN J STROKE, V37, P41; Demchuk AM, 2012, LANCET NEUROL, V11, P307, DOI 10.1016/S1474-4422(12)70038-8; Ezekowitz MD, 2007, AM J CARDIOL, V100, P1419, DOI 10.1016/j.amjcard.2007.06.034; Faust AC, 2014, J EMERG MED, V46, P525, DOI 10.1016/j.jemermed.2013.11.097; Garber ST, 2012, J NEUROSURG, V116, P1093, DOI 10.3171/2012.2.JNS112132; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hagii J, 2014, STROKE, V45, P2805, DOI 10.1161/STROKEAHA.114.006661; HANA A, 2014, B SOC SCI MED GRAND, V1, P57; Hankey GJ, 2014, STROKE, V45, P1304, DOI 10.1161/STROKEAHA.113.004506; Hippisley-Cox J, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4606; Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454; Kaneko M, 2013, DRUG METAB PHARMACOK, V28, P321, DOI 10.2133/dmpk.DMPK-12-RG-109; Kasliwal MK, 2015, J CLIN NEUROSCI, V22, P212, DOI 10.1016/j.jocn.2014.04.025; Komori M, 2014, CIRC J, V78, P1335, DOI 10.1253/circj.CJ-13-1534; Kono S, 2014, STROKE, V45, P2404, DOI 10.1161/STROKEAHA.114.005316; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Ross B, 2014, J MED TOXICOL, V10, P223, DOI 10.1007/s13181-013-0364-1; Saji N, 2015, CIRC J, V79, P1018, DOI 10.1253/circj.CJ-14-1209; SHOJI A, 2014, JPN J STROKE, V36, P186; Simonsen CZ, 2014, J STROKE CEREBROVASC, V23, pE133, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.011; Toyoda K, 2010, STROKE, V41, P1440, DOI 10.1161/STROKEAHA.110.580506; Uchiyama S, 2014, CEREBROVASC DIS, V37, P296, DOI 10.1159/000360811; Wassef SN, 2013, NEUROSURGERY, V73, pE368, DOI 10.1227/01.neu.0000430763.95349.5f	34	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132900	10.1371/journal.pone.0132900	http://dx.doi.org/10.1371/journal.pone.0132900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171862	gold, Green Submitted, Green Published			2022-12-27	WOS:000358194900099
J	Cheng, XE; Wang, SH; Qian, ZM; Chen, YQ				Cheng, Xi En; Wang, Shuo Hong; Qian, Zhi-Ming; Chen, Yan Qiu			Estimating Orientation of Flying Fruit Flies	PLOS ONE			English	Article							FLIGHT INITIATION; TRACKING; MANEUVERS; MOTION; BEHAVIOR; TARGETS; SYSTEM	The recently growing interest in studying flight behaviours of fruit flies, Drosophila melanogaster, has highlighted the need for developing tools that acquire quantitative motion data. Despite recent advance of video tracking systems, acquiring a flying fly's orientation remains a challenge for these tools. In this paper, we present a novel method for estimating individual flying fly's orientation using image cues. Thanks to the line reconstruction algorithm in computer vision field, this work can thereby focus on the practical detail of implementation and evaluation of the orientation estimation algorithm. The orientation estimation algorithm can be incorporated into tracking algorithms. We rigorously evaluated the effectiveness and accuracy of the proposed algorithm by running experiments both on simulation data and on real-world data. This work complements methods for studying the fruit fly's flight behaviours in a three-dimensional environment.	[Cheng, Xi En; Wang, Shuo Hong; Qian, Zhi-Ming; Chen, Yan Qiu] Fudan Univ, Sch Comp Sci, Shanghai Key Lab Intelligent Informat Proc, Shanghai 200433, Peoples R China; [Cheng, Xi En] Jingdezhen Ceram Inst, Jingdezhen, Peoples R China	Fudan University; Jingdezhen Ceramic Institute	Chen, YQ (corresponding author), Fudan Univ, Sch Comp Sci, Shanghai Key Lab Intelligent Informat Proc, Shanghai 200433, Peoples R China.	chenyq@fudan.edu.cn			National Natural Science Foundation of China [61175036, 60875024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research work presented in this paper is supported by National Natural Science Foundation of China, grant nos. 61175036 and 60875024 awarded to YQC.	Ardekani R, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0547; Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Attanasi A, 2014, ARXIV13075631; Bergou AJ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.148101; Card G, 2008, J EXP BIOL, V211, P341, DOI 10.1242/jeb.012682; Censi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002891; Cheng B, 2011, J EXP BIOL, V214, P4092, DOI 10.1242/jeb.062760; Corke P, 2011, ROBOTICS VISION CONT, VSecond, P219; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Fontaine EI, 2009, J EXP BIOL, V212, P1307, DOI 10.1242/jeb.025379; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Grover D, 2008, J R SOC INTERFACE, V5, P1181, DOI 10.1098/rsif.2007.1333; Hartley R., 2004, ROBOTICA; Inan OT, 2011, J NEUROSCI METH, V202, P45, DOI 10.1016/j.jneumeth.2011.08.039; Kelley DH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01073; Kohlhoff KJ, 2011, INTEGR BIOL-UK, V3, P755, DOI 10.1039/c0ib00149j; Liu Y, 2012, LECT NOTES COMPUT SC, V7575, P730, DOI 10.1007/978-3-642-33765-9_52; Maimon G, 2008, CURR BIOL, V18, P464, DOI 10.1016/j.cub.2008.02.054; Muijres FT, 2014, SCIENCE, V344, P172, DOI 10.1126/science.1248955; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Reiser MB, 2013, J EXP BIOL, V216, P719, DOI 10.1242/jeb.074732; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Ristroph L, 2009, J EXP BIOL, V212, P1324, DOI 10.1242/jeb.025502; Schilstra C, 1999, J EXP BIOL, V202, P1481; Straw AD, 2011, J R SOC INTERFACE, V8, P395, DOI 10.1098/rsif.2010.0230; Tammero LF, 2002, J EXP BIOL, V205, P327; van Breugel F, 2012, J EXP BIOL, V215, P1783, DOI 10.1242/jeb.066498; Weir PT, 2012, CURR BIOL, V22, P21, DOI 10.1016/j.cub.2011.11.026	29	1	1	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132101	10.1371/journal.pone.0132101	http://dx.doi.org/10.1371/journal.pone.0132101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173128	Green Submitted, gold, Green Published			2022-12-27	WOS:000358194900032
J	Drgonova, J; Walther, D; Singhal, S; Johnson, K; Kessler, B; Troncoso, J; Uhl, GR				Drgonova, Jana; Walther, Donna; Singhal, Sulabh; Johnson, Kennedy; Kessler, Brice; Troncoso, Juan; Uhl, George R.			Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SMOKING-CESSATION SUCCESS; RISK VARIANT RS10503253; MOLECULAR-GENETICS; NICOTINE REPLACEMENT; SCHIZOPHRENIA; ADDICTION; MICE; DEPENDENCE; TRIAL	The CUB and sushi multiple domains 1 (CSMD1) gene harbors signals provided by clusters of nearby SNPs with 10(-2) > p > 10(-8) associations in genome wide association (GWAS) studies of addiction-related phenotypes. A CSMD1 intron 3 SNP displays p < 10(-8) association with schizophrenia and more modest associations with individual differences in performance on tests of cognitive abilities. CSDM1 encodes a cell adhesion molecule likely to influence development, connections and plasticity of brain circuits in which it is expressed. We tested association between CSMD1 genotypes and expression of its mRNA in postmortem human brains (n = 181). Expression of CSMD1 mRNA in human postmortem cerebral cortical samples differs 15-25%, in individuals with different alleles of simple sequence length and SNP polymorphisms located in the gene's third/ fifth introns, providing nominal though not Bonferroni-corrected significance. These data support mice with altered CSMD1 expression as models for common human CSMD1 allelic variation. We tested baseline and/ or cocaine-evoked addiction, emotion, motor and memory-related behaviors in +/- and -/-csmd1 knockout mice on mixed and on C57-backcrossed genetic backgrounds. Initial csmd1 knockout mice on mixed genetic backgrounds displayed a variety of coat colors and sizable individual differences in responses during behavioral testing. Backcrossed mice displayed uniform black coat colors. Cocaine conditioned place preference testing revealed significant influences of genotype (p = 0.02). Homozygote knockouts displayed poorer performance on aspects of the Morris water maze task. They displayed increased locomotion in some, though not all, environments. The combined data thus support roles for common level-of-expression CSMD1 variation in a drug reward phenotype relevant to addiction and in cognitive differences that might be relevant to schizophrenia. Mouse model results can complement data from human association findings of modest magnitude that identify likely polygenic influences.	[Drgonova, Jana; Walther, Donna; Singhal, Sulabh; Johnson, Kennedy; Kessler, Brice] NIDA, Mol Nuropsychiatry Res Branch, NIH IRP, Baltimore, MD 21224 USA; [Troncoso, Juan] Johns Hopkins Sch Med, Div Neuropathol, Baltimore, MD USA; [Uhl, George R.] New Mexico VA Healthcare Syst, Off Res Dev, Albuquerque, NM 87108 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Johns Hopkins University; Johns Hopkins Medicine	Uhl, GR (corresponding author), New Mexico VA Healthcare Syst, Off Res Dev, Albuquerque, NM 87108 USA.	george.uhl@va.gov		Kessler, Brice/0000-0002-2006-5026	National Institutes on Drug Abuse Intramural Research Program; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000165] Funding Source: NIH RePORTER	National Institutes on Drug Abuse Intramural Research Program; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by National Institutes on Drug Abuse Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnedo J, 2015, AM J PSYCHIAT, V172, P139, DOI 10.1176/appi.ajp.2014.14040435; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; Bhatia S, 2014, HUM GENET, V133, P815, DOI 10.1007/s00439-014-1424-6; Distler MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051235; Donohoe G, 2013, GENES BRAIN BEHAV, V12, P203, DOI 10.1111/gbb.12016; Drgon T, 2011, AM J MED GENET B, V156B, P125, DOI 10.1002/ajmg.b.31143; Drgon T, 2009, MOL MED, V15, P268, DOI 10.2119/molmed.2009.00040; Drgon T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008832; Drgon T, 2009, MOL MED, V15, P21, DOI 10.2119/molmed.2008.00096; Drgonova J, 2010, NEUROSCIENCE, V165, P882, DOI 10.1016/j.neuroscience.2009.10.007; Hall FS, 2012, PSYCHOPHARMACOLOGY, V219, P35, DOI 10.1007/s00213-011-2370-9; Havik B, 2011, BIOL PSYCHIAT, V70, P35, DOI 10.1016/j.biopsych.2011.01.030; Hishimoto A, 2007, HUM MOL GENET, V16, P2880, DOI 10.1093/hmg/ddm247; Ishiguro H, 2006, NEUROPSYCHOPHARMACOL, V31, P572, DOI 10.1038/sj.npp.1300855; Jackson KJ, 2010, J PHARMACOL EXP THER, V334, P137, DOI 10.1124/jpet.110.165738; Johnson C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019210; Johnson C, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-113; Koiliari E, 2014, SCHIZOPHR RES, V154, P42, DOI 10.1016/j.schres.2014.02.017; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Li M, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-79; McCleery A, 2014, SCHIZOPHR RES, V157, P33, DOI 10.1016/j.schres.2014.04.039; McGue M, 2013, BEHAV GENET, V43, P363, DOI 10.1007/s10519-013-9606-x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rose EJ, 2013, AM J MED GENET B, V162, P530, DOI 10.1002/ajmg.b.32182; Sleiman P, 2013, SCI REP-UK, V3, DOI 10.1038/srep03075; Sora I, 2010, ANN NY ACAD SCI, V1187, P218, DOI 10.1111/j.1749-6632.2009.05276.x; Steen VM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079501; Swaminathan S., 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/729478; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Uhl GR, 2014, MOL PSYCHIATR, V19, P50, DOI 10.1038/mp.2012.155; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Uhl GR, 2008, BIOCHEM PHARMACOL, V75, P98, DOI 10.1016/j.bcp.2007.06.042; Uhl GR, 2010, MOL MED, V16, P513, DOI 10.2119/molmed.2010.00052; Uhl GR, 2010, PHARMACOGENOMICS, V11, P357, DOI [10.2217/pgs.09.156, 10.2217/PGS.09.156]; Uhl GR, 2008, ANN NY ACAD SCI, V1141, P318, DOI 10.1196/annals.1441.018; Xiang Bo, 2012, Zhonghua Yixue Yichuanxue Zazhi, V29, P255, DOI 10.3760/cma.j.issn.1003-9406.2012.03.002	38	4	4	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0120908	10.1371/journal.pone.0120908	http://dx.doi.org/10.1371/journal.pone.0120908			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171607	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900001
J	Mickenautsch, S; Yengopal, V				Mickenautsch, Steffen; Yengopal, Veerasamy			Do Laboratory Results Concerning High-Viscosity Glass-Ionomers versus Amalgam for Tooth Restorations Indicate Similar Effect Direction and Magnitude than that of Controlled Clinical Trials? - A Meta-Epidemiological Study	PLOS ONE			English	Article							CONVENTIONAL CAVITY PREPARATIONS; IN-VITRO; PRIMARY MOLARS; BOND STRENGTH; CAUSAL DIAGRAMS; RESIN; ART; PERMANENT; SURVIVAL; IMPACT	Background A large percentage of evidence concerning dental interventions is based on laboratory research. The apparent wealth of laboratory evidence is sometimes used as basis for clinical inference and recommendations for daily dental practice. In this study two null-hypotheses are tested: whether trial results from laboratory and controlled clinical trials concerning the comparison of high-viscosity glass-ionomer cements (HVGIC) to amalgam for restorations placed in permanent posterior teeth have: (i) similar effect direction and (ii) similar effect magnitude. Methods 7 electronic databases were searched, as well as reference lists. Odds ratios (OR) and Standardised Mean Differences (SMD) with 95% Confidence intervals were computed for extracted dichotomous and continuous data, respectively. Pooled effect estimates for laboratory and clinical data were computed to test for effect direction. Odds ratios were converted into SMDs. SMDs from laboratory and clinical data were statistically compared to test for differences in effect magnitude. The analysed results were further investigated within the context of potential influencing or confounding factors using a Directed acyclic graph. Results Of the accepted eight laboratory and nine clinical trials, 13 and 21 datasets could be extracted, respectively. The pooled results of the laboratory datasets were highly statistically significant in favor of amalgam. No statistically significant differences, between HVGICs and amalgam, were identified for clinical data. For effect magnitude, statistically significant differences between clinical and laboratory trial results were found. Both nullhypotheses were rejected. Conclusion Laboratory results concerning high-viscosity glass-ionomers versus amalgam for tooth restorations do not indicate similar effect direction and magnitude than that of controlled clinical trials.	[Mickenautsch, Steffen; Yengopal, Veerasamy] Univ Witwatersrand, Fac Hlth Sci, Dept Community Dent, Systemat Review Initiat Evidence Based Minimum In, Johannesburg, South Africa	University of Witwatersrand	Mickenautsch, S (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Community Dent, Systemat Review Initiat Evidence Based Minimum In, Johannesburg, South Africa.	neem@global.co.za	Mickenautsch, Steffen/D-1235-2013	Mickenautsch, Steffen/0000-0002-4994-2328				Bahadure R N, 2012, J Indian Soc Pedod Prev Dent, V30, P122, DOI 10.4103/0970-4388.99983; Bashar A K M, 2006, Bangladesh Med Res Counc Bull, V32, P1; Bax Leon, 2006, BMC Med Res Methodol, V6, P50, DOI 10.1186/1471-2288-6-50; Bellam KK, 2009, J APPL BIOMATER BIOM, V7, P179; CATE JMT, 1995, J DENT RES, V74, P1266; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; da Costa BR, 2012, INT J EPIDEMIOL, V41, P1445, DOI 10.1093/ije/dys124; Daou Maha H, 2008, Schweiz Monatsschr Zahnmed, V118, P290; de Amorim RG, 2014, CLIN ORAL INVEST, V18, P117, DOI 10.1007/s00784-013-0955-x; Dennison JB, 2012, J ORAL REHABIL, V39, P301, DOI 10.1111/j.1365-2842.2011.02267.x; DIONYSOPOULOS P, 1994, OPER DENT, V19, P183; Donly K J, 1999, Spec Care Dentist, V19, P24, DOI 10.1111/j.1754-4505.1999.tb01364.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Estupinan-Day S, 2006, 091024ATNJF7025RG PA; Frencken JE, 2006, J DENT RES, V85, P622, DOI 10.1177/154405910608500708; Gama-Teixeira Adriana, 2007, Braz. oral res., V21, P368, DOI 10.1590/S1806-83242007000400015; Gao W, 2003, QUINTESSENCE INT, V34, P31; Gateau P, 2001, J PROSTHET DENT, V86, P149, DOI 10.1067/mpr.2001.114882; Geirsson J, 2004, AM J DENT, V17, P417; Geirsson J, 2004, DENT MATER, V20, P987, DOI 10.1016/j.dental.2004.07.003; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Guelmann Marcio, 2004, J Dent Child (Chic), V71, P209; Hattab F N, 1991, Quintessence Int, V22, P221; Heintze SD, 2007, J ADHES DENT, V9, P77; Heintze Siegward D, 2011, Schweiz Monatsschr Zahnmed, V121, P1024; Heintze SD, 2010, J ADHES DENT, V12, P443, DOI 10.3290/j.jad.a18240; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hilgert LA, 2014, DENT MATER, V30, P1172, DOI 10.1016/j.dental.2014.07.010; Honkala E, 2003, Int J Paediatr Dent, V13, P172, DOI 10.1046/j.1365-263X.2003.00455.x; Ilie N, 2007, DENT MATER J, V26, P526, DOI 10.4012/dmj.26.526; Ilie N, 2014, J DENT, V42, P850, DOI 10.1016/j.jdent.2014.03.013; Ilie N, 2012, CLIN ORAL INVEST, V16, P489, DOI 10.1007/s00784-011-0525-z; Jaafar NA, 2013, INT MED J, V20, P490; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Khan MFR, 1998, J CLIN LASER MED SUR, V16, P305, DOI 10.1089/clm.1998.16.305; Lai GY, 2013, J PROSTHET DENT, V110, P363, DOI 10.1016/j.prosdent.2013.06.011; Lauerer B, 2013, THESIS; Lee Sh-W, 2001, J KOREAN ACAD PROSTH, V39, P682; Mickenautsch S, 2012, J MINIM INTERV DENT, V5, P273; Mickenautsch S, 2014, J MINIMUM INTERV DEN, V7, P37; Mickenautsch Steffen, 2011, BMC Res Notes, V4, P58, DOI 10.1186/1756-0500-4-58; Mijan M, 2014, CLIN ORAL INVEST, V18, P1061, DOI 10.1007/s00784-013-1077-1; Moher D, 2000, J CLIN EPIDEMIOL, V53, P964, DOI 10.1016/S0895-4356(00)00188-8; Mueller PS, 2006, SWISS MED WKLY, V136, P441; Naasan MA, 1998, AM J DENT, V11, P36; Papagiannoulis L, 2002, DENT MATER, V18, P561, DOI 10.1016/S0109-5641(01)00090-2; Pearl J, 1995, BIOMETRIKA, V82, P669, DOI 10.2307/2337329; PRENTICE RL, 1989, STAT MED, V8, P431, DOI 10.1002/sim.4780080407; PROSPERO, INT PROSP REG SYST R; Purk JH, 2004, J AM DENT ASSOC, V135, P185, DOI 10.14219/jada.archive.2004.0150; Rahimtoola Salim, 2002, ASDC J Dent Child, V69, P16; Rajablou N, 2001, Aust Endod J, V27, P119; Sabdi S, 2011, ARCH OROFAC SCI, V6, P66; Taifour D, 2002, CARIES RES, V36, P437, DOI 10.1159/000066531; Van Meerbeek B, 2010, DENT MATER, V26, pE100, DOI 10.1016/j.dental.2009.11.148; Vichi A, 2013, CLIN ORAL INVEST, V17, P1497, DOI 10.1007/s00784-012-0846-6; Virmani S, 1997, J Clin Pediatr Dent, V22, P55; Wandera A, 1998, J DENT CHILD, V65, P239; Winkmann G, 2002, DEUT MED WOCHENSCHR, V127, P131, DOI 10.1055/s-2002-19715; Yip HK, 2002, QUINTESSENCE INT, V33, P17; Yip KHK, 2002, J AM DENT ASSOC, V133, P744, DOI 10.14219/jada.archive.2002.0272; Yu C, 2004, INT DENT J, V54, P42, DOI 10.1111/j.1875-595X.2004.tb00251.x	62	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132246	10.1371/journal.pone.0132246	http://dx.doi.org/10.1371/journal.pone.0132246			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168274	Green Submitted, Green Published, gold			2022-12-27	WOS:000358193100033
J	Narayanan, S; Dubarry, M; Lawless, C; Banks, AP; Wilkinson, DJ; Whitehall, SK; Lydall, D				Narayanan, Siddharth; Dubarry, Marion; Lawless, Conor; Banks, A. Peter; Wilkinson, Darren J.; Whitehall, Simon K.; Lydall, David			Quantitative Fitness Analysis Identifies exo1 Delta and Other Suppressors or Enhancers of Telomere Defects in Schizosaccharomyces pombe	PLOS ONE			English	Article							TERT PROMOTER MUTATIONS; GENETIC INTERACTIONS; RIBOSOMAL-PROTEIN; HIGH-THROUGHPUT; DNA-DAMAGE; YEAST; CONSERVATION; ORGANIZATION; SUMOYLATION; MARKER	Synthetic genetic array (SGA) has been successfully used to identify genetic interactions in S. cerevisiae and S. pombe. In S. pombe, SGA methods use either cycloheximide (C) or heat shock (HS) to select double mutants before measuring colony size as a surrogate for fitness. Quantitative Fitness Analysis (QFA) is a different method for determining fitness of microbial strains. In QFA, liquid cultures are spotted onto solid agar and growth curves determined for each spot by photography and model fitting. Here, we compared the two S. pombe SGA methods and found that the HS method was more reproducible for us. We also developed a QFA procedure for S. pombe. We used QFA to identify genetic interactions affecting two temperature sensitive, telomere associated query mutations (taz1 Delta and pot11). We identify exo1 Delta and other gene deletions as suppressors or enhancers of S. pombe telomere defects. Our study identifies known and novel gene deletions affecting the fitness of strains with telomere defects. The interactions we identify may be relevant in human cells.	[Narayanan, Siddharth; Dubarry, Marion; Lawless, Conor; Whitehall, Simon K.; Lydall, David] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Banks, A. Peter] Newcastle Univ, Newcastle Biomed, High Throughput Screening Facil, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Wilkinson, Darren J.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Lydall, D (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	david.lydall@newcastle.ac.uk	Narayanan, Siddharth/AAZ-2384-2021	Dubarry, Marion/0000-0001-5648-5770; Lydall, David/0000-0003-2478-085X; Narayanan, Siddharth/0000-0002-5553-3221; Wilkinson, Darren James/0000-0003-0736-802X	 [C23629/A13314]; BBSRC [BB/M002314/1, BB/F023545/1] Funding Source: UKRI; MRC [MR/L001284/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1093879, 1368997, BB/M002314/1, BB/F023545/1] Funding Source: researchfish; Cancer Research UK [13314] Funding Source: researchfish; Medical Research Council [MR/L001284/1, 1094244] Funding Source: researchfish	; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding provided by C23629/A13314 (http://www.cancerresearchuk.org/).	Addinall SG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001362; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Babu M, 2011, METHODS MOL BIOL, V765, P125, DOI 10.1007/978-1-61779-197-0_9; Banks AP, 2012, JOVE-J VIS EXP, DOI 10.3791/4018; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Beltrao P, 2010, CELL, V141, P739, DOI 10.1016/j.cell.2010.05.019; Boone C, 2014, GENETICS, V198, P435, DOI 10.1534/genetics.114.169128; Boucher Benjamin, 2013, Frontiers in Genetics, V4, P290, DOI 10.3389/fgene.2013.00290; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cremona CA, 2012, BIOMOLECULES, V2, P376, DOI 10.3390/biom2030376; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Forsburg SL, 2003, CURR PROTOC MOL BIOL, V13; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Garg M, 2014, EMBO REP, V15, P871, DOI 10.15252/embr.201438919; Gibbs-Seymour I, 2014, MOL CELL; Gibson TJ, 2009, TRENDS BIOCHEM SCI, V34, P471, DOI 10.1016/j.tibs.2009.06.007; Gunes C, 2013, CELL, V152, P390, DOI 10.1016/j.cell.2013.01.010; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jain D, 2010, ANNU REV GENET, V44, P243, DOI 10.1146/annurev-genet-102108-134841; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; KAWAI S, 1992, J BACTERIOL, V174, P254, DOI 10.1128/jb.174.1.254-262.1992; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; KONDO K, 1995, J BACTERIOL, V177, P7171, DOI 10.1128/jb.177.24.7171-7177.1995; Lawless C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-287; Lehner B, 2007, J EXP BIOL, V210, P1559, DOI 10.1242/jeb.002311; Lewis KA, 2012, STRUCTURE, V20, P28, DOI 10.1016/j.str.2011.10.017; Linger BR, 2009, CRIT REV BIOCHEM MOL, V44, P434, DOI 10.3109/10409230903307329; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Miller KM, 2005, EMBO J, V24, P3128, DOI 10.1038/sj.emboj.7600779; Miller KM, 2003, MOL CELL, V11, P303, DOI 10.1016/S1097-2765(03)00041-8; Miyagawa K, 2014, P NATL ACAD SCI USA, V111, P5950, DOI 10.1073/pnas.1401359111; Nagai S, 2011, CELL RES, V21, P474, DOI 10.1038/cr.2011.31; Nakamura TM, 2002, GENETICS, V161, P1437; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; Ngo GHP, 2014, NUCLEIC ACIDS RES; Park S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.2; Pitt CW, 2010, NUCLEIC ACIDS RES, V38, P6968, DOI 10.1093/nar/gkq580; Ramsay AJ, 2013, NAT GENET, V45, P526, DOI 10.1038/ng.2584; Robles-Espinoza CD, 2014, NAT GENET, V46, P478, DOI 10.1038/ng.2947; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Roguev A, 2013, NAT METHODS, V10, P432, DOI [10.1038/nmeth.2398, 10.1038/NMETH.2398]; Ryan CJ, 2012, MOL CELL, V46, P691, DOI 10.1016/j.molcel.2012.05.028; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shi J, 2014, NAT GENET; Sipiczki M, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-2-reviews1011, DOI 10.1186/GB-2000-1-2-REVIEWS1011]; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Stevens DR, 2001, MOL GEN GENET, V264, P790, DOI 10.1007/s004380000368; Sugioka-Sugiyama R, 2011, BIOCHEM BIOPH RES CO, V406, P444, DOI 10.1016/j.bbrc.2011.02.068; SUNNERHAGEN P, 1993, BIOTECHNIQUES, V14, P18; Tomita K, 2004, MOL CELL BIOL, V24, P9557, DOI 10.1128/MCB.24.21.9557-9567.2004; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Tosti E, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0068-4; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Varma A, 2000, YEAST, V16, P1397, DOI 10.1002/1097-0061(200011)16:15&lt;1397::AID-YEA636&gt;3.0.CO;2-1	71	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132240	10.1371/journal.pone.0132240	http://dx.doi.org/10.1371/journal.pone.0132240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168240	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100032
J	Wang, ZJ; de la Fuente-Nunez, C; Shen, Y; Haapasalo, M; Hancock, REW				Wang, Zhejun; de la Fuente-Nunez, Cesar; Shen, Ya; Haapasalo, Markus; Hancock, Robert E. W.			Treatment of Oral Multispecies Biofilms by an Anti-Biofilm Peptide	PLOS ONE			English	Article							2 CHLORHEXIDINE PREPARATIONS; ENTEROCOCCUS-FAECALIS; PSEUDOMONAS-AERUGINOSA; CATIONIC PEPTIDES; IN-VITRO; BACTERIA; AGENTS	Human oral biofilms are multispecies microbial communities that exhibit high resistance to antimicrobial agents. Dental plaque gives rise to highly prevalent and costly biofilm-related oral infections, which lead to caries or other types of oral infections. We investigated the ability of the recently identified anti-biofilm peptide 1018 to induce killing of bacterial cells present within oral multispecies biofilms. At 10 mu g/ml (6.5 mu M), peptide 1018 was able to significantly (p<0.05) prevent biofilm formation over 3 days. The activity of the peptide on preformed biofilms was found to be concentration-dependent since more than 60% of the total plaque biofilm cell population was killed by 10 mu g/ml of peptide 1018 in 3 days, while at 5 mu g/ml 50% of cells were dead and at 1 mu g/ml the peptide triggered cell death in around 30% of the total bacterial population, as revealed by confocal microscopy. The presence of saliva did not affect peptide activity, since no statistically significant difference was found in the ability of peptide 1018 to kill oral biofilms using either saliva coated and non-saliva coated hydroxyapatite surfaces. Scanning electron microscopy experiments indicated that peptide 1018 induced cell lysis in plaque biofilms. Furthermore, combined treatment using peptide 1018 and chlorhexidine (CHX) increased the anti-biofilm activity of each compound compared to when these were used alone, resulting in >50% of the biofilm being killed and >35% being dispersed in only 3 minutes. Peptide 1018 may potentially be used by itself or in combination with CHX as a non-toxic and effective anti-biofilm agent for plaque disinfection in clinical dentistry.	[Wang, Zhejun; Shen, Ya; Haapasalo, Markus] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Div Endodont, Vancouver, BC V5Z 1M9, Canada; [de la Fuente-Nunez, Cesar; Hancock, Robert E. W.] Univ British Columbia, Dept Microbiol & Immunol, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada; [Wang, Zhejun] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China; [Wang, Zhejun] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430072, Peoples R China	University of British Columbia; University of British Columbia; Wuhan University; Wuhan University	Haapasalo, M (corresponding author), Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Div Endodont, Vancouver, BC V5Z 1M9, Canada.	markush@dentistry.ubc.ca; bob@hancocklab.com	Hancock, Robert E. W./E-1145-2013; de la Fuente, Cesar/ABE-2369-2021; Shen, Ya/X-5855-2019	Hancock, Robert E. W./0000-0001-5989-8503; de la Fuente, Cesar/0000-0002-2005-5629; , Ya/0000-0002-0792-4279	Faculty of Dentistry, University of British Columbia, Canada; Canada Foundation for Innovation (CFI fund) [32623]; National Natural Science Foundation of China (NSFC) [81300904]; Canadian Institutes for Health Research (CIHR); National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R21AI098701]; Fundacion "la Caixa"; Fundacion Canada (Spain); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI098701, R33AI098701] Funding Source: NIH RePORTER	Faculty of Dentistry, University of British Columbia, Canada; Canada Foundation for Innovation (CFI fund); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fundacion "la Caixa"(La Caixa Foundation); Fundacion Canada (Spain); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by start-up funds from the Faculty of Dentistry, University of British Columbia, Canada, Canada Foundation for Innovation (CFI fund; Project No. 32623), National Natural Science Foundation of China (NSFC; Grant No. 81300904), and by grants from the Canadian Institutes for Health Research (CIHR). Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R21AI098701. R.E.W.H. holds a Canada Research Chair in Health and Genomics. C.D.L.F.-N. received a scholarship from the Fundacion "la Caixa" and Fundacion Canada (Spain).	Athanassiadis B, 2007, AUST DENT J, V52, pS64, DOI 10.1111/j.1834-7819.2007.tb00527.x; Baehni PC, 2003, ORAL DIS, V9, P23, DOI 10.1034/j.1601-0825.9.s1.5.x; Basrani Bettina, 2005, Aust Endod J, V31, P48; Brown A T, 1986, Compendium, V7, P719; Bucki R, 2008, J ANTIMICROB CHEMOTH, V62, P329, DOI 10.1093/jac/dkn176; de la Fuente-Nunez C, 2015, CHEM BIOL, V22, P196, DOI 10.1016/j.chembiol.2015.01.002; de la Fuente-Nunez C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004152; de la Fuente-Nunez C, 2013, CURR OPIN MICROBIOL, V16, P580, DOI 10.1016/j.mib.2013.06.013; de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12; Falconer SB, 2011, NAT CHEM BIOL, V7, P416, DOI [10.1038/nchembio.590, 10.1038/NCHEMBIO.590]; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Happasalo M., 2005, ENDODONTIC TOPICS, V10, P77; Hirt H, 2013, ANTIMICROB AGENTS CH, V57, P4903, DOI 10.1128/AAC.00311-13; Hojo K, 2009, J DENT RES, V88, P982, DOI 10.1177/0022034509346811; Hosoya Y, 2010, J DENT, V38, P423, DOI 10.1016/j.jdent.2010.02.001; Kim SS, 2003, CARIES RES, V37, P425, DOI 10.1159/000073394; Kim YS, 2014, J DENT, V42, P691, DOI 10.1016/j.jdent.2014.03.006; Leung KP, 2005, J DENT RES, V84, P1172, DOI 10.1177/154405910508401215; Love RM, 2001, INT ENDOD J, V34, P399, DOI 10.1046/j.1365-2591.2001.00437.x; Chau NPT, 2014, J DENT, V42, P726, DOI 10.1016/j.jdent.2014.03.009; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Shen Y, 2011, J ENDODONT, V37, P657, DOI 10.1016/j.joen.2011.02.007; Shen Y, 2010, J ENDODONT, V36, P100, DOI 10.1016/j.joen.2009.09.018; Shen Y, 2009, J ENDODONT, V35, P981, DOI 10.1016/j.joen.2009.04.030; Steinstraesser L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039373; Tao R, 2011, PEPTIDES, V32, P1748, DOI 10.1016/j.peptides.2011.06.008; Tong ZX, 2013, J ENDODONT, V39, P674, DOI 10.1016/j.joen.2012.12.010; Wang ZJ, 2012, J ENDODONT, V38, P1376, DOI 10.1016/j.joen.2012.06.035; Wieczorek M, 2010, CHEM BIOL, V17, P970, DOI 10.1016/j.chembiol.2010.07.007; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wiradharma N, 2011, BIOMATERIALS, V32, P2204, DOI 10.1016/j.biomaterials.2010.11.054; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623; Zhang W, 2014, J DENT, V42, P1078, DOI 10.1016/j.jdent.2014.06.001	34	57	57	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132512	10.1371/journal.pone.0132512	http://dx.doi.org/10.1371/journal.pone.0132512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168273	gold, Green Submitted, Green Published			2022-12-27	WOS:000358193100048
J	Arandjelovic, O				Arandjelovic, Ognjen			Clinical Trial Adaptation by Matching Evidence in Complementary Patient Subgroups of Auxiliary Blinding Questionnaire Responses	PLOS ONE			English	Article							DESIGN; SUCCESS	Clinical trial adaptation refers to any adjustment of the trial protocol after the onset of the trial. Such adjustment may take on various forms, including the change in the dose of administered medicines, the frequency of administering an intervention, the number of trial participants, or the duration of the trial, to name just some possibilities. The main goal is to make the process of introducing new medical interventions to patients more efficient, either by reducing the cost or the time associated with evaluating their safety and efficacy. The principal challenge, which is an outstanding research problem, is to be found in the question of how adaptation should be performed so as to minimize the chance of distorting the outcome of the trial. In this paper we propose a novel method for achieving this. Unlike most of the previously published work, our approach focuses on trial adaptation by sample size adjustment i.e. by reducing the number of trial participants in a statistically informed manner. We adopt a stratification framework recently proposed for the analysis of trial outcomes in the presence of imperfect blinding and based on the administration of a generic auxiliary questionnaire that allows the participants to express their belief concerning the assigned intervention (treatment or control). We show that this data, together with the primary measured variables, can be used to make the probabilistically optimal choice of the particular sub-group a participant should be removed from if trial size reduction is desired. Extensive experiments on a series of simulated trials are used to illustrate the effectiveness of our method.	Deakin Univ, Ctr Pattern Recognit & Data Analyt, Sch Informat Technol, Geelong, Vic 3217, Australia	Deakin University	Arandjelovic, O (corresponding author), Deakin Univ, Ctr Pattern Recognit & Data Analyt, Sch Informat Technol, Geelong, Vic 3217, Australia.	ognjen.arandjelovic@gmail.com	Arandjelović, Ognjen/V-5255-2019	Arandjelović, Ognjen/0000-0002-9314-194X				Aitchison J, 1996, LOG NORMAL DISTRIBUT; [Anonymous], 2013, BAYESIAN DIS MAPPING; Arandjelovic O, 2012, ADV NEURAL INF PROC, V25, P530; Arandjelovic O, 2015, AAAI CONF ARTIF INTE, P1693; Arandjelovic Ognjen, 2012, PLoS One, V7, pe48984, DOI 10.1371/journal.pone.0048984; Bang HJ, 2004, CONTROL CLIN TRIALS, V25, P143, DOI 10.1016/j.cct.2003.10.016; Berger VW, 2005, STAT PRACT, P1, DOI 10.1002/0470863641; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; Berry DA, 2012, NAT REV CLIN ONCOL, V9, P199, DOI 10.1038/nrclinonc.2011.165; Berry DA, 2011, J CLIN ONCOL, V29, P606, DOI 10.1200/JCO.2010.32.2685; Berry SM, 2010, CH CRC BIOSTAT SER, P1, DOI 10.1201/EBK1439825488; Bhattacharyya A., 1943, B CALCUTTA MATH SOC, V35, P99; Biswas S, 2009, CLIN TRIALS, V6, P205, DOI 10.1177/1740774509104992; Broglio KR, 2014, J BIOPHARM STAT, V24, P685, DOI 10.1080/10543406.2014.888569; Chen MH, 2010, FRONTIERS OF STATISTICAL DECISION MAKING AND BAYESIAN ANALYSIS: IN HONOR OF JAMES O. BERGER, P257, DOI 10.1007/978-1-4419-6944-6_8; Chow SC, 2012, CH CRC BIOSTAT SER, P1; Cohen SB, 2008, ARTHRITIS RHEUM, V58, P1299, DOI 10.1002/art.23417; Cui L, 1999, BIOMETRICS, V55, P853, DOI 10.1111/j.0006-341X.1999.00853.x; Fisher LD, 1998, STAT MED, V17, P1551, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1551::AID-SIM868>3.0.CO;2-E; Friedman L. M., 1998, FUNDAMENTALS CLIN TR; Gao P, 2008, J BIOPHARM STAT, V18, P1184, DOI 10.1080/10543400802369053; Gelman A., 2021, BAYESIAN DATA ANAL; Gilks W. R., 1995, MARKOV CHAIN MONTE C, DOI 10.1201/b14835; Haahr MT, 2006, CLIN TRIALS, V3, P360, DOI 10.1177/1740774506069153; Hellinger E, 1909, J REINE ANGEW MATH, V136, P210, DOI 10.1515/crll.1909.136.210; Hemila H, 2005, CONTEMP CLIN TRIALS, V26, P512, DOI 10.1016/j.cct.2005.04.002; Henneicke-von Zeplin HH, 2005, CONTEMP CLIN TRIALS, V26, P512, DOI 10.1016/j.cct.2005.04.004; Hrobjartsson A, 2007, INT J EPIDEMIOL, V36, P654, DOI 10.1093/ije/dym020; Hung HMJ, 2006, PHARM STAT, V5, P99, DOI 10.1002/pst.219; James KE, 1996, STAT MED, V15, P1421; Jennison C, 2003, STAT MED, V22, P971, DOI 10.1002/sim.1457; Kadane JB, 2011, BAYESIAN METHODS ETH; Kolahi J, 2009, COMMUNITY DENT ORAL, V37, P477, DOI 10.1111/j.1600-0528.2009.00494.x; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lang T, 2011, AM J TROP MED HYG, V85, P967, DOI 10.4269/ajtmh.2011.11-0151; Lee JJ, 2012, STAT MED, V31, P2955, DOI 10.1002/sim.5404; Leon AC, 2008, SCHIZOPHRENIA BULL, V34, P664, DOI 10.1093/schbul/sbn035; Ly LP, 2001, J CLIN ENDOCR METAB, V86, P4078, DOI 10.1210/jc.86.9.4078; Meinert CL, 1986, CLIN TRIALS DESIGN C; Meurer WJ, 2012, ANN EMERG MED, V60, P451, DOI 10.1016/j.annemergmed.2012.01.020; Nelson NJ, 2010, J NATL CANCER I, V102, P1217, DOI 10.1093/jnci/djq319; Nissen SE, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010035; Onisko A, 2013, ARTIF INTELL MED, V57, P197, DOI 10.1016/j.artmed.2013.01.004; Orloff J, 2009, NAT REV DRUG DISCOV, V8, P949, DOI 10.1038/nrd3025; Penston J, 2005, MED HYPOTHESES, V64, P651, DOI 10.1016/j.mehy.2004.09.006; PIANTADOSI S, 1997, CLIN TRIALS METHODOL; Sackett DL, 2007, INT J EPIDEMIOL, V36, P664, DOI 10.1093/ije/dym088; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; U S Department of Health and Human Services, 2010, GUIDANCE IND ADAPTIV; Wickens C.D., 1992, ENG PSYCHOL HUMAN PE, V2nd ed.; Yin G, 2013, CLIN TRIAL DESIGN BA; Zang Y, 2014, CHIN CLIN ONCOL, V3, DOI 10.3978/j.issn.2304-3865.2014.06.04	52	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131524	10.1371/journal.pone.0131524	http://dx.doi.org/10.1371/journal.pone.0131524			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161797	Green Submitted, gold, Green Published			2022-12-27	WOS:000358162300042
J	Boger, E; Ellis, J; Latter, S; Foster, C; Kennedy, A; Jones, F; Fenerty, V; Kellar, I; Demain, S				Boger, Emma; Ellis, Jaimie; Latter, Sue; Foster, Claire; Kennedy, Anne; Jones, Fiona; Fenerty, Vicky; Kellar, Ian; Demain, Sara			Self-Management and Self-Management Support Outcomes: A Systematic Review and Mixed Research Synthesis of Stakeholder Views	PLOS ONE			English	Article							LONG-TERM CONDITIONS; CHRONIC ILLNESS; COLORECTAL-CANCER; STRUCTURED EDUCATION; FOCUS GROUPS; CARE; STROKE; INTERVENTIONS; EXPERIENCES; PROGRAM	Introduction Self-management has received growing attention as an effective approach for long-term condition management. Little is known about which outcomes of supported self-management are valued by patients, their families, health professionals and those who commission self-management services. This study systematically reviewed published empirical evidence in accordance with PRISMA guidelines to determine the outcomes of self-management valued by these key stakeholder groups, using three prominent exemplar conditions: colorectal cancer, diabetes and stroke. Aim To systematically review the literature to identify which generic outcomes of self-management have been targeted and are considered important using three exemplar conditions (colorectal cancer, diabetes and stroke), which collectively have a range of features that are likely to be representative of generic self-management issues. Methods Systematic searching of nine electronic databases was conducted in addition to hand searches of review articles. Abstracts were identified against inclusion criteria and appraised independently by two reviewers, using a critical appraisal tool. Synthesis of findings was conducted using mixed research synthesis. Results Over 20,536 abstracts were screened. 41 studies which met the review criteria were fully retrieved and appraised. The majority of evidence related to diabetes. Few studies directly focussed on stakeholders' views concerning desired self-management outcomes; the majority of evidence was derived from studies focusing upon the experience of self-management. The views of health care commissioners were absent from the literature. We identified that self-management outcomes embrace a range of indicators, from knowledge, skills, and bio-psychosocial markers of health through to positive social networks. Conclusions Patients', families', health professionals' and commissioners' views regarding which outcomes of self-management are important have not been clearly elicited. The extent to which bio-psychosocial indicators relate to successful self-management from the perspectives of all groups of stakeholders is unknown. Further investigation regarding which self-management outcomes are considered important by all stakeholders is necessary to guide the commissioning and design of future self-management services.	[Boger, Emma; Ellis, Jaimie; Latter, Sue; Foster, Claire; Kennedy, Anne; Fenerty, Vicky; Demain, Sara] Univ Southampton, Fac Hlth Sci, Southampton, Hants, England; [Jones, Fiona] St Georges & Kingston Univ London, Dept Social Care & Educ, London, England; [Kellar, Ian] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England	University of Southampton; University of Leeds	Boger, E (corresponding author), Univ Southampton, Fac Hlth Sci, Southampton, Hants, England.	e.j.boger@soton.ac.uk	Foster, Claire/N-6223-2016; Fenerty, Vicky/AAN-3129-2020; Fenerty, Vicky/AAM-7173-2020; Kellar, Ian/F-5536-2015	Foster, Claire/0000-0002-4703-8378; Kellar, Ian/0000-0003-1608-5216; Fenerty, Victoria/0000-0002-1712-5614; Jones, Fiona/0000-0002-1452-3895; Latter, Susan/0000-0003-0973-0512	Health Foundation Insight award; National Institute for Health Research [PDF-2011-04-016] Funding Source: researchfish	Health Foundation Insight award; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by The Health Foundation Insight award, www.health.org.uk Funding was awarded to EB, SD, SL, AK, CF, FJ and IK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjaye-Gbewonyo K, 2013, TRANSL BEHAV MED, V3, P72, DOI 10.1007/s13142-012-0187-7; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Anderson AS, 2013, SUPPORT CARE CANCER, V21, P35, DOI 10.1007/s00520-012-1487-7; [Anonymous], 2005, PREV CHRON DIS VIT I; [Anonymous], 2012, NVIVO 10 SOFTWARE; Balfe M, 2009, J ADV NURS, V65, P2367, DOI 10.1111/j.1365-2648.2009.05098.x; Bandura A., 1997, SELF EFFICACY EXERCI; Barlow JH, 2002, HLTH ED J, V61, P365, DOI DOI 10.1177/001789690206100408; Boger EJ, 2013, DISABIL REHABIL, V35, P1415, DOI 10.3109/09638288.2012.737080; Bury Mike, 2005, Health Serv J, V115, P18; Bycroft J, 2006, NEW ZEALAND FAMILY P, V33; Cadilhac DA, 2011, STROKE, V42, P1673, DOI 10.1161/STROKEAHA.110.601997; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Carbone ET, 2007, PATIENT EDUC COUNS, V66, P202, DOI 10.1016/j.pec.2006.12.003; Centre for Reviews and Dissemination, 2009, SYST REV CRDS GUID U; Chang H, 2005, PREV MED, V40, P249; Collins A, 2014, MEASURING REALLY MAT; Collins MM, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-6; Corcoran KJ, 2013, AUST HEALTH REV, V37, P19, DOI 10.1071/AH11092; Coster S, 2009, INT J NURS STUD, V46, P508, DOI 10.1016/j.ijnurstu.2008.09.009; de Silva D., 2011, HELPING PEOPLE HELP; Demain S, PLOS ONE; Department of Health, 2012, LONG TERM CONDITIONS, Vthird; Department of Health, 2013, NHS OUTCOMES FRAMEWO; Department of Health, 2012, QUALITY OUTCOMES FRA; Dixon A, 2011, IMPACT QUALITY OUT C; Docherty A, 2004, PATIENT EXPERIENCE C; Dyson PA, 2010, J HUM NUTR DIET, V23, P353, DOI 10.1111/j.1365-277X.2010.01077.x; Funnell MM, 2011, DIABETES CARE, V34, pS89, DOI 10.2337/dc11-S089; Funnell MM, 2010, PRACTICAL DIABETES I, V27, P222; Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030; Gao WJ, 2011, INT NURS REV, V58, P288, DOI 10.1111/j.1466-7657.2011.00907.x; Goodwin J, 2006, GERIATRIC MED, P17; Grant L, 2013, DIABETIC MED, V30, P724, DOI 10.1111/dme.12164; Grund J, 2012, J PRIM CARE COMMUNIT, V3, P230, DOI 10.1177/2150131911435263; Gucciardi E, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-46; Hargraves JL, 2012, J AMBUL CARE MANAG, V35, P15, DOI 10.1097/JAC.0b013e31822cbe35; Heisler M, 2009, AM J PREV MED, V37, pS270, DOI 10.1016/j.amepre.2009.08.016; Howard L M, 2012, Educ Health (Abingdon), V25, P66; Huang ES, 2005, J AM GERIATR SOC, V53, P306, DOI 10.1111/j.1532-5415.2005.53119.x; Hunt LM, 1998, WESTERN J NURS RES, V20, P656, DOI 10.1177/019394599802000602; Johnston M, 2007, DISABIL REHABIL, V29, P1117, DOI 10.1080/03323310600950411; Jones F, 2006, DISABIL REHABIL, V28, P841, DOI 10.1080/09638280500534952; Jones F, 2013, PHYSIOTHER RES INT, V18, P91, DOI 10.1002/pri.1531; Jones F, 2009, CLIN REHABIL, V23, P522, DOI 10.1177/0269215508101749; Jones MC, 2011, J NURSING HEALTHCARE, V10, P174; Kendall E, 2007, SOC SCI MED, V64, P735, DOI 10.1016/j.socscimed.2006.09.012; Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538; Kidd L, 2008, J ADV NURS, V64, P469, DOI 10.1111/j.1365-2648.2008.04796.x; Kidd L, 2009, J CLIN NURS, V18, P2292, DOI 10.1111/j.1365-2702.2009.02802.x; Kralik D, 2004, J CLIN NURS, V13, P259, DOI 10.1046/j.1365-2702.2003.00826.x; Lasch KE, 2010, QUAL LIFE RES, V19, P1087, DOI 10.1007/s11136-010-9677-6; Lin CC, 2008, J CLIN NURS, V17, P34, DOI 10.1111/j.1365-2702.2007.01962.x; Lorig K R, 2001, Eff Clin Pract, V4, P256; Lorig KR, 2006, MED CARE, V44, P964, DOI 10.1097/01.mlr.0000233678.80203.c1; Lundberg PC, 2012, J ADV NURS, V68, P550, DOI 10.1111/j.1365-2648.2011.05756.x; Lynch EB, 2012, HEALTH EDUC RES, V27, P814, DOI 10.1093/her/cys058; Maillet NA, 1996, DIABETES EDUCATOR, V22, P39, DOI 10.1177/014572179602200106; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P399; May C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2803; McCorkle R, 2011, CA-CANCER J CLIN, V61, P50, DOI 10.3322/caac.20093; Minet LKR, 2011, QUAL HEALTH RES, V21, P1115, DOI 10.1177/1049732311405066; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morrow AS, 2008, PATIENT EDUC COUNS, V72, P418, DOI 10.1016/j.pec.2008.05.017; Murphy K, 2011, J CLIN NURS, V20, P1282, DOI 10.1111/j.1365-2702.2010.03564.x; Naik AD, 2011, PATIENT EDUC COUNS, V85, P383, DOI 10.1016/j.pec.2011.01.010; National Institute for Health and Care Excellence, 2014, TYPE 1 DIABETES DIAG; New N, 2010, J AM ACAD NURSE PRAC, V22, P316, DOI 10.1111/j.1745-7599.2010.00514.x; Nolte S, 2013, QUAL LIFE RES, V22, P1805, DOI 10.1007/s11136-012-0302-8; Norris M, 2014, DISABIL REHABIL, V36, P32, DOI 10.3109/09638288.2013.776645; Palmer NRA, 2013, PALLIAT SUPPORT CARE, V11, P101, DOI 10.1017/S1478951512000788; Paterson B, 2010, TRANSLATING CHRONIC; Paul GM, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-45; Peel E, 2004, BRIT J GEN PRACT, V54, P183; Pierce Linda L, 2004, Rehabil Nurs, V29, P14; Porter LS, 2008, PAIN, V137, P306, DOI 10.1016/j.pain.2007.09.010; Puder JJ, 2006, SWISS MED WKLY, V136, P574; Quandt SA, 2013, J APPL GERONTOL, V32, P783, DOI 10.1177/0733464811435506; Rasmussen B, 2011, J CLIN NURS, V20, P1981, DOI 10.1111/j.1365-2702.2010.03657.x; Rees R, 2009, CHILDRENS VIEWS OBES; Reeves D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098340; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Rise MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064009; Rygg LO, 2010, SCAND J PUBLIC HEALT, V38, P788, DOI 10.1177/1403494810382475; Sandelowski Margarete, 2006, Res Sch, V13, P29; Satink T, 2014, DISABILITY REHABILIT, P1; Schabert J, 2013, PATIENT, V6, P1, DOI 10.1007/s40271-012-0001-0; Shakibazadeh E, 2011, IRAN J PUBLIC HEALTH, V40, P146; Singh D, 2008, WHO REGIONAL OFFICE; Sprague MA, 2006, FAM COMMUNITY HEALTH, V29, P245, DOI 10.1097/00003727-200610000-00003; Steed L, 2003, PATIENT EDUC COUNS, V51, P5, DOI 10.1016/S0738-3991(02)00213-6; Sturt J, 2005, PRIM HEALTH CARE RES, V6, P291; Thoolen B, 2007, DIABETES CARE, V30, P2832, DOI 10.2337/dc07-0777; Thorne SE, 2001, PATIENT EDUC COUNS, V42, P81, DOI 10.1016/S0738-3991(00)00095-1; van der Wulp I, 2012, DIABETIC MED, V29, pe390, DOI 10.1111/j.1464-5491.2012.03629.x; Vassilev I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059723; Veg A, 2007, DIABETIC MED, V24, P408, DOI 10.1111/j.1464-5491.2006.02064.x; Vincent D, 2006, DIABETES EDUCATOR, V32, P89, DOI 10.1177/0145721705284372; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wilkinson A, 2009, INT J NURS STUD, V46, P1143, DOI 10.1016/j.ijnurstu.2008.12.011; Wilson PM, 2006, INT J NURS STUD, V43, P803, DOI 10.1016/j.ijnurstu.2005.10.011; Woodman P, 2014, DISABIL REHABIL, V36, P2031, DOI 10.3109/09638288.2014.887796	102	92	92	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130990	10.1371/journal.pone.0130990	http://dx.doi.org/10.1371/journal.pone.0130990			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26162086	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000358162300027
J	El Hadri, K; Denoyelle, C; Ravaux, L; Viollet, B; Foretz, M; Friguet, B; Rouis, M; Raymondjean, M				El Hadri, Khadija; Denoyelle, Chantal; Ravaux, Lucas; Viollet, Benoit; Foretz, Marc; Friguet, Bertrand; Rouis, Mustapha; Raymondjean, Michel			AMPK Signaling Involvement for the Repression of the IL-1 beta-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs	PLOS ONE			English	Article							ACTIVATED-PROTEIN-KINASE; SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; A(2) GENE; TRANSCRIPTIONAL REGULATION; ENDOTHELIAL-CELLS; METFORMIN; ATHEROSCLEROSIS; INFLAMMATION; BCL6	Secretory Phospholipase A2 of type IIA (sPLA2 IIA) plays a crucial role in the production of lipid mediators by amplifying the neointimal inflammatory context of the vascular smooth muscle cells (VSMCs), especially during atherogenesis. Phenformin, a biguanide family member, by its anti-inflammatory properties presents potential for promoting beneficial effects upon vascular cells, however its impact upon the IL-1 beta-induced sPLA2 gene expression has not been deeply investigated so far. The present study was designed to determine the relationship between phenformin coupling AMP-activated protein kinase (AMPK) function and the molecular mechanism by which the sPLA2 IIA expression was modulated in VSMCs. Here we find that 5-aminoimidazole-4-carboxamide-1-beta-D-ribonucleotide (AICAR) treatment strongly repressed IL-1 beta-induced sPLA2 expression at least at the transcriptional level. Our study reveals that phenformin elicited a dose-dependent inhibition of the sPLA2 IIA expression and transient overexpression experiments of constitutively active AMPK demonstrate clearly that AMPK signaling is involved in the transcriptional inhibition of sPLA2-IIA gene expression. Furthermore, although the expression of the transcriptional repressor B-cell lymphoma-6 protein (BCL-6) was markedly enhanced by phenformin and AICAR, the repression of sPLA2 gene occurs through a mechanism independent of BCL-6 DNA binding site. In addition we show that activation of AMPK limits IL-1 beta-induced NF-kappa B pathway activation. Our results indicate that BCL-6, once activated by AMPK, functions as a competitor of the IL-1 beta induced NF-kappa B transcription complex. Our findings provide insights on a new anti-inflammatory pathway linking phenformin, AMPK and molecular control of sPLA2 IIA gene expression in VSMCs.	[El Hadri, Khadija; Ravaux, Lucas; Friguet, Bertrand; Rouis, Mustapha; Raymondjean, Michel] Univ Paris 06, Sorbonne Univ, Biol Adaptat & Ageing CNRS UMR8256 B2A, INSERM ERL U1064, F-75005 Paris, France; [Denoyelle, Chantal] Univ Paris Diderot, Sorbonne Paris Cite, BFA CNRS UMR8251, F-75013 Paris, France; [Viollet, Benoit; Foretz, Marc] Inst Cochin, Inserm U1016, Paris, France; [Viollet, Benoit; Foretz, Marc] CNRS, UMR 8104, Paris, France; [Viollet, Benoit; Foretz, Marc] Univ Paris 05, Sorbonne Paris Cite, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	El Hadri, K (corresponding author), Univ Paris 06, Sorbonne Univ, Biol Adaptat & Ageing CNRS UMR8256 B2A, INSERM ERL U1064, F-75005 Paris, France.	khadija.zegouagh@upmc.fr	Viollet, Benoit/N-2397-2019; FORETZ, Marc/O-7334-2017; Rouis, Mustapha/E-4993-2016; Viollet, Benoit/O-6927-2017	Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; EL HADRI, KHADIJA/0000-0002-1275-9861; Rouis, Mustapha/0000-0003-4197-6555	Universite Pierre et Marie Curie (University Paris 6); Chancellerie des Universites de Paris; Ministere de l'Education Nationale de la Recherche et de la Technologie	Universite Pierre et Marie Curie (University Paris 6); Chancellerie des Universites de Paris; Ministere de l'Education Nationale de la Recherche et de la Technologie	This work was supported by the Universite Pierre et Marie Curie (University Paris 6) and by grants from the "Leg Poix-2007" and "Leg Poix-2009" of the Chancellerie des Universites de Paris. Dr. Lucas Ravaux was supported by doctoral fellowships from the Ministere de l'Education Nationale de la Recherche et de la Technologie.	Andreani M, 2000, BBA-MOL CELL BIOL L, V1488, P149, DOI 10.1016/S1388-1981(00)00117-7; Antonio V, 2003, BIOCHEM J, V376, P351, DOI 10.1042/BJ20030098; Antonio V, 2002, BIOCHEM J, V368, P415, DOI 10.1042/BJ20020658; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Barroso E, 2011, BIOCHEM PHARMACOL, V81, P534, DOI 10.1016/j.bcp.2010.12.004; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Bousserouel S, 2004, EUR J BIOCHEM, V271, P4462, DOI 10.1111/j.1432-1033.2004.04385.x; Bousserouel S, 2003, J LIPID RES, V44, P601, DOI 10.1194/jlr.M200092-JLR200; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Cai XJ, 2010, MOL ENDOCRINOL, V24, P218, DOI 10.1210/me.2009-0128; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Clement N, 2006, J CELL PHYSIOL, V208, P495, DOI 10.1002/jcp.20673; Couturier C, 1999, J BIOL CHEM, V274, P23085, DOI 10.1074/jbc.274.33.23085; Csiszar A, 2011, ANN NY ACAD SCI, V1215, P117, DOI 10.1111/j.1749-6632.2010.05848.x; Devaraj S, 2008, ARTERIOSCL THROM VAS, V28, P1368, DOI 10.1161/ATVBAHA.108.163303; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Ewart MA, 2008, ARTERIOSCL THROM VAS, V28, P2255, DOI 10.1161/ATVBAHA.108.175919; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gongol B, 2013, P NATL ACAD SCI USA, V110, P3161, DOI 10.1073/pnas.1222051110; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hamaguchi K, 2003, BBA-MOL CELL BIOL L, V1635, P37, DOI 10.1016/j.bbalip.2003.10.004; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hattori Y, 2006, HYPERTENSION, V47, P265, DOI 10.1161/01.HYP.0000198425.21604.aa; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Heishi M, 2008, J TOXICOL SCI, V33, P339, DOI 10.2131/jts.33.339; Hurt-Camejo E, 2013, ARTERIOSCL THROM VAS, V33, P2707, DOI 10.1161/ATVBAHA.113.301410; HurtCamejo E, 1997, ATHEROSCLEROSIS, V132, P1, DOI 10.1016/S0021-9150(97)00085-3; Igata M, 2005, CIRC RES, V97, P837, DOI 10.1161/01.RES.0000185823.73556.06; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Jaulmes A, 2005, ARTERIOSCL THROM VAS, V25, P1161, DOI 10.1161/01.ATV.0000164310.67356.a9; Jaulmes A, 2006, FASEB J, V20, P1727, DOI 10.1096/fj.05-5514fje; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kundu JK, 2006, CARCINOGENESIS, V27, P1465, DOI 10.1093/carcin/bgi349; LEBAIL O, 1993, EMBO J, V12, P5043, DOI 10.1002/j.1460-2075.1993.tb06197.x; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Motoshima H, 2004, BIOCHEM BIOPH RES CO, V315, P264, DOI 10.1016/j.bbrc.2004.01.049; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; Neumann D, 2007, MOL BIOTECHNOL, V36, P220, DOI 10.1007/s12033-007-0029-x; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Ouchi N, 2008, ARTERIOSCL THROM VAS, V28, P1219, DOI 10.1161/ATVBAHA.108.165068; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parekh S, 2007, BLOOD, V110, P2067, DOI 10.1182/blood-2007-01-069575; Perez-Rosado A, 2008, J PATHOL, V214, P498, DOI 10.1002/path.2279; Ravaux L, 2007, MOL CELL BIOL, V27, P8374, DOI 10.1128/MCB.00623-07; Rosengren B, 2006, BBA-MOL CELL BIOL L, V1761, P1301, DOI 10.1016/j.bbalip.2006.06.008; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Schuhmacher S, 2011, ARTERIOSCL THROM VAS, V31, P560, DOI 10.1161/ATVBAHA.110.219543; Sharma P, 2013, J BIOL CHEM, V288, P16321, DOI 10.1074/jbc.M112.445569; Song P, 2011, CIRC RES, V109, P1230, DOI 10.1161/CIRCRESAHA.111.250423; Sullivan CP, 2010, J BIOL CHEM, V285, P565, DOI 10.1074/jbc.M109.070565; Thompson AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085495; Tili E, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/102431; Tili E, 2010, CARCINOGENESIS, V31, P1561, DOI 10.1093/carcin/bgq143; Tischfield JA, 1997, J BIOL CHEM, V272, P17247, DOI 10.1074/jbc.272.28.17247; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu YZ, 2010, BIOCHIMIE, V92, P583, DOI 10.1016/j.biochi.2010.01.024; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zhang Y, 2011, ARTERIOSCL THROM VAS, V31, P2897, DOI 10.1161/ATVBAHA.111.237453; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	78	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132498	10.1371/journal.pone.0132498	http://dx.doi.org/10.1371/journal.pone.0132498			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162096	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300141
J	Eom, YH; Puliga, M; Smailovic, J; Mozetic, I; Caldarelli, G				Eom, Young-Ho; Puliga, Michelangelo; Smailovic, Jasmina; Mozetic, Igor; Caldarelli, Guido			Twitter-Based Analysis of the Dynamics of Collective Attention to Political Parties	PLOS ONE			English	Article							BEHAVIOR	Large-scale data from social media have a significant potential to describe complex phenomena in the real world and to anticipate collective behaviors such as information spreading and social trends. One specific case of study is represented by the collective attention to the action of political parties. Not surprisingly, researchers and stakeholders tried to correlate parties' presence on social media with their performances in elections. Despite the many efforts, results are still inconclusive since this kind of data is often very noisy and significant signals could be covered by (largely unknown) statistical fluctuations. In this paper we consider the number of tweets (tweet volume) of a party as a proxy of collective attention to the party, identify the dynamics of the volume, and show that this quantity has some information on the election outcome. We find that the distribution of the tweet volume for each party follows a log-normal distribution with a positive autocorrelation of the volume over short terms, which indicates the volume has large fluctuations of the log-normal distribution yet with a short-term tendency. Furthermore, by measuring the ratio of two consecutive daily tweet volumes, we find that the evolution of the daily volume of a party can be described by means of a geometric Brownian motion (i.e., the logarithm of the volume moves randomly with a trend). Finally, we determine the optimal period of averaging tweet volume for reducing fluctuations and extracting short-term tendencies. We conclude that the tweet volume is a good indicator of parties' success in the elections when considered over an optimal time window. Our study identifies the statistical nature of collective attention to political issues and sheds light on how to model the dynamics of collective attention in social media.	[Eom, Young-Ho; Puliga, Michelangelo; Caldarelli, Guido] IMT, Inst Adv Studies, I-55100 Lucca, Italy; [Smailovic, Jasmina; Mozetic, Igor] Jozef Stefan Inst, Ljubljana 1000, Slovenia; [Caldarelli, Guido] ISC, I-00185 Rome, Italy; [Caldarelli, Guido] London Inst Math Sci, London W1K 2XF, England; [Caldarelli, Guido] Linkalab, Complex Syst Computat Lab, Cagliari, Italy	IMT School for Advanced Studies Lucca; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Eom, YH (corresponding author), IMT, Inst Adv Studies, Piazza San Francesco 19, I-55100 Lucca, Italy.	youngho.eom@imtlucca.it	Caldarelli, Guido/AAB-8206-2022; puliga, michelangelo/AAS-9954-2020; Caldarelli, Guido/A-5274-2010	Mozetic, Igor/0000-0002-5466-0608; Eom, Young-Ho/0000-0002-4828-7333; Caldarelli, Guido/0000-0001-9377-3616	EC project SIMPOL [610704]; FET project DOLFINS [640772]; FET IP project MULTIPLEX [317532]; EC project SoBigData [654024]; Slovenian ARRS programme [P2-103]	EC project SIMPOL; FET project DOLFINS; FET IP project MULTIPLEX; EC project SoBigData; Slovenian ARRS programme(Slovenian Research Agency - Slovenia)	This work was supported by the EC project SIMPOL nr. 610704, the FET project DOLFINS nr. 640772, and the FET IP project MULTIPLEX nr. 317532. YHE and GC thank the EC project SoBigData nr. 654024. JS and IM also acknowledge support of the Slovenian ARRS programme no. P2-103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118093; Bordino I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040014; Borondo J, 2012, CHAOS, V22, DOI 10.1063/1.4729139; Caldarelli G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095809; Cheng J, 2014, WWW'14: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P925, DOI 10.1145/2566486.2567997; Conover M. D., 2011, 5 INT AAAI C WEBL SO, DOI DOI 10.1021/JA202932E; Conover MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064679; Conover MD, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds6; Conte R, 2012, EUR PHYS J-SPEC TOP, V214, P325, DOI 10.1140/epjst/e2012-01697-8; Curme C, 2014, P NATL ACAD SCI USA, V111, P11600, DOI 10.1073/pnas.1324054111; DiGrazia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079449; Eom YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114825; Eom YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074554; Gayo-Avello D., 2015, PREPRINT; Gayo-Avello D, 2013, SOC SCI COMPUT REV, V31, P649, DOI 10.1177/0894439313493979; Giles J, 2012, NATURE, V488, P448, DOI 10.1038/488448a; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Gonzalez-Bailon S, 2014, SOC NETWORKS, V38, P16, DOI 10.1016/j.socnet.2014.01.004; Gonzalez-Bailon S, 2013, AM BEHAV SCI, V57, P943, DOI 10.1177/0002764213479371; Jungherr Andreas, 2013, P 2 WORKSHOP POLITIC, P5, DOI [DOI 10.1145/2508436.2508437, 10.1145/2508436.2508437]; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lehmann J., 2012, P 21 INT C WORLD WID, P251, DOI [10.1145/2187836.2187871, DOI 10.1145/2187836.2187871]; Lerman K, 2010, ICWSM, V10, P90, DOI DOI 10.1146/ANNUREV.AN.03.100174.001431; Llorente A, 2015, PREPRINT; Marathe R. R., 2005, Engineering Economist, V50, P159, DOI 10.1080/00137910590949904; Mathiesen J, 2013, P NATL ACAD SCI USA, V110, P17259, DOI 10.1073/pnas.1304179110; Mestyan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071226; Miotto JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111506; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Moat HS, 2014, BEHAV BRAIN SCI, V37, P92, DOI 10.1017/S0140525X13001817; Mocanu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061981; OConnor B., 2010, ICWSM, P122; Ross S., 1998, INTRO MATH FINANCE; Smailovic J, 2014, MONITORING TWITTER S; Ugander J, PREPRINT; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Wikipedia, 2013, WIKIPEDIA OPINION PO; WILK MB, 1968, BIOMETRIKA, V55, P1; Yasseri T, 2014, IT-INF TECHNOL, V56, P246, DOI 10.1515/itit-2014-1046	40	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131184	10.1371/journal.pone.0131184	http://dx.doi.org/10.1371/journal.pone.0131184			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161795	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000358162300030
J	Raimondi, D; Orlando, G; Vranken, WF				Raimondi, Daniele; Orlando, Gabriele; Vranken, Wim F.			An Evolutionary View on Disulfide Bond Connectivities Prediction Using Phylogenetic Trees and a Simple Cysteine Mutation Model	PLOS ONE			English	Article							RECURSIVE NEURAL-NETWORKS; WEB SERVER; PROTEINS; STATE	Disulfide bonds are crucial for many structural and functional aspects of proteins. They have a stabilizing role during folding, can regulate enzymatic activity and can trigger allosteric changes in the protein structure. Moreover, knowledge of the topology of the disulfide connectivity can be relevant in genomic annotation tasks and can provide long range constraints for ab-initio protein structure predictors. In this paper we describe PhyloCys, a novel unsupervised predictor of disulfide bond connectivity from known cysteine oxidation states. For each query protein, PhyloCys retrieves and aligns homologs with HHblits and builds a phylogenetic tree using ClustalW. A simplified model of cysteine co-evolution is then applied to the tree in order to hypothesize the presence of oxidized cysteines in the inner nodes of the tree, which represent ancestral protein sequences. The tree is then traversed from the leaves to the root and the putative disulfide connectivity is inferred by observing repeated patterns of tandem mutations between a sequence and its ancestors. A final correction is applied using the Edmonds-Gabow maximum weight perfect matching algorithm. The evolutionary approach applied in PhyloCys results in disulfide bond predictions equivalent to Sephiroth, another approach that takes whole sequence information into account, and is 26-29% better than state of the art methods based on cysteine covariance patterns in multiple sequence alignments, while requiring one order of magnitude fewer homologous sequences (10(3) instead of 10(4)), thus extending its range of applicability.	[Raimondi, Daniele; Orlando, Gabriele; Vranken, Wim F.] ULB VUB, Interuniv Inst Bioinformat Brussels, Brussels, Belgium; [Raimondi, Daniele; Orlando, Gabriele; Vranken, Wim F.] Vrije Univ Brussel, Struct Biol Brussels, Brussels, Belgium; [Raimondi, Daniele; Orlando, Gabriele; Vranken, Wim F.] VIB, Dept Biol Struct, Brussels, Belgium; [Raimondi, Daniele; Orlando, Gabriele] ULB, Machine Learning Grp, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Universite Libre de Bruxelles	Vranken, WF (corresponding author), ULB VUB, Interuniv Inst Bioinformat Brussels, Brussels, Belgium.	wvranken@vub.ac.be	Vranken, Wim F/J-5051-2016; Orlando, Gabriele/GVU-4650-2022	Vranken, Wim F/0000-0001-7470-4324; 	Agency for Innovation by Science and Technology in Flanders (IWT); Brussels Institute for Research and Innovation (Innoviris) grant [BB2B2010-1-12]	Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Brussels Institute for Research and Innovation (Innoviris) grant(Innoviris)	DR is funded by the Agency for Innovation by Science and Technology in Flanders (IWT) (http://www.iwt.be/). WFV is funded by the Brussels Institute for Research and Innovation (Innoviris) grant BB2B2010-1-12 (http://www.innoviris.be/nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazy H, 2012, NUCLEIC ACIDS RES, V40, pW580, DOI 10.1093/nar/gks498; Ceroni A, 2006, NUCLEIC ACIDS RES, V34, pW177, DOI 10.1093/nar/gkl266; Cheng JL, 2006, PROTEINS, V62, P617, DOI 10.1002/prot.20787; Chuang CC, 2003, PROTEINS, V53, P1, DOI 10.1002/prot.10492; Ekeberg M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012707; Elias I, 2005, P INT C AUT LANG PRO; Fariselli P, 2001, BIOINFORMATICS, V17, P957, DOI 10.1093/bioinformatics/17.10.957; Felsenstein J., 2004, INFERRING PHYLOGENIE; Ferre F, 2005, NUCL ACIDS RES, V33; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; GABOW HN, 1976, J ACM, V23, P221, DOI 10.1145/321941.321942; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Martelli PL, 2002, PROTEIN SCI, V11, P2735, DOI 10.1110/ps.0219602; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Raimondi D., 2014, BIOINFORMATICS, V2014, P1; Remmert M, 2012, NATURE METHODS; Rubinstein R, 2008, BIOINFORMATICS, V24, P498, DOI 10.1093/bioinformatics/btm637; Savojardo C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S1-S10; Savojardo C, 2011, BIOINFORMATICS, V27, P2224, DOI 10.1093/bioinformatics/btr387; Singh Rahul, 2008, Briefings in Functional Genomics & Proteomics, V7, P157, DOI 10.1093/bfgp/eln008; Tsai CH, 2007, CURR PROTEIN PEPT SC, V8, P243, DOI 10.2174/138920307780831848; van Vlijmen HWT, 2004, J MOL BIOL, V335, P1083, DOI 10.1016/j.jmb.2003.10.077; Velankar S, 2012, NUCL ACIDS RES; Vullo A, 2004, BIOINFORMATICS, V20, P653, DOI 10.1093/bioinformatics/btg463; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P7032, DOI 10.1021/bi005111p; Zhao E, 2005, BIOINFORMATICS, V21, P1415, DOI 10.1093/bioinformatics/bti179	29	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131792	10.1371/journal.pone.0131792	http://dx.doi.org/10.1371/journal.pone.0131792			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161671	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300059
J	Sippel, D; Marckmann, G; Atangana, EN; Strech, D				Sippel, Daniel; Marckmann, Georg; Atangana, Etienne Ndzie; Strech, Daniel			Clinical Ethics in Gabon: The Spectrum of Clinical Ethical Issues Based on Findings from In-Depth Interviews at Three Public Hospitals	PLOS ONE			English	Article							INFORMED-CONSENT; DEVELOPING-COUNTRIES; CANCER-DIAGNOSIS; HEALTH; DISCLOSURE; BIOETHICS; CARE; PERSPECTIVE; CONTEXT; UNESCO	Introduction Unlike issues in biomedical research ethics, ethical challenges arising in daily clinical care in Sub-Saharan African countries have not yet been studied in a systematic manner. However this has to be seen as a distinct entity as we argue in this paper. Our aim was to give an overview of the spectrum of clinical ethical issues and to understand what influences clinical ethics in the Sub-Saharan country of Gabon. Materials and Methods In-depth interviews with 18 health care professionals were conducted at three hospital sites in Gabon. Interview transcripts were analyzed using a grounded theory approach (open and axial coding), giving a qualitative spectrum of categories for clinical ethical issues. Validity was checked at a meeting with study participants and other health care experts in Gabon after analysis of the data. Results Twelve main categories (with 28 further-specified subcategories) for clinical ethical issues were identified and grouped under three core categories: A) micro level: "confidentiality and information", "interpersonal, relational and behavioral issues", "psychological strain of individuals", and "scarce resources"; B) meso level: "structural issues of medical institutions", "issues with private clinics", "challenges connected to the family", and "issues of education, training and competence"; and C) macro level: "influence of society, culture, religion and superstition", "applicability of western medicine", "structural issues on the political level", and "legal issues". Discussion Interviewees reported a broad spectrum of clinical ethical issues that go beyond challenges related to scarce financial and human resources. Specific socio-cultural, historical and educational backgrounds also played an important role. In fact these influences are central to an understanding of clinical ethics in the studied local context. Further research in the region is necessary to put our study into perspective. As many participants reported a lack of awareness of ethical issues amongst other health care professionals in daily clinical practice, we suggest that international organizations and national medical schools should consider infrastructure and tools to improve context-sensitive capacity building in clinical ethics for Sub-Saharan African countries like Gabon.	[Sippel, Daniel] Tech Univ Dresden, Dept Neurol, Carl Gustav Carus Univ Hosp, D-01062 Dresden, Germany; [Sippel, Daniel] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany; [Marckmann, Georg] Univ Munich, Inst Eth Hist & Theory Med, Munich, Germany; [Atangana, Etienne Ndzie] Univ Med Ctr Gottingen, Dept Neurosurg, Gottingen, Germany; [Strech, Daniel] Hannover Med Sch, Inst Hist Eth & Philosophy Med, Ctr Eth & Law Life Sci, Hannover, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; University of Munich; University of Gottingen; Hannover Medical School	Strech, D (corresponding author), Hannover Med Sch, Inst Hist Eth & Philosophy Med, Ctr Eth & Law Life Sci, Hannover, Germany.	Strech.Daniel@mh-hannover.de		Strech, Daniel/0000-0002-9153-079X; Marckmann, Georg/0000-0002-6898-9500	intramural funds of Hannover Medical School and University of Tubingen; German Academic Exchange Service (DAAD) [PKZ P07/07257]	intramural funds of Hannover Medical School and University of Tubingen; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This project was funded by intramural funds of Hannover Medical School and University of Tubingen and by the German Academic Exchange Service (DAAD, PKZ P07/07257, www.daad.de/en). Carsten Kohler, University of Tuebingen, Germany received the fund and invited the authors to participate in capacity building seminars. This project was performed outside these seminars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Mark J, 2003, J Int Assoc Physicians AIDS Care (Chic), V2, P81; Alolo N., 2007, AFRICAN TRADITIONAL; Asante AD, 2006, HEALTH POLICY, V78, P135, DOI 10.1016/j.healthpol.2006.03.013; Aulisio M.P., 2003, ETHICS CONSULTATION; BARRY M, 1988, NEW ENGL J MED, V319, P1083, DOI 10.1056/NEJM198810203191609; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Bennett S, 2005, B WORLD HEALTH ORGAN, V83, P541; Braunack-Mayer AJ, 2001, J MED ETHICS, V27, P98, DOI 10.1136/jme.27.2.98; Brennan T, 2002, LANCET, V359, P520, DOI 10.1016/s0140-6736(02)07684-5; Chima SC, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-S1-S3; CIA, WORLD FACTB GAB; Daniels N, 2005, B WORLD HEALTH ORGAN, V83, P534; Denny CC, 2007, J MED ETHICS, V33, P382, DOI 10.1136/jme.2006.017681; Diniz D, 2010, DEV WORLD BIOETH, V10, pII, DOI [10.1111/j.1471-8847.2010.00291.x, 10.1111/j.1471-8847.2010.00279.x]; Flick U., 1998, INTRO QUALITATIVE RE; Friedland BA, 2013, AIDS BEHAV; GBADEGESIN S, 1993, BIOETHICS, V7, P257, DOI 10.1111/j.1467-8519.1993.tb00292.x; Groth Susan W, 2010, J N Y State Nurses Assoc, V41, P11; Groth SW, 2010, J N Y STATE NURSES A, P22; Halpern SD, 2004, ARCH INTERN MED, V164, P801, DOI 10.1001/archinte.164.7.801; Harris JJ, 2003, SOC SCI MED, V56, P905, DOI 10.1016/S0277-9536(02)00090-4; Henley L, 1995, S AFR MED J, V85, P1273; Houston Stan, 2002, J Int Assoc Physicians AIDS Care (Chic), V1, P46, DOI 10.1177/154510970200100202; IJSSELMUIDEN CB, 1992, NEW ENGL J MED, V326, P830, DOI 10.1056/NEJM199203193261212; Irabor DO, 2009, DEV WORLD BIOETH, V9, P34, DOI 10.1111/j.1471-8847.2007.00198.x; Johansson KA, 2011, J MED ETHICS, V37, P221, DOI 10.1136/jme.2010.038570; JONSEN A. R., 2010, CLIN ETHICS PRACTICA, V7th; Kapiriri L, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-127; Karim QA, 1998, AM J PUBLIC HEALTH, V88, P637, DOI 10.2105/AJPH.88.4.637; Kevany S, 2013, GLOB PUBLIC HLTH; Kilama WL, 2005, ACTA TROP, V95, P276, DOI 10.1016/j.actatropica.2005.06.011; Krosin MT, 2006, CLIN TRIALS, V3, P306, DOI 10.1191/1740774506cn150oa; Kuhse H., 2015, BIOETHICS ANTHOLOGY; Kyaddondo D, 2013, SAHARA J-J SOC ASP H, V10, pS37, DOI 10.1080/02664763.2012.755323; London L, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-48; Makita-Ikouaya Euloge, 2010, Sante, V20, P179; Mathooko JM, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-S1-S2; Mbatchou GA, ETHIQUE RECHERCHE BI; Moyer E, 2013, SAHARA J-J SOC ASP H, V10, pS60, DOI 10.1080/02664763.2012.755339; Nwankwo KC, 2011, J PALLIAT MED, V14, P700, DOI 10.1089/jpm.2010.0440; Nyika A, 2007, DEV WORLD BIOETH, V7, P25, DOI 10.1111/j.1471-8847.2006.00157.x; Obermeyer CM, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-6; Obermeyer CM, 2014, COULD YOU HAVE SAID; Rowe K, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-15; Sow K, 2013, SAHARA J J SOCIAL AS; Strauss A., 1998, BASICS QUALITATIVE R; Strech D, 2013, BRIT J PSYCHIAT, V202, P400, DOI 10.1192/bjp.bp.112.116335; Strech D, 2011, J MED ETHICS, V37, P390, DOI 10.1136/jme.2010.040121; Stuttaford M, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24121; Sugarman J, 2010, METHODS MED ETHICS, V2; Tangwa GB, 1996, BIOETHICS, V10, P183, DOI 10.1111/j.1467-8519.1996.tb00118.x; ten Have H, 2006, KENNEDY INST ETHIC J, V16, P333; Ten Have H, 2011, CAMB Q HEALTHC ETHIC, V20, P380, DOI 10.1017/S0963180111000065; UNESCO, 2008, MED TERM STRAT 2008; United Nations Development Reports, HUM DEV REP 2014; United Nations Educational Scientific and Cultural Organization (UNESCO), 2013, CLIM CHANG CLASSR; United Nations Educational Scientific and Cultural Organization (UNESCO), 2013, GLOB ETH OBS GEOBS	57	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132374	10.1371/journal.pone.0132374	http://dx.doi.org/10.1371/journal.pone.0132374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161655	gold, Green Submitted, Green Published			2022-12-27	WOS:000358162300125
J	Techasintana, P; Davis, JW; Gubin, MM; Magee, JD; Atasoy, U				Techasintana, Patsharaporn; Davis, J. Wade; Gubin, Matthew M.; Magee, Joseph D.; Atasoy, Ulus			Transcriptomic-Wide Discovery of Direct and Indirect HuR RNA Targets in Activated CD4(+) T Cells	PLOS ONE			English	Article							BINDING PROTEIN HUR; DIFFERENTIAL EXPRESSION ANALYSIS; MESSENGER-RNA; GENE-EXPRESSION; NUCLEAR; ICOS; IDENTIFICATION; COSTIMULATION; TRANSLATION; COMPLEXES	Due to poor correlation between steady state mRNA levels and protein product, purely transcriptomic profiling methods may miss genes posttranscriptionally regulated by RNA binding proteins (RBPs) and microRNAs (miRNAs). RNA immunoprecipitation (RIP) methods developed to identify in vivo targets of RBPs have greatly elucidated those mRNAs which may be regulated via transcript stability and translation. The RBP HuR (ELAVL1) and family members are major stabilizers of mRNA. Many labs have identified HuR mRNA targets; however, many of these analyses have been performed in cell lines and oftentimes are not independent biological replicates. Little is known about how HuR target mRNAs behave in conditional knock-out models. In the present work, we performed HuR RIP-Seq and RNASeq to investigate HuR direct and indirect targets using a novel conditional knock-out model of HuR genetic ablation during CD4+ T activation and Th2 differentiation. Using independent biological replicates, we generated a high coverage RIP-Seq data set (>160 million reads) that was analyzed using bioinformatics methods specifically designed to find direct mRNA targets in RIP-Seq data. Simultaneously, another set of independent biological replicates were sequenced by RNA-Seq (>425 million reads) to identify indirect HuR targets. These direct and indirect targets were combined to determine canonical pathways in CD4+ T cell activation and differentiation for which HuR plays an important role. We show that HuR may regulate genes in multiple canonical pathways involved in T cell activation especially the CD28 family signaling pathway. These data provide insights into potential HuRregulated genes during T cell activation and immune mechanisms.	[Techasintana, Patsharaporn; Atasoy, Ulus] Univ Missouri, Dept Surg, Columbia, MO 65201 USA; [Techasintana, Patsharaporn; Atasoy, Ulus] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO USA; [Davis, J. Wade] Univ Missouri, Dept Biostat, Columbia, MO USA; [Gubin, Matthew M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Magee, Joseph D.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Washington University (WUSTL); University of Missouri System; University of Missouri Columbia	Atasoy, U (corresponding author), Univ Missouri, Dept Surg, Columbia, MO 65201 USA.	atasoyu@health.missouri.edu		Gubin, Matthew/0000-0001-7443-2752	National Institutes of Health [R21AI079341, R01AI080870]; NIH [2R01AI080870-05A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080870, R21AI079341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded by grant R21AI079341 National Institutes of Health (www.nih.gov) to UA; R01AI080870 National Institutes of Health (www.nih.gov) to UA; NIH grant 2R01AI080870-05A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atasoy U, 1998, J CELL SCI, V111, P3145; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Calaluce R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-126; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen J, 2013, J IMMUNOL, V191, P5441, DOI 10.4049/jimmunol.1301188; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Dahm GM, 2012, JOVE-J VIS EXP, DOI 10.3791/3851; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Gubin MM, 2014, MOL MED, V20, P93, DOI 10.2119/molmed.2013.00127; Gubin MM, 2010, CELL CYCLE, V9, P3337, DOI 10.4161/cc.9.16.12711; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hafner Markus, 2010, J Vis Exp, DOI 10.3791/2034; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hieronymus H, 2004, GENE DEV, V18, P2652, DOI 10.1101/gad.1241204; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Keene JD, 2003, MOL CELL, V12, P1347, DOI 10.1016/S1097-2765(03)00496-9; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kraushar ML, 2014, P NATL ACAD SCI USA, V111, pE3815, DOI 10.1073/pnas.1408305111; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt142; Lin MY, 2005, J IMMUNOL, V174, P5583, DOI 10.4049/jimmunol.174.9.5583; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Padilla J, 2011, AM J PHYSIOL-HEART C, V301, pH555, DOI 10.1152/ajpheart.00065.2011; Raghavan A, 2001, J BIOL CHEM, V276, P47958, DOI 10.1074/jbc.M109511200; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Rattenbacher B, 2010, MOL CELL BIOL, V30, P3970, DOI 10.1128/MCB.00624-10; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Stellato C, 2011, J IMMUNOL, V187, P441, DOI 10.4049/jimmunol.1001881; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Tenenbaum SA, 2003, GENE, V317, P79, DOI 10.1016/S0378-1119(03)00661-9; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; UMLAUF SW, 1995, MOL CELL BIOL, V15, P3197; Uren PJ, 2011, J BIOL CHEM, V286, P37063, DOI 10.1074/jbc.C111.266882; Wang JG, 2006, J IMMUNOL, V176, P2105, DOI 10.4049/jimmunol.176.4.2105; Watanabe M, 2005, J IMMUNOL, V174, P1989, DOI 10.4049/jimmunol.174.4.1989	48	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0129321	10.1371/journal.pone.0129321	http://dx.doi.org/10.1371/journal.pone.0129321			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162078	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300009
J	Viarouge, C; Breard, E; Zientara, S; Vitour, D; Sailleau, C				Viarouge, Cyril; Breard, Emmanuel; Zientara, Stephan; Vitour, Damien; Sailleau, Corinne			Duplex Real-Time RT-PCR Assays for the Detection and Typing of Epizootic Haemorrhagic Disease Virus	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; BLUETONGUE-VIRUS; NUCLEIC-ACID; SEROTYPES; CATTLE; ASSIGNMENT; PROTEINS; SEGMENTS; GENOME; ISLAND	Epizootic haemorrhagic disease virus (EHDV) may cause severe clinical episodes in some species of deer and sometimes in cattle. Laboratory diagnosis provides a basis for the design and timely implementation of disease control measures. There are seven distinct EHDV serotypes, VP2 coding segment 2 being the target for serotype specificity. This paper reports the development and validation of eight duplex real-time RT-PCR assays to simultaneously amplify the EHDV target (S9 for the pan-EHDV real-time RT-PCR assay and S2 for the serotyping assays) and endogenous control gene Beta-actin. Analytical and diagnostic sensitivity and specificity, inter-and intra-assay variation and efficiency were evaluated for each assay. All were shown to be highly specific and sensitive.	[Viarouge, Cyril; Breard, Emmanuel; Zientara, Stephan; Vitour, Damien; Sailleau, Corinne] ANSES INRA ENVA UPEC, UMR Virol 1161, F-94700 Maisons Alfort, France	INRAE; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Sailleau, C (corresponding author), ANSES INRA ENVA UPEC, UMR Virol 1161, 23 Ave Gen Gaulle, F-94700 Maisons Alfort, France.	corinne.sailleau@anses.fr	breard, emmanuel/E-2123-2011; Zientara, Stephan/A-5336-2016; Zientara, Stephan/AAA-7661-2021	Zientara, Stephan/0000-0003-0089-8175; Zientara, Stephan/0000-0002-6733-8503	EU [FP7-613996 Vmerge]	EU(European Commission)	This study was partially funded by EU grant FP7-613996 Vmerge (catalogued by the VMERGE Steering Committee as Vmerge004) and the additional funding has come from the laboratory's own resources.	Allison AB, 2010, J GEN VIROL, V91, P430, DOI 10.1099/vir.0.015651-0; Anthony SJ, 2009, VIRUS RES, V145, P200, DOI 10.1016/j.virusres.2009.07.012; BallagiPordany A, 1996, MOL CELL PROBE, V10, P159, DOI 10.1006/mcpr.1996.0022; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Breard E, 2004, VET REC, V155, P422, DOI 10.1136/vr.155.14.422; Breard E, 2013, RES VET SCI, V95, P794, DOI 10.1016/j.rvsc.2013.06.026; Cetre-Sossah C, 2014, VET MICROBIOL, V170, P383, DOI 10.1016/j.vetmic.2014.02.007; Chalmers G. A., 1964, Wildlife Diseases; Clavijo A, 2010, J VET DIAGN INVEST, V22, P588, DOI 10.1177/104063871002200414; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; HUISMANS H, 1979, ONDERSTEPOORT J VET, V46, P95; Maan Narender S, 2010, PLoS One, V5, DOI 10.1371/journal.pone.0012782; MECHAM JO, 1988, J GEN VIROL, V69, P1255, DOI 10.1099/0022-1317-69-6-1255; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; Mertens PPC., 2005, VIRUS TAXONOMY, P466; OIE (World Organization for Animal Health), 2014, MAN DIAGN TESTS VACC; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; Sailleau C, 2012, VET MICROBIOL, V155, P191, DOI 10.1016/j.vetmic.2011.09.006; Savini G, 2011, RES VET SCI, V91, P1, DOI 10.1016/j.rvsc.2011.05.004; Schroeder ME, 2013, J VET DIAGN INVEST, V25, P709, DOI 10.1177/1040638713503654; Shope RE, 1955, NEW JERSEY OUTDOORS, P21; SUGIYAMA M, 1989, RES VET SCI, V46, P283, DOI 10.1016/S0034-5288(18)31161-5; Sun F, 2014, J WILDLIFE DIS, V50, P639, DOI 10.7589/2013-11-302; Temizel EM, 2009, EMERG INFECT DIS, V15, P317, DOI 10.3201/eid1502.080572; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Toye PG, 2013, RES VET SCI, V94, P769, DOI 10.1016/j.rvsc.2012.11.001; Viarouge C, 2014, VET MICROBIOL, V174, P78, DOI 10.1016/j.vetmic.2014.09.006; Wilson WC, 2009, J VET DIAGN INVEST, V21, P760, DOI 10.1177/104063870902100602; Yadin H, 2008, VET REC, V162, P53, DOI 10.1136/vr.162.2.53	29	11	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132540	10.1371/journal.pone.0132540	http://dx.doi.org/10.1371/journal.pone.0132540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161784	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300150
J	Wu, WW; Xu, H; Wang, ZM; Mao, Y; Yuan, LS; Luo, W; Cui, ZQ; Cui, TX; Wang, XL; Shen, YH				Wu, Weiwei; Xu, Hao; Wang, Zemin; Mao, Yun; Yuan, Liangshuai; Luo, Wei; Cui, Zhaoqiang; Cui, Taixing; Wang, Xing Li; Shen, Ying H.			PINK1-Parkin-Mediated Mitophagy Protects Mitochondrial Integrity and Prevents Metabolic Stress-Induced Endothelial Injury	PLOS ONE			English	Article							MUTATIONS; DISEASE; PARKIN; REGULATORS; AUTOPHAGY; MEMBRANE	Mitochondrial injury and dysfunction, a significant feature in metabolic syndrome, triggers endothelial cell dysfunction and cell death. Increasing evidence suggests that mitophagy, a process of autophagic turnover of damaged mitochondria, maintains mitochondrial integrity. PINK1 (phosphatase and tensin homolog (PTEN)-induced putative kinase 1) and Parkin signaling is a key pathway in mitophagy control. In this study, we examined whether this pathway could protect mitochondria under metabolic stress. We found that palmitic acid (PA) induced significant mitophagy and activated PINK1 and Parkin in endothelial cells. Knocking down PINK1 or Parkin reduced mitophagy, leading to impaired clearance of damaged mitochondria and intracellular accumulation of mitochondrial fragments. Furthermore, PINK1 and Parkin prevented PA-induced mitochondrial dysfunction, ROS production and apoptosis. Finally, we show that PINK1 and Parkin were up-regulated in vascular wall of obese mice and diabetic mice. Our study demonstrates that PINK1-Parkin pathway is activated in response to metabolic stress. Through induction of mitophagy, this pathway protects mitochondrial integrity and prevents metabolic stress-induced endothelial injury.	[Wu, Weiwei; Xu, Hao; Wang, Zemin; Mao, Yun; Yuan, Liangshuai; Luo, Wei; Cui, Zhaoqiang; Cui, Taixing; Wang, Xing Li] Shandong Univ, Res Ctr Cell Therapy, Key Lab Cardiovasc Remodeling & Funct Res, Qilu Hosp, Jinan 250012, Peoples R China; [Cui, Taixing] Univ S Carolina, Dept Cell Biol & Anat, Columbus, SC 29209 USA; [Wang, Xing Li; Shen, Ying H.] Baylor Coll Med, Div Cardiothorac Surg, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Wang, Xing Li; Shen, Ying H.] Texas Heart Inst, Houston, TX 77025 USA	Shandong University; University of South Carolina; Baylor College of Medicine; Texas Heart Institute	Wang, XL (corresponding author), Shandong Univ, Res Ctr Cell Therapy, Key Lab Cardiovasc Remodeling & Funct Res, Qilu Hosp, Jinan 250012, Peoples R China.	xingliwang@sdu.edu.cn; hyshen@bcm.edu	shen, ying/HHS-5635-2022		Shandong University National Qianren Scholar Fund; National 973 Program Grant [2014CB542401]	Shandong University National Qianren Scholar Fund; National 973 Program Grant	This work was supported by the Shandong University National Qianren Scholar Fund (XLW) and by the National 973 Program Grant (2014CB542401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Chen YR, 2014, CIRC RES, V114, P524, DOI 10.1161/CIRCRESAHA.114.300559; Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d; Dorn G.W., 2014, CIRC RES; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; HAYWOOD LJ, 1988, JAMA-J AM MED ASSOC, V259, P1328; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; LI X, 2009, DIABETES; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Shen YH, 2013, CIRC RES, V112, P618, DOI 10.1161/CIRCRESAHA.112.300735; Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhu JH, 2011, METHODS MOL BIOL, V793, P325, DOI 10.1007/978-1-61779-328-8_21	26	98	104	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132499	10.1371/journal.pone.0132499	http://dx.doi.org/10.1371/journal.pone.0132499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161534	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300142
J	Gao, CX; Li, TT; Liu, J; Guo, Q; Tian, LM				Gao, Cuixia; Li, Tingting; Liu, Jing; Guo, Qian; Tian, Limin			Endothelial Functioning and Hemodynamic Parameters in Rats with Subclinical Hypothyroid and the Effects of Thyroxine Replacement	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; CORONARY-HEART-DISEASE; THYROID-HORMONE ACTION; CARDIOVASCULAR RISK-FACTORS; VASCULAR SMOOTH-MUSCLE; CARDIAC-FUNCTION; STIMULATING HORMONE; OXIDATIVE STRESS; DYSFUNCTION; ATHEROSCLEROSIS	Objective Subclinical hypothyroidism (SCH) and its associations with atherosclerosis (AS) and cardiovascular disease remain controversial. The purpose of our study was to observe changes in endothelial functioning and hemodynamics in rats with SCH and to determine whether L-thyroxine (L-T4) administration affects these changes. Methods In total, sixty male Wistar rats were randomly divided into the following three groups with 20 rats each: control euthyroid rats, SCH rats and SCH rats that had been treated with thyroxine (SCH+T4). The SCH rats were induced by administration of 10 mg.kg(-1). d(-1) methimazole (MMI) once daily by gavage for 3 months. The SCH+T4 rats were administered the same dose of MMI for three months in addition to 2 mu g.kg(-1). d(-1) L-T4 once daily by gavage after 45 days of MMI administration. The control rats received physiological saline via gavage. Results The SCH group had significantly higher thyroid-stimulating hormone (TSH), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and endothelin (ET) levels and a lower nitric oxide (NO) level than the control and SCH+T4 groups. The tail and carotid artery blood pressures, left ventricular systolic pressure, heart rate and aorta ventralis blood flow were significantly lower in the SCH group than in the control and SCH+T4 groups. ACH treatment caused concentration-dependent relaxation, which was reduced in the SCH arteries compared with the control and SCH+T4 arteries. Histopathological examination revealed the absence of pathological changes in the SCH rat arteries. Conclusions These findings demonstrate that L-T4 treatment ameliorates endothelial dysfunction and hemodynamic changes in SCH rats.	[Gao, Cuixia] Gansu Prov Hosp, Dept Ultrason Diag, Lanzhou, Gansu, Peoples R China; [Li, Tingting] Gansu Univ Chinese Med, Dept Clin Med, Lanzhou, Gansu, Peoples R China; [Liu, Jing; Guo, Qian; Tian, Limin] Gansu Prov Hosp, Dept Endocrinol, Lanzhou, Gansu, Peoples R China	Gansu University of Chinese Medicine	Tian, LM (corresponding author), Gansu Prov Hosp, Dept Endocrinol, Lanzhou, Gansu, Peoples R China.	tlm7066@sina.com	Tian, Limin/K-4855-2019		National Natural Science Foundation of China [81160100, 81360125]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by grants from the National Natural Science Foundation of China (81160100, 81360125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed OM, 2012, J DIABETES COMPLICAT, V26, P491, DOI 10.1016/j.jdiacomp.2012.05.021; BELL GM, 1983, CLIN ENDOCRINOL, V18, P511, DOI 10.1111/j.1365-2265.1983.tb02881.x; Billic-Komarica Edina, 2012, Mater Sociomed, V24, P212, DOI 10.5455/msm.2012.24.212-219; Biondi B, 2002, ANN INTERN MED, V137, P904, DOI 10.7326/0003-4819-137-11-200212030-00011; Biondi B, 1999, J CLIN ENDOCR METAB, V84, P2064, DOI 10.1210/jc.84.6.2064; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Biondi B, 2007, THYROID, V17, P625, DOI 10.1089/thy.2007.0158; Biondi B, 2009, EUR J ENDOCRINOL, V161, P323, DOI 10.1530/EJE-09-0196; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Cabral MD, 2011, CLINICS, V66, P1321, DOI 10.1590/S1807-59322011000800003; Cai YF, 2011, HYPERTENS RES, V34, P1098, DOI 10.1038/hr.2011.91; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; Cappola AR, 2003, J CLIN ENDOCR METAB, V88, P2438, DOI 10.1210/jc.2003-030398; Chen X, 2013, J CARDIOL, V61, P8, DOI 10.1016/j.jjcc.2012.08.017; Chopra S, 2011, INDIAN J ENDOCRINOL, V15, P354; DILLMANN WH, 1990, AM J MED, V88, P626, DOI 10.1016/0002-9343(90)90530-Q; Dorr M, 2005, J CLIN ENDOCR METAB, V90, P673, DOI 10.1210/jc.2004-1554; Drexler H, 1997, PROG CARDIOVASC DIS, V39, P287, DOI 10.1016/S0033-0620(97)80030-8; Fazio S, 2004, RECENT PROG HORM RES, V59, P31, DOI 10.1210/rp.59.1.31; FOLDES J, 1987, ACTA MED HUNG, V44, P337; Fraczek Magdalena Maria, 2014, Pol Merkur Lekarski, V37, P170; Gerdes AM, 2015, AM J PHYSIOL-HEART C, V308, pH1, DOI 10.1152/ajpheart.00704.2014; GRAETTINGER JS, 1958, J CLIN INVEST, V37, P502, DOI 10.1172/JCI103631; Gunaldi M, 2016, J ONCOL PHARM PRACT, V22, P242, DOI 10.1177/1078155214567162; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; HEALY B, 1990, J AM COLL CARDIOL, V16, P357, DOI 10.1016/0735-1097(90)90585-D; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Herwig A, 2014, THYROID, V24, P1575, DOI 10.1089/thy.2014.0169; Imaizumi M, 2004, J CLIN ENDOCR METAB, V89, P3365, DOI 10.1210/jc.2003-031089; Iqbal A, 2007, J CLIN ENDOCR METAB, V92, P3504, DOI 10.1210/jc.2007-0727; Kahaly GJ, 2005, ENDOCR REV, V26, P704, DOI 10.1210/er.2003-0033; Karthick N, 2013, J CLIN DIAGN RES, V7, P2122, DOI 10.7860/JCDR/2013/5777.3448; KLEIN I, 1994, J CLIN ENDOCR METAB, V78, P1026, DOI 10.1210/jc.78.5.1026; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; Leal ALRC, 2007, ENDOCRINE, V31, P174, DOI 10.1007/s12020-007-0029-4; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lombardi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116498; Mariotti S, 2008, INT J CARDIOL, V126, P190, DOI 10.1016/j.ijcard.2007.03.130; Martins RM, 2011, ARQ BRAS ENDOCRINOL, V55, P460, DOI 10.1590/S0004-27302011000700005; Meena C L, 2012, Acta Inform Med, V20, P218, DOI 10.5455/aim.2012.20.21-218-220; Monzani F, 2001, J CLIN ENDOCR METAB, V86, P1110, DOI 10.1210/jc.86.3.1110; Nam SM, 2013, NEURAL REGEN RES, V8, P2458, DOI 10.3969/j.issn.1673-5374.2013.26.007; Ochs N, 2008, ANN INTERN MED, V148, P832, DOI 10.7326/0003-4819-148-11-200806030-00225; Ojamaa K, 1996, THYROID, V6, P505, DOI 10.1089/thy.1996.6.505; OJAMAA K, 1993, ENDOCRINOLOGY, V132, P1002, DOI 10.1210/en.132.3.1002; Osman Faizel, 2001, Current Opinion in Pharmacology, V1, P626, DOI 10.1016/S1471-4892(01)00107-2; Owen PJD, 2006, J CLIN ENDOCR METAB, V91, P2126, DOI 10.1210/jc.2005-2108; Razvi S, 2007, J CLIN ENDOCR METAB, V92, P1715, DOI 10.1210/jc.2006-1869; Roos A, 2007, J CLIN ENDOCR METAB, V92, P491, DOI 10.1210/jc.2006-1718; Santi A, 2014, EXP CLIN ENDOCR DIAB, V122, P533, DOI 10.1055/s-0034-1376968; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Schultz M, 2011, HORM METAB RES, V43, P653, DOI 10.1055/s-0031-1283162; Sigal GA, 2011, THYROID, V21, P347, DOI 10.1089/thy.2010.0313; Silva JF, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-75; Sunbul M, 2013, EUR REV MED PHARMACO, V17, P3323; Tian LM, 2014, ENDOCRINE, V46, P651, DOI 10.1007/s12020-013-0135-4; Tian LM, 2014, J MOL ENDOCRINOL, V52, P215, DOI 10.1530/JME-13-0119; Torrens C, 2006, HYPERTENSION, V47, P982, DOI 10.1161/01.HYP.0000215580.43711.d1; Torrens C, 2009, HYPERTENSION, V53, P661, DOI 10.1161/HYPERTENSIONAHA.108.122820; Treskatsch S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087531; Tsujio M, 2008, VET PATHOL, V45, P505, DOI 10.1354/vp.45-4-505; Valentina VN, 2011, ARQ BRAS ENDOCRINOL, V55, P475, DOI 10.1590/S0004-27302011000700007; Vanhoutte PM, 2009, CIRC J, V73, P595, DOI 10.1253/circj.CJ-08-1169; Walsh JP, 2005, ARCH INTERN MED, V165, P2467, DOI 10.1001/archinte.165.21.2467; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055599; Xu C, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-44; Yang SS, 2014, NEUROENDOCRINOL LETT, V35, P80; Yazici M, 2004, INT J CARDIOL, V95, P135, DOI 10.1016/j.ijcard.2003.05.015; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yonetci N, 2002, EXP TOXICOL PATHOL, V54, P197, DOI 10.1078/0940-2993-00248; Yotani K, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-23; Zaki SM, 2013, FOLIA MORPHOL, V72, P333, DOI 10.5603/FM.2013.0056	73	5	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131776	10.1371/journal.pone.0131776	http://dx.doi.org/10.1371/journal.pone.0131776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158620	Green Submitted, Green Published, gold			2022-12-27	WOS:000358161200038
J	Brooks, JD; Wei, W; Hawley, S; Auman, H; Newcomb, L; Boyer, H; Fazli, L; Simko, J; Hurtado-Coll, A; Troyer, DA; Carroll, PR; Gleave, M; Lance, R; Lin, DW; Nelson, PS; Thompson, IM; True, LD; Feng, ZD; McKenney, JK				Brooks, James D.; Wei, Wei; Hawley, Sarah; Auman, Heidi; Newcomb, Lisa; Boyer, Hilary; Fazli, Ladan; Simko, Jeff; Hurtado-Coll, Antonio; Troyer, Dean A.; Carroll, Peter R.; Gleave, Martin; Lance, Raymond; Lin, Daniel W.; Nelson, Peter S.; Thompson, Ian M.; True, Lawrence D.; Feng, Ziding; McKenney, Jesse K.			Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients	PLOS ONE			English	Article							ACTIVE SURVEILLANCE; PROTEIN EXPRESSION; PSA RECURRENCE; INCREASED RISK; CANCER; FUSION; TMPRSS2-ERG; PROGRESSION; PTEN; REARRANGEMENT	Distinguishing between patients with early stage, screen detected prostate cancer who must be treated from those that can be safely watched has become a major issue in prostate cancer care. Identification of molecular subtypes of prostate cancer has opened the opportunity for testing whether biomarkers that characterize these subtypes can be used as biomarkers of prognosis. Two established molecular subtypes are identified by high expression of the ERG oncoprotein, due to structural DNA alterations that encode for fusion transcripts in approximately 1/2 of prostate cancers, and over-expression of SPINK1, which is purportedly found only in ERG-negative tumors. We used a multi-institutional prostate cancer tissue microarray constructed from radical prostatectomy samples with associated detailed clinical data and with rigorous selection of recurrent and non-recurrent cases to test the prognostic value of immunohistochemistry staining results for the ERG and SPINK1 proteins. In univariate analysis, ERG positive cases (419/1067; 39%) were associated with lower patient age, pre-operative serum PSA levels, lower Gleason scores (<3+4=7) and improved recurrence free survival (RFS). On multivariate analysis, ERG status was not correlated with RFS, disease specific survival (DSS) or overall survival (OS). High-level SPINK1 protein expression (33/1067 cases; 3%) was associated with improved RFS on univariate and multivariate Cox regression analysis. Over-expression of either protein was not associated with clinical outcome. While expression of ERG and SPINK1 proteins was inversely correlated, it was not mutually exclusive since 3 (0.28%) cases showed high expression of both. While ERG and SPINK1 appear to identify discrete molecular subtypes of prostate cancer, only high expression of SPINK1 was associated with improved clinical outcome. However, by themselves, neither ERG nor SPINK1 appear to be useful biomarkers for prognostication of early stage prostate cancer.	[Brooks, James D.] Stanford Univ, Dept Urol, Stanford, CA 94305 USA; [Wei, Wei; Feng, Ziding] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Hawley, Sarah; Auman, Heidi] Canary Ctr Stanford, Canary Fdn, Palo Alto, CA USA; [Newcomb, Lisa; Lin, Daniel W.] Univ Washington, Med Ctr, Dept Urol, Seattle, WA 98195 USA; [Boyer, Hilary; Fazli, Ladan; Gleave, Martin] Univ British Columbia, Vancouver Gen Hosp, Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Simko, Jeff] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Hurtado-Coll, Antonio; Troyer, Dean A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Troyer, Dean A.] Eastern Virginia Med Sch, Pathol Microbiol & Mol Biol, Norfolk, VA 23501 USA; [Carroll, Peter R.] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA; [Lance, Raymond] Eastern Virginia Med Sch, Dept Urol, Norfolk, VA 23501 USA; [Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Thompson, Ian M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA; [True, Lawrence D.] Univ Washington, Med Ctr, Dept Pathol, Seattle, WA 98195 USA; [McKenney, Jesse K.] Cleveland Clin, Dept Pathol, Cleveland, OH 44106 USA	Stanford University; University of Texas System; UTMD Anderson Cancer Center; University of Washington; University of Washington Seattle; University of British Columbia; University of California System; University of California San Francisco; University of Texas System; University of Texas Health San Antonio; Eastern Virginia Medical School; University of California System; University of California San Francisco; Eastern Virginia Medical School; Fred Hutchinson Cancer Center; University of Texas System; University of Texas Health San Antonio; University of Washington; University of Washington Seattle; Cleveland Clinic Foundation	Brooks, JD (corresponding author), Stanford Univ, Dept Urol, Stanford, CA 94305 USA.	jdbrooks@stanford.edu		Gleave, Martin/0000-0003-4235-0167; Wei, Wei/0000-0002-0960-7269	Canary Foundation; Department of Defense [W81XWH-11-1-0380]; NCI Early Detection Research Network [CA152737-01, CA08636815]; NATIONAL CANCER INSTITUTE [U01CA152737, P30CA016672] Funding Source: NIH RePORTER	Canary Foundation; Department of Defense(United States Department of Defense); NCI Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Canary Foundation, the Department of Defense (W81XWH-11-1-0380) and the NCI Early Detection Research Network (CA152737-01, JDB and CA08636815, ZF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Bashir S, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-21; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Ateeq B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001498; Attard G, 2015, CLIN CANCER RES, V21, P1621, DOI 10.1158/1078-0432.CCR-14-1961; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Berg KD, 2014, EUR UROL, V66, P851, DOI 10.1016/j.eururo.2014.02.058; Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593; Brooks JD, 2013, CANCER-AM CANCER SOC, V119, P3906, DOI 10.1002/cncr.28301; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chaux A, 2012, MODERN PATHOL, V25, P1543, DOI 10.1038/modpathol.2012.104; Chaux A, 2011, AM J SURG PATHOL, V35, P1014, DOI 10.1097/PAS.0b013e31821e8761; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Flavin R, 2014, CLIN CANCER RES, V20, P4904, DOI 10.1158/1078-0432.CCR-13-1341; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Grupp K, 2013, PROSTATE, V73, P1690, DOI 10.1002/pros.22707; Guo CC, 2009, MODERN PATHOL, V22, P866, DOI 10.1038/modpathol.2009.57; Hawley S, 2013, ADV ANAT PATHOL, V20, P39, DOI 10.1097/PAP.0b013e31827b665b; Hermans KG, 2009, CLIN CANCER RES, V15, P6398, DOI 10.1158/1078-0432.CCR-09-1176; Jhavar S, 2009, BJU INT, V103, P1256, DOI 10.1111/j.1464-410X.2008.08200.x; Karnes RJ, 2010, CANCER RES, V70, P8994, DOI 10.1158/0008-5472.CAN-10-1358; King CR, 2009, UROL ONCOL-SEMIN ORI, V27, P592, DOI 10.1016/j.urolonc.2008.05.009; Klein EA, 2014, EUR UROL, V66, P550, DOI 10.1016/j.eururo.2014.05.004; Krohn A, 2012, AM J PATHOL, V181, P401, DOI 10.1016/j.ajpath.2012.04.026; Lee JJ, 2015, PROSTATE, V75, P183, DOI 10.1002/pros.22903; Leinonen KA, 2013, CANCER EPIDEM BIOMAR, V22, P2333, DOI 10.1158/1055-9965.EPI-13-0333-T; Leinonen KA, 2010, CLIN CANCER RES, V16, P2845, DOI 10.1158/1078-0432.CCR-09-2505; Lichtensztajn DY, 2014, J UROLOGY, V191, P952, DOI 10.1016/j.juro.2013.10.075; Lin DW, 2013, CLIN CANCER RES, V19, P2442, DOI 10.1158/1078-0432.CCR-12-3283; Lu B, 2009, UROLOGY, V74, P1156, DOI 10.1016/j.urology.2009.01.087; Magi-Galluzzi C, 2011, PROSTATE, V71, P489, DOI 10.1002/pros.21265; Minner S, 2011, CLIN CANCER RES, V17, P5878, DOI 10.1158/1078-0432.CCR-11-1251; Mosquera JM, 2009, CLIN CANCER RES, V15, P4706, DOI 10.1158/1078-0432.CCR-08-2927; Park K, 2010, NEOPLASIA, V12, P590, DOI 10.1593/neo.10726; Pettersson A, 2012, CANCER EPIDEM BIOMAR, V21, P1497, DOI 10.1158/1055-9965.EPI-12-0042; Reid AHM, 2010, BRIT J CANCER, V102, P678, DOI 10.1038/sj.bjc.6605554; Sabaliauskaite R, 2012, GENE CHROMOSOME CANC, V51, P781, DOI 10.1002/gcc.21963; SAKR WA, 1994, IN VIVO, V8, P439; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Schaefer G, 2013, PROSTATE CANCER P D, V16, P132, DOI 10.1038/pcan.2013.4; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sirma H, 2013, ONCOL LETT, V6, P1245, DOI 10.3892/ol.2013.1563; Terry S, 2015, CANCER-AM CANCER SOC, V121, P1422, DOI 10.1002/cncr.29233; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2008, CANCER CELL, V13, P519, DOI 10.1016/j.ccr.2008.04.016; Tomlins SA, 2015, EUR UROL, V68, P555, DOI 10.1016/j.eururo.2015.04.033; Weinmann S, 2013, PROSTATE, V73, P1371, DOI 10.1002/pros.22684; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Xu B, 2014, HUM PATHOL, V45, P488, DOI 10.1016/j.humpath.2013.10.012	49	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132343	10.1371/journal.pone.0132343	http://dx.doi.org/10.1371/journal.pone.0132343			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172920	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900044
J	Shargorodsky, J; Garcia-Esquinas, E; Galan, I; Navas-Acien, A; Lin, SY				Shargorodsky, Josef; Garcia-Esquinas, Esther; Galan, Inaki; Navas-Acien, Ana; Lin, Sandra Y.			Allergic Sensitization, Rhinitis and Tobacco Smoke Exposure in US Adults	PLOS ONE			English	Article							RESPIRATORY SYMPTOMS; CIGARETTE-SMOKE; NASAL SYMPTOMS; RISK-FACTORS; PREVALENCE; ASTHMA; INFLAMMATION; ADOLESCENTS; CHILDREN; DISEASE	Introduction Tobacco exposure has been linked with sinonasal pathology and may be associated with allergic sensitization. This study evaluates the association between exposure to active smoking or secondhand smoke (SHS) and the prevalence of rhinitis and allergic sensitization in the US adult population. Methods Cross-sectional study in 4,339 adults aged 20-85 in the National Health and Nutrition Examination Survey, 2005-2006. Never smoking was defined as reported lifetime smoking less than 100 cigarettes and serum cotinine levels <10ng/ml, while active smoking was defined as self-reported smoking or serum cotinine concentrations > 10 ng/mL. Self-reported rhinitis was based on symptoms during the past 12 months, and allergen sensitization was defined as a positive response to any of the 19 specific IgE antigens tested. Results Almost half of the population (43%) had detectable levels of IgE specific to at least one inhaled allergen and 32% reported a history of rhinitis. After multivariate adjustment, there was a statistically significant association between the highest serum cotinine tertile and rhinitis in active smokers (OR 1.42; 95% CI 1.00-2.00). The association between active smoking and rhinitis was stronger in individuals without allergic sensitization (OR 2.47; 95% CI 1.44-4.23). There was a statistically significant association between increasing cotinine tertiles and decreased odds of inhaled allergen sensitization (p-trend <.01). Conclusion Tobacco smoke exposure was associated with increased prevalence of rhinitis symptoms, but not with allergic sensitization. The results indicate that the relationship between tobacco smoke exposure and sinonasal pathology in adults may be independent of allergic sensitization.	[Shargorodsky, Josef; Lin, Sandra Y.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Shargorodsky, Josef] Coastal Ear Nose & Throat, Neptune, NJ USA; [Garcia-Esquinas, Esther; Galan, Inaki] Univ Autonoma Madrid, Sch Med, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Galan, Inaki] Carlos III Hlth Inst, Natl Ctr Epidemiol, Madrid, Spain; [Garcia-Esquinas, Esther] Ciber Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Garcia-Esquinas, Esther; Navas-Acien, Ana] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Navas-Acien, Ana] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA	Johns Hopkins University; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Shargorodsky, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jshargo1@gmail.com	garcia, esther/AAR-8372-2021; Galán, Ignacio/P-6451-2015	Galán, Ignacio/0000-0003-0624-9993; garcia-esquinas, Esther/0000-0002-8688-5174	Flight Attendant Medical Research Institute	Flight Attendant Medical Research Institute	This work was supported in part by the Flight Attendant Medical Research Institute (ANA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benowitz NL, 1996, EPIDEMIOL REV, V18, P188, DOI 10.1093/oxfordjournals.epirev.a017925; Berania I, 2014, INT FORUM ALLERGY RH; Bottema RWB, 2008, EUR RESPIR J, V32, P593, DOI 10.1183/09031936.00162407; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Chen H, 2007, J IMMUNOL, V179, P6097, DOI 10.4049/jimmunol.179.9.6097; Ciaccio CE, 2013, ANN ALLERG ASTHMA IM, V111, P387, DOI 10.1016/j.anai.2013.07.023; Eisner MD, 2005, THORAX, V60, P814, DOI 10.1136/thx.2004.037283; Eriksson J, 2011, INT ARCH ALLERGY IMM, V154, P155, DOI 10.1159/000320230; Garcia-Esquinas E, 2013, PEDIATRICS, V131, pE1415, DOI 10.1542/peds.2012-3201; GELBER LE, 1993, AM REV RESPIR DIS, V147, P573, DOI 10.1164/ajrccm/147.3.573; Gibson PG, 2001, CHEST, V119, P1329, DOI 10.1378/chest.119.5.1329; HALKEN S, 1995, ALLERGY, V50, P97; Hancox RJ, 2008, J ALLERGY CLIN IMMUN, V121, P38, DOI 10.1016/j.jaci.2007.09.052; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Hoppin JA, 2013, ENVIRON HEALTH PERSP, V121, P1129, DOI 10.1289/ehp.1206211; Kulig M, 1999, ALLERGY, V54, P220, DOI 10.1034/j.1398-9995.1999.00753.x; Kum-Nji P, 2006, PEDIATRICS, V117, P1745, DOI 10.1542/peds.2005-1886; Lin SY, 2011, AM J RHINOL ALLERGY, V25, pE66, DOI 10.2500/ajra.2011.25.3580; MEGGS WJ, 1993, ENVIRON HEALTH PERSP, V101, P234, DOI 10.2307/3431548; Meltzer EO, 2011, ANN ALLERG ASTHMA IM, V106, pS12, DOI 10.1016/j.anai.2010.10.014; Menzies D, 2006, JAMA-J AM MED ASSOC, V296, P1742, DOI 10.1001/jama.296.14.1742; Nathan RA, 2008, ALLERGY ASTHMA PROC, V29, P600, DOI 10.2500/aap.2008.29.3179; Ouyang Y, 2000, J ALLERGY CLIN IMMUN, V106, P280, DOI 10.1067/mai.2000.107751; Quinto Kenneth B, 2013, NCHS Data Brief, P1; Reh DD, 2012, INT FORUM ALLERGY RH, V2, P362, DOI 10.1002/alr.21054; Salo PM, 2011, J ALLERGY CLIN IMMUN, V127, P1226, DOI 10.1016/j.jaci.2010.12.1106; Saulyte J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001611; Shargorodsky J, 2010, JAMA-J AM MED ASSOC, V304, P772, DOI 10.1001/jama.2010.1124; Singh Daljit, 2002, Indian Pediatr, V39, P23; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Tsai CH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-11; WHITE JR, 1980, NEW ENGL J MED, V302, P720, DOI 10.1056/NEJM198003273021304	32	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131957	10.1371/journal.pone.0131957	http://dx.doi.org/10.1371/journal.pone.0131957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172447	Green Published, gold			2022-12-27	WOS:000358194900025
J	Walpita, P; Johns, LM; Tandon, R; Moore, ML				Walpita, Pramila; Johns, Lisa M.; Tandon, Ravi; Moore, Martin L.			Mammalian Cell-Derived Respiratory Syncytial Virus-Like Particles Protect the Lower as well as the Upper Respiratory Tract	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; ENHANCED PULMONARY HISTOPATHOLOGY; INNATE IMMUNITY; FUSION PROTEIN; COTTON RATS; PROVIDES PROTECTION; BALB/C MICE; VACCINE; INFECTION; GLYCOPROTEIN	Globally, Respiratory Syncytial Virus (RSV) is a leading cause of bronchiolitis and pneumonia in children less than one year of age and in USA alone, between 85,000 and 144,000 infants are hospitalized every year. To date, there is no licensed vaccine. We have evaluated vaccine potential of mammalian cell-derived native RSV virus-like particles (RSV VLPs) composed of the two surface glycoproteins G and F, and the matrix protein M. Results of in vitro testing showed that the VLPs were functionally assembled and immunoreactive, and that the recombinantly expressed F protein was cleaved intracellularly similarly to the virus-synthesized F protein to produce the F1 and F2 subunits; the presence of the F1 fragment is critical for vaccine development since all the neutralizing epitopes present in the F protein are embedded in this fragment. Additional in vitro testing in human macrophage cell line THP-1 showed that both virus and the VLPs were sensed by TLR-4 and induced a Th1-biased cytokine response. Cotton rats vaccinated with RSV VLPs adjuvanted with alum and monophosphoryl lipid A induced potent neutralizing antibody response, and conferred protection in the lower as well as the upper respiratory tract based on substantial virus clearance from these sites. To the best of our knowledge, this is the first VLP/virosome vaccine study reporting protection of the lower as well as the upper respiratory tract: Prevention from replication in the nose is an important consideration if the target population is infants < 6 months of age. This is because continued virus replication in the nose results in nasal congestion and babies at this age are obligate nose breathers. In conclusion, these results taken together suggest that our VLPs show promise to be a safe and effective vaccine for RSV.	[Walpita, Pramila; Johns, Lisa M.; Tandon, Ravi] Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96822 USA; [Moore, Martin L.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Moore, Martin L.] Childrens Healthcare Atlanta, Atlanta, GA USA	University of Hawaii System; University of Hawaii Manoa; Emory University; Children's Healthcare of Atlanta (CHOA)	Walpita, P (corresponding author), Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96822 USA.	walpitap@hawaii.edu			Department of Tropical Medicine, University of Hawaii; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095464] Funding Source: NIH RePORTER	Department of Tropical Medicine, University of Hawaii; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was done with the help of Preclinical Services provided by NIAID. It was initiated at the University of Texas Medical Branch, Galveston TX, and is being continued at University of Hawaii School of Medicine, Honolulu, HI. A startup fund was provided to PW from the Department of Tropical Medicine, University of Hawaii.	Anderson R, 2010, FUTURE MICROBIOL, V5, P585, DOI 10.2217/FMB.10.22; Awate S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00114; Blanco JCG, 2010, HUM VACCINES, V6, P482, DOI 10.4161/hv.6.6.11562; Borchers AT, 2013, CLIN REV ALLERGY IMM; Boukhvalova MS, 2006, VACCINE, V24, P5027, DOI 10.1016/j.vaccine.2006.03.064; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; Cheon IS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094269; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Collins P. L., 2007, FIELDS VIROLOGY; Collins PL, 1999, ADV VIRUS RES, V54, P423, DOI 10.1016/S0065-3527(08)60374-7; CONNORS M, 1992, VACCINE, V10, P475, DOI 10.1016/0264-410X(92)90397-3; CONNORS M, 1994, J VIROL, V68, P5321, DOI 10.1128/JVI.68.8.5321-5325.1994; Crameri G, 2002, J VIROL METHODS, V99, P41, DOI 10.1016/S0166-0934(01)00377-9; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Feldman SA, 1999, J VIROL, V73, P6610, DOI 10.1128/JVI.73.8.6610-6617.1999; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Garcon N, 2011, BIODRUGS, V25, P217, DOI 10.2165/11591760-000000000-00000; Garcon N, 2011, EXPERT OPIN BIOL TH, V11, P667, DOI 10.1517/14712598.2011.573624; Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x; GRAHAM BS, 1993, J IMMUNOL, V151, P2032; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; HENDRY RM, 1986, J INFECT DIS, V153, P291, DOI 10.1093/infdis/153.2.291; Heydenreich B, 2014, CLIN EXP IMMUNOL, V176, P310, DOI 10.1111/cei.12294; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Johnson TR, 2014, MOL THER, V22, P196, DOI 10.1038/mt.2013.142; Jorquera PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074905; Kamphuis T, 2013, INFLUENZA OTHER RESP, V7, P1227, DOI 10.1111/irv.12112; Kamphuis T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036812; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Legg JP, 2003, AM J RESP CRIT CARE, V168, P633, DOI 10.1164/rccm.200210-1148OC; Liu FX, 2013, PROTEIN EXPRES PURIF, V90, P104, DOI 10.1016/j.pep.2013.05.009; Luchsinger V, 2012, CLIN INFECT DIS, V54, P905, DOI 10.1093/cid/cir955; McGinnes LW, 2011, J VIROL, V85, P366, DOI 10.1128/JVI.01861-10; Murawski MR, 2010, J VIROL, V84, P1110, DOI 10.1128/JVI.01709-09; Murawski MR, 2009, J VIROL, V83, P1492, DOI 10.1128/JVI.00671-08; MURPHY BR, 1986, J CLIN MICROBIOL, V24, P197, DOI 10.1128/JCM.24.2.197-202.1986; MURPHY BR, 1990, VACCINE, V8, P497, DOI 10.1016/0264-410X(90)90253-I; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Neuzil KM, 1996, AM J MED SCI, V311, P201, DOI 10.1097/00000441-199605000-00001; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; Oshansky CM, 2009, FUTURE MICROBIOL, V4, P279, DOI 10.2217/FMB.09.1; Piedra PA, 2003, VACCINE, V21, P2448, DOI 10.1016/S0264-410X(03)00098-7; PIEDRA PA, 1993, VACCINE, V11, P1415, DOI 10.1016/0264-410X(93)90170-3; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Prince GA, 2003, J VIROL, V77, P13156, DOI 10.1128/JVI.77.24.13156-13160.2003; Quan FS, 2011, J INFECT DIS, V204, P987, DOI 10.1093/infdis/jir474; Rixon HWM, 2002, J GEN VIROL, V83, P61, DOI 10.1099/0022-1317-83-1-61; Sandritter T, 1999, J Pediatr Health Care, V13, P191, DOI 10.1016/S0891-5245(99)90039-1; Sandritter T, 1999, J PEDIATR HEALTH CAR, V13, P196; Schmidt AC, 2011, SEMIN RESP CRIT CARE, V32, P527, DOI 10.1055/s-0031-1283289; Schmitt AP, 2002, J VIROL, V76, P3952, DOI 10.1128/JVI.76.8.3952-3964.2002; Shafique M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061287; Shafique M, 2012, VACCINE, V30, P597, DOI 10.1016/j.vaccine.2011.11.054; Singleton R, 2003, J VIROL, V77, P11303, DOI 10.1128/JVI.77.21.11303-11311.2003; Stokes KL, 2013, J VIROL, V87, P10070, DOI 10.1128/JVI.01347-13; Stone J, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/29/295102; Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444; Teng MN, 2000, J VIROL, V74, P9317, DOI 10.1128/JVI.74.19.9317-9321.2000; Walpita P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018437; Waris ME, 1996, J VIROL, V70, P2852, DOI 10.1128/JVI.70.5.2852-2860.1996; Wright PF, 2000, J INFECT DIS, V182, P1331, DOI 10.1086/315859	68	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0130755	10.1371/journal.pone.0130755	http://dx.doi.org/10.1371/journal.pone.0130755			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172453	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900009
J	Braid, ACR; Nielsen, SE				Braid, Andrew C. R.; Nielsen, Scott E.			Prioritizing Sites for Protection and Restoration for Grizzly Bears (Ursus arctos) in Southwestern Alberta, Canada	PLOS ONE			English	Article							RESOURCE-EXTRACTION INDUSTRIES; MULTIPLE-USE LANDSCAPE; HABITAT MODELS; CONSERVATION; MORTALITY; ECOSYSTEM; ROADS; CONNECTIVITY; BIODIVERSITY; MOUNTAINS	As the influence of human activities on natural systems continues to expand, there is a growing need to prioritize not only pristine sites for protection, but also degraded sites for restoration. We present an approach for simultaneously prioritizing sites for protection and restoration that considers landscape patterns for a threatened population of grizzly bears (Ursus arctos) in southwestern Alberta, Canada. We considered tradeoffs between bottom-up (food resource supply) and top-down (mortality risk from roads) factors affecting seasonal habitat quality for bears. Simulated annealing was used to prioritize source-like sites (high habitat productivity, low mortality risk) for protection, as well as sink-like sites (high habitat productivity, high mortality risk) for restoration. Priority source-like habitats identified key conservation areas where future developments should be limited, whereas priority sink-like habitats identified key areas for mitigating road-related mortality risk with access management. Systematic conservation planning methods can be used to complement traditional habitat-based methods for individual focal species by identifying habitats where conservation actions (both protection and restoration) have the highest potential utility.	[Braid, Andrew C. R.; Nielsen, Scott E.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Alberta	Braid, ACR (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	abraid@ualberta.ca	Nielsen, Scott/C-2842-2013; Nielsen, Scott/O-7482-2019	Nielsen, Scott/0000-0002-9754-0630; Nielsen, Scott/0000-0002-9754-0630	Natural Sciences and Engineering Research Council of Canada [445196]; Alberta Conservation Association	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Conservation Association	Funding for this project was provided by the Natural Sciences and Engineering Research Council of Canada (ACRB; Industrial Postgraduate Scholarship Program; Application ID 445196; http://www.nserc-crsng.gc.ca/index_eng.asp), as well as the Alberta Conservation Association (ACRB; http://www.ab-conservation.com/go/default/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya H. Resit, 2000, Ecological Bulletins, V48, P9; Aune K., 1989, FINAL REPORT E FRONT; Ball I., 2000, MARXAN V1 8 2 MARINE; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Benn B, 2002, URSUS, V13, P213; BOYCE M.S., 2001, INT ASS BEAR RES MAN, V4; Briers RA, 2002, BIOL CONSERV, V103, P77, DOI 10.1016/S0006-3207(01)00123-9; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Carroll C, 2001, ECOL APPL, V11, P961, DOI 10.1890/1051-0761(2001)011[0961:CAFSFC]2.0.CO;2; Carwardine J, 2007, BIODIVERS CONSERV, V16, P245, DOI 10.1007/s10531-006-9055-4; Carwardine J, 2009, CONSERV LETT, V2, P3, DOI 10.1111/j.1755-263X.2008.00042.x; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Elith J., 2009, SPATIAL CONSERVATION, P70; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Esri, 2013, ARCGIS DESKT 10 2; Fleishman Erica, 2000, Ecological Bulletins, V48, P85; Government of Alberta, 2010, C5 LANDSC ASS C5 FOR; Government of Alberta, 2010, C5 FOR MAN PLAN 2006; Government of Alberta, 2005, ALB VEG INV INT STAN; HAMER D, 1991, CAN FIELD NAT, V105, P325; Hamer D., 1987, INT C BEAR RES MANAG, V7, P179, DOI DOI 10.2307/3872624; Luan XF, 2011, J ENVIRON MANAGE, V92, P31, DOI 10.1016/j.jenvman.2010.08.001; Mace RD, 1996, J APPL ECOL, V33, P1395, DOI 10.2307/2404779; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McCarthy M. A., 2009, SPATIAL CONSERVATION, P122; McLellan BN, 2011, CAN J ZOOL, V89, P546, DOI 10.1139/Z11-026; MCLELLAN BN, 1989, J APPL ECOL, V26, P371, DOI 10.2307/2404067; MCLELLAN BN, 1989, WILDLIFE SOC B, V17, P269; McLellan BN, 1999, J WILDLIFE MANAGE, V63, P911, DOI 10.2307/3802805; McLellan BN, 2001, J WILDLIFE MANAGE, V65, P92, DOI 10.2307/3803280; MCLELLAN BN, 1988, J APPL ECOL, V25, P451, DOI 10.2307/2403836; Merrill T, 1999, BIOL CONSERV, V87, P231, DOI 10.1016/S0006-3207(98)00057-3; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Natural Regions Committee, 2006, NAT REG SUBR ALB; Naves J, 2003, CONSERV BIOL, V17, P1276, DOI 10.1046/j.1523-1739.2003.02144.x; Nielsen S.E., 2009, J CONSERVATION PLANN, V5, P38; Nielsen Scott, 2011, British Columbia Journal of Ecosystems and Management, V12, P136; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Nielsen SE, 2006, BIOL CONSERV, V130, P217, DOI 10.1016/j.biocon.2005.12.016; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; Nielsen SE, 2003, ECOSCIENCE, V10, P1; Northrup JM, 2012, J APPL ECOL, V49, P1159, DOI 10.1111/j.1365-2664.2012.02180.x; Noss R, 2009, SPATIAL CONSERVATION, P158; Pierce SM, 2005, BIOL CONSERV, V125, P441, DOI 10.1016/j.biocon.2005.04.019; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Roberts DR, 2014, ECOL APPL, V24, P1144, DOI 10.1890/13-0829.1; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schwartz CC, 2010, J WILDLIFE MANAGE, V74, P654, DOI 10.2193/2009-206; Smith RJ, 2006, ORYX, V40, P400, DOI 10.1017/S0030605306001232; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Watson J.E.M., 2011, CONSERVATION BIOGEOG, P136, DOI [DOI 10.1002/9781444390001.CH6, 10.1002/9781444390001.ch6]; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; Wielgus RB, 2002, CAN J FOREST RES, V32, P1597, DOI 10.1139/X02-084	55	13	13	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132501	10.1371/journal.pone.0132501	http://dx.doi.org/10.1371/journal.pone.0132501			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168055	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100046
J	Fu, H; Zhong, JY; Yuan, GX; Guo, CJ; Lou, Q; Zhang, W; Xu, J; Ni, LY; Xie, P; Cao, T				Fu, Hui; Zhong, Jiayou; Yuan, Guixiang; Guo, Chunjing; Lou, Qian; Zhang, Wei; Xu, Jun; Ni, Leyi; Xie, Ping; Cao, Te			Predicting Changes in Macrophyte Community Structure from Functional Traits in a Freshwater Lake: A Test of Maximum Entropy Model	PLOS ONE			English	Article							AQUATIC MACROPHYTES; ECOSYSTEM PROCESSES; COASTAL CALIFORNIA; PLASTIC RESPONSES; DEPTH GRADIENT; PLANT TRAITS; DIVERSITY; ECOLOGY; NUTRIENTS; ZONATION	Trait-based approaches have been widely applied to investigate how community dynamics respond to environmental gradients. In this study, we applied a series of maximum entropy (maxent) models incorporating functional traits to unravel the processes governing macro-phyte community structure along water depth gradient in a freshwater lake. We sampled 42 plots and 1513 individual plants, and measured 16 functional traits and abundance of 17 macrophyte species. Study results showed that maxent model can be highly robust (99.8%) in predicting the species relative abundance of macrophytes with observed community-weighted mean (CWM) traits as the constraints, while relative low (about 30%) with CWM traits fitted from water depth gradient as the constraints. The measured traits showed notably distinct importance in predicting species abundances, with lowest for perennial growth form and highest for leaf dry mass content. For tuber and leaf nitrogen content, there were significant shifts in their effects on species relative abundance from positive in shallow water to negative in deep water. This result suggests that macrophyte species with tuber organ and greater leaf nitrogen content would become more abundant in shallow water, but would become less abundant in deep water. Our study highlights how functional traits distributed across gradients provide a robust path towards predictive community ecology.	[Fu, Hui; Zhong, Jiayou; Yuan, Guixiang; Guo, Chunjing; Lou, Qian; Zhang, Wei] Jiangxi Inst Water Sci, Jiangxi Prov Key Lab Water Resources & Environm P, Nanchang, Peoples R China; [Fu, Hui; Xu, Jun; Ni, Leyi; Xie, Ping; Cao, Te] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Donghu Expt Stn Lake Ecosyst, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Zhong, JY (corresponding author), Jiangxi Inst Water Sci, Jiangxi Prov Key Lab Water Resources & Environm P, Nanchang, Peoples R China.	jiayou@jxsl.gov.cn; caote@ihb.ac.cn	Xie, Ping/AAL-7532-2020		National Science Foundation of China [31300398, 31400404]; Science and Technology Program of Jiangxi Provincial Department of Water Resources [KT201212]; Science program for postdoctoral of Jiangxi Province [2012RC20, 2013KY20]; National High Technology Research and Development Program of China [2012ZX07105-004]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Jiangxi Provincial Department of Water Resources; Science program for postdoctoral of Jiangxi Province; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This study (the study design, data collection and analysis, decision to publish, or preparation of the manuscript) was supported by the National Science Foundation of China (Grant No. 31300398, 31400404), the Science and Technology Program of Jiangxi Provincial Department of Water Resources (Grant No. KT201212), the Science program for postdoctoral of Jiangxi Province (Grant No. 2012RC20, 2013KY20) and the National High Technology Research and Development Program of China (Grant No. 2012ZX07105-004).	Bornette G, 2011, AQUAT SCI, V73, P1, DOI 10.1007/s00027-010-0162-7; Butterfield BJ, 2013, J ECOL, V101, P9, DOI 10.1111/1365-2745.12013; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; CHAMBERS PA, 1987, J ECOL, V75, P611, DOI 10.2307/2260193; CHAMBERS PA, 1987, J ECOL, V75, P621, DOI 10.2307/2260194; Cornwell WK, 2010, J ECOL, V98, P814, DOI 10.1111/j.1365-2745.2010.01662.x; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Engelhardt KAM, 2006, ECOL APPL, V16, P1808, DOI 10.1890/1051-0761(2006)016[1808:REARTI]2.0.CO;2; Fu H, 2014, FRESHWATER BIOL, V59, P2462, DOI 10.1111/fwb.12443; Fu H, 2014, ECOL EVOL, V4, P1516, DOI 10.1002/ece3.1022; Fu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062794; Fu H, 2012, ECOL RES, V27, P1087, DOI 10.1007/s11284-012-0991-z; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; IdestamAlmquist J, 1995, AQUAT BOT, V52, P205, DOI 10.1016/0304-3770(95)00499-8; Laughlin D.C., 2013, TRENDS PLANT SCI; Laughlin DC, 2011, J ECOL, V99, P1489, DOI 10.1111/j.1365-2745.2011.01885.x; MABERLY SC, 1993, J AQUAT PLANT MANAGE, V31, P34; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; Mokany K, 2008, J ECOL, V96, P884, DOI 10.1111/j.1365-2745.2008.01395.x; Moreira B, 2012, OECOLOGIA, V168, P671, DOI 10.1007/s00442-011-2127-5; Roscher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036760; Santamaria L, 2002, ACTA OECOL, V23, P137, DOI 10.1016/S1146-609X(02)01146-3; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; Shipley B, 2011, ECOLOGY, V92, P507, DOI 10.1890/10-0394.1; Shipley B, 2010, ECOLOGY, V91, P2794, DOI 10.1890/09-1255.1; SPENCE DHN, 1970, NEW PHYTOL, V69, P205, DOI 10.1111/j.1469-8137.1970.tb04064.x; SPENCE DHN, 1973, J ECOL, V61, P317, DOI 10.2307/2259028; Strand JA, 2001, J ECOL, V89, P166, DOI 10.1046/j.1365-2745.2001.00530.x; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; WEIHER E, 1995, OIKOS, V74, P159, DOI 10.2307/3545686; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yuan GX, 2013, FRESHWATER BIOL, V58, P2532, DOI 10.1111/fwb.12230	35	11	12	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131630	10.1371/journal.pone.0131630	http://dx.doi.org/10.1371/journal.pone.0131630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167856	Green Published, gold			2022-12-27	WOS:000358193100011
J	Mahdipour, M; Leitoguinho, ARC; Silva, RAZ; van Tol, HTA; Stout, TAE; Rodrigues, G; Roelen, BAJ				Mahdipour, Mahdi; Canhoto Leitoguinho, Ana Rita; Zacarias Silva, Ricardo A.; van Tol, Helena T. A.; Stout, Tom A. E.; Rodrigues, Gabriela; Roelen, Bernard A. J.			TACC3 Is Important for Correct Progression of Meiosis in Bovine Oocytes	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; AURORA-A; SPINDLE FORMATION; MOUSE OOCYTES; EXPRESSION; MATURATION; PROTEIN; KINASE; CLATHRIN; MLN8054	Transforming acidic coiled-coil (TACC) proteins are key players during mitosis via stabilization of the spindle. The roles of TACCs during meiosis are however less clear. We used bovine oocytes to study the expression and function of TACC3 during meiosis. TACC3 mRNA was detected in bovine oocytes during meiosis using qRT-PCR, and while it was also expressed in cleavage stage embryos, its expression was down-regulated at the morula and blastocyst stages. Immunofluorescence was used to demonstrate that TACC3 co-localized with tubulin in the metaphase I and II spindles. However, TACC3 was not detected at anaphase or telophase of the first meiotic division. Aurora A, which is known to phosphorylate and activate TACC3 in mitotic cells, showed a similar pattern of gene expression to that of TACC3 in meiotic oocytes and preimplantation embryos. Aurora A protein was however only very transiently associated to the meiotic spindle. Pharmaceutical inhibition of Aurora A activity inhibited TACC3 phosphorylation but did not prevent TACC3 appearance in the spindle. Inhibiting Aurora A activity did however lead to abnormal meiotic spindle formation and impaired maturation of bovine oocytes. Similar results were obtained by knockdown of TACC3 expression using siRNA injection. These results suggest that TACC3 is important for stabilizing the meiotic spindle, but phosphorylation of TACC3 by Aurora A is not required for its recruitment to the meiotic spindle although phosphorylation of TACC3 by other kinases cannot be excluded.	[Mahdipour, Mahdi; Canhoto Leitoguinho, Ana Rita; Zacarias Silva, Ricardo A.; van Tol, Helena T. A.; Stout, Tom A. E.; Roelen, Bernard A. J.] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, NL-3584 CM Utrecht, Netherlands; [Canhoto Leitoguinho, Ana Rita; Zacarias Silva, Ricardo A.; Rodrigues, Gabriela] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, P-1749016 Lisbon, Portugal; [Canhoto Leitoguinho, Ana Rita; Zacarias Silva, Ricardo A.; Rodrigues, Gabriela] Univ Lisbon, Fac Ciencias, Dept Biol Anim, P-1749016 Lisbon, Portugal; [Stout, Tom A. E.; Roelen, Bernard A. J.] Univ Utrecht, Fac Vet Med, Dept Equine Sci, NL-3584 CM Utrecht, Netherlands	Utrecht University; Universidade de Lisboa; Universidade de Lisboa; Utrecht University	Roelen, BAJ (corresponding author), Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Yalelaan 104, NL-3584 CM Utrecht, Netherlands.	b.a.j.roelen@uu.nl	Rodrigues, Gabriela/GQH-1711-2022; Rodrigues, Gabriela/A-1909-2013	Rodrigues, Gabriela/0000-0002-0598-4040; Mahdipour, Mahdi/0000-0002-2729-4593	Ministry of Science, Resreach and Technology (MSRT), Iran [42/5/33681]; EU Seventh Framework Programme (FP7) Anistem Industry-Academia Partnerships and Pathways (IAPP) [GA-2011-286264]; Epigenetics and periconception environment (EpiConcept) European Cooperation in Science and Technology (COST) Action [FA1201]; Erasmus programme EUC [29206-IC-2007-1-PT-ERASMUS-EUCX-1];  [GA-2013-317146]	Ministry of Science, Resreach and Technology (MSRT), Iran; EU Seventh Framework Programme (FP7) Anistem Industry-Academia Partnerships and Pathways (IAPP); Epigenetics and periconception environment (EpiConcept) European Cooperation in Science and Technology (COST) Action; Erasmus programme EUC; 	Ministry of Science, Resreach and Technology (MSRT), Iran 42/5/33681; EU Seventh Framework Programme (FP7) Anistem Industry-Academia Partnerships and Pathways (IAPP)-GA-2011-286264; EU Seventh Framework Programme (FP7) EpiHealthNet Initial Training Networks (ITN)-GA-2013-317146; Epigenetics and periconception environment (EpiConcept) European Cooperation in Science and Technology (COST) Action FA1201; and Erasmus programme EUC n. 29206-IC-2007-1-PT-ERASMUS-EUCX-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript The Anistem Industry-Academia Partnerships and Pathways is a European FP7 IAPP project (non-commercial); EpiHealthNet Initial Training Networks is a European FP7 ITN project (non-commercial). The funding does not alter the authors' adherence to PLOS ONE policies on sharing our data and materials. There are no restrictions on sharing the authors' data and/or materials.	Beaujean N, 2004, P NATL ACAD SCI USA, V101, P7636, DOI 10.1073/pnas.0400730101; Beker-van Woudenberg AR, 2004, BIOL REPROD, V70, P1465, DOI 10.1095/biolreprod.103.025684; Brunet S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003338; Fu WX, 2010, J CELL SCI, V123, P3645, DOI 10.1242/jcs.075911; Gergely F, 2000, P NATL ACAD SCI USA, V97, P14352, DOI 10.1073/pnas.97.26.14352; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Hoar K, 2007, MOL CELL BIOL, V27, P4513, DOI 10.1128/MCB.02364-06; Holzenspies JJ, 2010, REPRODUCTION, V140, P223, DOI 10.1530/REP-10-0045; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Li R, 2013, NAT REV MOL CELL BIO, V14, P141, DOI 10.1038/nrm3531; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Macarulla T, 2010, MOL CANCER THER, V9, P2844, DOI 10.1158/1535-7163.MCT-10-0299; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Memili E, 2000, ZYGOTE, V8, P87, DOI 10.1017/S0967199400000861; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; MUNNE S, 1995, FERTIL STERIL, V64, P382, DOI 10.1016/S0015-0282(16)57739-5; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; Piekorz RP, 2002, EMBO J, V21, P653, DOI 10.1093/emboj/21.4.653; Raff JW, 2002, TRENDS CELL BIOL, V12, P222, DOI 10.1016/S0962-8924(02)02268-7; Royle SJ, 2012, J CELL SCI, V125, P19, DOI 10.1242/jcs.094607; Sadek CM, 2003, GENE EXPR PATTERNS, V3, P203, DOI 10.1016/S1567-133X(02)00066-2; Uzbekova S, 2008, BIOL REPROD, V78, P218, DOI 10.1095/biolreprod.107.061036; van Tol HTA, 2008, MOL REPROD DEV, V75, P578, DOI 10.1002/mrd.20801; Yao LJ, 2004, BIOL REPROD, V70, P1392, DOI 10.1095/biolreprod.103.025155	27	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132591	10.1371/journal.pone.0132591	http://dx.doi.org/10.1371/journal.pone.0132591			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168150	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100056
J	Minamimoto, R; Saginoya, T; Kondo, C; Tomura, N; Ito, K; Matsuo, Y; Matsunaga, S; Shuto, T; Akabane, A; Miyata, Y; Sakai, S; Kubota, K				Minamimoto, Ryogo; Saginoya, Toshiyuki; Kondo, Chisato; Tomura, Noriaki; Ito, Kimiteru; Matsuo, Yuka; Matsunaga, Shigeo; Shuto, Takashi; Akabane, Atsuya; Miyata, Yoko; Sakai, Shuji; Kubota, Kazuo			Differentiation of Brain Tumor Recurrence from Post-Radiotherapy Necrosis with C-11-Methionine PET: Visual Assessment versus Quantitative Assessment	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; RADIATION NECROSIS; STEREOTACTIC RADIOSURGERY; F-18-FDG; DIAGNOSIS; BEVACIZUMAB; GLIOMAS	Purpose The aim of this multi-center study was to assess the diagnostic capability of visual assessment in L-methyl-C-11-methionine positron emission tomography (MET-PET) for differentiating a recurrent brain tumor from radiation-induced necrosis after radiotherapy, and to compare it to the accuracy of quantitative analysis. Methods A total of 73 brain lesions (glioma: 31, brain metastasis: 42) in 70 patients who underwent MET-PET were included in this study. Visual analysis was performed by comparison of MET uptake in the brain lesion with MET uptake in one of four regions (around the lesion, contralateral frontal lobe, contralateral area, and contralateral cerebellar cortex). The concordance rate and logistic regression analysis were used to evaluate the diagnostic ability of visual assessment. Receiver-operating characteristic curve analysis was used to compare visual assessment with quantitative assessment based on the lesion-to-normal (L/N) ratio of MET uptake. Results Interobserver and intraobserver kappa-values were highest at 0.657 and 0.714, respectively, when assessing MET uptake in the lesion compared to that in the contralateral cerebellar cortex. Logistic regression analysis showed that assessing MET uptake in the contralateral cerebellar cortex with brain metastasis was significantly related to the final result. The highest area under the receiver-operating characteristic curve (AUC) with visual assessment for brain metastasis was 0.85, showing no statistically significant difference with L/Nmax of the contralateral brain (AUC = 0.89) or with L/Nmean of the contralateral cerebellar cortex (AUC = 0.89), which were the areas that were the highest in the quantitative assessment. For evaluation of gliomas, no specific candidate was confirmed among the four areas used in visual assessment, and no significant difference was seen between visual assessment and quantitative assessment. Conclusion The visual assessment showed no significant difference from quantitative assessment of MET-PET with a relevant cut-off value for the differentiation of recurrent brain tumors from radiation-induced necrosis.	[Minamimoto, Ryogo; Kubota, Kazuo] Natl Ctr Global Hlth & Med, Dept Radiol, Div Nucl Med, Tokyo, Japan; [Saginoya, Toshiyuki; Tomura, Noriaki] Southern Tohoku Gen Hosp, Southern Tohoku Res Inst Neurosci, Dept Radiol, Fukushima, Japan; [Kondo, Chisato; Matsuo, Yuka; Sakai, Shuji] Tokyo Womens Med Univ, Dept Diagnost Imaging & Nucl Med, Tokyo, Japan; [Ito, Kimiteru] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Tokyo, Japan; [Matsunaga, Shigeo; Shuto, Takashi] Yokohama Rosai Hosp, Dept Neurosurg, Yokohama, Kanagawa, Japan; [Akabane, Atsuya] NTT Med Ctr Tokyo, Dept Neurosurg, Tokyo, Japan; [Miyata, Yoko] Natl Ctr Global Hlth & Med, Kohnodai Hosp, Dept Radiol, Chiba, Japan	National Center for Global Health & Medicine - Japan; Tokyo Women's Medical University; Tokyo Metropolitan Institute of Gerontology; Yokohama Rosai Hospital; Kanto Medical Center NTT EC; National Center for Global Health & Medicine - Japan	Minamimoto, R (corresponding author), Natl Ctr Global Hlth & Med, Dept Radiol, Div Nucl Med, Tokyo, Japan.	ryogominamimoto@yahoo.co.jp	Miyata, Yoko/AAR-6288-2021; Minamimoto, Ryogo/HCH-7365-2022	Minamimoto, Ryogo/0000-0003-1026-255X	Japan Radiological Society [KJ22-11]	Japan Radiological Society	This study was supported by a research grant from the Japan Radiological Society (KJ22-11) (http://www.radiology.jp/).	Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Chung JK, 2002, EUR J NUCL MED MOL I, V29, P176, DOI 10.1007/s00259-001-0690-4; Coope DJ, 2007, J NUCL MED, V48, P1971, DOI 10.2967/jnumed.107.043240; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fleiss JL, 2003, STAT METHODS RATES P, P598; Furuse M, 2013, JPN J CLIN ONCOL, V43, P337, DOI 10.1093/jjco/hys231; Galldiks N, 2012, J NUCL MED, V53, P1367, DOI 10.2967/jnumed.112.103325; Glaudemans AWJM, 2013, EUR J NUCL MED MOL I, V40, P615, DOI 10.1007/s00259-012-2295-5; Grosu AL, 2011, INT J RADIAT ONCOL, V81, P1049, DOI 10.1016/j.ijrobp.2010.07.002; Herholz K, 1998, NEUROLOGY, V50, P1316, DOI 10.1212/WNL.50.5.1316; da Cruz LCH, 2011, AM J NEURORADIOL, V32, P1978, DOI 10.3174/ajnr.A2397; ISHIWATA K, 1993, J NUCL MED, V34, P1936; Karunanithi S, 2013, EUR J NUCL MED MOL I, V40, P1025, DOI 10.1007/s00259-013-2384-0; Kim YH, 2010, CLIN NEUROL NEUROSUR, V112, P758, DOI 10.1016/j.clineuro.2010.06.005; Kracht LW, 2003, EUR J NUCL MED MOL I, V30, P868, DOI 10.1007/s00259-003-1148-7; Laperriere N, 2002, RADIOTHER ONCOL, V64, P259, DOI 10.1016/S0167-8140(02)00078-6; Matuschek C, 2011, STRAHLENTHER ONKOL, V187, P135, DOI 10.1007/s00066-010-2184-4; Nonoguchi N, 2011, J NEURO-ONCOL, V105, P423, DOI 10.1007/s11060-011-0610-9; Okamoto S, 2011, ANN NUCL MED, V25, P213, DOI 10.1007/s12149-010-0450-2; Pirotte B, 2004, J NUCL MED, V45, P1293; Popperl G, 2004, EUR J NUCL MED MOL I, V31, P1464, DOI 10.1007/s00259-004-1590-1; Terakawa Y, 2008, J NUCL MED, V49, P694, DOI 10.2967/jnumed.107.048082; Torcuator R, 2009, J NEURO-ONCOL, V94, P63, DOI 10.1007/s11060-009-9801-z; Tripathi M, 2012, CLIN NUCL MED, V37, P158, DOI 10.1097/RLU.0b013e318238f51a; Tsuyuguchi N, 2004, ANN NUCL MED, V18, P291, DOI 10.1007/BF02984466; Tsuyuguchi N, 2003, J NEUROSURG, V98, P1056, DOI 10.3171/jns.2003.98.5.1056; Yamane T, 2010, EUR J NUCL MED MOL I, V37, P685, DOI 10.1007/s00259-009-1302-y	27	52	53	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132515	10.1371/journal.pone.0132515	http://dx.doi.org/10.1371/journal.pone.0132515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167681	gold, Green Published, Green Submitted			2022-12-27	WOS:000358193100050
J	Oikawa, A; Otsuka, T; Nakabayashi, R; Jikumaru, Y; Isuzugawa, K; Murayama, H; Saito, K; Shiratake, K				Oikawa, Akira; Otsuka, Takao; Nakabayashi, Ryo; Jikumaru, Yusuke; Isuzugawa, Kanji; Murayama, Hideki; Saito, Kazuki; Shiratake, Katsuhiro			Metabolic Profiling of Developing Pear Fruits Reveals Dynamic Variation in Primary and Secondary Metabolites, Including Plant Hormones	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MASS-SPECTROMETRY; GENETIC METABOLOMICS; SIGNAL-TRANSDUCTION; PATHWAY; ARABIDOPSIS; NETWORKS; TOMATO; GRAPES; ACID	Metabolites in the fruits of edible plants include sweet sugars, visually appealing pigments, various products with human nutritional value, and biologically active plant hormones. Although quantities of these metabolites vary during fruit development and ripening because of cell division and enlargement, there are few reports describing the actual dynamics of these changes. Therefore, we applied multiple metabolomic techniques to identify the changes in metabolite levels during the development and ripening of pear fruits (Pyrus communis L. 'La France'). We quantified and classified over 250 metabolites into six groups depending on their specific patterns of variation during development and ripening. Approximately half the total number of metabolites, including histidine and malate, accumulated transiently around the blooming period, during which cells are actively dividing, and then decreased either rapidly or slowly. Furthermore, the amounts of sulfur-containing amino acids also increased in pear fruits around 3-4 months after the blooming period, when fruit cells are enlarging, but virtually disappeared from ripened fruits. Some metabolites, including the plant hormone abscisic acid, accumulated particularly in the receptacle prior to blooming and/or fruit ripening. Our results show several patterns of variation in metabolite levels in developing and ripening pear fruits, and provide fundamental metabolomic data that is useful for understanding pear fruit physiology and enhancing the nutritional traits of new cultivars.	[Oikawa, Akira; Otsuka, Takao; Nakabayashi, Ryo; Jikumaru, Yusuke; Saito, Kazuki] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan; [Oikawa, Akira; Murayama, Hideki] Yamagata Univ, Fac Agr, Tsuruoka, Yamagata 9978555, Japan; [Isuzugawa, Kanji] Yamagata Integrated Agr Res Ctr, Sagae, Yamagata 9997601, Japan; [Saito, Kazuki] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba 2608675, Japan; [Shiratake, Katsuhiro] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	RIKEN; Yamagata University; Chiba University; Nagoya University	Oikawa, A (corresponding author), RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan.	oikawa@tds1.tr.yamagata-u.ac.jp	Nakabayashi, Ryo/C-9734-2017; 亮, 中林/GVU-2660-2022; Oikawa, Akira/D-2715-2017; Saito, Kazuki/D-2670-2009	Nakabayashi, Ryo/0000-0002-8674-0928; Saito, Kazuki/0000-0001-6310-5342	Promotion of Basic and Applied Research for Innovation in Bio-oriented Industry (BRAIN)	Promotion of Basic and Applied Research for Innovation in Bio-oriented Industry (BRAIN)	This work was funded by Promotion of Basic and Applied Research for Innovation in Bio-oriented Industry (BRAIN) (http://www.naro.affrc.go.jp/english/brain/index.html) to AO, KI, and K. Shiratake.	Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; Ashikari M, 2006, TRENDS PLANT SCI, V11, P344, DOI 10.1016/j.tplants.2006.05.008; BARHAM D, 1972, ANALYST, V97, P142, DOI 10.1039/an9729700142; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Cruz-Hernandez A, 2012, CRIT REV FOOD SCI, V52, P272, DOI 10.1080/10408398.2010.499844; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; Gambetta GA, 2010, PLANTA, V232, P219, DOI 10.1007/s00425-010-1165-2; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Jacob JK, 2012, ANNU REV FOOD SCI T, V3, P79, DOI 10.1146/annurev-food-022811-101127; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Klee HJ, 2010, NEW PHYTOL, V187, P44, DOI 10.1111/j.1469-8137.2010.03281.x; Koulman A, 2009, RAPID COMMUN MASS SP, V23, P2253, DOI 10.1002/rcm.4142; Lin LZ, 2008, J AGR FOOD CHEM, V56, P9094, DOI 10.1021/jf8013487; Lombardo VA, 2011, PLANT PHYSIOL, V157, P1696, DOI 10.1104/pp.111.186064; Matsuda F, 2012, PLANT J, V70, P624, DOI 10.1111/j.1365-313X.2012.04903.x; MAZZA G, 1995, CRIT REV FOOD SCI, V35, P341, DOI 10.1080/10408399509527704; McAtee P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00079; McDougall G, 2008, J CHROMATOGR B, V871, P362, DOI 10.1016/j.jchromb.2008.06.032; Moco S, 2006, PLANT PHYSIOL, V141, P1205, DOI 10.1104/pp.106.078428; Morreel K, 2006, PLANT J, V47, P224, DOI 10.1111/j.1365-313X.2006.02786.x; Murayama H, 2002, POSTHARVEST BIOL TEC, V26, P15, DOI 10.1016/S0925-5214(01)00200-9; Ohkama-Ohtsu N, 2008, PLANT PHYSIOL, V148, P1603, DOI 10.1104/pp.108.125716; Oikawa A, 2006, PLANT PHYSIOL, V142, P398, DOI 10.1104/pp.106.080317; Oikawa A, 2011, J SEP SCI, V34, P3561, DOI 10.1002/jssc.201100466; Oikawa A, 2011, J SEP SCI, V34, P1063, DOI 10.1002/jssc.201000890; Osorio S, 2012, PLANT PHYSIOL, V159, P1713, DOI 10.1104/pp.112.199711; Ostergaard L, 2009, CURR OPIN PLANT BIOL, V12, P36, DOI 10.1016/j.pbi.2008.09.011; Rowe HC, 2008, PLANT CELL, V20, P1199, DOI 10.1105/tpc.108.058131; SCHRAM E, 1954, BIOCHEM J, V57, P33, DOI 10.1042/bj0570033; Son HS, 2009, J AGR FOOD CHEM, V57, P1481, DOI 10.1021/jf803388w; Symons GM, 2006, PLANT PHYSIOL, V140, P150, DOI 10.1104/pp.105.070706; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Toennies G, 1942, J AM CHEM SOC, V64, P3054, DOI 10.1021/ja01264a518; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Vardhini BV, 2002, PHYTOCHEMISTRY, V61, P843, DOI 10.1016/S0031-9422(02)00223-6; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Yoshimoto K, 2009, PLANT CELL, V21, P2914, DOI 10.1105/tpc.109.068635; Zamboni A, 2010, PLANT PHYSIOL, V154, P1439, DOI 10.1104/pp.110.160275; Zhang JJ, 2011, J EXP BOT, V62, P1103, DOI 10.1093/jxb/erq343; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	41	53	53	5	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131408	10.1371/journal.pone.0131408	http://dx.doi.org/10.1371/journal.pone.0131408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168247	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100008
J	Ren, ZY; Machuca-Gayet, I; Domenget, C; Buchet, R; Wu, YQ; Jurdic, P; Mebarek, S				Ren, Zhong-Yuan; Machuca-Gayet, Irma; Domenget, Chantal; Buchet, Rene; Wu, Yuqing; Jurdic, Pierre; Mebarek, Saida			Azanitrile Cathepsin K Inhibitors: Effects on Cell Toxicity, Osteoblast-Induced Mineralization and Osteoclast-Mediated Bone Resorption	PLOS ONE			English	Article							AZADIPEPTIDE NITRILE INHIBITORS; OSTEOPOROSIS; ODANACATIB; DESIGN; DENSITY; LIGAND; POTENT; ASSAYS; ACID; MICE	Aim The cysteine protease cathepsin K (CatK), abundantly expressed in osteoclasts, is responsible for the degradation of bone matrix proteins, including collagen type 1. Thus, CatK is an attractive target for new anti-resorptive osteoporosis therapies, but the wider effects of CatK inhibitors on bone cells also need to be evaluated to assess their effects on bone. Therefore, we selected, among a series of synthetized isothiosemicarbazides, two molecules which are highly selective CatK inhibitors (CKIs) to test their effects on osteoblasts and osteoclasts. Research Design and Methods Cell viability upon treatment of CKIs were was assayed on human osteoblast-like Saos-2, mouse monocyte cell line RAW 264.7 and mature mouse osteoclasts differentiated from bone marrow. Osteoblast-induced mineralization in Saos-2 cells and in mouse primary osteoblasts from calvaria, with or without CKIs,; were was monitored by Alizarin Red staining and alkaline phosphatase activity, while osteoclast-induced bone resorption was performed on bovine slices. Results Treatments with two CKIs, CKI-8 and CKI-13 in human osteoblast-like Saos-2, murine RAW 264.7 macrophages stimulated with RANKL and mouse osteoclasts differentiated from bone marrow stimulated with RANKL and MCSF were found not to be toxic at doses of up to 100 nM. As probed by Alizarin Red staining, CKI-8 did not inhibit osteoblast-induced mineralization in mouse primary osteoblasts as well as in osteoblast-like Saos-2 cells. However, CKI-13 led to a reduction in mineralization of around 40% at 10-100 nM concentrations in osteoblast-like Saos-2 cells while it did not in primary cells. After a 48-hour incubation, both CKI-8 and CKI-13 decreased bone resorption on bovine bone slices. CKI-13 was more efficient than the commercial inhibitor E-64 in inhibiting bone resorption induced by osteoclasts on bovine bone slices. Both CKI-8 and CKI-13 created smaller bone resorption pits on bovine bone slices, suggesting that the mobility of osteoclasts was slowed down by the addition of CKI-8 and CKI-13. Conclusion CKI-8 and CKI-13 screened here show promise as antiresorptive osteoporosis therapeutics but some off target effects on osteoblasts were found with CKI-13.	[Ren, Zhong-Yuan; Wu, Yuqing] Jilin Univ, State Key Lab Supramol Struct & Mat, Changchun 130012, Peoples R China; [Ren, Zhong-Yuan; Machuca-Gayet, Irma; Domenget, Chantal; Buchet, Rene; Jurdic, Pierre; Mebarek, Saida] Univ Lyon, F-69622 Villeurbanne, France; [Ren, Zhong-Yuan; Machuca-Gayet, Irma; Domenget, Chantal; Buchet, Rene; Jurdic, Pierre; Mebarek, Saida] Univ Lyon 1, F-69622 Villeurbanne, France; [Ren, Zhong-Yuan; Buchet, Rene; Mebarek, Saida] CPE Lyon, F-69622 Villeurbanne, France; [Ren, Zhong-Yuan; Buchet, Rene; Mebarek, Saida] Inst Natl Sci Appl, F-69622 Villeurbanne, France; [Ren, Zhong-Yuan; Buchet, Rene; Mebarek, Saida] Inst Chim & Biochim Mol & Supramol, F-69622 Villeurbanne, France; [Ren, Zhong-Yuan; Buchet, Rene; Mebarek, Saida] CNRS UMR 5246, F-69622 Villeurbanne, France; [Machuca-Gayet, Irma; Domenget, Chantal; Jurdic, Pierre] Ecole Normale Super Lyon, F-69634 Lyon, France; [Machuca-Gayet, Irma; Domenget, Chantal; Jurdic, Pierre] Inst Genom Fonct Lyon, F-69634 Lyon, France; [Machuca-Gayet, Irma; Domenget, Chantal; Jurdic, Pierre] CNRS UMR3444, F-69634 Lyon, France	Jilin University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Mebarek, S (corresponding author), Univ Lyon, F-69622 Villeurbanne, France.	saida.youjil@univ-lyon1.fr	Rene, Buchet/I-9781-2019; Mebarek, Saida/AAI-8237-2020	Rene, Buchet/0000-0002-7966-3856; Machuca- Gayet, irma/0000-0002-3010-9774; Mebarek, Saida/0000-0001-8806-8904; Ren, Zhongyuan/0000-0002-0300-7801	National Natural Science Foundation of China [21373101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from National Natural Science Foundation of China (No. 21373101) (YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron R, 2011, BONE, V48, P677, DOI 10.1016/j.bone.2010.11.020; Bone HG, 2015, OSTEOPOROSIS INT, V26, P699, DOI 10.1007/s00198-014-2944-6; Bone HG, 2010, J BONE MINER RES, V25, P937, DOI 10.1359/jbmr.091035; Boonen S, 2012, CURR OSTEOPOROS REP, V10, P73, DOI 10.1007/s11914-011-0085-9; Chambers TJ, 2013, J CLIN ENDOCR METAB, V98, P4329, DOI 10.1210/jc.2013-2630; Collin-Osdoby P, 2012, METHODS MOL BIOL, V816, P187, DOI 10.1007/978-1-61779-415-5_13; CYBORON GW, 1981, J BIOL CHEM, V256, P7262; Delbeck M, 2012, Patent Application, Patent No. [A1, WO2012156311, 2012156311]; Duong Le T, 2012, Bonekey Rep, V1, P67, DOI 10.1038/bonekey.2012.67; Frizler M, 2011, CHEM-EUR J, V17, P11419, DOI 10.1002/chem.201101350; Frizler M, 2011, J MED CHEM, V54, P396, DOI 10.1021/jm101272p; Fuller K, 2010, BONE, V46, P1400, DOI 10.1016/j.bone.2010.01.374; Georgess D, 2014, MOL BIOL CELL, V25, P380, DOI 10.1091/mbc.E13-07-0363; Gillette JM, 2004, J CELL SCI, V117, P441, DOI 10.1242/jcs.00909; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Kim MK, 2006, J PHARMACOL EXP THER, V318, P555, DOI 10.1124/jpet.106.102798; Kiviranta R, 2001, J BONE MINER RES, V16, P1444, DOI 10.1359/jbmr.2001.16.8.1444; Lems WF, 2014, CURR OPIN RHEUMATOL, V26, P245, DOI 10.1097/BOR.0000000000000057; Li WA, 2010, ANAL BIOCHEM, V401, P91, DOI 10.1016/j.ab.2010.02.035; Loser R, 2008, ANGEW CHEM INT EDIT, V47, P4331, DOI 10.1002/anie.200705858; Loh YH, 2010, CHEM COMMUN, V46, P8407, DOI 10.1039/c0cc03738a; Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.40; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakamura T, 2014, OSTEOPOROSIS INT, V25, P367, DOI 10.1007/s00198-013-2398-2; Ng KW, 2012, CLIN INTERV AGING, V7, P235, DOI 10.2147/CIA.S26729; Novack DV, 2011, AGEING RES REV, V10, P54, DOI 10.1016/j.arr.2009.09.005; Pennypacker B, 2009, BONE, V44, P199, DOI 10.1016/j.bone.2008.08.130; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Ren XF, 2013, ORG BIOMOL CHEM, V11, P1143, DOI 10.1039/c2ob26624e; Rousselle AV, 2002, BONE, V30, P533, DOI 10.1016/S8756-3282(02)00672-5; Schmitz J, 2014, ACS MED CHEM LETT, V5, P1076, DOI 10.1021/ml500238q; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Stoch SA, 2008, CLIN PHARMACOL THER, V83, P172, DOI 10.1038/sj.clpt.6100450; Stoch SA, 2013, BRIT J CLIN PHARMACO, V75, P1240, DOI 10.1111/j.1365-2125.2012.04471.x; Suda T, 1997, J BONE MINER RES, V12, P869, DOI 10.1359/jbmr.1997.12.6.869; Thouverey C, 2009, J CELL BIOCHEM, V106, P127, DOI 10.1002/jcb.21992; Vaingankar SM, 2004, AM J PHYSIOL-CELL PH, V286, pC1177, DOI 10.1152/ajpcell.00320.2003; Yamamoto A, 2002, J BONE MINER RES, V17, P612, DOI 10.1359/jbmr.2002.17.4.612; Yang PY, 2012, CHEM-EUR J, V18, P6528, DOI 10.1002/chem.201103322; Yuan XY, 2013, ORG BIOMOL CHEM, V11, P5847, DOI 10.1039/c3ob41165f	42	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132513	10.1371/journal.pone.0132513	http://dx.doi.org/10.1371/journal.pone.0132513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168340	Green Submitted, Green Published, gold			2022-12-27	WOS:000358193100049
J	Shaw, AG; Sim, K; Randell, P; Cox, MJ; McClure, ZE; Li, MS; Donaldson, H; Langford, PR; Cookson, WOCM; Moffatt, MF; Kroll, JS				Shaw, Alexander G.; Sim, Kathleen; Randell, Paul; Cox, Michael J.; McClure, Zoe E.; Li, Ming-Shi; Donaldson, Hugo; Langford, Paul R.; Cookson, William O. C. M.; Moffatt, Miriam F.; Kroll, J. Simon			Late-Onset Bloodstream Infection and Perturbed Maturation of the Gastrointestinal Microbiota in Premature Infants	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; SEPSIS; GUT; TRANSLOCATION; POPULATIONS; DIAGNOSIS	Background Late-onset bloodstream infection (LO-BSI) is a common complication of prematurity, and lack of timely diagnosis and treatment can have life-threatening consequences. We sought to identify clinical characteristics and microbial signatures in the gastrointestinal microbiota preceding diagnosis of LO-BSI in premature infants. Method Daily faecal samples and clinical data were collected over two years from 369 premature neonates (<32 weeks gestation). We analysed samples from 22 neonates who developed LO-BSI and 44 matched control infants. Next-generation sequencing of 16S rRNA gene regions amplified by PCR from total faecal DNA was used to characterise the microbiota of faecal samples preceding diagnosis from infants with LO-BSI and controls. Culture of selected samples was undertaken, and bacterial isolates identified using MALDI-TOF. Antibiograms from bloodstream and faecal isolates were compared to explore strain similarity. Results From the week prior to diagnosis, infants with LO-BSI had higher proportions of faecal aerobes/facultative anaerobes compared to controls. Risk factors for LO-BSI were identified by multivariate analysis. Enterobacteriaceal sepsis was associated with antecedent multiple lines, low birth weight and a faecal microbiota with prominent Enterobacteriaceae. Staphylococcal sepsis was associated with Staphylococcus OTU faecal over-abundance, and the number of days prior to diagnosis of mechanical ventilation and of the presence of centrally-placed lines. In 12 cases, the antibiogram of the bloodstream isolate matched that of a component of the faecal microbiota in the sample collected closest to diagnosis. Conclusions The gastrointestinal tract is an important reservoir for LO-BSI organisms, pathogens translocating across the epithelial barrier. LO-BSI is associated with an aberrant microbiota, with abundant staphylococci and Enterobacteriaceae and a failure to mature towards predominance of obligate anaerobes.	[Shaw, Alexander G.; Sim, Kathleen; Randell, Paul; McClure, Zoe E.; Li, Ming-Shi; Langford, Paul R.; Kroll, J. Simon] Univ London Imperial Coll Sci Technol & Med, Dept Med, Paediat Sect, London, England; [Cox, Michael J.; Cookson, William O. C. M.; Moffatt, Miriam F.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Mol Genet & Genom, London, England; [Donaldson, Hugo] NHS Trust, Imperial Coll, Dept Microbiol, London, England	Imperial College London; Imperial College London; Imperial College London	Kroll, JS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Paediat Sect, London, England.	a.shaw@imperial.ac.uk	Shaw, Alex/GWC-7464-2022; Langford, Paul/AAU-4189-2020; Cookson, William/HHC-1790-2022	Langford, Paul/0000-0002-6368-4724; Cox, Michael/0000-0002-4002-1506; Shaw, Alex/0000-0002-3166-872X	Meningitis Now [WMNP_35505]; Winnicott Foundation [WMNP_26859]; Livanos Trust; Wellcome Trust; Asmarley Trust; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial Healthcare NHS Trust and Imperial College London [WMNP_P35969]; NIHR Doctoral Research Fellowship [NIHR-DRF-2011-04-128]; Medical Research Council [G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10126, DRF-2011-04-128] Funding Source: researchfish; Wellcome Trust [096964/Z/11/Z] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre, MRC-AsthmaUKCentre] Funding Source: researchfish	Meningitis Now; Winnicott Foundation; Livanos Trust; Wellcome Trust(Wellcome TrustEuropean Commission); Asmarley Trust; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial Healthcare NHS Trust and Imperial College London(National Institute for Health Research (NIHR)); NIHR Doctoral Research Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Asthma UK	This work was supported by funding from Meningitis Now, https://www.meningitisnow.org/ [WMNP_35505] (AGS); the Winnicott Foundation, http://www.winnicott.org.uk/ [WMNP_26859] (AGS, KS, PR, PRL, JSK); the Livanos Trust (MSL); the Wellcome Trust, http://www.wellcome.ac.uk/ (MFM, WOCMC); the Asmarley Trust (MJC); and the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial Healthcare NHS Trust and Imperial College London, http://www.nihr.ac.uk/ [WMNP_P35969] (KS). KS is funded by an NIHR Doctoral Research Fellowship [NIHR-DRF-2011-04-128]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboleya S, 2012, FEMS MICROBIOL ECOL, V79, P763, DOI 10.1111/j.1574-6941.2011.01261.x; Benitz WE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.4.e41; Boghossian NS, 2013, J PEDIATR-US, V162, P1120, DOI 10.1016/j.jpeds.2012.11.089; British Society for Antimicrobial Chemotherapy, 2014, BSAC METH ANT SUSC T; Brooks B, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carl MA, 2014, CLIN INFECT DIS, V58, P1211, DOI 10.1093/cid/ciu084; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Costa SF, 2004, LANCET INFECT DIS, V4, P278, DOI 10.1016/S1473-3099(04)01003-5; Darmstadt GL, 2009, J INFECT DIS, V200, P906, DOI 10.1086/605473; Duffy LC, 2000, J NUTR, V130, p432S, DOI 10.1093/jn/130.2.432S; Eaves-Pyles T, 2001, SHOCK, V16, P148, DOI 10.1097/00024382-200116020-00011; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eggesbo M, 2011, APMIS, V119, P17, DOI 10.1111/j.1600-0463.2010.02688.x; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gosbell IB, 2005, INTERN MED J, V35, pS45, DOI 10.1111/j.1444-0903.2005.00979.x; Graham PL, 2006, PEDIATR INFECT DIS J, V25, P113, DOI 10.1097/01.inf.0000199310.52875.10; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; LaTuga MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027858; Madan JC, 2012, ARCH DIS CHILD-FETAL, V97, pF456, DOI 10.1136/fetalneonatal-2011-301373; Mai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052876; Manzoni P, 2009, JAMA-J AM MED ASSOC, V302, P1421, DOI 10.1001/jama.2009.1403; Marchant EA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/586076; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nair V, 2013, INT J PEDIAT, V2013, DOI 10.1155/2013/874726; Parm U, 2011, J HOSP INFECT, V78, P327, DOI 10.1016/j.jhin.2011.03.025; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin HL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-63; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Sannasiddappa TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023227; Schlapbach LJ, 2011, PEDIATRICS, V128, pE348, DOI 10.1542/peds.2010-3338; Sim K, 2015, CLIN INFECT DIS, V60, P389, DOI 10.1093/cid/ciu822; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; Team RDC, 2019, R LANG ENV STAT COMP; van den Berg JP, 2011, EARLY HUM DEV, V87, P67, DOI 10.1016/j.earlhumdev.2010.11.003; Vergnano S, 2011, ARCH DIS CHILD-FETAL, V96, pF9, DOI 10.1136/adc.2009.178798; Vermont Oxford Network Database, MAN OP 2	41	57	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132923	10.1371/journal.pone.0132923	http://dx.doi.org/10.1371/journal.pone.0132923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167683	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100098
J	Song, MA; Dasgupta, C; Zhang, LB				Song, Minwoo A.; Dasgupta, Chiranjib; Zhang, Lubo			Chronic Losartan Treatment Up-Regulates AT(1)R and Increases the Heart Vulnerability to Acute Onset of Ischemia and Reperfusion Injury in Male Rats	PLOS ONE			English	Article							II TYPE-2 RECEPTOR; KINASE-C-EPSILON; CIRCULATING MICRORNAS; MYOCARDIAL-INFARCTION; FUNCTIONAL RECOVERY; DELTA-PKC; ANGIOTENSIN; EXPRESSION; CARDIOPROTECTION; BLOCKADE	Inhibition of angiotensin II type 1 receptor (AT(1)R) is an important therapy in the management of hypertension, particularly in the immediate post-myocardial infarction period. Yet, the role of AT(1)R in the acute onset of myocardial ischemia and reperfusion injury still remains controversial. Thus, the present study determined the effects of chronic losartan treatment on heart ischemia and reperfusion injury in rats. Losartan (10 mg/kg/day) was administered to six-month-old male rats via an osmotic pump for 14 days and hearts were then isolated and were subjected to ischemia and reperfusion injury in a Langendorff preparation. Losartan significantly decreased mean arterial blood pressure. However, heart weight, left ventricle to body weight ratio and baseline cardiac function were not significantly altered by the losartan treatment. Of interest, chronic in vivo losartan treatment significantly increased ischemia-induced myocardial injury and decreased post-ischemic recovery of left ventricular function. This was associated with significant increases in AT(1)R and PKC delta expression in the left ventricle. In contrast, AT(2)R and PKCe were not altered. Furthermore, losartan treatment significantly increased microRNA (miR)-1, -15b, -92a, -133a, -133b, -210, and -499 expression but decreased miR-21 in the left ventricle. Of importance, addition of losartan to isolated heart preparations blocked the effect of increased ischemic-injury induced by in vivo chronic losartan treatment. The results demonstrate that chronic losartan treatment up-regulates AT(1)R/PKC delta and alters miR expression patterns in the heart, leading to increased cardiac vulnerability to ischemia and reperfusion injury.	[Song, Minwoo A.; Dasgupta, Chiranjib; Zhang, Lubo] Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol,Div Pharmacol, Loma Linda, CA 92354 USA	Loma Linda University	Zhang, LB (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol,Div Pharmacol, Loma Linda, CA 92354 USA.	lzhang@llu.edu		Zhang, Lubo/0000-0002-9386-8938	NIH [HL118861]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118861] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH HL118861.	AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; Abengozar MA, 2012, BLOOD, V119, P4565, DOI 10.1182/blood-2011-09-380006; Bae SC, 2005, J PHARMACOL EXP THER, V315, P1125, DOI 10.1124/jpet.105.090803; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bove CM, 2004, HYPERTENSION, V43, P680, DOI 10.1161/01.HYP.0000115924.94236.91; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; D'Ascenzo F, 2014, EUROINTERVENTION, V9, P1463, DOI 10.4244/EIJV9I12A244; Dasgupta C, 2011, DRUG DISCOV TODAY, V16, P22, DOI 10.1016/j.drudis.2010.11.016; Dong DL, 2010, HYPERTENSION, V55, P946, DOI 10.1161/HYPERTENSIONAHA.109.139519; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fiedler J, 2011, CIRCULATION, V124, P720, DOI 10.1161/CIRCULATIONAHA.111.039008; Flynn JD, 2003, PHARMACOTHERAPY, V23, P1401, DOI 10.1592/phco.23.14.1401.31947; Ford WR, 1996, CIRCULATION, V94, P3087, DOI 10.1161/01.CIR.94.12.3087; Giricz Z, 2014, J MOL CELL CARDIOL, V68, P75, DOI 10.1016/j.yjmcc.2014.01.004; Hausenloy DJ, 2008, REMOTE ISCHEMIC PREC; Hinkel R, 2013, CIRCULATION, V128, P1066, DOI 10.1161/CIRCULATIONAHA.113.001904; Hosoda T, 2011, CIRCULATION, V123, P1287, DOI 10.1161/CIRCULATIONAHA.110.982918; Hullinger TG, 2012, CIRC RES, V110, P71, DOI 10.1161/CIRCRESAHA.111.244442; Jalowy A, 1998, J AM COLL CARDIOL, V32, P1787, DOI 10.1016/S0735-1097(98)00441-0; Karakikes I, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000078; Kukreja RC, 2011, MOL PHARMACOL, V80, P558, DOI 10.1124/mol.111.073528; Kumar D, 2004, MOL CELL BIOCHEM, V258, P211, DOI 10.1023/B:MCBI.0000012857.06723.81; Lange SA, 2007, J CARDIOVASC PHARM, V49, P46, DOI 10.1097/FJC.0b013e31802c2f77; Lv P, 2012, CIRC RES, V111, P697, DOI 10.1161/CIRCRESAHA.112.272013; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; Moudgil R, 2001, J Cardiovasc Pharmacol Ther, V6, P183, DOI 10.1177/107424840100600210; Murriel CL, 2003, ARCH BIOCHEM BIOPHYS, V420, P246, DOI 10.1016/j.abb.2003.08.038; Nabialek E, 2013, MINERVA CARDIOANGIOL, V61, P627; Olson ER, 2008, HYPERTENSION, V51, P704, DOI 10.1161/HYPERTENSIONAHA.107.098459; Osboume A, 2014, J MOL CELL CARDIOL, V74, P53, DOI 10.1016/j.yjmcc.2014.04.024; Ozer MK, 2002, PHARMACOL RES, V45, P257, DOI 10.1006/phrs.2002.0965; Pan ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050515; Parlakpinar H, 2011, CYTOKINE, V56, P688, DOI 10.1016/j.cyto.2011.09.002; Patterson AJ, 2010, CIRC RES, V107, P365, DOI 10.1161/CIRCRESAHA.110.221259; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Raff U, 2014, J HYPERTENS, V32, P76; Raff U, 2014, J HYPERTENS, V32, P2267, DOI 10.1097/HJH.0000000000000313; Sato M, 2000, CIRCULATION, V102, P346; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Song MA, 2015, DRUG DISCOV TODAY, V20, P223, DOI 10.1016/j.drudis.2014.10.004; Tang YH, 2009, INT HEART J, V50, P377, DOI 10.1536/ihj.50.377; Urata H, 1996, AM J HYPERTENS, V9, P277, DOI 10.1016/0895-7061(95)00349-5; Wong SL, 2011, ARTERIOSCL THROM VAS, V31, P1169, DOI 10.1161/ATVBAHA.110.216044; Xu Y, 2000, HYPERTENSION, V36, P506, DOI 10.1161/01.HYP.36.4.506; Xu Y, 2002, AM J PHYSIOL-HEART C, V282, pH1206, DOI 10.1152/ajpheart.00839.2000; Xu Y, 2000, J Renin Angiotensin Aldosterone Syst, V1, P184, DOI 10.3317/jraas.2000.024; Xue Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106827; Xue Q, 2011, CARDIOVASC RES, V89, P300, DOI 10.1093/cvr/cvq303; Yan XH, 2003, AM J PHYSIOL-HEART C, V285, pH2179, DOI 10.1152/ajpheart.00361.2003; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yang BC, 1997, CIRCULATION, V96, P922; Yang ZQ, 2002, CIRCULATION, V106, P106, DOI 10.1161/01.CIR.0000020014.14176.6D; Yogalingam G, 2013, J BIOL CHEM, V288, P18947, DOI 10.1074/jbc.M113.466870	56	11	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132712	10.1371/journal.pone.0132712	http://dx.doi.org/10.1371/journal.pone.0132712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168042	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100070
J	An, WW; Zhang, ZZ; Zeng, LY; Yang, Y; Zhu, XL; Wu, JR				An, Weiwei; Zhang, Zhuzhen; Zeng, Liyong; Yang, Ying; Zhu, Xueliang; Wu, Jiarui			Cyclin Y Is Involved in the Regulation of Adipogenesis and Lipid Production	PLOS ONE			English	Article							ADIPOCYTE DIFFERENTIATION; HEPATIC STEATOSIS; CONSERVED CYCLIN; CELL-CYCLE; TRANSCRIPTION; METABOLISM; EXPRESSION; GLUCOSE; OBESITY; LIVER	A new member of the cyclin family cyclin Y (CCNY) is involved in the regulation of various physiological processes. In this study, the role of CCNY in energy metabolism was characterized. We found that compared with wild-type (WT) mice, Ccny knockout (KO) mice had both lower body weight and lower fat content. The Ccny KO mice also had a higher metabolic rate, resisted the stress of a high-fat diet, and were sensitive to calorie restriction. The expression levels of UCP1 and PGC1 alpha were significantly higher in the brown adipose tissue (BAT) of the Ccny KO mice than that of the WT littermate controls, whereas there was no significant difference in BAT weight between the WT and the Ccny KO mice. In addition, the down-regulation of Ccny resulted in suppression of white adipocyte differentiation both in vivo and in vitro, while the expression of Ccny was up-regulated by C/EBP alpha. Furthermore, both hepatocytes and HepG2 cells that were depleted of Ccny were insensitive to insulin stimulation, consistent with the significant inhibition of insulin sensitivity in the liver of the Ccny KO mice, but no significant changes in WAT and muscle, indicating that CCNY is involved in regulating the hepatic insulin signaling pathway. The hepatic insulin resistance generated by Ccny depletion resulted in down-regulation of the sterol-regulatory element-binding protein (SREBP1) and fatty acid synthase (FASN). Together, these results provide a new link between CCNY and lipid metabolism in mice, and suggest that inhibition of CCNY may offer a therapeutic approach to obesity and diabetes.	[An, Weiwei; Zhang, Zhuzhen; Yang, Ying; Wu, Jiarui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai 200031, Peoples R China; [Zeng, Liyong; Zhu, Xueliang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Wu, Jiarui] Chinese Acad Sci, Shanghai Adv Res Inst, Shanghai 201210, Peoples R China; [Wu, Jiarui] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS; ShanghaiTech University	Wu, JR (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai 200031, Peoples R China.	wujr@sibs.ac.cn		Zhang, Zhuzhen/0000-0001-6787-3920	National Natural Science Foundation of China [31130034, 31470808]; Science and Technology Commission of Shanghai Municipality [13DZ1940100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants to Wu JR from the National Natural Science Foundation of China (31130034 and 31470808) and from the Science and Technology Commission of Shanghai Municipality (13DZ1940100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Bengoechea-Alonso MT, 2009, J BIOL CHEM, V284, P5885, DOI 10.1074/jbc.M807906200; Blessing W, 2012, PHYSIOL BEHAV, V105, P966, DOI 10.1016/j.physbeh.2011.11.009; Chao PT, 2011, CELL METAB, V13, P573, DOI 10.1016/j.cmet.2011.02.019; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Guzzardi Maria A, 2011, Rev Diabet Stud, V8, P403, DOI 10.1900/RDS.2011.8.403; Hermann GE, 2006, BRAIN RES, V1117, P118, DOI 10.1016/j.brainres.2006.08.018; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jiang M, 2009, FEBS LETT, V583, P2171, DOI 10.1016/j.febslet.2009.06.010; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Li XY, 2009, MOL BIOL REP, V36, P97, DOI 10.1007/s11033-007-9156-5; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; Liu DM, 2010, FLY, V4, P278, DOI 10.4161/fly.4.4.12881; Liu DM, 2010, GENETICS, V184, P1025, DOI 10.1534/genetics.110.114017; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Mikolcevic P, 2012, MOL CELL BIOL, V32, P868, DOI 10.1128/MCB.06261-11; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Noble MEM, 1997, TRENDS BIOCHEM SCI, V22, P482, DOI 10.1016/S0968-0004(97)01144-4; Ootsuka Y, 2009, NEUROSCIENCE, V164, P849, DOI 10.1016/j.neuroscience.2009.08.013; Park M, 2011, NEURON, V70, P742, DOI 10.1016/j.neuron.2011.04.002; Pei H, 2011, CELL DEATH DIFFER, V18, P315, DOI 10.1038/cdd.2010.100; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shi YC, 2013, CELL METAB, V17, P236, DOI 10.1016/j.cmet.2013.01.006; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Speakman JR, 2007, J NUTR, V137, P1078, DOI 10.1093/jn/137.4.1078; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; van den Beukel JC, 2014, FRONT HORM RES, V42, P107, DOI 10.1159/000358320; Yang L, 2010, J HEPATOL, V53, P339, DOI 10.1016/j.jhep.2010.03.004	41	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132721	10.1371/journal.pone.0132721	http://dx.doi.org/10.1371/journal.pone.0132721			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161966	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300170
J	Baltazar, BM; Espinoza, LC; Banda, AE; Martinez, JMD; Tiznado, JAG; Garcia, JG; Gutierrez, MA; Rodriguez, JLG; Diaz, OH; Horak, MJ; Martinez, JIM; Schapaugh, AW; Stojsin, D; Montes, HRU; Garcia, FZ				Baltazar, Baltazar M.; Castro Espinoza, Luciano; Espinoza Banda, Armando; de la Fuente Martinez, Juan Manuel; Garzon Tiznado, Jose Antonio; Gonzalez Garcia, Juvencio; Antonio Gutierrez, Marco; Guzman Rodriguez, Jose Luis; Heredia Diaz, Oscar; Horak, Michael J.; Madueno Martinez, Jesus Ignacio; Schapaugh, Adam W.; Stojsin, Duska; Uribe Montes, Hugo Rau; Zavala Garcia, Francisco			Pollen-Mediated Gene Flow in Maize: Implications for Isolation Requirements and Coexistence in Mexico, the Center of Origin of Maize	PLOS ONE			English	Article							GRAIN PRODUCTION PRACTICES; GM; VARIABILITY; TIME; ZEA	Mexico, the center of origin of maize (Zea mays L.), has taken actions to preserve the identity and diversity of maize landraces and wild relatives. Historically, spatial isolation has been used in seed production to maintain seed purity. Spatial isolation can also be a key component for a strategy to minimize pollen-mediated gene flow in Mexico between transgenic maize and sexually compatible plants of maize conventional hybrids, landraces, and wild relatives. The objective of this research was to generate field maize-to-maize outcrossing data to help guide coexistence discussions in Mexico. In this study, outcrossing rates were determined and modeled from eight locations in six northern states, which represent the most economically important areas for the cultivation of hybrid maize in Mexico. At each site, pollen source plots were planted with a yellow-kernel maize hybrid and surrounded by plots with a white-kernel conventional maize hybrid (pollen recipient) of the same maturity. Outcrossing rates were then quantified by assessing the number of yellow kernels harvested from white-kernel hybrid plots. The highest outcrossing values were observed near the pollen source (12.9% at 1 m distance). The outcrossing levels declined sharply to 4.6, 2.7, 1.4, 1.0, 0.9, 0.5, and 0.5% as the distance from the pollen source increased to 2, 4, 8, 12, 16, 20, and 25 m, respectively. At distances beyond 20 m outcrossing values at all locations were below 1%. These trends are consistent with studies conducted in other world regions. The results suggest that coexistence measures that have been implemented in other geographies, such as spatial isolation, would be successful in Mexico to minimize transgenic maize pollen flow to conventional maize hybrids, landraces and wild relatives.	[Baltazar, Baltazar M.; Horak, Michael J.; Schapaugh, Adam W.; Stojsin, Duska] Monsanto Co, St Louis, MO 63167 USA; [Castro Espinoza, Luciano; Antonio Gutierrez, Marco] Inst Tecnol Sonora, Direcc Recursos Nat, Obregon 85000, Sonora, Mexico; [Espinoza Banda, Armando] Univ Autonoma Agr Antonio Narro, Unidad Laguna, Torreon 27059, Coahuila, Mexico; [de la Fuente Martinez, Juan Manuel; Heredia Diaz, Oscar] Monsanto Comercial, Mexico City 01210, DF, Mexico; [Garzon Tiznado, Jose Antonio; Madueno Martinez, Jesus Ignacio] Univ Autonoma Sinaloa, Fac Ciencias Quim Biol, Sinaloa 80000, Mexico; [Gonzalez Garcia, Juvencio; Uribe Montes, Hugo Rau] Univ Autonoma Chihuahua, Fac Ciencias Agr & Forestales, Chihuahua 33000, Mexico; [Guzman Rodriguez, Jose Luis; Zavala Garcia, Francisco] Univ Autonoma Nuevo Leon, Fac Agron, Escobedo 66050, Nuevo Leon, Mexico	Monsanto; Universidad Autonoma de Sinaloa; Universidad Autonoma de Nuevo Leon	Baltazar, BM (corresponding author), Monsanto Co, 800 N Lindbergh Blvd, St Louis, MO 63167 USA.	baltazar.baltazar@monsanto.com		/0000-0002-4384-1286; Schapaugh, Adam/0000-0001-8060-846X	Monsanto Company	Monsanto Company	Funding for these research studies was provided by Monsanto Company. Authors LCE, AEB, JAGT, FZG, JGG, MAG, JLGR, JIMM, and HRUM are full time researchers working for public Mexican research institutions and participated directly in study design, data collection, decision to publish and preparation of the manuscript.	[Anonymous], 2002, SAS SOFTWARE RELEASE; AOSCA, 1997, GENETIC CROP STANDAR; AOSCA, 2004, OPERATIONAL PROCEDUR; Baltazar BM, 2005, THEOR APPL GENET, V110, P519, DOI 10.1007/s00122-004-1859-6; Bannert M, 2007, EUR J AGRON, V27, P44, DOI 10.1016/j.eja.2007.01.002; BATEMAN AJ, 1947, HEREDITY, V1, P235, DOI 10.1038/hdy.1947.15; Bellon MR, 2006, AGR HUM VALUES, V23, P3, DOI 10.1007/s10460-004-5861-z; Bellon MR, 2004, PLANT PHYSIOL, V134, P883, DOI 10.1104/pp.103.038331; Bellon MR, 2001, WORLD DEV, V29, P799, DOI 10.1016/S0305-750X(01)00013-4; Brookes G., 2004, COEXISTENCE GM NONGM; Brookes G, 2003, COEXISTENCE GM NONGM; Burris JS, 2002, ADVENTITIOUS POLLEN; Cervantes MJE, 1998, THESIS COLEGIO POSTG; Diario Oficial de la Federacion, 2012, ACUERDO DETERMINATIO; Diario Oficial de la Federacion, 2008, REGLAMENTO LEY BIOSE; DIGIOVANNI F, 1995, GRANA, V34, P39, DOI 10.1080/00173139509429031; DIGIOVANNI F, 1991, CAN J FOREST RES, V21, P1155, DOI 10.1139/x91-163; Goggi AS, 2007, INT J BIOMETEOROL, V51, P493, DOI 10.1007/s00484-007-0088-5; Goggi AS, 2006, FIELD CROP RES, V99, P147, DOI 10.1016/j.fcr.2006.04.005; Gustafson DI, 2006, CROP SCI, V46, P2133, DOI 10.2135/cropsci2006.01.0060; Haegele JW, 2007, MAYDICA, V52, P117; Halsey ME, 2005, CROP SCI, V45, P2172, DOI 10.2135/cropsci2003.0664; ISAAA, CROP BIOTECH UPDATE; Jemison John M. Jr., 2001, AgBioForum, V4, P87; Jones JM, 1950, OKLAHOMA AGR EXP STA; JONES MD, 1948, J AM SOC AGRON, V40, P136; Kiesselbach TA, 1999, STRUCT REPRODUCTION; Kim S, 2012, R PACKAGE VERSION 10; LOUETTE D, 1996, 9603 NRG; Luna S, 2001, CROP SCI, V41, P1551, DOI 10.2135/cropsci2001.4151551x; Ma BL, 2004, CROP SCI, V44, P1273, DOI 10.2135/cropsci2004.1273; Marceau A, 2013, CROP SCI, V53, P1712, DOI 10.2135/cropsci2012.04.0224; Matsuoka Y, 2005, BREEDING SCI, V55, P383, DOI 10.1270/jsbbs.55.383; Mendoza RJL, 2003, FOLLETO TECNICO; Messeguer J, 2006, PLANT BIOTECHNOL J, V4, P633, DOI 10.1111/j.1467-7652.2006.00207.x; Nascimento VE, 2012, PESQUI AGROPECU BRAS, V47, P784, DOI 10.1590/S0100-204X2012000600008; OECD. (Organisation for Economic Co-operation and Development) Environment Health and Safety Publications, 2006, SERIES HARMONISATION, V23; OGDEN EC, 1969, AM J BOT, V56, P16, DOI 10.2307/2440389; Pla M, 2006, TRANSGENIC RES, V15, P219, DOI 10.1007/s11248-005-4945-x; R Core Team, 2021, R LANGUAGE ENV STAT; RAYNOR GS, 1972, AGRON J, V64, P420, DOI 10.2134/agronj1972.00021962006400040004x; Rodriguez JG, 2006, MAYDICA, V51, P383; Serratos JA, 1996, GENE FLOW MAIZE LAND, P1; Vargas-Parada L, 2014, NATURE, V511, P16, DOI 10.1038/511016a; Wang ChenYu, 2013, Crop, Environment & Bioinformatics, V10, P172; Weber WE, 2007, J AGRON CROP SCI, V193, P79, DOI 10.1111/j.1439-037X.2006.00245.x; WODEHOUSE RP, 1935, POLLEN GRAINS STRUCT	47	24	29	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131549	10.1371/journal.pone.0131549	http://dx.doi.org/10.1371/journal.pone.0131549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162097	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000358162300045
J	Brathwaite, R; Addo, J; Smeeth, L; Lock, K				Brathwaite, Rachel; Addo, Juliet; Smeeth, Liam; Lock, Karen			A Systematic Review of Tobacco Smoking Prevalence and Description of Tobacco Control Strategies in Sub-Saharan African Countries; 2007 to 2014	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; FORMER SOVIET-UNION; GENDER-DIFFERENCES; DETERMINANTS; POPULATION; URBAN; AREA	Objective To systematically review current smoking prevalence among adults in sub-Saharan Africa from 2007 to May 2014 and to describe the context of tobacco control strategies in these countries. Data Sources Five databases, Medline, Embase, Africa-wide Information, Cinahl Plus, and Global Health were searched using a systematic search strategy. There were no language restrictions. Study Selection 26 included studies measured current smoking prevalence in nationally representative adult populations in sub-Saharan African countries. Data Extraction Study details were independently extracted using a standard datasheet. Data on tobacco control policies, taxation and trends in prices were obtained from the Implementation Database of the WHO FCTC website. Results Studies represented 13 countries. Current smoking prevalence varied widely ranging from 1.8% in Zambia to 25.8% in Sierra Leone. The prevalence of smoking was consistently lower in women compared to men with the widest gender difference observed in Malawi (men 25.9%, women 2.9%). Rwanda had the highest prevalence of women smokers 12.6%) and Ghana had the lowest (0.2%). Rural, urban patterns were inconsistent. Most countries have implemented demand-reduction measures including bans on advertising, and taxation rates but to different extents. Conclusion Smoking prevalence varied widely across sub-Saharan Africa, even between similar country regions, but was always higher in men. High smoking rates were observed among countries in the eastern and southern regions of Africa, mainly among men in Ethiopia, Malawi, Rwanda, and Zambia and women in Rwanda and rural Zambia. Effective action to reduce smoking across sub-Saharan Africa, particularly targeting population groups at increased risk remains a pressing public health priority.	[Brathwaite, Rachel; Addo, Juliet; Smeeth, Liam] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Fac Epidemiol & Populat Hlth, London WC1, England; [Lock, Karen] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, Fac Publ Hlth & Policy, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Brathwaite, R (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Fac Epidemiol & Populat Hlth, London WC1, England.	Rachel.Brathwaite@lshtm.ac.uk	Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022	Government of Trinidad and Tobago; European Commission; Wellcome Trust Senior Research Fellowship in Clinical Science [098504/Z/12/Z]; National Institute for Health Research School for Public Health Research; Medical Research Council [MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	Government of Trinidad and Tobago; European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust); National Institute for Health Research School for Public Health Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	RB is the recipient of a Post Graduate Scholarship from the Government of Trinidad and Tobago. This work is part of RB's PhD thesis. JA is supported by a grant from the European Commission and LS is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science grant number 098504/Z/12/Z. KL is supported by a grant from the National Institute for Health Research School for Public Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo J, 2009, INT J ENV RES PUB HE, V6, P200, DOI 10.3390/ijerph6010200; Alaba O, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-63; Alemseged F, 2012, ETHIOPIAN J HLTH SCI, V22, P9; Alemu W., 2011, SIERRA LEONE J BIOME, V3, P49; Ayah R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-371; Baragou S, 2012, CARDIOVASC J AFR, V23, P308, DOI 10.5830/CVJA-2011-071; Beyer JD, 2003, TOBACCO CONTROL POLI; Bloomfield GS, 2013, HEART, V99, P1323, DOI 10.1136/heartjnl-2013-303913; Chaloupka FJ, 2012, TOB CONTROL, V21, P172, DOI 10.1136/tobaccocontrol-2011-050417; ELLENBERG JH, 1994, STAT MED, V13, P557, DOI 10.1002/sim.4780130518; Eriksen M, 2012, TOBACCO ATLAS; Gilmore AB, 2004, TOB CONTROL, V13, P143, DOI 10.1136/tc.2003.005108; Gilmore ABC, 2001, PREV MED, V33, P453, DOI 10.1006/pmed.2001.0915; Hald J, 2003, ACTA ONCOL, V42, P154, DOI 10.1080/02841860310005020; John RM, 2012, NICOTINE TOB RES, V14, P1205, DOI 10.1093/ntr/nts013; KAPLAN M, 1990, SOC SCI MED, V30, P305, DOI 10.1016/0277-9536(90)90186-V; Kinyanda E, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-97; Lo TQ, 2013, TROP MED INT HEALTH, V18, P506, DOI 10.1111/tmi.12066; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Maher D, 2011, INT J EPIDEMIOL, V40, P160, DOI 10.1093/ije/dyq156; Msyamboza KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020316; Mulenga D, 2013, RURAL REMOTE HEALTH, V13; Murphy GAV, 2013, INT J EPIDEMIOL, V42, P1740, DOI 10.1093/ije/dyt184; Musafiri S, 2011, RESP MED, V105, P1596, DOI 10.1016/j.rmed.2011.06.013; Nuwaha F, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-101; Nyembue TD, 2012, INT FORUM ALLERGY RH, V2, P285, DOI 10.1002/alr.21017; Owusu-Dabo E, 2009, TOB CONTROL, V18, P365, DOI 10.1136/tc.2009.030635; Pampel F, 2008, SOC SCI MED; Pampel Fred C, 2006, Int J Comp Sociol, V47, P466, DOI 10.1177/0020715206070267; Pessinaba S, 2013, ANN CARDIOL ANGEIOL, V62, P253, DOI 10.1016/j.ancard.2013.02.005; Pomerleau J, 2004, ADDICTION, V99, P1577, DOI 10.1111/j.1360-0443.2004.00885.x; Saffer H, 2000, J HEALTH ECON, V19, P1117, DOI 10.1016/S0167-6296(00)00054-0; Siziya S., 2011, Journal of Public Health and Epidemiology, V3, P43; Tafawa AO, 2012, CANCER CAUSE CONTROL, V23, P45, DOI 10.1007/s10552-012-9898-9; Townsend L, 2006, DRUG ALCOHOL DEPEN, V84, P14, DOI 10.1016/j.drugalcdep.2005.12.008; Ulasi I, 2010, CLIN NEPHROL, V74, pS159; University of California San Francisco Library, 1985, PERSP PM INT SMOK HL; WALDRON I, 1988, SOC SCI MED, V27, P1269, DOI 10.1016/0277-9536(88)90357-7; WHO, PART WHO FRAM CONV T; World Bank, 2010, WORLD DEV IND 2010; World Health Organization, 2014, WHO FRAM CONV TOB CO; World Health Organization, 2014, TOB CONTR COUNTR PRO; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP; Zyaambo C., 2013, Health, V5, P1021	44	66	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132401	10.1371/journal.pone.0132401	http://dx.doi.org/10.1371/journal.pone.0132401			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26162085	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000358162300129
J	Haraguchi, M; Sato, M; Ozawa, M				Haraguchi, Misako; Sato, Masahiro; Ozawa, Masayuki			CRISPR/Cas9n-Mediated Deletion of the Snail 1Gene (SNAI1) Reveals Its Role in Regulating Cell Morphology, Cell-Cell Interactions, and Gene Expression in Ovarian Cancer (RMG-1) Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR; TGF-BETA; GENOME; SCATTERING; DIFFERENTIATION; MECHANISMS; PROTEINS; SURVIVAL; MOTILITY	Snail1 is a transcription factor that induces the epithelial to mesenchymal transition (EMT). During EMT, epithelial cells lose their junctions, reorganize their cytoskeletons, and reprogram gene expression. Although Snail1 is a prominent repressor of E-cadherin transcription, its precise roles in each of the phenomena of EMT are not completely understood, particularly in cytoskeletal changes. Previous studies have employed gene knockdown systems to determine the functions of Snail1. However, incomplete protein knockdown is often associated with these systems, which may cause incorrect interpretation of the data. To more precisely evaluate the functions of Snail1, we generated a stable cell line with a targeted ablation of Snail1 (Snail1 KO) by using the CRISPR/Cas9n system. Snail1 KO cells show increased cell-cell adhesion, decreased cell-substrate adhesion and cell migration, changes to their cytoskeletal organization that include few stress fibers and abundant cortical actin, and upregulation of epithelial marker genes such as E-cadherin, occludin, and claudin-1. However, morphological changes were induced by treatment of Snail1 KO cells with TGF-beta. Other transcription factors that induce EMT were also induced by treatment with TGF-beta. The precise deletion of Snail1 by the CRISPR/Cas9n system provides clear evidence that loss of Snail1 causes changes in the actin cytoskeleton, decreases cell-substrate adhesion, and increases cell-cell adhesion. Treatment of RMG1 cells with TGF-beta suggests redundancy among the transcription factors that induce EMT.	[Haraguchi, Misako; Ozawa, Masayuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biochem & Mol Biol, Kagoshima 890, Japan; [Sato, Masahiro] Kagoshima Univ, Frontier Sci Res Ctr, Sect Gene Express Regulat, Kagoshima 890, Japan	Kagoshima University; Kagoshima University	Haraguchi, M (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biochem & Mol Biol, Kagoshima 890, Japan.	haraguci@m3.kufm.kagoshima-u.ac.jp		Sato, Masahiro/0000-0003-1334-2950	Ministry of Education, Culture, Sports, Science and Technology of Japan [22590287]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan. Grant number: 22590287 to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nieto MA, 2009, INT J DEV BIOL, V53, P1541, DOI 10.1387/ijdb.072410mn; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle R, 2013, ONCOGENE, V32, P3381, DOI 10.1038/onc.2012.342; Baygi ME, 2010, CELL BIOL TOXICOL, V26, P553, DOI 10.1007/s10565-010-9163-5; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Chen A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-552; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dave N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.168625; Engl W, 2014, NAT CELL BIOL, V16, P584, DOI 10.1038/ncb2973; Feng Y, 2015, J ORTHOP RES, V33, P199, DOI 10.1002/jor.22745; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Haraguchi M, 2008, J BIOL CHEM, V283, P23514, DOI 10.1074/jbc.M801125200; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Ishii K, 2005, J INVEST DERMATOL, V124, P939, DOI 10.1111/j.0022-202X.2005.23714.x; Kiguchi K, 1998, JPN J CANCER RES, V89, P923, DOI 10.1111/j.1349-7006.1998.tb00650.x; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li HS, 2011, J NAT GAS CHEM, V20, P1, DOI 10.1016/S1003-9953(10)60156-9; Li YY, 2014, BIOCHEM BIOPH RES CO, V452, P490, DOI 10.1016/j.bbrc.2014.08.110; Masuda M, 2005, J BIOL CHEM, V280, P42164, DOI 10.1074/jbc.M507136200; McGrail DJ, 2015, FASEB J, V29, P1280, DOI 10.1096/fj.14-257345; Nobusue H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4368; O'Connor JW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083188, 10.1371/journal.pone.0080504]; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Shields MA, 2012, J BIOL CHEM, V287, P6218, DOI 10.1074/jbc.M111.308940; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822	33	19	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132260	10.1371/journal.pone.0132260	http://dx.doi.org/10.1371/journal.pone.0132260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161782	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300108
J	Hofmann, T; Ahnis, A; Elbelt, U; Rose, M; Klapp, BF; Stengel, A				Hofmann, Tobias; Ahnis, Anne; Elbelt, Ulf; Rose, Matthias; Klapp, Burghard F.; Stengel, Andreas			NUCB2/nesfatin-1 Is Associated with Elevated Levels of Anxiety in Anorexia Nervosa	PLOS ONE			English	Article							AMPHETAMINE-REGULATED TRANSCRIPT; PERCEIVED STRESS QUESTIONNAIRE; EATING-DISORDER INVENTORY; PLASMA NESFATIN-1 LEVEL; BODY-MASS INDEX; FOOD-INTAKE; OBESE; IMMUNOREACTIVITY; VALIDATION; IDENTIFICATION	Objective NUCB2/nesfatin-1 is an anorexigenic hormone with elevated levels in obese and decreased levels in anorexia nervosa (AN) patients. Moreover, a role in the regulation of stress and emotions was suggested by several rodent and preliminary human studies. Since anxiety and depression are common comorbidities in AN, we investigated the association of NUCB2/nesfatin-1 with anxiety, depression and perceived stress in AN. Methods We analyzed circulating NUCB2/nesfatin-1 levels in 64 female inpatients diagnosed with anorexia nervosa (body mass index, BMI; mean +/- SD, 14.7 +/- 2.3 kg/m(2)). At the same time anxiety (GAD-7), depression (PHQ-9), stress (PSQ-20) and disordered eating (EDI-2) were measured psychometrically. Results No correlation was observed between NUCB2/nesfatin-1 and BMI (r = 0.06, p = 0.70). The study population was divided in patients with low anxiety (n = 32, GAD-7 scores, mean +/- SD, 7.5 +/- 3.3) and high anxiety (n = 32, 16.0 +/- 3.0, p<0.001). Patients with high anxiety scores displayed 65% higher NUCB2/nesfatin-1 levels (p = 0.04). This was reflected by a positive correlation of GAD-7 and NUCB2/nesfatin-1-levels (r = 0.32, p = 0.04). Scores of PSQ-20 (73.3 +/- 14.3 vs. 48.6 +/- 17.2) and PHQ-9 (18.8 +/- 5.0 vs. 10.3 +/- 5.1) were higher in the high anxiety group (p<0.001) but did not correlate with NUCB2/nesfatin-1 (p>0.05). EDI-2 total score was also higher in the high anxiety group (52.3 +/- 14.1 vs. 40.2 +/- 16.0, p = 0.02), while no correlations of EDI-2-scores with plasma NUCB2/nesfatin-1 were observed (p>0.05). Conclusions Circulating NUCB2/nesfatin-1 levels correlated positively with perceived anxiety, whereas no association with BMI or eating disorder symptoms was observed. NUCB2/nesfatin-1 might be primarily involved in the modulation of anxiety and subsequently in the regulation of eating habits and body weight in AN.	[Hofmann, Tobias; Ahnis, Anne; Elbelt, Ulf; Rose, Matthias; Klapp, Burghard F.; Stengel, Andreas] Charite, Charite Ctr Internal Med & Dermatol, Div Gen Internal & Psychosomat Med, D-13353 Berlin, Germany; [Elbelt, Ulf] Charite, Div Endocrinol Diabet & Nutr, Charite Ctr Internal Med Gastroenterol & Nephrol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hofmann, T (corresponding author), Charite, Charite Ctr Internal Med & Dermatol, Div Gen Internal & Psychosomat Med, D-13353 Berlin, Germany.	tobias.hofmann@charite.de	Elbelt, Ulf/AAJ-6469-2020	Stengel, Andreas/0000-0003-3294-4340; Elbelt, Ulf/0000-0002-7510-9284; Hofmann, Tobias/0000-0002-4002-3552	German Research Foundation [STE 1765/3-1]; Charite University [UFF 89-441-176]	German Research Foundation(German Research Foundation (DFG)); Charite University	German Research Foundation STE 1765/3-1 (http://www.dfg.de) and Charite University Funding UFF 89-441-176 (www.charite.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci A, 2013, PEDIATR DIABETES, V14, P189, DOI 10.1111/pedi.12009; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Ari M, 2011, PROG NEURO-PSYCHOPH, V35, P497, DOI 10.1016/j.pnpbp.2010.12.004; Basar O, 2012, SCAND J CLIN LAB INV, V72, P479, DOI 10.3109/00365513.2012.699097; Bloem B, 2012, NEUROPHARMACOLOGY, V62, P297, DOI 10.1016/j.neuropharm.2011.07.023; Brailoiu GC, 2007, ENDOCRINOLOGY, V148, P5088, DOI 10.1210/en.2007-0701; Emmerzaal TL, 2013, CURR PHARM DESIGN, V19, P6941, DOI 10.2174/138161281939131127125042; Fliege H, 2005, PSYCHOSOM MED, V67, P78, DOI 10.1097/01.psy.0000151491.80178.78; Foo KS, 2008, NEUROSCIENCE, V156, P563, DOI 10.1016/j.neuroscience.2008.07.054; Foo KS, 2010, J ENDOCRINOL, V204, P255, DOI 10.1677/JOE-09-0254; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Garner DM, 1991, EATING DISORDER INVE; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Godart N, 2006, INT J EAT DISORDER, V39, P772, DOI 10.1002/eat.20274; Godart NT, 2000, EUR PSYCHIAT, V15, P38, DOI 10.1016/S0924-9338(00)00212-1; Goebel M, 2009, BRAIN RES, V1300, P114, DOI 10.1016/j.brainres.2009.08.082; Goebel M, 2009, NEUROSCI LETT, V452, P241, DOI 10.1016/j.neulet.2009.01.064; Gonzalez R, 2009, BIOCHEM BIOPH RES CO, V381, P643, DOI 10.1016/j.bbrc.2009.02.104; Gunay H, 2012, PSYCHONEUROENDOCRINO, V37, P1949, DOI 10.1016/j.psyneuen.2012.04.007; Guo YF, 2014, ACUPUNCT MED, V32, P313, DOI 10.1136/acupmed-2014-010530; Hofmann T, 2013, PSYCHONEUROENDOCRINO, V38, P2502, DOI 10.1016/j.psyneuen.2013.05.013; Kaye WH, 2004, AM J PSYCHIAT, V161, P2215, DOI 10.1176/appi.ajp.161.12.2215; Keel PK, 2005, INT J EAT DISORDER, V38, P99, DOI 10.1002/eat.20168; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; L/we B., 2002, GESUNDHEITSFRAGEBOGE; LEVENSTEIN S, 1993, J PSYCHOSOM RES, V37, P19, DOI 10.1016/0022-3999(93)90120-5; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Merali Z, 2008, PSYCHOPHARMACOLOGY, V201, P115, DOI 10.1007/s00213-008-1252-2; Ogiso K, 2011, PEPTIDES, V32, P150, DOI 10.1016/j.peptides.2010.10.004; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Okere B, 2010, BRAIN RES, V1317, P92, DOI 10.1016/j.brainres.2009.12.053; Ramanjaneya M, 2010, ENDOCRINOLOGY, V151, P3169, DOI 10.1210/en.2009-1358; Saldanha JF, 2012, REGUL PEPTIDES, V173, P82, DOI 10.1016/j.regpep.2011.09.010; Shimizu H, 2009, ENDOCRINOLOGY, V150, P662, DOI 10.1210/en.2008-0598; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stengel A, 2013, HORM METAB RES, V45, P975, DOI 10.1055/s-0033-1351324; Stengel A, 2013, OBES REV, V14, P859, DOI 10.1111/obr.12063; Stengel A, 2009, ENDOCRINOLOGY, V150, P232, DOI 10.1210/en.2008-0747; Stengel A, 2013, HISTOCHEM CELL BIOL, V139, P909, DOI 10.1007/s00418-013-1087-8; Thiel A, 1997, PSYCHOTHER PSYCH MED, V47, P365; Tsuchiya T, 2010, CLIN ENDOCRINOL, V73, P484, DOI 10.1111/j.1365-2265.2010.03835.x; Wittkampf K, 2009, GEN HOSP PSYCHIAT, V31, P451, DOI 10.1016/j.genhosppsych.2009.06.001; WorldHealthOrganization, 2008, INT STAT CLASS DIS R; Yoshida N, 2010, AGING-US, V2, P775, DOI 10.18632/aging.100207	46	38	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132058	10.1371/journal.pone.0132058	http://dx.doi.org/10.1371/journal.pone.0132058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26162003	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300086
J	Hong, DQ; Zhang, YA; Gao, BX; Wang, JW; Li, GS; Wang, L; Zhang, LX				Hong, Daqing; Zhang, Yuan; Gao, Bixia; Wang, Jinwei; Li, Guisen; Wang, Li; Zhang, Luxia		China Natl Survey CKD Working Grp	Metabolic Syndrome without Diabetes or Hypertension Still Necessitates Early Screening for Chronic Kidney Disease: Information from a Chinese National Cross-Sectional Study	PLOS ONE			English	Article							RISK; ASSOCIATION; PREVALENCE; ADULTS; CKD	Metabolic syndrome (MS) is prevalent, with an increasing contribution to the incidence of chronic kidney disease (CKD). The study of the relationship between them is important. The CKD survey, a national cross-sectional study, provided a large database to accomplish this study. The study population were 41 131 adults from this survey between 2008 and 2009. CKD was defined as estimate glomerular filtration rate (eGFR) less than 60 mL/min per 1.73 m(2) or the presence of albuminuria. MS was diagnosed by National Cholesterol Education Program-Adult Treatment Panel III (ATPIII), ATPIII-modified or International Diabetes Federation (IDF) criteria. Logistic regression model was applied to study the impact of MS or its components on CKD or its components. The age and sex standardized prevalence of MS by ATPIII, ATPIII-modified and IDF criteria was 11.77% (11.13%-12.40%), 21.51% (20.69%-22.34%) and 16.67% (15.92-17.42)% respectively. Multivariate logistic regression models showed that MS and its components were associated with higher CKD prevalence. The risk for CKD and its components increased with the number of MS components. After adjusting for hypertension and diabetes, the odds ratios of MS for CKD decreased, but remained significantly more than 1 between 1.16(95% CI 1.07-1.26) and 1.37 (95% CI 1.25-1.50) across the different models. Similar results were found with albuminuria, while for decreased eGFR, after adjusting for hypertension and diabetes, the odds ratios of MS and MS components (except elevated TG) became insignificant. In conclusion, MS is prevalent and associated with a higher prevalence of CKD. Different MS components are associated with different risks for CKD, even after adjusting for hypertension and diabetes, which may mainly be contributed more by the increased risk for albuminuria than that for decreased eGFR. More attention must be paid to the population with MS, including those with elevated blood pressure and serum glucose.	[Hong, Daqing; Zhang, Yuan; Li, Guisen; Wang, Li] Sichuan Acad Med Sci, Div Nephrol, Chengdu, Peoples R China; [Hong, Daqing; Zhang, Yuan; Li, Guisen; Wang, Li] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Gao, Bixia; Wang, Jinwei; Zhang, Luxia] Peking Univ, Hosp 1, Inst Nephrol, Div Nephrol, Beijing 100871, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Peking University	Wang, L (corresponding author), Sichuan Acad Med Sci, Div Nephrol, Chengdu, Peoples R China.	scwangli62@163.com; zhanglx@bjmu.edu.cn	Li, Guisen/AAS-9461-2021	Li, Guisen/0000-0003-1970-9979; Luxia, Zhang/0000-0003-2349-2936	National Key Technology R&D Program from the Ministry of Science and Technology (China) [2007BAI04B10]; Science and Technology Commission of Shanghai [08dz1900502, 07JC14037]; Natural Science Funds of Ning Xia [NZ08102]; Science and Technology Department; National Natural Science Funds [30660069]; National Natural Science Foundation of China; Department of Health, Jiangsu Province [H200936]; Key Scientific and Technology Project from the Sichuan Science and Technology Department [05SG1635]; Program for New Century Excellent Talents in University from the Ministry of Education (China) [BMU2009131]; International Society of Nephrology Research Committee; China Health and Medical Development Foundation	National Key Technology R&D Program from the Ministry of Science and Technology (China)(National Key Technology R&D Program); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Natural Science Funds of Ning Xia; Science and Technology Department(Science and Technology Development Fund (STDF)United States Agency for International Development (USAID)US-Egypt Science and Technology Joint Fund); National Natural Science Funds(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Health, Jiangsu Province; Key Scientific and Technology Project from the Sichuan Science and Technology Department; Program for New Century Excellent Talents in University from the Ministry of Education (China); International Society of Nephrology Research Committee; China Health and Medical Development Foundation	This study was supported by the National Key Technology R&D Program from the Ministry of Science and Technology (China; 2007BAI04B10); the Science and Technology Commission of Shanghai (08dz1900502 and 07JC14037); the Natural Science Funds of Ning Xia (NZ08102); the Science and Technology Department, the National Natural Science Funds (30660069); the National Natural Science Foundation of China; the Department of Health, Jiangsu Province (H200936); the Key Scientific and Technology Project from the Sichuan Science and Technology Department (05SG1635); the Program for New Century Excellent Talents in University from the Ministry of Education (China; BMU2009131); the International Society of Nephrology Research Committee; and the China Health and Medical Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Chang A, 2013, AM J KIDNEY DIS, V62, P900, DOI 10.1053/j.ajkd.2013.04.022; Chen BD, 2010, CLIN CHIM ACTA, V411, P705, DOI 10.1016/j.cca.2010.01.038; Chen SY, 2013, CLIN NEPHROL, V80, P361, DOI 10.5414/CN108002; Elsayed EF, 2008, AM J KIDNEY DIS, V52, P29, DOI 10.1053/j.ajkd.2008.02.363; Gatti A, 2008, OBESITY, V16, P899, DOI 10.1038/oby.2007.59; group C.D.S.M.S.R.C, 2004, CHIN J DIABETES, V12, P151, DOI [10.3321/j.issn:1006-6187.2004.03.002, DOI 10.3321/J.ISSN:1006-6187.2004.03.002]; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Hradec J, 2013, CURR MED RES OPIN, V29, P589, DOI 10.1185/03007995.2013.783795; Jang CM, 2014, INSULIN RESISTANCE I; Kang YU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093795; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Lee IT, 2008, DIABETES RES CLIN PR, V81, P345, DOI 10.1016/j.diabres.2008.05.010; Li YQ, 2014, NEPHROLOGY, V19, P325, DOI 10.1111/nep.12219; Lucove J, 2008, AM J KIDNEY DIS, V51, P21, DOI 10.1053/j.ajkd.2007.09.014; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Ming J, 2014, CLIN CHIM ACTA, V430, P115, DOI 10.1016/j.cca.2014.01.004; Palaniappan L, 2003, AM J HYPERTENS, V16, P952, DOI 10.1016/S0895-7061(03)01009-4; Palaniappan LP, 2011, INT J OBESITY, V35, P393, DOI 10.1038/ijo.2010.152; Pang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097928; Rashidi A, 2007, CLIN J AM SOC NEPHRO, V2, P976, DOI 10.2215/CJN.01020207; Ryu S, 2009, AM J KIDNEY DIS, V53, P59, DOI 10.1053/j.ajkd.2008.07.027; Sun F, 2010, NEPHROLOGY, V15, P84, DOI 10.1111/j.1440-1797.2009.01150.x; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; USRDS, 2013, ANN DAT REP; Wang HY, 2005, KIDNEY INT, V67, pS63, DOI 10.1111/j.1523-1755.2005.09416.x; Watanabe H, 2010, DIABETES-METAB RES, V26, P26, DOI 10.1002/dmrr.1058; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zuo L, 2010, CLIN NEPHROL, V74, pS20	32	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132220	10.1371/journal.pone.0132220	http://dx.doi.org/10.1371/journal.pone.0132220			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161991	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300104
J	Schwartz, R; Vigo, A; de Oliveira, LD; Giugliani, ERJ				Schwartz, Renata; Vigo, Alvaro; de Oliveira, Luciana Dias; Justo Giugliani, Elsa Regina			The Effect of a Pro-Breastfeeding and Healthy Complementary Feeding Intervention Targeting Adolescent Mothers and Grandmothers on Growth and Prevalence of Overweight of Preschool Children	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; FOLLOW-UP; PUBLISHED EVIDENCE; CHILDHOOD OBESITY; RISK-FACTORS; LOW-INCOME; LIFE; DURATION; FOOD; INFANTS	Introduction The pattern and duration of breastfeeding (BF) and the age at onset of complementary feeding, as well as its quality, have been associated with the prevalence of overweight in childhood. Objective To assess the effect of a pro-BF and healthy complementary feeding intervention, targeted to adolescent mothers and maternal grandmothers, on growth and prevalence of overweight and obesity in children at preschool age. This intervention had a positive impact on duration of BF and timing of onset of complementary feeding. Methods This randomized clinical trial involved 323 adolescent mothers, their infants, and the infants' maternal grandmothers, when they cohabited. Mothers and grandmothers in the intervention group received counseling sessions on BF and healthy complementary feeding at the maternity ward and at home (7, 15, 30, 60, and 120 days after delivery). When children were aged 4 to 7 years, they underwent anthropometric assessment and collection of data on dietary habits. Multivariable Poisson regression with robust estimation was used for analysis. Results BMI-for-age and height-for-age were similar in the intervention and control groups, as was the prevalence of overweight (39% vs. 31% respectively; p=0.318). There were no significant between-group differences in dietary habits. Conclusion Although the intervention prolonged the duration of exclusive BF and delayed the onset of complementary feeding, it had no impact on growth or prevalence of overweight at age 4 to 7 years.	[Schwartz, Renata; Justo Giugliani, Elsa Regina] Univ Fed Rio Grande do Sul, Grad Program Child & Adolescent Hlth, Porto Alegre, RS, Brazil; [Vigo, Alvaro] Univ Fed Rio Grande do Sul, Dept Stat, Porto Alegre, RS, Brazil; [de Oliveira, Luciana Dias] Univ Fed Rio Grande do Sul, Dept Nutr, HCPA, Ctr Food & Nutr Studies CESAN, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Schwartz, R (corresponding author), Univ Fed Rio Grande do Sul, Grad Program Child & Adolescent Hlth, Porto Alegre, RS, Brazil.	rschwartz82@hotmail.com	Giugliani, Elsa Regina Justo/Y-9236-2019; Vigo, Alvaro/S-2243-2019	Vigo, Alvaro/0000-0002-5797-9470	FIPE-HCPA (Research and Events Support Fund at Hospital de Clinicas de Porto Alegre); CNPq (National Council for Scientific and Technological Development)	FIPE-HCPA (Research and Events Support Fund at Hospital de Clinicas de Porto Alegre); CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by FIPE-HCPA (Research and Events Support Fund at Hospital de Clinicas de Porto Alegre) and CNPq (National Council for Scientific and Technological Development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EC, 2012, PUBLIC HEALTH NUTR, V15, P1705, DOI 10.1017/S1368980012002686; Agostoni C, 2008, J PEDIATR GASTR NUTR, V46, P99, DOI 10.1097/01.mpg.0000304464.60788.bd; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; Armstrong J, 2014, J HUM LACT, V30, P201, DOI 10.1177/0890334413516383; Balaban Geni, 2004, J Pediatr (Rio J), V80, P7, DOI 10.1590/S0021-75572004000100004; Bentley M, 1999, SOC SCI MED, V49, P1085, DOI 10.1016/S0277-9536(99)00198-7; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Bernier MO, 2000, HUM REPROD UPDATE, V6, P374, DOI 10.1093/humupd/6.4.374; Bica OC, 2014, BIRTH-ISS PERINAT C, V41, P39, DOI 10.1111/birt.12097; Bland RM, 2003, ARCH DIS CHILD, V88, P778, DOI 10.1136/adc.88.9.778; Bortolini GA, 2012, CAD SAUDE PUBLICA, V28, P1759, DOI 10.1590/S0102-311X2012000900014; BRASIL, 2009, PESQUISA NACL DEMOGR, P300; BRASIL, 2011, CADERNETA SAUDE CRIA, P94; BRASIL, 2005, GUIA ALIMENTAR CRIAN, P152; BRASIL . Ministerio da Saude. Secretaria de AtencAo a Saude. Departamento de Acoes Programaticas e Estrategicas, 2009, 2 PESQUISA PREVALENC; Burnier D, 2011, EUR J CLIN NUTR, V65, P196, DOI 10.1038/ejcn.2010.238; Cai W, 2014, CURR OPIN CLIN NUTR, V17, P278, DOI 10.1097/MCO.0000000000000042; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Louzada MLD, 2012, PEDIATRICS, V129, pE1477, DOI 10.1542/peds.2011-3063; de Oliveira LD, 2012, EARLY HUM DEV, V88, P357, DOI 10.1016/j.earlhumdev.2011.09.010; de Onis M, 2006, DEPT NUTR HLTH DEV W; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; de Siqueira RS, 2007, REV SAUDE PUBL, V41, P5, DOI 10.1590/S0034-89102007000100002; Dias de Oliveira Luciana, 2014, Nutr J, V13, P73, DOI 10.1186/1475-2891-13-73; Galloway AT, 2003, J AM DIET ASSOC, V103, P692, DOI 10.1053/jada.2003.50134; Gillespie B, 2006, INT BREASTFEED J, V1, DOI 10.1186/1746-4358-1-4; Grassley J, 2008, BIRTH-ISS PERINAT C, V35, P329, DOI 10.1111/j.1523-536X.2008.00260.x; Griffiths LJ, 2009, ARCH DIS CHILD, V94, P577, DOI 10.1136/adc.2008.137554; Guardamagna O, 2012, ITAL J PEDIATR, V38, DOI 10.1186/1824-7288-38-73; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Horta BL, 2013, SYSTEMATIC REV; Huh SY, 2011, PEDIATRICS, V127, pE544, DOI 10.1542/peds.2010-0740; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2010, ANTROPOMETRIA ESTADO; Jarvisalo MJ, 2009, EUR J CLIN NUTR, V63, P640, DOI 10.1038/ejcn.2008.17; Giugliani ERJ, 2008, EARLY HUM DEV, V84, P305, DOI 10.1016/j.earlhumdev.2007.08.001; Kac Gilberto, 2003, Cad Saude Publica, V19 Suppl 1, pS4; Khan AI, 2013, ACTA PAEDIATR, V102, P815, DOI 10.1111/apa.12282; Kramer MS, 2007, AM J CLIN NUTR, V86, P1717; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Liese AD, 2001, INT J OBESITY, V25, P1644, DOI 10.1038/sj.ijo.0801800; Lipworth L, 2000, JNCI-J NATL CANCER I, V92, P302, DOI 10.1093/jnci/92.4.302; Martin RM, 2005, ARTERIOSCL THROM VAS, V25, P1482, DOI 10.1161/01.ATV.0000170129.20609.49; Ministerio da Saude, 2011, OR COL AN DAD ANTR S; Monasta L, 2010, OBES REV, V11, P695, DOI 10.1111/j.1467-789X.2010.00735.x; Simon VGN, 2009, REV SAUDE PUBL, V43, P60, DOI 10.1590/S0034-89102009000100008; Nesbitt SA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-149; Noble S, 2006, J HUM NUTR DIET, V19, P303, DOI 10.1111/j.1365-277X.2006.00708.x; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Owen CG, 2006, AM J CLIN NUTR, V84, P1043, DOI 10.1093/ajcn/84.5.1043; Pearce J, 2013, INT J OBESITY, V37, P477, DOI 10.1038/ijo.2013.8; Pilkauskas NV, 2014, MATERN CHILD HLTH J, V18, P1955, DOI 10.1007/s10995-014-1441-z; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Scheiwe A, 2010, MATERN CHILD NUTR, V6, P328, DOI 10.1111/j.1740-8709.2009.00231.x; Stuebe AM, 2005, JAMA-J AM MED ASSOC, V294, P2601, DOI 10.1001/jama.294.20.2601; Susin LRO, 2005, REV SAUDE PUBL, V39, P141, DOI 10.1590/S0034-89102005000200001; Triches RM, 2005, REV SAUDE PUBL, V39, P541, DOI 10.1590/S0034-89102005000400004; Vitolo MR, 2012, J NUTR EDUC BEHAV, V44, P140, DOI 10.1016/j.jneb.2011.06.012; Weng SF, 2012, ARCH DIS CHILD, V97, P1019, DOI 10.1136/archdischild-2012-302263; WHO, 2006, INFANT YOUNG CHILD F; WHO, 2006, WHO ANTHRO 2005 BETA; WHO, 1998, COMPLEMENTARY FEEDIN; WHO UNICEF, 2003, GLOBAL STRATEGY INFA; Wilson AC, 1998, BMJ-BRIT MED J, V316, P21, DOI 10.1136/bmj.316.7124.21; World Health Organization (WHO), 2009, WHO ANTHROPLUS PERSO; Wu TC, 2009, PEDIATR NEONATOL, V50, P135, DOI 10.1016/S1875-9572(09)60051-6; Xu ZZ, 2010, BIOMETRICS, V66, P813, DOI 10.1111/j.1541-0420.2009.01364.x	67	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131884	10.1371/journal.pone.0131884	http://dx.doi.org/10.1371/journal.pone.0131884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161657	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300071
J	Zhao, J; Zhu, TH; Chen, WJ; Fan, BJ; He, LM; Yang, BC; Deng, ZH				Zhao, Jun; Zhu, Tianhui; Chen, Wenjie; Fan, Bao Jian; He, Liumei; Yang, Baocheng; Deng, Zhihui			Human Leukocyte Antigens-B and -C Loci Associated with Posner-Schlossman Syndrome in a Southern Chinese Population	PLOS ONE			English	Article							ACUTE ANTERIOR UVEITIS; OPEN-ANGLE GLAUCOMA; VASCULAR ENDOTHELIAL DYSFUNCTION; BIRDSHOT RETINOCHOROIDOPATHY; GLAUCOMATOCYCLITIC CRISIS; HLA; CYTOMEGALOVIRUS; SUSCEPTIBILITY; HLA-B27; FLOW	The etiology of Posner-Schlossman syndrome (PSS) remains unknown. The association of human leukocyte antigens (HLA) allelic diversity with PSS has been poorly investigated. To evaluate the association of allelic polymorphisms of class I HLA-A, -B and -C and class II HLA-DRB1 and -DQB1 with PSS, 100 unrelated patients with PSS and 128 age-and ethnically matched control subjects were recruited from a southern Chinese Han population. Polymorphisms in exons 2-4 for HLA-A, -B, -C loci, exon 2 for HLA-DRB1 and exons 2,3 for HLA-DQB1 were analyzed for association with PSS at allele and haplotype levels. The allele frequency of HLA-C* 1402 in PSS patients was significantly higher than that in controls (P = 0.002, OR = 4.12). This association survived the Bonferroni correction (P-C = 0.04). The allele frequency of HLA-B* 1301 in PSS patients was lower than that in the control group (P = 0.003, OR = 0.21), although this association did not survive the Bonferroni correction (P-C = 0.16). In PSS patients, the haplotype frequencies of HLA-A* 1101 similar to C* 1402 and B* 5101 similar to C* 1402 were higher than that in controls (P = 0.03, OR = 4.44; P = 0.02, OR = 3.20; respectively), while the HLA-B* 1301 similar to C* 0304 was lower than that in controls (P = 0.007, OR = 0.23), although these associations did not survive the Bonferroni correction (P-C > 0.16). This study for the first time demonstrated that polymorphisms at the HLA-B and HLA-C loci were nominally associated with PSS in the southern Chinese Han population. Our results suggest that HLA-C* 1402, A* 1101 similar to C* 1402 and B* 5101 similar to C* 1402 might be risk factors for PSS, whereas HLA-B* 1301 plus B* 1301 similar to C* 0304 might be protective factors against PSS, but even larger datasets are required to confirm these findings. Findings from this study provide valuable new clues for investigating the mechanisms and development of new diagnosis and treatment for PSS.	[Zhao, Jun; Zhu, Tianhui; Chen, Wenjie] Jinan Univ, Shenzhen Eye Hosp, Shenzhen Key Lab Ophthalmol, Shenzhen, Guangdong, Peoples R China; [Zhao, Jun] Shenzhen Univ, Sch Ophthalmol & Optometry, Shenzhen, Guangdong, Peoples R China; [Fan, Bao Jian] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA 02114 USA; [He, Liumei; Yang, Baocheng; Deng, Zhihui] Shenzhen Blood Ctr, Immunogenet Lab, Shenzhen, Guangdong, Peoples R China	Jinan University; Shenzhen University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Zhao, J (corresponding author), Jinan Univ, Shenzhen Eye Hosp, Shenzhen Key Lab Ophthalmol, Shenzhen, Guangdong, Peoples R China.	doctorzhaojun@163.com; zhihui_deng@aliyun.com	陈, 文杰·/HHN-5495-2022	陈, 文杰·/0000-0003-0556-7391; deng, zhihui/0000-0002-2046-1467	Shenzhen Science & Technology Project, People's Republic of China [201102188]; Guangdong Nature Science Foundation, People's Republic of China [S2013010013464]	Shenzhen Science & Technology Project, People's Republic of China; Guangdong Nature Science Foundation, People's Republic of China	The funders, Shenzhen Science & Technology Project, People's Republic of China (No. 201102188) and Guangdong Nature Science Foundation, People's Republic of China (No. S2013010013464), had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JZ is the author who received the funding.	Chang JH, 2005, SURV OPHTHALMOL, V50, P364, DOI 10.1016/j.survophthal.2005.04.003; Chee SP, 2008, AM J OPHTHALMOL, V146, P883, DOI 10.1016/j.ajo.2008.09.001; Chung YM, 2009, SCAND J RHEUMATOL, V38, P84, DOI 10.1080/03009740802385423; Donvito B, 2010, INVEST OPHTH VIS SCI, V51, P2525, DOI 10.1167/iovs.09-4329; Ferreri G, 1998, ACTA OPHTHALMOL SCAN, V76, P17; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Gil-Carrasco F, 1999, AM J OPHTHALMOL, V128, P297, DOI 10.1016/S0002-9394(99)00180-4; GILCARRASCO F, 1994, AM J OPHTHALMOL, V118, P744, DOI 10.1016/S0002-9394(14)72553-X; HIROSE S, 1985, ARCH OPHTHALMOL-CHIC, V103, P1837; Jap A, 2001, OPHTHALMOLOGY, V108, P913, DOI 10.1016/S0161-6420(01)00551-6; Kang EH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3292; Kim Tae-Hyup, 2012, Korean J Ophthalmol, V26, P473, DOI 10.3341/kjo.2012.26.6.473; Knox D L, 1988, Trans Am Ophthalmol Soc, V86, P473; LEHOANG P, 1992, AM J OPHTHALMOL, V113, P33, DOI 10.1016/S0002-9394(14)75749-6; Levinson RD, 2004, AM J OPHTHALMOL, V138, P631, DOI 10.1016/j.ajo.2004.06.016; MIELANTS H, 1990, J RHEUMATOL, V17, P841; Oruc S, 2003, OCUL IMMUNOL INFLAMM, V11, P287, DOI 10.1076/ocii.11.4.287.18270; POSNER A, 1948, ARCH OPHTHALMOL-CHIC, V39, P517; Sacca SC, 2005, ARCH OPHTHALMOL-CHIC, V123, P458, DOI 10.1001/archopht.123.4.458; Shazly TA, 2011, SEMIN OPHTHALMOL, V26, P282, DOI 10.3109/08820538.2011.605821; Shen SC, 2010, INVEST OPHTH VIS SCI, V51, P272, DOI 10.1167/iovs.09-3849; Su WW, 2008, OPHTHALMOLOGY, V115, P1173, DOI 10.1016/j.ophtha.2007.10.026; Su WW, 2006, INVEST OPHTH VIS SCI, V47, P3390, DOI 10.1167/iovs.06-0024; Takusagawa Hana L, 2011, Int Ophthalmol Clin, V51, P105, DOI 10.1097/IIO.0b013e31822d6ab4; Teoh SCB, 2005, EYE, V19, P1338, DOI 10.1038/sj.eye.6701757; van Boxtel LAA, 2007, OPHTHALMOLOGY, V114, P1358, DOI 10.1016/j.ophtha.2006.09.035; Yabuki K, 2000, INT OPHTHALMOL CLIN, V40, P19, DOI 10.1097/00004397-200004000-00004; YAMAMOTO S, 1995, AM J OPHTHALMOL, V119, P796, DOI 10.1016/S0002-9394(14)72788-6; Zamecki KJ, 2010, AM J OPHTHALMOL, V149, P189, DOI 10.1016/j.ajo.2009.09.018	29	9	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132179	10.1371/journal.pone.0132179	http://dx.doi.org/10.1371/journal.pone.0132179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161794	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300102
J	Emerson, KJ; Conn, JE; Bergo, ES; Randel, MA; Sallum, MAM				Emerson, Kevin J.; Conn, Jan E.; Bergo, Eduardo S.; Randel, Melissa A.; Sallum, Maria Anice M.			Brazilian Anopheles darlingi Root (Diptera: Culicidae) Clusters by Major Biogeographical Region	PLOS ONE			English	Article							NEOTROPICAL MALARIA VECTOR; POPULATION-STRUCTURE; SOUTH-AMERICA; GENETIC-STRUCTURE; DNA-SEQUENCES; MARKERS; GAMBIAE; DIFFERENTIATION; PHYLOGEOGRAPHY; POLYMORPHISM	The major drivers of the extensive biodiversity of the Neotropics are proposed to be geological and tectonic events together with Pliocene and Pleistocene environmental and climatic change. Geographical barriers represented by the rivers Amazonas/Solimoes, the Andes and the coastal mountain ranges in eastern Brazil have been hypothesized to lead to diversification within the primary malaria vector, Anopheles(Nyssorhynchus) darlingi Root, which primarily inhabits rainforest. To test this biogeographical hypothesis, we analyzed 786 single nucleotide polymorphisms (SNPs) in 12 populations of An. darlingi from across the complex Brazilian landscape. Both model-based (STRUCTURE) and non-model-based (Principal Components and Discriminant Analysis) analysis of population structure detected three major genetic clusters that correspond with newly described Neotropical biogeographical regions: 1) Atlantic Forest province (= southeast population); 2) Parana Forest province (= West Atlantic forest population, with one Chacoan population -SP); and 3) Brazilian dominion population (= Amazonian population with one Chacoan population -TO). Significant levels of pairwise genetic divergences were found among the three clusters, allele sharing among clusters was negligible, and geographical distance did not contribute to differentiation. We infer that the Atlantic forest coastal mountain range limited dispersal between the Atlantic Forest province and the Parana Forest province populations, and that the large, diagonal open vegetation region of the Chacoan dominion dramatically reduced dispersal between the Parana and Brazilian dominion populations. We hypothesize that the three genetic clusters may represent three putative species.	[Emerson, Kevin J.] St Marys Coll Maryland, Dept Biol, St Marys City, MD 20686 USA; [Conn, Jan E.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Conn, Jan E.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA; [Bergo, Eduardo S.] Secretaria Estado Saude Sao Paulo, Superintendencia Controle Endemias, Araraquara, SP, Brazil; [Randel, Melissa A.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Sallum, Maria Anice M.] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, BR-01255 Sao Paulo, Brazil	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Oregon; Universidade de Sao Paulo	Emerson, KJ (corresponding author), St Marys Coll Maryland, Dept Biol, St Marys City, MD 20686 USA.	kjemerson@smcm.edu	Sallum, Maria Anice Mureb/B-8537-2012; Emerson, Kevin/AAC-8207-2020; Bergo, Eduardo/F-5374-2014	Sallum, Maria Anice Mureb/0000-0002-7051-2891; Emerson, Kevin/0000-0003-3283-0693; Bergo, Eduardo/0000-0003-4928-0368; Conn, Jan/0000-0002-5301-7020	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/20397-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [301666/2011-3]; St. Mary's College of Maryland; NIH [AI R0154139, AI R01110112]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054139, R01AI110112] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); St. Mary's College of Maryland; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP Grant no. 2011/20397-7) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Grant no. 301666/2011-3) was provided to MAMS and ESB; additionally, support was provided by St. Mary's College of Maryland to KJE and by NIH AI R0154139 and NIH AI R01110112 to JEC.	Alves LF, 2010, FOREST ECOL MANAG, V260, P679, DOI 10.1016/j.foreco.2010.05.023; Amorim DS, 1996, NEOTROPICAL BIOGEOGR, P183; Angella AF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-203; Armstrong KE, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00362; Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276; Cassone BJ, 2014, MOL ECOL, V23, P2242, DOI 10.1111/mec.12733; Castro MC, 2011, ECOLOGIES POLITICS H, P296; CATAO E, 2014, INT J MICROBIOL, V2014, P12, DOI DOI 10.1155/2014/156341; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Conn JE, 2006, AM J TROP MED HYG, V74, P798, DOI 10.4269/ajtmh.2006.74.798; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fitzpatrick SW, 2009, MOL ECOL, V18, P2877, DOI 10.1111/j.1365-294X.2009.04245.x; Forattini O.P., 2002, CULICIDOLOGIA MED ID; FORATTINI OP, 1987, REV SAUDE PUBL, V21, P291, DOI 10.1590/S0034-89101987000400002; GALVAO A. A., 1937, Revista de Biologia e Hygiene, V8, P37; Gutierrez LA, 2010, AM J TROP MED HYG, V83, P38, DOI 10.4269/ajtmh.2010.09-0381; Hahn MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085725; Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; KREUTZER RD, 1972, MOSQ NEWS, V32, P555; Lane J, 1939, CATALOGO MOSQUITOS N; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lounibos L. Philip, 2000, American Entomologist, V46, P238; Luca F, 2011, GENOME RES, V21, P1087, DOI 10.1101/gr.119792.110; Malafronte RS, 1999, J MED ENTOMOL, V36, P631, DOI 10.1093/jmedent/36.5.631; Manguin S, 1999, AM J TROP MED HYG, V60, P364, DOI 10.4269/ajtmh.1999.60.364; Marinotti O, 2013, NUCL ACIDS RES; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Merz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072262; Mirabello L, 2006, HEREDITY, V96, P311, DOI 10.1038/sj.hdy.6800805; Mirabello Lisa, 2008, BMC Ecology, V8, P3, DOI 10.1186/1472-6785-8-3; Morrone J. J., 1996, Zoologische Mededelingen (Leiden), V70, P1; Morrone JJ, 2014, ZOOTAXA, V 3782, P1, DOI 10.11646/zootaxa.3782.1.1; Morrone JJ, 2014, CLADISTICS, V30, P202, DOI 10.1111/cla.12039; Motoki MT, 2012, INFECT GENET EVOL, V12, P1246, DOI 10.1016/j.meegid.2012.04.002; Nihei SS, 2007, SYST ENTOMOL, V32, P477, DOI 10.1111/j.1365-3113.2006.00376.x; O'Loughlin SM, 2014, MOL BIOL EVOL, V31, P889, DOI 10.1093/molbev/msu040; Pedro PM, 2009, BIOL J LINN SOC, V97, P854, DOI 10.1111/j.1095-8312.2009.01226.x; Prado CPA, 2012, MOL ECOL, V21, P921, DOI 10.1111/j.1365-294X.2011.05409.x; Pritchard JK, 2000, GENETICS, V155, P945; Reidenbach KR, 2012, GENOME BIOL EVOL, V4, P1202, DOI 10.1093/gbe/evs095; Rona LDP, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-91; Rona LDP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-33; Root FM, 1926, AM J HYG, V6, P684, DOI 10.1093/oxfordjournals.aje.a120038; ROSAFREITAS MG, 1992, J AM MOSQUITO CONTR, V8, P357; Scarpassa VM, 2007, MEM I OSWALDO CRUZ, V102, P319, DOI 10.1590/S0074-02762007005000045; Silva Daniel P., 2014, PLoS ONE, V9, pe113246, DOI 10.1371/journal.pone.0113246; Silva JMC, 2005, MATA ATLANTICA BIODI; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	55	35	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0130773	10.1371/journal.pone.0130773	http://dx.doi.org/10.1371/journal.pone.0130773			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172559	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900010
J	Konnikova, Y; Zaman, MM; Makda, M; D'Onofrio, D; Freedman, SD; Martin, CR				Konnikova, Yelizaveta; Zaman, Munir M.; Makda, Meher; D'Onofrio, Danila; Freedman, Steven D.; Martin, Camilia R.			Late Enteral Feedings Are Associated with Intestinal Inflammation and Adverse Neonatal Outcomes	PLOS ONE			English	Article							NECROTIZING ENTEROCOLITIS; INFANTS BORN; 28TH WEEK; COLONIZATION; RETINOPATHY; NUTRITION; GUT	Background Morbidities of impaired immunity and dysregulated inflammation are common in preterm infants. Postnatal Intestinal development plays a critical role in the maturation of the immune system and is, in part, driven by exposure to an enteral diet. Objective The aim of this study was to evaluate the influence of the timing of the first enteral feeding on intestinal inflammation and risk of disease. Methods 30 infants <33 weeks' gestation were studied. Maternal and infant data were abstracted from the medical record. Single and multiplex ELISA assays quantified cytokines from fecal and serum samples at two weeks postnatal age. Results A delay in enteral feedings after the third postnatal day is associated with a 4.5 (95% CI 1.8-11.5, p=0.002) fold increase in chronic lung disease, 2.9 (1.1-7.8, p=0.03) fold increase in retinopathy of prematurity, and 3.4 (1.2-9.8, p=0.02) fold increase in multiple comorbidities compared to infants fed on or before the third day. Additionally, a delay in the initiation of feedings is associated with increased fecal IL-8 levels and a decreased IL-10: IL-8 ratio. Conclusions A delay in enteral feeding is associated with intestinal inflammation and increased risks of morbidities. To improve neonatal outcomes, early nutritional practices need to be reevaluated.	[Konnikova, Yelizaveta] Boston Childrens Hosp, Dept Pediat, Div Newborn Med, Boston, MA USA; [Zaman, Munir M.; Makda, Meher; D'Onofrio, Danila; Freedman, Steven D.] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA; [Freedman, Steven D.; Martin, Camilia R.] Beth Israel Deaconess Med Ctr, Div Translat Res, Boston, MA 02215 USA; [Martin, Camilia R.] Beth Israel Deaconess Med Ctr, Dept Neonatol, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Martin, CR (corresponding author), Beth Israel Deaconess Med Ctr, Div Translat Res, Boston, MA 02215 USA.	cmartin1@bidmc.harvard.edu		Konnikova, Yelizaveta/0000-0003-4804-5497	Program for Faculty Development and Diversity of Harvard Catalyst, Harvard Clinical and Translational Science Center, National Center for Research Resources [UL1 RR 025758]; Program for Faculty Development and Diversity of Harvard Catalyst, Harvard Clinical and Translational Science Center, National Center for Research Resources (Harvard University and its affiliated academic health care centers) [1R01DK104346-01]; Charles H. Hood Foundation; Alden Trust; Gerber Foundation	Program for Faculty Development and Diversity of Harvard Catalyst, Harvard Clinical and Translational Science Center, National Center for Research Resources; Program for Faculty Development and Diversity of Harvard Catalyst, Harvard Clinical and Translational Science Center, National Center for Research Resources (Harvard University and its affiliated academic health care centers); Charles H. Hood Foundation; Alden Trust; Gerber Foundation	CRM was supported by the Program for Faculty Development and Diversity of Harvard Catalyst, Harvard Clinical and Translational Science Center, National Center for Research Resources (award UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers), 1R01DK104346-01, the Charles H. Hood Foundation, the Alden Trust, the Gerber Foundation, and the generous philanthropic donors to the Infant Health Research Program at Beth Israel Deaconess Medical Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the National Center for Research Resources, or the National Institutes of Health. None of the funding bodies had any role in the study design or conduct; data collection, management, analysis or interpretation; or manuscript preparation, review, or approval.	Ambalavanan N, 2009, PEDIATRICS, V123, P1132, DOI 10.1542/peds.2008-0526; Arranz E, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/865638; Ballabh P, 2010, PEDIATR RES, V67, P1, DOI 10.1203/PDR.0b013e3181c1b176; Bhandari V, 2014, BIRTH DEFECTS RES A, V100, P189, DOI 10.1002/bdra.23220; Bose C, 2011, PEDIATR RES, V69, P347, DOI 10.1203/PDR.0b013e31820a58f3; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Deng WB, 2008, ARCH NEUROL-CHICAGO, V65, P1291, DOI 10.1001/archneur.65.10.1291; Good WV, 2005, PEDIATRICS, V116, P15, DOI 10.1542/peds.2004-1413; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Holman RC, 2006, PAEDIATR PERINAT EP, V20, P498, DOI 10.1111/j.1365-3016.2006.00756.x; Jantscher-Krenn E, 2012, GUT, V61, P1417, DOI 10.1136/gutjnl-2011-301404; Jung C, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/823710; Kalish BT, 2013, AM J PHYSIOL-GASTR L, V305, pG818, DOI 10.1152/ajpgi.00106.2013; Kudsk KA, 2002, AM J SURG, V183, P390, DOI 10.1016/S0002-9610(02)00821-8; Lee J, 2012, SEMIN FETAL NEONAT M, V17, P26, DOI 10.1016/j.siny.2011.08.007; Leviton A, 2011, CYTOKINE, V56, P392, DOI 10.1016/j.cyto.2011.07.014; Leviton A, 2011, J PEDIATR-US, V158, P897, DOI 10.1016/j.jpeds.2010.11.059; Leviton A, 2010, ACTA PAEDIATR, V99, P1795, DOI 10.1111/j.1651-2227.2010.01973.x; Martin CR, 2011, J PEDIATR-US, V159, P743, DOI 10.1016/j.jpeds.2011.04.039; Neu J, 2007, AM J CLIN NUTR, V85, p629S, DOI 10.1093/ajcn/85.2.629S; Niinikoski H, 2004, J NUTR, V134, P1467, DOI 10.1093/jn/134.6.1467; O'Shea TM, 2012, J PEDIATR-US, V160, P395, DOI 10.1016/j.jpeds.2011.08.069; Ostman S, 2006, EUR J IMMUNOL, V36, P2336, DOI 10.1002/eji.200535244; Payne NR, 2010, PEDIATRICS, V125, P437, DOI 10.1542/peds.2009-1272; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Sangild PT, 2006, GASTROENTEROLOGY, V130, P1776, DOI 10.1053/j.gastro.2006.02.026; Silveira RC, 2011, INVEST OPHTH VIS SCI, V52, P1297, DOI 10.1167/iovs.10-6279; Stoll B, 2010, J NUTR, V140, P2193, DOI 10.3945/jn.110.125799; Taschuk Ryan, 2012, Animal Health Research Reviews, V13, P129, DOI 10.1017/S1466252312000096; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838; Wereszczynska-Siemiatkowska U, 2013, PANCREAS, V42, P640, DOI 10.1097/MPA.0b013e318271bb61; Wildhaber BE, 2005, J SURG RES, V123, P8, DOI 10.1016/j.jss.2004.06.015	32	19	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132924	10.1371/journal.pone.0132924	http://dx.doi.org/10.1371/journal.pone.0132924			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172126	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900102
J	Leghmar, K; Cenac, N; Rolland, M; Martin, H; Rauwel, B; Bertrand-Michel, J; Le Faouder, P; Benard, M; Casper, C; Davrinche, C; Fournier, T; Chavanas, S				Leghmar, Kaoutar; Cenac, Nicolas; Rolland, Maude; Martin, Helene; Rauwel, Benjamin; Bertrand-Michel, Justine; Le Faouder, Pauline; Benard, Melinda; Casper, Charlotte; Davrinche, Christian; Fournier, Thierry; Chavanas, Stephane			Cytomegalovirus Infection Triggers the Secretion of the PPAR gamma Agonists 15-Hydroxyeicosatetraenoic Acid (15-HETE) and 13-Hydroxyoctadecadienoic Acid (13-HODE) in Human Cytotrophoblasts and Placental Cultures	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; INTRAUTERINE GROWTH RESTRICTION; CELL INVASION; IN-VITRO; MECHANISMS; LIPIDS; PREECLAMPSIA; PREGNANCY; ATHEROSCLEROSIS; TRANSMISSION	Introduction Congenital infection by human cytomegalovirus (HCMV) is a leading cause of congenital abnormalities of the central nervous system. Placenta infection by HCMV allows for viral spread to fetus and may result in intrauterine growth restriction, preeclampsia-like symptoms, or miscarriages. We previously reported that HCMV activates peroxisome proliferator-activated receptor gamma (PPAR gamma) for its own replication in cytotrophoblasts. Here, we investigated the molecular bases of PPAR. activation in infected cytotrophoblasts. Results We show that onboarded cPLA(2) carried by HCMV particles is required for effective PPAR. activation in infected HIPEC cytotrophoblasts, and for the resulting inhibition of cell migration. Natural PPAR. agonists are generated by PLA(2) driven oxidization of linoleic and arachidonic acids. Therefore, using HPLC coupled with mass spectrometry, we disclosed that cellular and secreted levels of 13-hydroxyoctadecadienoic acid (13-HODE) and 15-hydroxyeicosatetraenoic acid (15-HETE) were significantly increased in and from HIPEC cytotrophoblasts at soon as 6 hours post infection. 13-HODE treatment of uninfected HIPEC recapitulated the effect of infection (PPAR gamma activation, migration impairment). We found that infection of histocultures of normal, first-term, human placental explants resulted in significantly increased levels of secreted 15-HETE and 13-HODE. Conclusion Our findings reveal that 15-HETE and 13-HODE could be new pathogenic effectors of HCMV congenital infection They provide a new insight about the pathogenesis of congenital infection by HCMV.	[Leghmar, Kaoutar; Cenac, Nicolas; Rolland, Maude; Martin, Helene; Rauwel, Benjamin; Benard, Melinda; Casper, Charlotte; Davrinche, Christian; Chavanas, Stephane] INSERM U1043, Ctr Physiopathol Toulouse Purpan, Toulouse, France; [Leghmar, Kaoutar; Cenac, Nicolas; Rolland, Maude; Martin, Helene; Rauwel, Benjamin; Benard, Melinda; Casper, Charlotte; Davrinche, Christian; Chavanas, Stephane] CNRS U5282, Toulouse, France; [Leghmar, Kaoutar; Cenac, Nicolas; Rolland, Maude; Martin, Helene; Rauwel, Benjamin; Benard, Melinda; Casper, Charlotte; Davrinche, Christian; Chavanas, Stephane] Univ Toulouse 3, F-31062 Toulouse, France; [Bertrand-Michel, Justine; Le Faouder, Pauline] MetaToul Lipid Facil, Toulouse, France; [Bertrand-Michel, Justine; Le Faouder, Pauline] I2MC INSERM U1048, Toulouse, France; [Benard, Melinda; Casper, Charlotte] Childrens Hosp, Neonatal Unit, Toulouse, France; [Fournier, Thierry] INSERM UMR S1139, Paris, France; [Fournier, Thierry] Univ Paris 05, Paris, France; [Fournier, Thierry] PremUP, Paris, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Chavanas, S (corresponding author), INSERM U1043, Ctr Physiopathol Toulouse Purpan, Toulouse, France.	stephane.chavanas@inserm.fr	Cenac, Nicolas/P-4557-2017; Rolland, Maude/AAA-1756-2022; Fournier, Thierry C/E-5836-2016	Cenac, Nicolas/0000-0002-1552-7812; Rolland, Maude/0000-0002-8858-8915; chavanas, stephane/0000-0003-4323-2656; Tscherning, Charlotte/0000-0001-7111-8979; Fournier, Thierry/0000-0002-7515-339X	Agence Nationale de la Recherche, HCMV-PPAR-PREG	Agence Nationale de la Recherche, HCMV-PPAR-PREG(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche, HCMV-PPAR-PREG, http://www.agence-nationale-recherche.fr/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allal C, 2004, J VIROL, V78, P7717, DOI 10.1128/JVI.78.14.7717-7726.2004; Alsalem M, 2013, BRIT J PHARMACOL, V168, P1961, DOI 10.1111/bph.12092; Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629; Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002; Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08; Coutant F, 2004, J IMMUNOL, V172, P54, DOI 10.4049/jimmunol.172.1.54; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Fei J, 2012, ATHEROSCLEROSIS, V222, P395, DOI 10.1016/j.atherosclerosis.2012.02.040; Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000; Fournier T, 2007, PLACENTA, V28, P65, DOI 10.1016/j.placenta.2006.04.009; Gunthorpe MJ, 2008, CURR PHARM DESIGN, V14, P32; Holdsworth-Carson SJ, 2010, PLACENTA, V31, P222, DOI 10.1016/j.placenta.2009.12.009; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Johnson RD, 1998, AM J OBSTET GYNECOL, V178, P54, DOI 10.1016/S0002-9378(98)70626-X; Le Faouder P, 2013, J CHROMATOGR B, V932, P123, DOI 10.1016/j.jchromb.2013.06.014; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Lopez H, 2011, PLACENTA, V32, P522, DOI 10.1016/j.placenta.2011.04.016; Maidji E, 2010, AM J PATHOL, V177, P1298, DOI 10.2353/ajpath.2010.091210; Majed BH, 2012, PHARMACOL REV, V64, P540, DOI 10.1124/pr.111.004770; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Pavan L, 2004, ENDOCRINOLOGY, V145, P4583, DOI 10.1210/en.2003-1747; Pavan L, 2004, J CLIN ENDOCR METAB, V89, P1969, DOI 10.1210/jc.2003-032042; Pavan L, 2003, CARCINOGENESIS, V24, P1325, DOI 10.1093/carcin/bgg074; Pereira L, 2005, TRENDS MICROBIOL, V13, P164, DOI 10.1016/j.tim.2005.02.009; Pereira L, 2014, J INFECT DIS, V209, P1573, DOI 10.1093/infdis/jiu019; Pereira L, 2011, J INFECT DIS, V203, P1510, DOI 10.1093/infdis/jir126; Rak-Mardyla A, 2014, THERIOGENOLOGY, V82, P1, DOI 10.1016/j.theriogenology.2014.02.016; Rauwel B, 2010, J VIROL, V84, P2946, DOI 10.1128/JVI.01779-09; Schild RL, 2002, J CLIN ENDOCR METAB, V87, P1105, DOI 10.1210/jc.87.3.1105; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Staff AC, 2010, HYPERTENSION, V56, P1026, DOI 10.1161/HYPERTENSIONAHA.110.157743; Subbarayan V, 2006, ONCOGENE, V25, P6015, DOI 10.1038/sj.onc.1209617; Torry DS, 1999, AM J REPROD IMMUNOL, V41, P79; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Wang Y, 2011, PROSTAGLANDINS LEUKO, V86, P79; Winkler K, 2000, J CLIN ENDOCR METAB, V85, P4543, DOI 10.1210/jc.85.12.4543; Wittwer J, 2007, PROSTAG LEUKOTR ESS, V77, P67, DOI 10.1016/j.plefa.2007.08.001; Wu MY, 2013, EUR J PHARMACOL, V714, P388, DOI 10.1016/j.ejphar.2013.07.010; Yuan DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096510	39	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132627	10.1371/journal.pone.0132627	http://dx.doi.org/10.1371/journal.pone.0132627			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171612	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900065
J	Schuback, N; Schallenberg, C; Duckham, C; Maldonado, MT; Tortell, PD				Schuback, Nina; Schallenberg, Christina; Duckham, Carolyn; Maldonado, Maria T.; Tortell, Philippe D.			Interacting Effects of Light and Iron Availability on the Coupling of Photosynthetic Electron Transport and CO2-Assimilation in Marine Phytoplankton	PLOS ONE			English	Article							REPETITION RATE FLUOROMETRY; DUNALIELLA-TERTIOLECTA CHLOROPHYCEAE; PRIMARY PRODUCTION-RATES; PHOTOSYSTEM-II; PRIMARY PRODUCTIVITY; CARBON-FIXATION; MICROALGAL PHOTOSYNTHESIS; QUENCHING MECHANISMS; CLIMATE-CHANGE; QUANTUM YIELD	Iron availability directly affects photosynthesis and limits phytoplankton growth over vast oceanic regions. For this reason, the availability of iron is a crucial variable to consider in the development of active chlorophyll a fluorescence based estimates of phytoplankton primary productivity. These bio-optical approaches require a conversion factor to derive ecologically-relevant rates of CO2-assimilation from estimates of electron transport in photosystem II. The required conversion factor varies significantly across phytoplankton taxa and environmental conditions, but little information is available on its response to iron limitation. In this study, we examine the role of iron limitation, and the interacting effects of iron and light availability, on the coupling of photosynthetic electron transport and CO2-assimilation in marine phytoplankton. Our results show that excess irradiance causes increased decoupling of carbon fixation and electron transport, particularly under iron limiting conditions. We observed that reaction center II specific rates of electron transport (ETRRCII, mol e- mol RCII-1 s(-1)) increased under iron limitation, and we propose a simple conceptual model for this observation. We also observed a strong correlation between the derived conversion factor and the expression of non-photochemical quenching. Utilizing a dataset from in situ phytoplankton assemblages across a coastal - oceanic transect in the Northeast subarctic Pacific, this relationship was used to predict ETRRCII: CO2-assimilation conversion factors and carbon-based primary productivity from FRRF data, without the need for any additional measurements.	[Schuback, Nina; Duckham, Carolyn; Maldonado, Maria T.; Tortell, Philippe D.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada; [Schallenberg, Christina] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada; [Tortell, Philippe D.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of British Columbia; University of Victoria; University of British Columbia	Schuback, N (corresponding author), Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada.	nschuback@eos.ubc.ca	Maldonado, Maria T/N-2877-2017; Schallenberg, Christina/N-4187-2017	Maldonado, Maria T/0000-0001-8134-9375; Schallenberg, Christina/0000-0002-3073-7500; Tortell, Philippe/0000-0003-0212-2151	National Sciences and Engineering Research Council of Canada; UBC Peter Wall Institute for Advanced Studies	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); UBC Peter Wall Institute for Advanced Studies	This research was funded by grants to PDT and MTM from the National Sciences and Engineering Research Council of Canada, and from support from the UBC Peter Wall Institute for Advanced Studies to PDT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Arrigo KR, 2010, INTEGR COMP BIOL, V50, P950, DOI 10.1093/icb/icq021; Babin M, 1996, DEEP-SEA RES PT I, V43, P1241, DOI 10.1016/0967-0637(96)00058-1; Barranguet C, 2000, MAR ECOL PROG SER, V204, P39, DOI 10.3354/meps204039; Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; BEARDALL J, 1989, AQUAT BOT, V34, P105, DOI 10.1016/0304-3770(89)90052-1; Behrenfeld MJ, 2009, BIOGEOSCIENCES, V6, P779, DOI 10.5194/bg-6-779-2009; Behrenfeld MJ, 2008, PHILOS T R SOC B, V363, P2687, DOI 10.1098/rstb.2008.0019; Behrenfeld MJ, 2013, ANNU REV MAR SCI, V5, P217, DOI 10.1146/annurev-marine-121211-172356; Berges JA, 1996, PLANT PHYSIOL, V110, P689, DOI 10.1104/pp.110.2.689; BOOTH BC, 1988, MAR BIOL, V97, P275, DOI 10.1007/BF00391313; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Boyd PW, 2001, DEEP-SEA RES PT II, V48, P2529, DOI 10.1016/S0967-0645(01)00007-8; Boyd PW, 1997, OCEANOGR LIT REV, V44; BRAND L E, 1981, Journal of Plankton Research, V3, P193, DOI 10.1093/plankt/3.2.193; Briat JF, 2007, CURR OPIN PLANT BIOL, V10, P276, DOI 10.1016/j.pbi.2007.04.003; Cardol P, 2008, P NATL ACAD SCI USA, V105, P7881, DOI 10.1073/pnas.0802762105; Cardol P, 2011, BBA-BIOENERGETICS, V1807, P912, DOI 10.1016/j.bbabio.2010.12.004; Chappell PD, 2015, ISME J, V9, P592, DOI 10.1038/ismej.2014.171; Chavez FP, 2011, ANNU REV MAR SCI, V3, P227, DOI 10.1146/annurev.marine.010908.163917; Cheah W, 2011, DEEP-SEA RES PT II, V58, P2179, DOI 10.1016/j.dsr2.2011.05.023; Corno G, 2006, J PHYCOL, V42, P51, DOI 10.1111/j.1529-8817.2006.00163.x; Debes H, 2008, J MARINE SYST, V74, P686, DOI 10.1016/j.jmarsys.2008.07.004; DUBINSKY Z, 1986, PLANT CELL PHYSIOL, V27, P1335, DOI 10.1093/oxfordjournals.pcp.a077232; DUYSENS L. N. M., 1963, P353; Estevez-Blanco P, 2006, J PLANKTON RES, V28, P1153, DOI 10.1093/plankt/fbl046; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FALKOWSKI PG, 1981, PLANT PHYSIOL, V68, P969, DOI 10.1104/pp.68.4.969; FALKOWSKI PG, 1986, PLANT PHYSIOL, V81, P310, DOI 10.1104/pp.81.1.310; Feikema WO, 2006, BBA-BIOENERGETICS, V1757, P829, DOI 10.1016/j.bbabio.2006.06.003; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Fraser JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059861; Fujiki T, 2007, J PLANKTON RES, V29, P199, DOI 10.1093/plankt/fbm007; Fujiki T, 2011, J OCEANOGR, V67, P295, DOI 10.1007/s10872-011-0028-1; GEIDER RJ, 1994, PHOTOSYNTH RES, V39, P275, DOI 10.1007/BF00014588; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gilbert M, 2000, PHOTOSYNTHETICA, V38, P111, DOI 10.1023/A:1026708327185; Goss R, 2015, J PLANT PHYSIOL, V172, P13, DOI 10.1016/j.jplph.2014.03.004; Goto N, 2008, FUND APPL LIMNOL, V172, P121, DOI 10.1127/1863-9135/2008/0172-0121; GREENE RM, 1994, LIMNOL OCEANOGR, V39, P1061, DOI 10.4319/lo.1994.39.5.1061; GREENE RM, 1992, PLANT PHYSIOL, V100, P565, DOI 10.1104/pp.100.2.565; GREENE RM, 1991, LIMNOL OCEANOGR, V36, P1772, DOI 10.4319/lo.1991.36.8.1772; Grossman AR, 2010, J PHYCOL, V46, P629, DOI 10.1111/j.1529-8817.2010.00852.x; Halsey KH, 2015, ANNU REV MAR SCI, V7, P265, DOI 10.1146/annurev-marine-010814-015813; Halsey KH, 2013, NEW PHYTOL, V198, P1030, DOI 10.1111/nph.12209; Halsey KH, 2011, J PHYCOL, V47, P66, DOI 10.1111/j.1529-8817.2010.00945.x; Halsey KH, 2010, PHOTOSYNTH RES, V103, P125, DOI 10.1007/s11120-009-9526-z; Hancke K, 2008, J PHYCOL, V44, P501, DOI 10.1111/j.1529-8817.2008.00487.x; Hays GC, 2005, TRENDS ECOL EVOL, V20, P337, DOI 10.1016/j.tree.2005.03.004; Hopkinson BM, 2007, LIMNOL OCEANOGR, V52, P2540, DOI 10.4319/lo.2007.52.6.2540; Horton P, 2012, PHILOS T R SOC B, V367, P3455, DOI 10.1098/rstb.2012.0069; Huot Y, 2010, DEVEL APPL PHYCOL, V4, P31, DOI 10.1007/978-90-481-9268-7_3; Imre V, 2011, PHYSIOL PLANTARUM, V142, P6, DOI 10.1111/j.1399-3054.2011.01454.x; Ivanov AG, 2008, PHOTOSYNTH RES, V98, P565, DOI 10.1007/s11120-008-9365-3; Johnson WK, 2005, DEEP-SEA RES PT II, V52, P933, DOI 10.1016/j.dsr2.2004.08.017; Kaiblinger C, 2006, PHOTOSYNTH RES, V88, P19, DOI 10.1007/s11120-005-9018-8; KITAJIMA M, 1975, BIOCHIM BIOPHYS ACTA, V376, P105, DOI 10.1016/0005-2728(75)90209-1; Knap A., 1996, 19 JGOFS UNESCO; KOLBER Z, 1993, LIMNOL OCEANOGR, V38, P1646, DOI 10.4319/lo.1993.38.8.1646; KOLBER ZS, 1994, NATURE, V371, P145, DOI 10.1038/371145a0; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Krause GH, 2003, LIGHT HARVESTING ANT, P373; Kromkamp JC, 2008, EUR J PHYCOL, V43, P327, DOI 10.1080/09670260802080895; Kromkamp JC, 2011, EUROPEAN J PHYCOLOGY, P53; Laney SR, 2006, THESIS; Laureau C, 2013, PLANT CELL ENVIRON, V36, P1296, DOI 10.1111/pce.12059; Lawrenz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058137; LAWS EA, 1991, DEEP-SEA RES, V38, P143, DOI 10.1016/0198-0149(91)90059-O; Lee Yong Woo, 2011, Sea (Seoul), V16, P117; LEWIS MR, 1983, MAR ECOL PROG SER, V13, P99, DOI 10.3354/meps013099; Macey AI, 2014, LIMNOL OCEANOGR, V59, P1853, DOI 10.4319/lo.2014.59.6.1853; Mackey KRM, 2008, LIMNOL OCEANOGR, V53, P900, DOI 10.4319/lo.2008.53.3.0900; Mackey KRM, 2010, RESPONSE MARINE PHYT; Maldonado MT, 2006, LIMNOL OCEANOGR, V51, P1729, DOI 10.4319/lo.2006.51.4.1729; Marchetti A, 2006, DEEP-SEA RES PT II, V53, P2131, DOI 10.1016/j.dsr2.2006.05.032; Marra J, 2009, AQUAT MICROB ECOL, V56, P123, DOI 10.3354/ame01306; MAUZERALL D, 1989, BIOCHIM BIOPHYS ACTA, V974, P119, DOI 10.1016/S0005-2728(89)80365-2; McDonald AE, 2011, BBA-BIOENERGETICS, V1807, P954, DOI 10.1016/j.bbabio.2010.10.024; McKew BA, 2013, NEW PHYTOL, V200, P74, DOI 10.1111/nph.12373; Melrose DC, 2006, MAR ECOL PROG SER, V311, P37, DOI 10.3354/meps311037; Mitchell B.G., 2002, OCEAN OPTICS PROTOCO, V3, P231; Miyake C, 2003, ADV PHOTO RESPIRAT, V14, P183; Moore CM, 2006, LIMNOL OCEANOGR, V51, P936, DOI 10.4319/lo.2006.51.2.0936; Moore CM, 2003, MAR ECOL PROG SER, V259, P29, DOI 10.3354/meps259029; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; Napoleon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066423; Napoleon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040284; Nawrocki WJ, 2015, ANNU REV PLANT BIOL, V66, P49, DOI 10.1146/annurev-arplant-043014-114744; NIELSEN ES, 1951, NATURE, V167, P684, DOI 10.1038/167684b0; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Ort DR, 2002, CURR OPIN PLANT BIOL, V5, P193, DOI 10.1016/S1369-5266(02)00259-5; Oxborough K, 1997, PHOTOSYNTH RES, V54, P135, DOI 10.1023/A:1005936823310; Oxborough K, 2012, LIMNOL OCEANOGR-METH, V10, P142, DOI 10.4319/lom.2012.10.142; Pei S, 2013, DEEP-SEA RES PT I, V82, P1, DOI 10.1016/j.dsr.2013.07.011; Peltier G, 2010, PHOTOSYNTH RES, V106, P19, DOI 10.1007/s11120-010-9575-3; Pemberton KL, 2006, MAR ECOL PROG SER, V322, P51, DOI 10.3354/meps322051; Petrou K, 2011, DEEP-SEA RES PT II, V58, P2200, DOI 10.1016/j.dsr2.2011.05.020; Prasil O, 1996, PHOTOSYNTH RES, V48, P395, DOI 10.1007/BF00029472; PRICE N M, 1988, Biological Oceanography, V6, P443; Prieto L, 2008, J PLANKTON RES, V30, P43, DOI 10.1093/plankt/fbm093; Raateoja M, 2004, MAR ECOL PROG SER, V267, P9, DOI 10.3354/meps267009; Raateoja MP, 2004, BOREAL ENVIRON RES, V9, P263; Raven JA, 1999, PHOTOSYNTH RES, V60, P111, DOI 10.1023/A:1006282714942; Robinson C, 2014, J MARINE SYST, V139, P299, DOI 10.1016/j.jmarsys.2014.07.016; Robinson C, 2009, AQUAT MICROB ECOL, V54, P13, DOI 10.3354/ame01250; Rochaix JD, 2011, BBA-BIOENERGETICS, V1807, P878, DOI 10.1016/j.bbabio.2011.05.009; Rohacek K, 2002, PHOTOSYNTHETICA, V40, P13, DOI 10.1023/A:1020125719386; Ruban AV, 2015, J EXP BOT, V66, P7, DOI 10.1093/jxb/eru400; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P977, DOI 10.1016/j.bbabio.2012.03.026; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Ryan-Keogh TJ, 2012, J PHYCOL; Scheibe R, 2004, PHYSIOL PLANTARUM, V120, P21, DOI 10.1111/j.0031-9317.2004.0222.x; Schrader PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018753; Shinopoulos KE, 2012, BBA-BIOENERGETICS, V1817, P66, DOI 10.1016/j.bbabio.2011.08.002; Silsbe GM, 2015, LIMNOL OCEANOGR-METH, V13, P138, DOI 10.1002/lom3.10014; Smyth TJ, 2004, J PLANKTON RES, V26, P1337, DOI 10.1093/plankt/fbh124; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Suggett D, 2001, LIMNOL OCEANOGR, V46, P802, DOI 10.4319/lo.2001.46.4.0802; Suggett DJ, 2006, LIMNOL OCEANOGR, V51, P2064, DOI 10.4319/lo.2006.51.5.2064; Suggett DJ, 2010, DEVEL APPL PHYCOL, V4, P103, DOI 10.1007/978-90-481-9268-7_6; Suggett DJ, 2009, AQUAT MICROB ECOL, V56, P147, DOI 10.3354/ame01303; Suggett DJ, 2004, LIMNOL OCEANOGR-METH, V2, P316, DOI 10.4319/lom.2004.2.316; Taylor RL, 2013, J GEOPHYS RES-OCEANS, V118, P3260, DOI 10.1002/jgrc.20244; Thamatrakoln K, 2013, P NATL ACAD SCI USA, V110, P20123, DOI 10.1073/pnas.1304727110; Timmermans KR, 2001, MAR ECOL PROG SER, V217, P287, DOI 10.3354/meps217287; Tripathy SC, 2010, ESTUAR COAST SHELF S, V87, P163, DOI 10.1016/j.ecss.2010.01.006; Vass I, 2009, TRENDS PLANT SCI, V14, P200, DOI 10.1016/j.tplants.2009.01.009; VASSILIEV IR, 1995, PLANT PHYSIOL, V109, P963, DOI 10.1104/pp.109.3.963; WEBB WL, 1974, OECOLOGIA, V17, P281, DOI 10.1007/BF00345747; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Williams P J L B, 2008, PHYTOPLANKTON PRODUC; Yruela I, 2013, METALLOMICS, V5, P1090, DOI 10.1039/c3mt00086a; Zaks J, 2013, PHOTOSYNTH RES, V116, P389, DOI 10.1007/s11120-013-9857-7; Zehr JP, 2009, SCIENCE, V326, P945, DOI 10.1126/science.1181277	135	55	56	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133235	10.1371/journal.pone.0133235	http://dx.doi.org/10.1371/journal.pone.0133235			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171963	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900148
J	Sun, Z; Kong, XJ; Jing, X; Deng, RJ; Tian, ZB				Sun, Zhen; Kong, Xin-Juan; Jing, Xue; Deng, Run-Jun; Tian, Zi-Bin			Nutritional Risk Screening 2002 as a Predictor of Postoperative Outcomes in Patients Undergoing Abdominal Surgery: A Systematic Review and Meta-Analysis of Prospective Cohort Studies	PLOS ONE			English	Article							CLINICAL PREDICTOR; ENTERAL NUTRITION; ESPEN GUIDELINES; COMPLICATIONS; MORBIDITY; SUPPORT	Background The nutritional risk screening (NRS 2002) has been applied increasingly in patients who underwent abdominal surgery for nutritional risk assessment. However, the usefulness of the NRS 2002 for predicting is controversial. This meta-analysis was to examine whether a preoperative evaluation of nutritional risk by NRS 2002 provided prediction of postoperative outcomes in patients undergoing abdominal surgery. Methods A systematic literature search for published papers was conducted using the following online databases: MEDLINE, EMBASE, the Cochrane library, EBSCO, CRD databases, Cinahl, PsycInfo and BIOSIS previews. The pooled odds ratio (OR) or weight mean difference (WMD) was calculated using a random-effect model or a fix-effect model. Results Eleven studies with a total of 3527 patients included in this study. Postoperative overall complications were more frequent in nutritional risk patients versus patients without nutritional risk (the pooled OR 3.13 [2.51, 3.90] p<0.00001). The pooled OR of mortality for the nutritional risk group and non-nutritional risk group was 3.61 [1.38, 9.47] (p = 0.009). Furthermore, the postoperative hospital stay was significant longer in the preoperative nutritional risk group than in the nutritional normal group (WMD 5.58 [4.21, 6.95] p<0.00001). Conclusions The present study has demonstrated that patients at preoperative nutritional risk have increased complication rates, high mortality and prolonged hospital stay after surgery. However, NRS 2002 needs to be validated in larger samples of patients undergoing abdominal surgery by better reference method.	[Sun, Zhen; Kong, Xin-Juan; Jing, Xue; Deng, Run-Jun; Tian, Zi-Bin] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Gastroenterol, Qingdao 266003, Shandong, Peoples R China	Qingdao University	Tian, ZB (corresponding author), Qingdao Univ, Coll Med, Affiliated Hosp, Dept Gastroenterol, Qingdao 266003, Shandong, Peoples R China.	tianzibinqd@sina.com	Jing, Xue/AAV-8425-2021	Jing, Xue/0000-0001-6957-1811	National Natural Science Foundation of China [81070305]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81070305).	Correia MITD, 2003, CLIN NUTR, V22, P235, DOI 10.1016/S0261-5614(02)00215-7; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; FAN ST, 1994, NEW ENGL J MED, V331, P1547, DOI 10.1056/NEJM199412083312303; Guo WP, 2010, J GASTROEN HEPATOL, V25, P800, DOI 10.1111/j.1440-1746.2009.06198.x; Han Dong, 2013, Zhonghua Wei Chang Wai Ke Za Zhi, V16, P1067; Hill AG, 1998, BRIT J SURG, V85, P884; Jie B, 2012, NUTRITION, V28, P1022, DOI 10.1016/j.nut.2012.01.017; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; Kuppinger D, 2012, BRIT J SURG, V99, P728, DOI 10.1002/bjs.8710; Kwag SJ, 2014, ANN SURG TREAT RES, V86, P206, DOI 10.4174/astr.2014.86.4.206; Liu Hong, 2013, Zhonghua Wei Chang Wai Ke Za Zhi, V16, P552; Lochs H, 2006, CLIN NUTR, V25, P180, DOI 10.1016/j.clnu.2006.02.007; Ozkalkanli MY, 2009, NUTR CLIN PRACT, V24, P274, DOI 10.1177/0884533609332087; Schiesser M, 2008, CLIN NUTR, V27, P565, DOI 10.1016/j.clnu.2008.01.010; Schwegler I, 2010, BRIT J SURG, V97, P92, DOI 10.1002/bjs.6805; Shinkawa H, 2013, SURG TODAY, V43, P276, DOI 10.1007/s00595-012-0350-2; Song FJ, 2001, EVAL HEALTH PROF, V24, P126, DOI 10.1177/01632780122034849; Sorensen J, 2008, CLIN NUTR, V27, P340, DOI 10.1016/j.clnu.2008.03.012; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sungurtekin H, 2004, J AM COLL NUTR, V23, P227, DOI 10.1080/07315724.2004.10719365; Tevik K, 2015, CLIN NUTR, V34, P257, DOI 10.1016/j.clnu.2014.03.014; van Bokhorst-de van der Schueren MAE, 2014, CLIN NUTR, V33, P39, DOI 10.1016/j.clnu.2013.04.008; Velasco C, 2011, EUR J CLIN NUTR, V65, P269, DOI 10.1038/ejcn.2010.243; Weimann A, 2006, CLIN NUTR, V25, P224, DOI 10.1016/j.clnu.2006.01.015; Wu Li-min, 2011, Zhonghua Wei Chang Wai Ke Za Zhi, V14, P271; Zhou W, 2013, SURG ENDOSC, V27, P2569, DOI 10.1007/s00464-013-2790-1	26	46	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132857	10.1371/journal.pone.0132857	http://dx.doi.org/10.1371/journal.pone.0132857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172830	gold, Green Published, Green Submitted			2022-12-27	WOS:000358194900091
J	Bjorngaard, JH; Carslake, D; Nilsen, TIL; Linthorst, ACE; Smith, GD; Gunnell, D; Romundstad, PR				Bjorngaard, Johan Hakon; Carslake, David; Nilsen, Tom Ivar Lund; Linthorst, Astrid C. E.; Smith, George Davey; Gunnell, David; Romundstad, Pal Richard			Association of Body Mass Index with Depression, Anxiety and Suicide-An Instrumental Variable Analysis of the HUNT Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MENTAL-ILLNESS; RISK-FACTORS; OBESITY; POPULATION; DISORDERS; TESTOSTERONE; OVERWEIGHT; ADIPOSITY; GENETICS	Objective While high body mass index is associated with an increased risk of depression and anxiety, cumulative evidence indicates that it is a protective factor for suicide. The associations from conventional observational studies of body mass index with mental health outcomes are likely to be influenced by reverse causality or confounding by ill-health. In the present study, we investigated the associations between offspring body mass index and parental anxiety, depression and suicide in order to avoid problems with reverse causality and confounding by ill-health. Methods We used data from 32,457 mother-offspring and 27,753 father-offspring pairs from the Norwegian HUNT-study. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale and suicide death from national registers. Associations between offspring and own body mass index and symptoms of anxiety and depression and suicide mortality were estimated using logistic and Cox regression. Causal effect estimates were estimated with a two sample instrument variable approach using offspring body mass index as an instrument for parental body mass index. Results Both own and offspring body mass index were positively associated with depression, while the results did not indicate any substantial association between body mass index and anxiety. Although precision was low, suicide mortality was inversely associated with own body mass index and the results from the analysis using offspring body mass index supported these results. Adjusted odds ratios per standard deviation body mass index from the instrumental variable analysis were 1.22 (95% CI: 1.05, 1.43) for depression, 1.10 (95% CI: 0.95, 1.27) for anxiety, and the instrumental variable estimated hazard ratios for suicide was 0.69 (95% CI: 0.30, 1.63). Conclusion The present study's results indicate that suicide mortality is inversely associated with body mass index. We also found support for a positive association between body mass index and depression, but not for anxiety.	[Bjorngaard, Johan Hakon; Romundstad, Pal Richard] Norwegian Univ Sci & Technol, Dept Publ Hlth, Fac Med, N-7491 Trondheim, Norway; [Bjorngaard, Johan Hakon] Broset St Olavs Univ Hosp, Forens Dept, Trondheim, Norway; [Bjorngaard, Johan Hakon] Broset St Olavs Univ Hosp, Res Ctr, Trondheim, Norway; [Carslake, David; Smith, George Davey; Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Carslake, David; Smith, George Davey] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Nilsen, Tom Ivar Lund] Norwegian Univ Sci & Technol, Dept Human Movement Sci, N-7491 Trondheim, Norway; [Linthorst, Astrid C. E.] Univ Bristol, Sch Clin Sci, Neurobiol Stress & Behav Res Grp, Bristol, Avon, England	Norwegian University of Science & Technology (NTNU); University of Bristol; University of Bristol; Norwegian University of Science & Technology (NTNU); University of Bristol	Bjorngaard, JH (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth, Fac Med, N-7491 Trondheim, Norway.	johan.h.bjorngaard@ntnu.no	Davey Smith, George/A-7407-2013; Gunnell, David/ABE-6653-2020	Davey Smith, George/0000-0002-1407-8314; Gunnell, David/0000-0002-0829-6470; Romundstad, Pal Richard/0000-0003-2061-4336; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475; Carslake, David/0000-0003-2916-4546	UK Medical Research Council; University of Bristol; MRC [MR/K006525/1, MC_UU_12013/9, MC_UU_12013/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1, MC_UU_12013/1, MC_UU_12013/9] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10068] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	David Carslake works in a unit that receives funds from the UK Medical Research Council and the University of Bristol. David Gunnell is a National Institute for Health Research Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors state that there are no conflicts of interest.	ANGRIST JD, 1992, J AM STAT ASSOC, V87, P328; Batty GD, 2010, AM J EPIDEMIOL, V172, P890, DOI 10.1093/aje/kwq274; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bjerkeset O, 2008, AM J EPIDEMIOL, V167, P193, DOI 10.1093/aje/kwm280; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Chang SS, 2012, AM J EPIDEMIOL, V175, P804, DOI 10.1093/aje/kwr386; Costanza A, 2014, INT J LEGAL MED, V128, P73, DOI 10.1007/s00414-013-0835-6; Daumit GL, 2005, J NERV MENT DIS, V193, P641, DOI 10.1097/01.nmd.0000180737.85895.60; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Didelez V, 2010, STAT SCI, V25, P22, DOI 10.1214/09-STS316; Elovainio M, 2009, J AFFECT DISORDERS, V116, P218, DOI 10.1016/j.jad.2008.12.002; Erritzoe D, 2010, NEUROIMAGE, V52, P284, DOI 10.1016/j.neuroimage.2010.03.086; Gariepy G, 2010, INT J OBESITY, V34, P407, DOI 10.1038/ijo.2009.252; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; Gunnell D, 2005, BRIT J PSYCHIAT, V187, P206, DOI 10.1192/bjp.187.3.206; Gunnell D, 2011, INT HDB SUICIDE PREV; Harrell FE, 2001, REGRESSION MODELING, Vxxii; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Herpertz S, 2003, INT J OBESITY, V27, P1300, DOI 10.1038/sj.ijo.0802410; Hung CF, 2014, BRIT J PSYCHIAT, V205, P24, DOI 10.1192/bjp.bp.113.130419; Kendler KS, 2001, ARCH GEN PSYCHIAT, V58, P1005, DOI 10.1001/archpsyc.58.11.1005; Kivimaki M, 2011, AM J EPIDEMIOL, V173, P421, DOI 10.1093/aje/kwq444; Kivimaki M, 2009, BRIT J PSYCHIAT, V195, P149, DOI 10.1192/bjp.bp.108.057299; Klinitzke G, 2013, J AFFECT DISORDERS, V145, P277, DOI 10.1016/j.jad.2012.07.010; Laaksonen DE, 2004, DIABETES CARE, V27, P1036, DOI 10.2337/diacare.27.5.1036; Lam DD, 2010, PHARMACOL BIOCHEM BE, V97, P84, DOI 10.1016/j.pbb.2010.09.003; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Lawlor DA, 2011, J INTERN MED, V269, P525, DOI 10.1111/j.1365-2796.2011.02343.x; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Moore ME, 1997, OBES RES, V5, P503, DOI 10.1002/j.1550-8528.1997.tb00678.x; Mukamal KJ, 2010, AM J EPIDEMIOL, V172, P900, DOI 10.1093/aje/kwq278; Mukamal KJ, 2010, EPIDEMIOLOGY, V21, P82, DOI 10.1097/EDE.0b013e3181c1fa2d; Mukamal KJ, 2009, OBESITY, V17, P532, DOI 10.1038/oby.2008.538; Mustelin L, 2009, INT J OBESITY, V33, P29, DOI 10.1038/ijo.2008.258; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; O'Rahilly S, 2006, PHILOS T R SOC B, V361, P1095, DOI 10.1098/rstb.2006.1850; Osborn DPJ, 2007, SOC PSYCH PSYCH EPID, V42, P787, DOI 10.1007/s00127-007-0247-3; Parikh NI, 2007, AM J MED, V120, P242, DOI 10.1016/j.amjmed.2006.06.004; Pelusi C, 2012, CURR OBES REP, V1, P181, DOI 10.1007/s13679-012-0029-4; Peterhansel C, 2013, OBES REV, V14, P369, DOI 10.1111/obr.12014; Pompili M, 2010, EUR ARCH PSY CLIN N, V260, P583, DOI 10.1007/s00406-010-0108-z; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; Samaan Z, 2012, MOL PSYCHIAT; Silventoinen K, 2009, OBESITY FACTS, V2, P196, DOI 10.1159/000219675; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Smith GD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5043; Spencer SJ, 2011, STRESS, V14, P233, DOI 10.3109/10253890.2010.534831; Steckler T, 1999, BEST PRACT RES CL EN, V13, P597, DOI 10.1053/beem.1999.0046; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; Thomas DC, 2007, ANN EPIDEMIOL, V17, P511, DOI 10.1016/j.annepidem.2006.12.005; Tyrer P, 2008, BRIT J PSYCHIAT, V192, P242, DOI 10.1192/bjp.192.3.242; Yamada N, 2011, ENDOCRINOLOGY, V152, P2634, DOI 10.1210/en.2011-0004; Zhang J, 2013, J AFFECT DISORDERS, V148, P147, DOI 10.1016/j.jad.2012.05.048	56	31	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131708	10.1371/journal.pone.0131708	http://dx.doi.org/10.1371/journal.pone.0131708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167892	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100012
J	Boese, CK; Lechler, P; Rose, L; Dargel, J; Oppermann, J; Eysel, P; Geiges, H; Bredow, J				Boese, Christoph Kolja; Lechler, Philipp; Rose, Leonard; Dargel, Jens; Oppermann, Johannes; Eysel, Peer; Geiges, Hansjoerg; Bredow, Jan			Calibration Markers for Digital Templating in Total Hip Arthroplasty	PLOS ONE			English	Article							REPLACEMENT; ACCURACY; MAGNIFICATION; RADIOGRAPHS	Digital templating with external calibration markers is the standard method for planning total hip arthroplasty. We determined the geometrical basis of the magnification effect, compared magnification with external and internal calibration markers, and examined the influence on magnification of the position of the calibration markers, patient weight, and body mass index (BMI). A formula was derived to calculate magnification with internal and external calibration markers, informed by 100 digital radiographs of the pelvis. Intraclass correlations between the measured and calculated values and the strength of relationships between magnification, position and distance of calibration markers and height, weight, and BMI were sought. There was a weak correlation between magnification of internal and external calibration markers (r = 0.297-0.361; p < 0.01). Intraclass correlations were 0.882-1.000 (p = 0.000) for all parameters. There were also weak correlations between magnification of internal and external calibration markers and weight and BMI (r = 0.420, p = 0.000; r = 0.428, p = 0.000, respectively). The correlation between external and internal calibration markers was poor, indicating the need for more accurate calibration methods. While weight and BMI weakly correlated with the magnification of markers, future studies should examine this phenomenon in more detail.	[Boese, Christoph Kolja; Rose, Leonard; Dargel, Jens; Oppermann, Johannes; Eysel, Peer; Bredow, Jan] Univ Hosp Cologne, Dept Orthopaed & Trauma Surg, Cologne, Germany; [Lechler, Philipp] Univ Giessen & Marburg, Dept Trauma Hand & Reconstruct Surg, Marburg, Germany; [Geiges, Hansjoerg] Univ Cologne, Math Inst, D-50931 Cologne, Germany	University of Cologne; University of Cologne	Boese, CK (corresponding author), Univ Hosp Cologne, Dept Orthopaed & Trauma Surg, Cologne, Germany.	christoph.boese@uk-koeln.de						Bayne CO, 2009, J ARTHROPLASTY, V24, P407, DOI 10.1016/j.arth.2007.11.020; Conn KS, 2002, J BONE JOINT SURG BR, V84B, P269, DOI 10.1302/0301-620X.84B2.12599; Descamps S, 2010, SKELETAL RADIOL, V39, P273, DOI 10.1007/s00256-009-0732-8; Franken M, 2010, J BONE JOINT SURG BR, V92B, P136, DOI 10.1302/0301-620X.92B1.22257; Heinert G, 2009, J BONE JOINT SURG BR, V91B, P459, DOI 10.1302/0301-620X.91B4.21730; Kulkarni A, 2008, J BONE JOINT SURG BR, V90B, P1623, DOI 10.1302/0301-620X.90B12.20238; Sinclair VF, 2014, J ARTHROPLASTY, V29, P1658, DOI 10.1016/j.arth.2014.03.013; The B, 2005, MED PHYS, V32, P2580, DOI 10.1118/1.1984293; The B, 2005, ACTA ORTHOP, V76, P78, DOI 10.1080/00016470510030364; Wimsey S, 2006, J BONE JOINT SURG BR, V88B, P1508, DOI 10.1302/0301-620X.88B11.18017	10	20	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0128529	10.1371/journal.pone.0128529	http://dx.doi.org/10.1371/journal.pone.0128529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168410	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100001
J	Cornet, V; Henry, J; Goux, D; Duval, E; Bernay, B; Le Corguille, G; Corre, E; Zatylny-Gaudin, C				Cornet, Valerie; Henry, Joel; Goux, Didier; Duval, Emilie; Bernay, Benoit; Le Corguille, Gildas; Corre, Erwan; Zatylny-Gaudin, Celine			How Egg Case Proteins Can Protect Cuttlefish Offspring?	PLOS ONE			English	Article							CHICKEN EGGSHELL MATRIX; SEA-HARE; APLYSIANIN-E; SEPIA-OFFICINALIS; CHEMICAL DEFENSE; ANTIBACTERIAL; CAPSULES; PURIFICATION; COLLAGEN; PEPTIDE	Sepia officinalis egg protection is ensured by a complex capsule produced by the female accessory genital glands and the ink bag. Our study is focused on the proteins constituting the main egg case. De novo transcriptomes from female genital glands provided essential databases for protein identification. A proteomic approach in SDS-PAGE coupled with MS unveiled a new egg case protein family: SepECPs, for Sepia officinalis Egg Case Proteins. N-glycosylation was demonstrated by PAS staining SDS-PAGE gels. These glycoproteins are mainly produced in the main nidamental glands. SepECPs share high sequence homology, especially in the signal peptide and the three cysteine-rich domains. SepECPs have a high number of cysteines, with conserved motifs involved in 3D-structure. SDS-PAGE showed that SepECPs could form dimers; this result was confirmed by TEM observations, which also revealed a protein network. This network is similar to the capsule network, and it associates these structural proteins with polysaccharides, melanin and bacteria to form a tight mesh. Its hardness and elasticity provide physical protection to the embryo. In addition, SepECPs also have bacteriostatic antimicrobial activity on GRAM-bacteria. By observing the SepECP / Vibrio aestuarianus complex in SEM, we demonstrated the ability of these proteins to agglomerate bacteria and thus inhibit their growth. These original proteins identified from the outer egg case ensure the survival of the species by providing physical and chemical protection to the embryos released in the environment without any maternal protection.	[Cornet, Valerie; Henry, Joel; Goux, Didier; Duval, Emilie; Bernay, Benoit; Zatylny-Gaudin, Celine] Univ Caen Basse Normandie, F-14032 Caen, France; [Cornet, Valerie; Henry, Joel; Zatylny-Gaudin, Celine] BOREA CNRS INEE, UMR 7208, F-14032 Caen, France; [Henry, Joel; Bernay, Benoit] Plateforme Postgen PROTEOGEN, F-14032 Caen, France; [Goux, Didier] CMAbio, F-14032 Caen, France; [Le Corguille, Gildas; Corre, Erwan] UPMC CNRS, Stn Biol Roscoff, Plateforme ABiMS, F-29688 Roscoff, France	Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Zatylny-Gaudin, C (corresponding author), Univ Caen Basse Normandie, F-14032 Caen, France.	celine.gaudin@unicaen.fr	corre, erwan/O-4669-2019	corre, erwan/0000-0001-6354-2278; Zatylny-Gaudin, Celine/0000-0001-9258-9876; Le Corguille, Gildas/0000-0003-1742-9711				Ahlborn GJ, 2006, PROTEIN J, V25, P71, DOI 10.1007/s10930-006-0010-8; ALOYZ RS, 1995, PEPTIDES, V16, P331, DOI 10.1016/0196-9781(94)00140-5; Arrieta MC, 2006, EXP APPL ACAROL, V39, P297, DOI 10.1007/s10493-006-9014-5; Benkendorff K, 2001, J INVERTEBR PATHOL, V78, P109, DOI 10.1006/jipa.2001.5047; BERTRAM BCR, 1981, IBIS, V123, P207, DOI 10.1111/j.1474-919X.1981.tb00927.x; BIGGS J, 1991, J EXP ZOOL, V259, P263, DOI 10.1002/jez.1402590217; BLOODGOOD RA, 1977, TISSUE CELL, V9, P197, DOI 10.1016/0040-8166(77)90016-7; BOLETZKY SV, 1973, HELGOLAND WISS MEER, V25, P135, DOI 10.1007/BF01609965; Boletzky SV, 2003, ADV MAR BIOL, V44, P143, DOI 10.1016/S0065-2881(03)44003-0; BOLETZKY SV, 1986, AM MALACOL BULL, V4, P217; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN CH, 1955, Q J MICROSC SCI, V96, P483; Bulet P, 1999, M S-MED SCI, V15, P23, DOI 10.4267/10608/1192; Calvery HO, 1933, J BIOL CHEM, V100, P183; Cordeiro CMM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084112; Cornet V, 2014, J PROTEOMICS, V108, P209, DOI 10.1016/j.jprot.2014.05.019; COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153; Cummins SF, 2011, CURR BIOL, V21, P322, DOI 10.1016/j.cub.2011.01.038; Cummins SF, 2005, PEPTIDES, V26, P589, DOI 10.1016/j.peptides.2004.11.006; Cyran N, 2013, ZOOL ANZ, V253, P66, DOI 10.1016/j.jcz.2013.04.001; DASARO CN, 1988, NAUTILUS, V102, P134; Derby CD, 2013, BIOL BULL-US, V225, P152, DOI 10.1086/BBLv225n3p152; Duval E, 2009, PEPTIDES, V30, P1608, DOI 10.1016/j.peptides.2009.06.022; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gabe M., 1968, TECHNIQUES HISTOLOGI; Gautron J, 2001, J BIOL CHEM, V276, P39243, DOI 10.1074/jbc.M104543200; Gautron J, 2007, J BIOL CHEM, V282, P5273, DOI 10.1074/jbc.M610294200; Gautron J, 2011, BIOCHEM SOC T, V39, P971, DOI 10.1042/BST0390971; GILTURNES MS, 1989, SCIENCE, V246, P116, DOI 10.1126/science.2781297; GOMI F, 1986, ZOOL SCI, V3, P641; GUILLETTE LJ, 1989, J MORPHOL, V201, P145, DOI 10.1002/jmor.1052010205; Herfurth AH., 1936, BEITRAGE KENNTNIS BA; HINCKE MT, 1995, CALCIFIED TISSUE INT, V56, P578, DOI 10.1007/BF00298593; Hu XY, 2005, J BIOL CHEM, V280, P21220, DOI 10.1074/jbc.M412316200; IIJIMA R, 1995, DEV COMP IMMUNOL, V19, P13, DOI 10.1016/0145-305X(94)00055-K; Jecklin L., 1934, Revue Suisse de Zoologie, V41, P593; Jonchere V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-57; KAMIYA H, 1988, NIPPON SUISAN GAKK, V54, P773; Kamiya H, 1986, EXPERIENTIA, V42, P1984; Kaviarasan T., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P916, DOI 10.1016/S2221-1691(12)60253-6; KAWASAKI H, 1971, INSECT BIOCHEM, V1, P130, DOI 10.1016/0020-1790(71)90067-9; KELLETT E, 1994, J NEUROSCI, V14, P6564; KISUGI J, 1989, CHEM PHARM BULL, V37, P3050; KISUGI J, 1987, CANCER RES, V47, P5649; Klussmann-Kolb A, 1999, MAR BIOL, V133, P443, DOI 10.1007/s002270050483; Knupp C, 1998, J STRUCT BIOL, V122, P101, DOI 10.1006/jsbi.1998.3994; Kodali VK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018187; LORD A, 1986, AM MALACOL BULL, V4, P201; Luong TT, 1998, BIOCHEM BIOPH RES CO, V250, P657, DOI 10.1006/bbrc.1998.9282; Mann K, 2003, MATRIX BIOL, V22, P397, DOI 10.1016/S0945-053X(03)00072-6; Mann K, 2002, MATRIX BIOL, V21, P383, DOI 10.1016/S0945-053X(02)00031-8; Marie P, 2015, J PROTEOMICS, V113, P178, DOI 10.1016/j.jprot.2014.09.024; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Mine Y, 2003, J AGR FOOD CHEM, V51, P249, DOI 10.1021/jf020597x; Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516; Ramasamy MS, 2007, BIOFOULING, V23, P259, DOI 10.1080/08927010701278857; Rapoport HS, 2002, BIOMACROMOLECULES, V3, P42, DOI 10.1021/bm0155470; RAWLINGS TA, 1995, VELIGER, V38, P54; Rose-Martel M, 2013, EGGSHELL SOURCE NOVE, V3, P219; RUSAOUEN M, 1976, COMP BIOCHEM PHYS B, V53, P539, DOI 10.1016/0305-0491(76)90214-5; Sangster CR, 2003, BIOL BULL-US, V205, P233, DOI 10.2307/1543270; Thomason JC, 2009, J MAR BIOL ASSOC UK, V76, P777; von Boletzky S, 1998, OCEANOGR MAR BIOL<D>, V36, P341; Wang X, 2002, POULTRY SCI, V81, P805, DOI 10.1093/ps/81.6.805; WONG M, 1984, DEV BIOL, V104, P28, DOI 10.1016/0012-1606(84)90033-2; ZACHARIUS RM, 1969, ANAL BIOCHEM, V30, P148, DOI 10.1016/0003-2697(69)90383-2; Zatylny C, 2000, BIOCHEM BIOPH RES CO, V275, P217, DOI 10.1006/bbrc.2000.3286; Zatylny C, 2002, BIOCHEM BIOPH RES CO, V296, P1186, DOI 10.1016/S0006-291X(02)02036-3; Zhao AC, 2006, BIOCHEMISTRY-US, V45, P3348, DOI 10.1021/bi052414g	69	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132836	10.1371/journal.pone.0132836	http://dx.doi.org/10.1371/journal.pone.0132836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168161	gold, Green Published, Green Submitted			2022-12-27	WOS:000358193100087
J	Summermatter, S; Singer, F; Latzin, P; Yammine, S				Summermatter, Selina; Singer, Florian; Latzin, Philipp; Yammine, Sophie			Impact of Software Settings on Multiple-Breath Washout Outcomes	PLOS ONE			English	Article							INERT-GAS WASHOUT; LUNG CLEARANCE INDEX; ULTRASONIC FLOW SENSOR; CYSTIC-FIBROSIS; HYPERTONIC SALINE; CLINICAL-TRIALS; RESPONSE-TIME; DEAD-SPACE; DISEASE; CHILDREN	Background and Objectives Multiple-breath washout (MBW) is an attractive test to assess ventilation inhomogeneity, a marker of peripheral lung disease. Standardization of MBW is hampered as little data exists on possible measurement bias. We aimed to identify potential sources of measurement bias based on MBW software settings. Methods We used unprocessed data from nitrogen (N-2) MBW (Exhalyzer D, Eco Medics AG) applied in 30 children aged 5-18 years: 10 with CF, 10 formerly preterm, and 10 healthy controls. This setup calculates the tracer gas N-2 mainly from measured O-2 and CO2 concentrations. The following software settings for MBW signal processing were changed by at least 5 units or >10% in both directions or completely switched off: (i) environmental conditions, (ii) apparatus dead space, (iii) O-2 and CO2 signal correction, and (iv) signal alignment (delay time). Primary outcome was the change in lung clearance index (LCI) compared to LCI calculated with the settings as recommended. A change in LCI exceeding 10% was considered relevant. Results Changes in both environmental and dead space settings resulted in uniform but modest LCI changes and exceeded >10% in only two measurements. Changes in signal alignment and O-2 signal correction had the most relevant impact on LCI. Decrease of O-2 delay time by 40 ms (7%) lead to a mean LCI increase of 12%, with >10% LCI change in 60% of the children. Increase of O-2 delay time by 40 ms resulted in mean LCI decrease of 9% with LCI changing >10% in 43% of the children. Conclusions Accurate LCI results depend crucially on signal processing settings in MBW software. Especially correct signal delay times are possible sources of incorrect LCI measurements. Algorithms of signal processing and signal alignment should thus be optimized to avoid susceptibility of MBW measurements to this significant measurement bias.	[Summermatter, Selina; Latzin, Philipp; Yammine, Sophie] UKBB, Univ Childrens Hosp Basel, CH-4031 Basel, Switzerland; [Yammine, Sophie] Univ Childrens Hosp Bern, CH-3010 Bern, Switzerland; [Singer, Florian] Univ Childrens Hosp Zurich, CH-8032 Zurich, Switzerland	University of Basel; University of Bern; University Hospital of Bern; University Children's Hospital Zurich	Latzin, P (corresponding author), UKBB, Univ Childrens Hosp Basel, CH-4031 Basel, Switzerland.	philipp.latzin@ukbb.ch	Singer, Florian/O-7651-2015; Singer, Florian/AAO-1460-2021; Latzin, Philipp/F-2206-2017	Singer, Florian/0000-0003-3471-5664; Singer, Florian/0000-0003-3471-5664; Latzin, Philipp/0000-0002-5239-1571; Yammine, Sophie/0000-0001-7720-3445	Swiss Society for Cystic Fibrosis (CFCH); Gottfried und Julia Bangerter-Rhyner-Stiftung; FondationBotnar	Swiss Society for Cystic Fibrosis (CFCH); Gottfried und Julia Bangerter-Rhyner-Stiftung; FondationBotnar	This study was supported by the Swiss Society for Cystic Fibrosis (CFCH), the Gottfried und Julia Bangerter-Rhyner-Stiftung and the FondationBotnar.	Amin R, 2011, EUR RESPIR J, V37, P806, DOI 10.1183/09031936.00072510; Amin R, 2010, THORAX, V65, P379, DOI 10.1136/thx.2009.125831; ARIELI R, 1981, J APPL PHYSIOL, V51, P1417, DOI 10.1152/jappl.1981.51.6.1417; Aurora P, 2005, RESP PHYSIOL NEUROBI, V148, P125, DOI 10.1016/j.resp.2005.05.027; Aurora P, 2010, THORAX, V65, P373, DOI 10.1136/thx.2009.132100; Benseler A, 2015, RESPIROLOGY, V20, P459, DOI 10.1111/resp.12470; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boon M, 2015, THORAX, V70, P339, DOI 10.1136/thoraxjnl-2014-206578; BRUNNER JX, 1985, J APPL PHYSIOL, V59, P1008, DOI 10.1152/jappl.1985.59.3.1008; BUESS C, 2012, AM J RESP CRIT CARE, V185, pA1691; Ebdon AM, 2013, EUR RESPIR J, V42, p228s; Farmery AD, 2000, J APPL PHYSIOL, V89, P581, DOI 10.1152/jappl.2000.89.2.581; Fuchs SI, 2008, PEDIATR PULM, V43, P731, DOI 10.1002/ppul.20825; Fuchs SI, 2006, PEDIATR PULM, V41, P1218, DOI 10.1002/ppul.20524; Fuchs SI, 2009, PEDIATR PULM, V44, P1180, DOI 10.1002/ppul.21093; Gonem S, 2014, RESPIRATION, V87, P462, DOI 10.1159/000357786; Gustafsson PM, 2008, THORAX, V63, P129, DOI 10.1136/thx.2007.077784; Gustafsson PM, 2003, EUR RESPIR J, V22, P972, DOI 10.1183/09031936.03.00049502; Horsley A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098487; Jensen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056868; Kent L, 2014, J CYST FIBROS, V13, P123, DOI 10.1016/j.jcf.2013.09.005; Lum S, 2007, THORAX, V62, P341, DOI 10.1136/thx.2006.068262; Pillow JJ, 2004, EUR RESPIR J, V23, P763, DOI 10.1183/09031936.04.00091504; Robinson PD, 2013, EUR RESPIR J, V41, P507, DOI 10.1183/09031936.00069712; Schmidt A, 2015, PEDIATR PULM, V50, P607, DOI 10.1002/ppul.23010; Singer F, 2013, PEDIATR PULM, V48, P739, DOI 10.1002/ppul.22651; Singer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036083; Subbarao P, 2013, AM J RESP CRIT CARE, V188, P456, DOI 10.1164/rccm.201302-0219OC; Tang YQ, 2005, PHYSIOL MEAS, V26, P1103, DOI 10.1088/0967-3334/26/6/019; Thamrin C, 2007, PEDIATR PULM, V42, P920, DOI 10.1002/ppul.20683; Vermeulen F, 2014, THORAX, V69, P39, DOI 10.1136/thoraxjnl-2013-203807	31	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132250	10.1371/journal.pone.0132250	http://dx.doi.org/10.1371/journal.pone.0132250			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167682	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100034
J	Chatterjee, S; Saxena, RK				Chatterjee, Sreoshi; Saxena, Rajiv K.			Preferential Elimination of Older Erythrocytes in Circulation and Depressed Bone Marrow Erythropoietic Activity Contribute to Cadmium Induced Anemia in Mice	PLOS ONE			English	Article							ITAI-ITAI DISEASE; OXIDATIVE STRESS; EXPOSURE; EXPRESSION; CLEARANCE; IRON; INTOXICATION; POPULATION; MECHANISMS; EXPANSION	Feeding cadmium chloride (50 or 1000 ppm CdCl2 in drinking water, ad libitum) to C57BL/6 mice resulted in a significant and sustained fall in blood erythrocyte count and hemoglobin levels that started 4 and 3 weeks after the start of 50 and 1000 ppm cadmium doses respectively. A transient yet significant reticulocytosis occurred during the first 4 weeks of cadmium treatment. Using the recently developed double in vivo biotinylation (DIB) technique, turnover of erythrocyte cohorts of different age groups was simultaneously monitored in control and cadmium treated mice. A significant accumulation of younger erythrocytes and a concomitant decline in the relative proportions of older erythrocytes in circulation was observed in both 50 and 1000 ppm cadmium groups indicating that older erythrocytes were preferentially eliminated in cadmium induced anemia. A significant increase in the erythropoietin levels in plasma was seen in mice exposed to 1000 ppm cadmium. Levels of inflammatory cytokines (IL1A, IL6, TNF alpha, IFN gamma) were however not significantly altered in cadmium treated mice. A significant increase in cellular levels of reactive oxygen species (ROS) was observed in older erythrocytes in circulation but not in younger erythrocytes. Erythropoietic activity in the bone marrows and spleens of cadmium treated mice was examined by monitoring the relative proportion of cells belonging to the erythroid line of differentiation in these organs. Erythroid cells in bone marrow declined markedly (about 30%) in mice in the 1000 ppm cadmium group but the decline was not significant in the 50 ppm cadmium group. Cells representing various stages of erythroid differentiation in bone marrow and spleen were enumerated flow cytometrically by double staining with anti-Ter119 and anti-transferrin receptor (CD71) monoclonal antibodies. Decline of erythroid cells was essentially confined to pro-erythroblast and erythroblast-A, along with a concurrent increase in the splenic erythroid population indicating a stress response. In short cadmium exposure causes preferential clearance of older erythrocytes from circulation along with a depressed erythropoietic activity at higher doses.	[Chatterjee, Sreoshi] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Saxena, Rajiv K.] South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India	Jawaharlal Nehru University, New Delhi; South Asian University (SAU)	Saxena, RK (corresponding author), South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India.	rajivksaxena@hotmail.com		Chatterjee, Sreoshi/0000-0001-7731-1243	Department of Science and Technology, Government of India [SR/S0/HS/0261/2012]; Council of Scientific and Industrial Research, New Delhi	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant supported by Department of Science and Technology, Government of India, (Grants SR/S0/HS/0261/2012) to RKS. SC received Senior Research Fellowship from Council of Scientific and Industrial Research, New Delhi.	Beyersmann D, 1997, TOXICOL APPL PHARM, V144, P247, DOI 10.1006/taap.1997.8125; Bhardwaj N, 2015, NANOTOXICOL IN PRESS; Bhardwaj N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099364; Bhardwaj N, 2013, CURR SCI INDIA, V105, P1611; Casalino E, 2002, TOXICOLOGY, V179, P37, DOI 10.1016/S0300-483X(02)00245-7; Cuypers A, 2010, BIOMETALS, V23, P927, DOI 10.1007/s10534-010-9329-x; Faroon O., 2012, TOXICOLOGICAL PROFIL; Franz E, 2008, J FOOD PROTECT, V71, P2504, DOI 10.4315/0362-028X-71.12.2504; Gluhcheva Y, 2011, CLIN HEMORHEOL MICRO, V49, P417, DOI 10.3233/CH-2011-1491; HAMILTON DL, 1974, AM J PHYSIOL, V227, P1033, DOI 10.1152/ajplegacy.1974.227.5.1033; HORIGUCHI H, 1994, ARCH TOXICOL, V68, P632, DOI 10.1007/s002040050124; Horiguchi H, 1996, ARCH TOXICOL, V71, P11, DOI 10.1007/s002040050352; Horiguchi H, 2011, TOXICOL SCI, V122, P198, DOI 10.1093/toxsci/kfr100; Horiguchi H, 2010, INT ARCH OCC ENV HEA, V83, P953, DOI 10.1007/s00420-010-0510-x; IARC, 2012, IARC MONOGR EVAL CAR, V100C, P121; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Jin TY, 1998, NEUROTOXICOLOGY, V19, P529; Kalfa TA, 2010, HAEMATOL-HEMATOL J, V95, P27, DOI 10.3324/haematol.2009.006239; Kasuya M, 2000, WATER SCI TECHNOL, V42, P147, DOI 10.2166/wst.2000.0563; Khandelwal S, 2008, EXP GERONTOL, V43, P764, DOI 10.1016/j.exger.2008.05.002; Khandelwal S, 2007, TRANSFUSION, V47, P1725, DOI 10.1111/j.1537-2995.2007.01348.x; Khandelwal S, 2006, EXP GERONTOL, V41, P855, DOI 10.1016/j.exger.2006.06.045; KUNIMOTO M, 1985, TOXICOL APPL PHARM, V77, P451, DOI 10.1016/0041-008X(85)90185-1; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Lutton JD, 1984, ENVIRON RES, V39, P86; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Nawrot TS, 2010, BIOMETALS, V23, P769, DOI 10.1007/s10534-010-9343-z; Nordberg GF, 1986, CADMIUM HLTH TOXICOL, P103; Nordberg G, 2012, J TRACE ELEM MED BIO, V26, P197, DOI 10.1016/j.jtemb.2012.03.007; Nordberg GF, 2009, TOXICOL APPL PHARM, V238, P192, DOI 10.1016/j.taap.2009.03.015; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Sachar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022032; SAKATA S, 1988, EXP HEMATOL, V16, P581; Satarug S, 2004, ENVIRON HEALTH PERSP, V112, P1099, DOI 10.1289/ehp.6751; Saxena RK, 2012, TRANSFUS MED HEMOTH, V39, P335, DOI 10.1159/000342524; Saxena RK, 2009, CURR SCI INDIA, V97, P500; Schauder A, 2010, J ENVIRON PATHOL TOX, V29, P137, DOI 10.1615/JEnvironPatholToxicolOncol.v29.i2.70; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Sorahan T, 1997, OCCUP ENVIRON MED, V54, P194, DOI 10.1136/oem.54.3.194; Stohs Sidney J., 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P201; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Waalkes MP, 2000, J INORG BIOCHEM, V79, P241, DOI 10.1016/S0162-0134(00)00009-X; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Wang YD, 2004, FREE RADICAL BIO MED, V36, P1434, DOI 10.1016/j.freeradbiomed.2004.03.010; WHO, 2010, EXP CADM MAJ PUBL HL; WHO INT AGCY RES CANC, 1993, IARC MONOG EVAL CARC, V58, P119; Zhang GC, 2002, J OCCUP HEALTH, V44, P15, DOI 10.1539/joh.44.15	49	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132697	10.1371/journal.pone.0132697	http://dx.doi.org/10.1371/journal.pone.0132697			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161863	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300169
J	Fuentes, TI; Appleby, N; Raya, M; Bailey, L; Hasaniya, N; Stodieck, L; Kearns-Jonker, M				Fuentes, Tania I.; Appleby, Nancy; Raya, Michael; Bailey, Leonard; Hasaniya, Nahidh; Stodieck, Louis; Kearns-Jonker, Mary			Simulated Microgravity Exerts an Age-Dependent Effect on the Differentiation of Cardiovascular Progenitors Isolated from the Human Heart	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CARDIOSPHERE-DERIVED CELLS; MODELED MICROGRAVITY; OSTEOGENIC DIFFERENTIATION; FLOW-CYTOMETRY; EXPRESSION; MICRORNA; PHOSPHORYLATION; SPECIFICATION; MULTIPOTENT	Microgravity has a profound effect on cardiovascular function, however, little is known about the impact of microgravity on progenitors that reside within the heart. We investigated the effect of simulated microgravity exposure on progenitors isolated from the neonatal and adult human heart by quantifying changes in functional parameters, gene expression and protein levels after 6-7 days of 2D clinorotation. Utilization of neonatal and adult cardiovascular progenitors in ground-based studies has provided novel insight into how microgravity may affect cells differently depending on age. Simulated microgravity exposure did not impact AKT or ERK phosphorylation levels and did not influence cell migration, but elevated transcripts for paracrine factors were identified in neonatal and adult cardiovascular progenitors. Age-dependent responses surfaced when comparing the impact of microgravity on differentiation. Endothelial cell tube formation was unchanged or increased in progenitors from adults whereas neonatal cardiovascular progenitors showed a decline in tube formation (p<0.05). Von Willebrand Factor, an endothelial differentiation marker, and MLC2v and Troponin T, markers for cardiomyogenic differentiation, were elevated in expression in adult progenitors after simulated microgravity. DNA repair genes and telomerase reverse transcriptase which are highly expressed in early stem cells were increased in expression in neonatal but not adult cardiac progenitors after growth under simulated microgravity conditions. Neonatal cardiac progenitors demonstrated higher levels of MESP1, OCT4, and brachyury, markers for early stem cells. Micro-RNA profiling was used to further investigate the impact of simulated microgravity on cardiovascular progenitors. Fifteen microRNAs were significantly altered in expression, including microRNAs-99a and 100 (which play a critical role in cell dedifferentiation). These microRNAs were unchanged in adult cardiac progenitors. The effect of exposure to simulated microgravity in cardiovascular progenitors is age-dependent. Adult cardiac progenitors showed elevated expression of markers for endothelial and cardiomyogenic differentiation whereas neonatal progenitors acquired characteristics of dedifferentiating cells.	[Fuentes, Tania I.; Appleby, Nancy; Raya, Michael; Kearns-Jonker, Mary] Loma Linda Univ, Sch Med, Dept Pathol & Human Anat, Loma Linda, CA 92534 USA; [Bailey, Leonard; Hasaniya, Nahidh] Loma Linda Univ, Sch Med, Dept & Cardiothorac Surg, Loma Linda, CA USA; [Stodieck, Louis] Univ Colorado, Dept Aerosp Engn Sci, BioServe Space Technol, Boulder, CO 80309 USA	Loma Linda University; Loma Linda University; University of Colorado System; University of Colorado Boulder	Kearns-Jonker, M (corresponding author), Loma Linda Univ, Sch Med, Dept Pathol & Human Anat, Loma Linda, CA 92534 USA.	mkearnsjonker@llu.edu		Kearns-Jonker, Mary/0000-0002-8989-3698	Center for the Advancement of Science In Space [GA-2014-130]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060507] Funding Source: NIH RePORTER	Center for the Advancement of Science In Space; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Center for the Advancement of Science In Space, GA-2014-130, www.iss-casis.org.	Abrahamsen I, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-36; Aguirre A, 2014, CELL STEM CELL, V15, P589, DOI 10.1016/j.stem.2014.10.003; Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Amir G, 2008, ANN THORAC SURG, V86, P1311, DOI 10.1016/j.athoracsur.2008.06.058; Bier A, 2013, ONCOTARGET, V4, P665, DOI 10.18632/oncotarget.928; Boissart C, 2012, DEVELOPMENT, V139, P1247, DOI 10.1242/dev.073627; Bondue A, 2011, J CELL BIOL, V192, P751, DOI 10.1083/jcb.201007063; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bradamante Silvia, 2014, Life-Basel, V4, P267, DOI 10.3390/life4020267; Cheng K, 2014, JACC-HEART FAIL, V2, P49, DOI 10.1016/j.jchf.2013.08.008; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Dai ZQ, 2007, CELL PROLIFERAT, V40, P671, DOI 10.1111/j.1365-2184.2007.00461.x; David R, 2011, CARDIOVASC RES, V92, P115, DOI 10.1093/cvr/cvr158; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Espinosa-Jeffrey A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076963; Fuentes TI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077464; Gallego ME, 2001, P NATL ACAD SCI USA, V98, P1711, DOI 10.1073/pnas.98.4.1711; Gershovich JG, 2007, B EXP BIOL MED+, V144, P608, DOI 10.1007/s10517-007-0387-1; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Girardi C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/296747; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Huang Y, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-87; Hwang YS, 2009, BIOMATERIALS, V30, P499, DOI 10.1016/j.biomaterials.2008.07.028; Jesty SA, 2012, P NATL ACAD SCI USA, V109, P13380, DOI 10.1073/pnas.1208114109; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064434; Jun HS, 2011, BLOOD, V117, P3881, DOI 10.1182/blood-2010-08-302059; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kong W, 2014, ONCOGENE, V33, P679, DOI 10.1038/onc.2012.636; Krutzik PO, 2004, CLIN IMMUNOL, V110, P206, DOI 10.1016/j.clim.2003.11.009; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Kumari R, 2009, J CELL BIOCHEM, V107, P723, DOI 10.1002/jcb.22171; Li YQ, 2013, STEM CELLS, V31, P1213, DOI 10.1002/stem.1362; Lin Shi-Lung, 2013, Methods Mol Biol, V936, P295; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Mangala LS, 2011, J BIOL CHEM, V286, P32483, DOI 10.1074/jbc.M111.267765; McGuckin CP, 2005, CELL PROLIFERAT, V38, P245, DOI 10.1111/j.1365-2184.2005.00346.x; Meyers VE, 2004, J CELL BIOCHEM, V93, P697, DOI 10.1002/jcb.20229; Mishra R, 2011, CIRCULATION, V123, P364, DOI 10.1161/CIRCULATIONAHA.110.971622; Mitsuhara T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt184; Ontiveros C, 2003, J CELL BIOCHEM, V88, P427, DOI 10.1002/jcb.10410; Pisanu ME, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/470253; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Saxena R, 2007, ANN NY ACAD SCI, V1116, P494, DOI 10.1196/annals.1402.033; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Simpson DL, 2012, CIRCULATION, V126, pS46, DOI 10.1161/CIRCULATIONAHA.111.084699; Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229; Sun LW, 2008, ACTA ASTRONAUT, V63, P968, DOI 10.1016/j.actaastro.2007.12.008; Talbot NC, 2010, IN VITRO CELL DEV-AN, V46, P502, DOI 10.1007/s11626-010-9302-6; Tang JM, 2009, EXP CELL RES, V315, P3521, DOI 10.1016/j.yexcr.2009.09.026; Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207; Vannier JB, 2006, EMBO J, V25, P4577, DOI 10.1038/sj.emboj.7601345; Versari S, 2007, BBA-MOL CELL RES, V1773, P1645, DOI 10.1016/j.bbamcr.2007.05.014; Versari S, 2013, FASEB J, V27, P4466, DOI 10.1096/fj.13-229195; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Yuge L, 2011, STEM CELLS DEV, V20, P893, DOI 10.1089/scd.2010.0294; Zayzafoon M, 2004, ENDOCRINOLOGY, V145, P2421, DOI 10.1210/en.2003-1156; Zeng XM, 2007, STEM CELL REV, V3, P270, DOI 10.1007/s12015-007-9005-x; Zhang SC, 2015, BIOMATERIALS, V41, P15, DOI 10.1016/j.biomaterials.2014.11.019; Zhang XF, 2013, NATURWISSENSCHAFTEN, V100, P125, DOI 10.1007/s00114-012-1002-5; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607; Zhu WY, 2014, CANCER INVEST, V32, P394, DOI 10.3109/07357907.2014.922569	64	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132378	10.1371/journal.pone.0132378	http://dx.doi.org/10.1371/journal.pone.0132378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161778	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300126
J	Lin, MF; Lin, YY; Lan, CY				Lin, Ming-Feng; Lin, Yun-You; Lan, Chung-Yu			The Role of the Two-Component System BaeSR in Disposing Chemicals through Regulating Transporter Systems in Acinetobacter baumannii	PLOS ONE			English	Article							MULTIDRUG EFFLUX PUMP; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; TIGECYCLINE; EXPRESSION; ADEABC; ENVELOPE; TANNINS; FAMILY; ADEIJK	Bacterial two-component regulatory systems (TCSs) facilitate changes in gene expression in response to environmental stimuli. TCS BaeR regulons influence tigecycline susceptibility in Acinetobacter baumannii through positively regulating the pump genes adeA and adeB. In this study, we demonstrate that an additional two transport systems, AdeIJK and MacAB-TolC, are also regulated by BaeSR. In the wild type and clinical tigecycline-resistant A. baumannii strains, gene expression of AdeIJK and MacAB-TolC increased after tigecycline induction, implicating their importance to tigecycline resistance in addition to AdeABC. Phenotypic microarray results showed that A. baumannii is vulnerable to certain chemicals, especially tannic acid, after deleting baeR, which was confirmed using the spot assay. The wild-type strain of A. baumannii also exhibited 1.6-fold and 4.4-fold increase in gene expression of adeJ and macB in the medium with 100 mu g/mL tannic acid, but the increase was fully inhibited by baeR deletion. An electrophoretic motility shift assay based on an interaction between His-BaeR and the adeA, adeI and macA promoter regions did not demonstrate direct binding. In conclusion, A. baumannii can use the TCS BaeSR in disposing chemicals, such as tannic acid and tigecycline, through regulating the efflux pumps.	[Lin, Ming-Feng] Natl Taiwan Univ Hosp, Dept Med, Chu Tung Branch, Hsinchu, Taiwan; [Lin, Ming-Feng; Lin, Yun-You; Lan, Chung-Yu] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Lan, Chung-Yu] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan	National Taiwan University; National Taiwan University Hospital; National Tsing Hua University; National Tsing Hua University	Lan, CY (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	cylan@life.nthu.edu.tw	林, 明鋒/AAX-7999-2020	林, 明鋒/0000-0002-4819-4057; Lan, Chung-Yu/0000-0002-1533-3049	National Taiwan University Hospital Chu-Tung Branch	National Taiwan University Hospital Chu-Tung Branch	This study was supported by a grant from National Taiwan University Hospital Chu-Tung Branch. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2009, ANTIMICROB AGENTS CH, V53, P3628, DOI 10.1128/AAC.00284-09; Akiyama H, 2001, J ANTIMICROB CHEMOTH, V48, P487, DOI 10.1093/jac/48.4.487; Alm E, 2006, PLOS COMPUT BIOL, V2, P1329, DOI 10.1371/journal.pcbi.0020143; Anthony KB, 2008, CLIN INFECT DIS, V46, P567, DOI 10.1086/526775; Appia-Ayme C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023713; Baranova N, 2002, J BACTERIOL, V184, P4168, DOI 10.1128/JB.184.15.4168-4176.2002; Barrett JF, 1998, P NATL ACAD SCI USA, V95, P5317, DOI 10.1073/pnas.95.9.5317; Beceiro A, 2011, ANTIMICROB AGENTS CH, V55, P3370, DOI 10.1128/AAC.00079-11; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Cerqueira GM, 2014, J INFECT DIS, V210, P46, DOI 10.1093/infdis/jiu024; Chusri S, 2009, J ANTIMICROB CHEMOTH, V64, P1203, DOI 10.1093/jac/dkp381; Clinical and Laboratory Standards Institute (CLSI), 2012, CLSI DOCUMENT M07 A9; Coyne S, 2011, ANTIMICROB AGENTS CH, V55, P947, DOI 10.1128/AAC.01388-10; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P4389, DOI 10.1128/AAC.00155-10; Damier-Piolle L, 2008, ANTIMICROB AGENTS CH, V52, P557, DOI 10.1128/AAC.00732-07; Deng M, 2014, ANTIMICROB AGENTS CH, V58, P297, DOI 10.1128/AAC.01727-13; Harris TL, 2014, ACS CHEM BIOL, V9, P122, DOI 10.1021/cb400490k; Henry R, 2012, ANTIMICROB AGENTS CH, V56, P59, DOI 10.1128/AAC.05191-11; Hooper DC, 2005, CLIN INFECT DIS, V40, P1811, DOI 10.1086/430381; Hou PF, 2012, CHEMOTHERAPY, V58, P152, DOI 10.1159/000335599; HUPKENS P, 1995, BURNS, V21, P57, DOI 10.1016/0305-4179(95)90784-W; Kim TJ, 2010, FOOD CHEM, V118, P740, DOI 10.1016/j.foodchem.2009.05.060; Leblanc SKD, 2011, J BACTERIOL, V193, P3367, DOI 10.1128/JB.01534-10; Lin MF, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-119; Liou ML, 2014, J MICROBIOL IMMUNOL, V47, P275, DOI 10.1016/j.jmii.2012.12.004; Ma D, 1996, MOL MICROBIOL, V19, P101, DOI 10.1046/j.1365-2958.1996.357881.x; Magnet S, 2001, ANTIMICROB AGENTS CH, V45, P3375, DOI 10.1128/AAC.45.12.3375-3380.2001; Marchand I, 2004, ANTIMICROB AGENTS CH, V48, P3298, DOI 10.1128/AAC.48.9.3298-3304.2004; Nishino K, 2005, J BACTERIOL, V187, P1763, DOI 10.1128/JB.187.5.1763-1772.2005; Nishino K, 2007, J BACTERIOL, V189, P9066, DOI 10.1128/JB.01045-07; Pachon-Ibanez ME, 2004, ANTIMICROB AGENTS CH, V48, P4479, DOI 10.1128/AAC.48.11.4479-4481.2004; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Rajamohan G, 2010, J ANTIMICROB CHEMOTH, V65, P1919, DOI 10.1093/jac/dkq195; Roca I, 2009, ANTIMICROB AGENTS CH, V53, P4013, DOI 10.1128/AAC.00584-09; Roca I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00148; Rosenfeld N, 2012, ANTIMICROB AGENTS CH, V56, P2504, DOI 10.1128/AAC.06422-11; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Ruzin A, 2007, J ANTIMICROB CHEMOTH, V59, P1001, DOI 10.1093/jac/dkm058; Sambrook J., 2001, MOL CLONING LAB MANU; Srinivasan VB, 2009, ANTIMICROB AGENTS CH, V53, P5312, DOI 10.1128/AAC.00748-09; Stephenson K, 2002, PHARMACOL THERAPEUT, V93, P293, DOI 10.1016/S0163-7258(02)00198-5; Su XZ, 2005, ANTIMICROB AGENTS CH, V49, P4362, DOI 10.1128/AAC.49.10.4362-4364.2005; Sun JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049534; Tomaras AP, 2008, MICROBIOL-SGM, V154, P3398, DOI 10.1099/mic.0.2008/019471-0; Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509; Wang D, 2013, METALLOMICS, V5, P372, DOI 10.1039/c3mt20217h; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wieczorek P, 2008, FOLIA HISTOCHEM CYTO, V46, P257, DOI 10.2478/v10042-008-0056-x; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003; Zoetendal EG, 2008, APPL ENVIRON MICROB, V74, P535, DOI 10.1128/AEM.02271-07	50	35	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132843	10.1371/journal.pone.0132843	http://dx.doi.org/10.1371/journal.pone.0132843			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161744	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300180
J	Moya-Perez, A; Neef, A; Sanz, Y				Moya-Perez, Angela; Neef, Alexander; Sanz, Yolanda			Bifidobacterium pseudocatenulatum CECT 7765 Reduces Obesity-Associated Inflammation by Restoring the Lymphocyte-Macrophage Balance and Gut Microbiota Structure in High-Fat Diet-Fed Mice	PLOS ONE			English	Article							INDUCED HEPATIC STEATOSIS; GROUP-SPECIFIC PRIMERS; LEPTIN-RESISTANT MICE; ADIPOSE-TISSUE; INSULIN-RESISTANCE; T-CELLS; PREDOMINANT BACTERIA; HUMAN FECES; LIVER; PROBIOTICS	Background/Objectives The role of intestinal dysbiosis in obesity-associated systemic inflammation via the crosstalk with peripheral tissues is under debate. Our objective was to decipher the mechanisms by which intervention in the gut ecosystem with a specific Bifidobacterium strain reduces systemic inflammation and improves metabolic dysfunction in obese high-fat diet (HFD) fed mice. Methods Adult male wild-type C57BL-6 mice were fed either a standard or HFD, supplemented with placebo or Bifidobacterium pseudocatenulatum CECT 7765, for 14 weeks. Lymphocytes, macrophages and cytokine/chemokine concentrations were quantified in blood, gut, liver and adipose tissue using bead-based multiplex assays. Biochemical parameters in serum were determined by ELISA and enzymatic assays. Histology was assessed by hematoxylin-eosin staining. Microbiota was analyzed by 16S rRNA gene pyrosequencing and quantitative PCR. Results B. pseudocatenulatum CECT 7765 reduced obesity-associated systemic inflammation by restoring the balance between regulatory T cells (Tregs) and B lymphocytes and reducing pro-inflammatory cytokines of adaptive (IL-17A) and innate (TNF-alpha) immunity and endotoxemia. In the gut, the bifidobacterial administration partially restored the HFD-induced alterations in microbiota, reducing abundances of Firmicutes and of LPS-producing Proteobacteria, paralleled to reductions in B cells, macrophages, and cytokines (IL-6, MCP-1, TNF-alpha, IL-17A), which could contribute to systemic effects. In adipose tissue, bifidobacterial administration reduced B cells whereas in liver the treatment increased Tregs and shifted different cytokines (MCP-1 plus ILP-10 in adipose tissue and INF-gamma plus IL-1 beta in liver). In both tissues, the bifidobacteria reduced pro-inflammatory macrophages and, TNF-alpha and IL-17A concentrations. These effects were accompanied by reductions in body weight gain and in serum cholesterol, triglyceride, glucose and insulin levels and improved oral glucose tolerance and insulin sensitivity in obese mice. Conclusions Here, we provide evidence of the immune cellular mechanisms by which the inflammatory cascade associated with diet-induced obesity is attenuated by the administration of a specific Bifidobacterium strain and that these effects are associated with modulation of gut microbiota structure.	[Moya-Perez, Angela; Neef, Alexander; Sanz, Yolanda] CSIC, Natl Res Council IATA, Inst Agrochem & Food Technol, Microbial Ecol Nutr & Hlth Res Grp, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Sanz, Y (corresponding author), CSIC, Natl Res Council IATA, Inst Agrochem & Food Technol, Microbial Ecol Nutr & Hlth Res Grp, Valencia, Spain.	yolsanz@iata.csic.es	Neef, Alexander/A-7900-2012; Sanz, Yolanda/H-5498-2012	Neef, Alexander/0000-0002-4170-9425; Sanz, Yolanda/0000-0002-1615-1976; MOYA PEREZ, ANGELA/0000-0002-2265-3630	Spanish Ministry of Science and Innovation (MICINN, Spain) [AGL2011-25169, Consolider Fun-C-Food CSD2007-00063]; Spanish Ministry of Education, Culture and Sport (MECD)	Spanish Ministry of Science and Innovation (MICINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education, Culture and Sport (MECD)(Spanish Government)	This study was supported by public grants AGL2011-25169 and Consolider Fun-C-Food CSD2007-00063 from the Spanish Ministry of Science and Innovation (MICINN, Spain). The scholarship of A. Moya from Spanish Ministry of Education, Culture and Sport (MECD) is fully acknowledged.	Arndt T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064305; Borst SE, 2005, LIFE SCI, V77, P2156, DOI 10.1016/j.lfs.2005.03.021; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Corridoni D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042067; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Duffaut C, 2009, ARTERIOSCL THROM VAS, V29, P1608, DOI 10.1161/ATVBAHA.109.192583; Ericksen RE, 2014, GUT, V63, P385, DOI 10.1136/gutjnl-2013-305092; Esposito E, 2009, J NUTR, V139, P905, DOI 10.3945/jn.108.101808; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Cano PG, 2013, OBESITY, V21, P2310, DOI 10.1002/oby.20330; Gerner RR, 2013, CAN J PHYSIOL PHARM, V91, P867, DOI 10.1139/cjpp-2013-0050; Geurts L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00149; Goel A, 2014, J GASTROEN HEPATOL, V29, P1139, DOI 10.1111/jgh.12556; Jialal I, 2014, J CLIN ENDOCR METAB, V99, P39, DOI 10.1210/jc.2013-3092; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Li H, 2008, METABOLISM, V57, P1704, DOI 10.1016/j.metabol.2008.07.029; LI XM, 1991, HEPATOLOGY, V14, P121, DOI 10.1002/hep.1840140120; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; MIURA S, 1993, IMMUNOLOGY, V78, P142; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Paul G, 2006, INFLAMM BOWEL DIS, V12, P471, DOI 10.1097/00054725-200606000-00005; Poutahidis T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068596; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Sanz Y, 2013, PHARMACOL RES, V69, P144, DOI 10.1016/j.phrs.2012.10.021; Sanz Y, 2009, INT REV IMMUNOL, V28, P397, DOI 10.3109/08830180903215613; Schlegel PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082580; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shim JO, 2013, PEDIATR GASTROENTERO, V16, P17, DOI 10.5223/pghn.2013.16.1.17; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Winer D A, 2012, Int J Obes Suppl, V2, pS4; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Wolowczuk I, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/639803; Zhang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042529	50	132	140	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0126976	10.1371/journal.pone.0126976	http://dx.doi.org/10.1371/journal.pone.0126976			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161548	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300004
J	Muriel, C; Jalvo, B; Redondo-Nieto, M; Rivilla, R; Martin, M				Muriel, Candela; Jalvo, Blanca; Redondo-Nieto, Miguel; Rivilla, Rafael; Martin, Marta			Chemotactic Motility of Pseudomonas fluorescens F113 under Aerobic and Denitrification Conditions	PLOS ONE			English	Article							COMPETITIVE COLONIZATION ABILITY; ROOT COLONIZATION; RHIZOSPHERE COLONIZATION; SENSORY PROTEINS; AERUGINOSA; GENES; IDENTIFICATION; GROWTH; INVOLVEMENT; SELECTION	The sequence of the genome of Pseudomonas fluorescens F113 has shown the presence of multiple traits relevant for rhizosphere colonization and plant growth promotion. Among these traits are denitrification and chemotactic motility. Besides aerobic growth, F113 is able to grow anaerobically using nitrate and nitrite as final electron acceptors. F113 is able to perform swimming motility under aerobic conditions and under anaerobic conditions when nitrate is used as the electron acceptor. However, nitrite can not support swimming motility. Regulation of swimming motility is similar under aerobic and anaerobic conditions, since mutants that are hypermotile under aerobic conditions, such as gacS, sadB, kinB, algU and wspR, are also hypermotile under anaerobic conditions. However, chemotactic behavior is different under aerobic and denitrification conditions. Unlike most pseudomonads, the F113 genome encode three complete chemotaxis systems, Che1, Che2 and Che3. Mutations in each of the cheA genes of the three Che systems has shown that the three systems are functional and independent. Mutation of the cheA1 gene completely abolished swimming motility both under aerobic and denitrification conditions. Mutation of the cheA2 gene, showed only a decrease in swimming motility under both conditions, indicating that this system is not essential for chemotactic motility but is necessary for optimal motility. Mutation of the cheA3 gene abolished motility under denitrification conditions but only produced a decrease in motility under aerobic conditions. The three Che systems proved to be implicated in competitive rhizosphere colonization, being the cheA1 mutant the most affected.	[Muriel, Candela; Jalvo, Blanca; Redondo-Nieto, Miguel; Rivilla, Rafael; Martin, Marta] Univ Autonoma Madrid, Dept Biol, Madrid, Spain	Autonomous University of Madrid	Martin, M (corresponding author), Univ Autonoma Madrid, Dept Biol, Madrid, Spain.	m.martin@uam.es	Rivilla, Rafael/A-1659-2008; Jalvo Sánchez, Blanca/AGH-8156-2022; martin, marta/H-2169-2015; Basanta, Marta Martin/AAI-5459-2020; Redondo-Nieto, Miguel/A-6169-2011	Rivilla, Rafael/0000-0003-0701-2939; martin, marta/0000-0003-2498-9768; Basanta, Marta Martin/0000-0003-2498-9768; Redondo-Nieto, Miguel/0000-0002-3361-520X	Spanish Ministry of Economy and Competitiveness [BIO2012-31634]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was funded by the Spanish Ministry of Economy and Competitiveness, grant BIO2012-31634. Candela Muriel is the recipient of an FPI fellowship from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barahona E, 2011, APPL ENVIRON MICROB, V77, P5412, DOI 10.1128/AEM.00320-11; Barahona E, 2010, ENVIRON MICROBIOL, V12, P3185, DOI 10.1111/j.1462-2920.2010.02291.x; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; Capdevila S, 2004, MICROBIOL-SGM, V150, P3889, DOI 10.1099/mic.0.27362-0; CARLSON CA, 1983, APPL ENVIRON MICROB, V45, P1247, DOI 10.1128/AEM.45.4.1247-1253.1983; De La Fuente L, 2006, PHYTOPATHOLOGY, V96, P751, DOI 10.1094/PHYTO-96-0751; de Weert S, 2002, MOL PLANT MICROBE IN, V15, P1173, DOI 10.1094/MPMI.2002.15.11.1173; Ditty JL, 1998, FEMS MICROBIOL LETT, V159, P267, DOI 10.1016/S0378-1097(97)00581-8; FAHRAEUS G, 1957, J GEN MICROBIOL, V16, P374, DOI 10.1099/00221287-16-2-374; Ferrandez A, 2002, J BACTERIOL, V184, P4374, DOI 10.1128/JB.184.16.4374-4383.2002; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Ghiglione JF, 2002, FEMS MICROBIOL ECOL, V39, P121, DOI 10.1111/j.1574-6941.2002.tb00913.x; Ghirardi S, 2012, MICROB ECOL, V64, P725, DOI 10.1007/s00248-012-0065-3; GREENBERG EP, 1977, CAN J MICROBIOL, V23, P903, DOI 10.1139/m77-133; Guvener ZT, 2006, MOL MICROBIOL, V61, P106, DOI 10.1111/j.1365-2958.2006.05218.x; Hong CS, 2005, J BACTERIOL, V187, P1533, DOI 10.1128/JB.187.4.1533-1535.2005; Hong CS, 2004, J BIOSCI BIOENG, V97, P184, DOI 10.1263/jbb.97.184; Kato J, 1999, BIOSCI BIOTECH BIOCH, V63, P155, DOI 10.1271/bbb.63.155; Line L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00554; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Martinez-Granero F, 2005, MICROBIOL-SGM, V151, P975, DOI 10.1099/mic.0.27583-0; Martinez-Granero F, 2006, APPL ENVIRON MICROB, V72, P3429, DOI 10.1128/AEM.72.5.3429-3434.2006; Martinez-Granero F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-237; Martinez-Granero F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087608; Martinez-Granero F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031765; Miller SH, 2010, ENV MICROBIOL REP, V2, P403, DOI 10.1111/j.1758-2229.2009.00105.x; Naseby DC, 2001, MICROB ECOL, V42, P193; Navazo A, 2009, MICROB BIOTECHNOL, V2, P489, DOI 10.1111/j.1751-7915.2009.00103.x; Oku S, 2014, MICROBES ENVIRON, V29, P413, DOI 10.1264/jsme2.ME14128; Oku S, 2012, MICROBES ENVIRON, V27, P462, DOI 10.1264/jsme2.ME12005; Philippot L, 2001, BBA-GENE STRUCT EXPR, V1517, P436, DOI 10.1016/S0167-4781(00)00286-4; Redondo-Nieto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-54; Sanchez-Contreras M, 2002, J BACTERIOL, V184, P1587, DOI 10.1128/JB.184.6.1587-1596.2002; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHER FM, 1982, PHYTOPATHOLOGY, V72, P1567, DOI 10.1094/Phyto-72-1567; Shimizu TS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.37; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Simons M, 1996, MOL PLANT MICROBE IN, V9, P600, DOI 10.1094/MPMI-9-0600; von Felten A, 2011, J MICROBIOL METH, V84, P379, DOI 10.1016/j.mimet.2010.11.012; WILLIAMS DR, 1978, APPL ENVIRON MICROB, V36, P257, DOI 10.1128/AEM.36.2.257-263.1978	41	18	18	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132242	10.1371/journal.pone.0132242	http://dx.doi.org/10.1371/journal.pone.0132242			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161531	Green Submitted, gold, Green Published			2022-12-27	WOS:000358162300106
J	Yao, ZJ; Hu, B; Zheng, JX; Zheng, WH; Chen, XJ; Gao, X; Xie, YW; Fang, L				Yao, Zhijun; Hu, Bin; Zheng, Jiaxiang; Zheng, Weihao; Chen, Xuejiao; Gao, Xiang; Xie, Yuanwei; Fang, Lei		Alzheimer's Dis Neuroimaging Initi	A FDG-PET Study of Metabolic Networks in Apolipoprotein E epsilon 4 Allele Carriers	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; SMALL-WORLD; FUNCTIONAL CONNECTIVITY; TOPOLOGICAL PATTERNS; GENETIC INFLUENCE; AUDITORY-CORTEX; HESCHLS GYRUS; APOE GENOTYPE; FMRI EVIDENCE	Recently, some studies have applied the graph theory in brain network analysis in Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI). However, relatively little research has specifically explored the properties of the metabolic network in apolipoprotein E (APOE) epsilon 4 allele carriers. In our study, all the subjects, including ADs, MCIs and NCs (normal controls) were divided into 165 APOE epsilon 4 carriers and 165 APOE epsilon 4 noncarriers. To establish the metabolic network for all brain regions except the cerebellum, cerebral glucose metabolism data obtained from FDG-PET (F-18-fluorodeoxyglu-cose positron emission tomography) were segmented into 90 areas with automated anatomical labeling (AAL) template. Then, the properties of the networks were computed to explore the between-group differences. Our results suggested that both APOE epsilon 4 carriers and noncarriers showed the small-world properties. Besides, compared with APOE epsilon 4 noncarriers, the carriers showed a lower clustering coefficient. In addition, significant changes in 6 hub brain regions were found in between-group nodal centrality. Namely, compared with APOE epsilon 4 noncarriers, significant decreases of the nodal centrality were found in left insula, right insula, right anterior cingulate, right paracingulate gyri, left cuneus, as well as significant increases in left paracentral lobule and left heschl gyrus in APOE epsilon 4 carriers. Increased local short distance inter-regional correlations and disrupted long distance inter-regional correlations were found, which may support the point that the APOE epsilon 4 carriers were more similar with AD or MCI in FDG uptake. In summary, the organization of metabolic network in APOE epsilon 4 carriers indicated a less optimal pattern and APOE epsilon 4 might be a risk factor for AD.	[Yao, Zhijun; Hu, Bin; Zheng, Jiaxiang; Zheng, Weihao; Chen, Xuejiao; Gao, Xiang; Xie, Yuanwei] Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou 730000, Peoples R China; [Fang, Lei] Lanzhou Mil Area Command, Affiliated Lanzhou Gen Hosp, PET CT Ctr, Lanzhou, Peoples R China	Lanzhou University	Hu, B (corresponding author), Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou 730000, Peoples R China.	bh@lzu.edu.cn	Preda, Adrian/K-8889-2013; Hsiung, Robin/AAT-1661-2021	Preda, Adrian/0000-0003-3373-2438; Hsiung, Robin/0000-0002-8017-0856; Ponto, Laura/0000-0003-1197-6714	National Basic Research Program of China [2014CB744600]; International Cooperation Project of Ministry of Science and Technology [2013DFA11140]; National Natural Science Foundation of China [61210010]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); International Cooperation Project of Ministry of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Basic Research Program of China (2014CB744600), the International Cooperation Project of Ministry of Science and Technology (2013DFA11140) and the National Natural Science Foundation of China (61210010).	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Adamson MM, 2011, NEUROPSYCHOLOGIA, V49, P2448, DOI 10.1016/j.neuropsychologia.2011.04.022; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Alata W, 2015, J CEREBR BLOOD F MET, V35, P86, DOI 10.1038/jcbfm.2014.172; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bokde ALW, 2006, BRAIN, V129, P1113, DOI 10.1093/brain/awl051; Bondi MW, 2005, NEUROLOGY, V64, P501, DOI 10.1212/01.WNL.0000150885.00929.7E; Carbonell F, 2014, J CEREBR BLOOD F MET, V34, P1169, DOI 10.1038/jcbfm.2014.66; Caselli RJ, 2007, ARCH NEUROL-CHICAGO, V64, P1306, DOI 10.1001/archneur.64.9.1306; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Chen KW, 2007, AM J PSYCHIAT, V164, P916, DOI 10.1176/appi.ajp.164.6.916; Chen KW, 2012, NEUROIMAGE, V60, P2316, DOI 10.1016/j.neuroimage.2012.02.005; Chen YJ, 2015, J NEUROSCI, V35, P1423, DOI 10.1523/JNEUROSCI.1946-14.2015; Choo IH, 2013, J ALZHEIMERS DIS, V33, P929, DOI 10.3233/JAD-2012-121489; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; Da Costa S, 2011, J NEUROSCI, V31, P14067, DOI 10.1523/JNEUROSCI.2000-11.2011; Ewers M, 2011, TRENDS NEUROSCI, V34, P430, DOI 10.1016/j.tins.2011.05.005; Forster S, 2010, J PSYCHIATR RES, V44, P462, DOI 10.1016/j.jpsychires.2009.09.012; Ge JJ, 2014, NEURAL REGEN RES, V9, P763, DOI 10.4103/1673-5374.131586; GERDES LU, 1992, GENET EPIDEMIOL, V9, P155, DOI 10.1002/gepi.1370090302; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Han SD, 2007, NEUROBIOL AGING, V28, P238, DOI 10.1016/j.neurobiolaging.2005.12.013; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Indefrey P, 2001, P NATL ACAD SCI USA, V98, P5933, DOI 10.1073/pnas.101118098; Ito K, 2012, J PHARMACOKINET PHAR, V39, P601, DOI 10.1007/s10928-012-9271-3; Kim J, 2014, MOL CELLS, V37, P767, DOI 10.14348/molcells.2014.0248; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kim SM, 2013, NEURORADIOLOGY, V55, P25, DOI 10.1007/s00234-012-1077-x; Linden DEJ, 2012, NEURON, V73, P8, DOI 10.1016/j.neuron.2011.12.014; Morra JH, 2009, HUM BRAIN MAPP, V30, P2766, DOI 10.1002/hbm.20708; Morra JH, 2009, NEUROIMAGE, V45, pS3, DOI 10.1016/j.neuroimage.2008.10.043; Mosconi L, 2004, J NEUROL NEUROSUR PS, V75, P370, DOI 10.1136/jnnp.2003.014993; Mosconi L, 2008, BIOL PSYCHIAT, V63, P609, DOI 10.1016/j.biopsych.2007.05.030; Mosconi L, 2010, J ALZHEIMERS DIS, V20, P843, DOI 10.3233/JAD-2010-091504; Ossenkoppele R, 2013, NEUROLOGY, V80, P359, DOI 10.1212/WNL.0b013e31827f0889; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Reiman EM, 2001, P NATL ACAD SCI USA, V98, P3334, DOI 10.1073/pnas.061509598; Sanabria-Diaz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068860; Saykin AJ, 2004, BRAIN, V127, P1574, DOI 10.1093/brain/awh177; Scarmeas N, 2004, NEUROLOGY, V63, P913, DOI 10.1212/01.WNL.0000137274.93125.46; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Schuit AJ, 2001, MED SCI SPORT EXER, V33, P772; Seo EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083205; Seo EH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053922, 10.1371/journal.pone.0076875]; Shi J, 2014, HUM BRAIN MAPP, V35, P3903, DOI 10.1002/hbm.22447; Shi J, 2013, NEUROIMAGE, V78, P111, DOI 10.1016/j.neuroimage.2013.04.018; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Trachtenberg AJ, 2012, NEUROIMAGE, V59, P565, DOI 10.1016/j.neuroimage.2011.07.059; Vanni S, 2001, P NATL ACAD SCI USA, V98, P2776, DOI 10.1073/pnas.041600898; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westlye ET, 2011, J NEUROSCI, V31, P7775, DOI 10.1523/JNEUROSCI.1230-11.2011; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Zhu WL, 2012, NEUROBIOL AGING, V33, P899, DOI 10.1016/j.neurobiolaging.2010.06.022	63	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132300	10.1371/journal.pone.0132300	http://dx.doi.org/10.1371/journal.pone.0132300			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161964	gold, Green Published			2022-12-27	WOS:000358162300116
J	Zengin, T; Ekinci, B; Kucukkose, C; Yalcin-Ozuysal, O				Zengin, Talip; Ekinci, Burcu; Kucukkose, Cansu; Yalcin-Ozuysal, Ozden			IRF6 Is Involved in the Regulation of Cell Proliferation and Transformation in MCF10A Cells Downstream of Notch Signaling	PLOS ONE			English	Article							HUMAN BREAST-CANCER; EPITHELIAL-CELLS; P53 HOMOLOG; P63; DIFFERENTIATION; MICE; LIMB; IDENTIFICATION; COMMITMENT; ACTIVATION	IRF6, a member of Interferon Regulatory Factors (IRF) family, is involved in orofacial and epidermal development. In breast cancer cell lines ectopic expression of IRF6 reduces cell numbers suggesting a role as negative regulator of cell cycle. IRF6 is a direct target of canonical Notch signaling in keratinocyte differentiation. Notch is involved in luminal cell fate determination and stem cell regulation in the normal breast and is implicated as an oncogene in breast cancer. Notch activation is sufficient to induce proliferation and transformation in non-tumorigenic breast epithelial cell line, MCF10A. Delta Np63, which is downregulated by Notch activation in the breast, regulates IRF6 expression in keratinocytes. In this report, we investigate Notch-IRF6 and Delta Np63-IRF6 interactions in MCF10A and MDA MB 231 cells. We observed that in these cells, IRF6 expression is partially regulated by canonical Notch signaling and Delta Np63 downregulation. Furthermore, we demonstrate that IRF6 abrogation impairs Notch-induced proliferation and transformation in MCF10A cells. Thus, we confirm the previous findings by showing a tissue independent regulation of IRF6 by Notch signaling, and extend them by proposing a context dependent role for IRF6, which acts as a positive regulator of proliferation and transformation in MCF10A cells downstream of Notch signaling.	[Zengin, Talip; Ekinci, Burcu; Kucukkose, Cansu; Yalcin-Ozuysal, Ozden] Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey	Izmir Institute of Technology	Yalcin-Ozuysal, O (corresponding author), Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey.	ozdenyalcin@iyte.edu.tr	Zengin, Talip/AAR-2547-2021; Yalcin Ozuysal, Ozden/D-5528-2019	Zengin, Talip/0000-0003-4764-4615; Yalcin-Ozuysal, Ozden/0000-0003-0552-368X	Scientific and Technological Research Council of Turkey [110T895]; Izmir Institute of Technology	Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Izmir Institute of Technology(Izmir Institute of Technology)	This work was supported by the Scientific and Technological Research Council of Turkey, 110T895, (OYO), and the Izmir Institute of Technology, (OYO).	ALLEY MC, 1988, CANCER RES, V48, P589; Bailey CM, 2008, MOL CELL BIOL, V28, P2235, DOI 10.1128/MCB.01866-07; Bailey CM, 2009, DEV GROWTH DIFFER, V51, P473, DOI 10.1111/j.1440-169X.2009.01110.x; Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Biggs LC, 2012, J INVEST DERMATOL, V132, P50, DOI 10.1038/jid.2011.272; Botti E, 2011, P NATL ACAD SCI USA, V108, P13710, DOI 10.1073/pnas.1110931108; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; de la Garza G, 2013, J INVEST DERMATOL, V133, P68, DOI 10.1038/jid.2012.269; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; GALLAHAN D, 1987, J VIROL, V61, P66, DOI 10.1128/JVI.61.1.66-74.1987; Gallahan D, 1997, ONCOGENE, V14, P1883, DOI 10.1038/sj.onc.1201035; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; Han LF, 2014, CANCER RES, V74, P6509, DOI 10.1158/0008-5472.CAN-14-0816; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Iwata J, 2013, DEVELOPMENT, V140, P1220, DOI 10.1242/dev.089615; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Mangold E, 2011, TRENDS MOL MED, V17, P725, DOI 10.1016/j.molmed.2011.07.007; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moretti F, 2010, J CLIN INVEST, V120, P1570, DOI 10.1172/JCI40267; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Richardson RJ, 2009, HUM MOL GENET, V18, P2632, DOI 10.1093/hmg/ddp201; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Savitsky D, 2010, CANCER IMMUNOL IMMUN, V59, P489, DOI 10.1007/s00262-009-0804-6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SOULE HD, 1990, CANCER RES, V50, P6075; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Sun YP, 2005, ONCOGENE, V24, P5365, DOI 10.1038/sj.onc.1208528; Thomason HA, 2010, J CLIN INVEST, V120, P1561, DOI 10.1172/JCI40266; Yalcin-Ozuysal O, 2010, CELL DEATH DIFFER, V17, P1600, DOI 10.1038/cdd.2010.37; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	40	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132757	10.1371/journal.pone.0132757	http://dx.doi.org/10.1371/journal.pone.0132757			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161746	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300174
J	Zhao, MH; Liang, S; Kim, SH; Cui, XS; Kim, NH				Zhao, Ming-Hui; Liang, Shuang; Kim, Seon-Hyang; Cui, Xiang-Shun; Kim, Nam-Hyung			Fe(III) Is Essential for Porcine Embryonic Development via Mitochondrial Function Maintenance	PLOS ONE			English	Article							DIETARY IRON-DEFICIENCY; OOCYTE MATURATION; CYTOCHROME-C; FOLLICULAR-FLUID; ERYTHROID-CELLS; IN-VITRO; APOPTOSIS; BIOGENESIS; DEFEROXAMINE; METABOLISM	Iron is an important trace element involved in several biological processes. The role of iron in porcine early embryonic development remains unknown. In the present study, we depleted iron (III, Fe3+) with deferoxamine (DFM), a specific Fe3+ chelator, in cultured porcine parthenotes and monitored embryonic development, apoptosis, mitochondrial membrane potential, and ATP production. Results showed biphasic function of Fe3+ in porcine embryo development. 0.5 mu M DFM obviously increased blastocyst formation (57.49 +/- 2.18% vs. control, 43.99 +/- 1.72%, P < 0.05) via reduced (P < 0.05) production of reactive oxygen species (ROS), further increased mitochondrial membrane potential and ATP production in blastocysts (P < 0.05). 0.5 mu M DFM decreased mRNA expression of Caspase 3 (Casp3) and increased Bcl-xL. However, results showed a significant reduction in blastocyst formation in the presence of 5.0 mu M DFM compared with the control group (DFM, 21.62 +/- 3.92% vs. control, 43.99 +/- 1.73%, P < 0.05). Fe3+ depletion reduced the total (DFM, 21.10 +/- 8.78 vs. control, 44.09 +/- 13.65, P < 0.05) and increased apoptotic cell number (DFM, 11.10 +/- 5.24 vs. control, 2.64 +/- 1.43, P < 0.05) in the blastocyst. An obvious reduction in mitochondrial membrane potential and ATP level after 5.0 mu M DFM treatment was observed. Co-localization between mitochondria and cytochrome c was reduced after high concentration of DFM treatment. In conclusion, Fe3+ is essential for porcine embryonic development via mitochondrial function maintenance, but redundant Fe3+ impairs the function of mitochondria.	[Zhao, Ming-Hui; Liang, Shuang; Kim, Seon-Hyang; Cui, Xiang-Shun; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, Chungbuk, South Korea; [Zhao, Ming-Hui; Liang, Shuang; Kim, Seon-Hyang; Cui, Xiang-Shun; Kim, Nam-Hyung] Brain Korea 21 Ctr Bioresource Dev, Cheongju, Chungbuk, South Korea	Chungbuk National University	Cui, XS (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju, Chungbuk, South Korea.	xscui@chungbuk.ac.kr; nhkim@chungbuk.ac.kr			Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ011126]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by grants from the Next-Generation BioGreen 21 Program (PJ011126), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HS, 2006, J NUTR, V136, P1171, DOI 10.1093/jn/136.5.1171; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Baltz JM, 2010, HUM REPROD UPDATE, V16, P166, DOI 10.1093/humupd/dmp045; Barcroft LC, 2003, DEV BIOL, V256, P342, DOI 10.1016/S0012-1606(02)00127-6; BOSQUE MA, 1995, ARCH TOXICOL, V69, P467, DOI 10.1007/s002040050200; Cao ZB, 2012, ZYGOTE, V20, P229, DOI 10.1017/S0967199411000153; Cui XS, 2013, REPROD FERT DEVELOP, V25, P691, DOI 10.1071/RD12138; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dong F, 2005, CLIN SCI, V109, P277, DOI 10.1042/CS20040278; Duce JA, 2010, PROG NEUROBIOL, V92, P1, DOI 10.1016/j.pneurobio.2010.04.003; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; Ge HS, 2012, MOL REPROD DEV, V79, P392, DOI 10.1002/mrd.22042; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HWANG YF, 1964, ARCH INTERN MED, V114, P741, DOI 10.1001/archinte.1964.03860120053003; Jeong YW, 2008, ANIM REPROD SCI, V106, P13, DOI 10.1016/j.anireprosci.2007.03.021; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; Lee SK, 2015, THERIOGENOLOGY, V83, P121, DOI 10.1016/j.theriogenology.2014.08.019; Lee SK, 2014, J REPROD DEVELOP, V60, P128, DOI 10.1262/jrd.2013-098; Leist M, 1997, BIOCHEM BIOPH RES CO, V236, P1, DOI 10.1006/bbrc.1997.6890; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARCIANI MG, 1991, HAEMATOLOGICA, V76, P131; Martindale W., 1993, MARTINDALE THE EXTRA; MASINI A, 1994, BBA-BIOENERGETICS, V1188, P46, DOI 10.1016/0005-2728(94)90020-5; NOMIZU T, 1993, MOL REPROD DEV, V36, P419, DOI 10.1002/mrd.1080360403; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Okonko DO, 2004, J CARD FAIL, V10, pS5, DOI 10.1016/j.cardfail.2004.01.004; Perez GI, 2007, CELL DEATH DIFFER, V14, P524, DOI 10.1038/sj.cdd.4402050; Ponka P, 1997, BLOOD, V89, P1; Reubinoff BE, 1996, AM J OBSTET GYNECOL, V174, P914, DOI 10.1016/S0002-9378(96)70325-3; Rosell FI, 2002, BIOCHEMISTRY-US, V41, P7811, DOI 10.1021/bi016060e; Sendamarai AK, 2008, P NATL ACAD SCI USA, V105, P7410, DOI 10.1073/pnas.0801318105; Sluhots'ka I B, 2002, Lik Sprava, P141; Suzuki C, 2004, J REPROD DEVELOP, V50, P487, DOI 10.1262/jrd.50.487; Tong WH, 2007, BIOMETALS, V20, P549, DOI 10.1007/s10534-006-9047-6; Van Blerkom J, 2007, MOL HUM REPROD, V13, P759, DOI 10.1093/molehr/gam068; Van Thuan N, 2002, BIOL REPROD, V67, P1688, DOI DOI 10.1095/BIOLREPROD.102.004812; VAYSSIERE JL, 1994, P NATL ACAD SCI USA, V91, P11752, DOI 10.1073/pnas.91.24.11752; Walter PB, 2002, P NATL ACAD SCI USA, V99, P2264, DOI 10.1073/pnas.261708798; WATSON AJ, 1990, DEV GENET, V11, P41, DOI 10.1002/dvg.1020110106; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Yang CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014242; Zhao MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102097	45	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130791	10.1371/journal.pone.0130791	http://dx.doi.org/10.1371/journal.pone.0130791			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161974	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300020
J	Estevez, SR; Nikoloski, Z				Estevez, Semidan Robaina; Nikoloski, Zoran			Context-Specific Metabolic Model Extraction Based on Regularized Least Squares Optimization	PLOS ONE			English	Article							GLOBAL RECONSTRUCTION; TISSUE; NETWORK; LIVER	Genome-scale metabolic models have proven highly valuable in investigating cell physiology. Recent advances include the development of methods to extract context-specific models capable of describing metabolism under more specific scenarios (e.g., cell types). Yet, none of the existing computational approaches allows for a fully automated model extraction and determination of a flux distribution independent of user-defined parameters. Here we present RegrEx, a fully automated approach that relies solely on context-specific data and l(1)-norm regularization to extract a context-specific model and to provide a flux distribution that maximizes its correlation to data. Moreover, the publically available implementation of RegrEx was used to extract 11 context-specific human models using publicly available RNAseq expression profiles, Recon1 and also Recon2, the most recent human metabolic model. The comparison of the performance of RegrEx and its contending alternatives demonstrates that the proposed method extracts models for which both the structure, i.e., reactions included, and the flux distributions are in concordance with the employed data. These findings are supported by validation and comparison of method performance on additional data not used in context-specific model extraction. Therefore, our study sets the ground for applications of other regularization techniques in large-scale metabolic modeling.	[Estevez, Semidan Robaina; Nikoloski, Zoran] Max Planck Inst Mol Plant Physiol MPIMP, Syst Biol & Math Modeling Grp, Potsdam, Germany	Max Planck Society	Nikoloski, Z (corresponding author), Max Planck Inst Mol Plant Physiol MPIMP, Syst Biol & Math Modeling Grp, Potsdam, Germany.	nikoloski@mpimp-golm.mpg.de		Nikoloski, Zoran/0000-0003-2671-6763; Robaina Estevez, Semidan/0000-0003-0781-1677				Agren R, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.145122; Agren R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002518; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Blazier AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00299; Candes E, 2007, ANN STAT, V35, P2313, DOI 10.1214/009053606000001523; Dal'Molin CGD, 2010, PLANT PHYSIOL, V154, P1871, DOI 10.1104/pp.110.166488; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Estevez SR, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00491; Frayn KN, 2006, ESSAYS BIOCHEM, V42, P89, DOI 10.1042/bse0420089; Grafahrend-Belau E, 2013, PLANT PHYSIOL, V163, P637, DOI 10.1104/pp.113.224006; Gurobi Optimization I, 2014, GUR OPT REF MAN; Hastie T, 1996, J ROY STAT SOC B MET, V58, P155; Hesterberg T, 2008, STAT SURV, V2, P61, DOI 10.1214/08-SS035; Hyduke D., 2011, PROTOC EXCH, P1, DOI [DOI 10.1038/PROTEX.2011.234, 10.1038/protex.2011.234]; Hyduke DR, 2013, MOL BIOSYST, V9, P167, DOI 10.1039/c2mb25453k; Jensen PA, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-147; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; Kruger NJ, 2012, J EXP BOT, V63, P2309, DOI 10.1093/jxb/err382; Krupp M, 2012, BIOINFORMATICS, V28, P1184, DOI 10.1093/bioinformatics/bts084; Lash LH, 2005, TOXICOL APPL PHARM, V204, P329, DOI 10.1016/j.taap.2004.10.004; Lee D, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-73; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Machado D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003580; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Makhorin Andrew, 2012, GNU LINEAR PROGRAMMI; McDonald GC, 2009, WIRES COMPUT STAT, V1, DOI 10.1002/wics.14; Moxley JF, 2009, P NATL ACAD SCI USA, V106, P6477, DOI 10.1073/pnas.0811091106; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pan W, 2012, CORR, V1, P1; Ravikirthi P, 2011, BIOTECHNOL BIOENG, V108, P1372, DOI 10.1002/bit.23070; Rossell S, 2006, P NATL ACAD SCI USA, V103, P2166, DOI 10.1073/pnas.0509831103; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schmidt BJ, 2013, BIOINFORMATICS, V29, P2900, DOI 10.1093/bioinformatics/btt493; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Tirthankar Sengupta, 2013, PREPR 12 IFAC S COMP, P16; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vidaurre D, 2013, INT STAT REV, V81, P361, DOI 10.1111/insr.12023; Vlassis N, 2014, FASTCORE MATLAB IMPL; Vlassis N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003424; Wang YL, 2012, BMC SYST BIOL, V6, DOI [10.1186/1752-0509-6-153, 10.1186/1752-0509-6-S3-S21]; Young JD, 2011, METAB ENG, V13, P656, DOI 10.1016/j.ymben.2011.08.002; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zur H, 2010, BIOINFORMATICS, V26, P3140, DOI 10.1093/bioinformatics/btq602	44	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131875	10.1371/journal.pone.0131875	http://dx.doi.org/10.1371/journal.pone.0131875			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158726	Green Submitted, Green Published, gold			2022-12-27	WOS:000358161200040
J	Lin, SP; Long, YM; Chen, XH				Lin, Shao-Peng; Long, You-Ming; Chen, Xiao-Hui			The Effects of Statins on Infections after Stroke or Transient Ischemic Attack: A Meta-Analysis	PLOS ONE			English	Article							HIGH-DOSE ATORVASTATIN; RISK; COMPLICATIONS; ASSOCIATION; SIMVASTATIN; ACTIVATION; OUTCOMES; THERAPY; DISEASE	Background Previous studies have reported that statins can prevent infections, and these findings were ascribed to the anti-inflammatory and immunomodulatory properties of statins. However, the effects of statins on the risk of infection after stroke or transient ischemic attack (TIA) remain controversial. The aim of this study was to evaluate the relationship between statins and the risk of infection after stroke or TIA by means of a meta-analysis. Methodology and Findings Studies were found by searching major electronic databases using key terms and restricting the results to studies published in English language and human studies. Pooled odds ratio (OR) for the association between infection and statins were analyzed using Stata software. A total of five studies that included 8,791 stroke or TIA patients (3,269 patients in the statin use group and 5,522 in the placebo group) were eligible and abstracted. Pooled analysis demonstrated that statins did not significantly affect the incidence of infection after stroke or TIA compared with a placebo (OR 0.819, 95% CI 0.582-1.151, I-2 = 64.2%, p= 0.025). Sensitivity analyses showed that the removal of any single study did not significantly affect the pooled OR. Cumulative meta-analysis showed that the incidence of infection did not vary by publication year. No statistical evidence of publication bias was found among the studies selected, based on the results of Egger's (p = 1.000) and Begg's (p = 0.762) tests. Conclusions This meta-analysis does not support the hypothesis that statins reduce the risk of infections in stroke or TIA patients.	[Lin, Shao-Peng; Chen, Xiao-Hui] Guangzhou Med Univ, Affiliated Hosp 2, Dept Emergency, Guangzhou 510260, Guangdong, Peoples R China; [Long, You-Ming] Guangzhou Med Univ, Affiliated Hosp 2, Dept Neurol, Guangzhou 510260, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University	Chen, XH (corresponding author), Guangzhou Med Univ, Affiliated Hosp 2, Dept Emergency, 250 Changgang East Rd, Guangzhou 510260, Guangdong, Peoples R China.	cxhgz168@126.com			Key Medical Disciplines and Specialties Program of Guangzhou; Science and Technology plan project of Guangdong Province [2011B061300004]	Key Medical Disciplines and Specialties Program of Guangzhou; Science and Technology plan project of Guangdong Province	This study was supported by the Key Medical Disciplines and Specialties Program of Guangzhou and the Science and Technology plan project of Guangdong Province (2011B061300004).	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Almog Y, 2007, CRIT CARE MED, V35, P372, DOI 10.1097/01.CCM.0000253397.42079.D5; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Arboix A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-47; Aslanyan S, 2004, EUR J NEUROL, V11, P49, DOI 10.1046/j.1468-1331.2003.00749.x; Audebert HJ, 2004, STROKE, V35, P2128, DOI 10.1161/01.STR.0000137607.61697.77; Becker K, 2013, J STROKE CEREBROVASC, V22, P66, DOI 10.1016/j.jstrokecerebrovasdis.2011.06.008; Bergman P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024394; Bjorkhem-Bergman L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010702; Blank N, 2007, J IMMUNOL, V179, P3613, DOI 10.4049/jimmunol.179.6.3613; Chalmers JD, 2010, RESP MED, V104, P1081, DOI 10.1016/j.rmed.2010.04.005; Dormuth CR, 2009, CIRCULATION, V119, P2051, DOI 10.1161/CIRCULATIONAHA.108.824151; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fehr T, 2004, ATHEROSCLEROSIS, V175, P83, DOI 10.1016/j.atherosclerosis.2004.02.016; Giusti-Paiva A, 2004, SHOCK, V21, P271, DOI 10.1097/10.shk.0000115756.74059.ce; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Haeusler KG, 2008, CEREBROVASC DIS, V25, P50, DOI 10.1159/000111499; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hong KS, 2008, EUR J NEUROL, V15, P1324, DOI 10.1111/j.1468-1331.2008.02310.x; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Ionita CC, 2011, J STROKE CEREBROVASC, V20, P1, DOI 10.1016/j.jstrokecerebrovasdis.2009.09.011; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Janda Surinder, 2010, J Crit Care, V25, DOI 10.1016/j.jcrc.2010.02.013; Kayani WT, 2013, INT J CARDIOL, V168, P117, DOI 10.1016/j.ijcard.2012.09.060; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Meisel A, 2012, CEREBROVASC DIS, V33, P580, DOI 10.1159/000338080; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Montaner J, 2008, EUR J NEUROL, V15, P82, DOI 10.1111/j.1468-1331.2007.02015.x; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; de Antonio LAR, 2011, NEUROLOGIA, V26, P150, DOI 10.1016/j.nrl.2010.07.030; Rodriguez-Sanz A, 2013, CEREBROVASC DIS, V35, P291, DOI 10.1159/000347077; Scheitz JF, 2015, INT J STROKE, V10, P61, DOI 10.1111/j.1747-4949.2012.00864.x; Subramanian S, 2013, J AM COLL CARDIOL, V62, P2382, DOI 10.1016/j.jacc.2013.08.1627; van den Hoek HL, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7281; Vermeij FH, 2009, CEREBROVASC DIS, V27, P465, DOI 10.1159/000210093; Weant KA, 2007, PHARMACOTHERAPY, V27, P1279, DOI 10.1592/phco.27.9.1279; Wells G.A., NEWCASTLE OTTAWA SCA; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Zhang L, 2009, J CEREBR BLOOD F MET, V29, P1816, DOI 10.1038/jcbfm.2009.105	42	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130071	10.1371/journal.pone.0130071	http://dx.doi.org/10.1371/journal.pone.0130071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158560	Green Published, gold, Green Submitted			2022-12-27	WOS:000358161200010
J	Ashraf, MI; Meng, FR; Bourque, CPA; MacLean, DA				Ashraf, M. Irfan; Meng, Fan-Rui; Bourque, Charles P. -A.; MacLean, David A.			A Novel Modelling Approach for Predicting Forest Growth and Yield under Climate Change	PLOS ONE			English	Article							TRANSIENT-RESPONSE; POTENTIAL IMPACTS; NOVA-SCOTIA; ECOSYSTEM; MANAGEMENT	Global climate is changing due to increasing anthropogenic emissions of greenhouse gases. Forest managers need growth and yield models that can be used to predict future forest dynamics during the transition period of present-day forests under a changing climatic regime. In this study, we developed a forest growth and yield model that can be used to predict individual-tree growth under current and projected future climatic conditions. The model was constructed by integrating historical tree growth records with predictions from an ecological process-based model using neural networks. The new model predicts basal area (BA) and volume growth for individual trees in pure or mixed species forests. For model development, tree-growth data under current climatic conditions were obtained using over 3000 permanent sample plots from the Province of Nova Scotia, Canada. Data to reflect tree growth under a changing climatic regime were projected with JABOWA-3 (an ecological process-based model). Model validation with designated data produced model efficiencies of 0.82 and 0.89 in predicting individual-tree BA and volume growth. Model efficiency is a relative index of model performance, where 1 indicates an ideal fit, while values lower than zero means the predictions are no better than the average of the observations. Overall mean prediction error (BIAS) of basal area and volume growth predictions was nominal (i.e., for BA: -0.0177 cm(2) 5-year(-1) and volume: 0.0008 m(3) 5-year(-1)). Model variability described by root mean squared error (RMSE) in basal area prediction was 40.53 cm(2) 5-year(-1) and 0.0393 m(3) 5-year(-1) in volume prediction. The new modelling approach has potential to reduce uncertainties in growth and yield predictions under different climate change scenarios. This novel approach provides an avenue for forest managers to generate required information for the management of forests in transitional periods of climate change. Artificial intelligence technology has substantial potential in forest modelling.	[Ashraf, M. Irfan] Arid Agr Univ, Fac Forestry Range Management & Wildlife, Rawalpindi 46300, Pakistan; [Ashraf, M. Irfan; Meng, Fan-Rui; Bourque, Charles P. -A.; MacLean, David A.] Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB E3B 5A3, Canada	University of New Brunswick	Ashraf, MI (corresponding author), Arid Agr Univ, Fac Forestry Range Management & Wildlife, Murree Rd, Rawalpindi 46300, Pakistan.	irfan.ashraf@unb.ca	Bond-Lamberty, Benjamin/C-6058-2008; MacLean, David A/G-6011-2011; Ashraf, Irfan M./AAW-6619-2020	Bond-Lamberty, Benjamin/0000-0001-9525-4633; MacLean, David A/0000-0002-0314-4435; Ashraf, Irfan M./0000-0003-4794-3754	Higher Education Commission of Pakistan; Natural Sciences and Engineering Research Council of Canada (NSERC)	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The financial support to Dr. M. Irfan Ashraf for his doctoral studies at the University of New Brunswick (UNB), Canada was provided by Higher Education Commission of Pakistan. The partial funding for this study was provided by Natural Sciences and Engineering Research Council of Canada (NSERC) to Fan-Rui Meng and Charles P.-A. Bourque. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agriculture and Agri-Food Canada, 2013, PLANT HARD ZON CAN; Andreassen K, 2003, FOREST ECOL MANAG, V180, P11, DOI 10.1016/S0378-1127(02)00560-1; [Anonymous], 2000, SPECIAL REPORT EMISS; Ashraf MI, 2015, MITIG ADAPT STRAT GL, V20, P159, DOI 10.1007/s11027-013-9484-9; Ashraf MI, 2013, CAN J FOREST RES, V43, P1162, DOI 10.1139/cjfr-2013-0090; Ashraf MI, 2012, FOREST CHRON, V88, P708, DOI 10.5558/tfc2012-137; Beale M.H., 2010, THE MATHWORKS; Beale MH, 2012, NEURAL NETWORK TOOLB; Botkin D.B., 1993, FOREST DYNAMICS ECOL; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Bourque C.P.A., 2010, MODELLED POTENTIAL S; Bourque CPA, 2000, CAN J FOREST RES, V30, P1179, DOI 10.1139/cjfr-30-8-1179; Bugmann H, 2001, CLIMATIC CHANGE, V51, P249, DOI 10.1023/A:1012512102489; Bugmann H, 2001, CLIMATIC CHANGE, V51, P259, DOI 10.1023/A:1012525626267; BURKHART HE, 1994, FOREST MEASUREMENTS; Crookston NL, 2010, FOREST ECOL MANAG, V260, P1198, DOI 10.1016/j.foreco.2010.07.013; DALE VH, 1989, CAN J FOREST RES, V19, P1581, DOI 10.1139/x89-240; Dessai S., 2007, NWSE2007198 UTR U CO; Ehman JL, 2002, FOREST ECOL MANAG, V155, P237, DOI 10.1016/S0378-1127(01)00561-8; Environment Canada, 2014, CAN CTR CLIM MOD AN; Froese RE, 2007, CAN J FOREST RES, V37, P1438, DOI 10.1139/X07-002; Garcia-Gonzalo J, 2007, FOREST ECOL MANAG, V241, P243, DOI 10.1016/j.foreco.2007.01.008; Hamann A, 2006, ECOLOGY, V87, P2773, DOI 10.1890/0012-9658(2006)87[2773:PEOCCO]2.0.CO;2; Harkonen S, 2010, FOREST ECOL MANAG, V259, P573, DOI 10.1016/j.foreco.2009.11.015; Higgins J, 2011, THESIS DALHOUSIE U H; Honer T.G, 1983, MX140 MAR FOR RES CT; IPCC, 2007, CLIM CHANG PHYS SCI; IPCC-TGICA, 2007, GEN GUID US SCEN DAT; Iyer MS, 1999, IEEE T NEURAL NETWOR, V10, P427, DOI 10.1109/72.750573; Johnsen K, 2001, FOREST SCI, V47, P2; Keller T, 1997, J BIOGEOGR, V24, P857, DOI 10.1046/j.1365-2699.1997.00140.x; Kimmins J.P., 2004, FOREST ECOLOGY FDN S, V3rd; KIMMINS JP, 1990, FOREST CHRON, V66, P271, DOI 10.5558/tfc66271-3; Korzukhin MD, 1996, CAN J FOREST RES, V26, P879, DOI 10.1139/x26-096; Lek S., 2008, ENCY ECOLOGY, P237, DOI [10.1016/B978-008045405-4.00173-7, DOI 10.1016/B978-008045405-4.00173-7]; Loehle C, 1996, ECOL MODEL, V90, P1, DOI 10.1016/0304-3800(96)83709-4; Mckenney DW, 2007, BIOSCIENCE, V57, P939, DOI 10.1641/B571106; Mckenney DW, 2007, BIOSCIENCE, V57, P929, DOI 10.1641/B571105; Medlyn BE, 2011, WIRES CLIM CHANGE, V2, P332, DOI 10.1002/wcc.108; Miehle P, 2009, ECOL MODEL, V220, P734, DOI 10.1016/j.ecolmodel.2008.12.010; MOHREN GMJ, 1994, FOREST ECOL MANAG, V69, P1, DOI 10.1016/0378-1127(94)90215-1; Monserud R.A., 2003, BIOMODELL INFO SCI, V1, P35; Morrison J. L., 2006, PLANT GROWTH CLIMATE; NS DNR, 2004, 20043 FOR NOV SCOT D; NS DNR, 2008, 20083 NS DNR FOR; Pachauri R. K., 2007, CLIMATE CHANGE SYNTH; Park YR, 1996, IEEE T NEURAL NETWOR, V7, P501, DOI 10.1109/72.485683; PASTOR J, 1988, NATURE, V334, P55, DOI 10.1038/334055a0; Peng CH, 2000, FOREST ECOL MANAG, V132, P259, DOI 10.1016/S0378-1127(99)00229-7; Porte A, 2002, ECOL MODEL, V150, P141, DOI 10.1016/S0304-3800(01)00476-8; Pretzsch H, 2009, FOREST DYNAMICS, GROWTH AND YIELD: FROM MEASUREMENT TO MODEL, P1, DOI 10.1007/978-3-540-88307-4_1; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; Schwalm CR, 2002, US FOR SERV T R NC, V230, P130; Scrinzi G, 2007, ECOL MODEL, V206, P331, DOI 10.1016/j.ecolmodel.2007.04.001; SOLOMON AM, 1986, OECOLOGIA, V68, P567, DOI 10.1007/BF00378773; Solomon S., 2007, PHYS SCI BASIS WORKI; Sullivan M., 2007, STAT INFORM DECISION; Vanclay J. K., 1994, Modelling forest growth and yield: applications to mixed tropical forests.; VANCLAY JK, 1995, FOREST SCI, V41, P7, DOI 10.1093/forestscience/41.1.7; Vanclay JK, 1997, ECOL MODEL, V98, P1, DOI 10.1016/S0304-3800(96)01932-1; Vasseur L., 2008, IMPACTS ADAPTATION C, P119; Weiskittel AR, 2011, FOREST GROWTH AND YIELD MODELING, P1, DOI 10.1002/9781119998518; Williamson T.B., 2009, CLIMATE CHANGE CANAD; Winnett SM, 1998, CLIMATE RES, V11, P39, DOI 10.3354/cr011039; Woodbridge Associates, 2015, EC IMP AN TIMB MAN S	65	35	36	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132066	10.1371/journal.pone.0132066	http://dx.doi.org/10.1371/journal.pone.0132066			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173081	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900030
J	Colon-Perez, LM; Spindler, C; Goicochea, S; Triplett, W; Parekh, M; Montie, E; Carney, PR; Price, C; Mareci, TH				Colon-Perez, Luis M.; Spindler, Caitlin; Goicochea, Shelby; Triplett, William; Parekh, Mansi; Montie, Eric; Carney, Paul R.; Price, Catherine; Mareci, Thomas H.			Dimensionless, Scale Invariant, Edge Weight Metric for the Study of Complex Structural Networks	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; CORTICAL NETWORKS; BRAIN NETWORKS; DIFFUSION; TRACTOGRAPHY; CONNECTIVITY; RESOLUTION; MRI; ARCHITECTURE; EFFICIENCY	High spatial and angular resolution diffusion weighted imaging (DWI) with network analysis provides a unique framework for the study of brain structure in vivo. DWI-derived brain connectivity patterns are best characterized with graph theory using an edge weight to quantify the strength of white matter connections between gray matter nodes. Here a dimensionless, scale-invariant edge weight is introduced to measure node connectivity. This edge weight metric provides reasonable and consistent values over any size scale (e.g. rodents to humans) used to quantify the strength of connection. Firstly, simulations were used to assess the effects of tractography seed point density and random errors in the estimated fiber orientations; with sufficient signal-to-noise ratio (SNR), edge weight estimates improve as the seed density increases. Secondly to evaluate the application of the edge weight in the human brain, ten repeated measures of DWI in the same healthy human subject were analyzed. Mean edge weight values within the cingulum and corpus callosum were consistent and showed low variability. Thirdly, using excised rat brains to study the effects of spatial resolution, the weight of edges connecting major structures in the temporal lobe were used to characterize connectivity in this local network. The results indicate that with adequate resolution and SNR, connections between network nodes are characterized well by this edge weight metric. Therefore this new dimensionless, scale-invariant edge weight metric provides a robust measure of network connectivity that can be applied in any size regime.	[Colon-Perez, Luis M.] Univ Florida, Dept Phys, Gainesville, FL 32611 USA; [Spindler, Caitlin] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Goicochea, Shelby] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Triplett, William; Mareci, Thomas H.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32611 USA; [Parekh, Mansi; Carney, Paul R.] Univ Florida, Dept Pediat, Gainesville, FL 32611 USA; [Montie, Eric] Univ South Carolina Beaufort, Dept Nat Sci, Bluffton, SC USA; [Price, Catherine] Univ Florida, Dept Clin Heath Psychol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Colon-Perez, LM (corresponding author), Univ Florida, Dept Phys, Gainesville, FL 32611 USA.	lcolon@ufl.edu	Mareci, Thomas Harold/D-7745-2011; Colon-Perez, Luis/GOV-3520-2022	Mareci, Thomas Harold/0000-0003-4700-2364; Colon-Perez, Luis/0000-0001-8918-2418	VA Brain Rehabilitation Research Center, Gainesville, FL; NIH [K23 NS060660, RO1 NS063360, RO1 NR014181, R01 NS082386]; USAMRMC/TATRC grant Correlating Sleep Disturbances and Damaged White Matter Tracts in the Brainstem using Diffusion Weighted Imaging [W81XH-11-1-0454]; UF Center for Movement Disorder and Neurorestoration; Brain and Spinal Cord Injury Research Trust Fund of the State of Florida; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063360, K23NS060660, R01NS082386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014181] Funding Source: NIH RePORTER	VA Brain Rehabilitation Research Center, Gainesville, FL; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USAMRMC/TATRC grant Correlating Sleep Disturbances and Damaged White Matter Tracts in the Brainstem using Diffusion Weighted Imaging; UF Center for Movement Disorder and Neurorestoration; Brain and Spinal Cord Injury Research Trust Fund of the State of Florida; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Funding was provided by the VA Brain Rehabilitation Research Center, Gainesville, FL, NIH grants K23 NS060660, RO1 NS063360, RO1 NR014181, and R01 NS082386, USAMRMC/TATRC grant Correlating Sleep Disturbances and Damaged White Matter Tracts in the Brainstem using Diffusion Weighted Imaging (Contract #W81XH-11-1-0454), as well as the UF Center for Movement Disorder and Neurorestoration and the Brain and Spinal Cord Injury Research Trust Fund of the State of Florida.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bastin ME, 1998, MAGN RESON IMAGING, V16, P773, DOI 10.1016/S0730-725X(98)00098-8; Behrens TEJ, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P333, DOI 10.1016/B978-0-12-374709-9.00015-8; Bertram EH, 2009, EPILEPSY BEHAV, V14, P32, DOI 10.1016/j.yebeh.2008.09.017; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Buchanan CR, 2014, NEUROIMAGE, V86, P231, DOI 10.1016/j.neuroimage.2013.09.054; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chamberland M, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00059; Cheng H, 2012, NEUROIMAGE, V61, P1153, DOI 10.1016/j.neuroimage.2012.03.036; Cheng H, 2012, J NEUROSCI METH, V203, P264, DOI 10.1016/j.jneumeth.2011.09.021; Colon-Perez L.M., 2012, P ISMRM, P686; Costa LD, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-16; CRICK F, 1993, NATURE, V361, P109, DOI 10.1038/361109a0; Girard G, 2014, NEUROIMAGE, V98, P266, DOI 10.1016/j.neuroimage.2014.04.074; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Jian B, 2007, NEUROIMAGE, V37, P164, DOI 10.1016/j.neuroimage.2007.03.074; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Lebedev AV, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00045; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Lo CYZ, 2011, REV NEUROSCIENCE, V22, P551, DOI 10.1515/RNS.2011.039; Miles J, 2012, ISMRM 20 ANN M EXH 2; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nadler JV, 2003, NEUROCHEM RES, V28, P1649, DOI 10.1023/A:1026004904199; Ncube S., 2012, 2012 IEEE Workshop on Mathematical Methods in Biomedical Image Analysis (MMBIA), P1, DOI 10.1109/MMBIA.2012.6164746; Newman M.E.J., 2010, NETWORKS INTRO; PARK SK, 1983, COMPUT VISION GRAPH, V23, P258, DOI 10.1016/0734-189X(83)90026-9; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Ponten SC, 2009, EXP NEUROL, V217, P197, DOI 10.1016/j.expneurol.2009.02.001; Poustchi-Amin M, 2001, RADIOGRAPHICS, V21, P767, DOI 10.1148/radiographics.21.3.g01ma23767; Romero-Garcia R, 2012, NEUROIMAGE, V59, P3522, DOI 10.1016/j.neuroimage.2011.10.086; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Seunarine KK, 2013, DIFFUSION MRI QUANTI; Smith RE, 2012, NEUROIMAGE, V62, P1924, DOI 10.1016/j.neuroimage.2012.06.005; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Yap PT, 2014, NEUROIMAGE, V84, P939, DOI 10.1016/j.neuroimage.2013.09.016; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	53	12	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131493	10.1371/journal.pone.0131493	http://dx.doi.org/10.1371/journal.pone.0131493			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173147	gold, Green Published, Green Submitted			2022-12-27	WOS:000358194900016
J	Kasperkiewicz, P; Poreba, M; Snipas, SJ; Lin, SJ; Kirchhofer, D; Salvesen, GS; Drag, M				Kasperkiewicz, Paulina; Poreba, Marcin; Snipas, Scott J.; Lin, S. Jack; Kirchhofer, Daniel; Salvesen, Guy S.; Drag, Marcin			Design of a Selective Substrate and Activity Based Probe for Human Neutrophil Serine Protease 4	PLOS ONE			English	Article							UNNATURAL AMINO-ACIDS; CATHEPSIN-G; IRREVERSIBLE INHIBITION; SPECIFICITY; ELASTASE; LIBRARIES; NSP4; PROTEINASE-3; DERIVATIVES; CYSTEINE	Human neutrophil serine protease 4 (NSP4), also known as PRSS57, is a recently discovered fourth member of the neutrophil serine proteases family. Although its biological function is not precisely defined, it is suggested to regulate neutrophil response and innate immune reactions. To create optimal substrates and visualization probes for NSP4 that distinguish it from other NSPs we have employed a Hybrid Combinatorial Substrate Library approach that utilizes natural and unnatural amino acids to explore protease subsite preferences. Library results were validated by synthesizing individual substrates, leading to the identification of an optimal substrate peptide. This substrate was converted to a covalent diphenyl phosphonate probe with an embedded biotin tag. This probe demonstrated high inhibitory activity and stringent specificity and may be suitable for visualizing NSP4 in the background of other NSPs.	[Kasperkiewicz, Paulina; Poreba, Marcin; Drag, Marcin] Wroclaw Univ Technol, Div Bioorgan Chem, Fac Chem, PL-50370 Wroclaw, Poland; [Kasperkiewicz, Paulina; Snipas, Scott J.; Salvesen, Guy S.] Sanford Burnham Med Res Inst, Program Cell Death & Survival Networks, La Jolla, CA 92024 USA; [Lin, S. Jack; Kirchhofer, Daniel] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA	Wroclaw University of Science & Technology; Sanford Burnham Prebys Medical Discovery Institute; Roche Holding; Genentech	Salvesen, GS (corresponding author), Sanford Burnham Med Res Inst, Program Cell Death & Survival Networks, 10901 N Torrey Pines Rd, La Jolla, CA 92024 USA.	gsalvesen@sanfordburnham.org; marcin.drag@pwr.edu.pl			SKILLS project from European Union's funds under the European Social Fund; NIH grant [GM099040]; National Science Centre grant [2014/14/M/ST5/00619]; Polish Ministry of Science and Higher Education; Genentech Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099040] Funding Source: NIH RePORTER	SKILLS project from European Union's funds under the European Social Fund; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Centre grant(National Science Centre, Poland); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Genentech Inc.(Roche HoldingGenentech); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	PK is funded by SKILLS project financed from the European Union's funds under the European Social Fund (the Human Capital Operational Programme, Priority IV, Higher Education and Science, Measure 4.2. Developing R&D staff qualifications and increasing awareness of importance of science to economic growth). GSS and SJS are supported by NIH grant GM099040. MD is supported by National Science Centre grant 2014/14/M/ST5/00619. The work was also supported by a statutory activity subsidy from the Polish Ministry of Science and Higher Education for the Faculty of Chemistry at Wroclaw University of Technology. The funder (Genentech Inc.) provided support in the form of salaries for authors SJL and DK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; de Veer SJ, 2012, BIOL CHEM, V393, P331, DOI [10.1515/BC-2011-250, 10.1515/bc-2011-250]; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Kasperkiewicz P, 2014, P NATL ACAD SCI USA, V111, P2518, DOI 10.1073/pnas.1318548111; Kato D, 2005, NAT CHEM BIOL, V1, P33, DOI 10.1038/nchembio707; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Lin SJ, 2014, STRUCTURE, V22, P1333, DOI 10.1016/j.str.2014.07.008; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Maly DJ, 2002, J ORG CHEM, V67, P910, DOI 10.1021/jo016140o; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; Ng NM, 2009, BIOL CHEM, V390, P401, DOI 10.1515/BC.2009.065; O'Donoghue AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075141; OLEKSYSZYN J, 1989, BIOCHEM BIOPH RES CO, V161, P143, DOI 10.1016/0006-291X(89)91572-6; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Perera NC, 2013, J IMMUNOL, V191, P2700, DOI 10.4049/jimmunol.1301293; Perera NC, 2012, EXPERT REV CLIN IMMU, V8, P501, DOI 10.1586/ECI.12.39; Perera NC, 2012, P NATL ACAD SCI USA, V109, P6229, DOI 10.1073/pnas.1200470109; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Polanowska J, 1998, BBA-PROTEIN STRUCT M, V1386, P189, DOI 10.1016/S0167-4838(98)00085-5; Poreba M, 2014, CELL DEATH DIFFER, V21, P1482, DOI 10.1038/cdd.2014.64; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Rut W, 2015, BIOL CHEM, V396, P329, DOI 10.1515/hsz-2014-0315; Salvesen GS, 2001, INHIBITION PROTEOLYT, P105; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Sienczyk M, 2009, CURR MED CHEM, V16, P1673, DOI 10.2174/092986709788186246; Sivaraman KK, 2013, J MED CHEM, V56, P5213, DOI 10.1021/jm4005972; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639	29	43	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132818	10.1371/journal.pone.0132818	http://dx.doi.org/10.1371/journal.pone.0132818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172376	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900088
J	Lu, C; Yang, J; Yu, WL; Li, DJ; Xiang, Z; Lin, YM; Yu, CH				Lu, Chao; Yang, Jun; Yu, Weilai; Li, Dejian; Xiang, Zun; Lin, Yiming; Yu, Chaohui			Association between 25(OH)D Level, Ultraviolet Exposure, Geographical Location, and Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; BONE-MINERAL DENSITY; CROHNS-DISEASE; D DEFICIENCY; SEASONAL-VARIATIONS; ULCERATIVE-COLITIS; SUN EXPOSURE; RISK-FACTORS; EPIDEMIOLOGY; CHILDREN	Background There is no consensus on the vitamin D levels and inflammatory bowel disease (IBD). Aim To conduct a systematic review and meta-analysis to analyze the relationship between IBD and 25(OH) D, sun exposure, and latitude, and to determine whether vitamin D deficiency affects the severity of IBD. Methods We searched the PubMed, EBSCO, and ClinicalTrials. gov databases to identify all studies that assessed the association between 25(OH) D, sun exposure, latitude, and IBD through November 1, 2014, without language restrictions. Studies that compared 25(OH) D levels between IBD patients and controls were selected for inclusion in the meta-analysis. We calculated pooled standardized mean differences (SMDs) and odds ratios (ORs). Results Thirteen case-control studies investigating CD and 25(OH) D levels were included, and eight studies part of above studies also investigated the relationship between UC and 25(OH) D. Both CD patients (SMD: 0.26 nmol/L, 95% confidence interval [CI]: 0.09-0.42 nmol/L) and UC patients (SMD: 0.5 nmol/L, 95% CI: 0.15-0.85 nmol/L) had lower levels of 25(OH) D than controls. In addition, CD patients and UC patients were 1.95 times (OR, 1.95; 95% CI, 1.48-2.57) and 2.02 times (OR, 2.02; 95% CI, 1.13-3.60) more likely to be 25(OH) D deficient than controls. We also included 10 studies investigating the relationship between CD activity and vitamin D. Results showed that patients with active CD (CD Activity Index >= 150) were more likely to have low vitamin D levels. In addition, whether low sun exposure and high latitude were related to a high morbidity of CD need to be provided more evidence. Conclusion Our study shows that IBD patients have lower vitamin D levels. For active CD patients, vitamin D levels were low. These findings suggest that vitamin D may play an important role in the development of IBD, although a direct association could not be determined in our study.	[Lu, Chao; Yang, Jun; Yu, Weilai; Li, Dejian; Xiang, Zun; Lin, Yiming; Yu, Chaohui] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Yu, CH (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	ych623@sina.com	Li, Dejian/ABG-3740-2021					Ananthakrishnan AN, 2014, ALIMENT PHARM THER, V39, P1136, DOI 10.1111/apt.12706; Aratari A, 2006, DIGEST LIVER DIS, V38, P319, DOI 10.1016/j.dld.2005.10.002; Bendix-Struve M, 2010, ALIMENT PHARM THER, V32, P1364, DOI 10.1111/j.1365-2036.2010.04463.x; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Cantorna MT, 2004, EXP BIOL MED, V229, P1136, DOI 10.1177/153537020422901108; Chen YZ, 2013, J IMMUNOL, V190, P3687, DOI 10.4049/jimmunol.1203273; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Daniel C, 2008, J PHARMACOL EXP THER, V324, P23, DOI 10.1124/jpet.107.127209; de Bruyn JR, 2014, J CROHNS COLITIS, V8, P1267, DOI 10.1016/j.crohns.2014.03.004; De Souza HN, 2008, ARQ BRAS ENDOCRINOL, V52, P684, DOI 10.1590/S0004-27302008000400015; Deeks J J, 2003, Health Technol Assess, V7, piii; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Dumitrescu G, 2014, WORLD J GASTROENTERO, V20, P2392, DOI 10.3748/wjg.v20.i9.2392; Dunn OJ, 2009, BASIC STATISTICS A P; Economou M, 2008, INFLAMM BOWEL DIS, V14, P709, DOI 10.1002/ibd.20352; El-Matary W, 2011, DIGEST DIS SCI, V56, P825, DOI 10.1007/s10620-010-1380-5; Froicu M, 2006, IMMUNOLOGY, V117, P310, DOI 10.1111/j.1365-2567.2005.02290.x; Froicu M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-5; Fu YTN, 2012, DIGEST DIS SCI, V57, P2144, DOI 10.1007/s10620-012-2130-7; Garg M, 2013, INFLAMM BOWEL DIS, V19, P2634, DOI 10.1097/01.MIB.0000436957.77533.b2; Gascon-Barre M, 2003, HEPATOLOGY, V37, P1034, DOI 10.1053/jhep.2003.50176; Grunbaum A, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-145; Ham M, 2014, INFLAMM BOWEL DIS, V20, P856, DOI 10.1097/MIB.0000000000000016; HARVEY RF, 1980, LANCET, V1, P1134; Hassan V, 2013, Med J Malaysia, V68, P34; Hewison M, 2012, P NUTR SOC, V71, P50, DOI 10.1017/S0029665111001650; Holick MF, 1995, AM J CLIN NUTR S, V61, p638S, DOI DOI 10.1093/ajcn/61.3.638S; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; HUGHES MR, 1988, SCIENCE, V242, P1702, DOI 10.1126/science.2849209; Jantchou P, 2014, INFLAMM BOWEL DIS, V20, P75, DOI 10.1097/01.MIB.0000436275.12131.4f; Jorgensen S., 2013, J CROHNS COLITIS, V7, pe407, DOI [10.1016/j.crohns.2013.01.012, DOI 10.1016/J.CROHNS.2013.01.012]; Joseph AJ, 2009, INDIAN J MED RES, V130, P133; Khalili H, 2012, GUT, V61, P1686, DOI 10.1136/gutjnl-2011-301574; Kini GP, 2014, NEW ZEAL MED J, V127, P51; Koido S, 2013, WORLD J GASTROENTERO, V19, P9063, DOI 10.3748/wjg.v19.i47.9063; Levin AD, 2011, DIGEST DIS SCI, V56, P830, DOI 10.1007/s10620-010-1544-3; Limketkai BN, 2014, ALIMENT PHARM THER, V40, P508, DOI 10.1111/apt.12845; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; McCarthy D, 2005, ALIMENT PHARM THER, V21, P1073, DOI 10.1111/j.1365-2036.2005.02446.x; Middleton JP, 2013, J PEDIATR GASTR NUTR, V57, P587, DOI 10.1097/MPG.0b013e31829e0b89; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Mouli VP, 2014, ALIMENT PHARM THER, V39, P125, DOI 10.1111/apt.12553; MULLER K, 1992, CYTOKINE, V4, P506, DOI 10.1016/1043-4666(92)90012-G; Nerich V, 2011, ALIMENT PHARM THER, V33, P940, DOI 10.1111/j.1365-2036.2011.04601.x; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Peterlik M, 2009, EUR J CLIN NUTR, V63, P1377, DOI 10.1038/ejcn.2009.105; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Prosnitz AR, 2013, INFLAMM BOWEL DIS, V19, P45, DOI 10.1002/ibd.22969; Rosen CJ, 2012, J CLIN ENDOCR METAB, V97, P1146, DOI 10.1210/jc.2011-2218; Sentongo TA, 2002, AM J CLIN NUTR, V76, P1077, DOI 10.1093/ajcn/76.5.1077; Shivananda S, 1996, GUT, V39, P690, DOI 10.1136/gut.39.5.690; Suibhne TN, 2012, J CROHNS COLITIS, V6, P182, DOI 10.1016/j.crohns.2011.08.002; Tajika M, 2004, J GASTROENTEROL, V39, P527, DOI 10.1007/s00535-003-1338-x; Tan B, 2014, J DIGEST DIS, V15, P116, DOI 10.1111/1751-2980.12118; Ulitsky A, 2011, JPEN-PARENTER ENTER, V35, P308, DOI 10.1177/0148607110381267; Veit LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101583; Viswanathan M, 2008, ASSESSING THE RISK O; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wang TT, 2010, J BIOL CHEM, V285, P2237, DOI 10.1074/jbc.C109.071225; Wu SP, 2011, DISCOV MED, V11, P325; Wu SP, 2010, AM J PATHOL, V177, P686, DOI 10.2353/ajpath.2010.090998; Xue LN, 2013, INFLAMM BOWEL DIS, V19, P54, DOI 10.1002/ibd.22966; Yang LL, 2013, CLIN TRANSL GASTROEN, V4, DOI 10.1038/ctg.2013.1	67	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132036	10.1371/journal.pone.0132036	http://dx.doi.org/10.1371/journal.pone.0132036			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172950	Green Submitted, gold, Green Published			2022-12-27	WOS:000358194900028
J	Obala, AA; Mangeni, JN; Platt, A; Aswa, D; Abel, L; Namae, J; O'Meara, WP				Obala, Andrew A.; Mangeni, Judith Nekesa; Platt, Alyssa; Aswa, Daniel; Abel, Lucy; Namae, Jane; O'Meara, Wendy Prudhomme			What Is Threatening the Effectiveness of Insecticide-Treated Bednets? A Case-Control Study of Environmental, Behavioral, and Physical Factors Associated with Prevention Failure	PLOS ONE			English	Article							VECTOR ANOPHELES-GAMBIAE; BED NET EFFECTIVENESS; MALARIA TRANSMISSION; RESISTANCE MECHANISMS; PYRETHROID RESISTANCE; DETOXIFICATION GENES; CHILD-MORTALITY; MOSQUITO LARVAE; AEDES-AEGYPTI; OWNERSHIP	Background Insecticide-treated nets are the cornerstone of global malaria control and have been shown to reduce malaria morbidity by 50-60%. However, some areas are experiencing a resurgence in malaria following successful control. We describe an efficacy decay framework to understand why high malaria burden persists even under high ITN coverage in a community in western Kenya. Methods We enrolled 442 children hospitalized with malaria and paired them with age, time, village and gender-matched controls. We completed comprehensive household and neighborhood assessments including entomological surveillance. The indicators are grouped into five domains in an efficacy decay framework: ITN ownership, compliance, physical integrity, vector susceptibility and facilitating factors. After variable selection, case-control data were analyzed using conditional logistic regression models and mosquito data were analyzed using negative binomial regression. Predictive margins were calculated from logistic regression models. Results Measures of ITN coverage and physical integrity were not correlated with hospitalized malaria in our study. However, consistent ITN use (Adjusted Odds Ratio (AOR) = 0.23, 95% CI: 0.12-0.43), presence of nearby larval sites (AOR = 1.137, 95% CI: 1.02-1.27), and specific types of crops (AOR (grains) = 0.446, 95% CI: 0.24-0.82) were significantly correlated with malaria amongst children who owned an ITN. The odds of hospitalization for febrile malaria nearly tripled when one other household member had symptomatic malaria infection (AOR-2.76, 95% CI: 1.83-4.18). Overall, perfect household adherence could reduce the probability of hospitalization for malaria to less than 30% ( 95% CI: 0.12-0.46) and adjusting environmental factors such as elimination of larval sites and growing grains nearby could reduce the probability of hospitalization for malaria to less than 20% ( 95% CI: 0.04-0.31). Conclusion Availability of ITNs is not the bottleneck for malaria prevention in this community. Behavior change interventions to improve compliance and environmental management of mosquito breeding habitats may greatly enhance ITN efficacy. A better understanding of the relationship between agriculture and mosquito survival and feeding success is needed.	[Obala, Andrew A.; Mangeni, Judith Nekesa; O'Meara, Wendy Prudhomme] Moi Univ, Coll Hlth Sci, Eldoret, Kenya; [Platt, Alyssa; O'Meara, Wendy Prudhomme] Duke Global Hlth Inst, Durham, NC USA; [Aswa, Daniel; Abel, Lucy] Acad Model Providing Access Healthcare, Eldoret, Kenya; [Namae, Jane] Moi Univ, Webuye Hlth & Demog Surveillance Syst, Eldoret, Kenya; [O'Meara, Wendy Prudhomme] Duke Univ, Dept Med, Durham, NC USA	Moi University; Duke University; Moi University; Duke University	O'Meara, WP (corresponding author), Moi Univ, Coll Hlth Sci, Eldoret, Kenya.	wpo@duke.edu		Platt, Alyssa/0000-0001-6396-0170	Malaria Eradication Scientific Alliance (MESA)	Malaria Eradication Scientific Alliance (MESA)	This work was supported by a grant from the Malaria Eradication Scientific Alliance (MESA). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of MESA.	ABBOTT WS, 1987, J AM MOSQUITO CONTR, V3, P302; Abuelmaali SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080549; Aderibigbe SA, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.263.3927; Alaii JA, 2003, AM J TROP MED HYG, V68, P137, DOI 10.4269/ajtmh.2003.68.137; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], PLOS ONE; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113; Batisso E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-183; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Bennett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037927; Biadgilign S, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/235015; Castro MC, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-57; Central Bureau of Statistics-CBS/Kenya Ministry of Health-MOH/Kenya ORC Macro, 2004, KEN DEM HLTH SURV 20; Chouaibou M, 2008, TROP MED INT HEALTH, V13, P476, DOI 10.1111/j.1365-3156.2008.02025.x; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; David JP, 2006, INSECT BIOCHEM MOLEC, V36, P410, DOI 10.1016/j.ibmb.2006.02.004; Deressa W, 2014, T ROY SOC TROP MED H, V108, P616, DOI 10.1093/trstmh/tru129; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Division of Malaria Control [Ministry of Public Health and Sanitation], 2011, KEN NAT BUR STAT ICF; Furnival GM, 2000, TECHNOMETRICS, V42, P69, DOI 10.2307/1271435; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435; Kebede A, 2005, AM J TROP MED HYG, V73, P676, DOI 10.4269/ajtmh.2005.73.676; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Koenker H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097496; Koudou BG, 2010, ANN TROP MED PARASIT, V104, P109, DOI 10.1179/136485910X12607012374154; Larsen DA, 2014, AM J TROP MED HYG, V91, P950, DOI 10.4269/ajtmh.14-0318; Lwetoijera DW, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-57; Nkya TE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-28; Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025949; Ochomo E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-310; Ochomo EO, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-368; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; Ouedraogo LT, 2013, REV EPIDEMIOL SANTE, V61, P121, DOI 10.1016/j.respe.2012.09.004; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Riaz MA, 2009, AQUAT TOXICOL, V93, P61, DOI 10.1016/j.aquatox.2009.03.005; Rumisha SF, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-452; Sena LD, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-406; Shililu JI, 1998, TROP MED INT HEALTH, V3, P706; Smithuis FM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-364; Sougoufara S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-125; Stresman GH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-265; Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Toe KH, 2014, EMERG INFECT DIS, V20, P1691, DOI 10.3201/eid2010.140619; Tokponnon FT, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-265; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; Ursing J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101167; Wanzira H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-185; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wielgosz B, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-251; World Health Organization, 2003, WHOCDSCPESMT200218RE; Wotodjo AN, 2015, AM J TROP MED HYG, V92, P565, DOI 10.4269/ajtmh.14-0485; Yadouleton A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-60; Yadouleton AWM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-103; Ye-Ebiyo Y, 2000, AM J TROP MED HYG, V63, P90, DOI 10.4269/ajtmh.2000.63.90	63	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132778	10.1371/journal.pone.0132778	http://dx.doi.org/10.1371/journal.pone.0132778			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171962	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900084
J	Shen, CY; Tyan, YS; Kuo, LW; Wu, CW; Weng, JC				Shen, Chao-Yu; Tyan, Yeu-Sheng; Kuo, Li-Wei; Wu, Changwei W.; Weng, Jun-Cheng			Quantitative Evaluation of Rabbit Brain Injury after Cerebral Hemisphere Radiation Exposure Using Generalized q-Sampling Imaging	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RAT-BRAIN; DIFFUSION; MECHANISMS; DAMAGE; DEMYELINATION; IRRADIATION; TOXICITY; TISSUE; MRI	Radiation therapy is widely used for the treatment of brain tumors and may result in cellular, vascular and axonal injury and further behavioral deficits. The non-invasive longitudinal imaging assessment of brain injury caused by radiation therapy is important for determining patient prognoses. Several rodent studies have been performed using magnetic resonance imaging (MRI), but further studies in rabbits and large mammals with advanced magnetic resonance (MR) techniques are needed. Previously, we used diffusion tensor imaging (DTI) to evaluate radiation-induced rabbit brain injury. However, DTI is unable to resolve the complicated neural structure changes that are frequently observed during brain injury after radiation exposure. Generalized q-sampling imaging (GQI) is a more accurate and sophisticated diffusion MR approach that can extract additional information about the altered diffusion environments. Therefore, herein, a longitudinal study was performed that used GQI indices, including generalized fractional anisotropy (GFA), quantitative anisotropy (QA), and the isotropic value (ISO) of the orientation distribution function and DTI indices, including fractional anisotropy (FA) and mean diffusivity (MD) over a period of approximately half a year to observe long-term, radiation-induced changes in the different brain compartments of a rabbit model after a hemi-brain single dose (30 Gy) radiation exposure. We revealed that in the external capsule, the GFA right to left (R/L) ratio showed similar trends as the FA R/L ratio, but no clear trends in the remaining three brain compartments. Both the QA and ISO R/L ratios showed similar trends in the all four different compartments during the acute to early delayed post-irradiation phase, which could be explained and reflected the histopathological changes of the complicated dynamic interactions among astrogliosis, demyelination and vasogenic edema. We suggest that GQI is a promising non-invasive technique and as compared with DTI, it has better potential ability in detecting and monitoring the pathophysiological cascades in acute to early delayed radiation-induced brain injury by using clinical MR scanners.	[Shen, Chao-Yu; Tyan, Yeu-Sheng; Weng, Jun-Cheng] Chung Shan Med Univ, Sch Med Imaging & Radiol Sci, Taichung, Taiwan; [Shen, Chao-Yu; Tyan, Yeu-Sheng; Weng, Jun-Cheng] Chung Shan Med Univ Hosp, Dept Med Imaging, Taichung, Taiwan; [Shen, Chao-Yu; Tyan, Yeu-Sheng] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Kuo, Li-Wei] Natl Hlth Res Inst, Div Med Engn Res, Zhunan Township, Miaoli County, Taiwan; [Wu, Changwei W.] Natl Cent Univ, Grad Inst Biomed Engn, Taoyuan, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; National Health Research Institutes - Taiwan; National Central University	Weng, JC (corresponding author), Chung Shan Med Univ, Sch Med Imaging & Radiol Sci, Taichung, Taiwan.	jcweng@csmu.edu.tw	Kuo, Li-Wei/O-1312-2019	Kuo, Li-Wei/0000-0002-0306-7329; Wu, Changwei W./0000-0001-8968-9366	Ministry of Science and Technology, Taipei, Taiwan [NSC102-2320-B-040-002]; Chung Shan Medical University and Hospital, Taichung, Taiwan [CSMU-INT-103-08, CSH-2011-C-011]	Ministry of Science and Technology, Taipei, Taiwan; Chung Shan Medical University and Hospital, Taichung, Taiwan	This study was supported in part by the research program NSC102-2320-B-040-002 of the Ministry of Science and Technology, Taipei, Taiwan, and the intramural research programs CSMU-INT-103-08 and CSH-2011-C-011 of the Chung Shan Medical University and Hospital, Taichung, Taiwan.	Belka C, 2001, BRIT J CANCER, V85, P1233, DOI 10.1054/bjoc.2001.2100; Chan KC, 2009, J MAGN RESON IMAGING, V29, P1013, DOI 10.1002/jmri.21736; Greene-Schloesser D, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00073; Haldar JP, 2013, MAGN RESON MED, V69, P277, DOI 10.1002/mrm.24229; Hopewell JW, 1999, FRONT RADIAT THER ON, V33, P265; Illa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076453; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; KENNEDY AS, 1995, INVEST RADIOL, V30, P214, DOI 10.1097/00004424-199504000-00003; Kim JH, 2008, J NEURO-ONCOL, V87, P279, DOI 10.1007/s11060-008-9520-x; Lim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119932; Liu Y, 2010, AM J NEURORADIOL, V31, P383, DOI 10.3174/ajnr.A1801; LO EH, 1991, INT J RADIAT ONCOL, V20, P689, DOI 10.1016/0360-3016(91)90010-2; Lyubimova N, 2004, BRIT J RADIOL, V77, P488, DOI 10.1259/bjr/15169876; MiotNoirault E, 1996, AM J NEURORADIOL, V17, P907; NORTON WT, 1984, ANN NY ACAD SCI, V436, P5, DOI 10.1111/j.1749-6632.1984.tb14772.x; Peiffer AM, 2010, BRAIN RES, V1351, P23, DOI 10.1016/j.brainres.2010.06.049; REINHOLD HS, 1990, INT J RADIAT ONCOL, V18, P37, DOI 10.1016/0360-3016(90)90264-K; SHELINE GE, 1980, INT J RADIAT ONCOL, V6, P1215, DOI 10.1016/0360-3016(80)90175-3; SHEN CY, 2013, J NEUROSCIENCE NEURO, V2, P355; Siu A, 2012, ACTA NEUROCHIR, V154, P191, DOI 10.1007/s00701-011-1228-6; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4; Sykova E, 1996, NEUROSCIENCE, V70, P597, DOI 10.1016/0306-4522(95)00361-4; Tofilon PJ, 2000, RADIAT RES, V153, P357, DOI 10.1667/0033-7587(2000)153[0357:TROTCN]2.0.CO;2; Tsao MN, 2012, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003869.PUB3; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wang SL, 2009, CANCER RES, V69, P1190, DOI 10.1158/0008-5472.CAN-08-2661; Wang XJ, 2014, NMR BIOMED, V27, P843, DOI 10.1002/nbm.3129; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126; Zhang HL, 2013, NEUROSURGERY, V73, P1044, DOI 10.1227/NEU.0000000000000146; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	34	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0133001	10.1371/journal.pone.0133001	http://dx.doi.org/10.1371/journal.pone.0133001			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168047	gold, Green Submitted, Green Published			2022-12-27	WOS:000358193100102
J	Turner-Stokes, L; Vanderstay, R; Stevermuer, T; Simmonds, F; Khan, F; Eagar, K				Turner-Stokes, Lynne; Vanderstay, Roxana; Stevermuer, Tara; Simmonds, Frances; Khan, Fary; Eagar, Kathy			Comparison of Rehabilitation Outcomes for Long Term Neurological Conditions: A Cohort Analysis of the Australian Rehabilitation Outcomes Centre Dataset for Adults of Working Age	PLOS ONE			English	Article							FUNCTIONAL INDEPENDENCE MEASURE; UNIFORM DATA SYSTEM; SPINAL-CORD-INJURY; ASSESSMENT SCALES; POSTSTROKE REHABILITATION; NEUROREHABILITATION; DEPENDENCY; STROKE; DISABILITY; PROGRAMS	Objective To describe and compare outcomes from in-patient rehabilitation (IPR) in working-aged adults across different groups of long-term neurological conditions, as defined by the UK National Service Framework. Design Analysis of a large Australian prospectively collected dataset for completed IPR episodes (n = 28,596) from 2003-2012. Methods De-identified data for adults (16-65 years) with specified neurological impairment codes were extracted, cleaned and divided into 'Sudden-onset' conditions: (Stroke (n = 12527), brain injury (n = 7565), spinal cord injury (SCI) (n = 3753), Guillain-Barre syndrome (GBS) (n = 805)) and 'Progressive/stable' conditions (Progressive (n = 3750) and Cerebral palsy (n = 196)). Key outcomes included Functional Independence Measure (FIM) scores, length of stay (LOS), and discharge destination. Results Mean LOS ranged from 21-57 days with significant group differences in gender, source of admission and discharge destination. All six groups showed significant change (p<0.001) between admission and discharge that was likely to be clinically important across a range of items. Significant between-group differences were observed for FIM Motor and Cognitive change scores (Kruskal-Wallis p<0.001), and item-by-item analysis confirmed distinct patterns for each of the six groups. SCI and GBS patients were generally at the ceiling of the cognitive subscale. The 'Progressive/stable' conditions made smaller improvements in FIM score than the 'Sudden-onset conditions', but also had shorter LOS. Conclusion All groups made gains in independence during admission, although pattern of change varied between conditions, and ceiling effects were observed in the FIM-cognitive subscale. Relative cost-efficiency between groups can only be indirectly inferred. Limitations of the current dataset are discussed, together with opportunities for expansion and further development.	[Turner-Stokes, Lynne; Vanderstay, Roxana] Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England; [Stevermuer, Tara; Simmonds, Frances; Eagar, Kathy] Univ Wollongong, Australian Hlth Serv Res Inst, Australasian Rehabil Outcomes Ctr, Wollongong, NSW, Australia; [Khan, Fary] Univ Melbourne, Melbourne, Vic, Australia; [Khan, Fary] Royal Melbourne Hosp, Dept Rehabil, Melbourne, Vic, Australia	University of London; King's College London; University of Wollongong; University of Melbourne; Royal Melbourne Hospital	Turner-Stokes, L (corresponding author), Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England.	lynne.turner-stokes@dial.pipex.com	Turner-Stokes, Lynne/F-4418-2012; Khan, Fary/H-7077-2014	Turner-Stokes, Lynne/0000-0002-3302-9462; Eagar, Kathy/0000-0001-5802-8995; Khan, Fary/0000-0003-2232-6493	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme [RP-PG-0407-10185]; Dunhill Medical Trust, the Luff Foundation; National Institute for Health Research [RP-PG-0407-10185] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme(National Institute for Health Research (NIHR)); Dunhill Medical Trust, the Luff Foundation; National Institute for Health Research(National Institute for Health Research (NIHR))	This manuscript presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (RP-PG-0407-10185). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. Financial support for the preparation of this manuscript was also provided by the Dunhill Medical Trust, the Luff Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrescu R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110532; [Anonymous], 2010, LONG TERM NEUR COND; [Anonymous], 2005, COR SERV SPEC COMPL; [Anonymous], 2009, NAT DEF SET SPEC SER; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Cano SJ, 2006, NEUROLOGY, V67, P2056, DOI 10.1212/01.wnl.0000247664.97643.e8; Dallmeijer AJ, 2005, J REHABIL MED, V37, P346, DOI 10.1080/16501970510038284; DAVIDOFF GN, 1990, ARCH PHYS MED REHAB, V71, P326; DeJong G, 2005, ARCH PHYS MED REHAB, V86, pS1, DOI 10.1016/j.apmr.2005.09.003; Department of Health, 2005, NAT SERV FRAM LONG T; Deutsch A, 2006, STROKE, V37, P1477, DOI 10.1161/01.STR.0000221172.99375.5a; Eagar K, 1999, Aust Health Rev, V22, P180; Freeman JA, 2005, J NEUROL NEUROSUR PS, V76, P723, DOI 10.1136/jnnp.2004.035956; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Granger CV, 2009, AM J PHYS MED REHAB, V88, P961, DOI [10.1097/PHM.0b013e3181clec38, 10.1097/PHM.0b013e3181c1ec38]; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Green J, 2007, AUST HEALTH REV, V31, pS68; Hall K.M., 1993, J HEAD TRAUMA REHAB, DOI [10.1097/00001199-199308020-00008, DOI 10.1097/00001199-199308020-00008]; Hall KM, 1999, ARCH PHYS MED REHAB, V80, P1471, DOI 10.1016/S0003-9993(99)90260-5; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS8, DOI 10.1016/j.apmr.2005.08.116; Horn SD, 2007, MED CARE, V45, pS50, DOI 10.1097/MLR.0b013e318070c07b; Khan F, 2009, MULT SCLER J, V15, P869, DOI 10.1177/1352458509105230; Khan F., 2010, J CLIN MED RES, V2, P91; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; New PW, 2011, SPINAL CORD, V49, P397, DOI 10.1038/sc.2010.77; Ottenbacher KJ, 2008, STROKE, V39, P1514, DOI 10.1161/STROKEAHA.107.501254; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Svensson E, 2001, J REHABIL MED, V33, P47, DOI 10.1080/165019701300006542; Turner-Stokes L, 2006, J NEUROL NEUROSUR PS, V77, P634, DOI 10.1136/jnnp.2005.073411; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Turner-Stokes L, 1999, CLIN REHABIL, V13, P253, DOI 10.1191/026921599677787870; Turner-Stokes L, 1998, CLIN REHABIL, V12, P304, DOI 10.1191/026921598669173600; Turner-Stokes L, 1999, NEUROPSYCHOL REHABIL, V9, P329, DOI 10.1080/096020199389419; Turner-Stokes L, 2010, J NEUROL NEUROSUR PS, V81, P146, DOI 10.1136/jnnp.2009.173716; Turner-Stokes L, 2009, CLIN REHABIL, V23, P922, DOI 10.1177/0269215509337447; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; World Health Organisation (WHO), 2014, INT CLASS FUNCT DIS	41	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132275	10.1371/journal.pone.0132275	http://dx.doi.org/10.1371/journal.pone.0132275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167877	Green Submitted, Green Published, gold			2022-12-27	WOS:000358193100035
J	Gerbin, KA; Yang, XL; Murry, CE; Coulombe, KLK				Gerbin, Kaytlyn A.; Yang, Xiulan; Murry, Charles E.; Coulombe, Kareen L. K.			Enhanced Electrical Integration of Engineered Human Myocardium via Intramyocardial versus Epicardial Delivery in Infarcted Rat Hearts	PLOS ONE			English	Article							CELL-DERIVED CARDIOMYOCYTES; CARDIAC PATCH; SCAFFOLD-FREE; STEM-CELLS; TISSUE; TRANSPLANTATION; IMPROVES; MATURATION; SURVIVAL; PLATFORM	Cardiac tissue engineering is a promising approach to provide large-scale tissues for transplantation to regenerate the heart after ischemic injury, however, integration with the host myocardium will be required to achieve electromechanical benefits. To test the ability of engineered heart tissues to electrically integrate with the host, 10 million human embryonic stem cell (hESC)-derived cardiomyocytes were used to form either scaffold-free tissue patches implanted on the epicardium or micro-tissue particles (similar to 1000 cells/particle) delivered by intramyocardial injection into the left ventricular wall of the ischemia/reperfusion injured athymic rat heart. Results were compared to intramyocardial injection of 10 million dispersed hESC-cardiomyocytes. Graft size was not significantly different between treatment groups and correlated inversely with infarct size. After implantation on the epicardial surface, hESC-cardiac tissue patches were electromechanically active, but they beat slowly and were not electrically coupled to the host at 4 weeks based on ex vivo fluorescent imaging of their graft-autonomous GCaMP3 calcium reporter. Histologically, scar tissue physically separated the patch graft and host myocardium. In contrast, following intramyocardial injection of micro-tissue particles and suspended cardiomyocytes, 100% of the grafts detected by fluorescent GCaMP3 imaging were electrically coupled to the host heart at spontaneous rate and could follow host pacing up to a maximum of 300-390 beats per minute (5-6.5 Hz). Gap junctions between intramyocardial graft and host tissue were identified histologically. The extensive coupling and rapid response rate of the human myocardial grafts after intramyocardial delivery suggest electrophysiological adaptation of hESC-derived cardiomyocytes to the rat heart's pacemaking activity. These data support the use of the rat model for studying electromechanical integration of human cardiomyocytes, and they identify lack of electrical integration as a challenge to overcome in tissue engineered patches.	[Gerbin, Kaytlyn A.; Yang, Xiulan; Murry, Charles E.; Coulombe, Kareen L. K.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Gerbin, Kaytlyn A.; Yang, Xiulan; Murry, Charles E.; Coulombe, Kareen L. K.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Gerbin, Kaytlyn A.; Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Yang, Xiulan; Murry, Charles E.; Coulombe, Kareen L. K.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Med Cardiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Murry, CE (corresponding author), Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA.	murry@uw.edu; kareen_coulombe@brown.edu			National Institutes of Health (NIH) [K99 HL115123]; NSF Graduate Research Fellowship [DGE-0718124, DGE-1256082]; AHA Postdoctoral Fellowship [12POST11940060, 14POST20310023]; NIH [R01 HL084642, P01 HL094374, P01 GM81619, U01 HL100405]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL115123, R01HL084642, P01HL094374, K99HL115123, U01HL100405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); AHA Postdoctoral Fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge funding from National Institutes of Health (NIH) K99 HL115123 (to KLKC), NSF Graduate Research Fellowship DGE-0718124 and DGE-1256082 (to KAG), AHA Postdoctoral Fellowship 12POST11940060 and 14POST20310023 (to XY), and NIH R01 HL084642, P01 HL094374, P01 GM81619, and U01 HL100405 (to CEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian WN, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024109; Bian WN, 2014, BIOMATERIALS, V35, P3819, DOI 10.1016/j.biomaterials.2014.01.045; Boudou T, 2012, TISSUE ENG PT A, V18, P910, DOI [10.1089/ten.TEA.2011.0341, 10.1089/ten.tea.2011.0341]; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; Coulombe KLK, 2014, ANNU REV BIOMED ENG, V16, P1, DOI 10.1146/annurev-bioeng-071812-152344; Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106; Fernandes S, 2009, J CELL MOL MED, V13, P3703, DOI 10.1111/j.1582-4934.2009.00740.x; Haraguchi Y, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/845170; Hirt MN, 2014, CIRC RES, V114, P354, DOI 10.1161/CIRCRESAHA.114.300522; Janse MJ, 1998, CARDIOVASC RES, V39, P165, DOI 10.1016/S0008-6363(97)00313-1; Kreutziger KL, 2011, TISSUE ENG PT A, V17, P1219, DOI [10.1089/ten.tea.2010.0557, 10.1089/ten.TEA.2010.0557]; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lal H, 2015, CIRC RES, V116, P138, DOI 10.1161/CIRCRESAHA.116.303613; Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161; Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]; Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107; Moon SH, 2013, BIOMATERIALS, V34, P4013, DOI 10.1016/j.biomaterials.2013.02.022; Nunes SS, 2013, NAT METHODS, V10, P781, DOI [10.1038/NMETH.2524, 10.1038/nmeth.2524]; Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101; Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397; Sekine H, 2011, TISSUE ENG PT A, V17, P2973, DOI 10.1089/ten.tea.2010.0659; Shiba Y, 2014, J CARDIOVASC PHARM T, V19, P368, DOI 10.1177/1074248413520344; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Song H, 2010, P NATL ACAD SCI USA, V107, P3329, DOI 10.1073/pnas.0905729106; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Stevens KR, 2009, TISSUE ENG PT A, V15, P1211, DOI 10.1089/ten.tea.2008.0151; Thavandiran N, 2013, P NATL ACAD SCI USA, V110, pE4698, DOI 10.1073/pnas.1311120110; Thomson KS, 2013, TISSUE ENG PT A, V19, P967, DOI 10.1089/ten.tea.2012.0286; Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Vunjak-Noyakovic G, 2011, ANNU REV BIOMED ENG, V13, P245, DOI 10.1146/annurev-bioeng-071910-124701; Xu CH, 2011, REGEN MED, V6, P53, DOI 10.2217/RME.10.91; Zhang DH, 2013, BIOMATERIALS, V34, P5813, DOI 10.1016/j.biomaterials.2013.04.026; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394; Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106; Zwi-Dantsis L, 2013, EUR HEART J, V34, P1575, DOI 10.1093/eurheartj/ehs096	41	66	67	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131446	10.1371/journal.pone.0131446	http://dx.doi.org/10.1371/journal.pone.0131446			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161513	gold, Green Submitted, Green Published			2022-12-27	WOS:000358162300040
J	Jin, YH; Elalaf, H; Watanabe, M; Tamaki, S; Hineno, S; Matsunaga, K; Woltjen, K; Kobayashi, Y; Nagata, S; Ikeya, M; Kato, T; Okamoto, T; Matsuda, S; Toguchida, J				Jin, Yonghui; Elalaf, Hassan; Watanabe, Makoto; Tamaki, Sakura; Hineno, Sho; Matsunaga, Kazuhito; Woltjen, Knut; Kobayashi, Yukiko; Nagata, Sanae; Ikeya, Makoto; Kato, Tomohisa, Jr.; Okamoto, Takeshi; Matsuda, Shuichi; Toguchida, Junya			Mutant IDH1 Dysregulates the Differentiation of Mesenchymal Stem Cells in Association with Gene-Specific Histone Modifications to Cartilage- and Bone-Related Genes	PLOS ONE			English	Article							ONCOMETABOLITE 2-HYDROXYGLUTARATE; MYELOPROLIFERATIVE NEOPLASMS; MAFFUCCI SYNDROME; OLLIER DISEASE; MUTATIONS; CANCER; GLIOBLASTOMA; EXPRESSION; PROMOTER; COL2A1	Somatic mutations in the isocitrate dehydrogenase (IDH) 1/2 genes endow encoding proteins with neomorphic activity to produce the potential oncometabolite, 2-hydroxyglutarate (2-HG), which induces the hypermethylation of histones and DNA. The incidence of IDH1/2 mutations in cartilaginous tumors was previously shown to be the highest among various types of tumors, except for those in the central nervous system. Mutations have been detected in both benign (enchondromas) and malignant (chondrosarcomas) types of cartilaginous tumors, whereas they have rarely been found in other mesenchymal tumors such as osteosarcomas. To address this unique tumor specificity, we herein examined the effects of IDH1 R132C, which is the most prevalent mutant in cartilaginous tumors, on the differentiation properties of human mesenchymal stem cells (hMSCs). The induction of the IDH1 R132C gene into MSCs markedly increased the amount of 2-HG and up-regulated global histone methylation. The induction of IDH1 R132C promoted the chondrogenic differentiation of hMSCs by enhancing the expression of SOX9 and COL2A1 genes in association with an increase in the active mark (H3K4me3), but disrupted cartilage matrix formation. On the other hand, IDH1 R132C inhibited expression of the ALPL gene in association with an increase in the repressive mark (H3K9me3), and subsequently inhibited the osteogenic properties of hMSCs and human osteosarcoma cells. Since osteogenic properties are an indispensable feature for the diagnosis of osteosarcoma, the inhibitory effects of IDH1 R132C on osteogenic properties may contribute to the lack of osteosarcomas with the IDH1 R132C mutation. These results suggested that IDH1 R132C contributed to the formation of cartilaginous tumors by dysregulating the chondrogenic and osteogenic differentiation of hMSCs via gene-specific histone modulation.	[Jin, Yonghui; Elalaf, Hassan; Tamaki, Sakura; Hineno, Sho; Matsunaga, Kazuhito; Kobayashi, Yukiko; Kato, Tomohisa, Jr.; Toguchida, Junya] Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Kyoto, Japan; [Watanabe, Makoto; Matsunaga, Kazuhito; Nagata, Sanae; Ikeya, Makoto; Toguchida, Junya] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Okamoto, Takeshi; Matsuda, Shuichi; Toguchida, Junya] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Watanabe, Makoto] Shimadzu Cooperat, Life Sci Res Ctr, Kyoto, Japan; [Woltjen, Knut] Kyoto Univ, Dept Reprogramming Sci, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Matsunaga, Kazuhito] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi 755, Japan	Kyoto University; Kyoto University; Kyoto University; Shimadzu Corporation; Kyoto University; Yamaguchi University	Toguchida, J (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Kyoto, Japan.	togjun@frontier.kyoto-u.ac.jp		Kato, Tomohisa/0000-0002-3047-9847; Matsuda, Shuichi/0000-0003-0802-1255; Ikeya, Makoto/0000-0002-3930-8032; Woltjen, Knut/0000-0003-2293-1183	Japan Society of Promotion of Science [25670642]; Life Science Research Center; Shimadzu Cooperation; Grants-in-Aid for Scientific Research [15H04956] Funding Source: KAKEN	Japan Society of Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Life Science Research Center; Shimadzu Cooperation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society of the Promotion of Science to TO and JT (#25670642) (http://mhlw-grants.niph.go.jp/). One of the coauthors, Makoto Watanabe, is an employee of Shimadzu Cooperation. The Life Science Research Center, Shimadzu Cooperation provided support in the form of his salary, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of Makoto Watanabe (performed the experiments and analyzed the data) are articulated in the Authors Contributions section.	Abbas S, 2010, BLOOD, V116, P2122, DOI 10.1182/blood-2009-11-250878; Abdel-Wahab O, 2010, CANCER RES, V70, P447, DOI 10.1158/0008-5472.CAN-09-3783; Amary MF, 2011, NAT GENET, V43, P1262, DOI 10.1038/ng.994; Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Aoyama T, 2004, J BIOL CHEM, V279, P28789, DOI 10.1074/jbc.M401273200; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Delgado-Calle J, 2011, BONE, V49, P830, DOI 10.1016/j.bone.2011.06.006; FLETCHER CDM, 2002, WHO CLASSIFICATION T, P233; Furumatsu T, 2010, INT J BIOCHEM CELL B, V42, P148, DOI 10.1016/j.biocel.2009.10.003; Ghayor C, 2000, J BIOL CHEM, V275, P27421; Green A, 2010, NEW ENGL J MED, V362, P369, DOI 10.1056/NEJMc0910063; Kang MR, 2009, INT J CANCER, V125, P353, DOI 10.1002/ijc.24379; Kats LM, 2014, CELL STEM CELL, V14, P329, DOI 10.1016/j.stem.2013.12.016; Kim KI, 2013, J BONE MINER RES, V28, P1050, DOI 10.1002/jbmr.1843; Lu C, 2013, GENE DEV, V27, P1986, DOI 10.1101/gad.226753.113; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Millan JL, 2013, CALCIFIED TISSUE INT, V93, P299, DOI 10.1007/s00223-012-9672-8; Murugan AK, 2010, BIOCHEM BIOPH RES CO, V393, P555, DOI 10.1016/j.bbrc.2010.02.095; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pusch S, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-19; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Saha SK, 2014, NATURE, V513, P110, DOI 10.1038/nature13441; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Tarpey PS, 2013, NAT GENET, V45, P923, DOI 10.1038/ng.2668; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yen KE, 2010, ONCOGENE, V29, P6409, DOI 10.1038/onc.2010.444; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	36	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131998	10.1371/journal.pone.0131998	http://dx.doi.org/10.1371/journal.pone.0131998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161668	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300083
J	Kim, BJ; Chang, SA; Yang, J; Oh, SH; Xu, L				Kim, Bong Jik; Chang, Son-A; Yang, Jing; Oh, Seung-Ha; Xu, Li			Relative Contributions of Spectral and Temporal Cues to Korean Phoneme Recognition	PLOS ONE			English	Article							SPEECH RECOGNITION; SIGNAL PROCESSORS; CHANNELS; NOISE; STIMULATION; PROSTHESES; FEATURES; NUMBER; STOPS	This study was aimed to evaluate the relative contributions of spectral and temporal information to Korean phoneme recognition and to compare them with those to English phoneme recognition. Eleven normal-hearing Korean-speaking listeners participated in the study. Korean phonemes, including 18 consonants in a /Ca/ format and 17 vowels in a /hVd/ format, were processed through a noise vocoder. The spectral information was controlled by varying the number of channels (1, 2, 3, 4, 6, 8, 12, and 16) whereas the temporal information was controlled by varying the lowpass cutoff frequency of the envelope extractor (1 to 512 Hz in octave steps). A total of 80 vocoder conditions (8 numbers of channels x 10 lowpass cutoff frequencies) were presented to listeners for phoneme recognition. While vowel recognition depended on the spectral cues predominantly, a tradeoff between the spectral and temporal information was evident for consonant recognition. The overall consonant recognition was dramatically lower than that of English consonant recognition under similar vocoder conditions. The complexity of the Korean consonant repertoire, the three-way distinction of stops in particular, hinders recognition of vocoder-processed phonemes.	[Kim, Bong Jik; Oh, Seung-Ha] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Chang, Son-A] Woosong Univ, Sch Speech Language Therapy & Aural Rehabil, Taejon, South Korea; [Yang, Jing] Univ Cent Arkansas, Commun Sci & Disorders, Conway, AR 72035 USA; [Oh, Seung-Ha] Seoul Natl Univ, Med Res Ctr, Sensory Organ Res Inst, Seoul, South Korea; [Xu, Li] Ohio Univ, Commun Sci & Disorders, Athens, OH 45701 USA	Seoul National University (SNU); Woosong University; University of Central Arkansas; Seoul National University (SNU); University System of Ohio; Ohio University	Oh, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea.	shaoh@snu.ac.kr; xul@ohio.edu	Xu, Li/C-5908-2008	Xu, Li/0000-0002-0988-7934; Kim, Bong Jik/0000-0002-6384-2171	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2014043923]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2014043923). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho TH, 2002, J PHONETICS, V30, P193, DOI 10.1006/jpho.2001.0153; Dorman MF, 1998, J ACOUST SOC AM, V104, P3583, DOI 10.1121/1.423940; Dorman MF, 1997, J ACOUST SOC AM, V102, P2403, DOI 10.1121/1.419603; Dudley H., 1939, BELL LABS RECORD, V18, P122; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; HAN MS, 1970, PHONETICA, V22, P112, DOI 10.1159/000259311; Kim MR, 2004, J EAST ASIAN LINGUIS, V13, P59, DOI 10.1023/B:JEAL.0000007344.43938.4e; Kong YY, 2006, J ACOUST SOC AM, V120, P2830, DOI 10.1121/1.2346009; Lee H. B, 1999, HDB INT PHONETIC ASS, P120; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Shannon RV, 2004, ACTA OTO-LARYNGOL, V124, P50, DOI 10.1080/03655230410017562; Svirsky MA, 2013, INT CONF ACOUST SPEE, P8629, DOI 10.1109/ICASSP.2013.6639350; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Xu L, 2005, J ACOUST SOC AM, V117, P3255, DOI 10.1121/1.1886405; Xu L, 2002, J ACOUST SOC AM, V112, P247, DOI 10.1121/1.1487843; Xu L, 2008, HEARING RES, V242, P132, DOI 10.1016/j.heares.2007.12.010; Xu L, 2007, J ACOUST SOC AM, V122, P1758, DOI 10.1121/1.2767000; Yang HI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01419	18	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131807	10.1371/journal.pone.0131807	http://dx.doi.org/10.1371/journal.pone.0131807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162017	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300062
J	Salamone, M; Nicosia, A; Bennici, C; Quatrini, P; Catania, V; Mazzola, S; Ghersi, G; Cuttitta, A				Salamone, Monica; Nicosia, Aldo; Bennici, Carmelo; Quatrini, Paola; Catania, Valentina; Mazzola, Salvatore; Ghersi, Giulio; Cuttitta, Angela			Comprehensive Analysis of a Vibrio parahaemolyticus Strain Extracellular Serine Protease VpSP37	PLOS ONE			English	Article							STREPTOMYCES-GRISEUS TRYPSIN; HUMAN ISLET ISOLATION; CLASS-II; ENZYME BLENDS; SEQUENCE; PURIFICATION; COLLAGENASE; DISSOCIATION; EXPRESSION; MECHANISM	Proteases play an important role in the field of tissue dissociation combined with regenerative medicine. During the years new sources of proteolytic enzymes have been studied including proteases from different marine organisms both eukaryotic and prokaryotic. Herein we have purified a secreted component of an isolate of Vibrio parahaemolyticus, with electrophoretic mobilities corresponding to 36 kDa, belonging to the serine proteases family. Sequencing of the N-terminus enabled the in silico identification of the whole primary structure consisting of 345 amino acid residues with a calculated molecular mass of 37.4 KDa. The purified enzyme, named VpSP37, contains a Serine protease domain between residues 35 and 276 and a canonical Trypsin/Chimotrypsin 3D structure. Functional assays were performed to evaluate protease activity of purified enzyme. Additionally the performance of VpSP37 was evaluated in tissue dissociations experiments and the use of such enzyme as a component of enzyme blend for tissue dissociation procedures is strongly recommended.	[Salamone, Monica; Nicosia, Aldo; Bennici, Carmelo; Cuttitta, Angela] CNR, Inst Marine & Coastal Environm IAMC CNR, Lab Mol Ecol & Biotechnol, Detached Unit Capo Granitola, I-91021 Trapani, Sicily, Italy; [Quatrini, Paola; Catania, Valentina; Ghersi, Giulio; Cuttitta, Angela] Univ Palermo, Dipartimento Sci & Tecnol Biol Chim & Farmaceut S, Palermo, Sicily, Italy; [Mazzola, Salvatore; Ghersi, Giulio; Cuttitta, Angela] CNR, Inst Marine & Coastal Environm IAMC CNR, I-80133 Naples, Italy; [Ghersi, Giulio; Cuttitta, Angela] ABIEL Srl, I-91021 Trapani, Sicily, Italy	Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); University of Palermo; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Cuttitta, A (corresponding author), CNR, Inst Marine & Coastal Environm IAMC CNR, Lab Mol Ecol & Biotechnol, Detached Unit Capo Granitola, I-91021 Trapani, Sicily, Italy.	angela.cuttitta@iamc.cnr.it	Nicosia, Aldo/R-4462-2017; Cuttitta, Angela/AAK-2097-2020; salamone, monica/P-7422-2018	Nicosia, Aldo/0000-0002-1013-2862; Cuttitta, Angela/0000-0002-4896-5114; Mazzola, Salvatore/0000-0002-4622-8129; Ghersi, Giulio/0000-0001-7250-9808; salamone, monica/0000-0002-2274-927X	PON MIUR Project "Technologies and processes for an improved shelf-life of products in the agro-food industry through the use of innovative edible pectin films"	PON MIUR Project "Technologies and processes for an improved shelf-life of products in the agro-food industry through the use of innovative edible pectin films"	Funds were provided by PON MIUR Project "Technologies and processes for an improved shelf-life of products in the agro-food industry through the use of innovative edible pectin films" by A. Cuttitta.	BENDER ML, 1962, J AM CHEM SOC, V84, P2582, DOI 10.1021/ja00872a024; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Brandhorst H, 1999, TRANSPLANTATION, V68, P355, DOI 10.1097/00007890-199908150-00006; Brandhorst H, 2008, TRANSPLANTATION, V85, P456, DOI 10.1097/TP.0b013e31816050c8; Brandhorst H, 2009, TRANSPLANTATION, V87, P370, DOI 10.1097/TP.0b013e31819499f0; BUCK JD, 1984, J CLIN MICROBIOL, V20, P849, DOI 10.1128/JCM.20.5.849-851.1984; Cammarata M, 2014, DEV COMP IMMUNOL, V44, P332, DOI 10.1016/j.dci.2014.01.019; Castillo-Yanez FJ, 2005, COMP BIOCHEM PHYS B, V140, P91, DOI 10.1016/j.cbpc.2004.09.031; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; ERICKSON T, 1992, ANN EMERG MED, V21, P212, DOI 10.1016/S0196-0644(05)80169-6; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gadwal S, 2014, J BIOL CHEM, V289, P8288, DOI 10.1074/jbc.M113.525261; Gerday C, 2000, TRENDS BIOTECHNOL, V18, P103, DOI 10.1016/S0167-7799(99)01413-4; Haddad Jr V., 2000, REV SOC BRASILEIRA M; Haddad Junior Vidal, 2004, An. Bras. Dermatol., V79, P157, DOI 10.1590/S0365-05962004000200004; Haddar A, 2009, BIORESOURCE TECHNOL, V100, P3366, DOI 10.1016/j.biortech.2009.01.061; HOGE CW, 1989, J INFECT DIS, V160, P985, DOI 10.1093/infdis/160.6.985; Ishihara M, 2002, MICROBIOL IMMUNOL, V46, P299, DOI 10.1111/j.1348-0421.2002.tb02699.x; Jonsdottir G, 2004, PROTEIN EXPRES PURIF, V33, P110, DOI 10.1016/j.pep.2003.09.012; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KIM JC, 1991, BIOCHEM BIOPH RES CO, V181, P707, DOI 10.1016/0006-291X(91)91248-B; Kim SK, 2002, GENE, V283, P277, DOI 10.1016/S0378-1119(01)00882-4; Kin T, 2007, AM J TRANSPLANT, V7, P1233, DOI 10.1111/j.1600-6143.2007.01760.x; Kin T, 2008, TRANSPL INT, V21, P1059, DOI 10.1111/j.1432-2277.2008.00734.x; Klomklao S, 2006, COMP BIOCHEM PHYS B, V144, P47, DOI 10.1016/j.cbpb.2006.01.006; Kumar BK, 2014, GENOME ANNOUNC, V26, P2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawrence DA, 2011, J BIOL CHEM, V13, P286; Lee CY, 2002, FEMS MICROBIOL LETT, V209, P31, DOI 10.1111/j.1574-6968.2002.tb11105.x; Lin SJ, 2014, STRUCTURE, V22, P1333, DOI 10.1016/j.str.2014.07.008; Macouzet M, 2005, FEMS YEAST RES, V5, P851, DOI 10.1016/j.femsyr.2005.02.007; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; MANDL I, 1961, ADV ENZYMOL REL S BI, V23, P163; Mineo D, 2009, DIABETES CARE, V32, P1563, DOI 10.2337/dc09-0490; Miyoshi S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00339; MOORE S, 1948, J BIOL CHEM, V176, P367; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Nicosia A, 2013, MAR DRUGS, V11, P4213, DOI 10.3390/md11114213; OLAFSON RW, 1975, BIOCHEMISTRY-US, V14, P1168, DOI 10.1021/bi00677a011; PAVIA AT, 1989, ANN INTERN MED, V111, P85, DOI 10.7326/0003-4819-111-1-85; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; PIEN FD, 1983, DIAGN MICR INFEC DIS, V1, P229, DOI 10.1016/0732-8893(83)90022-6; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Riordan C, 2004, WILD ENVIRON MED, V15, P194, DOI 10.1580/1080-6032(2004)15[194:MEAITT]2.0.CO;2; Salamone M, 2010, TRANSPL P, V42, P2043, DOI 10.1016/j.transproceed.2010.05.107; Salamone M, 2014, CHEM ENGINEER TRANS, V38, P247, DOI 10.3303/CET1438042; Sawabe T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00414; Selvarajan S, 2001, NAT CELL BIOL, V3, P267, DOI 10.1038/35060059; TRAVERSO LW, 1978, TRANSPLANTATION, V25, P226, DOI 10.1097/00007890-197804000-00015; Uesugi Y, 2008, BBA-PROTEINS PROTEOM, V1784, P716, DOI 10.1016/j.bbapap.2008.01.017; Urbarova I, 2012, MAR DRUGS, V10, P2265, DOI 10.3390/md10102265; VANWART HE, 1985, BIOCHEMISTRY-US, V24, P6520, DOI 10.1021/bi00344a032; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WOLTERS GHJ, 1992, DIABETOLOGIA, V35, P735, DOI 10.1007/BF00429093; WOLTERS GHJ, 1995, DIABETES, V44, P227, DOI 10.2337/diabetes.44.2.227; Zhang C, 2010, MAR DRUGS, V8, P1920, DOI 10.3390/md8061920; Zmuda EJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2096	60	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0126349	10.1371/journal.pone.0126349	http://dx.doi.org/10.1371/journal.pone.0126349			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162075	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300003
J	Yeh, JSM; Sennoga, CA; McConnell, E; Eckersley, R; Tang, MX; Nourshargh, S; Seddon, JM; Haskard, DO; Nihoyannopoulos, P				Yeh, James Shue-Min; Sennoga, Charles A.; McConnell, Ellen; Eckersley, Robert; Tang, Meng-Xing; Nourshargh, Sussan; Seddon, John M.; Haskard, Dorian O.; Nihoyannopoulos, Petros			A Targeting Microbubble for Ultrasound Molecular Imaging	PLOS ONE			English	Article							INTRACAPILLARY BLOOD-VOLUME; CONTRAST AGENT; IN-VIVO; E-SELECTIN; MYOCARDIAL-ISCHEMIA; GENE TRANSFECTION; P-SELECTIN; EXPRESSION; ANGIOGENESIS; BR55	Rationale Microbubbles conjugated with targeting ligands are used as contrast agents for ultrasound molecular imaging. However, they often contain immunogenic (strept) avidin, which impedes application in humans. Although targeting bubbles not employing the biotin( strept) avidin conjugation chemistry have been explored, only a few reached the stage of ultrasound imaging in vivo, none were reported/evaluated to show all three of the following properties desired for clinical applications: (i) low degree of non-specific bubble retention in more than one non-reticuloendothelial tissue; (ii) effective for real-time imaging; and (iii) effective for acoustic quantification of molecular targets to a high degree of quantification. Furthermore, disclosures of the compositions and methodologies enabling reproduction of the bubbles are often withheld. Objective To develop and evaluate a targeting microbubble based on maleimide-thiol conjugation chemistry for ultrasound molecular imaging. Methods and Results Microbubbles with a previously unreported generic (non-targeting components) composition were grafted with anti-E-selectin F(ab')(2) using maleimide-thiol conjugation, to produce E-selectin targeting microbubbles. The resulting targeting bubbles showed high specificity to E-selectin in vitro and in vivo. Non-specific bubble retention was minimal in at least three non-reticuloendothelial tissues with inflammation (mouse heart, kidneys, cremaster). The bubbles were effective for real-time ultrasound imaging of E-selectin expression in the inflamed mouse heart and kidneys, using a clinical ultrasound scanner. The acoustic signal intensity of the targeted bubbles retained in the heart correlated strongly with the level of E-selectin expression (vertical bar r vertical bar >= 0.8), demonstrating a high degree of non-invasive molecular quantification. Conclusions Targeting microbubbles for ultrasound molecular imaging, based on maleimide-thiol conjugation chemistry and the generic composition described, may possess properties (i)-(iii) desired for clinical applications.	[Yeh, James Shue-Min; McConnell, Ellen; Nourshargh, Sussan; Haskard, Dorian O.; Nihoyannopoulos, Petros] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Yeh, James Shue-Min; Nihoyannopoulos, Petros] Hammersmith Hosp, Dept Cardiol, London, England; [Yeh, James Shue-Min; Sennoga, Charles A.; Eckersley, Robert] Univ London Imperial Coll Sci Technol & Med, MRC, Imaging Sci Dept, London, England; [Sennoga, Charles A.; Seddon, John M.] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AY, England; [Tang, Meng-Xing] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Nourshargh, Sussan] Univ London, William Harvey Res Inst, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; University of London; Queen Mary University London	Nihoyannopoulos, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	p.nihoyannopoulos@imperial.ac.uk		Nourshargh, Sussan/0000-0001-5677-1806; Seddon, John/0000-0002-7099-3402; Eckersley, Robert/0000-0001-9247-5350	Bristol-Myers Squibb Cardiovascular Prize Fellowship; British Heart Foundation Project Grant; Hammersmith Hospitals Trustees' Research Committee Small Project Grant; British Heart Foundation	Bristol-Myers Squibb Cardiovascular Prize Fellowship; British Heart Foundation Project Grant(British Heart Foundation); Hammersmith Hospitals Trustees' Research Committee Small Project Grant; British Heart Foundation(British Heart Foundation)	The work was supported by the following: Bristol-Myers Squibb Cardiovascular Prize Fellowship (JY); British Heart Foundation Project Grant (PN, MB, DOH, SN, JS, CS, EM, JY); and Hammersmith Hospitals Trustees' Research Committee Small Project Grant (PN, MB, DOH). DH receives professorial support from the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2007, STROKE, V38, P1508, DOI 10.1161/STROKEAHA.106.471391; Anderson CR, 2011, INVEST RADIOL, V46, P215, DOI 10.1097/RLI.0b013e3182034fed; Anderson CR, 2010, INVEST RADIOL, V45, P579, DOI 10.1097/RLI.0b013e3181efd581; Bettinger T, 2012, INVEST RADIOL, V47, P516, DOI 10.1097/RLI.0b013e31825cc605; Boeckler C, 1996, J IMMUNOL METHODS, V191, P1, DOI 10.1016/0022-1759(95)00284-7; Borden MA, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2013.00052; Bracco International B.V., 2005, SON SUMM PROD CHAR, P9; Bzyl J, 2013, EUR RADIOL, V23, P468, DOI 10.1007/s00330-012-2594-z; Bzyl J, 2011, EUR RADIOL, V21, P1988, DOI 10.1007/s00330-011-2138-y; Coulden R, 1997, FUNCTIONAL COMPUTED, P133; Davidson BP, 2014, J AM SOC ECHOCARDIOG, V27, P786, DOI 10.1016/j.echo.2014.03.013; Davidson BP, 2012, J AM COLL CARDIOL, V60, P1690, DOI 10.1016/j.jacc.2012.07.027; Della Martina A, 2008, EUR J PHARM BIOPHARM, V68, P555, DOI 10.1016/j.ejpb.2007.07.008; Eppihimer MJ, 1996, CIRC RES, V79, P560, DOI 10.1161/01.RES.79.3.560; Fisher NG, 2002, J AM COLL CARDIOL, V40, P811, DOI 10.1016/S0735-1097(02)02038-7; Fokong S, 2013, INVEST RADIOL, V48, P843, DOI 10.1097/RLI.0b013e31829d03ec; French RR, 1996, LEUKEMIA RES, V20, P607, DOI 10.1016/0145-2126(96)00007-0; Friedrich MG, 1998, CIRCULATION, V97, P1802, DOI 10.1161/01.CIR.97.18.1802; Frinking PJA, 2012, ULTRASOUND MED BIOL, V38, P1460, DOI 10.1016/j.ultrasmedbio.2012.03.018; Hu GQ, 2012, THROMB HAEMOSTASIS, V107, P172, DOI 10.1160/TH10-11-0701; Hu XW, 2012, INVEST RADIOL, V47, P398, DOI 10.1097/RLI.0b013e31824bd237; Hyvelin JM, 2014, INVEST RADIOL, V49, P224, DOI 10.1097/RLI.0000000000000018; Jamar F, 2002, RHEUMATOLOGY, V41, P53, DOI 10.1093/rheumatology/41.1.53; Kansas G, 2001, PHYSL INFLAMMATION, P222; Klibanov AL, 1999, PROCEED INTL SYMP CO, V26, P230; KNIGHT CG, 1976, BIOCHEM J, V159, P323, DOI 10.1042/bj1590323; Knowles JA, 2012, ARCH OTOLARYNGOL, V138, P662, DOI 10.1001/archoto.2012.1081; LABOW MA, 1994, IMMUNITY, V1, P709, DOI 10.1016/1074-7613(94)90041-8; Leng XP, 2014, MOL IMAGING, V13, DOI 10.2310/7290.2014.00006; Lindner JR, 2001, CIRCULATION, V104, P2107, DOI 10.1161/hc4201.097061; Lukac R, 2011, LANGMUIR, V27, P4829, DOI 10.1021/la104677b; PEETERS JM, 1989, J IMMUNOL METHODS, V120, P133, DOI 10.1016/0022-1759(89)90298-6; Pillai R, 2010, BIOCONJUGATE CHEM, V21, P556, DOI 10.1021/bc9005688; Pochon S, 2010, INVEST RADIOL, V45, P89, DOI 10.1097/RLI.0b013e3181c5927c; Reynolds PR, 2006, RADIOLOGY, V241, P469, DOI 10.1148/radiol.2412050490; Riviere JE, 1999, COMP PHARMACOKINETIC, P107; Sennoga CA, 2012, ULTRASOUND MED BIOL, V38, P834, DOI 10.1016/j.ultrasmedbio.2012.01.012; Sirsi SR, 2012, ULTRASOUND MED BIOL, V38, P1019, DOI 10.1016/j.ultrasmedbio.2012.01.014; St Michael F, 2011, GLYCOCONJUGATE J, V28, P397, DOI 10.1007/s10719-011-9339-0; Streif JUG, 2005, MAGN RESON MED, V53, P584, DOI 10.1002/mrm.20327; Tardy I, 2002, ACAD RADIOL, V9, pS294, DOI 10.1016/S1076-6332(03)80207-6; Timoshanko JR, 2003, J AM SOC NEPHROL, V14, P1785, DOI 10.1097/01.ASN.0000073902.38428.33; Unnikrishnan S, 2012, AM J ROENTGENOL, V199, P292, DOI 10.2214/AJR.12.8826; van Wamel A, 2007, IEEE ULTR S, P4; Vandegriff KD, 2009, ARTIF ORGANS, V33, P133, DOI 10.1111/j.1525-1594.2008.00697.x; Villanueva FS, 2007, CIRCULATION, V115, P345, DOI 10.1161/CIRCULATIONAHA.106.633917; Waller C, 2000, RADIOLOGY, V215, P189, DOI 10.1148/radiology.215.1.r00ap07189; Wang HJ, 2013, RADIOLOGY, V267, P818, DOI 10.1148/radiol.13122509; Wu WL, 2013, INVEST RADIOL, V48, P803, DOI 10.1097/RLI.0b013e318298652d; Xie A, 2012, JACC-CARDIOVASC IMAG, V5, P1253, DOI 10.1016/j.jcmg.2012.05.017; Yan P, 2014, BIOMATERIALS, V35, P1063, DOI 10.1016/j.biomaterials.2013.10.043; Yeh JS, 2005, J AM COLL CARDIOL, V45, p142A; Yeh JSM, 2010, THESIS U LONDON LOND	53	29	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0129681	10.1371/journal.pone.0129681	http://dx.doi.org/10.1371/journal.pone.0129681			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161541	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300010
J	Mayo, M; Collier, ZA; Winton, C; Chappell, MA				Mayo, Michael; Collier, Zachary A.; Winton, Corey; Chappell, Mark A.			Data-Driven Method to Estimate Nonlinear Chemical Equivalence	PLOS ONE			English	Article							LIFE-CYCLE ASSESSMENT; SELENIUM TOXICITY; IMPACT ASSESSMENT; DECISION-ANALYSIS; MULTIMEDIA FATE; RISK-ASSESSMENT; PART I; SUBSTANCES; POTENTIALS; EMISSIONS	There is great need to express the impacts of chemicals found in the environment in terms of effects from alternative chemicals of interest. Methods currently employed in fields such as life-cycle assessment, risk assessment, mixtures toxicology, and pharmacology rely mostly on heuristic arguments to justify the use of linear relationships in the construction of "equivalency factors," which aim to model these concentration-concentration correlations. However, the use of linear models, even at low concentrations, oversimplifies the nonlinear nature of the concentration-response curve, therefore introducing error into calculations involving these factors. We address this problem by reporting a method to determine a concentration-concentration relationship between two chemicals based on the full extent of experimentally derived concentration-response curves. Although this method can be easily generalized, we develop and illustrate it from the perspective of toxicology, in which we provide equations relating the sigmoid and non-monotone, or "biphasic," responses typical of the field. The resulting concentration-concentration relationships are manifestly nonlinear for nearly any chemical level, even at the very low concentrations common to environmental measurements. We demonstrate the method using real-world examples of toxicological data which may exhibit sigmoid and biphasic mortality curves. Finally, we use our models to calculate equivalency factors, and show that traditional results are recovered only when the concentration-response curves are "parallel," which has been noted before, but we make formal here by providing mathematical conditions on the validity of this approach.	[Mayo, Michael; Collier, Zachary A.; Chappell, Mark A.] US Army, Environm Lab, Engn Res & Dev Ctr, Vicksburg, MS 39183 USA; [Winton, Corey] US Army, Informat Technol Lab, Engn Res & Dev Ctr, Vicksburg, MS 39183 USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Mayo, M (corresponding author), US Army, Environm Lab, Engn Res & Dev Ctr, Vicksburg, MS 39183 USA.	Michael.L.Mayo@usace.army.mil			Military Materials in the Environment (MME) Program for the U.S Army Engineer Research & Development (ERDC) Laboratory	Military Materials in the Environment (MME) Program for the U.S Army Engineer Research & Development (ERDC) Laboratory	This work was funded through the Military Materials in the Environment (MME) Program for the U.S Army Engineer Research & Development (ERDC) Laboratory.	Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; [Anonymous], 1925, J ECON ENTOMOL; Beckon W, 2008, ENVIRON SCI TECHNOL, V42, P1308, DOI 10.1021/es071148m; Bennett MR, 2007, BIOPHYS J, V92, P3501, DOI 10.1529/biophysj.106.095638; Bjorklund AE, 2002, INT J LIFE CYCLE ASS, V7, P64, DOI 10.1065/lca2001.12/071; Brandes L. J., 1996, 719101029 RIVM; Brentrup F, 2001, EUR J AGRON, V14, P221, DOI 10.1016/S1161-0301(00)00098-8; Calabrese EJ, 2003, ANNU REV PHARMACOL, V43, P175, DOI 10.1146/annurev.pharmtox.43.100901.140223; CARLSON AR, 1987, ARCH ENVIRON CON TOX, V16, P129, DOI 10.1007/BF01055794; Ciliberto A, 2007, PLOS COMPUT BIOL, V3, P463, DOI 10.1371/journal.pcbi.0030045; Conolly RB, 2004, TOXICOL SCI, V77, P151, DOI 10.1093/toxsci/kfh007; de Bruijn H., 2002, HDB LIFE CYCLE ASSES, V7; Ekvall T, 2007, WASTE MANAGE, V27, P989, DOI 10.1016/j.wasman.2007.02.015; GUINEE J, 1993, CHEMOSPHERE, V26, P1925, DOI 10.1016/0045-6535(93)90086-K; Hamilton SJ, 2004, SCI TOTAL ENVIRON, V326, P1, DOI 10.1016/j.scitotenv.2004.01.019; Hamilton SJ, 2003, ECOTOX ENVIRON SAFE, V56, P201, DOI 10.1016/S0147-6513(02)00091-X; HAMILTON SJ, 1990, ENVIRON TOXICOL CHEM, V9, P347, DOI 10.1002/etc.5620090310; Harding LE, 2008, SCI TOTAL ENVIRON, V389, P350, DOI 10.1016/j.scitotenv.2007.09.026; HILTON JW, 1980, J NUTR, V110, P2527, DOI 10.1093/jn/110.12.2527; HOWARD RA, 1988, MANAGE SCI, V34, P679, DOI 10.1287/mnsc.34.6.679; Huijbregts MAJ, 2000, CHEMOSPHERE, V41, P541, DOI 10.1016/S0045-6535(00)00030-8; Huijbregts MAJ, 2005, INTEGR ENVIRON ASSES, V1, P181, DOI 10.1897/2004-007R.1; Huijbregts MAJ, 2011, ENVIRON SCI TECHNOL, V45, P3833, DOI 10.1021/es200918b; Humbert S, 2009, SCI TOTAL ENVIRON, V407, P4812, DOI 10.1016/j.scitotenv.2009.05.024; ISO, 2006, ISO140402006; Jolliet O, 2003, INT J LIFE CYCLE ASS, V8, P324, DOI 10.1007/BF02978505; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; LEBLANC GA, 1983, ARCH ENVIRON CON TOX, V12, P305, DOI 10.1007/BF01059407; Manneh R, 2010, ENVIRON SCI TECHNOL, V44, P4217, DOI 10.1021/es902983b; Mattson MP, 2010, HORMESIS: A REVOLUTION IN BIOLOGY, TOXICOLOGY AND MEDICINE, P1, DOI 10.1007/978-1-60761-495-1_1; Mayo M, 2014, SCI TOTAL ENVIRON, V494, P104, DOI 10.1016/j.scitotenv.2014.06.061; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Norris G., 2002, MANY DIMENSIONS UNCE; OWENS JW, 1996, INT J LCA, V1, P151; Pennington DW, 2004, ENVIRON TOXICOL CHEM, V23, P1796, DOI 10.1897/03-157; Peters SA., 2012, PHYSL BASED PHARMACO, P273; POSTON HA, 1976, J NUTR, V106, P892, DOI 10.1093/jn/106.7.892; Potting J, 1997, INT J LIFE CYCLE ASS, V2, P171, DOI 10.1007/BF02978815; Puntener W, 1981, MANUAL FIELD TRIALS, P205; Safe SH, 2004, ENVIRON HEALTH PER S, V106, P1051; Schultz TW, 2010, ISSUES TOXICOL, V7, P346; Seager TP, 2008, J IND ECOL, V12, P282, DOI 10.1111/j.1530-9290.2008.00048.x; Seppala J, 2004, INT J LIFE CYCLE ASS, V9, P90, DOI 10.1065/lca2004.02.145; Smadbeck P, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4770273; Smith SJ, 2000, CLIMATIC CHANGE, V44, P445, DOI 10.1023/A:1005584914078; Tallarida RJ, 2012, J PHARMACOL EXP THER, V342, P2, DOI 10.1124/jpet.112.193474; Udo de Haes H A, 1999, INT J LCA, V4, P66, DOI DOI 10.1007/BF02979403; Uhlman BW, 2010, CHEM ENG PROG, V106, P17	49	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130494	10.1371/journal.pone.0130494	http://dx.doi.org/10.1371/journal.pone.0130494			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158701	Green Submitted, Green Published, gold			2022-12-27	WOS:000358161200012
J	Schrauwen, I; Szelinger, S; Siniard, AL; Kurdoglu, A; Corneveaux, JJ; Malenica, I; Richholt, R; Van Camp, G; De Both, M; Swaminathan, S; Turk, M; Ramsey, K; Craig, DW; Narayanan, V; Huentelman, MJ				Schrauwen, Isabelle; Szelinger, Szabolcs; Siniard, Ashley L.; Kurdoglu, Ahmet; Corneveaux, Jason J.; Malenica, Ivana; Richholt, Ryan; Van Camp, Guy; De Both, Matt; Swaminathan, Shanker; Turk, Mari; Ramsey, Keri; Craig, David W.; Narayanan, Vinodh; Huentelman, Matthew J.			A Frame-Shift Mutation in CAV1 Is Associated with a Severe Neonatal Progeroid and Lipodystrophy Syndrome	PLOS ONE			English	Article							CONGENITAL GENERALIZED LIPODYSTROPHY; GENETIC-VARIANTS; CAVEOLIN-1; DEFICIENCY; HYPERTENSION; PHENOTYPES; DYSTROPHY; SECONDARY; ALIGNMENT; HUMANS	A 3-year-old female patient presenting with an unknown syndrome of a neonatal progeroid appearance, lipodystrophy, pulmonary hypertension, cutis marmorata, feeding disorder and failure to thrive was investigated by whole-genome sequencing. This revealed a de novo, heterozygous, frame-shift mutation in the Caveolin1 gene (CAV1) (p.Phe160X). Mutations in CAV1, encoding the main component of the caveolae in plasma membranes, cause Berardinelli-Seip congenital lipodystrophy type 3 (BSCL). Although BSCL is recessive, heterozygous carriers either show a reduced phenotype of partial lipodystrophy, pulmonary hypertension, or no phenotype. To investigate the pathogenic mechanisms underlying this syndrome in more depth, we performed next generation RNA sequencing of peripheral blood, which showed several dysregulated pathways in the patient that might be related to the phenotypic progeroid features (apoptosis, DNA repair/replication, mitochondrial). Secondly, we found a significant down-regulation of known Cav1 interaction partners, verifying the dysfunction of CAV1. Other known progeroid genes and lipodystrophy genes were also dysregulated. Next, western blotting of lysates of cultured fibroblasts showed that the patient shows a significantly decreased expression of wild-type CAV1 protein, demonstrating a loss-of-function mutation, though her phenotype is more severe that other heterozygotes with similar mutations. This phenotypic variety could be explained by differences in genetic background. Indications for this are supported by additional rare variants we found in AGPAT2 and LPIN1 lipodystrophy genes. CAV1, AGPAT2 and LPIN1 all play an important role in triacylglycerol (TAG) biosynthesis in adipose tissue, and the defective function in different parts of this pathway, though not all to the same extend, could contribute to a more severe lipoatrophic phenotype in this patient. In conclusion, we report, for the first time, an association of CAV1 dysfunction with a syndrome of severe premature aging and lipodystrophy. This may contribute to a better understanding of the aging process and pathogenic mechanisms that contribute to premature aging.	[Schrauwen, Isabelle; Szelinger, Szabolcs; Siniard, Ashley L.; Kurdoglu, Ahmet; Corneveaux, Jason J.; Malenica, Ivana; Richholt, Ryan; De Both, Matt; Swaminathan, Shanker; Turk, Mari; Ramsey, Keri; Craig, David W.; Narayanan, Vinodh; Huentelman, Matthew J.] Ctr Rare Childhood Disorders, Translat Genom Res Inst, Phoenix, AZ 85004 USA; [Schrauwen, Isabelle; Szelinger, Szabolcs; Siniard, Ashley L.; Kurdoglu, Ahmet; Corneveaux, Jason J.; Malenica, Ivana; Richholt, Ryan; De Both, Matt; Swaminathan, Shanker; Turk, Mari; Ramsey, Keri; Craig, David W.; Narayanan, Vinodh; Huentelman, Matthew J.] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ USA; [Schrauwen, Isabelle; Van Camp, Guy] Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium	Translational Genomics Research Institute; Translational Genomics Research Institute; University of Antwerp	Huentelman, MJ (corresponding author), Ctr Rare Childhood Disorders, Translat Genom Res Inst, Phoenix, AZ 85004 USA.	mhuentelman@tgen.org	Van Camp, Guy/F-3386-2013; Malenica, Ivana/J-2007-2019; Schrauwen, Isabelle/H-5908-2019; Craig, David Wesley/K-6961-2019	Van Camp, Guy/0000-0001-5105-9000; Malenica, Ivana/0000-0002-7404-8088; Schrauwen, Isabelle/0000-0001-7310-6082; Craig, David Wesley/0000-0003-2040-1955; Narayanan, Vinodh/0000-0002-0658-3847	State of Arizona DHS; TGen Foundation	State of Arizona DHS; TGen Foundation	Funding was received from the State of Arizona DHS and several anonymous donors. IS is a postdoctoral researcher of the FWO-Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Center for Rare Childhood Disorders receives funding from multiple donors and fundraising efforts organized through the TGen Foundation. Robyn Nebrich (Assistant Development Director) and Terry McManus (Vice President of Strategic Initiatives) would be happy to speak with you about the funding for the Center. They can be reached at: Robyn Nebrich (Email: rnebrich@tgen.org 602.343.8638 | c: 480.235.5811 | f: 602.343.8441) and Terry McManus (Email: tmcmanus@tgen.org 602.343.8527 | c: 480.316.4537 | f: 602.343.8441).	Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888; Burgdorf KS, 2010, EUR J ENDOCRINOL, V163, P81, DOI 10.1530/EJE-10-0068; Cao H, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-3; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Csaki LS, 2014, MOL METAB, V3, P145, DOI 10.1016/j.molmet.2013.11.008; Dreesen O, 2011, AGING-US, V3, P889, DOI 10.18632/aging.100383; Erhardt E, 2014, INT J OBESITY, V38, pS32, DOI 10.1038/ijo.2014.133; Feng X, 2001, J BIOL CHEM, V276, P8341, DOI 10.1074/jbc.M007116200; Garg A, 2015, AM J MED GENET A; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Higami Y, 2000, CELL TISSUE RES, V301, P125, DOI 10.1007/s004419900156; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046242; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Navarro CL, 2006, HUM MOL GENET, V15, pR151, DOI 10.1093/hmg/ddl214; Ost A, 2005, J BIOL CHEM, V280, P5, DOI 10.1074/jbc.C400429200; Pollier Jacob, 2013, Methods Mol Biol, V1011, P305, DOI 10.1007/978-1-62703-414-2_24; Razani B, 2001, AM J PHYSIOL-CELL PH, V281, pC1241, DOI 10.1152/ajpcell.2001.281.4.C1241; Reue K, 2000, J LIPID RES, V41, P1067; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Villegas Jacob, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2803s71; Vogel P, 2011, VET PATHOL, V48, P642, DOI 10.1177/0300985810383870; Volonte D, 2009, AGING-US, V1, P831, DOI 10.18632/aging.100079; Wiedmann S, 2008, DIABETES, V57, P209, DOI 10.2337/db07-0083; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Zhang M, 2011, FREE RADICAL BIO MED, V50, P1252, DOI 10.1016/j.freeradbiomed.2011.02.031; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338	34	28	29	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131797	10.1371/journal.pone.0131797	http://dx.doi.org/10.1371/journal.pone.0131797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176221	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600065
J	Augustine, EF; Perez, A; Dhall, R; Umeh, CC; Videnovic, A; Cambi, F; Wills, AMA; Elm, JJ; Zweig, RM; Shulman, LM; Nance, MA; Bainbridge, J; Suchowersky, O				Augustine, Erika F.; Perez, Adriana; Dhall, Rohit; Umeh, Chizoba C.; Videnovic, Aleksandar; Cambi, Franca; Wills, Anne-Marie A.; Elm, Jordan J.; Zweig, Richard M.; Shulman, Lisa M.; Nance, Martha A.; Bainbridge, Jacquelyn; Suchowersky, Oksana			Sex Differences in Clinical Features of Early, Treated Parkinson's Disease	PLOS ONE			English	Article							GENDER-DIFFERENCES; PREVALENCE; RISK; STROKE; WOMEN; MEN; EPIDEMIOLOGY; PROGRESSION; MECHANISMS; DEMENTIA	Introduction To improve our understanding of sex differences in the clinical characteristics of Parkinson's Disease, we sought to examine differences in the clinical features and disease severity of men and women with early treated Parkinson's Disease (PD) enrolled in a large-scale clinical trial. Methods Analysis was performed of baseline data from the National Institutes of Health Exploratory Trials in Parkinson's Disease (NET-PD) Long-term Study-1, a randomized, multi-center, double-blind, placebo-controlled study of 10 grams of oral creatine/day in individuals with early, treated PD. We compared mean age at symptom onset, age at PD diagnosis, and age at randomization between men and women using t-test statistics. Sex differences in clinical features were evaluated, including: symptoms at diagnosis (motor) and symptoms at randomization (motor, non-motor, and daily functioning). Results 1,741 participants were enrolled (62.5% male). No differences were detected in mean age at PD onset, age at PD diagnosis, age at randomization, motor symptoms, or daily functioning between men and women. Differences in non-motor symptoms were observed, with women demonstrating better performance compared to men on SCOPA-COG (Z = 5.064, p<0.0001) and Symbol Digit Modality measures (Z = 5.221, p<0.0001). Conclusions Overall, men and women did not demonstrate differences in clinical motor features early in the course of PD. However, the differences observed in non-motor cognitive symptoms suggests further assessment of the influence of sex on non-motor symptoms in later stages of PD is warranted.	[Augustine, Erika F.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Perez, Adriana] Univ Texas Austin, Sch Publ Hlth, Austin, TX 78712 USA; [Dhall, Rohit] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Umeh, Chizoba C.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Umeh, Chizoba C.; Cambi, Franca] Harvard Univ, Sch Med, Boston, MA USA; [Videnovic, Aleksandar] Massachusetts Gen Hosp, Neurol Clin Res Inst, Boston, MA 02114 USA; [Cambi, Franca] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Wills, Anne-Marie A.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Elm, Jordan J.] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Zweig, Richard M.] Louisiana State Univ, Hlth Sci Ctr, Shreveport, LA 71105 USA; [Shulman, Lisa M.] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Nance, Martha A.] Struthers Parkinsons Ctr, Minneapolis, MN USA; [Bainbridge, Jacquelyn] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA; [Suchowersky, Oksana] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Suchowersky, Oksana] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; [Suchowersky, Oksana] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	University of Rochester; University of Texas System; University of Texas Austin; Barrow Neurological Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Kentucky; Harvard University; Massachusetts General Hospital; Medical University of South Carolina; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University System of Maryland; University of Maryland Baltimore; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Alberta; University of Alberta; University of Alberta	Augustine, EF (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA.	erika_augustine@urmc.rochester.edu		Dhall, Rohit/0000-0001-9436-1920; Perez, Adriana/0000-0002-6859-9916	National Institute for Neurological Disorders and Stroke [U01NS43128, U01NS043127]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K12NS066098, U01NS043127, U01NS043128, K23NS072283] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The NET-PD LS-1 trial received funding support from the National Institute for Neurological Disorders and Stroke (U01NS43128 and U01NS043127). For the current report, a secondary analysis of trial data, the authors received no specific funding to support this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves G, 2009, J NEUROL NEUROSUR PS, V80, P851, DOI 10.1136/jnnp.2008.168211; Amantea D, 2005, PHARMACOL RES, V52, P119, DOI 10.1016/j.phrs.2005.03.002; Anderson GD, 2008, INT REV NEUROBIOL, V83, P1, DOI 10.1016/S0074-7742(08)00001-9; [Anonymous], 2004, J WOMEN HEALTH GEN-B, V10, P433, DOI [DOI 10.1089/152460901300233902, 10.1089/152460901300233902]; [Anonymous], 2001, NIH POLICY GUIDELINE; Baba Y, 2005, J NEUROL, V252, P1201, DOI 10.1007/s00415-005-0835-7; Baldereschi M, 2000, NEUROLOGY, V55, P1358, DOI 10.1212/WNL.55.9.1358; Bourque M, 2012, FRONT NEUROENDOCRIN, V33, P169, DOI 10.1016/j.yfrne.2012.02.003; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Cialone J, 2012, J INHERIT METAB DIS, V35, P549, DOI 10.1007/s10545-011-9421-6; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; DIAMOND SG, 1990, NEUROLOGY, V40, P763, DOI 10.1212/WNL.40.5.763; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Elm JJ, 2012, MOVEMENT DISORD, V27, P1513, DOI 10.1002/mds.25175; Haaxma CA, 2007, J NEUROL NEUROSUR PS, V78, P819, DOI 10.1136/jnnp.2006.103788; Hughes TA, 2000, NEUROLOGY, V54, P1596, DOI 10.1212/WNL.54.8.1596; Irvine K, 2012, J CLIN EXP NEUROPSYC, V34, P989, DOI 10.1080/13803395.2012.712676; Jorm AF, 2004, INTELLIGENCE, V32, P7, DOI 10.1016/j.intell.2003.08.001; Kehoe P, 1999, J MED GENET, V36, P108; Kieburtz K, 2015, JAMA-J AM MED ASSOC, V313, P584, DOI 10.1001/jama.2015.120; Kowal SL, 2013, MOVEMENT DISORD, V28, P311, DOI 10.1002/mds.25292; Leroi I, 2012, J GERIATR PSYCH NEUR, V25, P208, DOI 10.1177/0891988712464823; Lyons KE, 1998, CLIN NEUROPHARMACOL, V21, P118; Martinez-Martin P, 2012, J NEUROL, V259, P1639, DOI 10.1007/s00415-011-6392-3; Munro CA, 2012, AGING NEUROPSYCHOL C, V19, P759, DOI 10.1080/13825585.2012.690366; Pancholy SB, 2014, AM J CARDIOL, V113, P485, DOI 10.1016/j.amjcard.2013.10.035; Rana AQ, 2012, PSYCHIAT CLIN NEUROS, V66, P64, DOI 10.1111/j.1440-1819.2011.02291.x; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Regitz-Zagrosek V, 2006, NAT REV DRUG DISCOV, V5, P425, DOI 10.1038/nrd2032; Roos RAC, 1996, MOVEMENT DISORD, V11, P236, DOI 10.1002/mds.870110304; Saunders-Pullman R, 2011, GENDER MED, V8, P209, DOI 10.1016/j.genm.2011.05.002; Schrag A, 2000, BRIT MED J, V321, P21, DOI 10.1136/bmj.321.7252.21; Schrag A, 2006, MOVEMENT DISORD, V21, P1200, DOI 10.1002/mds.20914; Solla P, 2012, J NEUROL SCI, V323, P33, DOI 10.1016/j.jns.2012.07.026; Stavitsky K, 2011, COGN BEHAV NEUROL, V24, P43, DOI 10.1097/WNN.0b013e31821a4a95; Towfighi A, 2009, ARCH INTERN MED, V169, P1762, DOI 10.1001/archinternmed.2009.318; Umeh CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112287; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; van der Hoek TC, 2011, J NEUROL SCI, V310, P220, DOI 10.1016/j.jns.2011.07.007; Wexler DJ, 2005, DIABETES CARE, V28, P514, DOI 10.2337/diacare.28.3.514; Wooten GF, 2004, J NEUROL NEUROSUR PS, V75, P637, DOI 10.1136/jnnp.2003.020982; Zimprich A, 2001, NAT GENET, V29, P66, DOI 10.1038/ng709	42	37	38	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133002	10.1371/journal.pone.0133002	http://dx.doi.org/10.1371/journal.pone.0133002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171861	Green Submitted, gold, Green Published			2022-12-27	WOS:000358194900115
J	Carvalho, MS; Coeli, CM; Chor, D; Pinheiro, RS; da Fonseca, MDM; Carvalho, LCD				Carvalho, Marilia Sa; Coeli, Claudia Medina; Chor, Dora; Pinheiro, Rejane Sobrino; Mendes da Fonseca, Maria de Jesus; de Sa Carvalho, Luiz Carlos			The Challenge of Cardiovascular Diseases and Diabetes to Public Health: A Study Based on Qualitative Systemic Approach	PLOS ONE			English	Article							SOCIOECONOMIC POSITION; BLOOD-PRESSURE; SOCIAL-PARTICIPATION; WORK CHARACTERISTICS; AMERICAN-COLLEGE; ADVERSE EVENTS; AIR-POLLUTION; CARE; LIFE; RISK	The most common modeling approaches to understanding incidence, prevalence and control of chronic diseases in populations, such as statistical regression models, are limited when it comes to dealing with the complexity of those problems. Those complex adaptive systems have characteristics such as emerging properties, self-organization and feedbacks, which structure the system stability and resistance to changes. Recently, system science approaches have been proposed to deal with the range, complexity, and multifactor nature of those public health problems. In this paper we applied a multilevel systemic approach to create an integrated, coherent, and increasingly precise conceptual framework, capable of aggregating different partial or specialized studies, based on the challenges of the Longitudinal Study of Adult Health - ELSA-Brasil. The failure to control blood pressure found in several of the study's subjects was discussed, based on the proposed model, analyzing different loops, time lags, and feedback that influence this outcome in a population with high educational level, with reasonably good health services access. We were able to identify the internal circularities and cycles that generate the system's resistance to change. We believe that this study can contribute to propose some new possibilities of the research agenda and to the discussion of integrated actions in the field of public health.	[Carvalho, Marilia Sa] Fundacao Oswaldo Cruz, Comp Sci Program, Antiga Residencia Oficial, Rio De Janeiro, RJ, Brazil; [Coeli, Claudia Medina; Pinheiro, Rejane Sobrino] Univ Fed Rio de Janeiro, Inst Studies Collect Health, Rio De Janeiro, RJ, Brazil; [Chor, Dora; Mendes da Fonseca, Maria de Jesus] Fundacao Oswaldo Cruz, Dept Epidemiol, Natl Sch Publ Hlth, Rio De Janeiro, RJ, Brazil; [de Sa Carvalho, Luiz Carlos] Pontificia Univ Catolica Rio de Janeiro, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Pontificia Universidade Catolica do Rio de Janeiro	Carvalho, MS (corresponding author), Fundacao Oswaldo Cruz, Comp Sci Program, Antiga Residencia Oficial, Rio De Janeiro, RJ, Brazil.	carvalho@fiocruz.br	Pinheiro, Rejane S/J-5129-2015; CARVALHO, MARILIA S/C-3425-2013; CARVALHO, MARILIA/AAD-8283-2020; Coeli, Claudia M/P-4214-2016	Pinheiro, Rejane S/0000-0002-3361-3626; CARVALHO, MARILIA/0000-0002-9566-0284; Coeli, Claudia M/0000-0003-1757-3940	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [309692/2013-0, 300694/2010-5, 309728/2012-6]; FAPERJ - Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E_26/2014-203577]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ - Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	MSC, DC and RSP received a grant from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/) under award numbers 309692/2013-0, 300694/2010-5 and 309728/2012-6, respectively. MSC received a grant from FAPERJ - Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (http://www.faperj.br/) E_26/2014-203577.	Ackoff R, 2010, DIFFERENCES THAT MAK; Adler N, 2012, P NATL ACAD SCI USA, V109, P17154, DOI 10.1073/pnas.1121399109; Amico KR, 2011, J HEALTH PSYCHOL, V16, P1071, DOI 10.1177/1359105311398727; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Anderson CA, 2002, SCIENCE, V295, P2377, DOI 10.1126/science.1070765; Annagur BB, 2014, PAIN MED, V15, P772, DOI 10.1111/pme.12390; [Anonymous], 2010, B WORLD HEALTH ORGAN, V88, P646, DOI 10.2471/BLT.10.020910; [Anonymous], NETWORKS AN INTRODUC; [Anonymous], DOENCAS ISENTAM APOS; Anthony David, 2014, FP Essent, V421, P11; Appleton AA, 2013, CIRCULATION, V127, P905, DOI 10.1161/CIRCULATIONAHA.112.115782; Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294; Atkinson RW, 2014, THORAX, V69, P660, DOI 10.1136/thoraxjnl-2013-204492; Auchincloss AH, 2011, AM J PREV MED, V40, P303, DOI 10.1016/j.amepre.2010.10.033; Axon RN, 2010, AM J HYPERTENS, V23, P30, DOI 10.1038/ajh.2009.199; Babisch W, 2014, ENVIRON HEALTH PERSP, V122, P492, DOI 10.1289/ehp.1306981; Barclay KJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-784; Barros AJD, 2011, CAD SAUDE PUBLICA, V27, pS254, DOI 10.1590/S0102-311X2011001400012; Bateson G, 1972, STEPS TO AN ECOLOGY; Berkman LF, 2004, EPIDEMIOL REV, V26, P2, DOI 10.1093/epirev/mxh012; Berkman LE, 2009, ANNU REV PUBL HEALTH, V30, P27, DOI 10.1146/annurev.publhealth.031308.100310; Blackett PR, 2013, J CLIN LIPIDOL, V7, P65, DOI 10.1016/j.jacl.2012.04.079; Bossel H, 2007, SYSTEMS AND MODELS C; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Brook RD, 2009, HYPERTENSION, V54, P659, DOI 10.1161/HYPERTENSIONAHA.109.130237; Carrington MJ, 2013, J HYPERTENS, V31, P1265, DOI 10.1097/HJH.0b013e3283606bc7; Gomes FDC, 2014, CAD SAUDE PUBLICA, V30, P31, DOI 10.1590/0102-311X00176812; Chekland P, 1998, SOFT SYSTEMS METHODO; Chen H, 2014, INT J ENV RES PUB HE, V11, P5170, DOI 10.3390/ijerph110505170; Cheng JJ, 2013, INT J PUBLIC HEALTH, V58, P305, DOI 10.1007/s00038-012-0422-5; Cornelissen E, 2014, HEALTH POLICY, V117, P266, DOI 10.1016/j.healthpol.2014.04.010; de Camargo KR, 2013, REV SAUDE PUBL, V47, DOI 10.1590/S0034-8910.2013047004777; De F, 2014, J SCI FOOD AGR, V94, P1958, DOI [10.1002/jsfa.6163, DOI 10.1002/JSFA.6163]; Pinto JMD, 2012, CIENC SAUDE COLETIVA, V17, P521, DOI 10.1590/S1413-81232012000200025; de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; de Water HV, 2007, J OPER RES SOC, V58, P271, DOI 10.1057/palgrave.jors.2602156; Descartes R, 2001, DISCOURSE ON THE MET; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Dobelli R, 2013, GUARDIAN; Donihi AC, 2006, QUAL SAF HEALTH CARE, V15, P89, DOI 10.1136/qshc.2005.014381; Dooris M, 2013, J URBAN HEALTH, V90, pS74, DOI 10.1007/s11524-011-9623-0; Egede LE, 2010, GEN HOSP PSYCHIAT, V32, P563, DOI 10.1016/j.genhosppsych.2010.08.002; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; El-Sayed Abdulrahman M, 2012, Epidemiol Perspect Innov, V9, P1, DOI 10.1186/1742-5573-9-1; Ellaway A, 2007, SOC SCI MED, V64, P1384, DOI 10.1016/j.socscimed.2006.11.022; Engum A, 2007, J PSYCHOSOM RES, V62, P31, DOI 10.1016/j.jpsychores.2006.07.009; EVANS RG, 1990, SOC SCI MED, V31, P1347, DOI 10.1016/0277-9536(90)90074-3; Fontbonne A, 2013, CAD SAUDE PUBLICA, V29, P1195, DOI 10.1590/S0102-311X2013001000016; Freudenberg N, 2014, LETHAL BUT LEGAL COR; Freudenberg N, 2009, HEALTH EDUC BEHAV, V36, P230, DOI 10.1177/1090198107301330; Galea S, 2008, HANDBOOK OF URBAN HE; Galea S, 2007, MACROSOCIAL DETERMIN; Ganster DC, 2013, J MANAGE, V39, P1085, DOI 10.1177/0149206313475815; Glasgow RE, 2012, AM J PUBLIC HEALTH, V102, P1274, DOI 10.2105/AJPH.2012.300755; Glass TA, 2013, ANNU REV PUBL HEALTH, V34, P61, DOI 10.1146/annurev-publhealth-031811-124606; Greer S, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130340; Gruenewald TL, 2012, SOC SCI MED, V74, P75, DOI 10.1016/j.socscimed.2011.09.037; Haluza D, 2014, INT J ENV RES PUB HE, V11, P5445, DOI 10.3390/ijerph110505445; Hammond RA, 2012, P NATL ACAD SCI USA, V109, P12356, DOI 10.1073/pnas.0913003109; Hawkley LC, 2003, J PERS SOC PSYCHOL, V85, P105, DOI 10.1037/0022-3514.85.1.105; Herder C, 2014, DIABETOLOGIA, V57, P16, DOI 10.1007/s00125-013-3061-3; Holt-Lunstad J, 2014, INT J PSYCHOPHYSIOL, V93, P381, DOI 10.1016/j.ijpsycho.2014.05.014; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Hoven H, 2013, OCCUP ENVIRON MED, V70, P663, DOI 10.1136/oemed-2012-101331; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Iriart C, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-2; Jeffers AJ, 2013, EAT BEHAV, V14, P468, DOI 10.1016/j.eatbeh.2013.08.007; Joyce K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008009.pub2; Kaplan GA, 1999, PREV MED, V29, pS30, DOI 10.1006/pmed.1999.0540; Kawachi I, 2007, GLOBALIZATION AND HE; Keeling MJ, 2011, MODELING INFECTIOUS; Kenney WL, 2014, MED SCI SPORT EXER, V46, P1891, DOI 10.1249/MSS.0000000000000325; Kjellstrom T, 2010, INT J PUBLIC HEALTH, V55, P97, DOI 10.1007/s00038-009-0090-2; Klir G, 2001, FACETS OF SYSTEMS SC; Klir George J, 2001, FACETS OF SYSTEMS SC; Koestler A., 1978, JANUS A SUMMING UP; Krieger N, 1996, EPIDEMIOLOGY, V7, P107, DOI 10.1097/00001648-199601000-00020; Kullo IJ, 2014, MAYO CLIN PROC, V89, P1244, DOI 10.1016/j.mayocp.2014.06.018; Landen R, 2013, MODERN HEALTHCARE, V43; Langefors B, 1973, THEORETICAL ANALYSIS; Larsson SC, 2014, NEUROLOGY, V83, P1699, DOI 10.1212/WNL.0000000000000954; Lee PP, 1999, ARCH OPHTHALMOL-CHIC, V117, P100; Lehrer J, 2012, WIRED, V20, P102; Lehrer J, 2012, WILLNCE BLOGS; Lima SML, 2009, CAD SAUDE PUBLICA, V25, P2001, DOI 10.1590/S0102-311X2009000900014; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Lovasi GS, 2011, PUBLIC HEALTH REV, V33, P484, DOI 10.1007/BF03391647; Luepker RV, 2011, ANNU REV PUBL HEALTH, V32, P1, DOI 10.1146/annurev-publhealth-112810-151726; Luke DA, 2012, ANNU REV PUBL HEALTH, V33, P357, DOI 10.1146/annurev-publhealth-031210-101222; Lynch J, 2005, ANNU REV PUBL HEALTH, V26, P1, DOI 10.1146/annurev.publhealth.26.021304.144505; Machado AF, 2012, CAD SAUDE PUBLICA, V28, P758, DOI 10.1590/S0102-311X2012000400015; Maciel-Lima Sandra Mara, 2004, Cad. Saúde Pública, V20, P502, DOI 10.1590/S0102-311X2004000200018; Mann BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089168; Marchon SG, 2014, CAD SAUDE PUBLICA, V30, P1815, DOI 10.1590/0102-311X00114113; Marmot MG., 2006, SOCIAL DETERMINANTS; Matthews RA, 2014, J APPL PSYCHOL, V99, P1173, DOI 10.1037/a0036674; McAlister FA, 2011, CAN MED ASSOC J, V183, P1007, DOI 10.1503/cmaj.101767; McClellan MB, 2008, EVIDENCE BASED MEDIC; McHorney CA, 2012, PATIENT PREFER ADHER, V6, P789, DOI 10.2147/PPA.S36535; McMichael AJ, 1999, AM J EPIDEMIOL, V149, P887; Meadows DH, 2008, THINKING IN SYSTEMS; Mechanic D, 2007, MILBANK Q, V85, P533, DOI 10.1111/j.1468-0009.2007.00498.x; Mesarovic MD, 1970, THEORY OF HIERARCHIC; Mestre AM, 2015, EUR J OPER RES, V240, P791, DOI 10.1016/j.ejor.2014.07.024; Midgley G, 2006, AM J PUBLIC HEALTH, V96, P466, DOI 10.2105/AJPH.2005.067660; MITKA M, 2010, JAMA-J AM MED ASSOC, V303, P929, DOI DOI 10.1001/JAMA.2010.230; Moerenhout T, 2013, PATIENT PREFER ADHER, V7, P489, DOI 10.2147/PPA.S45777; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Mooney SJ, 2014, AM J EPIDEMIOL, V180, P626, DOI 10.1093/aje/kwu180; Moore LV, 2012, AM J EPIDEMIOL, V175, P1037, DOI 10.1093/aje/kwr445; Morin E., 2008, ON COMPLEXITY; Morin E, 1999, LINTELLIGENCE DA LA; Motivala SJ, 2011, ANN BEHAV MED, V42, P141, DOI 10.1007/s12160-011-9280-2; Murray ET, 2011, ANN EPIDEMIOL, V21, P589, DOI 10.1016/j.annepidem.2011.04.005; Murray J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-48; Murray J, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-120; Ness RB, 2007, ANN EPIDEMIOL, V17, P564, DOI 10.1016/j.annepidem.2006.10.014; O'Brien-Pallas L, 2011, J CLIN NURS, V20, P1640, DOI 10.1111/j.1365-2702.2010.03391.x; Oakes JM, 2006, METHODS IN SOCIAL EP; Papanicolas I, 2013, HEALTH POLICY, V112, P1, DOI 10.1016/j.healthpol.2013.07.018; Pastor M, 2014, HEALTH AFFAIR, V33, P1890, DOI 10.1377/hlthaff.2014.0640; Paternotte E, 2015, PATIENT EDUC COUNS, V98, P420, DOI 10.1016/j.pec.2014.11.018; Peacock W Frank, 2013, Crit Pathw Cardiol, V12, P116, DOI 10.1097/HPC.0b013e31828940e3; Pearce N, 1996, AM J PUBLIC HEALTH, V86, P678, DOI 10.2105/AJPH.86.5.678; Resnicow K, 2008, AM J PUBLIC HEALTH, V98, P1382, DOI 10.2105/AJPH.2007.129460; Ribeiro ST, 2010, J AM GERIATR SOC, V58, P383, DOI 10.1111/j.1532-5415.2009.02690.x; Richman LS, 2009, PSYCHOL HEALTH, V24, P919, DOI 10.1080/08870440802108926; Rickles D, 2007, J EPIDEMIOL COMMUN H, V61, P933, DOI 10.1136/jech.2006.054254; Rooks RN, 2012, SOC SCI MED, V74, P176, DOI 10.1016/j.socscimed.2011.09.040; Roux AVD, 2008, J EPIDEMIOL COMMUN H, V62, P957, DOI 10.1136/jech.2007.064311; Roux AVD, 2012, ANNU REV PUBL HEALTH, V33, P41, DOI 10.1146/annurev-publhealth-031811-124534; Roux AVD, 2011, AM J PUBLIC HEALTH, V101, P1627, DOI 10.2105/AJPH.2011.300149; Rowan CG, 2014, PHARMACOEPIDEM DR S, V23, P1294, DOI 10.1002/pds.3694; Sa Carvalho LC., 1993, REFLEXOES EMPIRICAS; Sa E, 2014, OCCUP ENVIRON MED SU, V71, pA102, DOI [10.1136/oemed-2014-102362.319, DOI 10.1136/OEMED-2014-102362.319]; Sanders JL, 2011, J AM GERIATR SOC, V59, P1581, DOI 10.1111/j.1532-5415.2011.03557.x; Sanderson K, 2013, AUST FAM PHYSICIAN, V42, P172; Santos MS, 2012, BEST PRACT RES CL EN, V26, P581, DOI 10.1016/j.beem.2012.03.003; Santos-Pinto CD, 2011, CIENC SAUDE COLETIVA, V16, P2963, DOI 10.1590/S1413-81232011000600034; Schaefer DR, 2013, HEALTH EDUC BEHAV, V40, p24S, DOI 10.1177/1090198113493091; Scheffer M, 2011, INTERFACE-BOTUCATU, V15, P947, DOI 10.1590/S1414-32832011000300030; Schmidt M. I., 2011, Lancet (British edition), V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Schofield D, 2013, INT J CARDIOL, V166, P68, DOI 10.1016/j.ijcard.2011.09.066; Senge P., 1990, 5 DISCIPLINE; Silvers JB, 2013, ANN FAM MED, V11, P402, DOI 10.1370/afm.1567; Sixsmith R, 2010, HEALTH PROMOT INT, V25, P24, DOI 10.1093/heapro/dap045; Smith BT, 2011, AM J EPIDEMIOL, V173, P438, DOI 10.1093/aje/kwq379; Soderberg M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1102; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369; Strasburger V.C., 2013, CHILDREN ADOLESCENTS; Sturm R, 2014, J MENT HEALTH POLICY, V17, P19; Sundquist K, 2004, SOC SCI MED, V58, P615, DOI 10.1016/S0277-9536(03)00229-6; Taal HR, 2012, HYPERTENSION, V59, P241, DOI 10.1161/HYPERTENSIONAHA.111.179481; Taylor RS, 2013, COCHRANE DATABASE OF; Tekola-Ayele F, 2013, PROG CARDIOVASC DIS, V56, P251, DOI 10.1016/j.pcad.2013.09.013; Thomas B, 2013, J LAW MED ETHICS, V41, P16, DOI 10.1111/jlme.12002; Travassos Claudia, 2004, Cad. Saúde Pública, V20, pS190; Tsouros A, 2013, J URBAN HEALTH, V90, pS4, DOI 10.1007/s11524-013-9825-8; Umberson D, 2010, ANNU REV SOCIOL, V36, P139, DOI 10.1146/annurev-soc-070308-120011; Valerdi R, 2010, WHEN SYSTEMS THINKIN, P184, DOI [10.1109/SYSTEMS.2010.5482446, DOI 10.1109/SYSTEMS.2010.5482446]; van de Vijver S, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.22510; Van Laethem M, 2013, SCAND J WORK ENV HEA, V39, P535, DOI 10.5271/sjweh.3376; Vandenbroeck P, 2007, FORESIGHT TACKLING O; Varghese MJ, 2014, ANN PEDIAT CARDIOL, V7, P107, DOI 10.4103/0974-2069.132478; Viberg N, 2013, HEALTH POLICY, V112, P53, DOI 10.1016/j.healthpol.2013.06.013; Voelker R, 2012, JAMA-J AM MED ASSOC, V308, P1514, DOI 10.1001/jama.2012.13712; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOSING THE GAP IN A; Witt J, 2012, PATIENT EDUC COUNS, V88, P256, DOI 10.1016/j.pec.2012.03.002; World Health Organization, WHO FRAMEWORK CONVEN; World Health Organization, 2012, HEALTH POLICY AND SY; Yamin A E, 2000, Health Hum Rights, V5, P116, DOI 10.2307/4065225; Yang YC, 2015, J AGING HEALTH, V27, P403, DOI 10.1177/0898264314551172; Young D, 2010, AM J PUBLIC HEALTH, V100, P1208, DOI 10.2105/AJPH.2009.184705	174	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132216	10.1371/journal.pone.0132216	http://dx.doi.org/10.1371/journal.pone.0132216			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26171854	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900035
J	Jia, Z; Johnson, AC; Wang, XX; Guo, ZB; Dreisbach, AW; Lewin, JR; Kyle, PB; Garrett, MR				Jia, Zhen; Johnson, Ashley C.; Wang, Xuexiang; Guo, Zibiao; Dreisbach, Albert W.; Lewin, Jack R.; Kyle, Patrick B.; Garrett, Michael R.			Allelic Variants in Arhgef11 via the Rho-Rock Pathway Are Linked to Epithelial-Mesenchymal Transition and Contributes to Kidney Injury in the Dahl Salt-Sensitive Rat	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; STRESS-FIBER FORMATION; TGF-BETA ANTIBODY; RENAL INJURY; MYOFIBROBLAST DIFFERENTIATION; GENETIC-VARIANTS; S RATS; DISEASE; KINASE; HYPERTENSION	Previously, genetic analyses identified that variants in Arhgef11 may influence kidney injury in the Dahl salt-sensitive (S) rat, a model of hypertensive chronic kidney disease. To understand the potential mechanism by which altered expression and/or protein differences in Arhgef11 could play a role in kidney injury, stably transduced Arhgef11 knockdown cell lines as well as primary cultures of proximal tubule cells were studied. Genetic knockdown of Arhgef11 in HEK293 and NRK resulted in reduced RhoA activity, decreased activation of Rho-ROCK pathway, and less stress fiber formation versus control, similar to what was observed by pharmacological inhibition (fasudil). Primary proximal tubule cells (PTC) cultured from the S exhibited increased expression of Arhgef11, increased RhoA activity, and up regulation of Rho-ROCK signaling compared to control (small congenic). The cells were also more prone (versus control) to TGF beta-1 induced epithelial-mesenchymal transition (EMT), a hallmark feature of the development of renal interstitial fibrosis, and characterized by development of spindle shape morphology, gene expression changes in EMT markers (Col1a3, Mmp9, Bmp7, and Ocln) and increased expression of N-Cadherin and Vimentin. S derived PTC demonstrated a decreased ability to uptake FITC-albumin compared to the small congenic in vitro, which was confirmed by assessment of albumin re-uptake in vivo by infusion of FITC-albumin and immunofluorescence imaging. In summary, these studies suggest that genetic variants in the S form of Arhgef11 via increased expression and/or protein activity play a role in promoting kidney injury in the S rat through changes in cell morphology (Rho-Rock and/or EMT) that impact the function of tubule cells.	[Jia, Zhen; Johnson, Ashley C.; Wang, Xuexiang; Guo, Zibiao; Garrett, Michael R.] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA; [Dreisbach, Albert W.; Garrett, Michael R.] Univ Mississippi, Med Ctr, Dept Med Nephrol, Jackson, MS 39216 USA; [Guo, Zibiao] Univ Mississippi, Med Ctr, Mol & Genom Core Facil, Jackson, MS 39216 USA; [Lewin, Jack R.; Kyle, Patrick B.] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Garrett, MR (corresponding author), Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA.	mrgarrett@umc.edu		Wang, Xuexiang/0000-0002-4091-8196	National Institutes of Health/National Heart, Lung, and Blood Institute [HL094446]; Robert M. Hearin Foundation; Mississippi IDeA Network of Biomedical Research Excellence [P20GM103476]; Center for Psychiatric Neuroscience (CPN)-Centers of Biomedical Research Excellence [P30GM103328]; Obesity, Cardiorenal and Metabolic Diseases- Centers of Biomedical Research Excellence [P20GM104357]; National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476, P20GM104357, P30GM103328] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert M. Hearin Foundation; Mississippi IDeA Network of Biomedical Research Excellence; Center for Psychiatric Neuroscience (CPN)-Centers of Biomedical Research Excellence; Obesity, Cardiorenal and Metabolic Diseases- Centers of Biomedical Research Excellence; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MRG is supported by National Institutes of Health/National Heart, Lung, and Blood Institute (HL094446) and Robert M. Hearin Foundation. The work performed through the UMMC Molecular and Genomics Facility is supported, in part, by funds from the National Institute of General Medical Sciences of the National Institutes of Health, including Mississippi IDeA Network of Biomedical Research Excellence (P20GM103476), Center for Psychiatric Neuroscience (CPN)-Centers of Biomedical Research Excellence (P30GM103328) and Obesity, Cardiorenal and Metabolic Diseases- Centers of Biomedical Research Excellence (P20GM104357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Akiyama K, 2010, J HUM GENET, V55, P656, DOI 10.1038/jhg.2010.82; Benigni A, 2003, J AM SOC NEPHROL, V14, P1816, DOI 10.1097/01.ASN.0000074238.61967.B7; Boger CA, 2011, KIDNEY BLOOD PRESS R, V34, P225, DOI 10.1159/000326901; Budzyn K, 2006, TRENDS PHARMACOL SCI, V27, P97, DOI 10.1016/j.tips.2005.12.002; Chai JY, 2007, GUT, V56, P621, DOI 10.1136/gut.2006.106674; Chen CCA, 2013, PHYSIOL GENOMICS, V45, P110, DOI 10.1152/physiolgenomics.00119.2012; Chen S, 2003, BIOCHEM BIOPH RES CO, V300, P16, DOI 10.1016/S0006-291X(02)02708-0; Erkan E, 2013, PEDIATR NEPHROL, V28, P1049, DOI 10.1007/s00467-012-2335-1; Fu M, 2007, DIABETES, V56, P1363, DOI 10.2337/db06-1421; Garrett MR, 2007, PHYSIOL GENOMICS, V30, P322, DOI 10.1152/physiolgenomics.00001.2007; Garrett MR, 2006, PHYSIOL GENOMICS, V25, P39, DOI 10.1152/physiolgenomics.00150.2005; Garrett MR, 2003, J AM SOC NEPHROL, V14, P1175, DOI 10.1097/01.ASN.0000060572.13794.58; Guillemot L, 2008, MOL BIOL CELL, V19, P4442, DOI 10.1091/mbc.E08-06-0558; Guillemot L, 2014, MOL BIOL CELL, V25, P1995, DOI 10.1091/mbc.E13-11-0680; Itoh M, 2012, P NATL ACAD SCI USA, V109, P9905, DOI 10.1073/pnas.1115063109; Jin Qing Song, 2010, Korean Diabetes J, V34, P368, DOI 10.4093/kdj.2010.34.6.368; Kawanabe Y, 2002, MOL PHARMACOL, V61, P277, DOI 10.1124/mol.61.2.277; Laliberte F, 2009, J MANAGE CARE PHARM, V15, P312, DOI 10.18553/jmcp.2009.15.4.312; Levey AS, 2010, KIDNEY INT, V78, P19, DOI 10.1038/ki.2010.115; Loeffler I, 2014, NEPHROL DIAL TRANSPL, V29, pI37, DOI 10.1093/ndt/gft267; Gorriz JL, 2012, TRANSPLANT REV-ORLAN, V26, P3, DOI 10.1016/j.trre.2011.10.002; Mattson DL, 2014, AM J PHYSIOL-RENAL, V307, pF499, DOI 10.1152/ajprenal.00258.2014; Mizuki Y, 2014, HUM PSYCHOPHARM CLIN, V29, P552, DOI 10.1002/hup.2435; Murphy SR, 2012, AM J PHYSIOL-REG I, V303, pR57, DOI 10.1152/ajpregu.00263.2011; Nishikimi T, 2004, J HYPERTENS, V22, P1787, DOI 10.1097/00004872-200409000-00024; Nishikimi T, 2007, J HYPERTENS, V25, P1053, DOI 10.1097/HJH.0b013e3280825440; Packard M, 2009, AM J PHYSIOL-RENAL, V296, pF839, DOI 10.1152/ajprenal.90370.2008; Park JW, 2011, J PHARMACOL EXP THER, V338, P271, DOI 10.1124/jpet.111.179457; Rangel A, 2013, J AM SOC NEPHROL, V24, P283, DOI 10.1681/ASN.2012090927; Rankinen T, 2008, HYPERTENS RES, V31, P1651, DOI 10.1291/hypres.31.1651; Renshaw MW, 1996, J BIOL CHEM, V271, P21691, DOI 10.1074/jbc.271.36.21691; Sah VP, 2000, ANNU REV PHARMACOL, V40, P459, DOI 10.1146/annurev.pharmtox.40.1.459; Said Sarmad, 2014, J Nephropathol, V3, P99, DOI 10.12860/jnp.2014.19; Sakai N, 2013, FASEB J, V27, P1830, DOI 10.1096/fj.12-219378; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Smith DH, 2004, J AM SOC NEPHROL, V15, P1300, DOI 10.1097/01.ASN.0000125670.64996.BB; Tsou PS, 2014, AM J PHYSIOL-CELL PH, V307, pC2, DOI 10.1152/ajpcell.00060.2014; van der Sijde MR, 2014, BBA-MOL BASIS DIS, V1842, P1903, DOI 10.1016/j.bbadis.2014.04.025; Wang X, 2014, J AM SOC NEPHROLOGY; Westbrook L, 2014, J AM SOC NEPHROL, V25, P2499, DOI 10.1681/ASN.2013070786; Williams JM, 2012, HYPERTENSION, V60, P1157, DOI 10.1161/HYPERTENSIONAHA.112.199240; Zhu J, 2013, INT J OPHTHALMOL-CHI, V6, P8, DOI 10.3980/j.issn.2222-3959.2013.01.02; Zicha J, 2012, PHYSIOL RES, V61, pS35, DOI 10.33549/physiolres.932363	44	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132553	10.1371/journal.pone.0132553	http://dx.doi.org/10.1371/journal.pone.0132553			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172442	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900057
J	Lin, CJ; Wu, V; Wu, PC; Wu, CJ				Lin, Cheng-Jui; Wu, Vincent; Wu, Pei-Chen; Wu, Chih-Jen			Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; BOUND UREMIC TOXINS; ELDERLY HEMODIALYSIS-PATIENTS; PUBLICATION BIAS; CLINICAL-OUTCOMES; RISK-FACTOR; PROTEIN; DIALYSIS; SOLUTES; STAGE	Background Indoxyl sulfate (IS) and p-cresyl sulfate (PCS) are protein-bound uremic toxins that increase in the sera of patients with chronic kidney disease (CKD), and are not effectively removed by dialysis. The purpose of this meta-analysis was to investigate the relationships of PCS and IS with cardiovascular events and all-cause mortality in patients with CKD stage 3 and above. Methodology/Principle Findings Medline, Cochrane, and EMBASE databases were searched until January 1, 2014 with combinations of the following keywords: chronic renal failure, end-stage kidney disease, uremic toxin, uremic retention, indoxyl sulfate, p-cresyl sulfate. Inclusion criteria were: 1) Patients with stage 1 to 5 CKD; 2) Prospective study; 3) Randomized controlled trial; 4) English language publication. The associations between serum levels of PCS and IS and the risks of all-cause mortality and cardiovascular events were the primary outcome measures. Of 155 articles initially identified, 10 prospective and one cross-sectional study with a total 1,572 patients were included. Free PCS was significantly associated with all-cause mortality among patients with chronic renal failure (pooled OR = 1.16, 95% CI = 1.03 to 1.30, P = 0.013). An elevated free IS level was also significantly associated with increased risk of all-cause mortality (pooled OR = 1.10, 95% CI = 1.03 to 1.17, P = 0.003). An elevated free PCS level was significantly associated with an increased risk of cardiovascular events among patients with chronic renal failure (pooled OR = 1.28, 95% CI = 1.10 to 1.50, P = 0.002), while free IS was not significantly associated with risk of cardiovascular events ( pooled OR = 1.05, 95% CI = 0.98 to 1.13, P = 0.196). Conclusions/Significance Elevated levels of PCS and IS are associated with increased mortality in patients with CKD, while PCS, but not IS, is associated with an increased risk of cardiovascular events.	[Lin, Cheng-Jui; Wu, Pei-Chen; Wu, Chih-Jen] Mackay Mem Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Lin, Cheng-Jui] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Wu, Vincent] Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei 100, Taiwan; [Wu, Chih-Jen] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Wu, Chih-Jen] Mackay Med Coll, Dept Med, New Taipei City, Taiwan	Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Mackay Medical College	Wu, CJ (corresponding author), Mackay Mem Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan.	wcjyali@yahoo.com.tw		WU, VIN-CENT/0000-0001-7935-0991				Bammens B, 2006, KIDNEY INT, V69, P1081, DOI 10.1038/sj.ki.5000115; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Chen TC, 2012, KIDNEY BLOOD PRESS R, V35, P583, DOI 10.1159/000339709; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; Dai WM, 2013, CHINESE MED J-PEKING, V126, P1957, DOI 10.3760/cma.j.issn.0366-6999.20130391; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang ST, 2012, TRANSPL P, V44, P621, DOI 10.1016/j.transproceed.2011.11.023; Ito S, 2014, TOXINS, V6, P665, DOI 10.3390/toxins6020665; Itoh Y, 2012, ANAL BIOANAL CHEM, V403, P1841, DOI 10.1007/s00216-012-5929-3; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Levin A, 2000, AM J KIDNEY DIS, V36, pS24, DOI 10.1053/ajkd.2000.19928; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; Lin CJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/526932; Lin CJ, 2013, ARCH MED RES, V44, P535, DOI 10.1016/j.arcmed.2013.09.007; Lin CJ, 2013, ARCH MED SCI, V9, P662, DOI 10.5114/aoms.2013.36901; Lin CJ, 2012, ARCH MED RES, V43, P451, DOI 10.1016/j.arcmed.2012.08.002; Lin CJ, 2011, J CLIN LAB ANAL, V25, P191, DOI 10.1002/jcla.20456; Lin CJ, 2010, NEPHROL DIAL TRANSPL, V25, P3693, DOI 10.1093/ndt/gfq251; Longenecker JC, 2002, J AM SOC NEPHROL, V13, P1918, DOI 10.1097/01.ASN.0000019641.41496.1E; Meijers BKI, 2010, CLIN J AM SOC NEPHRO, V5, P1182, DOI 10.2215/CJN.07971109; Melamed ML, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-134; Meyer TW, 2012, KIDNEY INT, V81, P949, DOI 10.1038/ki.2011.504; Neirynck N, 2013, BLOOD PURIFICAT, V35, P45, DOI 10.1159/000346223; Poesen R, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-87; Poveda J, 2014, NEPHROL DIAL TRANSPL, V29, P56, DOI 10.1093/ndt/gft367; Rossi M, 2014, NUTR METAB CARDIOVAS, V24, P1035, DOI 10.1016/j.numecd.2014.04.006; Rossi M, 2014, ARCH MED RES, V45, P309, DOI 10.1016/j.arcmed.2014.04.002; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Sutton AJ, 2000, STAT METHODS MED RES, V9, P421, DOI 10.1191/096228000701555244; Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813; Vanholder R, 2014, J AM SOC NEPHROL, V25, P1897, DOI 10.1681/ASN.2013101062; Viaene L, 2013, BIOPHARM DRUG DISPOS, V34, P165, DOI 10.1002/bdd.1834; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wu IW, 2012, NEPHROL DIAL TRANSPL, V27, P1169, DOI 10.1093/ndt/gfr453; Wu IW, 2011, NEPHROL DIAL TRANSPL, V26, P938, DOI 10.1093/ndt/gfq580	39	185	190	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132589	10.1371/journal.pone.0132589	http://dx.doi.org/10.1371/journal.pone.0132589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173073	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900062
J	Matsui, A; Stephens, D; Kantarci, A; Rittling, SR				Matsui, Aritsune; Stephens, Danielle; Kantarci, Alpdogan; Rittling, Susan R.			Early Cytokine Response to Infection with Pathogenic vs Non-Pathogenic Organisms in a Mouse Model of Endodontic Infection	PLOS ONE			English	Article							PERIAPICAL BONE DESTRUCTION; RESORPTION IN-VIVO; EXPERIMENTAL PERIODONTITIS; INTERLEUKIN-6 DEFICIENCY; DIFFERENT PATTERNS; MICE; INFLAMMATION; RECEPTOR; SUSCEPTIBILITY; RECRUITMENT	Using the subcutaneous chamber model of infection, we showed previously that a mixture of four endodontic pathogens (EP: P. intermedia, F. nucleatum, S. intermedius and P. micra) are able to persist without clearance for up to seven days, while a non-pathogenic oral species, S. mitis, was substantially cleared in this time. Here we have compared the cytokine response inside the chambers against these microorganisms. A majority of cytokines tested (17/24) showed different patterns of expression. Several cytokines had a peak of expression at 2 h after infection in response to the EP, while none showed this pattern in S. mitis infections. Chemokines were uniformly present at similar or higher levels in response to S. mitis, with redundant expression of CXCR2 ligands, while several growth/survival factors were present at higher levels in EP infections. Protease activity expressed by EP may be responsible for the lower levels of some chemokines. T-cell associated cytokines were in general expressed at extremely low levels, and did not differ between the two infections. The inflammatory markers IL-6, IL-1 alpha and IL1-beta were expressed at similar levels in both infections at early times, while TNF alpha was preferentially present in S. mitis infections. In EP infected chambers, reciprocal changes in levels of IL-6 and IL-1 alpha were observed at later times suggesting a switch in the inflammatory response. Analysis of the cytokine response to infection with the individual species from the EP mix suggests that P. intermedia drives this inflammatory switch. Together these results show a surprising level of divergence of the host response to pathogenic and non-pathogenic organisms associated with oral infections, and supports a dominant effect of P. intermedia in polymicrobial endodontic infections.	[Matsui, Aritsune; Stephens, Danielle; Kantarci, Alpdogan; Rittling, Susan R.] Forsyth Inst, Cambridge, MA 02142 USA; [Matsui, Aritsune; Kantarci, Alpdogan; Rittling, Susan R.] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA	Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine	Rittling, SR (corresponding author), Forsyth Inst, Cambridge, MA 02142 USA.	srittling@forsyth.org			National Institute of Dental and Craniofacial Research of the National Institutes of Health [RO1-DE22380]; Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]; Harvard University and its affiliated academic healthcare centers; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022380] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health); Harvard University and its affiliated academic healthcare centers; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Research reported in this publication was supported by the National Institute of Dental and Craniofacial Research of the National Institutes of Health under award number #RO1-DE22380 to SRR. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. www.nidcr.nih.gov. Support for statistical analysis was provided through The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health.	AlShwaimi E, 2013, J IMMUNOL, V191, P1785, DOI 10.4049/jimmunol.1202194; Balamayooran G, 2012, J IMMUNOL, V189, P5849, DOI 10.4049/jimmunol.1200585; Balto K, 2001, INFECT IMMUN, V69, P744, DOI 10.1128/IAI.69.2.744-750.2001; Biondo C, 2014, MBIO, V5, DOI 10.1128/mBio.01428-14; Bizzarri C, 2006, PHARMACOL THERAPEUT, V112, P139, DOI 10.1016/j.pharmthera.2006.04.002; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Byrne DP, 2010, BIOCHEM J, V425, P257, DOI 10.1042/BJ20090343; Chae P, 2002, INFECT IMMUN, V70, P3164, DOI 10.1128/IAI.70.6.3164-3169.2002; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Herbold W, 2010, INFECT IMMUN, V78, P2620, DOI 10.1128/IAI.01169-09; Hessle CC, 2005, CYTOKINE, V30, P311, DOI 10.1016/j.cyto.2004.05.008; Hou L, 2000, INFECT IMMUN, V68, P4681, DOI 10.1128/IAI.68.8.4681-4687.2000; Huang GTJ, 2001, ORAL SURG ORAL MED O, V92, P83, DOI 10.1067/moe.2001.115025; Kawashima N, 1999, ARCH ORAL BIOL, V44, P55, DOI 10.1016/S0003-9969(98)00094-6; Lqhal MK, 2008, J ENDODONT, V34, P519, DOI 10.1016/j.joen.2008.01.002; Marton IJ, 2000, ORAL MICROBIOL IMMUN, V15, P139, DOI 10.1034/j.1399-302x.2000.150301.x; Matsui A, 2014, INFECT IMMUN, V82, P4068, DOI 10.1128/IAI.02256-14; Polak D, 2009, J CLIN PERIODONTOL, V36, P406, DOI 10.1111/j.1600-051X.2009.01393.x; Potempa M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000316; Quinton LJ, 2012, J IMMUNOL, V188, P6300, DOI 10.4049/jimmunol.1200256; Rittling SR, 2010, IMMUNOLOGY, V129, P105, DOI 10.1111/j.1365-2567.2009.03159.x; Sasaki H, 2000, J IMMUNOL, V165, P3626, DOI 10.4049/jimmunol.165.7.3626; Sasaki H, 2004, CLIN DIAGN LAB IMMUN, V11, P106, DOI 10.1128/CDLI.11.1.106-110.2004; Siqueira JF, 2009, J DENT RES, V88, P969, DOI 10.1177/0022034509346549; Skovbjerg S, 2010, J INTERF CYTOK RES, V30, P23, DOI 10.1089/jir.2009.0033; Stashenko P, 1998, CRIT REV ORAL BIOL M, V9, P498, DOI 10.1177/10454411980090040701; Teles R, 1997, INFECT IMMUN, V65, P3781, DOI 10.1128/IAI.65.9.3781-3787.1997; ULICH TR, 1994, AM J PHYSIOL-LUNG C, V267, pL442, DOI 10.1152/ajplung.1994.267.4.L442; WANG CY, 1993, ORAL MICROBIOL IMMUN, V8, P50, DOI 10.1111/j.1399-302X.1993.tb00543.x; Wilensky A, 2009, J CLIN PERIODONTOL, V36, P915, DOI 10.1111/j.1600-051X.2009.01464.x; Wuyts A, 1999, J IMMUNOL, V163, P6155; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	32	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132752	10.1371/journal.pone.0132752	http://dx.doi.org/10.1371/journal.pone.0132752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171605	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900081
J	Smith, RAS; Nabok, A; Blakeman, BJF; Xue, WF; Abell, B; Smith, DP				Smith, Rachel A. S.; Nabok, Aleksey; Blakeman, Ben J. F.; Xue, Wei-Feng; Abell, Benjamin; Smith, David P.			Analysis of Toxic Amyloid Fibril Interactions at Natively Derived Membranes by Ellipsometry	PLOS ONE			English	Article							COMMON MECHANISM; SPECTROSCOPIC ELLIPSOMETRY; ALZHEIMERS-DISEASE; OLIGOMERS IMPLIES; ALPHA-SYNUCLEIN; BETA PEPTIDE; AGGREGATION; CYTOTOXICITY; ASSOCIATION; DISRUPTION	There is an ongoing debate regarding the culprits of cytotoxicity associated with amyloid disorders. Although small pre-fibrillar amyloid oligomers have been implicated as the primary toxic species, the fibrillar amyloid material itself can also induce cytotoxicity. To investigate membrane disruption and cytotoxic effects associated with intact and fragmented fibrils, the novel in situ spectroscopic technique of Total Internal Reflection Ellipsometry (TIRE) was used. Fibril lipid interactions were monitored using natively derived whole cell membranes as a model of the in vivo environment. We show that fragmented fibrils have an increased ability to disrupt these natively derived membranes by causing a loss of material from the deposited surface when compared with unfragmented fibrils. This effect was corroborated by observations of membrane disruption in live cells, and by dye release assay using synthetic liposomes. Through these studies we demonstrate the use of TIRE for the analysis of protein-lipid interactions on natively derived lipid surfaces, and provide an explanation on how amyloid fibrils can cause a toxic gain of function, while entangled amyloid plaques exert minimal biological activity.	[Smith, Rachel A. S.; Abell, Benjamin; Smith, David P.] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England; [Nabok, Aleksey] Sheffield Hallam Univ, Mat & Engn Res Inst, Sheffield S1 1WB, S Yorkshire, England; [Blakeman, Ben J. F.; Xue, Wei-Feng] Univ Kent, Sch Biosci, Canterbury, Kent, England	Sheffield Hallam University; Sheffield Hallam University; University of Kent	Smith, DP (corresponding author), Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England.	d.p.smith@shu.ac.uk	Nabok, Alexei/AAW-5758-2020	Xue, Wei-Feng/0000-0002-6504-0404; Smith, David/0000-0001-5177-8574	Biomedical Research Centre at Sheffield Hallam University; University of Kent [EP/H000275/1]; Royal Society project Grant [RG2010R1]; BBSRC research grant [BB/J008001/1]; BBSRC [BB/J008001/1] Funding Source: UKRI; EPSRC [EP/H000275/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J008001/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H000275/1] Funding Source: researchfish	Biomedical Research Centre at Sheffield Hallam University; University of Kent; Royal Society project Grant; BBSRC research grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Biomedical Research Centre at Sheffield Hallam University (http://www.shu.ac.uk/research/bmrc/) who funded RASS, BMA and DPS. The University of Kent funded BJFB Equipment was purchased via Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) Engineering for Life research grant (No. EP/H000275/1) and from a Royal Society (https://royalsociety.org/) project Grant (RG2010R1) and a BBSRC(www.bbsrc.ac.uk/) research grant (No. BB/J008001/1, awarded to WFX).	Babenko V, 2013, FEBS LETT, V587, P625, DOI 10.1016/j.febslet.2013.02.010; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Ciccotosto GD, 2004, J BIOL CHEM, V279, P42528, DOI 10.1074/jbc.M406465200; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Finot E, 2013, COLLOID SURFACE B, V104, P289, DOI 10.1016/j.colsurfb.2012.12.013; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Jakhria T, 2014, J BIOL CHEM, V289, P35781, DOI 10.1074/jbc.M114.586222; Kang LJ, 2011, J AM CHEM SOC, V133, P13465, DOI 10.1021/ja203979j; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kriechbaumer V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046221; Kriechbaumer V, 2011, BIOPHYS J, V101, P504, DOI 10.1016/j.bpj.2011.06.011; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020244; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Milanesi L, 2012, P NATL ACAD SCI USA, V109, P20455, DOI 10.1073/pnas.1206325109; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Mustafa MK, 2010, BIOSENS BIOELECTRON, V26, P1332, DOI 10.1016/j.bios.2010.07.042; Nabok A, 2008, THIN SOLID FILMS, V516, P8993, DOI 10.1016/j.tsf.2007.11.077; Ow SY, 2013, SOFT MATTER, V9, P9692, DOI 10.1039/c3sm51671g; Petty M.C., 1996, LANGMUIR BLODGETT FI, DOI 10.1017/CBO9780511622519; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Smith DP, 2008, BIOCHEMISTRY-US, V47, P1425, DOI 10.1021/bi701522m; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stefani M, 2012, PROG NEUROBIOL, V99, P226, DOI 10.1016/j.pneurobio.2012.03.002; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; STRIEBEL C, 1994, BIOSENS BIOELECTRON, V9, P139, DOI 10.1016/0956-5663(94)80105-3; Suleman M, 2014, ANTIMICROB AGENTS CH, V58, P2156, DOI 10.1128/AAC.01350-13; Tofoleanu F, 2012, PRION, V6, P339, DOI 10.4161/pri.21022; Woollam J. A., 2002, GUIDE USING WVASE32; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Xue WF, 2013, BIOPHYS J, V105, P2811, DOI 10.1016/j.bpj.2013.10.034; Xue WF, 2010, PRION, V4, P20, DOI 10.4161/pri.4.1.11378; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809	41	7	7	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132309	10.1371/journal.pone.0132309	http://dx.doi.org/10.1371/journal.pone.0132309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172440	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000358194900041
J	Zhou, J; Chen, L; Li, J; Li, HJ; Hong, ZW; Xie, M; Chen, SR; Yao, B				Zhou, Ji; Chen, Li; Li, Jie; Li, Hongjun; Hong, Zhiwei; Xie, Min; Chen, Shengrong; Yao, Bing			The Semen pH Affects Sperm Motility and Capacitation	PLOS ONE			English	Article							HUMAN SPERMATOZOA; REGULATORY MECHANISMS; MEMBRANE INTEGRITY; FOLLICULAR-FLUID; INTRACELLULAR PH; BOAR SPERMATOZOA; ALPHA-4 ISOFORM; PLASMA-MEMBRANE; HAMSTER SPERM; NA,K-ATPASE	As the chemical environment of semen can have a profound effect on sperm quality, we examined the effect of pH on the motility, viability and capacitation of human sperm. The sperm in this study was collected from healthy males to avoid interference from other factors. The spermatozoa cultured in sperm nutrition solution at pH 5.2, 6.2, 7.2 and 8.2 were analyzed for sperm total motility, progressive motility (PR), hypo-osmotic swelling (HOS) rate, and sperm penetration. Our results showed that these parameters were similar in pH 7.2 and 8.2 sperm nutrition solutions, but decreased in pH 5.2 and 6.2 solutions. The HOS rate exhibited positive correlation with the sperm total motility and PR. In addition, the sperm Na+/K+-ATPase activity at different pHs was measured, and the enzyme activity was significantly lower in pH 5.2 and 6.2 media, comparing with that in pH 8.2 and pH 7.2 solutions. Using flow cytometry (FCM) and laser confocal scanning microscopy (LCSM) analysis, the intracellular Ca2+ concentrations of sperm cultured in sperm capacitation solution at pH 5.2, 6.2, 7.2 and 8.2 were determined. Compared with that at pH 7.2, the mean fluorescence intensity of sperm in pH 5.2 and 6.2 media decreased significantly, while that of pH 8.2 group showed no difference. Our results suggested that the declined Na+/K+-ATPase activity at acidic pHs result in decreased sperm movement and capacitation, which could be one of the mechanisms of male infertility.	[Zhou, Ji; Chen, Li; Hong, Zhiwei; Xie, Min; Chen, Shengrong; Yao, Bing] Nanjing Univ, Ctr Reprod Med, Jinling Hosp, Clin Sch,Med Coll, Nanjing 210008, Jiangsu, Peoples R China; [Li, Jie] Nanjing Univ, Dept Neurosurg, Jinling Hosp, Clin Sch,Med Coll, Nanjing 210008, Jiangsu, Peoples R China; [Li, Hongjun] Chinese Acad Med Sci, Dept Urol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Li, Hongjun] Peking Union Med Coll, Beijing 100021, Peoples R China	Nanjing University; Nanjing University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yao, B (corresponding author), Nanjing Univ, Ctr Reprod Med, Jinling Hosp, Clin Sch,Med Coll, Nanjing 210008, Jiangsu, Peoples R China.	yaobing@nju.edu.cn			State Key Development Program for Basic Research of China [2013CB945200]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China)	This work was supported by the State Key Development Program for Basic Research of China (2013CB945200) http://www.973.gov.cn/Default_3.aspx, http://jcyxy.njmu.edu.cn/s/59/t/230/8f/58/info36696.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi SMH, 2004, REPRODUCTION, V128, P819, DOI 10.1530/rep.1.00244; Amer Soc Reprod Med Collaboration, 2008, FERTIL STERIL, V90, pS74, DOI 10.1016/j.fertnstert.2008.08.092; Andrzej C, 2002, T AM FISH SOC, V131, P9; [Anonymous], 2002, J PRACTICAL MED TECH, V9, P1; [Anonymous], 2006, J SHENYANG MED COLL, V8, P2; ASHIZAWA K, 1994, J REPROD FERTIL, V101, P593, DOI 10.1530/jrf.0.1010593; ASHIZAWA K, 1987, J REPROD FERTIL, V81, P495, DOI 10.1530/jrf.0.0810495; ASHRAF M, 1982, BIOCHEM BIOPH RES CO, V107, P1273, DOI 10.1016/S0006-291X(82)80135-6; BABCOCK DF, 1983, P NATL ACAD SCI-BIOL, V80, P1327, DOI 10.1073/pnas.80.5.1327; Banjoko SO, 2013, J CLIN DIAGN RES, V7, P2483, DOI 10.7860/JCDR/2013/6194.3585; Barna J, 1996, Acta Vet Hung, V44, P221; Blanco G, 2000, J HISTOCHEM CYTOCHEM, V48, P1023, DOI 10.1177/002215540004800801; Bonato M, 2012, ANIM REPROD SCI, V133, P123, DOI 10.1016/j.anireprosci.2012.06.008; Cincik M, 2007, ARCH ANDROLOGY, V53, P25, DOI 10.1080/01485010600888912; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Donders GGG, 2007, EUR J OBSTET GYN R B, V134, P220, DOI 10.1016/j.ejogrb.2006.07.016; Gandini L, 1999, HUM REPROD, V14, P1022, DOI 10.1093/humrep/14.4.1022; Garcia MA, 1999, MOL REPROD DEV, V52, P189, DOI 10.1002/(SICI)1098-2795(199902)52:2<189::AID-MRD10>3.0.CO;2-D; GATTI JL, 1993, J REPROD FERTIL, V98, P439, DOI 10.1530/jrf.0.0980439; Holm L, 1998, ANIM REPROD SCI, V54, P45, DOI 10.1016/S0378-4320(98)00142-0; Huang R, 2001, J FUZHOU TEACHERS CO, V20, P5; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Jimenez T, 2010, REPRODUCTION, V139, P835, DOI 10.1530/REP-09-0495; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; King LM, 2000, J ANDROL, V21, P65; Kocak-Toker N, 2002, INT J ANDROL, V25, P180, DOI 10.1046/j.1365-2605.2002.00346.x; L G H, 2013, CONT MED, V19, P2; Laurent C, 1995, ENVIRON BIOL FISH, V43, P9; Lin MH, 1998, FERTIL STERIL, V70, P1148, DOI 10.1016/S0015-0282(98)00351-3; LINDEMANN CB, 1988, CELL MOTIL CYTOSKEL, V10, P420, DOI 10.1002/cm.970100309; Liu, 2010, FUJIAN PROVINCE ANIM, V32, P4; Liu BJ, 2014, CELL PHYSIOL BIOCHEM, V33, P142, DOI 10.1159/000356657; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Moubasher AE, 2013, ANDROLOGIA, V45, P135, DOI 10.1111/j.1439-0272.2012.01310.x; MRSNY RJ, 1984, BIOL REPROD, V30, P573, DOI 10.1095/biolreprod30.3.573; Munire Mirihasimu, 2004, Journal of Medical and Dental Sciences, V51, P99; Nallella KP, 2006, FERTIL STERIL, V85, P629, DOI 10.1016/j.fertnstert.2005.08.024; Ostermeier GC, 2002, LANCET, V360, P772, DOI 10.1016/S0140-6736(02)09899-9; SASE I, 1995, J CELL BIOL, V131, P963, DOI 10.1083/jcb.131.4.963; SKOU JC, 1988, METHOD ENZYMOL, V156, P1; Sorensen MB, 1999, MOL HUM REPROD, V5, P331, DOI 10.1093/molehr/5.4.331; SUAREZ SS, 1993, P NATL ACAD SCI USA, V90, P4660, DOI 10.1073/pnas.90.10.4660; THOMAS P, 1989, BIOCHEM J, V264, P539, DOI 10.1042/bj2640539; THOMAS P, 1988, GAMETE RES, V20, P397, DOI 10.1002/mrd.1120200402; Ting D, 2015, CHIN J CLIN LAB SCI, V33, P3; URAYAMA O, 1989, J BIOL CHEM, V264, P8271; Wang L, 2010, ASIAN J ANDROL, V12, P667, DOI 10.1038/aja.2010.79; WISHART GJ, 1986, BRIT POULTRY SCI, V27, P97, DOI 10.1080/00071668608416859; WOLTERSEVERHARDT E, 1986, FERTIL STERIL, V46, P114; WONG PYD, 1981, EXP CELL RES, V131, P97, DOI 10.1016/0014-4827(81)90410-9; Woo AL, 2000, J BIOL CHEM, V275, P20693, DOI 10.1074/jbc.M002323200; YANAGIMA.R, 1970, J REPROD FERTIL, V23, P193, DOI 10.1530/jrf.0.0230193; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044; Zhao C, 2007, FERTIL STERIL, V87, P436, DOI 10.1016/j.fertnstert.2006.06.057	54	46	49	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132974	10.1371/journal.pone.0132974	http://dx.doi.org/10.1371/journal.pone.0132974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173069	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900110
J	Aebischer, B; Hill, JC; Hilfiker, R; Karstens, S				Aebischer, Bernhard; Hill, Jonathan C.; Hilfiker, Roger; Karstens, Sven			German Translation and Cross-Cultural Adaptation of the STarT Back Screening Tool	PLOS ONE			English	Article							PAIN CATASTROPHIZING SCALE; PSYCHOSOCIAL RISK-FACTORS; PRIMARY-CARE; GUIDELINES; MANAGEMENT; QUESTIONNAIRE; VALIDATION; VERSION; TRIAL	Background Although evidence based treatment approaches for acute low back pain are available, the prevention of persistent disabling symptoms remains a challenge. Subgroup targeted treatment using adequate screening tools may be a key component for the development of new treatment concepts and is demonstrating promising early evidence. The Keele STarT Back Screening Tool is a practical instrument, developed to stratify patients with back pain according to their risk of persistent disabling symptoms. The aim of this study was to translate and cross-culturally adapt the STarT tool into German (STarT-G) and to investigate its psychometric properties. Methods The translation was performed according to internationally accepted guidelines and pretested to assess face validity among patients. Psychometric testing was then performed within a cross-sectional cohort of adult patients attending physiotherapy practices for back pain. Patients completed a booklet containing STarT-G and 5 reference standard questionnaires. Measurement properties of the STarT-G were explored including construct validity, floor and ceiling effects, and discriminative abilities. Results The pretests (n=25) showed good face validity including strong comprehension and acceptability of the STarT-G with only item 5 (fear avoidance) manifesting some ambiguities. The questionnaires were sent to 74 and completed by 50 patients (68%) of whom mean age was 46 (SD 14.5) years and 52% were male. Spearman's rank correlations for construct validity ranged from 0.35 to 0.56. AUCs for discriminative ability ranged from 0.79 to 0.91. Neither floor nor ceiling effects were observed. There were 28 (57%) participants defined as low risk, 17 (35%) as medium risk, and 4 (8%) as high risk. Conclusion STarT-G is linguistically valid for German speaking countries. For the selected population, the correlations indicate acceptable validity and AUC showed satisfying discrimination. Data for psychometric properties have to be confirmed in a large scale study with a representative sample.	[Aebischer, Bernhard] Univ Appl Sci, Hlth Div, Bern, Switzerland; [Hill, Jonathan C.] Keele Univ, Inst Primary Care & Hlth Sci, Great Britain, Staffs, England; [Hilfiker, Roger] Univ Appl Sci & Arts Western Switzerland Valais, Sch Hlth Sci, Wallis, Switzerland; [Karstens, Sven] Univ Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany	Keele University; Ruprecht Karls University Heidelberg	Karstens, S (corresponding author), Univ Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany.	sven.karstens@med.uni-heidelberg.de	Hill, Jonathan/AAT-2744-2020; Karstens, Sven/AAF-7211-2020; Hilfiker, Roger/E-2846-2010	Karstens, Sven/0000-0001-7403-3452; Hilfiker, Roger/0000-0001-8662-6116	Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	The authors acknowledge financial support for the publication by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme "Open Access Publishing".	Ammon U, 2004, STANDARDSPRACHE OSTE; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bergbom S, 2011, PHYS THER, V91, P754, DOI 10.2522/ptj.20100136; Bergstrom C, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-81; Bundesamt fur Statistik, 2007, SCHWEIZ GES 2007; Dagenais S, 2010, SPINE J, V10, P514, DOI 10.1016/j.spinee.2010.03.032; Denis A, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-234; Exner V, 2000, SCHMERZ, V14, P392, DOI 10.1007/s004820070004; Foster NE, 2014, ANN FAM MED, V12, P102, DOI 10.1370/afm.1625; Grotle M, 2007, EUR J PAIN, V11, P290, DOI 10.1016/j.ejpain.2006.03.004; Hill J, 2008, THESIS KEELE U STAFF; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Hingorani AD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5793; Jensen MP, 2003, J PAIN, V4, P407, DOI 10.1016/S1526-5900(03)00716-8; Kent P, 2012, MANUAL THER, V17, P385, DOI 10.1016/j.math.2012.02.008; Kent P, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-62; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Meyer K, 2008, J PSYCHOSOM RES, V64, P469, DOI 10.1016/j.jpsychores.2007.12.004; Morso L, 2011, EUR SPINE J, V20, P2166, DOI 10.1007/s00586-011-1911-6; Nigbur K, 2009, EUR J PAIN, V13, pS239; Oesch P, 2011, ASSESSMENTS REHABILI, VVerlag Hans Huber, P305; Ramond A, 2011, FAM PRACT, V28, P12, DOI 10.1093/fampra/cmq072; Robert Koch Institut, 2006, GES DEUTSCHL; Sanders T, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-49; Snaith R, 2011, HOSP ANXIETY DEPRESS; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Vibe Fersum K, 2012, EUR J PAIN, P1; Wieser S, 2011, EUR J HEALTH ECON, V12, P455, DOI 10.1007/s10198-010-0258-y; Wiesinger, 1999, PHYS MED REHABIL, V24	32	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132068	10.1371/journal.pone.0132068	http://dx.doi.org/10.1371/journal.pone.0132068			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161669	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000358162300089
J	Churchill, NW; Spring, R; Afshin-Pour, B; Dong, F; Strother, SC				Churchill, Nathan W.; Spring, Robyn; Afshin-Pour, Babak; Dong, Fan; Strother, Stephen C.			An Automated, Adaptive Framework for Optimizing Preprocessing Pipelines in Task-Based Functional MRI	PLOS ONE			English	Article							NEUROIMAGING EXPERIMENTS; QUANTITATIVE-EVALUATION; PHYSIOLOGICAL NOISE; COMPONENT ANALYSIS; DEFAULT MODE; HEAD MOTION; FMRI; BRAIN; STATE; CONNECTIVITY	BOLD fMRI is sensitive to blood-oxygenation changes correlated with brain function; however, it is limited by relatively weak signal and significant noise confounds. Many preprocessing algorithms have been developed to control noise and improve signal detection in fMRI. Although the chosen set of preprocessing and analysis steps (the "pipeline") significantly affects signal detection, pipelines are rarely quantitatively validated in the neuroimaging literature, due to complex preprocessing interactions. This paper outlines and validates an adaptive resampling framework for evaluating and optimizing preprocessing choices by optimizing data-driven metrics of task prediction and spatial reproducibility. Compared to standard "fixed" preprocessing pipelines, this optimization approach significantly improves independent validation measures of within-subject test-retest, and between-subject activation overlap, and behavioural prediction accuracy. We demonstrate that preprocessing choices function as implicit model regularizers, and that improvements due to pipeline optimization generalize across a range of simple to complex experimental tasks and analysis models. Results are shown for brief scanning sessions (<3 minutes each), demonstrating that with pipeline optimization, it is possible to obtain reliable results and brain-behaviour correlations in relatively small datasets.	[Churchill, Nathan W.; Spring, Robyn; Afshin-Pour, Babak; Dong, Fan; Strother, Stephen C.] Baycrest Hosp, Rotman Res Inst, Toronto, ON, Canada; [Churchill, Nathan W.; Strother, Stephen C.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Spring, Robyn; Strother, Stephen C.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto	Churchill, NW (corresponding author), St Michaels Hosp, Neurosci Res Program, 30 Bond St, Toronto, ON M5B 1W8, Canada.	nchurchill.research@gmail.com	Strother, Stephen C/D-6752-2011; Strother, Stephen/ABF-3371-2021	Strother, Stephen C/0000-0002-3198-217X; Strother, Stephen/0000-0002-3198-217X	CIHR [MOP84483]; Bridging CIHR [IAO123872]; James S. McDonnell Foundation; Ontario Brain Institute; Heart and Stroke Foundation of Ontario	CIHR(Canadian Institutes of Health Research (CIHR)); Bridging CIHR; James S. McDonnell Foundation; Ontario Brain Institute; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was partially supported by CIHR grant #MOP84483, a Bridging CIHR grant #IAO123872, and a Brain, Mind and Behaviour grant from the James S. McDonnell Foundation. S.C.S., R.S. and F.D. acknowledge partial support from the Ontario Brain Institute, and S.C.S. and R.S. also acknowledge support of the Heart and Stroke Foundation of Ontario, through the Canadian Partnership for Stroke Recovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshin-Pour B, 2011, HUM BRAIN MAPP, V32, P699, DOI 10.1002/hbm.21057; Ardekani BA, 2001, MAGN RESON IMAGING, V19, P959, DOI 10.1016/S0730-725X(01)00418-0; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Birn RM, 2009, NEUROIMAGE, V47, P1092, DOI 10.1016/j.neuroimage.2009.05.030; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Bullmore ET, 1999, HUM BRAIN MAPP, V7, P38, DOI 10.1002/(SICI)1097-0193(1999)7:1<38::AID-HBM4>3.3.CO;2-H; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Caceres A, 2009, NEUROIMAGE, V45, P758, DOI 10.1016/j.neuroimage.2008.12.035; Campbell KL, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00073; Carbonell F, 2011, BRAIN CONNECT, V1, P496, DOI 10.1089/brain.2011.0065; Carp J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00149; Carp J, 2012, NEUROIMAGE, V63, P289, DOI 10.1016/j.neuroimage.2012.07.004; Churchill N, 2013, SPRINGER P MATH STAT, V56, P171, DOI 10.1007/978-1-4614-8283-3_11; Churchill NW, 2013, NEUROIMAGE, V82, P306, DOI 10.1016/j.neuroimage.2013.05.102; Churchill NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031147; Churchill NW, 2012, HUM BRAIN MAPP, V33, P609, DOI 10.1002/hbm.21238; Churchill NW, 2014, P 20 ANN M OHBM HAMB; Churchill NW, 2014, OHBM, V2014; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Evans JW, 2010, NEUROIMAGE, V50, P479, DOI 10.1016/j.neuroimage.2009.11.039; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Freire L, 2001, NEUROIMAGE, V14, P709, DOI 10.1006/nimg.2001.0869; Friedman L, 2006, J MAGN RESON IMAGING, V23, P827, DOI 10.1002/jmri.20583; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; He HJ, 2012, NEUROIMAGE, V59, P2339, DOI 10.1016/j.neuroimage.2011.09.018; Himmanen SA, 2003, J CLIN EXP NEUROPSYC, V25, P1178, DOI 10.1076/jcen.25.8.1178.16729; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Jones, 2009, NEUROIMAGE, V42, P582; Kjems U, 2002, NEUROIMAGE, V15, P772, DOI 10.1006/nimg.2001.1033; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; LaConte S, 2003, NEUROIMAGE, V18, P10, DOI 10.1006/nimg.2002.1300; Le TH, 1997, NMR BIOMED, V10, P160, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<160::AID-NBM458>3.0.CO;2-A; Lund TE, 2006, NEUROIMAGE, V29, P54, DOI 10.1016/j.neuroimage.2005.07.005; Mazaika P, 2007, OHBM, V13; Morgan VL, 2007, COMPUT MED IMAG GRAP, V31, P436, DOI 10.1016/j.compmedimag.2007.04.002; Nichols TE, 2009, PERSPECT PSYCHOL SCI, V4, P291, DOI 10.1111/j.1745-6924.2009.01126.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ollinger J. M., 2009, NEUROIMAGE, V47, pS122, DOI DOI 10.1016/S1053-8119(09)71160-71167; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; Poline JB, 2006, HUM BRAIN MAPP, V27, P351, DOI 10.1002/hbm.20268; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rasmussen PM, 2012, PATTERN RECOGN, V45, P2085, DOI 10.1016/j.patcog.2011.09.011; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Sarty G. E, 2007, COMPUTING BRAIN ACTI; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Seto E, 2001, NEUROIMAGE, V14, P284, DOI 10.1006/nimg.2001.0829; Shaw ME, 2003, NEUROIMAGE, V19, P988, DOI 10.1016/S1053-8119(03)00116-2; Sladky R, 2011, NEUROIMAGE, V58, P588, DOI 10.1016/j.neuroimage.2011.06.078; Specht K, 2003, J MAGN RESON IMAGING, V17, P463, DOI 10.1002/jmri.10277; Strother S, 2004, NEUROIMAGE, V23, pS196, DOI 10.1016/j.neuroimage.2004.07.022; Strothert SC, 2002, NEUROIMAGE, V15, P747, DOI 10.1006/nimg.2001.1034; Tam F, 2011, HUM BRAIN MAPP, V32, P240, DOI 10.1002/hbm.21013; Tanabe J, 2002, NEUROIMAGE, V15, P902, DOI 10.1006/nimg.2002.1053; Tegeler C, 1999, HUM BRAIN MAPP, V7, P267, DOI 10.1002/(SICI)1097-0193(1999)7:4<267::AID-HBM5>3.0.CO;2-3; TURIN GL, 1976, P IEEE, V64, P1092, DOI 10.1109/PROC.1976.10274; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; White T, 2001, NEUROIMAGE, V13, P577, DOI 10.1006/nimg.2000.0716; Wong CW, 2013, NEUROIMAGE, V83, P983, DOI 10.1016/j.neuroimage.2013.07.057; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Yourganov G, 2011, NEUROIMAGE, V56, P531, DOI 10.1016/j.neuroimage.2010.09.034; Yue Y, 2010, STAT INTERFACE, V3, P3; Zhang J, 2009, MAGN RESON IMAGING, V27, P264, DOI 10.1016/j.mri.2008.05.021	72	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131520	10.1371/journal.pone.0131520	http://dx.doi.org/10.1371/journal.pone.0131520			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161667	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300041
J	He, Q; Li, L; Yang, TT; Li, RJ; Li, AY				He, Qiang; Li, Le; Yang, Tingting; Li, Ruijuan; Li, Aiying			Functional Characterization of a Ketoreductase-Encoding Gene med-ORF12 Involved in the Formation of a Stereospecific Pyran Ring during the Biosynthesis of an Antitumor Antibiotic Medermycin	PLOS ONE			English	Article							STREPTOMYCES SP; GENOME SEQUENCE; ACTINORHODIN; CLUSTER; EXPRESSION; STRATEGIES; INHIBITORS; DISCOVERY; AM-7161; CLONING	Medermycin, a polyketide antibiotic, possesses strong bioactivity against a variety of tumors through a novel mechanism and is structurally featured with a pyran ring containing two chiral centers (3Sand 15R). By far the biosynthetic origin of such enantiomerical conformations still remains obscure. In the present study, we reported the functional characterization of a proposed ketoreductase Med-ORF12 encoded by medermycin biosynthetic cluster and revealed its involvement in the stereochemical control at C3 center of medermycin. Firstly, bioinformatics analysis of Med-ORF12 suggested that it belongs to a group of stereospecific ketoreductases. Next, a Med-ORF12-deficient mutant was obtained and LC/MS measurements demonstrated that medermycin production was completely abolished in this mutant. Meanwhile, it was found that two shunt products were accumulated at the absence of Med-ORF12. Finally, the reintroduction of Med-ORF12 into this mutant could restore the production of medermycin. In a conclusion, these data supported that Med-ORF12 is essential for the biosynthesis of medermycin and performs its role as a stereospecifc ketoreductase in the tailoring steps of medermycin biosynthetic pathway.	[He, Qiang; Li, Le; Yang, Tingting; Li, Ruijuan; Li, Aiying] Shandong Univ, State Key Lab Microbial Technol, Sch Life Sci, Helmholtz Inst Biotechnol, Jinan 250100, Peoples R China; [He, Qiang; Li, Le; Yang, Tingting; Li, Aiying] Cent China Normal Univ, Sch Life Sci, Wuhan, Peoples R China	Shandong University; Central China Normal University	Li, AY (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Sch Life Sci, Helmholtz Inst Biotechnol, Jinan 250100, Peoples R China.	aiyli@126.com			National Natural Science Foundation of China [31170050, 30770036]; Fundamental Research Funds for the Central University [CCNU10A02011]; Xinjiang Production & Construction Corps Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin [BRZD1401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central University; Xinjiang Production & Construction Corps Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin	Thanks for financial supports by the National Natural Science Foundation of China (No. 31170050 and 30770036), the Fundamental Research Funds for the Central University (No. CCNU10A02011), and Xinjiang Production & Construction Corps Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin (No. BRZD1401).	Barycki JJ, 1999, BIOCHEMISTRY-US, V38, P5786, DOI 10.1021/bi9829027; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Challis GL, 2008, J MED CHEM, V51, P2618, DOI 10.1021/jm700948z; Donner CD, 2013, TETRAHEDRON, V69, P377, DOI 10.1016/j.tet.2012.10.012; FEHR T, 1989, J ANTIBIOT, V42, P897, DOI 10.7164/antibiotics.42.897; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; Ichinose K, 2003, MICROBIOL-SGM, V149, P1633, DOI 10.1099/mic.0.26310-0; Ichinose K, 1998, CHEM BIOL, V5, P647, DOI 10.1016/S1074-5521(98)90292-7; Ichinose K., 1998, ACTINOMYCETOL, V12, P99; Itoh T, 2007, BIOCHEMISTRY-US, V46, P8181, DOI 10.1021/bi700190p; Kieser T., 2000, PRACTICAL STREPTOMYC, DOI DOI 10.2436/im.v3i4.9291; Kim HJ, 2014, J BIOL CHEM, V289, P34557, DOI 10.1074/jbc.M114.602334; Klassen JL, 2011, J BACTERIOL, V193, P6999, DOI 10.1128/JB.06257-11; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li AY, 2005, BIOORGAN MED CHEM, V13, P6856, DOI 10.1016/j.bmc.2005.07.060; LI Z, 1989, J ANTIBIOT, V42, P577, DOI 10.7164/antibiotics.42.577; MADDURI K, 1995, J BACTERIOL, V177, P3879, DOI 10.1128/jb.177.13.3879-3884.1995; MCDANIEL R, 1993, SCIENCE, V262, P1546, DOI 10.1126/science.8248802; Metsa-Ketela M, 2013, CURR OPIN CHEM BIOL, V17, P562, DOI 10.1016/j.cbpa.2013.06.032; Novakova R, 2010, FOLIA MICROBIOL, V55, P119, DOI 10.1007/s12223-010-0018-5; Novakova R, 2002, GENE, V297, P197, DOI 10.1016/S0378-1119(02)00889-2; Ogasawara Y, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00114-15; Okamoto S, 2009, CHEM BIOL, V16, P226, DOI 10.1016/j.chembiol.2009.01.015; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Persson B, 2013, CHEM-BIOL INTERACT, V202, P111, DOI 10.1016/j.cbi.2012.11.009; Rix U, 2002, NAT PROD REP, V19, P542, DOI 10.1039/b103920m; Sambrook J., 2001, MOL CLONING LAB MANU; Sun Rui, 2012, Weishengwu Xuebao, V52, P60; Sun YH, 2009, APPL MICROBIOL BIOT, V82, P303, DOI 10.1007/s00253-008-1793-7; Taguchi T, 2004, BIOORGAN MED CHEM, V12, P5917, DOI 10.1016/j.bmc.2004.08.026; Taguchi T, 2000, J ANTIBIOT, V53, P144, DOI 10.7164/antibiotics.53.144; TAKANO S, 1976, J ANTIBIOT, V29, P765, DOI 10.7164/antibiotics.29.765; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toral-Barza L, 2007, MOL CANCER THER, V6, P3028, DOI 10.1158/1535-7163.MCT-07-0211	37	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132431	10.1371/journal.pone.0132431	http://dx.doi.org/10.1371/journal.pone.0132431			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162081	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300135
J	Qubbaj, MR; Muneepeerakul, R; Aggarwal, RM; Anderies, JM				Qubbaj, Murad R.; Muneepeerakul, Rachata; Aggarwal, Rimjhim M.; Anderies, John M.			How Does a Divided Population Respond to Change?	PLOS ONE			English	Article							REGIME SHIFTS; DYNAMICS	Most studies on the response of socioeconomic systems to a sudden shift focus on long-term equilibria or end points. Such narrow focus forgoes many valuable insights. Here we examine the transient dynamics of regime shift on a divided population, exemplified by societies divided ideologically, politically, economically, or technologically. Replicator dynamics is used to investigate the complex transient dynamics of the population response. Though simple, our modeling approach exhibits a surprisingly rich and diverse array of dynamics. Our results highlight the critical roles played by diversity in strategies and the magnitude of the shift. Importantly, it allows for a variety of strategies to arise organically as an integral part of the transient dynamics-as opposed to an independent process-of population response to a regime shift, providing a link between the population's past and future diversity patterns. Several combinations of different populations' strategy distributions and shifts were systematically investigated. Such rich dynamics highlight the challenges of anticipating the response of a divided population to a change. The findings in this paper can potentially improve our understanding of a wide range of socio-ecological and technological transitions.	[Qubbaj, Murad R.; Muneepeerakul, Rachata; Aggarwal, Rimjhim M.; Anderies, John M.] Arizona State Univ, Sch Sustainabil, Tempe, AZ 85287 USA; [Muneepeerakul, Rachata] Arizona State Univ, Math Computat & Modeling Sci Ctr, Tempe, AZ 85287 USA; [Anderies, John M.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Qubbaj, MR (corresponding author), Arizona State Univ, Sch Sustainabil, Tempe, AZ 85287 USA.	murad.qubbaj@asu.edu	Qubbaj, Murad/L-5917-2019; Aggarwal, Rimjhim M/D-4812-2012	Aggarwal, Rimjhim M/0000-0002-3579-5363	National Science Foundation (NSF) [GEO-1115054]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by National Science Foundation (NSF) grant GEO-1115054. The authors who received funding are: JMA, RM, and RMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RM, 2011, ROUTLEDGE HDB S AS E, P44; Anderies JM, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044048; [Anonymous], WORLD SOCIAL SCI REP; [Anonymous], 2014, SCI MAGAZINE    0523, V344; [Anonymous], 1998, THEORY LEARNING GAME; Barnes DF, 1999, J INT AFFAIRS, V53, P237; Barrett CB, 2008, FOOD POLICY, V33, P299, DOI 10.1016/j.foodpol.2007.10.005; Chowdhury RR, 2010, P NATL ACAD SCI USA, V107, P5780, DOI 10.1073/pnas.0905892107; DEJANVRY A, 1991, ECON J, V101, P1400, DOI 10.2307/2234892; DiMaggio P, 1996, AM J SOCIOL, V102, P690, DOI 10.1086/230995; Doherty C, 2014, TECHNICAL REPORT; Fiorina MP, 2008, ANNU REV POLIT SCI, V11, P563, DOI 10.1146/annurev.polisci.11.053106.153836; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Grubler A, 1998, TECHNOLOGY GLOBAL CH; Heltberg R, 2005, ENVIRON DEV ECON, V10, P337, DOI 10.1017/S1355770X04001858; Heltberg R, 2003, 042 ESMAP WORLD BANK; Karev GP, 2010, B MATH BIOL, V72, P1124, DOI 10.1007/s11538-009-9484-9; Karev GP, 2010, J MATH BIOL, V60, P107, DOI 10.1007/s00285-009-0252-0; KINZIG AP, 2006, ECOLOGY SOC, V11; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lewis W. Arthur, 1954, MANCH SCH, V22, P139, DOI [10.1111/j.1467-9957.1954.tb00021.x, DOI 10.1111/J.1467-9957.1954.TB00021.X]; Manderscheid A, 2002, RANGIFER SPECIAL ISS, V15, P29; Muneepeerakul R, 2012, J R SOC INTERFACE, V9, P3303, DOI 10.1098/rsif.2012.0431; Piketty T, 2014, SCIENCE, V344, P838, DOI 10.1126/science.1251936; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Safarzynska K, 2011, J ECON BEHAV ORGAN, V78, P229, DOI 10.1016/j.jebo.2011.01.008; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; SCHUSTER P, 1983, J THEOR BIOL, V100, P533, DOI 10.1016/0022-5193(83)90445-9; Singer HW, 1999, DUAL EC, P202; Stiglitz Joseph E., 2012, PRICE INEQUALITY TOD; Stirling A., 1998, SPRU ELECT WORKING P, V28; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; The Nature Conservancy, 2014, TECHNICAL REPORT; Walker B., 2004, ECOLOGY SOC, V9; [No title captured]	35	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0128121	10.1371/journal.pone.0128121	http://dx.doi.org/10.1371/journal.pone.0128121			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161859	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300007
J	Sindato, C; Pfeiffer, DU; Karimuribo, ED; Mboera, LEG; Rweyemamu, MM; Paweska, JT				Sindato, Calvin; Pfeiffer, Dirk U.; Karimuribo, Esron D.; Mboera, Leonard E. G.; Rweyemamu, Mark M.; Paweska, Janusz T.			A Spatial Analysis of Rift Valley Fever Virus Seropositivity in Domestic Ruminants in Tanzania	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; IGG-SANDWICH; OUTBREAK; ANTIBODY; ELISA; SEROPREVALENCE; CIRCULATION; VALIDATION; LIVESTOCK; SHEEP	Rift Valley fever (RVF) is an acute arthropod-borne viral zoonotic disease primarily occurring in Africa. Since RVF-like disease was reported in Tanzania in 1930, outbreaks of the disease have been reported mainly from the eastern ecosystem of the Great Rift Valley. This cross-sectional study was carried out to describe the variation in RVF virus (RVFV) seropositivity in domestic ruminants between selected villages in the eastern and western Rift Valley ecosystems in Tanzania, and identify potential risk factors. Three study villages were purposively selected from each of the two Rift Valley ecosystems. Serum samples from randomly selected domestic ruminants (n = 1,435) were tested for the presence of specific immunoglobulin G (IgG) and M (IgM), using RVF enzyme-linked immunosorbent assay methods. Mixed effects logistic regression modelling was used to investigate the association between potential risk factors and RVFV seropositivity. The overall RVFV seroprevalence (n = 1,435) in domestic ruminants was 25.8% and speciesspecific seroprevalence was 29.7%, 27.7% and 22.0% in sheep (n = 148), cattle (n = 756) and goats (n = 531), respectively. The odds of seropositivity were significantly higher in animals sampled from the villages in the eastern than those in the western Rift Valley ecosystem (OR = 1.88, CI: 1.41, 2.51; p < 0.001), in animals sampled from villages with soils of good than those with soils of poor water holding capacity (OR = 1.97; 95% CI: 1.58, 3.02; p < 0.001), and in animals which had been introduced than in animals born within the herd (OR = 5.08, CI: 2.74, 9.44; p < 0.001). Compared with animals aged 1-2 years, those aged 3 and 4-5 years had 3.40 (CI: 2.49, 4.64; p < 0.001) and 3.31 (CI: 2.27, 4.82, p < 0.001) times the odds of seropositivity. The findings confirm exposure to RVFV in all the study villages, but with a higher prevalence in the study villages from the eastern Rift Valley ecosystem.	[Sindato, Calvin] Natl Inst Med Res, Tabora, Tanzania; [Sindato, Calvin; Karimuribo, Esron D.] Sokoine Univ Agr, Dept Vet Med & Publ Hlth, Morogoro, Tanzania; [Sindato, Calvin; Karimuribo, Esron D.; Rweyemamu, Mark M.] South African Ctr Infect Dis Surveillance, Morogoro, Tanzania; [Pfeiffer, Dirk U.] Univ London Royal Vet Coll, Econ & Publ Hlth Grp, Vet Epidemiol, London, England; [Mboera, Leonard E. G.] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Paweska, Janusz T.] Ctr Emerging & Zoonot Dis, Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Paweska, Janusz T.] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa	Sokoine University of Agriculture; University of London; University of London Royal Veterinary College; National Institute of Medical Research; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand	Sindato, C (corresponding author), Natl Inst Med Res, Tabora, Tanzania.	calvin.sindato@sacids.org	Pfeiffer, Dirk U/C-5002-2009	Pfeiffer, Dirk U/0000-0001-7000-0530	Wellcome Trust [WT087546MA]; Global Alliance for Livestock Veterinary Medicines, United Kingdom [SUO-R33A0297]	Wellcome Trust(Wellcome TrustEuropean Commission); Global Alliance for Livestock Veterinary Medicines, United Kingdom	This study forms part of the PhD study by CS under the Wellcome Trust Grant WT087546MA and was co-funded by the Global Alliance for Livestock Veterinary Medicines (SUO-R33A0297), United Kingdom. The funders had no role in study design, data collection and analysis or preparation of the manuscript.	Abdo-Salem S, 2006, ANN NY ACAD SCI, P1081; Adam AA, 2010, INT J INFECT DIS, V14, pE179, DOI 10.1016/j.ijid.2009.03.029; Al-Afaleq AI, 2011, VECTOR-BORNE ZOONOT, V11, P1513, DOI 10.1089/vbz.2010.0245; [Anonymous], 2011, TERRESTRIAL ANIMAL H; Anyamba A, 2000, PHOTOGRAM ENG REMOTE, V68, P137; Aradaib IE, 2013, EMERG INFECT DIS, V19, P246, DOI 10.3201/eid1902.120834; Archer BN, 2011, SAMJ S AFR MED J, V101, P263, DOI 10.7196/SAMJ.4544; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P153, DOI 10.1016/S0924-8579(02)00295-9; Chen X, 2010, LOGISTIC REGRESSION; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; Davies F Glyn, 2006, Vet Ital, V42, P31; DAVIES FG, 1992, EPIDEMIOL INFECT, V108, P185, DOI 10.1017/S0950268800049633; EFSA, 2005, EFSA J, V3, P1, DOI DOI 10.2903/J.EFSA.2005.238; El Mamy ABO, 2011, EMERG INFECT DIS, V17, P1894, DOI 10.3201/eid1710.110397; EVANS A, 2007, EPIDEMIOL INFECT, V11, P1; Fafetine J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002065; Fyumagwa RD, 2011, TANZANIA J HLTH R S1, V13; GAD AM, 1986, J TROP MED HYG, V89, P233; Hartley DM, 2011, EMERG INFECT DIS; Heinrich N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001557; ILCA, 1990, LIVESTOCK SYSTEMS RE, P287; Jeanmaire EM, 2011, VECTOR-BORNE ZOONOT, V11, P395, DOI 10.1089/vbz.2009.0249; Kamal SA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-532; Kifaro EG, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i2.717; LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; Martin V, 2007, GEOSPATIAL HEALTH, V2, P3, DOI 10.4081/gh.2007.250; Ministry of Health and Social Welfare United Republic of Tanzania, 2011, NATL INTEGRATED DIS; Mlingano Agricultural Research Institute Department of Research and Training Ministry of Agriculture Food Security and Co-Operatives Tanga Tanzania, 2006, SOILS TANZANIA POTEN; Monaco F, 2013, EMERG INFECT DIS, V19, P2025, DOI 10.3201/eid1912.130593; MORLEY CK, 1999, ACTA VULCANOLOGICA, V11, P1; Munyua P, 2010, AM J TROP MED HYG, V83, P58, DOI 10.4269/ajtmh.2010.09-0292; Murphy FA, 1999, VET VIROLOGY, P469; National Institute for Communicable Diseases. Special Pathogens Unit and Outbreak Response Unit, 2011, COMMUNICABLE DIS SUR, V9, P22; NIKLASSON B, 1983, J CLIN MICROBIOL, V17, P1026, DOI 10.1128/JCM.17.6.1026-1031.1983; NIKLASSON B, 1984, J CLIN MICROBIOL, V19, P225, DOI 10.1128/JCM.19.2.225-229.1984; Paweska JT, 2007, J VIROL METHODS, V146, P119, DOI 10.1016/j.jviromet.2007.06.006; Paweska JT, 2005, J VIROL METHODS, V127, P10, DOI 10.1016/j.jviromet.2005.02.008; Paweska JT, 2005, J VIROL METHODS, V124, P173, DOI 10.1016/j.jviromet.2004.11.020; Paweska JT, 2003, J VIROL METHODS, V113, P103, DOI 10.1016/S0166-0934(03)00228-3; Pourrut X, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000763; Rich KM, 2010, AM J TROP MED HYG, V83, P52, DOI 10.4269/ajtmh.2010.09-0291; Shoemaker T, 2002, EMERG INFECT DIS, V8, P1415, DOI 10.3201/eid0812.020195; Sindato C, 2011, TANZANIA J HLTH R S1, V13; Sindato C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088897; Sissoko D, 2009, EMERG INFECT DIS, V15, P568, DOI 10.3201/eid1504.081045; Sumaye RD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002356; Swai ES, 2009, VECTOR-BORNE ZOONOT, V9, P579, DOI 10.1089/vbz.2008.0108; Swanepoel R., 2004, INFECT DIS LIVESTOCK, V2, P1037; THIONGANE Y, 1991, RES VIROLOGY, V142, P67, DOI 10.1016/0923-2516(91)90029-3; Thonnon J, 1999, TROP MED INT HEALTH, V4, P580, DOI 10.1046/j.1365-3156.1999.00437.x; Versteirt V, SUPPORNTING PUBLICAT, P59; *WHO, 2007, WKLY EPIDEMIOL REC, V82, P169; Woods CW, 2002, EMERG INFECT DIS, V8, P138, DOI 10.3201/eid0802.010023; World Health Organization, 2010, WEEKLY EPIDEMIOLOGIC, V21, P185; Zaki A, 2006, J VIROL METHODS, V131, P34, DOI 10.1016/j.jviromet.2005.07.002	57	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131873	10.1371/journal.pone.0131873	http://dx.doi.org/10.1371/journal.pone.0131873			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162089	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300069
J	Yucel, M; Beaton, AD; Dengler, M; Mowlem, MC; Sohl, F; Sommer, S				Yuecel, Mustafa; Beaton, Alexander D.; Dengler, Marcus; Mowlem, Matthew C.; Sohl, Frank; Sommer, Stefan			Nitrate and Nitrite Variability at the Seafloor of an Oxygen Minimum Zone Revealed by a Novel Microfluidic In-Situ Chemical Sensor	PLOS ONE			English	Article							ANALYZER; WATERS; CIRCULATION; ENCELADUS; PHOSPHATE; SEAWATER; SYSTEM	Microfluidics, or lab-on-a-chip (LOC) is a promising technology that allows the development of miniaturized chemical sensors. In contrast to the surging interest in biomedical sciences, the utilization of LOC sensors in aquatic sciences is still in infancy but a wider use of such sensors could mitigate the undersampling problem of ocean biogeochemical processes. Here we describe the first underwater test of a novel LOC sensor to obtain in situ calibrated time-series (up to 40 h) of nitrate+nitrite (Sigma NOx) and nitrite on the seafloor of the Mauritanian oxygen minimum zone, offshore Western Africa. Initial tests showed that the sensor successfully reproduced water column (160 m) nutrient profiles. Lander deployments at 50, 100 and 170 m depth indicated that the biogeochemical variability was high over the Mauritanian shelf: The 50 m site had the lowest Sigma NOx concentration, with 15.2 to 23.4 mu M (median=18.3 mu M); while at the 100 site Sigma NOx varied between 21.0 and 30.1 mu M over 40 hours (median = 25.1 mu M). The 170 m site had the highest median Sigma NOx level (25.8 mu M) with less variability (22.8 to 27.7 mu M). At the 50 m site, nitrite concentration decreased fivefold from 1 to 0.2 mu M in just 30 hours accompanied by decreasing oxygen and increasing nitrate concentrations. Taken together with the time series of oxygen, temperature, pressure and current velocities, we propose that the episodic intrusion of deeper waters via cross-shelf transport leads to intrusion of nitrate-rich, but oxygen-poor waters to shallower locations, with consequences for benthic nitrogen cycling. This first validation of an LOC sensor at elevated water depths revealed that when deployed for longer periods and as a part of a sensor network, LOC technology has the potential to contribute to the understanding of the benthic biogeochemical dynamics.	[Yuecel, Mustafa; Dengler, Marcus; Sommer, Stefan] GEOMAR Helmholtz Ctr Ocean Res, Kiel, Germany; [Yuecel, Mustafa] Middle E Tech Univ, Inst Marine Sci, Erdemli, Mersin, Turkey; [Beaton, Alexander D.; Mowlem, Matthew C.] Natl Oceanog Ctr Southampton, Ocean Technol & Engn Grp, Southampton, Hants, England; [Sohl, Frank] DLR German Aerosp Ctr, Inst Planetary Sci, Berlin, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Middle East Technical University; NERC National Oceanography Centre; University of Southampton; Helmholtz Association; German Aerospace Centre (DLR)	Yucel, M (corresponding author), GEOMAR Helmholtz Ctr Ocean Res, Kiel, Germany.	myucel@ims.metu.edu.tr	Dengler, Marcus/A-7327-2014; Yücel, Mustafa/F-7067-2010	Dengler, Marcus/0000-0001-5993-9088; Yücel, Mustafa/0000-0002-7478-902X; Beaton, Alexander/0000-0002-0206-7466; Mowlem, Matthew/0000-0001-7613-6121	Helmholtz-Alliance ROBEX (Robotic Exploration of Extreme Environments); collaborative research center Climate-Biogeochemistry Interactions in the Tropical Ocean [SFB754]; NERC [NE/J011975/1, noc010013, noc010003, NE/I012974/1] Funding Source: UKRI; Natural Environment Research Council [NE/I012974/1, noc010013, NE/J011975/1, noc010003] Funding Source: researchfish	Helmholtz-Alliance ROBEX (Robotic Exploration of Extreme Environments); collaborative research center Climate-Biogeochemistry Interactions in the Tropical Ocean; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the Helmholtz-Alliance ROBEX (Robotic Exploration of Extreme Environments - http://www.robex-allianz.de/en, funds to SS, FS) and the collaborative research center Climate-Biogeochemistry Interactions in the Tropical Ocean (SFB754 - www.sfb754.de, funds to SS, MD).	Barton E.D., 1989, POLEWARD FLOWS E OCE, P82; Beaton AD, 2012, ENVIRON SCI TECHNOL, V46, P9548, DOI 10.1021/es300419u; Beaton AD, 2011, SENSOR ACTUAT B-CHEM, V156, P1009, DOI 10.1016/j.snb.2011.02.042; Bellingham JG, 2007, SCIENCE, V318, P1098, DOI 10.1126/science.1146230; Bohlen L, 2011, GEOCHIM COSMOCHIM AC, V75, P6094, DOI 10.1016/j.gca.2011.08.010; Brandt P, 2015, BIOGEOSCIENCES, V12, P489, DOI 10.5194/bg-12-489-2015; Campos CDM, 2013, RSC ADV, V3, P18216, DOI 10.1039/c3ra41561a; Dale AW, 2014, GEOCHIM COSMOCHIM AC, V134, P234, DOI 10.1016/j.gca.2014.02.026; Dickey TD, 2008, LIMNOL OCEANOGR, V53, P2057, DOI 10.4319/lo.2008.53.5_part_2.2057; Fernandez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020539; Floquet CFA, 2011, TALANTA, V84, P235, DOI 10.1016/j.talanta.2010.12.026; HOLLOWAY PE, 1985, J PHYS OCEANOGR, V15, P240, DOI 10.1175/1520-0485(1985)015<0240:ACOSIT>2.0.CO;2; Horstkotte B, 2013, ANAL LETT, V46, P2345, DOI 10.1080/00032719.2013.800539; Jackson C, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2007JC004220; Jang A, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/3/032001; Johnson KS, 2007, CHEM REV, V107, P623, DOI 10.1021/cr050354e; Johnson KS, 2013, J ATMOS OCEAN TECH, V30, P1854, DOI 10.1175/JTECH-D-12-00221.1; Johnson KS, 2010, NATURE, V465, P1062, DOI 10.1038/nature09170; Johnson KS, 2002, DEEP-SEA RES PT I, V49, P1291, DOI 10.1016/S0967-0637(02)00020-1; Jorgensen B.B., 2004, GEOL S AM, V379, P63, DOI DOI 10.1130/0-8137-2379-5.63; Le Bris N, 2000, MAR CHEM, V72, P1, DOI 10.1016/S0304-4203(00)00057-8; Legiret FE, 2013, TALANTA, V116, P382, DOI 10.1016/j.talanta.2013.05.004; Mann KH, 2006, DYNAMICS MARINE ECOS; Martz TR, 2010, LIMNOL OCEANOGR-METH, V8, P172, DOI 10.4319/lom.2010.8.172; Mason, 2013, SMART SENSORS REAL T, P125, DOI DOI 10.1007/978-3-642-37006-9_6; Milani A, 2015, TALANTA, V136, P15, DOI 10.1016/j.talanta.2014.12.045; MITTELSTAEDT E, 1991, PROG OCEANOGR, V26, P307, DOI 10.1016/0079-6611(91)90011-A; MITTELSTAEDT E, 1983, PROG OCEANOGR, V12, P307, DOI 10.1016/0079-6611(83)90012-5; Moore TS, 2009, ANNU REV MAR SCI, V1, P91, DOI 10.1146/annurev.marine.010908.163817; Ogilvie IRG, 2011, ANAL CHEM, V83, P4814, DOI 10.1021/ac200463y; Ogilvie IRG, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/6/065016; Patey MD, 2008, TRAC-TREND ANAL CHEM, V27, P169, DOI 10.1016/j.trac.2007.12.006; Pejcic B, 2009, 09010 CSIRO PETR RES; Pfannkuche O and the Science Party, 2014, MERIAN BERICHTE, DOI [10.2312/cr_msm17_4, DOI 10.2312/CR_MSM17_4.]; Provin C, 2013, IEEE J OCEANIC ENG, V38, P178, DOI 10.1109/JOE.2012.2208849; R Core Team, 2021, R LANGUAGE ENV STAT; Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118; Schafstall J, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005940; Sieben VJ, 2010, ANAL METHODS-UK, V2, P484, DOI 10.1039/c002672g; Sommer S, 2009, MAR ECOL PROG SER, V382, P69, DOI 10.3354/meps07956; Spencer JR, 2013, ANNU REV EARTH PL SC, V41, P693, DOI 10.1146/annurev-earth-050212-124025; Stramma L, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039593; Takeshita Y, 2013, J GEOPHYS RES-OCEANS, V118, P5640, DOI 10.1002/jgrc.20399; Tengberg A, 2006, LIMNOL OCEANOGR-METH, V4, P7, DOI 10.4319/lom.2006.4.7; Waite JH, 2009, NATURE, V460, P487, DOI 10.1038/nature08153; Wild-Allen K, 2014, MAR CHEM, V167, P135, DOI 10.1016/j.marchem.2014.06.011	46	26	26	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132785	10.1371/journal.pone.0132785	http://dx.doi.org/10.1371/journal.pone.0132785			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161958	gold, Green Published, Green Accepted			2022-12-27	WOS:000358162300176
J	Chung, YC; Kuo, JF; Wei, WC; Chang, KJ; Chao, WT				Chung, Yuan-Chiang; Kuo, Jang-Fang; Wei, Wan-Chen; Chang, King-Jen; Chao, Wei-Ting			Caveolin-1 Dependent Endocytosis Enhances the Chemosensitivity of HER-2 Positive Breast Cancer Cells to Trastuzumab Emtansine (T-DM1)	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PHASE-II TRIAL; DRUG CONJUGATE; TUMOR-GROWTH; RECEPTOR; INHIBITION; EXPRESSION; TRAFFICKING; SITE; IDENTIFICATION	The humanized monoclonal antibody-drug conjugate trastuzumab emtansine (T-DM1, Kadcyla) has been approved by the U.S. FDA to treat human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer. Despite its effectiveness in most patients, some are initially resistant or develop resistance. No biomarker of drug resistance to T-DM1 has been identified. Antibody-drug efficacy is associated with antibody internalization in the cell; therefore, cellular sensitivity of cells to the drug may be linked to cellular vesicle trafficking systems. Caveolin-1 is a 22 KD protein required for caveolae formation and endocytic membrane transport. In this study, the relationship between caveolin-1 expression and the chemosensitivity of HER-2-positive breast cancer cells to T-DM1 was investigated. Samples from 32 human breast cancer biopsy and normal tissue specimens were evaluated immunohistochemically for caveolin-1 expression. Caveolin-1 was shown to be expressed in 68% (22/32) of the breast cancer specimens. In addition, eight (72.7%, 8/11) HER-2 positive breast cancer specimens had a higher caveolin-1 expression than normal tissues. HER-2-positive BT-474 and SKBR-3 breast cancer cells that express low and moderate levels of caveolin-1, respectively, were treated with trastuzumab or its conjugate T-DM1. Cell viability and molecular localizations of caveolin-1, antibody and its conjugate were examined. Confocal microscopy showed that T-DM1 and caveolin-1 colocalized in SKBR-3 cells, which also were five times more sensitive to the conjugate in terms of cell survival than BT-474 cells, although T-DM1 also showed improved drug efficacy in BT-474 cells than trastuzumab treatment. Caveolin-1 expression in these lines was manipulated by transfection of GFP-tagged caveolin-1 or caveolin-1 siRNA. BT-474 cells overexpressing caveolin-1 were more sensitive to T-DM1 treatment than mock-transfected cells, whereas the siRNA-transfected SKBR-3 cells had decreased sensitivity to T-DM1 than mock-transfected SKBR-3 cells. The expression of caveolin-1 could mediate endocytosis and promote the internalization of T-DM1 into HER-2 positive cancer cells. Thus, caveolin-1 protein may be an effective predictor for determining the outcome of T-DM1 treatment in breast cancer patients.	[Chung, Yuan-Chiang; Wei, Wan-Chen; Chang, King-Jen] Cheng Ching Gen Hosp, Chungkang Branch, Dept Surg, Taichung, Taiwan; [Kuo, Jang-Fang] Cheng Ching Gen Hosp, Chungkang Branch, Dept Pathol, Taichung, Taiwan; [Wei, Wan-Chen; Chao, Wei-Ting] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan	Tunghai University	Chao, WT (corresponding author), Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan.	wtchao@thu.edu.tw	Tan, Ming/ABD-5847-2021	Tan, Ming/0000-0003-2007-9898; Chang, King jen/0000-0001-9811-3422	Cheng-Ching hospital [CH10100152]	Cheng-Ching hospital	This work was supported by a grant from Cheng-Ching hospital (CH10100152) to WTC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin CD, 2004, MOL BIOL CELL, V15, P5268, DOI 10.1091/mbc.E04-07-0591; Barok M, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3621; Barok M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2868; Ben-Kasus T, 2009, P NATL ACAD SCI USA, V106, P3294, DOI 10.1073/pnas.0812059106; Bouras T, 2004, CANCER BIOL THER, V3, P931, DOI 10.4161/cbt.3.10.1147; Chia S, 2006, J CLIN ONCOL, V24, P2773, DOI 10.1200/JCO.2005.03.8331; Chiu WT, 2011, CANCER RES, V71, P4932, DOI 10.1158/0008-5472.CAN-10-4249; Chung YC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-587; Elzagheid A, 2006, WORLD J GASTROENTERO, V12, P4304, DOI 10.3748/wjg.v12.i27.4304; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Gornstein E, 2014, NEUROPHARMACOLOGY, V76, P175, DOI 10.1016/j.neuropharm.2013.08.016; HAYASHI T, 1988, J PHARMACOBIO-DYNAM, V11, P146, DOI 10.1248/bpb1978.11.146; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hurvitz SA, 2013, J CLIN ONCOL, V31, P1157, DOI 10.1200/JCO.2012.44.9694; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; KOLESKE AJ, 1995, P NATL ACAD SCI USA, V92, P1381, DOI 10.1073/pnas.92.5.1381; Kovtun YV, 2007, CANCER LETT, V255, P232, DOI 10.1016/j.canlet.2007.04.010; Krop IE, 2014, LANCET ONCOL, V15, P689, DOI 10.1016/S1470-2045(14)70178-0; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; LoRusso PM, 2011, CLIN CANCER RES, V17, P6437, DOI 10.1158/1078-0432.CCR-11-0762; Ma XL, 2013, BREAST, V22, P462, DOI 10.1016/j.breast.2013.03.005; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Menard S, 2003, ONCOGENE, V22, P6570, DOI 10.1038/sj.onc.1206779; Mercier I, 2012, ADV EXP MED BIOL, V729, P83, DOI 10.1007/978-1-4614-1222-9_6; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Muthuswamy SK, 2011, NAT MED, V17, P416, DOI 10.1038/nm0411-416; Panowski S, 2014, MABS-AUSTIN, V6, P34, DOI 10.4161/mabs.27022; Parachoniak CA, 2012, TRENDS CELL BIOL, V22, P231, DOI 10.1016/j.tcb.2012.02.002; Park SS, 2005, HISTOPATHOLOGY, V47, P625, DOI 10.1111/j.1365-2559.2005.02303.x; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Rao X, 2013, ONCOGENE, V32, P4519, DOI 10.1038/onc.2012.474; Ritchie M, 2013, MABS-AUSTIN, V5, P13, DOI 10.4161/mabs.22854; Robert N, 2006, J CLIN ONCOL, V24, P2786, DOI 10.1200/JCO.2005.04.1764; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Rubin I, 2001, ANN ONCOL, V12, P3, DOI 10.1023/A:1011195320446; Savage K, 2007, CLIN CANCER RES, V13, P90, DOI 10.1158/1078-0432.CCR-06-1371; Seidman A, 2002, J CLIN ONCOL, V20, P1215, DOI 10.1200/JCO.20.5.1215; Sekhar SC, 2013, J CANCER, V4, P391, DOI 10.7150/jca.6470; Shaughnessy R, 2014, FEBS J, V281, P2172, DOI 10.1111/febs.12770; Shvets E, 2014, CURR OPIN CELL BIOL, V29, P99, DOI 10.1016/j.ceb.2014.04.011; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sloan EK, 2004, ONCOGENE, V23, P7893, DOI 10.1038/sj.onc.1208062; Sloan EK, 2009, AM J PATHOL, V174, P2035, DOI 10.2353/ajpath.2009.080924; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Tian JJ, 2012, HEAD NECK ONCOL, V4, DOI 10.1186/1758-3284-4-7; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Wang Z., 2012, MUTUAL REGULATION RE; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	55	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133072	10.1371/journal.pone.0133072	http://dx.doi.org/10.1371/journal.pone.0133072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172389	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900120
J	Jackson, JL; Cogbill, E; Santana-Davila, R; Eldredge, C; Collier, W; Gradall, A; Sehgal, N; Kuester, J				Jackson, Jeffrey L.; Cogbill, Elizabeth; Santana-Davila, Rafael; Eldredge, Christina; Collier, William; Gradall, Andrew; Sehgal, Neha; Kuester, Jessica			A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache	PLOS ONE			English	Article							LOW-DOSE TOPIRAMATE; DOUBLE-BLIND TRIAL; QUALITY-OF-LIFE; SEROTONIN REUPTAKE INHIBITORS; RANDOMIZED CONTROLLED-TRIAL; RECEPTOR BLOCKING-AGENT; SODIUM VALPROATE; PREVENTIVE TREATMENT; EPISODIC MIGRAINE; COMMON MIGRAINE	Objective To compare the effectiveness and side effects of migraine prophylactic medications. Design We performed a network meta-analysis. Data were extracted independently in duplicate and quality was assessed using both the JADAD and Cochrane Risk of Bias instruments. Data were pooled and network meta-analysis performed using random effects models. Data Sources PUBMED, EMBASE, Cochrane Trial Registry, bibliography of retrieved articles through 18 May 2014. Eligibility Criteria for Selecting Studies We included randomized controlled trials of adults with migraine headaches of at least 4 weeks in duration. Results Placebo controlled trials included alpha blockers (n = 9), angiotensin converting enzyme inhibitors (n = 3), angiotensin receptor blockers (n = 3), anticonvulsants (n = 32), beta-blockers (n = 39), calcium channel blockers (n = 12), flunarizine (n = 7), serotonin reuptake inhibitors (n = 6), serotonin norepinephrine reuptake inhibitors (n = 1) serotonin agonists (n = 9) and tricyclic antidepressants (n = 11). In addition there were 53 trials comparing different drugs. Drugs with at least 3 trials that were more effective than placebo for episodic migraines included amitriptyline (SMD: -1.2, 95% CI: -1.7 to -0.82), -flunarizine (-1.1 headaches/month (ha/month), 95% CI: -1.6 to -0.67), fluoxetine (SMD: -0.57, 95% CI: -0.97 to -0.17), metoprolol (-0.94 ha/month, 95% CI: -1.4 to -0.46), pizotifen (-0.43 ha/month, 95% CI: -0.6 to -0.21), propranolol (-1.3 ha/month, 95% CI: -2.0 to -0.62), topiramate (-1.1 ha/month, 95% CI: -1.9 to -0.73) and valproate (-1.5 ha/month, 95% CI: -2.1 to -0.8). Several effective drugs with less than 3 trials included: 3 ace inhibitors (enalapril, lisinopril, captopril), two angiotensin receptor blockers (candesartan, telmisartan), two anticonvulsants (lamotrigine, levetiracetam), and several beta-blockers (atenolol, bisoprolol, timolol). Network meta-analysis found amitriptyline to be better than several other medications including candesartan, fluoxetine, propranolol, topiramate and valproate and no different than atenolol, flunarizine, clomipramine or metoprolol. Conclusion Several drugs good evidence supporting efficacy. There is weak evidence supporting amitriptyline's superiority over some drugs. Selection of prophylactic medication should be tailored according to patient preferences, characteristics and side effect profiles.	[Jackson, Jeffrey L.; Kuester, Jessica] Zablocki VA Med Ctr, Gen Internal Med, Milwaukee, WI 53295 USA; [Cogbill, Elizabeth] Western Michigan Sch Med, Dept Med, Kalamazoo, MI USA; [Santana-Davila, Rafael] Univ Washington, Div Hematol & Oncol, Seattle, WA 98195 USA; [Eldredge, Christina] Med Coll Wisconsin, Dept Family & Community Med, Milwaukee, WI 53226 USA; [Collier, William] Med Coll Wisconsin, Dept Pharmacol, Milwaukee, WI 53226 USA; [Gradall, Andrew] Gollis Univ, Sch Hlth Sci, Hergaisa, Somalia; [Sehgal, Neha] Med Coll Wisconsin, Milwaukee, WI 53226 USA	University of Washington; University of Washington Seattle; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Jackson, JL (corresponding author), Zablocki VA Med Ctr, Gen Internal Med, Milwaukee, WI 53295 USA.	jjackson@mcw.edu	Jackson, Jeffrey/AAA-3519-2019	Jackson, Jeffrey/0000-0002-9820-5834				Adam E I, 1978, J R Coll Gen Pract, V28, P587; Adams AM, 2015, CEPHALALGIA, V35, P563, DOI 10.1177/0333102414552532; Ades AE, 2010, VALUE HEALTH, V13, P976, DOI 10.1111/j.1524-4733.2010.00784.x; ADLY C, 1992, HEADACHE, V32, P101, DOI 10.1111/j.1526-4610.1992.hed3202101.x; Afshari D, 2012, INT J NEUROSCI, V122, P60, DOI 10.3109/00207454.2011.626908; AHUJA GK, 1985, INDIAN J MED RES, V82, P263; ALBERS GW, 1989, HEADACHE, V29, P215, DOI 10.1111/j.1526-4610.1989.hed22904215.x; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; ALQASSAB HK, 1993, CEPHALALGIA, V13, P128, DOI 10.1046/j.1468-2982.1993.1302128.x; Amelin AV, 2000, ZH NEVROPATOL PSIKH, V100, P20; ANDERSSON PG, 1973, HEADACHE, V13, P68, DOI 10.1111/j.1526-4610.1973.hed1302068.x; ANDERSSON PG, 1981, ACTA NEUROL SCAND, V64, P280; ANDERSSON PG, 1983, CEPHALALGIA, V3, P207, DOI 10.1046/j.1468-2982.1983.0304207.x; [Anonymous], 1962, JAMA-J AM MED ASSOC, V179, P717; [Anonymous], 1989, Headache, V29, P639; ANSELL E, 1988, CEPHALALGIA, V8, P269, DOI 10.1046/j.1468-2982.1988.0804269.x; ARTHUR G P, 1971, New Zealand Medical Journal, V73, P5; Ashtari F, 2008, ACTA NEUROL SCAND, V118, P301, DOI 10.1111/j.1600-0404.2008.01087.x; BANK J, 1994, HEADACHE, V34, P476, DOI 10.1111/j.1526-4610.1994.hed3408476.x; Bartolini M, 2005, CLIN NEUROPHARMACOL, V28, P277, DOI 10.1097/01.wnf.0000192136.46145.44; BEHAN PO, 1986, HEADACHE, V26, P237, DOI 10.1111/j.1526-4610.1986.hed2605237.x; BELLAVANCE AJ, 1990, HEADACHE, V30, P710, DOI 10.1111/j.1526-4610.1990.hed3011710.x; Beran RG, 2011, CEPHALALGIA, V31, P530, DOI 10.1177/0333102410384886; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Blumenfeld AM, 2011, CEPHALALGIA, V31, P301, DOI 10.1177/0333102410381145; BOISEN E, 1978, ACTA NEUROL SCAND, V58, P288; Bonuso S, 1998, NEUROLOGY, V51, P1475, DOI 10.1212/WNL.51.5.1475; Bordini CA, 1997, ARQ NEURO-PSIQUIAT, V55, P536, DOI 10.1590/S0004-282X1997000400003; BORGESEN SE, 1974, ACTA NEUROL SCAND, V50, P651; Bostani A, 2013, INT J NEUROSCI, V123, P487, DOI 10.3109/00207454.2013.765419; Brandes JL, 2004, JAMA-J AM MED ASSOC, V291, P965, DOI 10.1001/jama.291.8.965; BREDFELDT RC, 1989, J FAM PRACTICE, V29, P153; BRIGGS RS, 1979, HEADACHE, V19, P379, DOI 10.1111/j.1526-4610.1979.hed1907379.x; BRUCKE T, 1995, J CEREBR BLOOD F MET, V15, P513; Bulut S, 2004, CLIN NEUROL NEUROSUR, V107, P44, DOI 10.1016/j.clineuro.2004.03.004; Cady RK, 2012, HEADACHE, V52, P749, DOI 10.1111/j.1526-4610.2011.02054.x; Cady RK, 2009, HEADACHE, V49, P216, DOI 10.1111/j.1526-4610.2008.01326.x; Carroll J D, 1975, Curr Med Res Opin, V3, P68, DOI 10.1185/03007997509113649; CERBO R, 1986, CEPHALALGIA, V6, P15, DOI 10.1046/j.1468-2982.1986.0601015.x; Chronicle E, 2004, ANTICONVULSANT DRUGS; Chronicle E, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003226.PUB2; Cleland PG, 1997, EUR NEUROL, V38, P31, DOI 10.1159/000112899; Couch JR, 2011, HEADACHE, V51, P33, DOI 10.1111/j.1526-4610.2010.01800.x; COUCH JR, 1979, ARCH NEUROL-CHICAGO, V36, P695, DOI 10.1001/archneur.1979.00500470065013; COUCH JR, 1976, NEUROLOGY, V26, P121, DOI 10.1212/WNL.26.2.121; d'Amato C C, 1999, Headache, V39, P716, DOI 10.1046/j.1526-4610.1999.3910716.x; DAHLOF C, 1987, CEPHALALGIA, V7, P459; de Tommaso M, 2007, CLIN NEUROPHYSIOL, V118, P2297, DOI 10.1016/j.clinph.2007.06.060; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Trapani G, 2000, Clin Ter, V151, P145; Diamond S, 1992, HEADACHE Q-CURR TREA, V4, P169; Diener HC, 2009, CEPHALALGIA, V29, P921, DOI 10.1111/j.1468-2982.2008.01825.x; Diener HC, 2007, CEPHALALGIA, V27, P814, DOI 10.1111/j.1468-2982.2007.01326.x; Diener HC, 2004, J NEUROL, V251, P943, DOI 10.1007/s00415-004-0464-6; Diener HC, 2002, CEPHALALGIA, V22, P209, DOI 10.1046/j.1468-2982.2002.t01-1-00309.x; Diener HC, 1996, CEPHALALGIA, V16, P441, DOI 10.1046/j.1468-2982.1996.1606441.x; Dodick DW, 2009, CLIN THER, V31, P542, DOI 10.1016/j.clinthera.2009.03.020; Domingues RB, 2009, ARQ NEURO-PSIQUIAT, V67, P973, DOI 10.1590/S0004-282X2009000600002; Edwards KR, 2003, CNS SPECTRUMS, V8, P428, DOI 10.1017/S1092852900018733; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EKBOM K, 1972, HEADACHE, V12, P15, DOI 10.1111/j.1526-4610.1972.hed1201015.x; EKBOM K, 1977, ACTA NEUROL SCAND, V56, P181; EKBOM K, 1975, HEADACHE, V15, P129, DOI 10.1111/j.1526-4610.1975.hed1502129.x; El-Chammas K, 2013, JAMA PEDIATR, V167, P250, DOI 10.1001/jamapediatrics.2013.508; Falavigna A, 2010, ARQ NEURO-PSIQUIAT, V68, P873, DOI 10.1590/S0004-282X2010000600008; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; FORMISANO R, 1991, EUR J CLIN PHARMACOL, V41, P69, DOI 10.1007/BF00280110; FORSSMAN B, 1976, HEADACHE, V16, P238, DOI 10.1111/j.1526-4610.1976.hed1605238.x; FORSSMAN B, 1972, ACTA NEUROL SCAND, V48, P204, DOI 10.1111/j.1600-0404.1972.tb07541.x; FORSSMAN B, 1983, HEADACHE, V23, P188, DOI 10.1111/j.1526-4610.1983.hed2304188.x; Freitag FG, 2002, NEUROLOGY, V58, P1652, DOI 10.1212/WNL.58.11.1652; FREITAG FG, 1984, J AM OSTEOPATH ASSOC, V84, P343; Freitag FG, 2007, CLIN THER, V29, P939, DOI 10.1016/j.clinthera.2007.05.008; Frenken CW, 1984, CLIN NEUROL NEUROSUR, V86, P17; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; GAWEL MJ, 1992, CAN J NEUROL SCI, V19, P340, DOI 10.1017/S0317167100041962; GELMERS HJ, 1983, HEADACHE, V23, P106; GELMERS HJ, 1989, HEADACHE, V29, P633; GERBER WD, 1991, CEPHALALGIA, V11, P37, DOI 10.1046/j.1468-2982.1991.1101037.x; Ghose K, 1998, METHOD FIND EXP CLIN, V20, P353, DOI 10.1358/mf.1998.20.4.485692; Goldberg LD, 2005, AM J MANAG CARE, V11, pS62; GOMERSALL JD, 1973, J NEUROL NEUROSUR PS, V36, P684, DOI 10.1136/jnnp.36.4.684; Gotzsche PC, 2007, JAMA-J AM MED ASSOC, V298, P430, DOI 10.1001/jama.298.4.430; Gupta P, 2007, HEADACHE, V47, P402, DOI 10.1111/j.1526-4610.2006.00599.x; Gupta VK, 2006, INT J CLIN PRACT, V60, P367, DOI 10.1111/j.1368-5031.2006.0796a.x; HAVANKAKANNIAINEN H, 1985, CEPHALALGIA, V5, P39, DOI 10.1046/j.1468-2982.1985.0501039.x; HERING R, 1992, CEPHALALGIA, V12, P81, DOI 10.1046/j.1468-2982.1992.1202081.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOLMES D, 1992, J CARDIOVASC PHARM, V19, pS61; Holroyd KA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4871; Hu XH, 1999, ARCH INTERN MED, V159, P813, DOI 10.1001/archinte.159.8.813; HUBBE P, 1973, ACTA NEUROL SCAND, V49, P108; HUGHES RC, 1971, CURR THER RES CLIN E, V13, P63; Jackson JL, 2012, JAMA-J AM MED ASSOC, V307, P1736, DOI 10.1001/jama.2012.505; Jackson JL, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5222; JACOBS H, 1972, J NEUROL NEUROSUR PS, V35, P500, DOI 10.1136/jnnp.35.4.500; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JENSEN R, 1994, NEUROLOGY, V44, P647, DOI 10.1212/WNL.44.4.647; JOHANNSSON V, 1987, HEADACHE, V27, P372, DOI 10.1111/j.1526-4610.1987.hed2707372.x; JOHNSON RH, 1986, ACTA NEUROL SCAND, V73, P490, DOI 10.1111/j.1600-0404.1986.tb04591.x; Kalita J, 2013, ACTA NEUROL SCAND, V128, P65, DOI 10.1111/ane.12081; KANGASNIEMI P, 1979, HEADACHE, V19, P219, DOI 10.1111/j.1526-4610.1979.hed1904219.x; KANGASNIEMI P, 1984, CEPHALALGIA, V4, P91, DOI 10.1046/j.1468-2982.1984.0402091.x; KANGASNIEMI PJ, 1983, ACTA NEUROL SCAND, V68, P262, DOI 10.1111/j.1600-0404.1983.tb04836.x; Kaniecki RG, 1997, ARCH NEUROL-CHICAGO, V54, P1141, DOI 10.1001/archneur.1997.00550210071015; Karli Necdet, 2006, J Headache Pain, V7, P75, DOI 10.1007/s10194-006-0273-7; KASS B, 1980, ACTA NEUROL SCAND, V61, P351; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Keskinbora K, 2008, CLIN NEUROL NEUROSUR, V110, P979, DOI 10.1016/j.clineuro.2008.05.025; Klapper J, 1997, CEPHALALGIA, V17, P103, DOI 10.1046/j.1468-2982.1997.1702103.x; Krymchantowski AV, 2012, J HEADACHE PAIN, V13, P53, DOI 10.1007/s10194-011-0395-4; Krymchantowski AV, 2002, HEADACHE, V42, P510, DOI 10.1046/j.1526-4610.2002.02125.x; Lance J W, 1968, Med J Aust, V1, P54; Landy S, 1999, HEADACHE, V39, P28, DOI 10.1046/j.1526-4610.1999.3901028.x; LANGOHR HD, 1985, HEADACHE, V25, P107, DOI 10.1111/j.1526-4610.1985.hed2502107.x; Law S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008042.pub2; LAWRENCE ER, 1977, HEADACHE, V17, P109, DOI 10.1111/j.1526-4610.1977.hed1703109.x; LEANDRI M, 1990, CEPHALALGIA, V10, P111, DOI 10.1046/j.1468-2982.1990.1003111.x; Leonardi M, 2010, HEADACHE, V50, P1576, DOI 10.1111/j.1526-4610.2010.01770.x; Linde K, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003225.PUB2; Linde K, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003225.PUB2; Lipton RB, 2003, CEPHALALGIA, V23, P441, DOI 10.1046/j.1468-2982.2003.00546.x; Lipton RB, 2003, CEPHALALGIA, V23, P429, DOI 10.1046/j.1468-2982.2003.00543.x; Lipton RB, 2011, CEPHALALGIA, V31, P18, DOI 10.1177/0333102410372427; LOUIS P, 1985, CEPHALALGIA, V5, P159, DOI 10.1046/j.1468-2982.1985.0503159.x; LOUIS P, 1981, HEADACHE, V21, P235, DOI 10.1111/j.1526-4610.1981.hed2106235.x; LOUIS P, 1982, CEPHALALGIA, V2, P197, DOI 10.1046/j.1468-2982.1982.0204197.x; LUCKING CH, 1988, CEPHALALGIA, V8, P21, DOI 10.1177/03331024880080S805; LUDIN HP, 1989, HEADACHE, V29, P219, DOI 10.1111/j.1526-4610.1989.hed22904219.x; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Luo N, 2012, PAIN MED, V13, P80, DOI 10.1111/j.1526-4637.2011.01295.x; Lynggaard F, 1975, Ugeskr Laeger, V137, P149; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MALVEA BP, 1973, HEADACHE, V12, P163, DOI 10.1111/j.1526-4610.1973.hed1204163.x; Mansoureh T, 2008, J HEADACHE PAIN, V9, P77, DOI 10.1007/s10194-008-0013-2; MARKLEY HG, 1984, NEUROLOGY, V34, P973, DOI 10.1212/WNL.34.7.973; MATHEW NT, 1981, HEADACHE, V21, P105, DOI 10.1111/j.1526-4610.1981.hed2103105.x; MATHEW NT, 1995, ARCH NEUROL-CHICAGO, V52, P281, DOI 10.1001/archneur.1995.00540270077022; Mathew NT, 2001, HEADACHE, V41, pS18; MCARTHUR JC, 1989, NEUROLOGY, V39, P284, DOI 10.1212/WNL.39.2.284; McCrory D, 2012, REPORT GABAPENTIN NE; McCrory DC, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002915, DOI 10.1002/14651858.CD002915]; Mei D, 2006, CLIN NEUROPHARMACOL, V29, P269, DOI 10.1097/01.WNF.000022888.49044.99; MENDENOPOULOS G, 1985, CEPHALALGIA, V5, P31, DOI 10.1046/j.1468-2982.1985.0501031.x; MIKKELSEN B, 1986, ACTA NEUROL SCAND, V73, P423, DOI 10.1111/j.1600-0404.1986.tb03299.x; Mitsikostas DD, 1997, FUNCT NEUROL, V12, P267; Mohammadianinejad SE, 2011, CLIN NEUROPHARMACOL, V34, P174, DOI 10.1097/WNF.0b013e318225140c; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moja PL, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002919.pub2; MONDRUP K, 1977, ACTA NEUROL SCAND, V56, P405; MORLAND TJ, 1979, HEADACHE, V19, P382, DOI 10.1111/j.1526-4610.1979.hed1907382.x; Mulleners WM, 2015, CEPHALALGIA, V35, P51, DOI 10.1177/0333102414534325; NADELMANN JW, 1986, HEADACHE, V26, P175, DOI 10.1111/j.1526-4610.1986.hed2604175.x; NANDA RN, 1978, HEADACHE, V18, P20, DOI 10.1111/j.1526-4610.1978.hed1801020.x; NOONE JF, 1980, J INT MED RES, V8, P49; OLERUD B, 1986, HEADACHE, V26, P490, DOI 10.1111/j.1526-4610.1986.hed2610490.x; OLSSON JE, 1984, ACTA NEUROL SCAND, V70, P160; OSTERMAN PO, 1977, ACTA NEUROL SCAND, V56, P17; Ozyalcin SN, 2005, HEADACHE, V45, P144, DOI 10.1111/j.1526-4610.2005.05029.x; PALFERMAN TG, 1983, BRIT J CLIN PRACT, V37, P28; Paterna S, 1992, Clin Ter, V141, P475; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; PINI LA, 1986, INT J CLIN PHARM RES, V6, P27; PITA E, 1977, Archivos de Farmacologia y Toxicologia, V3, P273; PRADALIER A, 1989, CEPHALALGIA, V9, P247, DOI 10.1046/j.1468-2982.1989.0904247.x; PRESTHUS J, 1971, ACTA NEUROL SCAND, V47, P514, DOI 10.1111/j.1600-0404.1971.tb07504.x; Pringsheim T, 2010, CAN MED ASSOC J, V182, pE269, DOI 10.1503/cmaj.081657; Radtke A, 2009, HEADACHE, V49, P79, DOI 10.1111/j.1526-4610.2008.01263.x; Raggi A, 2011, NEUROL SCI, V32, P387, DOI 10.1007/s10072-010-0466-3; Rampello L, 2004, NEUROPSYCHOBIOLOGY, V50, P322, DOI 10.1159/000080960; Rapaport AM, 1994, NEUROLOGY, V44, pS25; RASCOL A, 1986, HEADACHE, V26, P83, DOI 10.1111/j.1526-4610.1986.hed2602083.x; Rasmussen BK, 2001, CEPHALALGIA, V21, P774, DOI 10.1046/j.1468-2982.2001.00248.x; ROMPEL H, 1970, South African Medical Journal, V44, P75; Ryan R E, 1968, Headache, V8, P118, DOI 10.1111/j.1526-4610.1968.hed0803118.x; RYAN RE, 1975, HEADACHE, V15, P202, DOI 10.1111/j.1526-4610.1975.hed1503202.x; RYAN RE, 1984, AM HEART J, V108, P1156, DOI 10.1016/0002-8703(84)90600-8; RYAN RE, 1971, HEADACHE, V11, P6, DOI 10.1111/j.1526-4610.1971.hed110106.x; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Saper JR, 2002, HEADACHE, V42, P470, DOI 10.1046/j.1526-4610.2002.02122.x; SAPER JR, 1994, HEADACHE, V34, P497, DOI 10.1111/j.1526-4610.1994.hed3409497.x; Sarchielli P, 2014, EUR NEUROPSYCHOPHARM, V24, P1289, DOI 10.1016/j.euroneuro.2014.03.010; SARGENT J, 1985, HEADACHE, V25, P320; Scholz E, 1987, DIHYDROERGOTAMINE VS, P139; Schrader H, 2001, BMJ-BRIT MED J, V322, P19, DOI 10.1136/bmj.322.7277.19; SHAFAR J, 1972, LANCET, V1, P403; Shamliyan TA, 2013, J GEN INTERN MED, V28, P1225, DOI 10.1007/s11606-013-2433-1; Sharp S, 1998, STATA TECH B, V7, DOI DOI 10.1002/SIM.1187/FULL); Shaygannejad V, 2006, HEADACHE, V46, P642, DOI 10.1111/j.1526-4610.2006.00413.x; SHIMELL CJ, 1990, S AFR MED J, V77, P75; Shukla R, 1995, J Assoc Physicians India, V43, P770; Silberstein S, 2008, NEUROLOGY, V70, P548, DOI 10.1212/01.wnl.0000297551.27191.70; Silberstein S, 2008, CEPHALALGIA, V28, P484, DOI 10.1111/j.1468-2982.2008.01555.x; Silberstein SD, 2012, NEUROLOGY, V78, P1337, DOI 10.1212/WNL.0b013e3182535d20; Silberstein SD, 2004, ARCH NEUROL-CHICAGO, V61, P490, DOI 10.1001/archneur.61.4.490; Silberstein S, 2013, CEPHALALGIA, V33, P101, DOI 10.1177/0333102412466968; Silberstein SD, 2007, HEADACHE, V47, P170, DOI 10.1111/j.1526-4610.2006.00684.x; Silberstein SD, 2006, CLIN THER, V28, P1002, DOI 10.1016/j.clinthera.2006.07.003; Silvestrini M, 2003, CEPHALALGIA, V23, P820, DOI 10.1046/j.1468-2982.2003.00592.x; SJAASTAD O, 1972, ACTA NEUROL SCAND, V48, P124, DOI 10.1111/j.1600-0404.1972.tb07532.x; SOLOMON GD, 1983, JAMA-J AM MED ASSOC, V250, P2500, DOI 10.1001/jama.250.18.2500; Sonbolestan SA, 2013, INT J PREVENTIVE MED, V4, P72; SORENSEN PS, 1991, HEADACHE, V31, P650, DOI 10.1111/j.1526-4610.1991.hed3110650.x; SORENSEN PS, 1986, CEPHALALGIA, V6, P7, DOI 10.1046/j.1468-2982.1986.0601007.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Spira PJ, 2003, NEUROLOGY, V61, P1753, DOI 10.1212/01.WNL.0000100121.58594.11; STANDNES B, 1982, CEPHALALGIA, V2, P165, DOI 10.1046/j.1468-2982.1982.0203165.x; Steiner TJ, 1997, CEPHALALGIA, V17, P109, DOI 10.1046/j.1468-2982.1997.1702109.x; Steiner TJ, 1998, CEPHALALGIA, V18, P283, DOI 10.1046/j.1468-2982.1998.1805283.x; STEINER TJ, 1988, HEADACHE, V28, P15, DOI 10.1111/j.1365-2524.1988.hed2801015.x; STELLAR S, 1984, JAMA-J AM MED ASSOC, V252, P2576; STENSRUD P, 1976, ACTA NEUROL SCAND, V53, P229, DOI 10.1111/j.1600-0404.1976.tb04342.x; STENSRUD P, 1976, ACTA NEUROL SCAND, V53, P233, DOI 10.1111/j.1600-0404.1976.tb04343.x; STENSRUD P, 1979, HEADACHE, V19, P333, DOI 10.1111/j.1526-4610.1979.hed1906333.x; STENSRUD P, 1980, HEADACHE, V20, P204, DOI 10.1111/j.1526-4610.1980.h2004006.x; STEWART DJ, 1988, HEADACHE, V28, P260, DOI 10.1111/j.1526-4610.1988.hed2804260.x; Storey JR, 2001, HEADACHE, V41, P968, DOI 10.1046/j.1526-4610.2001.01190.x; Stovner LJ, 2014, CEPHALALGIA, V34, P523, DOI 10.1177/0333102413515348; SUDILOVSKY A, 1987, HEADACHE, V27, P421, DOI 10.1111/j.1526-4610.1987.hed2708421.x; Tarasova SV, 2008, ZH NEVROL PSIKHIATR, V108, P43; Tepper SJ, 2008, HEADACHE, V48, P730, DOI 10.1111/j.1526-4610.2008.01117_1.x; TFELTHANSEN P, 1984, ACTA NEUROL SCAND, V69, P1, DOI 10.1111/j.1600-0404.1984.tb07772.x; THOMAS M, 1991, HEADACHE, V31, P613, DOI 10.1111/j.1526-4610.1991.hed3109613.x; Tomkins GE, 2001, AM J MED, V111, P54, DOI 10.1016/S0002-9343(01)00762-8; Tronvik E, 2003, JAMA-J AM MED ASSOC, V289, P65, DOI 10.1001/jama.289.1.65; Vahedi K, 2002, J NEUROL, V249, P206, DOI 10.1007/PL00007866; vandeVen LLM, 1997, CEPHALALGIA, V17, P596, DOI 10.1046/j.1468-2982.1997.1705596.x; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Verma A, 2013, CLIN NEUROPHARMACOL, V36, P193, DOI 10.1097/WNF.0000000000000005; VILMING S, 1985, CEPHALALGIA, V5, P17, DOI 10.1046/j.1468-2982.1985.0501017.x; Wang Shuu-Jiun, 2003, Curr Neurol Neurosci Rep, V3, P104, DOI 10.1007/s11910-003-0060-7; WEBER RB, 1972, NEUROLOGY, V22, P366, DOI 10.1212/WNL.22.4.366; WIDEROE TE, 1974, BRIT MED J, V2, P699, DOI 10.1136/bmj.2.5921.699; Woods BS, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-54; Yurekli VA, 2008, J HEADACHE PAIN, V9, P37, DOI 10.1007/s10194-008-0002-5; Zain S, 2013, J PAK MED ASSOC, V63, P3; ZEEBERG I, 1981, ACTA NEUROL SCAND, V64, P452; ZIEGLER DK, 1987, ARCH NEUROL-CHICAGO, V44, P486, DOI 10.1001/archneur.1987.00520170016015	238	130	133	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0130733	10.1371/journal.pone.0130733	http://dx.doi.org/10.1371/journal.pone.0130733			60	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172390	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900008
J	Wu, Y; Feng, G; Song, JL; Zhang, YY; Yu, Y; Huang, L; Zheng, LL; Deng, F				Wu, Yan; Feng, Ge; Song, Jinlin; Zhang, Yuanyuan; Yu, Yong; Huang, Lan; Zheng, Leilei; Deng, Feng			TrAmplification of Human Dental Follicle Cells by piggyBac Transposon - Mediated Reversible Immortalization System	PLOS ONE			English	Article							HEPATIC PROGENITOR CELLS; OSTEOGENIC DIFFERENTIATION; MAMMALIAN-CELLS; T-ANTIGEN; STEM-CELLS; GENOME; SV40; REGENERATION; REPLICATION; THERAPY	Dental follicle cells (DFCs) are the precursor cells of periodontium. Under certain differentiation conditions, DFCs can be induced to differentiate into chondrogenic, osteogenic and adipogenic cells. However, DFCs has limited lifespan in vitro, so it's difficult to harvest enough cells for basic research and translational application. pMPH86 is a piggyBac transposon-mediated vector which contains SV40 T-Ag cassette that can be removed by flippase recognition target (FRT) recombinase. Here we demonstrated the pMPH86 can effectively amplify human DFCs through reversible immortalization. The immortalized DFCs (iDFCs) exhibit higher proliferate activity, which can be reversed to its original level before immortalization when deimmortalized by FLP recombinase. The iDFCs and deimmortalized DFCs (dDFCs) express most DFC markers and maintain multiple differentiation potential in vitro as they can be induced by BMP9 to differentiate into chondrogenic, osteogenic and adipogenic cells evidenced by gene expression and protein marker. We also proved telomerase activity of iDFCs are significantly increased and maintained at a high level, while the telomerase activity of primary DFCs was relatively low and decreased with every passage. After SV40 T-Ag was removed to deimmortalize the cells, telomerase activity was reduced to its original level before immortalization and decreased with passages just the same as primary DFCs. These results suggest that piggyBac immortalization system could be a potential strategy to amplify primary cells, which is critical for regenerative research and further clinical application.	[Wu, Yan; Feng, Ge; Song, Jinlin; Yu, Yong; Huang, Lan; Zheng, Leilei; Deng, Feng] Chongqing Med Univ, Dept Orthodont, Stomatol Hosp, Chongqing, Peoples R China; [Wu, Yan; Feng, Ge; Song, Jinlin; Yu, Yong; Huang, Lan; Zheng, Leilei; Deng, Feng] Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China; [Wu, Yan; Feng, Ge; Song, Jinlin; Yu, Yong; Huang, Lan; Zheng, Leilei; Deng, Feng] Chongqing Municipal Key Lab Oral Biomed Engn High, Chongqing, Peoples R China; [Zhang, Yuanyuan] Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC USA	Chongqing Medical University; Wake Forest University; Wake Forest University School of Medicine	Deng, F (corresponding author), Chongqing Med Univ, Dept Orthodont, Stomatol Hosp, Chongqing, Peoples R China.	deng63@263.com	zhang, yuanyuan/GYA-4428-2022	Huang, Lan/0000-0001-9594-4722	Natural Science Foundation of China [81271183, 81300914, 81470772]; Program for Innovation Team Building at Institutions of Higher Education in Chongqing; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovation Team Building at Institutions of Higher Education in Chongqing; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education	This project was supported by a research grant from the Natural Science Foundation of China (no. 81271183 to FD who designed the study), a research grant from the Natural Science Foundation of China (no. 81300914 to LH who help to prepare the manucript), a research grant from the Natural Science Foundation of China (no. 81470772 to LLZ who helped to write the manuscript), The Program for Innovation Team Building at Institutions of Higher Education in Chongqing, and Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education.	AARONSON SA, 1968, J CELL PHYSIOL, V72, P141, DOI 10.1002/jcp.1040720208; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; Bosshardt DD, 1996, ANAT RECORD, V245, P267; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Di Matteo Mario, 2012, Methods Mol Biol, V859, P241, DOI 10.1007/978-1-61779-603-6_14; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; FRASER MJ, 1983, J VIROL, V47, P287, DOI 10.1128/JVI.47.2.287-300.1983; Galvan DL, 2009, J IMMUNOTHER, V32, P837, DOI 10.1097/CJI.0b013e3181b2914c; Guo LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062332; Guo SJ, 2013, CELL TRANSPLANT, V22, P1061, DOI 10.3727/096368912X656036; He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499; Honda MJ, 2010, JPN DENT SCI REV, V46, P54, DOI 10.1016/j.jdsr.2009.10.006; Honda Masaki J, 2010, J Oral Sci, V52, P541, DOI 10.2334/josnusd.52.541; Honda MJ, 2011, ORAL SURG ORAL MED O, V111, P700, DOI 10.1016/j.tripleo.2010.08.004; Huang EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032428; Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x; Ivics Z, 2009, NAT METHODS, V6, P415, DOI [10.1038/NMETH.1332, 10.1038/nmeth.1332]; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kim A, 2011, MOL CELL BIOCHEM, V354, P301, DOI 10.1007/s11010-011-0832-3; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; Li M, 2013, INT J MED SCI, V10, P1035, DOI 10.7150/ijms.6639; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Meir YJJ, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-28; Meir Yaa-Jyuhn James, 2011, Chang Gung Med J, V34, P565; Morsczeck C, 2005, MATRIX BIOL, V24, P155, DOI 10.1016/j.matbio.2004.12.004; Morsczeck C, 2010, CLIN ORAL INVEST, V14, P433, DOI 10.1007/s00784-009-0310-4; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; PRIVES C, 1990, CELL, V61, P735, DOI 10.1016/0092-8674(90)90179-I; Rostovskaya M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks643; Saito M, 2005, J BONE MINER RES, V20, P50, DOI 10.1359/jbmr.041006; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Tsuchiya S, 2010, CONNECT TISSUE RES, V51, P197, DOI 10.3109/03008200903267542; Volponi AA, 2010, TRENDS CELL BIOL, V20, P715, DOI 10.1016/j.tcb.2010.09.012; vom Brocke J, 2006, CARCINOGENESIS, V27, P2141, DOI 10.1093/carcin/bg1101; Wang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097316; Wang XJ, 2014, J BIOMED MATER RES A, V102, P1017, DOI 10.1002/jbm.a.34764; Westerman KA, 1996, P NATL ACAD SCI USA, V93, P8971, DOI 10.1073/pnas.93.17.8971; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Wu JY, 2012, J ENDODONT, V38, P614, DOI 10.1016/j.joen.2012.01.014; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Yang B, 2012, BIOMATERIALS, V33, P2449, DOI 10.1016/j.biomaterials.2011.11.074; Yang K, 2012, J INVEST DERMATOL, V132, P2479, DOI 10.1038/jid.2012.145; Yao S, 2011, CELL PROLIFERAT, V44, P486, DOI 10.1111/j.1365-2184.2011.00778.x; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zhang WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011917; ZHU JY, 1991, J VIROL, V65, P6872, DOI 10.1128/JVI.65.12.6872-6880.1991	50	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0130937	10.1371/journal.pone.0130937	http://dx.doi.org/10.1371/journal.pone.0130937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172849	gold, Green Published, Green Submitted			2022-12-27	WOS:000358194900011
J	Zhao, JZ; Li, HJ; Zhou, RJ; Ma, G; Dekker, JD; Tucker, HO; Yao, ZJ; Guo, XZ				Zhao, Jianzhi; Li, Hanjun; Zhou, Rujiang; Ma, Gang; Dekker, Joseph D.; Tucker, Haley O.; Yao, Zhengju; Guo, Xizhi			Foxp1 Regulates the Proliferation of Hair Follicle Stem Cells in Response to Oxidative Stress during Hair Cycling	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SELF-RENEWAL; SKIN; MORPHOGENESIS; EXPRESSION; CANCER; NICHE; P53; ROS; PREVENTION	Hair follicle stem cells (HFSCs) in the bugle circularly generate outer root sheath (ORS) through linear proliferation within limited cycles during anagen phases. However, the mechanisms controlling the pace of HFSC proliferation remain unclear. Here we revealed that Foxp1, a transcriptional factor, was dynamically relocated from the nucleus to the cytoplasm of HFSCs in phase transitions from anagen to catagen, coupled with the rise of oxidative stress. Mass spectrum analyses revealed that the S468 phosphorylation of Foxp1 protein was responsive to oxidative stress and affected its nucleocytoplasmic translocation. Foxp1 deficiency in hair follicles led to compromised ROS accrual and increased HFSC proliferation. And more, NAC treatment profoundly elongated the anagen duration and HFSC proliferation in Foxp1-deficient background. Molecularly, Foxp1 augmented ROS levels through suppression of Trx1-mediated reductive function, thereafter imposing the cell cycle arrest by modulating the activity of p19/p53 pathway. Our findings identify a novel role for Foxp1 in controlling HFSC proliferation with cellular dynamic location in response to oxidative stress during hair cycling.	[Zhao, Jianzhi; Li, Hanjun; Zhou, Rujiang; Ma, Gang; Yao, Zhengju; Guo, Xizhi] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200240, Peoples R China; [Dekker, Joseph D.; Tucker, Haley O.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	Shanghai Jiao Tong University; University of Texas System; University of Texas Austin	Guo, XZ (corresponding author), Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200240, Peoples R China.	xzguo2005@sjtu.edu.cn	Dekker, Joseph D/G-4924-2013	Dekker, Joseph D/0000-0002-2068-3529; Guo, Xizhi/0000-0001-8047-6049; Li, Hanjun/0000-0002-7017-8782	973 program of China [2014CB942902, 2012CB966903]; NSFC [31171396, 31271553, 81421061, 31100624]; NIH [R01CA31534, CPRIT RP100612]; NATIONAL CANCER INSTITUTE [R01CA031534] Funding Source: NIH RePORTER	973 program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by grants from the 973 program of China (2014CB942902 and 2012CB966903), NSFC (31171396, 31271553, 81421061 and 31100624) (http://www.nsfc.gov.cn/) and NIH (R01CA31534, CPRIT RP100612).	Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Arck PC, 2006, FASEB J, V20, P1567, DOI 10.1096/fj.05-4039fje; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Duverger O, 2014, SEMIN CELL DEV BIOL, V25, P22, DOI 10.1016/j.semcdb.2013.12.006; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Feng J, 2012, AM J CLIN PATHOL, V138, P230, DOI 10.1309/AJCPDHQFNYJZ01YG; Feng XM, 2010, BLOOD, V115, P510, DOI 10.1182/blood-2009-07-232694; Folgueras AR, 2013, CELL STEM CELL, V13, P314, DOI 10.1016/j.stem.2013.06.018; Giatromanolaki A, 2006, MODERN PATHOL, V19, P9, DOI 10.1038/modpathol.3800494; Godic A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/860479; Guerriero G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00056; Hancock WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007890; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Hu CR, 2013, ACTA HISTOCHEM, V115, P137, DOI 10.1016/j.acthis.2012.06.001; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Ijichi N, 2013, VITAM HORM, V93, P203, DOI 10.1016/B978-0-12-416673-8.00006-X; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Jung K, 2008, SPECTROCHIM ACTA A, V69, P1423, DOI 10.1016/j.saa.2007.09.029; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Kimura-Ueki M, 2012, J INVEST DERMATOL, V132, P1338, DOI 10.1038/jid.2011.490; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Leishman E, 2013, DEVELOPMENT, V140, P3809, DOI 10.1242/dev.097477; Lewandowski D, 2010, BLOOD, V115, P443, DOI 10.1182/blood-2009-05-222711; Li YX, 2004, ONCOGENE, V23, P7355, DOI 10.1038/sj.onc.1207957; Lim X, 2013, COLD SPRING HARB PER, V5; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Moore L, 2003, ONCOGENE, V22, P7831, DOI 10.1038/sj.onc.1206985; Morimoto H, 2013, CELL STEM CELL, V12, P774, DOI 10.1016/j.stem.2013.04.001; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Seemann S, 2005, ONCOGENE, V24, P3853, DOI 10.1038/sj.onc.1208549; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Takayama K, 2008, BIOCHEM BIOPH RES CO, V374, P388, DOI 10.1016/j.bbrc.2008.07.056; Terada LS, 2006, J CELL BIOL, V174, P615, DOI 10.1083/jcb.200605036; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wlodarska I, 2005, LEUKEMIA, V19, P1299, DOI 10.1038/sj.leu.2403813; Woo WM, 2012, GENE DEV, V26, P1235, DOI 10.1101/gad.187401.112; Zhang YX, 2012, J CLIN PATHOL, V65, P528, DOI 10.1136/jclinpath-2011-200547; Zhang YZ, 2010, GENE DEV, V24, P1746, DOI 10.1101/gad.1929210; Zschauer TC, 2013, ANTIOXID REDOX SIGN, V18, P1053, DOI 10.1089/ars.2012.4822	54	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131674	10.1371/journal.pone.0131674	http://dx.doi.org/10.1371/journal.pone.0131674			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171970	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900020
J	Zoccola, E; Delamare-Deboutteville, J; Barnes, AC				Zoccola, Emmanuelle; Delamare-Deboutteville, Jerome; Barnes, Andrew C.			Identification of Barramundi (Lates calcarifer) DC-SCRIPT, a Specific Molecular Marker for Dendritic Cells in Fish	PLOS ONE			English	Article							STREPTOCOCCUS-INIAE; LIPOPOLYSACCHARIDE LPS; EXPRESSION; RESPONSES; CULTURES; EVOLUTION; SOFTWARE; RECEPTOR; TLR4; PCR	Antigen presentation is a critical step bridging innate immune recognition and specific immune memory. In mammals, the process is orchestrated by dendritic cells (DCs) in the lymphatic system, which initiate clonal proliferation of antigen-specific lymphocytes. However, fish lack a classical lymphatic system and there are currently no cellular markers for DCs in fish, thus antigen-presentation in fish is poorly understood. Recently, antigen-presenting cells similar in structure and function to mammalian DCs were identified in various fish, including rainbow trout (Oncorhynchus mykiss) and zebrafish (Danio rerio). The present study aimed to identify a potential molecular marker for DCs in fish and therefore targeted DC-SCRIPT, a well-conserved zinc finger protein that is preferentially expressed in all sub-types of human DCs. Putative dendritic cells were obtained in culture by maturation of spleen and pronephros-derived monocytes. DC-SCRIPT was identified in barramundi by homology using RACE PCR and genome walking. Specific expression of DC-SCRIPT was detected in barramundi cells by Stellaris mRNA FISH, in combination with MHCII expression when exposed to bacterial derived peptidoglycan, suggesting the presence of DCs in L. calcarifer. Moreover, morphological identification was achieved by light microscopy of cytospins prepared from these cultures. The cultured cells were morphologically similar to mammalian and trout DCs. Migration assays determined that these cells have the ability to move towards pathogens and pathogen associated molecular patterns, with a preference for peptidoglycans over lipopolysaccharides. The cells were also strongly phagocytic, engulfing bacteria and rapidly breaking them down. Barramundi DCs induced significant proliferation of responder populations of T-lymphocytes, supporting their role as antigen presenting cells. DC-SCRIPT expression in head kidney was higher 6 and 24 h following intraperitoneal challenge with peptidoglycan and lipopolysaccharide and declined after 3 days relative to PBS-injected controls. Relative expression was also lower in the spleen at 3 days post challenge but increased again at 7 days. As DC-SCRIPT is a constitutively expressed nuclear receptor, independent of immune activation, this may indicate initial migration of immature DCs from head kidney and spleen to the injection site, followed by return to the spleen for maturation and antigen presentation. DC-SCRIPT may be a valuable tool in the investigation of antigen presentation in fish and facilitate optimisation of vaccines and adjuvants for aquaculture.	[Barnes, Andrew C.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; Univ Queensland, Ctr Marine Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Barnes, AC (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia.	a.barnes@uq.edu.au	Zoccola, Emmanuelle/E-6898-2017; Zoccola, Emmanuelle/Y-8435-2019; Barnes, Andrew/J-9012-2014	Zoccola, Emmanuelle/0000-0002-5984-1774; Zoccola, Emmanuelle/0000-0002-5984-1774; Barnes, Andrew/0000-0002-3990-8070; Delamare Deboutteville, Jerome/0000-0003-4169-2456				Agnew W, 2007, VET MICROBIOL, V122, P1, DOI 10.1016/j.vetmic.2007.03.002; Arthur R, 2007, FAO FISHERIES P, V9, P271; Aviles F, 2013, VET MICROBIOL, V162, P151, DOI 10.1016/j.vetmic.2012.08.018; Bachrach G, 2001, APPL ENVIRON MICROB, V67, P3756, DOI 10.1128/AEM.67.8.3756-3758.2001; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barnes AC, 2003, DIS AQUAT ORGAN, V53, P241, DOI 10.3354/dao053241; Bassity E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033196; Bone Q., 2008, BIOL FISHES, DOI [10.1201/9781134186310, DOI 10.1201/9781134186310]; Broere F, 2011, PRINCIPLES IMMUNOPHA, P15, DOI [DOI 10.1007/978-3-0346-0136-8_2, 10.1007/978-3-0346-0136-8_2]; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Chettri JK, 2011, DEV COMP IMMUNOL, V35, P476, DOI 10.1016/j.dci.2010.12.001; Clark GJ, 2000, MICROBES INFECT, V2, P257, DOI 10.1016/S1286-4579(00)00302-6; De Santis C, 2011, MAR BIOTECHNOL, V13, P170, DOI 10.1007/s10126-010-9277-z; Dos Santos NMS, 2001, FISH SHELLFISH IMMUN, V11, P317, DOI 10.1006/fsim.2000.0320; Dowling D, 2008, CYTOKINE, V41, P254, DOI 10.1016/j.cyto.2007.11.020; Eyngor M, 2008, APPL ENVIRON MICROB, V74, P6892, DOI 10.1128/AEM.00853-08; Fierro-Castro C, 2012, FISH SHELLFISH IMMUN, V33, P389, DOI 10.1016/j.fsi.2012.05.019; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Ganassin RC, 1996, FISH SHELLFISH IMMUN, V6, P17, DOI 10.1006/fsim.1996.0003; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hontelez S, 2013, J IMMUNOL, V190, P3172, DOI 10.4049/jimmunol.1201776; Hontelez S, 2012, J IMMUNOL, V189, P138, DOI 10.4049/jimmunol.1103709; Jondal M, 1996, IMMUNITY, V5, P295, DOI 10.1016/S1074-7613(00)80255-1; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; KERMAN R, 1976, IMMUNOL COMMUN, V5, P685, DOI 10.3109/08820137609033876; Klein Jan, 1997, P271, DOI 10.1016/B978-012417540-2/50017-8; Lackie J.M., 2013, DICT CELL MOL BIOL; Levraud JP, 2009, M S-MED SCI, V25, P405, DOI 10.1051/medsci/2009254405; Lovy J, 2009, FISH SHELLFISH IMMUN, V27, P365, DOI 10.1016/j.fsi.2009.01.006; LU L, 1995, IMMUNOLOGY, V84, P127; Lugo-Villarino G, 2010, P NATL ACAD SCI USA, V107, P15850, DOI 10.1073/pnas.1000494107; MADSEN M, 1980, J IMMUNOL METHODS, V33, P323, DOI 10.1016/0022-1759(80)90003-4; Mak TW, 2006, IMMUNE RESPONSE: BASIC AND CLINICAL PRINCIPLES, P1; Millard CM, 2012, APPL ENVIRON MICROB, V78, P8219, DOI 10.1128/AEM.02216-12; Nafarnda WD, 2011, J ADV SCI RES; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Pettersen EF, 2008, FISH SHELLFISH IMMUN, V25, P809, DOI 10.1016/j.fsi.2008.08.014; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Sepulcre MP, 2007, MOL IMMUNOL, V44, P2009, DOI 10.1016/j.molimm.2006.09.022; Sepulcre MP, 2009, J IMMUNOL, V182, P1836, DOI 10.4049/jimmunol.0801755; STEINMAN RM, 1979, J EXP MED, V149, P1, DOI 10.1084/jem.149.1.1; Tort L., 2003, Inmunologia, V22, P277; Triantis V, 2006, J IMMUNOL, V176, P1081, DOI 10.4049/jimmunol.176.2.1081; Triantis V, 2006, J LEUKOCYTE BIOL, V79, P1083, DOI 10.1189/jlb.1005588; Tumbol RA, 2009, AQUACULTURE, V292, P180, DOI 10.1016/j.aquaculture.2009.04.030; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WEAVER CT, 1990, IMMUNOL TODAY, V11, P49; Wilson HL, 2000, EXP HEMATOL, V28, P193, DOI 10.1016/S0301-472X(99)00146-0; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yanagawa Y, 2007, J IMMUNOL, V178, P6173, DOI 10.4049/jimmunol.178.10.6173	50	17	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132687	10.1371/journal.pone.0132687	http://dx.doi.org/10.1371/journal.pone.0132687			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173015	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900077
J	Camacho, M; Quintana, MD; Calabuig, P; Luzardo, OP; Boada, LD; Zumbado, M; Oros, J				Camacho, Maria; del Pino Quintana, Maria; Calabuig, Pascual; Luzardo, Octavio P.; Boada, Luis D.; Zumbado, Manuel; Oros, Jorge			Acid-Base and Plasma Biochemical Changes Using Crystalloid Fluids in Stranded Juvenile Loggerhead Sea Turtles (Caretta caretta)	PLOS ONE			English	Article							RESPIRATORY STATUS; TEMPERATURE; RESPONSES; BALANCE; STRESS; GAS	Aim The aim of this study was to compare the efficacy and effects on acid-base and electrolyte status of several crystalloid fluids in 57 stranded juvenile loggerhead turtles. Methods Within a rehabilitation program four different crystalloid fluids were administered (0.9% Na Cl solution; 5% dextrose + 0.9% Na Cl solutions 1:1; 0.9% Na Cl + lactated Ringer's solutions 1:1; lactated Ringer's solution). Crystalloid fluids were intracoelomically administered during three days (20 ml/kg/day). Animals were sampled at three different moments: Upon admission for evaluating the type of acid-base or biochemical disorder, post-fluid therapy treatment for controlling the evolution of the disorder, and post-recovery period for obtaining the baseline values for rehabilitated loggerhead turtles. Each sample was analyzed with a portable electronic blood analyzer for pH, pO(2), pCO(2), lactate, sodium, potassium, chloride, glucose, and BUN concentration. Admission and post-fluid therapy treatment values were compared with those obtained for each turtle immediately before release. Results The highest percentage of acid-base recovery and electrolyte balance was observed in turtles treated with mixed saline-lactated Ringer's solution (63.6%), followed by turtles treated with physiological saline solution (55%), lactated Ringer's solution (33.3%), and dextrose-saline solutions (10%). Most turtles treated with lactated Ringer's solution had lower lactate concentrations compared with their initial values; however, 66.6% of turtles treated with lactated Ringer's solution had metabolic alkalosis after therapy. Significant higher concentrations of glucose were detected after saline-dextrose administration compared with all the remaining fluids. Conclusions This is the first study evaluating the effects of several crystalloid fluids on the acid-base status and plasma biochemical values in stranded loggerhead sea turtles. Reference convalescent venous blood gas, acid-base, and plasma biochemical values, useful for veterinary surgeons involved in sea turtle conservation, are also provided.	[Camacho, Maria; Luzardo, Octavio P.; Boada, Luis D.; Zumbado, Manuel; Oros, Jorge] Univ Las Palmas Gran Canaria, Fac Vet, Arucas, Las Palmas, Spain; [del Pino Quintana, Maria] Univ Las Palmas Gran Canaria, Dept Math, Las Palmas Gran Canaria, Spain; [Calabuig, Pascual] Cabildo Gran Canaria, Tafira Wildlife Rehabil Ctr, Tafira Baja Las Palmas D, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Oros, J (corresponding author), Univ Las Palmas Gran Canaria, Fac Vet, Arucas, Las Palmas, Spain.	jorge.oros@ulpgc.es	Luzardo, Octavio P./H-3045-2019; Calabuig, Pascual/AAB-1723-2019; Zumbado, Manuel/AAN-8373-2020; Zumbado, Manuel/B-4495-2010; Dominguez-Boada, Luis/L-5577-2015; Orós, Jorge/G-8824-2015; CAMACHO, MARIA/H-5085-2015; Staffieri, Francesco/K-4230-2016	Luzardo, Octavio P./0000-0002-4153-3028; Zumbado, Manuel/0000-0002-1534-7758; Dominguez-Boada, Luis/0000-0002-0195-4565; Orós, Jorge/0000-0002-8346-5393; CAMACHO, MARIA/0000-0003-2891-1474; Staffieri, Francesco/0000-0002-2085-376X; Quintana Montesdeoca, Maria del Pino/0000-0003-1276-7594				AGUIRRE AA, 1995, PHYSIOL ZOOL, V68, P831, DOI 10.1086/physzool.68.5.30163934; ASHWOOD ER, 1983, CLIN CHEM, V29, P1877; Bjorndal KA, 2001, FISH B-NOAA, V99, P240; Camacho M, 2013, JAVMA-J AM VET MED A, V242, P396, DOI 10.2460/javma.242.3.396; Casal AB, 2009, VET REC, V164, P663, DOI 10.1136/vr.164.21.663; Casal AB, 2009, VET CLIN PATH, V38, P213, DOI 10.1111/j.1939-165X.2008.00106.x; Chittick EJ, 2002, J AM VET MED ASSOC, V221, P1019, DOI 10.2460/javma.2002.221.1019; Chrisman CL, 1997, J AM VET MED ASSOC, V211, P1043; DiBartola SP., 2006, FLUID ELECTROLYTE, P325, DOI [10.1016/B0-72-163949-6/50017-5, DOI 10.1016/B0-72-163949-6/50017-5]; Flint M, 2010, J WILDLIFE DIS, V46, P731, DOI 10.7589/0090-3558-46.3.731; Gregory LF, 2001, GEN COMP ENDOCR, V124, P66, DOI 10.1006/gcen.2001.7683; Harms CA, 2003, J WILDLIFE DIS, V39, P366, DOI 10.7589/0090-3558-39.2.366; Innis CJ, 2007, J COMP PHYSIOL B, V177, P623, DOI 10.1007/s00360-007-0160-9; IUCN SSC, 2014, IUCN RED LIST THREAT; Jacobson ER, 2006, DIS AQUAT ORGAN, V70, P139, DOI 10.3354/dao070139; Kelly TR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115739; KRAUS DR, 1980, AM J PHYSIOL, V239, pR254, DOI 10.1152/ajpregu.1980.239.3.R254; LUTZ PL, 1989, J EXP BIOL, V144, P155; Mader D, 2006, REPTILE MED SURG 2 E, P533, DOI DOI 10.1016/B0-72-169327-X/50035-3; Martinez-Jimenez David, 2007, Veterinary Clinics of North America Exotic Animal Practice, V10, P557, DOI 10.1016/j.cvex.2007.02.003; Michell AR., 1989, VET FLUID THERAPY, P55; Mitchell M.A., 2006, REPTILE MED SURG, P631; Monzon-Arguello C, 2009, J EXP MAR BIOL ECOL, V373, P79, DOI 10.1016/j.jembe.2009.03.007; Norton Terry M., 2012, P239; Norton TM, 2005, SEMIN AVIAN EXOT PET, V14, P106, DOI 10.1053/j.saep.2005.04.005; Oros J, 2011, DIS AQUAT ORGAN, V95, P163, DOI 10.3354/dao02351; Prezant RM, 1997, PROCEEDINGS OF THE FOURTH ANNUAL CONFERENCE OF THE ASSOCIATION OF REPTILIAN AND AMPHIBIAN VETERINARIANS, P83; Seminoff Jeffrey A., 2004, Herpetological Review, V35, P24; STABENAU EK, 1991, COMP BIOCHEM PHYS A, V99, P107, DOI 10.1016/0300-9629(91)90243-6; Stabenau EK, 2003, FISH B-NOAA, V101, P889; STABENAU EK, 1993, J EXP BIOL, V180, P311; Stahl S., 2006, REPTILE MED SURG, V2e, P822; Wellman ML., 2006, FLUID ELECTROLYTE, P3, DOI [DOI 10.1016/B0-72-163949-6/50004-7, 10.1016/B0-72-163949-6/50004-7]; Whitaker Brent R., 1999, P217; Wilkinson R, 2004, MED SURG TORTOISES T, P481; Wyneken JE., 2006, REPTILE MED SURG, P972	36	14	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132217	10.1371/journal.pone.0132217	http://dx.doi.org/10.1371/journal.pone.0132217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167930	Green Published, gold			2022-12-27	WOS:000358193100029
J	Ge, JP; An, Q; Song, SS; Gao, DN; Ping, WX				Ge, Jingping; An, Qi; Song, Shanshan; Gao, Dongni; Ping, Wenxiang			Construction of Recombinant Baculoviruses Expressing Infectious Bursal Disease Virus Main Protective Antigen and Their Immune Effects on Chickens	PLOS ONE			English	Article							VP2 PROTEIN; VACCINE; IMMUNIZATION; RESPONSES	In order to overcome the limitations of conventional vaccines for infectious bursal disease virus (IBDV), we constructed recombinant dual expression system baculoviruses with VP2 and VP2/4/3, the main protective antigens of IBDV. We compared the immune effects of the baculoviruses in avian cells and detected their control effects on chickens with infectious bursal disease. We used Western blot analysis to measure VP2 protein and VP2/4/3 polyprotein expression in avian cells infected using the Bac-to-Bac baculovirus expression system. The recombinant baculoviruses were used to vaccinate specific pathogen-free chickens, which produced specific protective antibodies and strong cellular immune responses. The results of the virus challenge experiment revealed that the protective efficiency of VP2 and VP2/4/3 virus vaccines were 95.8% and 100%, respectively, both of which were higher than the vaccine group (87.5%), and significantly higher than the control group (50%). The results demonstrated that the immune effect of BV-S-ITRs-VP2/4/3 was superior to that of BV-S-ITRs-VP2. Compared with traditional attenuated vaccine and genetically engineered live vector vaccine, the dual expression viral vector vaccine has good bio-safety. The results of this study provide a foundation for the further development of poultry vaccines, in addition to providing a useful reference for developing non-replicating live vaccines against other viral diseases.	[Ge, Jingping; An, Qi; Song, Shanshan; Gao, Dongni; Ping, Wenxiang] Heilongjiang Univ, Key Lab Microbiol, Coll Life Sci, Harbin 150080, Peoples R China	Heilongjiang University	Ping, WX (corresponding author), Heilongjiang Univ, Key Lab Microbiol, Coll Life Sci, Harbin 150080, Peoples R China.	wenxiangp@aliyun.com			National Natural Science Foundation of China [31470537, 31270534, 31270143]; National Science Foundation for Distinguished Young Scholars of China [31300355]; High-level Talents (Innovation Team) Projects of Heilongjiang University [Hdtd2010-17]; Innovation Team in Science and Technology of Heilongjiang Province (the Fermentation Technology of Agricultural Microbiology) [2012td009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); High-level Talents (Innovation Team) Projects of Heilongjiang University; Innovation Team in Science and Technology of Heilongjiang Province (the Fermentation Technology of Agricultural Microbiology)	This work was supported by grants from the National Natural Science Foundation of China (31470537), the National Natural Science Foundation of China (31270534), the National Natural Science Foundation of China (31270143), the National Science Foundation for Distinguished Young Scholars of China (31300355), the High-level Talents (Innovation Team) Projects of Heilongjiang University (Hdtd2010-17), and the Innovation Team in Science and Technology of Heilongjiang Province (the Fermentation Technology of Agricultural Microbiology, 2012td009).	Cheng Tong, 2007, Sheng Wu Gong Cheng Xue Bao, V23, P546; Francois A, 2004, VACCINE, V22, P2351, DOI 10.1016/j.vaccine.2003.10.039; He F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-238; Hu YC, 2008, CURR GENE THER, V8, P54, DOI 10.2174/156652308783688509; Huang ZH, 2004, J VIROL, V78, P10054, DOI 10.1128/JVI.78.18.10054-10063.2004; Li JR, 2003, VIRUS RES, V98, P63, DOI 10.1016/j.virusres.2003.08.017; Li YM, 2009, J GENE MED, V11, P57, DOI 10.1002/jgm.1271; Mahonen AJ, 2007, J BIOTECHNOL, V131, P1, DOI 10.1016/j.jbiotec.2007.05.022; Mao Qun-ying, 2012, Chinese Journal of Biologicals, V25, P725; Muller H, 2012, AVIAN PATHOL, V41, P133, DOI 10.1080/03079457.2012.661403; Muller H, 2003, VET MICROBIOL, V97, P153, DOI 10.1016/j.vetmic.2003.08.005; Mundt E, 2003, VACCINE, V21, P4616, DOI 10.1016/S0264-410X(03)00448-1; Pradhan SN, 2012, VET IMMUNOL IMMUNOP, V148, P293, DOI 10.1016/j.vetimm.2012.06.019; RONG J, 2002, VACCINE, V23, P4822; Sakaguchi M, 1998, VACCINE, V16, P472, DOI 10.1016/S0264-410X(97)80001-1; Song KH, 2000, ACTA BIOCH BIOPH SIN, V32, P281; TUKAMOTO K, 2002, VIROLOGY, V76, P5637; Xu XG, 2011, AVIAN DIS, V55, P223, DOI 10.1637/9597-111210-Reg.1; Yuwen YQ, 2008, AVIAN DIS, V52, P284, DOI 10.1637/8175-111707-Reg.1	19	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132993	10.1371/journal.pone.0132993	http://dx.doi.org/10.1371/journal.pone.0132993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167907	Green Published, gold			2022-12-27	WOS:000358193100100
J	Martinez-Olivan, J; Fraga, H; Arias-Moreno, X; Ventura, S; Sancho, J				Martinez-Olivan, Juan; Fraga, Hugo; Arias-Moreno, Xabier; Ventura, Salvador; Sancho, Javier			Intradomain Confinement of Disulfides in the Folding of Two Consecutive Modules of the LDL Receptor	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; LIGAND-BINDING DOMAIN; CYSTEINE-RICH REPEAT; FAMILIAL HYPERCHOLESTEROLEMIA; 3-DIMENSIONAL STRUCTURE; DIFFERENT PROTEINS; BACKBONE DYNAMICS; HUMAN FIBROBLASTS; NMR STRUCTURE; CHOLESTEROL	The LDL receptor internalizes circulating LDL and VLDL particles for degradation. Its extracellular binding domain contains ten (seven LA and three EGF) cysteine-rich modules, each bearing three disulfide bonds. Despite the enormous number of disulfide combinations possible, LDLR oxidative folding leads to a single native species with 30 unique intradomain disulfides. Previous folding studies of the LDLR have shown that non native disulfides are initially formed that lead to compact species. Accordingly, the folding of the LDLR has been described as a "coordinated nonvectorial" reaction, and it has been proposed that early compaction funnels the reaction toward the native structure. Here we analyze the oxidative folding of LA4 and LA5, the modules critical for ApoE binding, isolated and in the LA45 tandem. Compared to LA5, LA4 folding is slow and inefficient, resembling that of LA5 disease-linked mutants. Without Ca++, it leads to a mixture of many two-disulfide scrambled species and, with Ca++, to the native form plus two three-disulfide intermediates. The folding of the LA45 tandem seems to recapitulate that of the individual repeats. Importantly, although the folding of the LA45 tandem takes place through formation of scrambled isomers, no interdomain disulfides are detected, i.e. the two adjacent modules fold independently without the assistance of interdomain covalent interactions. Reduction of incredibly large disulfide combinatorial spaces, such as that in the LDLR, by intradomain confinement of disulfide bond formation might be also essential for the efficient folding of other homologous disulfide-rich receptors.	[Martinez-Olivan, Juan; Arias-Moreno, Xabier; Sancho, Javier] Univ Zaragoza, Biocomputat & Complex Syst Phys Inst BIFI, Joint Unit BIFI IQFR, CSIC, Zaragoza, Spain; [Martinez-Olivan, Juan; Arias-Moreno, Xabier; Sancho, Javier] Univ Zaragoza, Dept Bioquim & Biol Mol & Cellular, Zaragoza, Spain; [Fraga, Hugo; Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra, Spain; [Fraga, Hugo; Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Spain; [Fraga, Hugo] Univ Porto, Fac Med, Dept Bioquim, P-4100 Oporto, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; University of Zaragoza; Autonomous University of Barcelona; Autonomous University of Barcelona; Universidade do Porto	Ventura, S (corresponding author), Univ Zaragoza, Biocomputat & Complex Syst Phys Inst BIFI, Joint Unit BIFI IQFR, CSIC, Zaragoza, Spain.	salvador.ventura@uab.es; jsancho@unizar.es	Sancho, javier/AAA-1225-2019; Mobli, Mehdi/O-7244-2014; MORENO, XABIER ARIAS/AAA-1176-2021; Ventura, Salvador/AAY-3170-2021; Ventura, Salvador/C-7021-2008; Fraga, Hugo/X-4850-2019	Sancho, javier/0000-0002-2879-9200; Mobli, Mehdi/0000-0003-2420-4262; MORENO, XABIER ARIAS/0000-0001-8601-9092; Ventura, Salvador/0000-0002-9652-6351; Ventura, Salvador/0000-0002-9652-6351; Fraga, Hugo/0000-0001-7677-4086	Ministerio de Ciencia e Innovacion (Spain) [BFU2010-14901, BFU2010-16297]; MINECO (Spain) [BFU2013-47064-P, BFU2013-44763-P]; AGAUR (Generalitat de Catalunya) [2009-SGR-760]; Diputacion General de Aragon, Spain [PI078/08]; Investigador FCT starting grant, Portugal	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MINECO (Spain)(Spanish Government); AGAUR (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Diputacion General de Aragon, Spain(Gobierno de Aragon); Investigador FCT starting grant, Portugal	The authors acknowledge financial support from grants BFU2010-14901 and BFU2010-16297 from Ministerio de Ciencia e Innovacion (Spain), BFU2013-47064-P and BFU2013-44763-P from MINECO (Spain), 2009-SGR-760 from AGAUR (Generalitat de Catalunya) and PI078/08 from (Diputacion General de Aragon, Spain). HF has been granted an Investigador FCT starting grant, Portugal.	Arias-Moreno X, 2008, J BIOL CHEM, V283, P22670, DOI 10.1074/jbc.M802153200; Arias-Moreno X, 2008, J BIOL CHEM, V283, P13627, DOI 10.1074/jbc.M800755200; Beglova N, 2001, BIOCHEMISTRY-US, V40, P2808, DOI 10.1021/bi0027276; BROWN MS, 1975, J CLIN INVEST, V55, P783, DOI 10.1172/JCI107989; BROWN MS, 1976, SCIENCE, V191, P150, DOI 10.1126/science.174194; Cheek S, 2006, J MOL BIOL, V359, P215, DOI 10.1016/j.jmb.2006.03.017; DALY NL, 1995, BIOCHEMISTRY-US, V34, P14474, DOI 10.1021/bi00044a025; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; ESSER V, 1988, J BIOL CHEM, V263, P13282; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; FLORY PJ, 1956, J AM CHEM SOC, V78, P5222, DOI 10.1021/ja01601a025; Fraga H, 2014, ANTIOXID REDOX SIGN, V21, P368, DOI 10.1089/ars.2013.5543; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; Go Gwang-woong, 2012, Yale Journal of Biology and Medicine, V85, P19; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; Guttman M, 2011, BIOCHEMISTRY-US, V50, P11001, DOI 10.1021/bi2014486; Guttman M, 2010, BIOCHEMISTRY-US, V49, P1207, DOI 10.1021/bi9017208; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Huang S, 2010, J LIPID RES, V51, P297, DOI 10.1194/jlr.M000422; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Kurniawan ND, 2000, PROTEIN SCI, V9, P1282, DOI 10.1110/ps.9.7.1282; Kurniawan ND, 2001, J MOL BIOL, V311, P341, DOI 10.1006/jmbi.2001.4867; Levinthal C., 1969, MOSSB SPECTR BIOL SY, P22; Martinez-Olivan J, 2014, FEBS J, V281, P2638, DOI 10.1111/febs.12811; Martinez-Olivan J, 2014, FEBS J, V281, P1534, DOI 10.1111/febs.12721; North CL, 2000, BIOCHEMISTRY-US, V39, P2564, DOI 10.1021/bi992087a; Oka OBV, 2013, MOL CELL, V50, P793, DOI 10.1016/j.molcel.2013.05.014; Pena F, 2010, J BIOL CHEM, V285, P8656, DOI 10.1074/jbc.M110.105718; Ranganathan S, 2011, J NEUROSCI, V31, P10836, DOI 10.1523/JNEUROSCI.5065-10.2011; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; Wilkins MR, 1999, METH MOL B, V112, P531; Willnow TE, 1999, NAT CELL BIOL, V1, pE157, DOI 10.1038/14109; Zhao ZZ, 2011, BBA-MOL CELL BIOL L, V1811, P397, DOI 10.1016/j.bbalip.2011.04.002	41	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132141	10.1371/journal.pone.0132141	http://dx.doi.org/10.1371/journal.pone.0132141			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168158	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100023
J	Viales, RR; Eichstaedt, CA; Ehlken, N; Fischer, C; Lichtblau, M; Grunlg, E; Hinderhofer, K				Viales, Rebecca Rodriguez; Eichstaedt, Christina A.; Ehlken, Nicola; Fischer, Christine; Lichtblau, Mona; Gruenlg, Ekkehard; Hinderhofer, Katrin			Mutation in BMPR2 Promoter: A 'Second Hit' for Manifestation of Pulmonary Arterial Hypertension?	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; INCOMPLETE PENETRANCE; EXERCISE; GENE; POLYMORPHISM; GENOMICS; MODIFIER; FORMS; D85N	Background Hereditary pulmonary arterial hypertension (HPAH) can be caused by autosomal dominant inherited mutations of TGF-beta genes, such as the bone morphogenetic protein receptor 2 (BMPR2) and Endoglin (ENG) gene. Additional modifier genes may play a role in disease manifestation and severity. In this study we prospectively assessed two families with known BMPR2 or ENG mutations clinically and genetically and screened for a second mutation in the BMPR2 promoter region. Methods We investigated the BMPR2 promoter region by direct sequencing in two index-patients with invasively confirmed diagnosis of HPAH, carrying a mutation in the BMPR2 and ENG gene, respectively. Sixteen family members have been assessed clinically by non-invasive methods and genetically by direct sequencing. Results In both index patients with a primary BMPR2 deletion (exon 2 and 3) and Endoglin missense variant (c. 1633G> A, p.(G545S)), respectively, we detected a second mutation (c.669G> A) in the promoter region of the BMPR2 gene. The index patients with 2 mutations/ variants were clinically severely affected at early age, whereas further family members with only one mutation had no manifest HPAH. Conclusion The finding of this study supports the hypothesis that additional mutations may lead to an early and severe manifestation of HPAH. This study shows for the first time that in the regulatory region of the BMPR2 gene the promoter may be important for disease penetrance.Further studies are needed to assess the incidence and clinical relevance of mutations of the BMPR2 promoter region in a larger patient cohort.	[Viales, Rebecca Rodriguez; Eichstaedt, Christina A.; Ehlken, Nicola; Lichtblau, Mona; Gruenlg, Ekkehard] Univ Heidelberg Hosp, Ctr Pulm Hypertens, Thoraxclin Heidelberg, Heidelberg, Germany; [Viales, Rebecca Rodriguez; Fischer, Christine; Hinderhofer, Katrin] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Hinderhofer, K (corresponding author), Heidelberg Univ, Inst Human Genet, Heidelberg, Germany.	Katrin.Hinderhofer@med.uni-heidelberg.de	Benjamin, Nicola/AAJ-4360-2021	Lichtblau, Mona/0000-0003-4485-1758; Rodriguez Viales, Rebecca/0000-0003-3739-7438				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aldred MA, 2007, AM J RESP CRIT CARE, V176, P819, DOI 10.1164/rccm.200701-164OC; Austin ED, 2013, SEMIN RESP CRIT CARE, V34, P568, DOI 10.1055/s-0033-1355443; Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888; Brakensiek K, 2008, CLIN GENET, V74, P171, DOI 10.1111/j.1399-0004.2008.01029.x; Chaouat A, 2004, THORAX, V59, P446, DOI 10.1136/thx.2003.11890; Cogan JD, 2006, AM J RESP CRIT CARE, V174, P590, DOI 10.1164/rccm.200602-165OC; De Cruz R, 2012, BRIT J DERMATOL, V166, P20, DOI 10.1111/j.1365-2133.2012.10861.x; Dunmore BJ, 2013, HUM MOL GENET, V22, P3667, DOI 10.1093/hmg/ddt216; Eyries M, 2014, NAT GENET, V46, P65, DOI 10.1038/ng.2844; Giudicessi JR, 2013, TRANSL RES, V161, P1, DOI 10.1016/j.trsl.2012.08.005; Grunig E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3883; Grunig E, 2012, EUR RESPIR J, V40, P84, DOI 10.1183/09031936.00123711; Grunig E, 2011, RESPIRATION, V81, P394, DOI 10.1159/000322475; Grunig E, 2009, CIRCULATION, V119, P1747, DOI 10.1161/CIRCULATIONAHA.108.800938; Hamid R, 2009, HUM MUTAT, V30, P649, DOI 10.1002/humu.20922; Hasegawa K, 2014, J ARRYTHM, V30, P161, DOI 10.1016/j.joa.2013.08.004; Hinderhofer K, 2013, PLOS ONE UNDER MINOR; Hinderhofer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091374; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Lahtinen AM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-11; Layeneziana P, 2014, EUR RESPIR J, V44, P1069, DOI 10.1183/09031936.00088914; LOYD JE, 1995, AM J RESP CRIT CARE, V152, P93, DOI 10.1164/ajrccm.152.1.7599869; LOYD JE, 1984, AM REV RESPIR DIS, V129, P194; Ma L, 2013, NEW ENGL J MED, V369, P351, DOI 10.1056/NEJMoa1211097; Machado RD, 2009, J AM COLL CARDIOL, V54, pS32, DOI 10.1016/j.jacc.2009.04.015; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Maloney JP, 2012, AM J PHYSIOL-LUNG C, V302, pL541, DOI 10.1152/ajplung.00282.2011; Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518; Maubaret CG, 2011, INVEST OPHTH VIS SCI, V52, P9304, DOI 10.1167/iovs.11-8372; Pfarr N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-99; Phillips JA, 2008, GENET MED, V10, P359, DOI 10.1097/GIM.0b013e318172dcdf; Pousada G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100261; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Remillard CV, 2007, AM J PHYSIOL-CELL PH, V292, pC1837, DOI 10.1152/ajpcell.00405.2006; Rosenzweig EB, 2008, J HEART LUNG TRANSPL, V27, P668, DOI 10.1016/j.healun.2008.02.009; Saini S, 2012, EXP EYE RES, V104, P82, DOI 10.1016/j.exer.2012.09.010; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shintani M, 2009, J MED GENET, V46, P331, DOI 10.1136/jmg.2008.062703; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Soubrier F, 2013, J AM COLL CARDIOL, V62, pD13, DOI 10.1016/j.jacc.2013.10.035; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; Trembath R. C., 2001, Journal of Heart and Lung Transplantation, V20, P175, DOI 10.1016/S1053-2498(00)00352-1; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; Velankar S, 2013, NUCLEIC ACIDS RES, V41, pD483, DOI 10.1093/nar/gks1258; Wang GL, 2014, INT J CARDIOL, V177, pE167, DOI 10.1016/j.ijcard.2014.08.124; Wang H, 2009, EUR J HUM GENET, V17, P1063, DOI 10.1038/ejhg.2009.3; Westenskow P, 2004, CIRCULATION, V109, P1834, DOI 10.1161/01.CIR.0000125524.34234.13; Wooderchak-Donahue WL, 2013, AM J HUM GENET, V93, P530, DOI 10.1016/j.ajhg.2013.07.004	49	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0133042	10.1371/journal.pone.0133042	http://dx.doi.org/10.1371/journal.pone.0133042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167679	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100106
J	Zhou, B; Lindsay, SA; Wasserman, SA				Zhou, Bo; Lindsay, Scott A.; Wasserman, Steven A.			Alternative NF-kappa B Isoforms in the Drosophila Neuromuscular Junction and Brain	PLOS ONE			English	Article							REGULATED NUCLEAR IMPORT; IMMUNE-RESPONSE; DORSOVENTRAL PATTERN; DORSAL PROTEIN; REL PROTEINS; CACTUS; LOCALIZATION; DIF; MELANOGASTER; GENE	The Drosophila NF-kappa B protein Dorsal is expressed at the larval neuromuscular junction, where its expression appears unrelated to known Dorsal functions in embryonic patterning and innate immunity. Using confocal microscopy with domain-specific antisera, we demonstrate that larval muscle expresses only the B isoform of Dorsal, which arises by intron retention. We find that Dorsal B interacts with and stabilizes Cactus at the neuromuscular junction, but exhibits Cactus independent localization and an absence of detectable nuclear translocation. We further find that the Dorsal-related immune factor Dif encodes a B isoform, reflecting a conservation of B domains across a range of insect NF-kappa B proteins. Carrying out mutagenesis of the Dif locus via a site-specific recombineering approach, we demonstrate that Dif B is the major, if not sole, Dif isoform in the mushroom bodies of the larval brain. The Dorsal and Dif B isoforms thus share a specific association with nervous system tissues as well as an alternative protein structure.	[Zhou, Bo; Lindsay, Scott A.; Wasserman, Steven A.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Wasserman, SA (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	stevenw@ucsd.edu			National Institutes of Health [RO1 GM050545]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, grant RO1 GM050545 to SW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BELVIN MP, 1995, GENE DEV, V9, P783, DOI 10.1101/gad.9.7.783; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Beremendi A, 2005, NEUROSCIENCE, V134, P397, DOI 10.1016/j.neuroscience.2005.04.046; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bolatto C, 2003, J NEUROBIOL, V54, P525, DOI 10.1002/neu.10179; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Cammarato A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018497; Cantera R, 1999, J NEUROBIOL, V38, P16, DOI 10.1002/(SICI)1097-4695(199901)38:1<16::AID-NEU2>3.0.CO;2-0; Cantera R, 1999, MOL CELL NEUROSCI, V13, P131, DOI 10.1006/mcne.1999.0739; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GILLESPIE SKH, 1994, MOL CELL BIOL, V14, P3559, DOI 10.1128/MCB.14.6.3559; Govind S, 1996, MOL CELL BIOL, V16, P1103; GOVIND S, 1993, DEVELOPMENT, V117, P135; Gross I, 1999, GENE, V228, P233, DOI 10.1016/S0378-1119(98)00595-2; Heckscher ES, 2007, NEURON, V55, P859, DOI 10.1016/j.neuron.2007.08.005; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; KIDD S, 1992, CELL, V71, P623, DOI 10.1016/0092-8674(92)90596-5; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kumar V, 2009, MOL BIOL CELL, V20, P2254, DOI 10.1091/mbc.E08-10-1072; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Lindsay SA, 2014, DEV COMP IMMUNOL, V42, P16, DOI 10.1016/j.dci.2013.04.011; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Nusslein-Volhard C., 1979, MATERNAL EFFECT MUTA; Paschinger K, 2009, GLYCOCONJUGATE J, V26, P385, DOI 10.1007/s10719-008-9155-3; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Reach M, 1996, DEV BIOL, V180, P353, DOI 10.1006/dbio.1996.0308; REICHHART JM, 1993, CR ACAD SCI III-VIE, V316, P1218; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; SCHUPBACH T, 1989, GENETICS, V121, P101; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; Shin SW, 2005, J BIOL CHEM, V280, P16499, DOI 10.1074/jbc.M500711200; St Johnston D, 2013, WIRES DEV BIOL, V2, P587, DOI 10.1002/wdev.101; STEWARD R, 1989, CELL, V59, P1179, DOI 10.1016/0092-8674(89)90773-3; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; TATEI K, 1995, MOL CELL BIOL, V15, P3627; Thomas U, 2000, CURR BIOL, V10, P1108, DOI 10.1016/S0960-9822(00)00696-5; Ursic-Bedoya R, 2009, INSECT MOL BIOL, V18, P681, DOI 10.1111/j.1365-2583.2009.00909.x; Venken KJT, 2007, DEVELOPMENT, V134, P3571, DOI 10.1242/dev.005686; Venken KJT, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn486; Wang W, 2011, DEV BIOL, V350, P414, DOI 10.1016/j.ydbio.2010.12.002; WHALEN AM, 1993, J CELL BIOL, V123, P523, DOI 10.1083/jcb.123.3.523; Wu LP, 1998, NATURE, V392, P93, DOI 10.1038/32195	50	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132793	10.1371/journal.pone.0132793	http://dx.doi.org/10.1371/journal.pone.0132793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167685	Green Published, gold			2022-12-27	WOS:000358193100082
J	Al-Ahmad, A; Bucher, M; Anderson, AC; Tennert, C; Hellwig, E; Wittmer, A; Vach, K; Karygianni, L				Al-Ahmad, A.; Bucher, M.; Anderson, A. C.; Tennert, C.; Hellwig, E.; Wittmer, A.; Vach, K.; Karygianni, L.			Antimicrobial Photoinactivation Using Visible Light Plus Water-Filtered Infrared-A (VIS plus wIRA) Alters In Situ Oral Biofilms	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; FUSOBACTERIUM-NUCLEATUM; METHYLENE-BLUE; CLINICAL-TRIAL; IRRADIATION; BACTERIA; VIVO; HYBRIDIZATION; COMMUNICATION; INFECTIONS	Recently, growing attention has been paid to antimicrobial photodynamic therapy (aPDT) in dentistry. Changing the microbial composition of initial and mature oral biofilm by aPDT using visible light plus water-filtered infrared-A wavelengths (VIS + wIRA) has not yet been investigated. Moreover, most aPDT studies have been conducted on planktonic bacterial cultures. Therefore, in the present clinical study we cultivated initial and mature oral biofilms in six healthy volunteers for 2 hours or 3 days, respectively. The biofilms were treated with aPDT using VIS+wIRA (200 mW cm(-2)), toluidine blue (TB) and chlorine e6 (Ce6) for 5 minutes. Chlorhexidine treated biofilm samples served as positive controls, while untreated biofilms served as negative controls. After aPDT treatment the colony forming units (CFU) of the biofilm samples were quantified, and the surviving bacteria were isolated in pure cultures and identified using MALDI-TOF, biochemical tests and 16S rDNA-sequencing. aPDT killed more than 99.9% of the initial viable bacterial count and 95% of the mature oral biofilm in situ, independent of the photosensitizer. The number of surviving bacterial species was highly reduced to 6 (TB) and 4 (Ce6) in the treated initial oral biofilm compared to the 20 different species of the untreated biofilm. The proportions of surviving bacterial species were also changed after TB-and Ce6-mediated aPDT of the mature oral biofilm, resulting in a shift in the microbial composition of the treated biofilm compared to that of the control biofilm. In conclusion, aPDT using VIS + wIRA showed a remarkable potential to eradicate both initial and mature oral biofilms, and also to markedly alter the remaining biofilm. This encourages the clinical use of aPDT with VIS + wIRA for the treatment of periimplantitis and periodontitis.	[Al-Ahmad, A.; Bucher, M.; Anderson, A. C.; Tennert, C.; Hellwig, E.; Karygianni, L.] Univ Freiburg, Ctr Dent Med, Dept Operat Dent & Periodontol, D-79106 Freiburg, Germany; [Wittmer, A.] Univ Freiburg, Inst Med Microbiol & Hyg, D-79106 Freiburg, Germany; [Vach, K.] Univ Freiburg, Ctr Med Biometry & Med Informat, Inst Med Biometry & Stat, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Al-Ahmad, A (corresponding author), Univ Freiburg, Ctr Dent Med, Dept Operat Dent & Periodontol, Hugstetter Str 55, D-79106 Freiburg, Germany.	ali.al-ahmad@uniklinik-freiburg.de	Vach, Kirstin/AAI-4643-2020; Vach, Kirstin/GQP-0449-2022	Vach, Kirstin/0000-0001-9278-2203; Vach, Kirstin/0000-0001-9278-2203	Swiss Dr. Braun Science Foundation; German Research Foundation (DFG) [AL 1179/2-1]	Swiss Dr. Braun Science Foundation; German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the Swiss Dr. Braun Science Foundation and in part by the German Research Foundation (DFG, AL 1179/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ahmad A, 2013, ARCH ORAL BIOL, V58, P1139, DOI 10.1016/j.archoralbio.2013.04.011; Al-Ahmad A, 2013, J MED MICROBIOL, V62, P467, DOI 10.1099/jmm.0.048843-0; Al-Ahmad A, 2007, J MED MICROBIOL, V56, P681, DOI 10.1099/jmm.0.47094-0; Al-Ahmad A, 2009, J MED MICROBIOL, V58, P1359, DOI 10.1099/jmm.0.011213-0; Anderson AC, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0312-5; Anderson AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049576; Beighton D, 2009, Adv Dent Res, V21, P69, DOI 10.1177/0895937409335641; Chambless JD, 2006, APPL ENVIRON MICROB, V72, P2005, DOI 10.1128/AEM.72.3.2005-2013.2006; Cieplik F, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00405; Cieplik F, 2014, CLIN ORAL INVEST, V18, P1763, DOI 10.1007/s00784-013-1151-8; de Oliveira RR, 2007, J PERIODONTOL, V78, P965, DOI 10.1902/jop.2007.060494; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Filoche S, 2010, J DENT RES, V89, P8, DOI 10.1177/0022034509351812; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Garcez AS, 2010, J ENDODONT, V36, P1463, DOI 10.1016/j.joen.2010.06.001; Griffen AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019051; Gursoy H, 2013, CLIN ORAL INVEST, V17, P1113, DOI 10.1007/s00784-012-0845-7; Hannig C, 2009, CLIN ORAL INVEST, V13, P123, DOI 10.1007/s00784-008-0243-3; Hartel M, 2006, BRIT J SURG, V93, P952, DOI 10.1002/bjs.5429; Hoffmann G, 2009, GMS HYG INFECT CONTR, V4, DOI 10.3205/dgkh000137; Jakubovics NS, 2010, MOL ORAL MICROBIOL, V25, P4, DOI 10.1111/j.2041-1014.2009.00563.x; Jori G, 2006, LASER SURG MED, V38, P468, DOI 10.1002/lsm.20361; Jung T, 2012, ANN NY ACAD SCI, V1259, P33, DOI 10.1111/j.1749-6632.2012.06581.x; Karygianni L, 2014, APPL ENVIRON MICROB, V80, P7324, DOI 10.1128/AEM.02490-14; Kharkwal GB, 2011, LASER SURG MED, V43, P755, DOI 10.1002/lsm.21080; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Kunzli BM, 2013, ANN SURG, V258, P887, DOI 10.1097/SLA.0000000000000235; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; Leprince J, 2010, OPER DENT, V35, P220, DOI 10.2341/09-203-L; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037919; Madianos PN, 2005, J CLIN PERIODONTOL, V32, P57, DOI 10.1111/j.1600-051X.2005.00821.x; Moon YH, 2009, ONCOL REP, V22, P1085, DOI 10.3892/or_00000540; Nagata JY, 2012, PHOTODIAGN PHOTODYN, V9, P122, DOI 10.1016/j.pdpdt.2011.11.006; Nogueira AC, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.5.055004; Paul S, 2013, J FLUORESC, V23, P283, DOI 10.1007/s10895-012-1146-x; Piazena H, 2010, PHOTOCHEM PHOTOBIOL, V86, P687, DOI 10.1111/j.1751-1097.2010.00729.x; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Rickard AH, 2013, ORAL MICROBIAL ECOLOGY: CURRENT RESEARCH AND NEW PERSPECTIVES, P97; Sigusch BW, 2010, J PERIODONTOL, V81, P975, DOI 10.1902/jop.2010.090246; Usacheva MN, 2003, J PHOTOCH PHOTOBIO B, V71, P87, DOI 10.1016/j.jphotobiol.2003.06.002; Usacheva MN, 2001, LASER SURG MED, V29, P165, DOI 10.1002/lsm.1105; von Felbert V, 2010, BRIT J DERMATOL, V163, P607, DOI 10.1111/j.1365-2133.2010.09817.x; von Felbert Verena, 2008, GMS Krankenhhyg Interdiszip, V2, pDoc52; Voos AC, 2014, LASER SURG MED, V46, P235, DOI 10.1002/lsm.22217; Wainwright M, 2010, LETT APPL MICROBIOL, V50, P486, DOI 10.1111/j.1472-765X.2010.02825.x; Zijnge V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009321	50	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132107	10.1371/journal.pone.0132107	http://dx.doi.org/10.1371/journal.pone.0132107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162100	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300093
J	Feng, L; Hu, YQ; Li, BW; Stanley, HE; Havlin, S; Braunstein, LA				Feng, Ling; Hu, Yanqing; Li, Baowen; Stanley, H. Eugene; Havlin, Shlomo; Braunstein, Lidia A.			Competing for Attention in Social Media under Information Overload Conditions	PLOS ONE			English	Article							OPINION; BEHAVIOR; NETWORKS; SPREAD	Modern social media are becoming overloaded with information because of the rapidlyexpanding number of information feeds. We analyze the user-generated content in Sina Weibo, and find evidence that the spread of popular messages often follow a mechanism that differs from the spread of disease, in contrast to common belief. In this mechanism, an individual with more friends needs more repeated exposures to spread further the information. Moreover, our data suggest that for certain messages the chance of an individual to share the message is proportional to the fraction of its neighbours who shared it with him/her, which is a result of competition for attention. We model this process using a fractional susceptible infected recovered (FSIR) model, where the infection probability of a node is proportional to its fraction of infected neighbors. Our findings have dramatic implications for information contagion. For example, using the FSIR model we find that real-world social networks have a finite epidemic threshold in contrast to the zero threshold in disease epidemic models. This means that when individuals are overloaded with excess information feeds, the information either reaches out the population if it is above the critical epidemic threshold, or it would never be well received.	[Feng, Ling; Li, Baowen] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore; [Feng, Ling; Li, Baowen] Natl Univ Singapore, Ctr Computat Sci & Engn, Singapore 117542, Singapore; [Feng, Ling] Agcy Sci Technol & Res, Inst High Performance Comp, Complex Syst Programme, Singapore 138632, Singapore; [Hu, Yanqing] Sun Yat Sen Univ, Sch Informat Sci & Technol, Guangzhou 510006, Guangdong, Peoples R China; [Hu, Yanqing] Southwest Jiaotong Univ, Sch Math, Chengdu 610031, Peoples R China; [Li, Baowen] Tongji Univ, Sch Phys Sci & Engn, Ctr Phonon & Thermal Energy Sci, Shanghai 200092, Peoples R China; [Stanley, H. Eugene] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [Stanley, H. Eugene] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Havlin, Shlomo] Bar Ilan Univ, Dept Phys, IL-52900 Ramat Gan, Israel; [Braunstein, Lidia A.] Univ Nacl Mar del Plata, CONICET, Inst Invest Fisicas Mar del Plata IFIMAR, RA-7600 Mar Del Plata, Buenos Aires, Argentina	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); Sun Yat Sen University; Southwest Jiaotong University; Tongji University; Boston University; Boston University; Bar Ilan University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata	Feng, L (corresponding author), Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore.	fengl@ihpc.a-star.edu.sg	Havlin, Shlomo/ABF-1527-2020; Li, Baowen/G-3003-2011; Feng, Ling/ABD-1751-2020	Li, Baowen/0000-0002-8728-520X; Feng, Ling/0000-0001-6578-2558; Stanley, H./0000-0003-2800-4495	Singapore National Science Foundation grant "Econophysics and Complex Networks" [R-144-000-313-133]; China National Science Foundation [61203156]; Fundamental Research Funds for the Central Universities [2682014RC17]; Defense Threat Reduction Agency (DTRA) [HDTRA1-14-1-0017]; Office of Naval Research (ONR) [N00014-14-1-0738]; National Science Foundation (NSF) [CMMI 1125290]; European MULTIPLEX; LINC; CONGAS projects; Israel Science Foundation; FONCyT PICT [0429/2013]	Singapore National Science Foundation grant "Econophysics and Complex Networks"; China National Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); Office of Naval Research (ONR)(Office of Naval Research); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); European MULTIPLEX; LINC; CONGAS projects; Israel Science Foundation(Israel Science Foundation); FONCyT PICT(ANPCyTFONCyT)	LF and BL are supported by the Singapore National Science Foundation grant "Econophysics and Complex Networks" (R-144-000-313-133). YH is supported by China National Science Foundation Grant No. 61203156 and the Fundamental Research Funds for the Central Universities Grant No. 2682014RC17. HES is supported by Defense Threat Reduction Agency (DTRA) - HDTRA1-14-1-0017, Office of Naval Research (ONR) - N00014-14-1-0738, National Science Foundation (NSF) - CMMI 1125290. SH is supported by the European MULTIPLEX, LINC and CONGAS projects and the Israel Science Foundation. LAB is supported by FONCyT PICT 0429/2013.	Adar E, 2005, 2005 IEEE/WIC/ACM International Conference on Web Intelligence, Proceedings, P207, DOI 10.1109/WI.2005.151; Anagnostopoulos A., 2008, P 14 ACM SIGKDD INT, P7, DOI DOI 10.1145/1401890.1401897; [Anonymous], 2014, ARXIV14036838PHYSICS, DOI DOI 10.1002/JBM.A.34687; [Anonymous], 2013, IFENG NEWS       FEB; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Aral S, 2011, MANAGE SCI, V57, P1623, DOI 10.1287/mnsc.1110.1421; Bailey NTJ, 1975, MATH THEORY INFECT D; Bakshy E., 2012, P 21 INT C WORLD WID, P519, DOI [10.1145/2187836.2187907, DOI 10.1145/2187836.2187907]; Borge-Holthoefer J, 2013, J COMPLEX NETW, V1, P3, DOI 10.1093/comnet/cnt006; Borge-Holthoefer J, 2013, J STAT PHYS, V151, P383, DOI 10.1007/s10955-012-0595-6; Braunstein LA, 2007, INT J BIFURCAT CHAOS, V17, P2215, DOI 10.1142/S0218127407018361; Bunde A., 1991, FRACTALS DISORDERED; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Cha M, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P1; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; Galam S, 2002, EUR PHYS J B, V25, P403, DOI 10.1140/epjb/e20020045; Galuba W., 2010, WOSN, V10, P3; Ghosh Rumi, 2011, ARXIV11060346; Granovetter M., 1983, SOCIOLOGICAL THEORY, V1, P201, DOI [10.2307/202051, DOI 10.2307/202051]; GRUHL D., 2004, SIGKDD EXPLORATIONS, V13, P491, DOI DOI 10.1145/1046456.1046462; Guo L, 2008, PODC'08: PROCEEDINGS OF THE 27TH ANNUAL ACM SYMPOSIUM ON PRINCIPLES OF DISTRIBUTED COMPUTING, P283, DOI 10.1145/1400751.1400789; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5; Hodas N. O., 2013, ARXIV13085015; Hodas NO, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P249, DOI 10.1109/SocialCom-PASSAT.2012.129; Hodas NO., 2013, P 7 INT AAAI C WEBL, V13, P8; Jong Gun Lee, 2010, Proceedings 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology (WI-IAT), P623, DOI 10.1109/WI-IAT.2010.209; Kenah E, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036113; Krapivsky PL, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238701; Lambiotte R, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/18007; Lerman K., 2010, P 4 INT C WEB SOC ME, P90, DOI DOI 10.1146/ANNUREV.AN.03.100174.001431; Li Q, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066101; Liggett T., 1999, STOCHASTIC INTERACTI, V324; Liu RR, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026110; Meloni S, 2012, SPRINGER SER OPTIM A, V57, P435, DOI 10.1007/978-1-4614-0754-6_15; Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122; Nekovee M, 2007, PHYSICA A, V374, P457, DOI 10.1016/j.physa.2006.07.017; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; NOWAK A, 1990, PSYCHOL REV, V97, P362, DOI 10.1037/0033-295X.97.3.362; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Romero D. M., 2011, P 20 INT C WORLD WID, P695, DOI [10.1145/1963405.1963503, DOI 10.1145/1963405.1963503]; Shao J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.018701; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; Valdez LD, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.050803; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499	45	63	65	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0126090	10.1371/journal.pone.0126090	http://dx.doi.org/10.1371/journal.pone.0126090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161956	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300002
J	Gibson-Reinemer, DK; Rahel, FJ				Gibson-Reinemer, Daniel K.; Rahel, Frank J.			Inconsistent Range Shifts within Species Highlight Idiosyncratic Responses to Climate Warming	PLOS ONE			English	Article							ELEVATIONAL GRADIENT; DYNAMICS; IMPACTS; COMMUNITIES; MIGRATION	Climate in part determines species' distributions, and species' distributions are shifting in response to climate change. Strong correlations between the magnitude of temperature changes and the extent of range shifts point to warming temperatures as the single most influential factor causing shifts in species' distributions species. However, other abiotic and biotic factors may alter or even reverse these patterns. The importance of temperature relative to these other factors can be evaluated by examining range shifts of the same species in different geographic areas. When the same species experience warming in different geographic areas, the extent to which they show range shifts that are similar in direction and magnitude is a measure of temperature's importance. We analyzed published studies to identify species that have documented range shifts in separate areas. For 273 species of plants, birds, mammals, and marine invertebrates with range shifts measured in multiple geographic areas, 42-50% show inconsistency in the direction of their range shifts, despite experiencing similar warming trends. Inconsistency of within-species range shifts highlights how biotic interactions and local, non-thermal abiotic conditions may often supersede the direct physiological effects of temperature. Assemblages show consistent responses to climate change, but this predictability does not appear to extend to species considered individually.	Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming	Gibson-Reinemer, DK (corresponding author), Illinois Nat Hist Survey, Havana, IL 62644 USA.	danielkgr@gmail.com						Araujo MB, 2011, ECOGRAPHY, V34, P897, DOI 10.1111/j.1600-0587.2011.06919.x; Archaux F, 2004, IBIS, V146, P138, DOI 10.1111/j.1474-919X.2004.00246.x; Bassler C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065842; Bodin J, 2013, J VEG SCI, V24, P269, DOI 10.1111/j.1654-1103.2012.01456.x; Boulangeat I, 2012, ECOL LETT, V15, P584, DOI 10.1111/j.1461-0248.2012.01772.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; Comte L, 2013, ECOGRAPHY, V36, P1236, DOI 10.1111/j.1600-0587.2013.00282.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Felde VA, 2012, ECOGRAPHY, V35, P922, DOI 10.1111/j.1600-0587.2011.07057.x; Foden W, 2007, DIVERS DISTRIB, V13, P245; Gibson-Reinemer DK, 2015, ECOL EVOL, V5, P2340, DOI 10.1002/ece3.1518; Graham RW, 1996, SCIENCE, V272, P1601; Hansen BB, 2013, SCIENCE, V339, P313, DOI 10.1126/science.1226766; Holzinger B, 2008, PLANT ECOL, V195, P179, DOI 10.1007/s11258-007-9314-9; IPCC, 2007, CLIMATE CHANGE 2007; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; MacArthur R.H., 1972, pvii; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parolo G, 2008, BASIC APPL ECOL, V9, P100, DOI 10.1016/j.baae.2007.01.005; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pitt NR, 2010, MAR FRESHWATER RES, V61, P963, DOI 10.1071/MF09225; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2011, J EXP MAR BIOL ECOL, V400, P145, DOI 10.1016/j.jembe.2011.02.018; Popy S, 2010, J BIOGEOGR, V37, P57, DOI 10.1111/j.1365-2699.2009.02197.x; Post E, 2002, NATURE, V420, P168, DOI 10.1038/nature01064; Przeslawski R, 2012, ESTUAR COAST SHELF S, V113, P205, DOI 10.1016/j.ecss.2012.08.005; R Core Development Team, 2013, R LANG ENV STAT COMP; Rowe RJ, 2010, GLOBAL CHANGE BIOL, V16, P2930, DOI 10.1111/j.1365-2486.2009.02150.x; Storlie C, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0576; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037	41	34	35	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132103	10.1371/journal.pone.0132103	http://dx.doi.org/10.1371/journal.pone.0132103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162013	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300092
J	Gong, Y; Li, J; Sun, Y; Fu, ZJ; Liu, CH; Evans, L; Tian, K; Saba, N; Fredrick, T; Morss, P; Chen, J; Smith, LEH				Gong, Yan; Li, Jie; Sun, Ye; Fu, Zhongjie; Liu, Chi-Hsiu; Evans, Lucy; Tian, Katherine; Saba, Nicholas; Fredrick, Thomas; Morss, Peyton; Chen, Jing; Smith, Lois E. H.			Optimization of an Image-Guided Laser-Induced Choroidal Neovascularization Model in Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; MURINE MODEL; AGE; ANGIOGENESIS; SEVERITY; DYSFUNCTION; MECHANISMS; MOUSE	The mouse model of laser-induced choroidal neovascularization (CNV) has been used in studies of the exudative form of age-related macular degeneration using both the conventional slit lamp and a new image-guided laser system. A standardized protocol is needed for consistent results using this model, which has been lacking. We optimized details of laser-induced CNV using the image-guided laser photocoagulation system. Four lesions with similar size were consistently applied per eye at approximately double the disc diameter away from the optic nerve, using different laser power levels, and mice of various ages and genders. After 7 days, the mice were sacrificed and retinal pigment epithelium/choroid/sclera was flat-mounted, stained with Isolectin B4, and imaged. Quantification of the area of the laser-induced lesions was performed using an established and constant threshold. Exclusion criteria are described that were necessary for reliable data analysis of the laser-induced CNV lesions. The CNV lesion area was proportional to the laser power levels. Mice at 12-16 weeks of age developed more severe CNV than those at 6-8 weeks of age, and the gender difference was only significant in mice at 12-16 weeks of age, but not in those at 6-8 weeks of age. Dietary intake of omega-3 long-chain polyunsaturated fatty acid reduced laser-induced CNV in mice. Taken together, laser-induced CNV lesions can be easily and consistently applied using the image-guided laser platform. Mice at 6-8 weeks of age are ideal for the laser-induced CNV model.	[Gong, Yan; Li, Jie; Sun, Ye; Fu, Zhongjie; Liu, Chi-Hsiu; Evans, Lucy; Tian, Katherine; Saba, Nicholas; Fredrick, Thomas; Morss, Peyton; Chen, Jing; Smith, Lois E. H.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston Childrens Hosp, Boston, MA 02138 USA; [Li, Jie] Sichuan Prov Hosp, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China; [Li, Jie] Sichuan Acad Med Sci, Chengdu, Sichuan, Peoples R China	Harvard University; Boston Children's Hospital; Harvard Medical School; Sichuan Provincial People's Hospital	Smith, LEH (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Boston Childrens Hosp, Boston, MA 02138 USA.	lois.smith@childrens.harvard.edu		Gong, Yan/0000-0002-4805-0459; Sun, Ye/0000-0002-7674-9056; FU, ZHONGJIE/0000-0002-8182-2983; Morss-Walton, Peyton/0000-0002-9200-9939	National Institutes of Health/National Eye Institute [R01 EY022275, R01 EY017017, P01 HD18655, R01 EY024963]; Lowy Medical Research Institute; European Commission FP7 [305485]; Ministry of Science and Technology, Taiwan, R.O.C. [104-2917-I-564-026]; China Scholarship Council [201306240082]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022275, R01EY017017, R01EY024963] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Lowy Medical Research Institute; European Commission FP7(European CommissionEuropean Commission Joint Research Centre); Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); China Scholarship Council(China Scholarship Council); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health/National Eye Institute (https://www.nei.nih.gov/, R01 EY022275, R01 EY017017, P01 HD18655), Lowy Medical Research Institute (http://www.lmri.net/), European Commission FP7 (http://cordis.europa.eu/fp7/home_en.html) project 305485 PREVENT-ROP (LEHS), National Institutes of Health/National Eye Institute (https://www.nei.nih.gov/, R01 EY024963, JC), Ministry of Science and Technology, Taiwan, R.O.C. (http://www.most.gov.tw/mp.aspx?mp=7) Postdoctoral Research Abroad Program (104-2917-I-564-026, CHL), and China Scholarship Council (http://en.csc.edu.cn/) State Scholarship Fund (201306240082, JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht ED, 2003, FRONT BIOSCI-LANDMRK, V8, pD416, DOI 10.2741/1001; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Ashcroft GS, 2002, J CLIN INVEST, V110, P615, DOI 10.1172/JCI200215704; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Espinosa-Heidmann DG, 2005, EXP EYE RES, V80, P413, DOI 10.1016/j.exer.2004.10.008; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Espinosa-Heidmann DG, 2002, INVEST OPHTH VIS SCI, V43, P1567; Framme C, 2008, OPHTHALMOLOGICA, V222, P254, DOI 10.1159/000136903; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Garvin S, 2003, CANCER RES, V63, P8742; Giani A, 2011, INVEST OPHTH VIS SCI, V52, P3880, DOI 10.1167/iovs.10-6266; He Q, 2014, J BONE MINER RES, V29, P1217, DOI 10.1002/jbmr.2114; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Jost M, 2007, AM J PATHOL, V171, P1369, DOI 10.2353/ajpath.2007.070074; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Lambert V, 2013, NAT PROTOC, V8, P2197, DOI 10.1038/nprot.2013.135; Li J, 2014, INVEST OPHTH VIS SCI, V55, P8267, DOI 10.1167/iovs.14-15623; Moghaddam-Taaheri S., 2011, J CLIN EXP OPHTHALMO, V2; Nagai N, 2014, INVEST OPHTH VIS SCI, V55, P3709, DOI 10.1167/iovs.14-13989; Noel A, 2007, TRENDS MOL MED, V13, P345, DOI 10.1016/j.molmed.2007.06.005; Pennesi ME, 2012, MOL ASPECTS MED, V33, P487, DOI 10.1016/j.mam.2012.06.003; Poor SH, 2014, INVEST OPHTH VIS SCI, V55, P6525, DOI 10.1167/iovs.14-15067; Ryan S J, 1979, Trans Am Ophthalmol Soc, V77, P707; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Shi YY, 2011, GRAEF ARCH CLIN EXP, V249, P1667, DOI 10.1007/s00417-011-1699-4; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Zhou JH, 2005, MOL VIS, V11, P414; Zhu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094743	29	50	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132643	10.1371/journal.pone.0132643	http://dx.doi.org/10.1371/journal.pone.0132643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161975	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300164
J	Huang, ASE; Chen, WC; Huang, WT; Huang, ST; Lo, YC; Wei, SH; Kuo, HW; Chan, PC; Hung, MN; Liu, YL; Mu, JJ; Yang, JY; Liu, DP; Chou, JH; Chuang, JH; Chang, FY				Huang, Angela Song-En; Chen, Wan-Chin; Huang, Wan-Ting; Huang, Shih-Tse; Lo, Yi-Chun; Wei, Sung-Hsi; Kuo, Hung-Wei; Chan, Pei-Chun; Hung, Min-Nan; Liu, Yu-Lun; Mu, Jung-Jung; Yang, Jyh-Yuan; Liu, Ding-Ping; Chou, Jih-Haw; Chuang, Jen-Hsiang; Chang, Feng-Yee			Public Health Responses to Reemergence of Animal Rabies, Taiwan, July 16-December 28, 2013	PLOS ONE			English	Article							REAL-TIME PCR; VIRUS; ASSAY; TAQMAN; VACCINATION; INFECTION; DIAGNOSIS; DESIGN; DNA	Taiwan had been free of indigenous human and animal rabies case since canine rabies was eliminated in 1961. In July 2013, rabies was confirmed among three wild ferret-badgers, prompting public health response to prevent human rabies cases. This descriptive study reports the immediate response to the reemergence of rabies in Taiwan. Response included enhanced surveillance for human rabies cases by testing stored cerebrospinal fluids (CSF) from patients with encephalitides of unknown cause by RT-PCR, prioritizing vaccine use for postexposure prophylaxis (PEP) during periods of vaccine shortage and subsequent expansion of PEP, surveillance of animal bites using information obtained from vaccine application, roll out of preexposure prophylaxis (PrEP) with vaccine stock restoration, surveillance for adverse events following immunization (AEFI), and ensuring surge capacity to respond to general public inquiries by phone and training for healthcare professionals. Enhanced surveillance for human rabies found no cases after testing 205 stored CSF specimens collected during January 2010-July 2013. During July 16 to December 28, 2013, we received 8,241 rabies PEP application; 6,634 (80.5%) were consistent with recommendations. Among the 6,501persons who received at least one dose of rabies vaccine postexposure, 4,953 (76.2%) persons who were bitten by dogs; only 59 (0.9%) persons were bitten by ferret-badgers. During the study period, 6,247 persons received preexposure prophylaxis. There were 23 reports of AEFI; but no anaphylaxis, Guillain-Barre syndrome, or acute disseminated encephalomyelitis were found. During the study period, there were 40,312 calls to the Taiwan Centers for Disease Control hotline, of which, 8,692 (22%) were related to rabies. Recent identification of rabies among ferret-badgers in a previously rabies-free country prompted rapid response. To date, no human rabies has been identified. Continued multifaceted surveillance and interministerial collaboration are crucial to achieve the goal of rabies-free status in Taiwan.	[Huang, Angela Song-En; Chen, Wan-Chin; Huang, Wan-Ting; Huang, Shih-Tse; Lo, Yi-Chun; Wei, Sung-Hsi; Chan, Pei-Chun; Hung, Min-Nan; Liu, Yu-Lun] Ctr Dis Control, Off Prevent Med, Taipei, Taiwan; [Kuo, Hung-Wei; Liu, Ding-Ping] Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan; [Mu, Jung-Jung; Yang, Jyh-Yuan] Ctr Dis Control, Ctr Res & Diagnost, Taipei, Taiwan; [Chou, Jih-Haw; Chuang, Jen-Hsiang] Ctr Dis Control, Off Deputy Director, Taipei, Taiwan; [Chang, Feng-Yee] Triserv Gen Hosp, Natl Def Med Ctr, Taipei, Taiwan	Centers For Disease Control - Taiwan; Centers For Disease Control - Taiwan; Centers For Disease Control - Taiwan; Centers For Disease Control - Taiwan; National Defense Medical Center; Tri-Service General Hospital	Chuang, JH (corresponding author), Ctr Dis Control, Off Deputy Director, Taipei, Taiwan.	jhchuang@cdc.gov.tw; fychang@ndmctsgh.edu.tw	Huang, Wan-Ting/E-3497-2010; Chuang, Jen-Hsiang/G-4356-2010	Huang, Wan-Ting/0000-0002-4344-9567; Chuang, Jen-Hsiang/0000-0002-7114-3418; Liu, Ding-Ping/0000-0002-8596-3572; Chen, Wan-Chin/0000-0002-2278-6193				[Anonymous], 2013, MEDICAL DICTIONARY F; [Anonymous], 2014, ANIMAL RABIES SURVEI; [Anonymous], 2008, SURV BAT RAB TAIW; Bonzel L, 2008, PEDIATR INFECT DIS J, V27, P589, DOI 10.1097/INF.0b013e3181694fb9; Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001; Chen Y, 2011, J CLIN MICROBIOL, V49, P1653, DOI 10.1128/JCM.02184-10; Chidlow GR, 2009, VIRUSES-BASEL, V1, P42, DOI 10.3390/v1010042; Chiou HY, 2014, EMERG INFECT DIS, V20, P790, DOI 10.3201/eid2005.131389; Chou CY WH, 2013, TAIWAN EPIDEMIOLOGY, V29, P30; Crepin P, 1998, J CLIN MICROBIOL, V36, P1117, DOI 10.1128/JCM.36.4.1117-1121.1998; Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008; Feyssaguet M, 2007, VACCINE, V25, P2244, DOI 10.1016/j.vaccine.2006.12.012; Fooks AR, 2014, LANCET, V384, P1389, DOI 10.1016/S0140-6736(13)62707-5; Funahashi Y, 2010, J CLIN MICROBIOL, V48, P825, DOI 10.1128/JCM.01699-09; Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004; Heaton PR, 1997, J CLIN MICROBIOL, V35, P2762, DOI 10.1128/JCM.35.11.2762-2766.1997; Hsu Yung-Hsiang, 2006, Kaohsiung Journal of Medical Sciences, V22, P94, DOI 10.1016/S1607-551X(09)70227-X; Huang WT, 2010, VACCINE, V28, P7161, DOI 10.1016/j.vaccine.2010.08.069; Knoll A, 2002, J MED VIROL, V67, P259, DOI 10.1002/jmv.2216; Lardon Z, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000723; Lee SH CK, 2003, ANIMAL HLTH RES I RE, V39, P19; Lee SH CK, 2006, ANIMAL HLTH RES I RE, V41, P11; Lee SH TK, 2004, ANIMAL HLTH RES I RE, V40, P51; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Ministry of Health and Welfare EY Taiwan, PHARMACOVIGILANCE IN; Noordhoek GT, 2008, J CLIN VIROL, V41, P75, DOI 10.1016/j.jcv.2007.09.011; Shirato K, 2005, J VIROL METHODS, V126, P119, DOI 10.1016/j.jviromet.2005.02.001; Smith IL, 2001, J VIROL METHODS, V98, P33, DOI 10.1016/S0166-0934(01)00354-8; Sugita S, 2008, BRIT J OPHTHALMOL, V92, P928, DOI 10.1136/bjo.2007.133967; Taiwan Animal Health Research Institute, 2013, SURV RAB AN BRAIN TI; Taiwan Centers for Disease Control, 2013, RABIES POSTEXPOSURE; Taiwan Centers for Disease Control, 2013, MIN HLTH WELF COUNC; Taiwan Centers for Disease Control, 2013, RESP ONG RAB SIT; Tuan YC HM, 2013, TAIWAN EPIDEMIOLOGY, V29, P201; U.S. Centers for Disease Control and Prevention, 2011, COST OF RABIES PREVE; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7; Weng HY, 2010, VET RES, V41, DOI 10.1051/vetres/2009059; World Health Organization, 2012, WORLD RABIES DAY 201; World Health Organization, 2013, WHO TECHN REP SER, V2nd; World Health Organization, 2014, RABIES GUIDE FOR POS; World Organization for Animal Health, 2013, WEEKLY DIS INFO 0801; World Organization for Animal Health, 2013, WEEKLY DIS INFO 0906; World Organization for Animal Health, 2013, WEEKLY DIS INFO 0718	43	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132160	10.1371/journal.pone.0132160	http://dx.doi.org/10.1371/journal.pone.0132160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162074	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300099
J	Rojo, D; Canuto, GAB; Castilho-Martins, EA; Tavares, MFM; Barbas, C; Lopez-Gonzalvez, A; Rivas, L				Rojo, David; Canuto, Gisele A. B.; Castilho-Martins, Emerson A.; Tavares, Marina F. M.; Barbas, Coral; Lopez-Gonzalvez, Angeles; Rivas, Luis			A Multiplatform Metabolomic Approach to the Basis of Antimonial Action and Resistance in Leishmania infantum	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; DRUG-RESISTANCE; GENE-EXPRESSION; TRYPAREDOXIN PEROXIDASE; DONOVANI AMASTIGOTES; ENERGY-METABOLISM; ELEVATED LEVELS; IN-VITRO; TRYPANOTHIONE; MILTEFOSINE	There is a rising resistance against antimony drugs, the gold-standard for treatment until some years ago. That is a serious problem due to the paucity of drugs in current clinical use. In a research to reveal how these drugs affect the parasite during treatment and to unravel the underlying basis for their resistance, we have employed metabolomics to study treatment in Leishmania infantum promastigotes. This was accomplished first through the untargeted analysis of metabolic snapshots of treated and untreated parasites both resistant and responders, utilizing a multiplatform approach to give the widest as possible coverage of the metabolome, and additionally through novel monitoring of the origin of the detected alterations through a C-13 traceability experiment. Our data stress a multi-target metabolic alteration with treatment, affecting in particular the cell redox system that is essential to cope with detoxification and biosynthetic processes. Additionally, relevant changes were noted in amino acid metabolism. Our results are in agreement with other authors studying other Leishmania species.	[Rojo, David; Canuto, Gisele A. B.; Castilho-Martins, Emerson A.; Barbas, Coral; Lopez-Gonzalvez, Angeles] Univ CEU San Pablo, Fac Farm, CEMBIO, Unidad Asociada Interacciones Metab & Bioanal CSI, Madrid 28668, Spain; [Canuto, Gisele A. B.; Tavares, Marina F. M.] Univ Sao Paulo, Inst Chem, BR-05508000 Sao Paulo, SP, Brazil; [Castilho-Martins, Emerson A.] Univ Fed Amapa, Colegiado Med, Macapa, AP, Brazil; [Rivas, Luis] CSIC, Unidad Asociada Interacciones Metab & Bioanal CSI, E-28040 Madrid, Spain	San Pablo CEU University; Universidade de Sao Paulo; Fundacao Universidade Federal do Amapa; Consejo Superior de Investigaciones Cientificas (CSIC)	Lopez-Gonzalvez, A (corresponding author), Univ CEU San Pablo, Fac Farm, CEMBIO, Unidad Asociada Interacciones Metab & Bioanal CSI, Campus Monteprincipe,Boadilla Monte, Madrid 28668, Spain.	alopgon@ceu.es; luis.rivas@cib.csic.es	Castilho-Martins, Emerson Augusto/I-2094-2014; Barbas, Coral/K-3871-2014; Canuto, Gisele A B/N-7338-2015; Rivas, Luis/O-8657-2017; Lopez-Gonzalvez, Angeles/K-4361-2014	Castilho-Martins, Emerson Augusto/0000-0003-0542-4294; Barbas, Coral/0000-0003-4722-491X; Canuto, Gisele A B/0000-0002-6616-3705; Rivas, Luis/0000-0002-2958-3233; Lopez-Gonzalvez, Angeles/0000-0002-6363-7135	Spanish Ministry of Economy and Competitiveness [CTQ2014-55279-R]; European Aeronautic Defence and Space Company - Construcciones Aeronauticas SA; Brazilian Air Force; FIS [PS12-02706]; VI PN de I+D+I; Instituto de Salud Carlos III Subdireccion General de Redes y Proyectos Cooperativos RD [12/0018/0007]; FAPESP;  [RD06/0021/0006-FEDER]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Aeronautic Defence and Space Company - Construcciones Aeronauticas SA; Brazilian Air Force; FIS(Instituto de Salud Carlos III); VI PN de I+D+I; Instituto de Salud Carlos III Subdireccion General de Redes y Proyectos Cooperativos RD; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); 	This work was supported by grants from Spanish Ministry of Economy and Competitiveness (CTQ2014-55279-R) (CB) and European Aeronautic Defence and Space Company - Construcciones Aeronauticas SA and Brazilian Air Force (FAB) (GC and EC) and from FIS PS12-02706 and VI PN de I+D+I 2008-2011, Instituto de Salud Carlos III Subdireccion General de Redes y Proyectos Cooperativos RD 12/0018/0007 (http://www.isciii.es/ISCIII/es/) and RD06/0021/0006-FEDER (LR). DR received a fellowship from the Spanish Ministry of Economy and Competitiveness (formerly MICINN). GABC is thankful to FAPESP for a graduate fellowship (http://www.fapesp.br/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gomez MA, 2014, J ANTIMICROB CHEMOTH, V69, P139, DOI 10.1093/jac/dkt334; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Ashutosh, 2012, ANTIMICROB AGENTS CH, V56, P518, DOI 10.1128/AAC.00736-11; Berg M, 2013, MOL MICROBIOL, V90, P428, DOI 10.1111/mmi.12374; Berg M, 2013, PARASITOLOGY, V140, P1492, DOI 10.1017/S0031182013000140; Biyani N, 2011, MOL BIOCHEM PARASIT, V179, P91, DOI 10.1016/j.molbiopara.2011.06.004; Boitz JM, 2012, TRENDS PARASITOL, V28, P345, DOI 10.1016/j.pt.2012.05.005; Brannigan JA, 2010, J MOL BIOL, V396, P985, DOI 10.1016/j.jmb.2009.12.032; Brotherton MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081899; Canuto GAB, 2012, ELECTROPHORESIS, V33, P1901, DOI 10.1002/elps.201200007; Carter NS, 2008, ADV EXP MED BIOL, V625, P141, DOI 10.1007/978-0-387-77570-8_12; Castilho-Martins EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027818; Choudhury K, 2008, INT J PARASITOL, V38, P1411, DOI 10.1016/j.ijpara.2008.03.005; Das S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002527; De Gaudenzi JG, 2011, ESSAYS BIOCHEM, V51, P31, DOI [10.1042/bse0510031, 10.1042/BSE0510031]; Downing T, 2012, INFECT GENET EVOL, V12, P149, DOI 10.1016/j.meegid.2011.11.005; El Fadili K, 2009, EXP PARASITOL, V123, P51, DOI 10.1016/j.exppara.2009.05.013; Flohe L, 2012, INT J MED MICROBIOL, V302, P216, DOI 10.1016/j.ijmm.2012.07.008; Fyfe PK, 2012, P NATL ACAD SCI USA, V109, P11693, DOI 10.1073/pnas.1202593109; Gika HG, 2008, J CHROMATOGR B, V871, P299, DOI 10.1016/j.jchromb.2008.05.048; Ginger ML, 2001, J BIOL CHEM, V276, P11674, DOI 10.1074/jbc.M006850200; Gonzalez U, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004834.pub2; Guimond C, 2003, NUCLEIC ACIDS RES, V31, P5886, DOI 10.1093/nar/gkg806; Haimeur A, 1999, MOL MICROBIOL, V34, P726, DOI 10.1046/j.1365-2958.1999.01634.x; HART DT, 1982, EXP PARASITOL, V54, P397, DOI 10.1016/0014-4894(82)90049-2; Manzano JI, 2011, ANTIMICROB AGENTS CH, V55, P1045, DOI 10.1128/AAC.01545-10; Krauth-Siegel RL, 2012, ANTIOXID REDOX SIGN, V17, P583, DOI 10.1089/ars.2011.4392; Kumar A, 2010, BRIT J CLIN PHARMACO, V70, P609, DOI 10.1111/j.1365-2125.2010.03716.x; Kumar D, 2009, ANTIMICROB AGENTS CH, V53, P835, DOI 10.1128/AAC.01233-08; Lefurgey A, 2005, J EUKARYOT MICROBIOL, V52, P277, DOI 10.1111/j.1550-7408.2005.00030.x; Manta B, 2013, BBA-GEN SUBJECTS, V1830, P3199, DOI 10.1016/j.bbagen.2013.01.013; Marquis N, 2005, MOL MICROBIOL, V57, P1690, DOI 10.1111/j.1365-2958.2005.04782.x; Matrangolo FSV, 2013, MOL BIOCHEM PARASIT, V190, P63, DOI 10.1016/j.molbiopara.2013.06.006; Maugeri DA, 2003, MOL BIOCHEM PARASIT, V130, P117, DOI 10.1016/S0166-6851(03)00173-7; Mehta A, 2006, FREE RADICAL BIO MED, V40, P1857, DOI 10.1016/j.freeradbiomed.2006.01.024; Mina JG, 2011, ORG BIOMOL CHEM, V9, P1823, DOI 10.1039/c0ob00871k; Moreira DS, 2013, INT J PARASITOL-DRUG, V3, P143, DOI 10.1016/j.ijpddr.2013.08.001; Mukherjee B, 2013, P NATL ACAD SCI USA, V110, pE575, DOI [10.1073/pnas.1213839110, 10.]; Muniz-Junqueira MI, 2008, INT IMMUNOPHARMACOL, V8, P1633, DOI 10.1016/j.intimp.2008.07.011; Novozhilova NM, 2010, BIOCHEMISTRY-MOSCOW+, V75, P686, DOI 10.1134/S0006297910060027; Opperdoes Fred R., 2008, P123; Pathak MK, 2001, J IMMUNOL, V167, P3391, DOI 10.4049/jimmunol.167.6.3391; Perez-Pertejo Y, 2006, BBA-GEN SUBJECTS, V1760, P10, DOI 10.1016/j.bbagen.2005.09.003; Perry MR, 2013, P NATL ACAD SCI USA, V110, P19932, DOI 10.1073/pnas.1311535110; Rai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074862; Requena JM, 2012, FRONT BIOSCI, V17, P2069, DOI DOI 10.2741/3840; Saunders EC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003888; Scheltema RA, 2010, PARASITOLOGY, V137, P1291, DOI 10.1017/S0031182009992022; Seblova V, 2014, ANTIMICROB AGENTS CH, V58, P6273, DOI 10.1128/AAC.02406-13; Singh N, 2007, PARASITOLOGY, V134, P777, DOI 10.1017/S0031182007002284; Solano-Gallego L, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-86; Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; t'Kindt R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000904; Tielens AGM, 1998, PARASITOL TODAY, V14, P265, DOI 10.1016/S0169-4758(98)01263-0; van Griensven J, 2010, LANCET INFECT DIS, V10, P184, DOI 10.1016/S1473-3099(10)70011-6; Vanaerschot M, 2014, FEMS MICROBIOL REV, V38, P41, DOI 10.1111/1574-6976.12032; Vanaerschot M, 2012, J INFECT DIS, V206, P752, DOI 10.1093/infdis/jis424; Vincent IM, 2015, J BIOMOL SCREEN, V20, P44, DOI 10.1177/1087057114551519; Vincent IM, 2014, INT J PARASITOL-DRUG, V4, P20, DOI 10.1016/j.ijpddr.2013.11.002; Walker J, 2012, MOL BIOCHEM PARASIT, V183, P166, DOI 10.1016/j.molbiopara.2012.03.002; Williams RAM, 2009, BIOCHEM J, V420, P451, DOI 10.1042/BJ20082441; Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200; Wyllie S, 2008, ANTIMICROB AGENTS CH, V52, P1359, DOI 10.1128/AAC.01563-07; Wyllie S, 2010, MOL BIOCHEM PARASIT, V173, P162, DOI 10.1016/j.molbiopara.2010.05.015; Zhang K, 2010, ADV EXP MED BIOL, V688, P238; Zhou Y, 2004, J BIOL CHEM, V279, P37445, DOI 10.1074/jbc.M404383200	69	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130675	10.1371/journal.pone.0130675	http://dx.doi.org/10.1371/journal.pone.0130675			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161866	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300019
J	Serok, N; Blumenfeld-Lieberthal, E				Serok, Nimrod; Blumenfeld-Lieberthal, Efrat			A Simulation Model for Intra-Urban Movements	PLOS ONE			English	Article							MOBILITY; EMERGENCE	Human mobility patterns (HMP) have become of interest to a variety of disciplines. The increasing availability of empirical data enables researchers to analyze patterns of people's movements. Recent work suggested that HMP follow a Levy-flight distribution and present regularity. Here, we present an innovative agent-based model that simulates HMP for various purposes. It is based on the combination of regular movements with spatial considerations, represented by an expanded gravitation model. The agents in this model have different attributes that affect their choice of destination and the duration they stay in each location. Thus, their movement mimics real-life situations. This is a stochastic, bottom-up model, yet it yields HMP that qualitatively fit HMP empirical data in terms of individuals, as well as the entire population. Our results also correspond to real-life phenomena in terms of urban spatial dynamics, that is, the emergence of popular locations in the city due to bottom-up behavior of people. Our model is novel in being based on the assumption that HMP are space-dependent as well as follow high regularity. To our knowledge, we are the first to succeed in simulating HMP not only at the inter-city scale but also at the intra-urban one.	[Serok, Nimrod; Blumenfeld-Lieberthal, Efrat] Tel Aviv Univ, Yolanda & David Katz Fac Arts, David Azrieli Sch Architecture, IL-69978 Tel Aviv, Israel	Tel Aviv University	Blumenfeld-Lieberthal, E (corresponding author), Tel Aviv Univ, Yolanda & David Katz Fac Arts, David Azrieli Sch Architecture, IL-69978 Tel Aviv, Israel.	efratbl@post.tau.ac.il	Lieberthal, Efrat Blumenfeld/AAW-1116-2021	Blumenfeld-Lieberthal, Efrat/0000-0003-3660-0035				Adamic L. A, 2000, ZIPF POWER LAWS PARE; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Batty M, 2003, INT J GEOGR INF SCI, V17, P673, DOI 10.1080/1365881031000135474; Batty M., 2007, CITIES COMPLEXITY UN; Benenson I., 2004, COMPUT ENVIRON URBAN, V28, P1, DOI [10.1016/S01989715(02)00067-4, DOI 10.1016/S0198-9715(02)00067-4, DOI 10.1016/S01989715(02)00067-4]; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brockmann D, 2008, IEEE PERVAS COMPUT, V7, P28, DOI 10.1109/MPRV.2008.77; Brown DG, 2005, INT J GEOGR INF SCI, V19, P153, DOI 10.1080/13658810410001713399; Camp T, 2002, WIREL COMMUN MOB COM, V2, P483, DOI 10.1002/wcm.72; Chen X, 2008, J OPER RES SOC, V59, P25, DOI 10.1057/palgrave.jors.2602321; Dai J, 2013, PHYSICA A; Elsenbroich C, 2014, MODELLING NORMS, P65; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Groenevelt R, 2006, WIREL NETW, V12, P561, DOI 10.1007/s11276-006-6535-0; Han XP, 2010, PHYSCS PROC, V3, P1907, DOI 10.1016/j.phpro.2010.07.035; Hui P, 2005, P 2005 ACM SIGCOMM W, P244, DOI DOI 10.1145/1080139.1080142; Ioannidis S, 2006, INFOCOM; Janssen M. A., 2005, MODELLING ECOLOGICAL, P155; Jia T, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/11/P11024; Jiang B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021136; Kleinberg J, 2007, NATURE, V449, P287, DOI 10.1038/449287a; Lee K, 2009, IEEE INFOCOM SER, P855, DOI 10.1109/INFCOM.2009.5061995; Masucci AP, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022812; Matthews RB, 2007, LANDSCAPE ECOL, V22, P1447, DOI 10.1007/s10980-007-9135-1; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Portugali J., 1999, SELF ORG CITY; Portugali J, 2011, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-3-642-19451-1; Scafetta N, 2011, CHAOS INTERDISCIPLIN, V21; Sengupta RR, 2003, INT J GEOGR INF SCI, V17, P157, DOI 10.1080/1365881022000015990; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Troisi A, 2005, P NATL ACAD SCI USA, V102, P255, DOI 10.1073/pnas.0408308102; Wei JR, 2013, PHYSICA A; Yang SS, 2010, IEEE NETWORK, V24, P6, DOI 10.1109/MNET.2010.5578912; Zhao M, 2008, MILITARY COMMUNICATI, P1	35	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132576	10.1371/journal.pone.0132576	http://dx.doi.org/10.1371/journal.pone.0132576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161640	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300155
J	Wang, W; Ding, JH; Zhu, XL; Li, Y; Gu, YJ; Peng, WJ				Wang, Wei; Ding, Jianhui; Zhu, Xiaoli; Li, Yuan; Gu, Yajia; Peng, Weijun			Magnetic Resonance Imaging Characteristics of Ovarian Clear Cell Carcinoma	PLOS ONE			English	Article							CT; DIAGNOSIS; TUMORS; MRI; CANCER; MASSES; COMMON	Purpose To probe the magnetic resonance imaging (MRI) features of ovarian clear cell carcinoma (OCCC). Methods This study retrospectively collected MRI data for 21 pathology-confirmed OCCCs from 19 female patients. The MRI findings were analyzed to determine the tumor size, shape/edge, shape and number of protrusions within the cyst, cystic or necrotic components, signal intensity (SI) and enhancement features. Results The age of the 19 patients ranged from 28 to 63 years (mean age: 53 years). Unilateral tumors were found in 17 patients (17/19, 89%); the average size of all tumors was 10.8 cm. The tumors on MRI were classified into two categories: (a) "cystic adnexal mass with solid protrusions" in 12 (57%) and (b) "solid adnexal mass with cystic areas or necrosis" in 9 (43%). For group a, high to very high SI was observed for most tumors (10/12, 83%) on T1-weighted images (T1WIs), and very high SI was observed on T2-weighted images (T2WIs) for all 12 tumors. Most solid protrusions were irregular and few in number and exhibited heterogeneous intermediate SI on T1WIs and T2WIs and prolonged enhanced SI in the contrast study. All 9 OCCCs in group b were predominantly solid masses with unequally sized necrotic or cystic areas in which some cysts were located at the periphery of the tumor (4/9, 44%). The solid components in all 9 tumors showed iso- or slightly high SI on T1WIs, heterogeneous iso-high SI on T2WIs and heterogeneous prolonged enhancement. According to FIGO classification, 14 tumors (14/19, 74%) were stages I-II, and 5 (5/19, 26%) were stages III-IV. Conclusions On MRI, OCCCs present as large unilateral multilocular or unilocular cystic masses with irregular intermediate SI solid protrusions or predominantly solid masses with cysts or necrosis at an early FIGO stage.	[Wang, Wei; Ding, Jianhui; Gu, Yajia; Peng, Weijun] Fudan Univ, Shanghai Canc Ctr, Dept Radiol, Shanghai 200032, Peoples R China; [Wang, Wei; Ding, Jianhui; Zhu, Xiaoli; Li, Yuan; Gu, Yajia; Peng, Weijun] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Zhu, Xiaoli; Li, Yuan] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Peng, WJ (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Radiol, Shanghai 200032, Peoples R China.	pengweijun601@163.com						Bazot M, 2013, CLIN RADIOL, V68, pE1, DOI 10.1016/j.crad.2012.08.021; Behbakht K, 1998, GYNECOL ONCOL, V70, P255, DOI 10.1006/gyno.1998.5071; Brown DL, 2001, RADIOLOGY, V219, P213, DOI 10.1148/radiology.219.1.r01ap28213; Choi HJ, 2006, J COMPUT ASSIST TOMO, V30, P875, DOI 10.1097/01.rct.0000220795.45782.1d; del Carmen MG, 2012, GYNECOL ONCOL, V126, P481, DOI 10.1016/j.ygyno.2012.04.021; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; HERRMANN UJ, 1987, OBSTET GYNECOL, V69, P777; Jeong YY, 2003, RADIOGRAPHICS, V23, P969, DOI 10.1148/rg.234035001; Jeong YY, 2000, RADIOGRAPHICS, V20, P1445, DOI 10.1148/radiographics.20.5.g00se101445; Jung SE, 2002, RADIOGRAPHICS, V22, P1305, DOI 10.1148/rg.226025033; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kurtz AB, 1999, RADIOLOGY, V212, P19, DOI 10.1148/radiology.212.1.r99jl3619; Lalwani N, 2011, RADIOGRAPHICS, V31, P625, DOI 10.1148/rg.313105066; Ma FH, 2014, J MAGN RESON IMAGING, V40, P745, DOI 10.1002/jmri.24408; Matsuoka Y, 2001, EUR RADIOL, V11, P946, DOI 10.1007/s003300000671; Pectasides D, 2006, ONCOLOGIST, V11, P1089, DOI 10.1634/theoncologist.11-10-1089; RICHARDSON GS, 1985, NEW ENGL J MED, V312, P474, DOI 10.1056/NEJM198502213120804; SCHWARTZ LB, 1994, RADIOLOGY, V192, P55, DOI 10.1148/radiology.192.1.8208966; Serov SF, 1973, INT HISTOLOGICAL CLA, P1; Shaaban Akram, 2010, Top Magn Reson Imaging, V21, P247, DOI 10.1097/RMR.0b013e31823d8063; Szklaruk J, 2003, RADIOGRAPHICS, V23, P403, DOI 10.1148/rg.232025089; Takano M, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-53; Takemori M, 2002, ACTA OBSTET GYN SCAN, V81, P157, DOI 10.1034/j.1600-0412.2002.810212.x; Tanaka YO, 2011, EUR J RADIOL, V80, pE91, DOI 10.1016/j.ejrad.2010.05.032; Tanaka YO, 2011, J MAGN RESON IMAGING, V33, P633, DOI 10.1002/jmri.22430; Tavasolli FA, 2003, WHO CLASSIFICATION T, P8; Wagner BJ, 1994, RADIOGRAPHICS, V14, P75, DOI DOI 10.1148/RADI0GRAPHICS.14.6.7855346; WAGNER PJ, 1994, RADIOGRAPHICS, V14, P1351, DOI 10.1148/radiographics.14.6.7855346	28	1	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132406	10.1371/journal.pone.0132406	http://dx.doi.org/10.1371/journal.pone.0132406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161555	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300130
J	Ashina, K; Tsubosaka, Y; Nakamura, T; Omori, K; Kobayashi, K; Hori, M; Ozaki, H; Murata, T				Ashina, Kohei; Tsubosaka, Yoshiki; Nakamura, Tatsuro; Omori, Keisuke; Kobayashi, Koji; Hori, Masatoshi; Ozaki, Hiroshi; Murata, Takahisa			Histamine Induces Vascular Hyperpermeability by Increasing Blood Flow and Endothelial Barrier Disruption In Vivo	PLOS ONE			English	Article							NITRIC-OXIDE; VE-CADHERIN; MICROVASCULAR PERMEABILITY; THROMBIN; ADHESION; LEAKAGE; INFLAMMATION; BRADYKININ; JUNCTIONS; ADHERENS	Histamine is a mediator of allergic inflammation released mainly from mast cells. Although histamine strongly increases vascular permeability, its precise mechanism under in vivo situation remains unknown. We here attempted to reveal how histamine induces vascular hyperpermeability focusing on the key regulators of vascular permeability, blood flow and endothelial barrier. Degranulation of mast cells by antigen-stimulation or histamine treatment induced vascular hyperpermeability and tissue swelling in mouse ears. These were abolished by histamine H1 receptor antagonism. Intravital imaging showed that histamine dilated vasculature, increased blood flow, while it induced hyperpermeability in venula. Whole-mount staining showed that histamine disrupted endothelial barrier formation of venula indicated by changes in vascular endothelial cadherin (VE-cadherin) localization at endothelial cell junction. Inhibition of nitric oxide synthesis (NOS) by L-NAME or vasoconstriction by phenylephrine strongly inhibited the histamine-induced blood flow increase and hyperpermeability without changing the VE-cadherin localization. In vitro, measurements of trans-endothelial electrical resistance of human dermal microvascular endothelial cells (HDMECs) showed that histamine disrupted endothelial barrier. Inhibition of protein kinase C (PKC) or Rho-associated protein kinase (ROCK), NOS attenuated the histamine-induced barrier disruption. These observations suggested that histamine increases vascular permeability mainly by nitric oxide (NO)-dependent vascular dilation and subsequent blood flow increase and maybe partially by PKC/ROCK/NO-dependent endothelial barrier disruption.	[Ashina, Kohei; Hori, Masatoshi; Ozaki, Hiroshi] Univ Tokyo, Dept Vet Pharmacol, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Tsubosaka, Yoshiki; Nakamura, Tatsuro; Omori, Keisuke; Kobayashi, Koji; Murata, Takahisa] Univ Tokyo, Dept Anim Radiol, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo	Murata, T (corresponding author), Univ Tokyo, Dept Anim Radiol, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan.	amurata@mail.ecc.u-tokyo.ac.jp		Murata, Takahisa/0000-0002-3328-0796	Program for Promotion of Basic and Applied Researches for innovations in Bio-oriented Industry [26029A]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry [26029A]; Japan Society for the Promotion of Science [25252049, 26660225]; Japan Health Foundation; SENSHIN Medical Research Foundation; Takeda Science Foundation;  [23-3505];  [24-1079]	Program for Promotion of Basic and Applied Researches for innovations in Bio-oriented Industry; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Health Foundation(Japan Health Foundation); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); ; 	This work was supported by a Grant-in-Aid for JSPS Fellows [23-3505 to Y.T., 24-1079 to K.K.] http://www.mext.go.jp/english/; the Program for Promotion of Basic and Applied Researches for innovations in Bio-oriented Industry [26029A to T.M.] http://www.naro.affrc.go.jp/english/index.html; the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry [26029A to T.M.] http://www.s.affrc.go.jp/docs/research_fund/2015/sinki_koubo_2015.htm; a Grant-in-Aid from the Japan Society for the Promotion of Science [25252049 and 26660225 to T.M.] http://www.mext.go.jp/english/; the Japan Health Foundation [to T.M.] http://www.jnhf.or.jp/; the SENSHIN Medical Research Foundation [to T.M.] http://www.mt-pharma.co.jp/zaidan/; and the Takeda Science Foundation [to T.M.] http://www.takeda-sci.or.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Aschner JL, 1997, J CELL PHYSIOL, V173, P387, DOI 10.1002/(SICI)1097-4652(199712)173:3<387::AID-JCP11>3.0.CO;2-9; Curry FRE, 2010, CARDIOVASC RES, V87, P218, DOI 10.1093/cvr/cvq115; DAHLEN SE, 1981, P NATL ACAD SCI-BIOL, V78, P3887, DOI 10.1073/pnas.78.6.3887; Di Lorenzo A, 2013, J CELL SCI, V126, P5541, DOI 10.1242/jcs.115972; Di Lorenzo A, 2009, P NATL ACAD SCI USA, V106, P14552, DOI 10.1073/pnas.0904073106; Feletou M, 1996, BRIT J PHARMACOL, V118, P1371, DOI 10.1111/j.1476-5381.1996.tb15547.x; Kevil CG, 1998, MICROCIRCULATION-LON, V5, P197, DOI 10.1038/sj.mn.7300011; Kobayashi K, 2013, ARTERIOSCL THROM VAS, V33, P565, DOI 10.1161/ATVBAHA.112.300993; Kolosova IA, 2004, AM J PHYSIOL-LUNG C, V287, pL970, DOI 10.1152/ajplung.00398.2003; LEACH L, 1995, MICROVASC RES, V50, P323, DOI 10.1006/mvre.1995.1062; Mikelis CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7725; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Moy AB, 1996, J CLIN INVEST, V97, P1020, DOI 10.1172/JCI118493; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Nathan RA, 2008, CLIN THER, V30, P573, DOI 10.1016/j.clinthera.2008.04.011; Omori K, 2014, BRIT J PHARMACOL, V171, P4879, DOI 10.1111/bph.12815; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; RAMIREZ MM, 1995, MICROVASC RES, V50, P223, DOI 10.1006/mvre.1995.1055; RILEY JF, 1953, J PHYSIOL-LONDON, V120, P528, DOI 10.1113/jphysiol.1953.sp004915; SALOGA J, 1993, J CLIN INVEST, V91, P133, DOI 10.1172/JCI116162; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824	26	103	107	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0132367	10.1371/journal.pone.0132367	http://dx.doi.org/10.1371/journal.pone.0132367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158531	Green Published, Green Submitted, gold			2022-12-27	WOS:000358161200051
J	Selga, E; Campuzano, O; Pinsach-Abuin, ML; Perez-Serra, A; Mademont-Soler, I; Riuro, H; Pico, F; Coll, M; Iglesias, A; Pagans, S; Sarquella-Brugada, G; Berne, P; Benito, B; Brugada, J; Porres, JM; Zea, ML; Castro-Urda, V; Fernandez-Lozano, I; Brugada, R				Selga, Elisabet; Campuzano, Oscar; Lina Pinsach-Abuin, Mel; Perez-Serra, Alexandra; Mademont-Soler, Irene; Riuro, Helena; Pico, Ferran; Coll, Monica; Iglesias, Anna; Pagans, Sara; Sarquella-Brugada, Georgia; Berne, Paola; Benito, Begona; Brugada, Josep; Porres, Jose M.; Lopez Zea, Matilde; Castro-Urda, Victor; Fernandez-Lozano, Ignacio; Brugada, Ramon			Comprehensive Genetic Characterization of a Spanish Brugada Syndrome Cohort	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; LONG QT SYNDROME; SCN5A MUTATIONS; PREVALENCE; SPECTRUM; VARIANTS; DISEASE; RISK	Background Brugada syndrome (BrS) is a rare genetic cardiac arrhythmia that can lead to sudden cardiac death in patients with a structurally normal heart. Genetic variations in SCN5A can be identified in approximately 20-25% of BrS cases. The aim of our work was to determine the spectrum and prevalence of genetic variations in a Spanish cohort diagnosed with BrS. Methodology/ Principal Findings We directly sequenced fourteen genes reported to be associated with BrS in 55 unrelated patients clinically diagnosed. Our genetic screening allowed the identification of 61 genetic variants. Of them, 20 potentially pathogenic variations were found in 18 of the 55 patients (32.7% of the patients, 83.3% males). Nineteen of them were located in SCN5A, and had either been previously reported as pathogenic variations or had a potentially pathogenic effect. Regarding the sequencing of the minority genes, we discovered a potentially pathogenic variation in SCN2B that was described to alter sodium current, and one nonsense variant of unknown significance in RANGRF. In addition, we also identified 40 single nucleotide variations which were either synonymous variants (four of them had not been reported yet) or common genetic variants. We next performed MLPA analysis of SCN5A for the 37 patients without an identified genetic variation, and no major rearrangements were detected. Additionally, we show that being at the 30-50 years range or exhibiting symptoms are factors for an increased potentially pathogenic variation discovery yield. Conclusions In summary, the present study is the first comprehensive genetic evaluation of 14 BrS-susceptibility genes and MLPA of SCN5A in a Spanish BrS cohort. The mean pathogenic variation discovery yield is higher than that described for other European BrS cohorts (32.7% vs 20-25%, respectively), and is even higher for patients in the 30-50 years age range.	[Selga, Elisabet; Campuzano, Oscar; Lina Pinsach-Abuin, Mel; Perez-Serra, Alexandra; Mademont-Soler, Irene; Riuro, Helena; Pico, Ferran; Coll, Monica; Iglesias, Anna; Pagans, Sara; Brugada, Ramon] Inst Invest Biomed Girona IDIBGi, Cardiovasc Genet Ctr, Girona, Spain; [Selga, Elisabet; Campuzano, Oscar; Lina Pinsach-Abuin, Mel; Perez-Serra, Alexandra; Mademont-Soler, Irene; Riuro, Helena; Pico, Ferran; Coll, Monica; Iglesias, Anna; Pagans, Sara; Brugada, Ramon] Univ Girona UdG, Sch Med, Girona, Spain; [Sarquella-Brugada, Georgia] Univ Barcelona, Hosp St Joan de Deu, Dept Cardiol, Paediat Arrhythmia Unit, Barcelona, Spain; [Berne, Paola; Benito, Begona; Brugada, Josep] Univ Barcelona, Hosp Clin Barcelona, Arrhythmia Unit, Barcelona, Spain; [Porres, Jose M.] Hosp Univ Donostia, Arrhythmia Unit, San Sebastian, Spain; [Lopez Zea, Matilde] Hosp Ramon & Cajal, Pediat Cardiol Serv, E-28034 Madrid, Spain; [Castro-Urda, Victor; Fernandez-Lozano, Ignacio] Hosp Puerta Hierro, Arrhythmia Unit, Madrid, Spain; [Brugada, Ramon] Hosp Josep Trueta, Girona, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitario Ramon y Cajal; Hospital Puerta de Hierro-Majadahonda; Universitat de Girona; Girona University Hospital Dr. Josep Trueta	Brugada, R (corresponding author), Inst Invest Biomed Girona IDIBGi, Cardiovasc Genet Ctr, Girona, Spain.	rbrugada@idibgi.org	Pinsach, Mel·lina/AAB-5293-2019; campuzano, oscar/J-1968-2014; Pagans, Sara/G-3407-2015; Selga, Elisabet/H-9007-2015; Stefanadis, Christodoulos/ABH-2232-2020; Sarquella-Brugada, Georgia/W-9278-2018; Berne, Paola/HHM-4858-2022	Pinsach, Mel·lina/0000-0001-7199-512X; campuzano, oscar/0000-0001-5298-5276; Pagans, Sara/0000-0003-0772-6982; Selga, Elisabet/0000-0002-4290-8370; Stefanadis, Christodoulos/0000-0001-5974-6454; Sarquella-Brugada, Georgia/0000-0002-6857-8904; Castro, Victor/0000-0002-8325-1379; Mademont-Soler, Irene/0000-0002-6501-9250; Fernandez Lozano, Ignacio/0000-0002-3092-8761; Berne, Paola/0000-0003-1160-4064	Obra social "la Caixa"; Centro Nacional de Investigaciones Cardiovasculares [CNIC-03-2008]; Instituto de Salud Carlos III [FIS-PI08/1800]; Instituto de Salud Carlos III (Fondo Europeo de Desarrollo Regional)	Obra social "la Caixa"(La Caixa Foundation); Centro Nacional de Investigaciones Cardiovasculares; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III (Fondo Europeo de Desarrollo Regional)	This work was supported by Obra social "la Caixa" (www.obrasocial.lacaixa.es/), Centro Nacional de Investigaciones Cardiovasculares (CNIC-03-2008; www.cnic.es/), and Instituto de Salud Carlos III (FIS-PI08/1800 and Fondo Europeo de Desarrollo Regional; www.isciii.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 2011, EUROPACE, V13, P1077, DOI 10.1093/europace/eur245; Ackerman MJ, 2004, HEART RHYTHM, V1, P600, DOI 10.1016/j.hrthm.2004.07.013; Berne P, 2012, CIRC J, V76, P1563, DOI 10.1253/circj.CJ-12-0717; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Campuzano O, 2014, CARDIOL J, V21, P121, DOI 10.5603/CJ.a2013.0125; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Cordeiro JM, 2006, CIRCULATION, V114, P2026, DOI 10.1161/CIRCULATIONAHA.106.627489; Crotti L, 2012, J AM COLL CARDIOL, V60, P1410, DOI 10.1016/j.jacc.2012.04.037; Eastaugh LJ, 2011, J CARDIOVASC ELECTR, V22, P1073, DOI 10.1111/j.1540-8167.2010.02003.x; Garcia-Castro M, 2010, REV ESP CARDIOL, V63, P856, DOI 10.1016/S0300-8932(10)70189-5; Garcia-Molina E, 2012, CLIN GENET; Giudicessi JR, 2013, TRANSL RES, V161, P1, DOI 10.1016/j.trsl.2012.08.005; Gollob MH, 2011, CAN J CARDIOL, V27, P232, DOI 10.1016/j.cjca.2010.12.078; Gouas L, 2005, EUR J HUM GENET, V13, P1213, DOI 10.1038/sj.ejhg.5201489; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Hedley PL, 2009, HUM MUTAT, V30, P1256, DOI 10.1002/humu.21066; Holst AG, 2010, CARDIOLOGY, V115, P311, DOI 10.1159/000312747; Hong K, 2004, J CARDIOVASC ELECTR, V15, P64, DOI 10.1046/j.1540-8167.2004.03341.x; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Koopmann TT, 2007, HEART RHYTHM, V4, P752, DOI 10.1016/j.hrthm.2007.02.021; Kotta CM, 2010, INT J CARDIOL, V145, P45, DOI 10.1016/j.ijcard.2009.03.134; Lizotte E, 2009, J CARDIOVASC ELECTR, V20, P1137, DOI 10.1111/j.1540-8167.2009.01508.x; Makiyama T, 2005, J AM COLL CARDIOL, V46, P2100, DOI 10.1016/j.jacc.2005.08.043; Mizusawa Y, 2012, CIRC-ARRHYTHMIA ELEC, V5, P606, DOI 10.1161/CIRCEP.111.964577; Mok N. S., 2004, Hong Kong Medical Journal, V10, P32; Nakajima T, 2011, INT HEART J, V52, P27, DOI 10.1536/ihj.52.27; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Nielsen MW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00179; Nunez L, 2013, HEART RHYTHM, V10, P264, DOI 10.1016/j.hrthm.2012.10.025; Olesen MS, 2011, CAN J CARDIOL, V27, DOI 10.1016/j.cjca.2011.01.003; Priori SG, 2002, CIRCULATION, V105, P1342, DOI 10.1161/hc1102.105288; Risgaard B, 2013, CLIN GENET, V84, P489, DOI 10.1111/cge.12126; Riuro H, 2013, HUM MUTAT, V34, P961, DOI 10.1002/humu.22328; Tarradas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053220; Taschner PEM, 2011, HUM MUTAT, V32, P507, DOI 10.1002/humu.21427; Vatta M, 2002, HUM MOL GENET, V11, P337, DOI 10.1093/hmg/11.3.337; Watanabe H, 2011, CIRC-ARRHYTHMIA ELEC, V4, P874, DOI 10.1161/CIRCEP.111.963983; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; Yokoi H, 2005, HEART RHYTHM, V2, P285, DOI 10.1016/j.hrthm.2004.11.022	40	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132888	10.1371/journal.pone.0132888	http://dx.doi.org/10.1371/journal.pone.0132888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173111	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900095
J	Baskota, A; Li, SY; Dhakal, N; Liu, GJ; Tian, HM				Baskota, Attit; Li, Sheyu; Dhakal, Niharika; Liu, Guanjian; Tian, Haoming			Bariatric Surgery for Type 2 Diabetes Mellitus in Patients with BMI <30 kg/m(2): A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							BODY-MASS INDEX; DUODENAL-JEJUNAL BYPASS; PREDICTIVE FACTORS; METABOLIC SURGERY; GASTRIC-CANCER; GASTRECTOMY; REMISSION; RESOLUTION; OPERATION; WEIGHT	Background and Objective The role of bariatric surgery in non-obese patients with type 2 diabetes (T2DM) remains unclear, and its use in clinical practice is controversial. We conducted a systemic review and meta-analysis to investigate the metabolic changes after surgical treatment in diabetic patients with body mass index (BMI) <30 kg/m(2). Methods We conducted a comprehensive search in MEDLINE (PubMed), EMBASE and the Cochrane Library of published articles from January 2000 to April 2013 reporting the clinical outcome changes in various metabolic outcomes in diabetic patients with BMI <30 kg/m(2). Results Ten prospective studies including 290 patients were included in the meta-analysis. Bariatric surgery led to an overall 2.79 kg/m(2) [95% CI 2.05 similar to 3.53, P<0.00001] reduction in BMI, a 1.88%[95% CI 1.32 similar to 2.43, P<0.00001] reduction in glycosylated hemoglobin, a 3.70 mmol/L [95% CI, 1.93 similar to 5.47, P<0.00001] reduction in fasting blood glucose, a 6.69 mmol/L [95% CI, 2.29 similar to 11.08, P=0.003] reduction in postprandial glucose, anda 3.37 [95% CI 0.55 similar to 6.18, P=0.02] reduction in homeostasis model assessment of insulin resistance (HOMA-IR). After surgical treatment, 76.2% of the patients were insulin free, and 61.8% patients were off medication. In total, 90(42.4%), 10(37%) and 34(37.2%) patients had post-surgical HbA1c levels of <6%,<6.5% and<7%, respectively. No deaths were observed in the included studies, and the major complication rate was 6.2%. Conclusions Based on the currently available data, bariatric surgery might improve glycemic control and weight loss in a very limited range with a doubled surgical complication rate in drug-refractory T2DM patients with BMI <30 kg/m(2). It remains too premature to suggest bariatric surgery for non-obese T2DM patients.	[Baskota, Attit; Li, Sheyu; Tian, Haoming] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu 610064, Peoples R China; [Dhakal, Niharika] Sichuan Univ, West China Hosp, Dept Anesthesiol & Pain Management, Chengdu 610064, Peoples R China; [Liu, Guanjian] Chinese Evidence Based Med Cochrane Ctr, Chengdu, Peoples R China	Sichuan University; Sichuan University	Tian, HM (corresponding author), Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu 610064, Peoples R China.	hmtian999@126.com	Li, Sheyu/O-3242-2016	Li, Sheyu/0000-0003-0060-0287; Tian, Haoming/0000-0002-1921-4733				Navarrete SA, 2011, OBES SURG, V21, P663, DOI 10.1007/s11695-011-0371-8; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Buchwald H., 2004, JAMA (Journal of the American Medical Association), V292, P1724, DOI 10.1001/jama.292.14.1724; Casella G, 2011, SURG OBES RELAT DIS, V7, P697, DOI 10.1016/j.soard.2011.08.014; Cohen RV, 2007, SURG OBES RELAT DIS, V3, P195, DOI 10.1016/j.soard.2007.01.009; DePaula AL, 2009, SURG ENDOSC, V23, P1313, DOI 10.1007/s00464-008-0156-x; Dixon JB, 2013, DIABETIC MED, V30, pe127, DOI 10.1111/dme.12107; Dixon JB, 2011, DIABETIC MED, V28, P628, DOI 10.1111/j.1464-5491.2011.03306.x; Garcia-Caballero M, 2012, NUTR HOSP, V27, P623, DOI [10.3305/nh.2012.27.2.5674, 10.1590/S0212-16112012000200041]; Geloneze B, 2012, ANN SURG, V256, P72, DOI 10.1097/SLA.0b013e3182592c62; Geloneze B, 2009, OBES SURG, V19, P1077, DOI 10.1007/s11695-009-9844-4; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hayes MT, 2011, OBES SURG, V21, P910, DOI 10.1007/s11695-011-0370-9; Kim JW, 2012, WORLD J GASTROENTERO, V18, P49, DOI 10.3748/wjg.v18.i1.49; Kim S, 2010, ANN SURG, V251, P1049, DOI 10.1097/SLA.0b013e3181d9769b; Kim WS, 2013, J KOREAN SURG SOC, V84, P88, DOI 10.4174/jkss.2013.84.2.88; Kim Z, 2011, WORLD J SURG, V35, P631, DOI 10.1007/s00268-010-0909-2; Lakdawala M, 2013, SURG OBES RELAT DIS, V9, P370, DOI 10.1016/j.soard.2012.07.017; Lee HC, 2010, OBES SURG, V20, P1530, DOI 10.1007/s11695-010-0248-2; Lee WJ, 2012, OBES SURG, V22, P293, DOI 10.1007/s11695-011-0565-0; Li Q, 2012, DIABETES OBES METAB, V14, P262, DOI 10.1111/j.1463-1326.2011.01524.x; Mechanick Jeffrey I, 2013, Endocr Pract, V19, P337, DOI 10.4158/EP12437.GL; Monteforte MJ, 2000, OBES SURG, V10, P391, DOI 10.1381/096089200321594246; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Ramos AC, 2009, OBES SURG, V19, P307, DOI 10.1007/s11695-008-9759-5; Reis CEG, 2012, DIABETES TECHNOL THE, V14, P365, DOI 10.1089/dia.2011.0127; Robert M, 2013, OBES SURG, V23, P770, DOI 10.1007/s11695-013-0868-4; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Scopinaro N, 2011, OBES SURG, V21, P880, DOI 10.1007/s11695-011-0407-0; Shimizu H, 2012, J OBES, V2012, DOI 10.1155/2012/147256; Shrestha C, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/240971; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Wang GF, 2015, OBES SURG, V25, P199, DOI 10.1007/s11695-014-1391-y; Wells G., NEWCASTLEOTTAWA SCAL; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yu JJ, 2015, OBES SURG, V25, P143, DOI 10.1007/s11695-014-1460-2	37	45	47	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132335	10.1371/journal.pone.0132335	http://dx.doi.org/10.1371/journal.pone.0132335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167910	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100036
J	Campbell-Palmer, R; Del Pozo, J; Gottstein, B; Girling, S; Cracknell, J; Schwab, G; Rosell, F; Pizzi, R				Campbell-Palmer, Roisin; Del Pozo, Jorge; Gottstein, Bruno; Girling, Simon; Cracknell, John; Schwab, Gerhard; Rosell, Frank; Pizzi, Romain			Echinococcus multilocularis Detection in Live Eurasian Beavers (Castor fiber) Using a Combination of Laparoscopy and Abdominal Ultrasound under Field Conditions	PLOS ONE			English	Article							EUROPEAN BEAVER; RISK; INTRAPERITONEAL; ESTABLISHMENT; IMPLANTATION; POPULATION; PREVALENCE; DOGS	Echinococcus multilocularis is an important pathogenic zoonotic parasite of health concern, though absent in the United Kingdom. Eurasian beavers (Castor fiber) may act as a rare intermediate host, and so unscreened wild caught individuals may pose a potential risk of introducing this parasite to disease-free countries through translocation programs. There is currently no single definitive ante-mortem diagnostic test in intermediate hosts. An effective non-lethal diagnostic, feasible under field condition would be helpful to minimise parasite establishment risk, where indiscriminate culling is to be avoided. This study screened live beavers (captive, n = 18 or wild-trapped in Scotland, n = 12) and beaver cadavers (wild Scotland, n = 4 or Bavaria, n = 11), for the presence of E. multilocularis. Ultrasonography in combination with minimally invasive surgical examination of the abdomen by laparoscopy was viable under field conditions for real-time evaluation in beavers. Laparoscopy alone does not allow the operator to visualize the parenchyma of organs such as the liver, or inside the lumen of the gastrointestinal tract, hence the advantage of its combination with abdominal ultrasonography. All live beavers and Scottish cadavers were largely unremarkable in their haematology and serum biochemistry with no values suspicious for liver pathology or potentially indicative of E. multilocularis infection. This correlated well with ultrasound, laparoscopy, and immunoblotting, which were unremarkable in these individuals. Two wild Bavarian individuals were suspected E. multilocularis positive at post-mortem, through the presence of hepatic cysts. Sensitivity and specificity of a combination of laparoscopy and abdominal ultrasonography in the detection of parasitic liver cyst lesions was 100% in the subset of cadavers (95% Confidence Intervals 34.24-100%, and 86.7-100% respectively). For abdominal ultrasonography alone sensitivity was only 50% (95% CI 9.590.6%), with specificity being 100% (95% CI 79.2-100%). For laparoscopy alone sensitivity was 100% (95% CI 34.2-100%), with specificity also being 100% (95% CI 77.2-100%). Further immunoblotting, PCR and histopathological examination revealed one individual positive for E. multilocularis, whilst the other individual was positive for Taenia martis.	[Campbell-Palmer, Roisin; Girling, Simon; Pizzi, Romain] Royal Zool Soc Scotland, Vet Dept & Conservat Programmes, Edinburgh, Midlothian, Scotland; [Del Pozo, Jorge] Univ Edinburgh, Royal Dick Sch Vet Studies, Dept Vet Pathol, Edinburgh EH9 1QH, Midlothian, Scotland; [Gottstein, Bruno] Univ Bern, Vetsuisse Fac, Inst Parasitol, Bern, Switzerland; [Cracknell, John] Longleat Safari & Adventure Pk, Warminster, England; [Schwab, Gerhard] Bund Naturschutz Bayern eV, Deggendorf, Germany; [Campbell-Palmer, Roisin; Rosell, Frank] Telemark Univ Coll, Dept Environm & Hlth Studies, Bo, Norway; [Pizzi, Romain] Natl Wildlife Rescue Ctr, Scottish Soc Prevent Cruelty Animals, Fishcross, Scotland	University of Edinburgh; University of Bern; University College of Southeast Norway	Campbell-Palmer, R (corresponding author), Royal Zool Soc Scotland, Vet Dept & Conservat Programmes, Edinburgh, Midlothian, Scotland.	rcampbellpalmer@rzss.org.uk	Pizzi, Romain/AAW-6360-2020	Pizzi, Romain/0000-0002-9030-9559; Girling, Simon/0000-0001-9927-9491	Scottish Natural Heritage; examination of the Scottish beavers; Swiss National Science Foundation [31003A-125990]	Scottish Natural Heritage; examination of the Scottish beavers; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding was recieved from Scottish Natural Heritage for the trapping and examination of the Scottish beavers (RCP, RP, SG). Payment was recieved for the screening of the captive collection animals, as a private client (RCP, RP). Royal Zoological Society of Scotland, Telemark University College and Zoological Medicine Ltd provided funding in the form of staff wages and expenses for screening work of Bavarian animals (RCP, SG, RP, FR). Molecular investigations were funded by Swiss National Science Foundation - grant no 31003A-125990. Longleat Safari and Adventure Park provided support in the form of salaries for authors [JC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred J., 2014, GUARDIAN; Bailey JE, 1999, VETERINARY ENDOSURGERY, P24; Barlow AM, 2011, VET REC, V169, DOI 10.1136/vr.d4673; Campbell RD, 2014, 540 SCOTT NAT HER; Campbell-Palmer R, 2015, 681 SCOTT NAT HER; Campbell-Palmer R, 2013, HUSBANDRY GUIDELINES; Campbell-Palmer R, 2012, VET REC, V170, P235, DOI 10.1136/vr.e1508; Cirovic D, 2012, VET REC, V171, DOI 10.1136/vr.100879; Coles B.J, 2006, BEAVERS BRITAINS; Cook Robert A., 1999, P30; Cronstedt-Fell A, 2010, 9 EWDA C VLIEL 2010; Davidson R, 2010, ANN REPORT 2009 NATL; DEFRA, 2012, QUAL RISK ASS; Deplazes P, 1999, J PARASITOL, V85, P115, DOI 10.2307/3285713; Dinkel A, 1998, J CLIN MICROBIOL, V36, P1871, DOI 10.1128/JCM.36.7.1871-1876.1998; Dore F, 2014, VET PARASITOL, V203, P59, DOI 10.1016/j.vetpar.2014.03.016; Eckert J, 2001, WHO/OIE MANUAL ON ECHINOCOCCOSIS IN HUMANS AND ANIMALS: A PUBLIC HEALTH PROBLEM OF GLOBAL CONCERN, P100; Eckert J., 1997, Parassitologia (Rome), V39, P337; Eckert J, 2000, INT J PARASITOL, V30, P1283, DOI 10.1016/S0020-7519(00)00130-2; FREEMAN LJ, 1999, VET ENDOSURGERY; Goodman G, 2012, J WILDLIFE DIS, V48, P971, DOI 10.7589/2011-06-153; Gottstein B, 2001, EMERG INFECT DIS, V7, P408; Gottsteina B, 2014, VET PARASITOL, V205, P113, DOI 10.1016/j.vetpar.2014.06.017; Gurnell J, 2009, ENV SOCIAL IMPACTS F, P109; Halley D, 2009, 457 NINA; Halley DJ, 2002, MAMMAL REV, V32, P153, DOI 10.1046/j.1365-2907.2002.00106.x; Halley D, 2012, BALT FOR, V18, P168; Janovsky M, 2002, J WILDLIFE DIS, V38, P618, DOI 10.7589/0090-3558-38.3.618; Kalema-Zikusoka G, 2001, J ZOO WILDLIFE MED, V32, P509, DOI 10.1638/1042-7260(2001)032[0509:RPIAFR]2.0.CO;2; Kapel CMO, 2006, INT J PARASITOL, V36, P79, DOI 10.1016/j.ijpara.2005.08.012; Kern P, 2010, CURR OPIN INFECT DIS, V23, P505, DOI 10.1097/QCO.0b013e32833d7516; Kosmider R, 2013, VET REC, V172, DOI 10.1136/vr.101572; Lhermette P, 2008, BSAVA MANUAL ENDOSCO, P1; McEwing R, 2015, 686 SCOTT NAT HER; Moons CPH, 2007, LAB ANIM-UK, V41, P262, DOI 10.1258/002367707780378177; Nolet BA, 1998, BIOL CONSERV, V83, P165, DOI 10.1016/S0006-3207(97)00066-9; Osterman Lind E, 2011, EURO SURVEILL, V16, DOI 19836; Pizzi R, 2011, VET REC, V169, DOI 10.1136/vr.d4985; Pizzi R., 2014, ZOO WILD ANIMAL MED, V8, P688; Pizzi Romain, 2011, Veterinary Medicine International, V2011, P1, DOI 10.4061/2011/131368; Pizzi R, 2012, VET REC, V170, P293, DOI 10.1136/vr.e2041; Quinn JH, 2010, J ZOO WILDLIFE MED, V41, P174, DOI 10.1638/2009-0125.1; Ranheim B, 2004, WILDLIFE BIOL, V10, P11, DOI 10.2981/wlb.2004.004; Romig T, 2006, PARASITOL INT, V55, pS187, DOI 10.1016/j.parint.2005.11.028; Rosell F, 2001, WILDLIFE SOC B, V29, P269; Saitoh T, 1998, RES POPUL ECOL, V40, P97, DOI 10.1007/BF02765225; Sergeant E., 2015, EPITOOLS EPIDEMIOLOG; Simpson V, 2011, VET REC, V169, P689, DOI 10.1136/vr.d8249; Torgerson PR, 2009, VET REC, V165, P366, DOI 10.1136/vr.165.13.366; Torgerson PR, 2009, TRENDS PARASITOL, V25, P164, DOI 10.1016/j.pt.2008.12.008; Toth B, 2010, CHANG LIK ECH MULT A, P29; Vuitton DA, 2003, PARASITOLOGY, V127, pS87, DOI 10.1017/S0031182003004153; Wahlstrom H, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-9; Wimmershoff J, 2012, P JOINT WDA EWDA C L, P37; Woodford MH., 2001, OFFICE INT EPIZOOTIE	55	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0130842	10.1371/journal.pone.0130842	http://dx.doi.org/10.1371/journal.pone.0130842			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167927	Green Published, gold			2022-12-27	WOS:000358193100005
J	Charbonnier, L; van der Laan, LN; Viergever, MA; Smeets, PAM				Charbonnier, Lisette; van der Laan, Laura N.; Viergever, Max A.; Smeets, Paul A. M.			Functional MRI of Challenging Food Choices: Forced Choice between Equally Liked High- and Low-Calorie Foods in the Absence of Hunger	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; ORBITOFRONTAL CORTEX; UNRESTRAINED EATERS; PREFRONTAL CORTEX; DECISION-MAKING; EATING BEHAVIOR; REWARD; BRAIN; ACTIVATION; ATTENTION	We are continuously exposed to food and during the day we make many food choices. These choices play an important role in the regulation of food intake and thereby in weight management. Therefore, it is important to obtain more insight into the mechanisms that underlie these choices. While several food choice functional MRI (fMRI) studies have been conducted, the effect of energy content on neural responses during food choice has, to our knowledge, not been investigated before. Our objective was to examine brain responses during food choices between equally liked high-and low-calorie foods in the absence of hunger. During a 10-min fMRI scan 19 normal weight volunteers performed a forced-choice task. Food pairs were matched on individual liking but differed in perceived and actual caloric content (high-low). Food choice compared with non-food choice elicited stronger unilateral activation in the left insula, superior temporal sulcus, posterior cingulate gyrus and (pre) cuneus. This suggests that the food stimuli were more salient despite subject's low motivation to eat. The right superior temporal sulcus (STS) was the only region that exhibited greater activation for high versus low calorie food choices between foods matched on liking. Together with previous studies, this suggests that STS activation during food evaluation and choice may reflect the food's biological relevance independent of food preference. This novel finding warrants further research into the effects of hunger state and weight status on STS, which may provide a marker of biological relevance.	[Charbonnier, Lisette; van der Laan, Laura N.; Viergever, Max A.; Smeets, Paul A. M.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Smeets, Paul A. M.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands	Utrecht University; Utrecht University Medical Center; Wageningen University & Research	Charbonnier, L (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands.	lisette@isi.uu.nl	Viergever, Max A/J-1215-2014; Smeets, Paul AM/B-7979-2010	Smeets, Paul AM/0000-0002-8695-9612; van der Laan, Laura Nynke/0000-0003-4307-0888	European Union [266408]	European Union(European Commission)	This study was part of the Full4Health project (www.full4health.eu), funded by the European Union Seventh Framework Program (FP7/2007-2013) under grant agreement number 266408.	Baecke S., 2008, J CONSUM BEHAV, V7, P342, DOI [DOI 10.1002/cb.256, 10.1002/cb.256]; Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Berthoud HR, 2006, OBESITY, V14, P197; Born JM, 2011, AM J CLIN NUTR, V94, P392, DOI 10.3945/ajcn.111.012161; Castellanos EH, 2009, INT J OBESITY, V33, P1063, DOI 10.1038/ijo.2009.138; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Coletta M, 2009, J ABNORM PSYCHOL, V118, P598, DOI 10.1037/a0016201; Epstein LH, 2006, APPETITE, V46, P22, DOI 10.1016/j.appet.2005.04.006; Fedoroff I, 2003, APPETITE, V41, P7, DOI 10.1016/S0195-6663(03)00026-6; Finlayson G, 2008, APPETITE, V50, P120, DOI 10.1016/j.appet.2007.06.007; Finlayson G, 2007, PHYSIOL BEHAV, V90, P36, DOI 10.1016/j.physbeh.2006.08.020; Fisher JO, 2002, AM J CLIN NUTR, V76, P226, DOI 10.1093/ajcn/76.1.226; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Grabenhorst F, 2013, NEUROIMAGE, V74, P152, DOI 10.1016/j.neuroimage.2013.02.012; Grabenhorst F, 2011, TRENDS COGN SCI, V15, P56, DOI 10.1016/j.tics.2010.12.004; Griffioen-Roose S, 2010, APPETITE, V55, P648, DOI 10.1016/j.appet.2010.09.018; Hare TA, 2011, J NEUROSCI, V31, P11077, DOI 10.1523/JNEUROSCI.6383-10.2011; Heekeren HR, 2003, NEUROREPORT, V14, P1215, DOI 10.1097/00001756-200307010-00005; Hein G, 2008, J COGNITIVE NEUROSCI, V20, P2125, DOI 10.1162/jocn.2008.20148; Kang MJ, 2011, J NEUROSCI, V31, P461, DOI 10.1523/JNEUROSCI.1583-10.2011; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; Kim H, 2011, CEREB CORTEX, V21, P769, DOI 10.1093/cercor/bhq145; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; Levy DJ, 2011, J NEUROSCI, V31, P14693, DOI 10.1523/JNEUROSCI.2218-11.2011; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Linder NS, 2010, NEUROIMAGE, V53, P215, DOI 10.1016/j.neuroimage.2010.05.077; McLellan F, 2002, LANCET, V359, P1412, DOI 10.1016/S0140-6736(02)08397-6; Mela DJ, 2006, APPETITE, V47, P10, DOI 10.1016/j.appet.2006.02.006; Narumoto J, 2001, COGNITIVE BRAIN RES, V12, P225, DOI 10.1016/S0926-6410(01)00053-2; Nijs IMT, 2010, APPETITE, V54, P243, DOI 10.1016/j.appet.2009.11.004; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Peters J C, 2002, Obes Rev, V3, P69, DOI 10.1046/j.1467-789X.2002.00059.x; Piech RM, 2010, BRAIN COGNITION, V72, P282, DOI 10.1016/j.bandc.2009.09.012; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Plassmann H, 2010, J NEUROSCI, V30, P10799, DOI 10.1523/JNEUROSCI.0788-10.2010; Rothemund Y, 2007, NEUROIMAGE, V37, P410, DOI 10.1016/j.neuroimage.2007.05.008; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Shomaker LB, 2010, AM J CLIN NUTR, V92, P697, DOI 10.3945/ajcn.2010.29812; Siep N, 2009, BEHAV BRAIN RES, V198, P149, DOI 10.1016/j.bbr.2008.10.035; Simmons WK, 2005, CEREB CORTEX, V15, P1602, DOI 10.1093/cercor/bhi038; Smeets PAM, 2013, BEHAV BRAIN RES, V248, P41, DOI 10.1016/j.bbr.2013.03.041; Smeets PAM, 2012, P NUTR SOC, V71, P511, DOI 10.1017/S0029665112000808; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Toepel U, 2010, FAT DETECTION TASTE; Toepel U, 2009, NEUROIMAGE, V44, P967, DOI 10.1016/j.neuroimage.2008.10.005; Uher R, 2006, BEHAV BRAIN RES, V169, P111, DOI 10.1016/j.bbr.2005.12.008; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; Van der Laan LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041738; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T	55	33	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131727	10.1371/journal.pone.0131727	http://dx.doi.org/10.1371/journal.pone.0131727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1PW	26167916	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100013
J	Kumar, R; Pradhan, A; Khan, FA; Lindstrom, P; Ragnvaldsson, D; Ivarsson, P; Olsson, PE; Jass, J				Kumar, Ranjeet; Pradhan, Ajay; Khan, Faisal Ahmad; Lindstrom, Pia; Ragnvaldsson, Daniel; Ivarsson, Per; Olsson, Per-Erik; Jass, Jana			Comparative Analysis of Stress Induced Gene Expression in Caenorhabditis elegans following Exposure to Environmental and Lab Reconstituted Complex Metal Mixture	PLOS ONE			English	Article							MULTIPLE HEAVY-METALS; INDUCED TOXICITY; NEMATODE; ZINC; MODEL; TRANSPORTER; RESISTANCE; FERRITIN; UTILITY; SOIL	Metals are essential for many physiological processes and are ubiquitously present in the environment. However, high metal concentrations can be harmful to organisms and lead to physiological stress and diseases. The accumulation of transition metals in the environment due to either natural processes or anthropogenic activities such as mining results in the contamination of water and soil environments. The present study used Caenorhabditis elegans to evaluate gene expression as an indicator of physiological response, following exposure to water collected from three different locations downstream of a Swedish mining site and a lab reconstituted metal mixture. Our results indicated that the reconstituted metal mixture exerted a direct stress response in C. elegans whereas the environmental waters elicited either a diminished or abrogated response. This suggests that it is not sufficient to use the biological effects observed from laboratory mixtures to extrapolate the effects observed in complex aquatic environments and apply this to risk assessment and intervention.	[Kumar, Ranjeet; Pradhan, Ajay; Khan, Faisal Ahmad; Olsson, Per-Erik; Jass, Jana] Univ Orebro, Life Sci Ctr Biol, Sch Sci & Technol, SE-70182 Orebro, Sweden; [Lindstrom, Pia] Boliden Mineral AB, Boliden, Sweden; [Ragnvaldsson, Daniel] Envix Nord AB, Umea, Sweden; [Ivarsson, Per] ALS Scandinavia AB, Taby, Sweden	Orebro University; Boliden AB	Jass, J (corresponding author), Univ Orebro, Life Sci Ctr Biol, Sch Sci & Technol, SE-70182 Orebro, Sweden.	jana.jass@oru.se	Pradhan, Ajay/AFS-6774-2022; Jass, Jana/D-1617-2013	Jass, Jana/0000-0001-7957-0310; Pradhan, Ajay/0000-0003-2305-8574; Khan, Faisal Ahmad/0000-0002-4267-3794; Olsson, Per-Erik/0000-0001-7336-6335	Knowledge Foundation, Sweden [20110183]; Orebro Universitet [J62200]; Boliden Mineral AB; Envix Nord AB; ALS Scandinavia AB	Knowledge Foundation, Sweden; Orebro Universitet; Boliden Mineral AB; Envix Nord AB; ALS Scandinavia AB	The study was financed by The Knowledge Foundation, Sweden, www.kks.se, Dnr 20110183, (PEO) and Orebro Universitet, www.oru.se, J62200 (JJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Boliden Mineral AB, Envix Nord AB, and ALS Scandinavia AB provided support in the form of salaries for authors PL, DR and PI, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams William J., 2011, Integrated Environmental Assessment and Management, V7, P75, DOI 10.1002/ieam.108; Baumeister R, 2006, J ENDOCRINOL, V190, P191, DOI 10.1677/joe.1.06856; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P1100, DOI 10.1897/1551-5028(2003)022&lt;1100:AOMTTN&gt;2.0.CO;2; Boyd Windy A, 2012, Methods Mol Biol, V889, P15, DOI 10.1007/978-1-61779-867-2_3; BRENNER S, 1974, GENETICS, V77, P71; Caito Samuel, 2012, Frontiers in Genetics, V3, P52, DOI 10.3389/fgene.2012.00052; Cedergreen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096580; Chu KW, 2002, AQUAT TOXICOL, V61, P53, DOI 10.1016/S0166-445X(02)00017-6; Clemens S, 2001, EUR J BIOCHEM, V268, P3640, DOI 10.1046/j.1432-1327.2001.02293.x; Davis DE, 2009, GENETICS, V182, P1015, DOI 10.1534/genetics.109.103614; DONKIN SG, 1995, ENVIRON TOXICOL CHEM, V14, P2139, DOI 10.1002/etc.5620141218; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Grun D, 2014, CELL REP, V6, P565, DOI 10.1016/j.celrep.2014.01.001; Guo YL, 2009, REPROD TOXICOL, V28, P90, DOI 10.1016/j.reprotox.2009.03.007; Hall J, 2012, TOXICOL SCI, V128, P418, DOI 10.1093/toxsci/kfs166; Harada H, 2007, ECOTOX ENVIRON SAFE, V66, P378, DOI 10.1016/j.ecoenv.2006.02.017; Harrington JM, 2012, TOXICOL SCI, V129, P49, DOI 10.1093/toxsci/kfs191; Hitchcock DR, 1997, ARCH ENVIRON CON TOX, V33, P252, DOI 10.1007/s002449900251; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Jadiya P, 2012, CNS NEUROL DISORD-DR, V11, P1001; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Jiang GCT, 2009, TOXICOL SCI, V111, P345, DOI 10.1093/toxsci/kfp161; Jonker MJ, 2004, ENVIRON TOXICOL CHEM, V23, P480, DOI 10.1897/03-29; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; KING G, 1982, FED PROC, V41, P641; Kurz CL, 2007, BIOCHEM BIOPH RES CO, V363, P438, DOI 10.1016/j.bbrc.2007.08.190; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Liao VHC, 2002, J BIOL CHEM, V277, P42049, DOI 10.1074/jbc.M206740200; Lundstedt T, 1998, CHEMOMETR INTELL LAB, V42, P3, DOI 10.1016/S0169-7439(98)00065-3; Martinez-Finley EJ, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/895236; Mukhopadhyay I, 2003, J BIOCHEM MOL TOXIC, V17, P249, DOI 10.1002/jbt.10086; Murphy JT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002013; Nazir A., 2008, J ENV BIOL, V29; Paquin PR, 2002, COMP BIOCHEM PHYS C, V133, P3, DOI 10.1016/S1532-0456(02)00112-6; Polak N, 2014, COMP BIOCHEM PHYS C, V160, P75, DOI 10.1016/j.cbpc.2013.12.001; PRICE D, 1982, P NATL ACAD SCI-BIOL, V79, P3116, DOI 10.1073/pnas.79.10.3116; Ragnvaldsson D, 2012, TECHNICAL REPORT EFT; Rodriguez M, 2013, TRENDS GENET, V29, P367, DOI 10.1016/j.tig.2013.01.010; Roh JY, 2006, ENVIRON TOXICOL CHEM, V25, P2946, DOI 10.1897/05-676R.1; Sahu SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066431; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwartz MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009564; Shen LL, 2009, ENVIRON TOXICOL PHAR, V28, P125, DOI 10.1016/j.etap.2009.03.009; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; Traunspurger W, 1997, ENVIRON TOXICOL CHEM, V16, P245, DOI [10.1897/1551-5028(1997)016&lt;0245:EAOASW&gt;2.3.CO;2, 10.1002/etc.5620160221]; Tvermoes BE, 2010, J CELL SCI, V123, P2123, DOI 10.1242/jcs.065433; Utgikar VP, 2004, WATER RES, V38, P3651, DOI 10.1016/j.watres.2004.05.022; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vatamaniuk OK, 2005, J BIOL CHEM, V280, P23684, DOI 10.1074/jbc.M503362200; Wang DY, 2008, J ENVIRON SCI-CHINA, V20, P1132, DOI 10.1016/S1001-0742(08)62160-9; Wang DY, 2009, ENVIRON TOXICOL PHAR, V28, P459, DOI 10.1016/j.etap.2009.07.008; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; Xu X, 2011, TOXICOL IN VITRO, V25, P294, DOI 10.1016/j.tiv.2010.09.007; Zeitoun-Ghandour S, 2011, MOL BIOSYST, V7, P2397, DOI 10.1039/c1mb05114h	54	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132896	10.1371/journal.pone.0132896	http://dx.doi.org/10.1371/journal.pone.0132896			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168046	gold, Green Submitted, Green Published			2022-12-27	WOS:000358193100095
J	Zhao, J; Zhong, Q; Zhao, Y; Hu, YX; Zhang, GZ				Zhao, Jing; Zhong, Qi; Zhao, Ye; Hu, Yan-xin; Zhang, Guo-zhong			Pathogenicity and Complete Genome Characterization of Fowl Adenoviruses Isolated from Chickens Associated with Inclusion Body Hepatitis and Hydropericardium Syndrome in China	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; GIZZARD EROSIONS; OUTBREAKS; SEQUENCE; STRAINS; INFECTION	In this study, we determined and genetically characterized three fowl adenoviruses isolated from chickens with inclusion body hepatitis (IBH) and hydropericardium syndrome (HPS) in China and assessed their pathogenicity. The full genome of HBQ12, BJH13 and JSJ13 was found to be 44,081, 43,966 and 43,756 nucleotides long, respectively. Sequence alignment and phylogenetic analysis revealed that strain HBQ12 and BJH13 were clustered together belonging to fowl adenoviruses D species and serotyped as FAdV-11, whereas strain JSJ13 was classified into fowl adenoviruses C species and serotyped as FAdV-4. To our knowledge, this is the first report of FAdV-4 strain circulating in China. The pathogenicity test showed that mortality for chickens infected with HBQ12 and JSJ13 within 21 days post infection (dpi) was 8.6% and 28.6%, respectively. Necropsy displayed mild or severe hepatitis and hydropericardium at 3 and 5 dpi as well as dead chickens. Viral DNA was detected in almost all tissues sampled from dead chickens. These results revealed that fowl adenovirus strains HBQ12 and JSJ13 are capable of causing IBH and HPS in chickens, indicating that preventive measures against FAdV infection on poultry farms should be implemented in China.	[Zhao, Jing; Zhong, Qi; Zhao, Ye; Hu, Yan-xin; Zhang, Guo-zhong] China Agr Univ, Minist Agr, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Zhang, GZ (corresponding author), China Agr Univ, Minist Agr, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, Beijing 100094, Peoples R China.	zhanggz@cau.edu.cn			China Agriculture Research System Poultry-related Science and Technology Innovation Team of Peking (CARS-PSTP)	China Agriculture Research System Poultry-related Science and Technology Innovation Team of Peking (CARS-PSTP)	This study was supported by the China Agriculture Research System Poultry-related Science and Technology Innovation Team of Peking (CARS-PSTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado IR, 2007, AVIAN DIS, V51, P27, DOI 10.1637/0005-2086(2007)051[0027:GCPAPS]2.0.CO;2; Chiocca S, 1996, J VIROL, V70, P2939, DOI 10.1128/JVI.70.5.2939-2949.1996; Choi KS, 2012, POULTRY SCI, V91, P2502, DOI 10.3382/ps.2012-02296; Dahiya S, 2002, AVIAN DIS, V46, P230, DOI 10.1637/0005-2086(2002)046[0230:FASAWO]2.0.CO;2; Domanska-Blicharz K, 2011, POULTRY SCI, V90, P983, DOI 10.3382/ps.2010-01214; Gjevre AG, 2013, AVIAN PATHOL, V42, P297, DOI 10.1080/03079457.2013.817665; Grgic H, 2014, VIRUS GENES, V48, P74, DOI 10.1007/s11262-013-0995-y; Grgic H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077601; Harrach B, 2012, VIRUS TAXONOMY, V9, P125, DOI DOI 10.1016/B978-0-12-384684-6.00009-4; Harrach B., 2011, SPRINGER INDEX VIRUS; Hess M, 2000, AVIAN PATHOL, V29, P195, DOI 10.1080/03079450050045440; Kajan GL, 2013, VET MICROBIOL, V167, P357, DOI 10.1016/j.vetmic.2013.09.025; Kim JN, 2008, AVIAN DIS, V52, P526, DOI 10.1637/8178-112207-Case; Li HaiYing, 2010, Chinese Veterinary Science / Zhongguo Shouyi Kexue, V40, P722; Marek A, 2013, VET MICROBIOL, V166, P250, DOI 10.1016/j.vetmic.2013.05.017; Marek A, 2010, J VET DIAGN INVEST, V22, P937, DOI 10.1177/104063871002200613; Mase M, 2012, J VET MED SCI, V74, P1087, DOI 10.1292/jvms.11-0443; Mazaheri A, 1998, AVIAN PATHOL, V27, P269, DOI 10.1080/03079459808419335; Mendelson C, 1995, AVIAN PATHOL, V24, P693, DOI 10.1080/03079459508419108; Mittal Dinesh, 2014, Indian Journal of Virology, V25, P114, DOI 10.1007/s13337-013-0183-7; Nakamura K, 1999, AVIAN DIS, V43, P414, DOI 10.2307/1592638; Ojkic D, 2000, J GEN VIROL, V81, P1833, DOI 10.1099/0022-1317-81-7-1833; Ojkic D, 2001, VIROLOGY, V283, P197, DOI 10.1006/viro.2000.0890; Ojkic D, 2008, AVIAN PATHOL, V37, P95, DOI 10.1080/03079450701805324; Okuda Y, 2004, J VET MED SCI, V66, P1561, DOI 10.1292/jvms.66.1561; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schachner A, 2014, VACCINE, V32, P1086, DOI 10.1016/j.vaccine.2013.12.056; Schonewille E, 2008, VET IMMUNOL IMMUNOP, V121, P130, DOI 10.1016/j.vetimm.2007.09.017; Senne DA., 1989, LAB MANUAL ISOLATION, V3rd Edit, P176; Steer PA, 2015, AVIAN PATHOL, V44, P106, DOI 10.1080/03079457.2015.1007919; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Toro H, 2002, AVIAN DIS, V46, P547, DOI 10.1637/0005-2086(2002)046[0547:POIBHH]2.0.CO;2; WELLS RJH, 1974, VET REC, V94, P481, DOI 10.1136/vr.94.21.481	33	76	107	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0133073	10.1371/journal.pone.0133073	http://dx.doi.org/10.1371/journal.pone.0133073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167857	gold, Green Published			2022-12-27	WOS:000358193100107
J	Guo, HC; Jin, Y; Han, SC; Sun, SQ; Wei, YQ; Liu, XJ; Feng, X; Liu, DX; Liu, XT				Guo, Hui-Chen; Jin, Ye; Han, Shi-Chong; Sun, Shi-Qi; Wei, Yan-Quan; Liu, Xian-Ji; Feng, Xia; Liu, Ding Xiang; Liu, Xiang-Tao			Quantitative Proteomic Analysis of BHK-21 Cells Infected with Foot-and-Mouth Disease Virus Serotype Asia 1	PLOS ONE			English	Article							PROTEIN-KINASE PKR; TRANSFER-RNA SYNTHETASES; ENDOPLASMIC-RETICULUM STRESS; RESPIRATORY SYNCYTIAL VIRUS; POLIOVIRUS INFECTION; SECRETORY PATHWAY; ESCRT MACHINERY; VIRAL-PROTEINS; HOST PROTEINS; 2B	Stable isotope labeling with amino acids in cell culture (SILAC) was used to quantitatively study the host cell gene expression profile, in order to achieve an unbiased overview of the protein expression changes in BHK-21 cells infected with FMDV serotype Asia 1. The SILAC-based approach identified overall 2,141 proteins, 153 of which showed significant alteration in the expression level 6 h post FMDV infection (57 up-regulated and 96 down-regulated). Among these proteins, six cellular proteins, including three down-regulated (VPS28, PKR, EVI5) and three up-regulated (LYPLA1, SEC62 and DARs), were selected according to the significance of the changes and/or the relationship with PKR. The expression level and pattern of the selected proteins were validated by immunoblotting and confocal microscopy. Furthermore, the functions of these cellular proteins were assessed by small interfering RNA-mediated depletion, and their functional importance in the replication of FMDV was demonstrated by western blot, reverse transcript PCR (RT-PCR) and 50% Tissue Culture Infective Dose (TCID50). The results suggest that FMDV infection may have effects on the expression of specific cellular proteins to create more favorable conditions for FMDV infection. This study provides novel data that can be utilized to understand the interactions between FMDV and the host cell.	[Guo, Hui-Chen; Jin, Ye; Han, Shi-Chong; Sun, Shi-Qi; Wei, Yan-Quan; Feng, Xia; Liu, Ding Xiang; Liu, Xiang-Tao] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol & OIE, Lanzhou, Gansu, Peoples R China; [Liu, Ding Xiang] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Liu, Xian-Ji] Guangzhou Fitgene Biotechnol Co Ltd, Guangzhou Int Business Incubator A110, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Sun, SQ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol & OIE, Lanzhou, Gansu, Peoples R China.	shiqisun21@hotmail.com	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	National Science and Technology Support Program [2013BAD12B00]; International Science & Technology Cooperation Program of China [2014DFA31890]; Fundamental Research Funds for the Chinese Academy of Agricultural Sciences [2015ZL062]; "Twelfth Five-Year" National Science and technology program in rural areas [2011AA10A211]; Guangzhou Fitgene biotechnology Co. Ltd.	National Science and Technology Support Program; International Science & Technology Cooperation Program of China; Fundamental Research Funds for the Chinese Academy of Agricultural Sciences; "Twelfth Five-Year" National Science and technology program in rural areas; Guangzhou Fitgene biotechnology Co. Ltd.	This research was supported by grants from the National Science and Technology Support Program (2013BAD12B00), International Science & Technology Cooperation Program of China (2014DFA31890), the Fundamental Research Funds for the Chinese Academy of Agricultural Sciences (2015ZL062), and the "Twelfth Five-Year" National Science and technology program in rural areas (2011AA10A211). Guangzhou Fitgene biotechnology Co. Ltd. provided support in the form of salaries for author [XJL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Aldabe R, 1997, J VIROL, V71, P6214, DOI 10.1128/JVI.71.8.6214-6217.1997; Balachandran Siddharth, 2007, V383, P277, DOI 10.1007/978-1-59745-335-6_18; Belov GA, 2007, J VIROL, V81, P558, DOI 10.1128/JVI.01820-06; Belsham GJ, 2000, J VIROL, V74, P272, DOI 10.1128/JVI.74.1.272-280.2000; Beske O, 2007, J CELL SCI, V120, P3207, DOI 10.1242/jcs.03483; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; BIENZ K, 1990, J VIROL, V64, P1156, DOI 10.1128/JVI.64.3.1156-1163.1990; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Braakman I, 2000, TRAFFIC, V1, P533, DOI 10.1034/j.1600-0854.2000.010702.x; Brock SC, 2003, P NATL ACAD SCI USA, V100, P15143, DOI 10.1073/pnas.2434327100; Bruce EA, 2010, J VIROL, V84, P5848, DOI 10.1128/JVI.00307-10; Campanella M, 2004, J BIOL CHEM, V279, P18440, DOI 10.1074/jbc.M309494200; Chambers R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010994; Chinsangaram J, 2001, J VIROL, V75, P5498, DOI 10.1128/JVI.75.12.5498-5503.2001; Choe SS, 2005, VIROLOGY, V337, P18, DOI 10.1016/j.virol.2005.03.036; de los Santos T, 2006, J VIROL, V80, P1906, DOI 10.1128/JVI.80.4.1906-1914.2006; de los Santos T, 2009, J VIROL, V83, P1800, DOI 10.1128/JVI.02112-08; Doedens JR, 1997, J VIROL, V71, P9054, DOI 10.1128/JVI.71.12.9054-9064.1997; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Egger D, 2005, J GEN VIROL, V86, P707, DOI 10.1099/vir.0.80442-0; Fan HY, 2012, J PROTEOME RES, V11, P995, DOI 10.1021/pr200755d; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; GRUBMAN MJ, 1985, J VIROL, V56, P120, DOI 10.1128/JVI.56.1.120-126.1985; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Hruby Dennis E., 1993, Trends in Microbiology, V1, P20, DOI 10.1016/0966-842X(93)90020-R; Jaiswal JK, 2003, J BIOSCIENCES, V28, P697, DOI 10.1007/BF02708430; Johns HL, 2009, J VIROL, V83, P6247, DOI 10.1128/JVI.02460-08; Johnson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075394; Karjalainen M, 2011, CELL MICROBIOL, V13, P1975, DOI 10.1111/j.1462-5822.2011.01685.x; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; Laflamme C, 2012, J CELL BIOL, V198, P57, DOI 10.1083/jcb.201112114; Lin J, 2010, J CHILD NEUROL, V25, P1425, DOI 10.1177/0883073810370897; Lin JY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-103; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; LUBROTH J, 1995, RES VET SCI, V59, P70, DOI 10.1016/0034-5288(95)90034-9; McDonald B, 2009, J CELL SCI, V122, P2167, DOI 10.1242/jcs.028308; Messmer M, 2011, BIOCHEM J, V433, P441, DOI 10.1042/BJ20101902; Moffat K, 2007, J VIROL, V81, P1129, DOI 10.1128/JVI.00393-06; Muller L, 2010, MOL BIOL CELL, V21, P691, DOI 10.1091/mbc.E09-08-0730; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nieva JL, 2003, FEBS LETT, V552, P68, DOI 10.1016/S0014-5793(03)00852-4; O'Donnell VK, 2001, VIROLOGY, V287, P151, DOI 10.1006/viro.2001.1035; Rowe RK, 2008, VIROLOGY, V382, P239, DOI 10.1016/j.virol.2008.09.021; RWEYEMAMU MM, 1978, J HYG-CAMBRIDGE, V81, P107, DOI 10.1017/S002217240005381X; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith JA, 2006, J VIROL, V80, P2019, DOI 10.1128/JVI.80.4.2019-2033.2006; Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000; Utley TJ, 2008, P NATL ACAD SCI USA, V105, P10209, DOI 10.1073/pnas.0712144105; van Kuppeveld FJM, 2005, TRENDS MICROBIOL, V13, P41, DOI 10.1016/j.tim.2004.12.005; vanKuppeveld FJM, 1997, EMBO J, V16, P3519, DOI 10.1093/emboj/16.12.3519; Veit M, 2001, VIROLOGY, V288, P89, DOI 10.1006/viro.2001.1063; Wang D, 2011, J VIROL, V85, P3758, DOI 10.1128/JVI.02589-10; Westlake CJ, 2007, P NATL ACAD SCI USA, V104, P1236, DOI 10.1073/pnas.0610500104; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wollert T, 2009, J CELL SCI, V122, P2163, DOI 10.1242/jcs.029884; Ye Y, 2013, J PROTEOME RES, V12, P363, DOI 10.1021/pr300611e; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	67	9	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132384	10.1371/journal.pone.0132384	http://dx.doi.org/10.1371/journal.pone.0132384			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161868	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300127
J	Kingston, AW; Roussel-Rossin, C; Dupont, C; Raleigh, EA				Kingston, Anthony W.; Roussel-Rossin, Chloe; Dupont, Claire; Raleigh, Elisabeth A.			Novel recA-Independent Horizontal Gene Transfer in Escherichia coli K-12	PLOS ONE			English	Article							FUNCTIONAL INTERACTION; BIOFILM FORMATION; DNA; RECOMBINATION; EVOLUTION; SEQUENCE; PROTEIN; IDENTIFICATION; REPAIR; RESTRICTION	In bacteria, mechanisms that incorporate DNA into a genome without strand-transfer proteins such as RecA play a major role in generating novelty by horizontal gene transfer. We describe a new illegitimate recombination event in Escherichia coli K-12: RecA-independent homologous replacements, with very large (megabase-length) donor patches replacing recipient DNA. A previously uncharacterized gene (yjiP) increases the frequency of RecA-independent replacement recombination. To show this, we used conjugal DNA transfer, combining a classical conjugation donor, HfrH, with modern genome engineering methods and whole genome sequencing analysis to enable interrogation of genetic dependence of integration mechanisms and characterization of recombination products. As in classical experiments, genomic DNA transfer begins at a unique position in the donor, entering the recipient via conjugation; antibiotic resistance markers are then used to select recombinant progeny. Different configurations of this system were used to compare known mechanisms for stable DNA incorporation, including homologous recombination, F'-plasmid formation, and genome duplication. A genome island of interest known as the immigration control region was specifically replaced in a minority of recombinants, at a frequency of 3 X 10(-12) CFU/recipient per hour.	[Kingston, Anthony W.; Roussel-Rossin, Chloe; Dupont, Claire; Raleigh, Elisabeth A.] New England Biolabs Inc, Ipswich, MA 01938 USA	New England Biolabs	Raleigh, EA (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	raleigh@neb.com		Raleigh, Elisabeth A./0000-0003-0745-9925	New England Biolabs	New England Biolabs	New England Biolabs provided financial support in the form of salaries for authors AWK, CD, CRR, EAR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ACHTMAN M, 1978, J BACTERIOL, V135, P1053, DOI 10.1128/JB.135.3.1053-1061.1978; AMUNDSEN SK, 1986, P NATL ACAD SCI USA, V83, P5558, DOI 10.1073/pnas.83.15.5558; Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; Babic A, 2008, SCIENCE, V319, P1533, DOI 10.1126/science.1153498; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; BACHMANN BJ, 1976, BACTERIOL REV, V40, P116, DOI 10.1128/MMBR.40.1.116-167.1976; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BLAKELY G, 1993, CELL, V75, P351, DOI 10.1016/0092-8674(93)80076-Q; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; Chaudhuri RR, 2012, INFECT GENET EVOL, V12, P214, DOI 10.1016/j.meegid.2012.01.005; Chayot R, 2010, P NATL ACAD SCI USA, V107, P2141, DOI 10.1073/pnas.0906355107; Cox MM, 2000, PROG NUCLEIC ACID RE, V63, P311, DOI 10.1016/S0079-6603(08)60726-6; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darmon E, 2014, MICROBIOL MOL BIOL R, V78, P1, DOI 10.1128/MMBR.00035-13; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; Didelot X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-256; Dordet-Frisoni E, 2014, MBIO, V5, DOI 10.1128/mBio.01958-14; Dutra BE, 2007, P NATL ACAD SCI USA, V104, P216, DOI 10.1073/pnas.0608293104; Grainge I, 2011, NUCLEIC ACIDS RES, V39, P5140, DOI 10.1093/nar/gkr078; Guglielmini J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002222; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Herzberg M, 2006, J BACTERIOL, V188, P587, DOI 10.1128/JB.188.2.587-598.2006; Kosinski J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-172; KOWALCZYKOWSKI SC, 1991, BIOCHIMIE, V73, P289, DOI 10.1016/0300-9084(91)90216-N; Kuzminov A, 1999, GENE DEV, V13, P345, DOI 10.1101/gad.13.3.345; LANKA E, 1995, ANNU REV BIOCHEM, V64, P141, DOI 10.1146/annurev.bi.64.070195.001041; Lawrence Jeffrey G., 2009, V532, P29, DOI 10.1007/978-1-60327-853-9_3; Lesic B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002529; LLOYD RG, 1995, GENETICS, V139, P1123; Luo CW, 2011, P NATL ACAD SCI USA, V108, P7200, DOI 10.1073/pnas.1015622108; Ma NJ, 2014, NAT PROTOC, V9, P2285, DOI 10.1038/nprot.2014.081; Madsen JS, 2012, FEMS IMMUNOL MED MIC, V65, P183, DOI 10.1111/j.1574-695X.2012.00960.x; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; MASSON L, 1986, NUCLEIC ACIDS RES, V14, P5693, DOI 10.1093/nar/14.14.5693; MCCLAIN MS, 1991, J BACTERIOL, V173, P5308, DOI 10.1128/jb.173.17.5308-5314.1991; McCusker MP, 2008, MOL MICROBIOL, V67, P171, DOI 10.1111/j.1365-2958.2007.06037.x; Merkel WK, 1996, FEMS MICROBIOL LETT, V143, P247, DOI 10.1016/0378-1097(96)00321-7; Milkman R, 2003, GENETICS, V163, P475; Murray NE, 2002, MICROBIOL-SGM, V148, P3, DOI 10.1099/00221287-148-1-3; PIEKAROWICZ A, 1991, NUCLEIC ACIDS RES, V19, P1831, DOI 10.1093/nar/19.8.1831; Puymege A, 2015, MOL GENET GENOMICS; Ragan MA, 2009, PHILOS T R SOC B, V364, P2241, DOI 10.1098/rstb.2009.0031; RALEIGH EA, 1992, MOL MICROBIOL, V6, P1079, DOI 10.1111/j.1365-2958.1992.tb01546.x; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Schubert S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000257; Sibley MH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1085; Sibley MH, 2004, NUCLEIC ACIDS RES, V32, P522, DOI 10.1093/nar/gkh194; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Steczkiewicz K, 2012, NUCLEIC ACIDS RES, V40, P7016, DOI 10.1093/nar/gks382; STERNBERG NL, 1991, METHOD ENZYMOL, V204, P18; Switt AIM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041247; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tamames J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-136; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; Vieira G, 2011, J BACTERIOL, V193, P1461, DOI 10.1128/JB.01192-10; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; Wiles TJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003175; WILLETTS NS, 1969, J BACTERIOL, V97, P244, DOI 10.1128/JB.97.1.244-249.1969; Yates J, 2006, MOL MICROBIOL, V59, P1754, DOI 10.1111/j.1365-2958.2005.05033.x; Zhang ZG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000689; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235	66	11	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130813	10.1371/journal.pone.0130813	http://dx.doi.org/10.1371/journal.pone.0130813			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162088	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300021
J	Li, SS; Wang, JK; Zhang, LY				Li, Shanshan; Wang, Jiankang; Zhang, Luyan			Inclusive Composite Interval Mapping of QTL by Environment Interactions in Biparental Populations	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; STATISTICAL POWER; DIGENIC EPISTASIS; REGRESSION; BARLEY; COVARIABLES; GENOTYPE; MARKERS; MAIZE; IDENTIFICATION	Identification of environment-specific QTL and stable QTL having consistent genetic effects across a wide range of environments is of great importance in plant breeding. Inclusive Composite Interval Mapping (ICIM) has been proposed for additive, dominant and epistatic QTL mapping in biparental populations for single environment. In this study, ICIM was extended to QTL by environment interaction (QEI) mapping for multi-environmental trials, where the QTL average effect and QEI effects could be properly estimated. Stepwise regression was firstly applied in each environment to identify the most significant marker variables which were then used to adjust the phenotypic values. One-dimensional scanning was then conducted on the adjusted phenotypic values across the environments in order to detect QTL with either average effect or QEI effects, or both average effect and QEI effects. In this way, the genetic background could be well controlled while the conventional interval mapping was applied. An empirical method to determine the threshold of logarithm of odds was developed, and the efficiency of the ICIM QEI mapping was demonstrated in simulated populations under different genetic models. One actual recombinant inbred line population was used to compare mapping results between QEI mapping and single-environment analysis.	[Zhang, Luyan] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China; Chinese Acad Agr Sci, CIMMYT China Off, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences	Zhang, LY (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China.	zhangluyan@caas.cn			National Natural Science Foundation of China [31271798]; National 973 Research Program of China [2014CB138105]; HarvestPlus Challenge Program of CGIAR	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Research Program of China; HarvestPlus Challenge Program of CGIAR(CGIAR)	This study was funded by the National Natural Science Foundation of China (project no. 31271798); the National 973 Research Program of China (project no. 2014CB138105), and the HarvestPlus Challenge Program of CGIAR.	Alves AA, 2012, EUPHYTICA, V183, P27, DOI 10.1007/s10681-011-0455-5; Boer MP, 2007, GENETICS, V177, P1801, DOI 10.1534/genetics.107.071068; Chen X, 2010, GENETICS, V186, P1053, DOI 10.1534/genetics.110.120311; CHURCHILL GA, 1994, GENETICS, V138, P963; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Crossa J, 1999, THEOR APPL GENET, V99, P611, DOI 10.1007/s001220051276; Gauch HG, 2011, CROP SCI, V51, P96, DOI 10.2135/cropsci2010.04.0206; Hackett CA, 2001, GENET RES, V77, P95, DOI 10.1017/S0016672300004869; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; JANSEN RC, 1995, THEOR APPL GENET, V91, P33, DOI 10.1007/BF00220855; JIANG CJ, 1995, GENETICS, V140, P1111; Korol AB, 1998, GENETICS, V148, P2015; Li H, 2010, HEREDITY, V105, P257, DOI 10.1038/hdy.2010.56; Li HH, 2008, THEOR APPL GENET, V116, P243, DOI 10.1007/s00122-007-0663-5; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li HH, 2012, CHINESE SCI BULL, V57, P2701, DOI 10.1007/s11434-012-5239-3; Li Q, 2012, PLOS ONE, V7; Li XM, 2014, EUPHYTICA, V198, P199, DOI 10.1007/s10681-014-1092-6; Malosetti M, 2004, EUPHYTICA, V137, P139, DOI 10.1023/B:EUPH.0000040511.46388.ef; Meng L, 2015, THE CROP JOURNAL IN; Meng X, 1993, BIOMETRIKA, V80, P67; Messmer R, 2009, THEOR APPL GENET, V119, P913, DOI 10.1007/s00122-009-1099-x; Njau PN, 2013, EUPHYTICA, V190, P33, DOI 10.1007/s10681-012-0763-4; Piepho HP, 2000, GENETICS, V156, P2043; Piepho HP, 2001, GENETICS, V157, P425; Pillen K, 2003, THEOR APPL GENET, V107, P340, DOI 10.1007/s00122-003-1253-9; [秦永生 QIN Yong-Sheng], 2009, [作物学报, Acta Agronomica Sinica], V35, P1812; Sun ZiQi, 2013, Acta Agronomica Sinica, V39, P1, DOI 10.3724/SP.J.1006.2013.00001; Tinker NA, 1995, J QUANTITATIVE TRAIT; van Eeuwijk F. A., 2002, P245, DOI 10.1079/9780851996011.0245; Vargas M, 2006, THEOR APPL GENET, V112, P1009, DOI 10.1007/s00122-005-0204-z; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Wang J K, 2014, GENE MAPPING BREEDIN, P128; Wang JianKang, 2009, Acta Agronomica Sinica, V35, P239, DOI 10.3724/SP.J.1006.2009.00239; Whittaker JC, 1996, HEREDITY, V77, P23, DOI 10.1038/hdy.1996.104; Wu W, 1998, J BIOMATHEMATICS, V13, P592; Yuste-Lisbona FJ, 2011, MOL BREEDING, V27, P181, DOI 10.1007/s11032-010-9421-5; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang LY, 2008, GENETICS, V180, P1177, DOI 10.1534/genetics.108.092122; Zhang LY, 2012, J INTEGR PLANT BIOL, V54, P270, DOI 10.1111/j.1744-7909.2012.01110.x; Zhao FP, 2012, G3-GENES GENOM GENET, V2, P779, DOI 10.1534/g3.112.002980	41	63	66	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132414	10.1371/journal.pone.0132414	http://dx.doi.org/10.1371/journal.pone.0132414			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161656	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300131
J	Paik, JS; Jung, SK; Han, KD; Kim, SD; Park, YM; Yang, SW				Paik, Ji-Sun; Jung, Su-Kyung; Han, Kyung-Do; Kim, Sang-Duck; Park, Yong-Moon; Yang, Suk-Woo			Obesity as a Potential Risk Factor for Blepharoptosis: The Korea National Health and Nutrition Examination Survey 2008-2010	PLOS ONE			English	Article							METABOLIC SYNDROME; DYSLIPIDEMIA	Purpose To examine obesity parameters as potential risk factors associated with blepharoptosis in a representative Korean population. Methods We analyzed the Korea National Health and Nutrition Examination Survey (KNHANES), conducted between 2008 and 2010. 10,285 Korean adults (4,441 men and 5,844 women) aged 40 years or older was enrolled. We compared body mass index (BMI), waist circumference (WC) and percentage body fat (BF), according to the severity of blepharoptosis. Multiple logistic regression analysis was conducted to examine the associations of each obesity parameter with blepharoptosis. Results The overall prevalence of age-related blepharoptosis was 14.8 % in South Korea. There were significant and graded associations between increasing blepharoptosis severity and the mean value of obesity parameters (P for trend < 0.05). As marginal reflex distance 1 (MRD1) decreased, the prevalence of general obesity and overweight status increased (P for trend=0.121 in men and < 0.001 in women); the prevalence of abdominal obesity increased (P for trend < 0.001 for both genders); the prevalence of highest quartile of percentage BF increased (P for trend <= 0.001 for both genders). Blepharoptosis was significantly associated with general obesity in women (adjusted odds ratio (aOR), 2.14; 95% confidence intervals (CI), 1.32-3.47); and with the highest quartile of percentage BF in men (aOR, 2.01; 95% CI, 1.34-2.97) and in women (aOR, 1.52; 95% CI, 1.06-2.3317, after adjusting for age, smoking exercise, drinking alcohol, total energy intake, fat intake, total cholesterol, and high density lipoprotein cholesterol, diabetes, hypertension, and family history of eye disease. Conclusions The etiology of age-related blepharoptosis may be multifactorial and is unclear. Our results suggest that obesity parameters such as BMI, WC and percentage BF might be potential risk factors for age-related blepharoptosis in a representative Korean population.	[Paik, Ji-Sun; Jung, Su-Kyung; Yang, Suk-Woo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Han, Kyung-Do] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Kim, Sang-Duck] Wonkwang Univ, Coll Med, Dept Ophthalmol, Iksan, South Korea; [Park, Yong-Moon] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Wonkwang University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Park, YM (corresponding author), Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, 800 Sumter St, Columbia, SC 29208 USA.	markYMpark@gmail.com; yswoph@catholic.ac.kr	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A1A3007696]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013R1A1A3007696). The authors discussed with Epidemiologic Survey Committee of the Korean Ophthalmologic Society to deal with national data correctly and accurately.	Ahmadi AJ, 2005, OPHTHAL PLAST RECONS, V21, P46, DOI 10.1097/01.IOP.0000151275.88977.84; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Bastiaensen L A, 1985, Ophthalmology, V92, p63A; BASTIAENSEN LAK, 1983, DOC OPHTHALMOL, V56, P5, DOI 10.1007/BF00154702; Bosco D, 2009, J NEUROL SCI, V284, P24, DOI 10.1016/j.jns.2009.03.017; Cahill K V, 1986, Ophthalmic Plast Reconstr Surg, V2, P213, DOI 10.1097/00002341-198601070-00008; Choi JY, 2013, MENOPAUSE, V20, P85, DOI 10.1097/gme.0b013e31825d26b6; COLLIN JRO, 1986, AUST NZ J OPHTHALMOL, V14, P109, DOI 10.1111/j.1442-9071.1986.tb00020.x; Cuillet C, 2005, DIABETES METAB, V31, p5S20; DORTZBACH RK, 1980, ARCH OPHTHALMOL-CHIC, V98, P2045, DOI 10.1001/archopht.1980.01020040897022; Kalpakian B, 1986, J Pediatr Ophthalmol Strabismus, V23, P170; Kantaputra PN, 2001, AM J MED GENET, V103, P283, DOI 10.1002/ajmg.1572; Kim David W, 2007, Facial Plast Surg Clin North Am, V15, P327, DOI 10.1016/j.fsc.2007.04.008; Kim MK, 2014, CLIN ENDOCRINOL, V80, P214, DOI 10.1111/cen.12162; Ko SH, 2014, DIABETES METAB J, V38, P51, DOI 10.4093/dmj.2014.38.1.51; Misra A, 2013, NUTRIENTS, V5, P2708, DOI 10.3390/nu5072708; Nam GE, 2013, PREV MED, V57, P304, DOI 10.1016/j.ypmed.2013.06.008; NETLAND PA, 1994, OPHTHALMOLOGY, V101, P174; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Park YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085068; REAVEN GM, 1993, J CLIN INVEST, V92, P141, DOI 10.1172/JCI116541; Shirado M, 2012, J PLAST RECONSTR AES, V65, pE146, DOI 10.1016/j.bjps.2012.01.009; SHORE JW, 1984, AM J OPHTHALMOL, V98, P21, DOI 10.1016/0002-9394(84)90183-1; Small R G, 1989, Ophthalmic Plast Reconstr Surg, V5, P171; Wong TY, 2004, INVEST OPHTH VIS SCI, V45, P2949, DOI 10.1167/iovs.04-0069; World Health Organisation IAftS of Obesity IOT, 2000, AISA PACIFIC PERSPEC; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421	27	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131427	10.1371/journal.pone.0131427	http://dx.doi.org/10.1371/journal.pone.0131427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162079	Green Submitted, gold, Green Published			2022-12-27	WOS:000358162300039
J	Voracek, M; Rieder, S; Stieger, S; Swami, V				Voracek, Martin; Rieder, Stephan; Stieger, Stefan; Swami, Viren			What's in a Surname? Physique, Aptitude, and Sports Type Comparisons between Tailors and Smiths	PLOS ONE			English	Article							TESTS	Combined heredity of surnames and physique, coupled with past marriage patterns and trade-specific physical aptitude and selection factors, may have led to differential assortment of bodily characteristics among present-day men with specific trade-reflecting surnames (Tailor vs. Smith). Two studies reported here were partially consistent with this genetic-social hypothesis, first proposed by Baumler (1980). Study 1 (N = 224) indicated significantly higher self-rated physical aptitude for prototypically strength-related activities (professions, sports, hobbies) in a random sample of Smiths. The counterpart effect (higher aptitude for dexterity-related activities among Tailors) was directionally correct, but not significant, and Tailor-Smith differences in basic physique variables were nil. Study 2 examined two large total-population-of-interest datasets (Austria/Germany combined, and UK: N = 7001 and 20532) of men's national high-score lists for track-and-field events requiring different physiques. In both datasets, proportions of Smiths significantly increased from light-stature over medium-stature to heavy-stature sports categories. The predicted counterpart effect (decreasing prevalences of Tailors along these categories) was not supported. Related prior findings, the viability of possible alternative interpretations of the evidence (differential positive selection for trades and occupations, differential endogamy and assortative mating patterns, implicit egotism effects), and directions for further inquiry are discussed in conclusion.	[Voracek, Martin; Rieder, Stephan; Stieger, Stefan] Univ Vienna, Sch Psychol, Dept Basic Psychol Res & Res Methods, Vienna, Austria; [Stieger, Stefan] Univ Konstanz, Dept Psychol, Constance, Germany; [Swami, Viren] Univ Westminster, Dept Psychol, London W1R 8AL, England; [Swami, Viren] HELP Univ Coll, Dept Psychol, Kuala Lumpur, Malaysia	University of Vienna; University of Konstanz; University of Westminster; Help University	Voracek, M (corresponding author), Univ Vienna, Sch Psychol, Dept Basic Psychol Res & Res Methods, Vienna, Austria.	martin.voracek@univie.ac.at	Stieger, Stefan/G-2572-2012; Voracek, Martin/S-5865-2016	Stieger, Stefan/0000-0002-7784-6624; Voracek, Martin/0000-0001-6109-6155				Arden NK, 1997, J BONE MINER RES, V12, P2076, DOI 10.1359/jbmr.1997.12.12.2076; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Barrai I, 2000, ANN HUM BIOL, V27, P607; BAUMLER G, 1987, PSYCHOL BEITR, V29, P587; BAUMLER G, 1984, PSYCHOL BEITR, V26, P552; BAUMLER G, 1980, PERS INDIV DIFFER, V1, P308, DOI 10.1016/0191-8869(80)90066-5; BENNETT HJ, 1992, JAMA-J AM MED ASSOC, V268, P3060, DOI 10.1001/jama.268.21.3060; Cerutti S., 1991, DOMESTIC STRATEGIES, P102; Clark G, 2014, HUM NATURE-INT BIOS, V25, P517, DOI 10.1007/s12110-014-9219-y; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Corcoran C. D., 2002, J MODERN APPL STAT M, V1, P42, DOI DOI 10.22237/jmasm/1020254880; Fowler A, 2012, LITERARY NAMES PERSO; Holland RW, 2009, SOC COGNITION, V27, P579, DOI 10.1521/soco.2009.27.4.579; Hoorens V, 2014, EUR REV SOC PSYCHOL, V25, P228, DOI 10.1080/10463283.2014.980085; Immel UD, 2006, EUR J HUM GENET, V14, P577, DOI 10.1038/sj.ejhg.5201572; Ioannidis JPA, 2014, INTENS CARE MED, V40, P99, DOI 10.1007/s00134-013-3100-z; Ioannidis JPA, 2012, J PSYCHOSOM RES, V73, P408, DOI 10.1016/j.jpsychores.2012.09.014; Larmuseau MHD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2400; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Mehta CP, 1991, AM STAT, V45, P74; Nesselroth PW, 1996, FICTION UPDATED THEO, P133; Pelham B, 2011, J PERS SOC PSYCHOL, V101, P25, DOI 10.1037/a0023526; Pelham BW, 2005, CURR DIR PSYCHOL SCI, V14, P106, DOI 10.1111/j.0963-7214.2005.00344.x; Sanchez-Munoz C., 2012, HDB ANTHROPOMETRY PH, P1865, DOI [10.1007/978-1-4419-1788-1, DOI 10.1007/978-1-4419-1788-1]; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Stemmler M, 2003, PSYCHOL SCI, V45, P254; VANDENBERG SG, 1972, BEHAV GENET, V2, P127, DOI 10.1007/BF01065686; Voracek M, 2010, PERS INDIV DIFFER, V49, P819, DOI 10.1016/j.paid.2010.06.028	29	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131795	10.1371/journal.pone.0131795	http://dx.doi.org/10.1371/journal.pone.0131795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161803	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000358162300060
J	Xin, W; Xiao, XS; Li, SQ; Jia, XY; Guo, XM; Zhang, QJ				Xin, Wei; Xiao, Xueshan; Li, Shiqiang; Jia, Xiaoyun; Guo, Xiangming; Zhang, Qingjiong			Identification of Genetic Defects in 33 Probands with Stargardt Disease by WES-Based Bioinformatics Gene Panel Analysis	PLOS ONE			English	Article							MACULAR DYSTROPHY; ABCA4 MUTATIONS; DEGENERATION; ELOVL4; POPULATION; FAMILIES; SPECTRUM; COHORT; MYOPIA; PRPH2	Stargardt disease (STGD) is the most common hereditary macular degeneration in juveniles, with loss of central vision occurring in the first or second decade of life. The aim of this study is to identify the genetic defects in 33 probands with Stargardt disease. Clinical data and genomic DNA were collected from 33 probands from unrelated families with STGD. Variants in coding genes were initially screened by whole exome sequencing. Candidate variants were selected from all known genes associated with hereditary retinal dystrophy and then confirmed by Sanger sequencing. Putative pathogenic variants were further validated in available family members and controls. Potential pathogenic mutations were identified in 19 of the 33 probands (57.6%). These mutations were all present in ABCA4, but not in the other four STGD-associated genes or in genes responsible for other retinal dystrophies. Of the 19 probands, ABCA4 mutations were homozygous in one proband and compound heterozygous in 18 probands, involving 28 variants (13 novel and 15 known). Analysis of normal controls and available family members in 12 of the 19 families further support the pathogenicity of these variants. Clinical manifestation of all probands met the diagnostic criteria of STGD. This study provides an overview of a genetic basis for STGD in Chinese patients. Mutations in ABCA4 are the most common cause of STGD in this cohort. Genetic defects in approximately 42.4% of STGD patients await identification in future studies.	[Xin, Wei; Xiao, Xueshan; Li, Shiqiang; Jia, Xiaoyun; Guo, Xiangming; Zhang, Qingjiong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, QJ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhangqji@mail.sysu.edu.cn	Zhang, Qingjiong/AAR-6331-2021	Zhang, Qingjiong/0000-0001-7508-848X	National Natural Science Foundation of China [U1201221]; Natural Science Foundation of Guangdong [S2013030012978]; Guangdong Department of Science and Technology Translational Medicine Center [2011A080300002]; Fundamental Research Funds of State Key Laboratory of Ophthalmology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Guangdong Department of Science and Technology Translational Medicine Center; Fundamental Research Funds of State Key Laboratory of Ophthalmology	This study was supported by the National Natural Science Foundation of China (U1201221), Natural Science Foundation of Guangdong (S2013030012978), Guangdong Department of Science and Technology Translational Medicine Center (2011A080300002), and the Fundamental Research Funds of State Key Laboratory of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Burke TR, 2011, OPHTHALMIC GENET, V32, P165, DOI 10.3109/13816810.2011.565397; Chacon-Camacho OF, 2013, EXP EYE RES, V109, P77, DOI 10.1016/j.exer.2013.02.006; Coco RM, 2010, EUR J OPHTHALMOL, V20, P724, DOI 10.1177/112067211002000413; FISHMAN GA, 1987, OPHTHALMOLOGY, V94, P809, DOI 10.1016/s0161-6420(87)33533-x; Fujinami K, 2013, INVEST OPHTH VIS SCI, V54, P6662, DOI 10.1167/iovs.13-12570; Hargitai J, 2005, INVEST OPHTH VIS SCI, V46, P4402, DOI 10.1167/iovs.05-0504; Jiang D, 2015, INVEST OPHTH VIS SCI, V56, P339, DOI 10.1167/iovs.14-14850; Kniazeva M, 1999, AM J HUM GENET, V64, P1394, DOI 10.1086/302377; Koenekoop Robert K, 2003, Ophthalmic Genet, V24, P75, DOI 10.1076/opge.24.2.75.13996; Logan S, 2014, ADV EXP MED BIOL, V801, P447, DOI 10.1007/978-1-4614-3209-8_57; Maia-Lopes S, 2009, MOL VIS, V15, P584; Oldani M, 2012, GENET MOL RES, V11, P4342, DOI 10.4238/2012.October.9.3; Pang CP, 2002, HUM MUTAT, V19, P189, DOI 10.1002/humu.10053; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Poloschek CM, 2010, INVEST OPHTH VIS SCI, V51, P4253, DOI 10.1167/iovs.09-4655; Riveiro-Alvarez R, 2013, OPHTHALMOLOGY, V120, P2332, DOI 10.1016/j.ophtha.2013.04.002; September AV, 2004, INVEST OPHTH VIS SCI, V45, P1705, DOI 10.1167/iovs.03-1167; Strom SP, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-67; Thiadens AAHJ, 2012, OPHTHALMOLOGY, V119, P819, DOI 10.1016/j.ophtha.2011.10.011; Utz VM, 2013, AM J OPHTHALMOL, V156, P1220, DOI 10.1016/j.ajo.2013.07.008; Valverde D, 2006, MOL VIS, V12, P902; Vasireddy V, 2010, PROG RETIN EYE RES, V29, P191, DOI 10.1016/j.preteyeres.2010.01.001; Walia S, 2009, OPHTHALMIC GENET, V30, P63, DOI 10.1080/13816810802695550; Wang Q, 2010, MOL VIS, V16, P303; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Yi JH, 2012, MOL MED REP, V6, P1045, DOI 10.3892/mmr.2012.1063; Zaneveld J, 2015, GENET MED, V17, P262, DOI 10.1038/gim.2014.174; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817; Zhang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095528	30	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132635	10.1371/journal.pone.0132635	http://dx.doi.org/10.1371/journal.pone.0132635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161775	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300162
J	Hopfner, S; Kesselring, S; Cazzoli, D; Gutbrod, K; Laube-Rosenpflanzer, A; Chechlacz, M; Nef, T; Mosimann, U; Bohlhalter, S; Muri, RM; Nyffeler, T				Hopfner, Simone; Kesselring, Sonja; Cazzoli, Dario; Gutbrod, Klemens; Laube-Rosenpflanzer, Annett; Chechlacz, Magdalena; Nef, Tobias; Mosimann, Urs; Bohlhalter, Stephan; Muri, Rene M.; Nyffeler, Thomas			Neglect and Motion Stimuli - Insights from a Touchscreen-Based Cancellation Task	PLOS ONE			English	Article							UNILATERAL SPATIAL NEGLECT; RIGHT-HEMISPHERE STROKE; VISUAL-FIELD DEFICITS; SUPERIOR COLLICULUS; LINE BISECTION; VISUOSPATIAL NEGLECT; BRAIN NETWORKS; ANATOMY; TRACTOGRAPHY; HEMIANOPIA	Background and Purpose In stroke patients, neglect diagnostic is often performed by means of paper-pencil cancellation tasks. These tasks entail static stimuli, and provide no information concerning possible changes in the severity of neglect symptoms when patients are confronted with motion. We therefore aimed to directly contrast the cancellation behaviour of neglect patients under static and dynamic conditions. Since visual field deficits often occur in neglect patients, we analysed whether the integrity of the optic radiation would influence cancellation behaviour. Methods Twenty-five patients with left spatial neglect after right-hemispheric stroke were tested with a touchscreen cancellation task, once when the evenly distributed targets were stationary, and once when the identic targets moved with constant speed on a random path. The integrity of the right optic radiation was analysed by means of a hodologic probabilistic approach. Results Motion influenced the cancellation behaviour of neglect patients, and the direction of this influence (i.e., an increase or decrease of neglect severity) was modulated by the integrity of the right optic radiation. In patients with an intact optic radiation, the severity of neglect significantly decreased in the dynamic condition. Conversely, in patients with damage to the optic radiation, the severity of neglect significantly increased in the dynamic condition. Conclusion Motion may influence neglect in stroke patients. The integrity of the optic radiation may be a predictor of whether motion increases or decreases the severity of neglect symptoms.	[Hopfner, Simone; Kesselring, Sonja; Bohlhalter, Stephan; Muri, Rene M.; Nyffeler, Thomas] Univ Hosp Bern, Percept & Eye Movement Lab, Dept Neurol & Clin Res, Inselspital, CH-3010 Bern, Switzerland; [Hopfner, Simone; Kesselring, Sonja; Gutbrod, Klemens; Bohlhalter, Stephan; Muri, Rene M.; Nyffeler, Thomas] Univ Bern, Bern, Switzerland; [Cazzoli, Dario; Nef, Tobias; Mosimann, Urs; Muri, Rene M.; Nyffeler, Thomas] Univ Bern, Gerontechnol & Rehabil Grp, Bern, Switzerland; [Cazzoli, Dario] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Gutbrod, Klemens; Muri, Rene M.] Univ Hosp Bern, Div Cognit & Restorat Neurol, Dept Neurol, Inselspital, CH-3010 Bern, Switzerland; [Laube-Rosenpflanzer, Annett] Bern Univ Appl Sci, Inst ICT Based Management, Div Comp Sci, Biel, Switzerland; [Chechlacz, Magdalena] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Nef, Tobias] Univ Bern, ARTORG Ctr Biomed Engn Res, Bern, Switzerland; [Mosimann, Urs] Univ Bern, Univ Hosp Old Age Psychiat & Psychotherapy, Bern, Switzerland; [Bohlhalter, Stephan; Nyffeler, Thomas] Luzerner Kantonsspital, Ctr Neurol & Neurorehabilitat, Luzern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Oxford; University of Bern; University Hospital of Bern; University of Oxford; University of Bern; University of Bern; University Hospital of Bern; Lucerne Cantonal Hospital	Nyffeler, T (corresponding author), Univ Hosp Bern, Percept & Eye Movement Lab, Dept Neurol & Clin Res, Inselspital, CH-3010 Bern, Switzerland.	thomas.nyffeler@luks.ch	Chechlacz, Magdalena/ABB-6360-2021; Muri, Rene/E-9320-2012	Chechlacz, Magdalena/0000-0003-1811-3946; Nyffeler, Thomas/0000-0003-2504-8935; Nef, Tobias/0000-0002-8069-9450; Bohlhalter, Stephan/0000-0002-0723-8164; Muri, Rene/0000-0001-6990-4188; Cazzoli, Dario/0000-0001-7217-7153; Gutbrod, Klemens/0000-0002-5723-3468	Swiss National Science Foundation [320030_140696]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the Swiss National Science Foundation (http://www.snf.ch); Grant Nb: No. 320030_140696. Prof. Thomas Nyffeler received the funding.	Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; Bird CM, 2006, J NEUROL NEUROSUR PS, V77, P1008, DOI 10.1136/jnnp.2006.094417; BUTTER CM, 1990, RESTOR NEUROL NEUROS, V2, P39, DOI 10.3233/RNN-1990-2105; Butter CM, 1995, J CLIN EXP NEUROPSYC, V17, P856, DOI 10.1080/01688639508402435; BUTTER CM, 1988, J NEUROL NEUROSUR PS, V51, P1581, DOI 10.1136/jnnp.51.12.1581; Cassidy TP, 1999, AGE AGEING, V28, P257, DOI 10.1093/ageing/28.3.257; CYNADER M, 1972, J NEUROPHYSIOL, V35, P187, DOI 10.1152/jn.1972.35.2.187; Doricchi F, 2008, CORTEX, V44, P983, DOI 10.1016/j.cortex.2008.03.006; Ferber S, 2001, J CLIN EXP NEUROPSYC, V23, P599, DOI 10.1076/jcen.23.5.599.1243; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; HALLIGAN PW, 1990, J NEUROL NEUROSUR PS, V53, P487, DOI 10.1136/jnnp.53.6.487; Halligan PW, 1999, J NEUROL NEUROSUR PS, V67, P565, DOI 10.1136/jnnp.67.5.565; Heilman K, 2003, CLIN NEUROPSYCHOLOGY, P296, DOI DOI 10.1016/J.NEUR0PSYCHOLOGIA.2011.09.030; Heilman KM, 2002, COGNITIVE NEURAL BAS, P416; Karnath HO, 2012, NEUROPSYCHOLOGIA, V50, P1010, DOI 10.1016/j.neuropsychologia.2011.06.027; Karnath HO, 2002, BRAIN, V125, P350, DOI 10.1093/brain/awf032; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Kerkhoff G, 1997, FORTSCHR NEUROL PSYC, V65, P278, DOI 10.1055/s-2007-996332; Krauzlis RJ, 2013, ANNU REV NEUROSCI, V36, P165, DOI 10.1146/annurev-neuro-062012-170249; Lovejoy LP, 2010, NAT NEUROSCI, V13, P261, DOI 10.1038/nn.2470; MATTINGLEY JB, 1994, J NEUROL NEUROSUR PS, V57, P1228, DOI 10.1136/jnnp.57.10.1228; MATTINGLEY JB, 1993, NEUROPSYCHOLOGIA, V31, P1201, DOI 10.1016/0028-3932(93)90068-B; Muller-Oehring EM, 2003, J CLIN EXP NEUROPSYC, V25, P1154, DOI 10.1076/jcen.25.8.1154.16727; Plummer P, 2006, BRAIN COGNITION, V60, P156, DOI 10.1016/j.bandc.2005.11.001; RIDDOCH MJ, 1983, NEUROPSYCHOLOGIA, V21, P589, DOI 10.1016/0028-3932(83)90056-8; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; SCHILLER PH, 1971, J NEUROPHYSIOL, V34, P920, DOI 10.1152/jn.1971.34.5.920; Thiebaut de Schotten M, 2014, CEREB CORTEX, V24, P691, DOI 10.1093/cercor/bhs351; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Urbanski M, 2008, J NEUROL NEUROSUR PS, V79, P598, DOI 10.1136/jnnp.2007.126276; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; Vuilleumier P, 2007, BEHAVIORAL AND COGNITIVE NEUROLOGY OF STROKE, P148, DOI 10.1017/CBO9780511544880.010; Wilson B. A., 1987, BEHAV INATTENTION TE; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411	35	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0132025	10.1371/journal.pone.0132025	http://dx.doi.org/10.1371/journal.pone.0132025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158619	Green Published, gold			2022-12-27	WOS:000358161200045
J	Kim, MH; Ahn, JY; Song, JE; Choi, H; Ann, HW; Kim, JK; Kim, JH; Jeon, YD; Kim, SB; Jeong, SJ; Ku, NS; Han, SH; Song, YG; Choi, JY; Kim, YS; Kim, JM				Kim, Min Hyung; Ahn, Jin Young; Song, Je Eun; Choi, Heun; Ann, Hea Won; Kim, Jae Kyoung; Kim, Jung Ho; Jeon, Yong Duk; Kim, Sun Bean; Jeong, Su Jin; Ku, Nam Su; Han, Sang Hoon; Song, Young Goo; Choi, Jun Young; Kim, Young Sam; Kim, June Myung			The C-Reactive Protein/Albumin Ratio as an Independent Predictor of Mortality in Patients with Severe Sepsis or Septic Shock Treated with Early Goal-Directed Therapy	PLOS ONE			English	Article							SURVIVING SEPSIS; INTENSIVE-CARE; BLOOD LACTATE; PROTEIN; MARKER; INFECTION; DISCHARGE; CAMPAIGN	Background Sepsis, including severe sepsis and septic shock, is a major cause of morbidity and mortality. Albumin and C-reactive protein (CRP) are considered as good diagnostic markers for sepsis. Thus, initial CRP and albumin levels were combined to ascertain their value as an independent predictor of 180-day mortality in patients with severe sepsis and septic shock. Materials and Methods We conducted a retrospective cohort study involving 670 patients (>18 years old) who were admitted to the emergency department and who had received a standardized resuscitation algorithm (early goal-directed therapy) for severe sepsis and septic shock, from November 2007 to February 2013, at a tertiary hospital in Seoul, Korea. The outcome measured was 180-day all-cause mortality. A multivariate Cox proportional hazard model was used to identify the independent risk factors for mortality. A receiver operating characteristic (ROC) curve analysis was conducted to compare the predictive accuracy of the CRP/albumin ratio at admission. Results The 180-day mortality was 28.35% (190/670). Based on the multivariate Cox proportional hazard analysis, age, the CRP/albumin ratio at admission (adjusted HR 1.06, 95% CI 1.031-10, p<0.001), lactate level at admission (adjusted HR 1.10, 95% CI 1.05-1.14, p<0.001), and the Sequential Organ Failure Assessment (SOFA) score at admission (adjusted HR 1.12, 95% CI 1.07-1.18, p<0.001) were independent predictors of 180-day mortality. The area under the curve of CRP alone and the CRP/albumin ratio at admission for 180-day mortality were 0.5620 ( P<0.001) and 0.6211 (P<0.001), respectively. Conclusion The CRP/albumin ratio was an independent predictor of mortality in patients with severe sepsis or septic shock.	[Kim, Min Hyung] Bundang Jesaeng Hosp, Seongam, Gyeonggi, South Korea; [Ahn, Jin Young; Song, Je Eun; Choi, Heun; Ann, Hea Won; Kim, Jae Kyoung; Kim, Jung Ho; Jeon, Yong Duk; Kim, Sun Bean; Jeong, Su Jin; Ku, Nam Su; Han, Sang Hoon; Song, Young Goo; Choi, Jun Young; Kim, Young Sam; Kim, June Myung] Yonsei Univ, Dept Internal Med, Coll Med, Seoul 120749, South Korea; [Ahn, Jin Young; Song, Je Eun; Choi, Heun; Ann, Hea Won; Kim, Jae Kyoung; Kim, Jung Ho; Jeon, Yong Duk; Kim, Sun Bean; Jeong, Su Jin; Ku, Nam Su; Han, Sang Hoon; Song, Young Goo; Choi, Jun Young; Kim, June Myung] Yonsei Univ, AIDS Res Inst, Coll Med, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Ku, NS (corresponding author), Yonsei Univ, Dept Internal Med, Coll Med, Seoul 120749, South Korea.	smileboy9@yuhs.ac	Song, Young Goo/AGV-5104-2022	Song, Young Goo/0000-0002-0733-4156; Choi, Jun Yong/0000-0002-2775-3315; Kim, Young Sam/0000-0001-9656-8482; Kim, Jung Ho/0000-0002-5033-3482; Choi, Heun/0000-0002-9622-9381; Ahn, Jin Young/0000-0002-3740-2826; Ku, Nam Su/0000-0002-9717-4327; Han, Sang Hoon/0000-0002-4278-5198; Jeong, Su Jin/0000-0003-4025-4542				Al-Subaie N, 2010, BRIT J ANAESTH, V105, P318, DOI 10.1093/bja/aeq171; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Artero A, 2010, J CRIT CARE, V25, P276, DOI 10.1016/j.jcrc.2009.12.004; Barbosa-Silva MCG, 2008, CURR OPIN CLIN NUTR, V11, P248, DOI 10.1097/MCO.0b013e3282fba5d7; Chen YX, 2009, AM J EMERG MED, V27, P701, DOI 10.1016/j.ajem.2009.02.001; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI [10.1007/s00134-012-2769-8, 10.1097/CCM.0b013e31827e83af]; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Gradel KO, 2011, CLIN MICROBIOL INFEC, V17, P627, DOI 10.1111/j.1469-0691.2010.03284.x; Ho KM, 2008, INTENS CARE MED, V34, P481, DOI 10.1007/s00134-007-0928-0; Hofhuis JGM, 2008, ANESTH ANALG, V107, P1957, DOI 10.1213/ane.0b013e318187bbd8; Juvela S, 2012, ACTA NEUROCHIR, V154, P397, DOI 10.1007/s00701-011-1243-7; Kaplan V, 2002, CRIT CARE MED, V30, P703, DOI 10.1097/00003246-200203000-00037; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McMillan DC, 2001, NUTR CANCER, V39, P210, DOI 10.1207/S15327914nc392_8; Mtove G, 2011, CLIN INFECT DIS, V53, P548, DOI 10.1093/cid/cir471; Osborn TM, 2005, ANN EMERG MED, V46, P228, DOI 10.1016/j.annemergmed.2005.04.007; PARKER MM, 1987, CRIT CARE MED, V15, P923, DOI 10.1097/00003246-198710000-00006; Povoa P, 2011, CRIT CARE, V15, DOI 10.1186/cc10313; Qian Su-yun, 2012, Zhonghua Er Ke Za Zhi, V50, P184; Ranzani OT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059321; Rodelo JR, 2012, AM J EMERG MED, V30, P1991, DOI 10.1016/j.ajem.2012.04.033; Routsi C, 2007, INFECTION, V35, P240, DOI 10.1007/s15010-007-6217-6; Schmidt H, 2008, CRIT CARE MED, V36, P967, DOI 10.1097/CCM.0B013E3181653263; Thiem U, 2009, AGE AGEING, V38, P693, DOI 10.1093/ageing/afp164; VIGUSHIN DM, 1993, J CLIN INVEST, V91, P1351, DOI 10.1172/JCI116336; Villacorta H, 2007, ARQ BRAS CARDIOL, V88, P585, DOI 10.1590/S0066-782X2007000500014; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vladimirova SG, 2013, TERAPEVT ARKH, V85, P34; Wacharasint P, 2012, SHOCK, V38, P4, DOI 10.1097/SHK.0b013e318254d41a; Xie QH, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-30	33	100	109	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0132109	10.1371/journal.pone.0132109	http://dx.doi.org/10.1371/journal.pone.0132109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158725	Green Submitted, Green Published, gold			2022-12-27	WOS:000358161200047
J	Vetter, SG; Ruf, T; Bieber, C; Arnold, W				Vetter, Sebastian G.; Ruf, Thomas; Bieber, Claudia; Arnold, Walter			What Is a Mild Winter? Regional Differences in Within-Species Responses to Climate Change	PLOS ONE			English	Article							BOAR SUS-SCROFA; WILD BOAR; BODY-SIZE; POPULATION-DENSITY; RED DEER; PULSED RESOURCES; BERGMANNS RULE; LITTER SIZE; TEMPERATURE; EVOLUTION	Climate change is known to affect ecosystems globally, but our knowledge of its impact on large and widespread mammals, and possibly population-specific responses is still sparse. We investigated large-scale and long-term effects of climate change on local population dynamics using the wild boar (Sus scrofa L.) as a model species. Our results show that population increases across Europe are strongly associated with increasingly mild winters, yet with region-specific threshold temperatures for the onset of exponential growth. Additionally, we found that abundant availability of critical food resources, e.g. beech nuts, can outweigh the negative effects of cold winters on population growth of wild boar. Availability of beech nuts is highly variable and highest in years of beech mast which increased in frequency since 1980, according to our data. We conclude that climate change drives population growth of wild boar directly by relaxing the negative effect of cold winters on survival and reproduction, and indirectly by increasing food availability. However, region-specific responses need to be considered in order to fully understand a species' demographic response to climate change.	[Vetter, Sebastian G.; Ruf, Thomas; Bieber, Claudia; Arnold, Walter] Univ Vet Med, Res Inst Wildlife Ecol, Dept Integrat Biol & Evolut, Vienna, Austria	University of Veterinary Medicine Vienna	Vetter, SG (corresponding author), Univ Vet Med, Res Inst Wildlife Ecol, Dept Integrat Biol & Evolut, Savoyenstr 1, Vienna, Austria.	sebastian.vetter@vetmeduni.ac.at	Arnold, Walter/C-3394-2013	Arnold, Walter/0000-0001-6785-5685; Vetter, Sebastian G./0000-0001-5374-5872; Bieber, Claudia/0000-0001-8919-3117; Ruf, Thomas/0000-0002-9235-7079	Austrian Research Promotion Agency (FFG) [829644]; governments of Lower Austria and Vienna	Austrian Research Promotion Agency (FFG); governments of Lower Austria and Vienna	This work was supported by the Austrian Research Promotion Agency (FFG, Grant #829644, https://www.ffg.at/en-CB) and the governments of Lower Austria and Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R, 2000, J ANIM ECOL, V69, P672, DOI 10.1046/j.1365-2656.2000.00425.x; Ballari SA, 2014, MAMMAL REV, V44, P124, DOI 10.1111/mam.12015; Barton K, 2013, MUMIN MULTIMODEL INF; Bergmann C. G. L. C., 1848, UEBER VERHALTNISSE W; Bieber C, 2005, J APPL ECOL, V42, P1203, DOI 10.1111/j.1365-2664.2005.01094.x; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Briedermann L, 2009, SCHWARZWILD; BRUINDERINK GWTAG, 1994, J ZOOL, V233, P631; Bruinderink GWTAG, 1996, CONSERV BIOL, V10, P1059, DOI 10.1046/j.1523-1739.1996.10041059.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Bywater KA, 2010, MAMMAL REV, V40, P212, DOI 10.1111/j.1365-2907.2010.00160.x; Choquenot D, 1998, J ANIM ECOL, V67, P887, DOI 10.1046/j.1365-2656.1998.6760887.x; CLUTTONBROCK TH, 1992, J ANIM ECOL, V61, P381, DOI 10.2307/5330; Coulson T, 2003, EVOLUTION, V57, P2879, DOI 10.1111/j.0014-3820.2003.tb01528.x; DAVIS SJM, 1981, PALEOBIOLOGY, V7, P101, DOI 10.1017/S0094837300003821; Fernandez-Llario P, 1998, ACTA THERIOL, V43, P439, DOI 10.4098/AT.arch.98-54; Focardi S, 2008, J MAMMAL, V89, P1113, DOI 10.1644/07-MAMM-A-164.1; Forchhammer MC, 2001, J ANIM ECOL, V70, P721, DOI 10.1046/j.0021-8790.2001.00532.x; Forchhammer MC, 1998, P ROY SOC B-BIOL SCI, V265, P341, DOI 10.1098/rspb.1998.0301; Gaillard JM, 2013, ECOL LETT, V16, P48, DOI 10.1111/ele.12059; GAILLARD JM, 1993, FOLIA ZOOL, V42, P204; Gamelon M, 2011, EVOLUTION, V65, P3100, DOI 10.1111/j.1558-5646.2011.01366.x; Geisser H, 2005, J ZOOL, V267, P89, DOI 10.1017/S095283690500734X; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Gethoffer F, 2005, THESIS; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Guthrie RD, 2003, NATURE, V426, P169, DOI 10.1038/nature02098; Husby A, 2011, AM NAT, V178, P202, DOI 10.1086/660834; Jedrzejewska B, 1997, ACTA THERIOL, V42, P399; JEDRZEJEWSKI W, 1992, OECOLOGIA, V90, P27, DOI 10.1007/BF00317805; Jensen LF, 2008, P ROY SOC B-BIOL SCI, V275, P2859, DOI 10.1098/rspb.2008.0870; KENDEIGH SC, 1974, COMP BIOCHEM PHYSIOL, V48, P175; Koskinen MT, 2002, NATURE, V419, P826, DOI 10.1038/nature01029; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; Massei Giovanna, 2004, Galemys, V16, P135; Massei G, 2015, PEST MANAG SCI, V71, P492, DOI 10.1002/ps.3965; Melis C, 2006, J BIOGEOGR, V33, P803, DOI 10.1111/j.1365-2699.2006.01434.x; Milner JM, 1999, J ANIM ECOL, V68, P1235, DOI 10.1046/j.1365-2656.1999.00366.x; Morellet N, 2013, J ANIM ECOL, V82, P1326, DOI 10.1111/1365-2656.12105; Nakagawa S, 2011, BEHAV ECOL SOCIOBIOL, V65, P103, DOI 10.1007/s00265-010-1044-7; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Overgaard R, 2007, FORESTRY, V80, P553, DOI 10.1093/forestry/cpm020; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Patterson BR, 2002, OECOLOGIA, V130, P62, DOI 10.1007/s004420100783; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pettorelli N, 2005, P ROY SOC B-BIOL SCI, V272, P2357, DOI 10.1098/rspb.2005.3218; R Core Team, 2021, R LANGUAGE ENV STAT; SAEZROYUELA C, 1986, MAMMAL REV, V16, P97; Scandura M, 2008, MOL ECOL, V17, P1745, DOI 10.1111/j.1365-294X.2008.03703.x; Scandura M, 2011, MAMMAL REV, V41, P125, DOI 10.1111/j.1365-2907.2010.00182.x; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schley L, 2003, MAMMAL REV, V33, P43, DOI 10.1046/j.1365-2907.2003.00010.x; Servanty S, 2011, J APPL ECOL, V48, P835, DOI 10.1111/j.1365-2664.2011.02017.x; Servanty S, 2009, J ANIM ECOL, V78, P1278, DOI 10.1111/j.1365-2656.2009.01579.x; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Speakman John R, 2010, Integr Comp Biol, V50, P793, DOI 10.1093/icb/icq049; Staudinger MD, 2013, FRONT ECOL ENVIRON, V11, P465, DOI 10.1890/120272; Tafani M, 2013, ECOLOGY, V94, P580, DOI 10.1890/12-0833.1; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; Toigo C, 2008, J WILDLIFE MANAGE, V72, P1532, DOI 10.2193/2007-378; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	65	83	84	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0132178	10.1371/journal.pone.0132178	http://dx.doi.org/10.1371/journal.pone.0132178			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158846	Green Submitted, gold, Green Published			2022-12-27	WOS:000358161200048
J	Yu, W; Zeng, L				Yu, Wei; Zeng, Li			l(0) Gradient Minimization Based Image Reconstruction for Limited-Angle Computed Tomography	PLOS ONE			English	Article							TOMOSYNTHESIS; INVERSION	In medical and industrial applications of computed tomography (CT) imaging, limited by the scanning environment and the risk of excessive X-ray radiation exposure imposed to the patients, reconstructing high quality CT images from limited projection data has become a hot topic. X-ray imaging in limited scanning angular range is an effective imaging modality to reduce the radiation dose to the patients. As the projection data available in this modality are incomplete, limited-angle CT image reconstruction is actually an ill-posed inverse problem. To solve the problem, image reconstructed by conventional filtered back projection (FBP) algorithm frequently results in conspicuous streak artifacts and gradual changed artifacts nearby edges. Image reconstruction based on total variation minimization (TVM) can significantly reduce streak artifacts in few-view CT, but it suffers from the gradual changed artifacts nearby edges in limited-angle CT. To suppress this kind of artifacts, we develop an image reconstruction algorithm based on l(0) gradient minimization for limited-angle CT in this paper. The l(0)-norm of the image gradient is taken as the regularization function in the framework of developed reconstruction model. We transformed the optimization problem into a few optimization sub-problems and then, solved these sub-problems in the manner of alternating iteration. Numerical experiments are performed to validate the efficiency and the feasibility of the developed algorithm. From the statistical analysis results of the performance evaluations peak signal-to-noise ratio (PSNR) and normalized root mean square distance (NRMSD), it shows that there are significant statistical differences between different algorithms from different scanning angular ranges (p<0.0001). From the experimental results, it also indicates that the developed algorithm outperforms classical reconstruction algorithms in suppressing the streak artifacts and the gradual changed artifacts nearby edges simultaneously.	[Yu, Wei] Hubei Univ Sci & Technol, Sch Biomed Engn, Xianning, Peoples R China; [Zeng, Li] Chongqing Univ, Coll Math & Stat, Chongqing 630044, Peoples R China; [Yu, Wei; Zeng, Li] Chongqing Univ, Engn Res Ctr Ind Computed Tomog Nondestruct Testi, Educ Minist China, Chongqing 630044, Peoples R China	Hubei University of Science & Technology; Chongqing University; Chongqing University	Zeng, L (corresponding author), Chongqing Univ, Coll Math & Stat, Chongqing 630044, Peoples R China.	drlizeng@cqu.edu.cn			National Natural Science Foundation of China [61271313]; National Instrumentation Program of China [2013YQ030629]; Chongqing science and technology research plan project [cstc2012gg-yyjs70016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Instrumentation Program of China; Chongqing science and technology research plan project	This work is supported by the National Natural Science Foundation of China under grant (61271313) (http://www.nsfc.gov.cn), National Instrumentation Program of China (2013YQ030629) (http://www.most.gov.cn), and Chongqing science and technology research plan project (cstc2012gg-yyjs70016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN AH, 1984, ULTRASONIC IMAGING, V6, P81, DOI 10.1016/0161-7346(84)90008-7; Armitage P., 2002, STAT METHODS MED RES; Bachar G, 2007, MED PHYS, V34, P4664, DOI 10.1118/1.2799492; Cai X, 2015, INF INFERENCE, V4, P43, DOI 10.1093/imaiai/iau010; Chen GH, 2008, MED PHYS, V35, P660, DOI 10.1118/1.2836423; Chen JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092414; Chen ZQ, 2013, PHYS MED BIOL, V58, P2119, DOI 10.1088/0031-9155/58/7/2119; Cho MK, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/03/P03007; Faramarzi E, 2013, IEEE T IMAGE PROCESS, V22, P2101, DOI 10.1109/TIP.2013.2237915; Frikel J, 2013, APPL COMPUT HARMON A, V34, P117, DOI 10.1016/j.acha.2012.03.005; Han Y, 2013, PATTERN RECOGN, V46, P1971, DOI 10.1016/j.patcog.2012.12.002; Herman GT, 2009, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84628-723-7; Jiang M, 2003, IEEE T IMAGE PROCESS, V12, P957, DOI 10.1109/TIP.2003.815295; Kak A.V., 1988, PRINCIPLES COMPUTERI, DOI DOI 10.1137/1.9780898719277.CH7; Kolehmainen V, 2003, PHYS MED BIOL, V48, P1465, DOI 10.1088/0031-9155/48/10/315; Lu XQ, 2011, PATTERN RECOGN, V44, P2427, DOI 10.1016/j.patcog.2010.12.016; Lu XQ, 2011, NEUROCOMPUTING, V74, P661, DOI 10.1016/j.neucom.2010.08.003; Lu XQ, 2010, IMAGE VISION COMPUT, V28, P696, DOI 10.1016/j.imavis.2009.10.011; Ning PG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092568; Noo F, 2002, PHYS MED BIOL, V47, P2525, DOI 10.1088/0031-9155/47/14/311; Pan XC, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123009; Pei SC, 2012, IEEE SIGNAL PROC LET, V19, P813, DOI 10.1109/LSP.2012.2220352; Rantala M, 2006, IEEE T MED IMAGING, V25, P210, DOI 10.1109/TMI.2005.862206; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Segars W P, 2001, J NUCL MED, V42, P7; Segars WP, 2001, IEEE T NUCL SCI, V48, P89, DOI 10.1109/23.910837; Sidky EY, 2006, J X-RAY SCI TECHNOL, V14, P119; Tingberg A, 2010, RADIAT PROT DOSIM, V139, P100, DOI 10.1093/rpd/ncq099; TUY HK, 1983, SIAM J APPL MATH, V43, P546, DOI 10.1137/0143035; Wang YL, 2008, SIAM J IMAGING SCI, V1, P248, DOI 10.1137/080724265; Wright SJ, 2009, IEEE T SIGNAL PROCES, V57, P2479, DOI 10.1109/TSP.2009.2016892; Wu DF, 2013, PHYS MED BIOL, V58, P4047, DOI 10.1088/0031-9155/58/12/4047; Xu L, 2011, ACM T GRAPHIC, V30, DOI 10.1145/2024156.2024208; Yu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109345; Zeng L, 2013, J INVERSE ILL-POSE P, V21, P735, DOI 10.1515/jip-2011-0010	35	30	30	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130793	10.1371/journal.pone.0130793	http://dx.doi.org/10.1371/journal.pone.0130793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158543	Green Submitted, gold, Green Published			2022-12-27	WOS:000358161200017
J	Tao, YF; Li, ZH; Xu, LX; Fang, F; Lu, J; Li, G; Cao, L; Wang, NN; Du, XJ; Sun, LC; Zhao, WL; Xiao, PF; Zhao, H; Su, GH; Li, YH; Li, YP; Xu, YY; Zhou, HT; Wu, Y; Jin, MF; Liu, L; Ni, J; Hu, SY; Zhu, XM; Feng, X; Wang, J; Pan, J				Tao Yan-Fang; Li Zhi-Heng; Xu Li-Xiao; Fang Fang; Lu Jun; Li Gang; Cao Lan; Wang Na-Na; Du Xiao-Juan; Sun Li-Chao; Zhao Wen-Li; Xiao Pei-Fang; Zhao He; Su Guang-Hao; Li Yan-Hong; Li Yi-Ping; Xu Yun-Yun; Zhou Hui-Ting; Wu Yi; Jin Mei-Fang; Liu Lin; Ni Jian; Hu Shao-Yan; Zhu Xue-Ming; Feng Xing; Wang Jian; Pan Jian			Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells	PLOS ONE			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; PHASE-I TRIAL; GASTRIC-CANCER; HDAC INHIBITOR; COLORECTAL-CANCER; MULTIPLE-MYELOMA; LUNG-CANCER; EXPRESSION; REPRIMO; APOPTOSIS	Background Wilms tumor (WT) is an embryonic kidney cancer, for which histone acetylation might be a therapeutic target. LBH589, a novel targeted agent, suppresses histone deacetylases in many tumors. This study investigated the antitumor activity of LBH589 in SK-NEP-1 and G401 cells. Methods SK-NEP-1 and G401 cell growth was assessed by CCK-8 and in nude mice experiments. Annexin V/propidium iodide staining followed by flow cytometry detected apoptosis in cell culture. Gene expressions of LBH589-treated tumor cells were analyzed using an Arraystar Human LncRNA Array. The Multi Experiment View cluster software analyzed the expression data. Differentially expressed genes from the cluster analyses were imported into the Ingenuity Pathway Analysis tool. Results LBH589 inhibited cell proliferation of SK-NEP-1 and G401 cells in a dose-dependent manner. Annexin V, TUNEL and Hochest 33342 staining analysis showed that LBH589-treated cells showed more apoptotic features compared with the control. LBH589 treatment inhibited the growth of SK-NEP-1 xenograft tumors in nude mice. Arraystar Human LncRNA Array analysis of genes and lncRNAs regulated by LBH589 identified 6653 mRNAs and 8135 lncRNAs in LBH589-treated SK-NEP-1 cells. The most enriched gene ontology terms were those involved in nucleosome assembly. KEGG pathway analysis identified cell cycle proteins, including CCNA2, CCNB2, CCND1, CCND2, CDK4, CDKN1B and HDAC2, etc. Ingenuity Pathway Analysis identified important upstream molecules: HIST2H3C, HIST1H4A, HIST1A, HIST1C, HIST1D, histone H1, histone H3, RPRM, HSP70 and MYC. Conclusions LBH589 treatment caused apoptosis and inhibition of cell proliferation of SK-NEP-1 and G401 cells. LBH589 had a significant effect and few side effects on SK-NEP-1 xenograft tumors. Expression profiling, and GO, KEGG and IPA analyses identified new targets and a new "network" of genes responding to LBH589 treatment in SK-NEP-1 cells. RPRM, HSP70 and MYC may be important regulators during LBH589 treatment. Our results provide new clues to the proapoptotic mechanism of LBH589.	[Tao Yan-Fang; Li Zhi-Heng; Xu Li-Xiao; Fang Fang; Lu Jun; Li Gang; Cao Lan; Wang Na-Na; Zhao Wen-Li; Xiao Pei-Fang; Zhao He; Su Guang-Hao; Li Yan-Hong; Li Yi-Ping; Xu Yun-Yun; Zhou Hui-Ting; Wu Yi; Jin Mei-Fang; Liu Lin; Hu Shao-Yan; Zhu Xue-Ming; Feng Xing; Wang Jian; Pan Jian] Soochow Univ, Dept Hematol & Oncol, Childrens Hosp, Suzhou, Peoples R China; [Du Xiao-Juan] 5th Hosp Chinese PLA, Dept Gastroenterol, Yin Chuan, Peoples R China; [Sun Li-Chao] Chinese Acad Med Sci, Peking Union Med Coll, Dept Cell & Mol Biol, Canc Inst Hosp, Beijing 100730, Peoples R China; [Ni Jian] Nanjing Med Univ, Hosp 2, Translat Res Ctr, Sch Clin 2, Nanjing, Peoples R China	Soochow University - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Nanjing Medical University	Wang, J (corresponding author), Soochow Univ, Dept Hematol & Oncol, Childrens Hosp, Suzhou, Peoples R China.	wj196312@vip.163.com; panjian2008@163.com			National Key Basic Research Program [2010CB933902]; key medical subjects of Jiangsu Province [XK201120]; Innovative team of Jiangsu Province [LJ201114, LJ201126]; Special Clinical Medical Science and Technology of Jiangsu Province [BL2012050, BL2013014]; Key Laboratory of Suzhou [SZS201108, SZS201307]; National Natural Science Foundation [81100371, 81370627, 81300423, 81272143]; Natural Science Foundation of Jiangsu Province [BK2011308]; Universities Natural Science Foundation of Jiangsu Province [11KJB320014]; Talent's subsidy project in science and education of Department of Public Health of Suzhou City [SWKQ1020]; Major Scientific and Technological Special Project for "significant new drugs creation" [2012ZX09103301-040]	National Key Basic Research Program(National Basic Research Program of China); key medical subjects of Jiangsu Province; Innovative team of Jiangsu Province; Special Clinical Medical Science and Technology of Jiangsu Province; Key Laboratory of Suzhou; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Universities Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Talent's subsidy project in science and education of Department of Public Health of Suzhou City; Major Scientific and Technological Special Project for "significant new drugs creation"	This work was supported by grants from the National Key Basic Research Program No. 2010CB933902, grants from key medical subjects of Jiangsu Province (XK201120), Innovative team of Jiangsu Province (LJ201114, LJ201126), Special Clinical Medical Science and Technology of Jiangsu Province (BL2012050, BL2013014), Key Laboratory of Suzhou (SZS201108, SZS201307), National Natural Science Foundation (81100371, 81370627, 81300423, 81272143), Natural Science Foundation of Jiangsu Province No. BK2011308, Universities Natural Science Foundation of Jiangsu Province No. 11KJB320014, Talent's subsidy project in science and education of Department of Public Health of Suzhou City No. SWKQ1020, and Major Scientific and Technological Special Project for "significant new drugs creation" No. 2012ZX09103301-040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahari-Javan S, 2012, J NEUROSCI, V32, P5062, DOI 10.1523/JNEUROSCI.0079-12.2012; Beasley WD, 2008, INT J COLORECTAL DIS, V23, P375, DOI 10.1007/s00384-007-0435-3; Bellucci L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054102; Bernal C, 2008, CLIN CANCER RES, V14, P6264, DOI 10.1158/1078-0432.CCR-07-4522; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brilli LL, 2013, PEDIATR NEPHROL, V28, P1909, DOI 10.1007/s00467-012-2320-8; Chou CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018087; Chuang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073401, 10.1371/journal.pone.0083116]; Crump M, 2008, ANN ONCOL, V19, P964, DOI 10.1093/annonc/mdn031; Darzynkiewicz Z, 2008, METHODS, V44, P250, DOI 10.1016/j.ymeth.2007.11.008; Davenport KP, 2012, SURG CLIN N AM, V92, P745, DOI 10.1016/j.suc.2012.03.004; de Marinis F, 2013, J THORAC ONCOL, V8, P1091, DOI 10.1097/JTO.0b013e318293d88c; Fortunati N, 2014, INT J ONCOL, V44, P700, DOI 10.3892/ijo.2013.2218; Ghobrial IM, 2013, BLOOD, V121, P1296, DOI 10.1182/blood-2012-06-439307; Gotze S, 2014, INT J ONCOL, V45, P1715, DOI 10.3892/ijo.2014.2550; Graham C, 2006, CLIN CANCER RES, V12, P223, DOI 10.1158/1078-0432.CCR-05-1225; Hrabeta J, 2014, BIOMED PAP, V158, P161, DOI 10.5507/bp.2013.085; Hsieh YJ, 2014, J NUCL MED, V55, P678, DOI 10.2967/jnumed.113.126573; Jeon YJ, 2013, INT J MOL MED, V32, P860, DOI 10.3892/ijmm.2013.1451; Juengel E, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-152; Kroesen M, 2014, ONCOTARGET; Lemaire M, 2012, CLIN CANCER RES, V18, P2230, DOI 10.1158/1078-0432.CCR-11-1764; Li XY, 2014, CURR DRUG TARGETS, V15, P622, DOI 10.2174/1389450115666140306152642; Ma YY, 2011, TAIWAN J OBSTET GYNE, V50, P165, DOI 10.1016/j.tjog.2011.01.022; Mithraprabhu S, 2013, BRIT J HAEMATOL, V162, P559, DOI 10.1111/bjh.12388; Nakagawa M, 2007, ONCOL REP, V18, P769; Oehme I, 2009, CLIN CANCER RES, V15, P91, DOI 10.1158/1078-0432.CCR-08-0684; Ohki R, 2000, J BIOL CHEM, V275, P22627, DOI 10.1074/jbc.C000235200; Ooki A, 2013, MOL CANCER RES, V11, P1362, DOI 10.1158/1541-7786.MCR-13-0091; Ren J, 2014, CURR PHARM DESIGN, V20, P1847, DOI 10.2174/13816128113199990528; Richardson P, 2008, LEUKEMIA LYMPHOMA, V49, P502, DOI 10.1080/10428190701817258; Russo D, 2013, EXPERT OPIN THER TAR, V17, P179, DOI 10.1517/14728222.2013.740013; Scuto A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.159; Scuto A, 2008, BLOOD, V111, P5093, DOI 10.1182/blood-2007-10-117762; Shi BW, 2013, DRUG DISCOV THER, V7, P129, DOI 10.5582/ddt.2013.v7.4.129; Smith MA, 2008, PEDIATR BLOOD CANCER, V50, P703, DOI 10.1002/pbc.21099; Song J, 2005, APMIS, V113, P264, DOI 10.1111/j.1600-0463.2005.apm_04.x; Song X, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-114; Tao YF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-619; Tarhini AA, 2013, ANTICANCER RES, V33, P4475; Valente S, 2014, EXPERT OPIN THER PAT, V24, P401, DOI 10.1517/13543776.2014.877446; Wang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076662; Wang L., 2014, DISCRETE DYN NAT SOC, V2014, P1, DOI DOI 10.1002/ASL2.454; Wegert J, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-136; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Woods DM, 2013, MELANOMA RES, V23, P341, DOI 10.1097/CMR.0b013e328364c0ed; Xiao WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074253; Xu M, 2012, ENDOCRINOLOGY, V153, P2963, DOI 10.1210/en.2011-2021; Xu Miqing, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1409; Yan SF, 2014, CURR PHARM DESIGN, V20, P1604, DOI 10.2174/13816128113199990544; Yasui W, 2003, ANN NY ACAD SCI, V983, P220, DOI 10.1111/j.1749-6632.2003.tb05977.x; Yu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042377; Zhao YX, 2014, INT J ONCOL, V44, P451, DOI 10.3892/ijo.2013.2193; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	55	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0126566	10.1371/journal.pone.0126566	http://dx.doi.org/10.1371/journal.pone.0126566			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176219	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600005
J	Kim, E; Park, Y; Kim, Y				Kim, Eunseong; Park, Youngjin; Kim, Yonggyun			A Transformed Bacterium Expressing Double-Stranded RNA Specific to Integrin beta 1 Enhances Bt Toxin Efficacy against a Polyphagous Insect Pest, Spodoptera exigua	PLOS ONE			English	Article							BEET ARMYWORM; GENE-EXPRESSION; INTERFERENCE; DSRNA; INGESTION; RESPONSES; MOSQUITO; DELIVERY; RECEPTOR; REVEALS	Background Oral toxicity of double-stranded RNA (dsRNA) specific to integrin beta 1 subunit (SeINT) was known in a polyphagous insect pest, Spodoptera exigua. For an application of the dsRNA to control the insect pest, this study prepared a transformed Escherichia coli expressing dsRNA specific to SeINT. Principal Findings The dsRNA expression was driven by T7 RNA polymerase overexpressed by an inducer in the transformed E. coli. The produced dsRNA amount was proportional to the number of the cultured bacteria. The transformed bacteria gave a significant oral toxicity to S. exigua larvae with a significant reduction of the SeINT expression. The resulting insect mortality increased with the fed number of the bacteria. Pretreatment with an ultra-sonication to disrupt bacterial cell wall/membrane significantly increased the insecticidal activity of the transformed bacteria. The larvae treated with the transformed bacteria suffered tissue damage in the midgut epithelium, which exhibited a marked loss of cell-cell contacts and underwent a remarkable cell death. Moreover, these treated larvae became significantly susceptible to a Cry toxin derived from Bacillus thuringiensis (Bt). Conclusions This study provides a novel and highly efficient application technique to use dsRNA specific to an integrin gene by mixing with a biopesticide, Bt.	[Kim, Eunseong; Park, Youngjin; Kim, Yonggyun] Andong Natl Univ, Dept Bioresource Sci, Andong 760749, South Korea	Andong National University	Kim, Y (corresponding author), Andong Natl Univ, Dept Bioresource Sci, Andong 760749, South Korea.	hosanna@andong.ac.kr			iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs	iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs	This research was supported by iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs to YK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2012, J INSECT PHYSIOL, V58, P391, DOI 10.1016/j.jinsphys.2011.12.014; Attasart P, 2013, VIRUS RES, V171, P252, DOI 10.1016/j.virusres.2012.11.012; Bachman PM, 2013, TRANSGENIC RES, V22, P1207, DOI 10.1007/s11248-013-9716-5; Barandoc K, 2009, J MICROBIOL BIOTECHN, V19, P610, DOI 10.4014/jmb.0808.495; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Broderick NA, 2006, P NATL ACAD SCI USA, V103, P15196, DOI 10.1073/pnas.0604865103; Chen J, 2010, PLOS ONE, V5; Chen X, 2008, B ENTOMOL RES, V98, P613, DOI 10.1017/S0007485308005932; Christiaens O, 2014, PEPTIDES, V53, P307, DOI 10.1016/j.peptides.2013.12.014; DELORME R, 1988, PESTIC BIOCHEM PHYS, V32, P240, DOI 10.1016/0048-3575(88)90107-1; GOH H G, 1991, Korean Journal of Applied Entomology, V30, P111; GOH H G, 1990, Korean Journal of Applied Entomology, V29, P180; Hwang J, 2011, J INVERTEBR PATHOL, V108, P194, DOI 10.1016/j.jip.2011.09.003; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim J, 2012, ARCH INSECT BIOCHEM, V81, P214, DOI 10.1002/arch.21051; KIM Y, 1999, KOR J APPL ENTOMOL, V38, P56; Liu JS, 2013, J INSECT PHYSIOL, V59, P646, DOI 10.1016/j.jinsphys.2013.03.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; MOAR WJ, 1995, APPL ENVIRON MICROB, V61, P2086, DOI 10.1128/AEM.61.6.2086-2092.1995; Park Y, 2013, J INVERTEBR PATHOL, V114, P285, DOI 10.1016/j.jip.2013.09.006; Park Y, 2013, J EXP BIOL, V216, P4196, DOI 10.1242/jeb.092031; SAS Institute Inc, 1989, SAS STAT US GUID, V2; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Shrestha S, 2011, J INSECT PHYSIOL, V57, P1568, DOI 10.1016/j.jinsphys.2011.08.010; Shrestha S, 2011, COMP BIOCHEM PHYS B, V158, P216, DOI 10.1016/j.cbpb.2010.11.007; Singh AD, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.6901; SMITS PH, 1987, ENTOMOL EXP APPL, V43, P67, DOI 10.1007/BF00350377; Srikanth K, 2011, ARCH INSECT BIOCHEM, V78, P145, DOI 10.1002/arch.20450; Surakasi VP, 2011, J INSECT PHYSIOL, V57, P1537, DOI 10.1016/j.jinsphys.2011.08.006; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Thakur N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087235; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Upgadhyay SK, 2011, J BIOSCIENCE, V36, P153; Xiong YH, 2013, INT J BIOL SCI, V9, P370, DOI 10.7150/ijbs.5929; Yu N, 2013, INSECT SCI, V20, P4, DOI 10.1111/j.1744-7917.2012.01534.x; Yu R, 2014, INT J BIOL SCI, V10, P1171, DOI 10.7150/ijbs.9598; Zhang X, 2010, INSECT MOL BIOL, V19, P683, DOI 10.1111/j.1365-2583.2010.01029.x; Zhu F, 2011, PEST MANAG SCI, V67, P175, DOI 10.1002/ps.2048; Zhuang S, 2008, DEV COMP IMMUNOL, V32, P365, DOI 10.1016/j.dci.2007.07.007	44	26	30	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132631	10.1371/journal.pone.0132631	http://dx.doi.org/10.1371/journal.pone.0132631			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171783	gold, Green Published, Green Submitted			2022-12-27	WOS:000358194900066
J	Li, DY; Li, XH; Wu, JL; Li, JH; Zhang, L; Xiong, T; Tang, J; Qu, Y; Mu, DZ				Li, Deyuan; Li, Xihong; Wu, Jinlin; Li, Jinhui; Zhang, Li; Xiong, Tao; Tang, Jun; Qu, Yi; Mu, Dezhi			Involvement of the JNK/FOXO3a/Bim Pathway in Neuronal Apoptosis after Hypoxic-Ischemic Brain Damage in Neonatal Rats	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; FOCAL CEREBRAL-ISCHEMIA; N-TERMINAL KINASE; SIGNALING PATHWAY; TUMOR SUPPRESSION; CELL-SURVIVAL; JNK; BIM; INJURY; NEUROINFLAMMATION	c-Jun N-terminal kinase (JNK) plays a key role in the regulation of neuronal apoptosis. Previous studies have revealed that forkhead transcription factor (FOXO3a) is a critical effector of JNK-mediated tumor suppression. However, it is not clear whether the JNK/FOXO3a pathway is involved in neuronal apoptosis in the developing rat brain after hypoxia-ischemia (HI). In this study, we generated an HI model using postnatal day 7 rats. Fluorescence immunolabeling and Western blot assays were used to detect the distribution and expression of total and phosphorylated JNK and FOXO3a and the pro-apoptotic proteins Bim and CC3. We found that JNK phosphorylation was accompanied by FOXO3a dephosphorylation, which induced FOXO3a translocation into the nucleus, resulting in the upregulation of levels of Bim and CC3 proteins. Furthermore, we found that JNK inhibition by AS601245, a specific JNK inhibitor, significantly increased FOXO3a phosphorylation, which attenuated FOXO3a translocation into the nucleus after HI. Moreover, JNK inhibition downregulated levels of Bim and CC3 proteins, attenuated neuronal apoptosis and reduced brain infarct volume in the developing rat brain. Our findings suggest that the JNK/FOXO3a/Bim pathway is involved in neuronal apoptosis in the developing rat brain after HI. Agents targeting JNK may offer promise for rescuing neurons from HI-induced damage.	[Li, Deyuan; Li, Xihong; Wu, Jinlin; Li, Jinhui; Zhang, Li; Xiong, Tao; Tang, Jun; Qu, Yi; Mu, Dezhi] Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu 610041, Peoples R China; [Li, Deyuan; Li, Xihong; Wu, Jinlin; Li, Jinhui; Zhang, Li; Xiong, Tao; Tang, Jun; Qu, Yi; Mu, Dezhi] Sichuan Univ, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, Minist Educ, Chengdu 610041, Sichuan, Peoples R China; [Mu, Dezhi] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	Sichuan University; Sichuan University; University of California System; University of California San Francisco	Mu, DZ (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu 610041, Peoples R China.	mudz@scu.edu.cn			National Natural Science Foundation of China [81000262, 81330016, 31171020, 81172174, 81270724, 81100457, 81200462]; Major State Basic Research Development Program [2013CB967404]; Ministry of Education of China [313037, 20110181130002]; State Commission of Science Technology of China [2012BAI04B04]; Science and Technology Bureau of Sichuan province [2010SZ0280, 2011JTD0005, 2012SZ0150]; Ministry of Health of China [1311200003303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program(National Basic Research Program of China); Ministry of Education of China(Ministry of Education, China); State Commission of Science Technology of China; Science and Technology Bureau of Sichuan province; Ministry of Health of China	This work was supported by the National Natural Science Foundation of China (No. 81000262 to Deyuan Li, No. 81330016 and 31171020 to Dezhi Mu; No. 81172174 and 81270724 to Yi Qu, No. 81100457 to Jinhui Li, and No. 81200462 to Li Zhang), the Major State Basic Research Development Program (2013CB967404), grants from the Ministry of Education of China (313037, 20110181130002), a grant from the State Commission of Science Technology of China (2012BAI04B04), grants from the Science and Technology Bureau of Sichuan province (2010SZ0280, 2011JTD0005, 2012SZ0150), and the Grant of Clinical Discipline Program (Neonatology) from the Ministry of Health of China (1311200003303).	Arden KC, 2007, CELL, V128, P235, DOI 10.1016/j.cell.2007.01.009; Bi WZ, 2010, J BIOL CHEM, V285, P6259, DOI 10.1074/jbc.M109.038570; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carboni S, 2004, J PHARMACOL EXP THER, V310, P25, DOI 10.1124/jpet.103.064246; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Frebel K, 2006, BIOCHEM SOC T, V34, P1287, DOI 10.1042/BST0341287; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gao YQ, 2005, J CEREBR BLOOD F MET, V25, P694, DOI 10.1038/sj.jcbfm.9600062; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Kamada H, 2007, J CEREBR BLOOD F MET, V27, P521, DOI 10.1038/sj.jcbfm.9600367; Khan M, 2005, J CEREBR BLOOD F MET, V25, P177, DOI 10.1038/sj.jcbfm.9600012; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Li L, 2007, BRAIN RES, V1180, P133, DOI 10.1016/j.brainres.2007.08.059; Linseman DA, 2002, J NEUROSCI, V22, P9287; Liu F, 2009, J NEUROSCI METH, V179, P1, DOI 10.1016/j.jneumeth.2008.12.028; Meller R, 2006, J BIOL CHEM, V281, P7429, DOI 10.1074/jbc.M512138200; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Ness JM, 2006, BRAIN RES, V1099, P150, DOI 10.1016/j.brainres.2006.04.132; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tu YF, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-40; Van den Tweel ERW, 2006, PEDIATR RES, V59, P434, DOI 10.1203/01.pdr.0000200799.64038.19; Wang LW, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-175; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Zanella F, 2008, CHEMBIOCHEM, V9, P2229, DOI 10.1002/cbic.200800255	33	41	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132998	10.1371/journal.pone.0132998	http://dx.doi.org/10.1371/journal.pone.0132998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171786	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900114
J	Lin, X; Li, JS; Luo, JW; Wu, XP; Tian, Y; Wang, W				Lin, Xin; Li, Junsheng; Luo, Jianwu; Wu, Xiaopu; Tian, Yu; Wang, Wei			Precipitation Mediates the Response of Carbon Cycle to Rising Temperature in the Mid-to-High Latitudes of the Northern Hemisphere	PLOS ONE			English	Article							DIFFERENCE VEGETATION INDEX; DROUGHT-INDUCED REDUCTION; SOIL RESPIRATION; ECOSYSTEM CARBON; ATMOSPHERIC CO2; PLANT-GROWTH; TERRESTRIAL ECOSYSTEMS; PHOTOSYNTHETIC TRENDS; SEASONAL CYCLE; BOREAL FOREST	Over the past decades, rising air temperature has been accompanied by changes in precipitation. Despite relatively robust literature on the temperature sensitivity of carbon cycle at continental to global scales, less is known about the way this sensitivity is affected by precipitation. In this study we investigate how precipitation mediates the response of the carbon cycle to warming over the mid-to-high latitudes in the Northern Hemisphere (north of 30 degrees N). Based on atmospheric CO2 observations at Point Barrow (BRW) in Alaska, satellite-derived NDVI (a proxy of vegetation productivity), and temperature and precipitation data, we analyzed the responses of carbon cycle to temperature change in wet and dry years (with precipitation above or below the multiyear average). The results suggest that, over the past three decades, the net seasonal atmospheric CO2 changes at BRW were significantly correlated with temperature in spring and autumn, yet only weakly correlated with temperature and precipitation during the growing season. We further found that responses of the net CO2 changes to warming in spring and autumn vary with precipitation levels, with the absolute temperature sensitivity in wet years roughly twice that in dry years. The analyses of NDVI and climate data also identify higher sensitivity of vegetation growth to warming in wet years for the growing season, spring and summer. The different temperature sensitivities in wet versus dry years probably result from differences in soil moisture and/or nutrient availability, which may enhance (inhibit) the responsiveness of carbon assimilation and/or decomposition to warming under high (low) precipitation levels. The precipitation-mediated response of the terrestrial carbon cycle to warming reported here emphasizes the important role of precipitation in assessing the temporal variations of carbon budgets in the past as well as in the future. More efforts are required to reduce uncertainty in future precipitation projections, and to better represent the nonlinearity of carbon cycle responses to climate in current state-of-the-art land surface models.	[Lin, Xin] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Lin, Xin; Li, Junsheng; Luo, Jianwu; Wu, Xiaopu; Tian, Yu; Wang, Wei] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China	Beijing Normal University; Chinese Research Academy of Environmental Sciences	Li, JS (corresponding author), Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China.	lijsh@craes.org.cn	Lin, Xin/GRJ-1583-2022	wang, wei/0000-0002-3864-4931; Lin, Xin/0000-0002-0605-6430	Environmental Protection Public Service Project of China [201209028]	Environmental Protection Public Service Project of China	This study was supported by the Environmental Protection Public Service Project of China (201209028) (URL: http://kjs.mep.gov.cn/gyxhykyzx/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Angert A, 2005, P NATL ACAD SCI USA, V102, P10823, DOI 10.1073/pnas.0501647102; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; Bauerle WL, 2012, P NATL ACAD SCI USA, V109, P8612, DOI 10.1073/pnas.1119131109; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Bunn AG, 2006, EARTH INTERACT, V10; Chapin FS, 2006, ECOSYSTEMS, V9, P1041, DOI 10.1007/s10021-005-0105-7; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; D'Arrigo RD, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002249; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Fabricante I, 2009, J ARID ENVIRON, V73, P745, DOI 10.1016/j.jaridenv.2009.02.006; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Goetz SJ, 2005, P NATL ACAD SCI USA, V102, P13521, DOI 10.1073/pnas.0506179102; Gong DY, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002300; Graven HD, 2013, SCIENCE, V341, P1085, DOI 10.1126/science.1239207; Hickler T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024370; Hoeppner SS, 2012, GLOBAL CHANGE BIOL, V18, P1754, DOI 10.1111/j.1365-2486.2011.02626.x; HOLBEN BN, 1986, INT J REMOTE SENS, V7, P1417, DOI 10.1080/01431168608948945; IPCC, 2007, CONTRIBUTION WORKING; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Lapenis A, 2005, GLOBAL CHANGE BIOL, V11, P2090, DOI 10.1111/j.1365-2486.2005.001069.x; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lucht W, 2002, SCIENCE, V296, P1687, DOI 10.1126/science.1071828; Luo YQ, 2008, GLOBAL CHANGE BIOL, V14, P1986, DOI 10.1111/j.1365-2486.2008.01629.x; Ma ZH, 2012, P NATL ACAD SCI USA, V109, P2423, DOI 10.1073/pnas.1111576109; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Myneni RB, 2001, P NATL ACAD SCI USA, V98, P14784, DOI 10.1073/pnas.261555198; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Owe M, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000769; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Park HS, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012752; Peng SS, 2013, NATURE, V501, P88, DOI 10.1038/nature12434; Peng SS, 2013, AGR FOREST METEOROL, V178, P46, DOI 10.1016/j.agrformet.2013.02.002; Peng SS, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044027; Penuelas J, 2004, ECOSYSTEMS, V7, P598, DOI 10.1007/s10021-004-0179-7; PETERSON JT, 1986, J ATMOS CHEM, V4, P491, DOI 10.1007/BF00053848; PETERSON JT, 1982, TELLUS, V34, P166, DOI 10.1111/j.2153-3490.1982.tb01804.x; Piao SL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028205; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Piao SL, 2013, GLOBAL CHANGE BIOL, V19, P2117, DOI 10.1111/gcb.12187; Piao SL, 2011, GLOBAL CHANGE BIOL, V17, P3228, DOI 10.1111/j.1365-2486.2011.02419.x; Piao SL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003339; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Piao SL, 2004, J VEG SCI, V15, P219, DOI 10.1658/1100-9233(2004)015[0219:VIASVI]2.0.CO;2; Qi Y, 2002, ECOL MODEL, V153, P131, DOI 10.1016/S0304-3800(01)00506-3; Qian HF, 2010, GLOBAL CHANGE BIOL, V16, P641, DOI 10.1111/j.1365-2486.2009.01989.x; Randerson JT, 1999, GEOPHYS RES LETT, V26, P2765, DOI 10.1029/1999GL900500; Randerson JT, 1997, GLOBAL BIOGEOCHEM CY, V11, P535, DOI 10.1029/97GB02268; Reich PB, 2010, SCIENCE, V329, P774, DOI 10.1126/science.1194353; Richardson AD, 2010, PHILOS T R SOC B, V365, P3227, DOI 10.1098/rstb.2010.0102; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schaeffer SM, 2013, GLOBAL CHANGE BIOL, V19, P3529, DOI 10.1111/gcb.12318; Schulze ED, 2006, BIOGEOSCIENCES, V3, P147, DOI 10.5194/bg-3-147-2006; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Slayback DA, 2003, GLOBAL CHANGE BIOL, V9, P1, DOI 10.1046/j.1365-2486.2003.00507.x; Suni T, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002381; Suseela V, 2014, SOIL BIOL BIOCHEM, V75, P102, DOI 10.1016/j.soilbio.2014.03.022; Swenson S, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006057; THONING KW, 1989, J GEOPHYS RES-ATMOS, V94, P8549, DOI 10.1029/JD094iD06p08549; Tucker CJ, 2001, INT J BIOMETEOROL, V45, P184, DOI 10.1007/s00484-001-0109-8; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Vesala T, 2010, BIOGEOSCIENCES, V7, P163, DOI 10.5194/bg-7-163-2010; Wang XH, 2014, NATURE, V506, P212, DOI 10.1038/nature12915; Welp LR, 2007, AGR FOREST METEOROL, V147, P172, DOI 10.1016/j.agrformet.2007.07.010; Weltzin JF, 2003, BIOSCIENCE, V53, P941, DOI 10.1641/0006-3568(2003)053[0941:ATROTE]2.0.CO;2; Yang YH, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035408; Zhang K, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000621; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590; Zhou L, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002510; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	73	1	2	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132663	10.1371/journal.pone.0132663	http://dx.doi.org/10.1371/journal.pone.0132663			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172277	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900071
J	Lu, P; Zheng, XP				Lu, Peng; Zheng, Xiaoping			Social Stratification and Cooperative Behavior in Spatial Prisoners' Dilemma Games	PLOS ONE			English	Article							PUBLIC-GOODS GAME; PROMOTES COOPERATION; PUNISHMENT; SELECTION; REPUTATION; DIVERSITY; DYNAMICS	It has been a long-lasting pursuit to promote cooperation, and this study aims to promote cooperation via the combination of social stratification and the spatial prisoners' dilemma game. It is previously assumed that agents share the identical payoff matrix, but the stratification or diversity exists and exerts influences in real societies. Thus, two additional classes, elites and scoundrels, derive from and coexist with the existing class, commons. Three classes have different payoff matrices. We construct a model where agents play the prisoners' dilemma game with neighbors. It indicates that stratification and temptation jointly influence cooperation. Temptation permanently reduces cooperation; elites play a positive role in promoting cooperation while scoundrels undermine it. As the temptation getting larger and larger, elites play a more and more positive and critical role while scoundrels' negative effect becomes weaker and weaker, and it is more obvious when temptation goes beyond its threshold.	[Lu, Peng; Zheng, Xiaoping] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Lu, Peng] Tsinghua Univ, Dept Sociol, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Zheng, XP (corresponding author), Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China.	asean@mail.tsinghua.edu.cn	Lu, Peng/G-4766-2015	Lu, Peng/0000-0003-1195-1816	National Science Fund for Distinguished Young Scholars [71225007]; National Basic Research Program of China (973 Program) [2011CB706900]; National Natural Science Foundation of China [91224008]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Science Fund for Distinguished Young Scholars (Grant no. 71225007, URL: http://www.nsfc.gov.cn), National Basic Research Program of China (973 Program) (Grant no.2011CB706900, URL: http://www.973.gov.cn), and the National Natural Science Foundation of China (Grant No. 91224008, URL: http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn TK, 2009, J POLIT, V71, P398, DOI 10.1017/S0022381609090355; Anderson SP, 1998, J PUBLIC ECON, V70, P297, DOI 10.1016/S0047-2727(98)00035-8; Bian YJ, 2002, ANNU REV SOCIOL, V28, P91, DOI 10.1146/annurev.soc.28.110601.140823; Cao XB, 2010, PHYSICA A, V389, P1273, DOI 10.1016/j.physa.2009.11.044; Charness G, 2014, GAME ECON BEHAV, V87, P322, DOI 10.1016/j.geb.2014.05.002; Choi JK, 2013, J ECON PSYCHOL, V35, P17, DOI 10.1016/j.joep.2013.01.001; Croson RTA, 2007, ECON INQ, V45, P199, DOI 10.1111/j.1465-7295.2006.00006.x; Dercole F, 2013, J THEOR BIOL, V326, P70, DOI 10.1016/j.jtbi.2012.11.034; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Gao J, 2012, PHYSICA A, V391, P4111, DOI 10.1016/j.physa.2012.03.027; Giddens A, 1993, CLASS STRUCTURE ADV; Goldthorpe John H., 1987, SOCIAL MOBILITY CLAS; Jaramillo JJ, 2010, AD HOC NETW, V8, P416, DOI 10.1016/j.adhoc.2009.10.002; Karagonlar G, 2013, ORGAN BEHAV HUM DEC, V120, P228, DOI 10.1016/j.obhdp.2012.07.006; Kwon K, 2007, MERRILL PALMER QUART, V53, P216, DOI 10.1353/mpq.2007.0012; McIntosh C, 2013, J ECON BEHAV ORGAN, V95, P270, DOI 10.1016/j.jebo.2012.09.013; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2007, J THEOR BIOL, V244, P518, DOI 10.1016/j.jtbi.2006.08.018; Parks CD, 2013, PSYCHOL SCI PUBL INT, V14, P119, DOI 10.1177/1529100612474436; Power C, 2009, JASSS-J ARTIF SOC S, V12; Raub W, 2013, SOC NETWORKS, V35, P720, DOI 10.1016/j.socnet.2013.05.006; Rezaei G, 2012, PHYSICA A, V391, P6199, DOI 10.1016/j.physa.2012.06.071; Rivas MF, 2011, ECON LETT, V112, P176, DOI 10.1016/j.econlet.2011.04.007; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos MD, 2012, J THEOR BIOL, V315, P81, DOI 10.1016/j.jtbi.2012.09.001; Shi DM, 2009, PHYSICA A, V388, P4646, DOI 10.1016/j.physa.2009.07.031; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Tan FF, 2008, ECONOMIST-NETHERLAND, V156, P269, DOI 10.1007/s10645-008-9094-1; Tepe S, 2007, MEDITERR Q, V18, P107, DOI 10.1215/10474552-2007-008; Van Vugt M, 2010, GROUP PROCESS INTERG, V13, P101, DOI 10.1177/1368430209342258; Volk S, 2011, PERS INDIV DIFFER, V50, P810, DOI 10.1016/j.paid.2011.01.001; Wang XF, 2013, CHAOS SOLITON FRACT, V56, P181, DOI 10.1016/j.chaos.2013.07.019; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wiegard A, 2013, CEA CRITIC, V75, P224; Wu T, 2014, PHYSICA A, V413, P86, DOI 10.1016/j.physa.2014.06.040; Xianyu B, 2014, JASSS-J ARTIF SOC S, V15, P3; Yang ZH, 2013, PHYSICA A, V392, P2038, DOI 10.1016/j.physa.2012.11.024; Zhang HF, 2014, PHYSICA A, V414, P86, DOI 10.1016/j.physa.2014.07.013; Zhu CJ, 2014, PHYSICA A, V406, P145, DOI 10.1016/j.physa.2014.03.035	39	8	9	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131005	10.1371/journal.pone.0131005	http://dx.doi.org/10.1371/journal.pone.0131005			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26173029	gold, Green Published, Green Submitted			2022-12-27	WOS:000358194900013
J	Sauter, TC; Lindner, G; Ahmad, SS; Leichtle, AB; Fiedler, GM; Exadaktylos, AK; Haider, DG				Sauter, Thomas C.; Lindner, Gregor; Ahmad, Sufian S.; Leichtle, Alexander Benedikt; Fiedler, Georg-Martin; Exadaktylos, Aristomenis K.; Haider, Dominik G.			Calcium Disorders in the Emergency Department: Independent Risk Factors for Mortality	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RENAL-INSUFFICIENCY; HEART-FAILURE; HYPERCALCEMIA; HYPOCALCEMIA; POPULATION; PREVALENCE; MALIGNANCY; MODERATE; OUTCOMES	Background Calcium disorders are common in both intensive care units and in patients with chronic kidney disease and are associated with increased morbidity and mortality. It is unknown whether calcium abnormalities in unselected emergency department admissions have an impact on in-hospital mortality. Methods This cross-sectional analysis included all admissions to the Emergency Department at the Inselspital Bern, Switzerland from 2010 to 2011. For hyper- and hypocalcaemic patients with a Mann-Whitney U-test, the differences between subgroups divided by age, length of hospital stay, creatinine, sodium, chloride, phosphate, potassium and magnesium were compared. Associations between calcium disorders and 28-day in-hospital mortality were assessed using the Cox proportional hazard regression model. Results 8,270 patients with calcium measurements were included in our study. Overall 264 (3.2%) patients died. 150 patients (6.13%) with hypocalcaemia and 7 patients with hypercalcaemia (6.19%) died, in contrast to 104 normocalcaemic patients (1.82%). In univariate analysis, calcium serum levels were associated with sex, mortality and pre-existing diuretic therapy (all p<0.05). In multivariate Cox regression analysis, hypocalcaemia and hypercalcaemia were independent risk factors for mortality (HR 2.00 and HR 1.88, respectively; both p<0.01). Conclusion Both hypocalcaemia and hypercalcaemia are associated with increased 28-day in-hospital mortality in unselected emergency department admissions.	[Sauter, Thomas C.; Lindner, Gregor; Ahmad, Sufian S.; Exadaktylos, Aristomenis K.; Haider, Dominik G.] Univ Hosp Bern, Dept Emergency Med, Inselspital, CH-3010 Bern, Switzerland; [Leichtle, Alexander Benedikt; Fiedler, Georg-Martin] Univ Hosp Bern, Ctr Lab Med, Inselspital, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Sauter, TC (corresponding author), Univ Hosp Bern, Dept Emergency Med, Inselspital, Freiburgstr, CH-3010 Bern, Switzerland.	thomas.sauter@insel.ch	Leichtle, Alexander/C-7262-2011; Ahmad, Sufian S/H-3881-2014; Fiedler, Georg Martin/C-8341-2011; Lindner, Gregor/AAR-6761-2020	Ahmad, Sufian S/0000-0001-9763-092X; Fiedler, Georg Martin/0000-0001-5689-4574; Lindner, Gregor/0000-0001-5551-8227; Sauter, Thomas C/0000-0002-6646-5789				Catalano A, 2012, AGING CLIN EXP RES, V24, P400; DESAI TK, 1988, AM J MED, V84, P209, DOI 10.1016/0002-9343(88)90415-9; Donovan PJ, 2015, J CLIN ENDOCR METAB; Drey N, 2003, AM J KIDNEY DIS, V42, P677, DOI 10.1016/S0272-6386(03)00916-8; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gromadzinski L, 2014, J CARDIOL, V63, P198, DOI 10.1016/j.jjcc.2013.08.003; Hurley K, 2005, J EMERG MED, V28, P155, DOI 10.1016/j.jemermed.2004.06.014; Kazmi AS, 2007, AM J MED SCI, V333, P226, DOI 10.1097/MAJ.0b013e318039b9c6; Kumar Shankar, 2014, World J Nephrol, V3, P143, DOI 10.5527/wjn.v3.i4.143; Lamy O, 2001, J INTERN MED, V250, P73, DOI 10.1046/j.1365-2796.2001.00859.x; Lee CT, 2006, AM J MED SCI, V331, P119, DOI 10.1097/00000441-200603000-00002; Lim LM, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-183; Lindner G, 2013, AM J EMERG MED, V31, P657, DOI 10.1016/j.ajem.2012.11.010; Lu X, 2014, PLOS ONE, V13; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Ross L, 2013, INT J CLIN PRACT, V67, P4, DOI 10.1111/ijcp.12069; Royer AM, 2014, AM SURGEON, V80, P732; SHEK CC, 1990, Q J MED, V77, P1277, DOI 10.1093/qjmed/77.3.1277; Vinas-Rios JM, 2014, NEUROL RES, V36, P102, DOI 10.1179/1743132813Y.0000000272; Vroonhof K, 2005, CLIN CHEM LAB MED, V43, P536, DOI 10.1515/CCLM.2005.093; WYSOLMERSKI JJ, 1994, ANNU REV MED, V45, P189, DOI 10.1146/annurev.med.45.1.189; Zhang Z, 2014, PLOS ONE, V15; Zivin JR, 2001, AM J KIDNEY DIS, V37, P689, DOI 10.1016/S0272-6386(01)80116-5	24	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132788	10.1371/journal.pone.0132788	http://dx.doi.org/10.1371/journal.pone.0132788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172117	gold, Green Published, Green Submitted			2022-12-27	WOS:000358194900086
J	Woo, HJ; Qin, Y; Park, SY; Park, SK; Cho, YG; Shin, KS; Lim, MH; Cho, HS				Woo, Hee-Jong; Qin, Yang; Park, Soo-Yun; Park, Soon Ki; Cho, Yong-Gu; Shin, Kong-Sik; Lim, Myung-Ho; Cho, Hyun-Suk			Development of Selectable Marker-Free Transgenic Rice Plants with Enhanced Seed Tocopherol Content through FLP/FRT-Mediated Spontaneous Auto-Excision	PLOS ONE			English	Article							VITAMIN-E; DNA EXCISION; SYSTEM; GENE; TRANSFORMATION; RECOMBINATION; STRATEGIES; RESISTANCE; EVOLUTION; PROMOTER	Development of marker-free transgenic plants is a technical alternative for avoiding concerns about the safety of selectable marker genes used in genetically modified (GM) crops. Here, we describe the construction of a spontaneous self-excision binary vector using an oxidative stress-inducible modified FLP/FRT system and its successful application to produce marker-free transgenic rice plants with enhanced seed tocopherol content. To generate selectable marker-free transgenic rice plants, we constructed a binary vector using the hpt selectable marker gene and the rice codon-optimized FLP (mFLP) gene under the control of an oxidative stress-inducible promoter between two FRT sites, along with multiple cloning sites for convenient cloning of genes of interest. Using this pCMF binary vector with the NtTC gene, marker-free T-1 transgenic rice plants expressing NtTC were produced by Agrobacterium-mediated stable transformation using hygromycin as a selective agent, followed by segregation of selectable marker genes. Furthermore, alpha-, gamma-, and total tocopherol levels were significantly increased in seeds of the marker-free transgenic TC line compared with those of wild-type plants. Thus, this spontaneous auto-excision system, incorporating an oxidative stress-inducible mFLP/FRT system to eliminate the selectable marker gene, can be easily adopted and used to efficiently generate marker-free transgenic rice plants. Moreover, nutritional enhancement of rice seeds through elevation of tocopherol content coupled with this marker-free strategy may improve human health and public acceptance of GM rice.	[Woo, Hee-Jong; Qin, Yang; Park, Soo-Yun; Shin, Kong-Sik; Lim, Myung-Ho; Cho, Hyun-Suk] Rural Dev Adm, Natl Acad Agr Sci, Biosafety Div, Jeonju, South Korea; [Park, Soon Ki] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea; [Cho, Yong-Gu] Chungbuk Natl Univ, Dept Crop Sci, Cheongju, South Korea	Rural Development Administration (RDA); Kyungpook National University; Chungbuk National University	Woo, HJ (corresponding author), Rural Dev Adm, Natl Acad Agr Sci, Biosafety Div, Jeonju, South Korea.	woo001@korea.kr	Cho, Yong-Gu/AAV-1904-2021		Research Program for Agricultural Science & Technology Development of the National Academy of Agricultural Science [PJ010902]; Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration, Republic of Korea [PJ008021]	Research Program for Agricultural Science & Technology Development of the National Academy of Agricultural Science; Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration, Republic of Korea	This study was supported by a grant from the Research Program for Agricultural Science & Technology Development (Project No. PJ010902) of the National Academy of Agricultural Science and the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center No. PJ008021), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bramley PM, 2000, J SCI FOOD AGR, V80, P913, DOI [10.1002/(SICI)1097-0010(20000515)80:7<913::AID-JSFA600>3.0.CO;2-3, 10.1002/(SICI)1097-0010(20000515)80:7&lt;913::AID-JSFA600&gt;3.0.CO;2-3]; CHAN MT, 1993, PLANT MOL BIOL, V22, P491, DOI 10.1007/BF00015978; Cheng M, 1997, PLANT PHYSIOL, V115, P971, DOI 10.1104/pp.115.3.971; Christou P, 1995, METHOD CELL BIOL, V50, P375, DOI 10.1016/S0091-679X(08)61044-4; Cuellar W, 2006, PLANT MOL BIOL, V62, P71, DOI 10.1007/s11103-006-9004-3; Darbani Behrooz, 2007, Biotechnology Journal, V2, P83, DOI 10.1002/biot.200600182; Delseny M, 2003, CURR OPIN PLANT BIOL, V6, P101, DOI 10.1016/S1369-5266(03)00010-4; deRijk MC, 1997, ARCH NEUROL-CHICAGO, V54, P762, DOI 10.1001/archneur.1997.00550180070015; Falk J, 2010, J EXP BOT, V61, P1549, DOI 10.1093/jxb/erq030; Fladung M, 2010, PLANT BIOLOGY, V12, P334, DOI 10.1111/j.1438-8677.2009.00293.x; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Gidoni D, 2008, IN VITRO CELL DEV-PL, V44, P457, DOI 10.1007/s11627-008-9140-3; Guo XY, 2007, FEBS LETT, V581, P1015, DOI 10.1016/j.febslet.2007.01.088; HAYASHIMOTO A, 1990, PLANT PHYSIOL, V93, P857, DOI 10.1104/pp.93.3.857; Heinemann RJB, 2008, CEREAL CHEM, V85, P243, DOI 10.1094/CCHEM-85-2-0243; Hoff T, 2001, PLANT MOL BIOL, V45, P41, DOI 10.1023/A:1006402308365; Khattri A, 2011, J BIOSCIENCES, V36, P37, DOI 10.1007/s12038-011-9010-8; Kim KY, 2003, PLANT MOL BIOL, V51, P831, DOI 10.1023/A:1023045218815; Kopertekh L., 2012, TRANSGENIC PLANTS AD, P449; Kumar R, 2005, FEBS LETT, V579, P1357, DOI 10.1016/j.febslet.2005.01.030; Lyznik LA, 1996, NUCLEIC ACIDS RES, V24, P3784, DOI 10.1093/nar/24.19.3784; MEYDANI SN, 1990, AM J CLIN NUTR, V52, P557, DOI 10.1093/ajcn/52.3.557; Miki B, 2004, J BIOTECHNOL, V107, P193, DOI 10.1016/j.jbiotec.2003.10.011; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Park SY, 2012, PLANT BIOTECHNOL REP, V6, P29, DOI 10.1007/s11816-011-0192-1; Puchta H, 2003, PLANT CELL TISS ORG, V74, P123, DOI 10.1023/A:1023934807184; Sambrook J., 2001, MOL CLONING LAB MANU; Schneider C, 2005, MOL NUTR FOOD RES, V49, P7, DOI 10.1002/mnfr.200400049; SHARP PM, 1989, J MOL EVOL, V28, P398, DOI 10.1007/BF02603075; Sreekala C, 2005, PLANT CELL REP, V24, P86, DOI 10.1007/s00299-004-0909-5; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Wang Y, 2005, TRANSGENIC RES, V14, P605, DOI 10.1007/s11248-005-0884-9; Woo HJ, 2014, PLANT CELL TISS ORG, V119, P257, DOI 10.1007/s11240-014-0530-4; Woo HJ, 2011, BIOTECHNOL BIOPROC E, V16, P1053, DOI 10.1007/s12257-011-0519-3; Woo HJ, 2009, TRANSGENIC RES, V18, P455, DOI 10.1007/s11248-008-9236-x; Yau YY, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-36; Zhang GY, 2013, TRANSGENIC RES, V22, P89, DOI 10.1007/s11248-012-9630-2; Zhang W, 2003, THEOR APPL GENET, V107, P1157, DOI 10.1007/s00122-003-1368-z; Zhang Y, 2009, TRANSGENIC RES, V18, P607, DOI 10.1007/s11248-009-9251-6; Zhang YY, 2006, BIOTECHNOL LETT, V28, P1247, DOI 10.1007/s10529-006-9081-z; Zuo JR, 2001, NAT BIOTECHNOL, V19, P157, DOI 10.1038/84428	42	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132667	10.1371/journal.pone.0132667	http://dx.doi.org/10.1371/journal.pone.0132667			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172549	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900074
J	Zhang, HT; Chai, M; Liu, CZ; Sun, JJ; Huang, CC; Yu, XY; Tian, Y; Luo, HL				Zhang, Haitao; Chai, Meng; Liu, Chaozhong; Sun, Jinjin; Huang, Congchun; Yu, Xinya; Tian, Yi; Luo, Huilan			Endoplasmic Reticulum Is Involved in Myocardial Injury in a Miniature Swine Model of Coronary Artery Stenosis Exposed to Acceleration-Associated Stress	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; OXIDATIVE STRESS; ISCHEMIA/REPERFUSION INJURY; INDUCED APOPTOSIS; FIGHTER PILOTS; AORTIC INDEXES; PLUS GZ; FORCES; RATS; CARVEDILOL	This study aimed to investigate the effects of myocardial injury in a minimally-invasive miniature swine model with different levels of coronary artery stenosis (CAS) and exposed to maximal tolerated +Gz. Proximal left anterior descending branch was ligated in 20 swine. Five swine underwent a sham operation. A trapezoid acceleration curve was used for +Gz stress. Pathological changes of myocardial tissue were detected by H&E staining. Apoptotic cardiomyocytes were detected by TUNEL. GRP78 and CHOP were investigated by immunohistochemistry and western blot. CAS models were successful in 18 animals. Compared with the sham-operated group (+8.00 +/- 0.71 Gz), the maximal tolerated +Gz values of the moderate stenosis (+6.00 +/- 0.89 Gz, P<0.05) and severe stenosis groups (+5.20 +/- 0.84 Gz, P<0.05) were decreased. Compared with sham animals (12.16 +/- 1.25%), after exposure to maximum +Gz, apoptotic cells of the moderate (43.53 +/- 8.42%, P<0.05) and severe stenosis group (60.50 +/- 9.35%, P<0.05) were increased, MDA content was increased (1.89 and 4.91 folds, respectively, P<0.05), and SOD activity was reduced (-13.66% and -21.71%, respectively). After exposure to maximum +Gz, GRP78 protein expression was low in the sham-operated (0.29 +/- 0.05) and mild stenosis groups (0.35 +/- 0.04), while expression was high in the moderate (0.72 +/- 0.04, P<0.05) and severe stenosis groups (0.65 +/- 0.07, P<0.05). CHOP protein expression was not observed in the sham-operated group, while expression was high in the moderate and severe stenosis groups. These results indicated that Under maximum exposure to +Gz stress, different levels of CAS led to different levels of myocardial injury. Endoplasmic reticulum response is involved in the apoptosis of cardiomyocytes after +Gz stress.	[Zhang, Haitao; Sun, Jinjin; Huang, Congchun; Yu, Xinya; Luo, Huilan] PLA, Gen Hosp Air Force, Dept Cardiol, Beijing 100142, Peoples R China; [Chai, Meng] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing 100029, Peoples R China; [Chai, Meng] Minist Educ, Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China; [Liu, Chaozhong] PLA, Gen Hosp Air Force, Beijing 100142, Peoples R China; [Tian, Yi] Fuwai Hosp, Natl Heart Ctr China, Ctr Expt Anim, Beijing 100037, Peoples R China	Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Luo, HL (corresponding author), PLA, Gen Hosp Air Force, Dept Cardiol, Beijing 100142, Peoples R China.	luohui_lansci@126.com	Tian, Yi/AFQ-7590-2022		'The twelfth five-year plan' momentous project of PLA [BWS11J054]	'The twelfth five-year plan' momentous project of PLA	The work was supported by the 'The twelfth five-year plan' momentous project of PLA (No.: BWS11J054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbas H, 2005, J INT MED RES, V33, P528, DOI 10.1177/147323000503300508; Assa A, 2011, J AM SOC ECHOCARDIOG, V24, P1163, DOI 10.1016/j.echo.2011.06.001; Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; Bonjour J, 2011, EUR J APPL PHYSIOL, V111, P2907, DOI 10.1007/s00421-011-1917-0; BRAUN M, 1993, PROTOPLASMA, V174, P50, DOI 10.1007/BF01404042; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Chen LE, 2014, CHIN J INTEGR MED; Chen LE, 2013, J PHYSIOL SCI, V63, P457, DOI 10.1007/s12576-013-0282-7; Convertino V A, 1998, J Gravit Physiol, V5, pP51; Fang SJ, 2010, CHINESE MED J-PEKING, V123, P3597, DOI 10.3760/cma.j.issn.0366-6999.2010.24.018; Feng SF, 2010, NEUROSCI LETT, V478, P150, DOI 10.1016/j.neulet.2010.05.006; Fong K. L., 1997, Annals Academy of Medicine Singapore, V26, P94; Ge CJ, 2012, CHINESE MED J-PEKING, V125, P2472, DOI 10.3760/cma.j.issn.0366-6999.2012.14.014; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; Grossman A, 2011, AVIAT SPACE ENVIR MD, V82, P901, DOI 10.3357/ASEM.2962.2011; Hiss DC, 2009, EXPERT OPIN DRUG DIS, V4, P799, DOI 10.1517/17460440903052559; HOIBERG A, 1985, AVIAT SPACE ENVIR MD, V56, P397; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kim HS, 2012, BIOMED RES-INDIA, V23, P375; Liao YH, 2012, J AM COLL CARDIOL, V59, P420, DOI 10.1016/j.jacc.2011.10.863; Lim WS, 2008, CIRCULATION, V117, P940, DOI 10.1161/CIRCULATIONAHA.107.711275; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Liu H J, 2001, Space Med Med Eng (Beijing), V14, P137; Lu WH, 2008, AVIAT SPACE ENVIR MD, V79, P1086, DOI 10.3357/ASEM.2353.2008; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Martin DS, 1999, AVIAT SPACE ENVIR MD, V70, P1197; Netticadan T, 1999, AM J PHYSIOL-CELL PH, V277, pC384, DOI 10.1152/ajpcell.1999.277.3.C384; Parlaktas BS, 2014, INT BRAZ J UROL, V40, P109, DOI 10.1590/S1677-5538.IBJU.2014.01.16; Pendergast DR, 2012, AVIAT SPACE ENVIR MD, V83, P488, DOI 10.3357/ASEM.3127.2012; Reimers B, 1997, CATHETER CARDIO DIAG, V40, P343, DOI 10.1002/(SICI)1097-0304(199704)40:4<343::AID-CCD3>3.0.CO;2-9; Rickards CA, 2005, AVIAT SPACE ENVIR MD, V76, P496; Sajdel-Sulkowska EV, 2007, ADV SPACE RES, V40, P1414, DOI 10.1016/j.asr.2007.08.004; Srichai MB, 2012, WORLD J RADIOL, V4, P258, DOI 10.4329/wjr.v4.i6.258; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Zawadzka-Bartczak E, 2005, Indian J Med Sci, V59, P471; Zhan H, 1999, Space Med Med Eng (Beijing), V12, P1; Zhang X, 1991, BASIC CLIN RES AVIAT	37	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132654	10.1371/journal.pone.0132654	http://dx.doi.org/10.1371/journal.pone.0132654			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167928	Green Submitted, Green Published, gold			2022-12-27	WOS:000358193100062
J	Al-Sawalha, N; Pokkunuri, I; Omoluabi, O; Kim, H; Thanawala, VJ; Hernandez, A; Bond, RA; Knoll, BJ				Al-Sawalha, Nour; Pokkunuri, Indira; Omoluabi, Ozozoma; Kim, Hosu; Thanawala, Vaidehi J.; Hernandez, Adrian; Bond, Richard A.; Knoll, Brian J.			Epinephrine Activation of the beta(2)-Adrenoceptor Is Required for IL-13-Induced Mucin Production in Human Bronchial Epithelial Cells	PLOS ONE			English	Article							N-TERMINAL KINASE; PROTEIN-KINASES; AIRWAY HYPERRESPONSIVENESS; ASTHMA PHENOTYPE; GENE-EXPRESSION; BETA-BLOCKER; MURINE MODEL; INFLAMMATION; INTERLEUKIN-13; HYPERPLASIA	Mucus hypersecretion by airway epithelium is a hallmark of inflammation in allergic asthma and results in airway narrowing and obstruction. Others have shown that administration a T(H)2 cytokine, IL-13 is sufficient to cause mucus hypersecretion in vivo and in vitro. Asthma therapy often utilizes beta(2)-adrenoceptor (beta(2)AR) agonists, which are effective acutely as bronchodilators, however chronic use may lead to a worsening of asthma symptoms. In this study, we asked whether beta(2)AR signaling in normal human airway epithelial (NHBE) cells affected mucin production in response to IL-13. This cytokine markedly increased mucin production, but only in the presence of epinephrine. Mucin production was blocked by ICI-118,551, a preferential beta(2)AR antagonist, but not by CGP-20712A, a preferential beta 1AR antagonist. Constitutive beta(2)AR activity was not sufficient for IL-13 induced mucin production and beta-agonist-induced signaling is required. A clinically important long-acting beta-agonist, formoterol, was as effective as epinephrine in potentiating IL-13 induced MUC5AC transcription. IL-13 induced mucin production in the presence of epinephrine was significantly reduced by treatment with selective inhibitors of ERK1/2 (FR180204), p38 (SB203580) and JNK (SP600125). Replacement of epinephrine with forskolin + IBMX resulted in a marked increase in mucin production in NHBE cells in response to IL-13, and treatment with the inhibitory cAMP analogue Rp-cAMPS decreased mucin levels induced by epinephrine + IL-13. Our findings suggest that beta 2AR signaling is required for mucin production in response to IL-13, and that mitogen activated protein kinases and cAMP are necessary for this effect. These data lend support to the notion that beta 2AR-agonists may contribute to asthma exacerbations by increasing mucin production via activation of beta 2ARs on epithelial cells.	[Al-Sawalha, Nour; Pokkunuri, Indira; Kim, Hosu; Thanawala, Vaidehi J.; Bond, Richard A.; Knoll, Brian J.] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA; [Omoluabi, Ozozoma; Hernandez, Adrian; Bond, Richard A.; Knoll, Brian J.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Houston System; University of Houston; University of Houston System; University of Houston	Knoll, BJ (corresponding author), Univ Houston, Dept Pharmacol & Pharmaceut Sci, 4800 Calhoun Rd, Houston, TX 77204 USA.	bknoll@Central.UH.edu		Al-Sawalha, Nour/0000-0002-7401-8065	National Institutes of Health [RO1A179236]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	BJK and RAB were supported by National Institutes of Health RO1A179236. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916; Atherton HC, 2003, AM J PHYSIOL-LUNG C, V285, pL730, DOI 10.1152/ajplung.00089.2003; Bai TR, 2005, CLIN SCI, V108, P463, DOI 10.1042/CS20040342; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Bennett BL, 2006, EUR RESPIR J, V28, P651, DOI 10.1183/09031936.06.00012106; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172; Chu HW, 2004, AM J PATHOL, V165, P1097, DOI 10.1016/S0002-9440(10)63371-8; Chung KF, 2011, CHEST, V139, P1470, DOI 10.1378/chest.10-1914; DAVIS PB, 1990, AM J PHYSIOL, V258, pC71, DOI 10.1152/ajpcell.1990.258.1.C71; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; DOSTMANN WRG, 1995, FEBS LETT, V375, P231, DOI 10.1016/0014-5793(95)01201-O; Doukas J, 2009, J PHARMACOL EXP THER, V328, P758, DOI 10.1124/jpet.108.144311; Duan W, 2005, INT IMMUNOPHARMACOL, V5, P495, DOI 10.1016/j.intimp.2004.10.015; Evans CM, 2009, CURR OPIN PULM MED, V15, P4, DOI 10.1097/MCP.0b013e32831da8d3; Fujisawa T, 2008, RESPIROLOGY, V13, P191, DOI 10.1111/j.1440-1843.2008.01237.x; Fujisawa T, 2009, J IMMUNOL, V183, P6236, DOI 10.4049/jimmunol.0900614; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hanania NA, 2008, PULM PHARMACOL THER, V21, P134, DOI 10.1016/j.pupt.2007.07.002; Holgate ST, 2003, EUR RESPIR J, V22, p24S, DOI 10.1183/09031936.03.00000803; Hollingsworth JW, 2010, AM J RESP CELL MOL, V43, P269, DOI 10.1165/rcmb.2009-0198OC; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Karmouty-Quintana H, 2013, J MOL MED, V91, P173, DOI 10.1007/s00109-013-0997-1; Kono Y, 2010, PULM PHARMACOL THER, V23, P36, DOI 10.1016/j.pupt.2009.10.005; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Kwak YG, 2003, J CLIN INVEST, V111, P1083, DOI 10.1172/JCI200316440; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Leopoldt D, 1998, J BIOL CHEM, V273, P7024, DOI 10.1074/jbc.273.12.7024; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Lim DH, 2009, AM J PHYSIOL-LUNG C, V296, pL210, DOI 10.1152/ajplung.90275.2008; Lin HX, 2007, J PHARM SCI-US, V96, P341, DOI 10.1002/jps.20803; Liu WM, 2008, J ALLERGY CLIN IMMUN, V121, P893, DOI 10.1016/j.jaci.2008.02.004; Lu Q, 2013, AM J PHYSIOL-LUNG C, V304, pL361, DOI 10.1152/ajplung.00161.2012; Ma Jing Ying, 2008, J Asthma Allergy, V1, P31; Myou S, 2003, J EXP MED, V198, P1573, DOI 10.1084/jem.20030298; Nath P, 2005, EUR J PHARMACOL, V506, P273, DOI 10.1016/j.ejphar.2004.11.040; Nguyen LP, 2008, AM J RESP CELL MOL, V38, P256, DOI 10.1165/rcmb.2007-0279RC; Nguyen LP, 2009, P NATL ACAD SCI USA, V106, P2435, DOI 10.1073/pnas.0810902106; Nichols HL, 2012, P NATL ACAD SCI USA, V109, P16660, DOI 10.1073/pnas.1208881109; Ordonez CL, 2001, AM J RESP CRIT CARE, V163, P517, DOI 10.1164/ajrccm.163.2.2004039; Park SW, 2005, CHEST, V128, P1921, DOI 10.1378/chest.128.4.1921; Pelaia G, 2005, J CELL PHYSIOL, V202, P642, DOI 10.1002/jcp.20169; Piccotti L, 2012, METHODS MOL BIOL, V842, P279, DOI 10.1007/978-1-61779-513-8_17; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Shiraishi Y, 2009, J ALLERGY CLIN IMMUN, V123, pS56, DOI 10.1016/j.jaci.2008.11.047; Stangherlin A, 2012, AM J PHYSIOL-HEART C, V302, pH379, DOI 10.1152/ajpheart.00766.2011; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; Thanawala VJ, 2013, AM J RESP CELL MOL, V48, P220, DOI 10.1165/rcmb.2012-0364OC; Williams OW, 2006, AM J RESP CELL MOL, V34, P527, DOI 10.1165/rcmb.2005-0436SF; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Yasuo M, 2006, RESPIRATION, V73, P347, DOI 10.1159/000091391; Yoshisue H, 2004, BIOSCI BIOTECH BIOCH, V68, P2024, DOI 10.1271/bbb.68.2024; Young HWJ, 2007, AM J RESP CELL MOL, V37, P273, DOI 10.1165/rcmb.2005-0460OC; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC	55	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132559	10.1371/journal.pone.0132559	http://dx.doi.org/10.1371/journal.pone.0132559			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161982	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300152
J	Ballard, SB; Reaves, EJ; Luna, CG; Silva, ME; Rocha, C; Heitzinger, K; Saito, M; Apaza, S; Espetia, S; Blazes, DL; Tilley, DH; Aguilar, RCG; Gilman, RH; Bausch, DG				Ballard, Sarah-Blythe; Reaves, Erik J.; Giannina Luna, C.; Silva, Maria E.; Rocha, Claudio; Heitzinger, Kristen; Saito, Mayuko; Apaza, Sonia; Espetia, Susan; Blazes, David L.; Tilley, Drake H.; Guzman Aguilar, Rene C.; Gilman, Robert H.; Bausch, Daniel G.			Epidemiology and Genetic Characterization of Noroviruses among Adults in an Endemic Setting, Peruvian Amazon Basin, 2004-2011	PLOS ONE			English	Article							GASTROENTERITIS; DIARRHEA; DISEASE; VACCINE; SHIPS	Background Successful vaccination strategies against norovirus will require understanding the burden of disease and relevant genotypes in populations. However, few data are available from cohort studies of adults living in low-and middle-income countries (LMIC). Materials and Methods We conducted a nested case-control study within a Peruvian military cohort to characterize the burden of norovirus infection, predominant genotypes, and associated symptoms from 2004 through 2011. Randomly selected case and control stools were tested for norovirus, bacteria, and parasites. The odds ratio of the association between norovirus infection and diarrhea was estimated using multiple logistic regression and co-infection adjusted attributable fractions were calculated. Results Of the 3,818 cohort study participants, 624 developed diarrhea. Overall and norovirus-associated diarrhea incidence rates were 42.3 and 6.0 per 100 person-years, respectively. The most prevalent norovirus genogroup was GII (72.5%, 29/40), which was associated with diarrhea (AOR 3.4, 95% CI: 1.3-8.7, P = 0.012). The co-infection adjusted GII attributable fraction was 6.4%. Discussion Norovirus was a frequent cause of diarrhea in an adult population followed longitudinally in an LMIC setting. Vaccine strategies should consider targeting adults in endemic settings and special populations that could serve as community transmission sources.	[Ballard, Sarah-Blythe; Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA; [Ballard, Sarah-Blythe; Reaves, Erik J.; Giannina Luna, C.; Silva, Maria E.; Bausch, Daniel G.] US Med Res Unit 6, Emerging Infect Dis Dept, Lima, Peru; [Rocha, Claudio; Heitzinger, Kristen; Tilley, Drake H.] US Med Res Unit 6, Dept Bacteriol, Lima, Peru; [Heitzinger, Kristen] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Saito, Mayuko] Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan; [Saito, Mayuko; Apaza, Sonia; Espetia, Susan] Univ Peruana Cayetano Heredia, Labs Invest & Desarrollamiento, Lima, Peru; [Blazes, David L.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Guzman Aguilar, Rene C.] Policlin Militar Chorrillos, Chorrillos, Peru; [Gilman, Robert H.] Asociac Benef PRISMA, Lima, Peru; [Bausch, Daniel G.] Tulane Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Washington; University of Washington Seattle; Tohoku University; Universidad Peruana Cayetano Heredia; Uniformed Services University of the Health Sciences - USA; Tulane University	Ballard, SB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA.	sballar3@jhu.edu	Rocha, Claudio A./N-4440-2017; Saito, Mayuko/J-4508-2018	Rocha, Claudio A./0000-0003-4221-3883; Saito, Mayuko/0000-0003-4622-7027; Espetia, Susan/0000-0002-1160-9677	Wenzhou Medical Association; Zhejiang Provincial Key Discipline-Neurobiology [437201203]; MRC [MR/K007467/1] Funding Source: UKRI; Medical Research Council [MR/K007467/1] Funding Source: researchfish	Wenzhou Medical Association; Zhejiang Provincial Key Discipline-Neurobiology; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by grants from Wenzhou Medical Association and partly supported by Zhejiang Provincial Key Discipline-Neurobiology (437201203). The funders had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the paper for publication.	Apaza S, 2012, JOVE-J VIS EXP, DOI 10.3791/3232; Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Atmar RL, 2006, GASTROENTEROL CLIN N, V35, P275, DOI 10.1016/j.gtc.2006.03.001; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Fernandez MDB, 2011, INFECT GENET EVOL, V11, P1631, DOI 10.1016/j.meegid.2011.06.005; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Centers for Disease Control and Prevention, 2013, ISOLATION VIBRIO CHO, P16; Chan MCW, 2006, EMERG INFECT DIS, V12, P1278, DOI 10.3201/eid1708.060081; Chapman Alice S, 2011, MSMR, V18, P2; Cramer EH, 2003, AM J PREV MED, V24, P227, DOI 10.1016/S0749-3797(02)00644-X; Desai R, 2012, CLIN INFECT DIS, V55, P189, DOI 10.1093/cid/cis372; El-Kamary SS, 2010, J INFECT DIS, V202, P1649, DOI 10.1086/657087; Ferreira MSR, 2010, J MED VIROL, V82, P1442, DOI 10.1002/jmv.21831; Frey S, 2011, 49 ANN M INFECT DIS; GILMAN RH, 1976, T ROY SOC TROP MED H, V70, P313, DOI 10.1016/0035-9203(76)90085-7; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Gray L, 1995, MANUAL CLIN MICROBIO; Hugh R, 1970, MANUAL CLIN MICROBIO; Jones FR, 2004, AM J TROP MED HYG, V70, P663, DOI 10.4269/ajtmh.2004.70.663; JUNG RC, 1951, PEDIATRICS, V8, P548; Kaufman SS, 2005, J PEDIATR GASTR NUTR, V40, P328, DOI 10.1097/01.MPG.0000155182.54001.48; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Lam TTY, 2012, J GEN VIROL, V93, P817, DOI 10.1099/vir.0.039057-0; Lee N, 2007, EMERG INFECT DIS, V13, P1399, DOI 10.3201/eid1309.061535; Lello J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2813; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lopman BA, 2004, EMERG INFECT DIS, V10, P1827, DOI 10.3201/eid1010.030941; Lopman B, 2014, AM J EPIDEMIOL, V179, P507, DOI 10.1093/aje/kwt287; McAtee CL, MOL EPIDEMIOLOGY POS; Nachamkin I., 1999, MANUAL CLIN MICROBIO; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Riddle MS, 2004, MIL MED, V169, P787, DOI 10.7205/MILMED.169.10.787; RITCHIE LAWRENCE S., 1948, BULL U S ARMY MED DEPT, V8, P326; Saito M, 2014, CLIN INFECT DIS, V58, P483, DOI 10.1093/cid/cit763; STACYPHIPPS S, 1995, J CLIN MICROBIOL, V33, P1054, DOI 10.1128/JCM.33.5.1054-1059.1995; Vesikari T, 2011, 6 INT VACC ENT DIS C; Yori PP, 2009, PEDIATR INFECT DIS J, V28, P844, DOI 10.1097/INF.0b013e3181a24730	38	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131646	10.1371/journal.pone.0131646	http://dx.doi.org/10.1371/journal.pone.0131646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161556	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300052
J	Castellano, R; Perruchot, MH; Conde-Aguilera, JA; van Milgen, J; Collin, A; Tesseraud, S; Mercier, Y; Gondret, F				Castellano, Rosa; Perruchot, Marie-Helene; Conde-Aguilera, Jose Alberto; van Milgen, Jaap; Collin, Anne; Tesseraud, Sophie; Mercier, Yves; Gondret, Florence			A Methionine Deficient Diet Enhances Adipose Tissue Lipid Metabolism and Alters Anti-Oxidant Pathways in Young Growing Pigs	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; OXIDATIVE STRESS; BODY PROTEIN; AMINO-ACIDS; RESTRICTION; GLUTATHIONE; MUSCLE; LIVER; SUPPLEMENTATION; EXPRESSION	Methionine is a rate-limiting amino-acid for protein synthesis but non-proteinogenic roles on lipid metabolism and oxidative stress have been demonstrated. Contrary to rodents where a dietary methionine deficiency led to a lower adiposity, an increased lipid accretion rate has been reported in growing pigs fed a methionine deficient diet. This study aimed to clarify the effects of a dietary methionine deficiency on different aspects of tissue lipid metabolism and anti-oxidant pathways in young pigs. Post-weaned pigs (9.8 kg initial body weight) were restrictively-fed diets providing either an adequate (CTRL) or a deficient methionine supply (MD) during 10 days (n=6 per group). At the end of the feeding trial, pigs fed the MD diet had higher lipid content in subcutaneous adipose tissue. Expression levels of genes involved in glucose uptake, lipogenesis but also lipolysis, and activities of NADPH enzyme suppliers were generally higher in subcutaneous and perirenal adipose tissues of MD pigs, suggesting an increased lipid turnover in those pigs. Activities of the anti-oxidant enzymes superoxide dismutase, catalase and glutathione reductase were increased in adipose tissues and muscle of MD pigs. Expression level and activity of the glutathione peroxidase were also higher in liver of MD pigs, but hepatic contents in the reduced and oxidized forms of glutathione and glutathione reductase activity were lower compared with control pigs. In plasma, superoxide dismutase activity was higher but total anti-oxidant power was lower in MD pigs. These results show that a dietary methionine deficiency resulted in increased levels of lipogenesis and lipolytic indicators in porcine adipose tissues. Decreased glutathione content in the liver and coordinated increase of enzymatic antioxidant activities in adipose tissues altered the cellular redox status of young pigs fed a methionine-deficient diet. These findings illustrate that a rapidly growing animal differently adapts tissue metabolisms when facing an insufficient methionine supply.	[Castellano, Rosa; Perruchot, Marie-Helene; Conde-Aguilera, Jose Alberto; van Milgen, Jaap; Gondret, Florence] INRA, UMR PEGASE 1348, St Gilles, France; [Castellano, Rosa; Perruchot, Marie-Helene; Conde-Aguilera, Jose Alberto; van Milgen, Jaap; Gondret, Florence] Agrocampus Ouest, UMR PEGASE 1348, Rennes, France; [Collin, Anne; Tesseraud, Sophie] INRA, UR83 Rech Avicoles URA, F-37380 Nouzilly, France; [Mercier, Yves] Adisseo France SAS, Antony, France	INRAE; Institut Agro; Agrocampus Ouest; INRAE; Adisseo France S.A.S.	Gondret, F (corresponding author), INRA, UMR PEGASE 1348, St Gilles, France.	Florence.gondret@rennes.inra.fr	van Milgen, Jaap/F-2787-2011	van Milgen, Jaap/0000-0002-6131-5255; Gondret, Florence/0000-0001-7997-1560; Perruchot, Marie-Helene/0000-0002-6608-9445	ADISSEO; INRA	ADISSEO(Adisseo France S.A.S.); INRA	The present study was supported by Research Grants from ADISSEO and INRA and both have contributed to the study design and manuscript preparation. The funder INRA also contributed to the conduct of the study, analysis of the samples and data, and interpretation of the findings. Funders did not interfere with the full presentation of this research, objective interpretation of the data and decision to submit for publication.	BASS A, 1969, EUR J BIOCHEM, V10, P198, DOI 10.1111/j.1432-1033.1969.tb00674.x; BATTERHAM ES, 1993, BRIT J NUTR, V70, P711, DOI 10.1079/BJN19930166; Bazin R, 2000, METH MOL B, V155, P121; Berg F, 2006, PLOS GENET, V2, P1178, DOI 10.1371/journal.pgen.0020129; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Conde-Aguilera JA, 2010, ANIMAL, V4, P1349, DOI 10.1017/S1751731110000340; Conde-Aguilera JA, 2015, EUR J NUTR; Corominas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-843; Esworthy RS, 2001, CURR PROTOC TOXICOL; Flachs P, 2013, BBA-MOL CELL BIOL L, V1831, P986, DOI 10.1016/j.bbalip.2013.02.003; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gardan D, 2008, DOMEST ANIM ENDOCRIN, V34, P45, DOI 10.1016/j.domaniend.2006.10.001; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Hasek BE, 2013, DIABETES, V62, P3362, DOI 10.2337/db13-0501; Hasek BE, 2010, AM J PHYSIOL-REG I, V299, pR728, DOI 10.1152/ajpregu.00837.2009; Henry Y, 1993, INRA PROD ANIM, V6, P199; Hocquette JF, 2010, ANIMAL, V4, P303, DOI 10.1017/S1751731109991091; Kloareg M, 2007, BRIT J NUTR, V97, P35, DOI 10.1017/S0007114507205793; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Maddineni S, 2013, EXP BIOL MED, V238, P392, DOI 10.1177/1535370213477988; Malloy VL, 2006, AGING CELL, V5, P305, DOI 10.1111/j.1474-9726.2006.00220.x; Martinez-Ramirez HR, 2008, J ANIM SCI, V86, P2156, DOI 10.2527/jas.2007-0235; MASSEY V, 1965, J BIOL CHEM, V240, P4470; Metayer S, 2008, J NUTR BIOCHEM, V19, P207, DOI 10.1016/j.jnutbio.2007.05.006; Milani P, 2013, NEUROBIOL DIS, V60, P51, DOI 10.1016/j.nbd.2013.08.005; Morales FJ, 2001, FOOD CHEM, V72, P119, DOI 10.1016/S0308-8146(00)00239-9; Morand C, 1997, J NUTR BIOCHEM, V8, P246, DOI 10.1016/S0955-2863(97)89661-1; Mourot J, 1999, REPROD NUTR DEV, V39, P125, DOI 10.1051/rnd:19990145; National Research Council, 1998, NUTR REQ SWIN, Vtenth; OHEA EK, 1969, J NUTR, V99, P338, DOI 10.1093/jn/99.3.338; Park J, 2007, DIABETES RES CLIN PR, V77, pS11, DOI 10.1016/j.diabres.2007.01.037; Perrone CE, 2008, J LIPID RES, V49, P12, DOI 10.1194/jlr.M700194-JLR200; Perrone CE, 2013, EXP GERONTOL, V48, P654, DOI 10.1016/j.exger.2012.07.005; Perrone CE, 2012, J NUTRIGENET NUTRIGE, V5, P132, DOI 10.1159/000339347; Plaisance EP, 2010, AM J PHYSIOL-REG I, V299, pR740, DOI 10.1152/ajpregu.00838.2009; Richie JP, 2004, NUTRITION, V20, P800, DOI 10.1016/j.nut.2004.05.009; Sadi G, 2012, DIABETES-METAB RES, V28, P228, DOI 10.1002/dmrr.1302; Sahena F, 2009, J FOOD ENG, V95, P240, DOI 10.1016/j.jfoodeng.2009.06.026; SAS, 2002, V91 SV CAR; Sauvant D, 2004, TABLES COMPOSITION N; Sochor J, 2010, MOLECULES, V15, P8618, DOI 10.3390/molecules15128618; Tansey JT, 2004, IUBMB LIFE, V56, P379, DOI 10.1080/15216540400009968; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Jacob MHVM, 2011, J STEROID BIOCHEM, V127, P331, DOI 10.1016/j.jsbmb.2011.07.007; Vigilanza P, 2011, J CELL PHYSIOL, V226, P2016, DOI 10.1002/jcp.22542; Watt MJ, 2008, BIOCHEM J, V414, P313, DOI 10.1042/BJ20080305; Young JF, 2005, J AGR FOOD CHEM, V53, P745, DOI 10.1021/jf0490652; Zheng P, 2013, BRIT J NUTR, V109, P2253, DOI 10.1017/S0007114512004321	48	41	44	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130514	10.1371/journal.pone.0130514	http://dx.doi.org/10.1371/journal.pone.0130514			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161654	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300017
J	Dambacher, F; Schuhmann, T; Lobbestael, J; Arntz, A; Brugman, S; Sack, AT				Dambacher, Franziska; Schuhmann, Teresa; Lobbestael, Jill; Arntz, Arnoud; Brugman, Suzanne; Sack, Alexander T.			No Effects of Bilateral tDCS over Inferior Frontal Gyrus on Response Inhibition and Aggression	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; BRAIN ACTIVITY; PROACTIVE AGGRESSION; ACTION CANCELLATION; PREFRONTAL CORTEX; AFFECTIVE VALENCE; ACTION RESTRAINT; SEX-DIFFERENCES; STOP-SIGNAL; ANGER	Response inhibition is defined as the capacity to adequately withdraw pre-planned responses. It has been shown that individuals with deficits in inhibiting pre-planned responses tend to display more aggressive behaviour. The prefrontal cortex is involved in both, response inhibition and aggression. While response inhibition is mostly associated with predominantly right prefrontal activity, the neural components underlying aggression seem to be left-lateralized. These differences in hemispheric dominance are conceptualized in cortical asymmetry theories on motivational direction, which assign avoidance motivation (relevant to inhibit responses) to the right and approach motivation (relevant for aggressive actions) to the left prefrontal cortex. The current study aimed to directly address the inverse relationship between response inhibition and aggression by assessing them within one experiment. Sixty-nine healthy participants underwent bilateral transcranial Direct Current Stimulation (tDCS) to the inferior frontal cortex. In one group we induced right-hemispheric fronto-cortical dominance by means of a combined right prefrontal anodal and left prefrontal cathodal tDCS montage. In a second group we induced left-hemispheric fronto-cortical dominance by means of a combined left prefrontal anodal and right prefrontal cathodal tDCS montage. A control group received sham stimulation. Response inhibition was assessed with a go/no-go task (GNGT) and aggression with the Taylor Aggression Paradigm (TAP). We revealed that participants with poorer performance in the GNGT displayed more aggression during the TAP. No effects of bilateral prefrontal tDCS on either response inhibition or aggression were observed. This is at odds with previous brain stimulation studies applying unilateral protocols. Our results failed to provide evidence in support of the prefrontal cortical asymmetry model in the domain of response inhibition and aggression. The absence of tDCS effects might also indicate that the methodological approach of shifting cortical asymmetry by means of bilateral tDCS protocols has failed.	[Dambacher, Franziska; Schuhmann, Teresa; Sack, Alexander T.] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Lobbestael, Jill; Arntz, Arnoud; Brugman, Suzanne] Maastricht Univ, Dept Clin Psychol Sci, Maastricht, Netherlands; [Dambacher, Franziska; Schuhmann, Teresa; Sack, Alexander T.] Maastricht Brain Imaging Ctr, Maastricht, Netherlands; [Arntz, Arnoud] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands	Maastricht University; Maastricht University; Maastricht University; University of Amsterdam	Dambacher, F (corresponding author), Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands.	franziska.dambacher@maastrichtuniversity.nl	Arntz, Arnoud/M-3011-2013	Arntz, Arnoud/0000-0002-7992-2272; Lobbestael, Jill/0000-0001-9205-3115; Sack, Alexander/0000-0002-1471-0885	Netherlands Organization for Scientific Research (NWO) [HCMI 10-19]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the Netherlands Organization for Scientific Research (NWO; HCMI 10-19).	Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231; Anderson CA, 1999, CURR DIR PSYCHOL SCI, V8, P3, DOI 10.1111/1467-8721.00002; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Asahi S, 2004, EUR ARCH PSY CLIN N, V254, P245, DOI 10.1007/s00406-004-0488-z; Beeli G, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-33; BERNSTEIN S, 1987, AGGRESSIVE BEHAV, V13, P15, DOI 10.1002/1098-2337(1987)13:1<15::AID-AB2480130104>3.0.CO;2-K; BJORKQVIST K, 1994, SEX ROLES, V30, P177, DOI 10.1007/BF01420988; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Chambers CD, 2007, J NEUROPHYSIOL, V98, P3638, DOI 10.1152/jn.00685.2007; d'Alfonso AAL, 2000, NEUROSCI LETT, V280, P195, DOI 10.1016/S0304-3940(00)00781-3; Dambacher F, 2015, SOCIAL COGN IN PRESS; Dambacher F, 2015, SOC COGN AFFECT NEUR, V10, P508, DOI 10.1093/scan/nsu077; Dambacher F, 2014, J COGNITIVE NEUROSCI, V26, P1775, DOI 10.1162/jocn_a_00595; Dambacher F, 2014, EUR J NEUROSCI, V39, P821, DOI 10.1111/ejn.12425; de Graaf TA, 2011, NEUROSCI BIOBEHAV R, V35, P871, DOI 10.1016/j.neubiorev.2010.10.006; Eagle DM, 2008, PSYCHOPHARMACOLOGY, V199, P439, DOI 10.1007/s00213-008-1127-6; EAGLY AH, 1986, PSYCHOL BULL, V100, P309, DOI 10.1037/0033-2909.100.3.309; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Giancola PR, 2008, AGGRESSIVE BEHAV, V34, P214, DOI 10.1002/ab.20235; GIANCOLA PR, 1995, AGGRESSIVE BEHAV, V21, P199, DOI 10.1002/1098-2337(1995)21:3<199::AID-AB2480210303>3.0.CO;2-Q; Harmon-Jones E, 1998, J PERS SOC PSYCHOL, V74, P1310, DOI 10.1037/0022-3514.74.5.1310; Harmon-Jones E, 2004, BIOL PSYCHOL, V67, P51, DOI 10.1016/j.biopsycho.2004.03.003; Harmon-Jones E, 2001, J PERS SOC PSYCHOL, V80, P797, DOI 10.1037/0022-3514.80.5.797; Hoaken PNS, 2003, AGGRESSIVE BEHAV, V29, P15, DOI 10.1002/ab.10023; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Hortensius R, 2012, SOC COGN AFFECT NEUR, V7, P342, DOI 10.1093/scan/nsr012; Horvath JC, 2015, BRAIN STIMUL, V8, P535, DOI 10.1016/j.brs.2015.01.400; Horvath JC, 2015, NEUROPSYCHOLOGIA, V66, P213, DOI 10.1016/j.neuropsychologia.2014.11.021; Jacobson L, 2011, J COGNITIVE NEUROSCI, V23, P3380, DOI 10.1162/jocn_a_00020; Karabanov A, 2015, BRAIN STIMUL, V8, P442, DOI 10.1016/j.brs.2015.01.404; LAGERSPETZ KMJ, 1988, AGGRESSIVE BEHAV, V14, P403, DOI 10.1002/1098-2337(1988)14:6<403::AID-AB2480140602>3.0.CO;2-D; Logan GD, 1997, PSYCHOL SCI, V8, P60, DOI 10.1111/j.1467-9280.1997.tb00545.x; Pawliczek CM, 2013, NEUROIMAGE, V79, P264, DOI 10.1016/j.neuroimage.2013.04.104; Poulin F, 2000, PSYCHOL ASSESSMENT, V12, P115, DOI 10.1037/1040-3590.12.2.115; Raine A, 2006, AGGRESSIVE BEHAV, V32, P159, DOI 10.1002/ab.20115; TAYLOR SP, 1967, J PERS, V35, P297, DOI 10.1111/j.1467-6494.1967.tb01430.x; van Honk J, 2006, PSYCHOL SCI, V17, P963, DOI 10.1111/j.1467-9280.2006.01813.x; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Ye H, 2015, BEHAV BRAIN RES, V286, P17, DOI 10.1016/j.bbr.2015.02.037; Ziemann U, 2008, BRAIN STIMUL, V1, P60, DOI 10.1016/j.brs.2007.08.003	42	45	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132170	10.1371/journal.pone.0132170	http://dx.doi.org/10.1371/journal.pone.0132170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161664	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300101
J	Fisher, MB; Williams, AR; Jalloh, MF; Saquee, G; Bain, RES; Bartram, JK				Fisher, Michael B.; Williams, Ashley R.; Jalloh, Mohamed F.; Saquee, George; Bain, Robert E. S.; Bartram, Jamie K.			Microbiological and Chemical Quality of Packaged Sachet Water and Household Stored Drinking Water in Freetown, Sierra Leone	PLOS ONE			English	Article							ACCRA; HEALTH; SOLD	Packaged drinking water (PW) sold in bottles and plastic bags/sachets is widely consumed in low-and middle-income countries (LMICs), and many urban users in sub-Saharan Africa (SSA) rely on packaged sachet water (PSW) as their primary source of water for consumption. However, few rigorous studies have investigated PSW quality in SSA, and none have compared PSW to stored household water for consumption (HWC). A clearer understanding of PSW quality in the context of alternative sources is needed to inform policy and regulation. As elsewhere in SSA, PSW is widely consumed in Sierra Leone, but government oversight is nearly nonexistent. This study examined the microbiological and chemical quality of a representative sample of PSW products in Freetown, Sierra Leone at packaged water manufacturing facilities (PWMFs) and at points of sale (POSs). Samples of HWC were also analyzed for comparison. The study did not find evidence of serious chemical contamination among the parameters studied. However, 19% of 45 PSW products sampled at the PWMF contained detectable Escherichia coli (EC), although only two samples exceeded 10 CFU/100 mL. Concentrations of total coliforms (TC) in PSW (but not EC) increased along the supply chain. Samples of HWC from 60 households in Freetown were significantly more likely to contain EC and TC than PSW at the point of production (p<0.01), and had significantly higher concentrations of both bacterial indicators (p<0.01). These results highlight the need for additional PSW regulation and surveillance, while demonstrating the need to prioritize the safety of HWC. At present, PSW may be the least unsafe option for many households.	[Fisher, Michael B.; Williams, Ashley R.; Bain, Robert E. S.; Bartram, Jamie K.] Univ N Carolina, Water Inst, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA; [Jalloh, Mohamed F.; Saquee, George] FOCUS 1000, Freetown, Sierra Leone	University of North Carolina; University of North Carolina Chapel Hill	Fisher, MB (corresponding author), Univ N Carolina, Water Inst, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA.	mbfisher@gmail.com; jbartram@email.unc.edu		Bartram, Jamie/0000-0002-6542-6315	National Institute of Environmental Health Sciences [T32ES007018]; Adam Smith International [13-2097]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007018] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Adam Smith International; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Adam Smith International (http://www.adamsmithinternational.com) Proposal 13-2097, "Improving the Regulation, Monitoring, and Quality of the Packaged (Sachet and Bottled) Water Industry in Sierra Leone and Sensitising the Customer Base." This grant provided support for MBF ARW MFJ GS JKB. This work was also supported in part by a grant from the National Institute of Environmental Health Sciences (http://www.niehs.nih.gov) Grant T32ES007018. This grant provided support for MBF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Salam Magda M, 2008, J Egypt Public Health Assoc, V83, P468; Ackah M, 2012, ADV APPL SCI RES, V3; Addo K, 2009, AFRICAN J FOOD, V9; Ajayi A, 2008, AFRICAN J BIOMEDICAL, V11; Ajayi OS, 2009, IRAN J RADIAT RES, V7, P151; Alhassan M. M., 2012, British Journal of Applied Science and Technology, V2, P146; Alli J, 2011, NEW YORK SCI J, V4; Bain R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001644; Barrell R A, 2000, Commun Dis Public Health, V3, P8; Beverage Marketing Corporation, 2012, 2011 GLOBAL BOTTLED; Cabral D, 2002, INT J FOOD MICROBIOL, V72, P73, DOI 10.1016/S0168-1605(01)00628-6; Dada AC, 2009, AFR J MICROBIOL RES, V3, P15; Dada AC, 2011, GLOBAL HLTH, V10, P1744; Egwari L, 2005, E AFRICAN MED J, V82; Ejechi EO, 2008, SOC INDIC RES, V85, P211, DOI 10.1007/s11205-007-9086-6; Fujikawa H, 1997, J APPL MICROBIOL, V82, P287, DOI 10.1046/j.1365-2672.1997.00353.x; Ghana Statistical Service, 2011, GHANA MULTIPLE INDIC; Herath AT, 2012, J FOOD SCI, V77, pM160, DOI 10.1111/j.1750-3841.2011.02588.x; Hunter PR, 2009, SCI TOTAL ENVIRON, V407, P2621, DOI 10.1016/j.scitotenv.2009.01.018; Kwakye-Nuako G, 2007, GHANA MED J, V41; LECHEVALLIER MW, 1990, J AM WATER WORKS ASS, V82, P74, DOI 10.1002/j.1551-8833.1990.tb07054.x; MCFETERS GA, 1986, APPL ENVIRON MICROB, V51, P1; MINTZ ED, 1995, JAMA-J AM MED ASSOC, V273, P948, DOI 10.1001/jama.273.12.948; Nunes SAP, 2008, J FOOD PROTECT, V71, P1253, DOI 10.4315/0362-028X-71.6.1253; Obiri-Danso K, 2003, LETT APPL MICROBIOL, V37, P334, DOI 10.1046/j.1472-765X.2003.01403.x; Oluwafemi F., 2012, OPEN J MED MICROBIOL, V2, P115, DOI [DOI 10.4236/ojmm.2012.23017, 10.4236/ojmm.2012.23017, DOI 10.4236/OJMM.2012.23017]; Opatunji O, 2011, 35 WEDC INT C LOUGHB; Orisakwe OE, 2006, ARCH ENVIRON OCCUP H, V61, P209, DOI 10.3200/AEOH.61.5.209-213; Osei AS, 2013, FOOD CONTROL, V31, P172, DOI 10.1016/j.foodcont.2012.08.025; Oshiro, 2002, 1604 US EPA; Pope ML, 2003, APPL ENVIRON MICROB, V69, P6201, DOI 10.1128/AEM.69.10.6201-6207.2003; Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537; Shields K, ENVIRONMENTAL HLTH P; Stoler J, 2014, AM J TROP MED HYG, V90, P272, DOI 10.4269/ajtmh.13-0461; Stoler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067257; Stoler J, 2012, J WATER SANIT HYG DE, V2, P223, DOI 10.2166/washdev.2012.104; Stoler J, 2012, HEALTH PLACE, V18, P250, DOI 10.1016/j.healthplace.2011.09.020; UNICEF, 2010, SIERRA LEONE MULTIPL; Vantarakis A, 2013, FOOD CONTROL, V33, P63, DOI 10.1016/j.foodcont.2013.01.034; Vapnek J, 2014, LEGISLATIVE REV RECO; WHO, 2011, MANGANESE DRINKING W; WHO, 2011, GUID DRINK WAT QUAL; Williams AR, 2014, IMPROVIN REGULATION	43	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131772	10.1371/journal.pone.0131772	http://dx.doi.org/10.1371/journal.pone.0131772			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162082	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300057
J	Simo-Riudalbas, L; Diaz-Lagares, A; Gatto, S; Gagliardi, M; Crujeiras, AB; Matarazzo, MR; Esteller, M; Sandoval, J				Simo-Riudalbas, L.; Diaz-Lagares, A.; Gatto, S.; Gagliardi, M.; Crujeiras, A. B.; Matarazzo, M. R.; Esteller, M.; Sandoval, J.			Genome-Wide DNA Methylation Analysis Identifies Novel Hypomethylated Non-Pericentromeric Genes with Potential Clinical Implications in ICF Syndrome	PLOS ONE			English	Article							SATELLITE DNA; EXPRESSION PATTERN; CANCER; CPG; MUTATIONS; DEFECTS; HETEROCHROMATIN; CHROMOSOME; MEIOSIS; REGIONS	Introduction and Results Immunodeficiency, centromeric instability and facial anomalies syndrome (ICF) is a rare autosomal recessive disease, characterized by severe hypomethylation in pericentromeric regions of chromosomes (1, 16 and 9), marked immunodeficiency and facial anomalies. The majority of ICF patients present mutations in the DNMT3B gene, affecting the DNA methyltransferase activity of the protein. In the present study, we have used the Infinium 450K DNA methylation array to evaluate the methylation level of 450,000 CpGs in lymphoblastoid cell lines and untrasformed fibroblasts derived from ICF patients and healthy donors. Our results demonstrate that ICF-specific DNMT3B variants A603T/STP807ins and V699G/R54X cause global DNA hypomethylation compared to wild-type protein. We identified 181 novel differentially methylated positions (DMPs) including subtelomeric and intrachromosomic regions, outside the classical ICF-related pericentromeric hypomethylated positions. Interestingly, these sites were mainly located in intergenic regions and inside the CpG islands. Among the identified hypomethylated CpG-island associated genes, we confirmed the overexpression of three selected genes, BOLL, SYCP2 and NCRNA00221, in ICF compared to healthy controls, which are supposed to be expressed in germ line and silenced in somatic tissues. Conclusions In conclusion, this study contributes in clarifying the direct relationship between DNA methylation defect and gene expression impairment in ICF syndrome, identifying novel direct target genes of DNMT3B. A high percentage of the DMPs are located in the subtelomeric regions, indicating a specific role of DNMT3B in methylating these chromosomal sites. Therefore, we provide further evidence that hypomethylation in specific non-pericentromeric regions of chromosomes might be involved in the molecular pathogenesis of ICF syndrome. The detection of DNA hypomethylation at BOLL, SYCP2 and NCRNA00221 may pave the way for the development of specific clinical biomarkers with the aim to facilitate the identification of ICF patients.	[Simo-Riudalbas, L.; Diaz-Lagares, A.; Crujeiras, A. B.; Esteller, M.; Sandoval, J.] Bellvitge Biomed Res Inst IDIBELL, PEBC, Barcelona, Catalonia, Spain; [Gatto, S.; Gagliardi, M.; Matarazzo, M. R.] CNR, Inst Genet & Biophys ABT, I-80125 Naples, Italy; [Esteller, M.] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona, Spain; [Esteller, M.] ICREA, Barcelona, Catalonia, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Barcelona; ICREA	Esteller, M (corresponding author), Bellvitge Biomed Res Inst IDIBELL, PEBC, Barcelona, Catalonia, Spain.	mesteller@idibell.cat; juan.sandoval@uv.es	sandoval, juan/M-4593-2015; Esteller, Manel/L-5956-2014; Crujeiras, Ana/ABA-8866-2021	sandoval, juan/0000-0002-5100-973X; Esteller, Manel/0000-0003-4490-6093; Crujeiras, Ana/0000-0003-4392-0301	Cellex Foundation; Instituto de Sanidad Carlos III (ISCIII); Health and Science Departments of the Generalitat de Catalunya; "Sara Borrell" postdoctoral contract from the ISCIII at the Spanish Ministry of Economy and Competitiveness [CD12/00738, C09/00365]; Epigenomics Flagship Project EPIGEN, MIUR-CNR; ISCIII grant [CP13/00055]; ICREA Funding Source: Custom	Cellex Foundation(Foundation CELLEX); Instituto de Sanidad Carlos III (ISCIII); Health and Science Departments of the Generalitat de Catalunya; "Sara Borrell" postdoctoral contract from the ISCIII at the Spanish Ministry of Economy and Competitiveness; Epigenomics Flagship Project EPIGEN, MIUR-CNR; ISCIII grant; ICREA(ICREA)	The research leading to these results has received funding from the Cellex Foundation, Instituto de Sanidad Carlos III (ISCIII) and the Health and Science Departments of the Generalitat de Catalunya. ADL and ABC were supported by the "Sara Borrell" postdoctoral contract (CD12/00738) and (C09/00365) from the ISCIII at the Spanish Ministry of Economy and Competitiveness. MRM is supported by the Epigenomics Flagship Project EPIGEN, MIUR-CNR. ME is an ICREA Research Professor. JS is a "Miguel Servet" researcher and this work was supported by CP13/00055 ISCIII grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Brun ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019464; Della Ragione F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00054; Ehrlich M, 2001, HUM MOL GENET, V10, P2917, DOI 10.1093/hmg/10.25.2917; Ehrlich M, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-2; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Gatto S, 2010, EPIGENETICS-US, V5, P427, DOI 10.4161/epi.5.5.11999; Hansen RS, 2000, HUM MOL GENET, V9, P2575, DOI 10.1093/hmg/9.18.2575; Heyn H, 2012, EPIGENETICS-US, V7, P542, DOI 10.4161/epi.20523; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; JEANPIERRE M, 1993, HUM MOL GENET, V2, P731, DOI 10.1093/hmg/2.6.731; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; Kondo T, 2000, HUM MOL GENET, V9, P597, DOI 10.1093/hmg/9.4.597; Li MZ, 2013, J CELL BIOCHEM, V114, P294, DOI 10.1002/jcb.24368; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Serra P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4608; Matarazzo MR, 2007, J CELL PHYSIOL, V210, P711, DOI 10.1002/jcp.20879; Matarazzo MR, 2002, HUM MOL GENET, V11, P3191, DOI 10.1093/hmg/11.25.3191; MINIOU P, 1994, HUM MOL GENET, V3, P2093, DOI 10.1093/hmg/3.12.2093; Miniou P, 1997, HUM GENET, V99, P738, DOI 10.1007/s004390050441; Moarefi AH, 2011, J MOL BIOL, V409, P758, DOI 10.1016/j.jmb.2011.04.050; Quintavalle C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074466; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stirzaker C, 2014, TRENDS GENET, V30, P75, DOI 10.1016/j.tig.2013.11.004; Velasco G, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-56; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; Walton Emma L, 2014, Biology (Basel), V3, P578, DOI 10.3390/biology3030578; Wang H, 2005, INT J MOL MED, V15, P949; Weemaes CMR, 2013, EUR J HUM GENET, V21, P1219, DOI 10.1038/ejhg.2013.40; Yehezkel S, 2008, HUM MOL GENET, V17, P2776, DOI 10.1093/hmg/ddn177; Zheng YH, 2009, REPRODUCTION, V138, P483, DOI 10.1530/REP-09-0163	33	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132517	10.1371/journal.pone.0132517	http://dx.doi.org/10.1371/journal.pone.0132517			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161907	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300145
J	Vereshchaka, AL; Kulagin, DN; Lunina, AA				Vereshchaka, Alexander L.; Kulagin, Dmitry N.; Lunina, Anastasia A.			Phylogeny and New Classification of Hydrothermal Vent and Seep Shrimps of the Family Alvinocarididae (Decapoda)	PLOS ONE			English	Article							CENTRAL INDIAN RIDGE; MID-ATLANTIC RIDGE; CARIDEA ALVINOCARIDIDAE; RIMICARIS-EXOCULATA; RETINAL ANATOMY; HYBRID ZONE; CRUSTACEA; GENUS; BRESILIIDAE; PACIFIC	The paper addresses the phylogeny and classification of the hydrothermal vent shrimp family Alvinocarididae. Two morphological cladistic analyses were carried out, which use all 31 recognized species of Alvinocarididae as terminal taxa. As outgroups, two species were included, both representing major caridean clades: Acanthephyra purpurea (Acanthephyridae) and Alpheus echiurophilus (Alpheidae). For additional support of the clades we utilised available data on mitochondrial Cytochrome c Oxidase I gene (CO1) and 16S ribosomal markers. Both morphological and molecular methods resulted in similar tree topologies and nearly identical clades. We consider these clades as evolutionary units and thus erect two new subfamilies: Rimicaridinae (Alvinocaridinides, Manuscaris, Opaepele, Shinkaicaris, Rimicaris), Alvinocaridinae (Alvinocaris), whilst recognising Mirocaridinae (with genera Mirocaris and Nautilocaris) at subfamily level. One genus, Keldyshicaris could not be assigned to any subfamily and is thus left as incertae sedis. The monophyly of Alvinocardinae was supported by morphological data, but not supported by molecular data (two analyses); the monophyly of all subfamilies was supported both by morphological and molecular data. Chorocaris is herein synonymized with Rimicaris, whilst Opaepele vavilovi is herein transferred to a new genus Keldyshicaris. Morphological trends within Alvinocarididae are discussed and short biogeographical remarks are given. We provide emended diagnoses for all subfamilies and genera along with keys to all recognized species.	[Vereshchaka, Alexander L.; Kulagin, Dmitry N.; Lunina, Anastasia A.] Russian Acad Sci, PP Shirshov Inst Oceanol, Moscow 117997, Russia	Russian Academy of Sciences; Shirshov Institute of Oceanology	Vereshchaka, AL (corresponding author), Russian Acad Sci, PP Shirshov Inst Oceanol, Moscow 117997, Russia.	alv@ocean.ru	Vereshchaka, Alexander L/E-6205-2014; Kulagin, Dmitry N./E-3137-2014; Lunina, Anastasia/L-3699-2014	Vereshchaka, Alexander L/0000-0002-6756-2468; Kulagin, Dmitry N./0000-0002-5521-8598; Lunina, Anastasia/0000-0002-1105-8027	Russian Foundation for Basic Research [15-04-08228]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The studies were supported by the Russian Foundation for Basic Research (grant number 15-04-08228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahyong ST, 2009, CRUSTACEANA, V82, P775, DOI 10.1163/156854009X427333; Anker A, 2015, ZOOTAXA, V3914, P441, DOI 10.11646/zootaxa.3914.4.4; Audzijonyte A, 2007, POLAR BIOL, V30, P1137, DOI 10.1007/s00300-007-0271-5; Beedessee G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081570; Bonnivard E, 2009, GENOME, V52, P524, DOI [10.1139/G09-027, 10.1139/g09-027]; Bracken H. D., 2009, DECAPOD CRUSTACEAN P, V18, P274; Bucklin A, 2010, DEEP-SEA RES PT II, V57, P2234, DOI 10.1016/j.dsr2.2010.09.025; Chan TY, 2010, INVERTEBR SYST, V24, P172, DOI 10.1071/IS09049; Darling JA, 2011, INVAD NAT SPRING SER, V6, P661, DOI 10.1007/978-94-007-0591-3_24; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Grave S., 2011, Zoologische Mededelingen (Leiden), V85, P195; Desbruyeres D., 2006, HDB DEEP SEA HYDROTH; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fujikura Katsunori, 1996, JAMSTEC Journal of Deep Sea Research, V12, P133; Fujikura Katsunori, 1995, JAMSTEC Journal of Deep Sea Research, V11, P227; Gebruk AV, 1997, ADV MAR BIOL, V32, P93; GOLOBOFF P, 2000, TNT TREE ANAL USING; Hiraoka R, 2013, ALVINOCARIS DISSIMIL; KIKUCHI T, 1995, J CRUSTACEAN BIOL, V15, P771, DOI 10.2307/1548826; Kikuchi Tomohiko, 2000, Species Diversity, V5, P135; Kim S.-J., 2013, MITOCHONDR DNA, P1; Komai T, 2006, SCI MAR, V70, P109, DOI 10.3989/scimar.2006.70n1109; Komai T, 2005, ZOOTAXA, P27; Komai T, 2005, J NAT HIST, V39, P1111, DOI 10.1080/00222930400002499; Komai T, 2004, J MAR BIOL ASSOC UK, V84, P1179, DOI 10.1017/S0025315404010628h; Komai Tomoyuki, 2007, Species Diversity, V12, P237; Komai T, 2015, J NAT HIST, V49, P1789, DOI 10.1080/00222933.2015.1006702; Komai T, 2010, ZOOTAXA, P15; Kuenzler RO, 1997, J MAR BIOL ASSOC UK, V77, P707, DOI 10.1017/S0025315400036146; Lakin RC, 1997, J COMP NEUROL, V385, P503; Li CP, 2011, ZOOL ANZ, V250, P270, DOI 10.1016/j.jcz.2011.04.003; Lunina A, 2011, THESIS SHIRSHOV I OC; Lunina A A, 2008, Dokl Biol Sci, V421, P266, DOI 10.1134/S0012496608040133; Lunina AA, 2010, ZOOTAXA, P69; MADDISON W.P., 2001, MESQUITE MODULAR SYS; Martin J.W., 2005, CONTRIBUTIONS SCI NA, V145, P445, DOI 10.1111/j.1096-3642.2005.00178.x; Martin JW, 1997, P BIOL SOC WASH, V110, P399; Martin JW, 2005, ZOOL J LINN SOC-LOND, V145, P445, DOI 10.1111/j.1096-3642.2005.00178.x; Martin JW, 2005, P BIOL SOC WASH, V118, P183, DOI 10.2988/0006-324X(2005)118[183:ANSOTS]2.0.CO;2; MARTIN JW, 1995, P BIOL SOC WASH, V108, P220; Milne-Edwards A, 1881, CR HEBD ACAD SCI, V93, P931; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Nye V, 2012, J MAR BIOL ASSOC UK, V92, P1; NYE V, 2011, J MAR BIOL ASSOC UK, V92, P1; O'Mullan GD, 2001, MOL ECOL, V10, P2819, DOI 10.1046/j.1365-294X.2001.t01-1-01401.x; ONEILL PJ, 1995, VISUAL NEUROSCI, V12, P861, DOI 10.1017/S0952523800009421; Pedersen RB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1124; PELLI DG, 1989, NATURE, V337, P460, DOI 10.1038/337460a0; Plouviez S, 2015, DEEP-SEA RES PT I, V97, P124, DOI 10.1016/j.dsr.2014.11.011; RENNINGER GH, 1995, BIOL BULL, V189, P69, DOI 10.2307/1542456; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shank TM, 1998, MOL MAR BIOL BIOTECH, V7, P88; Shank TM, 1999, MOL PHYLOGENET EVOL, V13, P244, DOI 10.1006/mpev.1999.0642; Teixeira S, 2013, MOL ECOL, V22, P4663, DOI 10.1111/mec.12419; Teixeira S, 2012, CONSERV GENET RESOUR, V4, P81, DOI 10.1007/s12686-011-9479-3; Teixeira S, 2011, J BIOGEOGR, V38, P564, DOI 10.1111/j.1365-2699.2010.02408.x; Tokuda G, 2006, BIOL LETTERS, V2, P257, DOI 10.1098/rsbl.2005.0420; Tsuchida S., 2008, DEEP SEA LIFE BIOL O, P100; Van Dover CL, 2003, DEEP-SEA RES PT I, V50, P281, DOI 10.1016/S0967-0637(02)00162-0; Vereshchaka AL, 1997, J MAR BIOL ASSOC UK, V77, P425, DOI 10.1017/S0025315400071770; Vereshchaka AL, 1996, J MAR BIOL ASSOC UK, V76, P951, DOI 10.1017/S002531540004090X; Vereshchaka AL, 2002, CAH BIOL MAR, V43, P303; Vereshchaka AL, 1997, DEEP-SEA RES PT I, V44, P1905, DOI 10.1016/S0967-0637(97)00031-9; Vereshchaka AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112057; Vereshchaka Alexander L., 2000, Galathea Report, V18, P69; Wang L, 1994, J Comput Biol, V1, P337, DOI 10.1089/cmb.1994.1.337; Watabe H, 2002, ZOOL SCI, V19, P1167, DOI 10.2108/zsj.19.1167; Watabe Hajime, 2000, JAMSTEC Journal of Deep Sea Research, V17, P29; Webber WR, 2004, ZOOTAXA, P1; WILLIAMS A B, 1982, Journal of Crustacean Biology, V2, P136, DOI 10.2307/1548118; WILLIAMS AB, 1995, P BIOL SOC WASH, V108, P228; WILLIAMS AB, 1988, FISH B-NOAA, V86, P263; WILLIAMS AB, 1986, J CRUSTACEAN BIOL, V6, P446, DOI 10.2307/1548184; Won Y, 2003, MOL ECOL, V12, P3185, DOI 10.1046/j.1365-294X.2003.01974.x; Wong JM, 2015, MOL PHYLOGENET EVOL, V83, P278, DOI 10.1016/j.ympev.2014.11.013; Yahagi T, 2014, ZOOTAXA, V3893, P101, DOI 10.11646/zootaxa.3893.1.4; Yang CH, 2012, MITOCHONDR DNA, V23, P417, DOI 10.3109/19401736.2012.710212; Yang JS, 2013, MOL BIOL EVOL, V30, P305, DOI 10.1093/molbev/mss224; Zelnio KA, 2009, P BIOL SOC WASH, V122, P52, DOI 10.2988/07-28.1	79	26	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0129975	10.1371/journal.pone.0129975	http://dx.doi.org/10.1371/journal.pone.0129975			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161742	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300012
J	Lin, HW; Chung, CL; Lin, YS; Yu, CM; Lee, CN; Bien, MY				Lin, Hui-Wen; Chung, Chi-Li; Lin, You Shuei; Yu, Chia-Ming; Lee, Chun-Nin; Bien, Mauo-Ying			Inhaled Pharmacotherapy and Stroke Risk in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Study Using Two-Stage Approach	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; COPD; INFLAMMATION; FLUTICASONE; PREVALENCE; SALMETEROL	Background and Purpose Patients with chronic obstructive pulmonary disease (COPD) are at higher risk of stroke than those without COPD. This study aims to explore the impact of inhaled pharmacotherapy on stroke risk in COPD patients during a three-year follow-up, using a nationwide, population- based study and a matched cohort design. Methods The study cohort comprised 10,413 patients who had received COPD treatment between 2004 and 2006; 41,652 randomly selected subjects comprised the comparison cohort. Cox proportional hazard regressions and two-stage propensity score calibration were performed to determine the impact of various inhaled therapies including short-acting muscarinic antagonists, long-acting muscarinic antagonists, short-acting beta-agonists (SABAs), long-acting beta-agonists (LABAs), and LABA plus inhaled corticosteroid (ICS), on the risk after adjustment for patient demographic characteristics and comorbid disorders. Results Of the 52,065 sampled patients, 2,689 (5.2%) developed stroke during follow-up, including 727 (7.0%) from the COPD cohort and 1,962 (4.7%) from the comparison cohort (p < 0.001). Treatment with SABA was associated with 1.67-fold (95% CI 1.45-1.91; p < 0.001) increased risk of stroke in COPD patients. By contrast, the cumulative incidence of stroke was significantly lower in those treated with LABA plus ICS than those treated without (adjusted hazard ratio 0.75, 95% CI 0.60-0.94, p = 0.014). Conclusions Among COPD patients, the use of inhaled SABA is associated with an increased risk of stroke, and combination treatment with inhaled LABA and ICS relates to a risk reduction. Further prospective research is needed to verify whether LABA plus ICS confers protection against stroke in patients with COPD.	[Lin, Hui-Wen] Soochow Univ, Dept Math, Taipei, Taiwan; [Chung, Chi-Li; Lee, Chun-Nin; Bien, Mauo-Ying] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Chung, Chi-Li; Bien, Mauo-Ying] Taipei Med Univ Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Lin, You Shuei] Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei, Taiwan; [Yu, Chia-Ming] Taipei Med Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lee, Chun-Nin; Bien, Mauo-Ying] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Lee, Chun-Nin] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan	Soochow University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Shuang Ho Hospital	Bien, MY (corresponding author), Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan.	mybien@tmu.edu.tw		Lin, You Shuei/0000-0003-1364-0245	National Science Council of Taiwan [NSC96-2314-B-038-029, NSC101-2314-B-038-044-MY3]; Wan Fang Hospital, Taipei, Taiwan [96TMU-WFH-16]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Wan Fang Hospital, Taipei, Taiwan	The work was supported by the following: NSC96-2314-B-038-029 from the National Science Council of Taiwan to Bien MY; 96TMU-WFH-16 from Wan Fang Hospital, Taipei, Taiwan to Bien MY; and NSC101-2314-B-038-044-MY3 from the National Science Council of Taiwan to Chung CL.	Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Cook D, 2001, AM J RESP CRIT CARE, V163, P85, DOI 10.1164/ajrccm.163.1.2004214; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; Feary JR, 2010, THORAX, V65, P956, DOI 10.1136/thx.2009.128082; Gross NJ, 2012, CHEST, V142, P1300, DOI 10.1378/chest.11-2766; Guo YH, 2012, EYE, V26, P684, DOI 10.1038/eye.2012.9; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Lin HW, 2014, AM J EPIDEMIOL, V180, P308, DOI 10.1093/aje/kwu130; Lin HW, 2010, HUM HERED, V69, P160, DOI 10.1159/000267996; Man S F Paul, 2005, Proc Am Thorac Soc, V2, P78, DOI 10.1513/pats.200406-034MS; Man SFP, 2012, CAN J CARDIOL, V28, P653, DOI 10.1016/j.cjca.2012.06.013; Pinto-Plata VM, 2006, THORAX, V61, P23, DOI 10.1136/thx.2005.042200; ROSNER B, 1990, AM J EPIDEMIOL, V132, P734, DOI 10.1093/oxfordjournals.aje.a115715; Salpeter SR, 2004, CHEST, V125, P2309, DOI 10.1378/chest.125.6.2309; Schnell K, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-26; Sin DD, 2008, AM J RESP CRIT CARE, V177, P1207, DOI 10.1164/rccm.200709-1356OC; Sinden NJ, 2010, THORAX, V65, P930, DOI 10.1136/thx.2009.130260; Sturmer T, 2005, AM J EPIDEMIOL, V162, P279, DOI 10.1093/aje/kwi192; Suissa Samy, 2012, Rambam Maimonides Med J, V3, pe0014, DOI 10.5041/RMMJ.10082; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Van Eeden S, 2012, AM J RESP CRIT CARE, V186, P11, DOI 10.1164/rccm.201203-0455PP; Varela S, 2009, J INVESTIG ALLERGOL, V123, P124; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wilchesky M, 2012, CHEST, V142, P305, DOI 10.1378/chest.11-1597	24	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130102	10.1371/journal.pone.0130102	http://dx.doi.org/10.1371/journal.pone.0130102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158649	Green Published, gold, Green Submitted			2022-12-27	WOS:000358161200011
J	Yip, JLY; Khawaja, AP; Chan, MPY; Broadway, DC; Peto, T; Tufail, A; Luben, R; Hayat, S; Bhaniani, A; Wareham, NJ; Khaw, KT; Foster, PJ				Yip, Jennifer L. Y.; Khawaja, Anthony P.; Chan, Michelle P. Y.; Broadway, David C.; Peto, Tunde; Tufail, Adnan; Luben, Robert; Hayat, Shabina; Bhaniani, Amit; Wareham, Nicholas J.; Khaw, Kay-Tee; Foster, Paul J.			Cross Sectional and Longitudinal Associations between Cardiovascular Risk Factors and Age Related Macular Degeneration in the EPIC-Norfolk Eye Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; POSTINFARCTION PATIENTS; POOLED FINDINGS; TERM INCIDENCE; PREVALENCE; DISEASE; MACULOPATHY; HYPERTENSION; POLYMORPHISM; CHOLESTEROL	Purpose To examine the cross sectional and longitudinal relationship between cardiovascular risk factors and age-related macular degeneration (AMD) in a large British cohort study. Methods The EPIC Norfolk Eye study is nested in a larger prospective cohort study. Data on cardiovascular risk factors were collected at baseline (1993-1997) and follow up (2006-2011) via clinical examination, validated lifestyle questionnaires and serum blood samples. AMD was ascertained using standardised grading of fundus photographs at the follow up. Logistic regression was used to examine associations between baseline and follow up risk factors with AMD. Results 5,344 pairs (62.0% of total 8623) of fundus photographs were of sufficient quality for grading of AMD in participants with mean age of 67.4 years old (range 44-91) at diagnosis. There were 28 cases of late AMD (0.5%, 95% confidence interval (CI)=0.3-0.8%) and 645 cases of early AMD (12.1%, 95%CI=11.2-13.0.%). In multivariable analysis, older people with higher levels of baseline high density lipoprotein-cholesterol (HDL-C) and C-reactive protein (CRP) were more likely to have any signs of AMD, after adjusting for sex, education, smoking, and systolic blood pressure. In cross sectional analysis, only older age and higher HDL were significantly associated with AMD. Conclusions We have found that older age and higher levels of CRP and HDL-C were associated with increased odds of AMD in this population in the longitudinal analysis, but older age and HDL-C, not CRP was significantly associated with AMD in the cross sectional analysis. The prevalence of AMD in this cohort was low compared to other cohorts in Europe, the US and Australia, and probably reflects the some selection biases in follow up participation as well as the low rate of smoking among our healthy participants.	[Yip, Jennifer L. Y.; Khawaja, Anthony P.; Luben, Robert; Hayat, Shabina; Bhaniani, Amit; Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Yip, Jennifer L. Y.; Khawaja, Anthony P.; Chan, Michelle P. Y.; Peto, Tunde; Tufail, Adnan; Foster, Paul J.] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England; [Yip, Jennifer L. Y.; Khawaja, Anthony P.; Chan, Michelle P. Y.; Peto, Tunde; Tufail, Adnan; Foster, Paul J.] UCL Inst Ophthalmol, London, England; [Broadway, David C.] Norfolk & Norwich Univ Hosp, Dept Ophthalmol, Norwich, Norfolk, England; [Wareham, Nicholas J.] Univ Cambridge, MRC, Epidemiol Unit, Sch Clin Med, Cambridge, England	University of Cambridge; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; University of Cambridge	Yip, JLY (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.	jlyy2@medschl.cam.ac.uk	Peto, Tunde/G-8812-2018; Luben, Robert N/H-5519-2015; Khaw, Kay-Tee/AAZ-3209-2021; Foster, Paul/V-7288-2019	Peto, Tunde/0000-0001-6265-0381; Luben, Robert N/0000-0002-5088-6343; Foster, Paul/0000-0002-4755-177X; Yip, Jennifer Lai Yee/0000-0003-3788-7170; Tufail, Adnan/0000-0001-6131-7640; Khawaja, Anthony/0000-0001-6802-8585	Medical Research Council [G0401527]; Cancer Research UK [C864/A8257]; Age UK Research into Ageing grant [262]; International Glaucoma Association; Richard Desmond Charitable Trust (via Fight for Sight); Department for Health through the NIHR to Moorfields Eye Hospital; University College London (UCL) Institute of Ophthalmology for a specialist Biomedical Research Centre for Ophthalmology; MRC [G1001939, MC_UU_12015/1] Funding Source: UKRI; Medical Research Council [G1001939, MC_UU_12015/1, G1000143, MC_U106179471] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114, CL-2010-14-004, NF-SI-0512-10135] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Age UK Research into Ageing grant; International Glaucoma Association; Richard Desmond Charitable Trust (via Fight for Sight); Department for Health through the NIHR to Moorfields Eye Hospital; University College London (UCL) Institute of Ophthalmology for a specialist Biomedical Research Centre for Ophthalmology; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	EPIC-Norfolk infrastructure and core functions are supported by grants from the Medical Research Council (G0401527) and Cancer Research UK (C864/A8257). The clinic for the third health examination was funded by Age UK Research into Ageing grant (262). Dr. Yip is a National Institute for Health Research (NIHR) Clinical Lecturer. Dr. Khawaja is a Wellcome Trust Clinical Research Fellow. Michelle Chan is an MRC/RCOphth Clinical Training Fellow and has received additional support from the International Glaucoma Association. Professor Foster has received additional support from the Richard Desmond Charitable Trust (via Fight for Sight). Professor Foster and Tunde Peto received funding from the Department for Health through the award made by the NIHR to Moorfields Eye Hospital and the University College London (UCL) Institute of Ophthalmology for a specialist Biomedical Research Centre for Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Cackett P, 2008, AM J OPHTHALMOL, V146, P960, DOI 10.1016/j.ajo.2008.06.026; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Corsetti JP, 2006, ATHEROSCLEROSIS, V187, P191, DOI 10.1016/j.atherosclerosis.2005.09.012; Corsetti JP, 2010, ARTERIOSCL THROM VAS, V30, P1657, DOI 10.1161/ATVBAHA.110.207977; Cougnard-Gregoire A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090973; Day N, 1999, BRIT J CANCER, V80, P95; Delcourt C, 2001, Ophthalmic Epidemiol, V8, P237, DOI 10.1076/opep.8.4.237.1613; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fraser-Bell S, 2008, AM J OPHTHALMOL, V145, P308, DOI 10.1016/j.ajo.2007.10.007; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hayat SA, 2014, INT J EPIDEMIOL, V43, P1063, DOI 10.1093/ije/dyt086; Hogg RE, 2008, OPHTHALMOLOGY, V115, P1046, DOI 10.1016/j.ophtha.2007.07.031; Hong T, 2011, SURV OPHTHALMOL, V56, P184, DOI 10.1016/j.survophthal.2010.08.007; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; Khaw KT, 2006, INT J EPIDEMIOL, V35, P1034, DOI 10.1093/ije/dyl079; Khawaja AP, 2013, BMJ OPEN, P3; Klein R, 2003, OPHTHALMOLOGY, V110, P636, DOI 10.1016/S0161-6420(02)01448-3; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2007, AM J OPHTHALMOL, V143, P473, DOI 10.1016/j.ajo.2006.11.058; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P750, DOI 10.1001/archophthalmol.2010.92; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Mitta VP, 2013, JAMA OPHTHALMOL, V131, P507, DOI 10.1001/jamaophthalmol.2013.2303; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Owen CG, 2012, BRIT J OPHTHALMOL, V96, P752, DOI 10.1136/bjophthalmol-2011-301109; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Reynolds R, 2010, OPHTHALMOLOGY, V117, P1989, DOI 10.1016/j.ophtha.2010.07.009; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Sun C, 2009, OPHTHALMOLOGY, V116, P1913, DOI 10.1016/j.ophtha.2009.03.046; Tan JSL, 2007, OPHTHALMOLOGY, V114, P1143, DOI 10.1016/j.ophtha.2006.09.033; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; van Leeuwen R, 2004, AM J OPHTHALMOL, V137, P750, DOI 10.1016/S0002-9394(03)01089-4; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Wong TY, 2006, ANN INTERN MED, V145, P98, DOI 10.7326/0003-4819-145-2-200607180-00007	42	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132565	10.1371/journal.pone.0132565	http://dx.doi.org/10.1371/journal.pone.0132565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176222	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000358197600125
J	Kondraskov, P; Schutz, N; Schussler, C; de Sequeira, MM; Guerra, AS; Caujape-Castells, J; Jaen-Molina, R; Marrero-Rodriguez, A; Koch, MA; Linder, P; Kovar-Eder, J; Thiv, M				Kondraskov, Paulina; Schuetz, Nicole; Schuessler, Christina; Menezes de Sequeira, Miguel; Santos Guerra, Arnoldo; Caujape-Castells, Juli; Jaen-Molina, Ruth; Marrero-Rodriguez, Aguedo; Koch, Marcus A.; Linder, Peter; Kovar-Eder, Johanna; Thiv, Mike			Biogeography of Mediterranean Hotspot Biodiversity: Re-Evaluating the 'Tertiary Relict' Hypothesis of Macaronesian Laurel Forests	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; PLANT RECORD; EVOLUTION; HISTORY; VEGETATION; LAURACEAE; ANGIOSPERMS; NEOGENE; L.; DIVERSIFICATION	The Macaronesian laurel forests (MLF) are dominated by trees with a laurophyll habit comparable to evergreen humid forests which were scattered across Europe and the Mediterranean in the Paleogene and Neogene. Therefore, MLF are traditionally regarded as an old, 'Tertiary relict' vegetation type. Here we address the question if key taxa of the MLF are relictual. We evaluated the relict hypothesis consulting fossil data and analyses based on molecular phylogenies of 18 representative species. For molecular dating we used the program BEAST, for ancestral trait reconstructions BayesTraits and Lagrange to infer ancestral areas. Our molecular dating showed that the origins of four species date back to the Upper Miocene while 14 originated in the Plio-Pleistocene. This coincides with the decline of fossil laurophyllous elements in Europe since the middle Miocene. Ancestral trait and area reconstructions indicate that MLF evolved partly from pre-adapted taxa from the Mediterranean, Macaronesia and the tropics. According to the fossil record laurophyllous taxa existed in Macaronesia since the Plio- and Pleistocene. MLF are composed of species with a heterogeneous origin. The taxa dated to the Pleistocene are likely not 'Tertiary relicts'. Some species may be interpreted as relictual. In this case, the establishment of most species in the Plio-Pleistocene suggests that there was a massive species turnover before this time. Alternatively, MLF were largely newly assembled through global recruitment rather than surviving as relicts of a once more widespread vegetation. This process may have possibly been triggered by the intensification of the trade winds at the end of the Pliocene as indicated by proxy data.	[Kondraskov, Paulina; Schuetz, Nicole; Schuessler, Christina; Kovar-Eder, Johanna; Thiv, Mike] State Museum Nat Hist Stuttgart, Dept Bot, Stuttgart, Germany; [Menezes de Sequeira, Miguel] Univ Madeira, Ctr Ciencias Vida, Funchal, Madeira, Portugal; [Santos Guerra, Arnoldo] Unidad Bot ICIA, Tenerife, Spain; [Caujape-Castells, Juli; Jaen-Molina, Ruth; Marrero-Rodriguez, Aguedo] CSIC, Jardin Bot Canario Viera y Clavijo Unidad Asociad, Las Palmas Gran Canaria, Spain; [Kondraskov, Paulina; Koch, Marcus A.] Heidelberg Univ, Dept Biodivers & Plant Systemat, Heidelberg, Germany; [Linder, Peter] Univ Zurich, Inst Systemat Bot, Zurich, Switzerland	Universidade da Madeira; Consejo Superior de Investigaciones Cientificas (CSIC); Ruprecht Karls University Heidelberg; University of Zurich	Thiv, M (corresponding author), State Museum Nat Hist Stuttgart, Dept Bot, Stuttgart, Germany.	mike.thiv@smns-bw.de	Koch, Marcus A/A-4924-2011; Caujapé-Castells, Juli/J-8938-2015	Koch, Marcus A/0000-0002-1693-6829; Caujapé-Castells, Juli/0000-0003-0600-1496; Buerki, Sven/0000-0002-8299-6539; Sequeira, Miguel/0000-0001-9728-465X; Eder, Johanna/0000-0001-8039-5441; Schussler, Christina/0000-0002-9935-7426				Aigoin DA, 2009, EVOLUTION, V63, P3248, DOI 10.1111/j.1558-5646.2009.00787.x; Arroyo-Garcia R, 2001, EUPHYTICA, V122, P155, DOI 10.1023/A:1012654514381; Bell CD, 2005, AM J BOT, V92, P284, DOI 10.3732/ajb.92.2.284; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Borges PAV, 1999, BIOL J LINN SOC, V66, P373, DOI 10.1111/j.1095-8312.1999.tb01897.x; Carine MA, 2010, SPEC SYST, V3, P101; Chao YS, 2014, ANN BOT-LONDON, V114, P109, DOI 10.1093/aob/mcu086; Coiffard C, 2009, PALAEONTOLOGY, V52, P323, DOI 10.1111/j.1475-4983.2009.00845.x; Comes Hans Peter, 2004, New Phytol, V164, P11, DOI 10.1111/j.1469-8137.2004.01194.x; Contreras-Diaz HG, 2007, MOL PHYLOGENET EVOL, V42, P687, DOI 10.1016/j.ympev.2006.10.007; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; CRONK QCB, 1992, BIOL J LINN SOC, V46, P91, DOI 10.1111/j.1095-8312.1992.tb00852.x; Desamore A, 2012, J BIOGEOGR, V39, P574, DOI 10.1111/j.1365-2699.2011.02622.x; Desamore A, 2011, J BIOGEOGR, V38, P164, DOI 10.1111/j.1365-2699.2010.02387.x; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Estrada-Ruiz E, 2012, INT J PLANT SCI, V173, P412, DOI 10.1086/664714; FERGUSON DK, 1974, BOT J LINN SOC, V68, P51, DOI 10.1111/j.1095-8339.1974.tb01747.x; Galley C, 2006, J BIOGEOGR, V33, P236, DOI 10.1111/j.1365-2699.2005.01376.x; Garcia-Maroto F, 2009, MOL PHYLOGENET EVOL, V52, P563, DOI 10.1016/j.ympev.2009.04.009; Garcia-Verdugo C, 2013, MOL ECOL, V22, P1546, DOI 10.1111/mec.12194; Geldmacher J, 2001, J VOLCANOL GEOTH RES, V111, P55, DOI 10.1016/S0377-0273(01)00220-7; Gonzalez J, 2009, J ORNITHOL, V150, P357, DOI 10.1007/s10336-008-0360-4; Heer O., 1857, NEUE DENKSCHR ALLG S, VXV, P1; Hooker J.D., 1867, GARDENERS CHRONICLE, V27, P6; Huguet V, 2005, MOL PHYLOGENET EVOL, V34, P557, DOI 10.1016/j.ympev.2004.11.018; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Kovar-Eder J, 2008, PALAIOS, V23, P97, DOI 10.2110/palo.2006.p06-039r; Kovar-Eder J, 2006, PALAEOGEOGR PALAEOCL, V238, P321, DOI 10.1016/j.palaeo.2006.03.031; Li L, 2011, AM J BOT, V98, P1520, DOI 10.3732/ajb.1100006; Anderson CL, 2009, J BIOGEOGR, V36, P2189, DOI 10.1111/j.1365-2699.2009.02222.x; Losch R, 1990, DISS BOT, P146; MAI DH, 1989, PLANT SYST EVOL, V162, P79, DOI 10.1007/BF00936911; Manen JF, 2010, MOL PHYLOGENET EVOL, V57, P961, DOI 10.1016/j.ympev.2010.09.006; Fernandez-Palacios JM, 2011, J BIOGEOGR, V38, P226, DOI 10.1111/j.1365-2699.2010.02427.x; MARTINETTO E, 2014, ALP MEDITERR QUAT, V27; Martinetto E, 2009, QUATERN INT, V204, P20, DOI 10.1016/j.quaint.2008.11.014; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Moreno A, 2001, QUATERNARY SCI REV, V20, P1327, DOI 10.1016/S0277-3791(00)00184-0; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ortiz JE, 2006, J QUATERNARY SCI, V21, P287, DOI 10.1002/jqs.962; OVERPECK JT, 1992, GEOLOGY, V20, P1071, DOI 10.1130/0091-7613(1992)020<1071:MENAVC>2.3.CO;2; Pagel M, 2013, BAYES TRAITS V2 TUTO; Paradis E, 2006; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ree RH, 2009, J BIOGEOGR, V36, P1211, DOI 10.1111/j.1365-2699.2008.02068.x; Rivas-Martinez S., 1993, ITINERA GEOBOT, V7, P169; Rodriguez-Sanchez F, 2009, J BIOGEOGR, V36, P1270, DOI 10.1111/j.1365-2699.2009.02091.x; Rohwer J. G., 1993, FAMILIES GENERA VASC, V2, P366, DOI DOI 10.1007/978-3-662-02899-5_46; RStudio, 2013, RSTUDIO INT DEV ENV; Salvo G, 2010, SYST BIOL, V59, P705, DOI 10.1093/sysbio/syq046; Schuettpelz E, 2006, SYST BIOL, V55, P485, DOI 10.1080/10635150600755438; Trauth MH, 2009, QUATERNARY SCI REV, V28, P399, DOI 10.1016/j.quascirev.2008.11.003; von Balthazar M, 2007, AM J BOT, V94, P2041, DOI 10.3732/ajb.94.12.2041; Wagner WL, 1995, HAWAIIAN BIOGEOGRAPH; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Worobiec Grzegorz, 2007, Acta Palaeobotanica, V47, P203	58	57	58	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132091	10.1371/journal.pone.0132091	http://dx.doi.org/10.1371/journal.pone.0132091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173113	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000358194900031
J	Ma, QG; Pei, GX; Jin, J				Ma, Qingguo; Pei, Guanxiong; Jin, Jia			What Makes You Generous? The Influence of Rural and Urban Rearing on Social Discounting in China	PLOS ONE			English	Article							ALCOHOL-USE; BEHAVIOR; DELAY; MODEL	An individual's willingness to share resources declines as the social distance between the decision maker and the recipient increases, which is known as social discounting. This social-distance-dependent prosocial behavior is likely to be influenced by the region in which individuals were raised. Based on previous studies on social discounting, this research focuses on the differing social distance-dependent prosocial behaviors between rural- and urban-reared participants in China. Our data showed that both groups' behaviors conform to the social discounting function and fit the hyperbolic model, as reported in previous studies about social discounting. Interestingly, individuals who were raised in rural areas yielded a smaller discount rate than those who were raised in urban areas, which indicated that a rural upbringing produced people who were more generous than those with an urban upbringing. Furthermore, this distinct type of generosity occurred notably among individuals with greater social distance, such as strangers or distant acquaintances. The reason may be due to the difference in dominant culture, production mode and lifestyle between rural and urban people.	[Ma, Qingguo; Pei, Guanxiong] Zhejiang Univ, Sch Management, Hangzhou 310003, Zhejiang, Peoples R China; [Ma, Qingguo; Pei, Guanxiong] Zhejiang Univ, Neuromanagement Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Jia] Ningbo Univ, Sch Business, Ningbo 315211, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Ningbo University	Jin, J (corresponding author), Ningbo Univ, Sch Business, Ningbo 315211, Zhejiang, Peoples R China.	jinjia@nbu.edu.cn	Pei, Guanxiong/ABC-6868-2020	Jin, Jia/0000-0003-1124-2999	National Natural Science Foundation [90924304, 71371167]; Natural Science Foundation of Zhejiang Province [LQ15G020003]; Ningbo University [XYW15001]; Social Science Association of Zhejiang Province [2014N092]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Ningbo University; Social Science Association of Zhejiang Province	This work was supported by grants 90924304 and 71371167 from the National Natural Science Foundation, grant LQ15G020003 from the Natural Science Foundation of Zhejiang Province, and grant XYW15001 from Ningbo University. Guanxiong Pei was funded by grant 2014N092 from the Social Science Association of Zhejiang Province as an annual project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonetti S, 1998, J ECON PSYCHOL, V19, P377, DOI 10.1016/S0167-4870(98)00012-9; Brehm SS, 1996, SOCIAL PSYCHOL; Buchan N, 2004, J ECON BEHAV ORGAN, V55, P485, DOI 10.1016/j.jebo.2003.11.005; Carlson J. E., 1981, RURAL SOC ENV AM; Christensen C, 1998, J SOC PSYCHOL, V138, P564, DOI 10.1080/00224549809600411; DONNERMEYER JF, 1995, INT J ADDICT, V30, P459, DOI 10.3109/10826089509048737; Fei H.T., 1992, SOIL FDN CHINESE SOC; Geert H., 1991, CULTURES ORG SOFTWAR; Goeree JK, 2010, AM ECON J-MICROECON, V2, P183, DOI 10.1257/mic.2.1.183; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Harrison F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018338; Hoffman E, 1996, AM ECON REV, V86, P653; Ito M, 2011, PSYCHOL REC, V61, P59, DOI 10.1007/BF03395746; Jones B, 2006, PSYCHOL SCI, V17, P283, DOI 10.1111/j.1467-9280.2006.01699.x; Jones B.A., 2007, SOCIAL DISCOUNTING S; Jones BA, 2009, J EXP ANAL BEHAV, V91, P61, DOI 10.1901/jeab.2009.91-61; KASHIMA Y, 1995, J PERS SOC PSYCHOL, V69, P925, DOI 10.1037/0022-3514.69.5.925; Koch B. J., 2007, Asia Pacific Journal of Management, V24, P207, DOI 10.1007/s10490-006-9004-5; Kuntz KM, 2002, J UNDERGRADUATE RES, V5, P233; Mazur J.E., 1987, ADJUSTING PROCEDURE; Musick MA, 2000, RES AGING, V22, P91, DOI 10.1177/0164027500222001; Nease D E Jr, 1993, Kans Med, V94, P246; Putnam R. D., 2001, BOWLING ALONE COLLAP; Rachlin H, 2008, J BEHAV DECIS MAKING, V21, P29, DOI 10.1002/bdm.567; SAMPSON RJ, 1988, AM SOCIOL REV, V53, P766, DOI 10.2307/2095822; Schram A, 2005, J ECON METHODOL, V12, P225, DOI 10.1080/13501780500086081; Sozou PD, 2009, P R SOC B, V276, P2955, DOI 10.1098/rspb.2009.0401; Strombach T, 2014, J BEHAV DECIS MAKING, V27, P235, DOI 10.1002/bdm.1802; Takahashi T, 2010, PHYSICA A, V389, P3600, DOI 10.1016/j.physa.2010.04.020; Takahashi T, 2007, MED HYPOTHESES, V68, P184, DOI 10.1016/j.mehy.2006.05.057; Yan J, 2006, FAM BUS REV, V19, P235, DOI 10.1111/j.1741-6248.2006.00072.x; Yang Mayfair Mei-Hui, 1994, J ASIAN STUD	32	17	17	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133078	10.1371/journal.pone.0133078	http://dx.doi.org/10.1371/journal.pone.0133078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26172452	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900121
J	Paulukonis, ST; Roberts, EM; Valle, JP; Collins, NN; English, PB; Kaye, WE				Paulukonis, Susan T.; Roberts, Eric M.; Valle, Jhaqueline P.; Collins, Natalie N.; English, Paul B.; Kaye, Wendy E.			Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases	PLOS ONE			English	Article							UNITED-STATES; PROGNOSTIC-FACTORS; ALS; MORTALITY; CERTIFICATES; DIAGNOSIS; ACCURACY; CRITERIA	Introduction Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder. Estimates of survival from disease onset range from 20 to 48 months and have been generated using clinical populations or death records alone. Methods Data on a cohort of ALS cases diagnosed between 2009-2011 were collected as part of the Los Angeles and San Francisco Bay Area Metropolitan ALS Surveillance projects; death records 2009-2013 were linked to these confirmed cases to determine survival post diagnosis and factors associated with survival time. Results There were 618 cases identified and 283 of these died during the follow up time period. Median age at death was 64.3 years, and median survival time post-diagnosis was 2.6 years. Age at diagnosis and year of diagnosis were predictors of survival time in adjusted models; those diagnosed at age 80 or older had shorter survival than those diagnosed at age 50 or younger. Most (92%) had ALS noted as a cause of death. Discussion Survival post-diagnosis may be improved compared with previous reports. Age at diagnosis continues to be the strongest predictor of prognosis; recall case reporting bias may play a role in estimates of survival time.	[Paulukonis, Susan T.; Roberts, Eric M.; Valle, Jhaqueline P.; Collins, Natalie N.] Inst Publ Hlth, Calif Environm Hlth Tracking Program, Richmond, CA 94804 USA; [English, Paul B.] Calif Dept Publ Hlth, Calif Environm Hlth Tracking Program, Richmond, CA USA; [Kaye, Wendy E.] McKing Consulting Corp, Atlanta, GA USA	Public Health Institute; California Department of Public Health	Paulukonis, ST (corresponding author), Inst Publ Hlth, Calif Environm Hlth Tracking Program, Richmond, CA 94804 USA.	susan.paulukonis@phi.org	English, Paul/GQB-1018-2022; Paulukonis, Susan/AAH-7635-2021		McKing Consulting Corporation - federal Agency for Toxic Substances and Disease Registry [200-2010-F-36614]; McKing Consulting Corporation	McKing Consulting Corporation - federal Agency for Toxic Substances and Disease Registry; McKing Consulting Corporation	This project was funded by McKing Consulting Corporation through a contract funded by the federal Agency for Toxic Substances and Disease Registry (Contract #200-2010-F-36614). Co-author WK is employed by McKing Consulting Corporation. McKing Consulting Corporation provided support in the form of salary for author WK, and oversaw study design and data collection, but did not have any additional role in and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Akaike H, 1999, PRACTICE TIME SERIES; [Anonymous], 2013, 12 ANN NE ALS CONS M; Antao VC, 2012, J ENVIRON HEALTH, V75, P28; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Byrne S, 2011, J NEUROL NEUROSUR PS, V82, P623, DOI 10.1136/jnnp.2010.224501; CDC, 1998, AM J FOREN MED PATH, V19, P234; CHIO A, 1992, J EPIDEMIOL COMMUN H, V46, P517, DOI 10.1136/jech.46.5.517; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; Conde Crystal, 2012, Tex Med, V108, P45; del Aguila MA, 2003, NEUROLOGY, V60, P813, DOI 10.1212/01.WNL.0000049472.47709.3B; Elamin M, 2011, NEUROLOGY, V76, P1263, DOI 10.1212/WNL.0b013e318214359f; Forbes RB, 2004, AGE AGEING, V33, P131, DOI 10.1093/ageing/afh013; Gordon PH, 2012, J NEUROL, V259, P1788, DOI 10.1007/s00415-011-6403-4; Hanzlick R, 1995, Leg Med, P117; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hoffman P M, 1970, Trans Am Neurol Assoc, V95, P261; Hoyert DL, 2005, PUBLIC HEALTH REP, V120, P288, DOI 10.1177/003335490512000312; Kurian KM, 2009, J NEUROL NEUROSUR PS, V80, P84, DOI 10.1136/jnnp.2008.149708; LEE JRJ, 1995, J NEUROL SCI, V132, P207, DOI 10.1016/0022-510X(95)00154-T; Marin B, 2011, NEUROEPIDEMIOLOGY, V36, P29, DOI 10.1159/000321930; Mehal JM, 2013, AMYOTROPH LAT SCL FR, V14, P346, DOI 10.3109/21678421.2013.787629; Noonan CW, 2005, NEUROLOGY, V64, P1215, DOI 10.1212/01.WNL.0000156518.22559.7F; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Ragonese P, 2004, NEUROEPIDEMIOLOGY, V23, P73, DOI 10.1159/000073978; Sejvar JJ, 2005, NEUROEPIDEMIOLOGY, V25, P144, DOI 10.1159/000086679; Sorenson EJ, 2007, NEUROLOGY, V68, P600, DOI 10.1212/01.wnl.0000254501.58158.e7; Testa D, 2004, AMYOTROPH LATERAL SC, V5, P208, DOI 10.1080/14660820410021311; Traynor BJ, 2003, J NEUROL NEUROSUR PS, V74, P1258, DOI 10.1136/jnnp.74.9.1258; Valle J, 2015, AMYOTROPHIC LATERAL, P1; Wexelman BA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120288; Zoccolella S, 2008, J NEUROL NEUROSUR PS, V79, P33, DOI 10.1136/jnnp.2007.118018	31	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131965	10.1371/journal.pone.0131965	http://dx.doi.org/10.1371/journal.pone.0131965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172548	gold, Green Submitted, Green Published			2022-12-27	WOS:000358194900026
J	Polo, J; Rodriguez, C; Rodenas, J; Russell, LE; Campbell, JM; Crenshaw, JD; Torrallardona, D; Pujols, J				Polo, Javier; Rodriguez, Carmen; Rodenas, Jesus; Russell, Louis E.; Campbell, Joy M.; Crenshaw, Joe D.; Torrallardona, David; Pujols, Joan			Ultraviolet Light (UV) Inactivation of Porcine Parvovirus in Liquid Plasma and Effect of UV Irradiated Spray Dried Porcine Plasma on Performance of Weaned Pigs	PLOS ONE			English	Article							RESPIRATORY SYNDROME; CIRCOVIRUS TYPE-2; DIARRHEA VIRUS; ANIMAL PLASMA; WEANLING PIGS; RADIATION; BACTERIA; PSEUDORABIES; EFFICACY	A novel ultraviolet light irradiation (UV-C, 254 nm) process was designed as an additional safety feature for manufacturing of spray dried porcine plasma (SDPP). In Exp. 1, three 10-L batches of bovine plasma were inoculated with 10(5.2 +/- 0.12) tissue culture infectious dose 50 (TCID50) of porcine parvovirus (PPV) per mL of plasma and subjected to UV-C ranging from 0 to 9180 J/L. No viable PPV was detected in bovine plasma by micro-titer assay in SK6 cell culture after UV-C at 2295 J/L. In Exp. 2, porcine plasma was subjected to UV-C (3672 J/L), then spray dried and mixed in complete mash diets. Diets were a control without SDPP (Control), UV-C SDPP either at 3% (UVSDPP3) or 6% (UVSDPP6) and non-UV-C SDPP at 3% (SDPP3) or 6% (SDPP6). Diets were fed ad libitum to 320 weaned pigs (26 d of age; 16 pens/diet; 4 pigs/pen) for 14 d after weaning and a common diet was fed d 15 to 28. During d 0 to 14, pigs fed UVSDPP3, UVSDPP6, or SDPP6 had higher (P < 0.05) weight gain and feed intake than control. During d 0 to 28, pigs fed UVSDPP3 and UVSDPP6 had higher (P < 0.05) weight gain and feed intake than control and SDPP3, and SDPP6 had higher (P < 0.05) feed intake than control. Also, pigs fed UVSDPP had higher (P < 0.05) weight gain than pigs fed SDPP. In conclusion, UV-C inactivated PPV in liquid plasma and UVSDPP used in pig feed had no detrimental effects on pig performance.	[Polo, Javier; Rodriguez, Carmen; Rodenas, Jesus] APC EUROPE, E-08403 Granollers, Spain; [Russell, Louis E.; Campbell, Joy M.; Crenshaw, Joe D.] APC Inc, Ankeny, IA 50021 USA; [Torrallardona, David] Inst Recerca & Tecnol Agroalimentaries, Monogastr Nutr, Mas de Bover, Constanti, Spain; [Pujols, Joan] Inst Recerca & Tecnol Agroalimentaries, Ctr Recerca Sanitat Anim CReSA, Barcelona 08193, Spain	IRTA; IRTA	Polo, J (corresponding author), APC EUROPE, SA Avda St Julia 246-258 Pol Ind El Congost, E-08403 Granollers, Spain.	javier.polo@ampc-europe.com	Torrallardona, David/L-3604-2017; Pujols, Joan/S-1141-2018; Pujols, Joan/K-9693-2015; Pujols, Joan/AAV-6427-2020	Torrallardona, David/0000-0001-7814-2939; Pujols, Joan/0000-0002-6940-1529; Pujols, Joan/0000-0002-6940-1529	APC, Inc., Ankeny, Iowa, United States of America; Spanish Government [IDI-20080591, IDI-20101014]; APC EUROPE; APC Inc.	APC, Inc., Ankeny, Iowa, United States of America; Spanish Government(Spanish GovernmentEuropean Commission); APC EUROPE; APC Inc.	Funding for this study was provided in part by APC, Inc., Ankeny, Iowa, United States of America. This study was also partially financed by the programs CDTI (IDI-20080591 and IDI-20101014) of the Spanish Government. APC EUROPE and APC Inc., provided support in the form of salaries for authors JP, CR, JR, LER, JMC and JDC retrospectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Burleson FG, 1997, VIROLOGY LAB MANUAL, P53; Caillet-Fauquet P, 2004, J VIROL METHODS, V118, P131, DOI 10.1016/j.jviromet.2004.02.002; Caruso C, 2014, J VIROL METHODS, V208, P79, DOI 10.1016/j.jviromet.2014.07.032; Coffey R. D., 2001, Pig News and Information, V22, p39N; CPMP, 1996, CPMPBWP26895 EUR AG; Darnell MER, 2004, J VIROL METHODS, V121, P85, DOI 10.1016/j.jviromet.2004.06.006; Dee S, 2011, VET MICROBIOL, V150, P96, DOI 10.1016/j.vetmic.2011.01.014; DeRouchey JM, 2004, J ANIM SCI, V82, P250; DeRouchey JM, 2003, J ANIM SCI, V81, P1799; Donaghy J, 2009, LETT APPL MICROBIOL, V49, P217, DOI 10.1111/j.1472-765X.2009.02644.x; Fredericks IN, 2011, FOOD MICROBIOL, V28, P510, DOI 10.1016/j.fm.2010.10.018; Groesbeck CN, 2009, J ANIM SCI, V87, P3997, DOI 10.2527/jas.2008-1156; Hijnen WAM, 2006, WATER RES, V40, P3, DOI 10.1016/j.watres.2005.10.030; Keyser M, 2008, INNOV FOOD SCI EMERG, V9, P348, DOI 10.1016/j.ifset.2007.09.002; Koutchma TN, 2009, CONTEMP FOOD ENG, P1; Mancini G., 1965, J IMMUNOCHEM, V2, P235; Matak KE, 2005, J FOOD PROTECT, V68, P2212, DOI 10.4315/0362-028X-68.10.2212; Opriessnig T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104766; Polo J, 2005, J ANIM SCI, V83, P1933; Polo J, 2004, J AOAC INT, V87, P78; Polo J, 2002, P 48 INT C MEAT SCI, V1, P194; Pujols J, 2008, VET REC, V163, P536, DOI 10.1136/vr.163.18.536; Pujols J., 2007, AM ASS SWINE VET, P281; Pujols J, 2011, VET J, V190, P16; Pujols J, 2014, VET MICROBIOL, V174, P427, DOI 10.1016/j.vetmic.2014.10.021; Remington KM, 2013, BIORESEARCH ON LINE; Royer RL, 2001, J SWINE HEALTH PROD, V9, P281; Schoborg RV, 2014, FRONT CELL INFECT MI, V4, DOI [10.3389/fcimb.2014.00097, 10.3389/fcimb.2014.00020]; Shen HG, 2011, J ANIM SCI, V89, P1930, DOI 10.2527/jas.2010-3502; Torrallardona D, 2010, ASIAN AUSTRAL J ANIM, V23, P131; Unluturk S, 2008, J FOOD ENG, V85, P561, DOI 10.1016/j.jfoodeng.2007.08.017; Wang J, 2004, VOX SANG, V86, P230, DOI 10.1111/j.0042-9007.2004.00485.x; Wyk R, 2011, IUVA NEWS, V13, P13	33	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133008	10.1371/journal.pone.0133008	http://dx.doi.org/10.1371/journal.pone.0133008			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171968	Green Submitted, gold, Green Published			2022-12-27	WOS:000358194900116
J	Akhtar, S; Al-Zaid, B; El-Hashim, AZ; Chandrasekhar, B; Attur, S; Yousif, MHM; Benter, IF				Akhtar, Saghir; Al-Zaid, Bashayer; El-Hashim, Ahmed Z.; Chandrasekhar, Bindu; Attur, Sreeja; Yousif, Mariam H. M.; Benter, Ibrahim F.			Cationic Polyamidoamine Dendrimers as Modulators of EGFR Signaling In Vitro and In Vivo	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DRUG-DELIVERY SYSTEMS; PAMAM DENDRIMERS; GENE-EXPRESSION; POLY(AMIDOAMINE) DENDRIMERS; DIABETIC-NEPHROPATHY; TOXICOGENOMICS; MECHANISMS; POLYMERS; TRANSACTIVATION	Cationic polyamidoamine (PAMAM) dendrimers are branch-like spherical polymers being investigated for a variety of applications in nanomedicine including nucleic acid drug delivery. Emerging evidence suggests they exhibit intrinsic biological and toxicological effects but little is known of their interactions with signal transduction pathways. We previously showed that the activated (fragmented) generation (G) 6 PAMAM dendrimer, Superfect (SF), stimulated epidermal growth factor receptor (EGFR) tyrosine kinase signaling-an important signaling cascade that regulates cell growth, survival and apoptosis-in cultured human embryonic kidney (HEK 293) cells. Here, we firstly studied the in vitro effects of Polyfect (PF), a non-activated (intact) G6 PAMAM dendrimer, on EGFR tyrosine kinase signaling via extracellular-regulated kinase 1/2 (ERK1/2) and p38 mitogen-activated protein kinase (MAPK) in cultured HEK 293 cells and then compared the in vivo effects of a single administration (10mg/kg i.p) of PF or SF on EGFR signaling in the kidneys of normal and diabetic male Wistar rats. Polyfect exhibited a dose- and time-dependent inhibition of EGFR, ERK1/2 and p38 MAPK phosphorylation in HEK-293 cells similar to AG1478, a selective EGFR inhibitor. Administration of dendrimers to non-diabetic or diabetic animals for 24h showed that PF inhibited whereas SF stimulated EGFR phosphorylation in the kidneys of both sets of animals. PF-mediated inhibition of EGFR phosphorylation as well as SF or PF-mediated apoptosis in HEK 293 cells could be significantly reversed by co-treatment with antioxidants such as tempol implying that both these effects involved an oxidative stress-dependent mechanism. These results show for the first time that SF and PF PAMAM dendrimers can differentially modulate the important EGFR signal transduction pathway in vivo and may represent a novel class of EGFR modulators. These findings could have important clinical implications for the use of PAMAM dendrimers in nanomedicine.	[Akhtar, Saghir; Al-Zaid, Bashayer; Chandrasekhar, Bindu; Attur, Sreeja; Yousif, Mariam H. M.; Benter, Ibrahim F.] Kuwait Univ, Fac Med, Dept Pharmacol & Toxicol, Safat 13110, Jabriya, Kuwait; [El-Hashim, Ahmed Z.] Kuwait Univ, Fac Pharm, Dept Pharmacol & Therapeut, Safat 13110, Jabriya, Kuwait; [Benter, Ibrahim F.] Eastern Mediterranean Univ, Fac Med, Gazimagusa, North Cyprus, Cyprus	Kuwait University; Kuwait University; Eastern Mediterranean University	Akhtar, S (corresponding author), Kuwait Univ, Fac Med, Dept Pharmacol & Toxicol, Safat 13110, Jabriya, Kuwait.	Saghir@hsc.edu.kw	Benter, Ibrahim Fadil/AAY-2527-2020	Akhtar, Saghir/0000-0003-3177-946X; Yousif, Mariam/0000-0002-6464-031X	Research Administration/Sector at Kuwait University [MR01/13]; OMICS Research Unit/RCF; General Facility Grant [SRUL02/13]	Research Administration/Sector at Kuwait University; OMICS Research Unit/RCF; General Facility Grant	This research is funded by a grant from the Research Administration/Sector at Kuwait University (MR01/13). The authors also acknowledge support from the OMICS Research Unit/RCF and the General Facility Grant (SRUL02/13).	Advani A, 2011, NEPHROLOGY, V16, P573, DOI 10.1111/j.1440-1797.2011.01451.x; Akhtar S, 2006, GENE THER, V13, P739, DOI 10.1038/sj.gt.3302692; Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494; Akhtar S, 2007, ADV DRUG DELIVER REV, V59, P164, DOI 10.1016/j.addr.2007.03.010; Akhtar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067813; Akhtar S, 2013, INT J PHARMACEUT, V448, P239, DOI 10.1016/j.ijpharm.2013.03.039; Akhtar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039066; Akhtar S, 2012, BRIT J PHARMACOL, V165, P1390, DOI 10.1111/j.1476-5381.2011.01613.x; Akhtar S, 2010, EXPERT OPIN DRUG MET, V6, P1347, DOI 10.1517/17425255.2010.518611; Alaoui-Jamali M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00017; Albertazzi L, 2010, MOL PHARMACEUT, V7, P680, DOI 10.1021/mp9002464; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Avaritt BR, 2014, PHARM RES-DORDR, V31, P2429, DOI 10.1007/s11095-014-1338-y; Benter IF, 2009, VASC PHARMACOL, V51, P101, DOI 10.1016/j.vph.2009.04.004; Benter IF, 2005, BRIT J PHARMACOL, V145, P829, DOI 10.1038/sj.bjp.0706238; Chauhan AS, 2009, BIOMACROMOLECULES, V10, P1195, DOI 10.1021/bm9000298; Conti DS, 2014, MOL PHARMACEUT, V11, P1808, DOI 10.1021/mp4006358; Cui J, 2014, TUMOR BIOL, V35, P11701, DOI 10.1007/s13277-014-2660-z; Dhomen Nathalie S., 2012, Critical Reviews in Oncogenesis, V17, P31; Duncan R, 2005, ADV DRUG DELIVER REV, V57, P2215, DOI 10.1016/j.addr.2005.09.019; Duran-Lara E, 2013, EUR J MED CHEM, V69, P601, DOI 10.1016/j.ejmech.2013.08.047; Endres NF, 2014, TRENDS BIOCHEM SCI, V39, P437, DOI 10.1016/j.tibs.2014.08.001; Forstner P, 2014, BIOMACROMOLECULES, V15, P2461, DOI 10.1021/bm500328v; Francois H, 2004, FASEB J, V18, P926, DOI 10.1096/fj.03-0702fje; Han JY, 2012, THER DELIV, V3, P263, DOI 10.4155/TDE.11.151; Hollins AJ, 2007, J DRUG TARGET, V15, P83, DOI 10.1080/10611860601151860; Hong SP, 2006, BIOCONJUGATE CHEM, V17, P728, DOI 10.1021/bc060077y; Jain S, 2012, P NATL ACAD SCI USA, V109, P12938, DOI 10.1073/pnas.1204928109; Jones CF, 2012, MOL PHARMACEUT, V9, P1599, DOI 10.1021/mp2006054; Juliano RL, 2013, J DRUG TARGET, V21, P27, DOI 10.3109/1061186X.2012.740674; Kabanov AV, 2006, ADV DRUG DELIVER REV, V58, P1597, DOI 10.1016/j.addr.2006.09.019; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; Kuo JHS, 2010, MOL PHARMACEUT, V7, P805, DOI 10.1021/mp900303s; Labieniec M, 2010, BIOCHIMIE, V92, P1296, DOI 10.1016/j.biochi.2010.06.002; Labieniec Magdalena, 2008, Int J Pharm, V364, P142, DOI 10.1016/j.ijpharm.2008.08.001; Labieniec-Watala M, 2015, J PHARM SCI-US, V104, P2, DOI 10.1002/jps.24222; Labieniec-Watala M, 2014, INT J PHARMACEUT, V464, P152, DOI 10.1016/j.ijpharm.2014.01.011; Lee JH, 2009, TOXICOL LETT, V190, P202, DOI 10.1016/j.toxlet.2009.07.018; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Li Y, 2014, NANOTOXICOLOGY, V8, P36, DOI 10.3109/17435390.2013.855827; Lill NL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003341; Luo K, 2014, BIOTECHNOL ADV, V32, P818, DOI 10.1016/j.biotechadv.2013.12.008; Movassaghian S, 2011, J DRUG TARGET, V19, P925, DOI 10.3109/1061186X.2011.628396; Mukherjee SP, 2010, TOXICOL APPL PHARM, V248, P259, DOI 10.1016/j.taap.2010.08.016; Mukherjee SP, 2010, TOXICOL IN VITRO, V24, P169, DOI 10.1016/j.tiv.2009.09.014; Naha PC, 2010, TOXICOL APPL PHARM, V246, P91, DOI 10.1016/j.taap.2010.04.014; Nyitrai G, 2013, BBA-BIOMEMBRANES, V1828, P1873, DOI 10.1016/j.bbamem.2013.04.004; Omerovic J, 2012, J PROTEOME RES, V11, P5157, DOI 10.1021/pr3007304; Omidi Y, 2003, J DRUG TARGET, V11, P311, DOI 10.1080/10611860310001636908; Pettit MW, 2011, THER DELIV, V2, P907, DOI 10.4155/TDE.11.55; Price KAR, 2015, ORAL ONCOL, V51, P399, DOI 10.1016/j.oraloncology.2015.01.018; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Sadekar S, 2012, ADV DRUG DELIVER REV, V64, P571, DOI 10.1016/j.addr.2011.09.010; Sadekar S, 2011, BIOMACROMOLECULES, V12, P88, DOI 10.1021/bm101046d; Seib FP, 2007, J CONTROL RELEASE, V117, P291, DOI 10.1016/j.jconrel.2006.10.020; Shakhbazau A, 2010, INT J PHARMACEUT, V383, P228, DOI 10.1016/j.ijpharm.2009.09.020; Shcharbin D, 2014, J CONTROL RELEASE, V181, P40, DOI 10.1016/j.jconrel.2014.02.021; Shcharbin D, 2013, EXPERT OPIN DRUG DEL, V10, P1687, DOI 10.1517/17425247.2013.853661; Siddiqui S, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/739428; Sun Y, 2015, PART FIBRE TOXICOL, V12, DOI 10.1186/s12989-015-0080-x; Sur S, 2014, CURR VASC PHARMACOL, V12, P190, DOI 10.2174/1570161112666140226123745; Tang MX, 1997, GENE THER, V4, P823, DOI 10.1038/sj.gt.3300454; Tang MX, 1996, BIOCONJUGATE CHEM, V7, P703, DOI 10.1021/bc9600630; Tang Y, 2015, BIOMACROMOLECULES, V16, P174, DOI 10.1021/bm501390d; Tomalia DA, 2007, BIOCHEM SOC T, V35, P61, DOI 10.1042/BST0350061; Wilcox CS, 2010, PHARMACOL THERAPEUT, V126, P119, DOI 10.1016/j.pharmthera.2010.01.003; Zhang MZ, 2014, DIABETES, V63, P2063, DOI 10.2337/db13-1279; Zhang Y, 2012, PHARM RES-DORDR, V29, P1627, DOI 10.1007/s11095-012-0676-x	69	18	18	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132215	10.1371/journal.pone.0132215	http://dx.doi.org/10.1371/journal.pone.0132215			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167903	gold, Green Published, Green Submitted			2022-12-27	WOS:000358193100028
J	Haarindraprasad, R; Hashim, U; Gopinath, SCB; Kashif, M; Veeradasan, P; Balakrishnan, SR; Foo, KL; Poopalan, P				Haarindraprasad, R.; Hashim, U.; Gopinath, Subash C. B.; Kashif, Mohd; Veeradasan, P.; Balakrishnan, S. R.; Foo, K. L.; Poopalan, P.			Low Temperature Annealed Zinc Oxide Nanostructured Thin Film-Based Transducers: Characterization for Sensing Applications	PLOS ONE			English	Article							SOL-GEL METHOD; SEED LAYER THICKNESS; OPTICAL-PROPERTIES; ZNO NANOSTRUCTURES; REFRACTIVE-INDEX; BULK MODULUS; PHOTOLUMINESCENCE PROPERTIES; INTERATOMIC SEPARATION; PRESSURE-DEPENDENCE; THERMAL-EXPANSION	The performance of sensing surfaces highly relies on nanostructures to enhance their sensitivity and specificity. Herein, nanostructured zinc oxide (ZnO) thin films of various thicknesses were coated on glass and p-type silicon substrates using a sol-gel spin-coating technique. The deposited films were characterized for morphological, structural, and optoelectronic properties by high-resolution measurements. X-ray diffraction analyses revealed that the deposited films have a c-axis orientation and display peaks that refer to ZnO, which exhibits a hexagonal structure with a preferable plane orientation (002). The thicknesses of ZnO thin films prepared using 1, 3, 5, and 7 cycles were measured to be 40, 60, 100, and 200 nm, respectively. The increment in grain size of the thin film from 21 to 52 nm was noticed, when its thickness was increased from 40 to 200 nm, whereas the band gap value decreased from 3.282 to 3.268 eV. Band gap value of ZnO thin film with thickness of 200 nm at pH ranging from 2 to 10 reduces from 3.263eV to 3.200 eV. Furthermore, to evaluate the transducing capacity of the ZnO nanostructure, the refractive index, optoelectric constant, and bulk modulus were analyzed and correlated. The highest thickness (200 nm) of ZnO film, embedded with an interdigitated electrode that behaves as a pH-sensing electrode, could sense pH variations in the range of 2-10. It showed a highly sensitive response of 444 mu AmM-1cm-2 with a linear regression of R-2 = 0.9304. The measured sensitivity of the developed device for pH per unit is 3.72 mu A/pH.	[Haarindraprasad, R.; Hashim, U.; Gopinath, Subash C. B.; Kashif, Mohd; Veeradasan, P.; Balakrishnan, S. R.; Foo, K. L.] Inst Nano Elect Engn, Biomed Nano Diagnost Res Grp, Kangar, Perlis, Malaysia; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Sch Bioproc Engn, Kangar, Perlis, Malaysia; [Poopalan, P.] Univ Malaysia Perlis, Sch Microelect Engn, Kuala Perlis, Perlis, Malaysia	Universiti Malaysia Perlis; Universiti Malaysia Perlis	Hashim, U (corresponding author), Inst Nano Elect Engn, Biomed Nano Diagnost Res Grp, Kangar, Perlis, Malaysia.	uda@unimap.edu.my	Foo, Kai Loong/D-2035-2015; Gopinath, Subash/D-2953-2015; Kashif, Muhammad/AAX-8659-2020; Balakrishnan, Sharma Rao/G-4561-2015; Balakrishnan, Sharma Rao/AAP-2889-2021	Foo, Kai Loong/0000-0001-6009-860X; Gopinath, Subash/0000-0002-8347-4687; Kashif, Muhammad/0000-0002-9874-0992; Balakrishnan, Sharma Rao/0000-0002-6796-2277; Balakrishnan, Sharma Rao/0000-0002-6796-2277; Perumal, Veeradasan/0000-0003-4492-0282; POOPALAN, PRABAKARAN/0000-0003-1698-0632	Universiti Malaysia Perlis (UniMAP); Ministry of Higher Education Malaysia through MTUN-COE grant [9016-00004]	Universiti Malaysia Perlis (UniMAP); Ministry of Higher Education Malaysia through MTUN-COE grant	The authors would like to thank Universiti Malaysia Perlis (UniMAP), and Ministry of Higher Education Malaysia for the financial support through MTUN-COE grant 9016-00004 to conduct the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Douri Y, 2004, MATER CHEM PHYS, V87, P14, DOI 10.1016/j.matchemphys.2003.11.043; Al-Douri Y, 2010, SOL ENERGY, V84, P1979, DOI 10.1016/j.solener.2010.10.006; Al-Douri Y, 2008, SOLID STATE COMMUN, V148, P521, DOI 10.1016/j.ssc.2008.09.055; Ali SMU, 2011, MICRO NANO LETT, V6, P609, DOI 10.1049/mnl.2011.0310; Ba-Abbad MM, 2013, J IND ENG CHEM, V19, P99, DOI 10.1016/j.jiec.2012.07.010; Balakrishnan SR, 2014, SENSOR ACTUAT A-PHYS, V220, P101, DOI 10.1016/j.sna.2014.09.027; Balzaretti NM, 1996, SOLID STATE COMMUN, V99, P943, DOI 10.1016/0038-1098(96)00341-9; Batista PD, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2084319; Boudjouan F, 2015, J LUMIN, V158, P32, DOI 10.1016/j.jlumin.2014.09.026; Caglar Y, 2010, J SOL-GEL SCI TECHN, V53, P372, DOI 10.1007/s10971-009-2105-0; Charifi Z, 2007, PHYS STATUS SOLIDI B, V244, P3154, DOI 10.1002/pssb.200642471; Chen Y, 2012, J PHYS CHEM SOLIDS, V73, P1259, DOI 10.1016/j.jpcs.2012.06.007; COHEN ML, 1985, PHYS REV B, V32, P7988, DOI 10.1103/PhysRevB.32.7988; Degen A, 2000, J EUR CERAM SOC, V20, P667, DOI 10.1016/S0955-2219(99)00203-4; Fabbri F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05158; Foo KL, 2014, CERAM INT, V40, P753, DOI 10.1016/j.ceramint.2013.06.065; Gedamu D, 2014, ADV MATER, V26, P1541, DOI 10.1002/adma.201304363; Ghayour H, 2011, VACUUM, V86, P101, DOI 10.1016/j.vacuum.2011.04.025; GHOSH DK, 1986, INFRARED PHYS, V26, P111, DOI 10.1016/0020-0891(86)90031-X; Godlewski M, 2009, THIN SOLID FILMS, V518, P1145, DOI 10.1016/j.tsf.2009.04.066; GUPTA VP, 1980, PHYS STATUS SOLIDI B, V100, P715, DOI 10.1002/pssb.2221000240; Hassan NK, 2012, INT J ELECTROCHEM SC, V7, P4625; He A, 2001, PHYS STATUS SOLIDI B, V223, P767, DOI 10.1002/1521-3951(200102)223:3<767::AID-PSSB767>3.0.CO;2-X; HERVE P, 1994, INFRARED PHYS TECHN, V35, P609, DOI 10.1016/1350-4495(94)90026-4; HERVE PJL, 1995, J APPL PHYS, V77, P5476, DOI 10.1063/1.359248; Hilt JZ, 2003, BIOMED MICRODEVICES, V5, P177, DOI 10.1023/A:1025786023595; Hrkac V, 2013, J APPL CRYSTALLOGR, V46, P396, DOI 10.1107/S0021889812051333; Ikizler B, 2014, THIN SOLID FILMS, V558, P149, DOI 10.1016/j.tsf.2014.03.019; Jaiswal AK, 2015, MATER CHEM PHYS, V154, P16, DOI 10.1016/j.matchemphys.2015.01.031; Janotti A, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126501; Jin X, 2013, ADV MATER, V25, P1342, DOI 10.1002/adma.201203849; Kao CH, 2014, J APPL PHYS, V115, DOI 10.1063/1.4874182; Kashif M, 2012, MICRO NANO LETT, V7, P163, DOI 10.1049/mnl.2011.0681; Kashif M, 2012, PHYS STATUS SOLIDI A, V209, P143, DOI 10.1002/pssa.201127357; KUMAR M, 1995, PHYSICA B, V205, P175, DOI 10.1016/0921-4526(94)00292-4; KUMAR M, 1994, PHYS STATUS SOLIDI B, V181, P55, DOI 10.1002/pssb.2221810106; LAM PK, 1987, PHYS REV B, V35, P9190, DOI 10.1103/PhysRevB.35.9190; Lee CT, 2014, IEEE SENS J, V14, P490, DOI 10.1109/JSEN.2013.2285488; Liu YC, 2008, J PHYS CHEM B, V112, P6484, DOI 10.1021/jp710399d; Maiolo L, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4894805; Mishra YK, 2014, KONA POWDER PART J, P92; Mishra YK, 2011, ANTIVIR RES, V92, P305, DOI 10.1016/j.antiviral.2011.08.017; MOSS TS, 1950, P PHYS SOC LOND B, V63, P167, DOI 10.1088/0370-1301/63/3/302; Pandey RK, 1998, J PHYS CHEM SOLIDS, V59, P1157, DOI 10.1016/S0022-3697(97)00164-9; PENN DR, 1962, PHYS REV, V128, P2093, DOI 10.1103/PhysRev.128.2093; Perumal V., 2013, APPL BIOMED, V11, P1, DOI DOI 10.1016/J.JAB.2013.02.001; Phillips J, 2012, BONDS BANDS SEMICOND; Rani S, 2008, SOL ENERG MAT SOL C, V92, P1639, DOI 10.1016/j.solmat.2008.07.015; RAVINDRA NM, 1979, PHYS STATUS SOLIDI B, V93, pK155, DOI 10.1002/pssb.2220930257; Rouhi J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123433; SAMARA GA, 1983, PHYS REV B, V27, P3494, DOI 10.1103/PhysRevB.27.3494; SHERRY AM, 1991, J PHYS CHEM SOLIDS, V52, P1145, DOI 10.1016/0022-3697(91)90047-4; Singh A, 2014, MAT SCI SEMICON PROC, V27, P934, DOI 10.1016/j.mssp.2014.08.029; Singh A, 2015, J ALLOY COMPD, V618, P475, DOI 10.1016/j.jallcom.2014.08.190; Singh S, 2014, MATER LETT, V131, P31, DOI 10.1016/j.matlet.2014.05.167; Sivakumar K, 2012, B MATER SCI, V35, P327, DOI 10.1007/s12034-012-0305-7; Tak M, 2014, BIOSENS BIOELECTRON, V59, P200, DOI 10.1016/j.bios.2014.03.036; TALLON JL, 1980, J PHYS CHEM SOLIDS, V41, P837, DOI 10.1016/0022-3697(80)90028-1; Tcheliebou F, 1997, THIN SOLID FILMS, V299, P14, DOI 10.1016/S0040-6090(96)09187-0; Thandavan TMK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121756; VANVECHTEN JA, 1969, PHYS REV, V182, P891, DOI 10.1103/PhysRev.182.891; Wang KXZ, 2014, ENERG ENVIRON SCI, V7, P2725, DOI 10.1039/c4ee00839a; Wang MR, 2006, MATER CHEM PHYS, V97, P219, DOI 10.1016/j.matchemphys.2005.07.072; Westermeier C, 2013, ADV MATER, V25, P5719, DOI 10.1002/adma.201300958; Willander M, 2009, METHODS MOL BIOL, V544, P187, DOI 10.1007/978-1-59745-483-4_13; Xu D, 2012, T NONFERR METAL SOC, V22, pS110, DOI 10.1016/S1003-6326(12)61693-8; Xu LH, 2014, J ALLOY COMPD, V583, P560, DOI 10.1016/j.jallcom.2013.09.009; Xu LH, 2012, APPL SURF SCI, V258, P7760, DOI 10.1016/j.apsusc.2012.04.137; Xu LH, 2011, APPL SURF SCI, V257, P4031, DOI 10.1016/j.apsusc.2010.11.170; Xu LH, 2010, J CRYST GROWTH, V312, P851, DOI 10.1016/j.jcrysgro.2009.12.062; Yang HY, 2010, APPL SURF SCI, V256, P6117, DOI 10.1016/j.apsusc.2010.03.129; Yoshino Y, 2000, VACUUM, V59, P403, DOI 10.1016/S0042-207X(00)00294-3; Zeng HB, 2008, ACS NANO, V2, P1661, DOI 10.1021/nn800353q; Zeng HB, 2008, J PHYS CHEM C, V112, P19620, DOI 10.1021/jp807309s; Zhong AH, 2011, APPL SURF SCI, V257, P4051, DOI 10.1016/j.apsusc.2010.11.173; Zhu YZ, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.245209	76	46	46	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132755	10.1371/journal.pone.0132755	http://dx.doi.org/10.1371/journal.pone.0132755			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167853	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100075
J	Li, M; Song, QB; Li, H; Lou, Y; Wang, LL				Li, Min; Song, Qinbin; Li, Hang; Lou, Yi; Wang, Lili			Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; MICRORNA PROFILES; MOLECULAR MARKERS; PROGNOSTIC-FACTOR; TUMOR-SUPPRESSOR; UP-REGULATION; CANCER; SERUM; TISSUE	Objective There is no effective and reliable biomarker to distinguish benign thyroid nodules from papillary thyroid carcinomas (PTC). This study aimed at examining the levels of plasma miRNAs in patients with PTC or benign nodules to explore the potential miRNA biomarkers for PTC. Patients and Methods Genome-wide plasma miRNA expression profiles were determined by the miRNA Microarray and the significantly higher levels of miRNAs were validated in plasma and tissues by quantitative RT-PCR. The levels of two miRNAs were further tested in seven patients before and after tumor excision and the potential values for the diagnosis of PTC were evaluated by receiver operating characteristic curve (ROC). Results In comparison with that in the patients with benign nodules, eight significantly higher and three lower levels of plasma miRNAs were detected in the PTC patients. Further validation indicated that the levels of plasma miR-25-3p, miR-451a, miR-140-3p and let-7i were significantly higher in the PTC cases than in those with benign nodules or the healthy controls. Significantly higher levels of miR-25-3p and miR-451a were detected in the thyroid tissues from the PTC patients. The levels of plasma miR-25-3p and miR-451a in seven patients significantly decreased after tumor excision. ROC analyses revealed that the levels of plasma miR-25-3p at cut-off 1.41 and miR-451a at 1.38 had sensitivity of 92.8% and 88.9%, and specificity of 68.8% and 66.7% for distinguishing PTC from benign nodules, respectively. Conclusion Our findings suggest that the levels of plasma miR-25-3p and miR-451a may be valuable for the diagnosis of PTC.	[Li, Min] China Med Univ, Affiliated Hosp 1, Dept Endocrinol, Shenyang 110001, Peoples R China; [Song, Qinbin; Li, Hang] China Med Univ, Affiliated Hosp 1, Dept Thyroid Surg, Shenyang 110001, Peoples R China; [Lou, Yi] China Med Univ, Dept Genet, Shenyang 110001, Peoples R China; [Wang, Lili] China Med Univ, Shengjing Hosp, Med Res Ctr, Shenyang 110004, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Song, QB (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Thyroid Surg, Shenyang 110001, Peoples R China.	sqb1966@163.com	wang, lili/HDL-7210-2022		Liaoning Provincial Natural Science Foundation of China [20102270, 20082077, 20082083]	Liaoning Provincial Natural Science Foundation of China	This work was supported by the Liaoning Provincial Natural Science Foundation of China (20102270, 20082077, 20082083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldini E, 2014, INT J SURG, V12, pS52, DOI 10.1016/j.ijsu.2014.05.054; Barut F, 2010, ENDOCR PATHOL, V21, P80, DOI 10.1007/s12022-010-9114-y; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Brenner B, 2011, WORLD J GASTROENTERO, V17, P3976, DOI 10.3748/wjg.v17.i35.3976; Cantara S, 2014, J CLIN ENDOCR METAB, V99, P4190, DOI 10.1210/jc.2014-1923; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Esposito F, 2012, J CLIN ENDOCR METAB, V97, pE710, DOI 10.1210/jc.2011-3068; Fryknas M, 2006, TUMOR BIOL, V27, P211, DOI 10.1159/000093056; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hu ZB, 2012, CARCINOGENESIS, V33, P828, DOI 10.1093/carcin/bgs030; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Konishi H, 2012, BRIT J CANCER, V106, P740, DOI 10.1038/bjc.2011.588; Lee JC, 2013, CANCER-AM CANCER SOC, V119, P4358, DOI 10.1002/cncr.28254; Li A, 2010, CANCER RES, V70, P5226, DOI 10.1158/0008-5472.CAN-09-4227; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li Q, 2013, CANCER LETT, V335, P168, DOI 10.1016/j.canlet.2013.02.029; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Luo JH, 2014, MOL MED REP, V10, P785, DOI 10.3892/mmr.2014.2274; Mehanna HM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b733; Nan Y, 2010, BRAIN RES, V1359, P14, DOI 10.1016/j.brainres.2010.08.074; Nishida N, 2012, CLIN CANCER RES, V18, P3054, DOI 10.1158/1078-0432.CCR-11-1078; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Razumilava N, 2012, HEPATOLOGY, V55, P465, DOI 10.1002/hep.24698; Sethi Kruttibas, 2010, J Exp Ther Oncol, V8, P341; Song QB, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-126; Tan A, 2011, ANN DIAGN PATHOL, V15, P108, DOI 10.1016/j.anndiagpath.2010.11.005; Tetzlaff MT, 2007, ENDOCR PATHOL, V18, P163, DOI 10.1007/s12022-007-0023-7; Wang X, 2014, CLIN TRANSL ONCOL, V16, P954, DOI 10.1007/s12094-014-1178-6; Wang ZH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0577-9; Wu CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092292; Xu FX, 2014, ASIAN PAC J CANCER P, V15, P1197, DOI 10.7314/APJCP.2014.15.3.1197; Yu S, 2012, J CLIN ENDOCR METAB, V97, P2084, DOI 10.1210/jc.2011-3059; Zhang J, 2013, INT J MED SCI, V10, P585, DOI 10.7150/ijms.5794; Zhang YJ, 2014, LIFE SCI, V118, P39, DOI 10.1016/j.lfs.2014.09.025; Zhao HY, 2014, MOL CELL BIOCHEM, V385, P207, DOI 10.1007/s11010-013-1829-x	36	45	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132403	10.1371/journal.pone.0132403	http://dx.doi.org/10.1371/journal.pone.0132403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168287	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100041
J	Li, Y; Wu, ZY; Zhang, SL; Chen, S; Li, P; Li, J; Cao, CW; Liu, B; Zhang, FC; Li, YZ				Li, Yuan; Wu, Ziyan; Zhang, Shulan; Chen, Si; Li, Ping; Li, Jing; Cao, Chongwei; Liu, Bin; Zhang, Fengchun; Li, Yongzhe			Genetic Variants of I kappa B Kinase beta (IKBKB) and Polymerase beta (POLB) Were Not Associated with Systemic Lupus Erythematosus Risk in a Chinese Han Population	PLOS ONE			English	Article							DNA-DAMAGE; RHEUMATOID-ARTHRITIS; POLYMORPHISMS; DISEASE; REPAIR; XRCC1; SUSCEPTIBILITY; NEUTROPHILS	A previous large-scale replication study validation of a genome wide association study (GWAS) identified I kappa B kinase beta (IKBKB) single nucleotide polymorphisms (SNPs) as a risk factor associated with systemic lupus erythematosus (SLE) in a Chinese Han population. IKBKB SNPs were associated with polymerase beta (POLB) SNPs and reduced POLB expression, and this was proposed to be an underlying cause of human SLE development. In the current case-control study, we evaluated IKBKB (rs12676482 and rs2272733) and POLB (rs3136717 and rs3136744) SNPs in 946 SLE patients and 961 healthy controls. We investigated the possible association of these four SNPs with SLE in a Chinese Han population using the polymerase chain reaction-ligation detection reaction (PCR-LDR) technique. The differences in the frequencies of the four SNP alleles and the genotypes and haplotypes of the POLB polymorphisms were statistically insignificant when the SLE patients were compared with the controls in the Chinese Han population enrolled in this study (all, p > 0.05). Furthermore, no associations were detected using different genetic models (additive, dominant, and recessive; all, p > 0.05). Our findings indicate that the IKBKB (rs12676482 and rs2272733) and POLB (rs3136717, rs3136744) SNPs confer no genetic predisposition to SLE risk in this Chinese Han population.	[Li, Yuan; Liu, Bin] Qingdao Univ, Affiliated Hosp, Dept Rheumatol, Qingdao 266071, Peoples R China; [Li, Yuan; Wu, Ziyan; Zhang, Shulan; Chen, Si; Li, Ping; Li, Jing; Cao, Chongwei; Zhang, Fengchun; Li, Yongzhe] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China; [Li, Yuan; Wu, Ziyan; Zhang, Shulan; Chen, Si; Li, Ping; Li, Jing; Cao, Chongwei; Zhang, Fengchun; Li, Yongzhe] Peking Union Med Coll, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing 100021, Peoples R China	Qingdao University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, B (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Rheumatol, Qingdao 266071, Peoples R China.	binliu72314@163.com; yongzhelipumch@126.com	zhang, shulan/AAS-6912-2020		Research Special Fund for Public Welfare Industry of Health [201202004]; National Natural Science Foundation of China [81072486, 81172857, 81373188]; Natural Sciences Foundation of China [81241094]; Technology program of basic research projects of Qingdao city [13-1-4-138-jch]	Research Special Fund for Public Welfare Industry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Technology program of basic research projects of Qingdao city	This work was supported by funding from the Research Special Fund for Public Welfare Industry of Health No. 201202004 (to FCZ), and the National Natural Science Foundation of China Grants 81072486, 81172857, 81373188 (to YZL) and the Natural Sciences Foundation of China No. 81241094 (to BL) and Technology program of basic research projects of Qingdao city No. 13-1-4-138-jch (BL).	Bassi CL, 2008, LUPUS, V17, P988, DOI 10.1177/0961203308093461; Courtney PA, 1999, ANN RHEUM DIS, V58, P309, DOI 10.1136/ard.58.5.309; Da SFA, 2013, GENE, V527, P435, DOI [10.1016/j.gene.2013.06.074, DOI 10.1016/J.GENE.2013.06.074]; Danchenko N, 2006, LUPUS, V15, P308, DOI 10.1191/0961203306lu2305xx; Dogliotti E, 2001, PROG NUCLEIC ACID RE, V68, P3; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Graessler J, 2005, J RHEUMATOL, V32, P1654; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hur JW, 2008, RHEUMATOL INT, V28, P783, DOI 10.1007/s00296-007-0509-0; Koyama A, 2006, RHEUMATOL INT, V26, P749, DOI 10.1007/s00296-005-0066-3; Lin YJ, 2010, J CLIN IMMUNOL, V30, P643, DOI 10.1007/s10875-010-9427-0; Mandel M, 2004, CLIN EXP IMMUNOL, V138, P164, DOI 10.1111/j.1365-2249.2004.02587.x; Martens HA, 2009, SCAND J RHEUMATOL, V38, P256, DOI 10.1080/03009740802552469; McConnell JR, 2002, CLIN EXP RHEUMATOL, V20, P653; McCurdy D, 1997, RADIAT RES, V147, P48, DOI 10.2307/3579442; Miceli-Richard C, 2015, JOINT BONE SPINE, V82, P90, DOI 10.1016/j.jbspin.2014.03.004; Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Narayan S, 1996, J BIOL CHEM, V271, P18508, DOI 10.1074/jbc.271.31.18508; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Senejani AG, 2014, CELL REP, V6, P1, DOI 10.1016/j.celrep.2013.12.017; Sheng YJ, 2011, RHEUMATOLOGY, V50, P682, DOI 10.1093/rheumatology/keq313; Thomas G, 2004, ELECTROPHORESIS, V25, P1668, DOI 10.1002/elps.200405886; Warchol T, 2012, DNA CELL BIOL, V31, P50, DOI 10.1089/dna.2011.1246; Yi P, 2009, PRENATAL DIAG, V29, P217, DOI 10.1002/pd.2072; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zeng QY, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2368; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	28	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132556	10.1371/journal.pone.0132556	http://dx.doi.org/10.1371/journal.pone.0132556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167925	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100054
J	Armijo-Olivo, S; da Costa, BR; Cummings, GG; Ha, C; Fuentes, J; Saltaji, H; Egger, M				Armijo-Olivo, Susan; da Costa, Bruno R.; Cummings, Greta G.; Ha, Christine; Fuentes, Jorge; Saltaji, Humam; Egger, Matthias			PEDro or Cochrane to Assess the Quality of Clinical Trials? A Meta-Epidemiological Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; METHODOLOGICAL QUALITY; ALLOCATION CONCEALMENT; SYSTEMATIC REVIEWS; EMPIRICAL-EVIDENCE; EXERCISE; SCORES; IMPACT; BIAS; OSTEOARTHRITIS	Objective There is debate on how the methodological quality of clinical trials should be assessed. We compared trials of physical therapy (PT) judged to be of adequate quality based on summary scores from the Physiotherapy Evidence Database (PEDro) scale with trials judged to be of adequate quality by Cochrane Risk of Bias criteria. Design Meta-epidemiological study within Cochrane Database of Systematic Reviews. Methods Meta-analyses of PT trials were identified in the Cochrane Database of Systematic Reviews. For each trial PeDro and Cochrane assessments were extracted from the PeDro and Cochrane databases. Adequate quality was defined as adequate generation of random sequence, concealment of allocation, and blinding of outcome assessors (Cochrane criteria) or as trials with a PEDro summary score >= 5 or >= 6 points. We combined trials of adequate quality using random-effects meta-analysis. Results Forty-one Cochrane reviews and 353 PT trials were included. All meta-analyses included trials with PEDro scores >= 5, 37 (90.2%) included trials with PEDro scores >= 6 and only 22 (53.7%) meta-analyses included trials of adequate quality according to the Cochrane criteria. Agreement between PeDro and Cochrane was poor for PeDro scores of >= 5 points (kappa = 0.12; 95% CI 0.07 to 0.16) and slight for >= 6 points (kappa 0.24; 95% CI 0.16-0.32). When combining effect sizes of trials deemed to be of adequate quality according to PEDro or Cochrane criteria, we found that a substantial difference in the combined effect size (>= 0.15) was evident in 9 (22%) out of the 41 meta- analyses for PEDro cutoff >= 5 and 10 (24%) for cutoff >= 6. Conclusions The PeDro and Cochrane approaches lead to different sets of trials of adequate quality, and different combined treatment estimates from meta-analyses of these trials. A consistent approach to assessing RoB in trials of physical therapy should be adopted.	[Armijo-Olivo, Susan; Cummings, Greta G.] Univ Alberta, Fac Nursing, CLEAR Outcomes Res Program, Edmonton, AB, Canada; [da Costa, Bruno R.] Univ Bern, Inst Primary Hlth Care, CH-3013 Bern, Switzerland; [Armijo-Olivo, Susan; Ha, Christine; Fuentes, Jorge] Univ Alberta, Rehabil Res Ctr, Fac Rehabil Med, Edmonton, AB, Canada; [Fuentes, Jorge] Catholic Univ Maule, Dept Phys Therapy, Talca, Chile; [Saltaji, Humam] Univ Alberta, Sch Dent, Orthodont Grad Program, Edmonton, AB, Canada; [Egger, Matthias] Univ Bern, ISPM, CH-3013 Bern, Switzerland	University of Alberta; University of Bern; University of Alberta; Universidad Catolica del Maule; University of Alberta; University of Bern	Armijo-Olivo, S (corresponding author), Univ Alberta, Fac Nursing, CLEAR Outcomes Res Program, Edmonton, AB, Canada.	sla4@ualberta.ca	Saltaji, Humam/N-6539-2014; Contreras, Jorge Fuentes/AAN-5633-2021; Cummings, Greta G/B-4121-2009	Saltaji, Humam/0000-0002-8978-458X; Contreras, Jorge Fuentes/0000-0003-0626-3656; Cummings, Greta G/0000-0002-0668-6176; Egger, Matthias/0000-0001-7462-5132; R. da Costa, Bruno/0000-0002-1786-6332	Canadian Institutes of Health Research (CIHR); Alberta Innovates Health Solution; Knowledge Translation (KT) Canada Research Stipend program; Physiotherapy Foundation of Canada (PFC); Knowledge Translation (KT) Canada; University of Alberta; Alberta Heritage Foundation for Medical Research; Canadian Institutes of Health Research; Centennial Professorship at the University of Alberta; Government of Chile; Alberta Innovates - Health Solutions (AIHS); Women and Children's Health Research Institute (WCHRI); National Institutes of Health; Bill and Melinda Gates Foundation; Swiss National Science Foundation; Cancer Research Switzerland; University Catholic of Maule; Alberta Innovates [201300026] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solution; Knowledge Translation (KT) Canada Research Stipend program; Physiotherapy Foundation of Canada (PFC); Knowledge Translation (KT) Canada; University of Alberta(University of Alberta); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Centennial Professorship at the University of Alberta; Government of Chile; Alberta Innovates - Health Solutions (AIHS); Women and Children's Health Research Institute (WCHRI); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cancer Research Switzerland; University Catholic of Maule; Alberta Innovates	This project is funded by the Canadian Institutes of Health Research (CIHR), Alberta Innovates Health Solution through a Knowledge Translation Initiative Grant, the Knowledge Translation (KT) Canada Research Stipend program, and the Physiotherapy Foundation of Canada (PFC) through a B.E. Schnurr Memorial Fund Award. The funding bodies had no input in the design, collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. Dr. Susan Armijo-Olivo is supported by the Canadian Institutes of Health Research (CIHR) through a full-time Banting Fellowship, the Alberta Innovates Health Solution through an Incentive Award, the STIHR Training Program from Knowledge Translation (KT) Canada, and the University of Alberta. Dr. Greta Cummings has been funded both provincially with a Population Health Investigator Award from the Alberta Heritage Foundation for Medical Research (2006-2013), and nationally with a New Investigator Award from the Canadian Institutes of Health Research (2006-2011). Currently, she holds a Centennial Professorship at the University of Alberta (2013-2020). Dr. Fuentes is supported by the Government of Chile, University of Alberta through a dissertation fellowship, and the University Catholic of Maule. Dr. Humam Saltaji is supported through a Clinician Fellowship Award by Alberta Innovates - Health Solutions (AIHS), the Honorary Izaak Walton Killam Memorial Scholarship by the University of Alberta and the WCHRI Award by the Women and Children's Health Research Institute (WCHRI). Dr. Egger is supported by the National Institutes of Health, the Bill and Melinda Gates Foundation, Swiss National Science Foundation and Cancer Research Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, JOURNAL OF CLINICAL, V64, P594, DOI [10.1016/j.jclinepi.2010.08.009, DOI 10.1016/J.JCLINEPI.2010.08.009]; Armijo-Olivo S, 2015, WHAT IS THE INFLUENC; Armijo-Olivo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096920; Armijo-Olivo S, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-116; Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Barker AL, 2014, ARCH PHYS MED REHAB, V95, P1776, DOI 10.1016/j.apmr.2014.04.005; Bendermacher-Bianca LW, 2006, SUPERVISEDEXERCISETH; Byrt T, 1996, EPIDEMIOLOGY, V7, P561, DOI 10.1097/00001648-199609000-00030; Cohen J., 1988, STAT POWER ANAL BEHA, V2, P1, DOI DOI 10.4324/9780203771587; Colle F, 2002, ARCH PHYS MED REHAB, V83, P1745, DOI 10.1053/apmr.2002.35657; Costa LOP, 2013, J CLIN EPIDEMIOL, V66, P1192, DOI 10.1016/j.jclinepi.2013.05.007; da Costa BR, 2013, J CLIN EPIDEMIOL, V66, P75, DOI 10.1016/j.jclinepi.2012.08.003; Davies P, 2010, COCHRANE DATABASE OF; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Dorstyn D, 2013, CLIN REHABIL, V27, P1072, DOI 10.1177/0269215513488001; Effing T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002990.pub2; Forster A, 2009, BURNS EILEEN REHABIL; Fransen M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007912; GREENLAND S, 1994, AM J EPIDEMIOL, V140, P300, DOI 10.1093/oxfordjournals.aje.a117250; Handoll-Helen HG, 2009, COCHRANE DATABASE OF; Hartling L, 2009, BMJ-BRIT MED J, V37, P339; Harvey LA, 2010, COCHRANE DATABASE OF; Herbert R, 1998, Health Inf Manag, V28, P186; Herbison P, 2011, J CLIN EPIDEMIOL, V64, P1070, DOI 10.1016/j.jclinepi.2010.12.018; Hewitt CE, 2010, J CLIN EPIDEMIOL, V63, P1264, DOI 10.1016/j.jclinepi.2010.01.010; Higgins JP., 2008, COCHRANE HDB SYSTEMA, DOI [10.1002/14651858.ED000142, DOI 10.1002/14651858.ED000142]; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Johnston BC, 2008, SPINE, V33, P914, DOI 10.1097/BRS.0b013e31816b4be4; Jolliffe J, 2001, EBRAHIMSHAHEXERCISEB; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Katalinic OM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007455.pub2; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Kramer MS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000180.pub2; Kunz R, 2006, J CLIN EPIDEMIOL, V59, P1239, DOI 10.1016/j.jclinepi.2006.03.009; Latif LA, 2011, ARCH PHYS MED REHAB, V92, P306, DOI 10.1016/j.apmr.2010.10.003; Liu Cj, 2009, COCHRANEDATABASEOF S; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; Main E, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002011.pub2; Manheimer E, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001977.pub2; Mead GE, 2009, LAWLORDEBBIEAEXERCIS; Mehrholz J, 2010, POHLMARCUSTREADMILLT; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W; Nfiesch E, 2009, BMJ-BRIT MED J, V339, P679; Nuesch E, 2009, ARTHRIT RHEUM-ARTHR, V61, P1633, DOI 10.1002/art.24894; O'Brien K, 2010, COCHRANEDATABASEOF S; Olivo SA, 2008, PHYS THER, V88, P156, DOI 10.2522/ptj.20070147; Orozco LJ, 2008, COCHRANE DATABASE OF; Ostelo-Raymond WJG, 2008, COCHRANE DATABASE OF; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Pollock A, 2007, COCHRANEDATABASEOF S; Pollock A, 2007, CLIN REHABIL, V21, P395, DOI 10.1177/0269215507073438; Puhan MA, 2009, COCHRANE DATABASE OF; Reichenbach S, 2007, ANN INTERN MED, V146, P580, DOI 10.7326/0003-4819-146-8-200704170-00009; Rutjes-Anne WS, 2010, COCHRANE DATABASE OF; Rutjes-Anne WS, 2009, COCHRANE DB SYST REV; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Schaafsma F, 2010, COCHRANE DATABASE OF; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Shaw KA, 2006, DELMARCHRISEXERCISEF; Sirtori V, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004433.pub2; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Spittle A, 2007, DATABASE OF SYSTEMAT; States RA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006075.pub2; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Taylor RS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007130.pub2; Trowman R, 2007, J CLIN EPIDEMIOL, V60, P1229, DOI 10.1016/j.jclinepi.2007.03.014; Watson L, 2008, EXERCISEFORINTERMITT; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Woodford HJ, 2007, PRICECHRISTOPHERIMEM; World Confederation for Physical Therapy, 2011, POSITION STATEMENT S	73	87	88	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132634	10.1371/journal.pone.0132634	http://dx.doi.org/10.1371/journal.pone.0132634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161653	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300161
J	Dorywalska, M; Strop, P; Melton-Witt, JA; Hasa-Moreno, A; Farias, SE; Casas, MG; Delaria, K; Lui, V; Poulsen, K; Sutton, J; Bolton, G; Zhou, DH; Moine, L; Dushin, R; Tran, TT; Liu, SH; Rickert, M; Foletti, D; Shelton, DL; Pons, J; Rajpal, A				Dorywalska, Magdalena; Strop, Pavel; Melton-Witt, Jody A.; Hasa-Moreno, Adela; Farias, Santiago E.; Casas, Meritxell Galindo; Delaria, Kathy; Lui, Victor; Poulsen, Kris; Sutton, Janette; Bolton, Gary; Zhou, Dahui; Moine, Ludivine; Dushin, Russell; Thomas-Toan Tran; Liu, Shu-Hui; Rickert, Mathias; Foletti, Davide; Shelton, David L.; Pons, Jaume; Rajpal, Arvind			Site-Dependent Degradation of a Non-Cleavable Auristatin-Based Linker-Payload in Rodent Plasma and Its Effect on ADC Efficacy	PLOS ONE			English	Article							THERAPEUTIC ACTIVITY; STABILITY; ANTIBODIES; CONJUGATE	The efficacy of an antibody-drug conjugate (ADC) is dependent on the properties of its linker-payload which must remain stable while in systemic circulation but undergo efficient processing upon internalization into target cells. Here, we examine the stability of a non-cleavable Amino-PEG6-based linker bearing the monomethyl auristatin D (MMAD) payload site-specifically conjugated at multiple positions on an antibody. Enzymatic conjugation with transglutaminase allows us to create a stable amide linkage that remains intact across all tested conjugation sites on the antibody, and provides us with an opportunity to examine the stability of the auristatin payload itself. We report a position-dependent degradation of the C terminus of MMAD in rodent plasma that has a detrimental effect on its potency. The MMAD cleavage can be eliminated by either modifying the C terminus of the toxin, or by selection of conjugation site. Both approaches result in improved stability and potency in vitro and in vivo. Furthermore, we show that the MMAD metabolism in mouse plasma is likely mediated by a serine-based hydrolase, appears much less pronounced in rat, and was not detected in cynomolgus monkey or human plasma. Clarifying these species differences and controlling toxin degradation to optimize ADC stability in rodents is essential to make the best ADC selection from preclinical models. The data presented here demonstrate that site selection and toxin susceptibility to mouse plasma degradation are important considerations in the design of non-cleavable ADCs, and further highlight the benefits of site-specific conjugation methods.	[Dorywalska, Magdalena; Strop, Pavel; Melton-Witt, Jody A.; Hasa-Moreno, Adela; Farias, Santiago E.; Casas, Meritxell Galindo; Delaria, Kathy; Lui, Victor; Poulsen, Kris; Sutton, Janette; Bolton, Gary; Thomas-Toan Tran; Liu, Shu-Hui; Rickert, Mathias; Foletti, Davide; Shelton, David L.; Pons, Jaume; Rajpal, Arvind] Pfizer Inc, Rinat Labs, San Francisco, CA 94080 USA; [Zhou, Dahui; Moine, Ludivine; Dushin, Russell] Pfizer Inc, Worldwide Med Chem, Groton, CT 06340 USA	Pfizer; Pfizer	Strop, P (corresponding author), Pfizer Inc, Rinat Labs, 230 East Grand Ave, San Francisco, CA 94080 USA.	pavel.strop@pfizer.com		Galindo Casas, Meritxell/0000-0002-5034-1722	Pfizer Inc.	Pfizer Inc.(Pfizer)	Pfizer Inc. provided support in the form of salaries for authors M.D., P.S., J.A.M.-W., A. H.-M., S. E.F., M.G.C., K.D., V.L., K.P., J.S., G.B., D.Z., L.M., R. D., T.-T.T., S.-H.L M.R., D.F., D.L.S., J.P., and A.R., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alley SC, 2008, BIOCONJUGATE CHEM, V19, P759, DOI 10.1021/bc7004329; Bender B, 2014, AAPS J, V16, P994, DOI 10.1208/s12248-014-9618-3; Dennler P, 2014, BIOCONJUGATE CHEM, V25, P569, DOI 10.1021/bc400574z; Doronina SO, 2006, BIOCONJUGATE CHEM, V17, P114, DOI 10.1021/bc0502917; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Dorywalska M, 2015, BIOCONJUGATE CHEM, V26, P650, DOI 10.1021/bc5005747; Ducry L, 2010, BIOCONJUGATE CHEM, V21, P5, DOI 10.1021/bc9002019; Farias SE, 2014, BIOCONJUGATE CHEM, V25, P240, DOI 10.1021/bc4003794; Girish S, 2012, CANCER CHEMOTH PHARM, V69, P1229, DOI 10.1007/s00280-011-1817-3; Jackson D, 2015, PHARM RES-DORDR, V32, P3458, DOI 10.1007/s11095-014-1536-7; Jeger S, 2010, ANGEW CHEM INT EDIT, V49, P9995, DOI 10.1002/anie.201004243; Junutula JR, 2010, CLIN CANCER RES, V16, P4769, DOI 10.1158/1078-0432.CCR-10-0987; Lambert JM, 2013, BRIT J CLIN PHARMACO, V76, P248, DOI 10.1111/bcp.12044; Lyon RP, 2014, NAT BIOTECHNOL, V32, P1059, DOI 10.1038/nbt.2968; Maderna A, 2014, J MED CHEM, V57, P10527, DOI 10.1021/jm501649k; McCombs JR, 2015, AAPS J, V17, P339, DOI 10.1208/s12248-014-9710-8; Panowski S, 2014, MABS-AUSTIN, V6, P34, DOI 10.4161/mabs.27022; PETTIT GR, 1987, J AM CHEM SOC, V109, P6883, DOI 10.1021/ja00256a070; Pillow TH, 2014, J MED CHEM, V57, P7890, DOI 10.1021/jm500552c; Rostami S, 2014, J ANTIBODY DRUG CONJ; Sanderson RJ, 2005, CLIN CANCER RES, V11, P843; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; Sievers EL, 2013, ANNU REV MED, V64, P15, DOI 10.1146/annurev-med-050311-201823; Sigma-Aldrich, 2009, LIFE SCI BIOFILES, V4; SMYTH DG, 1964, BIOCHEM J, V91, P589, DOI 10.1042/bj0910589; Strop P., 2012, Patent No. [WO 2012059882A2, 2012059882]; Strop P, 2013, CHEM BIOL, V20, P161, DOI 10.1016/j.chembiol.2013.01.010; Tannir NM, 2014, INVEST NEW DRUG, V32, P1246, DOI 10.1007/s10637-014-0151-0; Tumey LN, 2014, BIOCONJUGATE CHEM, V25, P1871, DOI 10.1021/bc500357n	29	39	41	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132282	10.1371/journal.pone.0132282	http://dx.doi.org/10.1371/journal.pone.0132282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161543	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300112
J	Lopes, GN; Souza, MF; Gotelli, NJ; Lemos, LJU; Godoy, WAC; Zucchi, RA				Lopes, Gleidyane N.; Souza-Filho, Miguel F.; Gotelli, Nicholas J.; Lemos, Leandro J. U.; Godoy, Wesley A. C.; Zucchi, Roberto A.			Temporal Overlap and Co-Occurrence in a Guild of Sub-Tropical Tephritid Fruit Flies	PLOS ONE			English	Article							FRATERCULUS COMPLEX DIPTERA; NULL MODEL ANALYSIS; PARASITOIDS HYMENOPTERA; DIVERSITY; BIODIVERSITY	Studies of community assembly have emphasized snapshot comparisons of spatially replicated samples from "natural" assemblages. Agro-ecosystems are characterized by relatively little habitat heterogeneity and no dispersal barriers for actively flying insects. Therefore, dynamic patterns of species segregation and aggregation are more likely to reflect the direct or indirect effects of species interactions. We studied the temporal organization of a guild of 21 congeneric species of Anastrepha that colonized fruit orchards in Monte Alegre do Sul, Sao Paulo, Brazil. This assemblage also included the introduced Mediterranean fruit fly Ceratitis capitata. One hundred six consecutive weekly censuses (11 Jan 2002-16 Jan 2004) of flies in guava, loquat, and peach orchards revealed a pattern of minimum abundance during the coldest months of each year (June and July) and a maximum abundance during periods of flowering and fruit ripening. Overall, phenological overlap was greater than expected by chance. However, conditioned on the pattern of seasonal abundances, temporal occurrence and abundance matrices exhibited patterns of significant species segregation and anti-nestedness. In each year, the 3 orchards contained a small number of species pairs that exhibited statistically significant temporal segregation or aggregation. Most aggregated and segregated pairs reflected seasonal shifts in species presences that were not related to variation in air temperature. Most of the significant pair-wise associations involved C. capitata: 8 of the 11 segregated pairs and 2 of the 7 aggregated pairs. These results suggest that species interactions between introduced and native species can be an important determinant of species associations in agro-ecosystems.	[Lopes, Gleidyane N.; Lemos, Leandro J. U.; Godoy, Wesley A. C.; Zucchi, Roberto A.] Univ Sao Paulo, ESALQ, Dept Entomol & Acarol, Piracicaba, SP, Brazil; [Souza-Filho, Miguel F.] Secretaria Agr & Abastecimento, Inst Biol, Campinas, SP, Brazil; [Gotelli, Nicholas J.] Univ Vermont, Dept Biol, Burlington, VT USA	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Vermont	Lopes, GN (corresponding author), Univ Sao Paulo, ESALQ, Dept Entomol & Acarol, Piracicaba, SP, Brazil.	gnlopesm@hotmail.com	Lopes Mielezrski, Gleidyane/O-9912-2015; Zucchi, Roberto/D-7738-2012; Godoy, Wesley AC/B-9787-2012; Filho, Miguel Souza/N-4312-2013	Zucchi, Roberto/0000-0001-9861-7460; Souza-Filho, Miguel Francisco de/0000-0001-7838-1489; Lopes-Mielezrski, Gleidyane/0000-0002-1455-3760	"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq); US National Science Foundation [11-44055, 13-6703]	"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); US National Science Foundation(National Science Foundation (NSF))	The "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq) awarded a grant to the first author. NJG was supported by US National Science Foundation Grants 11-44055 and 13-6703. RAZ is a fellow of the CNPq.	ALUJA M, 1994, ANNU REV ENTOMOL, V39, P155, DOI 10.1146/annurev.en.39.010194.001103; Aluja M, 2003, ENVIRON ENTOMOL, V32, P1377, DOI 10.1603/0046-225X-32.6.1377; Baliraine FN, 2004, MOL ECOL, V13, P683, DOI 10.1046/j.1365-294X.2004.02105.x; Blois J, ECOGRAPHY IN PRESS; Cash FBJ, 2012, AUSTRAL ECOL, V37, P903, DOI 10.1111/j.1442-9993.2011.02349.x; Castro-Arellano I, 2010, METHODS ECOL EVOL, V1, P311, DOI 10.1111/j.2041-210X.2010.00031.x; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Cody M.L, 1974, COMPETITION STRUCTUR; Diamond J.M., 1975, P342; Duyck PF, 2004, ECOL ENTOMOL, V29, P511, DOI 10.1111/j.0307-6946.2004.00638.x; Ekesi S, 2009, J ECON ENTOMOL, V102, P981, DOI 10.1603/029.102.0317; Ellwood MDF, 2009, ECOL LETT, V12, P277, DOI 10.1111/j.1461-0248.2009.01284.x; Enkerlin WR, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P651, DOI 10.1007/1-4020-4051-2_25; FEINSINGER P, 1981, ECOLOGY, V62, P27, DOI 10.2307/1936664; Fox BJ, 2000, GLOBAL ECOL BIOGEOGR, V9, P19, DOI 10.1046/j.1365-2699.2000.00184.x; Gillespie RG, 2008, MOL ECOL, V17, P45, DOI 10.1111/j.1365-294X.2007.03466.x; Gotelli N. J., 2012, ECOSIM 7 72 ACQUIRED; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Gotelli NJ, 2010, OECOLOGIA, V162, P463, DOI 10.1007/s00442-009-1474-y; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2000, ECOL LETT, V3, P257, DOI 10.1046/j.1461-0248.2000.00138.x; Hernandez-Ortiz V, 2012, ANN ENTOMOL SOC AM, V105, P305, DOI 10.1603/AN11123; Kukalova-Peck J, 2008, EVOL BIOL, V35, P4, DOI 10.1007/s11692-007-9013-4; MCCOY ED, 1987, J BIOGEOGR, V14, P79, DOI 10.2307/2844788; New TR, 2008, INSECT CONSERVATION, P3; Patrick CJ, 2011, J N AM BENTHOL SOC, V30, P259, DOI 10.1899/09-169.1; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Plummer CC, 1941, YELLOW CHAPOTE NATIV; Puzzi D., 1965, ARQ I BIO, V32, P9; R Core Team, 2021, R LANGUAGE ENV STAT; Ribas CR, 2002, OECOLOGIA, V131, P606, DOI 10.1007/s00442-002-0912-x; Sanders NJ, 2003, P NATL ACAD SCI USA, V100, P2474, DOI 10.1073/pnas.0437913100; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Selivon D, 2005, ANN ENTOMOL SOC AM, V98, P367, DOI 10.1603/0013-8746(2005)098[0367:AGCOTC]2.0.CO;2; Selivon D., 2000, MOSCAS DAS FRUTAS IM, P87; Silva RA, 2011, MOSCAS DAS FRUTAS AM, P199; Souza MF, 2009, BRAZ J BIOL, V69, P31, DOI 10.1590/S1519-69842009000100004; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Triantis Kostas A., 2011, P190; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2002, ECOL RES, V17, P229, DOI 10.1046/j.1440-1703.2002.00482.x; Ulrich W, 2008, PAIRS FORTRAN PROGRA; Ulrich W, 2006, COOCCURRENCE FORTRAN; Ulrich W, 2010, ECOLOGY, V91, P3384, DOI 10.1890/09-2157.1; Weiher Evan, 1999, P251, DOI 10.1017/CBO9780511542237.010; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Zucchi, 2001, HIST IMPACTO PRAGAS, P173; Zucchi RA., 2012, FRUIT FLIES BRAZIL H; Zucchi RA, 2008, FRUIT FLIES BRAZIL A; ZUCOLOTO F. S., 2000, MOSCAS DAS FRUTAS IM, P67	50	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132124	10.1371/journal.pone.0132124	http://dx.doi.org/10.1371/journal.pone.0132124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161855	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300097
J	Overholt, WA; Diaz, R; Rosskopf, E; Green, SJ; Overholt, WA				Overholt, Will A.; Diaz, Rodrigo; Rosskopf, Erin; Green, Stefan J.; Overholt, William A.			Deep Characterization of the Microbiomes of Calophya spp. (Hemiptera: Calophyidae) Gall-Inducing Psyllids Reveals the Absence of Plant Pathogenic Bacteria and Three Dominant Endosymbionts	PLOS ONE			English	Article							PHLOEM-SAP; DIAPHORINA-CITRI; LICE HEMIPTERA; GENOME; PSYLLOIDEA; SYMBIONTS; SEQUENCES; ANACARDIACEAE; LATIFORCEPS; DIVERSITY	Bacteria associated with sap-feeding insect herbivores include not only symbionts that may increase their hosts' fitness but also harmful plant pathogens. Calophya spp. gall-inducing psyllids (Hemiptera: Calophyidae) are being investigated for their potential as biological control agents of the noxious weed, Brazilian peppertree (Schinus terebinthifolia), in Florida. Although there are no examples of plant pathogen transmission by members of the family Calophyidae, several insects in the superfamily Psylloidea are known to transmit pathogenic bacteria in the genera Candidatus Liberibacter and Candidatus Phytoplasma. To determine whether Calophya spp. harbor potentially harmful plant pathogenic bacteria, we sequenced small subunit (SSU) ribosomal RNA (rRNA) gene amplicons generated from individuals from four Calophya spp. populations. All microbial SSU gene sequences fell into the bacterial domain, with 98-99% belonging to the Proteobacteria. The Calophya microbiomes contained a relatively simple community, with 49-79 operational taxonomic units (OTUs; 97%) detected, and only 5-8 OTUs with greater than 1% abundance. Candidatus Carsonella showed the highest relative abundance, with OTUs from this candidate genus representing between 51 - 65% of all recovered sequences. The next most abundant clade observed was an unclassified Enterobacteriacae group closely related to bacteria from the genera Buchnera and Blochmannia that ranged from 20-31% in relative abundance. Wolbachia populations were the third most abundant group and represented 7-27% of the diversity in microbial OTUs. No SSU rRNA gene sequences from putative pathogenic bacteria from the genera Ca. Liberibacter or Ca. Phytoplasma were detected in the microbiomes of the four Calophya populations. The probability that infected psyllids were present in our colonies, but were not sampled, was extremley low (1.39 x 10(-10)). As far as we are aware, our study is the first to characterize the microbiome of a candidate biological control agent, and coupled with previous work demonstrating a high degree of host specificity and absence of plant viruses, suggests that releasing Calophya spp. in United States poses minimal risk to non-target plants.	[Overholt, Will A.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Diaz, Rodrigo] Louisiana State Univ, Dept Entomol, Baton Rouge, LA 70803 USA; [Rosskopf, Erin] USDA, US Hort Res Lab, Ft Pierce, FL USA; [Green, Stefan J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Overholt, William A.] Univ Florida, Biol Control Res & Containment Lab, Ft Pierce, FL 34945 USA	University System of Georgia; Georgia Institute of Technology; Louisiana State University System; Louisiana State University; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University System of Florida; University of Florida	Overholt, WA (corresponding author), Univ Florida, Biol Control Res & Containment Lab, Ft Pierce, FL 34945 USA.	billover@ufl.edu	Overholt, Will/X-2461-2019; Diaz, Rodrigo/ABG-5508-2020	Overholt, Will/0000-0002-2897-6991; Diaz, Rodrigo/0000-0001-5493-9548; Green, Stefan/0000-0003-2781-359X	Florida Fish and Wildlife Conservation Commission; Florida Department of Agriculture and Consumer Services; National Science Foundation Graduate Research Fellowship [2013172310]; ARS [ARS-0426283] Funding Source: Federal RePORTER	Florida Fish and Wildlife Conservation Commission; Florida Department of Agriculture and Consumer Services; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded in part by grants from the Florida Fish and Wildlife Conservation Commission, the Florida Department of Agriculture and Consumer Services, and a National Science Foundation Graduate Research Fellowship, https://www.nsfgrfp.org/, (to WAO1) under Grant No. 2013172310. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aronesty E., 2011, COMMAND LINE TOOLS F; Arp AP, 2013, ENVIRON ENTOMOL, V42, P868, DOI 10.1603/EN12260; Bansal R, 2014, ENV MICROBIOL REP, V6, P57, DOI 10.1111/1758-2229.12108; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Buchner P., 1965, ENDOSYMBIOSIS OF ANI; Burckhardt D, 2000, J NAT HIST, V34, P57, DOI 10.1080/002229300299688; Burckhardt D, 2011, FLA ENTOMOL, V94, P489, DOI 10.1653/024.094.0313; Burckhardt D, 2014, FLA ENTOMOL, V97, P242, DOI 10.1653/024.097.0132; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carraro L., 1998, Journal of Plant Pathology, V80, P233; Clark MA, 2001, J BACTERIOL, V183, P1853, DOI 10.1128/JB.183.6.1853-1861.2001; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CLARKE KR, 2001, CHANGES IN MARINE CO; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Deng C, 2014, PRESEQR PREDICTING S; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Diaz R, 2015, FLA ENTOMOL, V98, P776, DOI 10.1653/024.098.0257; Diaz R, 2015, ENTOMOL EXP APPL, V154, P1, DOI 10.1111/eea.12249; Diaz R, 2014, BIOCONTROL SCI TECHN, V24, P536, DOI 10.1080/09583157.2013.878686; Doren RF, 1997, STRANGERS PARADISE I, P275; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fagen Jennie R, 2012, Open Microbiol J, V6, P29, DOI 10.2174/1874285801206010029; Feldhaar H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-48; Gioeli K, 1997, SS AGR 17; Haapalainen M, 2014, ANN APPL BIOL, V165, P172, DOI 10.1111/aab.12149; Hail D, 2012, ENVIRON ENTOMOL, V41, P98, DOI 10.1603/EN11198; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hardy NB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-257; Hodkinson I, 2009, J NAT HIST, V43, P65, DOI 10.1080/00222930802354167; Jensen DD, 1963, CALIF AGR, V17, P1; Jing XF, 2014, MOL ECOL, V23, P1433, DOI 10.1111/mec.12637; Koyama Y, 2004, ENTOMOL EXP APPL, V113, P35, DOI 10.1111/j.0013-8703.2004.00207.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Manrique V., 2013, J FLORIDA STUD, V1, P1; Matos LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078994; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Moran NA, 2006, MOL ECOL, V15, P1251, DOI 10.1111/j.1365-294X.2005.02744.x; Moran NA, 1998, BIOSCIENCE, V48, P295, DOI 10.2307/1313356; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Munyaneza JE, 2012, AM J POTATO RES, V89, P329, DOI 10.1007/s12230-012-9262-3; Munyaneza JE, 2010, SOUTHWEST ENTOMOL, V35, P471, DOI 10.3958/059.035.0335; Nachappa P, 2011, CURR MICROBIOL, V62, P1510, DOI 10.1007/s00284-011-9885-5; Nakabachi A, 2010, B ENTOMOL RES, V100, P27, DOI 10.1017/S0007485309006737; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Nakabachi A, 2013, CURR BIOL, V23, P1478, DOI 10.1016/j.cub.2013.06.027; Oksanen J, 2013, VAGAN COMMUNITY ECOL; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; R Core Team, 2013, R LANGUAGE ENV STAT; Rodgers L, 2012, STATUS NONINDIGENOUS, P1; SANDSTROM J, 1994, J INSECT PHYSIOL, V40, P947, DOI 10.1016/0022-1910(94)90133-3; Sandstrom J, 1999, ENTOMOL EXP APPL, V91, P203, DOI 10.1023/A:1003605508487; Simberloff D, 1997, STRANGERS IN PARADIS; Sloan DB, 2014, MOL BIOL EVOL, V31, P857, DOI 10.1093/molbev/msu004; Sloan DB, 2012, MOL BIOL EVOL, V29, P3781, DOI 10.1093/molbev/mss180; Subandiyah S, 2000, ZOOL SCI, V17, P983, DOI 10.2108/zsj.17.983; Tamames J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-181; Tedeschi R, 2009, EUR J PLANT PATHOL, V123, P301, DOI 10.1007/s10658-008-9367-1; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Thao ML, 2000, CURR MICROBIOL, V41, P300, DOI 10.1007/s002840010138; Thompson S., 2013, New Disease Reports, V27, P6, DOI 10.5197/j.2044-0588.2013.027.006; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; WOESE CR, 1975, NATURE, V254, P83, DOI 10.1038/254083a0; Workman R., 1979, TECHNICAL PROCEEDING; Wunderlin RP, 2008, ATLAS OF FLORIDA VAS	77	19	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132248	10.1371/journal.pone.0132248	http://dx.doi.org/10.1371/journal.pone.0132248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161659	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300107
J	Plzakova, L; Krocova, Z; Kubelkova, K; Macela, A				Plzakova, Lenka; Krocova, Zuzana; Kubelkova, Klara; Macela, Ales			Entry of Francisella tularensis into Murine B Cells: The Role of B Cell Receptors and Complement Receptors	PLOS ONE			English	Article							LIVE VACCINE STRAIN; BRUCELLA-ABORTUS; NONPHAGOCYTIC CELLS; IN-VITRO; INFECTION; ANTIGEN; MACROPHAGES; SALMONELLA; VIRULENCE; ADHERENCE	Francisella tularensis, the etiological agent of tularemia, is an intracellular pathogen that dominantly infects and proliferates inside phagocytic cells but can be seen also in nonphagocytic cells, including B cells. Although protective immunity is known to be almost exclusively associated with the type 1 pathway of cellular immunity, a significant role of B cells in immune responses already has been demonstrated. Whether their role is associated with antibody-dependent or antibody-independent B cell functions is not yet fully understood. The character of early events during B cell-pathogen interaction may determine the type of B cell response regulating the induction of adaptive immunity. We used fluorescence microscopy and flow cytometry to identify the basic requirements for the entry of F. tularensis into B cells within in vivo and in vitro infection models. Here, we present data showing that Francisella tularensis subsp. holarctica strain LVS significantly infects individual subsets of murine peritoneal B cells early after infection. Depending on a given B cell subset, uptake of Francisella into B cells is mediated by B cell receptors (BCRs) with or without complement receptor CR1/2. However, F. tularensis strain FSC200 Delta iglC and.ftdsbA deletion mutants are defective in the ability to enter B cells. Once internalized into B cells, F. tularensis LVS intracellular trafficking occurs along the endosomal pathway, albeit without significant multiplication. The results strongly suggest that BCRs alone within the B-1a subset can ensure the internalization process while the BCRs on B-1b and B-2 cells need co-signaling from the co receptor containing CR1/2 to initiate F. tularensis engulfment. In this case, fluidity of the surface cell membrane is a prerequisite for the bacteria's internalization. The results substantially underline the functional heterogeneity of B cell subsets in relation to F. tularensis.	[Plzakova, Lenka; Krocova, Zuzana; Kubelkova, Klara; Macela, Ales] Univ Def, Fac Mil Hlth Sci, Dept Mol Pathol & Biol, Hradec Kralove, Czech Republic	University of Defence - Czech Republic	Kubelkova, K (corresponding author), Univ Def, Fac Mil Hlth Sci, Dept Mol Pathol & Biol, Hradec Kralove, Czech Republic.	klara.kubelkova@unob.cz	Krocova, Zuzana/R-6364-2016	Krocova, Zuzana/0000-0002-6369-2695; Horcickova, Lenka/0000-0003-4320-2262	Czech Science Foundation [P302/11/1631]; Czech Ministry of Education, Youth and Sports	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	Grant No. P302/11/1631 from the Czech Science Foundation. Grant "Long-term organization plan 1011" received from the Czech Ministry of Education, Youth and Sports.	Abplanalp AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007920; Almeida SR, 2001, INT IMMUNOL, V13, P1193, DOI 10.1093/intimm/13.9.1193; BARD JA, 1985, INFECT IMMUN, V50, P935, DOI 10.1128/IAI.50.3.935-937.1985; Barel M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-145; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bolger CE, 2005, J LEUKOCYTE BIOL, V77, P893, DOI 10.1189/jlb.1104637; Bonazzi M, 2009, CELL MICROBIOL, V11, P693, DOI 10.1111/j.1462-5822.2009.01293.x; BRATESCU A, 1981, INFECT IMMUN, V31, P816, DOI 10.1128/IAI.31.2.816-821.1981; Broms JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050473; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; Castro-Eguiluz D, 2009, MICROB PATHOGENESIS, V47, P52, DOI 10.1016/j.micpath.2009.04.005; Chakraborty S, 2008, INFECT IMMUN, V76, P2852, DOI 10.1128/IAI.01726-07; Clemens DL, 2007, ANN NY ACAD SCI, V1105, P160, DOI 10.1196/annals.1409.001; Craven RR, 2008, INFECT IMMUN, V76, P2833, DOI 10.1128/IAI.00043-08; DETILLEUX PG, 1990, INFECT IMMUN, V58, P2320, DOI 10.1128/IAI.58.7.2320-2328.1990; Garcia-Perez BE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-246; Forestal CA, 2007, J INFECT DIS, V196, P134, DOI 10.1086/518611; Geier H, 2011, INFECT IMMUN, V79, P2204, DOI 10.1128/IAI.01382-10; Gimpl G, 2007, BIOSCIENCE REP, V27, P335, DOI 10.1007/s10540-007-9060-1; Goenka R, 2012, J INFECT DIS, V206, P91, DOI 10.1093/infdis/jis310; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; HEYMAN B, 1993, IMMUNOL TODAY, V14, P515, DOI 10.1016/0167-5699(93)90269-Q; Horzempa J, 2011, J INFECT DIS, V204, P51, DOI 10.1093/infdis/jir221; Krocova Z, 2008, MICROB PATHOGENESIS, V45, P79, DOI 10.1016/j.micpath.2008.01.010; Law HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104881; Law HT, 2011, SCI REP-UK, V1, DOI 10.1038/srep00192; Lindemann SR, 2007, INFECT IMMUN, V75, P3178, DOI 10.1128/IAI.01811-06; LOMBARDI G, 1987, RES CLIN LAB, V17, P1; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Meibom KL, 2009, FUTURE MICROBIOL, V4, P713, DOI 10.2217/FMB.09.37; Melillo A, 2006, FEMS MICROBIOL LETT, V263, P102, DOI 10.1111/j.1574-6968.2006.00413.x; Menon A, 2003, COMP IMMUNOL MICROB, V26, P157, DOI 10.1016/S0147-9571(02)00039-5; Moreau GB, 2013, VIRULENCE, V4, P826, DOI 10.4161/viru.25629; Mostowy S, 2009, CELL MOTIL CYTOSKEL, V66, P816, DOI 10.1002/cm.20353; Parra D, 2012, J LEUKOCYTE BIOL, V91, P525, DOI 10.1189/jlb.0711372; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Pizarro-Cerda J, 2000, MICROBES INFECT, V2, P829, DOI 10.1016/S1286-4579(00)90368-X; Pizarro-Cerda J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010009; Plzakova L, 2014, MICROB PATHOGENESIS, V75, P49, DOI 10.1016/j.micpath.2014.08.009; Qin AP, 2014, J BACTERIOL, V196, P3571, DOI 10.1128/JB.01359-13; Qin AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024611; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Ramond E, 2012, FUTURE MICROBIOL, V7, P1255, DOI [10.2217/fmb.12.103, 10.2217/FMB.12.103]; Ren G, 2014, MOL MICROBIOL, V94, P926, DOI 10.1111/mmi.12808; Rosales-Reyes R, 2012, MICROB PATHOGENESIS, V52, P367, DOI 10.1016/j.micpath.2012.03.007; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2006, TRENDS MICROBIOL, V14, P37, DOI 10.1016/j.tim.2005.11.008; Santic M, 2010, CELL MICROBIOL, V12, P129, DOI 10.1111/j.1462-5822.2009.01400.x; Schmidt C, 2009, EMBO J, V28, P711, DOI 10.1038/emboj.2009.20; Schulert GS, 2006, J LEUKOCYTE BIOL, V80, P563, DOI 10.1189/jlb.0306219; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Souwer Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050667; Souwer Y, 2009, J IMMUNOL, V182, P7473, DOI 10.4049/jimmunol.0802831; Straskova A, 2009, J PROTEOME RES, V8, P5336, DOI 10.1021/pr900570b; Sunyer J. Oriol, 2012, Infectious Disorders - Drug Targets, V12, P200; TEODORESCU M, 1982, ADV IMMUNOL, V33, P307, DOI 10.1016/S0065-2776(08)60838-X; VANNOESEL CJM, 1993, IMMUNOL TODAY, V14, P8, DOI 10.1016/0167-5699(93)90316-D; Veiga E, 2006, TRENDS CELL BIOL, V16, P499, DOI 10.1016/j.tcb.2006.08.005; Velge P, 2012, MICROBIOLOGYOPEN, V1, P243, DOI 10.1002/mbo3.28; VERJANS GMGM, 1994, INFECT IMMUN, V62, P2229, DOI 10.1128/IAI.62.6.2229-2235.1994; Vitry MA, 2014, INFECT IMMUN, V82, P3927, DOI 10.1128/IAI.01779-14; Zuidscherwoude M, 2014, J LEUKOCYTE BIOL, V95, P251, DOI 10.1189/jlb.0813440	65	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132571	10.1371/journal.pone.0132571	http://dx.doi.org/10.1371/journal.pone.0132571			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161475	gold, Green Submitted, Green Published			2022-12-27	WOS:000358162300154
J	Wielders, CCH; van Loenhout, JAF; Morroy, G; Rietveld, A; Notermans, DW; Wever, PC; Renders, NHM; Leenders, ACAP; van der Hoek, W; Schneeberger, PM				Wielders, Cornelia C. H.; van Loenhout, Joris A. F.; Morroy, Gabriella; Rietveld, Ariene; Notermans, Daan W.; Wever, Peter C.; Renders, Nicole H. M.; Leenders, Alexander C. A. P.; van der Hoek, Wim; Schneeberger, Peter M.			Long-Term Serological Follow-Up of Acute Q-Fever Patients after a Large Epidemic	PLOS ONE			English	Article							COXIELLA-BURNETII INFECTION; ENDOCARDITIS; DIAGNOSIS; NETHERLANDS; RESPONSES; ANEURYSMS; OUTBREAK; CRITERIA; DISEASE; GRAFTS	Background Serological follow-up of acute Q-fever patients is important for detection of chronic infection but there is no consensus on its frequency and duration. The 2007-2009 Q-fever epidemic in the Netherlands allowed for long-term follow-up of a large cohort of acute Q-fever patients. The aim of this study was to validate the current follow-up strategy targeted to identify patients with chronic Q-fever. Methods A cohort of adult acute Q-fever patients, diagnosed between 2007 and 2009, for whom a twelve-month follow-up sample was available, was invited to complete a questionnaire and provide a blood sample, four years after the acute episode. Antibody profiles, determined by immunofluorescence assay in serum, were investigated with a special focus on high titres of IgG antibodies against phase I of Coxiella burnetii, as these are considered indicative for possible chronic Q-fever. Results Of the invited 1,907 patients fulfilling inclusion criteria, 1,289 (67.6%) were included in the analysis. At any time during the four-year follow-up period, 58 (4.5%) patients were classified as possible, probable, or proven chronic Q-fever according to the Dutch Q-fever Consensus Group criteria (which uses IgG phase I >= 1: 1,024 to as serologic criterion for chronic Q-fever). Fifty-two (89.7%) of these were identified within the first year after the acute episode. Of the six patients that were detected for the first time at four-year follow-up, five had an IgG phase I titre of 1:512 at twelve months. Conclusions A twelve-month follow-up check after acute Q-fever is recommended as it adequately detects chronic Q-fever in patients without known risk factors. Additional serological and clinical follow-up is recommended for patients with IgG phase I >= 1:512, as they showed the highest risk to progress to chronic Q-fever.	[Wielders, Cornelia C. H.; Wever, Peter C.; Renders, Nicole H. M.; Leenders, Alexander C. A. P.; Schneeberger, Peter M.] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, sHertogenbosch, Netherlands; [Wielders, Cornelia C. H.; Notermans, Daan W.; van der Hoek, Wim; Schneeberger, Peter M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [van Loenhout, Joris A. F.; Morroy, Gabriella] Radboud Univ Nijmegen, Med Ctr, Radboudumc, Acad Collaborat Ctr AMPHI,Dept Primary & Communit, NL-6525 ED Nijmegen, Netherlands; [Morroy, Gabriella; Rietveld, Ariene] Municipal Hlth Serv GGD Hart voor Brabant, Dept Infect Dis Control, sHertogenbosch, Netherlands	Jeroen Bosch Ziekenhuis; Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen	van der Hoek, W (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	wim.van.der.hoek@rivm.nl; p.schneeberger@jbz.nl	van Loenhout, Joris/AAV-2075-2020; Wielders, Cornelia CH/I-1970-2019	van Loenhout, Joris/0000-0001-7810-7738; Wielders, Cornelia CH/0000-0002-2413-9088	ZonMw, Netherlands Organisation for Health Research and Development [205520006]	ZonMw, Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This work was supported by ZonMw, the Netherlands Organisation for Health Research and Development (grant number 205520006, http://www.zonmw.nl/). The funding source had no role in the study design, data collection, analysis and interpretation of data, writing of the report, and in the decision to submit the paper for publication. The corresponding author had full access to all the study data and had final responsibility for the decision to submit for publication.	Anderson A, 2013, MMWR RECOMM REP, V62, P1; Barten DG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-413; Botelho-Nevers E, 2007, EUR J CLIN MICROBIOL, V26, P635, DOI 10.1007/s10096-007-0357-6; BROUQUI P, 1993, ARCH INTERN MED, V153, P642, DOI 10.1001/archinte.153.5.642; Capuano AW, 2007, INFLUENZA OTHER RESP, V1, P87, DOI 10.1111/j.1750-2659.2007.00014.x; Dijkstra F, 2011, EPIDEMIOL INFECT, V139, P1332, DOI 10.1017/S0950268810002621; DUPUIS G, 1985, J CLIN MICROBIOL, V22, P484, DOI 10.1128/JCM.22.4.484-487.1985; Edouard S, 2014, J INFECTION, V68, P141, DOI 10.1016/j.jinf.2013.10.010; Fenollar F, 2001, CLIN INFECT DIS, V33, P312, DOI 10.1086/321889; Fournier PE, 1998, CLIN INFECT DIS, V26, P116, DOI 10.1086/516255; Hagenaars JCJP, 2014, EUR J CLIN MICROBIOL, V33, P1407, DOI 10.1007/s10096-014-2084-0; Jager MM, 2011, CLIN VACCINE IMMUNOL, V18, P963, DOI 10.1128/CVI.00009-11; Jaramillo-Gutierrez G, 2013, EURO SURVEILL, V18; Kampschreur LM, 2012, CLIN VACCINE IMMUNOL, V19, P1165, DOI 10.1128/CVI.00185-12; Kampschreur LM, 2012, EMERG INFECT DIS, V18, P563, DOI 10.3201/eid1804.111478; Landais C, 2007, CLIN INFECT DIS, V44, P1337, DOI 10.1086/515401; Lassche S, 2010, INFECT B, V21, P45; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Million M, 2013, CLIN INFECT DIS, V57, P836, DOI 10.1093/cid/cit419; Morroy G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060707; Raoult D, 2000, MEDICINE, V79, P109, DOI 10.1097/00005792-200003000-00005; Raoult D, 2011, CLIN INFECT DIS, V53, P1170, DOI 10.1093/cid/cir679; Schneeberger Peter M, 2010, Clin Vaccine Immunol, V17, P286, DOI 10.1128/CVI.00454-09; TISSOTDUPONT H, 1994, CLIN DIAGN LAB IMMUN, V1, P189; van der Hoek W, 2010, EUROSURVEILLANCE, V15, P4; van der Hoek W, 2012, EUROSURVEILLANCE, V17, P20059; van der Hoek W, 2011, CLIN INFECT DIS, V52, P1431, DOI 10.1093/cid/cir234; Wegdam-Blans MCA, 2013, EUR J CLIN MICROBIOL, V32, P353, DOI 10.1007/s10096-012-1749-9; Wegdam-Blans MCA, 2012, CLIN VACCINE IMMUNOL, V19, P1110, DOI 10.1128/CVI.05581-11; Wegdam-Blans MCA, 2012, J INFECTION, V64, P247, DOI 10.1016/j.jinf.2011.12.014; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x; Wielders CCH, 2012, CLIN VACCINE IMMUNOL, V19, P1661, DOI 10.1128/CVI.00322-12; Wielders CCH, 2013, EUR J CLIN INVEST, V43, P616, DOI 10.1111/eci.12073	34	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131848	10.1371/journal.pone.0131848	http://dx.doi.org/10.1371/journal.pone.0131848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161658	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300065
J	Janardhan, B; Vaderhobli, S; Bhagat, R; Srinivasamurthy, PC; Reddihalli, PV; Gawari, R; Krishnamoorthy, L				Janardhan, Bhaskari; Vaderhobli, Shilpa; Bhagat, Rahul; Srinivasamurthy, Premalata Chennagiri; Reddihalli, Pallavi Venketeshiah; Gawari, Ramesh; Krishnamoorthy, Lakshmi			Investigating impact of Vascular Endothelial Growth Factor Polymorphisms in Epithelial Ovarian Cancers: A Study in the Indian Population	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; FACTOR GENE POLYMORPHISMS; SPLICE VARIANT; BREAST-CANCER; RISK; VEGF(165)B; CARCINOMA; ANGIOGENESIS; HAPLOTYPES; EXPRESSION	Epithelial ovarian cancer is one of the increasingly incident malignancies that is notorious because of its evasiveness for early diagnosis and high mortality rates. Epithelial ovarian cancers are highly dependent on pathologic vasculature and Vascular Endothelial Growth Factor is known to be one of the most efficient angiogenic factors. Polymorphisms of the VEGF gene, in this study, were assessed for association with the malignancy and other clinico-pathological factors. 300 case samples and 320 age and mensus status matched controls were inculcated into the study. rs699947, rs833061, rs1570360, rs2010963, rs1413711 and rs3025039 were the six single nucleotide polymorphisms that were scrutinized. Genotyping was carried out by polymerase chain reaction and restriction fragment length polymorphism. rs 3025039 showed immense promise as a marker for disease aggression and recurrence and a factor for poor prognosis. rs699947 showed least association with the disease and clinico-pathologic factors studied. rs833061, rs 1570360 showed significant association with some clinico-pathological factors such as bilateral affliction of ovaries and post operative CA-125 levels. rs2010963 associated with presence of ascites in higher volumes. The SNPs under consideration showed no formidable linkage in our study samples. A haplotype analysis (excluding rs699947 and rs1413711) revealed 5 frontrunners being present in >85% of the population with TGGC and CGCC associating significantly as protective and risk factors respectively. These haplotypes showed a dose dependent additive effect of their seeming functionality. This study is unique and a first of its kind carried out in the Indian population of South-east Asia.	[Janardhan, Bhaskari; Vaderhobli, Shilpa; Bhagat, Rahul; Gawari, Ramesh; Krishnamoorthy, Lakshmi] Kidwai Mem Inst Oncol, Dept Biochem, Bangalore 560029, Karnataka, India; [Srinivasamurthy, Premalata Chennagiri] Kidwai Mem Inst Oncol, Dept Pathol, Bangalore 560029, Karnataka, India; [Reddihalli, Pallavi Venketeshiah] Kidwai Mem Inst Oncol, Dept Gyneconcol, Bangalore 560029, Karnataka, India	Kidwai Memorial Institute of Oncology; Kidwai Memorial Institute of Oncology; Kidwai Memorial Institute of Oncology	Krishnamoorthy, L (corresponding author), Sri Shankara Canc Hosp & Res Ctr, Dept Biochem, Bangalore 560004, Karnataka, India.	vkrishlakshmi@gmail.com			Indian Council of Medical Research [5/13/28/2010-NCD-III]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council of Medical Research, Ref No: 5/13/28/2010-NCD-III. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates DO, 2002, CANCER RES, V62, P4123; Bhaskari J, 2013, AUSTRAL ASIAN J CANC, V12, P269; Crawford Y, 2009, CELL TISSUE RES, V335, P261, DOI 10.1007/s00441-008-0675-8; Dekel YR, 2005, BBRC, V332, P271; Duhoux FP, 2010, J ONCOL, V2010, DOI 10.1155/2010/372547; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hofmann G, 2008, J CANCER RES CLIN, V134, P591, DOI 10.1007/s00432-007-0322-x; Jacobs EJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1400; JAIN L, 2009, MCR, V10, P1158; Kataoka N, 2006, CANCER EPIDEM BIOMAR, V15, P1148, DOI 10.1158/1055-9965.EPI-05-0871; Kim A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-14; Kong SY, 2007, HEPATOLOGY, V46, P446, DOI 10.1002/hep.21720; Langsenlehner T, 2008, EUR J CANCER, V44, P1572, DOI 10.1016/j.ejca.2008.04.021; Murthy NS, 2009, ASIAN PAC J CANCER P, V10, P1025; Park YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047158; PERETZ D, 1992, BIOCHEM BIOPH RES CO, V182, P1340, DOI 10.1016/0006-291X(92)91880-Y; Rinck JS, 2015, J CANCER RES CLIN, V141, P69, DOI 10.1007/s00432-014-1786-0; Seo JS, 2005, RHEUMATOLOGY, V44, P1299, DOI 10.1093/rheumatology/kei013; Smerdel MP, 2009, INT J GYNECOL CANCER, V19, P578, DOI 10.1111/IGC.0b013e3181a13168; Steffensen KD, 2010, GYNECOL ONCOL, V117, P109, DOI 10.1016/j.ygyno.2009.11.011; Stemke-Hale K, 2013, MODERN PATHOL, V26, P544, DOI 10.1038/modpathol.2012.194; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Varey AHR, 2008, BRIT J CANCER, V98, P1366, DOI 10.1038/sj.bjc.6604308; Woolard J, 2004, CANCER RES, V64, P7822, DOI 10.1158/0008-5472.CAN-04-0934; Yang XF, 2011, MOL VIS, V17, P3088; Zarbock R, 2009, HUM MOL GENET, V18, P3344, DOI 10.1093/hmg/ddp259; Zhai RH, 2008, CLIN CANCER RES, V14, P612, DOI 10.1158/1078-0432.CCR-07-1655	27	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131190	10.1371/journal.pone.0131190	http://dx.doi.org/10.1371/journal.pone.0131190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158818	Green Submitted, gold, Green Published			2022-12-27	WOS:000358161200026
J	Folayan, MO; Adebajo, S; Adeyemi, A; Ogungbemi, M				Folayan, Morenike Oluwatoyin; Adebajo, Sylvia; Adeyemi, Adedayo; Ogungbemi, Micheal			Differences in Sexual Practices, Sexual Behavior and HIV Risk Profile between Adolescents and Young Persons in Rural and Urban Nigeria	PLOS ONE			English	Article							PREVALENCE; HEALTH; WOMEN	Introduction We aimed to determine differences in sexual practices, HIV sexual risk behaviors, and HIV risk profile of adolescents and young persons' in rural and urban Nigeria. Methodology We recruited 772 participants 15 to 24 years old from urban and rural townships in Nigeria through a household survey. Information on participants' socio-demographic profile (age sex, residential area, number of meals taken per day), sexual practices (vagina, oral and anal sex; heterosexual and homosexual sex; sex with spouse, casual acquaintances, boy/girlfriend and commercial sex workers), sexual behavior (age of sexual debut, use of condom, multiple sex partners, transactional sex and age of sexual partner), and other HIV risk factors (use of alcohol and psychoactive substances, reason for sexual debut, knowledge of HIV prevention and HIV transmission, report of STI symptoms) were collected through an interviewer administered questionnaire. Differences in sexual behavior and sexual practices of adolescents and HIV risk profile of adolescents and young persons resident in urban and rural areas were determined. Results More than half (53.5%) of the respondents were sexually active, with more residing in the rural than urban areas (64.9% vs 44.1%; p<0.001) and more resident in the rural area reporting having more than one sexual partner (29.5% vs 20.4%; p = 0.04). Also, 97.3% of sexually active respondents reported having vaginal sex, 8.7% reported oral sex and 1.9% reported anal sex. More male than female respondents in the urban area used condoms during the last vaginal sexual intercourse (69.1% vs 51.9%; p = 0.02), and reported sex with casual partners (7.0% vs 15.3%; p = 0.007). More female than male respondents residing in the rural area engaged in transactional sex (1.0% vs 6.7%; p = 0.005). More females than males in both rural (3.6% vs 10.2%; p = 0.04) and urban (4.7% vs 26.6%; p<0.001) areas self-reported a history of discharge. More females than males in both rural (1.4% vs 17.0%; p = 0.04) and urban (15.0% vs 29.1%; p<0.001) areas self-reported a history of itching. Conclusion There are differences in the sexual behavior and practices of adolescents and young persons' residing in the urban and rural area with implication for HIV prevention programming.	[Folayan, Morenike Oluwatoyin] Obafemi Awolowo Univ, Inst Publ Hlth, Ife, Nigeria; [Folayan, Morenike Oluwatoyin] Obafemi Awolowo Univ, Dept Child Dent Hlth, Ife, Nigeria; [Adebajo, Sylvia] Populat Council, Abuja, Nigeria; [Adeyemi, Adedayo] MEASURE, Asokoro, Abuja, Nigeria; [Ogungbemi, Micheal] Natl Agcy Control AIDS, Strateg Knowledge Management Unit, Abuja, Nigeria	Obafemi Awolowo University; Obafemi Awolowo University	Folayan, MO (corresponding author), Obafemi Awolowo Univ, Inst Publ Hlth, Ife, Nigeria.	toyinukpong@yahoo.co.uk	Folayan, Morenike/A-8632-2018	Folayan, Morenike/0000-0002-9008-7730	Africa Initiative	Africa Initiative	Funding for this study was obtained through a grant support from Africa Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboki H, 2014, AFR J REPROD HEALTH, V18, P109; Bamidele James Olusegun, 2009, Int J Adolesc Med Health, V21, P387, DOI 10.1515/IJAMH.2009.21.3.387; Brody S, 2005, PLOS MED, V2, P458, DOI 10.1371/journal.pmed.0020137; Brown JD, 2009, COMMUN RES, V36, P129, DOI 10.1177/0093650208326465; Darj E, 2010, SEX REPROD HEALTHC, V1, P111, DOI 10.1016/j.srhc.2010.03.001; Dodoo FNA, 2007, SOC SCI MED, V64, P1019, DOI 10.1016/j.socscimed.2006.10.007; Federal Ministry of Health, 2005, NAT HIV AIDS REPR HL; Federal Ministry of Health, 2007, NAT HIV AIDS REPR HL; Federal Ministry of Health, 2010, 2010 NAT HIV SER SEN; Federal Ministry of Health, 2010, HIV STI INT BIOL BEH; Federal Ministry of Health, 2008, HIV STI INT BIOL BEH; Folayan MO, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-83; Folayan MO, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25583; Halperin DT, 1999, AIDS PATIENT CARE ST, V13, P717, DOI 10.1089/apc.1999.13.717; L'Engle KL, 2006, J ADOLESCENT HEALTH, V38, P186, DOI 10.1016/j.jadohealth.2005.03.020; Mmari K, 2014, ARCH DIS CHILD, V99, P778, DOI 10.1136/archdischild-2013-304072; National Agency for the Control of AIDS, 2014, GLOB AIDS RESP COUNT; National Agency for the Control of AIDS, 2008, MOD HIV TRANSM NIG A; Ogungbemi K, 2014, NIGERIAN J HLTH SCI, V14, P16; Okpani A O, 2000, Afr J Reprod Health, V4, P40, DOI 10.2307/3583241; UNAIDS, 2012, FACTSH; Voeten HACM, 2004, SEX TRANSM DIS, V31, P481, DOI 10.1097/01.olq.0000135989.14131.9d; WebMD, HIGH RISK SEX BEH TO	23	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0129106	10.1371/journal.pone.0129106	http://dx.doi.org/10.1371/journal.pone.0129106			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26171859	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900003
J	Tsuzuki, T; Shinozaki, S; Nakamoto, H; Kaneki, M; Goto, S; Shimokado, K; Kobayashi, H; Naito, H				Tsuzuki, Takamasa; Shinozaki, Shohei; Nakamoto, Hideko; Kaneki, Masao; Goto, Sataro; Shimokado, Kentaro; Kobayashi, Hiroyuki; Naito, Hisashi			Voluntary Exercise Can Ameliorate Insulin Resistance by Reducing iNOS-Mediated S-Nitrosylation of Akt in the Liver in Obese Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HYPERPHAGIC OLETF RATS; PROTEIN-KINASE-B/AKT; SKELETAL-MUSCLE; ADIPOSE-TISSUE; ENDURANCE EXERCISE; METABOLIC SYNDROME; RECEPTOR SUBSTRATE-1; GLUCOSE-HOMEOSTASIS; NITROSATIVE STRESS	Voluntary exercise can ameliorate insulin resistance. The underlying mechanism, however, remains to be elucidated. We previously demonstrated that inducible nitric oxide synthase (iNOS) in the liver plays an important role in hepatic insulin resistance in the setting of obesity. In this study, we tried to verify our hypothesis that voluntary exercise improves insulin resistance by reducing the expression of iNOS and subsequent S-nitrosylation of key molecules of glucose metabolism in the liver. Twenty-one Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of type 2 diabetes mellitus, and 18 non-diabetic control Long-Evans Tokushima Otsuka (LETO) rats were randomly assigned to a sedentary group or exercise group subjected to voluntary wheel running for 20 weeks. The voluntary exercise significantly reduced the fasting blood glucose and HOMA-IR in the OLETF rats. In addition, the exercise decreased the amount of iNOS mRNA in the liver in the OLETF rats. Moreover, exercise reduced the levels of S-nitrosylated Akt in the liver, which were increased in the OLETF rats, to those observed in the LETO rats. These findings support our hypothesis that voluntary exercise improves insulin resistance, at least partly, by suppressing the iNOS expression and subsequent S-nitrosylation of Akt, a key molecule of the signal transduction pathways in glucose metabolism in the liver.	[Tsuzuki, Takamasa; Kobayashi, Hiroyuki; Naito, Hisashi] Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba, Japan; [Tsuzuki, Takamasa] Japan Soc Promot Sci, Tokyo, Japan; [Shinozaki, Shohei] Tokyo Med & Dent Univ, Grad Sch Med, Dept Arteriosclerosis & Vasc Biol, Tokyo, Japan; [Nakamoto, Hideko; Goto, Sataro] Juntendo Univ, Grad Sch Hlth & Sports Sci, Inst Hlth & Sports Sci & Med, Chiba, Japan; [Kaneki, Masao] Harvard Univ, Sch Med, Shriners Hosp Children, Dept Anesthesia Crit Care & Pain Med,Massachusett, Charlestown, MA USA; [Shimokado, Kentaro] Tokyo Med & Dent Univ, Grad Sch Med, Dept Geriatr & Vasc Med, Tokyo, Japan; [Kobayashi, Hiroyuki] Tsukuba Univ Hosp, Mito Med Ctr, Dept Gen Med, Ibaraki, Japan	Juntendo University; Japan Society for the Promotion of Science; Tokyo Medical & Dental University (TMDU); Juntendo University; Harvard University; Tokyo Medical & Dental University (TMDU); University of Tsukuba	Naito, H (corresponding author), Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba, Japan.	hnaitou@juntendo.ac.jp	Tsuzuki, Takamasa/S-3563-2019; Shinozaki, Shohei/AAT-3018-2021; Naito, Hisashi/F-5655-2011	Tsuzuki, Takamasa/0000-0002-0241-1183; Naito, Hisashi/0000-0002-0522-9512; Andrews, Zane B./0000-0002-9097-7944	MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1101008]; JSPS [13J10819]; JSPS KANKENHI [25860231]; Kato Memorial Bioscience Foundation; Takeda Science Foundation; Japan Atherosclerosis Research Foundation	MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KANKENHI; Kato Memorial Bioscience Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Atherosclerosis Research Foundation	This work was supported by grants from the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1101008) to H. Naito, a Grant-in-Aid for JSPS Fellows (13J10819) to T. Tsuzuki, JSPS KANKENHI (25860231), Kato Memorial Bioscience Foundation and Takeda Science Foundation to S. Shinozaki and the Japan Atherosclerosis Research Foundation to K. Shimokado. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anand P, 2012, J MOL MED, V90, P233, DOI 10.1007/s00109-012-0878-z; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Carvalho MA, 2009, DIABETOLOGIA, V52, P2425, DOI 10.1007/s00125-009-1498-1; Chang YS, 2005, J LIPID RES, V46, P2624, DOI 10.1194/jlr.M500154-JLR200; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Crissey JM, 2014, AM J PHYSIOL-REG I, V306, pR596, DOI 10.1152/ajpregu.00493.2013; Dallaire P, 2008, DIABETES, V57, P1999, DOI 10.2337/db08-0540; Eghbalzadeh K, 2014, NITRIC OXIDE-BIOL CH, V37, P28, DOI 10.1016/j.niox.2013.12.009; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fontana L, 2010, AGE, V32, P97, DOI 10.1007/s11357-009-9118-z; Frank LL, 2005, OBES RES, V13, P615, DOI 10.1038/oby.2005.66; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; Galbo T, 2013, P NATL ACAD SCI USA, V110, P12780, DOI 10.1073/pnas.1311176110; GOODYEAR LJ, 1992, J APPL PHYSIOL, V72, P143, DOI 10.1152/jappl.1992.72.1.143; GOODYEAR LJ, 1992, DIABETES, V41, P1091, DOI 10.2337/diabetes.41.9.1091; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Herrema H, 2014, BIOCHEM BIOPH RES CO, V443, P689, DOI 10.1016/j.bbrc.2013.12.023; Hilder TL, 2003, FEBS LETT, V553, P63, DOI 10.1016/S0014-5793(03)00972-4; HILL JO, 1983, PHYSIOL BEHAV, V31, P133, DOI 10.1016/0031-9384(83)90107-5; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jenkins NT, 2012, J APPL PHYSIOL, V113, P1873, DOI 10.1152/japplphysiol.00936.2012; Jung TW, 2014, MOL CELL ENDOCRINOL, V391, P30, DOI 10.1016/j.mce.2014.04.012; Kaneki M, 2007, ANTIOXID REDOX SIGN, V9, P319, DOI 10.1089/ars.2006.1464; Kano Y, 2011, AM J PHYSIOL-REG I, V301, pR1350, DOI 10.1152/ajpregu.00294.2011; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Lakka TA, 2007, APPL PHYSIOL NUTR ME, V32, P76, DOI [10.1139/H06-113, 10.1139/h06-113]; Laye MJ, 2009, J PHYSIOL-LONDON, V587, P3729, DOI 10.1113/jphysiol.2009.172601; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Linden MA, 2013, AM J PHYSIOL-REG I, V304, pR763, DOI 10.1152/ajpregu.00537.2012; Liu QL, 2012, FREE RADICAL BIO MED, V53, P250, DOI 10.1016/j.freeradbiomed.2012.05.012; Louche K, 2013, J CLIN ENDOCR METAB, V98, P4863, DOI 10.1210/jc.2013-2058; Lu XM, 2013, INT J MOL MED, V31, P740, DOI 10.3892/ijmm.2013.1241; Malhotra D, 2011, J CLIN INVEST, V121, P4289, DOI 10.1172/JCI45144; McGillicuddy FC, 2013, AM J PHYSIOL-ENDOC M, V305, pE834, DOI 10.1152/ajpendo.00297.2013; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Morris PJ, 2003, OBES RES, V11, P1333, DOI 10.1038/oby.2003.180; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park YH, 2013, BIOCHEM BIOPH RES CO, V435, P244, DOI 10.1016/j.bbrc.2013.04.071; Pauli JR, 2008, J PHYSIOL-LONDON, V586, P659, DOI 10.1113/jphysiol.2007.142414; Pereira SMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031132; Radak Z, 2004, FASEB J, V18, P749, DOI 10.1096/fj.03-0509fje; Rector RS, 2008, AM J PHYSIOL-GASTR L, V294, pG619, DOI 10.1152/ajpgi.00428.2007; Rector RS, 2011, AM J PHYSIOL-GASTR L, V300, pG874, DOI 10.1152/ajpgi.00510.2010; Rector RS, 2010, AM J PHYSIOL-ENDOC M, V298, pE1179, DOI 10.1152/ajpendo.00703.2009; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Salanova M, 2013, REDOX BIOL, V1, P514, DOI 10.1016/j.redox.2013.10.006; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Schroeder M, 2010, HORM BEHAV, V57, P496, DOI 10.1016/j.yhbeh.2010.02.008; Sheldon RD, 2014, J APPL PHYSIOL, V116, P1156, DOI 10.1152/japplphysiol.01275.2013; SHIMA K, 1993, METABOLISM, V42, P971, DOI 10.1016/0026-0495(93)90009-D; Shinozaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075249; Shinozaki S, 2011, J BIOL CHEM, V286, P34959, DOI 10.1074/jbc.M110.187666; Sugita M, 2012, METABOLISM, V61, P127, DOI 10.1016/j.metabol.2011.06.001; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; Wagh Arati, 2004, Expert Rev Cardiovasc Ther, V2, P213, DOI 10.1586/14779072.2.2.213; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Yatsuya H, 2014, OBES RES CLIN PRACT, V8, pE350, DOI 10.1016/j.orcp.2013.08.002; Zhang BC, 2004, CELL SIGNAL, V16, P837, DOI 10.1016/j.cellsig.2004.01.001	64	22	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132029	10.1371/journal.pone.0132029	http://dx.doi.org/10.1371/journal.pone.0132029			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172834	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900027
J	Zhao, DJ; Lin, MY; Chen, J; Pedrosa, E; Hrabovsky, A; Fourcade, HM; Zheng, DY; Lachman, HM				Zhao, Dejian; Lin, Mingyan; Chen, Jian; Pedrosa, Erika; Hrabovsky, Anastasia; Fourcade, H. Matthew; Zheng, Deyou; Lachman, Herbert M.			MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del	PLOS ONE			English	Article							CARDIO-FACIAL SYNDROME; AUTISM SPECTRUM DISORDER; DELETION SYNDROME; VELOCARDIOFACIAL SYNDROME; SYNAPTIC-TRANSMISSION; EXPRESSION PATTERNS; PREFRONTAL CORTEX; SIGNALING PATHWAY; RISK-FACTOR; GENE	We are using induced pluripotent stem cell (iPSC) technology to study neuropsychiatric disorders associated with 22q11.2 microdeletions (del), the most common known schizophrenia (SZ)-associated genetic factor. Several genes in the region have been implicated; a promising candidate is DGCR8, which codes for a protein involved in microRNA (miRNA) biogenesis. We carried out miRNA expression profiling (miRNA-seq) on neurons generated from iPSCs derived from controls and SZ patients with 22q11.2 del. Using thresholds of p<0.01 for nominal significance and 1.5-fold differences in expression, 45 differentially expressed miRNAs were detected (13 lower in SZ and 32 higher). Of these, 6 were significantly down-regulated in patients after correcting for genome wide significance (FDR<0.05), including 4 miRNAs that map to the 22q11.2 del region. In addition, a nominally significant increase in the expression of several miRNAs was found in the 22q11.2 neurons that were previously found to be differentially expressed in autopsy samples and peripheral blood in SZ and autism spectrum disorders (e.g., miR-34, miR-4449, miR-146b-3p, and miR-23a-5p). Pathway and function analysis of predicted mRNA targets of the differentially expressed miRNAs showed enrichment for genes involved in neurological disease and psychological disorders for both up and down regulated miRNAs. Our findings suggest that: i. neurons with 22q11.2 del recapitulate the miRNA expression patterns expected of 22q11.2 haploinsufficiency, ii. differentially expressed miRNAs previously identified using autopsy samples and peripheral cells, both of which have significant methodological problems, are indeed disrupted in neuropsychiatric disorders and likely have an underlying genetic basis.	[Zhao, Dejian; Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Lin, Mingyan; Zheng, Deyou; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Chen, Jian; Pedrosa, Erika; Hrabovsky, Anastasia; Fourcade, H. Matthew; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Zheng, Deyou; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Lachman, Herbert M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Zheng, DY (corresponding author), Albert Einstein Coll Med, Dept Neurol, 1300 Morris Pk Ave, Bronx, NY 10467 USA.	deyou.zheng@einstein.yu.edu; herb.lachman@einstein.yu.edu	lin, mingyan/HDL-9420-2022; Zhao, Dejian/C-8321-2009	Zhao, Dejian/0000-0002-2105-3799; Zheng, Deyou/0000-0003-4354-5337	National Institute of Mental Health [MH087840, MH099427, MH093869, MH099452]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099427, R21MH093869, R21MH099452, R21MH087840, R33MH087840] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health grants MH087840, MH099427, MH093869 and MH099452. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 2008, NEUROGENETICS, V9, P153, DOI 10.1007/s10048-008-0133-5; Ahn K, 2014, MOL PSYCHIATR, V19, P568, DOI 10.1038/mp.2013.59; Aneja A, 2007, J CHILD ADOL PSYCHOP, V17, P105, DOI 10.1089/cap.2006.0023; Antshel KM, 2007, J AUTISM DEV DISORD, V37, P1776, DOI 10.1007/s10803-006-0308-6; Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bassett Anne S, 2008, Curr Psychiatry Rep, V10, P148; Belkaya S, 2013, J BIOL CHEM, V288, P30752, DOI 10.1074/jbc.M113.503532; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Beveridge NJ, 2014, SCHIZOPHRENIA BULL, V40, P399, DOI 10.1093/schbul/sbs198; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Brzustowicz Linda M., 2012, Frontiers in Genetics, V3, P291, DOI 10.3389/fgene.2012.00291; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Carlson C, 1997, AM J HUM GENET, V60, P851; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Cheung ENM, 2014, GENET MED, V16, P40, DOI 10.1038/gim.2013.71; Chiang CH, 2011, MOL PSYCHIATR, V16, P358, DOI 10.1038/mp.2011.13; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Clarke MC, 2012, BIOL PSYCHIAT, V71, P836, DOI 10.1016/j.biopsych.2012.01.011; Clarke RA, 2009, CASE REP MED, V2009, DOI 10.1155/2009/361518; Clipperton-Allen AE, 2014, HUM MOL GENET, V23, P3490, DOI 10.1093/hmg/ddu057; Das S, 2012, DEV DYNAM, V241, P1260, DOI 10.1002/dvdy.23811; de la Morena MT, 2013, CLIN IMMUNOL, V147, P11, DOI 10.1016/j.clim.2013.01.011; DeRosa BA, 2012, NEUROSCI LETT, V516, P9, DOI 10.1016/j.neulet.2012.02.086; Doherty JL, 2012, CLIN GENET, V81, P103, DOI 10.1111/j.1399-0004.2011.01773.x; Drerup CM, 2009, DEVELOPMENT, V136, P2623, DOI 10.1242/dev.030577; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; Earls LR, 2012, J NEUROSCI, V32, P14132, DOI 10.1523/JNEUROSCI.1312-12.2012; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Farra N, 2012, MOL PSYCHIATR, V17, P1261, DOI 10.1038/mp.2011.180; Forstner AJ, 2014, J PSYCHIATR NEUROSCI, V39, P386, DOI 10.1503/jpn.130189; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garbett KA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.24; Gasso P, 2014, J PSYCHIATR RES, V48, P94, DOI 10.1016/j.jpsychires.2013.09.017; Ghanizadeh A, 2011, INT J HYPERTHER, V27, P737, DOI 10.3109/02656736.2011.604665; Gothelf D, 2013, J AM ACAD CHILD PSY, V52, P1192, DOI 10.1016/j.jaac.2013.08.008; Green GH, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1302; Green MJ, 2013, MOL PSYCHIATR, V18, P774, DOI 10.1038/mp.2012.84; Guo R, 2012, MOLECULES, V17, P14733, DOI 10.3390/molecules171214733; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hall J., 2014, BIOL PSYCHIAT; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Henshall DC, 2014, CURR OPIN NEUROL, V27, P199, DOI 10.1097/WCO.0000000000000079; Hiramoto T, 2011, HUM MOL GENET, V20, P4775, DOI 10.1093/hmg/ddr404; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hsiao EY, 2012, P NATL ACAD SCI USA, V109, P12776, DOI 10.1073/pnas.1202556109; Hsu R, 2012, MOL CELL NEUROSCI, V50, P283, DOI 10.1016/j.mcn.2012.06.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isserlin Ruth, 2014, F1000Res, V3, P141, DOI 10.12688/f1000research.4536.1; Isshiki M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5742; Ivanov D, 2003, BRIT J PSYCHIAT, V183, P409, DOI 10.1192/bjp.183.5.409; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Karayiorgou M, 2004, MOL BRAIN RES, V132, P95, DOI 10.1016/j.molbrainres.2004.09.029; Kates WR, 2007, AM J MED GENET A, V143A, P2642, DOI 10.1002/ajmg.a.32012; Kates WR, 2006, J AM ACAD CHILD PSY, V45, P587, DOI 10.1097/01.chi.0000205704.33077.4a; Kim AH, 2012, SCHIZOPHR RES, V141, P60, DOI 10.1016/j.schres.2012.06.038; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Kim KY, 2012, TRENDS MOL MED, V18, P463, DOI 10.1016/j.molmed.2012.06.002; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Kumarasinghe N, 2013, INT J NEUROPSYCHOPH, V16, P1483, DOI 10.1017/S1461145713000035; Kwon E, 2013, MOL PSYCHIATR, V18, P11, DOI 10.1038/mp.2011.170; Lachman HM, 1996, AM J MED GENET, V67, P468, DOI 10.1002/(SICI)1096-8628(19960920)67:5<468::AID-AJMG5>3.0.CO;2-G; Lai CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021635; Lambert TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015182; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leblond CS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004580; Lepagnol-Bestel AM, 2013, MOL CELL NEUROSCI, V54, P84, DOI 10.1016/j.mcn.2013.01.006; Lett TA, 2013, MOL PSYCHIATR, V18, P443, DOI 10.1038/mp.2013.17; Li T, 2008, AM J MED GENET B, V147B, P654, DOI 10.1002/ajmg.b.30648; Lin MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094968; Lin MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044017; Lin MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023356; Lionel AC, 2013, HUM MOL GENET, V22, P2055, DOI 10.1093/hmg/ddt056; Liu J, 2012, STEM CELL REV REP, V8, P1129, DOI 10.1007/s12015-012-9411-6; Liu T, 2015, MOL NEUROBIOL, V51, P1053, DOI 10.1007/s12035-014-8770-1; Liu YF, 2013, STAT INTERFACE, V6, P1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lv JW, 2013, NEUROSCI BULL, V29, P773, DOI 10.1007/s12264-013-1382-3; Maekawa M, 2014, BIOL PSYCHIAT; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Merico D, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00238; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Meza-Sosa KF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00175; Migliore C, 2008, CANCER RES, V68, P10128, DOI 10.1158/0008-5472.CAN-08-2148; Missler M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005694; Montojo CA, 2013, CEREB CORTEX; Moreau MP, 2011, BIOL PSYCHIAT, V69, P188, DOI 10.1016/j.biopsych.2010.09.039; Morgado AL, 2015, MOL NEUROBIOL, V51, P1168, DOI 10.1007/s12035-014-8794-6; Muenthaisong S, 2012, EXP CELL RES, V318, P2482, DOI 10.1016/j.yexcr.2012.07.014; Murdoch JD, 2013, CURR OPIN GENET DEV, V23, P310, DOI 10.1016/j.gde.2013.02.003; Murphy KC, 2001, BRIT J PSYCHIAT, V179, P397, DOI 10.1192/bjp.179.5.397; Na KS, 2014, PROG NEURO-PSYCHOPH, V48, P277, DOI 10.1016/j.pnpbp.2012.10.022; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Pal R, 2013, J BIOSCI BIOENG, V115, P200, DOI 10.1016/j.jbiosc.2012.08.018; Pantano L, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1127; Papolos DF, 1998, MOL PSYCHIATR, V3, P346, DOI 10.1038/sj.mp.4000410; Parker-Athill EC, 2010, NEUROSIGNALS, V18, P113, DOI 10.1159/000319828; Penzes P, 2013, J NEUROCHEM, V126, P165, DOI 10.1111/jnc.12261; Pietrzykowski AZ, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00389; Porteous D, 2009, NEURON, V63, P711, DOI 10.1016/j.neuron.2009.09.017; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Robertson MM, 2006, J PSYCHOSOM RES, V61, P365, DOI 10.1016/j.jpsychores.2006.06.011; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Santarelli DM, 2011, BIOL PSYCHIAT, V69, P180, DOI 10.1016/j.biopsych.2010.09.030; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-14; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; Schneider M, 2014, AM J PSYCHIAT, V171, P627, DOI 10.1176/appi.ajp.2013.13070864; Schofield CM, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-11; Schulte LN, 2013, NUCLEIC ACIDS RES, V41, P542, DOI 10.1093/nar/gks1030; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Seno MMG, 2011, BRAIN RES, V1380, P85, DOI 10.1016/j.brainres.2010.09.046; Shaham L, 2015, BLOOD, V125, P1292, DOI 10.1182/blood-2014-06-581892; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; Simao I, 2013, J PEDIATR ENDOCR MET, V26, P381, DOI 10.1515/jpem-2012-0348; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Smalheiser NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086469; Smalheiser NR, 2009, NEUROMOL MED, V11, P133, DOI 10.1007/s12017-009-8065-2; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Stappert L, 2015, CELL TISSUE RES, V359, P47, DOI 10.1007/s00441-014-1981-y; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Strange A, 2012, BIOL PSYCHIAT, V72, P620, DOI 10.1016/j.biopsych.2012.05.035; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tian Y, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0075-5; Tsai NP, 2012, CELL, V151, P1581, DOI 10.1016/j.cell.2012.11.040; Urdinguio RG, 2010, EPIGENETICS-US, V5, P656, DOI 10.4161/epi.5.7.13055; Vaishnavi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056781; van Spronsen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074907; Vergoulis T, 2014, BIOINFORMATICS; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Wang LG, 2015, GENE, V554, P1, DOI 10.1016/j.gene.2014.10.032; Wei HG, 2012, BBA-MOL BASIS DIS, V1822, P831, DOI 10.1016/j.bbadis.2012.01.011; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu B, 2013, CELL, V152, P262, DOI 10.1016/j.cell.2012.11.052; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Yao JJ, 2013, AM J PHYSIOL-CELL PH, V305, pC197, DOI 10.1152/ajpcell.00041.2013; Zerbo O, 2013, J AUTISM DEV DISORD, V43, P25, DOI 10.1007/s10803-012-1540-x; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072652; Zhao WN, 2012, J BIOMOL SCREEN, V17, P1252, DOI 10.1177/1087057112456876	147	63	65	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132387	10.1371/journal.pone.0132387	http://dx.doi.org/10.1371/journal.pone.0132387			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173148	gold, Green Submitted, Green Published			2022-12-27	WOS:000358194900048
J	Gil-Alonso, S; Jauregizar, N; Eraso, E; Quindos, G				Gil-Alonso, Sandra; Jauregizar, Nerea; Eraso, Elena; Quindos, Guillermo			Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis	PLOS ONE			English	Article							IN-VITRO ACTIVITY; TIME-KILL; ANTIFUNGAL SUSCEPTIBILITY; AMPHOTERICIN-B; C. PARAPSILOSIS; ECHINOCANDINS; ANIDULAFUNGIN; CASPOFUNGIN; GLABRATA; ORTHOPSILOSIS	Micafungin is an effective antifungal agent useful for the therapy of invasive candidiasis. Candida albicans is the most common cause of invasive candidiasis; however, infections due to non-C. albicans species, such as Candida parapsilosis, are rising. Killing and postantifungal effects (PAFE) are important factors in both dose interval choice and infection outcome. The aim of this study was to determinate the micafungin PAFE against 7 C. albicans strains, 5 Candida dubliniensis, 2 Candida Africana, 3 C. parapsilosis, 2 Candida metapsilosis and 2 Candida orthopsilosis. For PAFE studies, cells were exposed to micafungin for 1 h at concentrations ranging from 0.12 to 8 mu g/ml. Time-kill experiments (TK) were conducted at the same concentrations. Samples were removed at each time point (0-48 h) and viable counts determined. Micafungin (2 mu g/ml) was fungicidal (>= 3 log(10) reduction) in TK against 5 out of 14 (36%) strains of C. albicans complex. In PAFE experiments, fungicidal endpoint was achieved against 2 out of 14 strains (14%). In TK against C. parapsilosis, 8 mu g/ml of micafungin turned out to be fungicidal against 4 out 7 (57%) strains. Conversely, fungicidal endpoint was not achieved in PAFE studies. PAFE results for C. albicans complex (41.83 +/- 2.18 h) differed from C. parapsilosis complex (8.07 +/- 4.2 h) at the highest tested concentration of micafungin. In conclusion, micafungin showed significant differences in PAFE against C. albicans and C. parapsilosis complexes, being PAFE for the C. albicans complex longer than for the C. parapsilosis complex.	[Gil-Alonso, Sandra; Eraso, Elena; Quindos, Guillermo] Univ Basque Country, Euskal Herriko Unibertsitatea, Fac Med & Odontol, Dept Inmunol Microbiol & Parasitol,Unidad Formac, E-48080 Bilbao, Bizkaia, Spain; [Gil-Alonso, Sandra; Jauregizar, Nerea] Univ Basque Country, Euskal Herriko Unibertsitatea, Fac Med & Odontol, Dept Farmacol,Unidad Formac & Invest Multidiscipl, E-48080 Bilbao, Bizkaia, Spain	University of Basque Country; University of Basque Country	Quindos, G (corresponding author), Univ Basque Country, Euskal Herriko Unibertsitatea, Fac Med & Odontol, Dept Inmunol Microbiol & Parasitol,Unidad Formac, E-48080 Bilbao, Bizkaia, Spain.	guillermo.quindos@ehu.eus	Jauregizar, Nerea/AAD-4042-2020; Quindós, Guillermo/I-2577-2015; Eraso, Elena/K-5443-2013	Quindós, Guillermo/0000-0003-0438-2248; Eraso, Elena/0000-0002-9043-9265; Gil-Alonso, Sandra/0000-0002-1470-4442	Consejeria de Educacion, Universidades e Investigacion [GIC12 210-IT-696-13]; Departamento de Industria, Comercio y Turismo of Gobierno Vasco-Eusko Jaurlaritza [S-PR12UN002, S-PE13UN025, S-PE13UN121]; UPV/EHU [UFI 11/25]; Fondo de Investigacion Sanitaria [FIS PI11/00203]	Consejeria de Educacion, Universidades e Investigacion; Departamento de Industria, Comercio y Turismo of Gobierno Vasco-Eusko Jaurlaritza; UPV/EHU; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This work was supported by Consejeria de Educacion, Universidades e Investigacion (GIC12 210-IT-696-13), the Departamento de Industria, Comercio y Turismo (S-PR12UN002, S-PE13UN025) of Gobierno Vasco-Eusko Jaurlaritza, and UPV/EHU (UFI 11/25). Elena Eraso and Guillermo Quindos have received grant support from Consejeria de Educacion, Universidades e Investigacion (GIC12 210-IT-696-13) and Departamento de Industria, Comercio y Turismo (S-PR12UN002, S-PE13UN121) of Gobierno Vasco-Eusko Jaurlaritza, Fondo de Investigacion Sanitaria (FIS PI11/00203), and UPV/EHU (UFI 11/25).	Canton E, 2004, ANTIMICROB AGENTS CH, V48, P2477, DOI 10.1128/AAC.48.7.2477-2482.2004; Canton E, 2013, J ANTIMICROB CHEMOTH, V68, P864, DOI 10.1093/jac/dks489; Canton E, 2010, ANTIMICROB AGENTS CH, V54, P2194, DOI 10.1128/AAC.01538-09; Gonzalez MC, 2008, REV IBEROAM MICOL, V25, P92, DOI 10.1016/S1130-1406(08)70026-3; Clancy CJ, 2006, ANTIMICROB AGENTS CH, V50, P2569, DOI 10.1128/AAC.00291-06; Clinical and Laboratory Standards Institute, 2012, M27A3S4 CLIN LAB STA; Clinical and Laboratory Standards Institute, 2008, M27A3 CLIN LAB STAND; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; Ellepola ANB, 2015, J INVESTIG CLIN DENT, V6, P186, DOI 10.1111/jicd.12095; Ellepola ANB, 2014, MYCOSES, V57, P56, DOI 10.1111/myc.12102; Emri T, 2013, APPL MICROBIOL BIOT, V97, P3267, DOI 10.1007/s00253-013-4761-9; Ernst EJ, 2000, ANTIMICROB AGENTS CH, V44, P1108, DOI 10.1128/AAC.44.4.1108-1111.2000; Ernst EJ, 2002, ANTIMICROB AGENTS CH, V46, P3846, DOI 10.1128/AAC.46.12.3846-3853.2002; Gil-Alonso S, 2015, DIAGN MICR INFEC DIS, V82, P57, DOI 10.1016/j.diagmicrobio.2015.01.010; Kovacs R, 2014, MYCOPATHOLOGIA, V178, P197, DOI 10.1007/s11046-014-9799-4; Lewis RE, 2002, J ANTIMICROB CHEMOTH, V49, P345, DOI 10.1093/jac/49.2.345; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P2659, DOI 10.1128/JCM.00803-08; Manavathu EK, 2004, J ANTIMICROB CHEMOTH, V53, P386, DOI 10.1093/jac/dkh066; Miranda-Zapico I, 2011, J ANTIMICROB CHEMOTH, V66, P2315, DOI 10.1093/jac/dkr298; Moriyama B, 2012, FUTURE MICROBIOL, V7, P565, DOI [10.2217/fmb.12.31, 10.2217/FMB.12.31]; Moudgal V, 2005, ANTIMICROB AGENTS CH, V49, P767, DOI 10.1128/AAC.49.2.767-769.2005; Nguyen KT, 2010, INT J ANTIMICROB AG, V35, P80, DOI 10.1016/j.ijantimicag.2009.09.003; Nguyen KT, 2009, ANTIMICROB AGENTS CH, V53, P3347, DOI 10.1128/AAC.01480-08; Oz Y, 2013, MED MYCOL, V51, P60, DOI 10.3109/13693786.2012.697198; Peman J, 2012, J ANTIMICROB CHEMOTH, V67, P1181, DOI 10.1093/jac/dks019; Pfaller MA, 2008, J CLIN MICROBIOL, V46, P150, DOI 10.1128/JCM.01901-07; Pfaller MA, 2014, ANTIMICROB AGENTS CH, V58, P916, DOI 10.1128/AAC.02020-13; Quindos G, 2014, REV IBEROAM MICOL, V31, P42, DOI 10.1016/j.riam.2013.10.001; Quindos G, 2009, REV IBEROAM MICOL, V26, P35, DOI 10.1016/S1130-1406(09)70006-3; Smith RP, 2011, DIAGN MICR INFEC DIS, V71, P131, DOI 10.1016/j.diagmicrobio.2011.06.018; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005	31	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132730	10.1371/journal.pone.0132730	http://dx.doi.org/10.1371/journal.pone.0132730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168269	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100072
J	Jabbari, E; Sarvestani, SK; Daneshian, L; Moeinzadeh, S				Jabbari, Esmaiel; Sarvestani, Samaneh K.; Daneshian, Leily; Moeinzadeh, Seyedsina			Optimum 3D Matrix Stiffness for Maintenance of Cancer Stem Cells Is Dependent on Tissue Origin of Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MARROW STROMAL CELLS; BREAST-CANCER; COLORECTAL-CANCER; MOLECULAR SUBTYPE; EXPRESSION; MICROENVIRONMENT; DIFFERENTIATION; PHENOTYPE; HYDROGEL	Introduction The growth and expression of cancer stem cells (CSCs) depend on many factors in the tumor microenvironment. The objective of this work was to investigate the effect of cancer cells' tissue origin on the optimum matrix stiffness for CSC growth and marker expression in a model polyethylene glycol diacrylate (PEGDA) hydrogel without the interference of other factors in the microenvironment. Methods Human MCF7 and MDA-MB-231 breast carcinoma, HCT116 colorectal and AGS gastric carcinoma, and U2OS osteosarcoma cells were used. The cells were encapsulated in PEGDA gels with compressive moduli in the 2-70 kPa range and optimized cell seeding density of 0.6x10(6) cells/mL. Micropatterning was used to optimize the growth of encapsulated cells with respect to average tumorsphere size. The CSC sub-population of the encapsulated cells was characterized by cell number, tumorsphere size and number density, and mRNA expression of CSC markers. Results The optimum matrix stiffness for growth and marker expression of CSC sub-population of cancer cells was 5 kPa for breast MCF7 and MDA231, 25 kPa for colorectal HCT116 and gastric AGS, and 50 kPa for bone U2OS cells. Conjugation of a CD44 binding peptide to the gel stopped tumorsphere formation by cancer cells from different tissue origin. The expression of YAP/TAZ transcription factors by the encapsulated cancer cells was highest at the optimum stiffness indicating a link between the Hippo transducers and CSC growth. The optimum average tumorsphere size for CSC growth and marker expression was 50 mu m. Conclusion The marker expression results suggest that the CSC sub-population of cancer cells resides within a niche with optimum stiffness which depends on the cancer cells' tissue origin.	[Jabbari, Esmaiel; Sarvestani, Samaneh K.; Daneshian, Leily; Moeinzadeh, Seyedsina] Univ S Carolina, Dept Chem Engn, Biomimet Mat & Tissue Engn Lab, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Jabbari, E (corresponding author), Univ S Carolina, Dept Chem Engn, Biomimet Mat & Tissue Engn Lab, Columbia, SC 29208 USA.	jabbari@mailbox.sc.edu	Jabbari, Esmaiel/AAJ-2369-2020	Jabbari, Esmaiel/0000-0001-6548-5422	National Science Foundation [CBET1403545]; National Institutes of Health [AR063745]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR063745] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1403545] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by research grants to EJ from the National Science Foundation under grant No. CBET1403545 and the National Institutes of Health under grant No. AR063745. The funding agencies did not have any role in designing experiments or in preparation of this manuscript.	Abu-Ali S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-47; Baker EL, 2010, BIOPHYS J, V99, P2048, DOI 10.1016/j.bpj.2010.07.051; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biddle A, 2012, CANCER METAST REV, V31, P285, DOI 10.1007/s10555-012-9345-0; Boyd NF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100937; Britton KM, 2012, CANCER LETT, V323, P97, DOI 10.1016/j.canlet.2012.03.041; Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056; Chen Z, 2009, J SURG ONCOL, V99, P414, DOI 10.1002/jso.21270; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Engberg K, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055006; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fang YT, 2012, ONCOL REP, V28, P2115, DOI 10.3892/or.2012.2054; Fenner A, 2012, NAT REV UROL, V9, P473, DOI [10.1038/nrurol.2012.126, 10.1038/nrurol.2012.13, 10.1038/nrurol.2012.139, 10.1038/nrurol.2012.168, 10.1038/nrurol.2012.190, 10.1038/nrurol.2012.119]; Ferraro JT, 2004, AM J PHYSIOL-CELL PH, V286, pC831, DOI 10.1152/ajpcell.00224.2003; Fessler E, 2013, CANCER LETT, V341, P97, DOI 10.1016/j.canlet.2012.10.015; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Flecha FLG, 2003, BIOCHEM MOL BIOL EDU, V31, P319; Hale NA, 2010, ACS APPL MATER INTER, V2, P2317, DOI 10.1021/am100346k; He XZ, 2008, LANGMUIR, V24, P12508, DOI 10.1021/la802447v; He XZ, 2012, LANGMUIR, V28, P5387, DOI 10.1021/la205005h; Henderson JA, 2008, MACROMOL BIOSCI, V8, P499, DOI 10.1002/mabi.200700127; Hibino S, 2004, CANCER RES, V64, P4810, DOI 10.1158/0008-5472.CAN-04-0129; Hiraga T, 2011, ONCOL REP, V25, P289, DOI 10.3892/or_00001073; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Jamal M, 2012, NEOPLASIA, V14, P150, DOI 10.1593/neo.111794; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Liu TJ, 2013, ONCOGENE, V32, P544, DOI 10.1038/onc.2012.85; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louie E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2773; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Mylona E., 2008, EUR S BIOMED ENG, P1; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057; Peppas N.A., 1986, HYDROGELS MED PHARM, DOI DOI 10.1016/80142-9612(03)00332-6; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Roy Sanchita, 2012, J Mol Signal, V7, P11, DOI 10.1186/1750-2187-7-11; Sakai K, 2011, BIOSCI TRENDS, V5, P10, DOI 10.5582/bst.2011.v5.1.10; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Soofi SS, 2009, J STRUCT BIOL, V167, P216, DOI 10.1016/j.jsb.2009.05.005; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Stokes ME, 2008, VALUE HEALTH, V11, P213, DOI 10.1111/j.1524-4733.2007.00226.x; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Sun YR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005498; Tang X, 2010, BIOPHYS J, V99, P2460, DOI 10.1016/j.bpj.2010.08.034; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Tirino V, 2011, FASEB J, V25, P2022, DOI 10.1096/fj.10-179036; Tobin NP, 2015, ANN ONCOL, V26, P81, DOI 10.1093/annonc/mdu498; Tsai WS, 2011, INT J COLORECTAL DIS, V26, P1329, DOI 10.1007/s00384-011-1214-8; Tse HTK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038986; Xie SP, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-40; Yamamoto M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3299; Yan J, 2009, BIOSENS BIOELECTRON, V24, P2604, DOI 10.1016/j.bios.2009.01.029; Yang XM, 2013, TISSUE ENG PT A, V19, P669, DOI [10.1089/ten.TEA.2012.0333, 10.1089/ten.tea.2012.0333]; Yang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059147; Ye J, 2014, TUMOR BIOL, V35, P3945, DOI 10.1007/s13277-013-1561-x; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	66	78	79	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132377	10.1371/journal.pone.0132377	http://dx.doi.org/10.1371/journal.pone.0132377			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168187	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100039
J	Skovgaard, A; Castro-Mejia, JL; Hansen, LH; Nielsen, DS				Skovgaard, Alf; Castro-Mejia, Josue Leonardo; Hansen, Lars Hestbjerg; Nielsen, Dennis Sandris			Host-Specific and pH-Dependent Microbiomes of Copepods in an Extensive Rearing System	PLOS ONE			English	Article							MARINE PLANKTONIC COPEPOD; VIBRIO-CHOLERAE; BACTERIAL COMMUNITY; GUT MICROBIOTA; FECAL PELLETS; MICROORGANISMS; ZOOPLANKTON; DEGRADATION; AEROMONAS; ABUNDANCE	Copepods are to an increasing extent cultivated as feed for mariculture fish larvae with variable production success. In the temperate climate zone, this production faces seasonal limitation due to changing abiotic factors, in particular temperature and light. Furthermore, the production of copepods may be influenced by biotic factors of the culture systems, such as competing microorganisms, harmful algae, or other eukaryotes and prokaryotes that may be non-beneficial for the copepods. In this study, the composition of bacteria associated with copepods was investigated in an extensive outdoor copepod production system. Light microscopy and scanning electron microscopy revealed that bacteria were primarily found attached to the exoskeleton of copepods although a few bacteria were also found in the gut as well as internally in skeletal muscle tissue. Through 16S rRNA gene-targeted denaturing gradient gel electrophoresis (DGGE) analysis, a clear difference was found between the microbiomes of the two copepod species, Acartia tonsa and Centropages hamatus, present in the system. This pattern was corroborated through 454/FLX-based 16S rRNA gene amplicon sequencing of copepod microbiomes, which furthermore showed that the abiotic parameters pH and oxygen concentration in rearing tank water were the key factors influencing composition of copepod microbiomes.	[Skovgaard, Alf] Univ Copenhagen, Dept Vet Dis Biol, DK-1870 Frederiksberg, Denmark; [Castro-Mejia, Josue Leonardo; Nielsen, Dennis Sandris] Univ Copenhagen, Dept Food Sci, DK-1958 Frederiksberg, Denmark; [Hansen, Lars Hestbjerg] Aarhus Univ, Dept Environm Sci, DK-4000 Roskilde, Denmark	University of Copenhagen; University of Copenhagen; Aarhus University	Skovgaard, A (corresponding author), Univ Roskilde, Dept Environm Social & Spatial Change, DK-4000 Roskilde, Denmark.	alf@sund.ku.dk	Skovgaard, Alf/B-5684-2009; Nielsen, Dennis/A-9769-2015; Castro-Mejia, Josue L./P-5649-2014	Nielsen, Dennis/0000-0001-8121-1114; Hestbjerg Hansen, Lars/0000-0003-0027-1524; Castro-Mejia, Josue L./0000-0002-1416-8205	IMPAQ, IMProvement of AQuaculture high quality fish fry production; Danish Council for Strategic Research [10-093522]; AMPHICOP, Acartia tonsa Molecular PHysiology-Implementation of novel and fast tools to assess COPepod physiological states; Villum Foundation [8960]; University of Copenhagen Excellence; Villum Fonden [00008689] Funding Source: researchfish	IMPAQ, IMProvement of AQuaculture high quality fish fry production; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); AMPHICOP, Acartia tonsa Molecular PHysiology-Implementation of novel and fast tools to assess COPepod physiological states; Villum Foundation(Villum Fonden); University of Copenhagen Excellence; Villum Fonden(Villum Fonden)	AS was supported through the projects IMPAQ, IMProvement of AQuaculture high quality fish fry production, funded by the Danish Council for Strategic Research (grant no. 10-093522), and AMPHICOP, Acartia tonsa Molecular PHysiology-Implementation of novel and fast tools to assess COPepod physiological states, funded by the Villum Foundation (project no. 8960). JLC-M was supported by a University of Copenhagen Excellence grant for interdisciplinary research (CALM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; BERTHE FCJ, 1995, DIS AQUAT ORGAN, V21, P151, DOI 10.3354/dao021151; Bojesen AM, 2003, J CLIN MICROBIOL, V41, P5167, DOI 10.1128/JCM.41.11.5167-5172.2003; Brandt P, 2010, HELGOLAND MAR RES, V64, P331, DOI 10.1007/s10152-010-0188-1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carman KR, 1997, MICROSC RES TECHNIQ, V37, P116, DOI 10.1002/(SICI)1097-0029(19970415)37:2<116::AID-JEMT2>3.0.CO;2-M; Colwell R, 2001, HYDROBIOLOGIA, V460, P141, DOI 10.1023/A:1013111016642; Cripps G, 2014, J PLANKTON RES, V36, P1165, DOI 10.1093/plankt/fbu052; De Corte D, 2014, AQUAT MICROB ECOL, V72, P215, DOI 10.3354/ame01696; Drillet G, 2011, AQUACULTURE, V315, P155, DOI 10.1016/j.aquaculture.2011.02.027; Dumontet S, 1996, COMP IMMUNOL MICROB, V19, P245, DOI 10.1016/0147-9571(96)00012-4; Dziallas C, 2013, ARCT ANTARCT ALP RES, V45, P471, DOI 10.1657/1938-4246.45.4.471; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gerdts G, 2013, HELGOLAND MAR RES, V67, P757, DOI 10.1007/s10152-013-0361-4; Grossart HP, 2010, P NATL ACAD SCI USA, V107, P11959, DOI 10.1073/pnas.1000668107; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; Gugliandolo C, 2008, MAR POLLUT BULL, V56, P600, DOI 10.1016/j.marpolbul.2007.12.001; Hansen B, 1996, J PLANKTON RES, V18, P257, DOI 10.1093/plankt/18.2.257; Hansen B, 1996, J PLANKTON RES, V18, P275, DOI 10.1093/plankt/18.2.275; Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7; Hansen PJ, 2002, AQUAT MICROB ECOL, V28, P279, DOI 10.3354/ame028279; Heidelberg JF, 2002, APPL ENVIRON MICROB, V68, P5498, DOI 10.1128/AEM.68.11.5498-5507.2002; Hufeldt MR, 2010, LAB ANIM-UK, V44, P283, DOI 10.1258/la.2010.010058; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; HUNTER JR, 1981, MARINE FISH LARVAE M, P34; HUQ A, 1983, APPL ENVIRON MICROB, V45, P275, DOI 10.1128/AEM.45.1.275-283.1983; IANORA A, 1990, J PLANKTON RES, V12, P249, DOI 10.1093/plankt/12.2.249; Khimmakthong U, 2013, MICROB PATHOGENESIS, V59-60, P33, DOI 10.1016/j.micpath.2013.03.001; KOIE M, 1990, J HELMINTHOL, V64, P193, DOI 10.1017/S0022149X00012165; Krause E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047035; Krych L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062578; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Melo RCN, 2007, MICRON, V38, P714, DOI 10.1016/j.micron.2007.05.002; Moller EF, 2007, AQUAT MICROB ECOL, V47, P99, DOI 10.3354/ame047099; NAGASAWA S, 1989, SCI PROG, V73, P169; NAGASAWA S, 1985, MAR BIOL, V87, P61, DOI 10.1007/BF00397006; NAGASAWA S, 1987, J PLANKTON RES, V9, P749, DOI 10.1093/plankt/9.4.749; NATION JL, 1983, STAIN TECHNOL, V58, P347, DOI 10.3109/10520298309066811; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; Skovgaard A, 2006, MAR ECOL PROG SER, V327, P37, DOI 10.3354/meps327037; Skovgaard A, 2011, J PLANKTON RES, V33, P1311, DOI 10.1093/plankt/fbr027; SOCHARD MR, 1979, APPL ENVIRON MICROB, V37, P750, DOI 10.1128/AEM.37.4.750-759.1979; Souissi A, 2013, J EXP MAR BIOL ECOL, V445, P38, DOI 10.1016/j.jembe.2013.04.002; Stottrup JG, 1997, AQUACULTURE, V155, P231, DOI 10.1016/S0044-8486(97)00120-8; Svitil AL, 1997, APPL ENVIRON MICROB, V63, P408, DOI 10.1128/AEM.63.2.408-413.1997; Tang K, 2009, BIOL LETTERS, V5, P549, DOI 10.1098/rsbl.2009.0076; Tang KW, 2006, AQUAT MICROB ECOL, V45, P219, DOI 10.3354/ame045219; Tang KW, 2011, ENVIRON MICROBIOL, V13, P378, DOI 10.1111/j.1462-2920.2010.02335.x; Tang KW, 2005, AQUAT MICROB ECOL, V38, P31, DOI 10.3354/ame038031; THEODORIDES J, 1989, ADV MAR BIOL, V25, P117; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277; Vezzulli L, 2010, ENV MICROBIOL REP, V2, P27, DOI 10.1111/j.1758-2229.2009.00128.x; Winther G, 2015, ACTA NEUROPSYCHIATR, V27, P168, DOI 10.1017/neu.2015.7; Zhu Xu-fen, 2007, Journal of Zhejiang University-Science B, V8, P831, DOI 10.1631/jzus.2007.B0831	57	16	17	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132516	10.1371/journal.pone.0132516	http://dx.doi.org/10.1371/journal.pone.0132516			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167852	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100051
J	Bouton, C; Geldreich, A; Ramel, L; Ryabova, LA; Dimitrova, M; Keller, M				Bouton, Clement; Geldreich, Angele; Ramel, Laetitia; Ryabova, Lyubov A.; Dimitrova, Maria; Keller, Mario			Cauliflower mosaic virus Transcriptome Reveals a Complex Alternative Splicing Pattern	PLOS ONE			English	Article							APHID TRANSMISSION FACTOR; PRE-MESSENGER-RNAS; READING FRAME-III; MOVEMENT PROTEIN; REVERSE TRANSCRIPTION; NUCLEOTIDE-SEQUENCE; HELPER COMPONENT; GENE-EXPRESSION; NUCLEAR EXPORT; VI PRODUCT	The plant pararetrovirus Cauliflower mosaic virus (CaMV) uses alternative splic-ing to generate several isoforms from its polycistronic pregenomic 35S RNA. This pro-cess has been shown to be essential for infectivity. Previous works have identified four splice donor sites and a single splice acceptor site in the 35S RNA 5' region and sug-gested that the main role of CaMV splicing is to downregulate expression of open read-ing frames (ORFs) I and II. In this study, we show that alternative splicing is a conserved process among CaMV isolates. In Cabb B-JI and Cabb-S isolates, splicing frequently leads to different fusion between ORFs, particularly between ORF I and II. The corresponding P1P2 fusion proteins expressed in E. coli interact with viral proteins P2 and P3 in vitro. However, they are detected neither during infection nor upon transient expression in planta, which suggests rapid degradation after synthesis and no important biological role in the CaMV infectious cycle. To gain a better understanding of the functional relevance of 35S RNA alternative splicing in CaMV infectivity, we inactivated the previously described splice sites. All the splicing mutants were as pathogenic as the corresponding wild-type isolate. Through RT-PCR-based analysis we demonstrate that CaMV 35S RNA exhibits a complex splicing pattern, as we identify new splice donor and acceptor sites whose selection leads to more than thirteen 35S RNA isoforms in infected turnip plants. Inactivating splice donor or acceptor sites is not lethal for the virus, since disrupted sites are systematically rescued by the activation of cryptic and/or seldom used splice sites. Taken together, our data depict a conserved, complex and flexible process, involving multiple sites, that ensures splicing of 35S RNA.	[Bouton, Clement; Geldreich, Angele; Ramel, Laetitia; Ryabova, Lyubov A.; Dimitrova, Maria; Keller, Mario] Univ Strasbourg, CNRS, Inst Biol Mol Plantes, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dimitrova, M (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol Plantes, Strasbourg, France.	maria.dimitrova@ibmp-cnrs.unistra.fr; mario.keller@ibmp-cnrs.unistra.fr		Bouton, Clement/0000-0001-9607-6533	French Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche	French Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche	CB was supported by a PhD fellowship from the French Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMOUR SL, 1983, VIROLOGY, V129, P25, DOI 10.1016/0042-6822(83)90392-6; ASHE MP, 1995, GENE DEV, V9, P3008, DOI 10.1101/gad.9.23.3008; Baek JM, 2008, PLANT MOL BIOL, V67, P499, DOI 10.1007/s11103-008-9334-4; Bayliss J, 2013, J HEPATOL, V59, P1022, DOI 10.1016/j.jhep.2013.06.018; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Chen WN, 2010, J GEN VIROL, V91, P2592, DOI 10.1099/vir.0.022517-0; Christie M, 2011, PLANT SIGNAL BEHAV, V6, P2035, DOI 10.4161/psb.6.12.18238; Christie M, 2011, PLANT J, V68, P159, DOI 10.1111/j.1365-313X.2011.04676.x; Damgaard CK, 2008, MOL CELL, V29, P271, DOI 10.1016/j.molcel.2007.11.035; DAUTEL S, 1994, VIROLOGY, V202, P1043, DOI 10.1006/viro.1994.1435; DELSENY M, 1983, PLASMID, V9, P31, DOI 10.1016/0147-619X(83)90029-X; ESPINOZA AM, 1991, VIROLOGY, V185, P337, DOI 10.1016/0042-6822(91)90781-6; FRANCK A, 1980, CELL, V21, P285, DOI 10.1016/0092-8674(80)90136-1; Froissart R, 2004, J GEN VIROL, V85, P2719, DOI 10.1099/vir.0.80029-0; FUTTERER J, 1994, VIROLOGY, V198, P663, DOI 10.1006/viro.1994.1078; Gamazon ER, 2014, HUM GENET, V133, P679, DOI 10.1007/s00439-013-1411-3; GOODALL GJ, 1989, CELL, V58, P473, DOI 10.1016/0092-8674(89)90428-5; GUILLEY H, 1983, EMBO J, V2, P277, DOI 10.1002/j.1460-2075.1983.tb01417.x; Haas M, 2005, PLANT CELL, V17, P927, DOI 10.1105/tpc.104.029017; Haas M, 2002, MOL PLANT PATHOL, V3, P419, DOI 10.1046/j.1364-3703.2002.00136.x; Hapiak M, 2008, VIRUS RES, V138, P119, DOI 10.1016/j.virusres.2008.09.002; Hebrard E, 2001, J VIROL, V75, P8538, DOI 10.1128/JVI.75.18.8538-8546.2001; HIROCHIKA H, 1985, EMBO J, V4, P1673, DOI 10.1002/j.1460-2075.1985.tb03836.x; HOWARTH AJ, 1981, VIROLOGY, V112, P678, DOI 10.1016/0042-6822(81)90313-5; INGLIS SC, 1981, NUCLEIC ACIDS RES, V9, P2727, DOI 10.1093/nar/9.12.2727; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Karsies A, 2001, PLANT J, V27, P335, DOI 10.1046/j.1365-313x.2001.01093.x; Khelifa M, 2010, VIROLOGY, V396, P238, DOI 10.1016/j.virol.2009.09.032; KISSLASZLO Z, 1995, EMBO J, V14, P3552, DOI 10.1002/j.1460-2075.1995.tb07361.x; KissLaszlo Z, 1996, TRENDS MICROBIOL, V4, P480, DOI 10.1016/S0966-842X(97)82909-5; Langemeier J, 2013, RNA BIOL, V10, P180, DOI 10.4161/rna.23314; Lee GH, 2008, VIRUS RES, V136, P1, DOI 10.1016/j.virusres.2008.05.007; Leh V, 2000, VIROLOGY, V266, P1, DOI 10.1006/viro.1999.0073; Leh V, 1999, EMBO J, V18, P7077, DOI 10.1093/emboj/18.24.7077; Leh V, 2001, J VIROL, V75, P100, DOI 10.1128/JVI.75.1.100-106.2001; Lutz L, 2012, VIRUS RES, V170, P150, DOI 10.1016/j.virusres.2012.08.017; MESNARD JM, 1993, BIOCHIMIE, V75, P645, DOI 10.1016/0300-9084(93)90094-9; Moissiard G, 2006, P NATL ACAD SCI USA, V103, P19593, DOI 10.1073/pnas.0604627103; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; OLSZEWSKI NE, 1983, NUCLEIC ACIDS RES, V11, P8901, DOI 10.1093/nar/11.24.8901; Park GS, 2008, VIRUS RES, V136, P166, DOI 10.1016/j.virusres.2008.05.005; PERBAL MC, 1993, VIROLOGY, V195, P281, DOI 10.1006/viro.1993.1375; PFEIFFER P, 1983, CELL, V33, P781, DOI 10.1016/0092-8674(83)90020-X; Qiu SG, 1997, VIROLOGY, V227, P180, DOI 10.1006/viro.1996.8314; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; RICHARDS KE, 1981, FEBS LETT, V134, P67, DOI 10.1016/0014-5793(81)80552-2; Roberts K, 2007, NEW PHYTOL, V175, P707, DOI 10.1111/j.1469-8137.2007.02136.x; Roy B, 2013, CURR GENOMICS, V14, P182, DOI 10.2174/1389202911314030004; Ryabova LA, 2006, VIRUS RES, V119, P52, DOI 10.1016/j.virusres.2005.10.017; Sajic R, 2007, NUCLEIC ACIDS RES, V35, P247, DOI 10.1093/nar/gkl022; Sanchez-Navarro J, 2010, J VIROL, V84, P4109, DOI 10.1128/JVI.02543-09; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHOLTHOF HB, 1991, VIROLOGY, V184, P290, DOI 10.1016/0042-6822(91)90845-3; Schrom EM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-55; Shivaprasad PV, 2008, NUCLEIC ACIDS RES, V36, P5896, DOI 10.1093/nar/gkn590; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sommer G, 2008, FRONT BIOSCI-LANDMRK, V13, P5533; Soussan P, 2003, J HEPATOL, V38, P343, DOI 10.1016/S0168-8278(02)00422-1; Stavolone L, 2005, P NATL ACAD SCI USA, V102, P6219, DOI 10.1073/pnas.0407731102; THOMAS CL, 1995, PLANT CELL, V7, P561, DOI 10.1105/tpc.7.5.561; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wright EA, 1997, PLANT J, V12, P1285, DOI 10.1046/j.1365-313x.1997.12061285.x; XIONG C, 1982, EMBO J, V1, P971, DOI 10.1002/j.1460-2075.1982.tb01280.x; XIONG C, 1984, P NATL ACAD SCI-BIOL, V81, P6608, DOI 10.1073/pnas.81.21.6608; Yasaka R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085641; Zheng ZM, 2010, INT J BIOL SCI, V6, P730	67	11	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132665	10.1371/journal.pone.0132665	http://dx.doi.org/10.1371/journal.pone.0132665			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162084	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300165
J	Chan, M; Chang, MC; Gonzalez, R; Lategan, B; del Barco, E; Vera-Badillo, F; Quesada, P; Goldstein, R; Cruz, I; Ocana, A; Cruz, JJ; Amir, E				Chan, Melissa; Chang, Martin C.; Gonzalez, Rosa; Lategan, Belinda; del Barco, Elvira; Vera-Badillo, Francisco; Quesada, Paula; Goldstein, Robyn; Cruz, Ignacio; Ocana, Alberto; Cruz, Juan J.; Amir, Eitan			Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer	PLOS ONE			English	Article							ADJUVANT ENDOCRINE THERAPY; AMERICAN-SOCIETY; CHEMOTHERAPY; IMMUNOHISTOCHEMISTRY; RECOMMENDATIONS; TRASTUZUMAB; CARCINOMA; PATTERNS; PLUS	Purpose To describe the clinical features and outcomes of estrogen receptor negative (ER-) and progesterone receptor positive (PgR+) breast cancer. Methods We retrospectively reviewed a well-characterized database of sequential patients diagnosed with early stage invasive breast carcinoma. Outcomes of interest were time to relapse (TTR) and overall survival (OS). Multivariable Cox proportional hazards analysis was conducted to assess the association of ER-/PgR+ with TTR and OS in comparison to ER+ and to ER-and PgR negative (ER-/PgR-) tumors irrespective of HER2 status. ER and PgR expression was conservatively defined as 10% or greater staining of cancer cells. Results 815 patients were followed for a median of 40.5 months; 56 patients (7%) had ER-/PgR+, 624 (77%) had ER+ and 136 (17%) had ER-/PgR- phenotypes. Compared with ER+ tumors, ER-/PgR+ tumors were associated with younger age (50 versus 59 years, p = 0.03), high grade (50% versus 24%, p < 0.001) and more frequent HER2 overexpression/amplification (43% versus 14%, p < 0.001). TTR for ER-/PgR+ was intermediate between ER+ and ER-/PgR- tumors, but was not significantly different from ER+ tumors. Recurrences in the ER-/PgR+ and ER-/PgR- groups occurred early in follow-up while in ER+ tumors recurrences continued to occur over the duration of follow-up. OS of ER-/PgR+ was similar to ER+ tumors and better than that of ER-/PgR- tumors. Conclusions The ER-/PgR+ phenotype is associated with higher grade with HER2 overexpression/amplification and occurs more commonly in younger women. Risk of relapse and death more closely resembles ER+ than ER-/PgR- tumors suggesting this phenotype represents a group of more aggressive hormone receptor positive tumors.	[Chan, Melissa; Vera-Badillo, Francisco; Goldstein, Robyn; Amir, Eitan] Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada; [Chan, Melissa; Vera-Badillo, Francisco; Amir, Eitan] Univ Toronto, Dept Med, Toronto, ON, Canada; [Chang, Martin C.; Lategan, Belinda] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Chang, Martin C.; Lategan, Belinda] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Gonzalez, Rosa] Univ Salamanca, Escuela Enfermeria, E-37008 Salamanca, Spain; [del Barco, Elvira; Quesada, Paula; Cruz, Juan J.] Salamanca Univ Hosp, Dept Med Oncol, Salamanca, Spain; [Cruz, Ignacio] Complejo Hosp Salamanca, Serv Cardiol, Salamanca, Spain; [Ocana, Alberto] Albacete Univ Hosp, Dept Med Oncol, Albacete, Spain; [Ocana, Alberto] Albacete Univ Hosp, Translat Res Unit, Albacete, Spain	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Salamanca	Amir, E (corresponding author), Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada.	eitan.amir@uhn.ca	Amir, Eitan/L-6052-2019; Chang, Martin/J-2329-2016	Amir, Eitan/0000-0002-3706-525X; Ocana, Alberto/0000-0002-1067-9630; Cruz Hernandez, Juan Jesus/0000-0003-1980-2751				Bardou VJ, 2003, J CLIN ONCOL, V21, P1973, DOI 10.1200/JCO.2003.09.099; Brenner H, 2004, J CLIN ONCOL, V22, P432, DOI 10.1200/JCO.2004.04.067; Colditz GA, 2004, JNCI-J NATL CANCER I, V96, P218, DOI 10.1093/jnci/djh025; Cserni G, 2011, PATHOL ONCOL RES, V17, P663, DOI 10.1007/s12253-011-9366-y; Cui XJ, 2005, J CLIN ONCOL, V23, P7721, DOI 10.1200/JCO.2005.09.004; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; De Maeyer L, 2006, INT J GYNECOL CAN S2, V16, P589; De Maeyer L, 2008, J CLIN ONCOL, V26, P335, DOI 10.1200/JCO.2007.14.8411; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Huang HJ, 2004, EJC SUPPL, V2, P103, DOI 10.1016/S1359-6349(04)90773-2; Maleki Z, 2012, ARCH IRAN MED, V15, P366, DOI 012156/AIM.0010; MARTIN MB, 1993, ADV EXP MED BIOL, V330, P143; Nadji M, 2005, AM J CLIN PATHOL, V123, P21, DOI 10.1309/4WV79N2GHJ3X1841; Ng Char Hong, 2012, Asian Pac J Cancer Prev, V13, P1111; OSBORNE CK, 1980, CANCER-AM CANCER SOC, V46, P2884, DOI 10.1002/1097-0142(19801215)46:12+<2884::AID-CNCR2820461429>3.0.CO;2-U; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pujol P, 1998, CANCER-AM CANCER SOC, V83, P698, DOI 10.1002/(SICI)1097-0142(19980815)83:4<698::AID-CNCR10>3.3.CO;2-I; Rakha EA, 2007, J CLIN ONCOL, V25, P4772, DOI 10.1200/JCO.2007.12.2747; RAVDIN PM, 1992, J CLIN ONCOL, V10, P1284, DOI 10.1200/JCO.1992.10.8.1284; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984	25	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132449	10.1371/journal.pone.0132449	http://dx.doi.org/10.1371/journal.pone.0132449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161666	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300137
J	Erickson, NA; Nystrom, EEL; Mundhenk, L; Arike, L; Glauben, R; Heimesaat, MM; Fischer, A; Bereswill, S; Birchenough, GMH; Gruber, AD; Johansson, MEV				Erickson, Nancy A.; Nystrom, Elisabeth E. L.; Mundhenk, Lars; Arike, Liisa; Glauben, Rainer; Heimesaat, Markus M.; Fischer, Andre; Bereswill, Stefan; Birchenough, George M. H.; Gruber, Achim D.; Johansson, Malin E. V.			The Goblet Cell Protein Clca1 (Alias mClca3 or Gob-5) Is Not Required for Intestinal Mucus Synthesis, Structure and Barrier Function in Naive or DSS-Challenged Mice	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; MOUSE STOMACH; MUCIN; EXPRESSION; GENE; LAYERS; FAMILY; INFLAMMATION; BACTERIA; COLITIS	The secreted, goblet cell-derived protein Clca1 (chloride channel regulator, calcium-activated-1) has been linked to diseases with mucus overproduction, including asthma and cystic fibrosis. In the intestine Clca1 is found in the mucus with an abundance and expression pattern similar to Muc2, the major structural mucus component. We hypothesized that Clca1 is required for the synthesis, structure or barrier function of intestinal mucus and therefore compared wild type and Clca1-deficient mice under naive and at various time points of DSS (dextran sodium sulfate)-challenged conditions. The mucus phenotype in Clca1-deficient compared to wild type mice was systematically characterized by assessment of the mucus protein composition using proteomics, immunofluorescence and expression analysis of selected mucin genes on mRNA level. Mucus barrier integrity was assessed in-vivo by analysis of bacterial penetration into the mucus and translocation into sentinel organs combined analysis of the fecal microbiota and ex-vivo by assessment of mucus penetrability using beads. All of these assays revealed no relevant differences between wild type and Clca1-deficient mice under steady state or DSS-challenged conditions in mouse colon. Clca1 is not required for mucus synthesis, structure and barrier function in the murine colon.	[Erickson, Nancy A.; Mundhenk, Lars; Gruber, Achim D.] Free Univ Berlin, Dept Vet Pathol, Berlin, Germany; [Nystrom, Elisabeth E. L.; Arike, Liisa; Birchenough, George M. H.; Johansson, Malin E. V.] Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden; [Glauben, Rainer] Charite, Div Gastroenterol Infectiol & Rheumatol, Dept Med, D-13353 Berlin, Germany; [Heimesaat, Markus M.; Fischer, Andre; Bereswill, Stefan] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany	Free University of Berlin; University of Gothenburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Johansson, MEV (corresponding author), Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden.	malin.johansson@medkem.gu.se	Gruber, Achim D./ABA-4514-2021; Arike, Liisa/AAF-7698-2020; Johansson, Malin E. V./HCH-7451-2022	Arike, Liisa/0000-0002-2184-0960; Johansson, Malin E. V./0000-0002-4237-6677; Heimesaat, Markus/0000-0001-6399-651X	Swedish Research Council [22220-01-5]; Wilhelm and Martina Lundgren's Foundation; Assar Gabrielsson's Foundation; Clas Groschinskys Foundation; National Institute of Allergy and Infectious Diseases [U01AI095776-03:9006862]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095776, U01AI095473] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Wilhelm and Martina Lundgren's Foundation; Assar Gabrielsson's Foundation; Clas Groschinskys Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swedish Research Council (no. 22220-01-5, http://www.vr.se/, to MEVJ), the Wilhelm and Martina Lundgren's Foundation (http://www.wmlundgren.se/, to MEVJ), the Assar Gabrielsson's Foundation (http://www.agfond.se/, to MEVJ), the Clas Groschinskys Foundation (http://www.groschinsky.org/, to MEVJ) and the National Institute of Allergy and Infectious Diseases (U01AI095776-03:9006862, http://www.niaid.nih.gov/Pages/default.aspx, to MEVJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnel M, 1999, FEBS LETT, V455, P295, DOI 10.1016/S0014-5793(99)00891-1; Al-Jumaily Mohammed, 2007, Neurosci Bull, V23, P293, DOI 10.1007/s12264-007-0044-8; Alevy YG, 2012, J CLIN INVEST, V122, P4555, DOI 10.1172/JCI64896; Ambort D., 2012, COLD SPRING HARB PER, V2; Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Bothe M, 2011, MOL CELLS, V32, P535, DOI 10.1007/s10059-011-0158-8; Braun J, 2010, J CYST FIBROS, V9, P351, DOI 10.1016/j.jcf.2010.06.003; Brouillard F, 2005, MOL CELL PROTEOMICS, V4, P1762, DOI 10.1074/mcp.M500098-MCP200; Buisine MP, 2001, GUT, V49, P544, DOI 10.1136/gut.49.4.544; Byrnes JJ, 2009, INFLAMM RES, V58, P819, DOI 10.1007/s00011-009-0053-3; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Ching JCH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083130; Corfield AP, 2000, GUT, V47, P589, DOI 10.1136/gut.47.4.589; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Desseyn JL, 2003, GENOMICS, V81, P433, DOI 10.1016/S0888-7543(03)00036-3; Dietert K, 2015, HISTOCHEM CELL BIOL, V143, P277, DOI 10.1007/s00418-014-1279-x; Dietert K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102606; Ermund A, 2013, AM J PHYSIOL-GASTR L, V305, pG341, DOI 10.1152/ajpgi.00046.2013; Escande F, 2004, BBA-GENE STRUCT EXPR, V1676, P240, DOI 10.1016/j.bbaexp.2004.01.001; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Gruber AD, 1998, GENOMICS, V54, P200, DOI 10.1006/geno.1998.5562; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011, 10.1152/ajpgi.00405.2011.]; Hasnain SZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001856; Hauber HP, 2004, EUR RESPIR J, V23, P846, DOI 10.1183/09031936.04.00096504; Hegab AE, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012484; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2010, GUT, V59, P1079, DOI 10.1136/gut.2009.197434; Hoebler C, 2006, DIGEST DIS SCI, V51, P381, DOI 10.1007/s10620-006-3142-y; Hoshino M, 2002, AM J RESP CRIT CARE, V165, P1132, DOI 10.1164/ajrccm.165.8.2107068; HUANG S, 1992, AM J PATHOL, V141, P981; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Johansson MEV, 2012, METHODS MOL BIOL, V842, P229, DOI 10.1007/978-1-61779-513-8_13; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Larsson JMH, 2011, INFLAMM BOWEL DIS, V17, P2299, DOI 10.1002/ibd.21625; Leverkoehne I, 2002, J HISTOCHEM CYTOCHEM, V50, P829, DOI 10.1177/002215540205000609; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Mukherjee S, 2011, AM J PATHOL, V179, P248, DOI 10.1016/j.ajpath.2011.03.003; Mundhenk L, 2006, J BIOL CHEM, V281, P30072, DOI 10.1074/jbc.M606489200; Mundhenk L, 2012, AM J RESP CELL MOL, V47, P87, DOI 10.1165/rcmb.2010-0508OC; Nakanishi A, 2001, P NATL ACAD SCI USA, V98, P5175, DOI 10.1073/pnas.081510898; Norris MD, 2000, MED PEDIATR ONCOL, V35, P585, DOI 10.1002/1096-911X(20001201)35:6<585::AID-MPO20>3.3.CO;2-G; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Patel AC, 2006, PHYSIOL GENOMICS, V25, P502, DOI 10.1152/physiolgenomics.00321.2005; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Plog S, 2009, J HISTOCHEM CYTOCHEM, V57, P1169, DOI 10.1369/jhc.2009.954594; Range F, 2007, VET PATHOL, V44, P901, DOI 10.1354/vp.44-6-901; Rausch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074026; Robichaud A, 2005, AM J RESP CELL MOL, V33, P303, DOI 10.1165/rcmb.2004-0372OC; Rodriguez-Pineiro AM, 2013, AM J PHYSIOL-GASTR L, V305, pG348, DOI 10.1152/ajpgi.00047.2013; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Sala-Rabanal M, 2015, ELIFE, V4, DOI 10.7554/eLife.05875; Song LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082367; Tetaert D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-39; Thoene-Reineke C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113406; Toda M, 2002, J ALLERGY CLIN IMMUN, V109, P246, DOI 10.1067/mai.2002.121555; Tytgat KMAJ, 1996, BIOCHEM BIOPH RES CO, V224, P397, DOI 10.1006/bbrc.1996.1039; van der Doef HPJ, 2010, J PEDIATR GASTR NUTR, V50, P347, DOI 10.1097/MPG.0b013e3181afce6c; van der Post S, 2014, MOL CELL PROTEOMICS, V13, P2277, DOI 10.1074/mcp.M114.040204; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; van Klinken BJW, 1998, AM J PHYSIOL-GASTR L, V274, pG871, DOI 10.1152/ajpgi.1998.274.5.G871; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yang B, 2015, CANCER; Yang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060861; Young FD, 2007, GASTROENTEROLOGY, V133, P1928, DOI 10.1053/j.gastro.2007.10.007; Yurtsever Z, 2012, J BIOL CHEM, V287, P42138, DOI 10.1074/jbc.M112.410282; Zhou YH, 2001, AM J RESP CELL MOL, V25, P486, DOI 10.1165/ajrcmb.25.4.4578	82	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131991	10.1371/journal.pone.0131991	http://dx.doi.org/10.1371/journal.pone.0131991			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162072	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300081
J	Hespeels, B; Li, X; Flot, JF; Pigneur, LM; Malaisse, J; Da Silva, C; Van Doninck, K				Hespeels, Boris; Li, Xiang; Flot, Jean-Francois; Pigneur, Lise-Marie; Malaisse, Jeremy; Da Silva, Corinne; Van Doninck, Karine			Against All Odds: Trehalose-6-Phosphate Synthase and Trehalase Genes in the Bdelloid Rotifer Adineta vaga Were Acquired by Horizontal Gene Transfer and Are Upregulated during Desiccation	PLOS ONE			English	Article							SWISS-MODEL; ABSCISIC-ACID; PROTEIN; TOLERANCE; ANHYDROBIOSIS; BIOSYNTHESIS; ARABIDOPSIS; 6-PHOSPHATE; PHOSPHATASE; METABOLISM	The disaccharide sugar trehalose is essential for desiccation resistance in most metazoans that survive dryness; however, neither trehalose nor the enzymes involved in its metabolism have ever been detected in bdelloid rotifers despite their extreme resistance to desiccation. Here we screened the genome of the bdelloid rotifer Adineta vaga for genes involved in trehalose metabolism. We discovered a total of four putative trehalose-6-phosphate synthase (TPS) and seven putative trehalase (TRE) gene copies in the genome of this ameiotic organism; however, no trehalose-6-phosphate phosphatase (TPP) gene or domain was detected. The four TPS copies of A. vaga appear more closely related to plant and fungi proteins, as well as to some protists, whereas the seven TRE copies fall in bacterial clades. Therefore, A. vaga likely acquired its trehalose biosynthesis and hydrolysis genes by horizontal gene transfers. Nearly all residues important for substrate binding in the predicted TPS domains are highly conserved, supporting the hypothesis that several copies of the genes might be functional. Besides, RNAseq library screening showed that trehalase genes were highly expressed compared to TPS genes, explaining probably why trehalose had not been detected in previous studies of bdelloids. A strong overexpression of their TPS genes was observed when bdelloids enter desiccation, suggesting a possible signaling role of trehalose-6-phosphate or trehalose in this process.	[Hespeels, Boris; Li, Xiang; Pigneur, Lise-Marie; Van Doninck, Karine] Univ Namur, URBE, Dept Biol, LEGE Lab, Namur, Belgium; [Flot, Jean-Francois] UCL, Dept Genet Evolut & Environm, London, England; [Malaisse, Jeremy] Cell & Tissue Lab, Res Unit Mol Physiol, Namur, Belgium; [Da Silva, Corinne] CEA, GENOSCOPE, Ctr Natl Sequencage, Inst Genom, Evry, France; [Van Doninck, Karine] Univ Namur, NaXys, Namur Ctr Complex Syst, Namur, Belgium	University of Namur; University of London; University College London; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Namur	Van Doninck, K (corresponding author), Univ Namur, URBE, Dept Biol, LEGE Lab, Namur, Belgium.	karine.vandoninck@unamur.be	; Van Doninck, Karine/B-3218-2016	Flot, Jean-Francois/0000-0003-4091-7916; Van Doninck, Karine/0000-0002-4790-8951; DA SILVA, Corinne/0000-0002-7618-7831	UNamur; Belgian National Fund for Scientific Research (Fonds National pour la Recherche Scientifique - FNRS) through PhD FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture) thesis grant; FRFC (Fonds de la Recherche Fondamentale Collective) grant [2.4.655.09.F]; CDR research grant DAMAGE [19597258]	UNamur; Belgian National Fund for Scientific Research (Fonds National pour la Recherche Scientifique - FNRS) through PhD FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture) thesis grant(Fonds de la Recherche Scientifique - FNRS); FRFC (Fonds de la Recherche Fondamentale Collective) grant(Fonds de la Recherche Scientifique - FNRS); CDR research grant DAMAGE	This work was supported by UNamur through an assistant PhD grant allocated to BH and a starting grant allocated to KVD and by the Belgian National Fund for Scientific Research (Fonds National pour la Recherche Scientifique - FNRS) through a PhD FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture) thesis grant allocated to XL and an FRFC (Fonds de la Recherche Fondamentale Collective) grant 2.4.655.09.F and a CDR research grant DAMAGE (19597258) allocated to KVD.	Adhikari BN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-69; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alpert P, 2005, INTEGR COMP BIOL, V45, P685, DOI 10.1093/icb/45.5.685; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Avonce N, 2004, PLANT PHYSIOL, V136, P3649, DOI 10.1104/pp.104.052084; Avonce N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-109; Avonce N, 2010, MOL BIOL EVOL, V27, P359, DOI 10.1093/molbev/msp241; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blazquez MA, 1998, PLANT J, V13, P685, DOI 10.1046/j.1365-313X.1998.00063.x; Boschetti C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003035; Boschetti C, 2011, J EXP BIOL, V214, P59, DOI 10.1242/jeb.050328; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caprioli M, 2004, COMP BIOCHEM PHYS A, V139, P527, DOI 10.1016/j.cbpb.2004.10.019; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; De Maesschalck C, 2009, UNRAVELING THE FUNCT; Delorge I, 2015, BIOCHEM J, V466, P283, DOI 10.1042/BJ20141322; Delorge I, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00147; Denekamp NY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-108; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fernandez J., 2011, Mycology - An International Journal on Fungal Biology, V2, P46, DOI 10.1080/21501203.2011.563431; Fernandez O, 2010, TRENDS PLANT SCI, V15, P409, DOI 10.1016/j.tplants.2010.04.004; Flot JF, 2013, NATURE, V500, P453, DOI 10.1038/nature12326; Friesen Vicki, 2000, P274; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Gibson RP, 2004, J BIOL CHEM, V279, P1950, DOI 10.1074/jbc.M307643200; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; Gladyshev EA, 2010, J HERED, V101, pS85, DOI 10.1093/jhered/esq008; Goddijn OJM, 1999, TRENDS PLANT SCI, V4, P315, DOI 10.1016/S1360-1385(99)01446-6; Goddijn OJM, 1997, PLANT PHYSIOL, V113, P181, DOI 10.1104/pp.113.1.181; Gusev O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014008; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Helaers R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-379; Hengherr S, 2011, PHYSIOL BIOCHEM ZOOL, V84, P147, DOI 10.1086/658499; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Hengherr S, 2011, PHYSIOL BIOCHEM ZOOL, V84, P249, DOI 10.1086/659314; Hespeels B, 2014, J EVOLUTION BIOL, V27, P1334, DOI 10.1111/jeb.12326; Hespeels B, 2014, EVOLUTIONARY BIOL GE, P207, DOI [10.1007/978-3-319-07623-2, DOI 10.1007/978-3-319-07623-2]; Howe KL, 2002, GENOME RES, V12, P1418, DOI 10.1101/gr.149502; HSU WS, 1956, BIOL BULL, V111, P364, DOI 10.2307/1539143; Hsu WS, 1956, CELLULE, V57, P283; Hur JH, 2009, MOL BIOL EVOL, V26, P375, DOI 10.1093/molbev/msn260; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jonsson I., 2014, OPEN ZOOL J, V3, P1, DOI [10.2174/1874336601003010001, DOI 10.2174/1874336601003010001]; KAASEN I, 1992, J BACTERIOL, V174, P889, DOI 10.1128/jb.174.3.889-898.1992; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lapinski J, 2003, FEBS LETT, V553, P387, DOI 10.1016/S0014-5793(03)01062-7; Li HW, 2011, PLANTA, V234, P1007, DOI 10.1007/s00425-011-1458-0; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; Lunn JE, 2014, PLANT J, V79, P544, DOI 10.1111/tpj.12509; MADIN KAC, 1975, J EXP ZOOL, V193, P335, DOI 10.1002/jez.1401930309; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Muller J, 2001, PLANT PHYSIOL, V125, P1086, DOI 10.1104/pp.125.2.1086; Ohtake S, 2011, J PHARM SCI-US, V100, P2020, DOI 10.1002/jps.22458; Pampurova S, 2014, J PLANT RES, V127, P803, DOI 10.1007/s10265-014-0663-x; Ponnu J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00070; Potts M, 2005, INTEGR COMP BIOL, V45, P800, DOI 10.1093/icb/45.5.800; Potts M, 2001, TRENDS MICROBIOL, V9, P553, DOI 10.1016/S0966-842X(01)02231-4; Puttikamonkul S, 2010, MOL MICROBIOL, V77, P891, DOI 10.1111/j.1365-2958.2010.07254.x; Rao KN, 2006, PROTEIN SCI, V15, P1735, DOI 10.1110/ps.062096606; RICCI CN, 1987, HYDROBIOLOGIA, V147, P117, DOI 10.1007/BF00025734; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakurai M, 2008, P NATL ACAD SCI USA, V105, P5093, DOI 10.1073/pnas.0706197105; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; Schluepmann H, 2003, P NATL ACAD SCI USA, V100, P6849, DOI 10.1073/pnas.1132018100; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SEGERS H, 2007, ZOOTAXA, V1564, P104; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suga K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000671; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsai AYL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00119; Tunnacliffe A, 2003, PHILOS T ROY SOC B, V358, P1755, DOI 10.1098/rstb.2002.1214; Van Dijck P, 2002, INFECT IMMUN, V70, P1772, DOI 10.1128/IAI.70.4.1772-1782.2002; Van Doninck K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000401; Van Houtte H, 2013, PLANT PHYSIOL, V161, P1158, DOI 10.1104/pp.112.211391; van Leeuwenhoek Antony, 1702, PHILOS T, V23, P1304; Vandesteene L, 2012, PLANT PHYSIOL, V160, P884, DOI 10.1104/pp.112.201400; Vandesteene L, 2010, MOL PLANT, V3, P406, DOI 10.1093/mp/ssp114; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wingler A, 2002, PHYTOCHEMISTRY, V60, P437, DOI 10.1016/S0031-9422(02)00137-1; Yadav UP, 2014, J EXP BOT, V65, P1051, DOI 10.1093/jxb/ert457; Zaparty M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061354	87	13	14	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131313	10.1371/journal.pone.0131313	http://dx.doi.org/10.1371/journal.pone.0131313			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161530	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300034
J	Ji, HF; Xuan, QJ; Nanding, A; Zhang, HY; Zhang, QY				Ji, Hongfei; Xuan, Qijia; Nanding, Abiyasi; Zhang, Haiyu; Zhang, Qingyuan			The Clinicopathologic and Prognostic Value of Altered Chromosome 17 Centromere Copy Number in HER2 Fish Equivocal Breast Carcinomas	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; POLYSOMY 17; GENE AMPLIFICATION; PROTEIN EXPRESSION; AMERICAN SOCIETY; HER-2/NEU STATUS; CANCER ANALYSIS; RECOMMENDATIONS; IMPACT; PATTERNS	Chromosome 17 centromere (CEP17) gain is frequently observed in breast cancer by fluorescence in situ hybridization (FISH). To address the biologic characteristics and clinical significance of CEP17 gain in a large population of breast cancer patients, we performed FISH on a series of 770 breast cancer tissues to evaluate the status of human epidermal growth factor receptor 2 (HER2) gene and CEP17 by immunohistochemistry (IHC) and FISH. Among the 770 specimens, 184 cases showed CEP17 gain (23.9%). Histological grade, nodal status, HER2 by IHC, Ki 67 index, and p53 expression were significantly different between CEP17 gain tumors and HER2-positive tumors. In contrast with HER2-negative tumors, CEP17 gain tumors showed higher histological grade, higher HER2 score by IHC, and higher Ki 67 index. The patients with CEP17 gain tumors had an intermediate survival between HER2-negative and HER2-positive patients. By comparison to HER2-negative and HER2-positive patients, survival in luminal B patients with CEP17 gain tumors also fell in between. In conclusion, CEP17 gain tumors show specific differences compared with HER2-negative and HER2-positive tumors in clinical parameters and prognosis.	[Ji, Hongfei; Zhang, Qingyuan] Harbin Med Univ, Inst Canc, Dept Canc Mol & Biol, Harbin, Peoples R China; [Xuan, Qijia; Zhang, Qingyuan] Harbin Med Univ, Tumor Hosp, Dept Med Oncol, Harbin, Peoples R China; [Nanding, Abiyasi] Harbin Med Univ, Tumor Hosp, Dept Pathol, Harbin, Peoples R China; [Zhang, Haiyu] Harbin Med Univ, Dept Biostat, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhang, QY (corresponding author), Harbin Med Univ, Inst Canc, Dept Canc Mol & Biol, Harbin, Peoples R China.	zqyxsci@126.com						Bartlett AI, 2011, AM J CLIN PATHOL, V136, P266, DOI 10.1309/AJCP0EN6AQMWETZZ; Bartlett JMS, 2008, AM J CLIN PATHOL, V130, P920, DOI 10.1309/AJCPSDG53BEANCYE; Chopra I, 2014, PATIENT-RELAT OUTCOM, V5, P71, DOI 10.2147/PROM.S49586; Cuadros M, 2011, CLIN TRANSL ONCOL, V13, P335, DOI 10.1007/s12094-011-0663-4; De Felice Francesca, 2014, J Clin Med Res, V6, P409, DOI 10.14740/jocmr1908w; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Egervari K, 2011, PATHOL RES PRACT, V207, P468, DOI 10.1016/j.prp.2011.05.008; Gaiser T, 2012, PATHOLOGE, V33, P307, DOI 10.1007/s00292-012-1663-z; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gunn S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-396; Hammond ME, 2011, J CLIN ONCOL, V29, pE458, DOI 10.1200/JCO.2011.35.2245; Hanna WM, 2014, MODERN PATHOL, V27, P4, DOI 10.1038/modpathol.2013.103; Hyun CL, 2008, J CLIN PATHOL, V61, P317, DOI 10.1136/jcp.2007.050336; Iqbal Nida, 2014, Mol Biol Int, V2014, P852748, DOI 10.1155/2014/852748; Jiang HY, 2014, ONCOL LETT, V7, P1954, DOI 10.3892/ol.2014.2001; Kim A, 2012, J BREAST CANCER, V15, P24, DOI 10.4048/jbc.2012.15.1.24; Krishnamurti U, 2009, MODERN PATHOL, V22, P1044, DOI 10.1038/modpathol.2009.61; Lin XH, 2013, INT J CLIN EXP PATHO, V6, P116; Ma Y, 2005, CLIN CANCER RES, V11, P4393, DOI 10.1158/1078-0432.CCR-04-2256; Mackay A, 2011, JNCI-J NATL CANCER I, V103, P662, DOI 10.1093/jnci/djr071; Marchio C, 2009, J PATHOL, V219, P16, DOI 10.1002/path.2574; Moelans CB, 2010, CLIN CANCER RES, V16, P6177, DOI 10.1158/1078-0432.CCR-10-0773; Moelans CB, 2010, BREAST CANCER RES TR, V120, P1, DOI 10.1007/s10549-009-0539-2; Murthy SS, 2011, INDIAN J PATHOL MICR, V54, P532, DOI 10.4103/0377-4929.85087; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pathmanathan N, 2012, PATHOLOGY, V44, P587, DOI 10.1097/PAT.0b013e328359cf9a; Phipps AI, 2011, CANCER CAUSE CONTROL, V22, P399, DOI 10.1007/s10552-010-9709-0; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Sahoo R, 2011, ONKOLOGIE, V34, P356, DOI 10.1159/000329595; Sapino A, 2014, ONCOLOGIST, V19, P1118, DOI 10.1634/theoncologist.2014-0195; Shah SS, 2009, DIAGN MOL PATHOL, V18, P30, DOI 10.1097/PDM.0b013e31817c1af8; Sneige N, 2006, MODERN PATHOL, V19, P622, DOI 10.1038/modpathol.3800571; Torrisi R, 2007, EUR J CANCER, V43, P2339, DOI 10.1016/j.ejca.2007.07.033; Vanden Bempt I, 2008, J CLIN ONCOL, V26, P4869, DOI 10.1200/JCO.2007.13.4296; Viale G, 2009, J PATHOL, V219, P1, DOI 10.1002/path.2593; Vranic S, 2011, CANCER-AM CANCER SOC, V117, P48, DOI 10.1002/cncr.25580; Wang SJ, 2002, MODERN PATHOL, V15, P137, DOI 10.1038/modpathol.3880505; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yeh IT, 2009, MODERN PATHOL, V22, P1169, DOI 10.1038/modpathol.2009.78	39	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132824	10.1371/journal.pone.0132824	http://dx.doi.org/10.1371/journal.pone.0132824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161550	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300178
J	Ji, L; Liu, JG; Hou, L; Guo, Q				Ji, Lei; Liu, Jian-Guo; Hou, Lei; Guo, Qiang			Identifying the Role of Common Interests in Online User Trust Formation	PLOS ONE			English	Article							SELECTION; FEATHER; BIRDS	Despite enormous recent efforts in detecting the mechanism of the social relation formation in online social systems, the underlying rules between the common interests and social relations are still under dispute. Do online users befriend others who have similar tastes, or do their tastes become more similar after they become friends? In this paper, we investigate the correlation between online user trust formation and their common interests, measured by the overlap rate rho and taste similarity theta respectively. The trust relation creation time is set as the zero timestamp. The statistical results before and after the trust formation for an online network, namely Epinions, show that, the overlap rate rho increases greatly before the trust formation, while it would increase smoothly after the creation of the trust relation. Comparing with the empirical results, two null models are presented by shuffling the temporal behaviors of online users, which suggests that the accumulation of the common interests can result in the trust formation. Furthermore, we investigate the taste similarity theta of the common interests, which can reflect the users' preference on their common interests. The empirical results show that the taste similarity theta is rapidly increased around the day when users trust the others. That is, the similar tastes on the common interests among users lead to the trust formation. Finally, we report that the user degree can also influence the effect of the taste similarity theta on user trust formation. This work may shed some light for deeply understanding the evolution mechanism of the online social systems.	[Ji, Lei; Liu, Jian-Guo; Hou, Lei; Guo, Qiang] Univ Shanghai Sci & Technol, Res Ctr Complex Syst Sci, Shanghai, Peoples R China	University of Shanghai for Science & Technology	Liu, JG (corresponding author), Univ Shanghai Sci & Technol, Res Ctr Complex Syst Sci, Shanghai, Peoples R China.	liujg004@ustc.edu.cn; qiang.guo@ustc.edu.cn	Liu, Jianguo/B-4492-2012; HOU, Lei/B-2899-2015; Guo, Qiang/B-2635-2014	Liu, Jianguo/0000-0002-5641-0266; HOU, Lei/0000-0002-8022-0729; 	National Natural Science Foundation of China [71171136, 61374177, 71371125]; Shanghai Leading Academic Discipline Project of China [XTKX2012]; MOE Project of Humanities and Social Science [13YJA630023]; USST Climbing Project of Humanities and Social Science [14XPB02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project of China(Shanghai Leading Academic Discipline Project); MOE Project of Humanities and Social Science; USST Climbing Project of Humanities and Social Science	This work was supported by the National Natural Science Foundation of China (grant nos. 71171136, 61374177, 71371125), the Shanghai Leading Academic Discipline Project of China (grant no. XTKX2012), MOE Project of Humanities and Social Science (grant no. 13YJA630023), and USST Climbing Project of Humanities and Social Science (grant no. 14XPB02).	Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Currarini S, 2010, P NATL ACAD SCI USA, V107, P4857, DOI 10.1073/pnas.0911793107; Dodds PS, 2003, SCIENCE, V301, P827, DOI 10.1126/science.1081058; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Ellison NB, 2007, J COMPUT-MEDIAT COMM, V12, P1143, DOI 10.1111/j.1083-6101.2007.00367.x; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; Guo Q, 2014, EPL-EUROPHYS LETT, V107, DOI 10.1209/0295-5075/107/18001; Guo Q, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/28004; Huang GC, 2014, AM J PUBLIC HEALTH, V104, pE51, DOI 10.2105/AJPH.2014.302038; KANDEL DB, 1978, AM J SOCIOL, V84, P427, DOI 10.1086/226792; KAPLAN AM, 2010, BUS HORIZONS, V53, P59, DOI [DOI 10.1016/J.BUSH0R.2009.09.003, 10.1016/j.bushor.2009.09.003, DOI 10.1016/J.BUSHOR.2009.09.003]; Kietzmann JH, 2011, BUS HORIZONS, V54, P241, DOI 10.1016/j.bushor.2011.01.005; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Liu JG, 2013, ACTA PHYS SIN-CH ED, V62, DOI 10.7498/aps.62.178901; Mark N, 1998, SOC FORCES, V77, P453, DOI 10.2307/3005535; MARSDEN PV, 1990, ANNU REV SOCIOL, V16, P435, DOI 10.1146/annurev.so.16.080190.002251; Massa P, 2005, PROCEEDINGS OF THE N, P1999; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Ni J, 2014, PHYSICA A, V402, P134, DOI 10.1016/j.physa.2014.01.046; Nie DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101675; Nie DC, 2013, INT J MOD PHYS C, V24, DOI 10.1142/S0129183113500228; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Ratkiewicz J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158701; Steglich C, 2010, SOCIOL METHODOL, V40, P329, DOI 10.1111/j.1467-9531.2010.01225.x	29	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0121105	10.1371/journal.pone.0121105	http://dx.doi.org/10.1371/journal.pone.0121105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161853	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300001
J	Pandey, SP; Singh, HK; Prasad, S				Pandey, Surya P.; Singh, Hemant K.; Prasad, S.			Alterations in Hippocampal Oxidative Stress, Expression of AMPA Receptor GluR2 Subunit and Associated Spatial Memory Loss by Bacopa monnieri Extract (CDRI-08) in Streptozotocin-Induced Diabetes Mellitus Type 2 Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FMR-1 GENE-EXPRESSION; SYNAPTIC PLASTICITY; INSULIN-RESISTANCE; COGNITIVE DYSFUNCTION; STANDARDIZED EXTRACT; CEREBRAL-CORTEX; EPILEPTIC RATS; NMDA RECEPTOR; BRAIN	Bacopa monnieri extract has been implicated in the recovery of memory impairments due to various neurological disorders in animal models and humans. However, the precise molecular mechanism of the role of CDRI-08, a well characterized fraction of Bacopa monnieri extract, in recovery of the diabetes mellitus-induced memory impairments is not known. Here, we demonstrate that DM2 mice treated orally with lower dose of CDRI-08 (50- or 100 mg/kg BW) is able to significantly enhance spatial memory in STZ-DM2 mice and this is correlated with a significant decline in oxidative stress and up regulation of the AMPA receptor GluR2 subunit gene expression in the hippocampus. Treatment of DM2 mice with its higher dose (150 mg/kg BW or above) shows anti-diabetic effect in addition to its ability to recover the spatial memory impairment by reversing the DM2-induced elevated oxidative stress and decreased GluR2 subunit expression near to their values in normal and CDRI-08 treated control mice. Our results provide evidences towards molecular basis of the memory enhancing and anti diabetic role of the Bacopa monnieri extract in STZ-induced DM2 mice, which may have therapeutic implications.	[Pandey, Surya P.; Prasad, S.] Banaras Hindu Univ, Ctr Adv Study Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India; [Singh, Hemant K.] Lumen Res Fdn, Chennai 600083, Tamil Nadu, India	Banaras Hindu University (BHU)	Prasad, S (corresponding author), Banaras Hindu Univ, Ctr Adv Study Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.	s.sprasadbhu@gmail.com			CSIR Project, Govt. of India [37/1389/09/EMR-II]; BRNS Project, Govt. of India [2009/37/55/3298]; UGC-UPE; Faculty of Science, Banaras Hindu University; Lumen Research Foundation, Chennai, India	CSIR Project, Govt. of India; BRNS Project, Govt. of India; UGC-UPE(University Grants Commission, India); Faculty of Science, Banaras Hindu University; Lumen Research Foundation, Chennai, India	The authors acknowledge CSIR (37/1389/09/EMR-II), BRNS (2009/37/55/3298) Projects, Govt. of India, UGC-UPE, Faculty of Science, Banaras Hindu University and Lumen Research Foundation, Chennai, India for partial financial support.	Arulmozhi D. K., 2004, Indian Journal of Pharmacology, V36, P217; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Azizi R, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.15424; Bhattacharya SK, 2000, PHYTOTHER RES, V14, P174, DOI 10.1002/(SICI)1099-1573(200005)14:3&lt;174::AID-PTR624&gt;3.0.CO;2-O; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bober Ece, 2005, Pediatr Endocrinol Rev, V2, P378; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brill J, 2008, J NEUROSCI, V28, P13918, DOI 10.1523/JNEUROSCI.3229-08.2008; CANTENYS D, 1981, VIRCHOWS ARCH B, V35, P109; Castilho AF, 2014, MOL VIS, V20, P894; Chakravarty AK, 2003, CHEM PHARM BULL, V51, P215, DOI 10.1248/cpb.51.215; Channa S, 2006, J ETHNOPHARMACOL, V104, P286, DOI 10.1016/j.jep.2005.10.009; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; Das Sidhartha, 1999, Journal of Nutritional and Environmental Medicine (Abingdon), V9, P229, DOI 10.1080/13590849961645; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; Dingledine R, 1999, PHARMACOL REV, V51, P7; Duarte Ana I, 2012, J Aging Res, V2012, P384017, DOI 10.1155/2012/384017; Dulcy CP, 2012, J NEUROSCI RES, V90, P2053, DOI 10.1002/jnr.23080; Farimani AR, 2015, IRAN J MED SCI, V40, P248; FOLLI F, 1994, J NEUROSCI, V14, P6412; Gaur P, 2014, MOL BIOL REP, V41, P6855, DOI 10.1007/s11033-014-3571-1; Gautam A, 2013, NEUROBIOL LEARN MEM, V106, P177, DOI 10.1016/j.nlm.2013.08.009; Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huber JD, 2006, AM J PHYSIOL-HEART C, V291, pH2660, DOI 10.1152/ajpheart.00489.2006; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jayanarayanan S, 2013, CHEM-BIOL INTERACT, V201, P39, DOI 10.1016/j.cbi.2012.11.024; KAKKAR R, 1995, MOL CELL BIOCHEM, V151, P113, DOI 10.1007/BF01322333; Kapoor R, 2009, ENVIRON TOXICOL PHAR, V27, P62, DOI 10.1016/j.etap.2008.08.007; Khan R, 2008, EPILEPSY BEHAV, V12, P54, DOI 10.1016/j.yebeh.2007.09.021; Kim B, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.3; Kodl CT, 2008, ENDOCR REV, V29, P494, DOI 10.1210/er.2007-0034; Krishnakumar A, 2015, NEUROCHEM RES, V40, P216, DOI 10.1007/s11064-014-1472-2; Li ZG, 2002, BRAIN RES, V946, P221, DOI 10.1016/S0006-8993(02)02887-1; Liu XJ, 2013, PHARMACOL BIOCHEM BE, V110, P224, DOI 10.1016/j.pbb.2013.07.007; Luiken JJFP, 2002, AM J PHYSIOL-ENDOC M, V283, pE612, DOI 10.1152/ajpendo.00011.2002; Manschot SM, 2003, BRAIN RES, V966, P274, DOI 10.1016/S0006-8993(02)04211-7; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Massaad CA, 2011, ANTIOXID REDOX SIGN, V14, P2013, DOI 10.1089/ars.2010.3208; Mathew J, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-25; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mukherjee A, 2015, TRENDS MOL MED, V21, P439, DOI 10.1016/j.molmed.2015.04.005; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Piyabhan Pritsana, 2014, Journal of the Medical Association of Thailand, V97, pS50; Preethi J, 2014, CELL MOL NEUROBIOL, V34, P577, DOI 10.1007/s10571-014-0042-0; Rai R, 2015, EVIDENCE COMPLEMENTA; Rajan KE, 2015, EVIDENCE COMPLEMENTA; Rajan KE, 2011, NEUROCHEM RES, V36, P2136, DOI 10.1007/s11064-011-0538-7; Rajathei DM, 2014, NAT PRODUCT BIOPROSP, V4, P251, DOI 10.1007/s13659-014-0031-5; Rani A, 2015, EVIDENCE COMPLEMENTA; Rosen P, 2001, DIABETES-METAB RES, V17, P189, DOI 10.1002/dmrr.196; Russo A, 2005, PHYTOMEDICINE, V12, P305, DOI 10.1016/j.phymed.2003.12.008; Russo A, 2003, PHYTOTHER RES, V17, P870, DOI 10.1002/ptr.1061; Russo A, 2003, LIFE SCI, V73, P1517, DOI 10.1016/S0024-3205(03)00476-4; RYAN CM, 1993, J CLIN EXP NEUROPSYC, V15, P685, DOI 10.1080/01688639308402589; RYAN CM, 1993, DIABETOLOGIA, V36, P329, DOI 10.1007/BF00400236; Sabina EP, 2014, INT J PHARM PHARM SC, V11, P347; Sacai H, 2014, NEUROSCI RES, V81-82, P55, DOI 10.1016/j.neures.2014.02.002; Sairam K, 2001, PHYTOMEDICINE, V8, P423, DOI 10.1078/S0944-7113(04)70060-4; Schindler TH, 2006, J AM COLL CARDIOL, V47, P1188, DOI 10.1016/j.jacc.2005.10.062; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; SHANMUGASUNDARAM ERB, 1991, J ETHNOPHARMACOL, V33, P269, DOI 10.1016/0378-8741(91)90088-U; Sima AAF, 2004, EUR J PHARMACOL, V490, P187, DOI 10.1016/j.ejphar.2004.02.056; Singh HK, 2013, NUTRIENTS, V5, P478, DOI 10.3390/nu5020478; Singh HK, 1997, INDIAN J PHARM, V29, P359; Singh K, 2007, MOL BIOL REP, V34, P173, DOI 10.1007/s11033-006-9032-8; Singh R, 1980, J RES AYUR SIDDHA, V1, P148; Sivarajan V, 1994, AYURVEDIC DRUGS PLAN; Skovso S, 2014, J DIABETES INVEST, V5, P349, DOI 10.1111/jdi.12235; Soares E, 2013, NEUROSCIENCE, V250, P565, DOI 10.1016/j.neuroscience.2013.07.055; Stewart R, 1999, DIABETIC MED, V16, P93, DOI 10.1046/j.1464-5491.1999.00027.x; Sumathy T, 2002, FITOTERAPIA, V73, P381, DOI 10.1016/S0367-326X(02)00114-4; Trudeau F, 2004, EUR J PHARMACOL, V490, P177, DOI 10.1016/j.ejphar.2004.02.055; UA O, 2012, AM J MED MED SCI, V2, P45; Vaithianathan T, 2003, SOC NEUROSCI; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Wan LK, 2011, NEUROMETHODS, V57, P13; Wang YB, 2015, EXP THER MED, V9, P451, DOI 10.3892/etm.2014.2090; Yoshikawa M, 2001, CHEM PHARM BULL, V49, P863, DOI 10.1248/cpb.49.863; Zhang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036675	84	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131862	10.1371/journal.pone.0131862	http://dx.doi.org/10.1371/journal.pone.0131862			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161865	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300067
J	Dettmer, AM; Rosenberg, KL; Suomi, SJ; Meyer, JS; Novak, MA				Dettmer, Amanda M.; Rosenberg, Kendra L.; Suomi, Stephen J.; Meyer, Jerrold S.; Novak, Melinda A.			Associations between Parity, Hair Hormone Profiles during Pregnancy and Lactation, and Infant Development in Rhesus Monkeys (Macaca mulatta)	PLOS ONE			English	Article							MATERNAL CORTISOL-LEVELS; LUTEINIZING-HORMONE; POSTNATAL ESTRADIOL; PSYCHOSOCIAL STRESS; NONHUMAN-PRIMATES; PRENATAL EXPOSURE; RELOCATION STRESS; STEROID-HORMONES; DOMINANCE RANK; LIFE-HISTORY	Studies examining hormones throughout pregnancy and lactation in women have been limited to single, or a few repeated, short-term measures of endocrine activity. Furthermore, potential differences in chronic hormonal changes across pregnancy/lactation between first-time and experienced mothers are not well understood, especially as they relate to infant development. Hormone concentrations in hair provide long-term assessments of hormone production, and studying these measures in non-human primates allows for repeated sampling under controlled conditions that are difficult to achieve in humans. We studied hormonal profiles in the hair of 26 female rhesus monkeys (Macaca mulatta, n=12 primiparous), to determine the influences of parity on chronic levels of cortisol ( hair cortisol concentration, HCC) and progesterone (hair progesterone concentration, HPC) during early-to mid-pregnancy (PREG1), in late pregnancy/early lactation (PREG2/LACT1), and in peak lactation (LACT2). We also assessed infants' neurobehavioral development across the first month of life. After controlling for age and stage of pregnancy at the first hair sampling period, we found that HCCs overall peaked in PREG2/LACT1 (p=0.02), but only in primiparous monkeys (p<0.001). HPCs declined across pregnancy and lactation for all monkeys (p<0.01), and primiparous monkeys had higher HPCs overall than multiparous monkeys (p=0.02). Infants of primiparous mothers had lower sensorimotor reflex scores (p=0.02) and tended to be more irritable (p=0.05) and less consolable (p=0.08) in the first month of life. Moreover, across all subjects, HCCs in PREG2/LACT1 were positively correlated with irritability (r((s))=0.43, p=0.03) and negatively correlated with sensorimotor scores (r((s))=-0.41, p=0.04). Together, the present results indicate that primiparity influences both chronic maternal hormonal profiles and infant development. These effects may, in part, reflect differential reproductive and maternal effort in mothers with varied caretaking experience. In addition, infant exposure to relatively higher levels of maternal cortisol during the late fetal and early postnatal periods is predictive of poorer developmental outcomes.	[Dettmer, Amanda M.; Suomi, Stephen J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Comparat Ethol Lab, NIH, Poolesville, MD 20837 USA; [Rosenberg, Kendra L.; Meyer, Jerrold S.; Novak, Melinda A.] Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Massachusetts System; University of Massachusetts Amherst	Dettmer, AM (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Comparat Ethol Lab, NIH, Poolesville, MD 20837 USA.	dettmera@mail.nih.gov		Meyer, Jerrold/0000-0002-8382-7075; Novak, Melinda/0000-0002-4224-2396	Eunice Kennedy Shriver National Institute of Child Health & Human Development Division of Intramural Research Grant [HD001106]; National Institutes of Health [OD011180]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001107] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011180] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development Division of Intramural Research Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	SJS: Eunice Kennedy Shriver National Institute of Child Health & Human Development Division of Intramural Research Grant #HD001106 https://dir.nichd.nih.gov/dirweb/home.html. MAN: National Institutes of Health Grant #OD011180 http://www.nih.gov/about/almanac/organization/NCRR.htm.	Albrecht ED, 1999, PLACENTA, V20, P129, DOI 10.1053/plac.1998.0359; ALTEMUS M, 1995, J CLIN ENDOCR METAB, V80, P2954, DOI 10.1210/jc.80.10.2954; Altmann J, 2004, AM J PRIMATOL, V64, P95, DOI 10.1002/ajp.20064; Bacci ML, 2014, REPROD BIOL, V14, P218, DOI 10.1016/j.repbio.2014.06.001; Bastian ML, 2003, DEV PSYCHOBIOL, V42, P44, DOI 10.1002/dev.10091; Bechshoft TO, 2011, SCI TOTAL ENVIRON, V409, P831, DOI 10.1016/j.scitotenv.2010.10.047; Bergman K, 2010, BIOL PSYCHIAT, V67, P1026, DOI 10.1016/j.biopsych.2010.01.002; Brazelton T. B., 1995, NEONATAL BEHAV ASSES; Bridges RS, 2015, FRONT NEUROENDOCRIN, V36, P178, DOI 10.1016/j.yfrne.2014.11.007; BRINKER RP, 1994, AM J MENT RETARD, V98, P463; Brouwers EPM, 2001, INFANT BEHAV DEV, V24, P95, DOI 10.1016/S0163-6383(01)00062-5; Bryan HM, 2015, FUNCT ECOL, V29, P347, DOI 10.1111/1365-2435.12354; CHALLIS JRG, 1971, J ENDOCRINOL, V51, P333, DOI 10.1677/joe.0.0510333; CHENAULT JR, 1975, J DAIRY SCI, V58, P709, DOI 10.3168/jds.S0022-0302(75)84632-7; CONCANNON PW, 1978, BIOL REPROD, V19, P1113, DOI 10.1095/biolreprod19.5.1113; D'Anna-Hernandez KL, 2011, PHYSIOL BEHAV, V104, P348, DOI 10.1016/j.physbeh.2011.02.041; Davenport MD, 2008, BIOL PSYCHIAT, V63, P990, DOI 10.1016/j.biopsych.2007.10.025; Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005; Davis EP, 2010, CHILD DEV, V81, P131, DOI 10.1111/j.1467-8624.2009.01385.x; Davis EP, 2007, J AM ACAD CHILD PSY, V46, P737, DOI 10.1097/chi.0b013e318047b775; de Weerth C, 2003, EARLY HUM DEV, V74, P139, DOI 10.1016/S0378-3782(03)00088-4; Dettenborn L, 2012, STRESS, V15, P348, DOI [10.3109/10253890.2011.619239, 10.3109/10253890.2012.654479]; Dettmer AM, 2014, PSYCHONEUROENDOCRINO, V42, P59, DOI 10.1016/j.psyneuen.2014.01.002; Dettmer AM, 2012, PSYCHONEUROENDOCRINO, V37, P191, DOI 10.1016/j.psyneuen.2011.06.003; Endo N, 2012, ANIM REPROD SCI, V134, P112, DOI 10.1016/j.anireprosci.2012.08.018; Essex MJ, 2002, BIOL PSYCHIAT, V52, P776, DOI 10.1016/S0006-3223(02)01553-6; Fairbanks LA, 2011, PSYCHONEUROENDOCRINO, V36, P1201, DOI 10.1016/j.psyneuen.2011.02.013; Fessler DMT, 2005, AM J PHYS ANTHROPOL, V127, P95, DOI 10.1002/ajpa.20039; Fleming AS, 1999, NEUROSCI BIOBEHAV R, V23, P673, DOI 10.1016/S0149-7634(99)00011-1; FOLMAN Y, 1973, J REPROD FERTIL, V34, P267, DOI 10.1530/jrf.0.0340267; Fooden J, 2000, FIELDIANA ZOOL, V96, P1, DOI DOI 10.5962/BHL.TITLE.7192; FUJIEDA K, 1982, J CLIN ENDOCR METAB, V54, P89, DOI 10.1210/jcem-54-1-89; Gameiro S, 2009, J REPROD INFANT PSYC, V27, P269, DOI 10.1080/02646830802350898; Gao W, 2013, J CHROMATOGR B, V928, P1, DOI 10.1016/j.jchromb.2013.03.008; Glynn LM, 2007, EARLY HUM DEV, V83, P675, DOI 10.1016/j.earlhumdev.2007.01.003; Grant KS, 2014, NEUROTOXICOL TERATOL, V43, P91, DOI 10.1016/j.ntt.2014.04.050; Grey KR, 2013, PSYCHONEUROENDOCRINO, V38, P1178, DOI 10.1016/j.psyneuen.2012.11.002; Hamosh M, 2001, PEDIATR CLIN N AM, V48, P69, DOI 10.1016/S0031-3955(05)70286-8; Hart S, 2004, INFANT BEHAV DEV, V27, P101, DOI 10.1016/j.infbeh.2003.06.002; Hinde K, 2009, AM J PHYS ANTHROPOL, V138, P148, DOI 10.1002/ajpa.20911; Hinde K, 2009, AM J HUM BIOL, V21, P512, DOI 10.1002/ajhb.20917; Hinde K, 2015, BEHAV ECOL, V26, P269, DOI 10.1093/beheco/aru186; Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709; HODGEN GD, 1977, AM J OBSTET GYNECOL, V127, P581, DOI 10.1016/0002-9378(77)90352-0; HOOLEY J M, 1981, Primates, V22, P379; Hung CH, 2007, KAOHSIUNG J MED SCI, V23, P352, DOI 10.1016/S1607-551X(09)70421-8; Jarcho MR, 2012, AM J PRIMATOL, V74, P462, DOI 10.1002/ajp.22003; Kapoor A, 2014, PEDIATR RES, V75, P476, DOI 10.1038/pr.2014.1; Kirschbaum C, 2009, PSYCHONEUROENDOCRINO, V34, P32, DOI 10.1016/j.psyneuen.2008.08.024; Koren L, 2002, ANIM BEHAV, V63, P403, DOI 10.1006/anbe.2001.1907; Lipkin EW, 2001, BONE, V29, P249, DOI 10.1016/S8756-3282(01)00508-7; Liu X. Y., 1988, International Journal of Animal Sciences, V3, P123; Macbeth BJ, 2010, CAN J ZOOL, V88, P935, DOI 10.1139/Z10-057; MAEDA KI, 1991, J REPROD FERTIL, V92, P371, DOI 10.1530/jrf.0.0920371; MAGNUS P, 1985, EARLY HUM DEV, V12, P49, DOI 10.1016/0378-3782(85)90136-7; Martin RD, 2007, YEARB PHYS ANTHROPOL, V50, P59, DOI 10.1002/ajpa.20734; Mas-Rivera A, 2008, AM J PRIMATOL, V70, P1047, DOI 10.1002/ajp.20596; Meyer JS, 2014, ILAR J, V55, P347, DOI 10.1093/ilar/ilu023; Meyer JS, 2012, ENDOCRINOLOGY, V153, P4120, DOI 10.1210/en.2012-1226; MITCHELL G, 1968, Developmental Psychobiology, V1, P280, DOI 10.1002/dev.420010411; MOLTZ H, 1970, PHYSIOL BEHAV, V5, P1373, DOI 10.1016/0031-9384(70)90122-8; Novak MA, 2014, J AM ASSOC LAB ANIM, V53, P261; Novak MA, 2013, APPL ANIM BEHAV SCI, V143, P135, DOI 10.1016/j.applanim.2012.10.012; Novak MFSX., 2006, DEV PRIMATOLOGY PROG, P513; Pang WW, 2007, J MAMMARY GLAND BIOL, V12, P211, DOI 10.1007/s10911-007-9054-4; PARVIZI N, 1976, J ENDOCRINOL, V69, P193, DOI 10.1677/joe.0.0690193; PATERSON JY, 1974, J ENDOCRINOL, V62, P371, DOI 10.1677/joe.0.0620371; PEPE GJ, 1995, ENDOCR REV, V16, P608, DOI 10.1210/er.16.5.608; Pereg D, 2011, STRESS, V14, P73, DOI 10.3109/10253890.2010.511352; Rawlins RG., 1986, CAYO SANTIAGO MACAQU; ROSENBERG M, 1977, J REPROD FERTIL, V51, P363, DOI 10.1530/jrf.0.0510363; ROUSSEL JD, 1983, THERIOGENOLOGY, V19, P535, DOI 10.1016/0093-691X(83)90174-7; Rutherford JN, 2013, BUILDING BABIES PRIM, P27, DOI DOI 10.1007/978-1-4614-4060-4_2; Saltzman W, 2011, PHYSIOL BEHAV, V104, P446, DOI 10.1016/j.physbeh.2011.05.005; SCHNEIDER ML, 1992, INFANT BEHAV DEV, V15, P155, DOI 10.1016/0163-6383(92)80021-L; Scholl T O, 1992, Ann Epidemiol, V2, P565; SEAY B, 1966, FOLIA PRIMATOL, V4, P146, DOI 10.1159/000155049; SMITH VG, 1973, J ANIM SCI, V36, P391; STERN JM, 1973, NEUROENDOCRINOLOGY, V12, P179, DOI 10.1159/000122167; Suarez-Jimenez B, 2013, AM J PRIMATOL, V75, P65, DOI 10.1002/ajp.22081; Sullivan EC, 2011, DEV PSYCHOBIOL, V53, P96, DOI 10.1002/dev.20483; Thompson ME, 2012, BEHAV ECOL, V23, P1234, DOI 10.1093/beheco/ars107; Trotter A, 2001, J CLIN ENDOCR METAB, V86, P601, DOI 10.1210/jc.86.2.601; Trotter A, 1999, J CLIN ENDOCR METAB, V84, P4531, DOI 10.1210/jc.84.12.4531; Tu MT, 2006, PSYCHONEUROENDOCRINO, V31, P812, DOI 10.1016/j.psyneuen.2006.03.006; TURNBULL AC, 1974, LANCET, V1, P101; Van Esch E, 2008, TOXICOL PATHOL, V36, p171S, DOI 10.1177/0192623308327415; VANWAGENEN G, 1956, AM J PHYS ANTHROPOL, V14, P245, DOI 10.1002/ajpa.1330140219; vom Saal F.S., 1988, P2351; Wallner B, 2011, PRIMATES, V52, P69, DOI 10.1007/s10329-010-0221-7; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; WILSON ME, 1992, J ENDOCRINOL, V134, P493, DOI 10.1677/joe.0.1340493; Yang HZ, 1998, J STEROID BIOCHEM, V67, P447, DOI 10.1016/S0960-0760(98)00120-4	93	30	30	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131692	10.1371/journal.pone.0131692	http://dx.doi.org/10.1371/journal.pone.0131692			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172048	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900021
J	Greco, SH; Tomkotter, L; Vahle, AK; Rokosh, R; Avanzi, A; Mahmood, SK; Deutsch, M; Alothman, S; Alqunaibit, D; Ochi, A; Zambirinis, C; Mohaimin, T; Rendon, M; Levie, E; Pansari, M; Torres-Hernandez, A; Daley, D; Barilla, R; Pachter, HL; Tippens, D; Malik, H; Boutajangout, A; Wisniewski, T; Miller, G				Greco, Stephanie H.; Tomkoetter, Lena; Vahle, Anne-Kristin; Rokosh, Rae; Avanzi, Antonina; Mahmood, Syed Kashif; Deutsch, Michael; Alothman, Sara; Alqunaibit, Dalia; Ochi, Atsuo; Zambirinis, Constantinos; Mohaimin, Tasnima; Rendon, Mauricio; Levie, Elliot; Pansari, Mridul; Torres-Hernandez, Alejandro; Daley, Donnele; Barilla, Rocky; Pachter, H. Leon; Tippens, Daniel; Malik, Hassan; Boutajangout, Allal; Wisniewski, Thomas; Miller, George			TGF-beta Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CONTROL MUSCLE MASS; TRANSFORMING GROWTH-FACTOR-BETA-1; DUAL INHIBITOR; ANOREXIA; MICE; INDUCTION; CELLS; CARCINOGENESIS; NEUROPEPTIDES	Cancer cachexia is a debilitating condition characterized by a combination of anorexia, muscle wasting, weight loss, and malnutrition. This condition affects an overwhelming majority of patients with pancreatic cancer and is a primary cause of cancer-related death. However, few, if any, effective therapies exist for both treatment and prevention of this syndrome. In order to develop novel therapeutic strategies for pancreatic cancer cachexia, appropriate animal models are necessary. In this study, we developed and validated a syngeneic, metastatic, murine model of pancreatic cancer cachexia. Using our model, we investigated the ability of transforming growth factor beta (TGF-beta) blockade to mitigate the metabolic changes associated with cachexia. We found that TGF-beta inhibition using the anti-TGF-beta antibody 1D11.16.8 significantly improved overall mortality, weight loss, fat mass, lean body mass, bone mineral density, and skeletal muscle proteolysis in mice harboring advanced pancreatic cancer. Other immunotherapeutic strategies we employed were not effective. Collectively, we validated a simplified but useful model of pancreatic cancer cachexia to investigate immunologic treatment strategies. In addition, we showed that TGF-beta inhibition can decrease the metabolic changes associated with cancer cachexia and improve overall survival.	[Greco, Stephanie H.; Tomkoetter, Lena; Vahle, Anne-Kristin; Rokosh, Rae; Avanzi, Antonina; Mahmood, Syed Kashif; Deutsch, Michael; Alothman, Sara; Alqunaibit, Dalia; Ochi, Atsuo; Zambirinis, Constantinos; Mohaimin, Tasnima; Rendon, Mauricio; Levie, Elliot; Pansari, Mridul; Torres-Hernandez, Alejandro; Daley, Donnele; Barilla, Rocky; Pachter, H. Leon; Tippens, Daniel; Malik, Hassan; Miller, George] NYU, Sch Med, Dept Surg, New York, NY 10003 USA; [Miller, George] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Boutajangout, Allal; Wisniewski, Thomas] NYU, Sch Med, Dept Neurol, New York, NY USA	New York University; New York University; New York University	Miller, G (corresponding author), NYU, Sch Med, Dept Surg, New York, NY 10003 USA.	george.miller@nyumc.org	Wisniewski, Thomas/Q-6525-2019	Wisniewski, Thomas/0000-0002-3379-8966; Alothman, Sarah/0000-0001-5509-2115; Barilla, Rocky/0000-0002-8062-7246; Ochi, Atsuo/0000-0003-2374-7249; Seifert, Lena/0000-0003-4763-8127; Zambirinis, Constantinos/0000-0003-2740-3259; Alothman, Sara/0000-0003-2375-5572; Rokosh, Rae/0000-0003-2832-5184; Alqunaibit, Dalia/0000-0002-8410-4143	America Hepato-biliary pancreatic Association; German Research Foundation; National Institute of Health [CA155649, CA168611]; German Cancer Aid; NATIONAL CANCER INSTITUTE [T32CA193111, R21CA155649, P30CA016087, R01CA168611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008051] Funding Source: NIH RePORTER	America Hepato-biliary pancreatic Association; German Research Foundation(German Research Foundation (DFG)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Cancer Aid(Deutsche Krebshilfe); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in-part by grants from the America Hepato-biliary pancreatic Association (SHG), the German Research Foundation (LT), National Institute of Health Awards CA155649 (GM), and CA168611 (GM), and German Cancer Aid (AKV).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Amirouche A, 2009, ENDOCRINOLOGY, V150, P286, DOI 10.1210/en.2008-0959; [Anonymous], 2014, SEER CANCER STATISTI; Banduseela V, 2007, Acta Myol, V26, P136; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Barrat FJ, 2007, EUR J IMMUNOL, V37, P3582, DOI 10.1002/eji.200737815; Bedrosian AS, 2011, GASTROENTEROLOGY, V141, P1915, DOI 10.1053/j.gastro.2011.07.033; Bennani-Baiti N, 2008, AM J HOSP PALLIAT ME, V25, P407, DOI 10.1177/1049909108315518; Bennani-Baiti N, 2011, SUPPORT CARE CANCER, V19, P1451, DOI 10.1007/s00520-010-0972-0; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Biegler KA, 2009, ACTA ONCOL, V48, P18, DOI 10.1080/02841860802415535; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Boutajangout A, 2012, METHODS MOL BIOL, V849, P529, DOI 10.1007/978-1-61779-551-0_35; Capella G, 1999, ANN NY ACAD SCI, V880, P103, DOI 10.1111/j.1749-6632.1999.tb09514.x; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; DeBoer MD, 2009, EXPERT OPIN DRUG DIS, V4, P1145, DOI 10.1517/17460440903300842; Gaspar NJ, 2007, MOL PHARMACOL, V72, P152, DOI 10.1124/mol.106.029025; Grippo PJ, 2005, METH MOLEC MED, V103, P217; Gumucio JP, 2013, ENDOCRINE, V43, P12, DOI 10.1007/s12020-012-9751-7; Hezel AF, 2012, CANCER RES, V72, P4840, DOI 10.1158/0008-5472.CAN-12-0634; Hotz Hubert G, 2003, Pancreas, V26, pe89, DOI 10.1097/00006676-200305000-00020; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Inui A, 2002, CA-CANCER J CLIN, V52, P72, DOI 10.3322/canjclin.52.2.72; Inui A, 1999, CANCER RES, V59, P4493; Jacobs EJ, 2014, CANCER CAUSE CONTROL, V25, P1083, DOI 10.1007/s10552-014-0409-z; Jaeschke R., 2008, POLSKIE ARCH MEDYCYN, V118, P1; Javle M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085942; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Jones-Bolin Susan, 2007, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1404s37; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim YJ, 2012, ANTICANCER RES, V32, P799; Kneuertz PJ, 2011, J GASTROINTEST SURG, V15, P1917, DOI 10.1007/s11605-011-1665-9; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; Lasheen W, 2010, SUPPORT CARE CANCER, V18, P265, DOI 10.1007/s00520-009-0772-6; Loiselle C, 2009, CURR PAIN HEADACHE R, V13, P271, DOI 10.1007/s11916-009-0043-8; Lopez AP, 2004, J PAIN SYMPTOM MANAG, V27, P360, DOI 10.1016/j.jpainsymman.2003.09.007; MATZUK MM, 1994, P NATL ACAD SCI USA, V91, P8817, DOI 10.1073/pnas.91.19.8817; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Mendias CL, 2012, MUSCLE NERVE, V45, P55, DOI 10.1002/mus.22232; Meyers CA, 2000, ONCOLOGY-NY, V14, P75; Michaud D S, 2004, Minerva Chir, V59, P99; Mitsunaga S, 2013, BRIT J CANCER, V108, P2063, DOI 10.1038/bjc.2013.174; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Ochi A, 2012, J CLIN INVEST, V122, P4118, DOI 10.1172/JCI63606; Ochi A, 2012, J EXP MED, V209, P1671, DOI 10.1084/jem.20111706; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Patra SK, 2012, CLIN CHIM ACTA, V413, P1025, DOI 10.1016/j.cca.2011.12.008; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; Ramos EJB, 2004, CURR OPIN CLIN NUTR, V7, P427, DOI 10.1097/01.mco.0000134363.53782.cb; Rao R, 2014, GASTROENTEROLOGY, V147, P473, DOI 10.1053/j.gastro.2014.04.042; Ronga I, 2014, ADV MED SCI-POLAND, V59, P1, DOI 10.1016/j.advms.2013.11.001; Garcia VR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004310.pub3; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Simeone DM, 2000, ANN SURG, V232, P73, DOI 10.1097/00000658-200007000-00011; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; Tan CR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00088; Truty MJ, 2007, PANCREATOLOGY, V7, P423, DOI 10.1159/000108959; Vaz J, 2014, WORLD J GASTROENTERO, V20, P5808, DOI 10.3748/wjg.v20.i19.5808; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Welle SL, 2009, AM J PHYSIOL-CELL PH, V296, pC1245, DOI 10.1152/ajpcell.00154.2009; Wu HQ, 2011, WORLD J GASTROENTERO, V17, P996, DOI 10.3748/wjg.v17.i8.996; Zambirinis CP, 2013, CELL CYCLE, V12, P1153, DOI 10.4161/cc.24488; Zhang DL, 2008, ANN CLIN LAB SCI, V38, P113; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525; ZUGMAIER G, 1991, CANCER RES, V51, P3590	67	49	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132786	10.1371/journal.pone.0132786	http://dx.doi.org/10.1371/journal.pone.0132786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172047	gold, Green Submitted, Green Published			2022-12-27	WOS:000358194900085
J	Muller, P; Doliva, R; Busch, M; Philippeit, C; Stephan, H; Dunker, N				Mueller, Patrick; Doliva, Rebekka; Busch, Maike; Philippeit, Claudia; Stephan, Harald; Duenker, Nicole			Additive Effects of Retinoic Acid (RA) and Bone Morphogenetic Protein 4 (BMP-4) Apoptosis Signaling in Retinoblastoma Cell Lines	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; BREAST-CANCER CELLS; EMBRYONAL CARCINOMA-CELLS; RECEPTOR-BETA; LUNG-CANCER; X-RECEPTORS; GROWTH-INHIBITION; NUCLEAR RECEPTOR; MAMMALIAN-CELLS; ACTIVATION	Retinoids have been shown to serve promising therapeutic agents for human cancers, e.g. the treatment of neuroblastoma. Synthetic retinoids, specific for particular retinoic acid (RA) receptors, are tested as new therapy strategies. In the present study, application of recombinant retinoic acid (RA) lowers retinoblastoma (RB) cell viability and induces apoptosis in RB cell lines. Combined treatment of RA and bone morphogenetic protein 4 (BMP-4) increases the pro-apoptotic effect of RA in the RB cells lines WERI-Rb1, Y-79, RB355, RBL-30 and RBL-15, indicating an additive effect. We could show that in WERI-Rb1 cells RA/BMP-4 mediated cell death is at least partially caspase-dependent, whereby RA and BMP-4 additively increased (i) Apaf-1 mRNA levels, (ii) caspase-9 cleavage activity and (iii) the number of activated, cleaved caspase-3 positive cells. Compared to single application of RA and BMP-4, combined RA/BMP-4 treatment significantly augments mRNA levels of the retinoic acid receptors (RARs) RAR alpha and RAR beta and the retinoic X receptor (RXR) RXR gamma suggesting an interaction in the induction of these RA receptor subtypes in WERI-Rb1 cells. Agonist studies revealed that both, RARs and RXRs are involved in RA/BMP-4 mediated apoptosis in WERI-Rb1 retinoblastoma cells. Employing specific RAR subtype antagonists and a RXR beta and RXR gamma knockdown, we proved that RA/BMP-4 apoptosis signaling in WERI-Rb1 cells requires the RA receptor subtypes RAR alpha, RAR beta, RXR beta and RXR gamma. Deciphering signaling mechanisms underlying apoptosis induction of RA and BMP-4 in WERI-Rb1 cells, our study provides useful starting-points for future retinoid-based therapy strategies in retinoblastoma.	[Mueller, Patrick; Doliva, Rebekka; Busch, Maike; Philippeit, Claudia; Duenker, Nicole] Univ Duisburg Essen, Inst Anat, Fac Med, Dept Neuroanat, Essen, Germany; [Stephan, Harald] Univ Duisburg Essen, Childrens Hosp, Div Haematol & Oncol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Dunker, N (corresponding author), Univ Duisburg Essen, Inst Anat, Fac Med, Dept Neuroanat, Essen, Germany.	nicole.duenker@uk-essen.de	Busch, Maike Anna/AGI-3929-2022; Stephan, Harald/AAT-6802-2021	Busch, Maike Anna/0000-0001-9651-031X; Dunker, Nicole/0000-0003-1273-0644	Else Kroner Fresenius foundation	Else Kroner Fresenius foundation	PM and RD were funded by the Else Kroner Fresenius foundation (http://www.ekfs.de/de/aktuell/promotionskolleg-2011.html).	ALLEGRETTO EA, 1993, J BIOL CHEM, V268, P26625; Brandebourg TD, 2005, J ANIM SCI, V83, P98; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003; CASTAIGNE S, 1990, BLOOD, V76, P1704; Chi HT, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-165; Decensi A, 2000, J CELL BIOCHEM, P84; DETHE H, 1989, EMBO J, V8, P429, DOI 10.1002/j.1460-2075.1989.tb03394.x; Donato LJ, 2005, CANCER RES, V65, P8193, DOI 10.1158/0008-5472.CAN-05-1177; Ferrari N, 1998, MOL CELL BIOL, V18, P6482, DOI 10.1128/MCB.18.11.6482; Fujita E, 1999, CELL DEATH DIFFER, V6, P1109, DOI 10.1038/sj.cdd.4400585; Gilardi F, 2014, SUBCELL BIOCHEM, V70, P75, DOI 10.1007/978-94-017-9050-5_5; Glozak MA, 1996, DEV BIOL, V179, P458, DOI 10.1006/dbio.1996.0275; GRIEGEL S, 1990, INT J CANCER, V46, P125, DOI 10.1002/ijc.2910460123; HARMON MA, 1995, P NATL ACAD SCI USA, V92, P6157, DOI 10.1073/pnas.92.13.6157; Hartmann L, 2010, AM J HUM GENET, V87, P480, DOI 10.1016/j.ajhg.2010.08.016; Haubold M, 2010, INT J BIOL SCI, V6, P700; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; HOULE B, 1991, GENE CHROMOSOME CANC, V3, P358, DOI 10.1002/gcc.2870030506; HU L, 1991, CANCER RES, V51, P3972; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; HUGGENVIK JI, 1995, PHARMACOL TOXICOL, V76, P17, DOI 10.1111/j.1600-0773.1995.tb00096.x; Kim DG, 1996, CANCER LETT, V107, P149, DOI 10.1016/0304-3835(96)04407-2; KOK K, 1987, NATURE, V330, P578, DOI 10.1038/330578a0; KYRITSIS A, 1984, JNCI-J NATL CANCER I, V73, P649; le Maire A, 2014, SUBCELL BIOCHEM, V70, P37, DOI 10.1007/978-94-017-9050-5_3; le Maire A, 2012, CURR TOP MED CHEM, V12, P505, DOI 10.2174/156802612799436687; Li AM, 2003, INVEST OPHTH VIS SCI, V44, P996, DOI 10.1167/iovs.02-0434; Li ML, 2014, CRIT REV ONCOL HEMAT, V91, P271, DOI 10.1016/j.critrevonc.2014.04.001; Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360; Li Y, 1998, INT J CANCER, V75, P88, DOI 10.1002/(SICI)1097-0215(19980105)75:1<88::AID-IJC14>3.0.CO;2-9; Lin BZ, 2000, MOL CELL BIOL, V20, P957, DOI 10.1128/MCB.20.3.957-970.2000; LIPPMAN SM, 1987, CANCER TREAT REP, V71, P493; Liu Y, 1996, MOL CELL BIOL, V16, P1138; Lu Tai-Ying, 2010, Zhonghua Zhong Liu Za Zhi, V32, P892; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MANGELSDORF DJ, 1991, CELL, V66, P555, DOI 10.1016/0092-8674(81)90018-0; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Mangiarotti R, 1998, BRIT J CANCER, V77, P186, DOI 10.1038/bjc.1998.32; Masetti R, 2012, ADV THER, V29, P747, DOI 10.1007/s12325-012-0047-3; MCFALL RC, 1977, CANCER RES, V37, P1003; NAGY L, 1995, MOL CELL BIOL, V15, P3540; Nichol JN, 2014, BEST PRACT RES CL HA, V27, P19, DOI 10.1016/j.beha.2014.04.009; Piskunov A, 2014, SUBCELL BIOCHEM, V70, P103, DOI 10.1007/978-94-017-9050-5_6; Poulaki V, 2005, INVEST OPHTH VIS SCI, V46, P358, DOI 10.1167/iovs.04-0324; REID TW, 1974, J NATL CANCER I, V53, P347, DOI 10.1093/jnci/53.2.347; ROBERTS AB, 1984, RETINOIDS, V2, P209; Somenzi G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000836; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; SWISSHELM K, 1994, CELL GROWTH DIFFER, V5, P133; Yuan SJ, 2013, STRUCTURE, V21, P501, DOI 10.1016/j.str.2013.02.024	51	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131467	10.1371/journal.pone.0131467	http://dx.doi.org/10.1371/journal.pone.0131467			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173116	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900015
J	Poggi, C; Giusti, B; Gozzini, E; Sereni, A; Romagnuolo, I; Kura, A; Pasquini, E; Abbate, R; Dani, C				Poggi, Chiara; Giusti, Betti; Gozzini, Elena; Sereni, Alice; Romagnuolo, Ilaria; Kura, Ada; Pasquini, Elisabetta; Abbate, Rosanna; Dani, Carlo			Genetic Contributions to the Development of Complications in Preterm Newborns	PLOS ONE			English	Article							INHALED NITRIC-OXIDE; ENDOTHELIAL GROWTH-FACTOR; ANGIOTENSIN-CONVERTING ENZYME; SYNTHASE GENE; RESPIRATORY-DISTRESS; INSERTION/DELETION POLYMORPHISM; PULMONARY-HYPERTENSION; HEME OXYGENASE-1; LUNG GROWTH; INFANTS	Aim We aimed to identify specific polymorphisms of genes encoding for vascular endothelial growth factor A (VEGFA), endothelial nitric oxide synthase (eNOS), renin-angiotensin system (angiotensinogen gene [AGT], angiotensinogen type 1 receptor [AGTR1], angiotensin-converting enzyme [ACE]), and heme oxygenase-1 (HMOX-1) in a cohort of preterm infants and correlate their presence with the development of respiratory distress syndrome (RDS) requiring mechanical ventilation (MV), bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH) and retinopathy of prematurity (ROP). Study Design We carried out a retrospective study to evaluate the allele frequency and genotype distribution of polymorphisms of VEGFA, eNOS, AGT, AGTR1, ACE, and HMOX-1 in a population of preterm neonates (n=342) with a gestational age <= 28 weeks according to the presence or absence of RDS requiring MV, BPD, IVH, or ROP. Moreover, we evaluated through the haplotype reconstruction analysis whether combinations of the selected polymorphisms are related to the occurrence of RDS, BPD, IVH and ROP. Results In our population 157 infants developed RDS requiring MV, 71 BPD, 70 IVH, and 43 ROP. We found that TC+CC rs2070744 eNOS (41.7 vs. 25.4%, p=0.01) and GT+TT rs1799983 eNOS (51.8 vs. 35.2%, p=0.01) polymorphisms are independent risk factors for BPD. Haplotype reconstruction showed that haplotypes in VEGF and eNOS are significantly associated with different effects on RDS, BPD, IVH, and ROP in our population. Conclusions We found that TC+CC rs2070744 eNOS and GT+TT rs1799983 eNOS polymorphisms are independent predictors of an increased risk of developing BPD. Haplotypes of VEGFA and eNOS may be independent protective or risk markers for prematurity complications.	[Poggi, Chiara; Gozzini, Elena] Careggi Univ Hosp Florence, Div Neonatol, Florence, Italy; [Giusti, Betti; Sereni, Alice; Romagnuolo, Ilaria; Kura, Ada; Abbate, Rosanna] Univ Florence, Dept Expt & Clin Med, Atherothrombot Dis Ctr, Careggi Univ Hosp Florence, Florence, Italy; [Romagnuolo, Ilaria] Univ Florence, Dept Informat Engn, Florence, Italy; [Pasquini, Elisabetta] Meyer Childrens Hosp, Clin Pediat Neurol, Metab & Muscular Unit, Florence, Italy; [Dani, Carlo] Careggi Univ Hosp Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Florence, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence; Azienda Ospedaliero Universitaria Careggi	Dani, C (corresponding author), Careggi Univ Hosp Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Florence, Italy.	cdani@unifi.It	Giusti, Betti/K-6978-2016; Sereni, Alice/K-6350-2016	Giusti, Betti/0000-0002-8708-9444; Sereni, Alice/0000-0002-6976-1110	Ente Cassa di Risparmio di Firenze	Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	The study was funded by Ente Cassa di Risparmio di Firenze to Fiorgen Foundation, Florence, Italy.	Abdel-Aziz TA, 2013, MOL BIOL REP, V40, P3065, DOI 10.1007/s11033-012-2380-7; Ballard RA, 2006, NEW ENGL J MED, V355, P343, DOI 10.1056/NEJMoa061088; Bassan H, 2009, CLIN PERINATOL, V36, P737, DOI 10.1016/j.clp.2009.07.014; Becker T, 2005, ANN HUM GENET, V69, P747, DOI 10.1111/j.1529-8817.2005.00198.x; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bhatt AJ, 2001, AM J RESP CRIT CARE, V164, P1971, DOI 10.1164/ajrccm.164.10.2101140; Colomba Daniela, 2008, Immun Ageing, V5, P4, DOI 10.1186/1742-4933-5-4; Dani C, 2008, NEONATOLOGY, V94, P87, DOI 10.1159/000119719; Dani C, 2011, J MATERN-FETAL NEO M, V24, P1427, DOI 10.3109/14767058.2011.572203; Davis JM, 1999, NEONATOLOGY, P509; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; Ehrenkranz RA, 2005, PEDIATRICS, V116, P1353, DOI 10.1542/peds.2005-0249; Fatini C, 2004, AM HEART J, V147, P516, DOI 10.1016/j.ahj.2003.10.032; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good WV, 2005, PEDIATRICS, V116, P15, DOI 10.1542/peds.2004-1413; Haider MZ, 2002, BIOL NEONATE, V82, P84, DOI 10.1159/000063092; Hollegaard MV, 2013, MOL GENET METAB, V110, P65, DOI 10.1016/j.ymgme.2013.06.004; Kazzi SNJ, 2005, J PEDIATR-US, V147, P818, DOI 10.1016/j.jpeds.2005.07.029; Koch W, 2005, CLIN CHEM, V51, P1547, DOI 10.1373/clinchem.2005.051656; Lassus P, 2001, AM J RESP CRIT CARE, V164, P1981, DOI 10.1164/ajrccm.164.10.2012036; Liu PL, 2012, MOL BIOL REP, V39, P10731, DOI 10.1007/s11033-012-1964-6; McCurnin DC, 2005, AM J PHYSIOL-LUNG C, V288, pL450, DOI 10.1152/ajplung.00347.2004; Mohamed S, 2009, PEDIATR RES, V65, P193, DOI 10.1203/PDR.0b013e31818d1dbd; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; PIERCE MR, 1995, PEDIATR PULM, V19, P371, DOI 10.1002/ppul.1950190611; Rubaltelli FF, 1998, ACTA PAEDIATR, V87, P1261, DOI 10.1080/080352598750030951; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Sivasli E, 2007, TURKISH J PEDIATR, V49, P69; Spiegler J, 2010, NEONATOLOGY, V97, P10, DOI 10.1159/000226602; Taha H, 2010, ARTERIOSCL THROM VAS, V30, P1634, DOI 10.1161/ATVBAHA.110.207316; Tang JR, 2007, AM J PHYSIOL-LUNG C, V293, pL1271, DOI 10.1152/ajplung.00224.2007; Tang JR, 2004, AM J PHYSIOL-LUNG C, V287, pL344, DOI 10.1152/ajplung.00291.2003; Tesauro M, 2000, P NATL ACAD SCI USA, V97, P2832, DOI 10.1073/pnas.97.6.2832; Vannemreddy P, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09143; Vazquez-Armenta G, 2013, TOHOKU J EXP MED, V231, P201, DOI 10.1620/tjem.231.201; Veldman BA, 2002, J HYPERTENS, V20, P2023, DOI 10.1097/00004872-200210000-00022; Wang MY, 2013, BIOMED REP, V1, P144, DOI 10.3892/br.2012.23; Yanamandra Krishna, 2004, BMC Pediatr, V4, P26, DOI 10.1186/1471-2431-4-26	38	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131741	10.1371/journal.pone.0131741	http://dx.doi.org/10.1371/journal.pone.0131741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172140	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900022
J	Shi, W; Wang, VB; Zhao, CE; Zhang, QC; Loo, SCJ; Yang, L; Xu, CJ				Shi, Wei; Wang, Victor Bochuan; Zhao, Cui-E; Zhang, Qichun; Loo, Say Chye Joachim; Yang, Liang; Xu, Chenjie			Anditalea andensis ANESC-S-T- An Alkaliphilic Halotolerant Bacterium Capable of Electricity Generation under Alkaline-Saline Conditions	PLOS ONE			English	Article							MICROBIAL FUEL-CELLS; WASTE-WATER TREATMENT; EXTRACELLULAR ELECTRON-TRANSFER; CONJUGATED OLIGOELECTROLYTES; ELECTROCHEMICAL TECHNOLOGIES; PERFORMANCE; BIOELECTRICITY; REMOVAL; BIOFILM; ENERGY	A great challenge in wastewater bioremediation is the sustained activity of viablemicroorganisms, which can contribute to the breakdown of waste contaminants, especially in alkaline pH conditions. Identification of extremophiles with bioremediation capability can improve the efficiency of wastewater treatment. Here, we report the discovery of an electrochemically active alkaliphilic halotolerant bacterium, Anditalea andensis ANESC-S-T (=CICC10485T=NCCB 100412(T)), which is capable of generating bioelectricity in alkaline-saline conditions. A. andensis ANESC-S-T was shown to grow in alkaline conditions between pH 7.0-11.0 and also under high salt condition (up to 4 wt% NaCl). Electrical output was further demonstrated in microbial fuel cells (MFCs) with an average current density of similar to 0.5 mu A/cm(2), even under the harsh condition of 4 wt% NaCl and pH 9.0. Subsequent introduction of secreted extracellular metabolites into MFCs inoculated with Escherichia coli or Pseudomonas aeruginosa yielded enhanced electrical output. The ability of A. andensis ANESC-S-T to generate energy under alkalinesaline conditions points towards a solution for bioelectricity recovery fromalkaline-saline wastewater. This is the first report of A. andensis ANESC-S-T producing bioelectricity at high salt concentration and pH.	[Shi, Wei; Xu, Chenjie] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 637551, Singapore; [Wang, Victor Bochuan; Loo, Say Chye Joachim; Yang, Liang] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore; [Wang, Victor Bochuan; Zhao, Cui-E; Zhang, Qichun; Loo, Say Chye Joachim] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Yang, Liang] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Shi, Wei] Nanjing Tech Univ, Natl Jiangsu Synergist Innovat Ctr Adv Mat, Key Lab Flexible Elect, Nanjing 211816, Jiangsu, Peoples R China; [Shi, Wei] Nanjing Tech Univ, Natl Jiangsu Synergist Innovat Ctr Adv Mat, Inst Adv Mat, Nanjing 211816, Jiangsu, Peoples R China	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanjing Tech University; Nanjing Tech University	Yang, L (corresponding author), Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore.	yangliang@ntu.edu.sg; cjxu@ntu.edu.sg	xu, chenjie/E-4075-2012; Yang, Liang/C-8487-2011; Loo, Say Chye Joachim/A-2234-2011; Qichun, Zhang/A-2253-2011	Yang, Liang/0000-0002-2362-0128; Loo, Say Chye Joachim/0000-0001-5300-1275; Qichun, Zhang/0000-0003-1854-8659; Xu, Chenjie/0000-0002-8278-3912	SMART Ignition Grant [ING137064-BIO]; Singapore Centre on Environmental Life Sciences Engineering (SCELSE) [M4330001.C70.703012]; School of Materials Science and Engineering [M020070110]; NTU-National Healthcare Group (NTU-NHG) [ARG/14012]	SMART Ignition Grant; Singapore Centre on Environmental Life Sciences Engineering (SCELSE); School of Materials Science and Engineering; NTU-National Healthcare Group (NTU-NHG)	This work was partially supported by SMART Ignition Grant (ING137064-BIO to C Xu). SCJ Loo and VBC Wang would also like to acknowledge the financial support from the Singapore Centre on Environmental Life Sciences Engineering (SCELSE) (M4330001.C70.703012), the School of Materials Science and Engineering (M020070110), and the NTU-National Healthcare Group (NTU-NHG) grant (ARG/14012).	Chen GH, 2004, SEP PURIF TECHNOL, V38, P11, DOI 10.1016/j.seppur.2003.10.006; Freguia S, 2009, BIOELECTROCHEMISTRY, V76, P14, DOI 10.1016/j.bioelechem.2009.04.001; Fricke K, 2008, ENERG ENVIRON SCI, V1, P144, DOI 10.1039/b802363h; Garner LE, 2012, ENERG ENVIRON SCI, V5, P9449, DOI 10.1039/c2ee22839d; Garner LE, 2010, J AM CHEM SOC, V132, P10042, DOI 10.1021/ja1016156; Huang YX, 2011, CHEM COMMUN, V47, P5795, DOI 10.1039/c1cc10159e; Jung S, 2007, APPL MICROBIOL BIOT, V77, P393, DOI 10.1007/s00253-007-1162-y; Kim BH, 2003, BIOTECHNOL LETT, V25, P541, DOI 10.1023/A:1022891231369; Lefebvre O, 2006, WATER RES, V40, P3671, DOI 10.1016/j.watres.2006.08.027; Li WW, 2014, ENERG ENVIRON SCI, V7, P911, DOI 10.1039/c3ee43106a; Logan BE, 2012, SCIENCE, V337, P686, DOI 10.1126/science.1217412; Marshall CW, 2009, ENERG ENVIRON SCI, V2, P699, DOI 10.1039/b823237g; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Meng XM, 2008, FUEL PROCESS TECHNOL, V89, P851, DOI 10.1016/j.fuproc.2008.02.006; Murata K, 2009, ENERG ENVIRON SCI, V2, P1280, DOI 10.1039/b912915d; Newton GJ, 2009, APPL ENVIRON MICROB, V75, P7674, DOI 10.1128/AEM.01142-09; Nielsen ME, 2008, ENERG ENVIRON SCI, V1, P584, DOI 10.1039/b811899j; O'Sullivan LA, 2006, INT J SYST EVOL MICR, V56, P169, DOI 10.1099/ijs.0.63941-0; Ha PT, 2012, ENVIRON SCI TECHNOL, V46, P3022, DOI 10.1021/es203861v; Pokhrel D, 2004, SCI TOTAL ENVIRON, V333, P37, DOI 10.1016/j.scitotenv.2004.05.017; Qiao Y, 2010, ENERG ENVIRON SCI, V3, P544, DOI 10.1039/b923503e; Rabaey K, 2005, ENVIRON SCI TECHNOL, V39, P3401, DOI 10.1021/es048563o; Rinaldi A, 2008, ENERG ENVIRON SCI, V1, P417, DOI 10.1039/b806498a; Ringeisen BR, 2006, ENVIRON SCI TECHNOL, V40, P2629, DOI 10.1021/es052254w; Shi W, 2012, ANTON LEEUW INT J G, V102, P703, DOI 10.1007/s10482-012-9770-7; Wang VB, 2014, CHEM COMMUN, V50, P8223, DOI 10.1039/c4cc02784a; Wang VB, 2014, BIORESOURCE TECHNOL, V155, P71, DOI 10.1016/j.biortech.2013.12.078; Wang VB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063129; Wang VB, 2013, PHYS CHEM CHEM PHYS, V15, P5867, DOI 10.1039/c3cp50437a; Werner CM, 2013, J MEMBRANE SCI, V428, P116, DOI 10.1016/j.memsci.2012.10.031; Yang L, 2007, MICROBIOL-SGM, V153, P1318, DOI 10.1099/mic.0.2006/004911-0; Zhang LX, 2008, ELECTROCHEM COMMUN, V10, P1641, DOI 10.1016/j.elecom.2008.08.030; Zhao C, 2013, J MATER CHEM A, V1, P12587, DOI 10.1039/c3ta12947k	33	8	8	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132766	10.1371/journal.pone.0132766	http://dx.doi.org/10.1371/journal.pone.0132766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171779	Green Published, gold			2022-12-27	WOS:000358194900082
J	Shih, YY; Hung, CC; Gong, GC; Chung, WC; Wang, YH; Lee, IH; Chen, KS; Ho, CY				Shih, Yung-Yen; Hung, Chin-Chang; Gong, Gwo-Ching; Chung, Wan-Chen; Wang, Yu-Huai; Lee, I-Huan; Chen, Kuo-Shu; Ho, Chuang-Yi			Enhanced Particulate Organic Carbon Export at Eddy Edges in the Oligotrophic Western North Pacific Ocean	PLOS ONE			English	Article							EAST CHINA SEA; MESOSCALE EDDIES; FIELD OBSERVATIONS; PARTICLE EXPORT; SEDIMENT TRAPS; FLUX; TH-234; KUROSHIO; CHLOROPHYLL; NITRATE	Mesoscale eddies in the subtropical oligotrophic ocean are ubiquitous and play an important role in nutrient supply and oceanic primary production. However, it is still unclear whether these mesoscale eddies can efficiently transfer CO2 from the atmosphere to deep waters via biological pump because of the sampling difficulty due to their transient nature. In 2007, particulate organic carbon (POC) fluxes, measured below the euphotic zone at the edge of warm eddy were 136-194 mg-C m(-2) d(-1) which was greatly elevated over that (POC flux = 26-35 mg-C m(-2) d(-1)) determined in the nutrient-depleted oligotrophic waters in the Western North Pacific (WNP). In 2010, higher POC fluxes (83-115 mg-C m(-2) d(-1)) were also observed at the boundary of mesoscale eddies in the WNP. The enhanced POC flux at the edge of eddies was mainly attributed to both large denuded diatom frustules and zooplankton fecal pellets based on scanning electron microscopy (SEM) examination. The result suggests that mesoscale eddies in the oligotrophic waters in the subtropical WNP can efficiently increase the oceanic carbon export flux and the eddy edge is a crucial conduit in carbon sequestration to deep waters.	[Shih, Yung-Yen; Hung, Chin-Chang; Wang, Yu-Huai; Lee, I-Huan; Chen, Kuo-Shu; Ho, Chuang-Yi] Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung 80424, Taiwan; [Gong, Gwo-Ching; Chung, Wan-Chen] Natl Taiwan Ocean Univ, Inst Marine Environm Chem & Ecol, Keelung 20224, Taiwan	National Sun Yat Sen University; National Taiwan Ocean University	Hung, CC (corresponding author), Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung 80424, Taiwan.	cchung@mail.nsysu.edu.tw			Top University Program; Ministry of Science and Technology of Taiwan [NSC101-2611-M-110-015-MY3, NSC100-2119-M-110-003]	Top University Program; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by the Top University Program and the Ministry of Science and Technology (NSC101-2611-M-110-015-MY3, NSC100-2119-M-110-003) of Taiwan.	Behrenfeld MJ, LIMNOLOGY OCEANOGRAP, V42, P1; Benitez-Nelson CR, 2007, SCIENCE, V316, P1017, DOI 10.1126/science.1136221; Bidigare RR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016393; BIGGS DC, 1992, J GEOPHYS RES-OCEANS, V97, P2143, DOI 10.1029/90JC02020; Boyd PW, 1999, DEEP-SEA RES PT I, V46, P63, DOI 10.1016/S0967-0637(98)00066-1; Buesseler KO, 2008, DEEP-SEA RES PT II, V55, P1426, DOI 10.1016/j.dsr2.2008.02.007; Buesseler KO, 2007, J MAR RES, V65, P345, DOI 10.1357/002224007781567621; Chang J, 2003, DEEP-SEA RES PT II, V50, P1265, DOI 10.1016/S0967-0645(03)00022-5; Chang J, 1996, MAR ECOL PROG SER, V140, P199, DOI 10.3354/meps140199; Chang MH, 2013, J GEOPHYS RES-OCEANS, V118, P1508, DOI 10.1002/jgrc.20151; Chelton DB, 2011, SCIENCE, V334, P328, DOI 10.1126/science.1208897; Chen KS, 2013, GEOPHYS RES LETT, V40, P5728, DOI 10.1002/2013GL058300; Chen YLL, 2003, MAR ECOL PROG SER, V259, P47, DOI 10.3354/meps259047; Chen YLL, 2008, LIMNOL OCEANOGR, V53, P1705, DOI 10.4319/lo.2008.53.5.1705; Chen YLL, 2007, J OCEANOGR, V63, P671, DOI 10.1007/s10872-007-0059-9; Chiang KP, 2002, CONT SHELF RES, V22, P3, DOI 10.1016/S0278-4343(01)00067-X; GARDNER WD, 1980, J MAR RES, V38, P41; Gong GC, 2003, CONT SHELF RES, V23, P213, DOI 10.1016/S0278-4343(02)00166-8; Gong GC, 1999, DEEP-SEA RES PT I, V46, P93, DOI 10.1016/S0967-0637(98)00057-0; Gong GC, 1992, THESIS NATL TAIWAN U, P1; Guo LD, 2002, MAR CHEM, V78, P103, DOI 10.1016/S0304-4203(02)00012-9; Hung CC, 2010, BIOGEOSCIENCES, V7, P3007, DOI 10.5194/bg-7-3007-2010; Hung CC, 2004, GEOCHEM J, V38, P601, DOI 10.2343/geochemj.38.601; Hung CC, 2000, LIMNOL OCEANOGR, V45, P836, DOI 10.4319/lo.2000.45.4.0836; Hung CC, 2012, GEOCHIM COSMOCHIM AC, V91, P60, DOI 10.1016/j.gca.2012.05.017; Hung CC, 2010, MAR CHEM, V121, P132, DOI 10.1016/j.marchem.2010.03.011; Hung CC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030236; Hung CC, 2009, MAR CHEM, V113, P19, DOI 10.1016/j.marchem.2008.11.004; Kameda T, 2005, J OCEANOGR, V61, P663, DOI 10.1007/s10872-005-0074-7; Kara AB, 2000, J GEOPHYS RES-OCEANS, V105, P16803, DOI 10.1029/2000JC900072; Karl DM, 1989, OCEANOGRAPHY, V2, P32, DOI DOI 10.5670/OCEANOG.1989.28; Lalande C, 2013, PROG OCEANOGR, V109, P70, DOI 10.1016/j.pocean.2012.09.006; Lee C., 1988, OCEANOGRAPHY, V1, P34, DOI [DOI 10.2307/43924419, 10.5670/oceanog.1988.06, DOI 10.5670/OCEANOG.1988.06]; Letelier RM, 2004, LIMNOL OCEANOGR, V49, P508, DOI 10.4319/lo.2004.49.2.0508; Malone T.C., 1980, Studies in Ecology, V7, P433; Maranon E, 2003, MAR ECOL PROG SER, V257, P1, DOI 10.3354/meps257001; MICHAELS AF, 1988, DEEP-SEA RES, V35, P473, DOI 10.1016/0198-0149(88)90126-4; Michaels AF, 2007, SCIENCE, V316, P992, DOI 10.1126/science.1140059; Moutin T, 2012, BIOGEOSCIENCES, V9, P3817, DOI 10.5194/bg-9-3817-2012; Santschi PH, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016046; Shih YY, 2013, TERR ATMOS OCEAN SCI, V24, P899, DOI 10.3319/TAO.2013.05.23.01(Oc); Sweeney EN, 2003, DEEP-SEA RES PT II, V50, P3017, DOI 10.1016/j.dsr2.2003.07.008; Verdeny E, 2008, DEEP-SEA RES PT II, V55, P1461, DOI 10.1016/j.dsr2.2008.02.009; Wakeham SG, 1997, GEOCHIM COSMOCHIM AC, V61, P5363, DOI 10.1016/S0016-7037(97)00312-8; WARD BB, 1989, LIMNOL OCEANOGR, V34, P493, DOI 10.4319/lo.1989.34.3.0493; Wei CL, 2011, BIOGEOSCIENCES, V8, P3793, DOI 10.5194/bg-8-3793-2011; Wormuth John H., 2000, Gulf of Mexico Science, V18, P23; Xiu P, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006800; Zhou KB, 2013, EARTH PLANET SC LETT, V381, P198, DOI 10.1016/j.epsl.2013.07.039	49	28	28	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131538	10.1371/journal.pone.0131538	http://dx.doi.org/10.1371/journal.pone.0131538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171611	gold, Green Submitted, Green Published			2022-12-27	WOS:000358194900017
J	Bach, JP; Gold, M; Mengel, D; Hattesohl, A; Lubbe, D; Schmid, S; Tackenberg, B; Rieke, J; Maddula, S; Baumbach, JI; Nell, C; Boeselt, T; Michelis, J; Alferink, J; Heneka, M; Oertel, W; Jessen, F; Janciauskiene, S; Vogelmeier, C; Dodel, R; Koczulla, AR				Bach, Jan-Philipp; Gold, Maike; Mengel, David; Hattesohl, Akira; Lubbe, Dirk; Schmid, Severin; Tackenberg, Bjoern; Rieke, Juergen; Maddula, Sasidhar; Baumbach, Joerg Ingo; Nell, Christoph; Boeselt, Tobias; Michelis, Joan; Alferink, Judith; Heneka, Michael; Oertel, Wolfgang; Jessen, Frank; Janciauskiene, Sabina; Vogelmeier, Claus; Dodel, Richard; Koczulla, Andreas Rembert			Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease	PLOS ONE			English	Article							ELECTRONIC NOSE; LUNG-CANCER; DIAGNOSIS; BREATH; CSF; DISCRIMINATION; DEMENTIA; COPD	Background Alzheimer's disease (AD) is diagnosed based upon medical history, neuropsychiatric examination, cerebrospinal fluid analysis, extensive laboratory analyses and cerebral imaging. Diagnosis is time consuming and labour intensive. Parkinson's disease (PD) is mainly diagnosed on clinical grounds. Objective The primary aim of this study was to differentiate patients suffering from AD, PD and healthy controls by investigating exhaled air with the electronic nose technique. After demonstrating a difference between the three groups the secondary aim was the identification of specific substances responsible for the difference(s) using ion mobility spectroscopy. Thirdly we analysed whether amyloid beta (A beta) in exhaled breath was causative for the observed differences between patients suffering from AD and healthy controls. Methods We employed novel pulmonary diagnostic tools (electronic nose device/ion-mobility spectrometry) for the identification of patients with neurodegenerative diseases. Specifically, we analysed breath pattern differences in exhaled air of patients with AD, those with PD and healthy controls using the electronic nose device (eNose). Using ion mobility spectrometry (IMS), we identified the compounds responsible for the observed differences in breath patterns. We applied ELISA technique to measure A beta in exhaled breath condensates. Results The eNose was able to differentiate between AD, PD and HC correctly. Using IMS, we identified markers that could be used to differentiate healthy controls from patients with AD and PD with an accuracy of 94%. In addition, patients suffering from PD were identified with sensitivity and specificity of 100%. Altogether, 3 AD patients out of 53 participants were misclassified. Although we found A beta in exhaled breath condensate from both AD and healthy controls, no significant differences between groups were detected. Conclusion These data may open a new field in the diagnosis of neurodegenerative disease such as Alzheimer's disease and Parkinson's disease. Further research is required to evaluate the significance of these pulmonary findings with respect to the pathophysiology of neurodegenerative disorders.	[Bach, Jan-Philipp] Rhein Westfal TH Aachen, Dept Neurol, D-52074 Aachen, Germany; [Gold, Maike; Mengel, David; Tackenberg, Bjoern; Rieke, Juergen; Oertel, Wolfgang; Dodel, Richard] Univ Marburg, Dept Neurol, D-35043 Marburg, Germany; [Hattesohl, Akira; Schmid, Severin; Nell, Christoph; Boeselt, Tobias; Vogelmeier, Claus; Koczulla, Andreas Rembert] Univ Marburg, Div Pulm Dis, Dept Internal Med, D-35043 Marburg, Germany; [Lubbe, Dirk] Univ Giessen, Div Methodol & Stat, Dept Psychol, D-35394 Giessen, Germany; [Maddula, Sasidhar; Baumbach, Joerg Ingo] Reutlingen Univ, Fac Appl Chem, D-72762 Reutlingen, Germany; [Michelis, Joan; Heneka, Michael] Univ Bonn, Dept Neurol, Clin Neurosci Unit, D-53105 Bonn, Germany; [Michelis, Joan; Alferink, Judith; Jessen, Frank] Univ Bonn, Dept Psychiat, D-53105 Bonn, Germany; [Alferink, Judith] Univ Munster, Dept Psychiat, D-48149 Munster, Germany; [Heneka, Michael; Jessen, Frank] German Ctr Neurodegenerat Dis DZNE, D-53105 Bonn, Germany; [Janciauskiene, Sabina] Leibniz Univ Hannover, Dept Internal Med, D-30625 Hannover, Germany	RWTH Aachen University; Philipps University Marburg; Philipps University Marburg; Justus Liebig University Giessen; University of Bonn; University of Bonn; University of Munster; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Leibniz University Hannover	Dodel, R (corresponding author), Univ Marburg, Dept Neurol, D-35043 Marburg, Germany.	dodel@med.uni-marburg.de	Boeselt, Tobias/HHM-5170-2022; Jessen, Frank/AAK-6170-2020; Boeselt, Tobias/AAE-8908-2021; Hattesohl, Akira/AAB-1341-2022; Heneka, Michael/AAE-8011-2019; Heneka, Michael/E-8072-2015	Schmid, Severin/0000-0001-8077-082X; Michelis, Joan Philipp/0000-0002-6349-7654; alferink, judith/0000-0002-3251-6584; Heneka, Michael/0000-0003-4996-1630	Behring Rontgen Initiative [56-0036]	Behring Rontgen Initiative	This work was financed by a research grant from the Behring Rontgen Initiative awarded to ARK and JPB (Behring Rontgen Stiftung, Grant title: non-invasive diagnostic in patients with AD, Grant number: 56-0036). The funding source was not involved in study design, the collection, analysis and interpretation of the data, in writing of the report, and in the decision to submit the article for publication.	Barth S, 2005, FORTSCHR NEUROL PSYC, V73, P568, DOI 10.1055/s-2004-830249; Baumbach JI, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/3/034001; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; de Leon MJ, 2007, ANN NY ACAD SCI, V1097, P114, DOI 10.1196/annals.1379.012; Dragonieri S, 2009, LUNG CANCER, V64, P166, DOI 10.1016/j.lungcan.2008.08.008; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Fens N, 2009, AM J RESP CRIT CARE, V180, P1076, DOI 10.1164/rccm.200906-0939OC; Goldman SM, 2012, ANN NEUROL, V71, P776, DOI 10.1002/ana.22629; Hattesohl ADM, 2011, RESPIROLOGY, V16, P1258, DOI 10.1111/j.1440-1843.2011.02047.x; Hoglund K, 2008, NEURODEGENER DIS, V5, P268, DOI 10.1159/000119457; Holtzman DM, 2011, NEUROBIOL AGING, V32, pS4, DOI 10.1016/j.neurobiolaging.2011.09.003; Huttmann EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027467; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; Lewis NS, 2004, ACCOUNTS CHEM RES, V37, P663, DOI 10.1021/ar030120m; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Peng G, 2010, BRIT J CANCER, V103, P542, DOI 10.1038/sj.bjc.6605810; Peng G, 2009, NAT NANOTECHNOL, V4, P669, DOI 10.1038/nnano.2009.235; Peng G, 2009, NANO LETT, V9, P1362, DOI 10.1021/nl8030218; Thaler ER, 2005, EXPERT REV MED DEVIC, V2, P559, DOI 10.1586/17434440.2.5.559; Tisch U, 2013, NANOMEDICINE-UK, V8, P43, DOI [10.2217/nnm.12.105, 10.2217/NNM.12.105]; Trojanowski JQ, 2010, ALZHEIMERS DEMENT, V6, P230, DOI 10.1016/j.jalz.2010.03.008; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; Westhoff M, 2009, THORAX, V64, P744, DOI 10.1136/thx.2008.099465; Wiltfang J, 2005, WORLD J BIOL PSYCHIA, V6, P69, DOI 10.1080/15622970510029786	25	33	35	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132227	10.1371/journal.pone.0132227	http://dx.doi.org/10.1371/journal.pone.0132227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168044	Green Published, gold			2022-12-27	WOS:000358193100030
J	Domingueti, CP; Dusse, LMS; Foscolo, RB; Reis, JS; Annichino-Bizzacchi, JM; Orsi, FLD; Mazetto, BD; Carvalho, MD; Gomes, KB; Fernandes, AP				Domingueti, Caroline Pereira; Dusse, Luci Maria S.; Foscolo, Rodrigo Bastos; Reis, Janice Sepulveda; Annichino-Bizzacchi, Joyce Maria; de Andrade Orsi, Fernanda Loureiro; Mazetto, Bruna de Moraes; Carvalho, Maria das Gracas; Gomes, Karina Braga; Fernandes, Ana Paula			Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; MICROALBUMINURIA; INFLAMMATION; RISK	We have investigated whether von Willebrand factor, ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13), and D-Dimer were associated with different levels of renal function in patients with type 1 diabetes. Patients were classified according to level of renal function through estimated glomerular filtration rate: >= 90 and <130mL/min/1,73m(2), n=52 (control group), >= 60 and <90mL/min/1,73m(2), n=29 (mild renal dysfunction group), <60mL/min/1,73m(2), n=28 (severe renal dysfunction group); and through urinary albumin excretion: normoalbuminuria, microalbuminuria and macroalbuminuria. Von Willebrand factor, ADAMTS13, and D-Dimer plasma levels were determined by enzyme-linked immunosorbent assay. ADAMTS13 activity was determined by fluorescence resonance energy transfer assay. Von Willebrand factor levels were increased in patients with mild (P=0.001) and severe (P<0.001) renal dysfunction as compared to the control group. ADAMTS13 levels were also increased in mild (P=0.029) and severe (P=0.002) renal dysfunction groups in comparison to the control group, while ADAMTS13 activity was increased only in the severe renal dysfunction group as compared to the control group (P=0.006). No significant differences were observed among the groups regarding vonWillebrand factor/ADAMTS13 ratio. ADAMTS13 activity/ADAMTS13 levels ratio was reduced in patients with mild (P=0.013) and severe (P=0.015) renal dysfunction as compared to the control group. D-Dimer levels were increased in patients with mild (P=0.006) and severe (P<0.001) renal dysfunction as compared to the control group; it was also higher in patients with severe renal dysfunction as compared to the mild renal dysfunction group (P=0.019). Similar results were found for albuminuria classification. Increased von Willebrand factor, ADAMTS13, and D-Dimer levels and decreased ADAMTS13 activity/ADAMTS13 levels ratio are associated with renal dysfunction in patients with type 1 diabetes, suggesting that endothelial dysfunction and hypercoagulability are associated with nephropathy in type 1 diabetes.	[Domingueti, Caroline Pereira; Dusse, Luci Maria S.; Carvalho, Maria das Gracas; Gomes, Karina Braga; Fernandes, Ana Paula] Univ Fed Minas Gerais, Dept Clin & Toxicol Anal, Fac Pharm, Belo Horizonte, MG, Brazil; [Foscolo, Rodrigo Bastos] Univ Fed Minas Gerais, Dept Clin Med, Fac Med, Belo Horizonte, MG, Brazil; [Reis, Janice Sepulveda] Inst Educ & Res Santa Casa Belo Horizonte, Dept Endocrinol & Metab, Belo Horizonte, MG, Brazil; [Annichino-Bizzacchi, Joyce Maria; de Andrade Orsi, Fernanda Loureiro; Mazetto, Bruna de Moraes] Univ Estadual Campinas, Hemoctr Campinas, Lab Hemostasis, Sao Paulo, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Insper; Instituto de Ensino Superior e Pesquisa da Santa Casa; Universidade Estadual de Campinas	Fernandes, AP (corresponding author), Univ Fed Minas Gerais, Dept Clin & Toxicol Anal, Fac Pharm, Belo Horizonte, MG, Brazil.	apfernandes.ufmg@gmail.com	Mazetto Fonseca, Bruna de Moraes/AIE-7685-2022; Carvalho, Maria das Graças/AAY-1619-2021; Orsi, Fernanda L.A./H-1203-2014	Orsi, Fernanda L.A./0000-0002-7908-9073; Dusse, Luci/0000-0002-7484-1684	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Pesquisa (CNPq/Brazil)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) - APF; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - APF; Conselho Nacional de Pesquisa (CNPq/Brazil) - APF. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NB, 2013, J THROMB HAEMOST, V11, P1078, DOI 10.1111/jth.12223; Almquist T, 2012, NEPHROL DIAL TRANSPL, V27, P3540, DOI 10.1093/ndt/gfs183; American Diabetes Association, 2013, DIABETES CARE, V36, pdc13; Bastos MG, 2010, REV ASSOC MED BRAS, V56, P248, DOI 10.1590/S0104-42302010000200028; Bernardo A, 2004, BLOOD, V104, P100, DOI 10.1182/blood-2004-01-0107; Chan NN, 2003, MED SCI MONITOR, V9, P297; Deckert T, 1996, BRIT MED J, V312, P871; Domingueti CP, 2013, CLIN CHIM ACTA, V415, P279, DOI 10.1016/j.cca.2012.10.061; El Asrar Mohamed A, 2012, Pediatr Endocrinol Rev, V9, P657; Frankel DS, 2008, CIRCULATION, V118, P2533, DOI 10.1161/CIRCULATIONAHA.108.792986; Fuller JH, 2001, DIABETOLOGIA, V44, pS54, DOI 10.1007/PL00002940; Goldberg RB, 2009, J CLIN ENDOCR METAB, V94, P3171, DOI 10.1210/jc.2008-2534; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Jenkins PV, 2006, TRANSFUSION, V46, P1836, DOI 10.1111/j.1537-2995.2006.00975.x; Karnib HH, 2010, DIABETES RES CLIN PR, V89, P201, DOI 10.1016/j.diabres.2010.05.022; Kassimatis TI, 2014, PHARMACOL RES, V88, P62, DOI 10.1016/j.phrs.2014.06.011; Kato S, 2010, J THROMB THROMBOLYS, V30, P281, DOI 10.1007/s11239-010-0442-z; Kessler L, 1998, DIABETES METAB, V24, P327; Kim WY, 2007, CIRCULATION, V115, P228, DOI 10.1161/CIRCULATIONAHA.106.633339; Levey AS, 2000, J AM SOC NEPHROL, V11, p155A; Lip GYH, 1997, CARDIOVASC RES, V34, P255, DOI 10.1016/S0008-6363(97)00039-4; Long Zhao-feng, 2001, Hunan Yike Daxue Xuebao, V26, P434; Marshall SM, 2004, POSTGRAD MED J, V80, P624, DOI 10.1136/pgmj.2004.021287; Murussi M, 2008, ARQ BRAS ENDOCRINOL, V52, P442, DOI 10.1590/S0004-27302008000300004; Nwose EU, 2007, PATHOLOGY, V39, P252, DOI 10.1080/00313020701230658; Reininger AJ, 2008, HAEMOPHILIA, V14, P11, DOI 10.1111/j.1365-2516.2008.01848.x; Rurali E, 2013, DIABETES, V62, P3599, DOI 10.2337/db13-0530; Scaldaferri F, 2007, J CLIN INVEST, V117, P1951, DOI 10.1172/JCI31027; Scheiflinger F, 2003, BLOOD, V102, P3241, DOI 10.1182/blood-2003-05-1616; Soares AL, 2010, CLIN APPL THROMB-HEM, V16, P204, DOI 10.1177/1076029609334626; STEHOUWER CDA, 1991, DIABETES, V40, P971, DOI 10.2337/diabetes.40.8.971; STEHOUWER CDA, 1995, DIABETES, V44, P561, DOI 10.2337/diabetes.44.5.561; Valmadrid CT, 2000, ARCH INTERN MED, V160, P1093, DOI 10.1001/archinte.160.8.1093; Wakabayashi I, 2009, J THROMB THROMBOLYS, V27, P29, DOI 10.1007/s11239-007-0155-0; WEKSLER BB, 1983, NEW ENGL J MED, V308, P800, DOI 10.1056/NEJM198304073081402	35	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132784	10.1371/journal.pone.0132784	http://dx.doi.org/10.1371/journal.pone.0132784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168189	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100080
J	Han, X; Adames, K; Sykes, EME; Srayko, M				Han, Xue; Adames, Kelly; Sykes, Ellen M. E.; Srayko, Martin			The KLP-7 Residue S546 Is a Putative Aurora Kinase Site Required for Microtubule Regulation at the Centrosome in C. elegans	PLOS ONE			English	Article							CENTROMERE-ASSOCIATED KINESIN; CAENORHABDITIS-ELEGANS; MITOTIC SPINDLE; CHROMOSOME SEGREGATION; A KINASE; DEPENDENT PHOSPHORYLATION; GENETIC INTERFERENCE; PROTEIN; MCAK; MEIOSIS	Regulation of microtubule dynamics is essential for many cellular processes, including proper assembly and function of the mitotic spindle. The kinesin-13 microtubule-depolymerizing enzymes provide one mechanism to regulate microtubule behaviour temporally and spatially. Vertebrate MCAK locates to chromatin, kinetochores, spindle poles, microtubule tips, and the cytoplasm, implying that the regulation of kinesin-13 activity and subcellular targeting is complex. Phosphorylation of kinesin-13 by Aurora kinase inhibits microtubule depolymerization activity and some Aurora phosphorylation sites on kinesin-13 are required for subcellular localization. Herein, we determine that a C. elegans deletion mutant klp-7 (tm2143) causes meiotic and mitotic defects that are consistent with an increase in the amount of microtubules in the cytoplasmic and spindle regions of meiotic embryos, and an increase in microtubules emanating from centrosomes. We show that KLP-7 is phosphorylated by Aurora A and Aurora B kinases in vitro, and that the phosphorylation by Aurora A is stimulated by TPXL-1. Using a structure-function approach, we establish that one putative Aurora kinase site, S546, within the C-terminal part of the core domain is required for the function, but not subcellular localization, of KLP-7 in vivo. Furthermore, FRAP analysis reveals microtubule-dependent differences in the turnover of KLP-7(S546A) and KLP-7 (S546E) mutant proteins at the centrosome, suggesting a possible mechanism for the regulation of KLP-7 by Aurora kinase.	[Han, Xue; Adames, Kelly; Sykes, Ellen M. E.; Srayko, Martin] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Srayko, M (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	srayko@ualberta.ca	Srayko, Martin/A-3755-2014	Avila-Sykes, Ellen/0000-0002-1010-5151; Srayko, Martin/0000-0003-0196-0364	Canadian Institutes of Health Research (CIHR); Alberta Innovates Scholar; CIHR New Investigator awards; National Science and Engineering Research Council post-graduate scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Scholar; CIHR New Investigator awards(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council post-graduate scholarship	This work was funded by grants from Canadian Institutes of Health Research (CIHR); M.S. was supported by Alberta Innovates Scholar and CIHR New Investigator awards; X.H. was supported by a National Science and Engineering Research Council post-graduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 1993, CHROMOSOME RES, V1, P15, DOI 10.1007/BF00710603; Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Bajaj M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071889; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; BRENNER S, 1974, GENETICS, V77, P71; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Carvalho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024656; CHAN CSM, 1993, GENETICS, V135, P677; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Dumont J, 2010, NAT CELL BIOL, V12, P894, DOI 10.1038/ncb2093; Encalada SE, 2005, MOL BIOL CELL, V16, P1056, DOI 10.1091/mbc.E04-08-0712; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Gopalan G, 1997, J CELL BIOL, V138, P643, DOI 10.1083/jcb.138.3.643; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Gusnowski EM, 2011, J CELL BIOL, V194, P377, DOI 10.1083/jcb.201103128; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Harris TW, 2014, NUCLEIC ACIDS RES, V42, pD789, DOI 10.1093/nar/gkt1063; HODGKIN J, 1979, GENETICS, V91, P67; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Illingworth C, 2010, DEVELOPMENT, V137, P2133, DOI 10.1242/dev.048306; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Mennella V, 2009, J CELL BIOL, V186, P481, DOI 10.1083/jcb.200902113; Moore A, 2004, TRENDS CELL BIOL, V14, P537, DOI 10.1016/j.tcb.2004.09.001; Moores CA, 2006, J CELL SCI, V119, P3905, DOI 10.1242/jcs.03224; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Ozlu N, 2005, DEV CELL, V9, P237, DOI 10.1016/j.devcel.2005.07.002; Pakala SB, 2012, J BIOL CHEM, V287, P40560, DOI 10.1074/jbc.M112.399576; Praitis V, 2001, GENETICS, V157, P1217; Rapsomaniki MA, 2012, BIOINFORMATICS, V28, P1800, DOI 10.1093/bioinformatics/bts241; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; Sanhaji M, 2010, MOL CELL BIOL, V30, P2594, DOI 10.1128/MCB.00098-10; Schlaitz AL, 2007, CELL, V128, P115, DOI 10.1016/j.cell.2006.10.050; Schumacher JM, 1998, DEVELOPMENT, V125, P4391; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Srayko M, 2003, CURR BIOL, V13, P1506, DOI 10.1016/S0960-9822(03)00597-9; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Walczak CE, 2002, CURR BIOL, V12, P1885, DOI 10.1016/S0960-9822(02)01227-7; Widlund PO, 2011, P NATL ACAD SCI USA, V108, P2741, DOI 10.1073/pnas.1016498108; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Woollard A, 1999, MECH DEVELOP, V82, P95, DOI 10.1016/S0925-4773(99)00020-9; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95; Zhang LY, 2011, J BIOL CHEM, V286, P3033, DOI 10.1074/jbc.M110.165340; Zhang X, 2008, MOL BIOL CELL, V19, P2752, DOI 10.1091/mbc.E08-02-0198; Zhang X, 2007, MOL BIOL CELL, V18, P3264, DOI 10.1091/mbc.E07-01-0086; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001	69	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132593	10.1371/journal.pone.0132593	http://dx.doi.org/10.1371/journal.pone.0132593			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168236	gold, Green Published, Green Submitted			2022-12-27	WOS:000358193100057
J	Coudrillier, B; Pijanka, JK; Jefferys, JL; Goel, A; Quigley, HA; Boote, C; Nguyen, TD				Coudrillier, Baptiste; Pijanka, Jacek K.; Jefferys, Joan L.; Goel, Adhiraj; Quigley, Harry A.; Boote, Craig; Nguyen, Thao D.			Glaucoma-related Changes in the Mechanical Properties and Collagen Micro-architecture of the Human Sclera	PLOS ONE			English	Article							OPTIC-NERVE HEAD; OPEN-ANGLE GLAUCOMA; HUMAN LAMINA-CRIBROSA; BIOMECHANICAL STRUCTURE; PERIPAPILLARY SCLERA; POSTERIOR SCLERA; OCULAR RIGIDITY; PULSE AMPLITUDE; IOP ELEVATIONS; MONKEY EYES	Objective The biomechanical behavior of the sclera determines the level of mechanical insult from intraocular pressure to the axons and tissues of the optic nerve head, as is of interest in glaucoma. In this study, we measure the collagen fiber structure and the strain response, and estimate the material properties of glaucomatous and normal human donor scleras. Methods Twenty-two posterior scleras from normal and diagnosed glaucoma donors were obtained from an eyebank. Optic nerve cross-sections were graded to determine the presence of axon loss. The specimens were subjected to pressure-controlled inflation testing. Full-field displacement maps were measured by digital image correlation (DIC) and spatially differentiated to compute surface strains. Maps of the collagen fiber structure across the posterior sclera of each inflated specimen were obtained using synchrotron wide-angle X-ray scattering (WAXS). Finite element (FE) models of the posterior scleras, incorporating a specimen-specific representation of the collagen structure, were constructed from the DIC-measured geometry. An inverse finite element analysis was developed to estimate the stiffness of the collagen fiber and inter-fiber matrix. Results The differences between glaucoma and non-glaucoma eyes were small in magnitude. Sectorial variations of degree of fiber alignment and peripapillary scleral strain significantly differed between normal and diagnosed glaucoma specimens. Meridional strains were on average larger in diagnosed glaucoma eyes compared with normal specimens. Non-glaucoma specimens had on average the lowest matrix and fiber stiffness, followed by undamaged glaucoma eyes, and damaged glaucoma eyes but the differences in stiffness were not significant. Conclusion The observed biomechanical and microstructural changes could be the result of tissue remodeling occuring in glaucoma and are likely to alter the mechanical environment of the optic nerve head and contribute to axonal damage.	[Coudrillier, Baptiste] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Pijanka, Jacek K.; Boote, Craig] Cardiff Univ, Struct Biophys Grp, Sch Optometry & Vis Sci, Cardiff CF10 3AX, S Glam, Wales; [Jefferys, Joan L.; Quigley, Harry A.] Johns Hopkins Univ, Sch Med, Wilmer Ophthalmol Inst, Glaucoma Ctr Excellence, Baltimore, MD 21205 USA; [Goel, Adhiraj; Nguyen, Thao D.] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA	University System of Georgia; Georgia Institute of Technology; Cardiff University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Nguyen, TD (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.	vicky.nguyen@jhu.edu	Nguyen, Thao/GWN-0419-2022; Nguyen, Thao/A-3391-2010	Nguyen, Thao/0000-0002-0312-1583; Boote, Craig/0000-0003-0348-6547	Public Health Service Research Grants [EY021500, EY02120, EY01765]; Fight For Sight grant [1360]; Leonard Wagner Charitable Trust; MRC [MR/K000837/1] Funding Source: UKRI; Medical Research Council [MR/K000837/1] Funding Source: researchfish; Fight for Sight [1359/60] Funding Source: researchfish; NATIONAL EYE INSTITUTE [P30EY001765, R56EY002120, R01EY002120, R01EY021500] Funding Source: NIH RePORTER	Public Health Service Research Grants; Fight For Sight grant; Leonard Wagner Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Public Health Service Research Grants EY021500 (Thao D. Nguyen), EY02120 and EY01765 (Harry A. Quigley and Wilmer Institute), the Fight For Sight grant 1360 (Craig Boote), the Leonard Wagner Charitable Trust, William T. Forrester, and Saranne and Livingston Kosberg (Harry A. Quigley). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argento A, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027615; Bellezza AJ, 2000, INVEST OPHTH VIS SCI, V41, P2991; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2004, INVEST OPHTH VIS SCI, V45, P4388, DOI 10.1167/iovs.04-0022; Campbell IC, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1009; Campbell IC, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026286; Coudrillier B, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029986; Coudrillier B, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029430; Coudrillier B, 2013, BIOMECH MODEL MECHAN, V12, P941, DOI 10.1007/s10237-012-0455-y; Coudrillier B, 2012, INVEST OPHTH VIS SCI, V53, P1714, DOI 10.1167/iovs.11-8009; Danford FL, 2013, INVEST OPHTH VIS SCI, V54, P7922, DOI 10.1167/iovs.13-12262; Dastiridou AI, 2013, INVEST OPHTH VIS SCI, V54, P4571, DOI 10.1167/iovs.13-12303; Downs JC, 2005, INVEST OPHTH VIS SCI, V46, P540, DOI 10.1167/iovs.04-0114; Fazio M. A., 2013, BIOMECH MODEL MECHAN, P1; FECHTNER RD, 1994, SURV OPHTHALMOL, V39, P23, DOI 10.1016/S0039-6257(05)80042-6; Girard MJA, 2015, CURR EYE RES, V40, P1, DOI 10.3109/02713683.2014.914543; Girard MJA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0459; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P5656, DOI 10.1167/iovs.10-6927; Girard MJA, 2009, INVEST OPHTH VIS SCI, V50, P5226, DOI 10.1167/iovs.08-3363; Girard MJA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3113683; Grytz R, 2014, INVEST OPHTH VIS SCI, V55, P8163, DOI 10.1167/iovs.14-14029; Grytz R, 2014, J MECH BEHAV BIOMED, V29, P602, DOI 10.1016/j.jmbbm.2013.03.027; Grytz R, 2011, BIOMECH MODEL MECHAN, V10, P371, DOI 10.1007/s10237-010-0240-8; HERNANDEZ MR, 1987, AM J OPHTHALMOL, V104, P567, DOI 10.1016/0002-9394(87)90165-6; Hommer A, 2008, INVEST OPHTH VIS SCI, V49, P4046, DOI 10.1167/iovs.07-1342; Jonas JB, 2005, INVEST OPHTH VIS SCI, V46, P1275, DOI 10.1167/iovs.04-0851; Jones HJ, QUANTITATIVE ANAL 3; KEELEY FW, 1984, EXP EYE RES, V39, P533, DOI 10.1016/0014-4835(84)90053-8; KENDELL KR, 1995, INVEST OPHTH VIS SCI, V36, P200; Kimball EC, 2014, EXP EYE RES, V128, P129, DOI 10.1016/j.exer.2014.08.016; Knepper PA, 1996, INVEST OPHTH VIS SCI, V37, P1360; Morris HJ, 2013, INVEST OPHTH VIS SCI, V54, P7215, DOI 10.1167/iovs.13-12441; Murienne BJ, 2015, ACTA BIOMATER, V12, P195, DOI 10.1016/j.actbio.2014.10.033; Myers KM, 2010, ACTA BIOMATER, V6, P4327, DOI 10.1016/j.actbio.2010.06.007; Nguyen C, 2013, INVEST OPHTH VIS SCI, V54, P1767, DOI 10.1167/iovs.12-10952; Norman RE, 2011, EXP EYE RES, V93, P4, DOI 10.1016/j.exer.2010.09.014; Petsche SJ, 2013, BIOMECHANICS MODELIN, P1; Pijanka JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118648; Pijanka JK, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-15047; Pijanka JK, 2012, INVEST OPHTH VIS SCI, V53, P5258, DOI 10.1167/iovs.12-9705; Pyne JD, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026224; QUIGLEY HA, 1991, CURR EYE RES, V10, P877, DOI 10.3109/02713689109013884; QUIGLEY HA, 1991, BRIT J OPHTHALMOL, V75, P552, DOI 10.1136/bjo.75.9.552; Ren RJ, 2009, INVEST OPHTH VIS SCI, V50, P2175, DOI 10.1167/iovs.07-1429; Roberts MD, 2009, INVEST OPHTH VIS SCI, V50, P681, DOI 10.1167/iovs.08-1792; Sigal I, 2014, METHOD ESTIMAT BIOME; Sigal IA, 2005, INVEST OPHTH VIS SCI, V46, P4189, DOI 10.1167/iovs.05-0541; Sigal IA, 2014, INVEST OPHTH VIS SCI, V55, P1, DOI 10.1167/iovs.13-12724; Sigal IA, 2011, INVEST OPHTH VIS SCI, V52, P1896, DOI 10.1167/iovs.10-5500; Steinhart MR, 2012, MOL VIS, V18, P1093; Strouthidis NG, 2013, CURR OPIN PHARMACOL, V13, P83, DOI 10.1016/j.coph.2012.09.001; Sutton MA, 2008, J BIOMED MATER RES A, V84A, P178, DOI 10.1002/jbm.a.31268; Tang JH, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007365; Tonge TK, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025105; TRIER K, 1990, ACTA OPHTHALMOL, V68, P304; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4; Zhang L, 2015, INVEST OPHTH VIS SCI, V56, P2031, DOI 10.1167/iovs.14-15734	58	64	67	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131396	10.1371/journal.pone.0131396	http://dx.doi.org/10.1371/journal.pone.0131396			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161963	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000358162300038
J	Jiang, JY; Cheng, YP; Mou, JH; Jin, K; Cui, J				Jiang, Jingyu; Cheng, Yuanping; Mou, Junhui; Jin, Kan; Cui, Jie			Effect of Water Invasion on Outburst Predictive Index of Low Rank Coals in Dalong Mine	PLOS ONE			English	Article							ADSORPTION; METHANE	To improve the coal permeability and outburst prevention, coal seam water injection and a series of outburst prevention measures were tested in outburst coal mines. These methods have become important technologies used for coal and gas outburst prevention and control by increasing the external moisture of coal or decreasing the stress of coal seam and changing the coal pore structure and gas desorption speed. In addition, techniques have had a significant impact on the gas extraction and outburst prevention indicators of coal seams. Globally, low rank coals reservoirs account for nearly half of hidden coal reserves and the most obvious feature of low rank coal is the high natural moisture content. Moisture will restrain the gas desorption and will affect the gas extraction and accuracy of the outburst prediction of coals. To study the influence of injected water on methane desorption dynamic characteristics and the outburst predictive index of coal, coal samples were collected from the Dalong Mine. The methane adsorption/desorption test was conducted on coal samples under conditions of different injected water contents. Selective analysis assessed the variations of the gas desorption quantities and the outburst prediction index (coal cutting desorption index). Adsorption tests indicated that the Langmuir volume of the Dalong coal sample is similar to 40.26 m(3)/t, indicating a strong gas adsorption ability. With the increase of injected water content, the gas desorption amount of the coal samples decreased under the same pressure and temperature. Higher moisture content lowered the accumulation desorption quantity after 120 minutes. The gas desorption volumes and moisture content conformed to a logarithmic relationship. After moisture correction, we obtained the long-flame coal outburst prediction (cutting desorption) index critical value. This value can provide a theoretical basis for outburst prediction and prevention of low rank coal mines and similar occurrence conditions of coal seams.	[Jiang, Jingyu; Cheng, Yuanping; Jin, Kan; Cui, Jie] China Univ Min & Technol, Fac Safety Engn, Key Lab Gas & Fire Control Coal Mine, Xuzhou 221116, Peoples R China; [Jiang, Jingyu; Cheng, Yuanping; Mou, Junhui] China Univ Min & Technol, Natl Engn Res Ctr Coal & Gas Control, Xuzhou 221116, Peoples R China; [Mou, Junhui] Chongqing Univ, State Key Lab Coal Mine Disaster Dynam & Control, Chongqing 400044, Peoples R China	China University of Mining & Technology; China University of Mining & Technology; Chongqing University	Cheng, YP (corresponding author), China Univ Min & Technol, Fac Safety Engn, Key Lab Gas & Fire Control Coal Mine, Xuzhou 221116, Peoples R China.	chengypcumt@163.com		Cheng, Yuanping/0000-0001-6519-6268	A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions; Fundamental Research Funds for the Central Universities [2013QNB01]; National Natural Science Foundation of China [51404260]; Basic Research Program of Jiangsu Province [BK20140206]; China Postdoctoral Science Foundation [2015M572112]	A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Program of Jiangsu Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Funding for this research was provided by "A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions", the Fundamental Research Funds for the Central Universities (No. 2013QNB01), the National Natural Science Foundation of China (No. 51404260), the Basic Research Program of Jiangsu Province (No. BK20140206), and the China Postdoctoral Science Foundation (No. 2015M572112).	[Anonymous], 2005, 117602005E ISO; [Anonymous], 1971, COAL MINE SAFETY, V3, P1; Chen LW, 2009, MINING SAFETY ENV PR, V36, P109; Chen XJ, 2015, NAT HAZARDS, V76, P1093, DOI 10.1007/s11069-014-1535-3; Cheng Y., 2007, J MINING SAFETY ENG, V24, P383; Chernov OH, 1979, PREPARATION COAL SEA; Duan KL, 2002, J CHINA COAL SOC, P50; Fang QC, 2009, COAL, V91, P1; Fu JH, 2007, MINING SAFETY ENG J, V24, P253; Hu QT, 2008, OPTIMIZATION MINE GA; Hughes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081172; Intelligence Institute of East Coal Company, 1988, PREV COAL GAS OUTB R; Intelligence Research Institute of Coal Ministry of China, 1984, SOV UN EXPL COAL MIN; JOUBERT JI, 1974, FUEL, V53, P186, DOI 10.1016/0016-2361(74)90009-X; JOUBERT JI, 1973, FUEL, V52, P181, DOI 10.1016/0016-2361(73)90076-8; Kang TH, 1995, CHINESE J ROCK MECH, V14, P260; Kong Y.F, 2013, ENERGY TECHNOL MANAG, V38, P41; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Li XH, 2009, J LIAONING TU, V28, P202; [李晓红 LI Xiao-hong], 2008, [煤炭学报, Journal of China Coal Society], V33, P1386; Limbri H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094641; [林柏泉 LIN Baiquan], 2007, [煤炭学报, Journal of China Coal Society], V32, P959; [刘明举 Liu Mingju], 2005, [煤炭学报, Journal of China Coal Society], V30, P451; Liu MJ, 2009, COAL ENG, V8, P61; MAHAJAN OP, 1971, FUEL, V50, P308, DOI 10.1016/0016-2361(71)90019-6; Rao ZH, 2015, PROG ENERG COMBUST, V46, P1, DOI 10.1016/j.pecs.2014.09.001; Ren PL, 2009, COAL SCI TECHNOLOGY, V37, P88; State Administration of Coal Mine Safety of China, 2015, FAIL AN REP CHIN COA; Stuart D, 1918, INT J COAL GEOL, V74, P203; Svabova M, 2011, FUEL, V90, P1892, DOI 10.1016/j.fuel.2011.01.005; Thomas JJ, 1976, 493 ILL STAT GEOL SU; Wang ZF, 2007, J HENAN POLYTECHNIC, V26, P117; Xie H., 2014, J CHINA COAL SOC, P1391; Yu BF, 2005, PREVENTION CONTROL G; Yu HL, 2000, J CHONGQING U, V23, P32; Yu QY, 2012, COLE MINE GAS CONTRO; Zhai JB, 2009, COAL TECHNOLOGY, V28, P92; Zhang HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105139; [张占存 ZHANG Zhancun], 2008, [煤炭学报, Journal of China Coal Society], V33, P144; Zhou SN, 1979, CHINA MINING U J, V2, P53; Zhou YJ, 2009, COAL MINING TECHNOLO, V4, P86; Zimny T, 2005, J COLLOID INTERF SCI, V285, P56, DOI 10.1016/j.jcis.2004.11.029	42	9	9	6	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132355	10.1371/journal.pone.0132355	http://dx.doi.org/10.1371/journal.pone.0132355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161959	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300122
J	Lu, AT; Zhang, MC; Shao, YL; Yu, YP; Zheng, S; Ye, J; Yi, H; Wang, L				Lu, Aitao; Zhang, Meichao; Shao, Yulan; Yu, Yanping; Zheng, Shuang; Ye, Jing; Yi, Hui; Wang, Lu			What Directions Do We Look at Power from? Up-Down, Left-Right, and Front-Back	PLOS ONE			English	Article							MENTAL REPRESENTATION; PERCEPTUAL SYMBOLS; LANGUAGE; TIME; ENGLISH; CONCEPTIONS; MANDARIN; THOUGHT; THINK	Three experiments were carried out to investigate whether the the kinship concept had spatial representations along up-down (Experiment 1), left-right (Experiment 2), and front-back (Experiment 3) orientation. Participants identified the letter P or Q after judging whether kinship words were elder or junior terms. The results showed that participants responded faster to letters placed at the top, right side, and front following elder terms, and faster at the bottom, left side, and back following junior terms. The regression results further confirmed that these shifts of attention along up-down, right-left, and front-back dimensions in external space were uniquely attributed to the power construct embedded in the kinship concept, but not number or time. The results provide evidence for the multiple spatial representations in power, and can be explained by the theoretical construct of structural mapping.	[Lu, Aitao; Zhang, Meichao; Shao, Yulan; Yu, Yanping; Zheng, Shuang; Ye, Jing; Yi, Hui; Wang, Lu] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Lu, Aitao; Zhang, Meichao; Shao, Yulan; Yu, Yanping; Zheng, Shuang; Ye, Jing; Yi, Hui; Wang, Lu] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Lu, Aitao; Zhang, Meichao; Shao, Yulan; Yu, Yanping; Zheng, Shuang; Ye, Jing; Yi, Hui; Wang, Lu] Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China; [Lu, Aitao; Zhang, Meichao; Shao, Yulan; Yu, Yanping; Zheng, Shuang; Ye, Jing; Yi, Hui; Wang, Lu] Guangdong Ctr Mental Assistance & Contingency Tec, Guangzhou, Guangdong, Peoples R China; [Zhang, Meichao] Chinese Acad Sci, Inst Psychol, Behav Sci Lab, Beijing 100101, Peoples R China; [Zhang, Meichao] Univ Chinese Acad Sci, Beijing, Peoples R China	South China Normal University; South China Normal University; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lu, AT (corresponding author), S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	atlupsy@gmail.com	Yu, Yan/GYV-4514-2022		National Natural Science Foundation of China [31200762]; Guangdong NSF, China [S2011040001823]; General research for Humanities and Social Sciences Project, Chinese Ministry of Education [11YJC740071]; National Training Fund for Basic Research [J1030729, J1210024]; Foundation for Outstanding Young Teachers in Higher Education of Guangdong, China [HS2015001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong NSF, China; General research for Humanities and Social Sciences Project, Chinese Ministry of Education; National Training Fund for Basic Research; Foundation for Outstanding Young Teachers in Higher Education of Guangdong, China	This work was supported by the National Natural Science Foundation of China (No. 31200762), Guangdong NSF, China (S2011040001823), General research for Humanities and Social Sciences Project, Chinese Ministry of Education (11YJC740071), the National Training Fund for Basic Research (J1030729 and J1210024), and the Foundation for Outstanding Young Teachers in Higher Education of Guangdong, China (HS2015001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barner D, 2009, COGNITION, V111, P329, DOI 10.1016/j.cognition.2009.02.008; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Barsalou LW, 2008, CURR DIR PSYCHOL SCI, V17, P91, DOI 10.1111/j.1467-8721.2008.00555.x; Boroditsky L, 2001, COGNITIVE PSYCHOL, V43, P1, DOI 10.1006/cogp.2001.0748; Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6; Boroditsky L, 2011, COGNITION, V118, P123, DOI 10.1016/j.cognition.2010.09.010; Chasteen AL, 2010, NEUROPSYCHOLOGIA, V48, P627, DOI 10.1016/j.neuropsychologia.2009.09.029; CHOI S, 1991, COGNITION, V41, P83, DOI 10.1016/0010-0277(91)90033-Z; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; de la Fuente J, 2014, PSYCHOL SCI, V25, P1682, DOI 10.1177/0956797614534695; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; FISCHER MH, 2005, PSYCHOL SCI, V47, P22; Gevers W, 2006, ACTA PSYCHOL, V122, P221, DOI 10.1016/j.actpsy.2005.11.004; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Giessner SR, 2007, ORGAN BEHAV HUM DEC, V104, P30, DOI 10.1016/j.obhdp.2006.10.001; Ikels Charlotte, 2004, FILIAL PIETY PRACTIC; Imai M, 1997, COGNITION, V62, P169, DOI 10.1016/S0010-0277(96)00784-6; Lakoff George, 2003, METAPHOR WE LIVE BY; Landau MJ, 2010, PSYCHOL BULL, V136, P1045, DOI 10.1037/a0020970; Majid A, 2004, TRENDS COGN SCI, V8, P108, DOI 10.1016/j.tics.2004.01.003; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Meier BP, 2007, J PERS SOC PSYCHOL, V93, P699, DOI 10.1037/0022-3514.93.5.699; Meier BP, 2007, PERS INDIV DIFFER, V43, P757, DOI 10.1016/j.paid.2007.02.001; Miles LK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010825; Miles LK, 2010, PSYCHOL SCI, V21, P222, DOI 10.1177/0956797609359333; Ouellet M, 2010, EXP PSYCHOL, V57, P308, DOI 10.1027/1618-3169/a000036; Proctor RW, 2006, PSYCHOL BULL, V132, P416, DOI 10.1037/0033-2909.132.3.416; Santos, 2006, EUROPEAN J E ASIAN S, V5, P275, DOI DOI 10.1163/157006106778869298; Schubert TW, 2005, J PERS SOC PSYCHOL, V89, P1, DOI 10.1037/0022-3514.89.1.1; Schwarz W, 2004, PERCEPT PSYCHOPHYS, V66, P651, DOI 10.3758/BF03194909; Sherman GD, 2009, PSYCHOL SCI, V20, P1019, DOI 10.1111/j.1467-9280.2009.02403.x; Torralbo A, 2006, COGNITIVE SCI, V30, P745, DOI 10.1207/s15516709cog0000_67; TVERSKY B, 1991, COGNITIVE PSYCHOL, V23, P515, DOI 10.1016/0010-0285(91)90005-9; Verheyen S, 2011, MEM COGNITION, V39, P1117, DOI 10.3758/s13421-011-0083-2; Weger UW, 2008, PSYCHON B REV, V15, P426, DOI 10.3758/PBR.15.2.426; Williams LE, 2009, EUR J SOC PSYCHOL, V39, P1257, DOI 10.1002/ejsp.665; Yoshida H, 2003, DEVELOPMENTAL SCI, V6, P30, DOI 10.1111/1467-7687.00249; Zanolie K, 2012, BRAIN COGNITION, V78, P50, DOI 10.1016/j.bandc.2011.10.006	39	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132756	10.1371/journal.pone.0132756	http://dx.doi.org/10.1371/journal.pone.0132756			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161645	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300173
J	Mackay, DS; Bennett, TM; Shiels, A				Mackay, Donna S.; Bennett, Thomas M.; Shiels, Alan			Exome Sequencing Identifies a Missense Variant in EFEMP1 Co-Segregating in a Family with Autosomal Dominant Primary Open-Angle Glaucoma	PLOS ONE			English	Article							HONEYCOMB RETINAL DYSTROPHY; MACULAR DEGENERATION; R345W MUTATION; DRUSEN; GENE; ASSOCIATION; MICE; PATHOPHYSIOLOGY; POPULATIONS; EXPRESSION	Primary open-angle glaucoma (POAG) is a clinically important and genetically heterogeneous cause of progressive vision loss as a result of retinal ganglion cell death. Here we have utilized trio-based, whole-exome sequencing to identify the genetic defect underlying an autosomal dominant form of adult-onset POAG segregating in an African-American family. Exome sequencing identified a novel missense variant (c.418C>T, p.Arg140Trp) in exon-5 of the gene coding for epidermal growth factor (EGF) containing fibulin-like extracellular matrix protein 1 (EFEMP1) that co-segregated with disease in the family. Linkage and haplotype analyses with microsatellite markers indicated that the disease interval overlapped a known POAG locus (GLC1H) on chromosome 2p. The p.Arg140Trp substitution was predicted in silico to have damaging effects on protein function and transient expression studies in cultured cells revealed that the Trp140-mutant protein exhibited increased intracellular accumulation compared with wild-type EFEMP1. In situ hybridization of the mouse eye with oligonucleotide probes detected the highest levels of EFEMP1 transcripts in the ciliary body, cornea, inner nuclear layer of the retina, and the optic nerve head. The recent finding that a common variant near EFEMP1 was associated with optic nerve-head morphology supports the possibility that the EFEMP1 variant identified in this POAG family may be pathogenic.	[Mackay, Donna S.; Bennett, Thomas M.; Shiels, Alan] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA	Washington University (WUSTL)	Shiels, A (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	shiels@vision.wustl.edu		Mackay, Donna/0000-0002-2499-1203	National Institutes of Health (NIH) [EY012284, EY02687]; Research to Prevent Blindness (RPB); NIH [P30 CA91842, UL1 TR000448]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012284, P30EY002687] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH) grants EY012284 (to A.S.) and EY02687 (Core Grant for Vision Research), and by an unrestricted grant to the Department of Ophthalmology and Visual Sciences from Research to Prevent Blindness (RPB). The Genome Technology Access Center (GTAC) at Washington University School of Medicine is partially supported by NIH grants P30 CA91842, and UL1 TR000448. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alapati A, 2014, INVEST OPHTH VIS SCI, V55, P5510, DOI 10.1167/iovs.14-14359; Nguyen A, 2015, EXP EYE RES, V130, P66, DOI 10.1016/j.exer.2014.12.002; Balasubbu S, 2012, INVEST OPHTH VIS SCI, V53, P1861, DOI 10.1167/iovs.11-8602; Boon CJF, 2013, PROG RETIN EYE RES, V37, P90, DOI 10.1016/j.preteyeres.2013.08.003; Chen LJ, 2012, MOL VIS, V18, P1629; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Djokic J, 2013, J BIOL CHEM, V288, P22821, DOI 10.1074/jbc.M112.439158; Fan BJ, 2010, J CLIN INVEST, V120, P3064, DOI 10.1172/JCI43085; Fu L, 2007, HUM MOL GENET, V16, P2411, DOI 10.1093/hmg/ddm198; Fuchshofer R, 2009, EXP EYE RES, V88, P1020, DOI 10.1016/j.exer.2009.01.002; Gemenetzi M, 2012, EYE, V26, P355, DOI 10.1038/eye.2011.309; Hulleman JD, 2011, MOL BIOL CELL, V22, P4765, DOI 10.1091/mbc.E11-08-0695; Janssen SF, 2013, PROG RETIN EYE RES, V37, P31, DOI 10.1016/j.preteyeres.2013.09.001; Jiao XD, 2009, P NATL ACAD SCI USA, V106, P17105, DOI 10.1073/pnas.0907564106; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; Lin Y, 2008, MOL VIS, V14, P739; Liu T, 2012, MOL VIS, V18, P2119; Liu YT, 2013, INVEST OPHTH VIS SCI, V54, P6248, DOI 10.1167/iovs.13-12779; Liu YT, 2011, EXP EYE RES, V93, P331, DOI 10.1016/j.exer.2011.08.007; Liu YT, 2010, P NATL ACAD SCI USA, V107, pE61, DOI 10.1073/pnas.0913838107; Marmorstein LY, 2007, HUM MOL GENET, V16, P2423, DOI 10.1093/hmg/ddm199; Matsumoto M, 2001, AM J OPHTHALMOL, V131, P810, DOI 10.1016/S0002-9394(00)00926-0; McLaughlin PJ, 2007, HUM MOL GENET, V16, P3059, DOI 10.1093/hmg/ddm264; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Roybal CN, 2005, INVEST OPHTH VIS SCI, V46, P3973, DOI 10.1167/iovs.05-0070; Springelkamp H, 2015, GENET EPIDEMIOL, V39, P207, DOI 10.1002/gepi.21886; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Suriyapperuma SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P86, DOI 10.1001/archopht.125.1.86; Takamoto M, 2014, JPN J OPHTHALMOL, V58, P1, DOI 10.1007/s10384-013-0286-0; Takeuchi T, 2010, INVEST OPHTH VIS SCI, V51, P1643, DOI 10.1167/iovs.09-4497; Tarttelin EE, 2001, J MED GENET, V38, P381, DOI 10.1136/jmg.38.6.381; Templeton JP, 2013, INVEST OPHTH VIS SCI, V54, P2599, DOI 10.1167/iovs.12-11175; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30; Williams SEI, 2015, SCI REP-UK, V5, DOI 10.1038/srep08378; Zhang T, 2014, RETINA-J RET VIT DIS, V34, P2462, DOI 10.1097/IAE.0000000000000259	37	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132529	10.1371/journal.pone.0132529	http://dx.doi.org/10.1371/journal.pone.0132529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162006	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300146
J	Fu, C; Chen, D; Chen, RJ; Hu, QS; Wang, GH				Fu, Cheng; Chen, Dong; Chen, Ruijie; Hu, Qingsong; Wang, Guanghui			The Schizophrenia-Related Protein Dysbindin-1A Is Degraded and Facilitates NF-Kappa B Activity in the Nucleus	PLOS ONE			English	Article							SDY MUTANT MICE; SUSCEPTIBILITY GENE; SYNAPTIC PLASTICITY; NEURITE OUTGROWTH; UBIQUITIN LIGASE; MEMORY FORMATION; WORKING-MEMORY; SPATIAL MEMORY; DTNBP1; EXPRESSION	Dystrobrevin-binding protein 1 (DTNBP1), a gene encoding dysbindin-1, has been identified as a susceptibility gene for schizophrenia. Functioning with partners in synapses or the cytoplasm, this gene regulates neurite outgrowth and neurotransmitter release. Loss of dysbindin-1 affects schizophrenia pathology. Dysbindin-1 is also found in the nucleus, however, the characteristics of dysbindin in the nucleus are not fully understood. Here, we found that dysbindin-1A is degraded in the nucleus via the ubiquitin-proteasome system and that amino acids 2-41 at the N-terminus are required for this process. By interacting with p65, dysbindin-1A promotes the transcriptional activity of NF-kappa B in the nucleus and positively regulates MMP-9 expression. Taken together, the data obtained in this study demonstrate that dysbindin-1A protein levels are highly regulated in the nucleus and that dysbindin-1A regulates transcription factor NF-kappa B activity to promote the expression of MMP-9 and TNF-alpha.	[Fu, Cheng; Wang, Guanghui] Univ Sci & Technol China, Chinese Acad Sci, Key Lab Brain Funct & Dis, Lab Mol Neuropathol, Hefei 230026, Anhui, Peoples R China; [Fu, Cheng; Wang, Guanghui] Univ Sci & Technol China, Chinese Acad Sci, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Chen, Dong; Hu, Qingsong; Wang, Guanghui] Soochow Univ, Jiangsu Key Lab Translat Res & Therapy Neuropsyco, Lab Mol Neuropathol, Suzhou, Jiangsu, Peoples R China; [Chen, Dong; Hu, Qingsong; Wang, Guanghui] Soochow Univ, Coll Pharmaceut Sci, Suzhou, Jiangsu, Peoples R China; [Chen, Ruijie] Wenzhou Med Univ, Affiliated Hosp 2, Dept Clin Pharm & Pharmacol, Wenzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Soochow University - China; Soochow University - China; Wenzhou Medical University	Wang, GH (corresponding author), Univ Sci & Technol China, Chinese Acad Sci, Key Lab Brain Funct & Dis, Lab Mol Neuropathol, Hefei 230026, Anhui, Peoples R China.	wghui@ustc.edu.cn	Wang, Guanghui/U-3979-2017	Wang, Guanghui/0000-0001-8551-6468; Lim, Kah-Leong/0000-0002-5440-2588	National High-tech Research and Development program of China 973-projects [2012CB947602]; National Natural Sciences Foundation of China [31330030, 81371393]; Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases [BM2013003]	National High-tech Research and Development program of China 973-projects(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases	The National High-tech Research and Development program of China 973-projects (2012CB947602, http://www.most.gov.cn/), the National Natural Sciences Foundation of China (Nos. 31330030 and 81371393, http://www.nsfc.gov.cn/) and Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases (BM2013003, http://www.jstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2008, LEARN MEMORY, V15, P539, DOI 10.1101/lm.866408; Alvarez-Castelao B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055999; Ao Li X, 2009, BDM PUB COMPUTATIONA; Boersma MCH, 2011, J NEUROSCI, V31, P5414, DOI 10.1523/JNEUROSCI.2456-10.2011; Burdick KE, 2007, SCHIZOPHR RES, V89, P169, DOI 10.1016/j.schres.2006.09.008; Burdick KE, 2006, HUM MOL GENET, V15, P1563, DOI 10.1093/hmg/ddi481; Chen XW, 2008, J CELL BIOL, V181, P791, DOI 10.1083/jcb.200711021; Cox MM, 2009, GENES BRAIN BEHAV, V8, P390, DOI 10.1111/j.1601-183X.2009.00477.x; Dash PK, 2005, J NEUROCHEM, V93, P269, DOI 10.1111/j.1471-4159.2004.03016.x; Denis-Donini S, 2008, J NEUROSCI, V28, P3911, DOI 10.1523/JNEUROSCI.0148-08.2008; Dziembowska M, 2012, INT J BIOCHEM CELL B, V44, P709, DOI 10.1016/j.biocel.2012.01.023; Fei EK, 2010, J BIOL CHEM, V285, P38630, DOI 10.1074/jbc.M110.107912; Feng YQ, 2008, SCHIZOPHR RES, V106, P218, DOI 10.1016/j.schres.2008.07.018; Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58; Gutierrez H, 2005, DEVELOPMENT, V132, P1713, DOI 10.1242/dev.01702; Hattori S, 2008, BIOCHEM BIOPH RES CO, V373, P298, DOI 10.1016/j.bbrc.2008.06.016; HOUGH R, 1986, J BIOL CHEM, V261, P2400; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Ito H, 2010, MOL PSYCHIATR, V15, P976, DOI [10.1038/mp.2010.69, 10.1038/mp.2010.93]; Jia JM, 2014, J NEUROSCI, V34, P13725, DOI 10.1523/JNEUROSCI.0184-14.2014; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Karlsgodt KH, 2011, BIOL PSYCHIAT, V69, P28, DOI 10.1016/j.biopsych.2010.09.012; Kubota K, 2009, BIOCHEM BIOPH RES CO, V379, P191, DOI 10.1016/j.bbrc.2008.12.017; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Lingbeck JM, 2003, J BIOL CHEM, V278, P1817, DOI 10.1074/jbc.M208815200; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Ma X, 2011, MOL PSYCHIATR, V16, P1105, DOI 10.1038/mp.2011.43; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; Okuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008773; Oyama S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004199; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Roussos P, 2013, NEUROPSYCHOPHARMACOL, V38, P533, DOI 10.1038/npp.2012.215; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Trausch-Azar J, 2010, J BIOL CHEM, V285, P40192, DOI 10.1074/jbc.M110.131615; Vawter MP, 2002, MOL PSYCHIATR, V7, P571, DOI 10.1038/sj.mp.4001158; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Weickert CS, 2004, ARCH GEN PSYCHIAT, V61, P544, DOI 10.1001/archpsyc.61.6.544; Yap MYA, 2014, NEUROCHEM INT, V79, P65, DOI 10.1016/j.neuint.2014.10.001; Yeh SH, 2002, J BIOL CHEM, V277, P46720, DOI 10.1074/jbc.M206258200	43	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132639	10.1371/journal.pone.0132639	http://dx.doi.org/10.1371/journal.pone.0132639			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171858	Green Submitted, gold, Green Published			2022-12-27	WOS:000358194900067
J	Han, K; Chao, AC; Chang, FC; Chung, CP; Hsu, HY; Sheng, WY; Wu, J; Hu, HH				Han, Ke; Chao, A-Ching; Chang, Feng-Chi; Chung, Chih-Ping; Hsu, Hung-Yi; Sheng, Wen-Yung; Wu, Jiang; Hu, Han-Hwa			Obstruction of Venous Drainage Linked to Transient Global Amnesia	PLOS ONE			English	Article							INTERNAL JUGULAR-VEIN; CEREBRAL-CIRCULATION; COMPRESSION SYNDROME; MULTIPLE-SCLEROSIS; VALVE INCOMPETENCE; CAVERNOUS SINUS; CT ANGIOGRAPHY; BASAL VEIN; MR; OUTFLOW	Abnormal extracranial venous drainage modality has been considered an etiology of transient global amnesia (TGA). Evidence suggests that the transmission of the intrathoracic/intraabdominal pressure during a Valsalva maneuver (VM) is mainly through the vertebral venous system, and patency of internal jugular vein (IJV) is essential for venous drainage and pressure releasing. We hypothesize that obstruction of IJV venous drainage is a contributing factor in TGA pathogenesis. A magnetic resonance (MR) imaging protocol was used in 45 TGA patients and 45 age-and sex-matched controls to assess the morphologies of IJV, brachiocephalic vein (BCV) and asymmetry of transverse sinus (TS). The IJV was divided into the upper-and middle-IJV segments. Compared to the controls, TGA patients had significantly higher rates of moderate and severe compression/stenosis at the bilateral upper-IJV segment (left: 37.8% vs. 17.8%, P = 0.0393; right: 57.8% vs. 15.6%, P<0.0012), in left BCV (60% vs. 8.9%, P<0.0004), and in TS hypoplasia (53.3%% vs. 31.1%, P = 0.0405). The prevalence of at least one site of venous compression/stenosis in IJV or BCV was significantly higher in patients than in controls (91.1% vs. 33.3%, P<0.0004). The diameter of the left TS in MRV, but not in T1 contrast imaging, was significantly smaller in TGA patients than in controls (0.31 +/- 0.21 vs. 0.41 +/- 0.19, P = 0.0290), which was compatible with downstream venous stenosis/obstruction. TGA patients have a higher prevalence of compression/stenosis of the bilateral IJV and the left BCV and TS hypoplasia, which is new evidence that supports the role of extracranial veins in TGA pathogenesis.	[Han, Ke; Wu, Jiang] Jilin Univ, Hosp 1, Dept Neurol, Changchun 130023, Jilin Province, Peoples R China; [Chao, A-Ching] Kaohsiung Med Univ, Dept Neurol, Coll Med, Kaohsiung, Taiwan; [Chao, A-Ching] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Chang, Feng-Chi] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Chang, Feng-Chi; Chung, Chih-Ping; Sheng, Wen-Yung] Natl Yang Ming Univ, Taipei 112, Taiwan; [Chung, Chih-Ping; Sheng, Wen-Yung] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Hsu, Hung-Yi] Chung Shan Med Univ, Tungs Taichung Metro Harbor Hosp, Dept Neurol, Taichung, Taiwan; [Hsu, Hung-Yi] Chung Shan Med Univ, Dept Neurol, Sch Med, Taichung, Taiwan; [Hu, Han-Hwa] Taipei Med Univ & Hosp, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Hu, Han-Hwa] Taipei Med Univ & Hosp, Dept Neurol, Coll Med, Taipei, Taiwan	Jilin University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital	Wu, J (corresponding author), Jilin Univ, Hosp 1, Dept Neurol, Changchun 130023, Jilin Province, Peoples R China.	doctorwujiang@sina.cn; hanhwa@hotmail.com		Chung, Chih-Ping/0000-0001-9419-9070	Taiwan National Science Council Research Grant [NSC101-2314-B-037-069-MY2]	Taiwan National Science Council Research Grant	This work was supported by the Taiwan National Science Council Research Grant (NSC101-2314-B-037-069-MY2); The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baracchini C, 2012, STROKE, V43, P2289, DOI 10.1161/STROKEAHA.112.654087; BOK B, 1978, EUR J NUCL MED, V3, P63; Cejas C, 2010, STROKE, V41, P67, DOI 10.1161/STROKEAHA.109.566315; Cheng CY, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-94; Chung CP, 2006, NEUROLOGY, V66, P1873, DOI 10.1212/01.wnl.0000219620.69618.9d; Chung CP, 2007, ULTRASOUND MED BIOL, V33, P1727, DOI 10.1016/j.ultrasmedbio.2007.05.018; Chung JI, 2005, INTERV NEURORADIOL, V11, P123, DOI 10.1177/159101990501100202; Dashti SR, 2012, NEUROSURGERY, V70, pE795, DOI 10.1227/NEU.0b013e3182333859; EPSTEIN HM, 1970, ANESTHESIOLOGY, V32, P332, DOI 10.1097/00000542-197004000-00007; Feng W, 2012, REV RECENT CLIN TRIA, V7, P117, DOI 10.2174/157488712800100206; Fofi L, 2012, HEADACHE, V52, P1254, DOI 10.1111/j.1526-4610.2012.02154.x; Frydrychowski AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048245; Gianesini S, 2014, PHLEBOLOGY, V29, P632, DOI 10.1177/0268355513489549; Gisolf J, 2004, J PHYSIOL-LONDON, V560, P317, DOI 10.1113/jphysiol.2004.070409; GUERCI AD, 1985, CIRC RES, V56, P20, DOI 10.1161/01.RES.56.1.20; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; Hsu HY, 2008, ANN NEUROL, V63, P247, DOI 10.1002/ana.21299; Jayaraman MV, 2012, AM J NEURORADIOL, V33, P1247, DOI 10.3174/ajnr.A2953; Kim BS, 2009, NEURORADIOLOGY, V51, P327, DOI 10.1007/s00234-009-0500-4; Law M, 2004, RADIOLOGY, V231, P645, DOI 10.1148/radiol.2313030996; Lewis SL, 1998, LANCET, V352, P397, DOI 10.1016/S0140-6736(98)01442-1; Lin CJ, 2014, AM J NEURORADIOL, V35, P1132, DOI 10.3174/ajnr.A3838; Liu MJ, 2015, J VASC SURG, V61, P1511, DOI 10.1016/j.jvs.2014.02.021; Lo CP, 2007, CLIN RADIOL, V62, P185, DOI 10.1016/j.crad.2006.09.019; Lochner P, 2014, J NEUROIMAGING, V24, P479, DOI 10.1111/jon.12042; MCHEDLISHVILI GI, 1964, CIRCULATION, V30, P597, DOI 10.1161/01.CIR.30.4.597; Modabbernia A, 2012, ACTA NEUROL BELG, V112, P237, DOI 10.1007/s13760-012-0072-7; Niggemann P, 2011, CENT EUR NEUROSURG, V72, P32, DOI 10.1055/s-0030-1253348; Paksoy Y, 2003, AM J NEURORADIOL, V24, P1364; Parkinson D, 2000, J NEUROSURG, V92, P585, DOI 10.3171/jns.2000.92.4.0585; Quinette P, 2006, BRAIN, V129, P1640, DOI 10.1093/brain/awl105; Schreiber SJ, 2005, J NEUROL NEUROSUR PS, V76, P509, DOI 10.1136/jnnp.2004.043844; STEINBACH JJ, 1976, J NUCL MED, V17, P61; Suzuki Y, 2001, AM J NEURORADIOL, V22, P670; Takahashi S, 2005, EUR RADIOL, V15, P1694, DOI 10.1007/s00330-004-2597-5; TANAKA T, 1993, RADIOLOGY, V188, P355, DOI 10.1148/radiology.188.2.8327678; Valdueza JM, 2000, LANCET, V355, P200; Velasco R, 2008, REV NEUROLOGIA, V47, P301, DOI 10.33588/rn.4706.2008112; Yu WG, 2009, STROKE, V40, P3736, DOI 10.1161/STROKEAHA.109.563080; Zaharchuk G, 2011, AM J NEURORADIOL, V32, P1482, DOI 10.3174/ajnr.A2549; Zamboni P, 2009, CURR NEUROVASC RES, V6, P204, DOI 10.2174/156720209788970054; ZOUAOUI A, 1988, ACTA ANAT, V133, P318	42	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132893	10.1371/journal.pone.0132893	http://dx.doi.org/10.1371/journal.pone.0132893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173146	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900096
J	Szalonek, M; Sierpien, B; Rymaszewski, W; Gieczewska, K; Garstka, M; Lichocka, M; Sass, L; Paul, K; Vass, I; Vankova, R; Dobrev, P; Szczesny, P; Marczewski, W; Krusiewicz, D; Strzelczyk-Zyta, D; Hennig, J; Konopka-Postupolska, D				Szalonek, Michal; Sierpien, Barbara; Rymaszewski, Wojciech; Gieczewska, Katarzyna; Garstka, Maciej; Lichocka, Malgorzata; Sass, Laszlo; Paul, Kenny; Vass, Imre; Vankova, Radomira; Dobrev, Peter; Szczesny, Pawel; Marczewski, Waldemar; Krusiewicz, Dominika; Strzelczyk-Zyta, Danuta; Hennig, Jacek; Konopka-Postupolska, Dorota			Potato Annexin STANN1 Promotes Drought Tolerance and Mitigates Light Stress in Transgenic Solanum tuberosum L. Plants	PLOS ONE			English	Article							MEDIATED OXIDATIVE STRESS; BRASSICA-JUNCEA ANNEXIN-3; REDOX SIGNALING PATHWAYS; SALICYLIC-ACID; ASCORBATE PEROXIDASE; ABIOTIC STRESS; HYDROGEN-PEROXIDE; TOBACCO PLANTS; PHOTOOXIDATIVE STRESS; PROTEOMIC IDENTIFICATION	Annexins are a family of calcium-and membrane-binding proteins that are important for plant tolerance to adverse environmental conditions. Annexins function to counteract oxidative stress, maintain cell redox homeostasis, and enhance drought tolerance. In the present study, an endogenous annexin, STANN1, was overexpressed to determine whether crop yields could be improved in potato (Solanum tuberosum L.) during drought. Nine potential potato annexins were identified and their expression characterized in response to drought treatment. STANN1 mRNA was constitutively expressed at a high level and drought treatment strongly increased transcription levels. Therefore, STANN1 was selected for overexpression analysis. Under drought conditions, transgenic potato plants ectopically expressing STANN1 were more tolerant to water deficit in the root zone, preserved more water in green tissues, maintained chloroplast functions, and had higher accumulation of chlorophyll b and xanthophylls (especially zeaxanthin) than wild type (WT). Droughtinduced reductions in the maximum efficiency and the electron transport rate of photosystem II (PSII), as well as the quantum yield of photosynthesis, were less pronounced in transgenic plants overexpressing STANN1 than in the WT. This conferred more efficient non-photochemical energy dissipation in the outer antennae of PSII and probably more efficient protection of reaction centers against photooxidative damage in transgenic plants under drought conditions. Consequently, these plants were able to maintain effective photosynthesis during drought, which resulted in greater productivity than WT plants despite water scarcity. Although the mechanisms underlying this stress protection are not yet clear, annexin-mediated photoprotection is probably linked to protection against light-induced oxidative stress.	[Szalonek, Michal; Sierpien, Barbara; Rymaszewski, Wojciech; Lichocka, Malgorzata; Szczesny, Pawel; Hennig, Jacek; Konopka-Postupolska, Dorota] Polish Acad Sci, Inst Biochem & Biophys, Plant Pathogenesis Lab, Warsaw, Poland; [Gieczewska, Katarzyna; Garstka, Maciej] Univ Warsaw, Dept Metab Regulat, Warsaw, Poland; [Sass, Laszlo; Paul, Kenny; Vass, Imre] Hungarian Acad Sci, Biol Res Ctr, Lab Mol Stress & Photobiol, H-6701 Szeged, Hungary; [Vankova, Radomira; Dobrev, Peter] Inst Expt Bot AS CR, Lab Hormonal Regulat Plants, Prague, Czech Republic; [Marczewski, Waldemar; Krusiewicz, Dominika; Strzelczyk-Zyta, Danuta] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Potato Genet & Parental Lines, Mlochow, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Institute of Plant Breeding & Acclimatization	Konopka-Postupolska, D (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Dept Plant Biochem, Warsaw, Poland.	konopka@ibb.waw.pl	Vass, Imre/AAS-6171-2021; Gieczewska, Katarzyna B./ABI-6264-2020; Lichocka, Małgorzata/ABF-2236-2020; Garstka, Maciej Z/T-4962-2018; Konopka-Postupolska, Dorota/AAE-9134-2020; Konopka-Postupolska, Dorota M/H-1916-2012	Vass, Imre/0000-0003-4987-7842; Lichocka, Małgorzata/0000-0002-9894-8195; Garstka, Maciej Z/0000-0001-7141-505X; Paul, Kenny/0000-0003-4948-765X; Marczewski, Waldemar/0000-0002-1424-7325; Hennig, Jacek/0000-0003-0156-1320; Gieczewska, Katarzyna/0000-0001-5400-868X; Konopka-Postupolska, Dorota/0000-0002-3181-5478	Transnational Access Capacities of the European Plant Phenotyping Network (EPPN) - FP7 Research Infrastructures Program of the European Union [284443]; Ministry of Science and Higher Education [N N301 567540, PBZMNiSW-213/2006/5]; European Union - the European Regional Development Fund within the Operational Programme "Innovative economy"	Transnational Access Capacities of the European Plant Phenotyping Network (EPPN) - FP7 Research Infrastructures Program of the European Union; Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Union - the European Regional Development Fund within the Operational Programme "Innovative economy"	This work was supported by Transnational Access Capacities of the European Plant Phenotyping Network (EPPN, grant agreement no 284443) - FP7 Research Infrastructures Program of the European Union, http://cordis.europa.eu/fp7/ict/e-infrastructure/ (to MS); Grant N N301 567540 Ministry of Science and Higher Education, http://www.nauka.gov.pl/en/ (to DKP); Grant PBZMNiSW-213/2006/5 - Ministry of Science and Higher Education, http://www. nauka.gov.pl/en/ (to JH); and the use of CePT infrastructure was financed by the European Union - the European Regional Development Fund within the Operational Programme "Innovative economy" for 2007-2013, https://cept.wum.edu.pl/ (MG and KG)	Aghaei K, 2008, J PROTEOME RES, V7, P4858, DOI 10.1021/pr800460y; Aimar D, 2011, PLANTS ENV; Argueso CT, 2009, PLANT CELL ENVIRON, V32, P1147, DOI 10.1111/j.1365-3040.2009.01940.x; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Asselbergh B, 2008, MOL PLANT MICROBE IN, V21, P709, DOI 10.1094/MPMI-21-6-0709; Baebler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029009; Baier M, 2005, J EXP BOT, V56, P1449, DOI 10.1093/jxb/eri161; Bartoli CG, 2013, ENVIRON EXP BOT, V94, P73, DOI 10.1016/j.envexpbot.2012.05.003; BAULCOMBE DC, 1986, NATURE, V321, P446, DOI 10.1038/321446a0; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Bhargava A, 2013, PLANT PHYSIOL, V162, P272, DOI 10.1104/pp.113.217026; Bhargava S, 2013, PLANT BREEDING, V132, P21, DOI 10.1111/pbr.12004; Bick JA, 2001, BIOCHEMISTRY-US, V40, P9040, DOI 10.1021/bi010518v; Broin M, 2003, PLANT PHYSIOL, V132, P1335, DOI 10.1104/pp.103.021626; Caplan JF, 2004, J BIOL CHEM, V279, P7740, DOI 10.1074/jbc.M313049200; Chaves I, 2009, PROTEOMICS, V9, P4154, DOI 10.1002/pmic.200700649; Chen SG, 2010, BBA-BIOENERGETICS, V1797, P391, DOI 10.1016/j.bbabio.2009.12.007; Chen Z, 2008, J BIOL CHEM, V283, P21347, DOI 10.1074/jbc.M802601200; CHEN ZX, 1993, P NATL ACAD SCI USA, V90, P9533, DOI 10.1073/pnas.90.20.9533; Chow B, 2004, J EXP BOT, V55, P247, DOI 10.1093/jxb/erh032; Chu P, 2012, PLANTA, V235, P1271, DOI 10.1007/s00425-011-1573-y; Clark G, 2010, PLANT SIGNAL BEHAV, V5, P303, DOI 10.4161/psb.5.3.10835; Clark GB, 2012, NEW PHYTOL, V196, P695, DOI 10.1111/j.1469-8137.2012.04308.x; Cortleven A, 2014, PLANT PHYSIOL, V164, P1470, DOI 10.1104/pp.113.224667; Dalal A, 2014, PLANT SCI, V219, P9, DOI 10.1016/j.plantsci.2013.12.016; Dalal A, 2014, FEBS LETT, V588, P584, DOI 10.1016/j.febslet.2014.01.006; DalCorso G, 2008, CELL, V132, P273, DOI 10.1016/j.cell.2007.12.028; Davies Julia M., 2014, Plants-Basel, V3, P128, DOI 10.3390/plants3010128; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Dempsey D'Maris Amick, 2011, Arabidopsis Book, V9, pe0156, DOI 10.1199/tab.0156; Divya K, 2010, PLANT MOL BIOL, V73, P293, DOI 10.1007/s11103-010-9615-6; Dobrev Petre I, 2012, Methods Mol Biol, V913, P251, DOI 10.1007/978-1-61779-986-0_17; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; DURNER J, 1995, P NATL ACAD SCI USA, V92, P11312, DOI 10.1073/pnas.92.24.11312; Durner J, 1996, J BIOL CHEM, V271, P28492, DOI 10.1074/jbc.271.45.28492; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Folgado R, 2013, INT J MOL SCI, V14, P4912, DOI 10.3390/ijms14034912; Fotopoulos V, 2008, J EXP BOT, V59, P729, DOI 10.1093/jxb/erm359; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; FOYER CH, 1994, PHYSIOL PLANTARUM, V92, P696, DOI 10.1111/j.1399-3054.1994.tb03042.x; Foyer CH, 2013, ANTIOXID REDOX SIGN, V18, P2087, DOI 10.1089/ars.2013.5278; Foyer CH, 2012, J EXP BOT, V63, P1637, DOI 10.1093/jxb/ers013; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Foyer CH, 2011, PLANT PHYSIOL, V155, P93, DOI 10.1104/pp.110.166181; Gajdosova S, 2011, J EXP BOT, V62, P2827, DOI 10.1093/jxb/erq457; Gao Q, 2008, J PLANT PHYSIOL, V165, P138, DOI 10.1016/j.jplph.2007.04.002; Gidrol X, 1996, P NATL ACAD SCI USA, V93, P11268, DOI 10.1073/pnas.93.20.11268; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gomez LD, 2004, PLANT PHYSIOL, V134, P1662, DOI 10.1104/pp.103.033027; Gorecka KM, 2005, BIOCHEM BIOPH RES CO, V336, P868, DOI 10.1016/j.bbrc.2005.08.181; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; Halim VA, 2007, MOL PLANT MICROBE IN, V20, P1346, DOI 10.1094/MPMI-20-11-1346; Hassanpanah D, 2010, POTATO RES, V53, P383, DOI 10.1007/s11540-010-9179-5; Havaux M, 2005, PLANT CELL, V17, P3451, DOI 10.1105/tpc.105.037036; Havaux M, 2000, PLANT PHYSIOL, V124, P273, DOI 10.1104/pp.124.1.273; Havlova M, 2008, PLANT CELL ENVIRON, V31, P341, DOI 10.1111/j.1365-3040.2007.01766.x; Hipkins MF, 1986, SPECTROSCOPY, P51; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hoekstra AY, 2005, GLOBAL ENVIRON CHANG, V15, P45, DOI 10.1016/j.gloenvcha.2004.06.004; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Hoser R, 2013, NEW PHYTOL, V200, P158, DOI 10.1111/nph.12347; Hossain M. A., 2011, Frontiers of Agriculture in China, V5, P1, DOI 10.1007/s11703-010-1070-2; Hossain M.A., 2013, J PLANT SCI MOL BREE, V2, P2, DOI [10.7243/2050-2389-2-2, DOI 10.7243/2050-2389-2-2]; Ishibashi Y, 2012, PLANT PHYSIOL, V158, P1705, DOI 10.1104/pp.111.192740; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Jami SK, 2012, PLANT CELL REP, V31, P813, DOI 10.1007/s00299-011-1201-0; Jami SK, 2008, PLANT PHYSIOL BIOCH, V46, P1019, DOI 10.1016/j.plaphy.2008.07.006; Janda T, 2014, ACTA PHYSIOL PLANT, V36, P2537, DOI 10.1007/s11738-014-1620-y; JEFFERIES RA, 1993, ANN APPL BIOL, V122, P105, DOI 10.1111/j.1744-7348.1993.tb04018.x; Jeon J, 2010, J BIOL CHEM, V285, P23369, DOI 10.1074/jbc.M109.096644; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Kitajima S, 2008, PHOTOCHEM PHOTOBIOL, V84, P1404, DOI 10.1111/j.1751-1097.2008.00452.x; Konopka-Postupolska D, 2011, PLANT SCI, V181, P230, DOI 10.1016/j.plantsci.2011.05.013; Konopka-Postupolska D, 2009, PLANT PHYSIOL, V150, P1394, DOI 10.1104/pp.109.135228; Koornneef A, 2008, PLANT PHYSIOL, V147, P1358, DOI 10.1104/pp.108.121392; Kwak JM, 2006, PLANT PHYSIOL, V141, P323, DOI 10.1104/pp.106.079004; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Kwon M, 2005, J BIOL CHEM, V280, P23584, DOI 10.1074/jbc.M504325200; Labudda M, 2014, ACTA SOC BOT POL, V83, P3, DOI 10.5586/asbp.2014.003; Laohavisit A, 2013, PLANT PHYSIOL, V163, P253, DOI 10.1104/pp.113.217810; Laohavisit A, 2011, NEW PHYTOL, V189, P40, DOI 10.1111/j.1469-8137.2010.03533.x; Laohavisit A, 2010, PLANT PHYSIOL, V152, P1824, DOI 10.1104/pp.109.145458; Laohavisit A, 2009, PLANT CELL, V21, P479, DOI 10.1105/tpc.108.059550; Lascano Ramiro, 2011, P135; Lehesranta SJ, 2005, PLANT PHYSIOL, V138, P1690, DOI 10.1104/pp.105.060152; Li ZR, 2012, PLANT PHYSIOL, V158, P313, DOI 10.1104/pp.111.181230; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Lin F, 2009, J EXP BOT, V60, P3221, DOI 10.1093/jxb/erp157; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Lu YG, 2012, GENE, V499, P14, DOI 10.1016/j.gene.2012.03.026; Mac A, 2004, CELL MOL BIOL LETT, V9, P843; Mackova H, 2013, J EXP BOT, V64, P2805, DOI 10.1093/jxb/ert131; Madureira PA, 2013, INT J MOL SCI, V14, P3568, DOI 10.3390/ijms14023568; Madureira PA, 2011, ONCOTARGET, V2, P1075, DOI 10.18632/oncotarget.375; Mano J, 2001, BBA-BIOENERGETICS, V1504, P275, DOI 10.1016/S0005-2728(00)00256-5; Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753; Mateo A, 2006, J EXP BOT, V57, P1795, DOI 10.1093/jxb/erj196; Maughan SC, 2010, P NATL ACAD SCI USA, V107, P2331, DOI 10.1073/pnas.0913689107; Merewitz EB, 2011, J EXP BOT, V62, P5311, DOI 10.1093/jxb/err166; Merewitz EB, 2010, J AM SOC HORTIC SCI, V135, P230, DOI 10.21273/JASHS.135.3.230; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Mhamdi A, 2010, PLANT PHYSIOL, V153, P1144, DOI 10.1104/pp.110.153767; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Miller G, 2007, PLANT PHYSIOL, V144, P1777, DOI 10.1104/pp.107.101436; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Miura K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00004; Monneveux P, 2013, PLANT SCI, V205, P76, DOI 10.1016/j.plantsci.2013.01.011; Mortimer JC, 2008, J EXP BOT, V59, P533, DOI 10.1093/jxb/erm344; Mortimer JC, 2009, PLANT SIGNAL BEHAV, V4, P428, DOI [10.4161/psb.4.5.8297, 10.1105/tpc.108.059550]; Muller-Moule P, 2002, PLANT PHYSIOL, V128, P970, DOI 10.1104/pp.010924; Munne-Bosch S, 2003, PLANTA, V217, P758, DOI 10.1007/s00425-003-1037-0; Murphy JP, 2010, PROTEOMICS, V10, P4258, DOI 10.1002/pmic.200900718; Muthuramalingam M, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00089, 10.3389/fpls.2013.00054]; Navarre DA, 2004, PHYSIOL MOL PLANT P, V64, P179, DOI 10.1016/j.pmpp.2004.09.001; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Noctor G, 2012, ANN BOT, V89, P841; O'Brien JA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00451; Pal AK, 2013, BIOL PLANTARUM, V57, P359, DOI 10.1007/s10535-012-0277-x; Pasternak M, 2008, PLANT J, V53, P999, DOI 10.1111/j.1365-313X.2007.03389.x; Pastori GM, 2003, PLANT CELL, V15, P939, DOI 10.1105/tpc.010538; PERL A, 1993, THEOR APPL GENET, V85, P568, DOI 10.1007/BF00220915; Pfannschmidt T, 2000, EUR J BIOCHEM, V267, P253, DOI 10.1046/j.1432-1327.2000.00991.x; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Plieth C, 2012, PLANT SIGNAL BEHAV, V7, P650, DOI 10.4161/psb.20065; Prochazkova D, 2008, CELL BIOCHEM FUNCT, V26, P582, DOI 10.1002/cbf.1481; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Queval G, 2011, PLANT CELL ENVIRON, V34, P21, DOI 10.1111/j.1365-3040.2010.02222.x; Queval G, 2009, MOL PLANT, V2, P344, DOI 10.1093/mp/ssp002; Rahantaniaina MS, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00477; Rashotte AM, 2003, PLANT PHYSIOL, V132, P1998, DOI 10.1104/pp.103.021436; Raspor M, 2012, J PLANT GROWTH REGUL, V31, P460, DOI 10.1007/s00344-011-9255-3; Reynolds M, 2008, CURR OPIN PLANT BIOL, V11, P171, DOI 10.1016/j.pbi.2008.02.005; Richards SL, 2014, PLANT J, V77, P136, DOI 10.1111/tpj.12372; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Rivero RM, 2010, PLANT CELL PHYSIOL, V51, P1929, DOI 10.1093/pcp/pcq143; Rivero RM, 2009, PLANT PHYSIOL, V150, P1530, DOI 10.1104/pp.109.139378; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rizhsky L, 2002, PLANT J, V32, P329, DOI 10.1046/j.1365-313X.2002.01427.x; Salekdeh GH, 2009, TRENDS PLANT SCI, V14, P488, DOI 10.1016/j.tplants.2009.07.007; Sanchez G, 2010, MOL PLANT MICROBE IN, V23, P394, DOI 10.1094/MPMI-23-4-0394; Sareddy GR, 2013, J CANC SCI THER, V5, P256; Schmidt R, 2015, BBA-GEN SUBJECTS, V1850, P1497, DOI 10.1016/j.bbagen.2014.12.020; Schmitz G, 2010, MOL PLANT MICROBE IN, V23, P1584, DOI 10.1094/MPMI-02-10-0045; Schraudner M, 1998, PLANT J, V16, P235, DOI 10.1046/j.1365-313x.1998.00294.x; Seregelyes C, 2003, PLANT SCI, V165, P541, DOI 10.1016/S0168-9452(03)00213-9; Shao HB, 2008, INT J BIOL SCI, V4, P8; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Sobrino-Plata J, 2014, PLANT SOIL, V377, P369, DOI 10.1007/s11104-013-2006-4; Steiner S, 2011, PLANT PHYSIOL, V157, P1043, DOI 10.1104/pp.111.184515; Su D, 2014, FREE RADICAL BIO MED, V67, P460, DOI 10.1016/j.freeradbiomed.2013.12.004; Suzuki N, 2012, FREE RADICAL BIO MED, V53, P2269, DOI 10.1016/j.freeradbiomed.2012.10.538; Tang L, 2006, PLANT CELL REP, V25, P1380, DOI 10.1007/s00299-006-0199-1; Tripathy BC, 2012, PLANT SIGNAL BEHAV, V7, P1621, DOI 10.4161/psb.22455; Urbany C, 2012, J PROTEOME RES, V11, P703, DOI 10.1021/pr2006186; Vasquez-Robinet C, 2008, J EXP BOT, V59, P2109, DOI 10.1093/jxb/ern073; Veljovic-Jovanovic SD, 2001, PLANT PHYSIOL, V127, P426, DOI 10.1104/pp.010141; Voss I, 2013, PLANT BIOLOGY, V15, P713, DOI 10.1111/j.1438-8677.2012.00710.x; Xia XJ, 2015, J EXP BOT, V66, P2839, DOI 10.1093/jxb/erv089; Xie YJ, 2011, PLANT J, V66, P280, DOI 10.1111/j.1365-313X.2011.04488.x; Xue LJ, 2013, PLANT CELL, V25, P2714, DOI 10.1105/tpc.113.112839; Yang YN, 2004, PLANT J, V40, P909, DOI 10.1111/j.1365-313X.2004.02267.x; Yuan S, 2008, Z NATURFORSCH C, V63, P313; Zaffagnini M, 2012, PLANT SCI, V185, P86, DOI 10.1016/j.plantsci.2012.01.005; Zagorchev L, 2013, INT J MOL SCI, V14, P7405, DOI 10.3390/ijms14047405; Zechmann B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00566; Zhu JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102407; Zhu JG, 2014, MOL PLANT, V7, P751, DOI 10.1093/mp/sst171; Zingaretti SM, RESPONSES ORGANISMS	173	49	50	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132683	10.1371/journal.pone.0132683	http://dx.doi.org/10.1371/journal.pone.0132683			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172952	Green Submitted, gold, Green Published			2022-12-27	WOS:000358194900076
J	Welsh, JQ; Bellwood, DR				Welsh, Justin Q.; Bellwood, David R.			Simulated Macro-Algal Outbreak Triggers a Large-Scale Response on Coral Reefs	PLOS ONE			English	Article							HOME-RANGE SIZE; HABITAT UTILIZATION; HERBIVOROUS FISHES; SEED DISPERSAL; MOBILE LINKS; SUCCESSION; PATTERNS; EXPLOITATION; RESILIENCE; DIVERSITY	Ecosystem degradation has become common throughout the world. On coral reefs, macroalgal outbreaks are one of the most widely documented signs of degradation. This study simulated local-scale degradation on a healthy coral reef to determine how resident taxa, with the potential to reverse algal outbreaks, respond. We utilized a combination of acoustic and video monitoring to quantify changes in the movements and densities, respectively, of coral reef herbivores following a simulated algal outbreak. We found an unprecedented accumulation of functionally important herbivorous taxa in response to algal increases. Herbivore densities increased by 267% where algae were present. The increase in herbivore densities was driven primarily by an accumulation of the browsing taxa Naso unicornis and Kyphosus vaigiensis, two species which are known to be important in removing macroalgae and which may be capable of reversing algal outbreaks. However, resident individuals at the site of algal increase exhibited no change in their movements. Instead, analysis of the size classes of the responding individuals indicates that large functionally-important nonresident individuals changed their movement patterns to move in and feed on the algae. This suggests that local-scale reef processes may not be sufficient to mitigate the effects of local degradation and highlights the importance of mobile links and cross-scale interactions.	[Welsh, Justin Q.] MSci Pty Ltd, Perth, WA, Australia; [Welsh, Justin Q.; Bellwood, David R.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Welsh, Justin Q.; Bellwood, David R.] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Welsh, JQ (corresponding author), MSci Pty Ltd, Perth, WA, Australia.	Justin.Welsh@my.jcu.edu.au			Australian Museum, Lizard Island Doctoral Fellowship; Australian Research Council-Centres of Excellence ARC Centre of Excellence	Australian Museum, Lizard Island Doctoral Fellowship; Australian Research Council-Centres of Excellence ARC Centre of Excellence(Australian Research Council)	JQW received funding from the Australian Museum, Lizard Island Doctoral Fellowship. (URL: http://australianmuseum.net.au/doctoral-fellowships) DRB received funding from Australian Research Council-Centres of Excellence ARC Centre of Excellence for Integrated Coral Reef Studies. (URL: http://www.coralcoe.org.au) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso P, 2009, MAR ECOL PROG SER, V381, P273, DOI 10.3354/meps07946; Bejarano S, 2013, MAR ECOL PROG SER, V482, P197, DOI 10.3354/meps10270; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2011, P ROYAL SOC B; Brandl SJ, 2013, J FISH BIOL, V82, P2031, DOI 10.1111/jfb.12131; BRUGGEMANN JH, 1994, MAR ECOL PROG SER, V112, P51, DOI 10.3354/meps112051; Burgess SC, 2006, CORAL REEFS, V25, P390, DOI 10.1007/s00338-006-0108-7; Burkepile DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008963; Ceccarelli DM, 2011, J EXP MAR BIOL ECOL, V399, P60, DOI 10.1016/j.jembe.2011.01.019; Cheal A, 2012, MAR BIOL, V159, P1143, DOI 10.1007/s00227-012-1893-x; Chong-Seng KM, 2014, CORAL REEFS, V33, P409, DOI 10.1007/s00338-014-1134-5; Chong-Seng KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042167; Couvreur M, 2004, APPL VEG SCI, V7, P229, DOI 10.1111/j.1654-109X.2004.tb00614.x; COX PA, 1991, CONSERV BIOL, V5, P448, DOI 10.1111/j.1523-1739.1991.tb00351.x; Cvitanovic C, 2009, CORAL REEFS, V28, P127, DOI 10.1007/s00338-008-0433-0; Duncan RS, 1999, ECOL APPL, V9, P998, DOI 10.1890/1051-0761(1999)009[0998:SDAPFS]2.0.CO;2; Eristhee N, 2001, J FISH BIOL, V59, P129, DOI 10.1006/jfbi.2001.1754; Fox RJ, 2011, FUNCT ECOL, V25, P1096, DOI 10.1111/j.1365-2435.2011.01874.x; Friedlander AM, 2007, MAR ECOL PROG SER, V351, P221, DOI 10.3354/meps07112; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Green A.L., 2009, MONITORING FUNCTIONA; HAY ME, 1981, AM NAT, V118, P520, DOI 10.1086/283845; Henry M, 2007, J ANIM ECOL, V76, P801, DOI 10.1111/j.1365-2656.2007.01258.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoey AS, 2010, MAR ECOL PROG SER, V411, P299, DOI 10.3354/meps08660; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Ishii HT, 2004, FOREST SCI, V50, P342; Khalil MT, 2013, ENVIRON BIOL FISH, V96, P1065, DOI 10.1007/s10641-012-0103-5; Lefevre CD, 2010, MAR BIOL, V157, P955, DOI 10.1007/s00227-009-1376-x; LEWIS SM, 1985, J EXP MAR BIOL ECOL, V87, P215, DOI 10.1016/0022-0981(85)90206-0; Long SP, 2013, GLOBAL CHANGE BIOL, V19, P1, DOI 10.1111/gcb.12101; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; Marshell A, 2011, CORAL REEFS, V30, P631, DOI 10.1007/s00338-011-0770-2; McClanaban TR, 1999, CORAL REEFS, V18, P195, DOI 10.1007/s003380050181; McKinney JA, 2012, MAR ECOL PROG SER, V458, P199, DOI 10.3354/meps09777; Meyer CG, 2005, ENVIRON BIOL FISH, V73, P201, DOI 10.1007/s10641-005-0559-7; Muscarella R, 2007, BIOL REV, V82, P573, DOI 10.1111/j.1469-185X.2007.00026.x; Nash KL, 2013, ECOL APPL, V23, P1632, DOI 10.1890/12-2031.1; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Olds AD, 2012, J APPL ECOL, V49, P1195, DOI 10.1111/jpe.12002; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Polovina JJ, 1996, FISH OCEANOGR, V5, P114, DOI 10.1111/j.1365-2419.1996.tb00110.x; Pomilla C, 2005, BIOL LETTERS, V1, P476, DOI 10.1098/rsbl.2005.0351; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; Verges A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017115; Welsh JQ, 2014, CORAL REEFS, V33, P303, DOI 10.1007/s00338-014-1124-7; Welsh JQ, 2012, CORAL REEFS, V31, P693, DOI 10.1007/s00338-012-0892-1; Welsh JQ, 2012, CORAL REEFS, V31, P55, DOI 10.1007/s00338-011-0813-8; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; Wunderle JM, 1997, FOREST ECOL MANAG, V99, P223, DOI 10.1016/S0378-1127(97)00208-9	54	9	9	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132895	10.1371/journal.pone.0132895	http://dx.doi.org/10.1371/journal.pone.0132895			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171788	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000358194900098
J	Zhang, H; Wang, WQ; Liu, SJ; Moller, IM; Song, SQ				Zhang, Hong; Wang, Wei-Qing; Liu, Shu-Jun; Moller, Ian Max; Song, Song-Quan			Proteome Analysis of Poplar Seed Vigor	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; RIPARIAN COTTONWOODS; EXPRESSION ANALYSIS; INSTREAM FLOWS; ACTIVE OXYGEN; GENE FAMILY; ARABIDOPSIS; GERMINATION; DETERIORATION; GLUTATHIONE	Seed vigor is a complex property that determines the seed's potential for rapid uniform emergence and subsequent growth. However, the mechanism for change in seed vigor is poorly understood. The seeds of poplar (Populus x Canadensis Moench), which are short-lived, were stored at 30 degrees C and 75 +/- 5% relative humidity for different periods of time (0-90 days) to obtain different vigor seeds (from 95 to 0% germination). With decreasing seed vigor, the temperature range of seed germination became narrower; the respiration rate of the seeds decreased markedly, while the relative electrolyte leakage increased markedly, both levelling off after 45 days. A total of 81 protein spots showed a significant change in abundance (>= 1.5-fold, P < 0.05) when comparing the proteomes among seeds with different vigor. Of the identified 65 proteins, most belonged to the groups involved in metabolism (23%), protein synthesis and destination (22%), energy (18%), cell defense and rescue (17%), and storage protein (15%). These proteins accounted for 95% of all the identified proteins. During seed aging, 53 and 6 identified proteins consistently increased and decreased in abundance, respectively, and they were associated with metabolism (22%), protein synthesis and destination (22%), energy (19%), cell defense and rescue (19%), storage proteins (15%), and cell growth and structure (3%). These data show that the decrease in seed vigor (aging) is an energy-dependent process, which requires protein synthesis and degradation as well as cellular defense and rescue.	[Zhang, Hong; Wang, Wei-Qing; Liu, Shu-Jun; Song, Song-Quan] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China; [Moller, Ian Max] Aarhus Univ, Dept Mol Biol & Genet, Slagelse, Denmark	Chinese Academy of Sciences; Institute of Botany, CAS; Aarhus University	Song, SQ (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China.	sqsong@ibcas.ac.cn			National Science Foundation of China [31300529, 31171624]; National Science and Technology Support Program [2012BAC01B05]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program	Funds for this study were provided by the National Science Foundation of China (31300529, 31171624) and the National Science and Technology Support Program (2012BAC01B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, INT RUL SEED TEST; Aylott MJ, 2008, NEW PHYTOL, V178, P358, DOI 10.1111/j.1469-8137.2008.02396.x; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Bailly C, 2001, J EXP BOT, V52, P701, DOI 10.1093/jexbot/52.357.701; Bailly C, 1996, PHYSIOL PLANTARUM, V97, P104, DOI 10.1111/j.1399-3054.1996.tb00485.x; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; Bewley J. D., 2013, SEEDS, DOI [10.1017/S0960258513000287, DOI 10.1007/978-1-4614-4693-4_1]; Bleicheret F, 2010, CRIT REV BIOCHEM MOL, V45, P331, DOI 10.3109/10409238.2010.496772; Borset O., 1960, Scottish Forestry, V14, P68; Bove J, 2005, PLANT MOL BIOL, V57, P593, DOI 10.1007/s11103-005-0953-8; Braatne JH, 2007, RIVER RES APPL, V23, P247, DOI 10.1002/rra.978; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campanini B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/353270; Catusse J, 2011, PROTEOMICS, V11, P1569, DOI 10.1002/pmic.201000586; Cheng HY, 2008, J INTEGR PLANT BIOL, V50, P1549, DOI 10.1111/j.1744-7909.2008.00723.x; Cheng LB, 2010, MOL BREEDING, V26, P1, DOI 10.1007/s11032-009-9371-y; Chepyshko H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-309; Chu P, 2012, PLANTA, V235, P1271, DOI 10.1007/s00425-011-1573-y; DELOUCHE J C, 1973, Seed Science and Technology, V1, P427; Dixon DP, 2011, BIOCHEM J, V438, P63, DOI 10.1042/BJ20101884; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; Gallardo K, 2001, PLANT PHYSIOL, V126, P835, DOI 10.1104/pp.126.2.835; Ginting EL, 2014, PREP BIOCHEM BIOTECH, V44, P480, DOI 10.1080/10826068.2013.833114; Gonzalez E, 2010, TREES-STRUCT FUNCT, V24, P151, DOI 10.1007/s00468-009-0388-y; Hayano T, 2003, J BIOL CHEM, V278, P34309, DOI 10.1074/jbc.M304304200; He XMM, 2002, ANNU REV BIOCHEM, V71, P701, DOI 10.1146/annurev.biochem.71.110601.135339; Hendry George A. F., 1993, Seed Science Research, V3, P141, DOI 10.1017/S0960258500001720; HEYDECKER W, 1973, NATURE, V246, P42, DOI 10.1038/246042a0; Huang H, 2009, J INTEGR PLANT BIOL, V51, P67, DOI 10.1111/j.1744-7909.2008.00772.x; Huang H, 2012, J PROTEOMICS, V75, P1247, DOI 10.1016/j.jprot.2011.10.036; Hyndman D, 2003, CHEM-BIOL INTERACT, V143, P621, DOI 10.1016/S0009-2797(02)00193-X; Jin Y, 2007, ANNU REV PHARMACOL, V47, P263, DOI 10.1146/annurev.pharmtox.47.120505.105337; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; Kalemba EM, 2008, ENVIRON EXP BOT, V63, P274, DOI 10.1016/j.envexpbot.2007.12.011; Karrenberg S, 2003, AM J BOT, V90, P749, DOI 10.3732/ajb.90.5.749; Kawai K, 2010, PLANT BIOTECHNOL-NAR, V27, P75, DOI 10.5511/plantbiotechnology.27.75; Kermode Allison R., 2002, P149, DOI 10.1079/9780851995342.0149; Kermode AR., 1997, SEED SCI RES; Kim HM, 2011, BBA-GENE REGUL MECH, V1809, P67, DOI 10.1016/j.bbagrm.2010.08.008; Kupper M, 2014, FEMS MICROBIOL LETT, V353, P1, DOI 10.1111/1574-6968.12390; Mazorra-Manzano MA, 2010, PHYTOCHEMISTRY, V71, P515, DOI 10.1016/j.phytochem.2009.12.005; McDonald MB, 1999, SEED SCI TECHNOL, V27, P177; McDonald MB, 2000, SEED TECHNOLOGY ITS, P287; Miernyk JA, 2011, J PROTEOMICS, V74, P389, DOI 10.1016/j.jprot.2010.12.004; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; Moss EH, 1937, BOT GAZ, V99, P529; Nambara E, 2010, SEED SCI RES, V20, P55, DOI 10.1017/S0960258510000012; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Nonogaki H, 2010, PLANT SCI, V179, P574, DOI 10.1016/j.plantsci.2010.02.010; Ohta D, 2000, PLANT PHYSIOL, V122, P907, DOI 10.1104/pp.122.3.907; Pedreno S, 2012, BIOCHEMISTRY-US, V51, P8027, DOI 10.1021/bi300808b; Priestley D.A., 1986, SEED AGING IMPLICATI; Prieto-Dapena P, 2006, PLANT PHYSIOL, V142, P1102, DOI 10.1104/pp.106.087817; Rabbani N, 2014, BIOCHEM SOC T, V42, P419, DOI 10.1042/BST20140008; Rajjou L, 2007, SEEDS: BIOLOGY, DEVELOPMENT AND ECOLOGY, P324, DOI 10.1079/9781845931971.0324; Rajjou L, 2008, PLANT PHYSIOL, V148, P620, DOI 10.1104/pp.108.123141; Rajjou L, 2006, PLANT PHYSIOL, V141, P910, DOI 10.1104/pp.106.082057; Rajjou L, 2012, ANNU REV PLANT BIOL, V63, P507, DOI 10.1146/annurev-arplant-042811-105550; ROOD SB, 1995, CAN J BOT, V73, P1250, DOI 10.1139/b95-136; Sanhewe AJ, 1996, J EXP BOT, V47, P949, DOI 10.1093/jxb/47.7.949; Schiltz S, 2004, PLANT PHYSIOL, V135, P2241, DOI 10.1104/pp.104.041947; Schimoler-O'Rourke R, 2001, APPL ENVIRON MICROB, V67, P2365, DOI 10.1128/AEM.67.5.2365-2366.2001; Seabra AR, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-137; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Taiz L., 2014, PLANT PHYSL DEV, V6th; Tekrony DM, 1997, CURR PLANT SCI BIOT, V30, P593; Tiwari S, 2008, PLANT CELL, V20, P2387, DOI 10.1105/tpc.108.061929; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Walters C., 2006, ENCY SEEDS SCI TECHN, P137; Wang LQ, 2012, J PROTEOMICS, V75, P2109, DOI 10.1016/j.jprot.2012.01.007; Wang WQ, 2015, PLANT PHYSIOL BIOCH, V86, P1, DOI 10.1016/j.plaphy.2014.11.003; Wang WQ, 2014, J PROTEOME RES, V13, P606, DOI 10.1021/pr4007574; Wang WQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062868; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Wu HM, 2012, BIOLOGIA, V67, P48, DOI 10.2478/s11756-011-0164-5; Xin X, 2011, PHYSIOL PLANTARUM, V143, P126, DOI 10.1111/j.1399-3054.2011.01497.x; Yacoubi R, 2011, J PROTEOME RES, V10, P3891, DOI 10.1021/pr101274f; Zhao Y, 1996, PLANT PHYSIOL, V111, P1299, DOI 10.1104/pp.111.4.1299	80	28	31	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132509	10.1371/journal.pone.0132509	http://dx.doi.org/10.1371/journal.pone.0132509			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172265	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900055
J	Ma, XY; Zhang, Y; Zhu, D; Lu, Y; Zhou, GD; Liu, W; Cao, YL; Zhang, WJ				Ma, Xiao Yun; Zhang, Yun; Zhu, Dan; Lu, Yang; Zhou, Guangdong; Liu, Wei; Cao, Yilin; Zhang, Wen Jie			Corneal Stroma Regeneration with Acellular Corneal Stroma Sheets and Keratocytes in a Rabbit Model	PLOS ONE			English	Article							PENETRATING KERATOPLASTY; SCAFFOLDS; TRANSPLANTATION; RECONSTRUCTION; CONSTRUCTION; CELLS	Acellular corneal stroma matrix has been used for corneal stroma engineering. However, because of its compact tissue structure, regrowth of keratocytes into the scaffold is difficult. Previously, we developed a sandwich model for cartilage engineering using acellular cartilage sheets. In the present study, we tested this model for corneal stroma regeneration using acellular porcine corneal stroma (APCS) sheets and keratocytes. Porcine corneas were decellularized by NaCl treatment, and the APCS was cut into 20-mu m-thick sheets. A rabbit corneal stroma defect model was created by lamellar keratoplasty and repaired by transplantation of five pieces of APCS sheets with keratocytes. Six months after transplantation, transparent corneas were present in the experimental group, which were confirmed by anterior segment optical coherence tomography examination and transmittance examination. The biomechanical properties in the experimental group were similar to those of normal cornea. Histological analyses showed an even distribution of keratocytes and well-oriented matrix in the stroma layer in the experimental group. Together, these results demonstrated that the sandwich model using acellular corneal stroma sheets and keratocytes could be potentially useful for corneal stroma regeneration.	[Ma, Xiao Yun; Lu, Yang; Zhou, Guangdong; Liu, Wei; Cao, Yilin; Zhang, Wen Jie] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med,Natl Tissue Engn Ctr China, Dept Plast & Reconstruct Surg,Shanghai Key Lab Ti, Shanghai 200030, Peoples R China; [Ma, Xiao Yun; Zhang, Yun; Zhu, Dan] Shanghai Guanghua Integrat Med Hosp, Dept Ophthalmol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Cao, YL (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med,Natl Tissue Engn Ctr China, Dept Plast & Reconstruct Surg,Shanghai Key Lab Ti, Shanghai 200030, Peoples R China.	yilincao@yahoo.com; wenjieboshi@aliyun.cn		Ljubimov, Alexander/0000-0003-2398-5319	Major State Basic Research Development Program of China [2011CB964704]; National Basic Research Program of China [30800231, 31170944]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the Major State Basic Research Development Program of China (2011CB964704), and the National Basic Research Program of China (30800231, 31170944).	Ahearne M, 2008, TOP TISSUE ENG, V4, P1; Builles N, 2010, BIOMATERIALS, V31, P8313, DOI 10.1016/j.biomaterials.2010.07.066; Deshpande P, 2010, REGEN MED, V5, P395, DOI [10.2217/rme.10.16, 10.2217/RME.10.16]; Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316; Espandar L, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/894319; Fagerholm P, 2014, BIOMATERIALS, V35, P2420, DOI 10.1016/j.biomaterials.2013.11.079; Fu Y, 2010, CELLS TISSUES ORGANS, V191, P193, DOI 10.1159/000235680; Germain L, 2000, PROG RETIN EYE RES, V19, P497, DOI 10.1016/S1350-9462(00)00005-7; Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078; Gonzalez-Andrades M, 2011, INVEST OPHTH VIS SCI, V52, P215, DOI 10.1167/iovs.09-4773; Guan L, 2013, CELLS TISSUES ORGANS, V198, P190, DOI 10.1159/000355944; Hashimoto Y, 2010, BIOMATERIALS, V31, P3941, DOI 10.1016/j.biomaterials.2010.01.122; Javadi MA, 2010, CORNEA, V29, P365, DOI 10.1097/ICO.0b013e3181b81b71; Kadakia Arpita, 2008, Critical Reviews in Biomedical Engineering, V36, P441, DOI 10.1615/CritRevBiomedEng.v36.i5-6.50; KIM EY, 2014, INFLAMM REGEN, V34, P4; Liu W, 2003, TISSUE ENG, V9, pS17; Lynch AP, 2013, EXP EYE RES, V108, P42, DOI 10.1016/j.exer.2012.12.012; Meek KM, 2003, EYE, V17, P927, DOI 10.1038/sj.eye.6700574; Melles GRJ, 1999, BRIT J OPHTHALMOL, V83, P327, DOI 10.1136/bjo.83.3.327; Menon NG, 2003, ANN PLAS SURG, V50, P523, DOI 10.1097/01.SAP.0000044252.76804.6B; Myung D, 2008, BIOTECHNOL PROGR, V24, P735, DOI 10.1021/bp070476n; Oliva MS, 2012, INDIAN J OPHTHALMOL, V60, P423, DOI 10.4103/0301-4738.100540; Marquez SP, 2009, ACTA BIOMATER, V5, P1839, DOI 10.1016/j.actbio.2009.02.011; Schwab IR, 2000, CORNEA, V19, P421, DOI 10.1097/00003226-200007000-00003; Shah A, 2008, PEDIATR RES, V63, P535, DOI 10.1203/PDR.0b013e31816bdf54; SONODA Y, 1992, TRANSPLANTATION, V54, P694, DOI 10.1097/00007890-199210000-00026; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Uzunalli G, 2014, ACTA BIOMATER, V10, P1156, DOI 10.1016/j.actbio.2013.12.002; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Williams KA, 2010, CLIN EXP OPHTHALMOL, V38, P93, DOI 10.1111/j.1442-9071.2009.02179.x; Wilson SL, 2013, J FUNCT BIOMATER, V4, P114, DOI 10.3390/jfb4030114; Wu Z, 2009, BIOMATERIALS, V30, P3513, DOI 10.1016/j.biomaterials.2009.03.003; Xiao JH, 2011, BIOMATERIALS, V32, P6962, DOI 10.1016/j.biomaterials.2011.05.084; Xie LX, 2007, CORNEA, V26, P1070, DOI 10.1097/ICO.0b013e318093de07; Yang ZQ, 2010, TISSUE ENG PART C-ME, V16, P865, DOI [10.1089/ten.tec.2009.0444, 10.1089/ten.TEC.2009.0444]; Zhang YQ, 2008, TISSUE ENG PT A, V14, P295, DOI 10.1089/tea.2007.0200	36	16	16	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132705	10.1371/journal.pone.0132705	http://dx.doi.org/10.1371/journal.pone.0132705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167895	Green Submitted, Green Published, gold			2022-12-27	WOS:000358193100068
J	Ota, RR; Message, HJ; da Graca, WJ; Pavanelli, CS				Ota, Renata Rubia; Message, Hugo Jose; da Graca, Weferson Junio; Pavanelli, Carla Simone			Neotropical Siluriformes as a Model for Insights on Determining Biodiversity of Animal Groups	PLOS ONE			English	Article							ECOLOGY; FISHES	We performed an analysis of the descriptions of new species of Neotropical Siluriformes (catfishes) to estimate the number of new species that remain to be described for a complete knowledge on biodiversity of this order, to verify the effectiveness of taxonomic support, and to identify trends and present relevant information for future policies. We conducted a literature review of species descriptions between January 1990 and August 2014. The following metadata were recorded from each article: year of publication, number of species, journal and impact factor, family(s) of the described species, number of authors, age of the authors and coauthors, country of the first author's institution and ecoregion of the type-locality. From accumulation of descriptions, we built an estimate model for number of species remaining to be described. We found 595 described species in 402 articles. The data demonstrated that there has been an increased understanding of the diversity of Siluriformes over the last 25 years in the Neotropical region, although 35% of the species still remain to be described. The model estimated that with the current trends and incentives, the biodiversity will be known in almost seven decades. We have reinforced the idea that greater joint efforts should be made by society and the scientific community to obtain this knowledge in a shorter period of time through enhanced programs for promoting science, training and the advancement of professionals before undiscovered species become extinct. The model built in this study can be used for similar estimates of other groups of animals.	[Ota, Renata Rubia; Message, Hugo Jose; da Graca, Weferson Junio; Pavanelli, Carla Simone] Univ Estadual Maringa, Res Ctr Limnol Ichthyol & Aquaculture, Nupelia, Maringa, Parana, Brazil; [da Graca, Weferson Junio] Univ Estadual Maringa, Dept Biol, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	Ota, RR (corresponding author), Univ Estadual Maringa, Res Ctr Limnol Ichthyol & Aquaculture, Nupelia, Maringa, Parana, Brazil.	renata_ota@yahoo.com.br	Fapesp, Biota/F-8655-2017; Pavanelli, Carla/G-6399-2012; Graca, Weferson/D-8358-2013	Fapesp, Biota/0000-0002-9887-8449; Pavanelli, Carla/0000-0003-4059-984X; Graca, Weferson/0000-0002-8925-5629	National Counsel of Technological and Scientific Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq); Brazilian Federal Agency for Support and Evaluation of Graduate Education (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES/Proex)	National Counsel of Technological and Scientific Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Federal Agency for Support and Evaluation of Graduate Education (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES/Proex)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank the National Counsel of Technological and Scientific Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq http://www.cnpq.br/) for granting scholarship and providing grant to RRO and CSP, respectively. The authors also thank the Brazilian Federal Agency for Support and Evaluation of Graduate Education (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES/Proex http://www.capes.gov.br/) for providing a scholarship to HJM and the Araucaria Foundation	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Agostinho A.A., 2004, STRUCTURE FUNCTIONIN; Agostinho CS, 2009, RESERVATORIO PEIXE A; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; [Anonymous], 2002, NATURE, V419, P863, DOI 10.1038/419863a; Armbruster JW, 2011, AM FISH S S, V77, P15; BOHLKE J E, 1978, Acta Amazonica, V8, P657; Braga RR, 2012, REV FISH BIOL FISHER, V22, P915, DOI 10.1007/s11160-012-9273-7; Brown J. H., 1998, BIOGEOGRAPHY; Castro RMC, 2004, BIOTA NEOTROP, P4; Costello MJ, 2011, GLOBAL ECOL BIOGEOGR, V20, P319, DOI 10.1111/j.1466-8238.2010.00603.x; De Carvalho MR, 2014, CLADISTICS, V30, P322, DOI 10.1111/cla.12045; de Carvalho MR, 2005, SCIENCE, V307, P353; Dubois Alain, 2010, Taprobanica, V2, P6; Ebach MC, 2011, CLADISTICS, V27, P550, DOI 10.1111/j.1096-0031.2011.00348.x; Eschmeyer W.N., 2014, CATALOG FISHES GENER; Eschmeyer WN, 2014, SPECIES FISHES FAMIL; Ferraris Carl J. Jr., 2007, Zootaxa, V1418, P1; Ferraris Jr. Carl J., 2005, Neotrop. ichthyol., V3, P453, DOI 10.1590/S1679-62252005000400001; Fontaine B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036881; Froese R., 2014, FISHBASE; Ghazzi MS., 2007, CATALOGO ESPECIES PE; Gotelli NJ, 2008, PRIMER ECOLOGY, V4th; Joppa LN, 2011, TRENDS ECOL EVOL, V26, P551, DOI 10.1016/j.tree.2011.07.010; Kullander S.O., 2003, CHECK LIST FRESHWATE, P605; Langeani F., 2007, BIOTA NEOTROP, V7, P1, DOI DOI 10.1590/S1676-06032007000300020; Leveque C, 2008, HYDROBIOLOGIA, V595, P545, DOI 10.1007/s10750-007-9034-0; Linnaeus C, 1758, SYSTEMA NATURAE; Lohrmann V, 2012, TAXONOMISCHE FORSCHU; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Lomolino MV, 2004, FRONTIERS OF BIOGEOGRAPHY: NEW DIRECTIONS IN THE GEOGRAPHY OF NATURE, P1; Lundberg JG, 2000, ANN MO BOT GARD, V87, P26, DOI 10.2307/2666207; Man JP, 2004, EUR J EPIDEMIOL, V19, P811; Marques Antonio Carlos, 2006, Pap. Avulsos Zool. (São Paulo), V46, P139, DOI 10.1590/S0031-10492006001300001; Menezes NA, 2007, PEIXES AGUA DOCE MAT; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pavanelli CS., 2007, PEIXES PLANICIE INUN; R Core Team, 2021, R LANGUAGE ENV STAT; Sabaj Perez MH, 2003, ALL CATFISH SPECIES; Santos G. M., 2004, PEIXES BAIXO RIO TOC; Thomaz SM, 2004, BIO INL WAT, P75; Vari Richard P., 1998, P1; Wheeler QD, 2004, SCIENCE, V303, P285, DOI 10.1126/science.303.5656.285	43	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132913	10.1371/journal.pone.0132913	http://dx.doi.org/10.1371/journal.pone.0132913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168270	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100097
J	Gouin, M; Flamant, C; Gascoin, G; Rouger, V; Florin, A; Guimard, P; Roze, JC; Hanf, M				Gouin, Marion; Flamant, Cyril; Gascoin, Geraldine; Rouger, Valerie; Florin, Agnes; Guimard, Philippe; Roze, Jean-Christophe; Hanf, Matthieu			The Association of Urbanicity with Cognitive Development at Five Years of Age in Preterm Children	PLOS ONE			English	Article							BIRTH-WEIGHT; FOLLOW-UP; ENVIRONMENT; BORN; DISABILITIES; OUTCOMES; NEURODEVELOPMENT; DEPRIVATION; EXPOSURE; EPIPAGE	Objective To determine the association of urbanicity, defined as living in an urban area, with cognitive development at five years of age in preterm children who were free of any disabilities or neurodevelopmental delays. Design Prospective population-based cohort. Setting French regional Loire Infant Follow-up Team (LIFT) network. Participants Included in the study were 1738 surviving infants born between March 2003 and December 2008 before 35 weeks of gestational age. At two years of age, the children were free of any disabilities and neurodevelopmental delays and were living in the Pays de la Loire region from their birth to five years of age. Main Outcome Measures The cognitive development at five years of age was evaluated with the Global School Adaptation score (GSA). The urbanicity of the residence for each child was classified into three groups: urban, quasi-rural, and rural area. Results Quantile regression approaches were used to identify a significant association between urbanicity and the GSA score at five years of age (adjusting for child and family characteristics). We found that the negative impact of urbanicity on the GSA score was more important for the lower quantile of the GSA scores. Conclusions Urbanicity was significantly associated with cognitive neurodevelopment at five years of age in preterm children born before 35 weeks of gestation. Complementary results additionally suggest that this relation could be mediated at the residence level by a high socioeconomic deprivation level. If these results are confirmed, more personalized follow- ups could be developed for preterm children. Further studies are needed to finely identify the contextual characteristics of urbanicity that underlie this association.	[Gouin, Marion; Flamant, Cyril; Roze, Jean-Christophe] Nantes Univ Hosp, Dept Neonatal Med, Nantes, France; [Flamant, Cyril; Roze, Jean-Christophe; Hanf, Matthieu] Nantes Univ Hosp, Natl Inst Hlth & Med Res CIC 1413, Nantes, France; [Gascoin, Geraldine] Angers Univ Hosp, Dept Neonatal Med, Angers, France; [Rouger, Valerie] Nantes Univ Hosp, Reseau Grandir Ensemble, Nantes, France; [Florin, Agnes; Guimard, Philippe] Univ Nantes, Fac Psychol, Res Ctr Educ, CREN EA 2661, Nantes, France	Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Nantes Universite; CHU de Nantes; Nantes Universite	Hanf, M (corresponding author), Nantes Univ Hosp, Natl Inst Hlth & Med Res CIC 1413, Nantes, France.	matthieu@hanf.fr	Rozé, Jean-Christophe/AAS-1314-2021; Gascoin, Geraldine/ABE-4950-2020	Hanf, Matthieu/0000-0001-7133-1323; Roze, Jean-Christophe/0000-0003-3367-512X	Regional Health Agency of Pays de la Loire	Regional Health Agency of Pays de la Loire	The LIFT (Loire Infant Follow-Up Team) cohort is supported by grants from the Regional Health Agency of Pays de la Loire. The sponsor had no role in this manuscript (http://www.ars.paysdelaloire.sante.fr/Internet.paysdelaloire.O.html).	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; [Anonymous], [No title captured]; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Bottino CJ, 2012, HEALTH PLACE, V18, P1000, DOI 10.1016/j.healthplace.2012.06.007; BOUCHER J, 1969, J VERB LEARN VERB BE, V8, P1, DOI 10.1016/S0022-5371(69)80002-2; Boussicault G, 2012, ARCH PEDIATRIE, V19, P381, DOI [10.1016/j.arcped.2012.01.023, 10.1016/.arcped.2012.01.023]; Boussicault G, 2013, J PEDIATR-US, V163, P460, DOI 10.1016/j.jpeds.2013.01.052; Charkaluk ML, 2011, EARLY HUM DEV, V87, P297, DOI 10.1016/j.earlhumdev.2011.01.033; Charkaluk ML, 2010, ACTA PAEDIATR, V99, P684, DOI 10.1111/j.1651-2227.2010.01695.x; Cummins SK, 2001, PEDIATR CLIN N AM, V48, P1241, DOI 10.1016/S0031-3955(05)70372-2; Dahly DL, 2007, SOC SCI MED, V64, P1407, DOI 10.1016/j.socscimed.2006.11.019; de Kieviet JF, 2012, J PEDIATR-US, V161, P824, DOI 10.1016/j.jpeds.2012.05.010; Evans GW, 2006, ANNU REV PSYCHOL, V57, P423, DOI 10.1146/annurev.psych.57.102904.190057; Ferguson KT, 2013, INT J PSYCHOL, V48, P437, DOI 10.1080/00207594.2013.804190; Flamant C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020004; Florin A, 1998, MAITRISE LANGUE ORAL; Geraci M, 2014, STAT COMPUT, V24, P461, DOI 10.1007/s11222-013-9381-9; GUIMARD P, 2001, PSYCHOL PSYCHOM, V22, P75; Guimard P, 2002, EUR REV APPL PSYCHOL, V52, P63; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Hattie JAC, 2009, VISIBLE LEARNING: A SYNTHESIS OF OVER 800 META-ANALYSES RELATING TO ACHIEVEMENT, P1; Havard S, 2008, SOC SCI MED, V67, P2007, DOI 10.1016/j.socscimed.2008.09.031; Jefferis BJMH, 2002, BRIT MED J, V325, P305, DOI 10.1136/bmj.325.7359.305; Johnson S, 2006, EARLY HUM DEV, V82, P173, DOI 10.1016/j.earlhumdev.2006.01.008; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Luo W, 2009, HEALTH PLACE, V15, P1100, DOI 10.1016/j.healthplace.2009.06.002; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; National Institute of Statistics and Economic Studies, 2014, URBAN UNIT; Orsini N, 2011, STATA J, V11, P327, DOI 10.1177/1536867X1101100301; Perera FP, 2006, ENVIRON HEALTH PERSP, V114, P1287, DOI 10.1289/ehp.9084; Perera FP, 2009, PEDIATRICS, V124, pE195, DOI 10.1542/peds.2008-3506; Potharst ES, 2012, DEV MED CHILD NEUROL, V54, P240, DOI 10.1111/j.1469-8749.2011.04181.x; Potharst ES, 2011, J PEDIATR-US, V159, P79, DOI 10.1016/j.jpeds.2010.12.055; Rey G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-33; Roberts G, 2010, ARCH DIS CHILD, V95, P786, DOI 10.1136/adc.2009.160283; Salt A, 2006, EARLY HUM DEV, V82, P185, DOI 10.1016/j.earlhumdev.2005.12.015; Suglia SF, 2013, J DEV BEHAV PEDIATR, V34, P549, DOI 10.1097/DBP.0b013e3182a509c0; Vlahov D, 2002, J URBAN HEALTH, V79, pS1, DOI 10.1093/jurban/79.suppl_1.S1; Watson K, 2013, J INT COMP EDUC, V2, P72, DOI 10.14425/00.50.26; Zeka A, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-60	41	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131749	10.1371/journal.pone.0131749	http://dx.doi.org/10.1371/journal.pone.0131749			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161862	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300055
J	Martin, CC; Keyes, CLM				Martin, Chris C.; Keyes, Corey L. M.			Investigating the Goldilocks Hypothesis: The Non-Linear Impact of Positive Trait Change on Well-Being	PLOS ONE			English	Article							PERSONALITY-TRAITS; 5-FACTOR MODEL; REINFORCEMENT SENSITIVITY; STATE EXTROVERSION; LIFE SATISFACTION; SUBJECTIVE CHANGE; MENTAL-HEALTH; MEAN-LEVEL; NEUROTICISM; SELF	This paper attempts to reconcile two perspectives on the impact of positive trait change. The first perspective views positive trait change as salubrious because it reflects the process of self-enhancement, whereas the second perspective views positive change as costly because it disrupts the self-verification process. We propose that benefits and costs accrue at discrete rates, such that moderate positive trait change is more beneficial than too little and too much positive change. This constitutes a Goldilocks hypothesis. Using the MIDUS longitudinal dataset (N = 1,725) we test this hypothesis on four traits, namely, social extraversion, agentic extraversion (agency), conscientiousness, and neuroticism. The Goldilocks hypothesis was supported for social extraversion, agentic extraversion (agency), and conscientiousness. Reduction in neuroticism seemed uniformly predictive of higher well-being. Thus, not all amounts of positive trait change are beneficial. While we find no evidence for a limit to the benefits of reduced neuroticism, there is a "just right" amount of positive change in extraversion and conscientiousness that results in the highest level of well-being. Our findings suggest that non-monotonic models may be more valid in investigations of personality change and well-being.	[Martin, Chris C.; Keyes, Corey L. M.] Emory Univ, Atlanta, GA 30322 USA	Emory University	Martin, CC (corresponding author), Emory Univ, Atlanta, GA 30322 USA.	chris.martin.e@gmail.com		Martin, Chris/0000-0002-7806-5838	NIA NIH HHS [P01 AG020166, U19 AG051426] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [U19AG051426, P01AG020166] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALBERT S, 1977, PSYCHOL REV, V84, P485, DOI 10.1037/0033-295X.84.6.485; Ames DR, 2007, J PERS SOC PSYCHOL, V92, P307, DOI 10.1037/0022-3514.92.2.307; [Anonymous], 1997, HDB PERSONALITY PSYC, DOI DOI 10.1016/B978-012134645-4/50030-5; Antonakis J, 2010, LEADERSHIP QUART, V21, P1086, DOI 10.1016/j.leaqua.2010.10.010; Bem S. L., 1981, J PERS SOC PSYCHOL; Blanchflower DG, 2008, SOC SCI MED, V66, P1733, DOI 10.1016/j.socscimed.2008.01.030; Block JH, 1980, DEVELOPMENT OF COGNI; BRANDTSTADTER J, 1994, DEV REV, V14, P52, DOI 10.1006/drev.1994.1003; BROWN JD, 1989, J PERS SOC PSYCHOL, V57, P1103, DOI 10.1037/0022-3514.57.6.1103; Burke Peter J., 1996, PSYCHOSOCIAL STRESS, P141; BURKE PJ, 1991, AM SOCIOL REV, V56, P836, DOI 10.2307/2096259; Canli T, 2006, P NATL ACAD SCI USA, V103, P16033, DOI 10.1073/pnas.0601674103; Cantril H, 1966, THE PATTERN OF HUMAN; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COOMBS CH, 1977, PSYCHOL REV, V84, P216, DOI 10.1037/0033-295X.84.2.216; Corr PJ, 2004, NEUROSCI BIOBEHAV R, V28, P317, DOI 10.1016/j.neubiorev.2004.01.005; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; Deci EL, 2008, J HAPPINESS STUD, V9, P1, DOI 10.1007/s10902-006-9018-1; DeNeve KM, 1998, PSYCHOL BULL, V124, P197, DOI 10.1037/0033-2909.124.2.197; Edwards J. R., 2002, ADV MEASUREMENT DATA, P350, DOI DOI 10.1037/E576892011-020; Edwards JR, 2009, STATISTICAL AND METHODOLOGICAL MYTHS AND URBAN LEGENDS: DOCTRINE, VERITY AND FABLE IN THE ORGANIZATIONAL AND SOCIAL SCIENCES, P143; Edwards JR, 2001, ORGAN RES METHODS, V4, P265, DOI 10.1177/109442810143005; Edwards JR, EXCEL FILE FOR PLOTT; Edwards JR, 2013, RESPONSE SURFACE ANA; Eizenman DR, 1997, PSYCHOL AGING, V12, P489, DOI 10.1037/0882-7974.12.3.489; Elliot AJ, 2002, J PERS SOC PSYCHOL, V82, P804, DOI 10.1037/0022-3514.82.5.804; Elliot AJ, 2010, J PERS, V78, P865, DOI 10.1111/j.1467-6494.2010.00636.x; Fanous AH, 2007, PSYCHOL MED, V37, P1163, DOI 10.1017/S0033291707000244; Foote NN, 1951, AM SOCIOL REV, V16, P14, DOI 10.2307/2087964; Gallagher MW, 2009, J PERS, V77, P1025, DOI 10.1111/j.1467-6494.2009.00573.x; Goldberg L. R., 1992, PSYCHOL ASSESSMENT, V4, P26, DOI [10.1037/1040-3590.4.1.26, DOI 10.1037/1040-3590.4.1.26]; [宫火良 GONG HuoLiang], 2006, [中国心理卫生杂志, Chinese Mental Health Journal], V20, P465; Goodwin RD, 2006, J HEALTH PSYCHOL, V11, P643, DOI 10.1177/1359105306066610; Grant AM, 2011, PERSPECT PSYCHOL SCI, V6, P61, DOI 10.1177/1745691610393523; Graziano W. G., 2009, HDB INDIVIDUAL DIFFE, P46, DOI DOI 10.1037/0022-3514.50.1.212; Griffith JW, 2010, PSYCHOL MED, V40, P1125, DOI 10.1017/S0033291709991449; Gross JJ, 1998, PERS SOC PSYCHOL B, V24, P279, DOI 10.1177/0146167298243005; Hayes AF, 2007, BEHAV RES METHODS, V39, P709, DOI 10.3758/BF03192961; Heller D, 2004, PSYCHOL BULL, V130, P574, DOI 10.1037/0033-2909.130.4.574; Hoyle RH, 2000, J PERS, V68, P1203, DOI 10.1111/1467-6494.00132; Hoyle rh, 2009, HDB INDIVIDUAL DIFFE, P257, DOI DOI 10.1007/S00018-010-0311-0; Human LJ, 2013, J PERS, V81, P249, DOI 10.1111/jopy.12002; Insel KC, 2006, J AGING HEALTH, V18, P407, DOI 10.1177/0898264306286200; Janoff-Bulman R., 2010, SHATTERED ASSUMPTION; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; John OP, 1990, HANDBOOK OF PERSONAL; JONES SC, 1973, PSYCHOL BULL, V79, P185, DOI 10.1037/h0033957; Judge TA, 1999, PERS PSYCHOL, V52, P621, DOI 10.1111/j.1744-6570.1999.tb00174.x; Judge TA, 2002, J APPL PSYCHOL, V87, P530, DOI 10.1037//0021-9010.87.3.530; Judge TA, 2002, J APPL PSYCHOL, V87, P797, DOI 10.1037//0021-9010.87.4.797; Keyes CLM, 2002, J PERS SOC PSYCHOL, V82, P1007, DOI 10.1037//0022-3514.82.6.1007; Keyes CLM, 2000, MOTIV EMOTION, V24, P67, DOI 10.1023/A:1005659114155; Keyes CLM, 2000, SOC PSYCHOL QUART, V63, P264, DOI 10.2307/2695873; LARSEN RJ, 1991, J PERS SOC PSYCHOL, V61, P132, DOI 10.1037/0022-3514.61.1.132; LARSEN RJ, 1989, PERS INDIV DIFFER, V10, P1221, DOI 10.1016/0191-8869(89)90233-X; Le H, 2011, J APPL PSYCHOL, V96, P113, DOI 10.1037/a0021016; Lecky P, 1945, SELF CONSISTENCY A T; Little T. D., 2013, LONGITUDINAL STRUCTU; Lucas RE, 2004, J PERS SOC PSYCHOL, V86, P473, DOI 10.1037/0022-3514.86.3.473; Lucas RE, 2009, SOC INDIC RES SER, V37, P75, DOI 10.1007/978-90-481-2350-6_4; MacKinnon D P, 1994, NIDA Res Monogr, V139, P127; Malouff JM, 2007, J DRUG EDUC, V37, P277, DOI 10.2190/DE.37.3.d; Malouff JM, 2006, J DRUG EDUC, V36, P47, DOI 10.2190/9EP8-17P8-EKG7-66AD; MARTIN M, 1985, PERS INDIV DIFFER, V6, P353, DOI 10.1016/0191-8869(85)90060-1; McAdams DP, 2010, ANNU REV PSYCHOL, V61, P517, DOI 10.1146/annurev.psych.093008.100507; MCCRAE RR, 1991, PERS SOC PSYCHOL B, V17, P227, DOI 10.1177/014616729101700217; McNiel JM, 2006, J RES PERS, V40, P529, DOI 10.1016/j.jrp.2005.05.003; McNiel JM, 2010, EUR J PERSONALITY, V24, P18, DOI 10.1002/per.738; Molloy GJ, 2014, ANN BEHAV MED, V47, P92, DOI 10.1007/s12160-013-9524-4; Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127; Pavot W., 2013, OXFORD HDB HAPPINESS, P134; Prenda KM, 2001, PSYCHOL AGING, V16, P206, DOI 10.1037//0882-7974.16.2.206; Radler BT, 2010, J AGING HEALTH, V22, P307, DOI 10.1177/0898264309358617; Raskin N.J., 2005, CURRENT PSYCHOTHERAP, P130; Roberts B., 2013, HDB PSYCHOL, V5, P183; Roberts BW, 2008, CURR DIR PSYCHOL SCI, V17, P31, DOI 10.1111/j.1467-8721.2008.00543.x; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Rogers GM, 1998, J PERS SOC PSYCHOL, V74, P1592; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Shanock LR, 2010, J BUS PSYCHOL, V25, P543, DOI 10.1007/s10869-010-9183-4; Smillie LD, 2008, EUR J PERSONALITY, V22, P359, DOI 10.1002/per.674; Smillie LD, 2012, J PERS SOC PSYCHOL, V103, P306, DOI 10.1037/a0028372; Specht J, 2011, J PERS SOC PSYCHOL, V101, P862, DOI 10.1037/a0024950; Steel P, 2008, PSYCHOL BULL, V134, P138, DOI 10.1037/0033-2909.134.1.138; Stone AA, 2010, P NATL ACAD SCI USA, V107, P9985, DOI 10.1073/pnas.1003744107; Suls J., 1982, PSYCHOL PERSPEC SELF, P97; Swann W.B., 1990, SOCIAL SUPPORT INTER, P150; Swann W.B., 1990, HDB MOTIVATION COGNI, P408; SWANN WB, 1987, J PERS SOC PSYCHOL, V52, P881, DOI 10.1037/0022-3514.52.5.881; Tabachnick B.G., 2014, USING MULTIVARIATE S, V6th Ed., P659; ten Have M, 2005, SOC PSYCH PSYCH EPID, V40, P425, DOI 10.1007/s00127-005-0916-z; Terracciano A, 2010, J RES PERS, V44, P31, DOI 10.1016/j.jrp.2009.09.006; Uziel L, 2006, PERS INDIV DIFFER, V41, P745, DOI 10.1016/j.paid.2006.03.011; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; Westerhof GJ, 2006, J GERONTOL B-PSYCHOL, V61, pS240, DOI 10.1093/geronb/61.5.S240; Weston SJ, 2015, SOC PSYCHOL PERS SCI, V6, P309, DOI 10.1177/1948550614553248; Wiggins J.S., 1991, THINKING CLEARLY PSY, P89; Winter DG, 1998, PSYCHOL REV, V105, P230, DOI 10.1037/0033-295X.105.2.230; ZAJONC RB, 1984, AM PSYCHOL, V39, P117, DOI 10.1037/0003-066X.39.2.117; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151; Zhengjue, 2000, CULTIVATING THE EMPT; Zimprich D, 2012, PSYCHOL ASSESSMENT, V24, P173, DOI 10.1037/a0025265	104	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131316	10.1371/journal.pone.0131316	http://dx.doi.org/10.1371/journal.pone.0131316			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161648	Green Published, gold			2022-12-27	WOS:000358162300035
J	Mayer, C; Bergholdt, R; Cucak, H; Rolin, BC; Sams, A; Rosendahl, A				Mayer, Christopher; Bergholdt, Regine; Cucak, Helena; Rolin, Bidda Charlotte; Sams, Anette; Rosendahl, Alexander			Neutralizing Anti-IL20 Antibody Treatment Significantly Modulates Low Grade Inflammation without Affecting HbA1c in Type 2 Diabetic db/db Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BETA-CELLS; OBESITY; IL-20; MACROPHAGES; EXPRESSION; INSULIN; GLUCOSE; INTERLEUKIN-20; HEMOGLOBIN	Low grade inflammation is present in pre-clinical and human type 2 diabetes. In this process, several cytokines like IL-1 beta and inflammatory cells like macrophages are activated and demonstrated to participate to the disease initiation and progression. IL-20 is a cytokine known to play non-redundant roles in progression of several inflammatory diseases. To address the therapeutic effect of inhibiting the IL-20 pathway in diabetes, diabetic db/db mice were treated with neutralizing anti-IL20 antibodies in vivo and both metabolic and inflammatory parameters were followed. Diabetic islets expressed the IL-20 cytokine and all IL-20 receptor components in elevated levels compared to resting non-diabetic islets. Islets were responsive to ex vivo IL-20 stimulation measured as SOCS induction and KC and IL-6 production. Neutralizing anti-IL20 treatment in vivo had no effect on HbA1c or weight although the slope of blood glucose increase was lowered. In contrast, anti-IL20 treatment significantly reduced the systemic low-grade inflammation and modulated the local pancreatic immunity. Significant reduction of the systemic IL-1 beta and MCP-1 was demonstrated upon anti-IL20 treatment which was orchestrated with a reduced RANTES, IL-16 and IL-2 but increased TIMP-1, MCP-1 and IL-6 protein expression locally in the pancreas. Interestingly, anti-IL20 treatment induced an expansion of the myeloid suppressor CD11bGr1(int) macrophage while reducing the number of CD8 T cells. Taken together, anti-IL20 treatment showed moderate effects on metabolic parameters, but significantly altered the low grade local and systemic inflammation. Hence, future combination therapies with anti-IL20 may provide beneficial therapeutic effects in type 2 diabetes through a reduction of inflammation.	[Mayer, Christopher; Bergholdt, Regine; Cucak, Helena; Sams, Anette; Rosendahl, Alexander] Novo Nordisk AS, Global Res, Dept Diabet Complicat Biol, Malov, Denmark; [Rolin, Bidda Charlotte] Novo Nordisk AS, Global Res, Dept Translat Pharmacol, Malov, Denmark	Novo Nordisk; Novo Nordisk	Rosendahl, A (corresponding author), Novo Nordisk AS, Dept Biopharmaceut New Haemophilia, DK-2820 Gentofte, Denmark.	alexander.rosendahl.axrd@gmail.com	Sams, Anette/R-1764-2016	Sams, Anette/0000-0002-9203-4333	Novo Nordisk	Novo Nordisk(Novo Nordisk)	Novo Nordisk provided support in the form of salaries for authors [BCR, CM, HC, RB, AS, AR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANDERSEN L, 1993, CLIN CHEM, V39, P578; Arora M, 2011, INT IMMUNOPHARMACOL, V11, P827, DOI 10.1016/j.intimp.2011.01.034; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Calderon B, 2008, J IMMUNOL, V181, P6964, DOI 10.4049/jimmunol.181.10.6964; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chen WY, 2006, ARTERIOSCL THROM VAS, V26, P2090, DOI 10.1161/01.ATV.0000232502.88144.6f; Chiu YS, 2014, HEPATOLOGY, V60, P1003, DOI 10.1002/hep.27189; Cohen RM, 2008, CURR OPIN CLIN NUTR, V11, P512, DOI 10.1097/MCO.0b013e32830467bd; COLEMAN DL, 1982, DIABETES, V31, P1; Cucak H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107140; Cucak H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090685; Cucak H, 2014, J LEUKOCYTE BIOL, V95, P149, DOI 10.1189/jlb.0213075; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Fink LN, 2013, DIABETOLOGIA, V56, P1623, DOI 10.1007/s00125-013-2897-x; Fonseca VA, 2009, DIABETES CARE, V32, pS151, DOI 10.2337/dc09-S301; Hammer T, 2009, MICROVASC RES, V78, P25, DOI 10.1016/j.mvr.2009.02.007; Hempe JM, 2002, J DIABETES COMPLICAT, V16, P313, DOI 10.1016/S1056-8727(01)00227-6; Herder C, 2006, EUR J ENDOCRINOL, V154, P311, DOI 10.1530/eje.1.02090; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; Hsieh MY, 2006, GENES IMMUN, V7, P234, DOI 10.1038/sj.gene.6364291; Jenkins JK, 2002, AM J MED SCI, V323, P197, DOI 10.1097/00000441-200204000-00006; Jiang HW, 2007, DIABETES, V56, P49, DOI 10.2337/db06-0710; Kilpatrick ES, 1998, DIABETES CARE, V21, P261, DOI 10.2337/diacare.21.2.261; Kunz S, 2006, EXP DERMATOL, V15, P991, DOI 10.1111/j.1600-0625.2006.00516.x; Liu L, 2003, BLOOD, V102, P3206, DOI 10.1182/blood-2003-05-1419; Mandrup-Poulsen Thomas, 2012, Rev Diabet Stud, V9, P338, DOI 10.1900/RDS.2012.9.338; Meier JJ, 2006, DIABETOLOGIA, V49, P83, DOI 10.1007/s00125-005-0069-3; Musah S, 2012, TOXICOLOGY, V299, P125, DOI 10.1016/j.tox.2012.05.014; Packham DK, 2012, AM J KIDNEY DIS, V59, P75, DOI 10.1053/j.ajkd.2011.09.017; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Tritsaris K, 2007, P NATL ACAD SCI USA, V104, P15364, DOI 10.1073/pnas.0707302104; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Uto-Konomi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040343; Vassiliou EK, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-25; Virtue MA, 2004, DIABETES CARE, V27, P931, DOI 10.2337/diacare.27.4.931; Volk Hans-Dieter, 2001, Trends in Immunology, V22, P414, DOI 10.1016/S1471-4906(01)01985-8; Waight JD, 2013, J CLIN INVEST, V123, P4464, DOI 10.1172/JCI68189; Welsh N, 2005, DIABETES, V54, P3238, DOI 10.2337/diabetes.54.11.3238	45	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131306	10.1371/journal.pone.0131306	http://dx.doi.org/10.1371/journal.pone.0131306			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162095	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300033
J	Ren, P; Yao, SX; Li, JX; Valdes-Sosa, PA; Kendrick, KM				Ren, Peng; Yao, Shuxia; Li, Jingxuan; Valdes-Sosa, Pedro A.; Kendrick, Keith M.			Improved Prediction of Preterm Delivery Using Empirical Mode Decomposition Analysis of Uterine Electromyography Signals	PLOS ONE			English	Article							BIRTH; EPIDEMIOLOGY; TERM	Preterm delivery increases the risk of infant mortality and morbidity, and therefore developing reliable methods for predicting its likelihood are of great importance. Previous work using uterine electromyography (EMG) recordings has shown that they may provide a promising and objective way for predicting risk of preterm delivery. However, to date attempts at utilizing computational approaches to achieve sufficient predictive confidence, in terms of area under the curve (AUC) values, have not achieved the high discrimination accuracy that a clinical application requires. In our study, we propose a new analytical approach for assessing the risk of preterm delivery using EMG recordings which firstly employs Empirical Mode Decomposition (EMD) to obtain their Intrinsic Mode Functions (IMF). Next, the entropy values of both instantaneous amplitude and instantaneous frequency of the first ten IMF components are computed in order to derive ratios of these two distinct components as features. Discrimination accuracy of this approach compared to those proposed previously was then calculated using six differently representative classifiers. Finally, three different electrode positions were analyzed for their prediction accuracy of preterm delivery in order to establish which uterine EMG recording location was optimal signal data. Overall, our results show a clear improvement in prediction accuracy of preterm delivery risk compared with previous approaches, achieving an impressive maximum AUC value of 0.986 when using signals from an electrode positioned below the navel. In sum, this provides a promising new method for analyzing uterine EMG signals to permit accurate clinical assessment of preterm delivery risk.	[Ren, Peng; Yao, Shuxia; Valdes-Sosa, Pedro A.; Kendrick, Keith M.] Univ Elect Sci & Technol China, Ctr Informat Biomed, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Li, Jingxuan] Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China	University of Electronic Science & Technology of China; Nanjing University of Science & Technology	Ren, P (corresponding author), Univ Elect Sci & Technol China, Ctr Informat Biomed, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	pren28@uestc.edu.cn; k.kendrick.uestc@gmail.com	Valdes-Sosa, Pedro A./AFT-6873-2022	Valdes-Sosa, Pedro A./0000-0001-5485-2661; Yao, Shuxia/0000-0002-5259-6374				Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Alamedine D, 2013, Comput Math Methods Med, V2013, P485684, DOI 10.1155/2013/485684; Amir F, 2011, INT J ADV SCI TECHNO; [Anonymous], 2008, B2812904 OR; [Anonymous], DAT AND STAT; Ante SE, 2008, BUSINESS WEEK; Baghamoradi S. Mohammad-Sina, 2011, 2011 18th Iranian Conference of Biomedical Engineering (ICBME), P81, DOI 10.1109/ICBME.2011.6168591; Berbel P, 2010, CEREB CORTEX, V20, P1462, DOI 10.1093/cercor/bhp212; Blinowska JK, 2012, PRACTICAL BIOMEDICAL; Boashash J, 2013, TIME FREQUENCY SIGNA; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Campbell MJ, 2005, MED STAT TXB HLTH SC; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chawla NV, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P875, DOI 10.1007/978-0-387-09823-4_45; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen Zhibin, 2007, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V24, P973; COVER T. M., 2012, ELEMENTS INFORM THEO, DOI 10.1002/0471200611; Deepa VB, 2010, INN COMP TECHN ICICT, P1; Diab A, 2012, IEEE ENG MED BIO, P1045, DOI 10.1109/EMBC.2012.6346113; Diab Mohamad O., 2010, Journal of Biomedical Science & Engineering, V3, P837, DOI 10.4236/jbise.2010.39113; Echeverria JC, 2001, MED BIOL ENG COMPUT, V39, P471, DOI 10.1007/BF02345370; Euliano TY, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.10.873; Fele-Zorz G, 2008, MED BIOL ENG COMPUT, V46, P911, DOI 10.1007/s11517-008-0350-y; Fergus P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077154; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hassan M, 2011, MED ENG PHYS, V33, P980, DOI 10.1016/j.medengphy.2011.03.010; Hassan M, 2013, IEEE T BIO-MED ENG, V60, P1160, DOI 10.1109/TBME.2012.2229279; Huang NE, 2005, HILBERT-HUANG TRANSFORM IN ENGINEERING, P1; Huang NE, 1999, ANNU REV FLUID MECH, V31, P417, DOI 10.1146/annurev.fluid.31.1.417; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Jerneja V, 2012, APPL EMG CLIN SPORTS; Jezewski J, 2005, PHYSIOL MEAS, V26, P753, DOI 10.1088/0967-3334/26/5/014; Kandil MA, 2012, EUR J OBSTET GYN R B, V160, P18, DOI 10.1016/j.ejogrb.2011.09.035; Kavsek G, THESIS U LJUBLJANA L; Khalil M, 2007, IEEE T BIOMEDICAL EN, V47, P748; La Rosa PS, 2008, IEEE T BIO-MED ENG, V55, P453, DOI 10.1109/TBME.2007.912663; Laforet J, 2011, IEEE T BIO-MED ENG, V58, P3487, DOI 10.1109/TBME.2011.2167970; Lau H, 2014, BMC PREGNANCY CHILDB, V14, P1082; Liang HL, 2005, NEUROCOMPUTING, V65, P801, DOI 10.1016/j.neucom.2004.10.077; Lin YY, 2014, COMP MATH MATH PHYS, V2014, P119; Lucovnik M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.024; Mahsereci EM, 2014, J MED SYST, P38; McPheeters ML, 2005, AM J OBSTET GYNECOL, V192, P1325, DOI 10.1016/j.ajog.2004.12.055; Morra JH, 2010, IEEE T MED IMAGING, V29, P30, DOI 10.1109/TMI.2009.2021941; Moslem B., 2011, 2011 18th IEEE International Conference on Electronics, Circuits and Systems (ICECS 2011), P631, DOI 10.1109/ICECS.2011.6122354; Murray M, 2008, LABOR DELIVERY NURSI; Posner G, 2013, OXORN FOOTE HUMAN LA; Rabotti C, 2008, PHYSIOL MEAS, V29, P829, DOI 10.1088/0967-3334/29/7/011; Rabotti C, 2010, IEEE T BIO-MED ENG, V57, P2178, DOI 10.1109/TBME.2010.2049111; Reed RD, 1998, NEURALSMITHING SUPER; Rilling G, 2003, IEEE EURASIP WORKSH, V3; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Seow WK, 1997, AUST DENT J, V42, P85, DOI 10.1111/j.1834-7819.1997.tb00102.x; Simhan HN, 2007, NEW ENGL J MED, V357, P477, DOI 10.1056/NEJMra050435; Small M, 2011, DYNAMICS BIOL SYSTEM; Smrdel A, 2015, PHYSIOL MEAS, V36, P341, DOI 10.1088/0967-3334/36/2/341; Stankovic L, 2013, ARTECH HSE RADAR LIB, P1; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Virk J, 2007, NEW ENGL J MED, V357, P648, DOI 10.1056/NEJMoa070445; Witten I.H., 2005, DATA MINING PRACTICA	62	41	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132116	10.1371/journal.pone.0132116	http://dx.doi.org/10.1371/journal.pone.0132116			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161639	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300095
J	Xu, Q; Zheng, TQ; Hu, X; Cheng, LR; Xu, JL; Shi, YM; Li, ZK				Xu, Qin; Zheng, Tian-Qing; Hu, Xia; Cheng, Li-Rui; Xu, Jian-Long; Shi, Yu-Min; Li, Zhi-Kang			Examining Two Sets of Introgression Lines in Rice (Oryza sativa L.) Reveals Favorable Alleles that Improve Grain Zn and Fe Concentrations	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; BROWN RICE; CADMIUM ACCUMULATION; ZINC CONCENTRATIONS; IDENTIFICATION; TRANSLOCATION; IRON; MICRONUTRIENTS; EXPRESSION; CULTIVARS	In the modern world, the grain mineral concentration (GMC) in rice (Oryza sativa L.) not only includes important micronutrient elements such as iron (Fe) and zinc (Zn), but it also includes toxic heavy metal elements, especially cadmium (Cd) and lead (Pb). To date, the genetic mechanisms underlying the regulation of GMC, especially the genetic background and G x E effects of GMC, remain largely unknown. In this study, we adopted two sets of backcross introgression lines (BILs) derived from IR75862 (a Zn-dense rice variety) as the donor parent and two elite indica varieties, Ce258 and Zhongguangxiang1, as recurrent parents to detect QTL affecting GMC traits including Fe, Zn, Cd and Pb concentrations in two environments. We detected a total of 22 loci responsible for GMC traits, which are distributed on all 12 rice chromosomes except 5, 9 and 10. Six genetic overlap (GO) regions affecting multiple elements were found, in which most donor alleles had synergistic effects on GMC. Some toxic heavy metal-independent loci (such as qFe1, qFe2 and qZn12) and some regions that have opposite genetic effects on micronutrient (Fe and Zn) and heavy metal element (Pb) concentrations (such as GO-IV) may be useful for marker-assisted biofortification breeding in rice. We discuss three important points affecting biofortification breeding efforts in rice, including correlations between different GMC traits, the genetic background effect and the G x E effect.	[Xu, Qin; Zheng, Tian-Qing; Hu, Xia; Cheng, Li-Rui; Xu, Jian-Long; Li, Zhi-Kang] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Xu, Jian-Long; Li, Zhi-Kang] Chinese Acad Agr Sci, Inst Agr Genom Shenzhen, Shenzhen, Peoples R China; [Shi, Yu-Min] Guangxi Acad Agr Sci, Rice Res Inst, Nanning, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Guangxi Academy of Agricultural Sciences	Xu, JL (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, 12 South Zhong Guan Cun St, Beijing 100193, Peoples R China.	xujlcaas@126.com	Xu, Jianlong/AAI-8310-2020		Harvest Plus Program [2014H8325.CAA]; "863" project from Chinese Ministry of Science Technology [2012AA101101]; "948" project from Chinese Ministry of Agriculture [2010-G2B]; Special Fund of Chinese Central Government for Basic Scientific Research Operations in Commonweal Research Institutes [2014JB04-012]; "Green Super Rice" project from Bill & Melinda Gates' Foundation [OPPGD1393]	Harvest Plus Program; "863" project from Chinese Ministry of Science Technology; "948" project from Chinese Ministry of Agriculture; Special Fund of Chinese Central Government for Basic Scientific Research Operations in Commonweal Research Institutes; "Green Super Rice" project from Bill & Melinda Gates' Foundation	Harvest Plus Program (2014H8325.CAA); "863" project from the Chinese Ministry of Science & Technology (2012AA101101); the "948" project from the Chinese Ministry of Agriculture (2010-G2B); the Special Fund of Chinese Central Government for Basic Scientific Research Operations in Commonweal Research Institutes (2014JB04-012); and the "Green Super Rice" project from Bill & Melinda Gates' Foundation (OPPGD1393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, BREEDING SCI, V61, P43, DOI 10.1270/jsbbs.61.43; Al-Saleh I, 2001, BIOL TRACE ELEM RES, V83, P91, DOI 10.1385/BTER:83:1:91; [Anonymous], 2004, SAS STAT 9 1 USERS G; [Anonymous], 2014, CMAO GRAMENE DATABAS; Aoyama T, 2009, PLANT MOL BIOL, V70, P681, DOI 10.1007/s11103-009-9500-3; Bekele Berhanu D, 2013, Pak J Biol Sci, V16, P1714, DOI 10.3923/pjbs.2013.1714.1721; Belouchi A, 1997, PLANT MOL BIOL, V33, P1085, DOI 10.1023/A:1005723304911; Bhullar NK, 2013, BIOTECHNOL ADV, V31, P50, DOI 10.1016/j.biotechadv.2012.02.001; Chen Zhi-De, 2009, Yichuan, V31, P1135, DOI 10.3724/SP.J.1005.2009.01135; CHURCHILL GA, 1994, GENETICS, V138, P963; CLARKSON DT, 1980, ANNU REV PLANT PHYS, V31, P239, DOI 10.1146/annurev.pp.31.060180.001323; Dawe D., 2010, The rice crisis: markets, policies and food security, P15; De Steur H, 2012, NEW BIOTECHNOL, V29, P432, DOI 10.1016/j.nbt.2011.11.012; Fu JJ, 2008, CHEMOSPHERE, V71, P1269, DOI 10.1016/j.chemosphere.2007.11.065; Gomez-Becerra HF, 2010, EUPHYTICA, V171, P39, DOI 10.1007/s10681-009-9987-3; Gregorio G.B., 2003, RICE SCI INNOVATIONS, P1022; Hang XS, 2009, ENVIRON POLLUT, V157, P2542, DOI 10.1016/j.envpol.2009.03.002; HarvestPlus, 2014, BIOFORTIFICATION PRO; Huang SS, 2007, CHEMOSPHERE, V67, P2148, DOI 10.1016/j.chemosphere.2006.12.043; Impa SM, 2013, J EXP BOT, V64, P2739, DOI 10.1093/jxb/ert118; Ishikawa S, 2005, NEW PHYTOL, V168, P345, DOI 10.1111/j.1469-8137.2005.01516.x; Jia Qian, 2010, Acta Agronomica Sinica, V36, P979, DOI 10.1016/S1875-2780(09)60056-0; Kashiwagi T, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-8; Li B, 2012, J ENVIRON SCI-CHINA, V24, P1790, DOI 10.1016/S1001-0742(11)60972-8; Li HH, 2008, THEOR APPL GENET, V116, P243, DOI 10.1007/s00122-007-0663-5; Li ZK, 2003, THEOR APPL GENET, V108, P141, DOI 10.1007/s00122-003-1401-2; Lu R.Q, 1999, SOIL AGRO CHEM ANAL; Ma GS, 2008, PUBLIC HEALTH NUTR, V11, P632, DOI 10.1017/S1368980007001085; Malosetti M, 2013, FRONT PHYSIOL, P4, DOI [10.3389/fphys.2013.00414, DOI 10.3389/FPHYS.2013.00414]; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; McLaughlin MJ, 1999, FIELD CROP RES, V60, P143, DOI 10.1016/S0378-4290(98)00137-3; Narayanan NN, 2007, PLANT PHYSIOL BIOCH, V45, P277, DOI 10.1016/j.plaphy.2007.03.021; Pfeiffer Wolfgang H., 2007, P61, DOI 10.1002/9780470376447.ch3; Ramesh SA, 2003, PLANT PHYSIOL, V133, P126, DOI 10.1104/pp.103.026815; [沈希宏 Shen Xihong], 2008, [分子植物育种, Molecular Plant Breeding], V6, P1061; Tang S. Q., 2007, QTL MAPPING COOKING; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; Tezuka K, 2010, THEOR APPL GENET, V120, P1175, DOI 10.1007/s00122-009-1244-6; Ueno D, 2009, NEW PHYTOL, V182, P644, DOI 10.1111/j.1469-8137.2009.02784.x; Ueno D, 2010, P NATL ACAD SCI USA, V107, P16500, DOI 10.1073/pnas.1005396107; Uraguchi S, 2014, PHYSL PLANT; Uraguchi S, 2011, P NATL ACAD SCI USA, V108, P20959, DOI 10.1073/pnas.1116531109; Zhang XQ, 2011, EUPHYTICA, V180, P173, DOI 10.1007/s10681-011-0346-9; Zheng TQ, 2011, CROP SCI, V51, P2525, DOI 10.2135/cropsci2011.05.0259; Zhong L, 2010, ATL ANAL MINERAL ELE	53	22	26	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131846	10.1371/journal.pone.0131846	http://dx.doi.org/10.1371/journal.pone.0131846			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161553	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300064
J	An, N; Wang, R; Gao, Y; Yang, HL; Qian, DP				An, Ning; Wang, Rui; Gao, Yuan; Yang, Hailong; Qian, Depei			Balancing the Lifetime and Storage Overhead on Error Correction for Phase Change Memory	PLOS ONE			English	Article							HARD; ECC	As DRAM is facing the scaling difficulty in terms of energy cost and reliability, some nonvolatile storage materials were proposed to be the substitute or supplement of main memory. Phase Change Memory (PCM) is one of the most promising nonvolatile memory that could be put into use in the near future. However, before becoming a qualified main memory technology, PCM should be designed reliably so that it can ensure the computer system's stable running even when errors occur. The typical wear-out errors in PCM have been well studied, but the transient errors, that caused by high-energy particles striking on the complementary metal-oxide semiconductor (CMOS) circuit of PCM chips or by resistance drifting in multilevel cell PCM, have attracted little focus. In this paper, we propose an innovative mechanism, Local-ECC-Global-ECPs (LEGE), which addresses both soft errors and hard errors (wear-out errors) in PCM memory systems. Our idea is to deploy a local error correction code (ECC) section to every data line, which can detect and correct one-bit errors immediately, and a global error correction pointers (ECPs) buffer for the whole memory chip, which can be reloaded to correct more hard error bits. The local ECC is used to detect and correct the unknown one-bit errors, and the global ECPs buffer is used to store the corrected value of hard errors. In comparison to ECP-6, our method provides almost identical lifetimes, but reduces approximately 50% storage overhead. Moreover, our structure reduces approximately 3.55% access latency overhead by increasing 1.61% storage overhead compared to PAYG, a hard error only solution.	[An, Ning; Wang, Rui] Beihang Univ, State Key Lab Software Dev Environm, Beijing 100191, Peoples R China; [Gao, Yuan; Yang, Hailong; Qian, Depei] Beihang Univ, Sch Comp Sci & Engn, Beijing 100191, Peoples R China	Beihang University; Beihang University	Yang, HL (corresponding author), Beihang Univ, Sch Comp Sci & Engn, Beijing 100191, Peoples R China.	hailong.yang@buaa.edu.cn	yang, hailong/GXH-9625-2022		863 Program of China [2012AA010902]; NSF of China [61133004, 61073011]; State Key Laboratory of Software Development Environment [SKLSDE2013ZX-22]	863 Program of China(National High Technology Research and Development Program of China); NSF of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Software Development Environment	This research is supported by 863 Program of China under grant 2012AA010902, by the NSF of China under grants 61133004 and 61073011, and by State Key Laboratory of Software Development Environment under grant SKLSDE2013ZX-22.	[Anonymous], 2007, BIOS KERNEL DEV GUID; Awasthi M, 2012, INT S HIGH PERF COMP, P15; Azevedo R., 2013, SIGARCH COMPUT ARCHI, P452, DOI DOI 10.1145/2508148.2485961; Baumann R, 2005, IEEE DES TEST COMPUT, V22, P258, DOI 10.1109/MDT.2005.69; Burr GW, 2010, J VAC SCI TECHNOL B, V28, P223, DOI 10.1116/1.3301579; CHEN CL, 1984, IBM J RES DEV, V28, P124, DOI 10.1147/rd.282.0124; Ipek E, 2010, ACM SIGPLAN NOTICES, V45, P3, DOI 10.1145/1735971.1736023; Jacobvitz AN, 2013, INT S HIGH PERF COMP, P222, DOI 10.1109/HPCA.2013.6522321; Kang DH, 2008, S VLSI TECH, P75; Kim K, 2005, INT RELIAB PHY SYM, P157, DOI 10.1109/RELPHY.2005.1493077; Liu JM, 2012, CONF PROC INT SYMP C, P1, DOI 10.1109/ISCA.2012.6237001; Nak Hee Seong, 2010, Proceedings 2010 43rd Annual IEEE/ACM International Symposium on Microarchitecture (MICRO 2010), P115, DOI 10.1109/MICRO.2010.46; Qureshi MK, 2011, INT SYMP MICROARCH, P318; Sangyeun Cho, 2009, Proceedings of the 2009 42nd Annual IEEE/ACM International Symposium on Microarchitecture (MICRO 2009), P347; Schechter S, 2010, CONF PROC INT SYMP C, P141; Seong N. H., 2013, P 40 ANN INT S COMPU, P440, DOI DOI 10.1145/2485922.2485960; Yeo S, 2012, 10 ANN WORKSH DUPL D; Yokoyama Y, 2001, IEEE J SOLID-ST CIRC, V36, P503, DOI 10.1109/4.910489; Yoon DH, 2011, INT S HIGH PERF COMP, P466, DOI 10.1109/HPCA.2011.5749752; Yoon DH, 2010, ACM SIGPLAN NOTICES, V45, P397, DOI 10.1145/1735971.1736064; Zhang WY, 2011, I C DEPEND SYS NETWO, P197, DOI 10.1109/DSN.2011.5958219	21	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131964	10.1371/journal.pone.0131964	http://dx.doi.org/10.1371/journal.pone.0131964			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158524	Green Submitted, gold, Green Published			2022-12-27	WOS:000358161200044
J	Sun, J; Xu, GR; Wang, ZS; Li, Q; Cui, Y; Xie, LP; Zhang, RQ				Sun, Juan; Xu, Guangrui; Wang, Zeshi; Li, Qing; Cui, Yu; Xie, Liping; Zhang, Rongqing			The Effect of NF-kappa B Signalling Pathway on Expression and Regulation of Nacrein in Pearl Oyster, Pinctada fucata	PLOS ONE			English	Article							CARBONIC-ANHYDRASE; MATRIX PROTEINS; ACTIVATION; HOMOLOG; RANKL; LAYER; REL	Nacrein is the first identified and widely investigated molluscan matrix protein and is considered to play an important role in the shell formation of the pearl oyster, Pinctada fucata. Here, we investigate the effect of the NF-kappa B signalling pathway on Nacrein gene expression in P. fucata to elucidate the mechanisms involved in shell formation. Inhibition of NF-kappa B signalling decreased Nacrein promoter-dependent luciferase activity. However, co-transfection of the Nacrein promoter vector with Pf-IKK or Pf-Rel expression plasmids could enhance luciferase activity, thus proving NF-kappa B signalling could regulate the transcriptional activity of the Nacrein promoter. Gene silencing by RNA interference and subsequent observation of the inner surface of the nacreous layer of oyster shells by SEM, showed that suppression of the gene Pf-Rel lead to a partial inhibition of Nacrein expression, not only at the mRNA level but also at the protein level. The inner surface of the shells became abnormal. Electrophoretic mobility shift assays (EMSAs) revealed that Pf-Rel could directly bind to the relative sites of the Nacrein promoter. These results confirm that an important component of the NF-kappa B signalling pathway, Pf-Rel, can directly bind the Nacrein promoter in P. fucata, and regulate its transcription and shell formation.	[Sun, Juan; Xu, Guangrui; Wang, Zeshi; Li, Qing; Cui, Yu; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China; [Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Xie, LP (corresponding author), Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Basic Research Program of China [2010CB126405]; National High Technology Research and Development Program of China [2010AA09Z405]; National Natural Science Foundation of China [31172382, U0831001]; Independent Research Projects of Tsinghua University [20111080964]; Major Project of Ministry of Agriculture [2011ZX08011-006]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Research Projects of Tsinghua University; Major Project of Ministry of Agriculture	This work was supported by National Basic Research Program of China Grant 2010CB126405, National High Technology Research and Development Program of China Grant 2010AA09Z405, National Natural Science Foundation of China Grants 31172382 and U0831001 (Joint Fund with Guangdong), and Independent Research Projects of Tsinghua University Grant 20111080964. Grant 2011ZX08011-006 is a Major Project of Ministry of Agriculture.	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Batra S, 2011, ARCH IMMUNOL THER EX, V59, P335, DOI 10.1007/s00005-011-0136-z; Boyce BF, 1999, BONE, V25, P137, DOI 10.1016/S8756-3282(99)00105-2; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gong NP, 2008, J STRUCT BIOL, V164, P33, DOI 10.1016/j.jsb.2008.05.009; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hetru C, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000232; Hou WT, 2006, CRYST GROWTH DES, V6, P1086, DOI 10.1021/cg0504861; Kim K, 2010, J IMMUNOL, V185, P7460, DOI 10.4049/jimmunol.1000885; Liu XJ, 2012, P ROY SOC B-BIOL SCI, V279, P1000, DOI 10.1098/rspb.2011.1661; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowenstam HA, 1989, BIOMINERALIZATION; Marie B, 2009, CHEMBIOCHEM, V10, P1495, DOI 10.1002/cbic.200900009; Miyamoto H, 2005, ZOOL SCI, V22, P311, DOI 10.2108/zsj.22.311; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Nakashima T, 2003, CURR OPIN RHEUMATOL, V15, P280, DOI 10.1097/00002281-200305000-00016; OSNES T, 1993, SCAND J CLIN LAB INV, V53, P757, DOI 10.3109/00365519309092582; Reinhard K, 2012, INT J MED MICROBIOL, V302, P230, DOI 10.1016/j.ijmm.2012.07.006; Salles A, J PHYSL PARIS; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Wu X, 2007, ACTA BIOCH BIOPH SIN, V39, P533, DOI 10.1111/j.1745-7270.2007.00306.x; Xiong XH, 2008, DEV COMP IMMUNOL, V32, P15, DOI 10.1016/j.dci.2007.03.013; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Zhang DC, 2009, FISH SHELLFISH IMMUN, V26, P84, DOI 10.1016/j.fsi.2008.10.009	30	15	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131711	10.1371/journal.pone.0131711	http://dx.doi.org/10.1371/journal.pone.0131711			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158525	Green Published, Green Submitted, gold			2022-12-27	WOS:000358161200037
J	Allain, EP; Boudreau, LH; Flamand, N; Surette, ME				Allain, Eric P.; Boudreau, Luc H.; Flamand, Nicolas; Surette, Marc E.			The Intracellular Localisation and Phosphorylation Profile of the Human 5-Lipoxygenase Delta 13 Isoform Differs from That of Its Full Length Counterpart	PLOS ONE			English	Article							COACTOSIN-LIKE PROTEIN; BASOPHILIC LEUKEMIA-CELLS; LEUKOTRIENE BIOSYNTHESIS; NUCLEAR IMPORT; ARACHIDONIC-ACID; POLYMORPHONUCLEAR LEUKOCYTES; ALVEOLAR MACROPHAGES; HUMAN NEUTROPHILS; ENZYME-ACTIVITY; TRANSLOCATION	5-Lipoxygenase (5-LO) catalyzes leukotriene (LT) biosynthesis by a mechanism that involves interactions with 5-lipoxygenase activating protein (FLAP) and coactosin-like protein (CLP). 5-LO splice variants were recently identified in human myeloid and lymphoid cells, including the catalytically inactive Delta 13 isoform (5-LO Delta 13) whose transcript lacks exon 13.5-LO Delta 13 inhibits 5-LO product biosynthesis when co-expressed with active full length 5-LO (5-LO1). The objective of this study was to investigate potential mechanisms by which 5-LO Delta 13 interferes with 5-LO product biosynthesis in transfected HEK293 cells. When co-expressed with 5-LO1, 5-LO Delta 13 inhibited LT but not 5-hydroxyeicosatetraenoic acid (5-HETE) biosynthesis. This inhibition was independent of 5-LO Delta 13-FLAP interactions since it occurred in cells expressing FLAP or not. In cell-free assays CLP enhances 5-LO activity through interactions with tryptophan-102 of 5-LO. In the current study, the requirement for W102 was extended to whole cells, as cells expressing the 5-LO1-W102A mutant produced little 5-LO products. W102A mutants of 5-LO Delta 13 inhibited 5-LO product biosynthesis as effectively as 5-LO Delta 13 suggesting that inhibition is independent of interactions with CLP. Confocal microscopy showed that 5-LO1 was primarily in the nucleoplasm whereas W102A mutants showed a diffuse cellular expression. Despite the retention of known nuclear localisation sequences, 5-LO Delta 13 was cytosolic and concentrated in ER-rich perinuclear regions where its effect on LT biosynthesis may occur. W102A mutants of 5-LO Delta 13 showed the same pattern. Consistent with subcellular distribution patterns, 5-LO Delta 13 was hyper-phosphorylated on S523 and S273 compared to 5-LO1. Together, these results reveal a role for W102 in nuclear targeting of 5-LO1 suggesting that interactions with CLP are required for nuclear localization of 5-LO1, and are an initial characterisation of the 5-LO Delta 13 isoform whose inhibition of LT biosynthesis appears independent of interactions with CLP and FLAP. Better knowledge of the regulation and properties of alternative 5-LO isoforms will contribute to understanding the complex regulation of LT biosynthesis.	[Allain, Eric P.; Boudreau, Luc H.; Surette, Marc E.] Univ Moncton, Dept Chim & Biochim, Moncton, NB E1A 3E9, Canada; [Flamand, Nicolas] Univ Laval, Dept Med, Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ G1K 7P4, Canada; [Flamand, Nicolas] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada	University of Moncton; Laval University; Laval University	Surette, ME (corresponding author), Univ Moncton, Dept Chim & Biochim, Moncton, NB E1A 3E9, Canada.	marc.surette@umoncton.ca	Flamand, Nicolas/H-5823-2019; Surette, Marc/AAW-1078-2021	Flamand, Nicolas/0000-0001-5944-7200; Allain, Eric/0000-0003-4283-6060; Boudreau, Luc H/0000-0002-3674-5026	Heart and Stroke Foundation of Canada; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Fonds de recherche du Quebec-Sante; New Brunswick Health Research Foundation	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); New Brunswick Health Research Foundation	This work was supported by grants from the Heart and Stroke Foundation of Canada (to MES), and the Natural Sciences and Engineering Research Council of Canada (to NF). MES was supported by the Canada Research Chairs Program. NF is the recipient of a salary award from the Fonds de recherche du Quebec-Sante. EA was supported by a graduate student scholarship from the New Brunswick Health Research Foundation. LHB was the recipient of a fellowship from the Fonds de recherche du Quebec-Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOVITZ M, 1993, EUR J BIOCHEM, V215, P105, DOI 10.1111/j.1432-1033.1993.tb18012.x; Basavarajappa D, 2014, P NATL ACAD SCI USA, V111, P11371, DOI 10.1073/pnas.1410983111; Bhatia B, 2003, J BIOL CHEM, V278, P25091, DOI 10.1074/jbc.M301920200; Bishayee K, 2013, ACTA BIOCH BIOPH SIN, V45, P709, DOI 10.1093/abbs/gmt064; BOADO RJ, 1992, P NATL ACAD SCI USA, V89, P9044, DOI 10.1073/pnas.89.19.9044; BORGEAT P, 1990, METHOD ENZYMOL, V187, P98; BORGEAT P, 1979, P NATL ACAD SCI USA, V76, P2148, DOI 10.1073/pnas.76.5.2148; Boudreau LH, 2011, FASEB J, V25, P1097, DOI 10.1096/fj.10-173856; BROCK TG, 1995, ADV PROSTAG THROMB L, V23, P151; Brock TG, 1997, J BIOL CHEM, V272, P8276, DOI 10.1074/jbc.272.13.8276; Brock TG, 1999, J IMMUNOL, V162, P1669; BROCK TG, 1995, J BIOL CHEM, V270, P21652, DOI 10.1074/jbc.270.37.21652; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; CHEN XS, 1995, J BIOL CHEM, V270, P17993, DOI 10.1074/jbc.270.30.17993; Chen XS, 1998, J BIOL CHEM, V273, P31237, DOI 10.1074/jbc.273.47.31237; Chu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070991; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Esser J, 2010, BIOCHEM J, V425, P265, DOI 10.1042/BJ20090856; Fanning LB, 2013, ANN ALLERG ASTHMA IM, V111, P155, DOI 10.1016/j.anai.2013.06.031; Flamand N, 2006, J BIOL CHEM, V281, P129, DOI 10.1074/jbc.M506513200; Flamand N, 2009, J BIOL CHEM, V284, P306, DOI 10.1074/jbc.M805593200; Gerstmeier J, 2014, BBA-GEN SUBJECTS, V1840, P2961, DOI 10.1016/j.bbagen.2014.05.016; Hafner AK, 2011, BIOL CHEM, V392, P1097, DOI [10.1515/BC.2011.200, 10.1515/BC-2011-200]; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hammarberg T, 2001, BIOCHEMISTRY-US, V40, P6371, DOI 10.1021/bi001595d; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Jones SM, 2003, J BIOL CHEM, V278, P10257, DOI 10.1074/jbc.M211021200; Jones SM, 2002, J BIOL CHEM, V277, P38550, DOI 10.1074/jbc.M206070200; Luo M, 2005, J BIOL CHEM, V280, P40609, DOI 10.1074/jbc.M507045200; OCHI K, 1983, J BIOL CHEM, V258, P5754; Ochs MJ, 2014, BASIC CLIN PHARMACOL, V114, P78, DOI 10.1111/bcpt.12115; Ochs MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031363; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Plante H, 2006, BIOCHEM J, V393, P211, DOI 10.1042/BJ20060669; Provost P, 2001, BIOCHEM J, V359, P255, DOI 10.1042/0264-6021:3590255; Radmark O, 2010, BIOCHEM BIOPH RES CO, V396, P105, DOI 10.1016/j.bbrc.2010.02.173; Rakonjac M, 2006, P NATL ACAD SCI USA, V103, P13150, DOI 10.1073/pnas.0605150103; Woods J. W., 1993, J EXP MED, V178, P1935; WOODS JW, 1995, J CLIN INVEST, V95, P2035, DOI 10.1172/JCI117889; Zhang YY, 2000, BIOCHEM J, V351, P697, DOI 10.1042/0264-6021:3510697	40	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132607	10.1371/journal.pone.0132607	http://dx.doi.org/10.1371/journal.pone.0132607			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173130	gold, Green Submitted, Green Published			2022-12-27	WOS:000358194900064
J	Guo, X; Zhao, D; Jung, DW; Li, Q; Kong, LF; Ni, G; Nakano, T; Matsukuma, A; Kim, S; Park, C; Lee, HJ; Park, JK				Guo, Xiang; Zhao, Dan; Jung, Daewui; Li, Qi; Kong, Ling-Feng; Ni, Gang; Nakano, Tomoyuki; Matsukuma, Akihiko; Kim, Sanghee; Park, Chungoo; Lee, Hyuk Je; Park, Joong-Ki			Phylogeography of the Rock Shell Thais clavigera (Mollusca): Evidence for Long-Distance Dispersal in the Northwestern Pacific	PLOS ONE			English	Article							GENETIC DIFFERENTIATION; POPULATION EXPANSION; MARGINAL SEAS; PLEISTOCENE ISOLATION; LARVAL DISPERSAL; MARINE; DIVERGENCE; MODEL; MURICIDAE; SOFTWARE	The present-day genetic structure of a species reflects both historical demography and patterns of contemporary gene flow among populations. To precisely understand how these factors shape current population structure of the northwestern (NW) Pacific marine gastropod, Thais clavigera, we determined the partial nucleotide sequences of the mitochondrial COI gene for 602 individuals sampled from 29 localities spanning almost the whole distribution of T. clavigera in the NW Pacific Ocean (similar to 3,700 km). Results from population genetic and demographic analyses (AMOVA, phi(ST)-statistics, haplotype networks, Tajima's D, Fu's F-S, mismatch distribution, and Bayesian skyline plots) revealed a lack of genealogical branches or geographical clusters, and a high level of genetic (haplotype) diversity within each of studied population. Nevertheless, low but significant genetic structuring was detected among some geographical populations separated by the Changjiang River, suggesting the presence of geographical barriers to larval dispersal around this region. Several lines of evidence including significant negative Tajima's D and Fu's FS statistics values, the unimodally shaped mismatch distribution, and Bayesian skyline plots suggest a population expansion at marine isotope stage 11 (MIS 11; 400 ka), the longest and warmest interglacial interval during the Pleistocene epoch. The lack of genetic structure among the great majority of the NW Pacific T. clavigera populations may be attributable to high gene flow by current- driven long-distance dispersal of prolonged planktonic larval phase of this species.	[Guo, Xiang; Park, Joong-Ki] Ewha Womans Univ, Div EcoSci, Seoul 120750, South Korea; [Zhao, Dan; Li, Qi; Kong, Ling-Feng; Ni, Gang; Matsukuma, Akihiko] Ocean Univ China, Key Lab Mariculture, Minist Educ, Qingdao 266003, Peoples R China; [Jung, Daewui] Chungbuk Natl Univ, Coll Med, Program Cell Biol & Genet, Cheongju 361763, South Korea; [Jung, Daewui] Chungbuk Natl Univ, Coll Med, Dept Parasitol, Cheongju 361763, South Korea; [Nakano, Tomoyuki] Kyoto Univ, Seto Marine Biol Lab, Shirahama, Wakayama Prefec, Japan; [Kim, Sanghee] Korea Polar Res Inst, Inchon 406840, South Korea; [Park, Chungoo] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Lee, Hyuk Je] Sangji Univ, Dept Biol Sci, Coll Sci & Engn, Wonju 220702, South Korea	Ewha Womans University; Ocean University of China; Chungbuk National University; Chungbuk National University; Kyoto University; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Chonnam National University; Sangji University	Li, Q (corresponding author), Ocean Univ China, Key Lab Mariculture, Minist Educ, Qingdao 266003, Peoples R China.	qili66@ouc.edu.cn; jkpark@ewha.ac.kr	Park, Joong-Ki/S-8855-2019; Kong, Lingfeng/AAJ-3402-2021; Kong, Lingfeng/AAG-2473-2019	Kong, Lingfeng/0000-0001-5263-1697	Marine Biotechnology Program (Genome Analysis of Marine Organisms and Development of Functional Applications and Marine Mollusk Resource Bank of Korea) [PJT200620]; National Natural Science Foundation of China [41276138]; Ministry of Oceans and Fisheries, Korea	Marine Biotechnology Program (Genome Analysis of Marine Organisms and Development of Functional Applications and Marine Mollusk Resource Bank of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Oceans and Fisheries, Korea	This research was supported by a grant from Marine Biotechnology Program (PJT200620, Genome Analysis of Marine Organisms and Development of Functional Applications and Marine Mollusk Resource Bank of Korea) to J-KP and funded by the Ministry of Oceans and Fisheries, Korea, and National Natural Science Foundation of China (41276138) to QL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison JA, 2008, MOL ECOL, V17, P4222, DOI 10.1111/j.1365-294X.2008.03905.x; [Anonymous], 2014, TRACER V1 6; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Avise JC, 2004, MOL MARKERS NATURAL, P248; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Candy I, 2014, EARTH-SCI REV, V128, P18, DOI 10.1016/j.earscirev.2013.09.006; Cardenas L, 2009, J BIOGEOGR, V36, P969, DOI 10.1111/j.1365-2699.2008.02056.x; Cheang CC, 2012, J BIOGEOGR, V39, P1819, DOI 10.1111/j.1365-2699.2012.02742.x; Cox LN, 2014, J BIOGEOGR, V41, P615, DOI 10.1111/jbi.12217; Dong Yu-lin, 2012, PLoS One, V7, pe34435, DOI 10.1371/journal.pone.0034435; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FOIGHIL DO, 1989, MAR BIOL, V103, P349; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Guo EM, 2012, MOL BIOL REP, V39, P1453, DOI 10.1007/s11033-011-0882-3; Guo ZT, 2000, GEOPHYS RES LETT, V27, P1751, DOI 10.1029/1999GL008419; Hayashi T, 1999, ZOOL SCI, V16, P81, DOI 10.2108/zsj.16.81; Hearty Paul J., 2002, Pacific Science, V56, P65, DOI 10.1353/psc.2002.0004; Hearty PJ, 1999, GEOLOGY, V27, P375, DOI 10.1130/0091-7613(1999)027<0375:AMMPSL>2.3.CO;2; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hoffman JI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032415; Hsieh Y-C, 2001, THESIS NATL SUN YAT; Hu J., 2000, J OCEANOGR, V56, P607, DOI DOI 10.1023/A:1011117531252; Huang J-R, 2013, THESIS XIAMEN U; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ito Toshimichi, 1995, Journal of Oceanography, V51, P267, DOI 10.1007/BF02285165; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kang JH, 2012, GENET MOL RES, V11, P3988, DOI 10.4238/2012.November.21.2; Kariya C, 2010, QUATERNARY SCI REV, V29, P1863, DOI 10.1016/j.quascirev.2010.04.005; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Lambeck K, 2002, NATURE, V419, P199, DOI 10.1038/nature01089; Lee HJ, 2003, DEEP-SEA RES PT II, V50, P1065, DOI 10.1016/S0967-0645(03)00010-9; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057473, 10.1371/journal.pone.0050719, 10.1371/journal.pone.0064143]; Liu JX, 2007, MOL ECOL, V16, P275, DOI 10.1111/j.1365-294X.2006.03140.x; Liu Y, 2009, HYDROBIOLOGIA, V618, P125, DOI 10.1007/s10750-008-9570-2; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; Ni G, 2014, MOL ECOL, V23, P534, DOI 10.1111/mec.12620; Ni G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049487; Nunes FLD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022298; 이순목, 2011, [Korean Journal of Food and Cookery Science, 한국식품조리과학회지], V27, P1; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Purcell JFH, 2006, P ROY SOC B-BIOL SCI, V273, P1483, DOI 10.1098/rspb.2006.3470; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Romero MS, 2004, MAR BIOL, V145, P681, DOI 10.1007/s00227-004-1368-9; SCHELTEMA RS, 1971, BIOL BULL-US, V140, P284, DOI 10.2307/1540075; Shanks AL, 2009, BIOL BULL-US, V216, P373; Song N, 2010, J FISH BIOL, V77, P388, DOI 10.1111/j.1095-8649.2010.02694.x; Stamatis C, 2004, MOL ECOL, V13, P1377, DOI 10.1111/j.1365-294X.2004.02165.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan KS, 2001, ZOOL SCI, V18, P1275, DOI 10.2108/zsj.18.1275; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TONG L K Y, 1988, Asian Marine Biology, V5, P65; Tsang LM, 2008, MOL ECOL, V17, P4151, DOI 10.1111/j.1365-294X.2008.03907.x; Wang PX, 1999, MAR GEOL, V156, P5, DOI 10.1016/S0025-3227(98)00172-8; Wang X, 2013, THESIS ZHEJIANG OCEA; Xiao YS, 2009, ENVIRON BIOL FISH, V85, P303, DOI 10.1007/s10641-009-9497-0; Xu JW, 2009, MOL PHYLOGENET EVOL, V52, P45, DOI 10.1016/j.ympev.2009.02.007; Xue DX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095436; York KL, 2008, MOL ECOL, V17, P1948, DOI 10.1111/j.1365-294X.2008.03735.x; You ZJ, 2010, J ZHEJIANG OCEAN U N, V29, P306; Zane L, 2006, MOL ECOL, V15, P4499, DOI 10.1111/j.1365-294X.2006.03105.x	68	30	31	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0129715	10.1371/journal.pone.0129715	http://dx.doi.org/10.1371/journal.pone.0129715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171966	gold, Green Published, Green Submitted			2022-12-27	WOS:000358194900004
J	Sekine, J; Nakatani, E; Ohira, K; Hideshima, K; Kanno, T; Nariai, Y; Kagimura, T; Urano, T				Sekine, Joji; Nakatani, Eiji; Ohira, Koichiro; Hideshima, Katsumi; Kanno, Takahiro; Nariai, Yoshiki; Kagimura, Tatsuo; Urano, Takeshi			Nucleus Accumbens-Associated Protein 1 Expression Has Potential as a Marker for Distinguishing Oral Epithelial Dysplasia and Squamous Cell Carcinoma	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MALIGNANT-TRANSFORMATION; CANCER; PLURIPOTENCY; PROGNOSIS; NETWORK; NACL	Background Oral epithelial dysplasia (OED) and carcinoma in situ (CIS) are defined by dysplastic cells in the epithelium. Over a third of oral squamous cell carcinoma (OSCC) patients present with associated OED. However, accurate histopathological diagnosis of such lesions is difficult. Nucleus accumbens-associated protein 1 (NAC1) is a member of the Pox virus and Zinc finger/Bric-a-brac Tramtrack Broad complex family of proteins, and is overexpressed in OSCC. This study aimed to determine whether NAC1 has the potential to be used as a marker to distinguish OED and OSCC. Methods and Findings The study included 114 patients (64 men, 50 women). There were 67, 10, and 37 patients with OED, CIS, and OSCC, respectively. NAC1 labeling indices (LIs) and immunoreactivity intensities (IRI) were evaluated. The patients' pathological classification was significantly associated with age, sex, NAC1 LIs, and NAC1 IRI (p = 0.025, p = 0.022, p < 0.001, and p < 0.001, respectively). As a result of multivariate analysis, a predictive model was made; this identified the NAC1 LIs (OR [95% CI] 1.18 [1.11-1.28], p < 0.001) and NAC1 IRI (0.78 [0.68-0.86], p < 0.001) as predictive factors for CIS/OSCC. The NAC1 LIs/IRI cut-off values which discriminated between OED and CIS/OSCC were 50%/124 pixels. For NAC1 LIs with > 50% positivity the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 0.766, 0.910, 0.857, and 0.847, respectively. For NAC1 IRI with <= 124 positive pixels, the sensitivity, specificity, PPV, and NPV were 0.787, 0.866, 0.804, and 0.853, respectively. Though there are several potential limitations to this study and the results were obtained from a retrospective analysis of a single site cohort, the data suggest that the NAC1 LIs/IRI is a strong predictor of CIS/OSCC. Conclusions NAC1 has potential as a marker for distinguishing OED from CIS/OSCC.	[Sekine, Joji; Ohira, Koichiro; Hideshima, Katsumi; Kanno, Takahiro; Nariai, Yoshiki] Shimane Univ, Fac Med, Dept Oral & Maxillofacial Surg, Izumo, Shimane, Japan; [Nakatani, Eiji; Kagimura, Tatsuo] Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Kobe, Hyogo, Japan; [Urano, Takeshi] Shimane Univ, Fac Med, Dept Biochem, Izumo, Shimane, Japan	Shimane University; Institute for Biomedical Research & Innovation (IBRI); Shimane University	Sekine, J (corresponding author), Shimane Univ, Fac Med, Dept Oral & Maxillofacial Surg, Izumo, Shimane, Japan.	georges@med.shimane-u.ac.jp	Nakatani, Eiji/O-2782-2013	Nakatani, Eiji/0000-0002-4876-446X	research budget of the Department of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine	research budget of the Department of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine	This study was not supported by a national grant but was supported by the research budget of the Department of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes L., 2005, WHO CLASSIFICATION T; Cawson RA, 2001, ORAL DIS; Dost F, 2014, OR SURG OR MED OR PA, V117, P343, DOI 10.1016/j.oooo.2013.09.017; El Hallani S, 2013, ORAL ONCOL, V49, P582, DOI 10.1016/j.oraloncology.2013.01.009; Garcia-de Marcos JA, 2014, INT J ORAL MAX SURG, V43, P274, DOI 10.1016/j.ijom.2013.10.016; Kaur J, 2014, INT J CANCER, V134, P1379, DOI 10.1002/ijc.28473; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Nakabayashi M, 2014, ONCOL LETT, V7, P750, DOI 10.3892/ol.2013.1775; Nakayama K, 2010, GYNECOL ONCOL, V119, P469, DOI 10.1016/j.ygyno.2010.08.031; Nankivell P, 2013, BRIT J CANCER, V109, P2864, DOI 10.1038/bjc.2013.600; Nevill BW, 2001, ORAL MAXILLOFACIAL P, P315; Ohira K, 2015, SHIMANE J MED SCI, V31, P29; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rahman MT, 2012, BRIT J CANCER, V107, P300, DOI 10.1038/bjc.2012.246; Ramasubramanian Abilasha, 2013, J Nat Sci Biol Med, V4, P349, DOI 10.4103/0976-9668.117011; Sankaranarayanan R, 1998, ANTICANCER RES, V18, P4779; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; van Zyl AW, 2012, HEAD NECK PATHOL, V6, P322, DOI 10.1007/s12105-012-0352-9; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wittekindt C, 2012, GMS CURR TOP OTORHIN, V11, pDoc09, DOI DOI 10.3205/CTO000091	20	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131752	10.1371/journal.pone.0131752	http://dx.doi.org/10.1371/journal.pone.0131752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172271	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900023
J	Sobral, M; Veiga, T; Dominguez, P; Guitian, JA; Guitian, P; Guitian, JM				Sobral, Mar; Veiga, Tania; Dominguez, Paula; Guitian, Javier A.; Guitian, Pablo; Guitian, Jose M.			Selective Pressures Explain Differences in Flower Color among Gentiana lutea Populations	PLOS ONE			English	Article							MIMULUS-AURANTIACUS; NATURAL-SELECTION; FLORAL-COLOR; WILD RADISH; POLLINATORS; HERBIVORES; ANTHOCYANINS; PIGMENTATION; CAROTENOIDS; MAINTENANCE	Flower color variation among plant populations might reflect adaptation to local conditions such as the interacting animal community. In the northwest Iberian Peninsula, flower color of Gentiana lutea varies longitudinally among populations, ranging from orange to yellow. We explored whether flower color is locally adapted and the role of pollinators and seed predators as agents of selection by analyzing the influence of flower color on (i) pollinator visitation rate and (ii) escape from seed predation and (iii) by testing whether differences in pollinator communities correlate with flower color variation across populations. Finally, (iv) we investigated whether variation in selective pressures explains flower color variation among 12 G. lutea populations. Flower color influenced pollinator visits and differences in flower color among populations were related to variation in pollinator communities. Selective pressures on flower color vary among populations and explain part of flower color differences among populations of G. lutea. We conclude that flower color in G. lutea is locally adapted and that pollinators play a role in this adaptation.	[Sobral, Mar; Guitian, Jose M.] Univ Santiago de Compostela, Area Ecol, Santiago De Compostela 15782, Galicia, Spain; [Sobral, Mar] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Veiga, Tania; Dominguez, Paula; Guitian, Javier A.; Guitian, Pablo] Univ Santiago de Compostela, Dept Bot, Santiago De Compostela 15782, Galicia, Spain	Universidade de Santiago de Compostela; Stanford University; Universidade de Santiago de Compostela	Sobral, M (corresponding author), Univ Santiago de Compostela, Area Ecol, Santiago De Compostela 15782, Galicia, Spain.	sobral.bernal.mar@gmail.com	Sobral, Mar/Q-9812-2017	Sobral, Mar/0000-0001-6995-0491	Ministerio de Ciencia [CGL2009-08959]; Plan Galego de Investigacion e Crecemento (Plan I2C), Conselleria de Educacion e Ordenacion Universitaria e Innovacion	Ministerio de Ciencia(Spanish Government); Plan Galego de Investigacion e Crecemento (Plan I2C), Conselleria de Educacion e Ordenacion Universitaria e Innovacion	This work was financed by the Plan Nacional de I + D + I (2008-2011), CGL2009-08959 Ministerio de Ciencia. T.V. was supported by a PhD grant from the Plan Galego de Investigacion e Crecemento 2011/2015 (Plan I2C), Conselleria de Educacion e Ordenacion Universitaria e Innovacion.	Alarcon M, 2012, MOL PHYLOGENET EVOL, V63, P866, DOI 10.1016/j.ympev.2012.02.031; Alcantara JM, 2010, J EVOLUTION BIOL, V23, P1218, DOI 10.1111/j.1420-9101.2010.01981.x; Arista M, 2013, J ECOL, V101, P1613, DOI 10.1111/1365-2745.12151; Borghesi E, 2011, J AGR FOOD CHEM, V59, P11676, DOI 10.1021/jf2021623; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carlson JE, 2013, OECOLOGIA, V171, P905, DOI 10.1007/s00442-012-2453-2; Caruso CM, 2010, INT J PLANT SCI, V171, P1020, DOI 10.1086/656511; Chittka L, 1997, ISRAEL J PLANT SCI, V45, P169, DOI 10.1080/07929978.1997.10676682; Conner J. K., 2004, PRIMER ECOLOGICAL GE; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Frey FM, 2004, EVOLUTION, V58, P2426, DOI 10.1111/j.0014-3820.2004.tb00872.x; Gonzalez-Lopez O, 2014, INT J MOL SCI, V15, P10052, DOI 10.3390/ijms150610052; Herrera C.M., 2006, ECOLOGY EVOLUTION FL, P278; Irwin RE, 2003, ECOLOGY, V84, P1733, DOI 10.1890/0012-9658(2003)084[1733:TROHIT]2.0.CO;2; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kohlein F, 1991, GENTIANS; Kolb A, 2007, PERSPECT PLANT ECOL, V9, P79, DOI 10.1016/j.ppees.2007.09.001; Kugler H., 1943, ERG BIOL, V19, P323; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Manzaneda AJ, 2008, ECOGRAPHY, V31, P583, DOI 10.1111/j.0906-7590.2008.05345.x; Saiz JCM, 2013, J BIOGEOGR, V40, P90, DOI 10.1111/j.1365-2699.2012.02774.x; Newman E, 2012, P ROY SOC B-BIOL SCI, V279, P2309, DOI 10.1098/rspb.2011.2375; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Rausher MD, 2008, INT J PLANT SCI, V169, P7, DOI 10.1086/523358; RAUSHER MD, 1992, EVOLUTION, V46, P616, DOI 10.1111/j.1558-5646.1992.tb02070.x; Renoult JP, 2013, J EVOLUTION BIOL, V26, P2415, DOI 10.1111/jeb.12234; Rodriguez-Girones MA, 2004, PLOS BIOL, V2, P1515, DOI 10.1371/journal.pbio.0020350; Rossi M, 2014, FLORA, V209, P164, DOI 10.1016/j.flora.2014.02.002; Schemske DW, 2007, EVOLUTION, V61, P2528, DOI 10.1111/j.1558-5646.2007.00219.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stinchcombe JR, 2002, AM NAT, V160, P511, DOI 10.1086/342069; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; Strauss SY, 2004, J ECOL, V92, P132, DOI 10.1111/j.1365-2745.2004.00843.x; Streisfeld MA, 2007, J EVOLUTION BIOL, V20, P122, DOI 10.1111/j.1420-9101.2006.01216.x; Streisfeld MA, 2005, EVOLUTION, V59, P2548, DOI 10.1111/j.0014-3820.2005.tb00968.x; Struwe L, 2002, GENTIANACEAE SYSTEMA; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Thompson JD., 1994, COEVOLUTIONARY PROCE; Veiga T, 2015, EVOL ECOL, V29, P451, DOI 10.1007/s10682-014-9751-6; Yoshida K, 2003, PLANT CELL PHYSIOL, V44, P262, DOI 10.1093/pcp/pcg033; Zhu CF, 2002, PLANT MOL BIOL, V48, P277, DOI 10.1023/A:1013383120392; Zhu CF, 2010, ARCH BIOCHEM BIOPHYS, V504, P132, DOI 10.1016/j.abb.2010.07.028; Zhua CF, 2003, BBA-GENE STRUCT EXPR, V1625, P305, DOI 10.1016/S0167-4781(03)00017-4	46	30	31	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132522	10.1371/journal.pone.0132522	http://dx.doi.org/10.1371/journal.pone.0132522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172378	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900056
J	Farahani, F; Shariatpanahi, E; Jahanshahi, J; Poorolajal, J				Farahani, Farhad; Shariatpanahi, Elnaz; Jahanshahi, Javane; Poorolajal, Jalal			Diagnostic Performance of Endoscopic and Microscopic Procedures for Identifying Different Middle Ear Structures and Remaining Disease in Patients with Chronic Otitis Media: A Prospective Cohort Study	PLOS ONE			English	Article							CHOLESTEATOMA; MANAGEMENT; TYMPANOPLASTY	Background The diagnostic performance of endoscopic and microscopic procedures for detecting diseases of the middle ear in patients with chronic otitis media (COM) has rarely been investigated. This study was conducted to compare the performance of these procedures for identifying middle ear structures and their associated diseases in COM patients. Methods In this prospective cohort study, 58 patients with chronic COM, who were candidates for tympanoplasty with or without a mastoidectomy, were enrolled. Before the surgical intervention, the middle ear was examined via an operating microscope and then through an endoscope to identify the middle ear structures as well as diseases associated with the middle ear. Results The patients were 15 years of age or older. The anatomical parts of the middle ear - the epitympanic, posterior mesotympanic, and hypotympanic structures - were more visible through an endoscope than through a microscope. In addition, the various segments of the mesotympanum, oval window, round window, and Eustachian tube were more visible via endoscopy. The post-operative endoscopic reevaluation of the middle ear revealed that a cholesteatoma had remained in four of 13 patients after surgery. Conclusion According to the results of this study, in cases in which there is poor visibility with the operating microscope or the surgeon suspects remaining disease within the middle ear, endoscopy could be utilized to improve the evaluation of more hidden middle ear pits and structures, particularly if there is a potentially recrudescent pathology.	[Farahani, Farhad; Shariatpanahi, Elnaz; Jahanshahi, Javane] Hamadan Univ Med Sci, Sch Med, Dept Otolaryngol, Hamadan, Iran; [Poorolajal, Jalal] Hamadan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Modeling Noncommunicable Dis Res Ctr, Hamadan, Iran		Poorolajal, J (corresponding author), Hamadan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Modeling Noncommunicable Dis Res Ctr, Hamadan, Iran.	poorolajal@umsha.ac.ir	farahani, farhad/N-5865-2018; jahanshahi, javaneh/H-1440-2017; Poorolajal, Jalal/D-3506-2013; Shariatpanahi, Elnaz/P-5763-2017	farahani, farhad/0000-0001-7977-089X; jahanshahi, javaneh/0000-0002-0064-7408; Shariatpanahi, Elnaz/0000-0003-0218-5689	Hamadan University of Medical Sciences	Hamadan University of Medical Sciences	This article was part of the MD thesis in Otolaryngology which was funded by Hamadan University of Medical Sciences.	Ayache S, 2008, OTOL NEUROTOL, V29, P1085, DOI 10.1097/MAO.0b013e318188e8d7; Badr-el-Dine M, 2002, OTOL NEUROTOL, V23, P631, DOI 10.1097/00129492-200209000-00004; BOTTRILL ID, 1995, AM J OTOL, V16, P158; Campbell AP, 2010, LARYNGOSCOPE, V120, P1619, DOI 10.1002/lary.20979; El-Begermy M, 2003, INT C SERIES, V1240, P919; El-Begermy MA, 2003, INT C SERIES, V1240, P907; Flint PW, 2010, COMMINGS OTOLARYNGOL; Fritsch MH, 2009, OTOLARYNGOLOGIC CLIN, V48, P8; GLASSCOCK ME, 1976, LARYNGOSCOPE, V86, P1639, DOI 10.1288/00005537-197611000-00005; Junior JFN, 2009, INT OTORHINOLOGY, V13, P46; Liu Y, 2010, CHINESE MED J-PEKING, V123, P291, DOI 10.3760/cma.j.issn.0366-6999.2010.03.007; Marchioni D, 2010, LARYNGOSCOPE, V120, P1847, DOI 10.1002/lary.21069; Marchioni D, 2010, LARYNGOSCOPE, V120, P1880, DOI 10.1002/lary.20995; Poe DS, 1992, OPER TECH OTOLAYNGOL, V3, P239; Snyderman CH, 2006, OP TECH OTOLARYNGOL, V17, P168; Tarabichi M, 1999, ANN OTO RHINOL LARYN, V108, P39, DOI 10.1177/000348949910800106; Tarabichi M, 1997, AM J OTOL, V18, P544; Tarabichi M, 2000, OTOLARYNG HEAD NECK, V122, P874, DOI 10.1016/S0194-5998(00)70017-9; Tarabichi M., 2004, LARYNGOSCOPE, V114, P1157; Tarabichi M, 2010, OTOL NEUROTOL, V31, P580, DOI 10.1097/MAO.0b013e3181db72f8; Wang JL, 2010, ACTAOTOLARYNG, V96, P72; Yadav SPS, 2009, SINGAP MED J, V50, P510	22	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132890	10.1371/journal.pone.0132890	http://dx.doi.org/10.1371/journal.pone.0132890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167935	gold, Green Published, Green Submitted			2022-12-27	WOS:000358193100094
J	Rossi, R				Rossi, Rodolfo			Do Maternal Living Arrangements Influence the Vaccination Status of Children Age 12-23 Months? A Data Analysis of Demographic Health Surveys 2010-11 from Zimbabwe	PLOS ONE			English	Article							IMMUNIZATION; COVERAGE	Introduction Although vaccination is an effective intervention to reduce childhood mortality and morbidity, reasons for incomplete vaccination, including maternal living arrangements, have been marginally explored. This study aims at assessing whether maternal living arrangements are associated with vaccination status of children aged 12-23 months in Zimbabwe. It also explores other variables that may be associated with having children not fully vaccinated. Materials and Methods A cross-sectional analysis was performed on the DHS-VI done in Zimbabwe in 2010-2011 (response rate 93%). Incomplete vaccination of children (outcome), was defined as not having received one dose of BCG and measles, 3 doses of polio and DPT/Pentavalent. Maternal living arrangements (main exposure), and other exposure variables were analysed. Survey logistic regression was used to calculate crude and adjusted OR for exposures against the outcome. Results The dataset included 1,031 children aged 12-23 months. 65.8% of children were fully vaccinated. 65.7% of the mothers were married and cohabitating with a partner, 20.3% were married/partnered but living separately and 14% were not married. Maternal living arrangements were not associated with the vaccination status of children both in crude and adjusted analysis. Factors associated with poorer vaccination status of the children included: no tetanus vaccination for mothers during pregnancy (adjusted OR = 2.1, 95% CI 1.5; 3.0), child living away from mother (adjusted OR = 1.5, 95% CI 1.2; 1.8), mother's education (adjusted OR = 0.6, 95% CI 0.4; 0.9), high number of children living in the household (adjusted OR = 1.5, 95% CI 1.1; 2.2), child age (adjusted OR = 0.7, 95% CI 0.5; 0.9). Discussion Maternal living arrangements were not associated with vaccination status of Zimbabwean children. Other factors, such as the mother's health-seeking behaviour and education were major factors associated with the children's vaccination status. Given the results of this study, it is strongly recommended that the vaccination coverage is increased by improving access to antenatal care and education for the parents.	London Sch Hyg & Trop Med, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Rossi, R (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	rossirodolfo@yahoo.co.uk						Aemro B., 2011, INEQUALITIES CHILDHO; Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6; Bishai DM, 2008, LANCET, V372, P2004, DOI 10.1016/S0140-6736(08)61853-X; Calhoun LM, 2014, AM J TROP MED HYG, V90, P234, DOI 10.4269/ajtmh.13-0127; Clark A, 2009, LANCET, V373, P1543, DOI 10.1016/S0140-6736(09)60317-2; Ekra D., 2009, B SOC PATHOL EXOT, V102, P59, DOI [10.3185/pathexo3223, DOI 10.3185/PATHEXO3223]; Faye A., 2010, MED AFRIQUE NOIR 201, V57; Harrison KA, 1997, LANCET, V349, P644, DOI 10.1016/S0140-6736(97)02192-2; ICF International, 2011, DEM HLTH SURV METH Q; Jani JV, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-161; Khowaja AR, 2012, B WORLD HEALTH ORGAN, V90, P822, DOI 10.2471/BLT.12.106260; King R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-319; Larson HJ, 2013, LANCET INFECT DIS, V13, P606, DOI 10.1016/S1473-3099(13)70108-7; Lim SS, 2008, LANCET, V372, P2031, DOI 10.1016/S0140-6736(08)61869-3; Lu CL, 2006, LANCET, V368, P1088, DOI 10.1016/S0140-6736(06)69337-9; Luman ET, 2007, INT J EPIDEMIOL, V36, P633, DOI 10.1093/ije/dym025; Maher D, 2013, B WORLD HEALTH ORGAN, V91, P283, DOI 10.2471/BLT.12.111831; Sackou K J, 2012, Bull Soc Pathol Exot, V105, P284, DOI 10.1007/s13149-012-0212-6; Salmon DA, 2006, LANCET, V367, P436, DOI 10.1016/S0140-6736(06)68144-0; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; WHO/UNICEF, 2014, GLOB REG IMM PROF WH; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2	22	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132357	10.1371/journal.pone.0132357	http://dx.doi.org/10.1371/journal.pone.0132357			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167939	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100037
J	Li, YN; Zhou, Q; Hu, Z; Yang, B; Li, QS; Wang, JH; Zheng, JH; Cao, WW				Li, Yongning; Zhou, Qi; Hu, Zheng; Yang, Bin; Li, Qingsong; Wang, Jianhua; Zheng, Jinhua; Cao, Wenwu			5-Aminolevulinic Acid-Based Sonodynamic Therapy Induces the Apoptosis of Osteosarcoma in Mice	PLOS ONE			English	Article							LOW-INTENSITY ULTRASOUND; CELLS IN-VITRO; PROTOPORPHYRIN IX; TUMOR-GROWTH; K562 CELLS; HEMATOPORPHYRIN; SONOSENSITIZER; CANCER	Objective Sonodynamic therapy (SDT) is promising for treatment of cancer, but its effect on osteosarcoma is unclear. This study examined the effect of 5-Aminolevulinic Acid (5-ALA)-based SDT on the growth of implanted osteosarcoma and their potential mechanisms in vivo and in vitro. Methods The dose and metabolism of 5-ALA and ultrasound periods were optimized in a mouse model of induced osteosarcoma and in UMR-106 cells. The effects of ALA-SDT on the proliferation and apoptosis of UMR-106 cells and the growth of implanted osteosarcoma were examined. The levels of mitochondrial membrane potential (Delta psi M), ROS production, BcL-2, Bax, p53 and caspase 3 expression in UMR-106 cells were determined. Results Treatment with 5-ALA for eight hours was optimal for ALA-SDT in the mouse tumor model and treatment with 2 mM 5-ALA for 6 hours and ultrasound (1.0 MHz 2.0 W/cm(2)) for 7 min were optimal for UMR-106 cells. SDT, but not 5-ALA, alone inhibited the growth of implanted osteosarcoma in mice (P<0.01) and reduced the viability of UMR-106 cells (p<0.05). ALA-SDT further reduced the tumor volumes and viability of UMR-106 cells (p<0.01 for both). Pre-treatment with 5-ALA significantly enhanced the SDT-mediated apoptosis (p<0.01) and morphological changes. Furthermore, ALA-SDT significantly reduced the levels of Delta psi M, but increased levels of ROS in UMR-106 cells (p<0.05 or p<0.01 vs. the Control or the Ultrasound). Moreover, ALA-SDT inhibited the proliferation of osteosarcoma cells and BcL-2 expression, but increased levels of Bax, p53 and caspase 3 expression in the implanted osteosarcoma tissues (p<0.05 or p<0.01 vs. the Control or the Ultrasound). Conclusions The ALA-SDT significantly inhibited osteosarcoma growth in vivo and reduced UMR-106 cell survival by inducing osteosarcoma cell apoptosis through the ROS-related mitochondrial pathway.	[Li, Yongning; Cao, Wenwu] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150080, Peoples R China; [Zhou, Qi; Hu, Zheng; Yang, Bin] Harbin Inst Technol, Lab Photo & Sonotheranost Technol, Harbin 150080, Peoples R China; [Zhou, Qi; Hu, Zheng; Yang, Bin] Harbin Inst Technol, Condensed Matter Sci & Technol Inst, Harbin 150080, Peoples R China; [Li, Qingsong] Dalian Med Univ, Affiliated Hosp 1, Cardiovasc Inst, Dalian 116011, Peoples R China; [Wang, Jianhua; Zheng, Jinhua] Harbin Med Univ, Coll Basic Med Sci, Dept Anat, Harbin 150080, Peoples R China; [Cao, Wenwu] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA	Harbin Institute of Technology; Harbin Institute of Technology; Harbin Institute of Technology; Dalian Medical University; Harbin Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cao, WW (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150080, Peoples R China.	dzk@psu.edu	金华, 郑/GWM-7529-2022; Hu, Zheng/AAI-3025-2020; Cao, Wenwu/F-6091-2012	Hu, Zheng/0000-0002-3323-0369; Cao, Wenwu/0000-0002-2447-1486	National Key Technology R&D Program of China [2013BAI03B06]	National Key Technology R&D Program of China(National Key Technology R&D Program)	This work was supported by the National Key Technology R&D Program of China (Grant No. 2013BAI03B06).	Ahmadi F, 2012, PROG BIOPHYS MOL BIO, V108, P119, DOI 10.1016/j.pbiomolbio.2012.01.004; Cheng JL, 2013, INT J NANOMED, V8, P669, DOI 10.2147/IJN.S39844; Chou Alexander J, 2008, Paediatr Drugs, V10, P315, DOI 10.2165/00148581-200810050-00005; Gao ZXZ, 2013, CANCER LETT, V335, P93, DOI 10.1016/j.canlet.2013.02.006; Hagiya Y, 2013, PHOTODIAGN PHOTODYN, V10, P288, DOI 10.1016/j.pdpdt.2013.02.001; Hasanzadeh H, 2011, ULTRASON SONOCHEM, V18, P394, DOI 10.1016/j.ultsonch.2010.07.005; He Y, 2010, ULTRASONICS, V50, P777, DOI 10.1016/j.ultras.2010.03.004; Ketola A, 2008, CANCER RES, V68, P8342, DOI 10.1158/0008-5472.CAN-08-0251; Kinoshita M, 2006, RADIAT RES, V165, P299, DOI 10.1667/RR3510.1; Komori C, 2009, ANTICANCER RES, V29, P2411; Li HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059473; Li YS, 2008, CANCER LETT, V266, P156, DOI 10.1016/j.canlet.2008.02.041; Lv YH, 2012, CELL PHYSIOL BIOCHEM, V30, P321, DOI 10.1159/000339067; Rosenthal I, 2004, ULTRASON SONOCHEM, V11, P349, DOI 10.1016/j.ultsonch.2004.03.004; Sakamoto A, 2008, REV RECENT CLIN TRIA, V3, P228, DOI 10.2174/157488708785700267; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Shibaguchi H, 2011, ANTICANCER RES, V31, P2425; Song W, 2011, ANTICANCER RES, V31, P39; Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105; Su XM, 2014, ULTRASONICS, V54, P275, DOI 10.1016/j.ultras.2013.07.015; Tang W, 2010, ULTRASONICS, V50, P567, DOI 10.1016/j.ultras.2009.12.001; Tang W, 2009, ULTRASONICS, V49, P786, DOI 10.1016/j.ultras.2009.06.002; Tian ZD, 2010, INTEGR CANCER THER, V9, P365, DOI 10.1177/1534735410379013; Tian ZD, 2009, J ULTRAS MED, V28, P1695, DOI 10.7863/jum.2009.28.12.1695; Tsuang YH, 2011, ARTIF ORGANS, V35, P373, DOI 10.1111/j.1525-1594.2010.01086.x; Tsuru H, 2012, FREE RADICAL BIO MED, V53, P464, DOI 10.1016/j.freeradbiomed.2012.04.025; Uto Y, 2014, ANTICANCER RES, V34, P4583; Wang S, 2014, ULTRASOUND MED BIOL, V40, P2125, DOI 10.1016/j.ultrasmedbio.2014.05.007; Wang XB, 2010, ULTRASOUND MED BIOL, V36, P667, DOI 10.1016/j.ultrasmedbio.2009.09.006; Wang XB, 2010, ULTRASONICS, V50, P803, DOI 10.1016/j.ultras.2010.04.004; Xiang JY, 2011, ULTRASONICS, V51, P390, DOI 10.1016/j.ultras.2010.11.005; YUMITA N, 1989, JPN J CANCER RES, V80, P219, DOI 10.1111/j.1349-7006.1989.tb02295.x	32	27	28	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132074	10.1371/journal.pone.0132074	http://dx.doi.org/10.1371/journal.pone.0132074			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161801	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300090
J	Matsuzaki, M; Pant, R; Kulkarni, B; Kinra, S				Matsuzaki, Mika; Pant, Rashmi; Kulkarni, Bharati; Kinra, Sanjay			Comparison of Bone Mineral Density between Urban and Rural Areas: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HIP-FRACTURES; SWEDISH URBAN; MASS; POPULATION; MORTALITY; MEN; OSTEOPOROSIS; URBANIZATION; WOMEN	Background Studies from high income countries (HIC) have generally shown higher osteoporotic fracture rates in urban areas than rural areas. Low bone mineral density (BMD) increases susceptibility to fractures. This review aimed to assess whether urbanicity is consistently associated with lower BMD globally. Method Ovid MEDLINE, EMBASE, and Global Health (-April 2013) were searched for articles investigating differences in bone mineral content (BMC) or BMD between urban and rural areas. Ratio of means (RoM) of BMD were used to estimate effect sizes in meta-analysis, with an exception for one study that only presented BMC data. Results Fifteen articles from eleven distinct populations were included in the review; seven populations from four high income countries and four from three low and middle income countries (LMIC). Meta-analysis showed conflicting evidence for urban-rural difference in BMD; studies from high income countries generally showed higher BMD in rural areas while the results were more mixed in studies from low and middle income countries (HIC RoM = 0.05; 95% CI: 0.03 to 0.06; LMIC RoM = -0.04: 95% CI: -0.1 to 0.01). Conclusions Urban-rural differences of bone mineral density may be context-specific. BMD may be higher in urban areas in some lower income countries. More studies with robust designs and analytical techniques are needed to understand mechanisms underlying the effects of urbanization on bone mass accrual and loss.	[Matsuzaki, Mika; Kinra, Sanjay] London Sch Hyg & Trop Med, Dept Non Communicable Dis Epidemiol, London WC1, England; [Pant, Rashmi] Indian Inst Publ Hlth, Hyderabad, Andhra Pradesh, India; [Kulkarni, Bharati] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India	University of London; London School of Hygiene & Tropical Medicine; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Matsuzaki, M (corresponding author), London Sch Hyg & Trop Med, Dept Non Communicable Dis Epidemiol, London WC1, England.	mika.matsuzaki@lshtm.ac.uk	Pant, Rashmi/AAH-5146-2019; Kulkarni, Bharati/ABB-3188-2020	Kulkarni, Bharati/0000-0003-0636-318X				Allender S, 2010, B WORLD HEALTH ORGAN, V88, P297, DOI 10.2471/BLT.09.065847; [Anonymous], WE CLASS COUNTRIES; Bachrach LK, 2001, TRENDS ENDOCRIN MET, V12, P22, DOI 10.1016/S1043-2760(00)00336-2; Brauer Carmen A, 2009, JAMA, V302, P1573, DOI 10.1001/jama.2009.1462; Brennan SL, 2010, J EPIDEMIOL COMMUN H, V64, P656, DOI 10.1136/jech.2008.085738; Cohen B, 2006, TECHNOL SOC, V28, P63, DOI 10.1016/j.techsoc.2005.10.005; Drake MT, 2012, J CLIN ENDOCR METAB, V97, P1861, DOI 10.1210/jc.2011-3058; Filip RS, 2001, ANN AGR ENV MED, V8, P221; Friedrich JO, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-32; GARDSELL P, 1991, J BONE MINER RES, V6, P67; Gu WJ, 2007, BONE, V41, P393, DOI 10.1016/j.bone.2007.05.010; Handa R, 2008, BEST PRACT RES CL RH, V22, P693, DOI 10.1016/j.berh.2008.04.002; Ho-Pham LT, 2009, AM J CLIN NUTR, V90, P943, DOI 10.3945/ajcn.2009.27521; Kanis JA, 2003, BONE, V32, P468, DOI 10.1016/S8756-3282(03)00061-9; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Li Wanli, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P97; Marks R, 2003, AGEING RES REV, V2, P57, DOI 10.1016/S1568-1637(02)00045-4; Meyer HE, 2004, AM J EPIDEMIOL, V160, P1039, DOI 10.1093/aje/kwh337; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Omsland TK, 2011, J BONE MINER RES, V26, P850, DOI 10.1002/jbmr.280; Pongchaiyakul C, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-5; Pongchaiyakul C, 2005, OSTEOPOROSIS INT, V16, P1761, DOI 10.1007/s00198-005-1921-5; Pongchaiyakul Chatlert, 2006, Journal of the Medical Association of Thailand, V89, P160; Ranathunga RMTK, 2008, TROPICAL AGR RES; Ringsberg KAM, 2001, GERONTOLOGY, V47, P15, DOI 10.1159/000052765; Rosengren BE, 2012, SCAND J PUBLIC HEALT, V40, P102, DOI 10.1177/1403494811425604; Rosengren BE, 2010, ACTA ORTHOP, V81, P453, DOI 10.3109/17453674.2010.492762; Specker B, 2004, BONE, V35, P1389, DOI 10.1016/j.bone.2004.09.005; Sundberg M, 1997, ACTA ORTHOP SCAND, V68, P456, DOI 10.3109/17453679708996262; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Woolf Anthony D, 2005, Curr Osteoporos Rep, V3, P84, DOI 10.1007/s11914-005-0015-9	31	11	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132239	10.1371/journal.pone.0132239	http://dx.doi.org/10.1371/journal.pone.0132239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162093	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000358162300105
J	Tomita, M; Kubota, T; Ishioka, F				Tomita, Makoto; Kubota, Takafumi; Ishioka, Fumio			Spatial Clustering Properties in the Temporal Variation of Suicide Rates/Numbers among Japanese Citizens: A Comprehensive Comparison and Discussion	PLOS ONE			English	Article							TESTS	Objective The number of suicides in Japan has remained high for many years. To effectively resolve this problem, firm understanding of the statistical data is required. Using a large quantity of wide-ranging data on Japanese citizens, the purpose of this study was to analyze the geographical clustering properties of suicides and how suicide rates have evolved over time, and to observe detailed patterns and trends in a variety of geographic regions. Methods Using adjacency data from 2008, the spatial and temporal/spatial clustering structure of geographic statistics on suicides were clarified. Echelon scans were performed to identify regions with the highest-likelihood ratio of suicide as the most likely suicide clusters. Results In contrast to results obtained using temporal/spatial analysis, the results of a period-by-period breakdown of evolving suicide rates demonstrated that suicides among men increased particularly rapidly during 1988-1992, 1993-1997, and 1998-2002 in certain cluster regions located near major metropolitan areas. For women, results identified cluster regions near major metropolitan areas in 1993-1997, 1998-2002, and 2003-2007. Conclusions For both men and women, the cluster regions identified are located primarily near major metropolitan areas, such as greater Tokyo and Osaka.	[Tomita, Makoto] Tokyo Med & Dent Univ, Clin Res Ctr, Bunkyo Ward, Tokyo, Japan; [Kubota, Takafumi] Tama Univ, Sch Management & Informat Sci, Tama Ku, Tokyo, Japan; [Ishioka, Fumio] Okayama Univ, Sch Law, Okayama, Okayama, Japan	Tokyo Medical & Dental University (TMDU); Okayama University	Tomita, M (corresponding author), Tokyo Med & Dent Univ, Clin Res Ctr, Bunkyo Ward, Tokyo, Japan.	tomita.crc@tmd.ac			KAKENHI [24500337]; Grants-in-Aid for Scientific Research [24500337] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from KAKENHI (24500337, Grant-in-Aid for Scientific Research (C), http://www.jsps.go.jp/english/e-grants/index.html).	ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; BESAG J, 1991, J ROY STAT SOC A STA, V154, P143, DOI 10.2307/2982708; Cabinet Office Government of Japan, 2008, 2008 WHIT PAP SUIC P; Chang SS, 2009, SOC SCI MED, V68, P1322, DOI 10.1016/j.socscimed.2009.01.010; DWASS M, 1957, ANN MATH STAT, V28, P181, DOI 10.1214/aoms/1177707045; Fujita T, 2009, STAT COMMUNITY DEATH; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kurihara K, 2004, ST CLASS DAT ANAL, P251; Martiello MA, 2006, EPIDEMIOL PSICHIAT S, V15, P202, DOI 10.1017/S1121189X00004450; Myers W, 1997, ENVIRON ECOL STAT, V4, P131, DOI 10.1023/A:1018518327329; Openshaw S, 1987, INT J GEOGR INF SYST, V1, P335, DOI DOI 10.1080/02693798708927821; Patil GP, 2004, ENVIRON ECOL STAT, V11, P183, DOI 10.1023/B:EEST.0000027208.48919.7e; Qi X, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-106; Qi X, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-46; Bastos MDRP, 2009, REV SAUDE PUBL, V43, P123; TANGO T, 1995, STAT MED, V14, P2323, DOI 10.1002/sim.4780142105; Tango T, 2010, STAT METHODS DIS CLU; Tango Toshiro, 2005, Int J Health Geogr, V4, P11, DOI 10.1186/1476-072X-4-11; Yamauchi T, 2013, J PUBLIC HEALTH-UK, V35, P49, DOI 10.1093/pubmed/fds054	20	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0127358	10.1371/journal.pone.0127358	http://dx.doi.org/10.1371/journal.pone.0127358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161651	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300005
J	Torkamaneh, D; Belzile, F				Torkamaneh, Davoud; Belzile, Francois			Scanning and Filling: Ultra-Dense SNP Genotyping Combining Genotyping-By-Sequencing, SNP Array and Whole-Genome Resequencing Data	PLOS ONE			English	Article							GENETIC DIVERSITY ANALYSIS; LINKAGE DISEQUILIBRIUM; WIDE ASSOCIATION; IMPUTATION; PREDICTION; MARKERS; SELECTION; ACCURACY; PATTERNS; COVERAGE	Genotyping-by-sequencing (GBS) represents a highly cost-effective high-throughput geno-typing approach. By nature, however, GBS is subject to generating sizeable amounts of missing data and these will need to be imputed for many downstream analyses. The extent to which such missing data can be tolerated in calling SNPs has not been explored widely. In this work, we first explore the use of imputation to fill in missing genotypes in GBS data-sets. Importantly, we use whole genome resequencing data to assess the accuracy of the imputed data. Using a panel of 301 soybean accessions, we show that over 62,000 SNPs could be called when tolerating up to 80% missing data, a five-fold increase over the number called when tolerating up to 20% missing data. At all levels of missing data examined (between 20% and 80%), the resulting SNP datasets were of uniformly high accuracy (96-98%). We then used imputation to combine complementary SNP datasets derived from GBS and a SNP array (SoySNP50K). We thus produced an enhanced dataset of >100,000 SNPs and the genotypes at the previously untyped loci were again imputed with a high level of accuracy (95%). Of the >4,000,000 SNPs identified through resequencing 23 accessions (among the 301 used in the GBS analysis), 1.4 million tag SNPs were used as a reference to impute this large set of SNPs on the entire panel of 301 accessions. These previously untyped loci could be imputed with around 90% accuracy. Finally, we used the 100K SNP dataset (GBS + SoySNP50K) to perform a GWAS on seed oil content within this collection of soybean accessions. Both the number of significant marker-trait associations and the peak significance levels were improved considerably using this enhanced catalog of SNPs relative to a smaller catalog resulting from GBS alone at <= 20% missing data. Our results demonstrate that imputation can be used to fill in both missing genotypes and untyped loci with very high accuracy and that this leads to more powerful genetic analyses.	[Belzile, Francois] Univ Laval, Dept Phytol, Quebec City, PQ G1K 7P4, Canada; Univ Laval, IBIS, Quebec City, PQ, Canada	Laval University; Laval University	Belzile, F (corresponding author), Univ Laval, Dept Phytol, Quebec City, PQ G1K 7P4, Canada.	francois.belzile@fsaa.ulaval.ca		Belzile, Francois/0000-0001-6893-4529; Torkamaneh, Davoud/0000-0002-9782-5695	Canadian Field Crop Research Alliance [AIP CL-23]	Canadian Field Crop Research Alliance	1. Funding for this research was provided by the Canadian Field Crop Research Alliance (http://www.fieldcropresearch.ca/; Project no. AIP CL-23). 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Crossa J, 2013, G3-GENES GENOM GENET, V3, P1903, DOI 10.1534/g3.113.008227; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; De Donato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062137; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Ellinghaus David, 2009, Hum Genomics, V3, P371; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fu YB, 2014, G3-GENES GENOM GENET, V4, P891, DOI 10.1534/g3.114.010942; Fu YB, 2014, GENET RESOUR CROP EV, V61, P579, DOI 10.1007/s10722-013-0058-1; Fu YB, 2012, MOL ECOL RESOUR, V12, P492, DOI 10.1111/j.1755-0998.2011.03100.x; Fu YB, 2011, PLANT GENOME-US, V4, P226, DOI 10.3835/plantgenome2011.08.0022; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Hao K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-27; He Sang, 2015, BMC Genomics, V16, P168, DOI 10.1186/s12864-015-1366-y; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang BE, 2014, GENETICS, V197, P401, DOI 10.1534/genetics.113.158014; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Jarquin D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-740; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kumar S., 2012, INT J COMP APP IRAFI, V5, P1; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Ha NT, 2014, EUR J HUM GENET, V22, P1124, DOI 10.1038/ejhg.2013.304; Pei YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003551; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Porto-Neto LR, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-22; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rutkoski JE, 2013, G3-GENES GENOM GENET, V3, P427, DOI 10.1534/g3.112.005363; Santana MHA, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-21; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Shifman S, 2003, HUM MOL GENET, V12, P771, DOI 10.1093/hmg/ddg088; Sonah H, 2015, PLANT BIOTECHNOL J, V13, P211, DOI 10.1111/pbi.12249; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Song Q., 2015, FINGERPRINTING SOYBE; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Wang M, 2012, PLANT SCI, V196, P125, DOI 10.1016/j.plantsci.2012.08.004; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yang ZY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-87; Zheng J, 2011, GENET EPIDEMIOL, V35, P102, DOI 10.1002/gepi.20552; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	48	44	45	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131533	10.1371/journal.pone.0131533	http://dx.doi.org/10.1371/journal.pone.0131533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161900	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300043
J	Wang, YP; Sun, ZL; Lam, KM				Wang, Ya-Ping; Sun, Zhan-Li; Lam, Kin-Man			An Effective Approach for NRSFM of Small-Size Image Sequences	PLOS ONE			English	Article							SHAPE	In recent years, non-rigid structure from motion (NRSFM) has become one of the hottest issues in computer vision due to its wide applications. In practice, the number of available high-quality images may be limited in many cases. Under such a condition, the performances may not be satisfactory when existing NRSFM algorithms are applied directly to estimate the 3D coordinates of a small-size image sequence. In this paper, a sub-sequence-based integrated algorithm is proposed to deal with the NRSFM problem with small sequence sizes. In the proposed method, sub-sequences are first extracted from the original sequence. In order to obtain diversified estimations, multiple weaker estimators are constructed by applying the extracted sub-sequences to a recent NRSFM algorithm with a rotation-invariant kernel (RIK). Compared to other first-order statistics, the trimmed mean is a relatively robust statistic. Considering the fact that the estimations of some weaker estimators may have large errors, the trimmed means of the outputs for all the weaker estimators are computed to determine the final estimated 3D shapes. Compared to some existing methods, the proposed algorithm can achieve a higher estimation accuracy, and has better robustness. Experimental results on several widely used image sequences demonstrate the effectiveness and feasibility of the proposed algorithm.	[Wang, Ya-Ping; Sun, Zhan-Li] Anhui Univ, Sch Elect Engn & Automat, Hefei 230039, Peoples R China; [Lam, Kin-Man] Hong Kong Polytech Univ, Dept Elect & Informat Engn, Hong Kong, Hong Kong, Peoples R China	Anhui University; Hong Kong Polytechnic University	Sun, ZL (corresponding author), Anhui Univ, Sch Elect Engn & Automat, Hefei 230039, Peoples R China.	zhlsun2006@126.com			National Natural Science Foundation of China [61370109]; Natural Science Foundation of Anhui Province [1308085MF85]; Zhan-Li Sun's Technology Foundation from department of human resources and social security of Anhui Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Zhan-Li Sun's Technology Foundation from department of human resources and social security of Anhui Province	The work was supported by a grant from National Natural Science Foundation of China (No. 61370109), a grant from Natural Science Foundation of Anhui Province (No. 1308085MF85), and 2013 Zhan-Li Sun's Technology Foundation for Selected Overseas Chinese Scholars from department of human resources and social security of Anhui Province (Project name: Research on structure from motion and its application on 3D face reconstruction). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter I, 2009, NEURAL INFORM PROCES, P42; Akhter I, 2011, IEEE T PATTERN ANAL, V33, P1442, DOI 10.1109/TPAMI.2010.201; Akhter I, 2009, PROC CVPR IEEE, P1534, DOI 10.1109/CVPRW.2009.5206620; Bregler C, 2000, PROC CVPR IEEE, P690, DOI 10.1109/CVPR.2000.854941; Gotardo P. F. U., 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P3065, DOI 10.1109/CVPR.2011.5995560; Gotardo PFU, 2011, IEEE I CONF COMP VIS, P802, DOI 10.1109/ICCV.2011.6126319; Gotardo PFU, 2011, IEEE T PATTERN ANAL, V33, P2051, DOI 10.1109/TPAMI.2011.50; Hamsici OC, 2012, LECT NOTES COMPUT SC, V7575, P260, DOI 10.1007/978-3-642-33765-9_19; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Paladini M, 2009, PROC CVPR IEEE, P2890; Scholkopf B, 2002, LEARNING KERNELS SUP, P2491; Scocchia L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059217; Stonkute S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037734; Sun ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055700; Torresani L, 2004, ADV NEUR IN, V16, P1555; Torresani L, 2008, IEEE T PATTERN ANAL, V30, P878, DOI 10.1109/TPAMI.2007.70752; Xiao J, 2004, COMPUTER VISION PATT, V1, P675	17	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132370	10.1371/journal.pone.0132370	http://dx.doi.org/10.1371/journal.pone.0132370			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161521	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300124
J	Wright, NC; Curtis, JR; Arora, T; Smith, WK; Kilgore, ML; Saag, KG; Safford, MM; Delzell, ES				Wright, Nicole C.; Curtis, Jeffrey R.; Arora, Tarun; Smith, Wilson K.; Kilgore, Meredith L.; Saag, Kenneth G.; Safford, Monika M.; Delzell, Elizabeth S.			The Validity of Claims-Based Algorithms to Identify Serious Hypersensitivity Reactions and Osteonecrosis of the Jaw	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; ANAPHYLACTIC SHOCK; VALIDATED METHODS; RISK; ORGANIZATION; ALENDRONATE; FRACTURES; CHILDREN	Validation of claims-based algorithms to identify serious hypersensitivity reactions and osteonecrosis of the jaw has not been performed in large osteoporosis populations. The objective of this project is to estimate the positive predictive value of the claims-based algorithms in older women with osteoporosis enrolled in Medicare. Using the 2006-2008 Medicare 5% sample data, we identified potential hypersensitivity and osteonecrosis of the jaw cases based on ICD-9 diagnosis codes. Potential hypersensitivity cases had a 995.0, 995.2, or 995.3 diagnosis code on emergency department or inpatient claims. Potential osteonecrosis of the jaw cases had >= 1 inpatient or outpatient physician claim with a 522.7, 526.4, 526.5, or 733.45 diagnosis code or >= 2 claims of any type with a 526.9 diagnosis code. All retrieved records were redacted and reviewed by experts to determine case status: confirmed, not confirmed, or insufficient information. We calculated the positive predictive value as the number of confirmed cases divided by the total number of retrieved records with sufficient information. We requested 412 potential hypersensitivity and 304 potential osteonecrosis of the jaw records and received 174 (42%) and 84 (28%) records respectively. Of 84 potential osteonecrosis of the jaw cases, 6 were confirmed, resulting in a positive predictive value (95% CI) of 7.1% (2.7, 14.9). Of 174 retrieved potential hypersensitivity records, 95 were confirmed. After exclusion of 25 records with insufficient information for case determination, the overall positive predictive value (95% CI) for hypersensitivity reactions was 76.0% (67.5, 83.2). In a random sample of Medicare data, a claim-based algorithm to identify serious hypersensitivity reactions performed well. An algorithm for osteonecrosis of the jaw did not, partly due to the inclusion of diagnosis codes that are not specific for osteoporosis of the jaw.	[Wright, Nicole C.; Arora, Tarun; Smith, Wilson K.; Delzell, Elizabeth S.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35233 USA; [Curtis, Jeffrey R.; Saag, Kenneth G.] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Kilgore, Meredith L.] Univ Alabama Birmingham, Dept Hlth Care Org & Policy, Birmingham, AL 35294 USA; [Safford, Monika M.] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wright, NC (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35233 USA.	ncwright@uab.edu	Arora, Tarun/I-6808-2019; Smith, Wilson/GXN-1893-2022	Wright, Nicole/0000-0001-8414-4842; Arora, Tarun/0000-0003-0837-6873	UAB; Amgen, Inc.	UAB; Amgen, Inc.(Amgen)	This project was funded by a contract between UAB and Amgen, Inc. All authors received research support from Amgen, Inc. Amgen played a role in the study design by providing the algorithms evaluated in our project. However, they played no role in data collection and analysis. Per contract policies for the parent project of this study, all manuscripts are reviewed by Amgen prior to submission for a 30 day, non-binding courtesy review. Publication of the manuscript was not conditional on approval from Amgen.	Abrahamsen B, 2010, CURR OPIN RHEUMATOL, V22, P404, DOI 10.1097/BOR.0b013e32833ad677; Abrahamsen B, 2009, J BONE MINER RES, V24, P1095, DOI [10.1359/JBMR.081247, 10.1359/jbmr.081247]; America's Bone Health, 2002, STATE OSTEOPOROSIS L; [Anonymous], 2011, BISPHOSPHONATE MARKE; [Anonymous], 2004, SERVICES UDOHAH; [Anonymous], 2010, HIGHLIGHTS PRESCRIBI; [Anonymous], 1963, CLIN ASPECTS IMMUNOL; Bergdahl Johan, 2013, Clin Epidemiol, V5, P1, DOI 10.2147/CLEP.S37664; Bohlke K, 2004, J ALLERGY CLIN IMMUN, V113, P536, DOI 10.1016/j.jaci.2003.11.033; Cartsos VM, 2008, J AM DENT ASSOC, V139, P23, DOI 10.14219/jada.archive.2008.0016; Gammelager Henrik, 2013, Clin Epidemiol, V5, P263, DOI 10.2147/CLEP.S45226; Iribarren C, 2010, ANN ALLERG ASTHMA IM, V104, P371, DOI 10.1016/j.anai.2010.03.004; Johannes CB, 2007, DRUG SAFETY, V30, P705, DOI 10.2165/00002018-200730080-00007; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Lenart BA, 2008, NEW ENGL J MED, V358, P1304, DOI 10.1056/NEJMc0707493; Leung F, 2009, BMJ CASE REP, P2009, DOI [10.1136/bcr.10.2008.1073bcr10.2008.1073, DOI 10.1136/BCR.10.2008.1073BCR10.2008.1073]; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; Nordstrom BL, 2007, PHARMACOEPIDEM DR S, V16, P289, DOI 10.1002/pds.1337; Palaska PK, 2009, ONCOLOGIST, V14, P1154, DOI 10.1634/theoncologist.2009-0115; Ruggiero SL, 2009, J ORAL MAXIL SURG, V67, P2, DOI 10.1016/j.joms.2009.01.009; Schneider G, 2012, PHARMACOEPIDEM DR S, V21, P248, DOI 10.1002/pds.2333; Schneider G, 2012, PHARMACOEPIDEM DR S, V21, P240, DOI 10.1002/pds.2327; West SL, 2007, PHARMACOEPIDEM DR S, V16, P1255, DOI 10.1002/pds.1502; Zavras AI, 2006, J ORAL MAXIL SURG, V64, P917, DOI 10.1016/j.joms.2006.02.011	24	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131601	10.1371/journal.pone.0131601	http://dx.doi.org/10.1371/journal.pone.0131601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161858	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300049
J	Farrell, KA; Harpole, WS; Stein, C; Suding, KN; Borer, ET				Farrell, Kelly Anne; Harpole, W. Stanley; Stein, Claudia; Suding, Katharine N.; Borer, Elizabeth T.			Grassland Arthropods Are Controlled by Direct and Indirect Interactions with Cattle but Are Largely Unaffected by Plant Provenance	PLOS ONE			English	Article							INSECT COMMUNITIES; LIFE-HISTORY; DIVERSITY; HERBIVORY; DOMINANCE; RICHNESS; INVASION; BIOMASS; DECOMPOSITION; CONSEQUENCES	Cattle grazing and invasion by non-native plant species are globally-ubiquitous changes occurring to plant communities that are likely to reverberate through whole food webs. We used a manipulative field experiment to quantify how arthropod community structure differed in native and non-native California grassland communities in the presence and absence of grazing. The arthropod community was strongly affected by cattle grazing: the biovolume of herbivorous arthropods was 79% higher in grazed than ungrazed plots, whereas the biovolume of predatory arthropods was 13% higher in ungrazed plots. In plots where non-native grasses were grazed, arthropod biovolume increased, possibly in response to increased plant productivity or increased nutritional quality of rapidly-growing annual plants. Grazing may thus affect plant biomass both through the direct removal of biomass, and through arthropod-mediated impacts. We also expected the arthropod community to differ between native and non-native plant communities; surprisingly, arthropod richness and diversity did not vary consistently between these grass community types, although arthropod abundance was slightly higher in plots with native and ungrazed grasses. These results suggest that whereas cattle grazing affects the arthropod community via direct and indirect pathways, arthropod community changes commonly associated with non-native plant invasions may not be due to the identity or dominance of the invasive species in those systems, but to accompanying changes in plant traits or functional group composition, not seen in this experiment because of the similarity of the plant communities.	[Farrell, Kelly Anne] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Harpole, W. Stanley] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [Stein, Claudia] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Suding, Katharine N.] Univ Calif Berkeley, Policy & Management, Environm Sci, Berkeley, CA 94720 USA; [Borer, Elizabeth T.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	Oregon State University; Iowa State University; Washington University (WUSTL); University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities	Farrell, KA (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	kelfathetree@gmail.com	Suding, Katharine/O-6290-2017; Stein, Claudia/AAV-8970-2020; Harpole, William S/C-2814-2013	Suding, Katharine/0000-0002-5357-0176; Harpole, William S/0000-0002-3404-9174; Stein, Claudia/0000-0002-9586-8587; Borer, Elizabeth/0000-0003-2259-5853	United States Department of Agriculture [2006-01350]; University of California Integrated Hardwood and Range Management Program; University of Minnesota; Oregon State University	United States Department of Agriculture(United States Department of Agriculture (USDA)); University of California Integrated Hardwood and Range Management Program; University of Minnesota(University of Minnesota System); Oregon State University	The experiment and its design were funded by the United States Department of Agriculture (www. usda.gov) Managed Ecosystems Grant #2006-01350 to KNS and WSH, and athropod processing was funded by the University of California Integrated Hardwood and Range Management Program (http://ucanr.edu/sites/oak_range/) to ETB, Oregon State University, and the University of Minnesota.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arnett R. H, 2000, AM INSECTS HDB INSEC, V2nd; Arnett RH, 2002, AM BEETLES, V2; ARNETT RH, 2000, AM BEETLES ARCHOSTEM, V1; BARTOLOME JW, 2002, CALIFORNIA GUIDELINE; Belovsky GE, 2000, P NATL ACAD SCI USA, V97, P14412, DOI 10.1073/pnas.250483797; Borer ET, 2007, P NATL ACAD SCI USA, V104, P5473, DOI 10.1073/pnas.0608573104; Borer ET, 2006, ECOLOGY, V87, P2813, DOI 10.1890/0012-9658(2006)87[2813:AICREO]2.0.CO;2; Borer ET, 2012, ECOL LETT, V15, P1457, DOI 10.1111/ele.12006; Borer ET, 2009, ECOL APPL, V19, P1187, DOI 10.1890/08-1205.1; Borer ET, 2009, P NATL ACAD SCI USA, V106, P503, DOI 10.1073/pnas.0808778106; Brusca R.C., 1990, INVERTEBRATES; Chapman SK, 2003, ECOLOGY, V84, P2867, DOI 10.1890/02-0046; Conant RT, 2001, ECOL APPL, V11, P343, DOI 10.1890/1051-0761(2001)011[0343:GMACIG]2.0.CO;2; Coupe MD, 2003, ECOL ENTOMOL, V28, P511, DOI 10.1046/j.1365-2311.2003.00540.x; Dennis P, 2001, AGR ECOSYST ENVIRON, V86, P39, DOI 10.1016/S0167-8809(00)00263-2; Dyer MI, 1982, ROLE HERBIVORES GRAS, P255; Gaertner M, 2009, PROG PHYS GEOG, V33, P319, DOI 10.1177/0309133309341607; GARDNER SM, 1995, J VEG SCI, V6, P349, DOI 10.2307/3236234; GARNIER E, 1994, PLANT CELL ENVIRON, V17, P399, DOI 10.1111/j.1365-3040.1994.tb00308.x; Gibson D. J., 2009, GRASSES GRASSLAND EC; Goulet H., 1993, HYMENOPTERA WORLD ID, V1894E; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Hawkins BA, 2003, AM NAT, V161, P40, DOI 10.1086/345479; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; Kay AD, 2008, ECOLOGY, V89, P1188, DOI 10.1890/07-1622.1; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; MacDougall AS, 2004, CONSERV BIOL, V18, P455, DOI 10.1111/j.1523-1739.2004.00483.x; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MAJOR J, 1977, TERRESTRIAL VEGETATI; Malmstrom CM, 2005, OECOLOGIA, V145, P153, DOI 10.1007/s00442-005-0099-z; McAlpine J. F., 1981, AGR CANADA MONOGRAPH, V27, P1; McAlpine JF, 1987, MONOGRAPH AGR CANADA, V2, pvi; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; MCNAUGHTON SJ, 1979, AM NAT, V113, P691, DOI 10.1086/283426; Moran MD, 1998, OECOLOGIA, V113, P126, DOI 10.1007/s004420050360; MURDOCH WW, 1972, ECOLOGY, V53, P819, DOI 10.2307/1934297; Oldeman L. R., 1994, SOIL RESILIENCE SUST, P9; Oliver I, 2005, AGR ECOSYST ENVIRON, V109, P323, DOI 10.1016/j.agee.2005.02.022; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Polis GA, 1999, OIKOS, V86, P3, DOI 10.2307/3546565; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; RITCHIE ME, 1995, ECOLOGY, V76, P2648, DOI 10.2307/2265835; Rosenthal JP, 1997, EVOL ECOL, V11, P337, DOI 10.1023/A:1018420504439; Schaffers AP, 2008, ECOLOGY, V89, P782, DOI 10.1890/07-0361.1; Schuh RT, 1995, TRUE BUGS WORLD HEMI; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Simao MCM, 2010, OIKOS, V119, P1553, DOI 10.1111/j.1600-0706.2010.18382.x; Spyreas G, 2010, BIOL INVASIONS, V12, P1253, DOI 10.1007/s10530-009-9544-y; STEWART AJA, 1995, ECOL ENTOMOL, V20, P98, DOI 10.1111/j.1365-2311.1995.tb00434.x; Triplehorn CA, 2004, BORROR DELONGS INTRO; TSCHARNTKE T, 1995, ANNU REV ENTOMOL, V40, P535, DOI 10.1146/annurev.en.40.010195.002535	57	9	10	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0129823	10.1371/journal.pone.0129823	http://dx.doi.org/10.1371/journal.pone.0129823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158494	Green Published, Green Submitted, gold			2022-12-27	WOS:000358161200009
J	Giri, A; Edwards, TL; Motley, SS; Byerly, SH; Fowke, JH				Giri, Ayush; Edwards, Todd L.; Motley, Saundra S.; Byerly, Susan H.; Fowke, Jay H.			Genetic Determinants of Metabolism and Benign Prostate Enlargement: Associations with Prostate Volume	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; CANCER PREVENTION TRIAL; X(C)(-) CYSTINE/GLUTAMATE ANTIPORTER; NUTRITION EXAMINATION SURVEY; RISK-FACTORS; BODY-SIZE; WHITE MEN; HYPERPLASIA; OBESITY; HEALTH	Prostate enlargement leading to clinical benign prostatic hyperplasia (BPH) is associated with metabolic dysregulation and obesity. The genetic basis of this association is unclear. Our objective was to evaluate whether single nucleotide polymorphisms (SNPs) previously associated with metabolic disorders are also associated with prostate volume (PV). Participants included 876 men referred for prostate biopsy and found to be prostate cancer free. PV was measured by transrectal ultrasound. Samples were genotyped using the Illumina Cardio-MetaboChip platform. Multivariable adjusted linear regression models were used to evaluate SNPs (additive coding) in relation to natural-log transformed (log) PV. We compared SNP-PV results from biopsy-negative men to 442 men with low-grade prostate cancer with similar levels of obesity and PV. Beta-coefficients from the discovery and replication samples were then aggregated with fixed effects inverse variance weighted meta-analysis. SNP rs11736129 (near the pseudo-gene LOC100131429) was significantly associated with log-PV (beta: 0.16, p-value 1.16x10(-8)) after adjusting for multiple testing. Other noteworthy SNPs that were nominally associated (p-value < 1x10(-4)) with log-PV included rs9583484 (intronic SNP in COL4A2), rs10146527 (intronic SNP in NRXN3), rs9909466 (SNP near RPL32P31), and rs2241606 (synonymous SNP in SLC12A7). We found several SNPs in metabolic loci associated with PV. Further studies are needed to confirm our results and elucidate the mechanism between these genetic loci, PV, and clinical BPH.	[Giri, Ayush; Edwards, Todd L.; Fowke, Jay H.] Vanderbilt Univ, Inst Med & Publ Hlth, Vanderbilt Epidemiol Ctr, Med Ctr, Nashville, TN 37235 USA; [Edwards, Todd L.] Vanderbilt Univ, Vanderbilt Genet Inst, Nashville, TN 37235 USA; [Edwards, Todd L.; Motley, Saundra S.; Byerly, Susan H.; Fowke, Jay H.] Vanderbilt Univ, Div Epidemiol, Dept Med, Med Ctr, Nashville, TN 37235 USA; [Fowke, Jay H.] Vanderbilt Univ, Dept Urol Surg, Med Ctr, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Fowke, JH (corresponding author), Vanderbilt Univ, Inst Med & Publ Hlth, Vanderbilt Epidemiol Ctr, Med Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.	jay.fowke@vanderbilt.edu			National Institutes of Health [RO1CA121060, RO1DK087962]; NATIONAL CANCER INSTITUTE [R01CA121060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for the Nashville Men's Health Study (NMHS) was provided by the National Institutes of Health Grant numbers: RO1CA121060 and RO1DK087962. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; [Anonymous], 1993, SCAND J UROL NEPHR S; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Chambers KF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-45; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Dahle SE, 2002, J UROLOGY, V168, P599, DOI 10.1016/S0022-5347(05)64687-3; Di Silverio F, 2003, EUR UROL, V43, P164, DOI 10.1016/S0302-2838(02)00548-1; Edwards TL, 2013, CANCER EPIDEM BIOMAR, V22, P1538, DOI 10.1158/1055-9965.EPI-13-0123; Fowke JH, 2007, PROSTATE CANCER P D, V10, P137, DOI 10.1038/sj.pcan.4500924; Fowke JH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-23; Fowke JH, 2011, J GEN INTERN MED, V26, P1305, DOI 10.1007/s11606-011-1776-8; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; GIOVANNUCCI E, 1994, AM J EPIDEMIOL, V140, P989, DOI 10.1093/oxfordjournals.aje.a117206; Gupta A, 2006, UROLOGY, V68, P1198, DOI 10.1016/j.urology.2006.09.034; Guyon I, 2005, U.S. Patent Application, Patent No. [11/214,931, 11214931]; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Joseph MA, 2003, AM J EPIDEMIOL, V157, P906, DOI 10.1093/aje/kwg051; KAPLAN SA, 1995, J UROLOGY, V154, P1764, DOI 10.1016/S0022-5347(01)66779-X; Kristal AR, 2007, J UROLOGY, V177, P1395, DOI 10.1016/j.juro.2006.11.065; Kristal AR, 2010, PROSTATE, V70, P584, DOI 10.1002/pros.21092; Lo M, 2008, BRIT J CANCER, V99, P464, DOI 10.1038/sj.bjc.6604485; Mononen N, 2002, HUM GENET, V111, P166, DOI 10.1007/s00439-002-0776-5; Muller RL, 2013, EUR UROL, V63, P1115, DOI 10.1016/j.eururo.2013.02.038; Nandeesha H, 2006, CLIN CHIM ACTA, V370, P89, DOI 10.1016/j.cca.2006.01.019; Nickel JC, 2008, UROL CLIN N AM, V35, P109, DOI 10.1016/j.ucl.2007.09.012; Ozden C, 2007, EUR UROL, V51, P199, DOI 10.1016/j.eururo.2006.05.040; Parsons JK, 2008, EUR UROL, V53, P1228, DOI 10.1016/j.eururo.2008.02.019; Parsons JK, 2008, BJU INT, V101, P313, DOI 10.1111/j.1464-410X.2007.07332.x; Parsons JK, 2007, J UROLOGY, V178, P395, DOI 10.1016/j.juro.2007.03.103; Parsons JK, 2006, J CLIN ENDOCR METAB, V91, P2562, DOI 10.1210/jc.2005-2799; Parsons JK, 2010, CURR BLADDER DYSFUNC, V5, P212, DOI 10.1007/s11884-010-0067-2; Parsons JK, 2009, J UROLOGY, V182, pS27, DOI 10.1016/j.juro.2009.07.086; Parsons JK, 2009, J UROLOGY, V182, P1463, DOI 10.1016/j.juro.2009.06.038; PARTIN AW, 1994, UROLOGY, V44, P646; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Pham AN, 2010, J PHARMACOL EXP THER, V332, P949, DOI 10.1124/jpet.109.162248; Platz EA, 2000, J UROLOGY, V163, P490, DOI 10.1016/S0022-5347(05)67909-8; Pritchard CC, 2008, DIFFERENTIATION, V76, P624, DOI 10.1111/j.1432-0436.2008.00274.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi J, 2013, PROSTATE, V73, P1182, DOI 10.1002/pros.22666; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; Roberts RO, 2005, PROSTATE, V62, P380, DOI 10.1002/pros.20142; Roehrborn CG, 2008, INT J IMPOT RES, V20, pS19, DOI 10.1038/ijir.2008.53; Roehrborn CG, 2011, MED CLIN N AM, V95, P87, DOI 10.1016/j.mcna.2010.08.013; Rohrmann S, 2005, PROSTATE, V62, P27, DOI 10.1002/pros.20110; Rohrmann S, 2004, AM J EPIDEMIOL, V159, P390, DOI 10.1093/aje/kwh060; Salam MT, 2005, UROL ONCOL-SEMIN ORI, V23, P246, DOI 10.1016/j.urolonc.2004.12.014; Sarma AV, 2009, J UROLOGY, V182, pS32, DOI 10.1016/j.juro.2009.07.088; Sarma AV, 2003, UROLOGY, V61, P1086, DOI 10.1016/S0090-4295(03)00154-7; Sauver JLS, 2009, AM J EPIDEMIOL, V169, P1281, DOI 10.1093/aje/kwp085; Schenk JM, 2010, AM J EPIDEMIOL, V171, P571, DOI 10.1093/aje/kwp406; Seim A, 2005, BJU INT, V96, P88, DOI 10.1111/j.1464-410X.2005.05573.x; Singh AP, 2008, CANCER LETT, V259, P28, DOI 10.1016/j.canlet.2007.09.018; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STAMEY TA, 1994, SCAND J UROL NEPHROL, P73; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wei JT, 2005, J UROLOGY, V173, P1256, DOI 10.1097/01.ju.0000155709.37840.fe	60	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0132028	10.1371/journal.pone.0132028	http://dx.doi.org/10.1371/journal.pone.0132028			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158673	Green Published, gold, Green Submitted			2022-12-27	WOS:000358161200046
J	Tsai, MJ; Huang, YB; Fang, JW; Fu, YS; Wu, PC				Tsai, Ming-Jun; Huang, Yaw-Bin; Fang, Jhih-Wun; Fu, Yaw-Syan; Wu, Pao-Chu			Preparation and Characterization of Naringenin-Loaded Elastic Liposomes for Topical Application	PLOS ONE			English	Article							ENHANCED SKIN DELIVERY; IN-VIVO; ANTIINFLAMMATORY ACTIVITY; ULTRADEFORMABLE VESICLES; FLAVONOID NARINGENIN; FLAVANONE NARINGENIN; POTENTIAL TREATMENT; SURFACE-CHARGE; MELANOMA-CELLS; VITRO	Excessive production of radical oxygen species in skin is a contributor to a variety of skin pathologies. Naringenin is a potent antioxidant. The purpose of the present study was to develop elastic liposomes for naringenin topical application. Naringenin-loaded elastic liposomes containing different amounts of Tween 80 and cholesterol were prepared. The physicochemical properties including vesicle size, surface charge, encapsulation efficiency, and permeability capacity were determined to evaluate the effect of components. The stability of formulation and skin irritation caused by drug-loaded elastic liposomes were also evaluated for assessment of the clinical utility of elastic liposomes. Saturated aqueous solution of naringenin and naringenin dissolved in 10% Tween 80 solution (5 mg/mL) were used as the control group. The result showed that in using elastic liposomes as carrier, the deposition amounts in the skin of naringenin were significantly increased about 7.3 +/- 11.8-fold and 1.2 +/- 1.9-fold respectively, when compared with the saturated aqueous solution and Tween 80 solution-treated groups. The level of drug was more than 98.89 +/- 3.90% after 3 months of storage at 4 degrees C. In a skin irritation test, the result showed experimental formulation exhibit considerably less irritating than the positive control (paraformaldehyde-treated) group, suggesting its potential therapeutic application.	[Tsai, Ming-Jun] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Tsai, Ming-Jun] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Huang, Yaw-Bin; Fang, Jhih-Wun; Wu, Pao-Chu] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan; [Fu, Yaw-Syan] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University	Wu, PC (corresponding author), Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan.	pachwu@kmu.edu.tw		Fu, Yaw-Syan/0000-0001-8715-9644; FANG, CHIH-WUN/0000-0002-1067-9024; Huang, Yaw-Bin/0000-0002-6024-0108	NSC [102-2320-B-037-006-MY2, NSC101-2320-B-037-33]; Ministry of Science and Technology of Taiwan	NSC(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by NSC 102-2320-B-037-006-MY2 and NSC101-2320-B-037-33, the Ministry of Science and Technology of Taiwan, PCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Suwayeh SA, 2014, SCI WORLD J, DOI 10.1155/2014/127495; Azeem A, 2009, AAPS PHARMSCITECH, V10, P1093, DOI 10.1208/s12249-009-9306-2; BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6; Black HS, 1997, J PHOTOCH PHOTOBIO B, V40, P29, DOI 10.1016/S1011-1344(97)00021-3; Cavia-Saiz M, 2010, J SCI FOOD AGR, V90, P1238, DOI 10.1002/jsfa.3959; Celia C, 2012, BIOMED MICRODEVICES, V14, P119, DOI 10.1007/s10544-011-9590-y; CEVC G, 1992, BIOCHIM BIOPHYS ACTA, V1104, P226, DOI 10.1016/0005-2736(92)90154-E; Cevc G, 2001, BBA-BIOMEMBRANES, V1514, P191, DOI 10.1016/S0005-2736(01)00369-8; Coderch L, 2000, J CONTROL RELEASE, V68, P85, DOI 10.1016/S0168-3659(00)00240-6; Cosco D, 2012, INT J PHARMACEUT, V422, P229, DOI 10.1016/j.ijpharm.2011.10.056; De Paula D, 2008, BIOMED CHROMATOGR, V22, P1416, DOI 10.1002/bmc.1075; El Zaafarany GM, 2010, INT J PHARMACEUT, V397, P164, DOI 10.1016/j.ijpharm.2010.06.034; Elnaggar YSR, 2014, J CONTROL RELEASE, V180, P10, DOI 10.1016/j.jconrel.2014.02.004; Elsayed MMA, 2006, INT J PHARMACEUT, V322, P60, DOI 10.1016/j.ijpharm.2006.05.027; Felgines C, 2000, AM J PHYSIOL-GASTR L, V279, pG1148, DOI 10.1152/ajpgi.2000.279.6.G1148; Ge Y, 2015, J LIPOSOME RES, V25, P222, DOI 10.3109/08982104.2014.987786; Gesualdi NM, 2006, FREE RADICAL RES, V40, P467, DOI 10.1080/10715760600570547; Ghanbarzadeh S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/616810; Gillet A, 2009, INT J PHARMACEUT, V380, P174, DOI 10.1016/j.ijpharm.2009.06.027; Hsiu SL, 2002, LIFE SCI, V70, P1481, DOI 10.1016/S0024-3205(01)01491-6; Huang YB, 2010, CHEM PHARM BULL, V58, P611, DOI 10.1248/cpb.58.611; Huang YC, 2011, PHYTOMEDICINE, V18, P1244, DOI 10.1016/j.phymed.2011.06.028; Krause MR, 2014, ACCOUNTS CHEM RES, V47, P3512, DOI 10.1021/ar500260t; Lademann J, 2009, EUR J PHARM BIOPHARM, V72, P317, DOI 10.1016/j.ejpb.2008.08.008; Lasic DD., 1997, LIPOSOMES GENE DELIV; Lewis GA., 1999, PHARM EXPT DESIGN; Li C, 2013, INT J NANOMED, V8, P1285, DOI 10.2147/IJN.S41695; Li LN, 1997, J DERMATOL SCI, V14, P101, DOI 10.1016/S0923-1811(96)00557-9; Magarkar A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05005; Malakar J, 2012, SAUDI PHARM J, V20, P355, DOI 10.1016/j.jsps.2012.02.001; Manosroi A, 2008, INT J PHARMACEUT, V360, P156, DOI 10.1016/j.ijpharm.2008.04.033; Marianecci C, 2010, J CONTROL RELEASE, V147, P127, DOI 10.1016/j.jconrel.2010.06.022; Montenegro L., 2008, International Journal of Cosmetic Science, V30, P57, DOI 10.1111/j.1468-2494.2008.00417.x; Mura P, 2007, EUR J PHARM BIOPHARM, V67, P86, DOI 10.1016/j.ejpb.2007.01.020; Mura P, 2014, INT J PHARMACEUT, V475, P306, DOI 10.1016/j.ijpharm.2014.08.066; Mutalik S, 2004, J PHARM SCI-US, V93, P1577, DOI 10.1002/jps.20058; Nawaz A, 2013, PAK J PHARM SCI, V26, P617; Ohguchi K, 2006, BIOSCI BIOTECH BIOCH, V70, P1499, DOI 10.1271/bbb.50635; Paolino D, 2005, J CONTROL RELEASE, V106, P99, DOI 10.1016/j.jconrel.2005.04.007; Paolino D, 2002, INT J PHARMACEUT, V244, P21, DOI 10.1016/S0378-5173(02)00295-8; Paolino D, 2014, BIOMATERIALS, V35, P7101, DOI 10.1016/j.biomaterials.2014.04.088; Paolino D, 2012, J CONTROL RELEASE, V162, P143, DOI 10.1016/j.jconrel.2012.05.050; Paolino D, 2012, EUR J PHARM BIOPHARM, V81, P102, DOI 10.1016/j.ejpb.2012.02.008; Paolino D, 2010, J CONTROL RELEASE, V144, P144, DOI 10.1016/j.jconrel.2010.02.021; Pasut G, 2015, J CONTROL RELEASE, V199, P106, DOI 10.1016/j.jconrel.2014.12.008; Portugal M, 2007, BIOMED PHARMACOTHER, V61, P412, DOI 10.1016/j.biopha.2007.05.010; Renugadevi J, 2009, TOXICOLOGY, V256, P128, DOI 10.1016/j.tox.2008.11.012; Scharffetter-Kochanek K, 1997, BIOL CHEM, V378, P1247; Semple SC, 1996, BIOCHEMISTRY-US, V35, P2521, DOI 10.1021/bi950414i; Shulman M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018033; Song CK, 2012, COLLOID SURFACE B, V92, P299, DOI 10.1016/j.colsurfb.2011.12.004; TRENAM CW, 1992, J INVEST DERMATOL, V99, P675, DOI 10.1111/1523-1747.ep12613740; Tsai MJ, 2015, INT J PHARMACEUT, V481, P84, DOI 10.1016/j.ijpharm.2015.01.034; Verma DD, 2003, INT J PHARM, V258, P141, DOI 10.1016/S0378-5173(03)00183-2; Verma DD, 2003, EUR J PHARM BIOPHARM, V55, P271, DOI 10.1016/S0939-6411(03)00021-3; Vicentini FTMC, 2008, EUR J PHARM BIOPHARM, V69, P948, DOI 10.1016/j.ejpb.2008.01.012; Vrhovnik K, 1998, PHARMACEUT RES, V15, P525, DOI 10.1023/A:1011965423986; Xia SQ, 2015, COLLOID SURFACE B, V128, P172, DOI 10.1016/j.colsurfb.2015.02.004; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Zhao YZ, 2013, INT J PHARMACEUT, V454, P302, DOI 10.1016/j.ijpharm.2013.06.052	60	47	47	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131026	10.1371/journal.pone.0131026	http://dx.doi.org/10.1371/journal.pone.0131026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158639	gold, Green Published, Green Submitted			2022-12-27	WOS:000358161200024
J	Adhi, M; Ferrara, D; Mullins, RF; Baumal, CR; Mohler, KJ; Kraus, MF; Liu, J; Badaro, E; Alasil, T; Hornegger, J; Fujimoto, JG; Duker, JS; Waheed, NK				Adhi, Mehreen; Ferrara, Daniela; Mullins, Robert F.; Baumal, Caroline R.; Mohler, Kathrin J.; Kraus, Martin F.; Liu, Jonathan; Badaro, Emmerson; Alasil, Tarek; Hornegger, Joachim; Fujimoto, James G.; Duker, Jay S.; Waheed, Nadia K.			Characterization of Choroidal Layers in Normal Aging Eyes Using Enface Swept-Source Optical Coherence Tomography	PLOS ONE			English	Article							NERVE-FIBER LAYER; HEALTHY EYES; MACULAR DEGENERATION; THICKNESS; CHORIOCAPILLARIS; FEATURES	Purpose To characterize qualitative and quantitative features of the choroid in normal eyes using enface swept-source optical coherence tomography (SS-OCT). Methods Fifty-two eyes of 26 consecutive normal subjects were prospectively recruited to obtain multiple three-dimensional 12x12mm volumetric scans using a long-wavelength high-speed SS-OCT prototype. A motion-correction algorithm merged multiple SS-OCT volumes to improve signal. Retinal pigment epithelium (RPE) was segmented as the reference and enface images were extracted at varying depths every 4.13 mu m intervals. Systematic analysis of the choroid at different depths was performed to qualitatively assess the morphology of the choroid and quantify the absolute thicknesses as well as the relative thicknesses of the choroidal vascular layers including the choroidal microvasculature (choriocapillaris, terminal arterioles and venules; CC) and choroidal vessels (CV) with respect to the subfoveal total choroidal thickness (TC). Subjects were divided into two age groups: younger (<40 years) and older (>= 40 years). Results Mean age of subjects was 41.92 (24-66) years. Enface images at the level of the RPE, CC, CV, and choroidal-scleral interface were used to assess specific qualitative features. In the younger age group, the mean absolute thicknesses were: TC 379.4 mu m (SD +/- 75.7 mu m), CC 81.3 mu m (SD +/- 21.2 mu m) and CV 298.1 mu m (SD +/- 63.7 mu m). In the older group, the mean absolute thicknesses were: TC 305.0 mu m (SD +/- 50.9 mu m), CC 56.4 mu m (SD +/- 12.1 mu m) and CV 248.6 mu m (SD +/- 49.7 mu m). In the younger group, the relative thicknesses of the individual choroidal layers were: CC 21.5% (SD +/- 4.0%) and CV 78.4% (SD +/- 4.0%). In the older group, the relative thicknesses were: CC 18.9% (SD +/- 4.5%) and CV 81.1% (SD +/- 4.5%). The absolute thicknesses were smaller in the older age group for all choroidal layers (TC p=0.006, CC p=0.0003, CV p=0.03) while the relative thickness was smaller only for the CC (p=0.04). Conclusions Enface SS-OCT at 1050nm enables a precise qualitative and quantitative characterization of the individual choroidal layers in normal eyes. Only the CC is relatively thinner in the older eyes. In-vivo evaluation of the choroid at variable depths may be potentially valuable in understanding the natural history of age-related posterior segment disease.	[Adhi, Mehreen; Ferrara, Daniela; Baumal, Caroline R.; Badaro, Emmerson; Alasil, Tarek; Duker, Jay S.; Waheed, Nadia K.] Tufts Med Ctr, New England Eye Ctr, Dept Ophthalmol, Boston, MA 02111 USA; [Adhi, Mehreen; Mohler, Kathrin J.; Kraus, Martin F.; Liu, Jonathan; Fujimoto, James G.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Adhi, Mehreen; Mohler, Kathrin J.; Kraus, Martin F.; Liu, Jonathan; Fujimoto, James G.] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Mullins, Robert F.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Mohler, Kathrin J.] Univ Munich, Fac Phys, Munich, Germany; [Kraus, Martin F.; Hornegger, Joachim] Univ Erlangen Nurnberg, Pattern Recognit Lab, D-91054 Erlangen, Germany; [Kraus, Martin F.; Hornegger, Joachim] Univ Erlangen Nurnberg, Grad Sch Adv Opt Technol, D-91054 Erlangen, Germany	Tufts Medical Center; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Iowa; University of Munich; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Waheed, NK (corresponding author), Tufts Med Ctr, New England Eye Ctr, Dept Ophthalmol, Boston, MA 02111 USA.	nadiakwaheed@gmail.com	Mullins, Robert F/I-6717-2013; Adhi, Mehreen/AAS-9733-2021; Hornegger, Joachim/H-2465-2017	Hornegger, Joachim/0000-0002-1834-8844; Mullins, Robert/0000-0002-5006-0891	National Institute of Health [R01-EY011289-27, R44EY022864-01, R01-CA075289-16]; Air Force Office of Scientific Research [FA9550-10-1-0551, FA9550-10-1-0063]; Research to Prevent Blindness; Massachusetts Lions Clubs; DFG German Science Foundation [DFG-GSC80-SAOT]; NATIONAL CANCER INSTITUTE [R01CA075289] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011289, R44EY022864] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Massachusetts Lions Clubs; DFG German Science Foundation(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by funding from National Institute of Health (R01-EY011289-27, R44EY022864-01, R01-CA075289-16) to JGF; Air Force Office of Scientific Research (FA9550-10-1-0551 and FA9550-10-1-0063) to JGF; Research to Prevent Blindness unrestricted grant to the New England Eye Center (JSD); Massachusetts Lions Clubs (JSD); DFG German Science Foundation (DFG-GSC80-SAOT) to JH. The funding organizations had no role in design or conduct of this research.	Adhi M, 2014, AM J OPHTHALMOL, V157, P1272, DOI 10.1016/j.ajo.2014.02.034; Alizadeh Yousef, 2014, J Ophthalmic Vis Res, V9, P38; ANSI, 2007, Z136 ANSI; Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066; CARPEL EF, 1981, AM J OPHTHALMOL, V91, P588, DOI 10.1016/0002-9394(81)90056-8; Esmaeelpour M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099690; Ferrara D, 2014, OPHTHALMOLOGY, V121, P719, DOI 10.1016/j.ophtha.2013.10.014; Flores-Moreno I, 2013, AM J OPHTHALMOL, V155, P314, DOI 10.1016/j.ajo.2012.07.015; Gurses-Ozden R, 2004, J GLAUCOMA, V13, P238; HAYREH SS, 1990, EYE, V4, P273, DOI 10.1038/eye.1990.39; HAYREH SS, 1975, BRIT J OPHTHALMOL, V59, P631, DOI 10.1136/bjo.59.11.631; Hsu SY, 2008, J GLAUCOMA, V17, P30, DOI 10.1097/IJG.0b013e31811243b4; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Kim SW, 2011, RETINA-J RET VIT DIS, V31, P1904, DOI 10.1097/IAE.0b013e31821801c5; Kraus MF, 2012, BIOMED OPT EXPRESS, V3, P1182, DOI 10.1364/BOE.3.001182; Lopes FSS, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-72; Lutty G, 1999, MOL VIS, V5; Manjunath V, 2011, AM J OPHTHALMOL, V152, P663, DOI 10.1016/j.ajo.2011.03.008; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; MCLEOD DS, 1994, INVEST OPHTH VIS SCI, V35, P3799; Motaghiannezam R, 2012, INVEST OPHTH VIS SCI, V53, P2337, DOI 10.1167/iovs.11-7823; Mullins RF, 2005, MOL VIS, V11, P509; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; Mullins RF, 2014, AM J PATHOL, V184, P3142, DOI 10.1016/j.ajpath.2014.07.017; Potsaid B, 2010, OPT EXPRESS, V18, P20029, DOI 10.1364/OE.18.020029; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Sohn EH, 2014, INVEST OPHTH VIS SCI, V55, P1352, DOI 10.1167/iovs.13-13754; Sohrab M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048631; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Spaide RF, 2009, AM J OPHTHALMOL, V147, P801, DOI 10.1016/j.ajo.2008.12.010; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P5103, DOI 10.1167/iovs.08-2127; Unterhuber A, 2005, OPT EXPRESS, V13, P3252, DOI 10.1364/OPEX.13.003252; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048	34	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133080	10.1371/journal.pone.0133080	http://dx.doi.org/10.1371/journal.pone.0133080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172550	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900122
J	Chaisson, LH; Katamba, A; Haguma, P; Ochom, E; Ayakaka, I; Mugabe, F; Miller, C; Vittinghoff, E; Davis, JL; Handley, MA; Cattamanchi, A				Chaisson, Lelia H.; Katamba, Achilles; Haguma, Priscilla; Ochom, Emmanuel; Ayakaka, Irene; Mugabe, Frank; Miller, Cecily; Vittinghoff, Eric; Davis, J. Lucian; Handley, Margaret A.; Cattamanchi, Adithya			Theory-Informed Interventions to Improve the Quality of Tuberculosis Evaluation at Ugandan Health Centers: A Quasi-Experimental Study	PLOS ONE			English	Article							SPUTUM SMEAR MICROSCOPY; PULMONARY TUBERCULOSIS; ASSESSMENT GUIDELINES; LABORATORY DIAGNOSIS; TREATMENT INITIATION; SERVICES; IMPACT; PRACTITIONERS; BEHAVIOR; DOCTORS	Background Tuberculosis (TB) remains under-diagnosed in many countries, in part due to poor evaluation practices at health facilities. Theory-informed strategies are needed to improve implementation of TB evaluation guidelines. We aimed to evaluate the impact of performance feedback and same-day smear microscopy on the quality of TB evaluation at 6 health centers in rural Uganda. Methods We tested components of a multi-faceted intervention to improve adherence to the International Standards for Tuberculosis Care(ISTC): performance feedback and same-day smear microscopy. The strategies were selected based on a qualitative assessment guided by the Theory of Planned Behavior and the PRECEDE model. We collected patient data 6 months before and after the introduction of each intervention component, and compared ISTC adherence in the pre- and post-intervention periods for adults with cough >= 2 weeks' duration. Results The performance feedback evaluation included 1,446 adults; 838 (58%) were evaluated during the pre-intervention period and 608 (42%) during the post-intervention period. Performance feedback resulted in a 15% (95% CI +10% to +20%, p<0.001) increase in the proportion of patients receiving ISTC-adherent care. The same-day microscopy evaluation included 1,950 adults; 907 (47%) were evaluated during the pre-intervention period and 1,043 (53%) during the post-intervention period. Same-day microscopy was associated with a 14% (95% CI +10% to +18%, p<0.001) increase in the proportion of patients receiving ISTC-adherent care. Conclusions Performance feedback and same-day microscopy should be considered along with ISTC training as part of a multi-faceted intervention to improve the quality of TB evaluation in other high TB burden countries.	[Chaisson, Lelia H.; Davis, J. Lucian; Cattamanchi, Adithya] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Katamba, Achilles] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda; [Katamba, Achilles; Haguma, Priscilla; Ochom, Emmanuel; Ayakaka, Irene; Davis, J. Lucian; Cattamanchi, Adithya] Infect Dis Res Collaborat, Kampala, Uganda; [Mugabe, Frank] Uganda Minist Hlth, Natl TB & Leprosy Control Programme, Kampala, Uganda; [Miller, Cecily; Vittinghoff, Eric; Handley, Margaret A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Davis, J. Lucian; Cattamanchi, Adithya] Univ Calif San Francisco, San Francisco Gen Hosp, Curry Int TB Ctr, San Francisco, CA USA; [Handley, Margaret A.] Univ Calif San Francisco, San Francisco Gen Hosp, Ctr Vulnerable Populat, San Francisco, CA USA; [Handley, Margaret A.] Univ Calif San Francisco, Ctr Trauma, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chaisson, LH (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.	chaissonl@medsfgh.ucsf.edu; acattamanchi@medsfgh.ucsf.edu	Davis, J. Lucian/AAC-8376-2019	Davis, J. Lucian/0000-0002-8629-9992; EMMANUEL, OCHOM/0000-0003-0999-3275	National Institutes of Health [R21 AI096158, P60MD006902, UL1 TR000004]; UK Department for International Development; Medical Research Council; Wellcome Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI096158, P30AI027763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD006902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Department for International Development; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Work was supported by the National Institutes of Health (www.nih.gov; (R21 AI096158 (AC), P60MD006902 (MAH), UL1 TR000004 (MAH))) and a Joint Global Health Trials scheme pilot grant from the UK Department for International Development, the Medical Research Council, and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo KK, 2006, INT J TUBERC LUNG D, V10, P812; Ajzen I., 1985, ACTION CONTROL, P11, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; [Anonymous], 2011, COMMUNICATION; Assistance TCfT, 2006, INT STAND TUB CAR IS; Aziz MA, 2002, EXTERNAL QUALITY ASS; Botha E, 2008, INT J TUBERC LUNG D, V12, P936; Botha E, 2008, INT J TUBERC LUNG D, V12, P820; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Cattamanchi A, BMC HLTH SE IN PRESS; Cattamanchi A, 2011, AM J RESP CRIT CARE, V183, P547, DOI 10.1164/rccm.201008-1207OC; Creek TL, 2000, INT J TUBERC LUNG D, V4, P956; DAVIS DA, 1992, JAMA-J AM MED ASSOC, V268, P1111, DOI 10.1001/jama.268.9.1111; Davis JL, 2011, AM J RESP CRIT CARE, V184, P362, DOI 10.1164/rccm.201012-1984OC; Godin G, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-36; Green L.W., 2005, HLTH PROGRAM PLANNIN, V4th; Grimshaw JM, 2001, MED CARE, V39, pII2; Hopewell PC, 2005, JAMA-J AM MED ASSOC, V293, P2790, DOI 10.1001/jama.293.22.2790; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Kemp JR, 2007, B WORLD HEALTH ORGAN, V85, P580, DOI 10.2471/BLT.06.033167; Marinucci F, 2013, AM J TROP MED HYG, V88, P547, DOI 10.4269/ajtmh.12-0628; Martinez A, 2005, INT J TUBERC LUNG D, V9, P301; MULLEN PD, 1987, SOC SCI MED, V24, P973, DOI 10.1016/0277-9536(87)90291-7; Olle-Goig JE, 1999, INT J TUBERC LUNG D, V3, P74; Otero L, 2011, INT J TUBERC LUNG D, V15, P211; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Perkins MB, 2007, PSYCHIAT SERV, V58, P342, DOI 10.1176/appi.ps.58.3.342; Prasad R, 2003, INT J TUBERC LUNG D, V7, P52; Shah S K, 2003, East Mediterr Health J, V9, P776; Siddiqi K, 2007, INT J TUBERC LUNG D, V11, P665; Singla N, 1998, INT J TUBERC LUNG D, V2, P384; Squire SB, 2005, INT J TUBERC LUNG D, V9, P25; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Suleiman B A, 2003, East Mediterr Health J, V9, P789; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; Van Rie A, 2008, J CLIN MICROBIOL, V46, P897, DOI 10.1128/JCM.01553-07; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2010, GLOB PLAN STOP TB201	37	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132573	10.1371/journal.pone.0132573	http://dx.doi.org/10.1371/journal.pone.0132573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172948	gold, Green Published, Green Submitted			2022-12-27	WOS:000358194900060
J	Cona, G; Cavazzana, A; Paoli, A; Marcolin, G; Grainer, A; Bisiacchi, PS				Cona, Giorgia; Cavazzana, Annachiara; Paoli, Antonio; Marcolin, Giuseppe; Grainer, Alessandro; Bisiacchi, Patrizia Silvia			It's a Matter of Mind! Cognitive Functioning Predicts the Athletic Performance in Ultra-Marathon Runners	PLOS ONE			English	Article							ATTENTIONAL FOCUS; EXERCISE; TASK; EMOTIONS; BASEBALL; FITNESS	The present study was aimed at exploring the influence of cognitive processes on performance in ultra-marathon runners, providing an overview of the cognitive aspects that characterize outstanding runners. Thirty runners were administered a battery of computerized tests right before their participation in an ultra-marathon. Then, they were split according to the race rank into two groups (i.e., faster runners and slower runners) and their cognitive performance was compared. Faster runners outperformed slower runners in trials requiring motor inhibition and were more effective at performing two tasks together, successfully suppressing the activation of the information for one of the tasks when was not relevant. Furthermore, slower runners took longer to remember to execute pre-defined actions associated with emotional stimuli when such stimuli were presented. These findings suggest that cognitive factors play a key role in running an ultra-marathon. Indeed, if compared with slower runners, faster runners seem to have a better inhibitory control, showing superior ability not only to inhibit motor response but also to suppress processing of irrelevant information. Their cognitive performance also appears to be less influenced by emotional stimuli. This research opens new directions towards understanding which kinds of cognitive and emotional factors can discriminate talented runners from less outstanding runners.	[Cona, Giorgia; Cavazzana, Annachiara; Bisiacchi, Patrizia Silvia] Univ Padua, Dept Gen Psychol, Padua, Italy; [Cona, Giorgia] Univ Padua, Dept Neurosci, Padua, Italy; [Paoli, Antonio; Marcolin, Giuseppe; Grainer, Alessandro] Univ Padua, Dept Biomed Sci, Padua, Italy; [Bisiacchi, Patrizia Silvia] Univ Padua, Ctr Cognit Neurosci, Padua, Italy	University of Padua; University of Padua; University of Padua; University of Padua	Cona, G (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	giorgia.cona@unipd.it	Marcolin, Giuseppe/ABD-5831-2020; Paoli, Antonio/A-6151-2015	Paoli, Antonio/0000-0003-0474-4229; Marcolin, Giuseppe/0000-0002-2768-3257; bisiacchi, patrizia/0000-0003-2760-8000; , Giorgia/0000-0003-1844-9327; Cavazzana, Annachiara/0000-0003-2947-5424	University of Padova (Strategic Grant NEURAT) [STPD11B8HM_004]	University of Padova (Strategic Grant NEURAT)	This study was supported by a grant from the University of Padova (Strategic Grant NEURAT; STPD11B8HM_004) to P.B. The funder did not have any role in study, data collection or analysis, decision to publish, or preparation of the manuscript.	Ali A, 2011, SCAND J MED SCI SPOR, V21, P170, DOI 10.1111/j.1600-0838.2010.01256.x; Alves H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00036; Amodio P, 2010, GASTROENTEROLOGY, V139, P510, DOI 10.1053/j.gastro.2010.04.057; Bate D., 1996, SCI SOCCER; Beilock SL, 2002, J EXP PSYCHOL-APPL, V8, P6, DOI 10.1037/1076-898X.8.1.6; Bisiacchi P, 2014, METAB BRAIN DIS, V29, P945, DOI 10.1007/s11011-014-9529-0; Castaneda B, 2007, J SPORT EXERCISE PSY, V29, P60, DOI 10.1123/jsep.29.1.60; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Cona G, 2015, NEUROSCI BIOBEHAV R, V52, P21, DOI 10.1016/j.neubiorev.2015.02.007; Cona G, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00010; Cona G, 2014, CLIN NEUROPHYSIOL, V125, P1138, DOI 10.1016/j.clinph.2013.10.048; Cona G, 2013, NEUROPSYCHOLOGY, V27, P378, DOI 10.1037/a0032708; Di Russo F, 2006, NEUROSCI LETT, V408, P113, DOI 10.1016/j.neulet.2006.08.085; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Ericsson K. A., 2003, ADV RES SPORT EXPERT, P371; Hayes SM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00031; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Holyoak K. J., 1991, GEN THEORY EXPERTISE, V301; Jackson RC, 2006, J SPORT EXERCISE PSY, V28, P49, DOI 10.1123/jsep.28.1.49; Jansen P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048620; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Lazarus RS, 2000, SPORT PSYCHOL; Masters KS, 1998, SPORT PSYCHOL, V12, P253, DOI 10.1123/tsp.12.3.253; Morgan W P, 1977, Ann N Y Acad Sci, V301, P382, DOI 10.1111/j.1749-6632.1977.tb38215.x; Nakamoto H, 2008, PERCEPT MOTOR SKILL, V106, P163, DOI 10.2466/PMS.106.1.163-170; Neil R, 2011, PSYCHOL SPORT EXERC, V12, P460, DOI 10.1016/j.psychsport.2011.02.001; NOAKES TD, 1988, MED SCI SPORT EXER, V20, P319, DOI 10.1249/00005768-198808000-00001; Pontifex MB, 2011, J COGNITIVE NEUROSCI, V23, P1332, DOI 10.1162/jocn.2010.21528; Robazza C, 2004, PSYCHOL SPORT EXERC, V5, P379, DOI 10.1016/S1469-0292(03)00034-7; Robazza C, 2004, J APPL SPORT PSYCHOL, V16, P151, DOI 10.1080/10413200490437679; Schucker L, 2009, J SPORT SCI, V27, P1241, DOI 10.1080/02640410903150467; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; Starkes JL, 1993, COGNITIVE ISSUES MOT, P365; Verburgh L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091254; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Wang CH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055773, 10.1371/journal.pone.0073985]; Williams A. M., 1999, VISUAL PERCEPTION AC; Wulf G., 2007, E J BEWEG TRAIN, V1, P1	39	60	60	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132943	10.1371/journal.pone.0132943	http://dx.doi.org/10.1371/journal.pone.0132943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26172546	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900106
J	Haun, AM; Peli, E				Haun, Andrew M.; Peli, Eli			Similar Sensitivity to Ladder Contours in Macular Degeneration Patients and Controls	PLOS ONE			English	Article							CORTICAL REORGANIZATION; INTEGRATION	Purpose To determine whether people with central field loss (CFL) from macular degeneration have improved ability to recognize a particularly difficult spatial configuration embedded in noise, the peripherally-viewed 'ladder contour'. The visibility of these configuration has been linked to general contour integration ability and crowding limitations in peripheral vision. Methods We used a trial-based yes-no task. CFL patients and normally-sighted controls performed the task, looking for ladder contours embedded in a field of randomly oriented Gabor patches, at a range of stimulus presentation times (varying stimulus difficulty). Viewing eccentricity in CFL patients was set by their preferred retinal loci (PRLs) and matched artificially in the control group. The contours were presented so as to be tangent to the CFL region, given a patient's PRL location. Results CFL and normally-sighted groups performed similarly on the task. The only significant determinant of performance was the viewing eccentricity. Conclusions CFL patients do not seem to develop any improved ability to recognize ladder contours with their parafoveal retina, which suggests that there is no underlying improvement in contour integration or reduction in crowding limitations in the region of the PRL despite extended daily use.	[Haun, Andrew M.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Peli, Eli] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst,Mass Eye & Ear, Boston, MA USA	University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Schepens Eye Research Institute	Haun, AM (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	amhaun01@gmail.com	; Haun, Andrew/I-4956-2012	Peli, Eli/0000-0002-1340-9257; Haun, Andrew/0000-0001-9458-8957	 [NIH EY05957]; NATIONAL EYE INSTITUTE [R01EY005957] Funding Source: NIH RePORTER	; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NIH EY05957	Baker CI, 2005, J NEUROSCI, V25, P614, DOI 10.1523/JNEUROSCI.3476-04.2005; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chakravarthi R, 2011, J VIS, P11; Cheung SH, 2005, VISUAL NEUROSCI, V22, P187, DOI 10.1017/S0952523805222071; Chung STL, 2013, J NEUROSCI, V33, P18080, DOI 10.1523/JNEUROSCI.2764-13.2013; Chung STL, 2011, INVEST OPHTH VIS SCI, V52, P1164, DOI 10.1167/iovs.10-6034; Dilks DD, 2007, J NEUROSCI, V27, P9585, DOI 10.1523/JNEUROSCI.2650-07.2007; Dilks DD, 2009, J NEUROSCI, V29, P2768, DOI 10.1523/JNEUROSCI.5258-08.2009; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Masuda Y, 2008, CEREB CORTEX, V18, P2483, DOI 10.1093/cercor/bhm256; May KA, 2007, J VISION, V7, DOI 10.1167/7.12.13; Nandy AS, 2012, NAT NEUROSCI, V15, P463, DOI 10.1038/nn.3021; Nugent AK, 2003, VISION RES, V43, P2427, DOI 10.1016/S0042-6989(03)00434-6; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Schumacher EH, 2008, RESTOR NEUROL NEUROS, V26, P391; TIMBERLAKE GT, 1986, INVEST OPHTH VIS SCI, V27, P1137; WHITE JM, 1990, INVEST OPHTH VIS SCI, V31, P1149; WHITTAKER SG, 1991, VISION RES, V31, P2209, DOI 10.1016/0042-6989(91)90173-3; Xiao LQ, 2008, CURR BIOL, V18, P1922, DOI 10.1016/j.cub.2008.10.030; Yu DY, 2010, VISION RES, V50, P860, DOI 10.1016/j.visres.2010.02.006	21	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0128119	10.1371/journal.pone.0128119	http://dx.doi.org/10.1371/journal.pone.0128119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171784	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900002
J	Kiss, HJ; Nemeth, J				Kiss, Huba J.; Nemeth, Janos			Isotonic Glycerol and Sodium Hyaluronate Containing Artificial Tear Decreases Conjunctivochalasis after One and Three Months: A Self-Controlled, Unmasked Study	PLOS ONE			English	Article							DRY EYE DISEASE; CONJUNCTIVAL FOLDS LIPCOF; OPHTHALMIC SOLUTION; EYEDROPS; EFFICACY; EPIDEMIOLOGY; 0.1-PERCENT; SUBCOMMITTEE; SEVERITY; SJOGREN	Dry eye complaints are ranked as the most frequent symptoms of patients visiting ophthalmologists. Conjunctivochalasis is a common dry eye disorder, which can cause an unstable tear film and ocular discomfort. The severe conjunctivochalasis characterized by high LId-Parallel COnjunctival Folds (LIPCOF) degree usually requires surgical intervention, where a conservative therapy would be highly desirable. Here we examined the efficacy of a preservative-free, inorganic salt-free unit-dose artificial tear, called Conheal containing isotonic glycerol and 0.015% sodium hyaluronate in a prospective, unmasked, self-controlled study involving 20 patients. The regular use of the glycerol/hyaluronate artificial tear in three months caused a significant improvement in the recorded parameters. Conjunctivochalasis decreased from a mean LIPCOF degree of 2.9 +/- 0.4 on both eyes to 1.4 +/- 0.6 on the right (median decrease of -2 points, 95% CI from -2.0 to -1.0), and to 1.4 +/- 0.7 on the left eye (median decrease of -1 points, 95% CI from -2.0 to -1.0) (p<0.001 for both sides). The tear film breakup time (TFBUT) lengthened from 4.8 +/- 1.9 seconds on both eyes to 5.9 +/- 2.3 seconds (mean increase of 1.1 seconds, 95% CI from 0.2 to 2.0) and 5.7 +/- 1.8 seconds (mean increase of 0.9 seconds, 95% CI from 0.3 to 1.5) on the right and left eyes, respectively (p(right eyes) = 0.020, p(left eyes) = 0.004). The corneal lissamine staining (Oxford Scheme grade) was reduced from 1.3 +/- 0.6 on the right and 1.4 +/- 0.6 on the left eye significantly (p<0.001) to 0.3 +/- 0.4 and 0.2 +/- 0.4 on the right and the left eyes. The Ocular Surface Disease Index (OSDI) questionnaire score indicating the subjective complaints of the patients also decreased from a mean value of 36.2 +/- 25.3 to 15.6 +/- 16.7 (p<0.001). In this study, the artificial tear, Conheal decreased the grade of the conjunctivochalasis significantly after one month of regular use already, from the LIPCOF degree 3, considered as indication of conjunctival surgery, to a LIPCOF degree 2 or lower requiring a conservative therapy. Our results raise the possibility that vision-related quality of life can be significantly improved by conservative therapies even in severe conjunctivochalasis.	[Kiss, Huba J.; Nemeth, Janos] Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary	Semmelweis University	Nemeth, J (corresponding author), Semmelweis Univ, Dept Ophthalmol, Maria Str 39, H-1085 Budapest, Hungary.	janos.nemeth@med.semmelweis-univ.hu		Nemeth, Janos/0000-0001-8575-4888	Foundation "For our eyesight" (Budapest, Hungary)	Foundation "For our eyesight" (Budapest, Hungary)	Work in the authors' laboratory was supported by the Foundation "For our eyesight" (Budapest, Hungary). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sanchez MA, 2010, CORNEA, V29, P167, DOI 10.1097/ICO.0b013e3181b11648; Aragona P, 2013, EUR J OPHTHALMOL, V23, P368, DOI 10.5301/ejo.5000229; Baeyens V, 2012, J FR OPHTALMOL, V35, P412, DOI 10.1016/j.jfo.2011.07.017; Biro T, 2013, SKIN RES TECHNOL, V19, pe563; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Dausch D, 2006, KLIN MONATSBL AUGENH, V223, P974, DOI 10.1055/s-2006-927266; Eurostat, 2014, BAS FIG EU; Fodor E, 2010, CURR EYE RES, V35, P665, DOI 10.3109/02713681003770738; Gensheimer WG, 2012, J OCUL PHARMACOL TH, V28, P473, DOI 10.1089/jop.2011.0053; Hoh H, 2006, KLIN MONATSBL AUGENH, V223, P918, DOI 10.1055/s-2006-927103; Hoh H, 1995, Ophthalmologe, V92, P802; Hyon Joon Young, 2014, Korean J Ophthalmol, V28, P197, DOI 10.3341/kjo.2014.28.3.197; Johnson ME, 2006, GRAEF ARCH CLIN EXP, V244, P109, DOI 10.1007/s00417-005-0028-1; Johnson ME, 2008, OPTOMETRY VISION SCI, V85, P750, DOI 10.1097/OPX.0b013e318182476c; Kaercher T, 2009, CLIN OPHTHALMOL, V3, P33; Khaireddin R, 2010, KLIN MONATSBL AUGENH, V227, P128, DOI 10.1055/s-0028-1109686; Kiss HJ, 2013, OPHTHALMOLOGIA HUNGA, V150, P28; Lee S, 2004, KLIN MONATSBL AUGENH, V221, P825, DOI 10.1055/s-2004-813715; Lemp MA, 2007, OCUL SURF, V5, P75; Liu XW, 2012, CORNEA, V31, P1235, DOI 10.1097/ICO.0b013e31824988e5; Lopez-Garcia JS, 2014, ACTA OPHTHALMOL, V92, pE22, DOI 10.1111/aos.12167; Meller D, 1998, SURV OPHTHALMOL, V43, P225, DOI 10.1016/S0039-6257(98)00037-X; MENGHER LS, 1986, BRIT J OPHTHALMOL, V70, P442, DOI 10.1136/bjo.70.6.442; Murube J, 2005, OCUL SURF, V3, P7, DOI 10.1016/S1542-0124(12)70118-0; Na KS, 2012, INVEST OPHTH VIS SCI, V53, P5443, DOI 10.1167/iovs.11-9417; Nakasato S, 2012, CORNEA, V31, P514, DOI 10.1097/ICO.0b013e3181dc81d2; Nelson JD, 2006, DRY EYE DIS CLIN GUI, P43; Nemeth J, 2012, BRIT J OPHTHALMOL, V96, P1380, DOI 10.1136/bjophthalmol-2012-301580; Petricek I, 2006, OPHTHALMOLOGICA, V220, P229, DOI 10.1159/000093076; Rah MJ, 2011, OPTOMETRY, V82, P38, DOI 10.1016/j.optm.2010.08.003; Schaumberg DA, 2002, ADV EXP MED BIOL, V506, P989; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Smith JA, 2007, OCUL SURF, V5, P93; Solomon A, 1998, J OCUL PHARMACOL TH, V14, P497, DOI 10.1089/jop.1998.14.497; Su CY, 2005, J FORMOS MED ASSOC, V104, P968; Szalai E, 2012, CORNEA, V31, P867, DOI 10.1097/ICO.0b013e3182532047; Troiano P, 2008, CORNEA, V27, P1126, DOI 10.1097/ICO.0b013e318180e55c; Vogel R, 2010, AM J OPHTHALMOL, V149, P594, DOI 10.1016/j.ajo.2009.09.023; Xu ML, 2013, J OCUL PHARMACOL TH, V29, P794, DOI 10.1089/jop.2013.0002; Yang HS, 2013, CORNEA, V32, P574, DOI 10.1097/ICO.0b013e318255eaaa; Zhang XR, 2013, CHINESE MED J-PEKING, V126, P3118, DOI 10.3760/cma.j.issn.0366-6999.20130899; Zhang Xing-ru, 2009, Zhonghua Yan Ke Za Zhi, V45, P135; Zhang XR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-198	43	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132656	10.1371/journal.pone.0132656	http://dx.doi.org/10.1371/journal.pone.0132656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172053	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900069
J	Musinguzi, G; Bastiaens, H; Matovu, JKB; Nuwaha, F; Mujisha, G; Kiguli, J; Arinaitwe, J; Van Geertruyden, JP; Wanyenze, RK				Musinguzi, Geofrey; Bastiaens, Hilde; Matovu, Joseph K. B.; Nuwaha, Fred; Mujisha, Geoffrey; Kiguli, Juliet; Arinaitwe, Jim; Van Geertruyden, Jean-Pierre; Wanyenze, Rhoda K.			Barriers to Condom Use among High Risk Men Who Have Sex with Men in Uganda: A Qualitative Study	PLOS ONE			English	Article							HIV TRANSMISSION RISK; ANAL INTERCOURSE; YOUNG MEN; BEHAVIORS; HIV/AIDS; PERCEPTIONS; WORKERS; NONUSE; GAY	Background Unprotected sexual intercourse is a major risk factor for HIV transmission. Men who have sex with men (MSM) face challenges in accessing HIV prevention services, including condoms. However, there is limited in-depth assessment and documentation of the barriers to condom use among MSM in sub-Saharan Africa. In this paper, we examine the barriers to condom use among MSM in Uganda. Methods The data for this study were extracted from a larger qualitative study conducted among 85 self-identified adult (> 18 years) MSM in 11 districts in Uganda between July and December 2013. Data on sexual behaviours and access and barriers to condom use were collected using semi-structured interviews. All interviews were audio-recorded and transcribed verbatim. This paper presents an analysis of data for 33 MSM who did not use condoms at last sex, with a focus on barriers to condom use. Analysis was conducted using the content analysis approach. Results Six major barriers to condom use were identified: Difficulties with using condoms, access challenges, lack of knowledge and misinformation about condom use, partner and relationship related issues, financial incentives and socio-economic vulnerability, and alcohol consumption. Conclusion The findings suggest that several reasons account for lack of condom use among high-risk MSM. The findings are valuable to inform interventions needed to increase condom use among MSM.	[Musinguzi, Geofrey; Nuwaha, Fred; Wanyenze, Rhoda K.] Makerere Univ, Sch Publ Hlth, Dis Control & Environm Hlth, Kampala, Uganda; [Musinguzi, Geofrey; Van Geertruyden, Jean-Pierre] Univ Antwerp, Int Hlth, B-2020 Antwerp, Belgium; [Bastiaens, Hilde] Univ Antwerp, Primary & Interdisciplinary Care, B-2020 Antwerp, Belgium; [Matovu, Joseph K. B.; Kiguli, Juliet] Makerere Univ, Sch Publ Hlth, Community Hlth & Behav Sci, Kampala, Uganda; [Mujisha, Geoffrey] MARPS Network, Kampala, Uganda; [Arinaitwe, Jim] Minist Hlth, Kampala, Uganda	Makerere University; University of Antwerp; University of Antwerp; Makerere University	Musinguzi, G (corresponding author), Makerere Univ, Sch Publ Hlth, Dis Control & Environm Hlth, Kampala, Uganda.	mgeof@musph.ac.ug	Van geertruyden, Jean-Pierre/K-6425-2014; Van geertruyden, Jean-Pierre/S-3254-2019; Matovu, Joseph/AAO-5790-2020	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Bastiaens, Hilde/0000-0002-5509-3406	Global Fund; VLIR-UOS	Global Fund; VLIR-UOS	The study was funded by the Global Fund to RW. Geofrey Musinguzi received a short research stay support by VLIR-UOS and used the data to draft this manuscript.	Adams J, 2009, QUAL HEALTH RES, V19, P1669, DOI 10.1177/1049732309353046; Alexander M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088858; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Blake SM, 2001, AM J PUBLIC HEALTH, V91, P940, DOI 10.2105/AJPH.91.6.940; CarballoDieguez A, 1996, AM J PUBLIC HEALTH, V86, P1619, DOI 10.2105/AJPH.86.11.1619; Dudley MG, 2004, AIDS EDUC PREV, V16, P328, DOI 10.1521/aeap.16.4.328.40397; Fields EL, 2012, J ADOLESCENT HEALTH, V50, P296, DOI 10.1016/j.jadohealth.2011.07.007; Geofrey Musinguzi HB, 2014, BARRIERS TO AND OPPO; Gysels M, 2001, AIDS CARE, V13, P373, DOI 10.1080/09540120120044026; Hladik W, 2008, AIDS, V22, P503, DOI 10.1097/QAD.0b013e3282f470be; Hladik W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038143; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; King R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082937; Koblin BA, 2003, AM J PUBLIC HEALTH, V93, P926, DOI 10.2105/AJPH.93.6.926; Li HC, 2010, AIDS CARE, V22, P1481, DOI 10.1080/09540121.2010.482121; Lightfoot M, 2005, JAIDS-J ACQ IMM DEF, V38, P61, DOI 10.1097/00126334-200501010-00012; Mishra SR, 2013, HIV AIDS-RES PALLIAT, V5, P81, DOI 10.2147/HIV.S42795; Morse JM, 2008, QUAL HEALTH RES, V18, P727, DOI 10.1177/1049732308314930; Musinguzi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085646; Okal J, 2009, CULT HEALTH SEX, V11, P811, DOI 10.1080/13691050902906488; Ostergren JE, 2011, CULT HEALTH SEX, V13, P123, DOI 10.1080/13691058.2010.520168; Pando MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039834; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Raymond HF, 2009, AIDS BEHAV, V13, P677, DOI 10.1007/s10461-009-9557-7; SAGE Publications I, ENCYCLOPEDIA OF SOCI; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Tucker Saroj, 2012, Indian J Sex Transm Dis AIDS, V33, P9, DOI 10.4103/0253-7184.93787; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Varga C A, 1997, Afr J Reprod Health, V1, P74, DOI 10.2307/3583277; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; World Health Organization, 2013, GLOBAL REPORT UNAIDS	32	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132297	10.1371/journal.pone.0132297	http://dx.doi.org/10.1371/journal.pone.0132297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26172374	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900040
J	Popp, M; Thielmann, I; Nieswandt, B; Stegner, D				Popp, Michael; Thielmann, Ina; Nieswandt, Bernhard; Stegner, David			Normal Platelet Integrin Function in Mice Lacking Hydrogen Peroxide-Induced Clone-5 (Hic-5)	PLOS ONE			English	Article							IN-VIVO; ACTIVATION; ADHESION; AGGREGATION; BINDING; HEMOSTASIS; MECHANISMS; THROMBOSIS; COLLAGEN; PROTEIN	Integrin alpha IIb beta 3 plays a central role in the adhesion and aggregation of platelets and thus is essential for hemostasis and thrombosis. Integrin activation requires the transmission of a signal from the small cytoplasmic tails of the a or beta subunit to the large extracellular domains resulting in conformational changes of the extracellular domains to enable ligand binding. Hydrogen peroxide-inducible clone-5 (Hic-5), a member of the paxillin family, serves as a focal adhesion adaptor protein associated with alpha IIb beta 3 at its cytoplasmic tails. Previous studies suggested Hic-5 as a novel regulator of integrin alpha IIb beta 3 activation and platelet aggregation in mice. To assess this in more detail, we generated Hic-5-null mice and analyzed activation and aggregation of their platelets in vitro and in vivo. Surprisingly, lack of Hic-5 had no detectable effect on platelet integrin activation and function in vitro and in vivo under all tested conditions. These results indicate that Hic-5 is dispensable for integrin alpha IIb beta 3 activation and consequently for arterial thrombosis and hemostasis in mice.	[Stegner, David] Univ Wurzburg, Univ Hosp, Dept Expt Biomed Vasc Med, D-97070 Wurzburg, Germany; Univ Wurzburg, Rudolf Virchow Ctr, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Stegner, D (corresponding author), Univ Wurzburg, Univ Hosp, Dept Expt Biomed Vasc Med, D-97070 Wurzburg, Germany.	stegner@virchow.uni-wuerzburg.de	Stegner, David/AAA-4948-2019	Stegner, David/0000-0003-1059-9865	Rudolf Virchow Center; Deutsche Forschungsgemeinschaft [SFB688]; German Research Foundation (DFG); University of Wuerzburg	Rudolf Virchow Center; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by the Rudolf Virchow Center and the Deutsche Forschungsgemeinschaft (SFB688). This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing.	Cheli Y, 2008, BLOOD, V111, P1266, DOI 10.1182/blood-2007-09-111369; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Grosse J, 2007, J CLIN INVEST, V117, P3540, DOI 10.1172/JCI32312; Hagmann J, 1998, J CELL SCI, V111, P2181; Kim-Kaneyama JR, 2012, J THROMB HAEMOST, V10, P1867, DOI 10.1111/j.1538-7836.2012.04856.x; Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Lei XF, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000747; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Morgenstern E, 1990, BLOOD COAGUL FIBRIN, V1, P547; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Nieswandt B, 2011, J THROMB HAEMOST, V9, P92, DOI 10.1111/j.1538-7836.2011.04361.x; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Pleines I, 2010, BLOOD, V115, P3364, DOI 10.1182/blood-2009-09-242271; Rathore VB, 2007, BIOCHEM J, V403, P275, DOI 10.1042/BJ20061618; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Sakata A, 2014, THROMB J, V12, DOI 10.1186/1477-9560-12-1; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Stritt S, 2015, BLOOD, V125, P219, DOI 10.1182/blood-2014-08-597542; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991	27	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133429	10.1371/journal.pone.0133429	http://dx.doi.org/10.1371/journal.pone.0133429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172113	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900150
J	Roedgaard, M; Fredsoe, J; Pedersen, JM; Bjergbaek, L; Andersen, AH				Roedgaard, Morten; Fredsoe, Jacob; Pedersen, Jakob Madsen; Bjergbaek, Lotte; Andersen, Anni Hangaard			DNA Topoisomerases Are Required for Preinitiation Complex Assembly during GAL Gene Activation	PLOS ONE			English	Article							NUCLEOSOME OCCUPANCY; POL II; YEAST; CHROMATIN; TRANSCRIPTION; REPLICATION; GALACTOSE; PROTEIN; EXPRESSION; BINDING	To investigate the importance of topoisomerases for transcription of the galactose induced genes, we have studied the expression of GAL1, GAL2, GAL7 and GAL10 in Saccharomyces cerevisiae cells deficient for topoisomerases I and II. We find that topoisomerases are required for transcriptional activation of the GAL genes, but are dispensable for ongoing transcription, eliminating a role of the enzymes in transcriptional elongation. Furthermore, we demonstrate that promoter chromatin remodeling of the GAL genes is unaffected in the topoisomerase deficient strain. However, the cells fail to successfully recruit RNA polymerase II due to an inability of the TATA-binding protein (TBP) to bind to the TATA box in these promoters. We therefore argue that topoisomerases are required for accurate assembly of the preinitiation complex at the promoters of the GAL genes.	[Roedgaard, Morten; Fredsoe, Jacob; Pedersen, Jakob Madsen; Bjergbaek, Lotte; Andersen, Anni Hangaard] Aarhus Univ, Dept Mol Biol & Genet, Lab Genome Res, DK-8000 Aarhus C, Denmark	Aarhus University	Andersen, AH (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Lab Genome Res, CF Mollers Alle 3, DK-8000 Aarhus C, Denmark.	aha@mbg.au.dk	Bjergbæk, Lotte/AAW-6302-2021; Fredsøe, Jacob/AAD-6677-2019; Andersen, Anni/O-1162-2017	Fredsøe, Jacob/0000-0002-7319-2467; Bjergbaek, Lotte/0000-0002-8233-3356; Andersen, Anni/0000-0001-7194-3258	Danish Natural Science Research Council; Novo Nordisk Foundation; Karen Elise Jensen Foundation; Gangsted Foundation; Simon Fougner Hartmanns Foundation; Dagmar Marshalls Foundation; Astrid Thaysens Foundation; Villum Kann Rasmussen Foundation	Danish Natural Science Research Council(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Karen Elise Jensen Foundation; Gangsted Foundation; Simon Fougner Hartmanns Foundation; Dagmar Marshalls Foundation; Astrid Thaysens Foundation; Villum Kann Rasmussen Foundation(Villum Fonden)	This work was supported by the Danish Natural Science Research Council, the Novo Nordisk Foundation, the Karen Elise Jensen Foundation, the Gangsted Foundation, the Simon Fougner Hartmanns Foundation, the Dagmar Marshalls Foundation, the Astrid Thaysens Foundation, and the Villum Kann Rasmussen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramczyk D, 2012, EUKARYOT CELL, V11, P334, DOI 10.1128/EC.05294-11; Bancaud A, 2006, NAT STRUCT MOL BIOL, V13, P444, DOI 10.1038/nsmb1087; Bermejo R, 2007, GENE DEV, V21, P1921, DOI 10.1101/gad.432107; Bermejo R, 2009, CELL, V138, P870, DOI 10.1016/j.cell.2009.06.022; BRILL SJ, 1987, NATURE, V326, P414, DOI 10.1038/326414a0; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; CLARK DJ, 1991, EMBO J, V10, P387, DOI 10.1002/j.1460-2075.1991.tb07960.x; Durand-Dubief M, 2010, EMBO J, V29, P2126, DOI 10.1038/emboj.2010.109; Garinther WI, 1997, MOL CELL BIOL, V17, P3520, DOI 10.1128/MCB.17.7.3520; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Hamiche A, 1996, P NATL ACAD SCI USA, V93, P7588, DOI 10.1073/pnas.93.15.7588; Jiang FL, 2009, MOL CELL BIOL, V29, P5604, DOI 10.1128/MCB.00632-09; Joshi RS, 2012, NUCLEIC ACIDS RES, V40, P7907, DOI 10.1093/nar/gks626; Joshi RS, 2010, EMBO J, V29, P740, DOI 10.1038/emboj.2009.391; Kahn JD, 2000, BIOCHEMISTRY-US, V39, P3520, DOI 10.1021/bi992263f; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; LUE NF, 1987, MOL CELL BIOL, V7, P3446, DOI 10.1128/MCB.7.10.3446; Martinez E, 2002, PLANT MOL BIOL, V50, P925, DOI 10.1023/A:1021258713850; Nikolaou C, 2013, NUCLEIC ACIDS RES, V41, P9243, DOI 10.1093/nar/gkt707; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; Pedersen JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003128; Pilauri V, 2005, GENETICS, V169, P1903, DOI 10.1534/genetics.104.036723; Platt A, 1998, EMBO J, V17, P4086, DOI 10.1093/emboj/17.14.4086; Salceda J, 2006, EMBO J, V25, P2575, DOI 10.1038/sj.emboj.7601142; Sarge KD, 2005, TRENDS BIOCHEM SCI, V30, P605, DOI 10.1016/j.tibs.2005.09.004; Sellick CA, 2008, INT REV CEL MOL BIO, V269, P111, DOI 10.1016/S1937-6448(08)01003-4; Sil AK, 1999, MOL CELL BIOL, V19, P7828; Sperling AS, 2011, P NATL ACAD SCI USA, V108, P12693, DOI 10.1073/pnas.1106834108; SVAREN J, 1994, EMBO J, V13, P4856, DOI 10.1002/j.1460-2075.1994.tb06812.x; TABUCHI H, 1993, BIOCHEM BIOPH RES CO, V192, P1432, DOI 10.1006/bbrc.1993.1576; Traven A, 2006, EMBO REP, V7, P496, DOI 10.1038/sj.embor.7400679; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799	40	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132739	10.1371/journal.pone.0132739	http://dx.doi.org/10.1371/journal.pone.0132739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173127	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900080
J	Roh, HW; Hong, CH; Lee, Y; Oh, BH; Lee, KS; Chang, KJ; Kang, DR; Kim, J; Lee, S; Back, JH; Chung, YK; Lim, KY; Noh, JS; Kim, D; Son, SJ				Roh, Hyun Woong; Hong, Chang Hyung; Lee, Yunhwan; Oh, Byoung Hoon; Lee, Kang Soo; Chang, Ki Jung; Kang, Dae Ryong; Kim, Jinhee; Lee, SooJin; Back, Joung Hwan; Chung, Young Ki; Lim, Ki Young; Noh, Jai Sung; Kim, Dongsoo; Son, Sang Joon			Participation in Physical, Social, and Religious Activity and Risk of Depression in the Elderly: A Community-Based Three-Year Longitudinal Study in Korea	PLOS ONE			English	Article							OLDER-ADULTS; MENTAL-HEALTH; PSYCHOSOCIAL INTERVENTIONS; SYMPTOMS; SUPPORT; PEOPLE; SPIRITUALITY; ASSOCIATION; PREDICTORS; PREVENTION	Background We examined the longitudinal association between participation in individual or combinations of physical, social, and religious activity and risk of depression in the elderly. Methods Elderly subjects aged >= 60 years who completed the Living Profiles of Older People Survey in Korea (n = 6,647) were included. The baseline assessment, Wave 1, was conducted in 2008, and a follow-up assessment, Wave 2, was conducted in 2011. We defined participation in frequent physical activity as >= 3 times weekly (at least 30 minutes per activity). Frequent participation in social and religious activity was defined as >= 1 activity weekly. The primary outcome was depression at 3-year follow up. Results Multivariable logistic regression analysis showed that subjects who participated in frequent physical, social, and religious activity had an adjusted odds ratio of 0.81 (95% confidence interval [CI], 0.69-0.96), 0.87 (95% CI, 0.75-1.00), and 0.78 (95% CI, 0.67-0.90), respectively, compared with participants who did not participate in each activity. Participants who participated in only one type of activity frequently and participants who participated in two or three types of activities frequently had an adjusted odds ratio of 0.86 (95% CI, 0.75-0.98) and 0.64 (95% CI, 0.52-0.79), respectively, compared with participants who did not participate in any type of physical, social, and religious activity frequently. Conclusion Participation in physical, social, and religious activity was associated with decreased risk of depression in the elderly. In addition, risk of depression was much lower in the elderly people who participated in two or three of the above-mentioned types of activity than that in the elderly who did not.	[Roh, Hyun Woong; Hong, Chang Hyung; Chang, Ki Jung; Chung, Young Ki; Lim, Ki Young; Noh, Jai Sung; Kim, Dongsoo; Son, Sang Joon] Ajou Univ, Sch Med, Dept Psychiat, Suwon 441749, South Korea; [Roh, Hyun Woong; Hong, Chang Hyung; Lee, Yunhwan; Chang, Ki Jung; Kim, Jinhee; Son, Sang Joon] Ajou Univ, Inst Aging, Med Ctr, Suwon 441749, South Korea; [Lee, Yunhwan; Kim, Jinhee] Ajou Univ, Dept Prevent Med & Publ Hlth, Sch Med, Suwon 441749, South Korea; [Oh, Byoung Hoon] Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Oh, Byoung Hoon] Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea; [Lee, Kang Soo] CHA Univ, Dept Psychiat, Sch Med, CHA Hosp, Gangnam, South Korea; [Kang, Dae Ryong] Ajou Univ, Dept Med Humanities & Social Med, Off Biostat, Sch Med, Suwon 441749, South Korea; [Lee, SooJin] Backseok Arts Univ, Dept Medicare Adm, Seoul, South Korea; [Back, Joung Hwan] Natl Hlth Insurance Serv, Seoul, South Korea	Ajou University; Ajou University; Ajou University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pochon Cha University; Ajou University; National Health Insurance Service	Son, SJ (corresponding author), Ajou Univ, Sch Med, Dept Psychiat, Suwon 441749, South Korea.	sjsonpsy@ajou.ac.kr	Lee, Yunhwan/F-4967-2010	Lee, Yunhwan/0000-0001-8484-4750	Haesong Geriatric Psychiatry Research Fund from the Korean Mental Health Foundation	Haesong Geriatric Psychiatry Research Fund from the Korean Mental Health Foundation	This study was supported by a Haesong Geriatric Psychiatry Research Fund from the Korean Mental Health Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Arean PA, 2005, BIOL PSYCHIAT, V58, P277, DOI 10.1016/j.biopsych.2005.03.037; Bac JN, 2004, J PSYCHOSOM RES, V57, P297, DOI 10.1016/j.jpsychores.2004.01.004; Braam AW, 2004, J AGING HEALTH, V16, P467, DOI 10.1177/0898264304265765; Bridle C, 2012, BRIT J PSYCHIAT, V201, P180, DOI 10.1192/bjp.bp.111.095174; Bruce ML, 2002, BIOL PSYCHIAT, V52, P175, DOI 10.1016/S0006-3223(02)01410-5; Chen HT, 2007, INT J GERIATR PSYCH, V22, P144, DOI 10.1002/gps.1704; Chiao C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-292; Cruwys T, 2013, SOC SCI MED, V98, P179, DOI 10.1016/j.socscimed.2013.09.013; Dickens AP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-647; Erickson Kirk I, 2013, Dialogues Clin Neurosci, V15, P99; Forsman AK, 2011, HEALTH PROMOT INT, V26, pI85, DOI 10.1093/heapro/dar074; Forsman AK, 2011, J AGING HEALTH, V23, P387, DOI 10.1177/0898264310378041; Guerra M, 2009, BRIT J PSYCHIAT, V195, P510, DOI 10.1192/bjp.bp.109.064055; Hahn CY, 2004, INT J GERIATR PSYCH, V19, P1148, DOI 10.1002/gps.1204; Han ES, 2014, INT PSYCHOGERIATR, V26, P155, DOI 10.1017/S1041610213001841; Harris T, 2003, AGE AGEING, V32, P510, DOI 10.1093/ageing/afg087; Hayward RD, 2012, AM J GERIAT PSYCHIAT, V20, P188, DOI 10.1097/JGP.0b013e31822ccd51; 이성찬, 2013, [Journal of Korean Geriatirc Psychiatry, 노인정신의학], V17, P36; Kim KHC, 2004, PUBLIC HEALTH NUTR, V7, P773, DOI 10.1079/PHN2004601; Koenig HG, 2007, AM J GERIAT PSYCHIAT, V15, P282, DOI 10.1097/01.JGP.0000246875.93674.0c; Koenig HG, 1997, AM J GERIAT PSYCHIAT, V5, P131; Krause Neal, 2003, J Gerontol B Psychol Sci Soc Sci, V58, pS160; 이동영, 2002, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V41, P508; Lee Kang Soo, 2009, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V48, P61; Lee Y, 2014, GERONTOLOGY, V60, P475, DOI 10.1159/000362330; Lucas M, 2011, AM J EPIDEMIOL, V174, P1017, DOI 10.1093/aje/kwr218; Correa AAM, 2011, REV BRAS PSIQUIATR, V33, P157, DOI 10.1590/S1516-44462011000200011; Maki Y, 2012, J AM GERIATR SOC, V60, P1590, DOI 10.1111/j.1532-5415.2012.04091.x; Manning LK, 2013, QUAL HEALTH RES, V23, P568, DOI 10.1177/1049732312471730; MEEUSEN R, 1995, SPORTS MED, V20, P160, DOI 10.2165/00007256-199520030-00004; Miller L, 2014, JAMA PSYCHIAT, V71, P128, DOI 10.1001/jamapsychiatry.2013.3067; Miller L, 2012, AM J PSYCHIAT, V169, P89, DOI 10.1176/appi.ajp.2011.10121823; Mura Gioia, 2013, Clin Pract Epidemiol Ment Health, V9, P125, DOI 10.2174/1745017901309010125; Oyama H, 2006, PSYCHIAT CLIN NEUROS, V60, P110, DOI 10.1111/j.1440-1819.2006.01468.x; Park J.E., 2014, INT J GERIATR PSYCHI; Pasco JA, 2011, INT PSYCHOGERIATR, V23, P292, DOI 10.1017/S1041610210001833; Razafsha M, 2012, METHODS MOL BIOL, V829, P49, DOI 10.1007/978-1-61779-458-2_3; Sarris J, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-107; Schwarzbach M, 2014, INT J GERIATR PSYCH, V29, P1, DOI 10.1002/gps.3971; Shankar A, 2011, HEALTH PSYCHOL, V30, P377, DOI 10.1037/a0022826; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Son J, 2008, J HEALTH SOC BEHAV, V49, P104, DOI 10.1177/002214650804900108; Sugihara Y, 2008, J GERONTOL B-PSYCHOL, V63, pP227, DOI 10.1093/geronb/63.4.P227; Teo AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062396; Uebelacker LA, 2013, SOC PSYCH PSYCH EPID, V48, P1971, DOI 10.1007/s00127-013-0693-z; Wassink-Vossen S, 2014, J AFFECT DISORDERS, V161, P65, DOI 10.1016/j.jad.2014.03.001; who, ACT AG POL FRAM; Won C.W., 2002, J KOREAN GERIATRICS, V6, P273; Won CW, 2002, J KOREAN GERIATR SOC, V6, P107, DOI DOI 10.1037/T06803-000]; Zou JX, 2014, SOC PSYCH PSYCH EPID, V49, P911, DOI 10.1007/s00127-013-0785-9	51	64	68	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132838	10.1371/journal.pone.0132838	http://dx.doi.org/10.1371/journal.pone.0132838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26172441	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900089
J	Hunter, MO; Keller, M; Morton, D; Cook, B; Lefsky, M; Ducey, M; Saleska, S; de Oliveira, RC; Schietti, J				Hunter, Maria O.; Keller, Michael; Morton, Douglas; Cook, Bruce; Lefsky, Michael; Ducey, Mark; Saleska, Scott; de Oliveira, Raimundo Cosme, Jr.; Schietti, Juliana			Structural Dynamics of Tropical Moist Forest Gaps	PLOS ONE			English	Article							RAIN-FOREST; PHASE REGENERATION; TREE DIVERSITY; CANOPY GAPS; AMAZONIAN FOREST; STEADY-STATE; FIRME FOREST; LEAF-AREA; DISTURBANCE; LIDAR	Gap phase dynamics are the dominant mode of forest turnover in tropical forests. However, gap processes are infrequently studied at the landscape scale. Airborne lidar data offer detailed information on three-dimensional forest structure, providing a means to characterize fine-scale (1 m) processes in tropical forests over large areas. Lidar-based estimates of forest structure (top down) differ from traditional field measurements (bottom up), and necessitate clear-cut definitions unencumbered by the wisdom of a field observer. We offer a new definition of a forest gap that is driven by forest dynamics and consistent with precise ranging measurements from airborne lidar data and tall, multi-layered tropical forest structure. We used 1000 ha of multi-temporal lidar data (2008, 2012) at two sites, the Tapajos National Forest and Ducke Reserve, to study gap dynamics in the Brazilian Amazon. Here, we identified dynamic gaps as contiguous areas of significant growth, that correspond to areas > 10 m(2), with height < 10 m. Applying the dynamic definition at both sites, we found over twice as much area in gap at Tapajos National Forest (4.8 %) as compared to Ducke Reserve (2.0 %). On average, gaps were smaller at Ducke Reserve and closed slightly more rapidly, with estimated height gains of 1.2 m y(-1) versus 1.1 m y(-1) at Tapajos. At the Tapajos site, height growth in gap centers was greater than the average height gain in gaps (1.3 m y(-1) versus 1.1 m y(-1)). Rates of height growth between lidar acquisitions reflect the interplay between gap edge mortality, horizontal ingrowth and gap size at the two sites. We estimated that approximately 10% of gap area closed via horizontal ingrowth at Ducke Reserve as opposed to 6 % at Tapajos National Forest. Height loss (interpreted as repeat damage and/or mortality) and horizontal ingrowth accounted for similar proportions of gap area at Ducke Reserve (13% and 10 %, respectively). At Tapajos, height loss had a much stronger signal (23 % versus 6 %) within gaps. Both sites demonstrate limited gap contagiousness defined by an increase in the likelihood of mortality in the immediate vicinity (similar to 6 m) of existing gaps.	[Hunter, Maria O.] Univ New Hampshire, Earth Sci Res Ctr, Durham, NH 03824 USA; [Keller, Michael] USDA Forest Serv, Int Inst Trop Forestry, San Juan, PR USA; [Keller, Michael] EMBRAPA Monitoramento Satelite, Campinas, SP, Brazil; [Morton, Douglas; Cook, Bruce] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Lefsky, Michael] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Ducey, Mark] Univ New Hampshire, Dept Nat Resources, Durham, NH 03824 USA; [Saleska, Scott] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [de Oliveira, Raimundo Cosme, Jr.] EMBRAPA Amazonia Oriental, Belem, Para, Brazil; [Schietti, Juliana] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil	University System Of New Hampshire; University of New Hampshire; United States Department of Agriculture (USDA); United States Forest Service; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Colorado State University; University System Of New Hampshire; University of New Hampshire; University of Arizona; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Institute Nacional de Pesquisas da Amazonia	Hunter, MO (corresponding author), Univ New Hampshire, Earth Sci Res Ctr, Durham, NH 03824 USA.	Hunter.maria@gmail.com	Schietti, Juliana/AAV-7451-2020; Saleska, Scott R/K-1733-2016; Keller, Michael/A-8976-2012; Morton, Douglas C/D-5044-2012; Schietti, Juliana/B-8226-2015; Ducey, Mark/K-1101-2016	Schietti, Juliana/0000-0002-1687-4373; Saleska, Scott R/0000-0002-4974-3628; Keller, Michael/0000-0002-0253-3359; Schietti, Juliana/0000-0002-1687-4373; 	NASA [NNX09AO46H, NNG06GE11A, NNX09AI33G, NNG04G073G, NNX06AH36G]; NSF [DEB0721140]; USAid Sustainable Landscapes	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); USAid Sustainable Landscapes(United States Agency for International Development (USAID))	Funding provided by NASA Grant NNX09AO46H, NASA grant NNG06GE11A, NASA grant NNX09AI33G, NASA grant NNG04G073G, NASA grant NNX06AH36G, NSF grant DEB0721140, USAid Sustainable Landscapes (www.nasa.gov,www.nsf.gov,www.usaid.gov/climate/sustainablelandscapes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2003, REMOTE SENS ENVIRON, V87, P521, DOI 10.1016/j.rse.2003.08.006; Asner GP, 2002, REMOTE SENS ENVIRON, V80, P483, DOI 10.1016/S0034-4257(01)00326-1; Asner GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060875; BORMANN FH, 1979, AM SCI, V67, P660; Boyd DS, 2013, ECOL APPL, V23, P1588, DOI 10.1890/12-0371.1; Brokaw N, 2000, TRENDS ECOL EVOL, V15, P183, DOI 10.1016/S0169-5347(00)01822-X; BROKAW NVL, 1982, BIOTROPICA, V14, P158, DOI 10.2307/2387750; BROKAW NVL, 1987, J ECOL, V75, P9, DOI 10.2307/2260533; BROKAW NVL, 1985, ECOLOGY, V66, P682, DOI 10.2307/1940529; Chambers JQ, 2013, P NATL ACAD SCI USA, V110, P3949, DOI 10.1073/pnas.1202894110; Chambers JQ, 2009, ECOL LETT, V12, pE22, DOI 10.1111/j.1461-0248.2009.01398.x; Chao KJ, 2009, J VEG SCI, V20, P260, DOI 10.1111/j.1654-1103.2009.05755.x; CHAUVEL A, 1987, EXPERIENTIA, V43, P234, DOI 10.1007/BF01945546; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Cook BD, 2013, REMOTE SENS-BASEL, V5, P4045, DOI 10.3390/rs5084045; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; de Toledo JJ, 2012, FOREST ECOL MANAG, V263, P253, DOI 10.1016/j.foreco.2011.09.017; DENSLOW JS, 1987, ANNU REV ECOL SYST, V18, P431, DOI 10.1146/annurev.es.18.110187.002243; DESTEVEN D, 1988, J TROP ECOL, V4, P407, DOI 10.1017/S0266467400003084; Doughty CE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI [10.1029/2007JG000632, 10.1029/2007JG000590]; Drake JB, 2002, REMOTE SENS ENVIRON, V79, P305, DOI 10.1016/S0034-4257(01)00281-4; Efron B, 1994, INTRO BOOTSTRAP; Espirito-Santo FDB, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043146; Espirito-Santo FDB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4434; Espirito-Santo FDB, 2014, PLANT ECOL DIVERS, V7, P305, DOI 10.1080/17550874.2013.795629; Ferry B, 2010, J ECOL, V98, P106, DOI 10.1111/j.1365-2745.2009.01604.x; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; Frazer GW, 2005, FOREST ECOL MANAG, V214, P65, DOI 10.1016/j.foreco.2005.03.056; Gale N, 2001, J VEG SCI, V12, P337, DOI 10.2307/3236847; Gale N, 1999, J TROP ECOL, V15, P415, DOI 10.1017/S0266467499000929; Gaulton R, 2010, INT J REMOTE SENS, V31, P1193, DOI 10.1080/01431160903380565; Gloor M, 2009, GLOBAL CHANGE BIOL, V15, P2418, DOI 10.1111/j.1365-2486.2009.01891.x; Hubbell S. P., 1986, PLANT ECOL, P77; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hunter MO, 2013, BIOGEOSCIENCES, V10, P8385, DOI 10.5194/bg-10-8385-2013; JANS L, 1993, BIOTROPICA, V25, P258, DOI 10.2307/2388784; Jansen PA, 2008, ECOLOGY, V89, P3490, DOI 10.1890/07-1682.1; KAPOS V, 1990, BIOTROPICA, V22, P218, DOI 10.2307/2388531; Keller M, 2004, ECOL APPL, V14, pS3, DOI 10.1890/03-6003; Kellner JR, 2014, ECOL LETT, V17, P556, DOI 10.1111/ele.12256; Kellner JR, 2009, ECOL LETT, V12, P887, DOI 10.1111/j.1461-0248.2009.01345.x; Kellner JR, 2009, ECOL LETT, V12, P155, DOI 10.1111/j.1461-0248.2008.01274.x; Laurance WF, 1998, ECOLOGY, V79, P2032, DOI 10.1890/0012-9658(1998)079[2032:RFFATD]2.0.CO;2; LAWTON RO, 1988, ECOLOGY, V69, P764, DOI 10.2307/1941025; Lefsky MA, 2002, BIOSCIENCE, V52, P19, DOI 10.1641/0006-3568(2002)052[0019:LRSFES]2.0.CO;2; LIEBERMAN D, 1985, J ECOL, V73, P915, DOI 10.2307/2260157; Lloyd J, 2009, ECOL LETT, V12, pE19, DOI 10.1111/j.1461-0248.2009.01326.x; Lobo E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3218; Luizao F.J., 1989, GEOJOURNAL, V19, P407, DOI [DOI 10.1007/BF00176910, 10.1007/BF00176910]; LUIZAO FJ, 1987, EXPERIENTIA, V43, P259, DOI 10.1007/BF01945549; Malhado ACM, 2009, FOREST ECOL MANAG, V258, P1161, DOI 10.1016/j.foreco.2009.06.002; Molino JF, 2001, SCIENCE, V294, P1702, DOI 10.1126/science.1060284; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; Nath CD, 2006, J BIOSCIENCES, V31, P651, DOI 10.1007/BF02708418; Negron-Juarez RI, 2011, REMOTE SENS ENVIRON, V115, P3322, DOI 10.1016/j.rse.2011.07.015; Oliver C.D., 1996, FOREST STAND DYNAMIC; Palace M, 2007, FOREST ECOL MANAG, V238, P309, DOI 10.1016/j.foreco.2006.10.026; POORTER L, 1994, J TROP ECOL, V10, P385, DOI 10.1017/S0266467400008063; PUTZ FE, 1983, BIOTROPICA, V15, P185, DOI 10.2307/2387827; Pyle EH, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000592; Ray D, 2005, ECOL APPL, V15, P1664, DOI 10.1890/05-0404; RUNKLE JR, 1981, ECOLOGY, V62, P1041, DOI 10.2307/1937003; RUNKLE JR, 1987, ECOLOGY, V68, P417, DOI 10.2307/1939273; Schliemann SA, 2011, FOREST ECOL MANAG, V261, P1143, DOI 10.1016/j.foreco.2011.01.011; Silver WL, 2000, ECOSYSTEMS, V3, P193, DOI 10.1007/s100210000019; St-Onge B, 2004, POWER, V140, p200uJ; Stark SC, 2012, ECOL LETT, V15, P1406, DOI 10.1111/j.1461-0248.2012.01864.x; Thompson J, 1998, FOREST ECOL MANAG, V102, P305, DOI 10.1016/S0378-1127(97)00171-0; vanderMeer PJ, 1996, VEGETATIO, V126, P167, DOI 10.1007/BF00045602; VANDERMEER PJ, 1994, ACTA OECOL, V15, P701; Vepakomma U, 2008, REMOTE SENS ENVIRON, V112, P2326, DOI 10.1016/j.rse.2007.10.001; Vepakomma U, 2011, ECOL APPL, V21, P99, DOI 10.1890/09-0896.1; Vieira S, 2004, OECOLOGIA, V140, P468, DOI 10.1007/s00442-004-1598-z; Whitmore TC, 1996, PHILOS T R SOC B, V351, P1195, DOI 10.1098/rstb.1996.0102; WHITMORE TC, 1993, J TROP ECOL, V9, P131, DOI 10.1017/S0266467400007112; YOUNG TP, 1991, ECOLOGY, V72, P1464, DOI 10.2307/1941119; Zhang KQ, 2003, IEEE T GEOSCI REMOTE, V41, P872, DOI 10.1109/TGRS.2003.810682	78	21	22	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132144	10.1371/journal.pone.0132144	http://dx.doi.org/10.1371/journal.pone.0132144			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168242	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100024
J	Liu, QH; Zhou, ZC; Wei, YC; Shen, DY; Feng, ZP; Hong, SP				Liu, Qinghua; Zhou, Zhichun; Wei, Yongcheng; Shen, Danyu; Feng, Zhongping; Hong, Shanping			Genome-Wide Identification of Differentially Expressed Genes Associated with the High Yielding of Oleoresin in Secondary Xylem of Masson Pine (Pinus massoniana Lamb) by Transcriptomic Analysis	PLOS ONE			English	Article							INDUCED TERPENE SYNTHASE; FUNCTIONAL-CHARACTERIZATION; CONIFER DEFENSE; CDNA ISOLATION; SITKA SPRUCE; RESIN YIELD; BIOSYNTHESIS; RESISTANCE; ENZYMES; INSECTS	Masson pine is an important timber and resource for oleoresin in South China. Increasing yield of oleoresin in stems can raise economic benefits and enhance the resistance to bark beetles. However, the genetic mechanisms for regulating the yield of oleoresin were still unknown. Here, high-throughput sequencing technology was used to investigate the transcriptome and compare the gene expression profiles of high and low oleoresin-yielding genotypes. A total of 40,690,540 reads were obtained and assembled into 137,499 transcripts from the secondary xylem tissues. We identified 84,842 candidate unigenes based on sequence annotation using various databases and 96 unigenes were candidates for terpenoid backbone biosynthesis in pine. By comparing the expression profiles of high and low oleoresin-yielding genotypes, 649 differentially expressed genes (DEGs) were identified. GO enrichment analysis of DEGs revealed that multiple pathways were related to high yield of oleoresin. Nine candidate genes were validated by QPCR analysis. Among them, the candidate genes encoding geranylgeranyl diphosphate synthase (GGPS) and (-)-alpha/beta-pinene synthase were up-regulated in the high oleoresin-yielding genotype, while tricyclene synthase revealed lower expression level, which was in good agreement with the GC/MS result. In addition, DEG encoding ABC transporters, pathogenesis-related proteins (PR5 and PR9), phosphomethylpyrimidine synthase, non-specific lipid-transfer protein-like protein and ethylene responsive transcription factors (ERFs) were also confirmed to be critical for the biosynthesis of oleoresin. The next-generation sequencing strategy used in this study has proven to be a powerful means for analyzing transcriptome variation related to the yield of oleoresin in masson pine. The candidate genes encoding GGPS, (-)-alpha/beta-pinene, tricyclene synthase, ABC transporters, non-specific lipid-transfer protein-like protein, phosphomethylpyrimidine synthase, ERFs and pathogen responses may play important roles in regulating the yield of oleoresin. These DEGs are worthy of special attention in future studies.	[Liu, Qinghua; Zhou, Zhichun; Wei, Yongcheng; Shen, Danyu] Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang, Zhejiang, Peoples R China; [Liu, Qinghua; Zhou, Zhichun; Wei, Yongcheng] Zhejiang Prov Key Lab Tree Breeding, Fuyang, Zhejiang, Peoples R China; [Feng, Zhongping; Hong, Shanping] Laoshan Forest Farm Chunan Cty, Chunan, Zhejiang, Peoples R China	Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Zhou, ZC (corresponding author), Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang, Zhejiang, Peoples R China.	zczhou_risf@163.com			National Science & Technology Pillar Program of China [2012BAD01B02]; National Natural Science Foundation of China [31100491]; Major Science & Technology Project of New Agricultural Variety Cultivation of Zhejiang Province, China [2012C12908-12]	National Science & Technology Pillar Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science & Technology Project of New Agricultural Variety Cultivation of Zhejiang Province, China	This work was supported by funds from: 1) National Science & Technology Pillar Program of China (No. 2012BAD01B02, http://kjzc.jhgl.org/), ZZ. The funders had a role in decision to publish; 2) National Natural Science Foundation of China (31100491), QL. The funders had a role in study design; 3) Major Science & Technology Project of New Agricultural Variety Cultivation of Zhejiang Province, China (2012C12908-12), ZZ. The funders had a role in data collection and analysis, decision to publish.	Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Bohlmann J, 2000, RECENT ADV PHYTOCHEM, V34, P109, DOI 10.1016/S0079-9920(00)80006-4; Bouvier F, 2005, PROG LIPID RES, V44, P357, DOI 10.1016/j.plipres.2005.09.003; Byun-McKay A, 2006, PLANT PHYSIOL, V140, P1009, DOI 10.1104/pp.105.071803; Coppen J. J. W., 1995, Non-Wood Forest Products; da Silva Rodrigues-Corr ^ea K.C., 2013, NATURAL PRODUCTS, P4037; Dafoe NJ, 2009, J PROTEOME RES, V8, P2341, DOI 10.1021/pr800968r; Davis EM, 2000, TOP CURR CHEM, V209, P53; Faldt J, 2003, PLANT MOL BIOL, V51, P119, DOI 10.1023/A:1020714403780; Gu Y, 2011, BIOMASS CHEM ENG, V45, P21; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Harvey BG, 2010, ENERG FUEL, V24, P267, DOI 10.1021/ef900799c; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Jasinski M, 2001, PLANT CELL, V13, P1095, DOI 10.1105/tpc.13.5.1095; Karanikas C, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009132; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; Kelkar VM, 2006, BIOMASS BIOENERG, V30, P316, DOI 10.1016/j.biombioe.2005.07.009; Lange BM, 2003, PLANT MOL BIOL, V51, P925, DOI 10.1023/A:1023005504702; Lee HJ, 2001, TETRAHEDRON, V57, P6155, DOI 10.1016/S0040-4020(01)00605-6; Li SiGuang, 2008, Journal of Zhejiang Forestry College, V25, P158; Liu, 2006, FORESTRY SCI TECHNOL, V31, P1; Liu QH, 2013, SILVAE GENET, V62, P38, DOI 10.1515/sg-2013-0005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin D, 2005, RECENT ADV PHYTOCHEM, V39, P29; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; McKay SAB, 2003, PLANT PHYSIOL, V133, P368, DOI 10.1104/pp.103.022723; Miller B, 2005, PLANT PHYSIOL, V137, P369, DOI 10.1104/pp.104.050187; Nagy NE, 2000, AM J BOT, V87, P302, DOI 10.2307/2656626; Phillips MA, 2003, ARCH BIOCHEM BIOPHYS, V411, P267, DOI 10.1016/S0003-9861(02)00746-4; [秦小薇 QIN Xiaowei], 2006, [分析测试学报, Journal of Instrumental Analysis], V25, P6; Ralph SG, 2006, PLANT CELL ENVIRON, V29, P1545, DOI 10.1111/j.1365-3040.2006.01532.x; Roberds JH, 2003, CAN J FOREST RES, V33, P2469, DOI 10.1139/X03-186; ROBERTS WK, 1990, J GEN MICROBIOL, V136, P1771, DOI 10.1099/00221287-136-9-1771; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Garcia A, 2014, FOREST ECOL MANAG, V313, P47, DOI 10.1016/j.foreco.2013.10.038; Schmidt A, 2011, PLANT MOL BIOL, V77, P577, DOI 10.1007/s11103-011-9832-7; Steele CL, 1998, J BIOL CHEM, V273, P2078, DOI 10.1074/jbc.273.4.2078; Strom BL, 2002, FOREST ECOL MANAG, V158, P169, DOI 10.1016/S0378-1127(00)00710-6; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tadesse W., 2001, Forest Genetics, V8, P271; Thabet I, 2012, MOL BIOL REP, V39, P3235, DOI 10.1007/s11033-011-1091-9; Trapp S, 2001, ANNU REV PLANT PHYS, V52, P689, DOI 10.1146/annurev.arplant.52.1.689; Uehara T, 2010, PLANT CELL PHYSIOL, V51, P1524, DOI 10.1093/pcp/pcq109; Wang Z. H., 2007, BIOMASS CHEM ENG, V41, P1; [翁海龙 Weng Hailong], 2010, [西北林学院学报, Journal of Northwest Forestry College], V25, P71; Westbrook JW, 2013, NEW PHYTOL, V199, P89, DOI 10.1111/nph.12240; Xu ZS, 2007, PLANT MOL BIOL, V65, P719, DOI 10.1007/s11103-007-9237-9; Zulak KG, 2010, J INTEGR PLANT BIOL, V52, P86, DOI 10.1111/j.1744-7909.2010.00910.x	49	25	30	5	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132624	10.1371/journal.pone.0132624	http://dx.doi.org/10.1371/journal.pone.0132624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167875	gold, Green Submitted, Green Published			2022-12-27	WOS:000358193100059
J	Shi, Y; Zhao, QP; Fan, HF; Liu, Q				Shi, Yang; Zhao, Qinpei; Fan, Hongfei; Liu, Qin			Secure Obfuscation for Encrypted Group Signatures	PLOS ONE			English	Article							IDENTITY-BASED ENCRYPTION; PRIVACY; SCHEME; AUTHENTICATION; SYSTEM	In recent years, group signature techniques are widely used in constructing privacy-preserving security schemes for various information systems. However, conventional techniques keep the schemes secure only in normal black-box attack contexts. In other words, these schemes suppose that (the implementation of) the group signature generation algorithm is running in a platform that is perfectly protected from various intrusions and attacks. As a complementary to existing studies, how to generate group signatures securely in a more austere security context, such as a white-box attack context, is studied in this paper. We use obfuscation as an approach to acquire a higher level of security. Concretely, we introduce a special group signature functionality-an encrypted group signature, and then provide an obfuscator for the proposed functionality. A series of new security notions for both the functionality and its obfuscator has been introduced. The most important one is the average-case secure virtual black-box property w.r.t. dependent oracles and restricted dependent oracles which captures the requirement of protecting the output of the proposed obfuscator against collision attacks from group members. The security notions fit for many other specialized obfuscators, such as obfuscators for identity-based signatures, threshold signatures and key-insulated signatures. Finally, the correctness and security of the proposed obfuscator have been proven. Thereby, the obfuscated encrypted group signature functionality can be applied to variants of privacy-preserving security schemes and enhance the security level of these schemes.	[Shi, Yang; Zhao, Qinpei; Fan, Hongfei; Liu, Qin] Tongji Univ, Sch Software Engn, Shanghai 200092, Peoples R China	Tongji University	Liu, Q (corresponding author), Tongji Univ, Sch Software Engn, Shanghai 200092, Peoples R China.	qin.liu@tongji.edu.cn			National Natural Science Foundation of China [61202382]; Fundamental Research Funds for the Central Universities [2013KJ033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 61202382, www.nsfc.gov.cn) and the Fundamental Research Funds for the Central Universities (No. 2013KJ033, www.moe.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak B., 2001, Advances in Cryptology - CRTPTO 2001. 21st Annual International Cryptology Conference, Proceedings (Lecture Notes in Computer Science Vol.2139), P1; Barak B, 2014, LECT NOTES COMPUT SC, V8441, P221, DOI 10.1007/978-3-642-55220-5_13; Barak B, 2012, J ACM, V59, DOI 10.1145/2160158.2160159; Bellare M, 2003, LECT NOTES COMPUT SC, V2656, P614; Bitansky N, 2013, STOC'13: PROCEEDINGS OF THE 2013 ACM SYMPOSIUM ON THEORY OF COMPUTING, P241; Boneh D, 2004, LECT NOTES COMPUT SC, V3152, P41, DOI 10.1007/978-3-540-28628-8_3; Boyen X, 2007, LECT NOTES COMPUT SC, V4450, P1; Boyen X, 2006, LECT NOTES COMPUT SC, V4117, P290; Brakerski Z., 2014, INNOVATIONS THEORETI, P235; Brakerski Z, 2014, LECT NOTES COMPUT SC, V8349, P1, DOI 10.1007/978-3-642-54242-8_1; Canetti R, 1997, LECT NOTES COMPUT SC, V1294, P455; Chandran N, 2014, LECT NOTES COMPUT SC, V8383, P95, DOI 10.1007/978-3-642-54631-0_6; Chandran N, 2012, LECT NOTES COMPUT SC, V7194, P404, DOI 10.1007/978-3-642-28914-9_23; Chaum D, 1991, GROUP SIGNATURES, P257; Chen L., 1995, LNCS, V950, P171; Chen MT, 2012, INT J INNOV COMPUT I, V8, P4469; Chen YY, 2013, INT J COMPUT MATH, V90, P2614, DOI 10.1080/00207160.2013.807916; Cheng R, 2011, LECT NOTES COMPUT SC, V6980, P188, DOI 10.1007/978-3-642-24316-5_14; Dodis Y, 2003, LECT NOTES COMPUT SC, V2567, P130; Elahi G, GOAL ORIENTED MODELI; Feng X, 2014, SECURE OBFUSCATOR EN, P311; Garg S, 2013, ANN IEEE SYMP FOUND, P40, DOI 10.1109/FOCS.2013.13; Goldwasser S, 2005, ANN IEEE SYMP FOUND, P553, DOI 10.1109/SFCS.2005.60; Goldwasser S, 2014, J CRYPTOL, V27, P480, DOI 10.1007/s00145-013-9151-z; Guo LK, 2012, INT CON DISTR COMP S, P224, DOI 10.1109/ICDCS.2012.45; Hada S, 2010, LECT NOTES COMPUT SC, V6110, P92; Hofheinz D, 2012, LECT NOTES COMPUT SC, V7417, P590, DOI 10.1007/978-3-642-32009-5_35; Hofheinz D, 2010, J CRYPTOL, V23, P121, DOI 10.1007/s00145-009-9046-1; Hohenberger S, 2011, J CRYPTOL, V24, P694, DOI 10.1007/s00145-010-9077-7; Hsu CL, 2012, J MED SYST, V36, P3637, DOI 10.1007/s10916-012-9838-y; Hwang SO, 2009, IEEE T BROADCAST, V55, P686, DOI 10.1109/TBC.2009.2029911; Jensen M, 2010, ANONYMOUS ACCESS CON, P540; Li C, 2012, COMM COM INF SC, V345, P680; Lian B, 2014, INT J INF SECUR, V13, P271, DOI 10.1007/s10207-014-0240-2; Liang XH, 2011, J COMMUN NETW-S KOR, V13, P102, DOI 10.1109/JCN.2011.6157409; Liu XF, 2013, IEEE T PARALL DISTR, V24, P1182, DOI 10.1109/TPDS.2012.331; Tornos JL, 2013, 2013 IFIP/IEEE INTERNATIONAL SYMPOSIUM ON INTEGRATED NETWORK MANAGEMENT (IM 2013), P1346; Lynn B, 2004, LECT NOTES COMPUT SC, V3027, P20; Mejri MN, 2014, VEH COMMUN, V1, P53, DOI 10.1016/j.vehcom.2014.05.001; Nishimaki R., 2014, DESIGN CODE CRYPTOGR, P1; Nishimoto Y, 2009, IEEE T BROADCAST, V55, P419, DOI 10.1109/TBC.2009.2016496; Razzaque M. A., 2013, WIRELESS NETWORKS SE, P107, DOI DOI 10.1007/978-3-642-36169-2_4; Regev O, 2009, J ACM, V56, DOI 10.1145/1568318.1568324; Rong Cheng, 2013, 2013 5th International Conference on Intelligent Networking and Collaborative Systems, P30, DOI 10.1109/INCoS.2013.15; Shamir A., 1984, LECT NOTES COMPUTER, P47, DOI [DOI 10.1007/3-540-39568-7, 10.1007/3-540-39568-7_5]; Shen E, 2009, LECT NOTES COMPUT SC, V5444, P457; Shi Y, 2013, APPL MATH INFORM SCI, V7, P823, DOI 10.12785/amis/070254; Shi Y, 2011, J INTERNET TECHNOL, V12, P981; Sookhak M, 2014, J NETW COMPUT APPL, V43, P121, DOI 10.1016/j.jnca.2014.04.011; Tague P, 2009, IEEE T MOBILE COMPUT, V8, P1221, DOI 10.1109/TMC.2009.33; Wang BY, 2013, IEEE ICC, DOI 10.1109/ICC.2013.6654808; Waters B, 2005, LECT NOTES COMPUT SC, V3494, P114; Wee H., 2005, 37 ANN ACM S THEORY, P523, DOI DOI 10.1145/1060590.1060669; Wei X, 2013, 2013 9TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND SECURITY (CIS), P589, DOI 10.1109/CIS.2013.130; Yager RR, 2013, IEEE T FUZZY SYST, V21, P672, DOI 10.1109/TFUZZ.2012.2227263; Yang W, 2013, WIRELESS NETWORK SEC, P95; Yu Y, 2014, FUTURE GENER COMP SY, V30, P127, DOI 10.1016/j.future.2013.05.005; Yum DH, 2012, IEEE T WIREL COMMUN, V11, P1638, DOI 10.1109/TWC.2012.031212.110887; Zhang K, 2014, INFORM SCIENCES, V284, P130, DOI 10.1016/j.ins.2014.06.011; Zhu LH, 2012, SENSOR LETT, V10, P1785, DOI 10.1166/sl.2012.2631; Zhu XY, 2014, IEEE T VEH TECHNOL, V63, P907, DOI 10.1109/TVT.2013.2294032	61	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131550	10.1371/journal.pone.0131550	http://dx.doi.org/10.1371/journal.pone.0131550			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167686	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100010
J	Shringarpure, KS; Isaakidis, P; Sagili, KD; Baxi, RK				Shringarpure, Kalpita S.; Isaakidis, Petros; Sagili, Karuna D.; Baxi, R. K.			Loss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It	PLOS ONE			English	Article							TREATMENT OUTCOMES; DEFAULT; METAANALYSIS	Background Multidrug-resistant Tuberculosis (MDR-TB) is a rising global threat to public health and concerted efforts for its treatment are diluted if the outcomes are not successful, loss to follow up (LFU) being one of them. It is therefore necessary to know the proportion and the associated reasons for LFU and devise effective patient-centered strategies to improve retention in care. Methods A retrospective cohort study was conducted at the MDR-TB treatment site (DR-TB Site) in Central Gujarat among all patients registered from February 2010 to June 2013. LFU patients were defined as those whose treatment was interrupted for two or more consecutive months for any reason. Descriptive statistics, survival analysis and multivariate modeling were used to determine the proportion of patients LFU and to assess associations between LFU and selected demographic and clinical factors. Results A total of 796 patients were enrolled during the study period; 71.9% were male and the median age was 35 years [Interquartile range (IQR) 27-45]. The overall proportion of LFU patients was 153/796 (19.2%). The majority of LFU patients (133/153 i.e. 87%) were lost within the first 6 months of treatment. Ambulatory treatment initiation (adjusted Hazards ratio aHR=2.63, CI: 1.01-6.86), different providers in IP and CP (aHR=1.27, CI: 1.18-1.38) and culture conversion after more than 4 months of treatment(aHR=1.34, CI: 1.21-1.49) were found to be significantly associated with LFU in multivariate models. Conclusions A high proportion of LFU among patients on MDR-TB treatment was found in a programmatic setting in India. Clinical but equally important programmatic factors were associated with LFU, accounting for one-fifth of all the outcomes of MDR-TB treatment. Proper training for DOT providers and aggressive counseling and health system strengthening with patient friendly follow up services may help reduce LFU.	[Shringarpure, Kalpita S.; Baxi, R. K.] Govt Med Coll, Dept Prevent Social Med, Baroda, Gujarat, India; [Isaakidis, Petros] Med Sans Frontieres, Operat Res Unit, Mumbai, Maharashtra, India; [Sagili, Karuna D.] Union, South East Asia Off, New Delhi, India	Maharaja Sayajirao University Baroda	Shringarpure, KS (corresponding author), Govt Med Coll, Dept Prevent Social Med, Baroda, Gujarat, India.	kshringarpure@gmail.com		Isaakidis, Petros/0000-0002-7881-1554	American People through the United States Agency for International Development (USAID); State RNTCP Cell, Gandhinagar	American People through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); State RNTCP Cell, Gandhinagar	Funding for the operational research course was made possible by the support of the American People through the United States Agency for International Development (USAID). Funding for the project was made possible through support of the State RNTCP Cell, Gandhinagar. Funders had no role in study design, data collection, analysis and interpretation of data, decision to publish or preparation of the manuscript. The contents of this paper do not necessarily reflect the views of USAID, the United States Government, International Union Against Tuberculosis and Lung Disease (The Union) or the State RNTCP cell, Gujarat.	Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Cavanaugh JS, 2012, INT J TUBERC LUNG D, V16, P1069, DOI 10.5588/ijtld.11.0696; Chiang CY, 2006, EUR RESPIR J, V28, P980, DOI 10.1183/09031936.06.00125705; Chiang CY, 2010, RESPIROLOGY, V15, P413, DOI 10.1111/j.1440-1843.2010.01738.x; Datta BS, 2008, MULTIDRUG RESISTANT, P15; Government of India, 2014, TB INDIA 2014 REVISE; Hasker E, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-97; Holtz TH, 2006, INT J TUBERC LUNG D, V10, P649; Isaakidis P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068869; Isaakidis P, 2013, TROP MED INT HEALTH, V18, P1128, DOI 10.1111/tmi.12146; Jeon DS, 2011, J KOREAN MED SCI, V26, P33, DOI 10.3346/jkms.2011.26.1.33; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Revised National Tuberculosis Control Programme, 2012, GUIDELINES ON PROGRA; Sahu GB, 2011, ECONOMICAND POLITICA, VXLVI; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Singla R, 2009, INT J TUBERC LUNG D, V13, P976; State Health Society (RNTCP Sub Committee) CoH; Medical Services and Medical Education (HS), ANNUAL STATUS REPORT; World Health Organization, 2013, ZHURNAL EKSPERIMENTA	19	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132543	10.1371/journal.pone.0132543	http://dx.doi.org/10.1371/journal.pone.0132543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167891	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100052
J	Sohn, I; Liu, HP; Ansari, N				Sohn, Insoo; Liu, Huaping; Ansari, Nirwan			Optimizing Cellular Networks Enabled with Renewal Energy via Strategic Learning	PLOS ONE			English	Article							GAME-THEORY	An important issue in the cellular industry is the rising energy cost and carbon footprint due to the rapid expansion of the cellular infrastructure. Greening cellular networks has thus attracted attention. Among the promising green cellular network techniques, the renewable energy-powered cellular network has drawn increasing attention as a critical element towards reducing carbon emissions due to massive energy consumption in the base stations deployed in cellular networks. Game theory is a branch of mathematics that is used to evaluate and optimize systems with multiple players with conflicting objectives and has been successfully used to solve various problems in cellular networks. In this paper, we model the green energy utilization and power consumption optimization problem of a green cellular network as a pilot power selection strategic game and propose a novel distributed algorithm based on a strategic learning method. The simulation results indicate that the proposed algorithm achieves correlated equilibrium of the pilot power selection game, resulting in optimum green energy utilization and power consumption reduction.	[Sohn, Insoo] Dongguk Univ, Div Elect & Elect Engn, Seoul, South Korea; [Liu, Huaping] Oregon State Univ, Sch Elect Engn & Comp Sci, Corvallis, OR 97331 USA; [Ansari, Nirwan] New Jersey Inst Technol, Dept Elect & Comp Engn, Newark, NJ 07102 USA	Dongguk University; Oregon State University; New Jersey Institute of Technology	Sohn, I (corresponding author), Dongguk Univ, Div Elect & Elect Engn, Seoul, South Korea.	isohn@dongguk.edu	Ansari, Nirwan/N-1264-2019	Ansari, Nirwan/0000-0001-8541-3565	Dongguk University Research Fund	Dongguk University Research Fund	This work was supported by the Dongguk University Research Fund.	Akkarajitsakul K, 2011, IEEE COMMUN SURV TUT, V13, P372, DOI 10.1109/SURV.2011.122310.000119; Arent DJ, 2011, ENERG ECON, V33, P584, DOI 10.1016/j.eneco.2010.11.003; AUMANN RJ, 1987, ECONOMETRICA, V55, P1, DOI 10.2307/1911154; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Gartner, 2007, ITXPO C; Han T, 2014, IEEE WIREL COMMUN, V21, P90, DOI 10.1109/MWC.2014.6757901; Han T, 2012, IEEE COMMUN LETT, V16, P866, DOI 10.1109/LCOMM.2012.042312.120486; Hart S, 2001, J ECON THEORY, V98, P26, DOI 10.1006/jeth.2000.2746; Hasan Z, 2011, IEEE COMMUN SURV TUT, V13, P524, DOI 10.1109/SURV.2011.092311.00031; Hassan HA, 2013, 2013 IEEE 24TH INTERNATIONAL SYMPOSIUM ON PERSONAL, INDOOR, AND MOBILE RADIO COMMUNICATIONS (PIMRC), P2967, DOI 10.1109/PIMRC.2013.6666655; Huang JW, 2011, IEEE T COMMUN, V59, P3485, DOI 10.1109/TCOMM.2011.093011.100693; Karmokar A, 2013, IEEE POTENTIALS, V32, P38, DOI 10.1109/MPOT.2013.2245946; Larsson EG, 2009, IEEE SIGNAL PROC MAG, V26, P18, DOI 10.1109/MSP.2009.933370; Myerson R., 1997, GAME THEORY ANAL CON; Piro G, 2013, IEEE INTERNET COMPUT, V17, P32, DOI 10.1109/MIC.2012.124; Quattrociocchi W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087986; REN21, 2014, REN 2014 GLOB STAT R; Sohn I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116592; Srivastava V, 2005, IEEE COMMUN SURV TUT, V7, P46, DOI 10.1109/COMST.2005.1593279; Tombaz S, 2011, P CHIN; Trestian R, 2012, IEEE COMMUN SURV TUT, V14, P1212, DOI 10.1109/SURV.2012.010912.00081; Xia CY, 2009, INT J MOD PHYS B, V23, P2203, DOI 10.1142/S021797920905211X; Xia CY, 2012, NONLINEAR DYNAM, V69, P927, DOI 10.1007/s11071-011-0313-y; Young H.P., 2010, STRATEGIC LEARNING I	25	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132997	10.1371/journal.pone.0132997	http://dx.doi.org/10.1371/journal.pone.0132997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167934	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100101
J	Wu, BX; Fan, J; Boyer, NP; Jenkins, RW; Koutalos, Y; Hannun, YA; Crosson, CE				Wu, Bill X.; Fan, Jie; Boyer, Nicholas P.; Jenkins, Russell W.; Koutalos, Yiannis; Hannun, Yusuf A.; Crosson, Craig E.			Lack of Acid Sphingomyelinase Induces Age-Related Retinal Degeneration	PLOS ONE			English	Article							NIEMANN-PICK-DISEASE; PIGMENT EPITHELIAL-CELLS; MACULAR DEGENERATION; DEFICIENT MICE; DRUSEN FORMATION; AUTOPHAGY; LIGHT; NEURONS; SPHINGOLIPIDS; INTERMEDIATE	Background Mutations of acid sphingomyelinase (ASMase) cause Niemann-Pick diseases type A and B, which are fatal inherited lipid lysosomal storage diseases, characterized with visceral organ abnormalities and neurodegeneration. However, the effects of suppressing retinal ASMase expression are not understood. The goal of this study was to determine if the disruption of ASMase expression impacts the retinal structure and function in the mouse, and begin to investigate the mechanisms underlying these abnormalities. Methods Acid sphingomyelinase knockout (ASMase KO) mice were utilized to study the roles of this sphingolipid metabolizing enzyme in the retina. Electroretinogram and morphometric analysis were used to assess the retinal function and structure at various ages. Sphingolipid profile was determined by liquid chromatography-mass spectrometry. Western blots evaluated the level of the autophagy marker LC3-II. Results When compared to control animals, ASMase KO mice exhibited significant age-dependent reduction in ERG a- and b-wave amplitudes. Associated with these functional deficits, morphometric analysis revealed progressive thinning of retinal layers; however, the most prominent degeneration was observed in the photoreceptor and outer nuclear layer. Additional analyses of ASMase KO mice revealed early reduction in ERG c-wave amplitudes and increased lipofuscin accumulation in the retinal pigment epithelium (RPE). Sphingolipid analyses showed abnormal accumulation of sphingomyelin and sphingosine in ASMase KO retinas. Western blot analyses showed a higher level of the autophagosome marker LC3- II. Conclusions These studies demonstrate that ASMase is necessary for the maintenance of normal retinal structure and function. The early outer retinal dysfunction, outer segment degeneration, accumulation of lipofuscin and autophagosome markers provide evidence that disruption of lysosomal function contributes to the age-dependent retinal degeneration exhibited by ASMase KO mice.	[Wu, Bill X.; Jenkins, Russell W.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Fan, Jie; Boyer, Nicholas P.; Koutalos, Yiannis; Crosson, Craig E.] Med Univ S Carolina, Storm Eye Inst, Dept Ophthalmol, Charleston, SC 29425 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA	Medical University of South Carolina; Medical University of South Carolina; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Fan, J (corresponding author), Med Univ S Carolina, Storm Eye Inst, Dept Ophthalmol, Charleston, SC 29425 USA.	fan@musc.edu			National Institutes of Health (NIH) [EY021368, CA 097132]; South Carolina Clinical & Translational Research (SCTR) institute with an academic home at the Medical University of South Carolina CTSA, NIH/NCATS [UL1TR000062]; National Center for Research Resources; Office of the Director of the National Institutes of Health [C06 RR018823]; Research to Prevent Blindness (RPB) (New York, NY); NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043825] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Clinical & Translational Research (SCTR) institute with an academic home at the Medical University of South Carolina CTSA, NIH/NCATS; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB) (New York, NY)(Research to Prevent Blindness (RPB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following: 1. National Institutes of Health (NIH) Grant EY021368 (C.E.C.), http://www.nih.gov/. This funder had roles in study design, data collection and analysis, decision to publish and preparation of the manuscript. 2. National Institutes of Health (NIH) Grant CA 097132 (Y.A.H.), http://www.nih.gov/. This funder had roles in data collection and analysis. 3. South Carolina Clinical & Translational Research (SCTR) institute, with an academic home at the Medical University of South Carolina CTSA, NIH/NCATS grant number UL1TR000062, http://academicdepartments.musc.edu/sctr/index.htm. This funder had roles in study design, data collection and analysis. 4. National Center for Research Resources and the Office of the Director of the National Institutes of Health through Grant Number C06 RR018823, http://www.nih.gov/. This funder had roles in data collection and analysis. 5. Unrestricted grant to the Department of Ophthalmology, Storm Eye Institute, Medical University of South Carolina, from Research to Prevent Blindness (RPB) (New York, NY), http://www.rpbusa.org/rpb/. This funder had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript	Abrahan CE, 2010, INVEST OPHTH VIS SCI, V51, P1171, DOI 10.1167/iovs.09-3909; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; Bazan NG, 2009, PROSTAG LEUKOTR ESS, V81, P205, DOI 10.1016/j.plefa.2009.05.024; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Boini KM, 2011, AM J PATHOL, V179, P2210, DOI 10.1016/j.ajpath.2011.07.019; Boyer NP, 2012, J BIOL CHEM, V287, P22276, DOI 10.1074/jbc.M111.329235; BROWNSTEIN S, 1978, ARCH OPHTHALMOL-CHIC, V96, P864, DOI 10.1001/archopht.1978.03910050466015; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Chen H, 2012, ADV EXP MED BIOL, V723, P553, DOI 10.1007/978-1-4614-0631-0_70; Ledesma MD, 2011, J NEUROCHEM, V116, P779, DOI 10.1111/j.1471-4159.2010.07034.x; Fan J, 2010, J NEUROSCI, V30, P2496, DOI 10.1523/JNEUROSCI.6254-09.2010; Filling-Katz M R, 1992, Metab Pediatr Syst Ophthalmol (1985), V15, P16; Fliesler SJ, 2010, J LIPID RES, V51, P3399, DOI 10.1194/jlr.R010538; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Gabande-Rodriguez E, 2014, CELL DEATH DIFFER, V21, P864, DOI 10.1038/cdd.2014.4; Galvan C, 2008, MOL BIOL CELL, V19, P509, DOI 10.1091/mbc.E07-05-0439; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Jenkins RW, 2011, J BIOL CHEM, V286, P13292, DOI 10.1074/jbc.M110.163378; Kaarniranta K, 2009, AGEING RES REV, V8, P128, DOI 10.1016/j.arr.2009.01.001; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Klettner A, 2013, INT J BIOCHEM CELL B, V45, P1457, DOI 10.1016/j.biocel.2013.04.013; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Krohne TU, 2010, EXP EYE RES, V90, P465, DOI 10.1016/j.exer.2009.12.011; Kuemmel TA, 1997, J NEUROPATH EXP NEUR, V56, P171, DOI 10.1097/00005072-199702000-00008; Li CP, 2013, BIOCHEM BIOPH RES CO, V438, P739, DOI 10.1016/j.bbrc.2013.07.097; McGovern MM, 2004, OPHTHALMOLOGY, V111, P1424, DOI 10.1016/j.ophtha.2003.10.034; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Opreanu M, 2011, DIABETES, V60, P2370, DOI 10.2337/db10-0550; OTTERBACH B, 1995, CELL, V81, P1053, DOI 10.1016/S0092-8674(05)80010-8; Rajala RVS, 2010, MOL NEUROBIOL, V42, P39, DOI 10.1007/s12035-010-8130-8; ROBB RM, 1973, INVEST OPHTH VISUAL, V12, P366; Rodriguez-Muela N, 2013, AGING CELL, V12, P478, DOI 10.1111/acel.12072; Rotstein NP, 2010, J LIPID RES, V51, P1247, DOI 10.1194/jlr.R003442; Ryhanen T, 2009, J CELL MOL MED, V13, P3616, DOI 10.1111/j.1582-4934.2008.00577.x; Sango K, 2008, OPHTHALMIC RES, V40, P241, DOI 10.1159/000127831; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Toops KA, 2015, MOL BIOL CELL, V26, P1, DOI 10.1091/mbc.E14-05-1028; Wang AL, 2009, AUTOPHAGY, V5, P563, DOI 10.4161/auto.5.4.8163; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Wasserstein MP, 2006, J PEDIATR-US, V149, P554, DOI 10.1016/j.jpeds.2006.06.034; Yu Y, 2011, INVEST OPHTH VIS SCI, V52, P4663, DOI 10.1167/iovs.10-7070; Zeidan YH, 2006, J BIOL CHEM, V281, P24695, DOI 10.1074/jbc.M604713200; Zhao ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019456	46	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0133032	10.1371/journal.pone.0133032	http://dx.doi.org/10.1371/journal.pone.0133032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168297	Green Submitted, Green Published, gold			2022-12-27	WOS:000358193100105
J	Wu, MN; Matsubara, JH; Gordon, KE				Wu, Mengnan; Matsubara, Jesse H.; Gordon, Keith E.			General and Specific Strategies Used to Facilitate Locomotor Maneuvers	PLOS ONE			English	Article							ANTICIPATORY POSTURAL ADJUSTMENTS; INCREASED ROTATIONAL INERTIA; LOCAL DYNAMIC STABILITY; CENTER-OF-MASS; FRONTAL PLANE; LATERAL STABILIZATION; STEPPING STRATEGIES; WALKING; BALANCE; GAIT	People make anticipatory changes in gait patterns prior to initiating a rapid change of direction. How they prepare will change based on their knowledge of the maneuver. To investigate specific and general strategies used to facilitate locomotor maneuvers, we manipulated subjects' ability to anticipate the direction of an upcoming lateral "lane-change" maneuver. To examine specific anticipatory adjustments, we observed the four steps immediately preceding a maneuver that subjects were instructed to perform at a known time in a known direction. We hypothesized that to facilitate a specific change of direction, subjects would proactively decrease margin of stability in the future direction of travel. Our results support this hypothesis: subjects significantly decreased lateral margin of stability by 69% on the side ipsilateral to the maneuver during only the step immediately preceding the maneuver. This gait adaptation may have improved energetic efficiency and simplified the control of the maneuver. To examine general anticipatory adjustments, we observed the two steps immediately preceding the instant when subjects received information about the direction of the maneuver. When the maneuver direction was unknown, we hypothesized that subjects would make general anticipatory adjustments that would improve their ability to actively initiate a maneuver in multiple directions. This second hypothesis was partially supported as subjects increased step width and stance phase hip flexion during these anticipatory steps. These modifications may have improved subjects' ability to generate forces in multiple directions and maintain equilibrium during the onset and execution of the rapid maneuver. However, adapting these general anticipatory strategies likely incurred an additional energetic cost.	[Wu, Mengnan; Matsubara, Jesse H.; Gordon, Keith E.] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Gordon, Keith E.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL USA	Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Wu, MN (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA.	mengnan.mary.wu@gmail.com		Gordon, Keith/0000-0001-6057-7651	United States Department of Veterans Affairs, Rehabilitation Research and Development Service [1 IK2 RX000717-01]; National Institutes of Health [T32HD057845]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057845] Funding Source: NIH RePORTER	United States Department of Veterans Affairs, Rehabilitation Research and Development Service; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	KG received funding from Career Development Award #1 IK2 RX000717-01 from the United States Department of Veterans Affairs, Rehabilitation Research and Development Service, http://www.rehab.research.va.gov/.JM received funding from the National Institutes of Health, T32HD057845, http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; Bertram JEA, 2001, J THEOR BIOL, V209, P445, DOI 10.1006/jtbi.2001.2279; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Bingham JT, 2011, J NEUROPHYSIOL, V106, P437, DOI 10.1152/jn.00010.2011; Blum Y, 2011, J THEOR BIOL, V281, P97, DOI 10.1016/j.jtbi.2011.04.029; Bruijn SM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0999; Cao C, 1997, J GERONTOL A-BIOL, V52, pM88, DOI 10.1093/gerona/52A.2.M88; Chang CL, 2008, J BIOMECH, V41, P1317, DOI 10.1016/j.jbiomech.2008.01.023; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; Dean JC, 2007, IEEE T BIO-MED ENG, V54, P1919, DOI 10.1109/TBME.2007.901031; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Dingwell JB, 2006, J BIOMECH, V39, P444, DOI 10.1016/j.jbiomech.2004.12.014; Donelan JM, 2001, P ROY SOC B-BIOL SCI, V268, P1985, DOI 10.1098/rspb.2001.1761; Glaister BC, 2007, GAIT POSTURE, V25, P289, DOI 10.1016/j.gaitpost.2006.04.003; Gordon KE, 2009, ARCH PHYS MED REHAB, V90, P136, DOI 10.1016/j.apmr.2008.07.014; Hak L, 2013, CLIN BIOMECH, V28, P1041, DOI 10.1016/j.clinbiomech.2013.10.010; Hak L, 2013, J BIOMECH, V46, P905, DOI 10.1016/j.jbiomech.2012.12.017; HIROKAWA S, 1989, J BIOMED ENG, V11, P449, DOI 10.1016/0141-5425(89)90038-1; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hof AL, 2007, GAIT POSTURE, V25, P250, DOI 10.1016/j.gaitpost.2006.04.013; Hollands KL, 2010, NEUROREHAB NEURAL RE, V24, P358, DOI 10.1177/1545968309348508; Houck JR, 2006, GAIT POSTURE, V24, P314, DOI 10.1016/j.gaitpost.2005.10.005; Hurt CP, 2015, J BIOMECH, V48, P592, DOI 10.1016/j.jbiomech.2015.01.003; Huxham F, 2008, MOVEMENT DISORD, V23, P817, DOI 10.1002/mds.21932; Kubow TM, 1999, PHILOS T ROY SOC B, V354, P849, DOI 10.1098/rstb.1999.0437; Kuo AD, 1999, INT J ROBOT RES, V18, P917, DOI 10.1177/02783649922066655; Le Pellec A, 2000, J ELECTROMYOGR KINES, V10, P171, DOI 10.1016/S1050-6411(00)00006-7; Lee DV, 2001, J EXP BIOL, V204, P3927; Lemay JF, 2014, J ELECTROMYOGR KINES, V24, P739, DOI 10.1016/j.jelekin.2014.04.013; Liechti M, 2008, CLIN NEUROPHYSIOL, V119, P2804, DOI 10.1016/j.clinph.2008.05.033; Lyon IN, 1997, EXP BRAIN RES, V115, P345, DOI 10.1007/PL00005703; MACKINNON CD, 1993, J BIOMECH, V26, P633, DOI 10.1016/0021-9290(93)90027-C; Matsubara JH, 2015, GAIT POSTURE, V41, P646, DOI 10.1016/j.gaitpost.2015.01.015; Matsusaka N., 1985, BIOMECHANICS A, P427; Musselman KE, 2007, J REHABIL MED, V39, P567, DOI 10.2340/16501977-0090; Patla AE, 2003, IEEE ENG MED BIOL, V22, P48, DOI 10.1109/MEMB.2003.1195695; PATLA AE, 1991, J EXP PSYCHOL HUMAN, V17, P603, DOI 10.1037/0096-1523.17.3.603; Patla AE, 1999, EXP BRAIN RES, V129, P629, DOI 10.1007/s002210050932; Patton J, 2008, TOP STROKE REHABIL, V15, P131, DOI 10.1310/tsr1502-131; Qiao M, 2014, J EXP BIOL, V217, P432, DOI 10.1242/jeb.087569; Rosenblatt NJ, 2010, GAIT POSTURE, V31, P380, DOI 10.1016/j.gaitpost.2010.01.002; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Sefati S, 2013, P NATL ACAD SCI USA, V110, P18798, DOI 10.1073/pnas.1309300110; Strike SC, 2009, GAIT POSTURE, V29, P597, DOI 10.1016/j.gaitpost.2008.12.015; Thigpen MT, 2009, GAIT POSTURE, V29, P113, DOI 10.1016/j.gaitpost.2008.07.009; Thigpen MT, 2000, PHYS THER, V80, P1174, DOI 10.1093/ptj/80.12.1174; Toebes MJP, 2012, GAIT POSTURE, V36, P527, DOI 10.1016/j.gaitpost.2012.05.016; van Hedel HJA, 2005, SPINAL CORD, V43, P593, DOI 10.1038/sj.sc.3101768; Webb PW, 2006, FISH PHYSIOL, V23, P281, DOI 10.1016/S1546-5098(05)23008-X; Xu DL, 2004, J MOTOR BEHAV, V36, P316, DOI 10.3200/JMBR.36.3.316-326; Young PMM, 2012, J BIOMECH, V45, P1053, DOI 10.1016/j.jbiomech.2011.12.027	51	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132707	10.1371/journal.pone.0132707	http://dx.doi.org/10.1371/journal.pone.0132707			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167931	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100069
J	Arampatzis, G; Katsoulakis, MA; Pantazis, Y				Arampatzis, Georgios; Katsoulakis, Markos A.; Pantazis, Yannis			Accelerated Sensitivity Analysis in High-Dimensional Stochastic Reaction Networks	PLOS ONE			English	Article							GRADIENT ESTIMATION; SIMULATION; SYSTEMS; PACKAGE	Existing sensitivity analysis approaches are not able to handle efficiently stochastic reaction networks with a large number of parameters and species, which are typical in the modeling and simulation of complex biochemical phenomena. In this paper, a two-step strategy for parametric sensitivity analysis for such systems is proposed, exploiting advantages and synergies between two recently proposed sensitivity analysis methodologies for stochastic dynamics. The first method performs sensitivity analysis of the stochastic dynamics by means of the Fisher Information Matrix on the underlying distribution of the trajectories; the second method is a reduced-variance, finite-difference, gradient-type sensitivity approach relying on stochastic coupling techniques for variance reduction. Here we demonstrate that these two methods can be combined and deployed together by means of a new sensitivity bound which incorporates the variance of the quantity of interest as well as the Fisher Information Matrix estimated from the first method. The first step of the proposed strategy labels sensitivities using the bound and screens out the insensitive parameters in a controlled manner. In the second step of the proposed strategy, a finite-difference method is applied only for the sensitivity estimation of the (potentially) sensitive parameters that have not been screened out in the first step. Results on an epidermal growth factor network with fifty parameters and on a protein homeostasis with eighty parameters demonstrate that the proposed strategy is able to quickly discover and discard the insensitive parameters and in the remaining potentially sensitive parameters it accurately estimates the sensitivities. The new sensitivity strategy can be several times faster than current state-of-the-art approaches that test all parameters, especially in "sloppy" systems. In particular, the computational acceleration is quantified by the ratio between the total number of parameters over the number of the sensitive parameters.	[Arampatzis, Georgios; Katsoulakis, Markos A.; Pantazis, Yannis] Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Katsoulakis, MA (corresponding author), Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA.	markos@math.umass.edu		Katsoulakis, Markos/0000-0003-4354-1766	Office of Advanced Scientific Computing Research, U.S. Department of Energy [DE-SC0010723]; European Union (European Social Fund); Greece (National Strategic Reference Framework), under the THALES Program, grant AMOSICSS	Office of Advanced Scientific Computing Research, U.S. Department of Energy(United States Department of Energy (DOE)); European Union (European Social Fund)(European Social Fund (ESF)); Greece (National Strategic Reference Framework), under the THALES Program, grant AMOSICSS	The work of GA, MAK, and YP was supported in part by the Office of Advanced Scientific Computing Research, U.S. Department of Energy under Contract No. DE-SC0010723 as well as in part by the European Union (European Social Fund) and Greece (National Strategic Reference Framework), under the THALES Program, grant AMOSICSS.	Anderson DF, 2012, SIAM J NUMER ANAL, V50, P2237, DOI 10.1137/110849079; Arampatzis G, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4868649; Bader DA, 2007, P 21TH INT PARALLEL, P1, DOI [10.1109/IPDPS.2007.370445, DOI 10.1109/IPDPS.2007.370445]; Brown R.G., 2012, INTRO RANDOM SIGNALS, P324; Casella G, 2002, STAT INFERENCE, V2nd; Chatterjee A, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1833357; Cover T. M., 1991, ELEMENTS INFORM THEO; DiStefano J, 2014, DYNAMIC SYSTEMS BIOLOGY MODELING AND SIMULATION, P1; Erguler K, 2011, MOL BIOSYST, V7, P1593, DOI 10.1039/c0mb00107d; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GLYNN PW, 1990, COMMUN ACM, V33, P75, DOI 10.1145/84537.84552; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hu W, J STAT SOFTWAR UNPUB; Kay S. M., 1993, FUNTAMENTALS STAT SI; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kim D, 2007, BIOPHYS J, V92, P379, DOI 10.1529/biophysj.106.085084; Kim H, 1999, EXP CELL RES, V253, P78, DOI 10.1006/excr.1999.4706; Komorowski M, 2012, BIOINFORMATICS, V28, P731, DOI 10.1093/bioinformatics/btr714; Komorowski M, 2011, P NATL ACAD SCI USA, V108, P8645, DOI 10.1073/pnas.1015814108; Lehmann E. L., 1998, THEORY POINT ESTIMAT; Liu J. S., 2001, SPRINGER SERIES STAT; Maiwald T, 2008, BIOINFORMATICS, V24, P2037, DOI 10.1093/bioinformatics/btn350; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; McGill JA, 2012, J COMPUT PHYS, V231, P7170, DOI 10.1016/j.jcp.2012.06.037; Moghal N, 1999, CURR OPIN CELL BIOL, V11, P190, DOI 10.1016/S0955-0674(99)80025-8; NAKAYAMA M., 1994, STOCH MODELS, V10, P701; Pantazis Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-311; Pantazis Y, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4789612; Plyasunov S, 2007, J COMPUT PHYS, V221, P724, DOI 10.1016/j.jcp.2006.06.047; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Proctor CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022038; Rathinam M, 2003, J CHEM PHYS, V119, P12784, DOI 10.1063/1.1627296; Rathinam M, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3280166; Rodriguez-Fernandez M, 2010, BIOINFORMATICS, V26, P1675, DOI 10.1093/bioinformatics/btq242; Saltelli A., 2008, GLOBAL SENSITIVITY A; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Sheppard PW, 2013, BIOINFORMATICS, V29, P140, DOI 10.1093/bioinformatics/bts642; Sheppard PW, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3677230; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; Slepoy A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2919546; Stochss Org, 2013, STOCHSS STOCHASTIC S; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203	51	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130825	10.1371/journal.pone.0130825	http://dx.doi.org/10.1371/journal.pone.0130825			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161544	gold, Green Submitted, Green Published			2022-12-27	WOS:000358162300022
J	Chen, JN; Ahmad, R; Suenaga, H; Li, W; Sasaki, K; Swain, M; Li, Q				Chen, Junning; Ahmad, Rohana; Suenaga, Hanako; Li, Wei; Sasaki, Keiichi; Swain, Michael; Li, Qing			Shape Optimization for Additive Manufacturing of Removable Partial Dentures - A New Paradigm for Prosthetic CAD/CAM	PLOS ONE			English	Article							PRESSURE-PAIN THRESHOLD; 3-DIMENSIONAL FINITE-ELEMENT; COMPOSITE DENTAL BRIDGE; EDENTULOUS ORAL-MUCOSA; PERIODONTAL-LIGAMENT; STRESS-ANALYSIS; CONTACT PROBLEMS; BONE-RESORPTION; RESIDUAL RIDGE; BLOOD-FLOW	With ever-growing aging population and demand for denture treatments, pressure-induced mucosa lesion and residual ridge resorption remain main sources of clinical complications. Conventional denture design and fabrication are challenged for its labor and experience intensity, urgently necessitating an automatic procedure. This study aims to develop a fully automatic procedure enabling shape optimization and additive manufacturing of removable partial dentures (RPD), tomaximize the uniformity of contact pressure distribution on the mucosa, thereby reducing associated clinical complications. A 3D heterogeneous finite element (FE) model was constructed from CT scan, and the critical tissue of mucosa was modeled as a hyperelastic material from in vivo clinical data. A contact shape optimization algorithm was developed based on the bi-directional evolutionary structural optimization (BESO) technique. Both initial and optimized dentures were prototyped by 3D printing technology and evaluated with in vitro tests. Through the optimization, the peak contact pressure was reduced by 70%, and the uniformity was improved by 63%. In vitro tests verified the effectiveness of this procedure, and the hydrostatic pressure induced in the mucosa is well below clinical pressure-pain thresholds (PPT), potentially lessening risk of residual ridge resorption. This proposed computational optimization and additive fabrication procedure provides a novel method for fast denture design and adjustment at low cost, with quantitative guidelines and computer aided design and manufacturing (CAD/CAM) for a specific patient. The integration of digitalizedmodeling, computational optimization, and free-form fabrication enablesmore efficient clinical adaptation. The customized optimal denture design is expected to minimize pain/discomfort and potentially reduce long-term residual ridge resorption.	[Chen, Junning; Li, Wei; Li, Qing] Univ Sydney, Sch Aerosp Mech & Mechatron Engn, Sydney, NSW 2006, Australia; [Ahmad, Rohana] Univ Teknol MARA, Unit Prosthodont, Fac Dent, Shah Alam & Integrat Pharmacogen Inst iPROMISE, Bandar Puncak Alam 42300, Selangor, Malaysia; [Suenaga, Hanako] Tohoku Univ, Grad Sch Dent, Div Prevent Dent, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Sasaki, Keiichi] Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Swain, Michael] Univ Sydney, Fac Dent, Sydney, NSW 2006, Australia	University of Sydney; Universiti Teknologi MARA; Tohoku University; Tohoku University; University of Sydney	Li, Q (corresponding author), Univ Sydney, Sch Aerosp Mech & Mechatron Engn, Sydney, NSW 2006, Australia.	qing.li@sydney.edu.au	Ahmad, Rohana/AAA-2226-2020; Ahmad, Rohana/I-3499-2012; Li, Qing/B-3422-2009; Chen, Junning/F-5287-2016; Swain, Michael V/J-7266-2017	Ahmad, Rohana/0000-0003-4298-5672; Ahmad, Rohana/0000-0003-4298-5672; Li, Qing/0000-0002-7930-2145; Chen, Junning/0000-0001-7121-0994; Swain, Michael/0000-0002-8801-8656	Australian Research Council [DP1095140, FT120100947]; Grants-in-Aid for Scientific Research [26462912] Funding Source: KAKEN	Australian Research Council(Australian Research Council); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Australian Research Council Discovery Scheme, grant number DP1095140 (http://www.arc.gov.au/ncgp/dp/dp_default.htm), and the Australian Research Council Fellowship Scheme, grant number FT120100947 (http://www.arc.gov.au/ncgp/futurefel/future_default.htm).	Ahmad R, 2015, INT J ORAL MAX IMPL, V30, P657, DOI 10.11607/jomi.3844; Akazawa H, 2002, J ORAL REHABIL, V29, P336, DOI 10.1046/j.1365-2842.2002.00912.x; Archangelo CM, 2012, J APPL ORAL SCI, V20, P362, DOI 10.1590/S1678-77572012000300012; ASHTON H, 1975, CLIN ORTHOP RELAT R, P15; Aspenberg P, 1998, ACTA ORTHOP SCAND, V69, P1, DOI 10.3109/17453679809002344; Bae KH, 2006, J ORAL REHABIL, V33, P317, DOI 10.1111/j.1365-2842.2005.01565.x; Bail M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100293; Bergomi M, 2011, J BIOMECH, V44, P34, DOI 10.1016/j.jbiomech.2010.08.019; Bidra AS, 2013, J PROSTHET DENT, V109, P361, DOI 10.1016/S0022-3913(13)60318-2; Blum IR, 2004, CLIN ORAL IMPLAN RES, V15, P700, DOI 10.1111/j.1600-0501.2004.01057.x; BRADLEY JC, 1981, INT J ORAL MAXILLOF, V10, P71; Butscher A, 2013, ACTA BIOMATER, V9, P9149, DOI 10.1016/j.actbio.2013.07.019; Carlsson Gunnar E, 2004, Gerodontology, V21, P65, DOI 10.1111/j.1741-2358.2004.00005.x; CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954, DOI 10.2106/00004623-197759070-00021; Chang CC, 2006, INT J ADV MANUF TECH, V31, P41, DOI 10.1007/s00170-005-0181-z; Chen J, 2015, COMPUT METH IN PRESS; Chen JN, 2014, J BIOMECH, V47, P1689, DOI 10.1016/j.jbiomech.2014.02.030; Chen JN, 2013, J MECH BEHAV BIOMED, V20, P387, DOI 10.1016/j.jmbbm.2012.08.019; DAVENPORT JC, 1969, ARCH ORAL BIOL, V14, P1267, DOI 10.1016/0003-9969(69)90199-X; Farzadi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108252; Field C, 2010, J BIOMECH, V43, P1771, DOI 10.1016/j.jbiomech.2010.02.016; HART RT, 1992, J BIOMECH, V25, P261, DOI 10.1016/0021-9290(92)90025-V; Hill EE, 2009, J PROSTHODONT, V18, P195, DOI 10.1111/j.1532-849X.2008.00382.x; Hyde TP, 2010, J DENT, V38, P853, DOI 10.1016/j.jdent.2010.07.003; Imai Y, 2002, J ORAL REHABIL, V29, P72, DOI 10.1046/j.1365-2842.2002.00799.x; Inokoshi M, 2012, DENT MATER J, V31, P40, DOI 10.4012/dmj.2011-113; Itoh H, 1998, J PROSTHET DENT, V79, P465, DOI 10.1016/S0022-3913(98)70163-5; Jain A, 2013, J CLIN DIAGN RES, V7, P2394, DOI 10.7860/JCDR/2013/6149.3536; Kanbara R, 2012, DENT MATER J, V31, P297, DOI 10.4012/dmj.2011-165; Karim L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035047; Kim SH, 2010, TISSUE ENG REGEN MED, V7, P388; Kishi M., 1972, SHIKA GAKUHO DENT SC, V72, P1043; KORIOTH TWP, 1992, AM J PHYS ANTHROPOL, V88, P69, DOI 10.1002/ajpa.1330880107; Kubo K, 2009, J PROSTHODONT RES, V53, P15, DOI 10.1016/j.jpor.2008.08.006; Kupczik K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097677; KYDD WL, 1974, J PROSTHET DENT, V32, P493, DOI 10.1016/0022-3913(74)90003-1; KYDD WL, 1982, J PROSTHET DENT, V47, P317, DOI 10.1016/0022-3913(82)90162-7; LAWSON WA, 1978, J DENT, V6, P43, DOI 10.1016/0300-5712(78)90005-2; Lee CJ, 2010, DENT MATER J, V29, P411, DOI 10.4012/dmj.2009-105; Li Q, 2001, INT J SOLIDS STRUCT, V38, P5661, DOI 10.1016/S0020-7683(00)00365-6; Li W, 2005, COMPUT METHOD APPL M, V194, P3394, DOI 10.1016/j.cma.2004.12.024; Li W, 2005, J BIOMED MATER RES B, V74B, P520, DOI 10.1002/jbm.b.30233; Li W, 2004, BIOMATERIALS, V25, P4995, DOI 10.1016/j.biomaterials.2004.01.011; Li W, 2003, FINITE ELEM ANAL DES, V40, P61, DOI 10.1016/S0168-874X(02)00179-8; Li W, 2003, P I MECH ENG C-J MEC, V217, P435, DOI 10.1243/095440603321509711; Liebenberg WH, 1995, QUINTESSENCE INT, V26, P175; LIST T, 1991, Journal of Craniomandibular Disorders, V5, P173; Maezawa N, 2007, INT J ORAL MAX IMPL, V22, P710; Maruo Y, 2010, ARCH ORAL BIOL, V55, P873, DOI 10.1016/j.archoralbio.2010.07.022; McMillian Anne S., 1995, Journal of Orofacial Pain, V9, P44; Mori S, 1997, J ORAL REHABIL, V24, P37, DOI 10.1046/j.1365-2842.1997.00443.x; Muraki H, 2004, J DENT, V32, P659, DOI 10.1016/j.jdent.2004.07.003; Mycroft RH, 2002, COGN NEUROPSYCHOL, V19, P291, DOI 10.1080/02643290143000150; Neumann JK, 2001, J PROSTHET DENT, V85, P305, DOI 10.1067/mpr.2001.114273; Ogawa T, 2004, J DENT, V32, P219, DOI 10.1016/j.jdent.2003.11.001; Ogawa T, 2003, J ORAL REHABIL, V30, P1062, DOI 10.1046/j.1365-2842.2003.01183.x; Ogimoto T, 2002, J ORAL REHABIL, V29, P620, DOI 10.1046/j.1365-2842.2002.00874.x; Prinz JF, 2007, FOOD HYDROCOLLOID, V21, P402, DOI 10.1016/j.foodhyd.2006.05.005; Rozvany GIN, 2009, STRUCT MULTIDISCIP O, V37, P217, DOI 10.1007/s00158-007-0217-0; Sajewicz E, 2009, TRIBOL INT, V42, P327, DOI 10.1016/j.triboint.2008.07.001; Sarrafpour B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058803; Sato T, 1998, J DENT RES, V77, P387, DOI 10.1177/00220345980770020701; Satoh Y, 2000, J ORAL REHABIL, V27, P660, DOI 10.1046/j.1365-2842.2000.00566.x; Sawada A, 2011, J DENT RES, V90, P590, DOI 10.1177/0022034510396881; SCAPINO RP, 1967, J MORPHOL, V122, P89, DOI 10.1002/jmor.1051220203; Rodrigues RCS, 2013, J PROSTHODONT RES, V57, P24, DOI 10.1016/j.jpor.2012.07.001; Suzuki Y, 2011, EUR J PROSTHODONT RE, V19, P184, DOI 10.1922/EJPRD_994Suzuki03; Tanaka M, 2004, J ORAL REHABIL, V31, P873, DOI 10.1111/j.1365-2842.2004.01321.x; Wakabayashi N, 2013, J DENT BIOMECH, V4; Wright PS, 2002, CLIN ORAL IMPLAN RES, V13, P169, DOI 10.1034/j.1600-0501.2002.130207.x; Zaw K, 2009, J BIOMECH, V42, P634, DOI 10.1016/j.jbiomech.2008.12.001	71	32	32	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132552	10.1371/journal.pone.0132552	http://dx.doi.org/10.1371/journal.pone.0132552			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161878	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300151
J	Farias, LR; Schimmelpfeng, PHC; Togawa, RC; Costa, MMC; Grynberg, P; Martins, NF; Borges, M; Blassioli-Moraes, MC; Laumann, RA; Bao, SN; Paula, DP				Farias, Luciana R.; Schimmelpfeng, Pedro H. C.; Togawa, Roberto C.; Costa, Marcos M. C.; Grynberg, Priscila; Martins, Natalia F.; Borges, Miguel; Blassioli-Moraes, Maria Carolina; Laumann, Raul A.; Bao, Sonia N.; Paula, Debora P.			Transcriptome-Based Identification of Highly Similar Odorant-Binding Proteins among Neotropical Stink Bugs and Their Egg Parasitoid	PLOS ONE			English	Article							EUSCHISTUS-HEROS HETEROPTERA; PHEROMONE-BINDING; TRISSOLCUS-BASALIS; TELENOMUS-PODISI; SEX-PHEROMONE; CHEMOSENSORY PROTEINS; DEFENSIVE SECRETIONS; GENOME ANNOTATION; ANOPHELES-GAMBIAE; NEZARA-VIRIDULA	Olfaction plays a fundamental role in insect survival through resource location and intra and interspecific communications. We used RNA-Seq to analyze transcriptomes for odorant-binding proteins (OBPs) from major stink bug pest species in Brazil, Euschistus heros, Chinavia ubica, and Dichelops melacanthus, and from their egg parasitoid, Telenomus podisi. We identified 23 OBPs in E. heros, 25 OBPs in C. ubica, 9 OBPs in D. melacanthus, and 7 OBPs in T. podisi. The deduced amino acid sequences of the full-length OBPs had low intraspecific similarity, but very high similarity between two pairs of OBPs from E. heros and C. ubica (76.4 and 84.0%) and between two pairs of OBPs from the parasitoid and its preferred host E. heros (82.4 and 88.5%), confirmed by a high similarity of their predicted tertiary structures. The similar pairs of OBPs from E. heros and C. ubica may suggest that they have derived from a common ancestor, and retain the same biological function to bind a ligand perceived or produced in both species. The T. podisi OBPs similar to E. heros were not orthologous to any known hymenopteran OBPs, and may have evolved independently and converged to the host OBPs, providing a possible basis for the host location of T. podisi using E. heros semiochemical cues.	[Farias, Luciana R.; Schimmelpfeng, Pedro H. C.; Bao, Sonia N.] Univ Brasilia, BR-70910900 Brasilia, DF, Brazil; [Farias, Luciana R.; Schimmelpfeng, Pedro H. C.; Togawa, Roberto C.; Costa, Marcos M. C.; Grynberg, Priscila; Martins, Natalia F.; Borges, Miguel; Blassioli-Moraes, Maria Carolina; Laumann, Raul A.; Paula, Debora P.] Embrapa Genet Resources & Biotechnol, BR-70770917 Brasilia, DF, Brazil	Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Paula, DP (corresponding author), Embrapa Genet Resources & Biotechnol, Parque Estacao Biol,W5 Norte,POB 02372, BR-70770917 Brasilia, DF, Brazil.	debora.pires@embrapa.br	Borges, Miguel/K-9918-2019; laumann, raul/AAC-4416-2019; Báo, Sônia/V-1214-2019; martins, natalia florencio/AAE-7875-2019; Blassioli-Moraes, Maria carolina/C-6072-2013; Borges, Miguel/C-6937-2013; Grynberg, Priscila/AAX-3019-2020	Borges, Miguel/0000-0003-3364-9677; laumann, raul/0000-0003-3531-2613; Blassioli-Moraes, Maria carolina/0000-0001-7569-9985; Grynberg, Priscila/0000-0003-4009-9538; Togawa, Roberto/0000-0001-7179-3210; Bao, Sonia/0000-0002-9873-3098	CNPq/Embrapa grant [562307/201-9]; FAPDF/PRONEX grant [193.000.583/2009]; CNPq; CAPES	CNPq/Embrapa grant; FAPDF/PRONEX grant; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	MB received CNPq/Embrapa grant (code 562307/201-9). SNB received FAPDF/PRONEX grant (code 193.000.583/2009). LRF and PHCS received post-graduation fellowships from CNPq and CAPES, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH JR, 1995, J CHEM ECOL, V21, P1031, DOI 10.1007/BF02033806; BIN F, 1993, PHYSIOL ENTOMOL, V18, P7, DOI 10.1111/j.1365-3032.1993.tb00443.x; Borges M, 2011, J APPL ENTOMOL, V135, P68, DOI 10.1111/j.1439-0418.2010.01507.x; Borges M, 1999, PHYSIOL ENTOMOL, V24, P227, DOI 10.1046/j.1365-3032.1999.00136.x; BORGES M, 1992, EXPERIENTIA, V48, P893, DOI 10.1007/BF02118429; Borges M, 1998, J APPL ENTOMOL, V122, P335, DOI 10.1111/j.1439-0418.1998.tb01508.x; Borges M, 1998, PHYSIOL ENTOMOL, V23, P202, DOI 10.1046/j.1365-3032.1998.233086.x; BORGES M, 1987, ENTOMOL EXP APPL, V44, P205, DOI 10.1007/BF00369180; Borges M, 2007, J CHEM ECOL, V33, P1235, DOI 10.1007/s10886-007-9294-1; Bruni R, 2000, J INSECT BEHAV, V13, P165, DOI 10.1023/A:1007728012482; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Colazza S, 1999, BIOL CONTROL, V16, P310, DOI 10.1006/bcon.1999.0763; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conti E, 2003, J CHEM ECOL, V29, P115, DOI 10.1023/A:1021980614512; Correa-Ferreira BS, 2009, 67 EMBR; Correa-Ferreira BS, 1999, 24 EMBRAPACNPSO; CORREAFERREIRA BS, 1995, BIOL CONTROL, V5, P196, DOI 10.1006/bcon.1995.1024; Danty E, 1999, J NEUROSCI, V19, P7468, DOI 10.1523/JNEUROSCI.19-17-07468.1999; De Medeiros MA, 1998, PESQUI AGROPECU BRAS, V33, P1431; Fan J, 2011, GENET MOL RES, V10, P3056, DOI 10.4238/2011.December.8.2; Farias LR, 2014, NEOTROP ENTOMOL, V43, P106, DOI 10.1007/s13744-013-0187-4; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Michereff MFF, 2011, J CHEM ECOL, V37, P273, DOI 10.1007/s10886-011-9917-4; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073524; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; He M, 2014, COMP BIOCHEM PHYS B, V174, P1, DOI 10.1016/j.cbpb.2014.04.008; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hull JJ, 2014, INSECT MOL BIOL, V23, P78, DOI 10.1111/imb.12064; Ji P, 2013, APPL ENTOMOL ZOOL, V48, P301, DOI 10.1007/s13355-013-0188-0; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Lagarde A, 2011, BIOCHEM J, V437, P423, DOI 10.1042/BJ20110522; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Laumann RA, 2011, ANIM BEHAV, V82, P1175, DOI 10.1016/j.anbehav.2011.08.017; Laumann RA, 2009, J CHEM ECOL, V35, P8, DOI 10.1007/s10886-008-9578-0; Li ZX, 2005, ARCH INSECT BIOCHEM, V58, P175, DOI 10.1002/arch.20047; Liu RH, 2010, CELL MOL LIFE SCI, V67, P919, DOI 10.1007/s00018-009-0221-1; Marques FA, 2007, J BRAZIL CHEM SOC, V18, P1242, DOI 10.1590/S0103-50532007000600020; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; MATTIACCI L, 1993, J CHEM ECOL, V19, P1167, DOI 10.1007/BF00987378; Michereff MFF, 2015, J APPL ENTOMOL, V139, P207, DOI 10.1111/jen.12148; Moraes M.C.B., 2008, J PLANT INTERACT, V3, P1742; Moraes MCB, 2008, PHYSIOL ENTOMOL, V33, P43, DOI 10.1111/j.1365-3032.2007.00600.x; Moraes MCB, 2009, ENTOMOL EXP APPL, V131, P178, DOI 10.1111/j.1570-7458.2009.00836.x; Moraes MCB, 2008, NEOTROP ENTOMOL, V37, P489, DOI 10.1590/S1519-566X2008000500001; Moraes MCB, 2005, ENTOMOL EXP APPL, V115, P227, DOI 10.1111/j.1570-7458.2005.00290.x; Nishimura O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050664; Pacheco D.J.P., 1998, ANAIS SOC ENTOMOLOGI, V27, P585; Panizzi AR, 2000, HETEROPTERA OF ECONOMIC IMPORTANCE, P421; Pareja M, 2007, J INSECT PHYSIOL, V53, P639, DOI 10.1016/j.jinsphys.2007.04.004; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; PELOSI P, 1994, CRIT REV BIOCHEM MOL, V29, P199, DOI 10.3109/10409239409086801; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Plettner E, 2000, BIOCHEMISTRY-US, V39, P8953, DOI 10.1021/bi000461x; PRESTWICH GD, 1995, CHEM SENSES, V20, P461, DOI 10.1093/chemse/20.4.461; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; Schuh R.T, 1995, BUGS WORLD HEMIPTERA; Schultze A, 2012, INSECT MOL BIOL, V21, P187, DOI 10.1111/j.1365-2583.2011.01125.x; Silva CC, 2006, PESQUI AGROPECU BRAS, V41, P1093, DOI 10.1590/S0100-204X2006000700004; Steinbrecht RA, 1996, CHEM SENSES, V21, P719, DOI 10.1093/chemse/21.6.719; Sujii ER, 2002, PESQUI AGROPECU BRAS, V37, P1541, DOI 10.1590/S0100-204X2002001100004; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vandermoten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023608; Vieira FG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043034; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 1989, J NEUROSCI, V9, P3332; Vogt RG, 1999, CHEM SENSES, V24, P481, DOI 10.1093/chemse/24.5.481; VOGT RG, 1991, J NEUROBIOL, V22, P74, DOI 10.1002/neu.480220108; VOGT RG, 1991, J NEUROSCI, V11, P2972; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yin XW, 2013, CELL MOL LIFE SCI, V70, P3029, DOI 10.1007/s00018-013-1308-2; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007	82	18	19	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132286	10.1371/journal.pone.0132286	http://dx.doi.org/10.1371/journal.pone.0132286			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161752	Green Published, gold			2022-12-27	WOS:000358162300114
J	Ruan, YT; Sun, J; He, J; Chen, FY; Chen, RP; Chen, H				Ruan, Yuting; Sun, Jia; He, Jie; Chen, Fangyao; Chen, Rongping; Chen, Hong			Effect of Probiotics on Glycemic Control: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials	PLOS ONE			English	Review							LACTOBACILLUS-ACIDOPHILUS; INSULIN-RESISTANCE; GUT MICROBIOTA; CHOLESTEROL LEVELS; BLOOD-PRESSURE; DOUBLE-BLIND; CONSUMPTION; YOGURT; WOMEN; RISK	Background Previous clinical trials indicate that probiotic consumption may improve blood glucose control, however, results from randomized trials on glycemic control have been inconsistent. Objective To investigate the effects of probiotics on glycemic control in a systematic review and meta-analysis of randomized controlled trials. Data Sources PubMed, Embase, Cochrane Library, and Clinicaltrial.gov through October 2014. Data Extraction and Synthesis Two independent reviewers extracted relevant data and assessed study quality and risk of bias. Data were pooled using a random-effects model and expressed as mean differences (MD) with 95% CI. Heterogeneity was assessed (Cochran Q-statistic) and quantified (I-2). Results Seventeen randomized controlled trials were included, in which 17 fasting blood glucose (n = 1105), 11 fasting plasma insulin (n = 788), 8 homeostasis model assessment of insulin resistance (n = 635) comparisons were reported. Probiotic consumption, compared with placebo, significantly reduced fasting glucose (MD = -0.31 mmol/L; 95% CI 0.56, 0.06; p = 0.02), fasting plasma insulin (MD = -1.29 mu U/mL; 95% CI -2.17, -0.41; p = 0.004), and HOMA-IR (MD = 0.48; 95% CI -0.83, -0.13; p = 0.007). Conclusions Probiotic consumption may improve glycemic control modestly. Modification of gut microbiota by probiotic supplementation may be a method for preventing and control hyperglycemia in clinical practice.	[Ruan, Yuting; Sun, Jia; Chen, Rongping; Chen, Hong] Southern Med Univ, Zhujiang Hosp, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China; [He, Jie] Southern Med Univ, Clin Coll 2, Guangzhou, Guangdong, Peoples R China; [Chen, Fangyao] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Biostat, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Chen, RP (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China.	rpink_fimmu@qq.com; rubychq@163.com	Zannini, Emanuele/N-3071-2019	Zannini, Emanuele/0000-0003-4144-4575; Arendt, Elke/0000-0001-8414-7701; Ruan, Yuting/0000-0002-7837-0883	National Natural Science Foundation of China [81300689, 81403215]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China, (81300689, 81403215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaretti A, 2013, APPL MICROBIOL BIOT, V97, P809, DOI 10.1007/s00253-012-4241-7; Andreasen AS, 2010, BRIT J NUTR, V104, P1831, DOI 10.1017/S0007114510002874; Moro-Garcia MA, 2013, AGE, V35, P1311, DOI 10.1007/s11357-012-9434-6; Asemi Z, 2013, EUR J CLIN NUTR, V67, P71, DOI 10.1038/ejcn.2012.189; Asemi Z, 2013, ANN NUTR METAB, V63, P1, DOI 10.1159/000349922; Bukowska H, 1998, ATHEROSCLEROSIS, V137, P437; Burcelin R, 2009, FRONT BIOSCI-LANDMRK, V14, P5107, DOI 10.2741/3589; Cani PD, 2008, PATHOL BIOL, V56, P305, DOI 10.1016/j.patbio.2007.09.008; Chapman CMC, 2011, EUR J NUTR, V50, P1, DOI 10.1007/s00394-010-0166-z; Chen M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0215-1; de LeBlanc AD, 2010, P NUTR SOC, V69, P421, DOI 10.1017/S002966511000159X; Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203; Ejtahed HS, 2012, NUTRITION, V28, P539, DOI 10.1016/j.nut.2011.08.013; Ferreira L, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/592760; Gao DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073965; Gomes AC, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-60; Guo Z, 2011, NUTR METAB CARDIOVAS, V21, P844, DOI 10.1016/j.numecd.2011.04.008; Hernandez-Alonso P, 2014, DIABETES CARE, V37, P3098, DOI 10.2337/dc14-1431; Ivey KL, 2014, EUR J CLIN NUTR, V68, P447, DOI 10.1038/ejcn.2013.294; Jones ML, 2012, REGUL TOXICOL PHARM, V63, P313, DOI 10.1016/j.yrtph.2012.04.003; Jung SP, 2013, KOREAN J FAM MED, V34, P80, DOI 10.4082/kjfm.2013.34.2.80; Khalesi S, 2014, HYPERTENSION, V64, P897, DOI 10.1161/HYPERTENSIONAHA.114.03469; Laitinen K, 2009, BRIT J NUTR, V101, P1679, DOI 10.1017/S0007114508111461; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lindsay KL, 2014, AM J CLIN NUTR, V99, P1432, DOI 10.3945/ajcn.113.079723; Mohamadshahi M, 2014, BIOIMPACTS, V4, P83, DOI 10.5681/bi.2014.007; Moosheer SM, 2014, PRIM CARE DIABETES, V8, P308, DOI 10.1016/j.pcd.2014.02.004; Moroti C, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-29; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Naruszewicz M, 2002, AM J CLIN NUTR, V76, P1249, DOI 10.1093/ajcn/76.6.1249; Rajkumar H, 2015, J CARDIOVASC PHARM T, V20, P289, DOI 10.1177/1074248414555004; Rajkumar H, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/348959; Reid G, 2003, FEMS IMMUNOL MED MIC, V35, P131, DOI 10.1016/S0928-8244(02)00465-0; Shakeri H, 2014, LIPIDS, V49, P695, DOI 10.1007/s11745-014-3901-z; Sharafedtinov KK, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-138; Shavakhi A, 2013, INT J PREVENTIVE MED, V4, P531; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Tabuchi M, 2003, BIOSCI BIOTECH BIOCH, V67, P1421, DOI 10.1271/bbb.67.1421; Uskova M. A., 2009, Voprosy Pitaniya, V78, P18; Yadav H, 2007, NUTRITION, V23, P62, DOI 10.1016/j.nut.2006.09.002; Yadav H, 2008, J DAIRY RES, V75, P189, DOI 10.1017/S0022029908003129; Yun SI, 2009, J APPL MICROBIOL, V107, P1681, DOI 10.1111/j.1365-2672.2009.04350.x	42	109	111	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132121	10.1371/journal.pone.0132121	http://dx.doi.org/10.1371/journal.pone.0132121			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161741	gold, Green Submitted, Green Published			2022-12-27	WOS:000358162300096
J	Fourrier, J; Deschamps, M; Droin, L; Alaux, C; Fortini, D; Beslay, D; Le Conte, Y; Devillers, J; Aupinel, P; Decourtye, A				Fourrier, Julie; Deschamps, Matthieu; Droin, Lea; Alaux, Cedric; Fortini, Dominique; Beslay, Dominique; Le Conte, Yves; Devillers, James; Aupinel, Pierrick; Decourtye, Axel			Larval Exposure to the Juvenile Hormone Analog Pyriproxyfen Disrupts Acceptance of and Social Behavior Performance in Adult Honeybees	PLOS ONE			English	Article							APIS-MELLIFERA WORKERS; DIVISION-OF-LABOR; RISK-ASSESSMENT; AGE POLYETHISM; BEE LARVAE; HYMENOPTERA; DIFFERENTIATION; MELANIZATION; INSECTICIDES; RECOGNITION	Background Juvenile hormone (JH) plays an important role in honeybee development and the regulation of age-related division of labor. However, honeybees can be exposed to insect growth regulators (IGRs), such as JH analogs developed for insect pest and vector control. Although their side effects as endocrine disruptors on honeybee larval or adult stages have been studied, little is known about the subsequent effects on adults of a sublethal larval exposure. We therefore studied the impact of the JH analog pyriproxyfen on larvae and resulting adults within a colony under semi-field conditions by combining recent laboratory larval tests with chemical analysis and behavioral observations. Oral and chronic larval exposure at cumulative doses of 23 or 57 ng per larva were tested. Results Pyriproxyfen-treated bees emerged earlier than control bees and the highest dose led to a significant rate of malformed adults (atrophied wings). Young pyriproxyfen-treated bees were more frequently rejected by nestmates from the colony, inducing a shorter life span. This could be linked to differences in cuticular hydrocarbon (CHC) profiles between control and pyriproxyfen-treated bees. Finally, pyriproxyfen-treated bees exhibited fewer social behaviors (ventilation, brood care, contacts with nestmates or food stocks) than control bees. Conclusion Larval exposure to sublethal doses of pyriproxyfen affected several life history traits of the honeybees. Our results especially showed changes in social integration (acceptance by nestmates and social behaviors performance) that could potentially affect population growth and balance of the colony.	[Fourrier, Julie; Deschamps, Matthieu; Droin, Lea] ACTA, ICB VETAGROSUP, F-69280 Marcy Letoile, France; [Alaux, Cedric; Beslay, Dominique; Le Conte, Yves] INRA, UR Abeilles & Environm 406, F-84914 Avignon 9, France; [Alaux, Cedric; Beslay, Dominique; Le Conte, Yves; Decourtye, Axel] UMT PrADE, Avignon, France; [Fortini, Dominique; Aupinel, Pierrick] INRA, UE1255, UE Entomol, Stn Magneraud, F-17700 Surgeres, France; [Devillers, James] CTIS, F-69140 Rillieux La Pape, France; [Decourtye, Axel] ACTA, F-84914 Avignon 9, France; [Decourtye, Axel] ITSAP Inst Abeille, Avignon, France	INRAE; INRAE	Fourrier, J (corresponding author), ACTA, ICB VETAGROSUP, 1 Ave C Bourgelat, F-69280 Marcy Letoile, France.	julie.fourrier@acta.asso.fr	Le Conte, Yves/AAP-2379-2021; Alaux, Cedric/B-4667-2013; Le Conte, Yves M/B-3246-2016; Le Conte, Yves/M-4442-2018; Aupinel, Pierrick/Y-5436-2019; Rueppell, Olav/G-2679-2010	Le Conte, Yves/0000-0002-8466-5370; Alaux, Cedric/0000-0002-3045-2599; Le Conte, Yves M/0000-0002-8466-5370; Le Conte, Yves/0000-0002-8466-5370; Rueppell, Olav/0000-0001-5370-4229	French Ministry of Ecology, Environment and Sustainable Development for the National Research Program on Endocrine Disruptors (PNRPE program); CTIS	French Ministry of Ecology, Environment and Sustainable Development for the National Research Program on Endocrine Disruptors (PNRPE program); CTIS	This work was supported by grants from the French Ministry of Ecology, Environment and Sustainable Development for the National Research Program on Endocrine Disruptors (PNRPE program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author James Devillers is employed by CTIS. CTIS provided support in the form of salary for author JD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; [Anonymous], 2010, R LANG ENV STAT COMP; Aupinel Merrick, 2007, Redia, V90, P91; Aupinel P, 2007, PEST MANAG SCI, V63, P1090, DOI 10.1002/ps.1446; Aupinel Pierrick, 2005, Bulletin of Insectology, V58, P107; Babendreier D, 2004, APIDOLOGIE, V35, P293, DOI 10.1051/apido:2004016; Baracchi D, 2012, J INSECT PHYSIOL, V58, P1589, DOI 10.1016/j.jinsphys.2012.09.014; Bates D., 2013, LME4 LINEAR MIXED EF; Beshers SN, 2001, J THEOR BIOL, V213, P461, DOI 10.1006/jtbi.2001.2427; Bitondi MMG, 1998, J INSECT PHYSIOL, V44, P499, DOI 10.1016/S0022-1910(97)00113-3; BREED MD, 1985, P NATL ACAD SCI USA, V82, P3058, DOI 10.1073/pnas.82.9.3058; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Devillers J, 2013, QSAR ENVIRON HEALTH, P127; Devillers J, 2014, IN SILICO BEES, P179; DOULL K M, 1976, Apidologie, V7, P61, DOI 10.1051/apido:19760104; Elekonich MM, 2003, J INSECT PHYSIOL, V49, P359, DOI 10.1016/S0022-1910(03)00020-9; Fernandez FC, 2012, MICROSC RES TECHNIQ, V75, P844, DOI 10.1002/jemt.22003; Heimken C, 2009, J EXP BIOL, V212, P1032, DOI 10.1242/jeb.022582; HERBERS JM, 1983, ANIM BEHAV, V31, P759, DOI 10.1016/S0003-3472(83)80233-4; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; HUANG ZY, 1992, P NATL ACAD SCI USA, V89, P11726, DOI 10.1073/pnas.89.24.11726; HUANG ZY, 1995, J COMP PHYSIOL B, V165, P18, DOI 10.1007/BF00264682; HUANG ZY, 1994, J COMP PHYSIOL A, V174, P731, DOI 10.1007/BF00192722; HUANG ZY, 1991, J INSECT PHYSIOL, V37, P733, DOI 10.1016/0022-1910(91)90107-B; HUSSEIN MH, 1978, Z ANGEW ENTOMOL, V87, P109; JAYCOX ER, 1974, ANN ENTOMOL SOC AM, V67, P529, DOI 10.1093/aesa/67.4.529; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; KOLMES SA, 1984, J APICULT RES, V23, P189, DOI 10.1080/00218839.1984.11100631; Lambert O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067007; LE CONTE Y, 1995, J ECON ENTOMOL, V88, P798, DOI 10.1093/jee/88.4.798; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Liang D, 2000, NATURWISSENSCHAFTEN, V87, P412, DOI 10.1007/s001140050752; Mattila HR, 2006, APIDOLOGIE, V37, P533, DOI 10.1051/apido:2006037; McDonnell CM, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-25; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; OEPP/EPPO, 2010, B OEPP EPPO B, V40, P323; Pinto LZ, 2000, J INSECT PHYSIOL, V46, P153, DOI 10.1016/S0022-1910(99)00111-0; RACHINSKY A, 1990, J INSECT PHYSIOL, V36, P189, DOI 10.1016/0022-1910(90)90121-U; RACHINSKY A, 1990, GEN COMP ENDOCR, V79, P31, DOI 10.1016/0016-6480(90)90085-Z; REMBOLD H, 1987, INSECT BIOCHEM, V17, P1003, DOI 10.1016/0020-1790(87)90110-7; Reyment RA, 1989, TERRA NOVA, V1, P29, DOI 10.1111/j.1365-3121.1989.tb00322.x; Richard FJ, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-50; Richard FJ, 2004, CHEMOECOLOGY, V14, P9, DOI 10.1007/s00049-003-0251-3; Richard FJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-558; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1987, BEHAV ECOL SOCIOBIOL, V20, P329, DOI 10.1007/BF00300679; ROBINSON GE, 1989, SCIENCE, V246, P109, DOI 10.1126/science.246.4926.109; Robinson GE, 1997, ARCH INSECT BIOCHEM, V35, P559, DOI 10.1002/(SICI)1520-6327(1997)35:4<559::AID-ARCH13>3.0.CO;2-9; ROBINSON GE, 1985, J INSECT PHYSIOL, V31, P277, DOI 10.1016/0022-1910(85)90003-4; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Salvy M, 2001, PARASITOLOGY, V122, P145, DOI 10.1017/S0031182001007181; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Sullivan JP, 2000, HORM BEHAV, V37, P1, DOI 10.1006/hbeh.1999.1552; Tasei JN, 2001, APIDOLOGIE, V32, P527, DOI 10.1051/apido:2001102; Thompson HM, 2007, PEST MANAG SCI, V63, P1081, DOI 10.1002/ps.1457; Thompson HM, 2005, ECOTOXICOLOGY, V14, P757, DOI 10.1007/s10646-005-0024-6; Thompson HM, 2003, ECOTOXICOLOGY, V12, P317, DOI 10.1023/A:1022575315413; Villa S, 2000, ECOTOXICOLOGY, V9, P287, DOI 10.1023/A:1026522112328; Winston M. L., 1987, The biology of the honey bee.; Yang E. C., 2010, P INT SEM ENH FUNCT; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547; Zufelato MS, 2000, ARTHROPOD STRUCT DEV, V29, P111, DOI 10.1016/S1467-8039(00)00023-2	64	27	27	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132985	10.1371/journal.pone.0132985	http://dx.doi.org/10.1371/journal.pone.0132985			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171610	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900113
J	Juzenas, S; Salteniene, V; Kupcinskas, J; Link, A; Kiudelis, G; Jonaitis, L; Jarmalaite, S; Kupcinskas, L; Malfertheiner, P; Skieceviciene, J				Juzenas, Simonas; Salteniene, Violeta; Kupcinskas, Juozas; Link, Alexander; Kiudelis, Gediminas; Jonaitis, Laimas; Jarmalaite, Sonata; Kupcinskas, Limas; Malfertheiner, Peter; Skieceviciene, Jurgita			Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer	PLOS ONE			English	Article							CELL-PROLIFERATION; PCR DATA; EXPRESSION; QUANTIFICATION; NORMALIZATION; METASTASIS; SIGNATURE	Background MicroRNAs (miRNAs) are widely studied non-coding RNAs that modulate gene expression. MiRNAs are deregulated in different tumors including gastric cancer (GC) and have potential diagnostic and prognostic implications. The aim of our study was to determine miRNA profile in GC tissues, followed by evaluation of deregulated miRNAs in plasma of GC patients. Using available databases and bioinformatics methods we also aimed to evaluate potential target genes of confirmed differentially expressed miRNA and validate these findings in GC tissues. Methods The study included 51 GC patients and 51 controls. Initially, we screened miRNA expression profile in 13 tissue samples of GC and 12 normal gastric tissues with TaqMan low density array (TLDA). In the second stage, differentially expressed miRNAs were validated in a replication cohort using qRT-PCR in tissue and plasma samples. Subsequently, we analyzed potential target genes of deregulated miRNAs using bioinformatics approach, determined their expression in GC tissues and performed correlation analysis with targeting miRNAs. Results Profiling with TLDA revealed 15 deregulated miRNAs in GC tissues compared to normal gastric mucosa. Replication analysis confirmed that miR-148a-3p, miR-204-5p, miR-223-3p and miR-375 were consistently deregulated in GC tissues. Analysis of GC patients' plasma samples showed significant down-regulation of miR-148a-3p, miR-375 and up-regulation of miR-223-3p compared to healthy subjects. Further, using bioinformatic tools we identified targets of replicated miRNAs and performed disease-associated gene enrichment analysis. Ultimately, we evaluated potential target gene BCL2 and DNMT3B expression by qRT-PCR in GC tissue, which correlated with targeting miRNA expression. Conclusions Our study revealed miRNA profile in GC tissues and showed that miR-148a-3p, miR-223-3p and miR-375 are deregulated in GC plasma samples, but these circulating miRNAs showed relatively weak diagnostic performance as sole biomarkers. Target gene analysis demonstrated that BCL2 and DNMT3B expression in GC tissue correlated with their targeting miRNA expression.	[Juzenas, Simonas; Salteniene, Violeta; Kupcinskas, Juozas; Kiudelis, Gediminas; Jonaitis, Laimas; Kupcinskas, Limas; Skieceviciene, Jurgita] Lithuanian Univ Hlth Sci, Inst Digest Res, Kaunas, Lithuania; [Kupcinskas, Juozas; Kiudelis, Gediminas; Jonaitis, Laimas; Kupcinskas, Limas] Lithuanian Univ Hlth Sci, Dept Gastroenterol, Kaunas, Lithuania; [Link, Alexander; Malfertheiner, Peter] Univ Magdeburg, Dept Gastroenterol Hepatol & Infect Dis, D-39106 Magdeburg, Germany; [Jarmalaite, Sonata] Vilnius State Univ, Fac Nat Sci, Res Ctr, Div Human Genome, Vilnius, Lithuania	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Otto von Guericke University; Vilnius University	Kupcinskas, J (corresponding author), Lithuanian Univ Hlth Sci, Inst Digest Res, Kaunas, Lithuania.	j_kupcinskas@yahoo.com	Juzenas, Simonas/F-3187-2018; Jarmalaite, Sonata/CAF-4301-2022; Kupcinskas, Juozas/AAU-6968-2021	Juzenas, Simonas/0000-0001-9293-0691; 	European Social Fund [VP1-3.1-SMM-07-K-01-156]; German Federal Ministry of Education and Research in the frame of ERA-Net PathoGenoMics [BMBF-0315905D]	European Social Fund(European Social Fund (ESF)); German Federal Ministry of Education and Research in the frame of ERA-Net PathoGenoMics	This work of JK, LJ, SiJu, LK, JS was supported by the European Social Fund No. VP1-3.1-SMM-07-K-01-156. The work of PM is supported by German Federal Ministry of Education and Research in the frame of ERA-Net PathoGenoMics. Grant No: BMBF-0315905D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmedin J., 2014, CA-CANCER J CLIN, V61, P69; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bae IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122554; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Benz F, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.81; Bornschein J, 2014, FRONT BIOSCI-LANDMRK, V19, P312, DOI 10.2741/4210; Bornschein J, 2011, HELICOBACTER, V16, P45, DOI 10.1111/j.1523-5378.2011.00880.x; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Fujimoto D, 2013, INT J ONCOL, V42, P565, DOI 10.3892/ijo.2012.1738; Genovesi Laura A, 2012, BMC Res Notes, V5, P507, DOI 10.1186/1756-0500-5-507; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo SL, 2011, INT J BIOL SCI, V7, P567, DOI 10.7150/ijbs.7.567; Han TS, 2015, GUT, V64, P203, DOI 10.1136/gutjnl-2013-306640; Hashimoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062589; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Kang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033919; Kim CH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-79; Kim SY, 2013, J MOL DIAGN, V15, P661, DOI 10.1016/j.jmoldx.2013.04.004; Kutmon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082160; Lamba Vishal, 2014, BMC Res Notes, V7, P129, DOI 10.1186/1756-0500-7-129; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lauss M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-532; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li GR, 2011, INVEST OPHTH VIS SCI, V52, P2999, DOI 10.1167/iovs.10-6708; Li XH, 2010, GUT, V59, P579, DOI 10.1136/gut.2008.175497; Li XH, 2011, ONCOL REP, V26, P1431, DOI 10.3892/or.2011.1437; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Link A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08270; Link A, 2013, ADV CLIN CHEM, V62, P221, DOI 10.1016/B978-0-12-800096-0.00006-8; Link A, 2012, DIGEST DIS, V30, P255, DOI 10.1159/000336919; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Minn YK, 2014, INT J ONCOL, V45, P2403, DOI 10.3892/ijo.2014.2680; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Sacconi A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.160; Shen ZY, 2014, EXP THER MED, V7, P1757, DOI 10.3892/etm.2014.1627; Shrestha S, 2014, CANCER MED-US, V3, P878, DOI 10.1002/cam4.246; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Steponaitiene R, 2016, MOL CARCINOGEN, V55, P376, DOI 10.1002/mc.22287; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113401; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xiang MQ, 2014, BIOCHEM BIOPH RES CO, V454, P210, DOI 10.1016/j.bbrc.2014.10.064; Xiao B, 2009, J INFECT DIS, V200, P916, DOI 10.1086/605443; Xu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099516; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zheng GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083025; Zhou XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101457; Zhu C, 2014, BRIT J CANCER, V110, P2291, DOI 10.1038/bjc.2014.119	57	40	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132327	10.1371/journal.pone.0132327	http://dx.doi.org/10.1371/journal.pone.0132327			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172537	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900042
J	Ketema, T; Bacha, K; Alemayehu, E; Ambelu, A				Ketema, Tsige; Bacha, Ketema; Alemayehu, Esayas; Ambelu, Argaw			Incidence of Severe Malaria Syndromes and Status of Immune Responses among Khat Chewer Malaria Patients in Ethiopia	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CATHA-EDULIS; BLOOD-PRESSURE; URIC-ACID; CIGARETTE-SMOKING; CLINICAL MALARIA; IN-VITRO; IMMUNOGLOBULIN; THROMBOCYTOPENIA; ANTIBODIES	Although more emphasis has been given to the genetic and environmental factors that determine host vulnerability to malaria, other factors that might have a crucial role in burdening the disease have not been evaluated yet. Therefore, this study was designed to assess the effect of khat chewing on the incidence of severe malaria syndromes and immune responses during malaria infection in an area where the two problems co-exist. Clinical, physical, demographic, hematological, biochemical and immunological data were collected from Plasmodium falciparum mono-infected malaria patients (age >= 10 years) seeking medication in Halaba Kulito and Jimma Health Centers. In addition, incidences of severe malaria symptoms were assessed. The data were analyzed using SPSS (version 20) software. Prevalence of current khat chewer malaria patients was 57.38% (95% CI = 53-61.56%). Malaria symptoms such as hyperpyrexia, prostration and hyperparasitemia were significantly lower (P<0.05) among khat chewer malaria patients. However, relative risk to jaundice and renal failure were significantly higher (P<0.05) in khat chewers than in non-khat chewer malaria patients. Longer duration of khat use was positively associated with incidence of anemia. IgM and IgG antibody titers were significantly higher (P<0.05) among khat chewer malaria patients than among malaria positive non-chewers. Although levels of IgG subclasses in malaria patients did not show significant differences (P>0.05), IgG3 antibody was significantly higher (P<0.001) among khat chewer malaria patients. Moreover, IgM, IgG, IgG1 and IgG3 antibodies had significant negative association (P<0.001) with parasite burden and clinical manifestations of severe malaria symptoms, but not with severe anemia and hypoglycemia. Additionally, a significant increment (P<0.05) in CD4(+) T-lymphocyte population was observed among khat users. Khat might be an important risk factor for incidence of some severe malaria complications. Nevertheless, it can enhance induction of humoral immune response and CD4(+) T-lymphocyte population during malaria infection. This calls for further investigation on the effect of khat on parasite or antigen-specifc protective malaria immunity and analysis of cytokines released upon malaria infection among khat chewers.	[Ketema, Tsige; Ambelu, Argaw] Jimma Univ, Dept Environm Hlth Sci & Technol, Coll Hlth Sci, Jimma, Ethiopia; [Ketema, Tsige; Bacha, Ketema] Jimma Univ, Dept Biol, Coll Nat Sci, Jimma, Ethiopia; [Alemayehu, Esayas] Jimma Univ, Inst Technol, Sch Civil & Environm Engn, Jimma, Ethiopia	Jimma University; Jimma University; Jimma University	Ketema, T (corresponding author), Jimma Univ, Dept Environm Hlth Sci & Technol, Coll Hlth Sci, Jimma, Ethiopia.	tsigeketema@gmail.com	Ambelu, Argaw/V-8317-2018; Prof., Esayas Alemayehu/AAK-1907-2020; Ambelu, Argaw/GQA-6114-2022	Ambelu, Argaw/0000-0003-1898-4100; Ambelu, Argaw/0000-0003-1898-4100; /0000-0002-6286-5689; Alemayehu, Esayas/0000-0001-8843-1136	L'Oreal UNESCO; DAAD; Jimma University	L'Oreal UNESCO(L'Oreal Group); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Jimma University	The study was financially supported by L'Oreal UNESCO, DAAD, and Jimma University.	Abdul Manan Junejo, 2006, J Ayub Med Coll Abbottabad, V18, P47; Abuye C, 2005, J CLIN IMMUNOL, V25, P127, DOI 10.1007/s10875-005-2818-y; ACMD, 2005, KHAT QAT ASS RISK IN; Adhanom TDW, 2006, EPIDEMIOLOGY ECOLOGY, P556; Al-Hashem FH, 2011, BAHRAIN MED B, V33; Al-hebshi N, 2006, ARCH ORAL BIOL, V51, P183, DOI 10.1016/j.archoralbio.2005.08.001; Al-Hebshi NN, 2005, ADDICT BIOL, V10, P299, DOI 10.1080/13556210500353020; Al-Mamary M, 2002, PHYTOTHER RES, V16, P127, DOI 10.1002/ptr.835; ALMESHAL IA, 1986, AGENTS ACTIONS, V17, P379, DOI 10.1007/BF01982654; Alsalahi A, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/829401; Alsanosy RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065504; ANAND A C, 1992, National Medical Journal of India, V5, P59; [Anonymous], 2006, 34 WHO ECDD; [Anonymous], 2012, MAN SEV MAL PRACT HD; Aucan C, 2000, INFECT IMMUN, V68, P1252, DOI 10.1128/IAI.68.3.1252-1258.2000; Balint EE, 2009, WIEN KLIN WOCHENSCHR, V121, P604, DOI 10.1007/s00508-009-1259-7; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Cheesbrough M, 2005, DISTRICT LAB PRACTIC, P462; Christian R, 1998, ENCY PSYCHOACTIVE PL; Clark IA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-85; Corkery JM, 2011, ANN I SUPER SANITA, V47, P445, DOI 10.4415/ANN_11_04_17; Cox D, 2010, CELL MOL LIFE SCI, V67, P557, DOI 10.1007/s00018-009-0211-3; Cox G, 2003, ADV PSYCHIAT TREAT, V9, P456, DOI [10.1192/apt.9.6.456, DOI 10.1192/APT.9.6.456]; Damena T, 2011, ETHIOP J HEALTH SCI, V21, P37; Deressa W, 2003, B WORLD HEALTH ORGAN, V81, P261; Dhaifalah Ishraq, 2004, Biomedical Papers (Olomouc), V148, P11; Elhag H, 1999, ANT CYT ACT EXTR KHA, P463; Felix K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082755; FIEVET N, 1993, CLIN EXP IMMUNOL, V91, P63, DOI 10.1111/j.1365-2249.1993.tb03355.x; Fitzgerald J, 2009, KHAT LIT REV; FMOH (Federal Ministry of Health of Ethiopia), 2007, P ANN REV M MAL PREV; FMOH (Federal Ministry of Health of Ethiopia), 2007, ENT PROF MAL ETH; FMOH (Federal ministry of Health of Ethiopia), 2012, NAT MAL GUID; FMOH (Federal Ministry of Health of Ethiopia), 1999, MAL OTH VECT BORN DI; Friedman JF, 2003, J INFECT DIS, V188, P449, DOI 10.1086/376596; Gelaw Y, 2004, ETHIOP J HEALTH DEV, V18, P179; Getahun W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-390; Graeme B, 2010, AUST J MED HERBAL, V22, P107; Hassan NA, 2005, SAUDI MED J, V26, P537; Hassan NAGM, 2000, TROP DOCT, V30, P107, DOI 10.1177/004947550003000219; Iman R, 2013, EGYPT J INTERN MED, V25, P37; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; KABILAN L, 1987, CLIN EXP IMMUNOL, V68, P288; KALIX P, 1987, BRIT J ADDICT, V82, P47; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; KELTON JG, 1983, J CLIN INVEST, V71, P832, DOI 10.1172/JCI110836; Ketema T, 2015, J BIOL CHEM RES, V32, P374; Kour K, 2011, J PHARM PHARMACOL, V63, P267, DOI 10.1111/j.2042-7158.2010.01195.x; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Laswar AKN, 2009, SAUDI J KIDNEY DIS T, V20, P862; Lee SH, 1997, THROMB HAEMOSTASIS, V77, P289; Mark L, 2003, BASIC REFERENCE, V28, P217; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murdoch C, 2011, J ETHNOPHARMACOL, V138, P780, DOI 10.1016/j.jep.2011.10.030; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Nutt D, 2007, LANCET, V369, P1047, DOI 10.1016/S0140-6736(07)60464-4; Odenwald M, 2010, J ETHNOPHARMACOL, V132, P615, DOI 10.1016/j.jep.2009.11.005; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Orengo JM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000013; Orengo JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005194; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Piguet PF, 2002, APOPTOSIS, V7, P91, DOI 10.1023/A:1014341611412; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Schumann RR, 2007, P NATL ACAD SCI USA, V104, P1743, DOI 10.1073/pnas.0610874104; Siddiqui R, 2012, J BACTERIOL PARASITO, V3, P1; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Tongren JE, 2006, INFECT IMMUN, V74, P257, DOI 10.1128/IAI.74.1.257-264.2006; Tulu NA, 1993, ECOLOGY HLTH DIS ETH, P341; UN-OCHA, 2003, CRIT EM SIT KAMB TAM; VANDERHEYDE HC, 1994, J IMMUNOL, V152, P4557; Wassmer SC, 2006, J IMMUNOL, V176, P1180, DOI 10.4049/jimmunol.176.2.1180; White NJ, 2008, CLIN INFECT DIS, V46, P172, DOI 10.1086/524889; WHO/UNICEF, 2005, WORLD MAL REP; WHO (World Health Organization), 2004, THE LANCET, P157; Wickramasinghe SN, 2000, BEST PRACT RES CL HA, V13, P277, DOI 10.1053/beha.1999.0072; World Health Organization, 2010, BAS MAL MICR 1; Yamaguchi S, 1997, AM J HEMATOL, V56, P183, DOI 10.1002/(SICI)1096-8652(199711)56:3&lt;183::AID-AJH9&gt;3.0.CO;2-U	79	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131212	10.1371/journal.pone.0131212	http://dx.doi.org/10.1371/journal.pone.0131212			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173100	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900014
J	Baikara, BT; Zholdybayeva, EV; Rakhimova, SE; Nigmatullina, NB; Momynaliev, KT; Ramanculov, YM				Baikara, Barshagul T.; Zholdybayeva, Elena V.; Rakhimova, Saule E.; Nigmatullina, Nazym B.; Momynaliev, Kuvat T.; Ramanculov, Yerlan M.			A Novel Mutation in a Kazakh Family with X-Linked Alport Syndrome	PLOS ONE			English	Article							PHENOTYPE CORRELATIONS; IV COLLAGEN; GENE	Alport syndrome is a genetic condition that results in hematuria, progressive renal impairment, hearing loss, and occasionally lenticonus and retinopathy. Approximately 80% of Alport syndrome cases are caused by X-linked mutations in the COL4A5 gene encoding type IV collagen. The objective of this study was to define the SNP profiles for COL4A5 in patients with hereditary nephritis and hematuria. For this, we examined four subjects from one Kazakh family clinically affected with X-linked Alport syndrome due to COL4A5 gene mutations. All 51 exons of the COL4A5 gene were screened by linkage analysis and direct DNA sequencing, resulting in the identification of a novel mutation (G641E) in exon 25. The mutation was found only in two affected family individuals but was not present in healthy family members or 200 unrelated healthy controls. This result demonstrates that this novel mutation is pathogenic and has meaningful implications for the diagnosis of patients with Alport syndrome.	[Baikara, Barshagul T.; Zholdybayeva, Elena V.; Rakhimova, Saule E.; Momynaliev, Kuvat T.; Ramanculov, Yerlan M.] Natl Biotechnol Ctr, Astana, Kazakhstan; [Rakhimova, Saule E.] Nazarbayev Univ, Ctr Sci, Astana, Kazakhstan; [Nigmatullina, Nazym B.] Natl Res Ctr Maternal & Child Hlth, Astana, Kazakhstan; [Ramanculov, Yerlan M.] Nazarbayev Univ, Sch Sci & Technol, Astana, Kazakhstan	National Center for Biotechnology (NCB); Nazarbayev University; Nazarbayev University	Baikara, BT (corresponding author), Natl Biotechnol Ctr, Astana, Kazakhstan.	baikara.barshagul@gmail.com	Ramankulov, Yerlan/AAG-7450-2019; Baikara, Barshagul/AAQ-7756-2020; Rakhimova, Saule Eslamovna/N-4602-2017; Zholdybayeva, Elena/AAB-1509-2020; Momynaliev, Kuvat/ADR-6456-2022	Ramankulov, Yerlan/0000-0001-6786-3028; Zholdybayeva, Elena/0000-0002-9677-008X; Momynaliev, Kuvat/0000-0003-4656-1025; Ramanculov, Erlan/0000-0001-6791-4497; Rakhimova, Saule/0000-0002-8245-2400	Ministry of Education and Science of the Republic of Kazakhstan; National Center for Biotechnology	Ministry of Education and Science of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan); National Center for Biotechnology	This study was supported by the Ministry of Education and Science of the Republic of Kazakhstan. The National Center for Biotechnology received this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alport AC, 1927, BMJ-BRIT MED J, V1927, P504, DOI 10.1136/bmj.1.3454.504; Arrondel C, 2004, KIDNEY INT, V65, P2030, DOI 10.1111/j.1523-1755.2004.00622.x; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; Deltas C, 2012, PEDIATR NEPHROL, V27, P1221, DOI 10.1007/s00467-011-1935-5; Gross O, 2002, NEPHROL DIAL TRANSPL, V17, P1218, DOI 10.1093/ndt/17.7.1218; Haas M, 2009, ARCH PATHOL LAB MED, V133, P224, DOI 10.1043/1543-2165-133.2.224; Hertz JM, 2012, EUR J HUM GENET, V20, DOI 10.1038/ejhg.2011.237; Hertz JM, 2009, DAN MED BULL, V56, P105; Jais JP, 2000, J AM SOC NEPHROL, V11, P649, DOI 10.1681/ASN.V114649; Kalluri R, 1997, J CLIN INVEST, V99, P2470, DOI 10.1172/JCI119431; Kashtan CE, 2009, PEDIATR NEPHROL, V24, P1951, DOI 10.1007/s00467-007-0622-z; LEMMINK HH, 1994, HUM MOL GENET, V3, P1269, DOI 10.1093/hmg/3.8.1269; Liapis H, 2002, HUM PATHOL, V33, P836, DOI 10.1053/hupa.2002.125374; Longo I, 2002, KIDNEY INT, V61, P1947, DOI 10.1046/j.1523-1755.2002.00379.x; Persikov AV, 2004, HUM MUTAT, V24, P330, DOI 10.1002/humu.20091; Spear G S, 1973, Clin Nephrol, V1, P336; Wang YF, 2004, BIOCHEM BIOPH RES CO, V316, P1143, DOI 10.1016/j.bbrc.2004.02.168	17	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132010	10.1371/journal.pone.0132010	http://dx.doi.org/10.1371/journal.pone.0132010			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168235	Green Submitted, gold, Green Published			2022-12-27	WOS:000358193100017
J	George, NM; Whitaker, J; Vieira, G; Geronimo, JT; Bellinger, DA; Fletcher, CA; Garner, JP				George, Nneka M.; Whitaker, Julia; Vieira, Giovana; Geronimo, Jerome T.; Bellinger, Dwight A.; Fletcher, Craig A.; Garner, Joseph P.			Antioxidant Therapies for Ulcerative Dermatitis: A Potential Model for Skin Picking Disorder	PLOS ONE			English	Article							OXIDATIVE STRESS; N-ACETYLCYSTEINE; C57BL/6 MICE; TRICHOTILLOMANIA; GLUTATHIONE; BEHAVIORS; MODULATOR	Skin Picking Disorder affects 4% of the general population, with serious quality of life impacts, and potentially life threatening complications. Standard psychoactive medications do not help most patients. Similarly, Mouse Ulcerative Dermatitis (skin lesions caused by excessive abnormal grooming behavior) is very common in widely used inbred strains of mice, and represents a serious animal welfare issue and cause of mortality. Treatment options for Ulcerative Dermatitis are largely palliative and ineffective. We have proposed mouse Ulcerative Dermatitis as a model for human Skin Picking Disorder based on similar epidemiology, behavior, and its comorbidity and mechanistic overlap with hair pulling (trichotillomania). We predicted that mouse Ulcerative Dermatitis would be treated by N-Acetylcysteine, as this compound is highly effective in treating both Skin Picking Disorder and Trichotillomania. Furthermore, we hypothesized that N-Acetylcysteine's mode of action is as a precursor to the production of the endogenous antioxidant glutathione in the brain, and therefore intranasal glutathione would also treat Ulcerative Dermatitis. Accordingly, we show in a heterogenous prospective trial, the significant reduction in Ulcerative Dermatitis lesion severity in mice receiving either N-acetylcysteine (oral administration) or glutathione (intranasal). The majority of mice treated with N-acetylcysteine improved slowly throughout the course of the study. Roughly half of the mice treated with glutathione showed complete resolution of lesion within 2-4 weeks, while the remainder did not respond. These findings are the first to show that the use of N-acetylcysteine and Glutathione can be curative for mouse Ulcerative Dermatitis. These findings lend additional support for mouse Ulcerative Dermatitis as a model of Skin Picking Disorder and also support oxidative stress and glutathione synthesis as the mechanism of action for these compounds. As N-Acetylcysteine is poorly tolerated by many patients, intranasal glutathione warrants further study as potential therapy in Skin Picking, trichotillomania and other body-focused repetitive behavior disorders.	[George, Nneka M.; Whitaker, Julia; Bellinger, Dwight A.; Fletcher, Craig A.] Univ N Carolina, Div Lab Anim Med, Dept Pathol & Lab Med, Chapel Hill, NC 27514 USA; [Vieira, Giovana] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Geronimo, Jerome T.; Garner, Joseph P.] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA; [Garner, Joseph P.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	University of North Carolina; University of North Carolina Chapel Hill; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Stanford University; Stanford University	George, NM (corresponding author), Univ N Carolina, Div Lab Anim Med, Dept Pathol & Lab Med, Chapel Hill, NC 27514 USA.	ngeorge@email.unc.edu	Garner, Joseph P/C-8422-2009	Bader, Michael/0000-0003-4780-4164	Timothy Foundation	Timothy Foundation	NMG JW DB and CAF received no specific funding for this work. JPG and JG were supported in part by the Timothy Foundation, a private nonprofit fund, whose strategic funding of Trichotillomania research is inspired by the prior head and founder of TLC, Christina Pearson, in recognition of her continuing dedication to reducing the suffering of those with Trichotillomania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar H, 2012, J CLIN PSYCHOPHARM, V32, P797, DOI 10.1097/JCP.0b013e318272677d; ANDREWS AG, 1994, VET PATHOL, V31, P293, DOI 10.1177/030098589403100301; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bechard A, 2011, J AM ASSOC LAB ANIM, V50, P171; Berman AE, 2011, ANN NEUROL, V69, P509, DOI 10.1002/ana.22162; Camfield DA, 2011, PROG NEURO-PSYCHOPH, V35, P887, DOI 10.1016/j.pnpbp.2011.02.011; Dufour BD, 2010, NEUROBIOLOGY GROOMIN; Dufour BD, 2010, NUTR NEUROSCI, V13, P256, DOI 10.1179/147683010X12611460764688; Ezell PC, 2012, J AM ASSOC LAB ANIM, V51, P609; Garner JP, 2011, BEHAV BRAIN RES, V219, P189, DOI 10.1016/j.bbr.2011.01.002; Garner JP, 2004, COMPARATIVE MED, V54, P216; Gaskill BN, 2011, THERMAL COMFORT MICE; Grant JE, 2012, AM J PSYCHIAT, V169, P1143, DOI 10.1176/appi.ajp.2012.12040508; Grant JE, 2009, ARCH GEN PSYCHIAT, V66, P756, DOI 10.1001/archgenpsychiatry.2009.60; Inagaki N, 2010, EUR J PHARMACOL, V626, P283, DOI 10.1016/j.ejphar.2009.09.043; Kassed CA, 2004, BEHAV BRAIN RES, V154, P577, DOI 10.1016/j.bbr.2004.03.026; Kastenmayer RJ, 2006, J AM ASSOC LAB ANIM, V45, P8; Mader JR, 2010, SCAND J LAB ANIM SCI, V37, P253; Miller JL, 2014, AM J MED GENET A, V164, P421, DOI 10.1002/ajmg.a.36306; Mischley LK, 2013, J ALTERN COMPLEM MED, V19, P459, DOI 10.1089/acm.2011.0673; Mischley LK, 2011, J ORTHOMOL MED, V26; Neuhaus B, 2012, EXP DERMATOL, V21, P712, DOI 10.1111/j.1600-0625.2012.01558.x; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Odlaug BL, 2008, GEN HOSP PSYCHIAT, V30, P61, DOI 10.1016/j.genhosppsych.2007.07.009; Odlaug BL, 2007, J CLIN PSYCHOPHARM, V27, P227, DOI 10.1097/01.jcp.0000264976.86990.00; Odlaug BL, 2013, GEN HOSP PSYCHIAT, V35, P168, DOI 10.1016/j.genhosppsych.2012.08.006; Odlaug BL, 2010, AM J DRUG ALCOHOL AB, V36, P296, DOI 10.3109/00952991003747543; Ohmura T, 2004, EUR J PHARMACOL, V491, P191, DOI 10.1016/j.ejphar.2004.03.047; Perkins SN, 1998, J INVEST DERMATOL, V111, P292, DOI 10.1046/j.1523-1747.1998.00270.x; Richter SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016461; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sims NR, 2004, J BIOENERG BIOMEMBR, V36, P329, DOI 10.1023/B:JOBB.0000041763.63958.e7; SUNDBERG JP, 1994, HDB MOUSE MUTATIONS, P485; Sundberg JP, 1996, PATHOBIOLOGY AGING M, P325; Tayebati SK, 2013, CURR PHARM DESIGN, V19, P510; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Vieira L.T. G., 2014, PREVENTING TREATING; Williams LK, 2012, COMPARATIVE MED, V62, P166; Williams-Fritze MJ, 2011, J AM ASSOC LAB ANIM, V50, P221	39	12	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132092	10.1371/journal.pone.0132092	http://dx.doi.org/10.1371/journal.pone.0132092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167859	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100019
J	Hagel, KR; Beriont, J; Tessier, CR				Hagel, Kimberly R.; Beriont, Jane; Tessier, Charles R.			Drosophila Cbp53E Regulates Axon Growth at the Neuromuscular Junction	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; CALRETININ-IMMUNOREACTIVE NEURONS; MENTAL-RETARDATION PROTEIN; MICE LACKING CALRETININ; MOTOR COORDINATION; ALZHEIMERS-DISEASE; CALBINDIN D28K; DENTATE GYRUS; CELLS; PARVALBUMIN	Calcium is a primary second messenger in all cells that functions in processes ranging from cellular proliferation to synaptic transmission. Proper regulation of calcium is achieved through numerous mechanisms involving channels, sensors, and buffers notably containing one or more EF-hand calcium binding domains. The Drosophila genome encodes only a single 6 EF-hand domain containing protein, Cbp53E, which is likely the prototypic member of a small family of related mammalian proteins that act as calcium buffers and calcium sensors. Like the mammalian homologs, Cbp53E is broadly though discretely expressed throughout the nervous system. Despite the importance of calcium in neuronal function and growth, nothing is known about Cbp53E's function in neuronal development. To address this deficiency, we generated novel null alleles of Drosophila Cbp53E and examined neuronal development at the well-characterized larval neuromuscular junction. Loss of Cbp53E resulted in increases in axonal branching at both peptidergic and glutamatergic neuronal terminals. This overgrowth could be completely rescued by expression of exogenous Cbp53E. Overexpression of Cbp53E, however, only affected the growth of peptidergic neuronal processes. These findings indicate that Cbp53E plays a significant role in neuronal growth and suggest that it may function in both local synaptic and global cellular mechanisms.	[Hagel, Kimberly R.; Beriont, Jane] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Tessier, Charles R.] Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46617 USA	University of Notre Dame; Indiana University System; Indiana University South Bend	Tessier, CR (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46617 USA.	crtessie@iupui.edu			Biomedical Research Enhancement Grant from Indiana University School of Medicine; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Biomedical Research Enhancement Grant from Indiana University School of Medicine; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Biomedical Research Enhancement Grant from Indiana University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 1997, P NATL ACAD SCI USA, V94, P1488, DOI 10.1073/pnas.94.4.1488; Bachstetter AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105191; Bastianelli E, 2003, CEREBELLUM, V2, P242, DOI 10.1080/14734220310022289; Bellido T, 2000, J BIOL CHEM, V275, P26328, DOI 10.1074/jbc.M003600200; Berggard T, 2002, J BIOL CHEM, V277, P16662, DOI 10.1074/jbc.M200415200; Bronner F, 2001, ScientificWorldJournal, V1, P919; CHARD PS, 1993, J PHYSIOL-LONDON, V472, P341, DOI 10.1113/jphysiol.1993.sp019950; Cheron G, 2000, PROG BRAIN RES, V124, P299; Choi JC, 2004, J NEUROPHYSIOL, V91, P2353, DOI 10.1152/jn.01115.2003; Coffee RL, 2010, DIS MODEL MECH, V3, P471, DOI 10.1242/dmm.004598; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Cukier HN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000179; Diaz-Balzac CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032689; Fahandejsaadi A, 2004, NEUROREPORT, V15, P443, DOI 10.1097/00001756-200403010-00012; FONSECA M, 1995, BRAIN RES, V691, P83, DOI 10.1016/0006-8993(95)00622-W; Franco B, 2004, J NEUROSCI, V24, P6573, DOI 10.1523/JNEUROSCI.1580-04.2004; Gall D, 2003, J NEUROSCI, V23, P9320; Gartner W, 2007, AM J PHYSIOL-ENDOC M, V293, pE347, DOI 10.1152/ajpendo.00055.2007; Gartner W, 2001, CEREB CORTEX, V11, P1161, DOI 10.1093/cercor/11.12.1161; Gilabert JA, 2012, ADV EXP MED BIOL, V740, P483, DOI 10.1007/978-94-007-2888-2_20; Goldberg JH, 2005, TRENDS NEUROSCI, V28, P158, DOI 10.1016/j.tins.2005.01.005; GORCZYCA M, 1993, J NEUROSCI, V13, P3692; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Gurden H, 1998, EUR J NEUROSCI, V10, P3029, DOI 10.1111/j.1460-9568.1998.00373.x; Hofbauer A, 2009, J NEUROGENET, V23, P78, DOI 10.1080/01677060802471627; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kavalali ET, 2015, NAT REV NEUROSCI, V16, P5, DOI 10.1038/nrn3875; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; Menon KP, 2013, WIRES DEV BIOL, V2, P647, DOI 10.1002/wdev.108; Metaxakis A, 2005, GENETICS, V171, P571, DOI 10.1534/genetics.105.041848; Miller DL, 2012, J NEUROSCI, V32, P13776, DOI 10.1523/JNEUROSCI.0508-12.2012; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; MOUATTPRIGENT A, 1994, BRAIN RES, V668, P62, DOI 10.1016/0006-8993(94)90511-8; Muqit MMK, 2002, NAT REV NEUROSCI, V3, P237, DOI 10.1038/nrn751; Odero GL, 2010, NEUROSCIENCE, V169, P532, DOI 10.1016/j.neuroscience.2010.04.004; PIKE CJ, 1995, BRAIN RES, V671, P293, DOI 10.1016/0006-8993(94)01354-K; REIFEGERSTE R, 1993, J NEUROSCI, V13, P2186; Rivlin PK, 2004, J COMP NEUROL, V468, P596, DOI 10.1002/cne.10977; ROGERS JH, 1992, BRAIN RES, V587, P147, DOI 10.1016/0006-8993(92)91439-L; Schiffmann SN, 1999, P NATL ACAD SCI USA, V96, P5257, DOI 10.1073/pnas.96.9.5257; Schwaller B, 1997, J BIOL CHEM, V272, P29663, DOI 10.1074/jbc.272.47.29663; Schwaller B, 2009, CELL MOL LIFE SCI, V66, P275, DOI 10.1007/s00018-008-8564-6; Schwaller Beat, 2002, Cerebellum, V1, P241, DOI 10.1080/147342202320883551; Schwaller B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004051; SLOVITER RS, 1991, J COMP NEUROL, V308, P381, DOI 10.1002/cne.903080306; Suo D, 2015, J NEUROSCI, V35, P3893, DOI 10.1523/JNEUROSCI.4402-14.2015; Tessier CR, 2008, DEVELOPMENT, V135, P1547, DOI 10.1242/dev.015867; Waites CL, 2011, TRENDS NEUROSCI, V34, P326, DOI 10.1016/j.tins.2011.03.004; Westerink RHS, 2012, BRAIN RES, V1450, P1, DOI 10.1016/j.brainres.2012.02.036; Wu Y, 2008, P NATL ACAD SCI USA, V105, P12399, DOI 10.1073/pnas.0805291105; Yuan HH, 2013, MOL NEUROBIOL, V47, P117, DOI 10.1007/s12035-012-8332-3; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	52	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132636	10.1371/journal.pone.0132636	http://dx.doi.org/10.1371/journal.pone.0132636			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167908	gold, Green Published, Green Submitted			2022-12-27	WOS:000358193100060
J	Nagaoka, K; Matoba, T; Mao, YJ; Nakano, Y; Ikeda, G; Egusa, S; Tokutome, M; Nagahama, R; Nakano, K; Sunagawa, K; Egashira, K				Nagaoka, Kazuhiro; Matoba, Tetsuya; Mao, Yajing; Nakano, Yasuhiro; Ikeda, Gentaro; Egusa, Shizuka; Tokutome, Masaki; Nagahama, Ryoji; Nakano, Kaku; Sunagawa, Kenji; Egashira, Kensuke			A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; GLYCOGEN-SYNTHASE KINASE-3-BETA; INDUCED CARDIOMYOCYTE APOPTOSIS; CELLULAR BIOLOGY; OXIDATIVE STRESS; EUROPEAN-SOCIETY; WORKING GROUP; MICE; ISCHEMIA/REPERFUSION; MONOCYTES	Aim There is an unmet need to develop an innovative cardioprotective modality for acute myocardial infarction (AMI), for which the effectiveness of interventional reperfusion therapy is hampered by myocardial ischemia-reperfusion (IR) injury. Pretreatment with statins before ischemia is shown to reduce MI size in animals. However, no benefit was found in animals and patients with AMI when administered at the time of reperfusion, suggesting insufficient drug targeting into the IR myocardium. Here we tested the hypothesis that nanoparticle-mediated targeting of pitavastatin protects the heart from IR injury. Methods and Results In a rat IR model, poly(lactic acid/glycolic acid) (PLGA) nanoparticle incorporating FITC accumulated in the IR myocardium through enhanced vascular permeability, and in CD11b-positive leukocytes in the IR myocardium and peripheral blood after intravenous treatment. Intravenous treatment with PLGA nanoparticle containing pitavastatin (Pitavastatin-NP, 1 mg/kg) at reperfusion reduced MI size after 24 hours and ameliorated left ventricular dysfunction 4-week after reperfusion; by contrast, pitavastatin alone (as high as 10 mg/kg) showed no therapeutic effects. The therapeutic effects of Pitavastatin-NP were blunted by a PI3K inhibitor wortmannin, but not by a mitochondrial permeability transition pore inhibitor cyclosporine A. Pitavastatin-NP induced phosphorylation of Akt and GSK3 beta, and inhibited inflammation and cardiomyocyte apoptosis in the IR myocardium. Conclusions Nanoparticle-mediated targeting of pitavastatin induced cardioprotection from IR injury by activation of PI3K/Akt pathway and inhibition of inflammation and cardiomyocyte death in this model. This strategy can be developed as an innovative cardioprotective modality that may advance currently unsatisfactory reperfusion therapy for AMI.	[Nagaoka, Kazuhiro; Matoba, Tetsuya; Mao, Yajing; Nakano, Yasuhiro; Ikeda, Gentaro; Tokutome, Masaki; Sunagawa, Kenji; Egashira, Kensuke] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan; [Egusa, Shizuka; Nagahama, Ryoji; Nakano, Kaku; Egashira, Kensuke] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Res Dev & Translat Med, Fukuoka 812, Japan	Kyushu University; Kyushu University	Egashira, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan.	egashira@cardiol.med.kyushu-u.ac.jp	Ikeda, Gentaro/AAC-4164-2022	Ikeda, Gentaro/0000-0003-4019-8990; Matoba, Tetsuya/0000-0003-4563-304X	Ministry of Education, Science, and Culture, Tokyo, Japan; Health Science Research Grants (Research on Translational Research, Intractable Diseases, and Nanomedicine) from the Ministry of Health Labor and Welfare, Tokyo, Japan; Japanese Government; Sentan Medical Inc	Ministry of Education, Science, and Culture, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health Science Research Grants (Research on Translational Research, Intractable Diseases, and Nanomedicine) from the Ministry of Health Labor and Welfare, Tokyo, Japan; Japanese Government; Sentan Medical Inc	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture, Tokyo, Japan and by Health Science Research Grants (Research on Translational Research, Intractable Diseases, and Nanomedicine) from the Ministry of Health Labor and Welfare, Tokyo, Japan. Dr. Egashira reports grant support from the Japanese Government as mentioned above to conduct this study, and personal fees from Sentan Medical Inc outside the submitted work. The specific roles of these authors are articulated in the 'author contributions' section.	Acharya S, 2011, ADV DRUG DELIVER REV, V63, P170, DOI 10.1016/j.addr.2010.10.008; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Becatti M, 2012, CELL MOL LIFE SCI, V69, P2245, DOI 10.1007/s00018-012-0925-5; Bergmann MW, 2004, J MOL CELL CARDIOL, V37, P681, DOI 10.1016/j.yjmcc.2004.05.025; Chen L, 2011, HYPERTENSION, V57, P343, DOI 10.1161/HYPERTENSIONAHA.110.157032; DAUBER IM, 1990, CIRC RES, V66, P986, DOI 10.1161/01.RES.66.4.986; Downey JM, 2009, CIRC J, V73, P1171, DOI 10.1253/circj.CJ-09-0338; Egashira K, 2003, HYPERTENSION, V41, P834, DOI 10.1161/01.HYP.0000051642.65283.36; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gomez L, 2008, CIRCULATION, V117, P2761, DOI 10.1161/CIRCULATIONAHA.107.755066; Gong R, 2008, AM J TRANSPLANT, V8, P1852, DOI 10.1111/j.1600-6143.2008.02319.x; Hausenloy DJ, 2013, CARDIOVASC RES, V98, P7, DOI 10.1093/cvr/cvt004; Hayasaki T, 2006, CIRC J, V70, P342, DOI 10.1253/circj.70.342; Jones SP, 2002, J AM COLL CARDIOL, V40, P1172, DOI 10.1016/S0735-1097(02)02115-0; Jones SP, 2001, ARTERIOSCL THROM VAS, V21, P2059, DOI 10.1161/hq1201.099509; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Katsuki S, 2014, CIRCULATION, V129, P896, DOI 10.1161/CIRCULATIONAHA.113.002870; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kimura S, 2008, CIRCULATION, V118, pS65, DOI 10.1161/CIRCULATIONAHA.107.740613; Kimura S, 2009, HYPERTENSION, V53, P877, DOI 10.1161/HYPERTENSIONAHA.108.121418; Kinugawa S, 2000, CIRC RES, V87, P392; Kocsis GF, 2008, AM J PHYSIOL-HEART C, V294, pH2406, DOI 10.1152/ajpheart.00862.2007; Kubo M, 2009, ARTERIOSCL THROM VAS, V29, P796, DOI 10.1161/ATVBAHA.108.182584; Lal H, 2012, CIRCULATION, V125, P65, DOI 10.1161/CIRCULATIONAHA.111.050666; Lefer AM, 1999, CIRCULATION, V100, P178, DOI 10.1161/01.CIR.100.2.178; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Lewis EF, 2003, J AM COLL CARDIOL, V42, P1446, DOI 10.1016/S0735-1097(03)01057-X; Lin MJ, 2013, ELIFE, V2, DOI 10.7554/eLife.01295; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Matsuki A, 2006, CIRC J, V70, P1643, DOI 10.1253/circj.70.1643; Monceau V, 2006, AM J PHYSIOL-HEART C, V291, pH965, DOI 10.1152/ajpheart.01053.2005; Nagahama R, 2012, ARTERIOSCLER THROMB; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nakano K, 2009, JACC-CARDIOVASC INTE, V2, P277, DOI 10.1016/j.jcin.2008.08.023; Oda S, 2010, J VASC SURG, V52, P412, DOI 10.1016/j.jvs.2010.03.020; Okumura H, 2004, CIRCULATION, V109, P242, DOI 10.1161/01.CIR.0000109214.30211.7C; Ovize M, 2010, CARDIOVASC RES, V87, P406, DOI 10.1093/cvr/cvq129; Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025; Post S, 2012, CATHETER CARDIOVASC; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sanada S, 2004, CIRCULATION, V110, P2143, DOI 10.1161/01.CIR.0000143830.59419.73; Sitniewska EM, 2001, REGUL PEPTIDES, V96, P105, DOI 10.1016/S0167-0115(00)00131-2; Steffens S, 2009, THROMB HAEMOSTASIS, V102, P240, DOI 10.1160/TH08-12-0837; Takahama H, 2009, J AM COLL CARDIOL, V53, P709, DOI 10.1016/j.jacc.2008.11.014; Tsukie N, 2013, J ATHEROSCLER THROMB, V20, P32, DOI 10.5551/jat.13862; Tuuminen R, 2011, CIRCULATION, V124, P1138, DOI 10.1161/CIRCULATIONAHA.110.005249; Wang XL, 2007, APOPTOSIS, V12, P1209, DOI 10.1007/s10495-007-0055-y; Xi JK, 2009, EUR J PHARMACOL, V604, P111, DOI 10.1016/j.ejphar.2008.12.024; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhai PY, 2011, CIRC RES, V109, P502, DOI 10.1161/CIRCRESAHA.111.249532; Zhao ZQ, 2001, APOPTOSIS, V6, P279, DOI 10.1023/A:1011335525219	52	66	69	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132451	10.1371/journal.pone.0132451	http://dx.doi.org/10.1371/journal.pone.0132451			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167913	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000358193100044
J	Oliveira, A; Leite, M; Kluskens, LD; Santos, SB; Melo, LDR; Azeredo, J				Oliveira, Ana; Leite, Marta; Kluskens, Leon D.; Santos, Slvio B.; Melo, Luis D. R.; Azeredo, Joana			The First Paenibacillus larvae Bacteriophage Endolysin (PlyPl23) with High Potential to Control American Foulbrood	PLOS ONE			English	Article							HONEY-BEES; AGENT	Endolysins, which are peptidoglycan-degrading enzymes expressed during the terminal stage of the reproduction cycle of bacteriophages, have great potential to control Gram-positive pathogens. This work describes the characterization of a novel endolysin (PlyPl23) encoded on the genome of Paenibacillus larvae phage phiIBB_Pl23 with high potential to control American foulbrood. This bacterial disease, caused by P. larvae, is widespread in North America and Europe and causes important economic losses in apiculture. The restriction to antibiotic residues in honey imposed by the EU legislation hinders its therapeutic use to combat American foulbrood and enforces the development of alternative antimicrobial methods. The new endolysin described herein has an N-acetylmuramoyl-L-alanine amidase catalytic domain and exhibits a broad-spectrum activity against common P. larvae genotypes. Moreover, the enzyme displays high antimicrobial activity in a range of pH that matches environmental conditions (pH between 5.0 and 7.0), showing its feasible application in the field. At pH 7.0, a concentration of 0.2 mu M of enzyme was enough to lyse 10(4) CFU.mL(-1) of P. larvae in no more than 2 h. The presence of sucrose and of the substances present in the larvae gut content did not affect the enzyme activity. Interestingly, an increase of activity was observed when PlyPl23 was previously incubated in royal jelly. Furthermore, in vivo safety evaluation assays demonstrated that this enzyme is not toxic to the bee larvae. The present work describes for the first time an endolysin encoded in a P. larvae phage that presents high potential to integrate a commercial product to control the problematic American foulbrood.	[Oliveira, Ana; Leite, Marta; Kluskens, Leon D.; Santos, Slvio B.; Melo, Luis D. R.; Azeredo, Joana] Univ Minho, CEB Ctr Biol Engn, P-4710057 Braga, Portugal	Universidade do Minho	Oliveira, A (corresponding author), Univ Minho, CEB Ctr Biol Engn, P-4710057 Braga, Portugal.	anaoliveira@deb.uminho.pt	Santos, Silvio/O-5491-2015; Melo, Luís/O-5488-2015; Kluskens, Leon/J-3019-2013	Santos, Silvio/0000-0003-0801-8080; Melo, Luís/0000-0002-6865-6044; Leite, Marta/0000-0002-4438-4662; Azeredo, Joana/0000-0002-5180-7133; Oliveira, Ana/0000-0002-6477-5345; Kluskens, Leon/0000-0002-0070-7837	Portuguese FCT-Foundation for Science and Technology [UID/BIO/04469/2013]; European Community fund FEDER [FCOMP-01-0124-FEDER-007025 (PTDC/AMB/68393/2006), PEst-OE/EQB/LA0023/2013, PEST-C/FIS/UI607/2013, RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462)]; FCT-Fundacao para a Ciencia e Tecnologia [SFRH/BPD/69356/2010, SFRH/BPD/75311/2010]; Fundação para a Ciência e a Tecnologia [RECI/BBB-EBI/0179/2012, PTDC/AMB/68393/2006] Funding Source: FCT	Portuguese FCT-Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Community fund FEDER(European Commission); FCT-Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This study was supported by the Portuguese FCT-Foundation for Science and Technology (http://www.fct.pt) strategic funding of UID/BIO/04469/2013 unit and the European Community fund FEDER, through Program COMPETE, under the scope of the Projects FCOMP-01-0124-FEDER-007025 (PTDC/AMB/68393/2006), PEst-OE/EQB/LA0023/2013, PEST-C/FIS/UI607/2013, RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462). Ana Oliveira was supported by the grant SFRH/BPD/69356/2010 and Silvio B. Santos was supported by the grant SFRH/BPD/75311/2010, both from the FCT-Fundacao para a Ciencia e Tecnologia (http://www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarado I, 2013, J BACTERIOL, V195, P1005, DOI 10.1128/JB.01958-12; Aupinel Pierrick, 2005, Bulletin of Insectology, V58, P107; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beynen AC, 2003, PRINCIPLES LAB ANIMA, P219; Bilikova K, 2001, APIDOLOGIE, V32, P275, DOI 10.1051/apido:2001129; Bogdanov S., 2014, BEE PRODUCT SCI, P1; BROUWERS EVM, 1987, J APICULT RES, V26, P11, DOI 10.1080/00218839.1987.11100729; Dobbelaere W, 2001, APIDOLOGIE, V32, P363, DOI 10.1051/apido:2001136; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Fischetti VA, 2006, NAT BIOTECHNOL, V24, P1508, DOI 10.1038/nbt1206-1508; Forsgren E, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.12; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Genersch E, 2003, APIDOLOGIE, V34, P195, DOI 10.1051/apido:2003025; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Gerova M, 2011, FEMS MICROBIOL LETT, V321, P83, DOI 10.1111/j.1574-6968.2011.02312.x; Hansen H, 1999, BEE WORLD, V80, P5, DOI 10.1080/0005772X.1999.11099415; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Il'iasov R A, 2012, Zh Evol Biokhim Fiziol, V48, P425; Kaftanoglu O, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.9601; Kochansky J, 2001, APIDOLOGIE, V32, P215, DOI 10.1051/apido:2001123; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Merrill BD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-745; Oliveira A, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00438-13; Oliveira H, 2013, J VIROL, V87, P4558, DOI 10.1128/JVI.03277-12; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pujirahayu N., 2014, INT J PHARM PHARM SC, V6, P338; SACKS LE, 1961, J BACTERIOL, V82, P331, DOI 10.1128/JB.82.3.331-341.1961; Schaeffer A B, 1933, Science, V77, P194, DOI 10.1126/science.77.1990.194; Schmelcher M, 2012, FUTURE MICROBIOL, V7, P1147, DOI [10.2217/fmb.12.97, 10.2217/FMB.12.97]; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Titera D, 2003, APIACTA, V38, P131; Turck M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030403; Viuda-Martos M, 2008, J FOOD SCI, V73, pR117, DOI 10.1111/j.1750-3841.2008.00966.x; WALLER GD, 1972, ANN ENTOMOL SOC AM, V65, P857, DOI 10.1093/aesa/65.4.857; Walmagh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036991; Yue D, 2008, ENVIRON MICROBIOL, V10, P1612, DOI 10.1111/j.1462-2920.2008.01579.x	39	20	21	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132095	10.1371/journal.pone.0132095	http://dx.doi.org/10.1371/journal.pone.0132095			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167894	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100020
J	Tilson, SG; Haley, EM; Triantafillu, UL; Dozier, DA; Langford, CP; Gillespie, GY; Kim, Y				Tilson, Samantha G.; Haley, Elizabeth M.; Triantafillu, Ursula L.; Dozier, David A.; Langford, Catherine P.; Gillespie, G. Yancey; Kim, Yonghyun			ROCK Inhibition Facilitates In Vitro Expansion of Glioblastoma Stem-Like Cells	PLOS ONE			English	Article							RHO/ROCK PATHWAY; SELF-RENEWAL; MODELS; MAINTENANCE; APOPTOSIS; SURVIVAL; TUMORS; LINES	Due to their stem-like characteristics and their resistance to existing chemo-and radiation therapies, there is a growing appreciation that cancer stem cells (CSCs) are the root cause behind cancer metastasis and recurrence. However, these cells represent a small subpopulation of cancer cells and are difficult to propagate in vitro. Glioblastoma is an extremely deadly form of brain cancer that is hypothesized to have a subpopulation of CSCs called glioblastoma stem cells (GSCs; also called brain tumor initiating cells, BTICs). We propose the use of selective Rho-kinase (ROCK) inhibitors, Y-27632 and fasudil, to promote GSC/BTIC-like cell survival and propagation in vitro. ROCK inhibitors have been implicated in suppressing apoptosis, and it was hypothesized that they would increase the number of GSC/BTIC-like cells grown in vitro and improve cloning efficiencies. Indeed, our data demonstrate that transient and continuous supplementation of non-toxic concentrations of Y-27632 and fasudil inhibited apoptosis, enhanced the cells' ability to form spheres, and increased stem cell marker expressing GSC/BTIC-like cell subpopulation. Our data indicated that pharmacological and genetic (siRNA) inhibitions of the ROCK pathway facilitates in vitro expansion of GSC/BTIC-like cells. Thus, ROCK pathway inhibition shows promise for future optimization of CSC culture media.	[Tilson, Samantha G.; Haley, Elizabeth M.; Triantafillu, Ursula L.; Dozier, David A.; Kim, Yonghyun] Univ Alabama, Dept Chem & Biol Engn, Tuscaloosa, AL 35401 USA; [Langford, Catherine P.; Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA	University of Alabama System; University of Alabama Tuscaloosa; University of Alabama System; University of Alabama Birmingham	Kim, Y (corresponding author), Univ Alabama, Dept Chem & Biol Engn, Tuscaloosa, AL 35401 USA.	ykim@eng.ua.edu	Kim, John/A-7234-2008	Kim, John/0000-0001-6344-1258; Muccilli, Samantha/0000-0001-6318-5784; Gillespie, George/0000-0001-6436-9542	National Science Foundation [1342388]; National Institutes of Health [P20 CA151129]; Howard Hughes Medical Institute Undergraduate Science Education grant; Directorate For Engineering [1342388] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P20CA151129] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Undergraduate Science Education grant; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This material is based upon work supported by the National Science Foundation (http://www.nsf.gov) Grant 1342388 (YK) and National Institutes of Health (http://www.nih.gov) Grant P20 CA151129 (GYG). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation or the National Institutes of Health. The authors are also grateful for the support from the 2010 Howard Hughes Medical Institute Undergraduate Science Education grant to The University of Alabama (http://bsc.ua.edu/howard-hughes-medical-institute-program/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Asin L, 2012, PHARM RES-DORDR, V29, P1319, DOI 10.1007/s11095-012-0710-z; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Carlson Brett L, 2011, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1416s52; Castro DJ, 2013, STEM CELLS, V31, P12, DOI 10.1002/stem.1224; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Flavahan WA, 2013, NAT NEUROSCI, V16, P1373, DOI 10.1038/nn.3510; Friedman GK, 2009, J NEURO-ONCOL, V95, P199, DOI 10.1007/s11060-009-9926-0; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Heddleston JM, 2011, CURR PHARM DESIGN, V17, P2386; Hulikova A, 2013, J CELL PHYSIOL, V228, P743, DOI 10.1002/jcp.24221; Joo KM, 2013, CELL REP, V3, P260, DOI 10.1016/j.celrep.2012.12.013; Kim Yonghyun, 2009, Int J Stem Cells, V2, P109; Kim Y, 2012, LAB INVEST, V92, P466, DOI 10.1038/labinvest.2011.161; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Krawetz RJ, 2009, BIOESSAYS, V31, P336, DOI 10.1002/bies.200800157; Lau CL, 2011, BRIT J PHARMACOL, V163, P533, DOI 10.1111/j.1476-5381.2011.01259.x; Lau CL, 2012, J CELL PHYSIOL, V227, P1199, DOI 10.1002/jcp.22838; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Merchant TE, 2008, PEDIATR BLOOD CANCER, V51, P110, DOI 10.1002/pbc.21530; Ohata H, 2012, CANCER RES, V72, P5101, DOI 10.1158/0008-5472.CAN-11-3812; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Rattan R, 2006, J NEUROSCI RES, V83, P243, DOI 10.1002/jnr.20707; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Routhier A, 2010, ONCOL REP, V23, P861, DOI 10.3892/or_00000708; Santini R, 2014, ONCOGENE, V33, P4697, DOI 10.1038/onc.2014.71; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2003, CANCER RES, V63, P5821; Vanner RJ, 2014, CANCER CELL, V26, P33, DOI 10.1016/j.ccr.2014.05.005; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	35	23	25	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132823	10.1371/journal.pone.0132823	http://dx.doi.org/10.1371/journal.pone.0132823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167936	gold, Green Published, Green Submitted			2022-12-27	WOS:000358193100085
J	Dugravot, A; Sabia, S; Shipley, MJ; Welch, C; Kivimaki, M; Singh-Manoux, A				Dugravot, Aline; Sabia, Severine; Shipley, Martin J.; Welch, Catherine; Kivimaki, Mika; Singh-Manoux, Archana			Detection of Outliers Due to Participants' Non-Adherence to Protocol in a Longitudinal Study of Cognitive Decline	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALZHEIMERS-DISEASE; LATE MIDLIFE; PERFORMANCE; REDUCTION; PROFILE; RESERVE; COHORT; HEALTH; AGE	Background Participants' non adherence to protocol affects data quality. In longitudinal studies, this leads to outliers that can be present at the level of the population or the individual. The purpose of the present study is to elaborate a method for detection of outliers in a study of cognitive ageing. Methods In the Whitehall II study, data on a cognitive test battery have been collected in 1997-99, 2002-04, 2007-09 and 2012-13. Outliers at the 2012-13 wave were identified using a 4-step procedure: (1) identify cognitive tests with potential non-adherence to protocol, (2) choose a prediction model between a simple model with socio-demographic covariates and one that also includes health behaviours and health measures, (3) define an outlier using a studentized residual, and (4) study the impact of exclusion of outliers by estimating the effect of age and diabetes on cognitive decline. Results 5516 participants provided cognitive data in 2012-13. Comparisons of rates of annual decline over the first three and all four waves of data suggested outliers in three of the 5 tests. Mean residuals for the 2012-13 wave were larger for the basic compared to the more complex prediction model (all p<0.001), leading us to use the latter for the identification of outliers. Residuals greater than two standard deviation of residuals identified approximately 7% of observations as being outliers. Removal of these observations from the analyses showed that both age and diabetes had associations with cognitive decline similar to that observed with the first three waves of data; these associations were weaker or absent in non-cleaned data. Conclusions Identification of outliers is important as they obscure the effects of known risk factor and introduce bias in the estimates of cognitive decline. We showed that an informed approach, using the range of data collected in a longitudinal study, may be able to identify outliers.	[Dugravot, Aline; Sabia, Severine; Singh-Manoux, Archana] INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France; [Dugravot, Aline; Singh-Manoux, Archana] Univ Paris 11, Le Kremlin Bicetre, France; [Sabia, Severine; Shipley, Martin J.; Welch, Catherine; Kivimaki, Mika; Singh-Manoux, Archana] UCL, Dept Epidemiol & Publ Hlth, London, England; [Sabia, Severine] Univ Versailles St Quentin, Versailles, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; UDICE-French Research Universities; Universite Paris Saclay	Singh-Manoux, A (corresponding author), INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France.	Archana.Singh-Manoux@inserm.fr	Singh-Manoux, Archana/F-6804-2013; Sabia, Séverine/G-2966-2017; Kivimaki, Mika/B-3607-2012	Singh-Manoux, Archana/0000-0002-1244-5037; Sabia, Séverine/0000-0003-3109-9720; Kivimaki, Mika/0000-0002-4699-5627; Welch, Catherine/0000-0002-6687-964X; Dugravot, Aline/0000-0002-4546-0970	US National Institutes of Health [R01AG013196, R01AG034454, R01HL036310]; UK Medical Research Council [K013351]; Economic and Social Research Council; British Heart Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196, R01AG034454] Funding Source: NIH RePORTER; British Heart Foundation [RG/13/2/30098] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1] Funding Source: researchfish; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the US National Institutes of Health (R01AG013196; R01AG034454, R01HL036310), the UK Medical Research Council (K013351), and the Economic and Social Research Council. MJS is partly funded by the British Heart Foundation.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Balding DJ, 2004, APPL LONGITUDINAL AN; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Britton A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-83; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; DIXON WJ, 1950, ANN MATH STAT, V21, P488, DOI 10.1214/aoms/1177729747; Dodd S, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-84; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Ferrer E, 2004, PSYCHOL AGING, V19, P243, DOI 10.1037/0882-7974.19.2.243; Ferrie JE, 2006, INT J EPIDEMIOL, V35, P1532, DOI 10.1093/ije/dyl184; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gavin JR, 1997, DIABETES CARE, V20, P1183; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Heim A.W., 1970, AH 4 GROUP TEST GEN; Jokela M, 2010, PSYCHOL MED, V40, P837, DOI 10.1017/S0033291709991024; Kaffashian S, 2011, EUR HEART J, V32, P2326, DOI 10.1093/eurheartj/ehr133; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; McClure FD, 2003, J AOAC INT, V86, P1045; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Rabbitt P, 2001, NEUROPSYCHOLOGIA, V39, P532, DOI 10.1016/S0028-3932(00)00099-3; Rabbitt P, 2008, J GERONTOL B-PSYCHOL, V63, pP235, DOI 10.1093/geronb/63.4.P235; Raven J.C., 1958, GUIDE USING MILL HIL; Sabia S, 2009, AM J EPIDEMIOL, V170, P428, DOI 10.1093/aje/kwp161; Singh-Manoux A, 2003, J AM GERIATR SOC, V51, P1445, DOI 10.1046/j.1532-5415.2003.51464.x; Singh-Manoux A, 2008, EUR HEART J, V29, P2100, DOI 10.1093/eurheartj/ehn298; Singh-Manoux A, 2011, ANN NEUROL, V70, P296, DOI 10.1002/ana.22391; Singh-Manoux A, 2010, J CLIN PSYCHIAT, V71, P1379, DOI 10.4088/JCP.09m05349gry; Solomon A, 2014, J INTERN MED, V275, P229, DOI 10.1111/joim.12178; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Ware J., 1993, SF 36 HLTH SURVEY MA; Watson R, 2008, PSYCHOL MED, V38, P575, DOI 10.1017/S003329170800281X; Welch C, 2012, PHARMACOEPIDEM DR S, V21, P725, DOI 10.1002/pds.2270	34	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132110	10.1371/journal.pone.0132110	http://dx.doi.org/10.1371/journal.pone.0132110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161552	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300094
J	Hu, Z; Zaman, MJ; Wang, JJ; Peacock, JL; Chen, RL				Hu, Zhi; Zaman, M. Justin; Wang, Jingjing; Peacock, Janet L.; Chen, Ruoling			Correlates of Untreated Hypercholesterolemia in Older Adults: A Community-Based Household Survey in China	PLOS ONE			English	Article							EUROPEAN COUNTRIES; LOWERING DRUGS; DISEASE; CHOLESTEROL; HEALTH; RISK; TRANSITION; DEPRESSION; DEMENTIA; PEOPLE	Hypercholesterolemia is common in older adults and less treated, but little is known about correlates of untreated hypercholesterolemia. Using a standard interview method we examined a random sample of 7,572 participants aged >= 60 years in a community-based household survey across 7 provinces of China during 2007-2012, and documented 328 cases of hypercholesterolemia from self-reported doctor diagnosis. Compared to participants with normal cholesterol, older adults with hypercholesterolemia had higher socioeconomic position and larger body mass index. In patients with hypercholesterolemia, 209 were not treated using lipid-lowering medications (63.7%, 95% confidence interval (CI) 58.5%-68.9%). Untreated hypercholesterolemia was significantly associated with female sex (adjusted odds ratio 2.13, 95%CI 1.17-3.89), current smoking (3.48, 1.44-8.44), heavy alcohol drinking (3.13, 1.11-8.84), chronic bronchitis (2.37, 1.14-4.90) and high level of meat consumptions (2.85, 1.22-6.65). Although having coronary heart disease exposed participants for treatment, half of participants with coronary heart disease did not receive lipid-lowering medications. Among hypercholesterolemia participants with stroke, hypertension or diabetes, more than half of them did not receive lipid-lowering medications. The high proportion of untreated hypercholesterolemia in older, high-risk Chinese adults needs to be mitigated through multi-faceted primary and secondary prevention strategies to increase population opportunities of treating hypercholesterolemia.	[Hu, Zhi; Wang, Jingjing] Anhui Med Univ, Sch Hlth Adm, Hefei, Peoples R China; [Zaman, M. Justin] James Paget Univ Hosp, Gorleston On Sea, Norfolk, England; [Zaman, M. Justin] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Peacock, Janet L.] Kings Coll London, Div Hlth & Social Care Res, London, England; [Peacock, Janet L.] NIHR Biomed Resaerch Ctr, London, England; [Peacock, Janet L.] Guys & St Thomas NHS Fdn Trust, London, England; [Peacock, Janet L.] Kings Coll London, London, England; [Chen, Ruoling] Wolverhampton Univ, Fac Educ Hlth & Wellbeing, Ctr Hlth & Social Care Improvement, Wolverhampton WV1 1DJ, W Midlands, England; [Chen, Ruoling] Wolverhampton Univ, Post Grad Acad Inst Med, Wolverhampton WV1 1DJ, W Midlands, England	Anhui Medical University; University of East Anglia; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Wolverhampton; University of Wolverhampton	Chen, RL (corresponding author), Wolverhampton Univ, Fac Educ Hlth & Wellbeing, Ctr Hlth & Social Care Improvement, Wolverhampton WV1 1DJ, W Midlands, England.	r.chen@wlv.ac.uk		Chen, Ruoling/0000-0002-3033-8753; Peacock, Janet/0000-0002-0310-2518	BUPA Foundation [45NOV06, TBF-M09-05]; Alzheimer's Research UK [ART/PPG2007B/2]; Anhui Province Natural Science Fund, China	BUPA Foundation; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Anhui Province Natural Science Fund, China	The data collection of this study was funded by research grants from the BUPA Foundation (Grants Nos. 45NOV06, and TBF-M09-05), the Alzheimer's Research UK (Grants Nos. ART/PPG2007B/2) and Anhui Province Natural Science Fund, China. The sponsors of the study had no role in study design, data analysis, data interpretation or writing of the report. The opinions expressed in this report are not necessarily those of the funders.	[Anonymous], 2007, CHIN J CARDIOL, V35, P390; CHAN TYK, 1993, LANCET, V342, P1532, DOI 10.1016/S0140-6736(05)80091-1; Chen RL, 2005, ARCH INTERN MED, V165, P2019, DOI 10.1001/archinte.165.17.2019; Chen RL, 2005, EUR J EPIDEMIOL, V20, P141, DOI 10.1007/s10654-004-4498-y; Chen RL, 2013, BRIT J PSYCHIAT, V203, P203, DOI 10.1192/bjp.bp.112.119354; Copeland JRM, 2002, INT J GERIATR PSYCH, V17, P729, DOI 10.1002/gps.667; Feng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114139; Gupta A, 2010, ADV THER, V27, P348, DOI 10.1007/s12325-010-0033-6; Hu Da-Yi, 2008, Zhonghua Nei Ke Za Zhi, V47, P723; Kotseva K, 2009, EUR J CARDIOV PREV R, V16, P121, DOI 10.1097/HJR.0b013e3283294b1d; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Lemaitre RN, 1998, ARCH INTERN MED, V158, P1761, DOI 10.1001/archinte.158.16.1761; Mannu GS, 2013, CURR CARDIOL REV, V9, P2, DOI 10.2174/1573403X11309010002; Mantel-Teeuwisse AK, 2004, BRIT J CLIN PHARMACO, V58, P310, DOI 10.1111/j.1365-2125.2004.02152.x; Mantel-Teeuwisse AK, 2003, BRIT J CLIN PHARMACO, V55, P389, DOI 10.1046/j.1365-2125.2003.01769.x; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Omran AR, 2005, MILBANK Q, V83, P731, DOI 10.1111/j.1468-0009.2005.00398.x; Poston DL, 2000, J FAM ISSUES, V21, P714, DOI 10.1177/019251300021006003; Primatesta P, 2006, CLIN ENDOCRINOL, V64, P292, DOI 10.1111/j.1365-2265.2006.02459.x; Primatesta P, 2000, BMJ-BRIT MED J, V321, P1322, DOI 10.1136/bmj.321.7272.1322; Prince MJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-219; Region WWP, 2013, CARDIOVASCULAR DIS; Sheng X, 2012, EUR J CLIN PHARMACOL, V68, P1201, DOI 10.1007/s00228-012-1234-5; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067611; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423	28	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131318	10.1371/journal.pone.0131318	http://dx.doi.org/10.1371/journal.pone.0131318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161751	Green Submitted, gold, Green Published			2022-12-27	WOS:000358162300036
J	Page, AP; Yergeau, E; Greer, CW				Page, Antoine P.; Yergeau, Etienne; Greer, Charles W.			Salix purpurea Stimulates the Expression of Specific Bacterial Xenobiotic Degradation Genes in a Soil Contaminated with Hydrocarbons	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; PLANT-ROOT EXTRACTS; POLYCHLORINATED-BIPHENYLS; PHYTOREMEDIATION SYSTEM; PAH DEGRADATION; CO2 EVOLUTION; CROP PLANTS; RHIZOSPHERE; BIODEGRADATION; METABOLISM	The objectives of this study were to uncover Salix purpurea-microbe xenobiotic degradation systems that could be harnessed in rhizoremediation, and to identify microorganisms that are likely involved in these partnerships. To do so, we tested S. purpurea's ability to stimulate the expression of 10 marker microbial oxygenase genes in a soil contaminated with hydrocarbons. In what appeared to be a detoxification rhizosphere effect, transcripts encoding for alkane 1-monooxygenases, cytochrome P450 monooxygenases, laccase/polyphenol oxidases, and biphenyl 2,3-dioxygenase small subunits were significantly more abundant in the vicinity of the plant's roots than in bulk soil. This gene expression induction is consistent with willows' known rhizoremediation capabilities, and suggests the existence of S. purpurea-microbe systems that target many organic contaminants of interest (i.e. C4-C16 alkanes, fluoranthene, anthracene, benzo(a)pyrene, biphenyl, polychlorinated biphenyls). An enhanced expression of the 4 genes was also observed within the bacterial orders Actinomycetales, Rhodospirillales, Burkholderiales, Alteromonadales, Solirubrobacterales, Caulobacterales, and Rhizobiales, which suggest that members of these taxa are active participants in the exposed partnerships. Although the expression of the other 6 marker genes did not appear to be stimulated by the plant at the community level, signs of additional systems that rest on their expression by members of the orders Solirubrobacterales, Sphingomonadales, Actinomycetales, and Sphingobacteriales were observed. Our study presents the first transcriptomics-based identification of microbes whose xenobiotic degradation activity in soil appears stimulated by a plant. It paints a portrait that contrasts with the current views on these consortia's composition, and opens the door for the development of laboratory test models geared towards the identification of root exudate characteristics that limit the efficiency of current willow-based rhizoremediation applications.	[Page, Antoine P.; Greer, Charles W.] McGill Univ, Dept Nat Resource Sci, Montreal, PQ, Canada; [Yergeau, Etienne; Greer, Charles W.] Natl Res Council Canada, Energy Min & Environm, Montreal, PQ, Canada	McGill University; National Research Council Canada	Page, AP (corresponding author), McGill Univ, Dept Nat Resource Sci, Montreal, PQ, Canada.	antoine.page@mcgill.ca	Yergeau, Etienne/AAZ-6145-2020; Yergeau, Etienne/B-5344-2008	Yergeau, Etienne/0000-0002-7112-3425; 	Genome Canada/Genome Quebec [2510]	Genome Canada/Genome Quebec(Genome Canada)	Genome Canada/Genome Quebec Grant 2510 (www.genomecanada.ca) (www.genomequebec.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly HAH, 2008, APPL ENVIRON MICROB, V74, P3812, DOI 10.1128/AEM.00226-08; Argus George W., 2007, Harvard Papers in Botany, V12, P335, DOI 10.3100/1043-4534(2007)12[335:SSDMAA]2.0.CO;2; Badri DV, 2013, J BIOL CHEM, V288, P4502, DOI 10.1074/jbc.M112.433300; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bell TH, 2014, ISME J, V8, P331, DOI 10.1038/ismej.2013.149; da Cunha ACB, 2012, WATER AIR SOIL POLL, V223, P4723, DOI 10.1007/s11270-012-1228-z; Bressler DC, 2000, CAN J MICROBIOL, V46, P397, DOI 10.1139/cjm-46-5-397; Ceasar SA, 2012, BIOTECHNOL LETT, V34, P995, DOI 10.1007/s10529-012-0871-1; Chen SH, 1999, ENVIRON SCI TECHNOL, V33, P435, DOI 10.1021/es9805730; Collinge DB, 2010, ANNU REV PHYTOPATHOL, V48, P269, DOI 10.1146/annurev-phyto-073009-114430; Collins PJ, 1996, APPL ENVIRON MICROB, V62, P4563, DOI 10.1128/AEM.62.12.4563-4567.1996; Cook RL, 2010, INT J PHYTOREMEDIAT, V12, P716, DOI 10.1080/15226510903390395; de Carcer DA, 2007, APPL ENVIRON MICROB, V73, P6224, DOI 10.1128/AEM.01254-07; Deavers K, 2010, ENVIRON SCI POLLUT R, V17, P1355, DOI 10.1007/s11356-010-0321-3; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dudasova H, 2012, INT BIODETER BIODEGR, V69, P23, DOI 10.1016/j.ibiod.2012.01.003; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Falchini L, 2003, SOIL BIOL BIOCHEM, V35, P775, DOI 10.1016/S0038-0717(03)00105-6; Ferro AM, 2013, INT J PHYTOREMEDIAT, V15, P232, DOI 10.1080/15226514.2012.687195; Filion M, 2008, MICROB BIOTECHNOL, V1, P463, DOI 10.1111/j.1751-7915.2008.00047.x; Fish JA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00291; Furukawa K, 2008, J BIOSCI BIOENG, V105, P433, DOI 10.1263/jbb.105.433; Gao YZ, 2011, SOIL SCI SOC AM J, V75, P1694, DOI 10.2136/sssaj2010.0244; Gerhardt KE, 2009, PLANT SCI, V176, P20, DOI 10.1016/j.plantsci.2008.09.014; Gilbert ES, 1997, APPL ENVIRON MICROB, V63, P1933, DOI 10.1128/AEM.63.5.1933-1938.1997; Glick BR, 2010, BIOTECHNOL ADV, V28, P367, DOI 10.1016/j.biotechadv.2010.02.001; Gontia-Mishra I, 2014, BIOTECHNOL LETT, V36, P889, DOI 10.1007/s10529-014-1458-9; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Herbst FA, 2013, PROTEOMICS, V13, P2910, DOI 10.1002/pmic.201200569; Huang XD, 2004, ENVIRON POLLUT, V130, P465, DOI 10.1016/j.envpol.2003.09.031; Hultgren J, 2010, INT J PHYTOREMEDIAT, V12, P54, DOI 10.1080/15226510902767122; Ionescu M, 2009, INT BIODETER BIODEGR, V63, P667, DOI 10.1016/j.ibiod.2009.03.009; Ji YR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00058; Jiang H, 2010, BIOCHEM ENG J, V49, P277, DOI 10.1016/j.bej.2010.01.003; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kirkpatrick WD, 2008, INT J PHYTOREMEDIAT, V10, P210, DOI 10.1080/15226510801997648; Landi L, 2006, SOIL BIOL BIOCHEM, V38, P509, DOI 10.1016/j.soilbio.2005.05.021; Leigh MB, 2006, APPL ENVIRON MICROB, V72, P2331, DOI 10.1128/AEM.72.4.2331-2342.2006; Liste HH, 2006, CHEMOSPHERE, V62, P1411, DOI 10.1016/j.chemosphere.2005.05.018; Liste HH, 2006, APPL SOIL ECOL, V31, P43, DOI 10.1016/j.apsoil.2005.04.006; Luepromchai E, 2002, FEMS MICROBIOL ECOL, V41, P191, DOI 10.1111/j.1574-6941.2002.tb00980.x; Mackova M, 2009, ENVIRON SCI POLLUT R, V16, P817, DOI 10.1007/s11356-009-0240-3; Martin BC, 2014, SCI TOTAL ENVIRON, V472, P642, DOI 10.1016/j.scitotenv.2013.11.050; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mills T, 2006, J ENVIRON MANAGE, V79, P232, DOI 10.1016/j.jenvman.2005.07.005; Nie Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04968; Oger PM, 2004, MICROB ECOL, V47, P96, DOI 10.1007/s00248-003-2012-9; Panagos P, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/158764; Pandey VC, 2014, INT J ENVIRON SCI TE, V11, P241, DOI 10.1007/s13762-013-0387-9; Peng RH, 2008, FEMS MICROBIOL REV, V32, P927, DOI 10.1111/j.1574-6976.2008.00127.x; Peng RH, 2010, REV ENVIRON CONTAM T, V206, P65, DOI 10.1007/978-1-4419-6260-7_4; Peuke AD, 2005, EMBO REP, V6, P497, DOI 10.1038/sj.embor.7400445; Phillips LA, 2012, APPL SOIL ECOL, V52, P56, DOI 10.1016/j.apsoil.2011.10.009; Pieper DH, 2008, J MOL MICROB BIOTECH, V15, P121, DOI 10.1159/000121325; REINER AM, 1971, J BACTERIOL, V108, P89, DOI 10.1128/JB.108.1.89-94.1971; Rentz JA, 2005, ENVIRON POLLUT, V136, P477, DOI 10.1016/j.envpol.2004.12.034; Rentz JA, 2004, ENVIRON MICROBIOL, V6, P574, DOI 10.1111/j.1462-2920.2004.00589.x; Resnick SM, 1996, J IND MICROBIOL BIOT, V17, P438, DOI 10.1007/BF01574775; Rivera-Hoyos CM, 2013, FUNGAL BIOL REV, V27, P67, DOI 10.1016/j.fbr.2013.07.001; Rojo F, 2009, ENVIRON MICROBIOL, V11, P2477, DOI 10.1111/j.1462-2920.2009.01948.x; SEEGER M, 1995, FEMS MICROBIOL LETT, V133, P259, DOI 10.1111/j.1574-6968.1995.tb07894.x; Selifonov SA, 1996, APPL ENVIRON MICROB, V62, P507, DOI 10.1128/AEM.62.2.507-514.1996; Siciliano SD, 2003, APPL ENVIRON MICROB, V69, P483, DOI 10.1128/AEM.69.1.483-489.2003; Singer AC, 2003, ENVIRON TOXICOL CHEM, V22, P1998, DOI 10.1897/02-471; Singer AC, 2001, SOIL BIOL BIOCHEM, V33, P765, DOI 10.1016/S0038-0717(00)00224-8; Singh A, 2009, SOIL BIOL, V17, P1, DOI 10.1007/978-3-540-89621-0_1; Slater H, 2011, CHEMOSPHERE, V84, P199, DOI 10.1016/j.chemosphere.2011.04.058; Strobel BW, 2001, GEODERMA, V99, P169, DOI 10.1016/S0016-7061(00)00102-6; Techer D, 2011, SCI TOTAL ENVIRON, V409, P4489, DOI 10.1016/j.scitotenv.2011.06.049; Toussaint JP, 2012, APPL MICROBIOL BIOT, V95, P1589, DOI 10.1007/s00253-011-3824-z; Uhlik O, 2013, APPL MICROBIOL BIOT, V97, P9245, DOI 10.1007/s00253-012-4627-6; van Beilen JB, 2005, CURR OPIN BIOTECH, V16, P308, DOI 10.1016/j.copbio.2005.04.005; van Beilen JB, 2003, OIL GAS SCI TECHNOL, V58, P427, DOI 10.2516/ogst:2003026; Walker TS, 2003, PLANT PHYSIOL, V132, P44, DOI 10.1104/pp.102.019661; Xie XM, 2012, CHEMOSPHERE, V88, P1190, DOI 10.1016/j.chemosphere.2012.03.068; Yateem A, 2007, SOIL SEDIMENT CONTAM, V16, P269, DOI 10.1080/15320380701285667; Yergeau E, 2014, ISME J, V8, P344, DOI 10.1038/ismej.2013.163; Yi H, 2007, ENVIRON SCI TECHNOL, V41, P4382, DOI 10.1021/es062397y; Yoshitomi KJ, 2001, SOIL BIOL BIOCHEM, V33, P1769, DOI 10.1016/S0038-0717(01)00102-X; Yousaf S, 2010, J HAZARD MATER, V184, P523, DOI 10.1016/j.jhazmat.2010.08.067; Yuste L, 1998, J BACTERIOL, V180, P5218, DOI 10.1128/JB.180.19.5218-5226.1998; Zalesny RS, 2005, INT J PHYTOREMEDIAT, V7, P177, DOI 10.1080/16226510500214632; Zeman NR, 2013, THESIS COLORADO STAT	84	47	48	4	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132062	10.1371/journal.pone.0132062	http://dx.doi.org/10.1371/journal.pone.0132062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161539	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300088
J	Sawiak, SJ; Perumal, SR; Rudiger, SR; Matthews, L; Mitchell, NL; McLaughlan, CJ; Bawden, CS; Palmer, DN; Kuchel, T; Morton, AJ				Sawiak, Stephen J.; Perumal, Sunthara Rajan; Rudiger, Skye R.; Matthews, Loren; Mitchell, Nadia L.; McLaughlan, Clive J.; Bawden, C. Simon; Palmer, David N.; Kuchel, Timothy; Morton, A. Jennifer			Rapid and Progressive Regional Brain Atrophy in CLN6 Batten Disease Affected Sheep Measured with Longitudinal Magnetic Resonance Imaging	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; MOUSE MODEL; MUTATION; JUVENILE; MRI	Variant late-infantile Batten disease is a neuronal ceroid lipofuscinosis caused by mutations in CLN6. It is a recessive genetic lysosomal storage disease characterised by progressive neurodegeneration. It starts insidiously and leads to blindness, epilepsy and dementia in affected children. Sheep that are homozygous for a natural mutation in CLN6 have an ovine form of Batten disease Here, we used in vivo magnetic resonance imaging to track brain changes in 4 unaffected carriers and 6 affected Batten disease sheep. We scanned each sheep 4 times, between 17 and 22 months of age. Cortical atrophy in all sheep was pronounced at the baseline scan in all affected Batten disease sheep. Significant atrophy was also present in other brain regions (caudate, putamen and amygdala). Atrophy continued measurably in all of these regions during the study. Longitudinal MRI in sheep was sensitive enough to measure significant volume changes over the relatively short study period, even in the cortex, where nearly 40% of volume was already lost at the start of the study. Thus longitudinal MRI could be used to study the dynamics of progression of neurodegenerative changes in sheep models of Batten disease, as well as to assess therapeutic efficacy.	[Sawiak, Stephen J.; Morton, A. Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Sawiak, Stephen J.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England; [Perumal, Sunthara Rajan; Matthews, Loren; Kuchel, Timothy] South Australian Res & Dev Inst, Roseworthy, SA, Australia; [Rudiger, Skye R.; McLaughlan, Clive J.; Bawden, C. Simon] South Australian Hlth & Med Res Inst, Preclin Imaging & Res Labs, Gilles Plains, SA, Australia; [Mitchell, Nadia L.; Palmer, David N.] Lincoln Univ, Dept Mol Biosci, Fac Agr & Life Sci, Lincoln, New Zealand; [Mitchell, Nadia L.; Palmer, David N.] Lincoln Univ, Batten Anim Res Network, Lincoln, New Zealand	University of Cambridge; University of Cambridge; South Australian Research & Development Institute (SARDI); Lincoln University - New Zealand; Lincoln University - New Zealand	Morton, AJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge, England.	ajm41@cam.ac.uk	Morton, Jenny/AAT-8642-2020; Sawiak, Stephen J/I-8944-2012	Morton, Jenny/0000-0003-0181-6346; Sawiak, Stephen J/0000-0003-4210-9816; Mitchell, Nadia/0000-0003-4801-2804; Perumal, Raj/0000-0001-6565-445X	CHDI Inc; US National Institutes of Health [NS 40297]; Neurological Foundation of NZ; Batten Disease Support and Research Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS040297] Funding Source: NIH RePORTER	CHDI Inc; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neurological Foundation of NZ; Batten Disease Support and Research Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from CHDI Inc to AJM. Founding the sheep flock, and costs in NZ relating to the rearing and genotyping of the animals were funded by a series of grants from the US National Institutes of Health (NS 40297), Neurological Foundation of NZ and the Batten Disease Support and Research Association (DNP, NLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg L, 2000, NEUROLOGY, V54, P1069, DOI 10.1212/WNL.54.5.1069; Alroy J, 2011, THE NEURONAL CEROID, P284; [Anonymous], 2013, BIOCHIM BIOPHYS ACTA, V1832, P1793, DOI [10.1016/j.bbadis.2013.05.025, DOI 10.1016/J.BBADIS.2013.05.025]; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashburner J, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00197; Autti T, 1996, NEURORADIOLOGY, V38, P476; Autti T, 1997, NEURORADIOLOGY, V39, P371, DOI 10.1007/s002340050427; Bond M, 2013, BBA-MOL BASIS DIS, V1832, P1842, DOI 10.1016/j.bbadis.2013.01.009; Boustany RMN, 2013, NAT REV NEUROL, V9, P583, DOI 10.1038/nrneurol.2013.163; Broom MF, 1998, J MED GENET, V35, P717, DOI 10.1136/jmg.35.9.717; Davidson Beverly L., 2007, P371, DOI 10.1007/978-0-387-70909-3_23; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Guerreiro R, 2013, EUR J PAEDIATR NEURO, V17, P657, DOI 10.1016/j.ejpn.2013.04.011; Jacobsen JC, 2010, HUM MOL GENET, V19, P1873, DOI 10.1093/hmg/ddq063; Jadav RH, 2014, PEDIATR NEUROL, V50, P85, DOI 10.1016/j.pediatrneurol.2013.08.008; Jolly R D, 1976, N Z Vet J, V24, P123, DOI 10.1080/00480169.1976.34298; JOLLY RD, 1980, NEUROPATH APPL NEURO, V6, P195, DOI 10.1111/j.1365-2990.1980.tb00290.x; Karageorgos L, 2011, J INHERIT METAB DIS, V34, P209, DOI 10.1007/s10545-010-9230-3; Kessell AE, 2012, VET PATHOL, V49, P248, DOI 10.1177/0300985810395783; Kielar C, 2009, HUM MOL GENET, V18, P4066, DOI 10.1093/hmg/ddp355; Kirveskari E, 2001, J CHILD NEUROL, V16, P707, DOI 10.1177/088307380101601001; Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624; Le NMD, 2012, J CHILD NEUROL, V27, P234, DOI 10.1177/0883073811419261; Linterman KS, 2011, HUM GENE THER, V22, P1011, DOI 10.1089/hum.2011.026; Mills KL, 2014, DEV COGN NEUROS-NETH, V9, P172, DOI 10.1016/j.dcn.2014.04.004; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Mole SE, 2011, THE NEURONAL CEROID; Morton AJ, 2014, HUM MOL GENET, V23, P3375, DOI 10.1093/hmg/ddu047; Nijssen PCG, 2002, MOVEMENT DISORD, V17, P482, DOI 10.1002/mds.10104; Oswald M J, 2001, Eur J Paediatr Neurol, V5 Suppl A, P135, DOI 10.1053/ejpn.2000.0450; Oswald MJ, 2005, NEUROBIOL DIS, V20, P49, DOI 10.1016/j.nbd.2005.01.025; Palmer D., 2011, NEURONAL CEROID LIPO, P284; Palmer DN, 2013, BBA-MOL BASIS DIS, V1832, P1882, DOI 10.1016/j.bbadis.2013.05.014; Platt FM, 2014, NATURE, V510, P68, DOI 10.1038/nature13476; Rider JA, 1997, NEUROPEDIATRICS, V28, P4, DOI 10.1055/s-2007-973653; Sawiak SJ, 2013, MAGN RESON IMAGING, V31, P1522, DOI 10.1016/j.mri.2013.06.001; Simonati A, 2000, NEUROPEDIATRICS, V31, P199, DOI 10.1055/s-2000-7453; Suarez-Vega A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081072; Tammen I, 2006, BBA-MOL BASIS DIS, V1762, P898, DOI 10.1016/j.bbadis.2006.09.004; Torres PA, 2010, MOL GENET METAB, V101, P357, DOI 10.1016/j.ymgme.2010.08.006; VANHANEN SL, 1994, AM J NEURORADIOL, V15, P1443; Weber K, 2013, J CHILD NEUROL, V28, P1123, DOI 10.1177/0883073813493666; Weimer JM, 2007, BRAIN RES, V1162, P98, DOI 10.1016/j.brainres.2007.05.018; Wong AMS, 2010, BIOCHEM SOC T, V38, P1484, DOI 10.1042/BST0381484	45	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132331	10.1371/journal.pone.0132331	http://dx.doi.org/10.1371/journal.pone.0132331			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161747	Green Submitted, gold, Green Published			2022-12-27	WOS:000358162300120
J	Shanks, L; Ritmeijer, K; Piriou, E; Siddiqui, MR; Kliescikova, J; Pearce, N; Ariti, C; Muluneh, L; Masiga, J; Abebe, A				Shanks, Leslie; Ritmeijer, Koert; Piriou, Erwan; Siddiqui, M. Ruby; Kliescikova, Jarmila; Pearce, Neil; Ariti, Cono; Muluneh, Libsework; Masiga, Johnson; Abebe, Almaz			Accounting for False Positive HIV Tests: Is Visceral Leishmaniasis Responsible?	PLOS ONE			English	Article							ALGORITHMS; INFECTION; DIAGNOSIS	Background Co-infection with HIV and visceral leishmaniasis is an important consideration in treatment of either disease in endemic areas. Diagnosis of HIV in resource-limited settings relies on rapid diagnostic tests used together in an algorithm. A limitation of the HIV diagnostic algorithm is that it is vulnerable to falsely positive reactions due to cross reactivity. It has been postulated that visceral leishmaniasis (VL) infection can increase this risk of false positive HIV results. This cross sectional study compared the risk of false positive HIV results in VL patients with non-VL individuals. Methodology/Principal Findings Participants were recruited from 2 sites in Ethiopia. The Ethiopian algorithm of a tiebreaker using 3 rapid diagnostic tests (RDTs) was used to test for HIV. The gold standard test was the Western Blot, with indeterminate results resolved by PCR testing. Every RDT screen positive individual was included for testing with the gold standard along with 10% of all negatives. The final analysis included 89 VL and 405 non-VL patients. HIV prevalence was found to be 12.8% (47/367) in the VL group compared to 7.9% (200/2526) in the non-VL group. The RDT algorithm in the VL group yielded 47 positives, 4 false positives, and 38 negatives. The same algorithm for those without VL had 200 positives, 14 false positives, and 191 negatives. Specificity and positive predictive value for the group with VL was less than the non-VL group; however, the difference was not found to be significant (p = 0.52 and p = 0.76, respectively). Conclusion The test algorithm yielded a high number of HIV false positive results. However, we were unable to demonstrate a significant difference between groups with and without VL disease. This suggests that the presence of endemic visceral leishmaniasis alone cannot account for the high number of false positive HIV results in our study.	[Shanks, Leslie; Ritmeijer, Koert; Piriou, Erwan; Kliescikova, Jarmila; Masiga, Johnson] Med Sans Frontieres, Amsterdam, Netherlands; [Siddiqui, M. Ruby] Med Sans Frontieres, London, England; [Pearce, Neil; Ariti, Cono] London Sch Hyg & Trop Med, London WC1, England; [Muluneh, Libsework; Abebe, Almaz] Ethiopian Hlth & Nutr Res Inst, Addis Ababa, Ethiopia	Doctors Without Borders; Doctors Without Borders; University of London; London School of Hygiene & Tropical Medicine; Ethiopian Health & Nutrition Research Institute	Shanks, L (corresponding author), Med Sans Frontieres, Amsterdam, Netherlands.	leslie.shanks@amsterdam.msf.org		Pearce, Neil/0000-0002-9938-7852; Siddiqui, Ruby/0000-0002-9638-594X				Aghokeng AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007702; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Diro E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002869; Gray RH, 2007, BRIT MED J, V335, P188, DOI 10.1136/bmj.39210.582801.BE; Klarkowski D, 2014, EXPERT REV ANTI-INFE, V12, P49, DOI 10.1586/14787210.2014.866516; Klarkowski D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081656; Klarkowski DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004351; Kroidl I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039529; Lejon V, 2010, J CLIN MICROBIOL, V48, P2836, DOI 10.1128/JCM.00456-10; Mehra Bhanu, 2014, ISRN AIDS, V2014, P296840, DOI 10.1155/2014/296840; RIBEIRO TT, 1993, J ACQ IMMUN DEF SYND, V6, P319; Ritmeijer K, 2011, CLIN INFECT DIS, V53, pE152, DOI 10.1093/cid/cir674; Salinas A, 2007, CLIN INFECT DIS, V45, P139, DOI 10.1086/518709; Sandler SG, 1988, AIDS ETIOLOGY DIAGNO, P121; Shanks L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0769-3; Shanks L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059906; World Health Organization, 2012, SERV DEL APPR HIV TE; Zeh C, 2011, J VIROL METHODS, V176, P24, DOI 10.1016/j.jviromet.2011.05.021; Zijlstra EE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003258	19	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132422	10.1371/journal.pone.0132422	http://dx.doi.org/10.1371/journal.pone.0132422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161864	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000358162300133
J	Stamboul, K; Lorin, J; Lorgis, L; Guenancia, C; Beer, JC; Touzery, C; Rochette, L; Vergely, C; Cottin, Y; Zeller, M				Stamboul, Karim; Lorin, Julie; Lorgis, Luc; Guenancia, Charles; Beer, Jean-Claude; Touzery, Claude; Rochette, Luc; Vergely, Catherine; Cottin, Yves; Zeller, Marianne			Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE ADMA; OXIDE SYNTHASE INHIBITION; DYSFUNCTION; DISEASE; RISK; MORTALITY; IMPACT; DEATH	Background Atrial fibrillation (AF), whether silent or symptomatic, is a frequent and severe complication of acute myocardial infarction (AMI). Asymmetric dimethylarginine (ADMA), an endogenous eNOS inhibitor, is a risk factor for endothelial dysfunction. We addressed the relationship between ADMA plasma levels and AF occurrence in AMI. Methods 273 patients hospitalized for AMI were included. Continuous electrocardiographic monitoring (CEM) >= 48 hours was recorded and ADMA was measured by High Performance Liquid Chromatography on admission blood sample. Results The incidence of silent and symptomatic AF was 39(14%) and 29 (11%), respectively. AF patients were markedly older than patients without AF (approximate to 20 y). There was a trend towards higher ADMA levels in patients with symptomatic AF than in patients with silent AF or no AF (0.53 vs 0.49 and 0.49 mu mol/L, respectively, p = 0.18,). After matching on age, we found that patients with symptomatic AF had a higher heart rate on admission and a higher rate of patients with LV dysfunction (28% vs. 3%, p = 0.025). Patients who developed symptomatic AF had a higher ADMA level than patients without AF (0.53 vs. 0.43 mu mol/L; p = 0.001). Multivariate logistic regression analysis to estimate symptomatic AF occurrence showed that ADMA was independently associated with symptomatic AF (OR: 2.46 [1.21-5.00], p = 0.013) beyond history of AF, LVEF<40% and elevated HR. Conclusion We show that high ADMA level is associated with the occurrence of AF. Although no causative role can be concluded from our observational study, our work further supports the hypothesis that endothelial dysfunction is involved in the pathogenesis of AF in AMI.	[Stamboul, Karim; Lorgis, Luc; Guenancia, Charles; Beer, Jean-Claude; Touzery, Claude; Cottin, Yves] Univ Hosp, Dept Cardiol, Dijon, France; [Lorin, Julie; Rochette, Luc; Vergely, Catherine; Zeller, Marianne] Univ Burgundy, Lab Cardiometab Physiopathol & Pharmacol, UMR INSERM U866, Dijon, France	CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Zeller, M (corresponding author), Univ Burgundy, Lab Cardiometab Physiopathol & Pharmacol, UMR INSERM U866, Dijon, France.	Marianne.zeller@u-bourgogne.fr	Vergely, Catherine/L-9534-2015; Guenancia, Charles/M-5558-2013; COTTIN, YVES/ABA-4622-2020	Vergely, Catherine/0000-0003-4009-776X; Guenancia, Charles/0000-0002-3554-7714; Rochette, Luc/0000-0001-9973-8803	University Hospital of Dijon, Association de Cardiologie de Bourgogne; Agence Regionale de Sante(ARS) de Bourgogne; Conseil Regional de Bourgogne; Federation Francaise de Cardiologie (FFC); Societe Francaise de Cardiologie (SFC)	University Hospital of Dijon, Association de Cardiologie de Bourgogne; Agence Regionale de Sante(ARS) de Bourgogne(Region Bourgogne-Franche-Comte); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); Federation Francaise de Cardiologie (FFC); Societe Francaise de Cardiologie (SFC)	This work was supported by the University Hospital of Dijon, Association de Cardiologie de Bourgogne, and by grants from the Agence Regionale de Sante(ARS) de Bourgogne, Conseil Regional de Bourgogne, Federation Francaise de Cardiologie (FFC) and Societe Francaise de Cardiologie (SFC).	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Antoniades C, 2009, EUR HEART J, V30, P1142, DOI 10.1093/eurheartj/ehp061; Boger RH, 2006, ANN MED, V38, P126, DOI 10.1080/07853890500472151; Cai H, 2002, CIRCULATION, V106, P2854, DOI 10.1161/01.CIR.0000039327.11661.16; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Caplin B, 2012, ARTERIOSCL THROM VAS, V32, P1343, DOI 10.1161/ATVBAHA.112.247726; Cengel A, 2008, ACTA CARDIOL, V63, P33, DOI 10.2143/AC.63.1.2025329; Chao TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071675; Closs EI, 1997, NITRIC OXIDE-BIOL CH, V1, P65, DOI 10.1006/niox.1996.0106; Duckelmann C, 2007, ARTERIOSCL THROM VAS, V27, P2037, DOI 10.1161/ATVBAHA.107.147595; Goette A, 2012, INT J CARDIOL, V154, P141, DOI 10.1016/j.ijcard.2010.09.004; Ivanova M, 2010, CLIN CHIM ACTA, V411, P1632, DOI 10.1016/j.cca.2010.06.001; Jabre P, 2011, CIRCULATION, V123, P2094, DOI 10.1161/CIRCULATIONAHA.110.990192; Kielstein JT, 2004, CIRCULATION, V109, P172, DOI 10.1161/01.CIR.0000105764.22626.B1; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li Y, 2011, J INTERV CARD ELECTR, V32, P147, DOI 10.1007/s10840-011-9588-7; Liu HY, 2008, BIOCHEM BIOPH RES CO, V377, P884, DOI 10.1016/j.bbrc.2008.10.080; Lorin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064796; Polovina MM, 2014, CURR PHARM DES; Purohit A, 2013, CIRCULATION, V128, P1748, DOI 10.1161/CIRCULATIONAHA.113.003313; Rahman F, 2014, NAT REV CARDIOL, V11, P639, DOI 10.1038/nrcardio.2014.118; Rochette L, 2013, PHARMACOL THERAPEUT, V140, P239, DOI 10.1016/j.pharmthera.2013.07.004; Saczynski JS, 2009, AM J CARDIOL, V104, P169, DOI 10.1016/j.amjcard.2009.03.011; Schepers E, 2009, NEPHROL DIAL TRANSPL, V24, P1429, DOI 10.1093/ndt/gfn670; Schmitt J, 2009, EUR HEART J, V30, P1038, DOI 10.1093/eurheartj/ehn579; Schnabel R, 2005, CIRC RES, V97, P53, DOI 10.1161/01.RES.0000181286.44222.61; Schulze F, 2010, ATHEROSCLEROSIS, V208, P518, DOI 10.1016/j.atherosclerosis.2009.06.039; Schwedhelm E, 2011, NAT REV NEPHROL, V7, P275, DOI 10.1038/nrneph.2011.31; Sibal L, 2010, CURR CARDIOL REV, V6, P82, DOI 10.2174/157340310791162659; Stamboul K, 2014, INT J CARDIOL, V174, P611, DOI 10.1016/j.ijcard.2014.04.158; Stuhlinger MC, 2003, CIRCULATION, V108, P933, DOI 10.1161/01.CIR.0000085067.55901.89; Suda O, 2004, ARTERIOSCL THROM VAS, V24, P1682, DOI 10.1161/01.ATV.0000136656.26019.6e; Tang WHW, 2008, EUR HEART J, V29, P2506, DOI 10.1093/eurheartj/ehn360; Usui M, 1998, LIFE SCI, V62, P2425, DOI 10.1016/S0024-3205(98)00225-2; von Leitner EC, 2011, CIRCULATION, V124, P2735, DOI 10.1161/CIRCULATIONAHA.111.060541; Xia W, 2009, PACE, V32, P1562, DOI 10.1111/j.1540-8159.2009.02554.x; Youn JY, 2013, J MOL CELL CARDIOL, V62, P72, DOI 10.1016/j.yjmcc.2013.04.019; Zairis MN, 2012, HEART, V98, P860, DOI 10.1136/heartjnl-2011-301372; Zeller M, 2008, ARTERIOSCL THROM VAS, V28, P954, DOI 10.1161/ATVBAHA.108.162768	39	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131439	10.1371/journal.pone.0131439	http://dx.doi.org/10.1371/journal.pone.0131439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158510	Green Published, gold, Green Submitted			2022-12-27	WOS:000358161200030
J	Ayaru, L; Ypsilantis, PP; Nanapragasam, A; Choi, RCH; Thillanathan, A; Min-Ho, L; Montana, G				Ayaru, Lakshmana; Ypsilantis, Petros-Pavlos; Nanapragasam, Abigail; Choi, Ryan Chang-Ho; Thillanathan, Anish; Min-Ho, Lee; Montana, Giovanni			Prediction of Outcome in Acute Lower Gastrointestinal Bleeding Using Gradient Boosting	PLOS ONE			English	Article							MANAGEMENT; MORTALITY; VALIDATION; HEMORRHAGE; IMPACT; RISK	Background There are no widely used models in clinical care to predict outcome in acute lower gastrointestinal bleeding (ALGIB). If available these could help triage patients at presentation to appropriate levels of care/intervention and improve medical resource utilisation. We aimed to apply a state-of-the-art machine learning classifier, gradient boosting (GB), to predict outcome in ALGIB using non-endoscopic measurements as predictors. Methods Non-endoscopic variables from patients with ALGIB attending the emergency departments of two teaching hospitals were analysed retrospectively for training/internal validation (n=170) and external validation (n=130) of the GB model. The performance of the GB algorithm in predicting recurrent bleeding, clinical intervention and severe bleeding was compared to a multiple logic regression (MLR) model and two published MLR-based prediction algorithms (BLEED and Strate prediction rule). Results The GB algorithm had the best negative predictive values for the chosen outcomes (>88%). On internal validation the accuracy of the GB algorithm for predicting recurrent bleeding, therapeutic intervention and severe bleeding were (88%, 88% and 78% respectively) and superior to the BLEED classification (64%, 68% and 63%), Strate prediction rule (78%, 78%, 67%) and conventional MLR (74%, 74% 62%). On external validation the accuracy was similar to conventional MLR for recurrent bleeding (88% vs. 83%) and therapeutic intervention (91% vs. 87%) but superior for severe bleeding (83% vs. 71%). Conclusion The gradient boosting algorithm accurately predicts outcome in patients with acute lower gastrointestinal bleeding and outperforms multiple logistic regression based models. These may be useful for risk stratification of patients on presentation to the emergency department.	[Ayaru, Lakshmana; Nanapragasam, Abigail; Choi, Ryan Chang-Ho; Thillanathan, Anish; Min-Ho, Lee] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Gastroenterol, London, England; [Ayaru, Lakshmana; Nanapragasam, Abigail; Choi, Ryan Chang-Ho; Thillanathan, Anish; Min-Ho, Lee] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London, England; [Ypsilantis, Petros-Pavlos; Montana, Giovanni] Kings Coll London, Dept Biomed Engn, London, England	Imperial College London; Imperial College London; University of London; King's College London	Ayaru, L (corresponding author), Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Gastroenterol, London, England.	Lakshmana.ayaru@imperial.nhs.uk; giovanni.montana@kcl.ac.uk						Aoki T, 2015, CLIN GASTROENTEROL H, V13, P488, DOI 10.1016/j.cgh.2014.06.023; Austin PC, 2012, BIOMETRICAL J, V54, P657, DOI 10.1002/bimj.201100251; Barnert J, 2009, NAT REV GASTRO HEPAT, V6, P637, DOI 10.1038/nrgastro.2009.167; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Breiman L., 2017, CLASSIFICATION REGRE; Casanova R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098587; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Chen YF, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/873595; Chu A, 2008, ARTIF INTELL MED, V42, P247, DOI 10.1016/j.artmed.2007.10.003; Das A, 2003, LANCET, V362, P1261, DOI 10.1016/S0140-6736(03)14568-0; Dodd S, 2014, J AFFECT DISORDERS, V168, P284, DOI 10.1016/j.jad.2014.05.014; Dworzynski K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3412; Farrell JJ, 2005, ALIMENT PHARM THER, V21, P1281, DOI 10.1111/j.1365-2036.2005.02485.x; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gurm HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096385; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Jianjun Xie, 2010, Statistical Analysis and Data Mining, V3, P253, DOI 10.1002/sam.10079; Kalai A, 2003, P 35 ANN ACM S THEOR, P195, DOI [10.1145/780542.780573, DOI 10.1145/780542.780573]; Kollef MH, 1997, CRIT CARE MED, V25, P1125, DOI 10.1097/00003246-199707000-00011; Lanas A, 2009, AM J GASTROENTEROL, V104, P1633, DOI 10.1038/ajg.2009.164; Maroco Joao, 2011, BMC Res Notes, V4, P299, DOI 10.1186/1756-0500-4-299; Martin R, 2006, PHARMACOGENOMICS, V7, P1003, DOI 10.2217/14622416.7.7.1003; Parker Donna R, 2011, J Med Econ, V14, P279, DOI 10.3111/13696998.2011.571328; Peng SY, 2010, EUR J NEUROL, V17, P945, DOI 10.1111/j.1468-1331.2010.02955.x; Strate LL, 2008, CLIN GASTROENTEROL H, V6, P1004, DOI 10.1016/j.cgh.2008.03.021; Strate LL, 2010, CLIN GASTROENTEROL H, V8, P333, DOI 10.1016/j.cgh.2009.12.017; Strate LL, 2005, AM J GASTROENTEROL, V100, P1821, DOI 10.1111/j.1572-0241.2005.41755.x; Strate LL, 2003, ARCH INTERN MED, V163, P838, DOI 10.1001/archinte.163.7.838; Velayos FS, 2004, CLIN GASTROENTEROL H, V2, P485, DOI 10.1016/S1542-3565(04)00167-3; Venkatesh PGK, 2014, INT J COLORECTAL DIS, V29, P953, DOI 10.1007/s00384-014-1915-x; Weiss JC, 2012, P INN APPL ART INT C	32	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132485	10.1371/journal.pone.0132485	http://dx.doi.org/10.1371/journal.pone.0132485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172121	gold, Green Published, Green Submitted			2022-12-27	WOS:000358194900054
J	Hsieh, HM; Gu, SM; Shin, SJ; Kao, HY; Lin, YC; Chiu, HC				Hsieh, Hui-Min; Gu, Song-Mao; Shin, Shyi-Jang; Kao, Hao-Yun; Lin, Yi-Chieh; Chiu, Herng-Chia			Cost-Effectiveness of a Diabetes Pay-For-Performance Program in Diabetes Patients with Multiple Chronic Conditions	PLOS ONE			English	Article							PREFERENCE-BASED MEASURE; HEALTH-CARE UTILIZATION; METABOLIC SYNDROME; QUALITY; COMPLICATIONS; MORTALITY; OUTCOMES; TAIWAN; MULTIMORBIDITY; COMORBIDITY	Pay for performance (P4P) has been used as a strategy to improve quality for patients with chronic illness. Little was known whether care provided to individuals with multiple chronic conditions in a P4P program were cost-effective. This study investigated cost effectiveness of a diabetes P4P program for caring patients with diabetes alone (DM alone) and diabetes with comorbid hypertension and hyperlipidemia (DMHH) from a single payer perspective in Taiwan. Analyzing data using population-based longitudinal databases, we compared costs and effectiveness between P4P and non-P4P diabetes patient groups in two cohorts. Propensity score matching (PSM) was used to match comparable control groups for intervention groups. Outcomes included life-years, quality-adjusted life-years (QALYs), program intervention costs, cost-savings and incremental cost-effectiveness ratios (ICERs). QALYs for P4P patients and non-P4P patients were 2.80 and 2.71 for the DM alone cohort and 2.74 and 2.66 for the DMHH patient cohort. The average incremental intervention costs per QALYs was TWD$167,251 in the DM alone cohort and TWD$145,474 in the DMHH cohort. The average incremental all-cause medical costs saved by the P4P program per QALYs were TWD$434,815 in DM alone cohort and TWD$506,199 in the DMHH cohort. The findings indicated that the P4P program for both cohorts were cost-effective and the resulting return on investment (ROI) was 2.60:1 in the DM alone cohort and 3.48:1 in the DMHH cohort. We conclude that the diabetes P4P program in both cohorts enabled the long-term cost-effective use of resources and cost-savings, especially for patients with multiple comorbid conditions.	[Hsieh, Hui-Min] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan; [Gu, Song-Mao] Ctr Dis Control, Div HIV AIDS & TB, Taipei, Taiwan; [Shin, Shyi-Jang] Kaohsiung Med Univ, Ctr Lipid & Glycomed Res, Kaohsiung, Taiwan; [Shin, Shyi-Jang] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Shin, Shyi-Jang] Kaohsiung Med Univ Hosp, Div Endocrinol & Metab, Kaohsiung, Taiwan; [Kao, Hao-Yun; Lin, Yi-Chieh; Chiu, Herng-Chia] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Chiu, Herng-Chia] Natl Sun Yat Sen Univ, Dept Business Adm, Kaohsiung 80424, Taiwan	Kaohsiung Medical University; Centers For Disease Control - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Sun Yat Sen University	Chiu, HC (corresponding author), Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan.	chiu@kmu.edu.tw	Kao, Hao-Yun/AAZ-5597-2021; Hao-Yun, Kao/AGD-6394-2022	Kao, Hao-Yun/0000-0002-9390-9314; 	National Institutes of Health Grant [HD049888]; Research to Prevent Blindness; NIH Cancer Center Support (CORE) grant [CA21765]; ALSAC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049888] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NIH Cancer Center Support (CORE) grant; ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health Grant HD049888, Research to Prevent Blindness (Unrestricted Grant), a NIH Cancer Center Support (CORE) grant CA21765, and ALSAC.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Boyd CM, 2010, PUBLIC HEALTH REV, V32, P451, DOI 10.1007/BF03391611; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Chen CC, 2013, MED CARE, V51, P231, DOI 10.1097/MLR.0b013e31827da5b9; Chen TT, 2011, HEALTH SERV RES, V46, P47, DOI 10.1111/j.1475-6773.2010.01182.x; Cheng SH, 2012, MED CARE, V50, P109, DOI 10.1097/MLR.0b013e31822d5d36; Cromwell J, 2011, PAY PERFORMANC EHLTH; Curtin K, 2006, J HEALTHC MANAG, V51, P365, DOI 10.1097/00115514-200611000-00005; de Bruin SR, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-272; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; Emmert M, 2012, EUR J HEALTH ECON, V13, P755, DOI 10.1007/s10198-011-0329-8; Gillam SJ, 2012, ANN FAM MED, V10, P461, DOI 10.1370/afm.1377; Glasziou P, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-21; Gold MR, 1996, COST EFFECTIVENESS H; Greene J, 2013, HEALTH SERV RES, V48, P1415, DOI 10.1111/1475-6773.12033; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hsieh HM, 2015, MED CARE, V53, P106, DOI 10.1097/MLR.0000000000000264; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Isomaa B, 2001, DIABETOLOGIA, V44, P1148, DOI 10.1007/s001250100615; Lee TT, 2010, AM J MANAG CARE, V16, P65; Lee TA, 2007, J GEN INTERN MED, V22, P403, DOI 10.1007/s11606-007-0277-2; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Mangin D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3526; Meacock R, 2014, HEALTH ECON, V23, P1, DOI 10.1002/hec.2978; Meduru P, 2007, J GEN INTERN MED, V22, P408, DOI 10.1007/s11606-007-0310-5; Nahra TA, 2006, MED CARE RES REV, V63, p49S, DOI 10.1177/1077558705283629; Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; Pickard A Simon, 2005, Health Qual Life Outcomes, V3, P11, DOI 10.1186/1477-7525-3-11; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; Tan ECH, 2014, QUAL LIFE RES, V23, P689, DOI 10.1007/s11136-013-0502-x; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P2493, DOI 10.1001/jama.2012.5265; Torrance GW, 1987, METHODS EC EVALUATIO; Tseng LN, 2012, J FORMOS MED ASSOC, V111, P625, DOI 10.1016/j.jfma.2012.09.010; Vaghela P, 2009, DIABETES CARE, V32, P427, DOI 10.2337/dc08-1999; Weintraub WS, 2009, CIRC-CARDIOVASC QUAL, V2, P55, DOI 10.1161/CIRCOUTCOMES.108.812321; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Young BA, 2008, AM J MANAG CARE, V14, P15	45	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133163	10.1371/journal.pone.0133163	http://dx.doi.org/10.1371/journal.pone.0133163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26173086	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900142
J	Ma, XL; Sheng, ZZ; Huang, B; Qi, LH; Li, YF; Yu, KX; Liu, CX; Qin, ZM; Wang, D; Song, MX; Li, F				Ma, Xiuli; Sheng, Zizhang; Huang, Bing; Qi, Lihong; Li, Yufeng; Yu, Kexiang; Liu, Cunxia; Qin, Zhuoming; Wang, Dan; Song, Minxun; Li, Feng			Molecular Evolution and Genetic Analysis of the Major Capsid Protein VP1 of Duck Hepatitis A Viruses: Implications for Antigenic Stability	PLOS ONE			English	Article							GENOMIC SEQUENCE; SEROTYPE	The duck hepatitis A virus (DHAV), a member of the family Picornaviridae, is the major cause of outbreaks with high mortality rates in young ducklings. It has three distinctive serotypes and among them, serotypes 1 (DHAV-1) and 3 (DHAV-3) were recognized in China. To investigate evolutionary and antigenic properties of the major capsid protein VP1 of these two serotypes, a primary target of neutralizing antibodies, we determined the VP1 coding sequences of 19 DHAV-1 (spanning 2000-2012) and 11 DHAV-3 isolates (spanning 2008-2014) associated with disease outbreaks. By bioinformatics analysis of VP1 sequences of these isolates and other DHAV strains reported previously, we demonstrated that DHAV-1 viruses evolved into two genetic lineages, while DHAV-3 viruses exhibited three distinct lineages. The rate of nucleotide substitution for DHAV-1 VP1 genes was estimated to be 5.57 x 10(-4) per site per year, which was about one-third times slower than that for DHAV-3 VP1 genes. The population dynamics analysis showed an upward trend for infection of DHAV-1 viruses over time with little change observed for DHAV-3 viruses. Antigenic study of representative DHAV-1 and DHAV-3 strains covering all observed major lineages revealed no detectable changes in viral neutralization properties within the serotype, despite the lack of cross-neutralization between serotypes 1 and 3 strains. Structural analysis identified VP1 mutations in DHAV-1 and DHAV-3 viruses that underpin the observed antigenic phenotypes. Results of our experiments described here shall give novel insights into evolution and antigenicity of duck picornaviruses.	[Ma, Xiuli; Huang, Bing; Qi, Lihong; Li, Yufeng; Yu, Kexiang; Liu, Cunxia; Qin, Zhuoming; Song, Minxun; Li, Feng] Shandong Acad Agr Sci, Inst Poultry Sci, Jinan 250023, Shandong, Peoples R China; [Sheng, Zizhang] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Huang, Bing; Wang, Dan; Li, Feng] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Huang, Bing; Li, Feng] S Dakota State Univ, Dept Vet & Biomed Sci, Brookings, SD 57007 USA	Shandong Academy of Agricultural Sciences; Columbia University; South Dakota State University; South Dakota State University	Song, MX (corresponding author), Shandong Acad Agr Sci, Inst Poultry Sci, 1 Jiaoxiao Rd, Jinan 250023, Shandong, Peoples R China.	mxsong@aliyun.com; feng.li@sdstate.edu	Li, yu/HHZ-5236-2022; Qi, LI/AAF-3389-2019; Sheng, Zizhang/AFR-8049-2022	Sheng, Zizhang/0000-0002-3253-3309; Wang, Dan/0000-0002-7263-8420; Li, Feng/0000-0002-8904-2893	Shandong Provincial Natural Science Foundation [BS2009YY019]; Shandong Modern Agricultural Technology & Industry System [SDAIT-13-011-01]; Youth Scientific Research Foundation of Shandong Academy of Agricultural Sciences [2014QNZ06]; Taishan Scholar Program to Institute of Poultry Science, Chinese National Science foundation [31172355/C1806]; Agro-scientific research in the public interest [201003012]; Office of Integrative Activities [1355423] Funding Source: National Science Foundation	Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Shandong Modern Agricultural Technology & Industry System; Youth Scientific Research Foundation of Shandong Academy of Agricultural Sciences; Taishan Scholar Program to Institute of Poultry Science, Chinese National Science foundation; Agro-scientific research in the public interest; Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	The study was partially supported by funds from Shandong Provincial Natural Science Foundation (BS2009YY019), Shandong Modern Agricultural Technology & Industry System (SDAIT-13-011-01), the Youth Scientific Research Foundation of Shandong Academy of Agricultural Sciences (2014QNZ06), the Taishan Scholar Program to Institute of Poultry Science, Chinese National Science foundation (31172355/C1806), and Agro-scientific research in the public interest (201003012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Ding CY, 2007, VIROLOGY, V361, P9, DOI 10.1016/j.virol.2007.01.007; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fan W, 2011, ANIMAL HUSBANDRY VET, V43, P65; Fu Y, 2008, VET MICROBIOL, V131, P247, DOI 10.1016/j.vetmic.2008.03.011; Gray RR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-131; He R, 2009, GUANGDONG J ANIMAL V, V34, P34; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kim MC, 2007, ARCH VIROL, V152, P2059, DOI 10.1007/s00705-007-1023-0; Kim MC, 2006, J GEN VIROL, V87, P3307, DOI 10.1099/vir.0.81804-0; Lemey P, 2006, AIDS REV, V8, P125; Liu Guang-qing, 2007, Virologica Sinica, V22, P353, DOI 10.1007/s12250-007-0032-1; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Pan M, 2009, CHINESE J VET MED, V45, P13; Racaniello V.R., 2001, FIELDS VIROLOGY, P455; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Shi Shaohua, 2009, Weishengwu Xuebao, V49, P309; Su Jing-liang, 2002, Chinese Journal of Veterinary Science & Technology, V32, P15; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tseng CH, 2007, VIRUS RES, V126, P19, DOI 10.1016/j.virusres.2007.01.012; Tseng CH, 2007, VIRUS RES, V123, P190, DOI 10.1016/j.virusres.2006.09.007; Wang P, 1980, ACTA SCICENTIARUM NA, P55; Woolcock PR., 2003, DIS POULTRY CHAPTER, V11, P343, DOI DOI 10.1111/1750-3841.12436; Xu Qian, 2013, Bing Du Xue Bao, V29, P522; Yuan ShuaiZhen, 2010, Zhongguo Yufang Shouyi Xuebao / Chinese Journal of Preventive Veterinary Medicine, V32, P507	26	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132982	10.1371/journal.pone.0132982	http://dx.doi.org/10.1371/journal.pone.0132982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173145	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900112
J	Osman, A; Hitzler, WE; Ameur, A; Provost, P				Osman, Abdimajid; Hitzler, Walter E.; Ameur, Adam; Provost, Patrick			Differential Expression Analysis by RNA-Seq Reveals Perturbations in the Platelet mRNA Transcriptome Triggered by Pathogen Reduction Systems	PLOS ONE			English	Article							PROTEIN; INACTIVATION	Platelet concentrates (PCs) are prepared at blood banks for transfusion to patients in certain clinical conditions associated with a low platelet count. To prevent transfusion-transmitted infections via PCs, different pathogen reduction (PR) systems have been developed that inactivate the nucleic acids of contaminating pathogens by chemical cross-linking, a mechanism that may also affect platelets' nucleic acids. We previously reported that treatment of stored platelets with the PR system Intercept significantly reduced the level of half of the microRNAs that were monitored, induced platelet activation and compromised the platelet response to physiological agonists. Using genome-wide differential expression (DE) RNA sequencing (RNA-Seq), we now report that Intercept markedly perturbs the mRNA transcriptome of human platelets and alters the expression level of >800 mRNAs (P<0.05) compared to other PR systems and control platelets. Of these, 400 genes were deregulated with DE corresponding to fold changes (FC) >= 2. At the p-value < 0.001, as many as 147 genes were deregulated by >= 2-fold in Intercept-treated platelets, compared to none in the other groups. Finally, integrated analysis combining expression data for microRNA (miRNA) and mRNA, and involving prediction of miRNA-mRNA interactions, disclosed several positive and inverse correlations between miRNAs and mRNAs in stored platelets. In conclusion, this study demonstrates that Intercept markedly deregulates the platelet mRNA transcriptome, concomitant with reduced levels of mRNA-regulatory miRNAs. These findings should enlighten authorities worldwide when considering the implementation of PR systems, that target nucleic acids and are not specific to pathogens, for the management of blood products.	[Osman, Abdimajid] Dept Clin Chem, Linkoping, Sweden; [Osman, Abdimajid] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Hitzler, Walter E.] Johannes Gutenberg Univ Mainz, Transfus Ctr, Univ Med Ctr, D-55122 Mainz, Germany; [Ameur, Adam] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Provost, Patrick] Univ Laval, CHUQ Res Ctr, CHUL, Quebec City, PQ, Canada	Linkoping University; Johannes Gutenberg University of Mainz; Uppsala University; Laval University	Osman, A (corresponding author), Dept Clin Chem, Ingang 64, Linkoping, Sweden.	majid.osman@liu.se	Ameur, Adam/E-6207-2011; Provost, Patrick/G-2786-2010	Ameur, Adam/0000-0001-6085-6749; Provost, Patrick/0000-0002-6099-6562; Osman, Abdimajid/0000-0002-5143-8315	Regional Council of Ostergotland, Sweden [LIO-353011]; Canadian Blood Services/Canadian Institutes of Health Research (CIHR) Blood Utilization and Conservation Initiative via Health Canada [293933]	Regional Council of Ostergotland, Sweden; Canadian Blood Services/Canadian Institutes of Health Research (CIHR) Blood Utilization and Conservation Initiative via Health Canada	This work was supported by grant no. LIO-353011 from the Regional Council of Ostergotland, Sweden (to A.O.), and grant no. 293933 from the Canadian Blood Services/Canadian Institutes of Health Research (CIHR) Blood Utilization and Conservation Initiative via Health Canada (to W.E.H and P.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, 101A HER BUND JUST, V62; BOOYSE FM, 1968, BIOCHIM BIOPHYS ACTA, V166, P689, DOI 10.1016/0005-2787(68)90376-6; Butler C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009072.pub2; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kerkhoffs JLH, 2010, BRIT J HAEMATOL, V150, P209, DOI 10.1111/j.1365-2141.2010.08227.x; KIEFFER N, 1987, EUR J BIOCHEM, V164, P189, DOI 10.1111/j.1432-1033.1987.tb11010.x; Kissopoulou A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081809; Landry P, 2009, NAT STRUCT MOL BIOL, V16, P961, DOI 10.1038/nsmb.1651; Londin ER, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-3; McCloskey C, 2010, J PHYSIOL-LONDON, V588, P1399, DOI 10.1113/jphysiol.2010.188136; McCullough J, 2004, BLOOD, V104, P1534, DOI 10.1182/blood-2003-12-4443; McRedmond JP, 2004, MOL CELL PROTEOMICS, V3, P133, DOI 10.1074/mcp.M300063-MCP200; Osman A, 2015, PLATELETS, V26, P154, DOI 10.3109/09537104.2014.898178; Ple H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050746; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Schubert S, 2014, BLOOD, V124, P493, DOI 10.1182/blood-2014-04-512756; Teruel-Montoya R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102259; TSAO CH, 1971, SCAND J HAEMATOL, V8, P134; Weyrich AS, 1998, P NATL ACAD SCI USA, V95, P5556, DOI 10.1073/pnas.95.10.5556; Wollowitz S, 2001, SEMIN HEMATOL, V38, P4, DOI 10.1053/shem.2001.29495; Zhang JD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-565; Zimmerman GA, 2008, ARTERIOSCL THROM VAS, V28, pS17, DOI 10.1161/ATVBAHA.107.160218	25	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133070	10.1371/journal.pone.0133070	http://dx.doi.org/10.1371/journal.pone.0133070			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172280	gold, Green Published, Green Submitted			2022-12-27	WOS:000358194900119
J	Sampaio, J; McGarry, T; Calleja-Gonzalez, J; Saiz, SJ; del Alcazar, XSI; Balciunas, M				Sampaio, Jaime; McGarry, Tim; Calleja-Gonzalez, Julio; Jimenez Saiz, Sergio; Schelling i del Alcazar, Xavi; Balciunas, Mindaugas			Exploring Game Performance in the National Basketball Association Using Player Tracking Data	PLOS ONE			English	Article							ELITE BASKETBALL; TEAM SPORTS; MOVEMENT SYSTEMS; DECISION-MAKING; BEHAVIOR; NBA; CONSTRAINTS; STATISTICS; DYNAMICS; MODELS	Recent player tracking technology provides new information about basketball game performance. The aim of this study was to (i) compare the game performances of all-star and non all-star basketball players from the National Basketball Association (NBA), and (ii) describe the different basketball game performance profiles based on the different game roles. Archival data were obtained from all 2013-2014 regular season games (n = 1230). The variables analyzed included the points per game, minutes played and the game actions recorded by the player tracking system. To accomplish the first aim, the performance per minute of play was analyzed using a descriptive discriminant analysis to identify which variables best predict the all-star and non all-star playing categories. The all-star players showed slower velocities in defense and performed better in elbow touches, defensive rebounds, close touches, close points and pull-up points, possibly due to optimized attention processes that are key for perceiving the required appropriate environmental information. The second aim was addressed using a k-means cluster analysis, with the aim of creating maximal different performance profile groupings. Afterwards, a descriptive discriminant analysis identified which variables best predict the different playing clusters. The results identified different playing profile of performers, particularly related to the game roles of scoring, passing, defensive and all-round game behavior. Coaching staffs may apply this information to different players, while accounting for individual differences and functional variability, to optimize practice planning and, consequently, the game performances of individuals and teams.	[Sampaio, Jaime] Univ Tras Os Montes & Alto Douro, Res Ctr Sports Sci Hlth & Human Dev, CIDESD, CreativeLab Res Community, Vila Real, Portugal; [McGarry, Tim] Univ New Brunswick, Fac Kinesiol, Fredericton, NB, Canada; [Calleja-Gonzalez, Julio] Univ Basque Country, Fac Phys Activ Sport Sci, Vitoria, Spain; [Jimenez Saiz, Sergio] Univ Europea Madrid, Fac Ciencias Actividad Fis & Deporte, Madrid, Spain; [Schelling i del Alcazar, Xavi] Natl Inst Phys Educ Catalonia INEFC, Complex Syst & Sport Res Grp, Barcelona, Spain; [Balciunas, Mindaugas] Lithuanian Sports Univ, Kaunas, Lithuania	University of Tras-os-Montes & Alto Douro; University of New Brunswick; University of Basque Country; European University of Madrid; Lithuanian Sports University	Sampaio, J (corresponding author), Univ Tras Os Montes & Alto Douro, Res Ctr Sports Sci Hlth & Human Dev, CIDESD, CreativeLab Res Community, Vila Real, Portugal.	ajaime@utad.pt	Calleja-Gonzalez, Julio/AAX-3058-2021; Jiménez, Sergio L./AAD-2148-2020; Sampaio, Jaime/B-7392-2008	Jiménez, Sergio L./0000-0002-5069-6099; Sampaio, Jaime/0000-0003-2335-9991; CALLEJA GONZALEZ, JULIO MARIA/0000-0003-4878-0176	Portuguese foundation for science and technology [PEst-OE/SAU/UI4045/2015]	Portuguese foundation for science and technology(Portuguese Foundation for Science and Technology)	This study was supported by the Portuguese foundation for science and technology (PEst-OE/SAU/UI4045/2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Apostolidis N, 2004, J SPORT MED PHYS FIT, V44, P157; Ben Abdelkrim N, 2007, BRIT J SPORT MED, V41, P69, DOI 10.1136/bjsm.2006.032318; Buchheit M, 2014, J SPORT SCI, V32, P1844, DOI 10.1080/02640414.2014.942687; Correa UC, 2014, EUR J SPORT SCI, V14, P169, DOI 10.1080/17461391.2012.730063; Davids K, 2006, ADAPT BEHAV, V14, P73, DOI 10.1177/105971230601400103; Davids K, 2005, EXERC SPORT SCI REV, V33, P36; Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001; Duarte A, 2009, PERSPECTIVES COGNITI, P157; Esteves PT, 2012, J SPORT SCI, V30, P1285, DOI 10.1080/02640414.2012.707327; Esteves PT, 2011, PSYCHOL SPORT EXERC, V12, P639, DOI 10.1016/j.psychsport.2011.06.007; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldsberry K, 2012, MIT SLOAN SPORTS AN; Gomez MA, 2013, J SPORT SCI, V31, P1578, DOI 10.1080/02640414.2013.792942; Gonzalez AM, 2013, J STRENGTH COND RES, V27, P611, DOI 10.1519/JSC.0b013e31825dd2d9; Headrick J, 2012, J SPORT SCI, V30, P247, DOI 10.1080/02640414.2011.640706; Huttermann S, 2014, J EXP PSYCHOL-APPL, V20, P147, DOI 10.1037/xap0000012; Ibanez SJ, 2008, EUR J SPORT SCI, V8, P369, DOI 10.1080/17461390802261470; Karipidis A, 2001, J HUM MOVEMENT STUD, V41, P385; Kauffman S.A., 1993, ORIGINS ORDER; KOZAR B, 1994, PERCEPT MOTOR SKILL, V78, P243, DOI 10.2466/pms.1994.78.1.243; Leite NM, 2014, INT J SPORTS MED, V35, P743, DOI 10.1055/s-0033-1363237; Maheswaran R, 2012, MIT SLOAN SPORTS AN; Malarranha J, 2013, INT J PERF ANAL SPOR, V13, P377, DOI 10.1080/24748668.2013.11868655; Mangine GT, 2014, J STRENGTH COND RES, V28, P2406, DOI 10.1519/JSC.0000000000000550; Memmert D, 2007, J SPORT EXERCISE PSY, V29, P365, DOI 10.1123/jsep.29.3.365; Messersmith LL, 1931, RES QUART, V2, P57; Mikolajec K, 2013, J HUM KINET, V37, P145, DOI 10.2478/hukin-2013-0035; NBA.com, 2015, MVP NASH HIGHL ALL N; Norusis M, 2004, SPSS 13 0 GUIDE DATA; O'Donoghue P, 2010, RES METHODS SPORTS P; Pedhazur E. J., 1982, MULTIPLE REGRESSION; Perse M, 2009, COMPUT VIS IMAGE UND, V113, P612, DOI 10.1016/j.cviu.2008.03.001; Pinder RA, 2011, J SPORT EXERCISE PSY, V33, P146, DOI 10.1123/jsep.33.1.146; Remmert H, 2003, EUROPEAN J SPORT SCI, V3, P1, DOI DOI 10.1080/17461390300073311; Sampaio J., 2003, INT J PERF ANAL SPOR, V3, P40, DOI DOI 10.1080/24748668.2003.11868273; Sampaio J, 2014, SCI SPORT; Sampaio J, 2006, EUR J SPORT SCI, V6, P173, DOI 10.1080/17461390600676200; Savelsbergh G., 2013, DEV MOVEMENT COORDIN; Schelling X, 2015, J STRENGTH COND RES, V29, P368, DOI 10.1519/JSC.0000000000000642; Simenz CJ, 2005, J STRENGTH COND RES, V19, P495, DOI 10.1519/15264.1; Vilar L, 2012, SPORTS MED, V42, P1, DOI 10.2165/11596520-000000000-00000; Weast JA, 2011, Q J EXP PSYCHOL, V64, P689, DOI 10.1080/17470218.2010.523474; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672	45	94	96	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132894	10.1371/journal.pone.0132894	http://dx.doi.org/10.1371/journal.pone.0132894			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171606	Green Submitted, gold, Green Published			2022-12-27	WOS:000358194900097
J	Beringhelli, T; Gianazza, E; Maggioni, D; Scanu, S; Parravicini, C; Sensi, C; Monaco, HL; Eberini, I				Beringhelli, Tiziana; Gianazza, Elisabetta; Maggioni, Daniela; Scanu, Sandra; Parravicini, Chiara; Sensi, Cristina; Monaco, Hugo L.; Eberini, Ivano			All-Purpose Containers? Lipid-Binding Protein - Drug Interactions	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; BOVINE BETA-LACTOGLOBULIN; FATTY-ACID; BILE-ACIDS; ALPHA-1-ACID GLYCOPROTEIN; MAGNETIC-RESONANCE; SEX-DIFFERENCES; PHARMACOKINETICS; NMR; PHARMACODYNAMICS	The combined use of in vitro (F-19-NMR) and in silico (molecular docking) procedures demonstrates the affinity of a number of human calycins (lipid-binding proteins from ileum, liver, heart, adipose tissue and epidermis, and retinol-binding protein from intestine) for different drugs (mainly steroids and vastatins). Comparative evaluations on the complexes outline some of the features relevant for interaction (non-polar character of the drugs; amino acids and water molecules in the protein calyx most often involved in binding). Dissociation constants (K-i) for drugs typically lie in the same range as K-i for natural ligands; in most instances (different proteins and docking conditions), vastatins are the strongest interactors, with atorvastatin ranking top in half of the cases. The affinity of some calycins for some of the vastatins is in the order of magnitude of the drug C-max after systemic administration in humans. The possible biological implications of this feature are discussed in connection with drug delivery parameters (route of administration, binding to carrier proteins, distribution to, and accumulation in, human tissues).	[Beringhelli, Tiziana; Maggioni, Daniela; Scanu, Sandra] Politecn Milan, Dipartimento Chim, I-20133 Milan, Italy; [Gianazza, Elisabetta] Univ Milan, Dipartimento Sci Farmacol & Biomol, Grp Studio Prote & Struttura Prot, Sez Sci Farmacol, I-20133 Milan, Italy; [Parravicini, Chiara; Sensi, Cristina; Eberini, Ivano] Univ Milan, Lab Biochim & Biofis Computaz, Dipartimento Sci Farmacol & Biomol, Sez Biochim Biofis Fisiol & Immunopatol, I-20134 Milan, Italy; [Monaco, Hugo L.] Univ Verona, Dipartimento Biotecnol, I-37134 Verona, Italy	Polytechnic University of Milan; University of Milan; University of Milan; University of Verona	Gianazza, E (corresponding author), Univ Milan, Dipartimento Sci Farmacol & Biomol, Grp Studio Prote & Struttura Prot, Sez Sci Farmacol, Via Balzaretti 9, I-20133 Milan, Italy.	elisabetta.gianazza@unimi.it	Maggioni, Daniela/A-5932-2012	Maggioni, Daniela/0000-0001-5201-4824; Monaco, Hugo L./0000-0002-2067-0365	intramural grant for young researchers (Fondo di Sviluppo UNIMI, Linea B)	intramural grant for young researchers (Fondo di Sviluppo UNIMI, Linea B)	This work was supported by an intramural grant for young researchers (Fondo di Sviluppo UNIMI, Linea B) to Ivano Eberini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; Assfalg M, 2007, J MED CHEM, V50, P5257, DOI 10.1021/jm070397i; Barbiroli A, 2010, BIOL CHEM, V391, P21, DOI 10.1515/BC.2010.008; BARRE J, 1983, INT J CLIN PHARM RES, V3, P215; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; Beringhelli T, 2001, BIOCHEMISTRY-US, V40, P12604, DOI 10.1021/bi011009w; Capaldi S, 2009, J MOL BIOL, V385, P99, DOI 10.1016/j.jmb.2008.10.007; Chuang S, 2008, J MED CHEM, V51, P3755, DOI 10.1021/jm701192w; Eberini I, 2008, PROTEINS, V71, P1889, DOI 10.1002/prot.21875; Eberini I, 2008, J MOL GRAPH MODEL, V26, P1004, DOI 10.1016/j.jmgm.2007.08.006; Eberini I, 2006, PROTEINS, V65, P555, DOI 10.1002/prot.21109; Elzoghby AO, 2012, J CONTROL RELEASE, V157, P168, DOI 10.1016/j.jconrel.2011.07.031; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Gambacorti-Passerini C, 2000, JNCI-J NATL CANCER I, V92, P1641, DOI 10.1093/jnci/92.20.1641; Gandhi M, 2004, ANNU REV PHARMACOL, V44, P499, DOI [10.1146/annurev.pharmtox.44.101802.121453, 10.2165/00003088-200948030-00001]; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Guariento M, 2010, BIOCHEM J, V425, P413, DOI 10.1042/BJ20091209; Hackett MJ, 2013, ADV DRUG DELIVER REV, V65, P1331, DOI 10.1016/j.addr.2012.07.012; He Y, 2007, BIOCHEMISTRY-US, V46, P12543, DOI 10.1021/bi701092r; He Y, 2011, BIOCHEMISTRY-US, V50, P1283, DOI 10.1021/bi101307h; Huang ZQ, 2013, CURR DRUG METAB, V14, P226; Israili ZH, 2001, DRUG METAB REV, V33, P161, DOI 10.1081/DMR-100104402; Kosa T, 1997, PHARMACEUT RES, V14, P1607, DOI 10.1023/A:1012138604016; Kratz F, 2012, J CONTROL RELEASE, V161, P429, DOI 10.1016/j.jconrel.2011.11.028; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Krenzel ES, 2013, BIOCHEMISTRY-US, V52, P1559, DOI 10.1021/bi301458b; Lan H, 2011, J LIPID RES, V52, P646, DOI 10.1194/jlr.M012757; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Matsumoto Kazuaki, 2002, Drug Metab Pharmacokinet, V17, P300, DOI 10.2133/dmpk.17.300; Nichesola D, 2004, BIOCHEMISTRY-US, V43, P14072, DOI 10.1021/bi0489661; Niwa T, 2011, MASS SPECTROM REV, V30, P510, DOI 10.1002/mas.20323; NOTARIANNI LJ, 1990, CLIN PHARMACOKINET, V18, P20, DOI 10.2165/00003088-199018010-00002; Perduca M, 2000, ELECTROPHORESIS, V21, P2316, DOI 10.1002/1522-2683(20000701)21:12<2316::AID-ELPS2316>3.0.CO;2-0; Ricchiuto P, 2008, J MOL RECOGNIT, V21, P347, DOI 10.1002/jmr.908; Richter A, 2014, FEBS LETT, V588, P213, DOI 10.1016/j.febslet.2013.11.006; Ross GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032036; SCAPIN G, 1988, FEBS LETT, V240, P196, DOI 10.1016/0014-5793(88)80367-3; Schiefner A, 2015, ACCOUNTS CHEM RES, V48, P976, DOI 10.1021/ar5003973; SCHIEVANO E, 1994, BIOPOLYMERS, V34, P879, DOI 10.1002/bip.360340707; Sharma A, 2011, J BIOL CHEM, V286, P31924, DOI 10.1074/jbc.M111.270165; Skerra A, 2000, BBA-PROTEIN STRUCT M, V1482, P337, DOI 10.1016/S0167-4838(00)00145-X; Skerra A, 2008, FEBS J, V275, P2677, DOI 10.1111/j.1742-4658.2008.06439.x; Sleep D, 2013, BBA-GEN SUBJECTS, V1830, P5526, DOI 10.1016/j.bbagen.2013.04.023; Smathers Rebecca L., 2011, Human Genomics, V5, P170; Soldin OP, 2009, CLIN PHARMACOKINET, V48, P143, DOI 10.2165/00003088-200948030-00001; Storch J, 2010, J BIOL CHEM, V285, P32679, DOI 10.1074/jbc.R110.135210; Sulsky R, 2007, BIOORG MED CHEM LETT, V17, P3511, DOI 10.1016/j.bmcl.2006.12.044; Takamura N, 1997, CLIN CHEM, V43, P2274; Tochtrop GP, 2002, P NATL ACAD SCI USA, V99, P1847, DOI 10.1073/pnas.012379199; Tomaselli S, 2007, PROTEINS, V69, P177, DOI 10.1002/prot.21517; Tornaselli S, 2008, J MED CHEM, V51, P6782, DOI 10.1021/jm800820b; Vallianatou T, 2013, EXPERT OPIN DRUG DIS, V8, P583, DOI 10.1517/17460441.2013.777424; Weiss GA, 2000, CHEM BIOL, V7, pR177; Yamasaki K, 2013, BBA-GEN SUBJECTS, V1830, P5435, DOI 10.1016/j.bbagen.2013.05.005; Zhang MM, 2014, MED CHEM, V10, P339, DOI 10.2174/15734064113096660045; Zsila F, 2011, BIOINFORMATICS, V27, P1806, DOI 10.1093/bioinformatics/btr284	57	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132096	10.1371/journal.pone.0132096	http://dx.doi.org/10.1371/journal.pone.0132096			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167932	gold, Green Published, Green Submitted			2022-12-27	WOS:000358193100021
J	Nissi, MJ; Toth, F; Wang, LN; Carlson, CS; Ellermann, JM				Nissi, Mikko J.; Toth, Ferenc; Wang, Luning; Carlson, Cathy S.; Ellermann, Jutta M.			Improved Visualization of Cartilage Canals Using Quantitative Susceptibility Mapping	PLOS ONE			English	Article							HIGH-FIELD MRI; HUMAN BRAIN; IN-VIVO; EX-VIVO; PHASE; CONTRAST; VENOGRAPHY; TESLA; OSTEOCHONDROSIS; IMAGES	Purpose Cartilage canal vessels are critical to the normal function of epiphyseal (growth) cartilage and damage to these vessels is demonstrated or suspected in several important developmental orthopaedic diseases. High-resolution, three-dimensional (3-D) visualization of cartilage canals has recently been demonstrated using susceptibility weighted imaging (SWI). In the present study, a quantitative susceptibility mapping (QSM) approach is evaluated for 3-D visualization of the cartilage canals. It is hypothesized that QSM post-processing improves visualization of the cartilage canals by resolving artifacts present in the standard SWI post-processing while retaining sensitivity to the cartilage canals. Methods Ex vivo distal femoral specimens from 3- and 8-week-old piglets and a 1-month-old human cadaver were scanned at 9.4 T with a 3-D gradient recalled echo sequence suitable for SWI and QSM post-processing. The human specimen and the stifle joint of a live, 3-week-old piglet also were scanned at 7.0 T. Datasets were processed using the standard SWI method and truncated k-space division QSM approach. To compare the post-processing methods, minimum/maximum intensity projections and 3-D reconstructions of the processed datasets were generated and evaluated. Results Cartilage canals were successfully visualized using both SWI and QSM approaches. The artifactual splitting of the cartilage canals that occurs due to the dipolar phase, which was present in the SWI post-processed data, was eliminated by the QSM approach. Thus, orientation-independent visualization and better localization of the cartilage canals was achieved with the QSM approach. Combination of GRE with a mask based on QSM data further improved visualization. Conclusions Improved and artifact-free 3-D visualization of the cartilage canals was demonstrated by QSM processing of the data, especially by utilizing susceptibility data as an enhancing mask. Utilizing tissue-inherent contrast, this method allows noninvasive assessment of the vasculature in the epiphyseal cartilage in the developing skeleton and potentially increases the opportunity to diagnose disease of this tissue in the preclinical stages, when treatment likely will have increased efficacy.	[Nissi, Mikko J.; Wang, Luning; Ellermann, Jutta M.] Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Nissi, Mikko J.; Wang, Luning] Univ Minnesota, Dept Orthopaed Surg, Minneapolis, MN 55455 USA; [Nissi, Mikko J.] Univ Oulu, Res Grp Med Imaging Phys & Technol, Fac Med, Oulu, Finland; [Nissi, Mikko J.] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Nissi, Mikko J.] Univ Oulu, Oulu, Finland; [Nissi, Mikko J.] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Toth, Ferenc; Ellermann, Jutta M.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Oulu; University of Oulu; University of Oulu; University of Eastern Finland; University of Minnesota System; University of Minnesota Twin Cities	Nissi, MJ (corresponding author), Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA.	mikko.nissi@uef.fi	Wang, Luning/B-2780-2016	Nissi, Mikko/0000-0002-5678-0689; Toth, Ferenc/0000-0002-6615-389X; Ellermann, Jutta/0000-0002-7109-9656	National Institutes of Health [T32 OD010993, K18 OD010468, P41 EB015894, S10 RR026783, R21 EB009138]; Academy of Finland grant [260321]; W. M. Keck Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015894, R21EB009138] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K18OD010468, T32OD010993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland grant(Academy of Finland); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (http://www.nih.gov/): grants T32 OD010993 (CSC), K18 OD010468 (CSC), P41 EB015894, S10 RR026783, R21 EB009138; Academy of Finland (http://www.aka.fi/): grant 260321; and W. M. Keck Foundation (http://www.wmkeck.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abduljalil AM, 2003, J MAGN RESON IMAGING, V18, P284, DOI 10.1002/jmri.10362; Abosch A, 2010, NEUROSURGERY, V67, P1745, DOI 10.1227/NEU.0b013e3181f74105; Barnes SRS, 2009, MAGN RESON IMAGING C, V17, P47, DOI 10.1016/j.mric.2008.12.002; Bilgic B, 2014, MAGN RESON MED, V72, P1444, DOI 10.1002/mrm.25029; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Fan AP, 2014, MAGN RESON MED, V72, P149, DOI 10.1002/mrm.24918; Gho SM, 2014, MAGN RESON MED, V72, P337, DOI 10.1002/mrm.24920; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haines RW, 1933, J ANAT, V68, P45; Jaramillo D, 2004, AM J ROENTGENOL, V182, P353, DOI 10.2214/ajr.182.2.1820353; Lehto LJ, 2012, NEUROIMAGE, V61, P761, DOI 10.1016/j.neuroimage.2012.03.002; Liu SF, 2014, J MAGN RESON IMAGING, V40, P698, DOI 10.1002/jmri.24413; Metzger GJ, 2013, MAGN RESON MED, V69, P114, DOI 10.1002/mrm.24237; Nissi MJ, 2014, MAGN RESON MED, V71, P2197, DOI 10.1002/mrm.24863; Nissi MJ, 2013, T ORTHOP RES SOC; Nissi MJ, 2013, P INT SOC MAG RESON; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Reichenbach JR, 2000, J COMPUT ASSIST TOMO, V24, P949, DOI 10.1097/00004728-200011000-00023; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Schweser F, 2013, MAGN RESON MED, V69, P1581, DOI 10.1002/mrm.24405; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Shmueli K, 2009, MAGN RESON MED, V62, P1510, DOI 10.1002/mrm.22135; Toth F, 2013, J ORTHOP RES, V31, P2006, DOI 10.1002/jor.22449; Van De Moortele PF, 2005, MAGN RESON MED, V54, P1503, DOI 10.1002/mrm.20708; Wang MY, 2011, MAGN RESON IMAGING, V29, P365, DOI 10.1016/j.mri.2010.10.016; Wang Y, 2000, J MAGN RESON IMAGING, V12, P661, DOI 10.1002/1522-2586(200011)12:5<661::AID-JMRI2>3.3.CO;2-C; Wharton S, 2010, NEUROIMAGE, V53, P515, DOI 10.1016/j.neuroimage.2010.06.070; Wharton S, 2010, MAGN RESON MED, V63, P1292, DOI 10.1002/mrm.22334; Yao B, 2009, NEUROIMAGE, V44, P1259, DOI 10.1016/j.neuroimage.2008.10.029; Ytrehus B, 2007, VET PATHOL, V44, P429, DOI 10.1354/vp.44-4-429	32	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132167	10.1371/journal.pone.0132167	http://dx.doi.org/10.1371/journal.pone.0132167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168296	Green Submitted, Green Published, gold			2022-12-27	WOS:000358193100025
J	Xing, Y; Azati, G; Pan, CX; Dang, J; Jha, S; Liu, WY				Xing, Yan; Azati, Gulina; Pan, Cun-xue; Dang, Jun; Jha, Sailendra; Liu, Wen-ya			Improving Patient to Patient CT Value Uniformity with an Individualized Contrast Medium Protocol Tailored to Body Weight and Contrast Medium Concentration in Coronary CT Angiography	PLOS ONE			English	Article							VASCULAR ATTENUATION; COMPUTED-TOMOGRAPHY; INDUCED NEPHROPATHY; INJECTION; STENOSIS; PHANTOM	To determine whether body weight and concentration dependent contrast medium (CM) injection protocols can improve patient to patient CT value uniformity more than the conventional injection protocols with fixed injection parameters in coronary CT angiography (CCTA), one hundred and sixty patients who underwent CCTA were prospectively randomized into two groups. Group A (n = 80) used individualized-protocol with adjusted injection rate based on patient weight and contrast medium concentration to obtain constant iodine load of 280 mgI/kg while group B (n = 80) followed the conventional contrast injection protocol with total injection volume of 80ml and constant injection rate of 5.5ml/s. For both groups, patients were further divided into four subgroups with different CM concentrations: A1, B1 (300 mg I/ml); A2, B2 (320 mg I/ml); A3, B3 (350 mg I/ml) and A4 and B4 (370 mg I/ml). For each patient, the CT values of the ascending aorta, left ventricle and coronary arteries were measured. One-way analysis of variance was used to compare CT values among subgroups. Among the subgroups of A, sufficient attenuation of greater than 300HU was obtained in all target vessels with no difference among them. Among the subgroups of B, the CT values had significant difference in left ventricle, left circumflex branch, proximal and distal segment of the right coronary artery (all p < 0.05), and the attenuation with 300 mg I/ml CM concentration was significantly lower than that with 370 mg I/ml. Compared with group B, group A used less volume (62.83 ml vs. 80.00 ml, P < 0.001) and lower rate (5.21 ml/s vs. 5.50 ml/s, P < 0.001) of CM. Compared with the conventional contrast medium injection protocol with fixed volume and injection rate, the individualized-protocol based on patient weight and contrast concentration provides overall contrast dose reduction and achieves more homogenous attenuation among different coronary vessels and patients.	[Xing, Yan; Azati, Gulina; Pan, Cun-xue; Dang, Jun; Jha, Sailendra; Liu, Wen-ya] Xinjiang Med Univ, Affiliated Hosp 1, Dept Radiol, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University	Liu, WY (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Radiol, Urumqi, Xinjiang, Peoples R China.	13999202977@163.com			Urumqi Science and Technology project [Y121320019]; Xinjiang Province Natural Science Foundation [2015211C074]	Urumqi Science and Technology project; Xinjiang Province Natural Science Foundation	This study was supported by the Urumqi Science and Technology project No. Y121320019 and the Xinjiang Province Natural Science Foundation No. 2015211C074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae KT, 2010, RADIOLOGY, V256, P32, DOI 10.1148/radiol.10090908; Cademartiri F, 2005, RADIOLOGY, V236, P661, DOI 10.1148/radiol.2362040468; Fei XL, 2008, AM J ROENTGENOL, V191, P43, DOI 10.2214/AJR.07.2653; Fleischmann D, 2003, EUR J RADIOL, V45, pS88, DOI 10.1016/S0720-048X(02)00365-0; Johnson TRC, 2007, J COMPUT ASSIST TOMO, V31, P265, DOI 10.1097/01.rct.0000236421.35761.7a; Komatsu S, 2013, J CARDIOL, V62, P82, DOI 10.1016/j.jjcc.2013.03.004; Lee J, 2014, KOREAN J RADIOL, V15, P456, DOI 10.3348/kjr.2014.15.4.456; Liu J, 2013, INT J CARDIOVAS IMAG, V29, P1115, DOI 10.1007/s10554-012-0170-x; Mihl C, 2013, INVEST RADIOL, V48, P813, DOI 10.1097/RLI.0b013e31829979e8; Minsinger KD, 2014, AM J CARDIOL, V113, P49, DOI 10.1016/j.amjcard.2013.08.040; Sakai S, 2010, EUR J RADIOL, V75, P173, DOI 10.1016/j.ejrad.2009.04.022; Sun ZH, 2010, WORLD J CARDIOL, V2, P333, DOI 10.4330/wjc.v2.i10.333; Tatsugami F, 2010, ACAD RADIOL, V17, P207, DOI 10.1016/j.acra.2009.09.010; Uehara M, 2013, INT J CARDIOL, V167, P809, DOI 10.1016/j.ijcard.2012.02.017; Verburg FA, 2013, EUR J RADIOL, V82, P2348, DOI 10.1016/j.ejrad.2013.09.013	15	4	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132412	10.1371/journal.pone.0132412	http://dx.doi.org/10.1371/journal.pone.0132412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167680	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100042
J	Bai, WQ; Zhou, C; Zhao, YJ; Wang, QH; Ma, YH				Bai, Wenqin; Zhou, Cheng; Zhao, Yueju; Wang, Qinhong; Ma, Yanhe			Structural Insight into and Mutational Analysis of Family 11 Xylanases: Implications for Mechanisms of Higher pH Catalytic Adaptation	PLOS ONE			English	Article							3-DIMENSIONAL STRUCTURE; TRICHODERMA-REESEI; ALKALINE ADAPTATION; CRYSTAL-STRUCTURE; BACILLUS; EXPRESSION; INCREASES; ENDO-1,4-BETA-XYLANASE-II; ENDO-BETA-1,4-XYLANASES; THERMOSTABILITY	To understand the molecular basis of higher pH catalytic adaptation of family 11 xylanases, we compared the structures of alkaline, neutral, and acidic active xylanases and analyzed mutants of xylanase Xyn11A-LC from alkalophilic Bacillus sp. SN5. It was revealed that alkaline active xylanases have increased charged residue content, an increased ratio of negatively to positively charged residues, and decreased Ser, Thr, and Tyr residue content relative to non-alkaline active counterparts. Between strands beta 6 and beta 7, alkaline xylanases substitute an alpha-helix for a coil or turn found in their non-alkaline counterparts. Compared with non-alkaline xylanases, alkaline active enzymes have an inserted stretch of seven amino acids rich in charged residues, which may be beneficial for xylanase function in alkaline conditions. Positively charged residues on the molecular surface and ionic bonds may play important roles in higher pH catalytic adaptation of family 11 xylanases. By structure comparison, sequence alignment and mutational analysis, six amino acids (Glu16, Trp18, Asn44, Leu46, Arg48, and Ser187, numbering based on Xyn11A-LC) adjacent to the acid/base catalyst were found to be responsible for xylanase function in higher pH conditions. Our results will contribute to understanding the molecular mechanisms of higher pH catalytic adaptation in family 11 xylanases and engineering xylanases to suit industrial applications.	[Bai, Wenqin; Wang, Qinhong; Ma, Yanhe] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin 300308, Peoples R China; [Bai, Wenqin; Zhou, Cheng; Ma, Yanhe] Chinese Acad Sci, Inst Microbiol, Natl Engn Lab Ind Enzymes, Beijing 100101, Peoples R China; [Bai, Wenqin] Shanxi Normal Univ, Sch Life Sci, Linfen 041004, Peoples R China; [Zhao, Yueju] Chinese Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Beijing 100193, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Shanxi Normal University; Chinese Academy of Agricultural Sciences	Bai, WQ (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin 300308, Peoples R China.	bai_wq@tib.cas.cn; ma_yh@tib.cas.cn	MA, YAN/HHN-2912-2022; Zhou, Cheng/Q-4416-2018	Zhou, Cheng/0000-0001-9720-9318	Natural Science Foundation of China [31400679]; Key Deployment Program of Chinese Academy of Sciences [KSZD-EW-Z-015]; National High Technology Research and Development Program of China [2012AA022203]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Deployment Program of Chinese Academy of Sciences; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This study was supported by the Natural Science Foundation of China (31400679), the Key Deployment Program of Chinese Academy of Sciences (KSZD-EW-Z-015) and the National High Technology Research and Development Program of China (863 Program, 2012AA022203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Balaa B, 2006, BIOSCI BIOTECH BIOCH, V70, P269, DOI 10.1271/bbb.70.269; Bai WQ, 2015, BIOTECHNOL APPL BIOC, V62, P208, DOI 10.1002/bab.1265; Bai WQ, 2014, BIOTECHNOL LETT, V36, P1495, DOI 10.1007/s10529-014-1512-7; Bai WQ, 2012, BIOTECHNOL LETT, V34, P2093, DOI 10.1007/s10529-012-1011-7; Balakrishnan H, 2002, J Biochem Mol Biol Biophys, V6, P325, DOI 10.1080/1025814021000003229; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Berrin JG, 2008, BIOTECHNOL LETT, V30, P1139, DOI 10.1007/s10529-008-9669-6; Besir H, 2005, FEBS LETT, V579, P6595, DOI 10.1016/j.febslet.2005.10.052; BIELY P, 1985, TRENDS BIOTECHNOL, V3, P286, DOI 10.1016/0167-7799(85)90004-6; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Dubnovitsky AP, 2005, PROTEIN SCI, V14, P97, DOI 10.1110/ps.041029805; Esteves FD, 2004, PROTEIN SCI, V13, P1209, DOI 10.1110/ps.03556104; Fushinobu S, 1998, PROTEIN ENG, V11, P1121, DOI 10.1093/protein/11.12.1121; Georis J, 2000, PROTEIN SCI, V9, P466; Georis J, 2000, ENZYME MICROB TECH, V26, P178, DOI 10.1016/S0141-0229(99)00141-6; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hakulinen N, 2003, EUR J BIOCHEM, V270, P1399, DOI 10.1046/j.1432-1033.2003.03496.x; He J, 2009, NEW BIOTECHNOL, V26, P53, DOI 10.1016/j.nbt.2009.04.002; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; ITO K, 1992, BIOSCI BIOTECH BIOCH, V56, P547, DOI 10.1271/bbb.56.547; Joshi MD, 2000, J MOL BIOL, V299, P255, DOI 10.1006/jmbi.2000.3722; Joshi MD, 2001, BIOCHEMISTRY-US, V40, P10115, DOI 10.1021/bi0105429; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Krengel U, 1996, J MOL BIOL, V263, P70, DOI 10.1006/jmbi.1996.0556; Liu XM, 2002, J MOL CATAL B-ENZYM, V18, P307, DOI 10.1016/S1381-1177(02)00111-X; Mamo G, 2009, BIOCHIMIE, V91, P1187, DOI 10.1016/j.biochi.2009.06.017; Manikandan K, 2006, PROTEIN SCI, V15, P1951, DOI 10.1110/ps.062220206; McIntosh LP, 1996, BIOCHEMISTRY-US, V35, P9958, DOI 10.1021/bi9613234; Michaux C, 2010, BIOCHIMIE, V92, P1407, DOI 10.1016/j.biochi.2010.07.003; Nielsen JE, 2003, PROTEIN SCI, V12, P1894, DOI 10.1110/ps.03114903; Nielsen JE, 2001, PROTEIN ENG, V14, P505, DOI 10.1093/protein/14.7.505; Oakley AJ, 2003, ACTA CRYSTALLOGR D, V59, P627, DOI 10.1107/S0907444903001227; Poon DKY, 2003, CARBOHYD RES, V338, P415, DOI 10.1016/S0008-6215(02)00486-X; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ruller R, 2006, BIOTECHNOL APPL BIOC, V43, P9, DOI 10.1042/BA20050016; RUSSELL AJ, 1987, NATURE, V328, P496, DOI 10.1038/328496a0; RZHETSKY A, 1993, MOL BIOL EVOL, V10, P1073; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shirai T, 1997, PROTEIN ENG, V10, P627, DOI 10.1093/protein/10.6.627; Shirai T, 2001, J MOL BIOL, V310, P1079, DOI 10.1006/jmbi.2001.4835; Shiraki K, 2002, EUR J BIOCHEM, V269, P4152, DOI 10.1046/j.1432-1033.2002.03110.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x; TORRONEN A, 1995, BIOCHEMISTRY-US, V34, P847, DOI 10.1021/bi00003a019; Torronen A, 1997, J BIOTECHNOL, V57, P137, DOI 10.1016/S0168-1656(97)00095-3; Turunen O, 2002, PROTEIN ENG, V15, P141, DOI 10.1093/protein/15.2.141; Turunen O, 2001, J BIOTECHNOL, V88, P37, DOI 10.1016/S0168-1656(01)00253-X; Umemoto H, 2009, BIOSCI BIOTECH BIOCH, V73, P965, DOI 10.1271/bbb.80869; WL D, 2002, THE PYMOL MOLECULAR; Xue HP, 2012, J IND MICROBIOL BIOT, V39, P1279, DOI 10.1007/s10295-012-1140-y; Zhang S, 2010, BIOCHEM BIOPH RES CO, V395, P200, DOI 10.1016/j.bbrc.2010.03.159; Zhao YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014608	54	16	17	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132834	10.1371/journal.pone.0132834	http://dx.doi.org/10.1371/journal.pone.0132834			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161643	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300179
J	Bonadies, N; Gottgens, B; Calero-Nieto, FJ				Bonadies, Nicolas; Goettgens, Berthold; Calero-Nieto, Fernando J.			The LMO2-25 Region Harbours GATA2-Dependent Myeloid Enhancer and RUNX-Dependent T-Lymphoid Repressor Activity	PLOS ONE			English	Article							LIM-PROTEIN RBTN2; ACUTE LYMPHOBLASTIC-LEUKEMIA; GENOME-WIDE ANALYSIS; CELL ACUTE-LEUKEMIA; B-CELL; CHROMOSOMAL TRANSLOCATION; EXPRESSION; COMPLEX; TRANSCRIPTION; GENE	Lim domain only 2 (LMO2) is a transcriptional co-factor required for angiogenesis and the specification of haematopoietic cells during development. LMO2 is widely expressed within haematopoiesis with the exception of T-cells. Failure to downregulate LMO2 during T-cell maturation leads to leukaemia, thus underlining the critical nature of context-dependent regulation of LMO2 expression. We previously identified a distal regulatory element of LMO2 (element -25) that cooperates with the proximal promoter in directing haematopoietic expression. Here we dissected the functional activity of element -25 and showed it to consist of two modules that conferred independent and cell-type specific activities: a 3' myeloid enhancer and a 5' T-cell repressor. The myeloid enhancer was bound by GATA2 in progenitors and its activity depended on a highly conserved GATA motif, whereas the T-cell repressor moiety of element -25 was bound by the Core Binding Factor in T-cells and its repressive activity depended on a highly conserved RUNT motif. Since the myeloid enhancer and nearby downstream region is recurrently involved in oncogenic translocations, our data suggest that the -25 enhancer region provides an open chromatin environment prone to translocations, which in turn cause aberrant LMO2-expression in T-cells due to the removal of the adjacent T-cell repressor.	[Bonadies, Nicolas; Goettgens, Berthold; Calero-Nieto, Fernando J.] Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust & MRC Cambridge Stem Cell Inst, Dept Haematol, Cambridge, England	University of Cambridge	Gottgens, B (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust & MRC Cambridge Stem Cell Inst, Dept Haematol, Cambridge, England.	fjc28@cam.ac.uk; bg200@cam.ac.uk	Bonadies, Nicolas/F-2388-2017	Bonadies, Nicolas/0000-0001-8761-2066; Gottgens, Berthold/0000-0001-6302-5705; Calero-Nieto, Fernando/0000-0003-3358-8253	Leukaemia and Lymphoma Research [07060, 12029]; Swiss National Science Foundation; Wellcome Trust [100140/Z/12/Z]; MRC Cambridge Stem Cell Institute [097922/Z/11/Z]; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish; Medical Research Council [MR/M008975/1, MC_PC_12009] Funding Source: researchfish; BBSRC [BB/I00050X/1] Funding Source: UKRI; MRC [MR/M008975/1] Funding Source: UKRI	Leukaemia and Lymphoma Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC Cambridge Stem Cell Institute(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Leukaemia and Lymphoma Research (BG) (http://leukaemialymphomaresearch.org.uk/, grants number 07060 and 12029), a fellowship from the Swiss National Science Foundation (NB) (http://www.snf.ch/) and Wellcome Trust Infrastructure support funding for the Cambridge Institute for Medical Research ((http://www.wellcome.ac.uk/) grant number 100140/Z/12/Z) and the Wellcome Trust and MRC Cambridge Stem Cell Institute (http://www.mrc.ac.uk/, grant number 097922/Z/11/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MK, 2006, IMMUNOL REV, V209, P191, DOI 10.1111/j.0105-2896.2006.00352.x; Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; Arribas Alberto J, 2012, Blood, V119, pe9, DOI 10.1182/blood-2011-02-339556; Beck D, 2013, BLOOD, V122, pE12, DOI 10.1182/blood-2013-03-490425; Blenk S, 2007, CANCER INFORM, V3, P399; BOEHM T, 1989, EMBO J, V8, P2621, DOI 10.1002/j.1460-2075.1989.tb08402.x; BOEHM T, 1988, EMBO J, V7, P385, DOI 10.1002/j.1460-2075.1988.tb02825.x; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; Bowers SR, 2009, MOL CELL BIOL, V29, P1682, DOI 10.1128/MCB.01411-08; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Calero-Nieto FJ, 2013, ONCOGENE, V32, P5471, DOI 10.1038/onc.2013.175; Chapman MA, 2004, GENOME RES, V14, P313, DOI 10.1101/gr.1759004; CHENG JT, 1990, J EXP MED, V171, P489, DOI 10.1084/jem.171.2.489; Cobanoglu U, 2010, HEMATOLOGY, V15, P132, DOI 10.1179/102453309X12583347113618; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; De Keersmaecker K, 2005, HAEMATOLOGICA, V90, P1116; DEXTER TM, 1979, NATURE, V277, P471, DOI 10.1038/277471a0; Dik WA, 2007, BLOOD, V110, P388, DOI 10.1182/blood-2006-12-064816; DUBE SK, 1975, P NATL ACAD SCI USA, V72, P1863, DOI 10.1073/pnas.72.5.1863; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; FITZGERALD TJ, 1992, BLOOD, V80, P3189; GARCIA IS, 1991, ONCOGENE, V6, P577; Gottgens B, 1997, ONCOGENE, V15, P2419, DOI 10.1038/sj.onc.1201426; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hammond SM, 2005, LEUKEMIA RES, V29, P89, DOI 10.1016/j.leukres.2004.05.013; Herblot S, 2000, NAT IMMUNOL, V1, P138, DOI 10.1038/77819; Kundu M, 2005, BLOOD, V106, P3621, DOI 10.1182/blood-2005-04-1447; Landry JR, 2009, BLOOD, V113, P5783, DOI 10.1182/blood-2008-11-187757; Landry JR, 2005, BLOOD, V106, P2680, DOI 10.1182/blood-2004-12-4755; LARSON RC, 1995, ONCOGENE, V11, P853; Larson RC, 1996, EMBO J, V15, P1021, DOI 10.1002/j.1460-2075.1996.tb00439.x; Lotem J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080467; Malumbres R, 2011, HAEMATOL-HEMATOL J, V96, P980, DOI 10.3324/haematol.2011.040568; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; Nam CH, 2006, MOL THER, V13, P15, DOI 10.1016/j.ymthe.2005.09.010; Natkunam Y, 2007, HEMATOLOGY, V1, P210, DOI DOI 10.1182/ASHEDUCATI0N-2007.1.210; Natkunam Y, 2008, J CLIN ONCOL, V26, P447, DOI 10.1200/JCO.2007.13.0690; Natkunam Y, 2007, BLOOD, V109, P1636, DOI 10.1182/blood-2006-08-039024; Nicholas KB, 1997, GENEDOC A TOOL FOR E; Oram SH, 2010, ONCOGENE, V29, P5796, DOI 10.1038/onc.2010.320; OSADA H, 1995, P NATL ACAD SCI USA, V92, P9585, DOI 10.1073/pnas.92.21.9585; Ptasinska A, 2014, CELL REP, V8, P1974, DOI 10.1016/j.celrep.2014.08.024; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; ROYERPOKORA B, 1995, ONCOGENE, V10, P1353; ROYERPOKORA B, 1991, ONCOGENE, V6, P1887; Sanchez-Castillo M, 2015, NUCLEIC ACIDS RES, V43, pD1117, DOI 10.1093/nar/gku895; SANCHEZGARCIA I, 1993, SEMIN CANCER BIOL, V4, P349; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Sun XJ, 2013, NATURE, V500, P93, DOI 10.1038/nature12287; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Valge-Archer V, 1998, ONCOGENE, V17, P3199, DOI 10.1038/sj.onc.1202353; VALGEARCHER VE, 1994, P NATL ACAD SCI USA, V91, P8617, DOI 10.1073/pnas.91.18.8617; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; YOFFE G, 1989, BLOOD, V74, P374; Younes SF, 2011, AM J CLIN PATHOL, V135, P697, DOI 10.1309/AJCP7Z2BIBUNQPLZ; Yu M, 2012, MOL CELL, V45, P330, DOI 10.1016/j.molcel.2011.11.032	62	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131577	10.1371/journal.pone.0131577	http://dx.doi.org/10.1371/journal.pone.0131577			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161748	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300048
J	Buck, AH; Ivens, A; Gordon, K; Craig, N; Houzelle, A; Roche, A; Turnbull, N; Beard, PM				Buck, Amy H.; Ivens, Alasdair; Gordon, Katrina; Craig, Nicola; Houzelle, Alexandre; Roche, Alice; Turnbull, Neil; Beard, Philippa M.			Quantitative Analysis of MicroRNAs in Vaccinia virus Infection Reveals Diversity in Their Susceptibility to Modification and Suppression	PLOS ONE			English	Article							SMALL SILENCING RNAS; POLY(A) POLYMERASE; BIOGENESIS; TURNOVER; TARGET; EXPRESSION; PATHWAY; GENOME; CANCER; DEGRADATION	Vaccinia virus (VACV) is a large cytoplasmic DNA virus that causes dramatic alterations to many cellular pathways including microRNA biogenesis. The virus encodes a poly(A) polymerase which was previously shown to add poly(A) tails to the 3' end of cellular miRNAs, resulting in their degradation by 24 hours post infection (hpi). Here we used small RNA sequencing to quantify the impact of VACV infection on cellular miRNAs in human cells at both early (6 h) and late (24 h) times post infection. A detailed quantitative analysis of individual miRNAs revealed marked diversity in the extent of their modification and relative change in abundance during infection. Some miRNAs became highly modified (e.g. miR29a- 3p, miR-27b-3p) whereas others appeared resistant (e.g. miR-16-5p). Furthermore, miRNAs that were highly tailed at 6 hpi were not necessarily among the most reduced at 24 hpi. These results suggest that intrinsic features of human cellular miRNAs cause them to be differentially polyadenylated and altered in abundance during VACV infection. We also demonstrate that intermediate and late VACV gene expression are required for optimal repression of some miRNAs including miR-27-3p. Overall this work reveals complex and varied consequences of VACV infection on host miRNAs and identifies miRNAs which are largely resistant to VACV-induced polyadenylation and are therefore present at functional levels during the initial stages of infection and replication.	[Buck, Amy H.; Ivens, Alasdair; Gordon, Katrina] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Craig, Nicola; Houzelle, Alexandre; Roche, Alice; Turnbull, Neil; Beard, Philippa M.] Roslin Inst, Royal Dick Sch Vet Studies, Infect & Immun, Easter Bush, Midlothian, Scotland	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Buck, AH (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Kings Bldg, Edinburgh, Midlothian, Scotland.	a.buck@ed.ac.uk; pip.beard@roslin.ed.ac.uk		Buck, Amy/0000-0003-2645-7191; Beard, Pip/0000-0002-2285-810X; Ivens, Al/0000-0002-0112-3876; Craig, Nicky/0000-0001-7370-4437	BBSRC; Wellcome Trust RCDF [WT097394AIA]; BBSRC project [BB/J001279/1]; Wellcome Trust strategic award [095831MA]; BBSRC [BBS/E/D/20241864, BB/J001279/1, BBS/E/D/20310000] Funding Source: UKRI; MRC [G0900740, MR/K001744/1] Funding Source: UKRI; NERC [NBAF010003] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864, BB/J001279/1, BBS/E/D/20310000] Funding Source: researchfish; Medical Research Council [MR/K001744/1, G0900740] Funding Source: researchfish; Natural Environment Research Council [NBAF010003] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust RCDF(Wellcome Trust); BBSRC project(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust strategic award(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Roslin Institute receives Institute Strategic Grant funding from the BBSRC. This work is supported by a Wellcome Trust RCDF (WT097394AIA) and BBSRC project (BB/J001279/1) awarded to A. Buck as well as a Wellcome Trust strategic award (095831MA) to the Centre for Immunity, Infection and Evolution supporting A. Ivens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Baccarini A, 2011, CURR BIOL, V21, P369, DOI 10.1016/j.cub.2011.01.067; Backes S, 2012, CELL HOST MICROBE, V12, P200, DOI 10.1016/j.chom.2012.05.019; Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chen JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120390; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; GERSHON PD, 1993, EMBO J, V12, P4705, DOI 10.1002/j.1460-2075.1993.tb06159.x; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grinberg M, 2012, ARCH VIROL, V157, P1719, DOI 10.1007/s00705-012-1366-z; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; JONES EV, 1987, J VIROL, V61, P1765, DOI 10.1128/JVI.61.6.1765-1771.1987; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li DN, 1997, EMBO J, V16, P1103, DOI 10.1093/emboj/16.5.1103; Libri V, 2013, CELL MOL LIFE SCI, V70, P3525, DOI 10.1007/s00018-012-1257-1; Libri V, 2012, P NATL ACAD SCI USA, V109, P279, DOI 10.1073/pnas.1114204109; McCaskill J, 2015, RNA BIOL, V12, P579, DOI 10.1080/15476286.2015.1034912; MEYER H, 1991, J GEN VIROL, V72, P1031, DOI 10.1099/0022-1317-72-5-1031; Moss B, 2007, FIELDS VIROLOGY, P2906; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; RAMSEYEWING A, 1995, VIROLOGY, V206, P984, DOI 10.1006/viro.1995.1021; Rouha H, 2010, NUCLEIC ACIDS RES, V38, P8328, DOI 10.1093/nar/gkq681; Ruegger S, 2012, TRENDS BIOCHEM SCI, V37, P436, DOI 10.1016/j.tibs.2012.07.002; Santhakumar D, 2010, P NATL ACAD SCI USA, V107, P13830, DOI 10.1073/pnas.1008861107; Shapiro JS, 2010, RNA, V16, P2068, DOI 10.1261/rna.2303610; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; SUTTER G, 1992, P NATL ACAD SCI USA, V89, P10847, DOI 10.1073/pnas.89.22.10847; TADDIE JA, 1993, J VIROL, V67, P4323, DOI 10.1128/JVI.67.7.4323-4336.1993; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wu XL, 2013, ONCOTARGET, V4, P1388, DOI 10.18632/oncotarget.1239; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Zhang Z, 2011, NUCLEIC ACIDS RES, V39, P4387, DOI 10.1093/nar/gkr020	48	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131787	10.1371/journal.pone.0131787	http://dx.doi.org/10.1371/journal.pone.0131787			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161560	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300058
J	Furutani, A; Ikeda, Y; Itokawa, M; Nagahama, H; Ohtsu, T; Furutani, N; Kamagata, M; Yang, ZH; Hirasawa, A; Tahara, Y; Shibata, S				Furutani, Akiko; Ikeda, Yuko; Itokawa, Misa; Nagahama, Hiroki; Ohtsu, Teiji; Furutani, Naoki; Kamagata, Mayo; Yang, Zhi-Hong; Hirasawa, Akira; Tahara, Yu; Shibata, Shigenobu			Fish Oil Accelerates Diet-Induced Entrainment of the Mouse Peripheral Clock via GPR120	PLOS ONE			English	Article							CIRCADIAN GENE-EXPRESSION; PANCREATIC BETA-CELLS; KNOCK-IN MICE; FATTY-ACIDS; LIVER CLOCK; DOCOSAHEXAENOIC ACID; INSULIN-RESISTANCE; RECEPTOR GPR40; SECRETION; GLUCOSE	The circadian peripheral clock is entrained by restricted feeding (RF) at a fixed time of day, and insulin secretion regulates RF-induced entrainment of the peripheral clock in mice. Thus, carbohydrate-rich food may be ideal for facilitating RF-induced entrainment, although the role of dietary oils in insulin secretion and RF-induced entrainment has not been described. The soybean oil component of standard mouse chow was substituted with fish or soybean oil containing docosahexaenoic acid (DHA) and/or eicosapentaenoic acid (EPA). Tuna oil (high DHA/EPA), menhaden oil (standard), and DHA/EPA dissolved in soybean oil increased insulin secretion and facilitated RF-induced phase shifts of the liver clock as represented by the bioluminescence rhythms of PER2::LUCIFERASE knock-in mice. In this model, insulin depletion blocked the effect of tuna oil and fish oil had no effect on mice deficient for GPR120, a polyunsaturated fatty acid receptor. These results suggest food containing fish oil or DHA/EPA is ideal for adjusting the peripheral clock.	[Furutani, Akiko; Ikeda, Yuko; Itokawa, Misa; Nagahama, Hiroki; Ohtsu, Teiji; Furutani, Naoki; Kamagata, Mayo; Tahara, Yu; Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Shinjuku Ku, Tokyo, Japan; [Yang, Zhi-Hong] Nippon Suisan Kaisha Ltd, Cent Res Lab, Hachioji, Tokyo, Japan; [Hirasawa, Akira] Kyoto Univ, Dept Genom Drug Discovery Sci, Sakyo Ku, Kyoto, Japan; [Hirasawa, Akira] Tokyo Womens Med Univ, Inst Integrated Med Sci, Shinjuku Ku, Tokyo, Japan	Waseda University; Nippon Suisan Kaisha, Ltd.; Kyoto University; Tokyo Women's Medical University	Shibata, S (corresponding author), Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Shinjuku Ku, Wakamatsu Cho 2-2, Tokyo, Japan.	shibatas@waseda.jp	Furutani, Akiko/AAH-6996-2019; Tahara, Yu/Q-4324-2018	Tahara, Yu/0000-0002-3015-8883	Council for Science, Technology and Innovation, SIP; Bio-oriented Technology Research Advancement Institution, NARO; Ministry of Education, Culture, Sports, Science and Technology of Japan [26220201]; Nippon Suisan Kaisha Ltd.	Council for Science, Technology and Innovation, SIP; Bio-oriented Technology Research Advancement Institution, NARO; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nippon Suisan Kaisha Ltd.	This work was partially supported by Council for Science, Technology and Innovation, SIP, "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO) (S.S.), and by a Grant-in-Aid for Scientific Research (S) (26220201) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.S.). Nippon Suisan Kaisha Ltd. provided support in the form of a salary for author ZHY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ando H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081119; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Calder PC, 2009, POSTGRAD MED, V121, P148, DOI 10.3810/pgm.2009.11.2083; Cottin SC, 2011, P NUTR SOC, V70, P215, DOI 10.1017/S0029665111000061; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Hirao A, 2010, AM J PHYSIOL-GASTR L, V299, pG1045, DOI 10.1152/ajpgi.00330.2010; Hirao A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006909; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Itokawa M, 2013, NUTR RES, V33, P109, DOI 10.1016/j.nutres.2012.12.004; Kawamoto T, 2006, J BIOCHEM, V140, P401, DOI 10.1093/jb/mvj165; Kebede M, 2008, DIABETES, V57, P2432, DOI 10.2337/db08-0553; Kidd PM, 2007, ALTERN MED REV, V12, P207; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Manerba A, 2010, FUTUR CARDIOL, V6, P343, DOI 10.2217/FCA.10.19; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Moran BM, 2014, DIABETES OBES METAB, V16, P1128, DOI 10.1111/dom.12330; Morishita M, 2008, J CONTROL RELEASE, V132, P99, DOI 10.1016/j.jconrel.2008.09.001; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Oike H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023709; Ouellet M, 2009, NEUROCHEM INT, V55, P476, DOI 10.1016/j.neuint.2009.04.018; Sato M, 2014, CELL REP, V8, P392, DOI 10.1016/j.celrep.2014.06.015; Shibata S, 2010, ADV DRUG DELIVER REV, V62, P918, DOI 10.1016/j.addr.2010.06.003; Shimazoe T, 2008, FASEB J, V22, P1479, DOI 10.1096/fj.07-9372com; Stephan FK, 1998, PHYSIOL BEHAV, V65, P277, DOI 10.1016/S0031-9384(98)00166-8; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Tahara Y, 2011, J BIOL RHYTHM, V26, P230, DOI 10.1177/0748730411405958; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P523, DOI 10.1007/s00210-007-0200-8; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Wei MY, 2011, CURR ATHEROSCLER REP, V13, P474, DOI 10.1007/s11883-011-0210-3; Wu T, 2010, PHYSIOL RES, V59, P581, DOI 10.33549/physiolres.931818; Yamajuku D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00439; Yang ZH, 2011, J AGR FOOD CHEM, V59, P7482, DOI 10.1021/jf201496h; Yang ZH, 2011, LIPIDS, V46, P425, DOI 10.1007/s11745-011-3553-1; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yurko-Mauro K, 2010, CURR ALZHEIMER RES, V7, P190, DOI 10.2174/156720510791050911	42	37	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132472	10.1371/journal.pone.0132472	http://dx.doi.org/10.1371/journal.pone.0132472			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161796	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300138
J	Kontro, H; Cannino, G; Rustin, P; Dufour, E; Kainulainen, H				Kontro, Heidi; Cannino, Giuseppe; Rustin, Pierre; Dufour, Eric; Kainulainen, Heikki			DAPIT Over-Expression Modulates Glucose Metabolism and Cell Behaviour in HEK293T Cells	PLOS ONE			English	Article							COPY-NUMBER ALTERATION; GENE-EXPRESSION; ATP SYNTHASE; MITOCHONDRIAL BIOGENESIS; GENOMIC ALTERATIONS; HUMAN CANCERS; BETA-CATENIN; REVEALS; HYPOXIA; CARCINOMA	Introduction Diabetes Associated Protein in Insulin-sensitive Tissues (DAPIT) is a subunit of mitochondrial ATP synthase and has also been found to associate with the vacuolar H+-ATPase. Its expression is particularly high in cells with elevated aerobic metabolism and in epithelial cells that actively transport nutrients and ions. Deletion of DAPIT is known to induce loss of mitochondrial ATP synthase but the effects of its over-expression are obscure. Results In order to study the consequences of high expression of DAPIT, we constructed a transgenic cell line that constitutively expressed DAPIT in human embryonal kidney cells, HEK293T. Enhanced DAPIT expression decreased mtDNA content and mitochondrial mass, and saturated respiratory chain by decreasing H+-ATP synthase activity. DAPIT over-expression also increased mitochondrial membrane potential and superoxide level, and translocated the transcription factors hypoxia inducible factor 1 alpha (Hif1 alpha) and beta-catenin to the nucleus. Accordingly, cells over-expressing DAPIT used more glucose and generated a larger amount of lactate compared to control cells. Interestingly, these changes were associated with an epithelial to mesenchymal (EMT)-like transition by changing E-cadherin to N-cadherin and up-regulating several key junction/adhesion proteins. At physiological level, DAPIT over-expression slowed down cell growth by G1 arrest and migration, and enhanced cell detachment. Several cancers also showed an increase in genomic copy number of Usmg5 (gene encoding DAPIT), thereby providing strong correlative evidence for DAPIT possibly having oncogenic function in cancers. Conclusions DAPIT over-expression thus appears to modulate mitochondrial functions and alter cellular regulations, promote anaerobic metabolism and induce EMT-like transition. We propose that DAPIT over-expression couples the changes in mitochondrial metabolism to physiological and pathophysiological regulations, and suggest it could play a critical role in H+-ATP synthase dysfunctions.	[Kontro, Heidi] Univ Tampere, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland; [Cannino, Giuseppe; Dufour, Eric] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Rustin, Pierre] INSERM, UMR 1141, Paris, France; [Rustin, Pierre] Univ Paris 07, Paris, France; [Kainulainen, Heikki] Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland	Tampere University; Tampere University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Jyvaskyla	Kainulainen, H (corresponding author), Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland.	heikki.s.o.kainulainen@jyu.fi	Dufour, Eric/AAF-6210-2020; Cannino, Giuseppe/AAS-7269-2021	Dufour, Eric/0000-0001-6690-5329	Competitive Research Funding of Pirkanmaa Hospital District grant [9G030]; Finnish Cultural Foundation; Pirkanmaa Regional fund; Finnish Diabetes Research Foundation; Academy of Finland; Finnish Cultural Foundation Central Fund	Competitive Research Funding of Pirkanmaa Hospital District grant; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Pirkanmaa Regional fund; Finnish Diabetes Research Foundation; Academy of Finland(Academy of Finland); Finnish Cultural Foundation Central Fund	The study was financially supported by the Competitive Research Funding of the Pirkanmaa Hospital District grant 9G030, HKo; Finnish Cultural Foundation, Pirkanmaa Regional fund, HKo; Finnish Diabetes Research Foundation, HKo; Academy of Finland, HKa; Finnish Cultural Foundation Central Fund, HKa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The URLs of funding sources are as follows in the order they are mentioned: http://www.pshp.fi/default.aspx?nodeid=10066&contentlan=2,https://www.skr.fi/en/finnish-cultural-foundation/regional-funds/pirkanmaaregional-fund,http://www.diabetestutkimus.fi/en,http://www.aka.fi/en-GB/A/Funding-and-guidance/Funding/,https://www.skr.fi/en/ grants.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Benit P, 2006, CLIN CHIM ACTA, V374, P81, DOI 10.1016/j.cca.2006.05.034; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cannino G, 2012, J BIOL CHEM, V287, P38729, DOI 10.1074/jbc.M112.386060; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen RM, 2007, FEBS LETT, V581, P3145, DOI 10.1016/j.febslet.2007.05.079; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Czerwinska Patrycja, 2015, Contemp Oncol (Pozn), V19, pA7, DOI 10.5114/wo.2014.47126; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Formentini L, 2012, MOL CELL, V45, P731, DOI 10.1016/j.molcel.2012.01.008; Fukuoh A, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145117; Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kontro H, 2012, Eur J Histochem, V56, pe18, DOI 10.4081/ejh.2012.18; Kotliarov Y, 2006, CANCER RES, V66, P9428, DOI 10.1158/0008-5472.CAN-06-1691; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CH, 2005, WORLD J GASTROENTERO, V11, P1937, DOI 10.3748/wjg.v11.i13.1937; Lee J, 2015, J BIOL CHEM, V290, P13308, DOI 10.1074/jbc.M115.645283; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; McFarland MA, 2008, MOL CELL PROTEOMICS, V7, P2123, DOI 10.1074/mcp.M800116-MCP200; Meyer B, 2007, MOL CELL PROTEOMICS, V6, P1690, DOI 10.1074/mcp.M700097-MCP200; Neale G, 2008, CLIN CANCER RES, V14, P4572, DOI 10.1158/1078-0432.CCR-07-5090; Nikolsky Y, 2008, CANCER RES, V68, P9532, DOI 10.1158/0008-5472.CAN-08-3082; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Ohsakaya S, 2011, J BIOL CHEM, V286, P20292, DOI 10.1074/jbc.M110.198523; Paivarinne H, 2001, ACTA DIABETOL, V38, P83; Peng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023452; Piantadosi CA, 2012, FREE RADICAL BIO MED, V53, P2043, DOI 10.1016/j.freeradbiomed.2012.09.014; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rothenberg SM, 2010, CANCER RES, V70, P2158, DOI 10.1158/0008-5472.CAN-09-3458; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Sanchez-Arago M, 2013, EMBO REP, V14, P638, DOI 10.1038/embor.2013.72; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Selga E, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-35; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; Talbot Lindsay J, 2012, Int J Biochem Mol Biol, V3, P117; Teittinen KJ, 2012, LEUKEMIA RES, V36, P232, DOI 10.1016/j.leukres.2011.06.038; Valcourt JR, 2012, CELL CYCLE, V11, P1680, DOI 10.4161/cc.19879; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Yang M, 2013, J CLIN INVEST, V123, P3652, DOI 10.1172/JCI67228; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang L, 2010, J PROTEOME RES, V9, P458, DOI 10.1021/pr900818g	64	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131990	10.1371/journal.pone.0131990	http://dx.doi.org/10.1371/journal.pone.0131990			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161955	gold, Green Published			2022-12-27	WOS:000358162300080
J	Brooks, GR; Larson, RA; Schwing, PT; Romero, I; Moore, C; Reichart, GJ; Jilbert, T; Chanton, JP; Hastings, DW; Overholt, WA; Marks, KP; Kostka, JE; Holmes, CW; Hollander, D				Brooks, Gregg R.; Larson, Rebekka A.; Schwing, Patrick T.; Romero, Isabel; Moore, Christopher; Reichart, Gert-Jan; Jilbert, Tom; Chanton, Jeff P.; Hastings, David W.; Overholt, Will A.; Marks, Kala P.; Kostka, Joel E.; Holmes, Charles W.; Hollander, David			Sedimentation Pulse in the NE Gulf of Mexico following the 2010 DWH Blowout	PLOS ONE			English	Article							HORIZON OIL-SPILL; ORGANIC-MATTER; EQUATORIAL PACIFIC; ACCUMULATION RATES; NORTHEASTERN GULF; WATER; PB-210; TRANSPORT; MISSISSIPPI; TH-234	The objective of this study was to investigate the impacts of the Deepwater Horizon (DWH) oil discharge at the seafloor as recorded in bottom sediments of the DeSoto Canyon region in the northeastern Gulf of Mexico. Through a close coupling of sedimentological, geochemical, and biological approaches, multiple independent lines of evidence from 11 sites sampled in November/December 2010 revealed that the upper similar to 1 cm depth interval is distinct from underlying sediments and results indicate that particles originated at the sea surface. Consistent dissimilarities in grain size over the surficial similar to 1 cm of sediments correspond to excess Th-234 depths, which indicates a lack of vertical mixing (bioturbation), suggesting the entire layer was deposited within a 4-5 month period. Further, a time series from four deep-sea sites sampled up to three additional times over the following two years revealed that excess Th-234 depths, accumulation rates, and Th-234 inventories decreased rapidly, within a few to several months after initial coring. The interpretation of a rapid sedimentation pulse is corroborated by stratification in solid phase Mn, which is linked to diagenesis and redox change, and the dramatic decrease in benthic formanifera density that was recorded in surficial sediments. Results are consistent with a brief depositional pulse that was also reported in previous studies of sediments, and marine snow formation in surface waters closer to the wellhead during the summer and fall of 2010. Although sediment input from the Mississippi River and advective transport may influence sedimentation on the seafloor in the DeSoto Canyon region, we conclude based on multidisciplinary evidence that the sedimentation pulse in late 2010 is the product of marine snow formation and is likely linked to the DWH discharge.	[Brooks, Gregg R.; Larson, Rebekka A.; Moore, Christopher; Hastings, David W.] Eckerd Coll, Dept Marine Sci, St Petersburg, FL 33733 USA; [Larson, Rebekka A.; Schwing, Patrick T.; Romero, Isabel; Hollander, David] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Reichart, Gert-Jan; Jilbert, Tom] Univ Utrecht, Dept Earth Sci, Utrecht, Netherlands; [Reichart, Gert-Jan] Royal Netherlands Inst Sea Res, Marine Geol Dept, Texel, Netherlands; [Chanton, Jeff P.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Overholt, Will A.; Marks, Kala P.; Kostka, Joel E.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Kostka, Joel E.] Georgia Inst Technol, Sch Earth, Atlanta, GA 30332 USA; [Kostka, Joel E.] Georgia Inst Technol, Sch Atmospher Sci, Atlanta, GA 30332 USA; [Holmes, Charles W.] Environchron, Bradenton, FL USA	State University System of Florida; University of South Florida; Utrecht University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); State University System of Florida; Florida State University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Brooks, GR (corresponding author), Eckerd Coll, Dept Marine Sci, St Petersburg, FL 33733 USA.	brooksgr@eckerd.edu	Schwing, Patrick/AAK-8593-2020; Jilbert, Tom/AAL-2273-2021; Reichart, Gert-Jan/N-6308-2018; Overholt, Will/X-2461-2019	Schwing, Patrick/0000-0001-8466-4952; Reichart, Gert-Jan/0000-0002-7256-2243; Overholt, Will/0000-0002-2897-6991; Romero, Isabel C./0000-0002-8590-5989	Gulf of Mexico Research Initiative through the Florida Institute of Oceanography; Center for Integrated Modeling and Analysis of Gulf Ecosystems; Deepsea to Coast Connectivity in the Eastern Gulf of Mexico consortia; Environchron	Gulf of Mexico Research Initiative through the Florida Institute of Oceanography; Center for Integrated Modeling and Analysis of Gulf Ecosystems; Deepsea to Coast Connectivity in the Eastern Gulf of Mexico consortia; Environchron	Funding was provided by the Gulf of Mexico Research Initiative (http://gulfresearchinitiative.org) through the Florida Institute of Oceanography (http://www.fio.usf.edu), Center for Integrated Modeling and Analysis of Gulf Ecosystems (http://www.marine.usf.edu/c-image/), and Deepsea to Coast Connectivity in the Eastern Gulf of Mexico (http://deep-c.org) consortia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Environchron provided support in the form of salaries for authors C.W.H., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	8272 EM, 2007, 8272 EM, P1; Aeppli C, 2014, ENVIRON SCI TECHNOL, V48, P6726, DOI 10.1021/es500825q; Alexander CR, 2010, MAR GEOL, V270, P213, DOI 10.1016/j.margeo.2009.10.015; ANDERS MH, 1987, J GEOL, V95, P1, DOI 10.1086/629103; [Anonymous], [No title captured]; APPLEBY PG, 1983, HYDROBIOLOGIA, V103, P29, DOI 10.1007/BF00028424; Balsam WL, 2003, DEEP-SEA RES PT I, V50, P1421, DOI 10.1016/j.dsr.2003.06.001; Barron MG, 2012, TOXICOL PATHOL, V40, P315, DOI 10.1177/0192623311428474; Baskaran M, 2002, CONT SHELF RES, V22, P1493, DOI 10.1016/S0278-4343(02)00017-1; Bianchi TS, 2011, MAR ENVIRON RES, V72, P248, DOI 10.1016/j.marenvres.2011.09.007; Binford, 1990, J PALEOLIMNOL, V3, P253, DOI DOI 10.1007/BF00219461; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; BONNETT PJP, 1991, HYDROBIOLOGIA, V214, P71, DOI 10.1007/BF00050934; Brooks GR, 2012, AGU ASLO OC SCI M FE; BURDIGE DJ, 1993, EARTH-SCI REV, V35, P249, DOI 10.1016/0012-8252(93)90040-E; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chanton J, 2015, ENVIRON SCI TECHNOL, V49, P847, DOI 10.1021/es5046524; Choi YH, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002261; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crusius J, 2007, ESTUAR COAST SHELF S, V71, P537, DOI 10.1016/j.ecss.2006.09.006; CUTSHALL NH, 1983, NUCL INSTRUM METHODS, V206, P309, DOI 10.1016/0167-5087(83)91273-5; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Dell'Amore C, 2010, NATL GEOGRAPHIC 0923; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Diercks A, 2013, 2013 MOSSFA M OCT 22; Dietrich JC, 2012, CONT SHELF RES, V41, P17, DOI 10.1016/j.csr.2012.03.015; DOYLE LJ, 1980, J SEDIMENT PETROL, V50, P905; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EMILIANI C, 1975, SCIENCE, V189, P1083, DOI 10.1126/science.189.4208.1083; Finney BP, 1988, PALEOCEANOGRAPHY, V3, P169, DOI 10.1029/PA003i002p00169; Folk R. L., 1965, PETROLOGY SEDIMENTAR; FROELICH PN, 1979, GEOCHIM COSMOCHIM AC, V43, P1075, DOI 10.1016/0016-7037(79)90095-4; Garcia-Pineda O, 2013, OCEANOGRAPHY, V26, P124, DOI 10.5670/oceanog.2013.38; GARDNER WD, 1985, MAR GEOL, V65, P199, DOI 10.1016/0025-3227(85)90057-X; Gould HR, 1956, SEPM SPEC PUBL, V3, P2; Graham WM, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/045301; GRIFFIN GM, 1962, GEOL SOC AM BULL, V73, P737, DOI 10.1130/0016-7606(1962)73[737:RCFOWI]2.0.CO;2; HARBISON RN, 1968, J GEOPHYS RES, V73, P5175, DOI 10.1029/JB073i016p05175; Herndl G J, 1999, Ann Ist Super Sanita, V35, P405; Hollander DJ, 2012, 2012 OC SCI M FEB 23; Holmes CW., 2001, SHORT LIVED ISOTOPES; Hussain N, 1996, APPL RADIAT ISOTOPES, V47, P473, DOI 10.1016/0969-8043(95)00319-3; Joye SB, 2014, BIOSCIENCE, V64, P766, DOI 10.1093/biosci/biu121; Joye SB, 2011, NAT GEOSCI, V4, P160, DOI [10.1038/ngeo1067, 10.1038/NGEO1067]; KITTO ME, 1991, APPL RADIAT ISOTOPES, V42, P835, DOI 10.1016/0883-2889(91)90221-L; Lubchenco J, 2012, P NATL ACAD SCI USA, V109, P20212, DOI 10.1073/pnas.1204729109; MCKEE BA, 1983, GEOLOGY, V11, P631, DOI 10.1130/0091-7613(1983)11<631:COSDAA>2.0.CO;2; Milliman J. D., 1974, MARINE CARBONATES; Nurnberg D, 2008, EARTH PLANET SC LETT, V272, P278, DOI 10.1016/j.epsl.2008.04.051; Olsson IU, 1986, HDB HOLOCENE PALAEOE, P298; Passow U, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035301; Passow U., 2014, DEEP SEA RES 2; PENNA N, 1993, WATER RES, V27, P1767, DOI 10.1016/0043-1354(93)90115-X; Pope RH, 1996, DEEP-SEA RES PT II, V43, P1339, DOI 10.1016/0967-0645(96)00009-4; Price BA, 1998, THESIS UCSD; PRINCE RC, 1994, ENVIRON SCI TECHNOL, V28, P142, DOI 10.1021/es00050a019; Romero IC, 2010, PLOS ONE; Rowe G., 2009, NO GULF MEXICO CONTI; Ryerson TB, 2012, P NATL ACAD SCI USA, V109, P20246, DOI 10.1073/pnas.1110564109; SADLER PM, 1981, J GEOL, V89, P569, DOI 10.1086/628623; Santschi PH, 2001, MAR CHEM, V73, P125, DOI 10.1016/S0304-4203(00)00101-8; Schwing PT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120565; Sionneau T, 2008, QUATERNARY SCI REV, V27, P1740, DOI 10.1016/j.quascirev.2008.07.001; Spier C, 2013, ENVIRON POLLUT, V173, P224, DOI 10.1016/j.envpol.2012.10.019; STACHOWITSCH M, 1990, PSZNI MAR ECOL, V11, P327, DOI 10.1111/j.1439-0485.1990.tb00387.x; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Thibodeaux LJ, 2011, ENVIRON ENG SCI, V28, P87, DOI 10.1089/ees.2010.0276; Tjallingii R, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001393; Valentine DL, 2014, P NATL ACAD SCI USA, V111, P15906, DOI 10.1073/pnas.1414873111; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; VOGEL JS, 1984, NUCL INSTRUM METH B, V5, P289, DOI 10.1016/0168-583X(84)90529-9; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yeager KM, 2004, MAR CHEM, V91, P1, DOI 10.1016/j.marchem.2004.03.016; Ziervogel K, 2014, DEEP SEA RES 2; Ziervogel K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034816	77	66	66	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132341	10.1371/journal.pone.0132341	http://dx.doi.org/10.1371/journal.pone.0132341			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172639	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900043
J	Humphrey, B; McLeod, N; Turner, C; Sutton, JM; Dark, PM; Warhurst, G				Humphrey, Bruce; McLeod, Neil; Turner, Carrie; Sutton, J. Mark; Dark, Paul M.; Warhurst, Geoffrey			Removal of Contaminant DNA by Combined UV-EMA Treatment Allows Low Copy Number Detection of Clinically Relevant Bacteria Using Pan-Bacterial Real-Time PCR	PLOS ONE			English	Article							PROPIDIUM MONOAZIDE; ETHIDIUM MONOAZIDE; ULTRAPURE WATER; RIBOSOMAL DNA; BLOOD; IDENTIFICATION; ELIMINATION; INDUSTRIAL; REAGENTS; SEPSIS	Background More than two decades after its discovery, contaminant microbial DNA in PCR reagents continues to impact the sensitivity and integrity of broad-range PCR diagnostic techniques. This is particularly relevant to their use in the setting of human sepsis, where a successful diagnostic on blood samples needs to combine universal bacterial detection with sensitivity to 1-2 genome copies, because low levels of a broad range of bacteria are implicated. Results We investigated the efficacy of ethidium monoazide (EMA) and propidium monoazide (PMA) treatment as emerging methods for the decontamination of PCR reagents. Both treatments were able to inactivate contaminating microbial DNA but only at concentrations that considerably affected assay sensitivity. Increasing amplicon length improved EMA/PMA decontamination efficiency but at the cost of assay sensitivity. The same was true for UV exposure as an alternative decontamination strategy, likely due to damage sustained by oligonucleotide primers which were a significant source of contamination. However, a simple combination strategy with UV-treated PCR reagents paired with EMA-treated primers produced an assay capable of two genome copy detection and a <5% contamination rate. This decontamination strategy could have important utility in developing improved pan-bacterial assays for rapid diagnosis of low pathogen burden conditions such as in the blood of patients with suspected blood stream infection.	[Humphrey, Bruce; Dark, Paul M.; Warhurst, Geoffrey] Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Manchester, Lancs, England; [Humphrey, Bruce; Dark, Paul M.; Warhurst, Geoffrey] Salford Royal NHS Fdn Trust, Infect Injury & Inflammat Res Grp, Salford, Lancs, England; [McLeod, Neil; Turner, Carrie; Sutton, J. Mark] Publ Hlth England, Microbiol Serv Div, Salisbury, Wilts, England	University of Manchester; Salford Royal NHS Foundation Trust; Public Health England	Humphrey, B (corresponding author), Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Manchester, Lancs, England.	bruce.humphrey@manchester.ac.uk		Dark, Paul/0000-0003-3309-0164	Technology Strategy Board UK grant [101187]	Technology Strategy Board UK grant	This work was funded by Technology Strategy Board UK grant #101187. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biedenbach DJ, 2004, DIAGN MICR INFEC DIS, V50, P59, DOI 10.1016/j.diagmicrobio.2004.05.003; Carroll NM, 1999, J CLIN MICROBIOL, V37, P3402, DOI 10.1128/JCM.37.10.3402-3404.1999; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Chang SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020303; Corless CE, 2000, J CLIN MICROBIOL, P38; Dark P, 2015, INTENS CARE MED, V41, P21, DOI 10.1007/s00134-014-3553-8; Emmadi R, 2011, J MOL DIAGN, V13, P583, DOI 10.1016/j.jmoldx.2011.05.011; Gomila M, 2007, INT J SYST EVOL MICR, V57, P2629, DOI 10.1099/ijs.0.65149-0; Goto M, 2005, FEMS MICROBIOL LETT, V246, P33, DOI 10.1016/j.femsle.2005.03.042; Hein I, 2007, J MICROBIOL METH, V71, P336, DOI 10.1016/j.mimet.2007.09.005; Heininger A, 2003, J CLIN MICROBIOL, V41, P1763, DOI 10.1128/JCM.41.4.1763-1765.2003; Huggett Jim F, 2008, BMC Res Notes, V1, P70, DOI 10.1186/1756-0500-1-70; Kulakov LA, 2002, APPL ENVIRON MICROB, V68, P1548, DOI 10.1128/AEM.68.4.1548-1555.2002; MEIER A, 1993, J CLIN MICROBIOL, V31, P646, DOI 10.1128/JCM.31.3.646-652.1993; Mennerat A, 2014, MICROB ECOL, V68, P834, DOI 10.1007/s00248-014-0453-y; Millar BC, 2002, J CLIN MICROBIOL, V40, P1575, DOI 10.1128/JCM.40.5.1575-1580.2002; Mohammadi T, 2003, J CLIN MICROBIOL, V41, P4796, DOI 10.1128/JCM.41.10.4796-4798.2003; Nogami T, 1998, ANAL CHEM, V70, P5296, DOI 10.1021/ac9805854; Ozbak H, 2012, J MOL DIAGN, V14, P176, DOI 10.1016/j.jmoldx.2011.12.004; Patel P, 2012, TRANSFUSION, V52, P1423, DOI 10.1111/j.1537-2995.2011.03484.x; Philipp S, 2010, TRANSFUS MED HEMOTH, V37, P21, DOI 10.1159/000265571; PRINCE AM, 1992, BIOTECHNIQUES, V12, P358; RAND KH, 1990, MOL CELL PROBE, V4, P445, DOI 10.1016/0890-8508(90)90003-I; Rueckert A, 2007, J MICROBIOL METH, V68, P596, DOI 10.1016/j.mimet.2006.11.006; SARKAR G, 1990, NATURE, V343, P27, DOI 10.1038/343027a0; Schnetzinger F, 2013, APPL MICROBIOL BIOT, V97, P2153, DOI 10.1007/s00253-013-4711-6; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; van Dongen WFD, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-11; YAGUPSKY P, 1990, CLIN MICROBIOL REV, V3, P269, DOI 10.1128/CMR.3.3.269-279.1990	29	11	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132954	10.1371/journal.pone.0132954	http://dx.doi.org/10.1371/journal.pone.0132954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172943	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900108
J	Zhao, YF; Liu, LJ; Huang, J; Shi, SF; Lv, JC; Liu, G; Zhao, MH; Zhang, H				Zhao, Yanfeng; Liu, Lijun; Huang, Jing; Shi, Sufang; Lv, Jicheng; Liu, Gang; Zhao, Minghui; Zhang, Hong			Plasma Soluble Urokinase Receptor Level Is Correlated with Podocytes Damage in Patients with IgA Nephropathy	PLOS ONE			English	Article							FOCAL-SEGMENTAL GLOMERULOSCLEROSIS; OXFORD CLASSIFICATION; GLOMERULAR-FILTRATION; SUPAR; VALIDATION; PREDICTORS; EXPRESSION	Background Focal segmental glomerulosclerosis (FSGS) lesions are similar in characteristics to S lesions of the Oxford classification of IgA nephropathy (IgAN) and may predict poor prognosis. In the present study, we aimed to explore the association between plasma soluble urokinase receptor (suPAR) levels and S lesions and podocytes damage in IgAN patients. Methods We enrolled 569 IgAN patients with follow-up data and detected plasma suPAR levels at renal biopsy by enzyme-linked immunosorbent assay. Results Plasma suPAR levels in IgAN patients with or without S lesions did not differ significantly (P = 0.411). However, suPAR levels were positively correlated with proteinuria (r = 0.202, P < 0.001), and negatively correlated with estimated glomerular filtration rate (eGFR, r = -0.236, P < 0.001). In the partial correlation to adjust for eGFR, plasma suPAR levels remained positively correlated with proteinuria (r = 0.112, P = 0.023). In a Cox proportional hazards model, higher levels of plasma suPAR were not associated with poor renal outcome. Plasma suPAR levels of IgAN and primary FSGS patients with nephrotic syndrome were not significantly different (P = 0.306). Plasma suPAR levels in patients with extensive effacement of the epithelial cell foot processes of glomerular podocytes were significantly higher than those with segmental effacement on the basis of comparable eGFR (P = 0.036). Conclusions In IgAN patients, plasma suPAR levels were not associated with S lesions. However, they were positively associated with proteinuria and negatively associated with eGFR. In addition, plasma suPAR levels were positively associated with the effacement degree of the foot processes, which might partially contribute to the development of proteinuria in patients with IgAN.	[Zhao, Yanfeng; Liu, Lijun; Huang, Jing; Shi, Sufang; Lv, Jicheng; Liu, Gang; Zhao, Minghui; Zhang, Hong] Peking Univ, Div Renal, Dept Med, Hosp 1, Beijing 100871, Peoples R China; [Zhao, Yanfeng; Liu, Lijun; Huang, Jing; Shi, Sufang; Lv, Jicheng; Liu, Gang; Zhao, Minghui; Zhang, Hong] Peking Univ, Inst Nephrol, Beijing 100871, Peoples R China; [Zhao, Yanfeng; Liu, Lijun; Huang, Jing; Shi, Sufang; Lv, Jicheng; Liu, Gang; Zhao, Minghui; Zhang, Hong] Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China; [Zhao, Yanfeng; Liu, Lijun; Huang, Jing; Shi, Sufang; Lv, Jicheng; Liu, Gang; Zhao, Minghui; Zhang, Hong] Peking Univ, Key Lab Chron Kidney Dis Prevent & Treatment, Minist Educ, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Liu, LJ (corresponding author), Peking Univ, Div Renal, Dept Med, Hosp 1, Beijing 100871, Peoples R China.	lijun.liu@medmail.com.cn			National Natural Science Foundation of China [81100503, 81370809, 81021004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (No. 81100503), the National Natural Science Foundation of China (No. 81370809) and Natural Science Foundation of China to the Innovation Research Group (81021004).	[Anonymous], 1982, KIDNEY INT, V22, P643; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Coppo R, 2014, KIDNEY INT, V86, P828, DOI 10.1038/ki.2014.63; D'Amico G, 2000, AM J KIDNEY DIS, V36, P227, DOI 10.1053/ajkd.2000.8966; DAMICO G, 1987, Q J MED, V64, P709; Deegens JK, 2014, NAT REV NEPHROL, V10, P431, DOI 10.1038/nrneph.2014.113; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; El Karoui K, 2011, KIDNEY INT, V79, P643, DOI 10.1038/ki.2010.460; Haas M, 1997, AM J KIDNEY DIS, V29, P829, DOI 10.1016/S0272-6386(97)90456-X; Haas M, 1996, AM J KIDNEY DIS, V28, P365, DOI 10.1016/S0272-6386(96)90493-X; Harita Y, 2014, PEDIATR NEPHROL, V29, P1553, DOI 10.1007/s00467-014-2808-5; Huang J, 2013, KIDNEY INT, V84, P366, DOI 10.1038/ki.2013.55; Kidney Diseases Improving Global Outcomes (KDIGO), 2012, KIDNEY INT S, V2, P259, DOI DOI 10.1038/KISUP.2012.30; Lee JH, 2014, KOREAN J INTERN MED, V29, P176, DOI 10.3904/kjim.2014.29.2.176; LEE SMK, 1982, HUM PATHOL, V13, P314, DOI 10.1016/S0046-8177(82)80221-9; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lv JC, 2013, AM J KIDNEY DIS, V62, P891, DOI 10.1053/j.ajkd.2013.04.021; Meijers B, 2014, KIDNEY INT, V85, P636, DOI 10.1038/ki.2013.505; Musetti C, 2014, J NEPHROL; Packham DK, 1996, CLIN NEPHROL, V46, P225; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Shi SF, 2011, CLIN J AM SOC NEPHRO, V6, P2175, DOI 10.2215/CJN.11521210; Shushakova N, 2005, J CELL SCI, V118, P2743, DOI 10.1242/jcs.02409; Sinha A, 2014, KIDNEY INT, V85, P649, DOI 10.1038/ki.2013.546; Sinniah R, 1984, Contrib Nephrol, V40, P156; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Spinale JM, 2014, KIDNEY INT; Spinale JM, 2015, KIDNEY INT, V87, P564, DOI 10.1038/ki.2014.346; Trachtman H, 2014, NAT REV NEPHROL, V10, P610, DOI 10.1038/nrneph.2014.113-c1; Weber CL, 2009, NEPHROL DIAL TRANSPL, V24, P483, DOI 10.1093/ndt/gfn513; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Zeng CH, 2012, AM J KIDNEY DIS, V60, P812, DOI 10.1053/j.ajkd.2012.06.011	33	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132869	10.1371/journal.pone.0132869	http://dx.doi.org/10.1371/journal.pone.0132869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167688	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100090
J	Arriagada, RA; Sills, EO; Ferraro, PJ; Pattanayak, SK				Arriagada, R. A.; Sills, E. O.; Ferraro, P. J.; Pattanayak, S. K.			Do Payments Pay Off? Evidence from Participation in Costa Rica's PES Program	PLOS ONE			English	Article							ENVIRONMENTAL SERVICES; ECOSYSTEM SERVICES; MULTIPLE IMPUTATION; FOREST CONSERVATION; BIODIVERSITY; IMPLEMENTATION; MANAGEMENT; EFFICIENCY; MECHANISM; STANDARDS	Payments for environmental services (PES) are often viewed as a way to simultaneously improve conservation outcomes and the wellbeing of rural households who receive the payments. However, evidence for such win-win outcomes has been elusive. We add to the growing literature on conservation program impacts by using primary household survey data to evaluate the socioeconomic impacts of participation in Costa Rica's PES program. Despite the substantial cash transfers to voluntary participants in this program, we do not detect any evidence of impacts on their wealth or self-reported well-being using a quasi-experimental design. These results are consistent with the common claim that voluntary PES do not harm participants, but they beg the question of why landowners participate if they do not benefit. Landowners in our sample voluntarily renewed their contracts after five years in the program and thus are unlikely to have underestimated their costs of participation. They apparently did not invest additional income from the program in farm inputs such as cattle or hired labor, since both decreased as a result of participation. Nor do we find evidence that participation encouraged moves off-farm. Instead, semi-structured interviews suggest that participants joined the program to secure their property rights and contribute to the public good of forest conservation. Thus, in order to understand the social impacts of PES, we need to look beyond simple economic rationales and material outcomes.	[Arriagada, R. A.] Pontificia Univ Catolica Chile, Dept Agr Econ, Ctr Appl Ecol & Sustainabil CAPES, Millennium Nucl Ctr Socioecon Impact Environm, Santiago, Chile; [Sills, E. O.] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Ferraro, P. J.] Georgia State Univ, Dept Econ, Andrew Young Sch Policy Studies, Atlanta, GA 30303 USA; [Pattanayak, S. K.] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA; [Pattanayak, S. K.] Duke Univ, Nicholas Sch Environm, Durham, NC USA	Pontificia Universidad Catolica de Chile; University of North Carolina; North Carolina State University; University System of Georgia; Georgia State University; Duke University; Duke University	Arriagada, RA (corresponding author), Pontificia Univ Catolica Chile, Dept Agr Econ, Ctr Appl Ecol & Sustainabil CAPES, Millennium Nucl Ctr Socioecon Impact Environm, Ave Vicuna Mackenna 4860, Santiago, Chile.	rarriagadac@uc.cl	Ferraro, Paul J/B-4435-2014	Ferraro, Paul J/0000-0002-4777-5108; Sills, Erin/0000-0001-8289-0489	National Science Foundation [SES-0519194]; Fondo Nacional de Financiamiento Forestal (FONAFIFO-Costa Rica)	National Science Foundation(National Science Foundation (NSF)); Fondo Nacional de Financiamiento Forestal (FONAFIFO-Costa Rica)	This work was supported by the National Science Foundation (SES-0519194) (EOS), and Fondo Nacional de Financiamiento Forestal (FONAFIFO-Costa Rica) (EOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca P, 2007, INDICE DESARROLLO SO; Alix-Garcia JM, 2012, LAND ECON, V88, P613, DOI 10.3368/le.88.4.613; Andam KS, 2010, P NATL ACAD SCI USA, V107, P9996, DOI 10.1073/pnas.0914177107; [Anonymous], 2003, REV INCOME WEALTH; Arriagada R. A., 2009, Journal of Sustainable Forestry, V28, P343, DOI 10.1080/10549810802701192; Arriagada RA, 2008, THESIS N CAROLINA ST; Arriagada RA, 2012, LAND ECON, V88, P382, DOI 10.3368/le.88.2.382; Baser O, 2006, VALUE HEALTH, V9, P377, DOI 10.1111/j.1524-4733.2006.00130.x; Bauch SC, 2014, WORLD DEV, V64, pS135, DOI 10.1016/j.worlddev.2014.03.009; Blackman A, 2010, ECOL ECON, V69, P1626, DOI 10.1016/j.ecolecon.2010.03.004; Cole RJ, 2010, INT J SUST DEV WORLD, V17, P208, DOI 10.1080/13504501003729085; Daniels AE, 2010, ECOL ECON, V69, P2116, DOI 10.1016/j.ecolecon.2010.06.011; Engel S, 2008, ECOL ECON, V65, P663, DOI 10.1016/j.ecolecon.2008.03.011; Ferraro PJ, 2008, ECOL ECON, V65, P810, DOI 10.1016/j.ecolecon.2007.07.029; Ferraro PJ, 2012, REV ENV ECON POLICY, V6, P20, DOI 10.1093/reep/rer019; Ferraro PJ, 2002, LAND ECON, V78, P339, DOI 10.2307/3146894; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fisher B, 2007, ECOL ECON, V62, P93, DOI 10.1016/j.ecolecon.2006.05.020; Greiner R, 2013, LAND USE POLICY, V31, P4, DOI 10.1016/j.landusepol.2011.11.012; Grieg-Gran M, 2005, WORLD DEV, V33, P1511, DOI 10.1016/j.worlddev.2005.05.002; Hartshorn G., 2005, EVALUATION WORLD BAN; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Imbens G., 2009, J ECON LIT, V48, P399; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Ingram JC, 2014, ECOSYST SERV, V7, P10, DOI 10.1016/j.ecoser.2013.12.003; Kolenikov S, 2009, REV INCOME WEALTH, V55, P128, DOI 10.1111/j.1475-4991.2008.00309.x; Larigauderie A, 2012, CURR OPIN ENV SUST, V4, P101, DOI 10.1016/j.cosust.2012.01.007; Legrand T, 2013, FOREST POLICY ECON, V37, P115, DOI 10.1016/j.forpol.2013.06.016; Locatelli B, 2008, FOREST POLICY ECON, V10, P275, DOI 10.1016/j.forpol.2007.11.007; Mainka SA, 2008, ENVIRONMENT, V50, P42, DOI 10.3200/ENVT.50.2.42-55; McGinley K, 2003, FOREST POLICY ECON, V5, P421, DOI 10.1016/S1389-9341(03)00040-6; Milder JC, 2010, ECOL SOC, V15; Miranda M., 2003, SOCIAL IMPACTS PAYME; Miteva DA, 2012, OXFORD REV ECON POL, V28, P69, DOI 10.1093/oxrep/grs009; Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118; Mullan K, 2014, FIELD METHOD, V26, P223, DOI 10.1177/1525822X13510370; Munoz Calvo R, 2004, THESIS U COSTA RICA; Muradian R, 2010, ECOL ECON, V69, P1202, DOI 10.1016/j.ecolecon.2009.11.006; Ortiz E, 1992, INFORME AVANCE ESTRA; Ortiz E., 2004, KUR REV FORESTAL, V1, P1; Pagiola S, 2008, ECOL ECON, V65, P712, DOI 10.1016/j.ecolecon.2007.07.033; Pagiola S, 2010, ENVIRON RESOUR ECON, V47, P371, DOI 10.1007/s10640-010-9383-4; Pannell DJ, 2008, LAND ECON, V84, P225, DOI 10.3368/le.84.2.225; Pattanayak SK, 2010, REV ENV ECON POLICY, V4, P254, DOI 10.1093/reep/req006; Persson UM, 2013, WORLD DEV, V43, P124, DOI 10.1016/j.worlddev.2012.10.006; Pfaff A, 2012, OXFORD REV ECON POL, V28, P164, DOI 10.1093/oxrep/grs012; Porras I., 2013, LEARNING 20 YEARS PA; Robalino J, 2013, LAND ECON, V89, P432, DOI 10.3368/le.89.3.432; Robalino JA, 2007, ENVIRON DEV ECON, V12, P521, DOI 10.1017/S1355770X07003671; Robalino JA, 2012, J DEV ECON, V97, P427, DOI 10.1016/j.jdeveco.2011.06.003; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; Rubin DB, 2004, MULTIPLE IMPUTATION; Samii C., 2014, CAMPBELL SYSTEMATIC, V11; Sanchez-Azofeifa GA, 2007, CONSERV BIOL, V21, P1165, DOI 10.1111/j.1523-1739.2007.00751.x; Sierra R, 2006, ECOL ECON, V59, P131, DOI 10.1016/j.ecolecon.2005.10.010; Snider AG, 2003, J FOREST, V101, P18; Sunderlin WD, 2008, ECOL SOC, V13; Uchida E, 2009, AM J AGR ECON, V91, P70, DOI 10.1111/j.1467-8276.2008.01184.x; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Weber JG, 2011, LAND ECON, V87, P661, DOI 10.3368/le.87.4.661; Wunder S, 2007, CONSERV BIOL, V21, P48, DOI 10.1111/j.1523-1739.2006.00559.x; Zbinden S, 2005, WORLD DEV, V33, P255, DOI 10.1016/j.worlddev.2004.07.012; Zhang W, 2011, ENVIRON CONSERV, V38, P406, DOI 10.1017/S0376892911000555; Zilberman D, 2008, ENVIRON DEV ECON, V13, P255, DOI 10.1017/S1355770X08004294	64	55	55	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131544	10.1371/journal.pone.0131544	http://dx.doi.org/10.1371/journal.pone.0131544			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26162000	Green Published, gold			2022-12-27	WOS:000358162300044
J	Gouleme, N; Gerard, CL; Bucci, MP				Gouleme, Nathalie; Gerard, Christophe-Loic; Bucci, Maria Pia			The Effect of Training on Postural Control in Dyslexic Children	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; BALANCE; PERFORMANCE; PARAMETERS; PLATFORM; GAIT	The aim of this study was to explore whether a short postural training period could affect postural stability in dyslexic children. Postural performances were evaluated using Multitest Equilibre from Framiral. Posture was recorded in three different viewing conditions (eyes open fixating a target, eyes closed and eyes open with perturbed vision) and in two different postural conditions (on stable and unstable support). Two groups of dyslexic children participated in the study, i.e. G1:16 dyslexic participants (mean age 9.9 +/- 0.3 years) who performed short postural training and G2: 16 dyslexic participants of similar ages (mean age 9.1 +/- 0.3 years) who did not perform any short postural training. Findings showed that short postural training improved postural stability on unstable support surfaces with perturbed vision: indeed the surface, the mean velocity of CoP and the spectral power indices in both directions decreased significantly, and the cancelling time in the antero-posterior direction improved significantly. Such improvement could be due to brain plasticity, which allows better performance in sensory process and cerebellar integration.	[Gouleme, Nathalie; Bucci, Maria Pia] Paris Diderot Univ, UMR 1141, INSERM, Robert Debre Hosp, Paris, France; [Gerard, Christophe-Loic] Hop Robert Debre, Child & Adolescent Psychiat Dept, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Gouleme, N (corresponding author), Paris Diderot Univ, UMR 1141, INSERM, Robert Debre Hosp, Paris, France.	gouleme.nathalie@gmail.com		Gouleme, Nathalie/0000-0002-0246-973X	Fondation Cotrel / Institut de France	Fondation Cotrel / Institut de France	The authors are grateful to the Fondation Cotrel / Institut de France for their financial support.	Abd El-Kafy EM, 2014, AM J PHYS MED REHAB, V93, P938, DOI 10.1097/PHM.0000000000000109; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Angulo-Barroso RM, 2013, RES DEV DISABIL, V34, P3629, DOI 10.1016/j.ridd.2013.07.037; Barela JA, 2011, RES DEV DISABIL, V32, P1814, DOI 10.1016/j.ridd.2011.03.011; Barge L, 2007, EXPLORATION REEDUCAT, P8; Bernard-Demanze L, 2009, Curr Aging Sci, V2, P139; Brandt T, 2003, VERTIGO ITS MULTISEN, P503; Bucci MP, 2012, EXP BRAIN RES, V222, P21, DOI 10.1007/s00221-012-3192-7; Bucci M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057801; Burciu RG, 2013, J NEUROSCI, V33, P4594, DOI 10.1523/JNEUROSCI.3381-12.2013; Chevrie-Muller C, 1997, BATTERIE LANGUAGE OR; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Eckert MA, 2003, BRAIN, V126, P482, DOI 10.1093/brain/awg026; Faigenbaum AD, 2013, J STRENGTH COND RES, V27, P323, DOI 10.1519/JSC.0b013e31827e135b; Fawcett A, 1999, REV ELECT INVEST PSI, V2, P35; GEURTS ACH, 1993, ARCH PHYS MED REHAB, V74, P1144; Ghulyan V, 2005, ACTA OTO-LARYNGOL, V125, P607, DOI 10.1080/00016480510026908; Gouleme N, 2015, CLIN NEUROPHYSIOL, V126, P1370, DOI 10.1016/j.clinph.2014.10.016; Ilg W, 2009, NEUROLOGY, V73, P1823, DOI 10.1212/WNL.0b013e3181c33adf; Ilg W, 2010, MOVEMENT DISORD, V25, P2239, DOI 10.1002/mds.23222; Ionescu E, 2006, INT J PEDIATR OTORHI, V70, P1457, DOI 10.1016/j.ijporl.2006.03.012; Katz-Leurer M, 2009, CLIN REHABIL, V23, P714, DOI 10.1177/0269215509335293; KohenRaz R, 1996, PERCEPT MOTOR SKILL, V82, P547, DOI 10.2466/pms.1996.82.2.547; Konczak J, 2005, BRAIN, V128, P1428, DOI 10.1093/brain/awh385; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Legrand A, 2021, PLOS ONE, V7, P1; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; Miyai I, 2012, NEUROREHAB NEURAL RE, V26, P515, DOI 10.1177/1545968311425918; Moe-Nilssen R, 2003, EXP BRAIN RES, V150, P237, DOI 10.1007/s00221-003-1450-4; Naschner LN, 2008, PROGR BRAIN RES, V1979, P177; Nicolson RI, 2007, TRENDS NEUROSCI, V30, P135, DOI 10.1016/j.tins.2007.02.003; O'Hare Anne, 2002, Dyslexia, V8, P234, DOI 10.1002/dys.230; Paillard T, 2002, BRIT J SPORT MED, V36, P304, DOI 10.1136/bjsm.36.4.304; Perennou D, 2006, EFFICIENCE DEFICIENC, P65; Pozzo T, 2006, NEUROSCI LETT, V403, P211, DOI 10.1016/j.neulet.2006.03.049; Rae C, 1998, LANCET, V351, P1849, DOI 10.1016/S0140-6736(97)99001-2; Reynolds D, 2003, DYSLEXIA, V9, P48, DOI 10.1002/dys.235; Sehm B, 2014, NEUROBIOL AGING, V35, P232, DOI 10.1016/j.neurobiolaging.2013.06.021; Stoodley CJ, 2005, EXP BRAIN RES, V167, P370, DOI 10.1007/s00221-005-0042-x; Taubert M, 2010, J NEUROSCI, V30, P11670, DOI 10.1523/JNEUROSCI.2567-10.2010; Viana AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072719; Vieira S, 2009, NEUROSCI LETT, V462, P125, DOI 10.1016/j.neulet.2009.06.093; Woollacott MH, 1989, DEV POSTURE GAIT LIF, P77; YAP RL, 1994, J LEARN DISABIL, V27, P660, DOI 10.1177/002221949402701006; Zech A, 2014, EUR J APPL PHYSIOL, V114, P395, DOI 10.1007/s00421-013-2786-5	45	8	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130196	10.1371/journal.pone.0130196	http://dx.doi.org/10.1371/journal.pone.0130196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26162071	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300015
J	Hansen, GAW; Ludvigsen, M; Jacobsen, C; Cangemi, C; Rasmussen, LM; Vorum, H; Honore, B				Hansen, Gry Aune Westergaard; Ludvigsen, Maja; Jacobsen, Christian; Cangemi, Claudia; Rasmussen, Lars Melholt; Vorum, Henrik; Honore, Bent			Fibulin-1C, C1 Esterase Inhibitor and Glucose Regulated Protein 75 Interact with the CREC Proteins, Calumenin and Reticulocalbin	PLOS ONE			English	Article							MULTIPLE EF-HAND; CALCIUM-BINDING PROTEIN; ENDOPLASMIC-RETICULUM; CA2+-BINDING PROTEIN; EXTRACELLULAR CALUMENIN; SECRETORY PATHWAY; POTENTIAL ROLE; EXPRESSION; FAMILY; LOCALIZATION	Affinity purification, immunoprecipitation, gel electrophoresis and mass spectrometry were used to identify fibulin-1C, C1 esterase inhibitor and glucose regulated protein 75, grp75, as binding partners of the CREC proteins, calumenin and reticulocalbin. Surface plasmon resonance was used to verify the interaction of all three proteins with each of the CREC proteins. Fibulin-1C interacts with calumenin and reticulocalbin with an estimated dissociation constant around 50-60 nM. The interaction, at least for reticulocalbin, was not dependent upon the presence of Ca2+. C1 esterase inhibitor interacted with both proteins with an estimated dissociation constant at 1 mu M for reticulocalbin and 150 nM for calumenin. The interaction, at least for calumenin, was dependent upon the presence of Ca2+ with strong interaction at 3.5 mM while no detectable interaction could be found at 0.1 mM. Grp75 binds with an affinity of approximately 3-7 nM with reticulocalbin as well as with calumenin. These interactions suggest functional participation of the CREC proteins in chaperone activity, cell proliferation and transformation, cellular aging, haemostasis and thrombosis as well as modulation of the complement system in fighting bacterial infection.	[Hansen, Gry Aune Westergaard; Ludvigsen, Maja; Jacobsen, Christian; Honore, Bent] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Cangemi, Claudia; Rasmussen, Lars Melholt] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Ctr Individualized Med Arterial Dis CIMA, DK-5000 Odense C, Denmark; [Vorum, Henrik] Aalborg Univ Hosp, Dept Ophthalmol, DK-9100 Aalborg, Denmark	Aarhus University; University of Southern Denmark; Odense University Hospital; Aalborg University; Aalborg University Hospital	Honore, B (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 3,Bldg 1182, DK-8000 Aarhus C, Denmark.	bh@biomed.au.dk	Honoré, Bent/ABF-3650-2021	Honore, Bent/0000-0002-3459-7429; Ludvigsen, Maja/0000-0001-5089-3271; Rasmussen, Lars Melholt/0000-0001-5795-4794	Danish Medical Research Council [52-00-1004, 22-01-0249]; Novo Nordic Foundation; Danish Cancer Foundation [DS 02 071]; Danish Heart Foundation [08-4-R64-A2008-B894-22450]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordic Foundation(Novo Nordisk Foundation); Danish Cancer Foundation(Danish Cancer Society); Danish Heart Foundation	The Danish Medical Research Council (Grant 52-00-1004 and 22-01-0249, BH). The Novo Nordic Foundation (BH). The Danish Cancer Foundation (Grant DS 02 071, GAWH). The Danish Heart Foundation (Grant 08-4-R64-A2008-B894-22450, GAWH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Cangemi C, 2014, ADV CLIN CHEM, V67, P245, DOI 10.1016/bs.acc.2014.09.008; Cangemi C, 2011, CLIN CHEM, V57, P1556, DOI 10.1373/clinchem.2011.162966; Carper D, 2001, FREE RADICAL BIO MED, V31, P90, DOI 10.1016/S0891-5849(01)00561-5; CHEN JJ, 1995, SCIENCE, V269, P529, DOI 10.1126/science.7624774; Chen L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.193; Clinton GM, 1996, P NATL ACAD SCI USA, V93, P316, DOI 10.1073/pnas.93.1.316; Cooper CR, 2008, J CELL BIOCHEM, V104, P2298, DOI 10.1002/jcb.21785; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; Davis A E 3rd, 1989, Immunodefic Rev, V1, P207; Davis AE, 2004, ADV IMMUNOL, V82, P331, DOI 10.1016/S0065-2776(04)82008-X; Feng H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.403; Godyna S, 1996, BLOOD, V88, P2569, DOI 10.1182/blood.V88.7.2569.bloodjournal8872569; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Hansen GAW, 2009, MOL CELL BIOCHEM, V320, P25, DOI 10.1007/s11010-008-9895-1; Honore B, 2004, EXP CELL RES, V295, P91, DOI 10.1016/j.yexcr.2003.11.029; Honore B, 2000, FEBS LETT, V466, P11, DOI 10.1016/S0014-5793(99)01780-9; Honore B, 2009, BIOESSAYS, V31, P262, DOI 10.1002/bies.200800186; Hseu MJ, 1999, FEBS LETT, V445, P440, DOI 10.1016/S0014-5793(99)00177-5; Huang YH, 2002, PROTEOMICS, V2, P1220, DOI 10.1002/1615-9861(200209)2:9<1220::AID-PROT1220>3.0.CO;2-3; Jung DH, 2006, BIOCHEM BIOPH RES CO, V343, P34, DOI 10.1016/j.bbrc.2006.02.115; Jung DH, 2004, GENE, V327, P185, DOI 10.1016/j.gene.2003.10.014; Lam PPL, 2007, MOL BIOL CELL, V18, P2473, DOI 10.1091/mbc.E06-10-0950; Liu ZD, 1997, BIOCHEM BIOPH RES CO, V231, P283, DOI 10.1006/bbrc.1997.6083; Ludvigsen M, 2009, PROTEOMICS, V9, P5267, DOI 10.1002/pmic.200900321; Nimmrich I, 2000, CANCER LETT, V160, P37, DOI 10.1016/S0304-3835(00)00553-X; Ostergaard M, 2006, PROTEOMICS, V6, P3509, DOI 10.1002/pmic.200500686; OZAWA M, 1995, J BIOCHEM-TOKYO, V117, P1113, DOI 10.1093/oxfordjournals.jbchem.a124815; OZAWA M, 1993, J BIOL CHEM, V268, P699; Pan TC, 1999, FEBS LETT, V444, P38, DOI 10.1016/S0014-5793(99)00024-1; Ran QT, 2000, BIOCHEM BIOPH RES CO, V275, P174, DOI 10.1006/bbrc.2000.3237; Sahoo SK, 2010, BMB REP, V43, P158, DOI 10.5483/BMBRep.2010.43.3.158; Sahoo SK, 2009, J BIOL CHEM, V284, P31109, DOI 10.1074/jbc.M109.031989; Scherer PE, 1996, J CELL BIOL, V133, P257, DOI 10.1083/jcb.133.2.257; Teng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040173; TRAN H, 1995, J BIOL CHEM, V270, P19458, DOI 10.1074/jbc.270.33.19458; Tsuji A, 2006, BIOCHEM J, V396, P51, DOI 10.1042/BJ20051524; TYEDMERS J, 2005, J BIOL SCI, V5, P70; Voora D, 2010, CLIN PHARMACOL THER, V87, P445, DOI 10.1038/clpt.2009.291; Vorum H, 2000, FEBS LETT, V465, P129, DOI 10.1016/S0014-5793(99)01734-2; Vorum H, 1999, EXP CELL RES, V248, P473, DOI 10.1006/excr.1999.4431; Vorum H, 1998, BBA-PROTEIN STRUCT M, V1386, P121, DOI 10.1016/S0167-4838(98)00089-2; WADHWA R, 1993, J BIOL CHEM, V268, P6615; Wajih N, 2004, J BIOL CHEM, V279, P25276, DOI 10.1074/jbc.M401645200; Wallin R, 2001, FASEB J, V15, P2542, DOI 10.1096/fj.01-0337fje; Wang Q, 2015, ONCOGENE, V34, P1006, DOI 10.1038/onc.2014.52; Wang QC, 2012, ADV GENET ENG BIOTEC, V1, P1, DOI [DOI 10.4172/AGEB.1000E101, 10.4172/2324-9021.1000e101, DOI 10.4172/2324-9021.1000E101]; WEIS K, 1994, J BIOL CHEM, V269, P19142; Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232; Yu LR, 2000, ELECTROPHORESIS, V21, P3058, DOI 10.1002/1522-2683(20000801)21:14<3058::AID-ELPS3058>3.0.CO;2-U	50	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132283	10.1371/journal.pone.0132283	http://dx.doi.org/10.1371/journal.pone.0132283			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161649	gold, Green Published			2022-12-27	WOS:000358162300113
J	Heckemann, RA; Ledig, C; Gray, KR; Aljabar, P; Rueckert, D; Hajnal, JV; Hammers, A				Heckemann, Rolf A.; Ledig, Christian; Gray, Katherine R.; Aljabar, Paul; Rueckert, Daniel; Hajnal, Joseph V.; Hammers, Alexander			Brain Extraction Using Label Propagation and Group Agreement: Pincram	PLOS ONE			English	Article							AUTOMATIC SEGMENTATION; INTRACRANIAL VOLUME; ATLAS; FUSION	Accurately delineating the brain on magnetic resonance (MR) images of the head is a prerequisite for many neuroimaging methods. Most existing methods exhibit disadvantages in that they are laborious, yield inconsistent results, and/or require training data to closely match the data to be processed. Here, we present pincram, an automatic, versatile method for accurately labelling the adult brain on T1-weighted 3D MR head images. The method uses an iterative refinement approach to propagate labels from multiple atlases to a given target image using image registration. At each refinement level, a consensus label is generated. At the subsequent level, the search for the brain boundary is constrained to the neighbourhood of the boundary of this consensus label. The method achieves high accuracy (Jaccard coefficient > 0.95 on typical data, corresponding to a Dice similarity coefficient of > 0.97) and performs better than many state-of-the-art methods as evidenced by independent evaluation on the Segmentation Validation Engine. Via a novel self-monitoring feature, the program generates the " success index," a scalar metadatum indicative of the accuracy of the output label. Pincram is available as open source software.	[Heckemann, Rolf A.] Sahlgrens Univ Hosp, MedTech West, Gothenburg, Sweden; [Heckemann, Rolf A.] Gothenburg Univ, Inst Neurosci & Physiol, Gothenburg, Sweden; [Heckemann, Rolf A.] Univ London Imperial Coll Sci Technol & Med, Ctr Brain Sci, London, England; [Heckemann, Rolf A.; Hammers, Alexander] Neurodis Fdn, Lyon, France; [Ledig, Christian; Gray, Katherine R.; Aljabar, Paul; Rueckert, Daniel] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England; [Aljabar, Paul; Hajnal, Joseph V.; Hammers, Alexander] Kings Coll London, Imaging Sci & Biomed Engn, London, England	Sahlgrenska University Hospital; University of Gothenburg; Imperial College London; Imperial College London; University of London; King's College London	Heckemann, RA (corresponding author), Sahlgrens Univ Hosp, MedTech West, Gothenburg, Sweden.	rolf.heckemann@medtechwest.se	Heckemann, Rolf Andreas/H-9022-2019; Hajnal, Joseph/P-6251-2018; Hammers, Alexander/D-9982-2015	Heckemann, Rolf Andreas/0000-0003-3582-3683; Hajnal, Joseph/0000-0002-2690-5495; Ledig, Christian/0000-0003-4862-3138; Hammers, Alexander/0000-0001-9530-4848	National Institutes of Health [P50 AG05681, P01 AG03991, R01 AG021910, P50 MH071616, U24 RR021382, R01 MH56584]; MRC [MR/K006355/1] Funding Source: UKRI; Medical Research Council [MR/K006355/1] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH071616, R01MH056584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003991, R01AG021910, P50AG005681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The following National Institutes of Health grants enabled the creation of the OASIS resource: P50 AG05681, P01 AG03991, R01 AG021910, P50 MH071616, U24 RR021382, R01 MH56584.	Aljabar P, 2007, LECT NOTES COMPUT SC, V4791, P523; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BAJCSY R, 1983, J COMPUT ASSIST TOMO, V7, P618, DOI 10.1097/00004728-198308000-00008; Eritaia J, 2000, MAGN RESON MED, V44, P973, DOI 10.1002/1522-2594(200012)44:6<973::AID-MRM21>3.0.CO;2-H; Eskildsen SF, 2012, NEUROIMAGE, V59, P2362, DOI 10.1016/j.neuroimage.2011.09.012; Freeborough PA, 1997, COMPUT METH PROG BIO, V53, P15, DOI 10.1016/S0169-2607(97)01803-8; Gousias I. S., 2012, Proceedings of the 2012 IEEE International Conference on Imaging Systems and Techniques (IST), P95, DOI 10.1109/IST.2012.6295511; Gousias I. S., 2010, 2010 IEEE International Conference on Imaging Systems and Techniques (IST 2010), P290, DOI 10.1109/IST.2010.5548493; Gousias IS, 2008, NEUROIMAGE, V40, P672, DOI 10.1016/j.neuroimage.2007.11.034; Gousias IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059990; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Heckemann RA, 2010, NEUROIMAGE, V51, P221, DOI 10.1016/j.neuroimage.2010.01.072; Huang MY, 2014, NEUROIMAGE, V92, P322, DOI 10.1016/j.neuroimage.2014.01.059; Keihaninejad S, 2010, NEUROIMAGE, V50, P1427, DOI 10.1016/j.neuroimage.2010.01.064; Landman B., 2012, MICCAI GRAND CHALLEN; Langerak TR, 2010, IEEE T MED IMAGING, V29, P2000, DOI 10.1109/TMI.2010.2057442; Lemieux L, 2003, MAGN RESON MED, V49, P872, DOI 10.1002/mrm.10436; Leung KK, 2011, NEUROIMAGE, V55, P1091, DOI 10.1016/j.neuroimage.2010.12.067; Manjon JV, 2014, INT J BIOMED IMAGING, V2014, DOI 10.1155/2014/820205; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Shattuck DW, 2009, NEUROIMAGE, V45, P431, DOI 10.1016/j.neuroimage.2008.10.066; Shi WZ, 2013, MED IMAGE ANAL, V17, P779, DOI 10.1016/j.media.2013.04.010; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908	29	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0129211	10.1371/journal.pone.0129211	http://dx.doi.org/10.1371/journal.pone.0129211			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161961	gold, Green Published			2022-12-27	WOS:000358162300008
J	Li, WB; Wang, PP; Li, YG; Zhang, KX; Ding, FQ; Nie, TK; Yang, X; Lv, QX; Zhao, L				Li, Wenbin; Wang, Pengpeng; Li, Yongguang; Zhang, Kexin; Ding, Fuquan; Nie, Tengkun; Yang, Xue; Lv, Qingxue; Zhao, Lin			Identification of MicroRNAs in Response to Different Day Lengths in Soybean Using High-Throughput Sequencing and qRT-PCR	PLOS ONE			English	Article							SHOOT APICAL MERISTEM; GAMYB-LIKE GENES; SMALL RNAS; TRANSLATIONAL INHIBITION; FLORAL DEVELOPMENT; CIRCADIAN CLOCK; FLOWERING TIME; TARGET GENES; ARABIDOPSIS; EXPRESSION	MicroRNAs (miRNAs) are short, non-coding single-strand RNA molecules that play important roles in plant growth, development and stress responses. Flowering time affects the seed yield and quality of soybean. However, the miRNAs involved in the regulation of flowering time in soybean have not been reported until recently. Here, high-throughput sequencing and qRT-PCR were used to identify miRNAs involved in soybean photoperiodic pathways. The first trifoliate leaves of soybean that receive the signal of light treatment were used to construct six libraries (0, 8, and 16 h under short-day (SD) treatment and 0, 8, and 16 h under long-day (LD) treatment). The libraries were sequenced using Illumina Solexa. A total of 318 known plant miRNAs belonging to 163 miRNA families and 81 novel predicted miRNAs were identified. Among these, 23 miRNAs at 0 h, 65 miRNAs at 8 h and 83 miRNAs at 16 h, including six novel predicted miRNAs at 8 h and six novel predicted miRNAs at 16 h, showed differences in abundance between LD and SD treatments. Furthermore, the results of GO and KEGG analyses indicated that most of the miRNA targets were transcription factors. Seven miRNAs at 0 h, 23 miRNAs (including four novel predicted miRNAs) at 8 h, 16 miRNAs (including one novel predicted miRNA) at 16 h and miRNA targets were selected for qRT-PCR analysis to assess the accuracy of the sequencing and target prediction. The results indicated that the expression patterns of the selected miRNAs and miRNA targets showed no differences between the qRT-PCR and sequencing results. In addition, 23 miRNAs at 0 h, 65 miRNAs at 8 h and 83 miRNAs at 16 h responded to day length changes in soybean, including six novel predicted miRNAs at 8 h and six novel predicted miRNAs at 16 h. These results provided an important molecular basis to understand the regulation of flowering time through photoperiodic pathways in soybean.	[Li, Wenbin; Wang, Pengpeng; Li, Yongguang; Zhang, Kexin; Ding, Fuquan; Nie, Tengkun; Yang, Xue; Lv, Qingxue; Zhao, Lin] Northeast Agr Univ, Chinese Educ Minist, Key Lab Biol & Genet & Breeding Soybean Northeast, Key Lab Soybean Biol, Harbin 150030, Peoples R China	Northeast Agricultural University - China	Zhao, L (corresponding author), Northeast Agr Univ, Chinese Educ Minist, Key Lab Biol & Genet & Breeding Soybean Northeast, Key Lab Soybean Biol, Harbin 150030, Peoples R China.	zhaolinneau@126.com	zhang, ke/AAH-8217-2019; Li, Yongguang/ACM-0755-2022	Li, Yongguang/0000-0002-9171-2729	National 863 project [2013AA102602]; Chinese National Natural Science Foundation [31271748]; National education Ministry; Chinese Key Projects of Soybean Transformation [2014ZX08004-005]; Hei Longjiang Province Natural Science Foundation [C2015009]; Youth Backbone Research program of Provincial Education Department [1253G010]; "Young Talents" Project of Northeast Agricultural University [14QC23]; Northeast Agricultural University Innovation Foundation [yjscx14047]	National 863 project(National High Technology Research and Development Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National education Ministry; Chinese Key Projects of Soybean Transformation; Hei Longjiang Province Natural Science Foundation(Natural Science Foundation of Heilongjiang Province); Youth Backbone Research program of Provincial Education Department; "Young Talents" Project of Northeast Agricultural University; Northeast Agricultural University Innovation Foundation	The project was financially supported by National 863 project (2013AA102602), Chinese National Natural Science Foundation (31271748), National education Ministry for the teams of soybean molecular design, Chinese Key Projects of Soybean Transformation (2014ZX08004-005), Hei Longjiang Province Natural Science Foundation (C2015009), Youth Backbone Research program of Provincial Education Department (1253G010), "Young Talents" Project of Northeast Agricultural University (14QC23) Northeast Agricultural University Innovation Foundation For Postgraduate (yjscx14047).	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blazquez MA, 2000, NATURE, V404, P889, DOI 10.1038/35009125; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Cardon G, 1999, GENE, V237, P91, DOI 10.1016/S0378-1119(99)00308-X; Chen R, 2009, J INTEGR PLANT BIOL, V51, P1071, DOI 10.1111/j.1744-7909.2009.00887.x; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Fornara F, 2009, CELL, V138, P625, DOI 10.1016/j.cell.2009.08.011; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Garcia D, 2006, CURR BIOL, V16, P933, DOI 10.1016/j.cub.2006.03.064; Gocal GFW, 2001, PLANT PHYSIOL, V127, P1682, DOI 10.1104/pp.010442; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hao QN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-525; Hayama R, 2003, CURR OPIN PLANT BIOL, V6, P13, DOI 10.1016/S1369-5266(02)00011-0; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Joshi T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S14; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Khraiwesh Basel, 2012, Biochim Biophys Acta, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kim VN, 2004, TRENDS CELL BIOL, V14, P156, DOI 10.1016/j.tcb.2004.02.006; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Kulcheski FR, 2010, ANAL BIOCHEM, V406, P185, DOI 10.1016/j.ab.2010.07.020; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li MY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-242; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meng YJ, 2010, J EXP BOT, V61, P3833, DOI 10.1093/jxb/erq209; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Mutum RD, 2013, FEBS J, V280, P1717, DOI 10.1111/febs.12186; Nogueira FTS, 2007, GENE DEV, V21, P750, DOI 10.1101/gad.1528607; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Sha AH, 2012, J PLANT BIOL, V55, P268, DOI 10.1007/s12374-011-0255-4; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang YW, 2009, BIOCHEM BIOPH RES CO, V378, P799, DOI 10.1016/j.bbrc.2008.11.140; Wong CE, 2011, J EXP BOT, V62, P2495, DOI 10.1093/jxb/erq437; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Xu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028009; Yang ZF, 2008, GENE, V407, P1, DOI 10.1016/j.gene.2007.02.034; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Zeng QY, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-182; Zhao JP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047811, 10.1371/journal.pone.0048131]; Zhou CM, 2013, J GENET GENOMICS, V40, P211, DOI 10.1016/j.jgg.2012.12.003; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024	70	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132621	10.1371/journal.pone.0132621	http://dx.doi.org/10.1371/journal.pone.0132621			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162069	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300159
J	Rao, ES; Kadirvel, P; Symonds, RC; Geethanjali, S; Thontadarya, RN; Ebert, AW				Rao, Eguru Sreenivasa; Kadirvel, Palchamy; Symonds, Rachael C.; Geethanjali, Subramaniam; Thontadarya, Ramadihalli N.; Ebert, Andreas W.			Variations in DREB1A and VP1.1 Genes Show Association with Salt Tolerance Traits in Wild Tomato (Solanum pimpinellifolium)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SALINITY TOLERANCE; TRANSCRIPTION FACTORS; FUNCTIONAL-ANALYSIS; STRESS TOLERANCE; POPULATION-STRUCTURE; EXPRESSION; RICE; DROUGHT; PLANTS	Association analysis was conducted in a core collection of 94 genotypes of Solanum pimpinellifolium to identify variations linked to salt tolerance traits (physiological and yield traits under salt stress) in four candidate genes viz., DREB1A, VP1.1, NHX1, and TIP. The candidate gene analysis covered a concatenated length of 4594 bp per individual and identified five SNP/Indels in DREB1A and VP1.1 genes explaining 17.0% to 25.8% phenotypic variation for various salt tolerance traits. Out of these five alleles, one at 297 bp in DREB1A had in-frame deletion of 6 bp (CTGCAT) or 12 bp (CTGCATCTGCAT), resulting in two alleles, viz., SpDREB1A_297_6 and SpDREB1A_297_12. These alleles individually or as haplotypes accounted for maximum phenotypic variance of about 25% for various salt tolerance traits. Design of markers for selection of the favorable alleles/haplotypes will hasten markerassisted introgression of salt tolerance from S. pimpinellifolium into cultivated tomato.	[Rao, Eguru Sreenivasa; Thontadarya, Ramadihalli N.] ICAR Indian Inst Hort Res, Div Vegetable Crops, Bengaluru, India; [Kadirvel, Palchamy] ICAR Indian Inst Oilseeds Res, Crop Improvement Sect, Hyderabad, Andhra Pradesh, India; [Symonds, Rachael C.] Univ Nottingham, Sch Biosci, Selangor, Darul Ehsan, Malaysia; [Geethanjali, Subramaniam] Tamil Nadu Agr Univ, Dept Millets, Ctr Plant Breeding & Genet, Coimbatore 641003, Tamil Nadu, India; [Rao, Eguru Sreenivasa; Kadirvel, Palchamy; Symonds, Rachael C.; Geethanjali, Subramaniam; Ebert, Andreas W.] AVRDC, Genet Resources & Seed Unit, Tainan, Taiwan	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Horticultural Research; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Oilseeds Research; University of Nottingham Malaysia; Tamil Nadu Agricultural University	Ebert, AW (corresponding author), AVRDC, Genet Resources & Seed Unit, Tainan, Taiwan.	Andreas.ebert@worldveg.org	Ebert, Andreas/J-6613-2019; Palchamy, Kadirvel/AAN-5960-2020	Ebert, Andreas/0000-0001-8146-3813; Palchamy, Kadirvel/0000-0003-4907-2796	program "Better Opportunities for Young Scientists in Chosen Area of Science and Technology (BOYSCAST)"; Department of Science & Technology of the government of India; Global Theme Germplasm of AVRDC - The World Vegetable Center	program "Better Opportunities for Young Scientists in Chosen Area of Science and Technology (BOYSCAST)"; Department of Science & Technology of the government of India; Global Theme Germplasm of AVRDC - The World Vegetable Center	This study was partially funded by a grant provided to Dr. Eguru Sreenivasa Rao under the program "Better Opportunities for Young Scientists in Chosen Area of Science and Technology (BOYSCAST)". The grant was provided by the Department of Science & Technology of the government of India and covered Dr. Rao's travel costs and living expenses at AVRDC - The World Vegetable Center. All funding for the implementation of the experiments, such as equipment, greenhouse space, materials and chemicals, was provided by Global Theme Germplasm of AVRDC - The World Vegetable Center. The external and internal funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Akhtar M, 2012, J GENET, V91, P385, DOI 10.1007/s12041-012-0201-3; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; [Anonymous], 2014, AVRDC VEGETABLE GENE; [Anonymous], 1994, GENRES DATA ENTRY MO; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Bagge M, 2008, MOL BREEDING, V22, P319, DOI 10.1007/s11032-008-9190-6; BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; Barendse W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029601; Barragan V, 2012, PLANT CELL, V24, P1127, DOI 10.1105/tpc.111.095273; Bassil E, 2012, J EXP BOT, V63, P5727, DOI 10.1093/jxb/ers250; Bauchet G, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0279-2; Bharati Pandey, 2014, Australian Journal of Crop Science, V8, P44; Bhaskaran S, 2011, J EXP BOT, V62, P5561, DOI 10.1093/jxb/err237; Blanca J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048198; BOLARIN MC, 1991, J AM SOC HORTIC SCI, V116, P286, DOI 10.21273/JASHS.116.2.286; Bonilla P, 2002, PHILIPP AGRIC SCI, V85, P68; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Celebi-Toprak F, 2005, BREEDING SCI, V55, P311, DOI 10.1270/jsbbs.55.311; Cong L, 2008, PLANT SCI, V174, P156, DOI 10.1016/j.plantsci.2007.11.002; CUARTERO J, 1992, NEW PHYTOL, V121, P63, DOI 10.1111/j.1469-8137.1992.tb01093.x; EDAE EA, 2013, PLANT GENOME, V6, P1; Erskine W, 2014, CABI CLIM CHANGE SER, V4, P236, DOI 10.1079/9781780641973.0236; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Foolad MR, 2004, PLANT CELL TISS ORG, V76, P101, DOI 10.1023/B:TICU.0000007308.47608.88; Gamerman D, 2006, MARKOV CHAIN MONTE C; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Geethanjali S, 2011, EUPHYTICA, V178, P283, DOI 10.1007/s10681-010-0331-8; Gowda M, 2014, HEREDITY, V112, P552, DOI 10.1038/hdy.2013.139; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamwieh A, 2011, EUPHYTICA, V179, P451, DOI 10.1007/s10681-011-0347-8; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hsieh TH, 2002, PLANT PHYSIOL, V130, P618, DOI 10.1104/pp.006783; Huang XS, 2011, J EXP BOT, V62, P5191, DOI 10.1093/jxb/err229; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Galvez FJ, 2012, PLANT PHYSIOL BIOCH, V51, P109, DOI 10.1016/j.plaphy.2011.10.012; Jia L, 2012, PLOS ONE, V7, P1; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kumar V, 2015, DNA RES, V22, P133, DOI 10.1093/dnares/dsu046; Latini A, 2007, ANN APPL BIOL, V150, P187, DOI 10.1111/j.1744-7348.2007.00128.x; Leidi EO, 2010, PLANT J, V61, P495, DOI 10.1111/j.1365-313X.2009.04073.x; Li YL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-146; Linh Le Hung, 2012, Int J Plant Genomics, V2012, P949038, DOI 10.1155/2012/949038; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Matsukura S, 2010, MOL GENET GENOMICS, V283, P185, DOI 10.1007/s00438-009-0506-y; Munns R, 2003, PLANT SOIL, V253, P201, DOI 10.1023/A:1024553303144; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Negrao S, 2013, PLANT BIOTECHNOL J, V11, P87, DOI 10.1111/pbi.12010; Long NV, 2013, THEOR APPL GENET, V126, P2335, DOI 10.1007/s00122-013-2139-0; Olsen KM, 2002, GENETICS, V162, P941; Pardo JM, 2010, CURR OPIN BIOTECH, V21, P185, DOI 10.1016/j.copbio.2010.02.005; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Peleg Z, 2011, ADV BOT RES, V57, P405, DOI 10.1016/B978-0-12-387692-8.00012-6; Pritchard JK, 2000, GENETICS, V155, P945; Qi XP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5340; Qin F, 2004, PLANT CELL PHYSIOL, V45, P1042, DOI 10.1093/pcp/pch118; Qin F, 2007, PLANT J, V50, P54, DOI 10.1111/j.1365-313X.2007.03034.x; Ranc N, 2012, G3-GENES GENOM GENET, V2, P853, DOI 10.1534/g3.112.002667; Rao ES, 2013, EUPHYTICA, V190, P215, DOI 10.1007/s10681-012-0801-2; Rao ES, 2012, PLANT GENET RESOUR-C, V10, P38, DOI 10.1017/S1479262111000955; Reeves PA, 2012, THEOR APPL GENET, V124, P1155, DOI 10.1007/s00122-011-1776-4; Reuscher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079052; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Rozen S, 2000, Methods Mol Biol, V132, P365; Sade N, 2009, NEW PHYTOL, V181, P651, DOI 10.1111/j.1469-8137.2008.02689.x; SARAFIAN V, 1992, P NATL ACAD SCI USA, V89, P1775, DOI 10.1073/pnas.89.5.1775; Sauvage C, 2014, PLANT PHYSIOL, V165, P1120, DOI 10.1104/pp.114.241521; Scholberg JMS, 1999, HORTSCIENCE, V34, P259, DOI 10.21273/HORTSCI.34.2.259; SLAVICH PG, 1993, AUST J SOIL RES, V31, P73, DOI 10.1071/SR9930073; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; TAJIMA F, 1989, GENETICS, V123, P585; TAL M, 1983, AUST J PLANT PHYSIOL, V10, P109, DOI 10.1071/PP9830109; Tanaka Y, 1999, PLANT SCI, V148, P131, DOI 10.1016/S0168-9452(99)00133-8; Tavakkoli E, 2011, J EXP BOT, V62, P2189, DOI 10.1093/jxb/erq422; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Xin SC, 2014, J PLANT RES, V127, P695, DOI 10.1007/s10265-014-0658-7; Yu JM, 2009, PLANT GENOME-US, V2, P63, DOI 10.3835/plantgenome2008.09.0009; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zuriaga E, 2009, GENET RESOUR CROP EV, V56, P39, DOI 10.1007/s10722-008-9340-z	85	16	16	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132535	10.1371/journal.pone.0132535	http://dx.doi.org/10.1371/journal.pone.0132535			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161546	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300148
J	Sorensen, MJ; Kjaersgaard, MIS; Pedersen, HS; Vestergaard, M; Christensen, J; Olsen, J; Parner, E; Pedersen, LH; Bech, BH				Sorensen, Merete Juul; Kjaersgaard, Maiken Ina Siegismund; Pedersen, Henrik Sondergaard; Vestergaard, Mogens; Christensen, Jacob; Olsen, Jorn; Parner, Erik; Pedersen, Lars Henning; Bech, Bodil Hammer			Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy	PLOS ONE			English	Article							POSTMARKETING SURVEILLANCE; WOMEN; SCHIZOPHRENIA; OUTCOMES; POPULATION; EXPERIENCE; OLANZAPINE; DISORDERS; REGISTER; EXPOSURE	Background Antipsychotic medications are increasingly used during pregnancy. Nevertheless, fetal risks are still not fully studied. It is currently unclear whether the antipsychotic treatment might induce a higher risk of fetal death. We aimed to determine if use of antipsychotic medication during pregnancy is associated with an increased risk of spontaneous abortion or stillbirth. Methods In a historical cohort study, we identified all clinically recognized pregnancies registered in the nationwide Danish registries from 1997 to 2008 (N = 1,005,319). Exposure was defined as any prescription of antipsychotic medications redeemed by the pregnant women during the exposure window, and recorded in the Danish National Prescription Register. Outcome was defined as any spontaneous abortion or stillbirth recorded in the Danish National Hospital Register and the Danish Medical Birth Register respectively. Results Women exposed to antipsychotic medications during pregnancy had a 34% higher risk of spontaneous abortion (adjusted relative risk = 1.34; 95% confidence interval = 1.22; 1.46) compared to unexposed women, but a similar risk compared to women exposed prior to (but not during) pregnancy (adjusted relative risk = 1.04; 95% confidence interval = 0.93; 1.17). The risk of spontaneous abortion was not increased in exposed pregnancies when compared to unexposed pregnancies in the same women (adjusted hazard ratio = 1.11; 95% CI = 0.94; 1.31). A twofold higher risk of stillbirth was found in women exposed to antipsychotic medications compared with unexposed women (relative risk = 2.27; 95% confidence interval = 1.45; 3.55) and compared with women exposed only prior to pregnancy (relative risk = 2.06; 95% confidence interval = 1.01; 4.19). Conclusions The increased risk of spontaneous abortion found in women treated with antipsychotic medications during pregnancy is most likely due to confounding factors. The risk of stillbirth was twofold higher in pregnancies exposed to antipsychotic medication during pregnancy. Treatment with antipsychotic medications during pregnancy requires careful consideration.	[Sorensen, Merete Juul] Aarhus Univ Hosp, Reg Ctr Child & Adolescent Psychiat, DK-8000 Aarhus, Denmark; [Kjaersgaard, Maiken Ina Siegismund; Parner, Erik] Aarhus Univ, Dept Publ Hlth, Biostat Sect, Aarhus, Denmark; [Pedersen, Henrik Sondergaard; Vestergaard, Mogens] Aarhus Univ, Res Unit Gen Practice, Dept Publ Hlth, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Sect Gen Med Practice, Dept Publ Hlth, Aarhus, Denmark; [Christensen, Jacob] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark; [Christensen, Jacob] Aarhus Univ Hosp, Dept Clin Pharmacol, DK-8000 Aarhus, Denmark; [Olsen, Jorn; Pedersen, Lars Henning; Bech, Bodil Hammer] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Pedersen, Lars Henning] Aarhus Univ, Inst Clin Med Obstet & Gynaecol, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Sorensen, MJ (corresponding author), Aarhus Univ Hosp, Reg Ctr Child & Adolescent Psychiat, DK-8000 Aarhus, Denmark.	meresoer@rm.dk	Bech, Bodil Hammer/B-9646-2016; Parner, Erik Thorlund/F-5532-2010	Bech, Bodil Hammer/0000-0002-0287-3687; Parner, Erik Thorlund/0000-0003-3661-1922; Christensen, Jakob/0000-0002-9385-6435	Regional Center for Child and Adolescent Psychiatry, Aarhus University Hospital, Risskov, Denmark	Regional Center for Child and Adolescent Psychiatry, Aarhus University Hospital, Risskov, Denmark	The Regional Center for Child and Adolescent Psychiatry, Aarhus University Hospital, Risskov, Denmark, contributed with funding to the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GC, 2011, PHARMACOEPIDEM DR S, V20, P177, DOI 10.1002/pds.2082; Andersen TF, 1999, DAN MED BULL, V46, P263; Bennedsen BE, 2001, ARCH GEN PSYCHIAT, V58, P674, DOI 10.1001/archpsyc.58.7.674; Biswas PN, 2001, J PSYCHOPHARMACOL, V15, P265, DOI 10.1177/026988110101500405; Coppola D, 2007, DRUG SAFETY, V30, P247, DOI 10.2165/00002018-200730030-00006; Diav-Citrin O, 2005, J CLIN PSYCHIAT, V66, P317, DOI 10.4088/JCP.v66n0307; Gentile S, 2010, SCHIZOPHRENIA BULL, V36, P518, DOI 10.1093/schbul/sbn107; Gissler M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-383; Goldstein DJ, 2000, J CLIN PSYCHOPHARM, V20, P399, DOI 10.1097/00004714-200008000-00002; Habermann F, 2013, J CLIN PSYCHOPHARM, V33, P453, DOI 10.1097/JCP.0b013e318295fe12; Hironaka M, 2011, J OBSTET GYNAECOL RE, V37, P1283, DOI 10.1111/j.1447-0756.2010.01512.x; Howard LM, 2003, BRIT J PSYCHIAT, V182, P63, DOI 10.1192/bjp.182.1.63; Johnson KC, 2012, ARCH GEN PSYCHIAT, V69, P787, DOI 10.1001/archgenpsychiatry.2012.160; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; King-Hele S, 2009, ARCH DIS CHILD-FETAL, V94, pF105, DOI 10.1136/adc.2007.135459; Knudsen LB, 1998, DAN MED BULL, V45, P320; Lin HC, 2010, SCHIZOPHR RES, V116, P55, DOI 10.1016/j.schres.2009.10.011; McKenna K, 2005, J CLIN PSYCHIAT, V66, P444, DOI 10.4088/JCP.v66n0406; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; Newport DJ, 2007, AM J PSYCHIAT, V164, P1214, DOI 10.1176/appi.ajp.2007.06111886; Nilsson E, 2002, SCHIZOPHR RES, V58, P221, DOI 10.1016/S0920-9964(01)00370-X; Olesen C, 2001, EPIDEMIOLOGY, V12, P497, DOI 10.1097/00001648-200109000-00006; Peng M, 2013, PSYCHOPHARMACOLOGY, V228, P577, DOI 10.1007/s00213-013-3060-6; Reis M, 2008, J CLIN PSYCHOPHARM, V28, P279, DOI 10.1097/JCP.0b013e318172b8d5; Sadowski A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003062; Stephenson CP, 2013, AUST NZ J PSYCHIAT, V47, P74, DOI 10.1177/0004867412466595; Twaites BR, 2007, J PSYCHOPHARMACOL, V21, P392, DOI 10.1177/0269881107073257; Vigod SN, 2012, SCHIZOPHR RES, V139, P169, DOI 10.1016/j.schres.2012.05.010; World Health Organization, 1993, THE ICD 10 CLASSIFIC	29	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132280	10.1371/journal.pone.0132280	http://dx.doi.org/10.1371/journal.pone.0132280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26162087	Green Submitted, gold, Green Published			2022-12-27	WOS:000358162300111
J	Soriano, S; Villa, P; Delagnes, A; Degano, I; Pollarolo, L; Lucejko, JJ; Henshilwood, C; Wadley, L				Soriano, Sylvain; Villa, Paola; Delagnes, Anne; Degano, Ilaria; Pollarolo, Luca; Lucejko, Jeannette J.; Henshilwood, Christopher; Wadley, Lyn			The Still Bay and Howiesons Poort at Sibudu and Blombos: Understanding Middle Stone Age Technologies	PLOS ONE			English	Article							DIEPKLOOF ROCK SHELTER; MODERN HUMAN-BEHAVIOR; ROSE COTTAGE CAVE; SOUTH-AFRICA; LATE PLEISTOCENE; WESTERN CAPE; ADDITIONAL EVIDENCE; HUNTING WEAPONS; KLASIES RIVER; CHRONOLOGY	The classification of archaeological assemblages in the Middle Stone Age of South Africa in terms of diversity and temporal continuity has significant implications with respect to recent cultural evolutionary models which propose either gradual accumulation or discontinuous, episodic processes for the emergence and diffusion of cultural traits. We present the results of a systematic technological and typological analysis of the Still Bay assemblages from Sibudu and Blombos. A similar approach is used in the analysis of the Howiesons Poort (HP) assemblages from Sibudu seen in comparison with broadly contemporaneous assemblages from Rose Cottage and Klasies River Cave 1A. Using our own and published data from other sites we report on the diversity between stone artifact assemblages and discuss to what extent they can be grouped into homogeneous lithic sets. The gradual evolution of debitage techniques within the Howiesons Poort sequence with a progressive abandonment of the HP technological style argues against the saltational model for its disappearance while the technological differences between the Sibudu and Blombos Still Bay artifacts considerably weaken an interpretation of similarities between the assemblages and their grouping into the same cultural unit. Limited sampling of a fragmented record may explain why simple models of cultural evolution do not seem to apply to a complex reality.	[Soriano, Sylvain] Univ Paris Ouest, CNRS, AnTET, ArScAn, F-92023 Nanterre, France; [Villa, Paola] Univ Colorado Museum, Boulder, CO 80309 USA; [Villa, Paola; Pollarolo, Luca] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, ZA-2050 Johannesburg, South Africa; [Villa, Paola; Delagnes, Anne] Univ Bordeaux, PACEA, CNRS, F-33615 Pessac, France; [Delagnes, Anne; Henshilwood, Christopher; Wadley, Lyn] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa; [Degano, Ilaria; Lucejko, Jeannette J.] Univ Pisa, Dipartimento Chim & Chim Ind, I-56126 Pisa, Italy; [Pollarolo, Luca] Univ Geneva, Dept Genet & Evolut, Anthropol Unit, Lab Archeol & Peuplement Afrique, CH-1211 Geneva 4, Switzerland; [Wadley, Lyn] Univ Bergen, Inst Archaeol Hist Culture & Religious Studies, N-5007 Bergen, Norway	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Colorado System; University of Colorado Boulder; University of Witwatersrand; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of Witwatersrand; University of Pisa; University of Geneva; University of Bergen	Soriano, S (corresponding author), Univ Paris Ouest, CNRS, AnTET, ArScAn, F-92023 Nanterre, France.	sylvain.soriano@mae.u-paris10.fr	Degano, Ilaria/F-9184-2012; LUCEJKO, Jeannette Jacqueline/ABA-4451-2020; Henshilwood, Christopher S/K-3806-2014; Lucejko, Jeannette/H-1585-2012; Wadley, Lyn/AAC-6577-2022	Degano, Ilaria/0000-0002-3585-8555; LUCEJKO, Jeannette Jacqueline/0000-0002-7717-4039; Henshilwood, Christopher S/0000-0002-2818-293X; Lucejko, Jeannette/0000-0002-7717-4039; Soriano, Sylvain/0000-0002-4288-9763; POLLAROLO, LUCA/0000-0001-9449-5937	National Science Foundation [BCS 0613319]; Wenner-Gren Foundation; Paleontological Scientific Trust; Frison Institute; School of Geography, Archaeology and Environmental Sciences, University of the Witwatersrand; European Research Council Advanced Grant, TRACSYMBOLS, under the FP7 programme at the University of Bergen, Norway [249587]; National Research Foundation/Department of Science and Technology funded Chair at the University of the Witwatersrand, South Africa; Scatterlings of Africa programme	National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Foundation; Paleontological Scientific Trust; Frison Institute; School of Geography, Archaeology and Environmental Sciences, University of the Witwatersrand; European Research Council Advanced Grant, TRACSYMBOLS, under the FP7 programme at the University of Bergen, Norway; National Research Foundation/Department of Science and Technology funded Chair at the University of the Witwatersrand, South Africa; Scatterlings of Africa programme	Research of PV, SS, and AD at Sibudu was funded by a grant from the National Science Foundation (BCS 0613319 to PV). PV's research was also funded by the Wenner-Gren Foundation, the Paleontological Scientific Trust, and the Frison Institute. The Paleontological Scientific Trust with its Scatterlings of Africa programme supported LP with postdoctoral funding in 2008. PV and LP acknowledge support from the School of Geography, Archaeology and Environmental Sciences, University of the Witwatersrand. Financial support for CSH was provided by a European Research Council Advanced Grant, TRACSYMBOLS No. 249587, awarded under the FP7 programme at the University of Bergen, Norway, and by a National Research Foundation/Department of Science and Technology funded Chair at the University of the Witwatersrand, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARD M, 1993, PALEO, V5, P179; Allott L.F., 2006, S AFR HUMANIT, V18, P173; Ambrose S.H., 2002, THINKING SMALL GLOBA, V12, P9; Andreotti A, 2006, ANAL CHEM, V78, P4490, DOI 10.1021/ac0519615; Astakhov VP, 2006, TRIBOL INTER ENG, V52, P1; Astakhov VP, 2010, SPRINGER SER ADV MAN, P1, DOI 10.1007/978-1-84996-053-3; Aubry T, 2008, WORLD ARCHAEOL, V40, P48, DOI 10.1080/00438240701843538; Boeda E, 2004, APPROCHES FONCTIONNE, P293; Boeda E., 2005, AROBASE, V1, P46; Boeda E., 1997, HABILITATION DIRIGER, V1; Bradley B, 1974, CASPER SITE HELL GAP, P191; Burger P, 2011, ARCHAEOL ANTHROP SCI, V3, P185, DOI 10.1007/s12520-010-0050-z; Callahan E., 1979, ARCHAEOLOGY E N AM, V7, P1; Charrie-Duhaut A, 2013, J ARCHAEOL SCI, V40, P3506, DOI 10.1016/j.jas.2012.12.026; Clark J.D., 1966, S AFRICAN ARCHAEOLOG, V21, P114, DOI [https://doi.org/10.2307/3888427, DOI 10.2307/3888427]; COTTERELL B, 1987, AM ANTIQUITY, V52, P675, DOI 10.2307/281378; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; d'Errico F, 2008, J ARCHAEOL SCI, V35, P2675, DOI 10.1016/j.jas.2008.04.023; d'Errico F, 2007, J HUM EVOL, V52, P142, DOI 10.1016/j.jhevol.2006.08.003; d'Errico F, 2011, PHILOS T R SOC B, V366, P1060, DOI 10.1098/rstb.2010.0340; de la Pen~a P., 2013, S AFR ARCHAEOL BULL, V68, P119; Deacon J, 1995, S AFRICAN ARCHAEOLOG, V50, P110, DOI DOI 10.2307/3889060; Delagnes A., 2006, SO AFRICAN HUMANITIE, V18, P43; Delagnes A., 2007, NEANDERTALIENS BIOLO, V23, P213; Evans U., 1994, S AFR FIELD ARCHAEOL, V3, P63; Faivre JP, 2014, QUATERN INT, V350, P227, DOI 10.1016/j.quaint.2014.05.048; Feblot-Augustins J., 1999, MIDDLE PALAEOLITHIC, P193; Fischer A., 1984, J DAN ARCHAEOL, V3, P19, DOI [10.1080/0108464X.1984.10589910, DOI 10.1080/0108464X.1984.10589910]; Frison G.C., 1980, FOLSOM TOOLS TECHNOL; Galbraith RF, 2015, J HUM EVOL, V80, P184, DOI 10.1016/j.jhevol.2014.10.006; Geneste J-M, 1990, FEUILLES PIERRE IND, P293; Gibson N. E., 2004, SOUTH AFR HUMANIT, V16, P1; Goldberg P, 2009, ARCHAEOL ANTHROP SCI, V1, P95, DOI 10.1007/s12520-009-0008-1; Grine FE, 2002, J HUM EVOL, V42, P293, DOI 10.1006/jhev.2001.0525; Grun R, 2003, J HUM EVOL, V45, P155, DOI 10.1016/S0047-2484(03)00102-7; Guerin G, 2013, J HUM EVOL, V64, P314, DOI 10.1016/j.jhevol.2013.01.006; Haaland M.M., 2012, THESIS U BERGEN; Harper PTN, 1997, S AFR J SCI, V93, P470; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; Henshilwood CS, 2014, J ARCHAEOL SCI, V45, P284, DOI 10.1016/j.jas.2014.01.033; Henshilwood CS, 2012, J WORLD PREHIST, V25, P205, DOI 10.1007/s10963-012-9060-3; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Henshilwood CS, 2008, S AFRICA EXCAVATIONS; Hogberg A, 2011, J HUM EVOL, V61, P133, DOI 10.1016/j.jhevol.2011.02.006; Inizan Marie -Louise, 1999, PRE HIST PIERRE TAIL; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Jacobs Z, 2006, J HUM EVOL, V51, P255, DOI 10.1016/j.jhevol.2006.03.007; Jacobs Z, 2015, J ARCHAEOL SCI, V63, P175, DOI 10.1016/j.jas.2015.01.023; Jacobs Z, 2013, J ARCHAEOL SCI, V40, P579, DOI 10.1016/j.jas.2012.06.037; Johnson J. K., 1979, LITHIC TECHNOL, VVIII, P25; Kleindienst MR, 2006, INTERD CONTRIB ARCH, P13, DOI 10.1007/0-387-24661-4_2; Koch John T., 2006, CELTIC CULTURE HIST; Liuveras A, 2010, ANAL CHEM, V82, P376, DOI 10.1021/ac902141m; Lombard M., 2006, SOUTH AFR HUMANIT, V18, P27; Lombard M, 2008, J ARCHAEOL SCI, V35, P26, DOI 10.1016/j.jas.2007.02.021; Lombard M, 2007, J HUM EVOL, V53, P406, DOI 10.1016/j.jhevol.2007.05.004; Lombard M, 2010, ANTIQUITY, V84, P635, DOI 10.1017/S0003598X00100134; Lombard M, 2010, J ARCHAEOL SCI, V37, P1773, DOI 10.1016/j.jas.2010.02.015; MARKS AE, 2003, MORE MEETS EYE STUDI, P265; McCall GS, 2012, AFR ARCHAEOL REV, V29, P7, DOI 10.1007/s10437-012-9107-y; Minichillo, 2005, THESIS U WASHINGTON; Mourre V, 2010, SCIENCE, V330, P659, DOI 10.1126/science.1195550; NEWCOMER MH, 1971, WORLD ARCHAEOL, V3, P85, DOI 10.1080/00438243.1971.9979493; Pargeter J, 2007, S AFR ARCHAEOL BULL, V62, P147, DOI 10.2307/20474970; Pelcin AW, 1997, J ARCHAEOL SCI, V24, P1107, DOI 10.1006/jasc.1996.0190; Pelegrin J., 2000, MEMOIRES PREHISTOIRE, P73; Pelegrin J., 1991, ACT C INT EXP ARCH B, P118; Porraz G, 2014, TRANSITIONS RUPTURES, P155; Porraz G., 2008, S AFRICAN ARCHAEOLOG, V10, P105; Porraz G, 2013, J ARCHAEOL SCI, V40, P3542, DOI 10.1016/j.jas.2013.02.024; Porraz G, 2013, J ARCHAEOL SCI, V40, P3376, DOI 10.1016/j.jas.2013.02.012; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Renard C, 2011, WORLD ARCHAEOL, V43, P726, DOI 10.1080/00438243.2011.624789; Shea JJ, 2014, QUATERN INT, V350, P169, DOI 10.1016/j.quaint.2014.01.024; Singer R., 1982, MIDDLE STONE AGE KLA; Soressi M., 2002, THESIS U BORDEAUX 1; Soriano S., 1998, GALL PR HIST, V40, P75, DOI [DOI 10.3406/GALIP.1998.2158, 10.3406/galip.1998.2158]; Soriano S., 2000, THESIS U PARIS X NAN; Soriano S, 2007, J ARCHAEOL SCI, V34, P681, DOI 10.1016/j.jas.2006.06.017; Soriano S, 2009, J AFR ARCHAEOL, V7, P41, DOI 10.3213/1612-1651-10121; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; Tiffagom M., 1998, PALEO, V10, P147, DOI DOI 10.3406/PAL.1998.1134; Todd, 1987, HORNER SITE TYPE SIT, P199; Tribolo C, 2013, J ARCHAEOL SCI, V40, P3401, DOI 10.1016/j.jas.2012.12.001; Vanhaeren M, 2013, J HUM EVOL, V64, P500, DOI 10.1016/j.jhevol.2013.02.001; Villa P, 2005, J ARCHAEOL SCI, V32, P399, DOI 10.1016/j.jas.2004.11.007; Villa P, 2010, J ARCHAEOL SCI, V37, P630, DOI 10.1016/j.jas.2009.10.028; Villa P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096424; Villa P, 2012, P NATL ACAD SCI USA, V109, P13208, DOI 10.1073/pnas.1202629109; Villa P, 2010, J ANTHROPOL RES, V66, P5, DOI 10.3998/jar.0521004.0066.102; Villa P, 2009, J ARCHAEOL SCI, V36, P850, DOI 10.1016/j.jas.2008.11.012; Villa P, 2009, J ARCHAEOL SCI, V36, P441, DOI 10.1016/j.jas.2008.09.028; Vogelsang R, 2010, J AFR ARCHAEOL, V8, P185, DOI 10.3213/1612-1651-10170; Wadley L, 2005, S AFR ARCHAEOL BULL, V60, P51; WADLEY L, 1992, S AFR J SCI, V88, P558; Wadley L, 2006, SOUTH AFR HUMANIT, V18, P1; Wadley L., 1989, S AFR ARCHAEOL BULL, V44, P23, DOI DOI 10.2307/3888316; Wadley L, 2008, S AFRICAN ARCHAEOLOG, V1, P122; Wadley L, 2008, J ARCHAEOL SCI, V35, P2594, DOI 10.1016/j.jas.2008.04.017; Wadley L, 2007, J HUM EVOL, V52, P681, DOI 10.1016/j.jhevol.2007.01.002; Wadley L, 2012, SOUTH AFR HUMANIT, V24, P79; Wadley L, 2011, SOUTH AFR HUMANIT, V23, P87; Wadley L, 2012, QUATERN INT, V247, P341, DOI 10.1016/j.quaint.2010.10.026; Wadley L, 2010, J ARCHAEOL SCI, V37, P2397, DOI 10.1016/j.jas.2010.04.012; Wadley L, 2010, J HUM EVOL, V58, P179, DOI 10.1016/j.jhevol.2009.10.004; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Wurz S, 2007, SOUTH AFR HUMANIT, V19, P1; Yaroshevich A, 2010, J ARCHAEOL SCI, V37, P368, DOI 10.1016/j.jas.2009.09.050	111	66	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131127	10.1371/journal.pone.0131127	http://dx.doi.org/10.1371/journal.pone.0131127			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CN1FD	26161665	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300029
J	Xu, JL; Wang, Y; Zhang, F; Wu, Y; Zheng, TQ; Wang, YH; Zhao, XQ; Cui, YR; Chen, K; Zhang, Q; Lin, HX; Li, JY; Li, ZK				Xu, Jian-Long; Wang, Yun; Zhang, Fan; Wu, Yuan; Zheng, Tian-Qing; Wang, Yong-Hong; Zhao, Xiu-Qin; Cui, Yan-Ru; Chen, Kai; Zhang, Qiang; Lin, Hong-Xuan; Li, Jia-Yang; Li, Zhi-Kang			SS1 (NAL1)- and SS2-Mediated Genetic Networks Underlying Source-Sink and Yield Traits in Rice (Oryza sativa L.)	PLOS ONE			English	Article							ADVANCED BACKCROSS POPULATION; OVERDOMINANT EPISTATIC LOCI; GRAIN-YIELD; INBREEDING DEPRESSION; MOLECULAR DISSECTION; INTROGRESSION LINES; NATURAL VARIATION; INCREASES YIELD; COMPLEX TRAITS; HEADING DATE	Source leaf/sink capacity (SS) traits are important determinants of grain yield (GY) of rice. To understand the genetic basis of the SS relationship in rice, five SS and GY traits of rice were genetically dissected using two reciprocal introgression populations. Seventy-three QTL affecting the SS and GY traits were identified, most of which were detected in one of the parental genetic backgrounds (GBs). Two major QTL at bins 4.7 (SS1) and 3.12 (SS2) were associated consistently with all measured SS and yield traits in both GBs across two contrasting environments. Strong interactions between SS1/SS2 and the detected QTL led us to the discovery of genetic networks affecting the SS and GY traits. The SS1 acted as a regulator controlling two groups of downstream QTL affecting the source leaf width and grain number per panicle (GNP). SS2 functioned as a regulator positively regulating different groups of downstream QTL affecting the source leaf length, GNP, grain weight, and GY. Map-based cloning of SS1 indicates that SS1 is NAL1 involved in polar auxin/IAA transport. Different alleles at NAL1 were apparently able to qualitatively and/or quantitatively control the IAA transport from the apical meristem to different plant tissues and thus regulate those downstream loci/pathways controlling different SS traits of rice. There was a functional allele and a non-functional mutation in the parents at each of the QTL downstream of SS1 or SS2, which were detectable only in the presence of the functional allele of SS1 or SS2. Our results provided direct evidence that SS and yield traits in rice are controlled by complex signaling pathways and suggest further improvement of rice yield potential with enhanced and balanced SS relationships can be achieved by accurately manipulating allelic combinations at loci in the SS1 and SS2 mediated pathways.	[Xu, Jian-Long; Zhang, Fan; Zheng, Tian-Qing; Zhao, Xiu-Qin; Cui, Yan-Ru; Chen, Kai; Zhang, Qiang; Li, Zhi-Kang] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100081, Peoples R China; [Xu, Jian-Long; Li, Zhi-Kang] Chinese Acad Agr Sci, Shenzhen Inst Innovat Breeding, Shenzhen 518120, Peoples R China; [Wang, Yun] Shenyang Agr Univ, Rice Inst, Minist Agr, Key Lab Crop Physiol Ecol Genet & Breeding, Shenyang 110866, Peoples R China; [Wu, Yuan; Lin, Hong-Xuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China; [Wang, Yong-Hong; Li, Jia-Yang] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Shenyang Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Li, ZK (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, 12 South Zhong Guan Cun St, Beijing 100081, Peoples R China.	lizhikang@caas.cn	Xu, Jianlong/AAI-8310-2020; Lin, Hong-Xuan/AEQ-6607-2022; Li, Jiayang/AAG-4377-2020	Lin, Hong-Xuan/0000-0002-2818-023X; 	National Natural Science Foundation [31261140369, 31071061]; Chinese Transgenic Key Project [2009ZX08009-124B]; Chinese Ministry of Science Technology; "948" Project [2011-G2B]; Chinese Ministry of Agriculture; Project of International S&T Cooperation Program of China [2012DFB32280]; 863 key Project [2014AA10A601]; "Green Super Rice" Project from Chinese Ministry of Science Technology [OR1393]; Bill & Melinda Gates Foundation; Shenzhen Peacock Plan [20130415095710361]; CAAS Innovative Team Award	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Transgenic Key Project; Chinese Ministry of Science Technology(Ministry of Science and Technology, China); "948" Project(Ministry of Agriculture & Rural Affairs); Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); Project of International S&T Cooperation Program of China; 863 key Project(National High Technology Research and Development Program of China); "Green Super Rice" Project from Chinese Ministry of Science Technology; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Shenzhen Peacock Plan; CAAS Innovative Team Award	This research was funded by the National Natural Science Foundation (31261140369 to JLX, 31071061 to YW, http://www.nsfc.gov.cn), the Chinese Transgenic Key Project to JLX (2009ZX08009-124B, http://www.most.gov.cn) from the Chinese Ministry of Science & Technology, the "948" Project to ZKL (2011-G2B, http://www.moa.gov.cn/) from the Chinese Ministry of Agriculture, the Project of International S&T Cooperation Program of China to ZKL (2012DFB32280, http://www.istcp.org.cn/), 863 key Project to JLX (2014AA10A601, http://www.most.gov.cn) and the "Green Super Rice" Project to ZKL (OR1393) from the Chinese Ministry of Science & Technology (http://www.most.gov.cn) and Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/), and the Shenzhen Peacock Plan (20130415095710361, http://www.szsti.gov.cn/) and the CAAS Innovative Team Award (http://www.caas.cn/) to ZK Li's team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELFORD RK, 1991, FIELD CROP RES, V26, P221, DOI 10.1016/0378-4290(91)90037-V; Chen HD, 2011, THEOR APPL GENET, V123, P869, DOI 10.1007/s00122-011-1633-5; Cheng LR, 2013, CROP SCI, V53, P1437, DOI 10.2135/cropsci2013.02.0075; Cho SH, 2014, PLANT MOL BIOL REP, V32, P270, DOI 10.1007/s11105-013-0675-z; Cui KH, 2003, THEOR APPL GENET, V106, P649, DOI 10.1007/s00122-002-1113-z; Ding XP, 2011, THEOR APPL GENET, V123, P815, DOI 10.1007/s00122-011-1629-1; DONALD CM, 1968, EUPHYTICA, V17, P385, DOI 10.1007/BF00056241; ESHED Y, 1995, GENETICS, V141, P1147; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; FOYER CH, 1987, PLANT PHYSIOL BIOCH, V25, P649; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Fujita D, 2013, P NATL ACAD SCI USA, V110, P20431, DOI 10.1073/pnas.1310790110; GLADUN IV, 1993, RUSS PLANT PHYSIOL+, V40, P215; Guo YA, 2010, J GENET GENOMICS, V37, P533, DOI 10.1016/S1673-8527(09)60073-4; Huang YX, 2003, WORLD SCI TECH R D, V12, P1; Iliadi KG, 2009, EXP GERONTOL, V44, P546, DOI 10.1016/j.exger.2009.05.008; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; LAFITTE HR, 1984, CROP SCI, V24, P447, DOI 10.2135/cropsci1984.0011183X002400030004x; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Li Z., 2013, GENETICS GENOMICS RI, P349, DOI [10.1007/978-1-4614-7903-1_23, DOI 10.1007/978-1-4614-7903-1_23]; Li ZK, 2013, CURR OPIN PLANT BIOL, V16, P261, DOI 10.1016/j.pbi.2013.03.008; Li ZK, 1997, GENETICS, V145, P453; Li ZK, 2003, THEOR APPL GENET, V108, P141, DOI 10.1007/s00122-003-1401-2; Li ZK, 2001, GENETICS, V158, P1737; Li ZK, 1998, MOL BREEDING, V4, P419, DOI 10.1023/A:1009608128785; Li ZK, 1997, MOL DISSECTION COMPL, P119; Liao CY, 2001, THEOR APPL GENET, V103, P104, DOI 10.1007/s001220000528; Lin HX, 1996, THEOR APPL GENET, V92, P920, DOI 10.1007/BF00224031; Luo LJ, 2001, GENETICS, V158, P1755; Mather K, 1982, BIOMETRICAL GENETICS; Mei HW, 2006, THEOR APPL GENET, V112, P648, DOI 10.1007/s00122-005-0167-0; Mohammad Ashraf, 1994, Genetic improvement of field crops., P413; Moncada P, 2001, THEOR APPL GENET, V102, P41, DOI 10.1007/s001220051616; Monforte AJ, 2000, GENOME, V43, P803, DOI 10.1139/gen-43-5-803; Qi J, 2008, PLANT PHYSIOL, V147, P1947, DOI 10.1104/pp.108.118778; SAS Institute, 2008, SAS STAT US GUID; Septiningsih EM, 2003, THEOR APPL GENET, V107, P1419, DOI 10.1007/s00122-003-1373-2; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Takai T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02149; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang P, 2012, MOL BREEDING, V29, P903, DOI 10.1007/s11032-011-9679-2; Wang P, 2012, MOL BREEDING, V29, P99, DOI 10.1007/s11032-010-9529-7; Wang W, 2015, PLANT GENOME, DOI [10.3835/plantgenome2014.10.0078, DOI 10.3835/PLANTGENOME2014.10.0078]; Wang Yun, 2009, Acta Agronomica Sinica, V35, P1386; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Wu B, 2013, GENETICS GENOMICS RI, P35; Wu RL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-84; Xie XB, 2006, THEOR APPL GENET, V113, P885, DOI 10.1007/s00122-006-0348-5; Xie XueWen, 2008, Acta Agronomica Sinica, V34, P1885, DOI 10.1016/S1875-2780(09)60013-4; Xu JL, 2006, J EXP BOT, V57, P2815, DOI 10.1093/jxb/erl046; Xu JL, 2005, THEOR APPL GENET, V111, P1642, DOI 10.1007/s00122-005-0099-8; Xu JL, 2004, PLANT BREEDING, V123, P43, DOI 10.1046/j.1439-0523.2003.00936.x; Xu ZhengJin, 1998, Acta Agronomica Sinica, V24, P47; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yang Jing, 2009, Acta Agronomica Sinica, V35, P974, DOI 10.3724/SP.J.1006.2009.00974; Yoshida S, 1981, FUNDAMENTALS RICE CR; Yuan L.P., 1997, HYBRID RICE, V12, P1, DOI DOI 10.16267/J.CNKI.1005-3956.1997.06.001; Yue Bing, 2006, Acta Genetica Sinica, V33, P824, DOI 10.1016/S0379-4172(06)60116-9; Zhang F, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-55; Zhang F, 2013, THEOR APPL GENET, V126, P1011, DOI 10.1007/s00122-012-2033-1; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014541; Zhang GH, 2014, MOL PLANT, V7, P1350, DOI 10.1093/mp/ssu055; Zhang YS, 2009, THEOR APPL GENET, V118, P1035, DOI 10.1007/s00122-008-0960-7; Zheng TQ, 2011, CROP SCI, V51, P2525, DOI 10.2135/cropsci2011.05.0259	66	13	17	7	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132060	10.1371/journal.pone.0132060	http://dx.doi.org/10.1371/journal.pone.0132060			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162098	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300087
J	Smaldino, PJ; Routh, ED; Kim, JH; Giri, B; Creacy, SD; Hantgan, RR; Akman, SA; Vaughn, JP				Smaldino, Philip J.; Routh, Eric D.; Kim, Jung H.; Giri, Banabihari; Creacy, Steven D.; Hantgan, Roy R.; Akman, Steven A.; Vaughn, James P.			Mutational Dissection of Telomeric DNA Binding Requirements of G4 Resolvase 1 Shows that G4-Structure and Certain 3 '-Tail Sequences Are Sufficient for Tight and Complete Binding	PLOS ONE			English	Article							G-QUADRUPLEX STRUCTURES; DEAH-BOX HELICASE; K+ SOLUTION; TETRAMOLECULAR QUADRUPLEX; TEMPLATE BOUNDARY; MAJOR SOURCE; HUMAN GENOME; IN-VITRO; RNA; EXTENSION	Ends of human chromosomes consist of the six nucleotide repeat d[pTTAGGG](n) known as telomeric DNA, which protects chromosomes. We have previously shown that the DHX36 gene product, G4 Resolvase 1 (G4R1), binds parallel G-quadruplex (G4) DNA with an unusually tight apparent K-d. Recent work associates G4R1 with the telomerase holoenzyme, which may allow it to access telomeric G4-DNA. Here we show that G4R1 can tightly bind telomeric G4-DNA, and in the context of the telomeric sequence, we determine length, sequence, and structural requirements sufficient for tight G4R1 telomeric binding. Specifically, G4R1 binds telomeric DNA in the K+-induced "3+1" G4-topology with an apparent K-d = 10 +/- 1.9 pM, a value similar as previously found for binding to unimolecular parallel G4-DNA. G4R1 binds to the Na+-induced "2+2" basket G4-structure formed by the same DNA sequence with an apparent K-d = 71 +/- 2.2 pM. While the minimal G4-structure is not sufficient for G4R1 binding, a 5' G4-structure with a 3' unstructured tail containing a guanine flanked by adenine(s) is sufficient for maximal binding. Mutations directed to disrupt G4-structure similarly disrupt G4R1 binding; secondary mutations that restore G4-structure also restore G4R1 binding. We present a model showing that a replication fork disrupting a T-loop could create a 5' quadruplex with an opened 3' tail structure that is recognized by G4R1.	[Smaldino, Philip J.; Routh, Eric D.; Kim, Jung H.; Creacy, Steven D.; Vaughn, James P.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; [Giri, Banabihari] Furman Univ, Dept Chem, Greenville, SC 29613 USA; [Creacy, Steven D.] Harmonyx Diagnost, Cordova, TN 38016 USA; [Hantgan, Roy R.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Akman, Steven A.] Roper St Francis Hosp, Dept Hematol & Oncol, Charleston, SC 29401 USA	Wake Forest University; Wake Forest University	Vaughn, JP (corresponding author), Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA.	jpvaughn@nanomedica.com	Smaldino, Philip/AAX-4203-2020	Routh, Eric/0000-0002-7371-1802	National Institutes of Health [P30-CA12197, T32-CA079448]; NATIONAL CANCER INSTITUTE [T32CA079448, P30CA012197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The National Institutes of Health (Grant P30-CA12197) and the National Institutes of Health (Grant T32-CA079448 (to P.J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Arimondo PB, 2000, NUCLEIC ACIDS RES, V28, P4832, DOI 10.1093/nar/28.24.4832; Bidzinska J, 2013, MOLECULES, V18, P12368, DOI 10.3390/molecules181012368; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Campbell Nancy, 2012, Curr Protoc Nucleic Acid Chem, VChapter 17, DOI 10.1002/0471142700.nc1706s50; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Chen JL, 2003, GENE DEV, V17, P2747, DOI 10.1101/gad.1140303; Chen MC, 2015, NUCLEIC ACIDS RES, V43, P2223, DOI 10.1093/nar/gkv051; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; Dai JX, 2008, BIOCHIMIE, V90, P1172, DOI 10.1016/j.biochi.2008.02.026; Doherty KM, 2006, RECENT PAT ANTI-CANC, V1, P185, DOI 10.2174/157489206777442232; Enokizono Y, 2005, J BIOL CHEM, V280, P18862, DOI 10.1074/jbc.M411822200; Fletcher TM, 1998, BIOCHEMISTRY-US, V37, P5536, DOI 10.1021/bi972681p; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Gomez DE, 2012, INT J ONCOL, V41, P1561, DOI 10.3892/ijo.2012.1611; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Huang WW, 2012, NUCLEIC ACIDS RES, V40, P1033, DOI 10.1093/nar/gkr849; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Hwang H, 2012, STRUCTURE, V20, P1872, DOI 10.1016/j.str.2012.08.018; Kamath-Loeb A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030189; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lai JC, 2012, BLOOD, V119, P4291, DOI 10.1182/blood-2011-08-362954; Lattmann S, 2011, NUCLEIC ACIDS RES, V39, P9390, DOI 10.1093/nar/gkr630; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Luu KN, 2006, J AM CHEM SOC, V128, P9963, DOI 10.1021/ja062791w; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Oeseburg H, 2010, PFLUG ARCH EUR J PHY, V459, P259, DOI 10.1007/s00424-009-0728-1; Oganesian L, 2006, EMBO J, V25, P1148, DOI 10.1038/sj.emboj.7601006; Oganesian L, 2007, BIOESSAYS, V29, P155, DOI 10.1002/bies.20523; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Phan AT, 2006, NUCLEIC ACIDS RES, V34, P5715, DOI 10.1093/nar/gkl726; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Sexton AN, 2011, MOL CELL BIOL, V31, P736, DOI 10.1128/MCB.01033-10; Singh V, 2012, CHEM COMMUN, V48, P8258, DOI 10.1039/c2cc32012f; Smith JS, 2011, NAT STRUCT MOL BIOL, V18, P478, DOI 10.1038/nsmb.2033; Stegle O, 2009, BIOINFORMATICS, V25, pI374, DOI 10.1093/bioinformatics/btp210; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Sun H, 2001, P NATL ACAD SCI USA, V98, P12444, DOI 10.1073/pnas.231479198; Sun HX, 2012, ANALYST, V137, P862, DOI 10.1039/c2an15870a; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; Viglasky V, 2010, BIOCHEMISTRY-US, V49, P2110, DOI 10.1021/bi902099u; Wang F, 2012, P NATL ACAD SCI USA, V109, P20413, DOI 10.1073/pnas.1200232109; Wang Q, 2011, NUCLEIC ACIDS RES, V39, P6229, DOI 10.1093/nar/gkr164; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2012, J BIOL CHEM, V287, P1007, DOI 10.1074/jbc.M111.276022; Wu YL, 2010, FEBS J, V277, P3470, DOI 10.1111/j.1742-4658.2010.07760.x; Xu Y, 2006, BIOORGAN MED CHEM, V14, P5584, DOI 10.1016/j.bmc.2006.04.033; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102; Zhang QS, 2006, RNA, V12, P1116, DOI 10.1261/rna.58806	59	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132668	10.1371/journal.pone.0132668	http://dx.doi.org/10.1371/journal.pone.0132668			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172836	gold, Green Published, Green Submitted			2022-12-27	WOS:000358194900075
J	Zhang, Q; Wang, J; Deng, F; Yan, ZJ; Xia, YL; Wang, ZL; Ye, JX; Deng, YL; Zhang, ZL; Qiao, M; Li, RF; Denduluri, SK; Wei, Q; Zhao, LG; Lu, S; Wang, X; Tang, SL; Liu, H; Luu, HH; Haydon, RC; He, TC; Jiang, L				Zhang, Qian; Wang, Jing; Deng, Fang; Yan, Zhengjian; Xia, Yinglin; Wang, Zhongliang; Ye, Jixing; Deng, Youlin; Zhang, Zhonglin; Qiao, Min; Li, Ruifang; Denduluri, Sahitya K.; Wei, Qiang; Zhao, Lianggong; Lu, Shun; Wang, Xin; Tang, Shengli; Liu, Hao; Luu, Hue H.; Haydon, Rex C.; He, Tong-Chuan; Jiang, Li			TqPCR: A Touchdown qPCR Assay with Significantly Improved Detection Sensitivity and Amplification Efficiency of SYBR Green qPCR	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; MESENCHYMAL STEM-CELLS; DENTAL APICAL PAPILLA; OSTEOGENIC DIFFERENTIATION; RT-PCR; PROGENITOR CELLS; OSTEO/ODONTOBLASTIC DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; RECOMBINANT ADENOVIRUSES	The advent of fluorescence-based quantitative real-time PCR (qPCR) has revolutionized the quantification of gene expression analysis in many fields, including life sciences, agriculture, forensic science, molecular diagnostics, and medicine. While SYBR Green-based qPCR is the most commonly-used platform due to its inexpensive nature and robust chemistry, quantifying the expression of genes with low abundance or RNA samples extracted from highly restricted or limited sources can be challenging because the detection sensitivity of SYBR Green-based qPCR is limited. Here, we develop a novel and effective touchdown qPCR (TqPCR) protocol by incorporating a 4-cycle touchdown stage prior to the quantification amplification stage. Using the same cDNA templates, we find that TqPCR can reduce the average Cq values for Gapdh, Rps13, and Hprt1 reference genes by 4.45, 5.47, and 4.94 cycles, respectively, when compared with conventional qPCR; the overall average Cq value reduction for the three reference genes together is 4.95. We further find that TqPCR can improve PCR amplification efficiency and thus increase detection sensitivity. When the quantification of Wnt3A-induced target gene expression in mesenchymal stem cells is analyzed, we find that, while both conventional qPCR and TqPCR can detect the up-regulation of the relatively abundant target Axin2, only TqPCR can detect the up-regulation of the lowly-expressed targets Oct4 and Gbx2. Finally, we demonstrate that the MRQ2 and MRQ3 primer pairs derived from mouse reference gene Tbp can be used to validate the RNA/cDNA integrity of qPCR samples. Taken together, our results strongly suggest that TqPCR may increase detection sensitivity and PCR amplification efficiency. Overall, TqPCR should be advantageous over conventional qPCR in expression quantification, especially when the transcripts of interest are lowly expressed, and/or the availability of total RNA is highly restricted or limited.	[Zhang, Qian; Wang, Zhongliang; He, Tong-Chuan; Jiang, Li] Chongqing Med Univ, Childrens Hosp, Dept Neurol, Chongqing 400046, Peoples R China; [Zhang, Qian; Wang, Zhongliang; He, Tong-Chuan; Jiang, Li] Chongqing Med Univ, Childrens Hosp, Minist Educ, Key Lab Child Dev & Disorders, Chongqing 400046, Peoples R China; [Zhang, Qian; Wang, Jing; Deng, Fang; Yan, Zhengjian; Wang, Zhongliang; Ye, Jixing; Deng, Youlin; Zhang, Zhonglin; Qiao, Min; Li, Ruifang; Denduluri, Sahitya K.; Wei, Qiang; Zhao, Lianggong; Lu, Shun; Wang, Xin; Tang, Shengli; Liu, Hao; Luu, Hue H.; Haydon, Rex C.; He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Orthopaed Surg & Rehabil Med, Mol Oncol Lab, Chicago, IL 60637 USA; [Wang, Jing; Yan, Zhengjian; Deng, Youlin; Qiao, Min; Wei, Qiang; Liu, Hao] Chongqing Med Univ, Minist Educ, Key Lab Diagnost Med, Chongqing 400016, Peoples R China; [Wang, Jing; Yan, Zhengjian; Deng, Youlin; Qiao, Min; Wei, Qiang; Liu, Hao] Chongqing Med Univ, Affiliated Hosp, Chongqing 400016, Peoples R China; [Deng, Fang] Third Mil Med Univ, Dept Cell Biol, Chongqing 400038, Peoples R China; [Xia, Yinglin] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Ye, Jixing] Chongqing Univ, Sch Bioengn, Chongqing 400044, Peoples R China; [Zhang, Zhonglin; Li, Ruifang; Tang, Shengli] Wuhan Univ, Zhongnan Hosp, Dept Gen Surg, Wuhan 430071, Peoples R China; [Zhang, Zhonglin; Li, Ruifang; Tang, Shengli] Wuhan Univ, Zhongnan Hosp, Dept Neurol, Wuhan 430071, Peoples R China; [Zhao, Lianggong] Lanzhou Univ, Affiliated Hosp 2, Dept Orthopaed Surg, Lanzhou 730000, Peoples R China; [Lu, Shun] Shandong Univ, Shandong Prov Hosp, Dept Orthopaed Surg, Jinan 250012, Peoples R China; [Wang, Xin] Sichuan Univ, West China Hosp, Dept Surg, Chengdu 610041, Peoples R China	Chongqing Medical University; Chongqing Medical University; University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Chongqing Medical University; Army Medical University; University of Rochester; Chongqing University; Wuhan University; Wuhan University; Lanzhou University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Sichuan University	He, TC (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Neurol, Chongqing 400046, Peoples R China.	tche@uchicago.edu; Dr_jiangli@hotmail.com			National Institutes of Health [AT004418, AR50142, AR054381]; National Natural Science Foundation of China (NSFC Grant) [81371452, 81271770]; University of Chicago Core Facility grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health [UL1 TR000430]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR050142, K08AR054381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China (NSFC Grant)(National Natural Science Foundation of China (NSFC)); University of Chicago Core Facility grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The reported work was supported in part by research grants from the National Institutes of Health (AT004418, AR50142, AR054381 to TCH, RCH and HHL), and the National Natural Science Foundation of China (NSFC Grant # 81371452 81271770 to LJ). This work was also supported in part by The University of Chicago Core Facility Subsidy grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health through Grant UL1 TR000430.	Bi Y, 2014, CELL PHYSIOL BIOCHEM, V34, P1318, DOI 10.1159/000366340; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao XM, 2012, BIOCHEM BIOPH RES CO, V427, P366, DOI 10.1016/j.bbrc.2012.09.066; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Chen X, 2013, CELL PHYSIOL BIOCHEM, V32, P1083, DOI 10.1159/000354508; Chen X, 2015, GENES DIS, V2, P96, DOI 10.1016/j.gendis.2014.12.001; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Denduluri SK, 2015, GENES DIS, V2, P13, DOI 10.1016/j.gendis.2014.10.004; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Gao YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082436; Gasparic MB, 2010, ANAL BIOANAL CHEM, V396, P2023, DOI 10.1007/s00216-009-3418-0; Gentle A, 2001, BIOTECHNIQUES, V31, P502, DOI 10.2144/01313st03; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hecker KH, 1996, BIOTECHNIQUES, V20, P478; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hu N, 2013, J CELL SCI, V126, P532, DOI 10.1242/jcs.114231; Huang EY, 2012, J BONE MINER RES, V27, P1566, DOI 10.1002/jbmr.1622; Huang EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032428; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jensen EC, 2012, ANAT REC, V295, P1, DOI 10.1002/ar.21487; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kim JH, 2013, THER ADV MUSCULOSKEL, V5, P13, DOI 10.1177/1759720X12466608; Kong YH, 2013, CELL PHYSIOL BIOCHEM, V32, P1187, DOI 10.1159/000354518; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lamplot J.D., 2015, CELL TRANSPLANT; Li B, 2009, DEVELOPMENT, V136, P3267, DOI 10.1242/dev.036954; Li M, 2013, INT J MED SCI, V10, P1035, DOI 10.7150/ijms.6639; Li R., 2014, CURR CANC DRUG TARGE; Libus J, 2006, BIOTECHNIQUES, V41, P156, DOI 10.2144/000112232; Liu X, 2013, J CELL MOL MED; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo JY, 2007, LAB INVEST, V87, P97, DOI 10.1038/labinvest.3700509; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo Q, 2007, GENE, V395, P160, DOI 10.1016/j.gene.2007.02.030; Luo XJ, 2008, CLIN ORTHOP RELAT R, V466, P2060, DOI 10.1007/s11999-008-0361-x; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Malinen E, 2003, MICROBIOL-SGM, V149, P269, DOI 10.1099/mic.0.25975-0; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Page RB, 2011, THESCIENTIFICWORLDJO, V11, P1383, DOI 10.1100/tsw.2011.124; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Pfaffl MW, 2010, METHODS, V50, P215, DOI 10.1016/j.ymeth.2010.02.005; Provenano M, 2007, ADV EXP MED BIOL, V593, P66; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wang JH, 2014, STEM CELLS DEV, V23, P1405, DOI 10.1089/scd.2013.0580; Wang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097316; Wang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093608; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; Wang T, 1999, ANAL BIOCHEM, V269, P198, DOI 10.1006/abio.1999.4022; Wang XJ, 2014, J BIOMED MATER RES A, V102, P1017, DOI 10.1002/jbm.a.34764; Wang Y, 2013, J ORTHOP RES, V31, P1796, DOI 10.1002/jor.22427; Weaver S, 2010, METHODS, V50, P271, DOI 10.1016/j.ymeth.2010.01.003; Wen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094397; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Wu N, 2014, GENE THER, V21, P629, DOI 10.1038/gt.2014.40; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Zhang HM, 2015, BIOMATERIALS, V39, P145, DOI 10.1016/j.biomaterials.2014.11.007; Zhang Y, 2014, ONCOL REP; Zhao C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092908; Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001	77	72	74	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132666	10.1371/journal.pone.0132666	http://dx.doi.org/10.1371/journal.pone.0132666			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172450	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900073
J	Feitosa, EL; Sampaio, VS; Salinas, JL; Queiroz, AM; da Silva, IM; Gomes, AA; Sachett, J; Siqueira, AM; Ferreira, LCL; dos Santos, MC; Lacerda, M; Monteiro, W				Feitosa, Esau L.; Sampaio, Vanderson S.; Salinas, Jorge L.; Queiroz, Amanda M.; da Silva, Iran Mendonca; Gomes, Andre A.; Sachett, Jacqueline; Siqueira, Andre M.; Ferreira, Luiz Carlos L.; dos Santos, Maria Cristina; Lacerda, Marcus; Monteiro, Wuelton			Older Age and Time to Medical Assistance Are Associated with Severity and Mortality of Snakebites in the Brazilian Amazon: A Case-Control Study	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; BOTHROPS; BITES; ACCIDENTS; SNAKES; STATE; PROFILE; STROKE; NORTH; INDIA	The Amazon region reports the highest incidence of snakebite envenomings in Brazil. We aimed to describe the epidemiology of snakebites in the state of Amazonas and to investigate factors associated with disease severity and lethality. We used a nested case-control study, in order to identify factors associated with snakebite severity and mortality using official Brazilian reporting systems, from 2007 to 2012. Patients evolving to severity or death were considered cases and those with non-severe bites were included in the control group. During the study period, 9,191 snakebites were recorded, resulting in an incidence rate of 52.8 cases per 100,000 person/years. Snakebites mostly occurred in males (79.0%) and in rural areas (70.2%). The most affected age group was between 16 and 45 years old (54.6%). Fifty five percent of the snakebites were related to work activities. Age <= 15 years [OR=1.26 (95% CI=1.03-1.52); (p=0.018)], age >= 65 years [OR=1.53 (95% CI=1.09-2.13); (p=0.012)], work related bites [OR=1.39 (95% CI=1.17-1.63); (p<0.001)] and time to medical assistance >6 hours [OR=1.73 (95% CI=1.45-2.07); (p<0.001)] were independently associated with the risk of severity. Age >= 65 years [OR=3.19 (95% CI=1.40-7.25); (p=0.006)] and time to medical assistance >6 hours [OR=2.01 (95% CI=1.15-3.50); (p=0.013)] were independently associated with the risk of death. Snakebites represent an occupational health problem for rural populations in the Brazilian Amazon with a wide distribution. These results highlight the need for public health strategies aiming to reduce occupational injuries. Most cases of severe disease occurred in the extremes of age, in those with delays in medical attention and those caused by Micrurus bites. These features of victims of snakebite demand adequate management according to well-defined protocols, including prompt referral to tertiary centres when necessary, as well as an effective response from surveillance systems and policy makers for these vulnerable groups.	[Feitosa, Esau L.; Sampaio, Vanderson S.; Queiroz, Amanda M.; da Silva, Iran Mendonca; Gomes, Andre A.; Sachett, Jacqueline; Ferreira, Luiz Carlos L.; Lacerda, Marcus; Monteiro, Wuelton] Fdn Med Trop Doutor Heitor Vieira Dourado, Dept Ensino & Pesquisa, Manaus, Amazonas, Brazil; [Feitosa, Esau L.; Sampaio, Vanderson S.; Queiroz, Amanda M.; da Silva, Iran Mendonca; Gomes, Andre A.; Sachett, Jacqueline; Ferreira, Luiz Carlos L.; Lacerda, Marcus; Monteiro, Wuelton] Univ Estado Amazonas, Escola Super Ciencias Saude, Manaus, Amazonas, Brazil; [Sampaio, Vanderson S.] Fundacao Vigilancia Saude Amazonas, Nucleo Sistemas Informacao, Manaus, Amazonas, Brazil; [Salinas, Jorge L.] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Siqueira, Andre M.] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil; [dos Santos, Maria Cristina] Univ Fed Amazonas, Inst Ciencias Biol, Manaus, Amazonas, Brazil; [Lacerda, Marcus] Fundacao Oswaldo Cruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas; Emory University; Fundacao Oswaldo Cruz; Universidade Federal de Amazonas; Fundacao Oswaldo Cruz	Monteiro, W (corresponding author), Fdn Med Trop Doutor Heitor Vieira Dourado, Dept Ensino & Pesquisa, Manaus, Amazonas, Brazil.	wueltonmm@gmail.com	Sampaio, Vanderson/AAQ-1418-2020; Salinas, Jorge/ABC-7735-2021; Sachett, Jacqueline/I-5642-2017; Siqueira, Andre M/G-1340-2010; Sampaio, Vanderson/M-4337-2015	Sampaio, Vanderson/0000-0001-7307-8851; Salinas, Jorge/0000-0002-9193-820X; Sachett, Jacqueline/0000-0001-5723-9977; Siqueira, Andre M/0000-0003-2208-0294; Sampaio, Vanderson/0000-0001-7307-8851; Dos-Santos, Maria Cristina/0000-0002-1504-2647	PPSUS Public Call (FAPEAM/SUSAM-SES-AM/MS/CNPq) [001/2013]	PPSUS Public Call (FAPEAM/SUSAM-SES-AM/MS/CNPq)	This study was supported by the PPSUS Public Call (FAPEAM/SUSAM-SES-AM/MS/CNPq number 001/2013). JLS is a fellow from Fogarty Global Health [R25TW009337]. MCS is a level 2 fellow from CNPq. MVGL is a level 1 fellow from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque PLMM, 2014, NEPHROLOGY, V19, P764, DOI 10.1111/nep.12327; Albuquerque PLMM, 2013, REV INST MED TROP SP, V55, P295, DOI 10.1590/S0036-46652013000500001; AMARAL CFS, 1986, REV I MED TROP, V28, P220, DOI 10.1590/S0036-46651986000400003; [Anonymous], 2007, REV PARAENSE MED, DOI DOI 10.5123/S0101-59072007000300012; Bard R, 1994, REV I MED TROP SAO P, V36; Bernarde Paulo Sérgio, 2012, Acta Amaz., V42, P65, DOI 10.1590/S0044-59672012000100008; Borges C. C., 1999, Revista da Sociedade Brasileira de Medicina Tropical, V32, P637, DOI 10.1590/S0037-86821999000600005; Brazilian Ministry of Health, 2009, GUIA VIG EP CAD 14 A; Brazilian Ministry of Health, 2014, SIST INF AGR NOT SIN; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; David S, 2012, J MED TOXICOL, V8, P118, DOI 10.1007/s13181-011-0204-0; de Carvalho M A, 1998, Cad Saude Publica, V14, P753, DOI 10.1590/S0102-311X1998000400017; Pardal PPD, 2010, REV INST MED TROP SP, V52, P333, DOI 10.1590/S0036-46652010000600009; Dharod Mrudul V, 2013, N Am J Med Sci, V5, P594, DOI 10.4103/1947-2714.120795; ENNIK F, 1980, WESTERN J MED, V133, P463; Feitosa ES, 2015, REV SOC BRA IN PRESS; Feitosa R F, 1997, Rev Soc Bras Med Trop, V30, P295, DOI 10.1590/S0037-86821997000400004; Fiszon Judith Tiomny, 2008, Rev. bras. epidemiol., V11, P114; Gutierrez JM, 2009, J PROTEOMICS, V72, P165, DOI 10.1016/j.jprot.2009.01.008; Habib AG, 2011, INT HEALTH, V3, P50, DOI 10.1016/j.inhe.2010.08.001; Harrison RA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000569; INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA, 2010, CENS DEM 2010; Kalantri S, 2006, TROP MED INT HEALTH, V11, P22, DOI 10.1111/j.1365-3156.2005.01535.x; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kim Jae Seok, 2008, Korean Journal of Internal Medicine, V23, P94, DOI 10.3904/kjim.2008.23.2.94; Lima JS, 2009, REV SOC BRAS MED TRO, V42, P561, DOI 10.1590/S0037-86822009000500015; Machado AS, 2010, REV SOC BRAS MED TRO, V43, P602, DOI 10.1590/S0037-86822010000500029; Mohapatra B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001018; Moreno E, 2005, REV SOC BRAS MED TRO, V38, P15, DOI 10.1590/S0037-86822005000100004; Mosquera A, 2003, NEUROLOGY, V60, P1577, DOI 10.1212/01.WNL.0000061614.52580.A1; Nascimento S P, 2000, Cad Saude Publica, V16, P271, DOI 10.1590/S0102-311X2000000100031; Ogunfowokan O, 2011, West Afr J Med, V30, P348; Pinho FMO, 2008, SEMIN NEPHROL, V28, P354, DOI 10.1016/j.semnephrol.2008.04.004; Otero R, 2002, TOXICON, V40, P1107, DOI 10.1016/S0041-0101(02)00104-6; Ozay G, 2005, PEDIATR INT, V47, P669, DOI 10.1111/j.1442-200x.2005.02134.x; Pardal PPD, 2004, T ROY SOC TROP MED H, V98, P28, DOI 10.1016/S0035-9203(03)00005-1; Pierini SV, 1996, TOXICON, V34, P225, DOI 10.1016/0041-0101(95)00125-5; Pinho FMO, 2005, KIDNEY INT, V67, P659, DOI 10.1111/j.1523-1755.2005.67122.x; Ribeiro L A, 1998, Rev Assoc Med Bras (1992), V44, P312, DOI 10.1590/S0104-42301998000400010; Ribeiro LA, 2008, REV SOC BRAS MED TRO, V41, P46, DOI 10.1590/S0037-86822008000100009; Sa-Neto R P, 1995, REV SOC BRASILEIRA M, V28, P171; Sa-Neto RP, 1995, REV SOC BRAS MED TRO, V28, P173; Sankar J, 2013, ARCH DIS CHILD, V98, P596, DOI 10.1136/archdischild-2012-303025; Santos MC, 2003, ANIMAS PECONHENTOS B, P115; Santos-Soares PC, 2007, ARQ NEURO-PSIQUIAT, V65, P341, DOI 10.1590/S0004-282X2007000200030; Saravu K, 2012, INDIAN J CRIT CARE M, V16, P187, DOI 10.4103/0972-5229.106499; Sharma SK, 2013, AM J TROP MED HYG, V89, P145, DOI 10.4269/ajtmh.12-0750; Sharma SK, 2004, AM J TROP MED HYG, V71, P234, DOI 10.4269/ajtmh.2004.71.234; Sharma SK, 2004, TROP DOCT, V34, P20, DOI 10.1177/004947550403400108; Lima ACSF, 2009, REV SOC BRAS MED TRO, V42, P329, DOI 10.1590/S0037-86822009000300017; Souza A, 2000, REV PATOL TROP, V31, P259; Suchithra N, 2008, EMERG MED J, V25, P200, DOI 10.1136/emj.2007.051136; Waldez Fabiano, 2009, Acta Amaz., V39, P681, DOI 10.1590/S0044-59672009000300025; Wen FH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003701; Williams D, 2010, LANCET, V375, P89, DOI 10.1016/S0140-6736(09)61159-4; World Health Organisation, 2015, NEGL TROP DIS	56	56	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132237	10.1371/journal.pone.0132237	http://dx.doi.org/10.1371/journal.pone.0132237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168155	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100031
J	Huber, MB; Wacker, ME; Vogelmeier, CF; Leidl, R				Huber, Manuel B.; Wacker, Margarethe E.; Vogelmeier, Claus F.; Leidl, Reiner			Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review	PLOS ONE			English	Review							OBSTRUCTIVE PULMONARY-DISEASE; DEPRESSION; MORTALITY; INDIVIDUALS; MORBIDITIES; MODERATE; EUROQOL; ANXIETY; ASTHMA; IMPACT	Background Chronic obstructive pulmonary disease (COPD) is a leading cause of mortality and of loss of disability-adjusted life years worldwide. It often is accompanied by the presence of comorbidity. Objectives To systematically review the influence of COPD comorbidity on generic health-related quality of life (HRQoL). Methods A systematic review approach was used to search the databases Pubmed, Embase and Cochrane Library for studies evaluating the influence of comorbidity on HRQoL in COPD. Identified studies were analyzed according to study characteristics, generic HRQoL measurement instrument, COPD severity and comorbid HRQoL impact. Studies using only nongeneric instruments were excluded. Results 25 studies met the selection criteria. Seven studies utilized the EQ-5D, six studies each used the SF-36 or SF-12. The remaining studies used one of six other instruments each. Utilities were calculated by four EQ-5D studies and one 15D study. Patient populations covered both early and advanced stages of COPD and ranged from populations with mostly stage 1 and 2 to studies with patients classified mainly stage 3 and 4. Evidence was mainly created for cardiovascular disease, depression and anxiety as well as diabetes but also for quantitative comorbid associations. Strong evidence is pointing towards the significant negative association of depression and anxiety on reduced HRQoL in COPD patients. While all studies found the occurrence of specific comorbidities to decrease HRQoL in COPD patients, the orders of magnitude diverged. Due to different patient populations, different measurement tools and different concomitant diseases the study heterogeneity was high. Conclusions Facilitating multimorbid intervention guidance, instead of applying a parsimony based single disease paradigm, should constitute an important goal for improving HRQoL of COPD patients in research and in clinical practice.	[Huber, Manuel B.; Wacker, Margarethe E.; Leidl, Reiner] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Comprehens Pneumol Ctr Munich, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Vogelmeier, Claus F.] Univ Marburg, Univ Med Ctr Giessen & Marburg UGMLC, Dept Med Pulm & Crit Care Med, Marburg, Germany; [Leidl, Reiner] Univ Munich, Munich Ctr Hlth Sci, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Philipps University Marburg; University of Munich	Huber, MB (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Comprehens Pneumol Ctr Munich, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany.	manuel.huber@helmholtz-muenchen.de	Leidl, Reiner M/B-7209-2009; Leidl, Reiner/GQY-7389-2022	Leidl, Reiner M/0000-0002-7115-7510; 				Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; [Anonymous], 2000, CENTERS FOR DISEASE; Ara R, 2013, MED DECIS MAKING, V33, P139, DOI 10.1177/0272989X12455461; Ara R, 2012, MED CARE, V50, P452, DOI 10.1097/MLR.0b013e318234a04a; Avis NE, 1996, MED CARE, V34, P1102, DOI 10.1097/00005650-199611000-00005; Badia X, 1999, MED CLIN-BARCELONA, V112, P79; Barnes PJ, 2013, NAT REV DRUG DISCOV, V12, P543, DOI 10.1038/nrd4025; Baty F, 2013, PLOS ONE, V8; Bentsen SB, 2014, QUAL LIFE RES, V23, P991, DOI 10.1007/s11136-013-0515-5; Blinderman CD, 2009, J PAIN SYMPTOM MANAG, V38, P115, DOI 10.1016/j.jpainsymman.2008.07.006; Boros PW, 2012, POL ARCH MED WEWN, V122, P73, DOI 10.20452/pamw.1177; Boyd CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041601; Briggs AH, 2010, EUR RESPIR J, V35, P532, DOI 10.1183/09031936.00153108; BURCKHARDT CS, 1989, RES NURS HEALTH, V12, P347, DOI 10.1002/nur.4770120604; Campo G, 2015, CARDIOVASC DRUG THER, V29, P147, DOI 10.1007/s10557-014-6569-y; Cleland JA, 2007, FAM PRACT, V24, P217, DOI 10.1093/fampra/cmm009; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Corner BS, 2015, PHARMACOL THERAPEUT, V147, P91, DOI 10.1016/j.pharmthera.2014.11.006; Cully JA, 2006, PSYCHOSOMATICS, V47, P312, DOI 10.1176/appi.psy.47.4.312; de Miguel-Diez J, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-8; Decramer M, 2013, LANCET RESP MED, V1, P73, DOI 10.1016/S2213-2600(12)70060-7; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Effing TW, 2014, J THORAC DIS, V6, P1597, DOI 10.3978/j.issn.2072-1439.2014.11.14; Engstrom CP, 2001, EUR RESPIR J, V18, P69, DOI 10.1183/09031936.01.00044901; Fabbri Leonardo M, 2012, Proc Am Thorac Soc, V9, P274, DOI 10.1513/pats.201208-063ST; Fabbri LM, 2012, AM J RESP CRIT CARE, V186, P117, DOI 10.1164/rccm.201205-0906ED; Frei A, 2014, J CLIN EPIDEMIOL, V67, P904, DOI 10.1016/j.jclinepi.2014.03.005; Gershon AS, 2015, EUR RESPIR J, V45, P51, DOI 10.1183/09031936.00061414; Glaser S, 2015, RESPIRATION, V89, P253, DOI 10.1159/000369863; Hanmer J, 2010, J CLIN EPIDEMIOL, V63, P331, DOI 10.1016/j.jclinepi.2009.06.013; Hillas G, 2015, INT J CHRONIC OBSTR, V10, P95, DOI 10.2147/COPD.S54473; Huber MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123292; HUNT SM, 1980, J EPIDEMIOL COMMUN H, V34, P281, DOI 10.1136/jech.34.4.281; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Janson C, 2013, EUR RESPIR J, V42, P1472, DOI 10.1183/09031936.00153712; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Kil SY, 2010, J CLIN NURS, V19, P1307, DOI 10.1111/j.1365-2702.2009.03053.x; Kind P, 2009, VALUE HEALTH, V12, pS27, DOI 10.1111/j.1524-4733.2009.00519.x; Koskela J, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-102; Krishnan Gokul, 2006, BMC Pulm Med, V6, P23, DOI 10.1186/1471-2466-6-23; Leidl R, 2011, PHARMACOECONOMICS, V29, P521, DOI 10.2165/11538380-000000000-00000; Varela MVL, 2013, ARCH BRONCONEUMOL, V49, P468, DOI 10.1016/j.arbres.2013.05.003; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Loscalzo J, 2011, WIRES SYST BIOL MED, V3, P619, DOI 10.1002/wsbm.144; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; Martinez FJ, 2011, LANCET, V378, P1027, DOI 10.1016/S0140-6736(11)61047-7; Meiners S, 2015, EUR RESPIR J, V45, P807, DOI 10.1183/09031936.00186914; Miravitlles M, 2014, RESP MED, V108, P1615, DOI 10.1016/j.rmed.2014.08.010; Miyazaki M, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-13; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Molken MPMHRV, 2006, CHEST, V130, P1117, DOI 10.1378/chest.130.4.1117; Morimoto Takeshi, 2002, J Epidemiol, V12, P160; Mullerova H, 2013, CHEST, V144, P1163, DOI 10.1378/chest.12-2847; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Naberan K, 2012, RESP MED, V106, P367, DOI 10.1016/j.rmed.2011.09.014; Ng TP, 2009, RESP MED, V103, P895, DOI 10.1016/j.rmed.2008.12.010; Parappil A, 2010, RESPIROLOGY, V15, P918, DOI 10.1111/j.1440-1843.2010.01781.x; Postma Dirkje S, 2006, Proc Am Thorac Soc, V3, P434, DOI 10.1513/pats.200601-006AW; Putcha N, 2013, COPD, V10, P324, DOI 10.3109/15412555.2012.744963; Raherison C, 2009, EUR RESPIR REV, V18, P213, DOI 10.1183/09059180.00003609; Rascon-Aguilar IE, 2011, DIGEST DIS SCI, V56, P1976, DOI 10.1007/s10620-010-1542-5; Scichilone N, 2014, RESPIRATION, V87, P11, DOI 10.1159/000355082; Shavro SA, 2012, INT J CHRONIC OBSTR, V7, P291, DOI 10.2147/COPD.S26405; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; Sintonen H, 2001, ANN MED, V33, P328, DOI 10.3109/07853890109002086; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Sundh J, 2015, INT J CHRONIC OBSTR, V10, P173, DOI 10.2147/COPD.S74645; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; van Manen JG, 2003, J CLIN EPIDEMIOL, V56, P1177, DOI 10.1016/S0895-4356(03)00208-7; van Manen JG, 2001, RESP MED, V95, P496, DOI 10.1053/rmed.2001.1077; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; Wacker ME, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-134; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wijnhoven HAH, 2003, RESP MED, V97, P468, DOI 10.1053/rmed.2002.1463; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Xiang YT, 2015, PERSPECT PSYCHIATR C, V51, P121, DOI 10.1111/ppc.12073	80	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132670	10.1371/journal.pone.0132670	http://dx.doi.org/10.1371/journal.pone.0132670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1PW	26168154	Green Submitted, Green Published, gold			2022-12-27	WOS:000358193100064
J	Labrie, M; Vladoiu, M; Leclerc, BG; Grosset, AA; Gaboury, L; Stagg, J; St-Pierre, Y				Labrie, Marilyne; Vladoiu, Maria; Leclerc, Bruno G.; Grosset, Andree-Anne; Gaboury, Louis; Stagg, John; St-Pierre, Yves			A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate	PLOS ONE			English	Article							CARCINOMA CELL-LINE; BREAST-CANCER CELLS; BETA-CATENIN; EXPRESSION; OVEREXPRESSION; IDENTIFICATION; KERATINOCYTES; ASSOCIATION; SUPPRESSION; PROGRESSION	The observation that galectin-7 (gal-7) is specifically expressed in mammary myoepithelial (basal) cells prompted us to investigate whether this protein is expressed in the basal cells of other tissues. Given that breast and prostate cancer have remarkable underlying biological similarities and given the important roles of basal cells in prostate cancer, we examined the expression patterns and role of gal-7 in human prostate cancer. Using tissue microarray, we found that although gal-7 is readily expressed in basal cells in normal prostate tissue, it is downregulated in prostate cancer (PCa) cells. De novo expression of gal-7 in prostate cancer cells increases their sensitivity to apoptosis in response to etoposide and cisplatin. The assessment of a carbohydrate-recognition domain (CRD)-defective mutant form of gal7 (R7S) showed that the ability of this protein to modulate apoptosis was independent of its CRD activity. This activity was also independent of its ability to translocate to the mitochondrial and nuclear compartments. However, CRD activity was necessary to inhibit the invasive behaviors of prostate cancer cells. In vivo, gal-7 overexpression in PCa cells led to a modest yet significant reduction in tumor size, while its CRD-defective mutant form significantly increased tumor growth compared to controls. Taken together, these results suggest that although de novo expression of gal-7 may be an interesting means of increasing the tumorigenic phenotypes of PCa cells, alterations in the CRD activity of this protein drive a phenotypic switch in its role in PCa cells. This CRD-independent activity represents a paradigm shift in our understanding of the functions of galectin. The R74S model will be useful to distinguish CRD-dependent and CRD-independent functions of gal-7 in cancer progression.	[Labrie, Marilyne; Vladoiu, Maria; Grosset, Andree-Anne; St-Pierre, Yves] Inst Armand Frappier, INRS, Laval, PQ, Canada; [Leclerc, Bruno G.; Stagg, John] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Grosset, Andree-Anne; Gaboury, Louis] Inst Rech Immunol & Cancerol, Montreal, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); Universite de Montreal; Universite de Montreal	St-Pierre, Y (corresponding author), Inst Armand Frappier, INRS, Laval, PQ, Canada.	yves.st-pierre@iaf.inrs.ca		St-Pierre, Yves/0000-0002-1948-2041; Labrie, Marilyne/0000-0003-3957-5533	Canadian Institutes for Health Research [MOP-89697]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes for Health Research (Grant No. MOP-89697) to YSP (http://www.cihr-irsc.gc.ca/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SJ, 2002, J BIOL CHEM, V277, P14859, DOI 10.1074/jbc.M200221200; Akahani S, 1997, CANCER RES, V57, P5272; Alves PM, 2011, PATHOL RES PRACT, V207, P236, DOI 10.1016/j.prp.2011.02.004; Bernerd F, 1999, P NATL ACAD SCI USA, V96, P11329, DOI 10.1073/pnas.96.20.11329; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Califice S, 2004, ONCOGENE, V23, P7527, DOI 10.1038/sj.onc.1207997; Campion CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095087; Campion CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072468; Cao ZY, 2002, J BIOL CHEM, V277, P42299, DOI 10.1074/jbc.M200981200; Davids MS, 2012, J CLIN ONCOL, V30, P3127, DOI 10.1200/JCO.2011.37.0981; Demers M, 2010, AM J PATHOL, V176, P3023, DOI 10.2353/ajpath.2010.090876; Demers M, 2009, BIOCHEM BIOPH RES CO, V387, P425, DOI 10.1016/j.bbrc.2009.07.015; Ellerhorst JA, 2002, PROSTATE, V50, P64, DOI 10.1002/pros.10033; Gendronneau G, 2008, MOL BIOL CELL, V19, P5541, DOI 10.1091/mbc.E08-02-0166; GIBAS Z, 1984, CANCER GENET CYTOGEN, V11, P399, DOI 10.1016/0165-4608(84)90020-7; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Grosset AA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-801; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kim SJ, 2013, ONCOTARGET, V4, P1461, DOI 10.18632/oncotarget.1219; Kim SJ, 2011, CLIN EXP METASTAS, V28, P743, DOI 10.1007/s10585-011-9406-8; Kuwabara I, 2002, J BIOL CHEM, V277, P3487, DOI 10.1074/jbc.M109360200; Labrie M, 2014, ONCOTARGET, V5, P7705, DOI 10.18632/oncotarget.2299; Lazebnik YA, 1995, J CELL SCI, P41; Magnaldo T, 1998, DIFFERENTIATION, V63, P159, DOI 10.1046/j.1432-0436.1998.6330159.x; MAGNALDO T, 1995, DEV BIOL, V168, P259, DOI 10.1006/dbio.1995.1078; Nakahara S, 2005, APOPTOSIS, V10, P267, DOI 10.1007/s10495-005-0801-y; Pacis RA, 2000, PROSTATE, V44, P118; Park JW, 2001, NUCLEIC ACIDS RES, V29, P3595, DOI 10.1093/nar/29.17.3595; Risbridger GP, 2010, NAT REV CANCER, V10, P205, DOI 10.1038/nrc2795; Rondanino C, 2011, AM J PHYSIOL-RENAL, V301, pF622, DOI 10.1152/ajprenal.00134.2011; Saussez S, 2006, ANN SURG ONCOL, V13, P999, DOI 10.1245/ASO.2006.08.033; Shimura T, 2004, CANCER RES, V64, P6363, DOI 10.1158/0008-5472.CAN-04-1816; Song SM, 2009, CANCER RES, V69, P1343, DOI 10.1158/0008-5472.CAN-08-4153; Song YK, 2002, AM J PATHOL, V160, P1069, DOI 10.1016/S0002-9440(10)64927-9; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Ueda S, 2004, CANCER RES, V64, P5672, DOI 10.1158/0008-5472.CAN-04-0985; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van den Brule FA, 2000, INT J CANCER, V89, P361, DOI 10.1002/1097-0215(20000720)89:4<361::AID-IJC8>3.3.CO;2-L; Villeneuve C, 2011, MOL BIOL CELL, V22, P999, DOI 10.1091/mbc.E10-06-0534; Vladoiu MC, 2014, INT J ONCOL, V44, P1001, DOI 10.3892/ijo.2014.2267; Weinberger PM, 2007, ARCH OTOLARYNGOL, V133, P503, DOI 10.1001/archotol.133.5.503; Zhu X, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-290	43	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131307	10.1371/journal.pone.0131307	http://dx.doi.org/10.1371/journal.pone.0131307			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168167	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000358193100007
J	Lam, E; Ramke, M; Warnecke, G; Schrepfer, S; Kopfnagel, V; Dobner, T; Heim, A				Lam, Elena; Ramke, Mirja; Warnecke, Gregor; Schrepfer, Sonja; Kopfnagel, Verena; Dobner, Thomas; Heim, Albert			Effective Apical Infection of Differentiated Human Bronchial Epithelial Cells and Induction of Proinflammatory Chemokines by the Highly Pneumotropic Human Adenovirus Type 14p1	PLOS ONE			English	Article							ACUTE RESPIRATORY-DISEASE; CILIATED AIRWAY EPITHELIA; INFLAMMATORY MEDIATORS; RECEPTOR; RECRUITS; LOCALIZATION; ATTACHMENT; EXPRESSION; PNEUMONIA; RESPONSES	Background Only a few pneumotropic types of the human adenoviruses (e.g. type B14p1) cause severe lower respiratory tract infections like pneumonia and acute respiratory distress syndrome (ARDS) even in immunocompetent patients. By contrast, many other human adenovirus (HAdV) types (e.g. HAdV-C5) are associated mainly with upper respiratory tract infections. This is in accordance with a highly physiological cell culture system consisting of differentiated primary human bronchial epithelial cells which are little susceptible for apical HAdV-C5 infections. Objective and Methods We hypothesized that a pneumotropic and highly pathogenic HAdV type infects differentiated human bronchial epithelial cells efficiently from the apical surface and also induces proinflammatory cytokines in order to establish ARDS and pneumonia. Therefore, the apical infection of differentiated primary human bronchial epithelial cells with the pneumotropic and virulent type HAdV-B14p1 was investigated in comparison to the less pneumotropic HAdV-C5 as a control. Results Binding of HAdV-B14p1 to the apical surface of differentiated human bronchial epithelial cells and subsequent internalization of HAdV DNA was 10 fold higher (p<0.01) compared to the less-pneumotropic HAdV-C5 one hour after infection. Overall, the replication cycle of HAdV-B14p1 following apical infection and including apical release of infectious virus progeny was about 1000-fold more effective compared to the non-pneumotropic HAdV-C5 (p<0.001). HAdV-B14p1 infected cells expressed desmoglein 2 (DSG2), which has been described as potential receptor for HAdV-B14p1. Moreover, HAdV-B14p1 induced proinflammatory chemokines IP-10 and I-Tac as potential virulence factors. Interestingly, IP-10 has already been described as a marker for severe respiratory infections e.g. by influenza virus A H5N1. Conclusions The efficient "apical to apical" replication cycle of HAdV-B14p1 can promote endobronchial dissemination of the infection from the upper to the lower respiratory tract. Simultaneous induction of proinflammatory cytokines probably contributes to the high virulence of HAdV-B14p1.	[Lam, Elena; Ramke, Mirja; Heim, Albert] Hannover Med Sch, Inst Virol, Hannover, Germany; [Lam, Elena; Dobner, Thomas] Heinrich Pette Inst, Dept Viral Transformat, Hamburg, Germany; [Warnecke, Gregor] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany; [Schrepfer, Sonja] Univ Klinikum Eppendorf, Univ Heart Ctr Hamburg, Transplant & Stem Cell Immunobiol Lab, Hamburg, Germany; [Kopfnagel, Verena] Hannover Med Sch, Dept Dermatol, Hannover, Germany	Hannover Medical School; Heinrich Pette Institute; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School	Heim, A (corresponding author), Hannover Med Sch, Inst Virol, Hannover, Germany.	heim.albert@mh-hannover.de		Mittermaier, Mirja/0000-0003-0678-6676	Robert Koch Institut (RKI) [FKZ 1369-380, 1369-461]	Robert Koch Institut (RKI)	This work was supported in part by Robert Koch Institut (RKI) grants FKZ 1369-380 and 1369-461. Elena Lam received Hannover biomedical research school stipend funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barraza EM, 1999, J INFECT DIS, V179, P1531, DOI 10.1086/314772; Bergelson JM, 1999, BIOCHEM PHARMACOL, V57, P975, DOI 10.1016/S0006-2952(98)00332-3; Borgland SL, 2000, J VIROL, V74, P3941, DOI 10.1128/JVI.74.9.3941-3947.2000; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; DUDDING BA, 1972, AM J EPIDEMIOL, V95, P140, DOI 10.1093/oxfordjournals.aje.a121378; Excoffon KJDA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009909; Fein AM, 2000, CRIT CARE CLIN, V16, P289, DOI 10.1016/S0749-0704(05)70111-1; Ganzenmueller T, 2012, REV MED VIROL, V22, P194, DOI 10.1002/rmv.724; Girouard G, 2013, EMERG INFECT DIS, V19, P119, DOI 10.3201/eid1901.120423; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Huang GH, 2013, INFLUENZA OTHER RESP, V7, P1048, DOI 10.1111/irv.12118; Karp Philip H, 2002, Methods Mol Biol, V188, P115; KENDALL EJC, 1957, BRIT MED J, V2, P131, DOI 10.1136/bmj.2.5037.131; Kiehl MG, 1998, CRIT CARE MED, V26, P1194, DOI 10.1097/00003246-199807000-00019; Lai CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053614; Lama E, 2011, J VIROL METHODS, V178, P117, DOI 10.1016/j.jviromet.2011.08.025; Louie JK, 2008, CLIN INFECT DIS, V46, P421, DOI 10.1086/525261; Metzgar D, 2007, J INFECT DIS, V196, P1465, DOI 10.1086/522970; Moro MR, 2009, PEDIATR INFECT DIS J, V28, P376, DOI 10.1097/INF.0b013e31819075a6; O'Flanagan D, 2009, 1 REPORTED CASES HUM, P16; Parcell BJ, 2014, J PUBLIC HLTH OXF; PEREIRA HG, 1958, VIROLOGY, V6, P601, DOI 10.1016/0042-6822(58)90109-0; PRINCE GA, 1993, J VIROL, V67, P101, DOI 10.1128/JVI.67.1.101-111.1993; Ryu JS, 2003, YONSEI MED J, V44, P732, DOI 10.3349/ymj.2003.44.4.732; SCHRADER E, 1981, J VIROL METHODS, V2, P321, DOI 10.1016/0166-0934(81)90055-0; Short JJ, 2006, VIRUS RES, V122, P144, DOI 10.1016/j.virusres.2006.07.009; Sirena D, 2004, J VIROL, V78, P4454, DOI 10.1128/JVI.78.9.4454-4462.2004; Sumino KC, 2010, THORAX, V65, P639, DOI 10.1136/thx.2009.132480; TOP FH, 1971, AM J EPIDEMIOL, V94, P142, DOI 10.1093/oxfordjournals.aje.a121306; TOP FH, 1971, J INFECT DIS, V124, P148, DOI 10.1093/infdis/124.2.148; VANDERVEEN J, 1957, AM J HYG, V65, P119; Walters RW, 1999, J BIOL CHEM, V274, P10219, DOI 10.1074/jbc.274.15.10219; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; Wu WX, 2010, J GEN VIROL, V91, P1155, DOI 10.1099/vir.0.017905-0; Yoon JS, 2007, PEDIATR PULM, V42, P277, DOI 10.1002/ppul.20574; Young AM, 2012, MOL THER, V20, P1676, DOI 10.1038/mt.2012.116; Zabner J, 1997, J CLIN INVEST, V100, P1144, DOI 10.1172/JCI119625; Zabner J, 1996, J VIROL, V70, P6994, DOI 10.1128/JVI.70.10.6994-7003.1996	39	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131201	10.1371/journal.pone.0131201	http://dx.doi.org/10.1371/journal.pone.0131201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168049	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100006
J	de Garibay, GR; Herranz, C; Llorente, A; Boni, J; Serra-Musach, J; Mateo, F; Aguilar, H; Gomez-Baldo, L; Petit, A; Vidal, A; Climent, F; Hernandez-Losa, J; Cordero, A; Gonzalez-Suarez, E; Sanchez-Mut, JV; Esteller, M; Llatjos, R; Varela, M; Lopez, JI; Garcia, N; Extremera, AI; Guma, A; Ortega, R; Pla, MJ; Fernandez, A; Pernas, S; Falo, C; Morilla, I; Campos, M; Gil, M; Roman, A; Molina-Molina, M; Ussetti, P; Laporta, R; Valenzuela, C; Ancochea, J; Xaubet, A; Casanova, A; Pujana, MA				Ruiz de Garibay, Gorka; Herranz, Carmen; Llorente, Alicia; Boni, Jacopo; Serra-Musach, Jordi; Mateo, Francesca; Aguilar, Helena; Gomez-Baldo, Laia; Petit, Anna; Vidal, August; Climent, Fina; Hernandez-Losa, Javier; Cordero, Alex; Gonzalez-Suarez, Eva; Vicente Sanchez-Mut, Jose; Esteller, Manel; Llatjos, Roger; Varela, Mar; Ignacio Lopez, Jose; Garcia, Nadia; Extremera, Ana I.; Guma, Anna; Ortega, Raul; Jesus Pla, Maria; Fernandez, Adela; Pernas, Sonia; Falo, Catalina; Morilla, Idoia; Campos, Miriam; Gil, Miguel; Roman, Antonio; Molina-Molina, Maria; Ussetti, Piedad; Laporta, Rosalia; Valenzuela, Claudia; Ancochea, Julio; Xaubet, Antoni; Casanova, Alvaro; Angel Pujana, Miguel			Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; SPORADIC PULMONARY LYMPHANGIOLEIOMYOMATOSIS; HUMAN BREAST-CANCER; DUCTAL CARCINOMA; SELF-RENEWAL; ID PROTEINS; GENE TSC2; EXPRESSION; TRANSPLANTATION; ACTIVATION	Lymphangioleiomyomatosis (LAM) is a rare lung-metastasizing neoplasm caused by the proliferation of smooth muscle-like cells that commonly carry loss-of-function mutations in either the tuberous sclerosis complex 1 or 2 (TSC1 or TSC2) genes. While allosteric inhibition of the mechanistic target of rapamycin (mTOR) has shown substantial clinical benefit, complementary therapies are required to improve response and/or to treat specific patients. However, there is a lack of LAM biomarkers that could potentially be used to monitor the disease and to develop other targeted therapies. We hypothesized that the mediators of cancer metastasis to lung, particularly in breast cancer, also play a relevant role in LAM. Analyses across independent breast cancer datasets revealed associations between low TSC1/2 expression, altered mTOR complex 1 (mTORC1) pathway signaling, and metastasis to lung. Subsequently, immunohistochemical analyses of 23 LAM lesions revealed positivity in all cases for the lung metastasis mediators fascin 1 (FSCN1) and inhibitor of DNA binding 1 (ID1). Moreover, assessment of breast cancer stem or luminal progenitor cell biomarkers showed positivity in most LAM tissue for the aldehyde dehydrogenase 1 (ALDH1), integrin-beta 3 (ITGB3/CD61), and/or the sex-determining region Y-box 9 (SOX9) proteins. The immunohistochemical analyses also provided evidence of heterogeneity between and within LAM cases. The analysis of Tsc2-deficient cells revealed relative over-expression of FSCN1 and ID1; however, Tsc2-deficient cells did not show higher sensitivity to ID1-based cancer inhibitors. Collectively, the results of this study reveal novel LAM biomarkers linked to breast cancer metastasis to lung and to cell stemness, which in turn might guide the assessment of additional or complementary therapeutic opportunities for LAM.	[Ruiz de Garibay, Gorka; Herranz, Carmen; Llorente, Alicia; Boni, Jacopo; Serra-Musach, Jordi; Mateo, Francesca; Aguilar, Helena; Gomez-Baldo, Laia; Garcia, Nadia; Extremera, Ana I.; Angel Pujana, Miguel] Bellvitge Inst Biomed Res IDIBELL, Catalan Inst Oncol ICO, Program Canc Therapeut Resistance ProCURE, Breast Canc & Syst Biol, Lhospitalet Del Llobrega, Catalonia, Spain; [Petit, Anna; Vidal, August; Climent, Fina; Llatjos, Roger; Varela, Mar] Univ Hosp Bellvitge, Bellvitge Inst Biomed Res IDIBELL, Dept Pathol, Lhospitalet Del Llobrega, Catalonia, Spain; [Hernandez-Losa, Javier] Vall dHebron Hosp, Dept Pathol, Barcelona, Catalonia, Spain; [Cordero, Alex; Gonzalez-Suarez, Eva; Vicente Sanchez-Mut, Jose; Esteller, Manel] Bellvitge Inst Biomed Res IDIBELL, Canc Epigenet & Biol Program, Lhospitalet Del Llobrega, Catalonia, Spain; [Esteller, Manel] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona, Catalonia, Spain; [Esteller, Manel] Inst Catalana Recerca & Estudis Avancats, Barcelona, Catalonia, Spain; [Ignacio Lopez, Jose] Univ Basque Country, BioCruces Res Inst, Cruces Univ Hosp, Baracaldo, Spain; [Guma, Anna; Ortega, Raul] Univ Hosp Bellvitge, Bellvitge Inst Biomed Res IDIBELL, Dept Radiol, Lhospitalet Del Llobrega, Catalonia, Spain; [Jesus Pla, Maria] Univ Hosp Bellvitge, Bellvitge Inst Biomed Res IDIBELL, Catalan Inst Oncol ICO, Dept Gynecol,Breast Canc Unit, Lhospitalet Del Llobrega, Catalonia, Spain; [Fernandez, Adela; Pernas, Sonia; Falo, Catalina; Morilla, Idoia; Campos, Miriam; Gil, Miguel] Bellvitge Inst Biomed Res IDIBELL, Catalan Inst Oncol ICO, Breast Canc Unit, Dept Med Oncol, Lhospitalet Del Llobrega, Catalonia, Spain; [Roman, Antonio] Vall dHebron Univ Hosp, Lymphangioleiomyomatosis LAM Clin, Lung Transplant Unit, Dept Pulmonol, Barcelona, Catalonia, Spain; [Molina-Molina, Maria] Univ Hosp Bellvitge, Bellvitge Inst Biomed Res IDIBELL, Dept Pneumol, Lhospitalet Del Llobrega, Catalonia, Spain; [Molina-Molina, Maria; Xaubet, Antoni] Biomed Res Ctr Network Resp Dis CIBERES, Madrid, Spain; [Ussetti, Piedad; Laporta, Rosalia] Univ Hosp Clin Puerta Hierro, Dept Pneumol, Madrid, Spain; [Valenzuela, Claudia; Ancochea, Julio] Hosp La Princesa, Inst Invest Sanitaria La Princesa, Dept Pneumol, Madrid, Spain; [Xaubet, Antoni] Hosp Clin Barcelona, Agusti Pi Suner Biomed Res Inst IDIBAPS, Dept Pneumol, Barcelona, Catalonia, Spain; [Casanova, Alvaro] Henares Hosp, Dept Pneumol, Madrid, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Hospital Universitari Vall d'Hebron; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; ICREA; Hospital Universitario Cruces; University of Basque Country; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Universitari Vall d'Hebron; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBERESP; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Pujana, MA (corresponding author), Bellvitge Inst Biomed Res IDIBELL, Catalan Inst Oncol ICO, Program Canc Therapeut Resistance ProCURE, Breast Canc & Syst Biol, Lhospitalet Del Llobrega, Catalonia, Spain.	mapujana@iconcologia.net	Laporta Hernandez, Rosalía/AFP-1538-2022; Casanovas, Alex Cordero/AAA-8157-2020; Sanchez-Mut, Jose V./A-8651-2019; de Garibay, Gorka Ruiz/AAB-6579-2020; Boni, Jacopo/I-9587-2016; Varela, Mar/J-1814-2016; Javier, Hernandez Losa/C-1173-2008; Esteller, Manel/L-5956-2014; Ussetti, Piedad/B-3853-2014; Herranz Ors, Carmen/K-1043-2017; Mateo, Francesca/K-7746-2015; Pujana, Miquel Angel/N-3127-2014; Vidal, August/N-4662-2016; Morilla, Idoia/P-6155-2019; Lopez, Jose Ignacio/L-3884-2019; Gonzalez-Suarez, Eva/L-6298-2014; Petit, Anna/GYU-5229-2022	Laporta Hernandez, Rosalía/0000-0002-8326-6626; Sanchez-Mut, Jose V./0000-0002-9292-8521; de Garibay, Gorka Ruiz/0000-0001-9936-8419; Varela, Mar/0000-0002-2129-6336; Javier, Hernandez Losa/0000-0003-1526-3201; Esteller, Manel/0000-0003-4490-6093; Ussetti, Piedad/0000-0002-3439-5536; Herranz Ors, Carmen/0000-0002-2866-0321; Mateo, Francesca/0000-0002-2342-7010; Pujana, Miquel Angel/0000-0003-3222-4044; Vidal, August/0000-0001-5727-2099; Morilla, Idoia/0000-0001-8237-5073; Lopez, Jose Ignacio/0000-0003-0842-5348; Gonzalez-Suarez, Eva/0000-0003-0858-8171; Extremera, Ana Isabel/0000-0002-3731-4367; Climent, Fina/0000-0002-4360-8388; Boni, Jacopo/0000-0003-2626-9393; Ancochea, julio/0000-0001-7451-4133; valenzuela, claudia/0000-0002-0856-6290; MOLINA MOLINA, MARIA/0000-0002-1852-1723; Llorente, Alicia/0000-0002-6056-0566; Cordero Casanovas, Alejandro/0000-0002-2224-7122	Government of Catalonia [SGR 2014-364]; Red Tematica de Investigacion Colaborativa en Cancer [RD12/0036/0008]; Telemaraton "Todos Somos Raros, Todos Somos Unicos [P35]; Spanish Ministry of Health "Instituto de Salud Carlos III Fondo de Investigacion Sanitaria" [PI12/01528]; Spanish Society of Pneumology and Thoracic Surgery (Sociedad Espanola de Neumologia y Cirugia Toracica, SEPAR); ICREA Funding Source: Custom	Government of Catalonia(Generalitat de Catalunya); Red Tematica de Investigacion Colaborativa en Cancer; Telemaraton "Todos Somos Raros, Todos Somos Unicos; Spanish Ministry of Health "Instituto de Salud Carlos III Fondo de Investigacion Sanitaria"(Instituto de Salud Carlos IIISpanish Government); Spanish Society of Pneumology and Thoracic Surgery (Sociedad Espanola de Neumologia y Cirugia Toracica, SEPAR); ICREA(ICREA)	This work was funded by the Government of Catalonia grant SGR 2014-364, the "Red Tematica de Investigacion Colaborativa en Cancer" grant RD12/0036/0008, the Telemaraton 2014 "Todos Somos Raros, Todos Somos Unicos" grant P35, the Spanish Ministry of Health "Instituto de Salud Carlos III Fondo de Investigacion Sanitaria" grant PI12/01528, and a Spanish Society of Pneumology and Thoracic Surgery (Sociedad Espanola de Neumologia y Cirugia Toracica, SEPAR) grant for 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton E, 2009, SARCOIDOSIS VASC DIF, V26, P85; Astrinidis A, 2000, J MED GENET, V37, P55, DOI 10.1136/jmg.37.1.55; Badri KR, 2013, AM J RESP CRIT CARE, V187, P663, DOI 10.1164/ajrccm.187.6.663; Bittmann I, 2003, HUM PATHOL, V34, P95, DOI 10.1053/hupa.2003.50; Blei F, 2011, LYMPHAT RES BIOL, V9, P185, DOI 10.1089/lrb.2011.0020; Boecker W, 2002, J PATHOL, V198, P458, DOI 10.1002/path.1241; BONETTI F, 1989, AM J CLIN PATHOL, V92, P491, DOI 10.1093/ajcp/92.4.491; Cai XO, 2010, AM J RESP CRIT CARE, V182, P1410, DOI 10.1164/rccm.201003-0489OC; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Chakravarty G, 2011, EXP BIOL MED, V236, P145, DOI 10.1258/ebm.2010.010086; Chu SC, 1999, CHEST, V115, P1041, DOI 10.1378/chest.115.4.1041; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Crooks DM, 2004, P NATL ACAD SCI USA, V101, P17462, DOI 10.1073/pnas.0407971101; Delaney SP, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00069; Ferrer I, 2014, J PATHOL, V233, P247, DOI 10.1002/path.4343; Finlay G, 2004, AM J PHYSIOL-LUNG C, V286, pL690, DOI 10.1152/ajplung.00311.2003; Fu NY, 2014, CURR TOP DEV BIOL, V107, P133, DOI 10.1016/B978-0-12-416022-4.00005-6; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gao L, 2014, VIRCHOWS ARCH, V464, P495, DOI 10.1007/s00428-014-1559-9; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gomez-Baldo L, 2010, CELL CYCLE, V9, P1143, DOI 10.4161/cc.9.6.11018; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hancock DB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003098; Hashimoto Y, 2011, J PATHOL, V224, P289, DOI 10.1002/path.2894; Hasskarl J, 2002, CANCER BIOL THER, V1, P91, DOI 10.4161/cbt.50; Hohman DW, 2008, EUR J INTERN MED, V19, P319, DOI 10.1016/j.ejim.2007.10.015; Honeth G, 2015, STEM CELL REP, V4, P699, DOI 10.1016/j.stemcr.2015.02.013; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Jiang WG, 2005, EUR J CANCER, V41, P1628, DOI 10.1016/j.ejca.2005.03.023; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karbowniczek M, 2003, AM J RESP CRIT CARE, V167, P976, DOI 10.1164/rccm.200208-969OC; Kobayashi E, 2010, MOL CANCER THER, V9, P535, DOI 10.1158/1535-7163.MCT-09-0774; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Landemaine T, 2008, CANCER RES, V68, P6092, DOI 10.1158/0008-5472.CAN-08-0436; Li CG, 2014, J EXP MED, V211, P15, DOI 10.1084/jem.20131080; Li ZD, 2009, FEBS LETT, V583, P1999, DOI 10.1016/j.febslet.2009.05.013; Lin HJ, 2005, BRIT J CANCER, V93, P1372, DOI 10.1038/sj.bjc.6602862; Lo PK, 2012, ONCOGENE, V31, P2614, DOI [10.1038/onc.2011.439, 10.1038/onc.2012.147]; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsui K, 2000, AM J RESP CRIT CARE, V161, P1002, DOI 10.1164/ajrccm.161.3.9904009; McAllister SD, 2011, BREAST CANCER RES TR, V129, P37, DOI 10.1007/s10549-010-1177-4; McCormack FX, 2008, CHEST, V133, P507, DOI 10.1378/chest.07-0898; McCormack FX, 2012, AM J RESP CRIT CARE, V186, P1210, DOI 10.1164/rccm.201205-0848OE; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mistry H, 2013, MOL CANCER THER, V12, P2651, DOI 10.1158/1535-7163.MCT-13-0103-T; Muzykewicz DA, 2009, J MED GENET, V46, P465, DOI 10.1136/jmg.2008.065342; Nasr Z, 2013, ONCOGENE, V32, P861, DOI 10.1038/onc.2012.105; Nishiyama K, 2007, J BIOL CHEM, V282, P17200, DOI 10.1074/jbc.M611609200; Pacheco-Rodriguez G, 2010, CRIT REV IMMUNOL, V30, P387, DOI 10.1615/CritRevImmunol.v30.i4.40; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Romero-Lanman EE, 2012, STEM CELLS DEV, V21, P384, DOI 10.1089/scd.2011.0428; Russell RC, 2011, DEVELOPMENT, V138, P3343, DOI 10.1242/dev.058230; Sato T, 2002, J HUM GENET, V47, P20, DOI 10.1007/s10038-002-8651-8; Seyama K, 2010, LYMPHAT RES BIOL, V8, P21, DOI 10.1089/lrb.2009.0018; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Soroceanu L, 2013, CANCER RES, V73, P1559, DOI 10.1158/0008-5472.CAN-12-1943; Steagall WK, 2015, AM J RESP CRIT CARE, V191, P854, DOI 10.1164/rccm.201412-2170LE; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taveira-DaSilva Angelo M, 2006, Cancer Control, V13, P276; Taveira-DaSilva AM, 2010, LYMPHAT RES BIOL, V8, P9, DOI 10.1089/lrb.2009.0024; Tobin NP, 2015, ANN ONCOL, V26, P81, DOI 10.1093/annonc/mdu498; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wagner SN, 1997, CANCER IMMUNOL IMMUN, V44, P239, DOI 10.1007/s002620050379; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu J, 2010, LYMPHAT RES BIOL, V8, P43, DOI 10.1089/lrb.2009.0020; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	70	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132546	10.1371/journal.pone.0132546	http://dx.doi.org/10.1371/journal.pone.0132546			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167915	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100053
J	Hong, JX; Shi, WY; Liu, ZG; Pineda, R; Cui, XH; Sun, XH; Xu, JJ				Hong, Jiaxu; Shi, Weiyun; Liu, Zuguo; Pineda, Roberto; Cui, Xinhan; Sun, Xinghuai; Xu, Jianjiang			Limitations of Keratoplasty in China: A Survey Analysis	PLOS ONE			English	Article								Purpose Each year, over 8,000 corneal transplantation surgeries are performed in China. Unlike developed countries, which have established standard requirements for operative experience for corneal specialists, little information exists on surgical training for keratoplasty in China. The aim of this study was to assess the keratoplasty experience of Chinese corneal specialists and to characterize their surgical patterns. Methods One hundred and twenty-one corneal specialists in 16 provinces (65 cities) in China were invited to complete an anonymous survey at the 2014 Chinese Corneal Society annual meeting, which consisted of questions with single or multiple-choice answers. Demographics, the number and type of keratoplasties performed, and the perceived limiting factors for performing keratoplasties were analyzed. Results An overwhelming 89% response rate was achieved. Of the 108 respondents, 76% worked in tertiary centers, and only 23% held a medical doctorate degree. Furthermore, 69% of the participants had received corneal fellowship training of less than one year. Only 71% were capable of keratoplasties. Among those doing keratoplasty, 68% performed less than 50 keratoplasties each year. Of the same group of keratoplasty surgeons, 88% of corneal specialists capable of keratoplasties had performed penetrating keratoplasties, 87% had performed lamellar keratoplasties, 12% had performed deep anterior lamellar keratoplasties, and 5% had performed Descemet's stripping endothelial keratoplasties. When questioned on the reasons for the low number of keratoplasties performed in China, the respondents deemed the following factors most important: lack of surgical training (71%), a shortage of donor supply (52%), and a lack of curricula (42%). A multivariate logistic regression analysis showed that corneal transplantation capabilities are significantly associated with responders' education levels and training time. Conclusion Keratoplasty surgery experience is suboptimal for Chinese corneal specialists. Penetrating and lamellar keratoplasties are the preferred surgical patterns. Our findings raise concerns about the adequacy of keratoplasty training in China.	[Hong, Jiaxu; Cui, Xinhan; Sun, Xinghuai; Xu, Jianjiang] Fudan Univ, Shanghai Med Coll, Dept Ophthalmol & Visual Sci, Eye & ENT Hosp, Shanghai 200433, Peoples R China; [Shi, Weiyun] Shandong Eye Hosp, Shandong Eye Inst, Qingdao, Peoples R China; [Hong, Jiaxu; Liu, Zuguo] Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China; [Hong, Jiaxu; Pineda, Roberto] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA USA	Fudan University; Shandong First Medical University & Shandong Academy of Medical Sciences; Xiamen University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Xu, JJ (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Ophthalmol & Visual Sci, Eye & ENT Hosp, Shanghai 200433, Peoples R China.	jianjiangxu@126.com			Key Clinic Medicine Research Program, the Ministry of Health, China [201302015]; National Science and Technology Research Program, the Ministry of Science and Technology, China [2012BAI08B01]; National Natural Science Foundation of China [81170817, 81200658, 81300735, 81270978, U1205025, 81330022]; Scientific Research Program, Science and Technology Commission of Shanghai Municipality, Shanghai [13441900900, 13430720400]; New Technology Joint Research Project in Shanghai Hospitals [SHDC12014114]	Key Clinic Medicine Research Program, the Ministry of Health, China; National Science and Technology Research Program, the Ministry of Science and Technology, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Program, Science and Technology Commission of Shanghai Municipality, Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); New Technology Joint Research Project in Shanghai Hospitals	The authors were supported by grants from the Key Clinic Medicine Research Program, the Ministry of Health, China (201302015); the National Science and Technology Research Program, the Ministry of Science and Technology, China (2012BAI08B01); the National Natural Science Foundation of China (81170817, 81200658, 81300735, 81270978, U1205025, and 81330022); and the Scientific Research Program, Science and Technology Commission of Shanghai Municipality, Shanghai (13441900900, 13430720400); New Technology Joint Research Project in Shanghai Hospitals (SHDC12014114). The sponsor or funding organization had no role in the design or conduct of this research.	Chu Ting, 2013, Chinese Medical Sciences Journal, V28, P20; Garg P, 2005, EYE, V19, P1106, DOI 10.1038/sj.eye.6701968; Lee WB, 2009, OPHTHALMOLOGY, V116, P1818, DOI 10.1016/j.ophtha.2009.06.021; Reinhart WJ, 2011, OPHTHALMOLOGY, V118, P209, DOI 10.1016/j.ophtha.2010.11.002; Tan Leshan, 2006, Community Eye Health, V19, P61; Zhang L., 2014, TRANSPLANTATION; Zhang Ming-Chang, 2007, Zhonghua Yan Ke Za Zhi, V43, P289	7	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132268	10.1371/journal.pone.0132268	http://dx.doi.org/10.1371/journal.pone.0132268			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161870	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300109
J	Kubo, H; Shibato, J; Saito, T; Ogawa, T; Rakwal, R; Shioda, S				Kubo, Hiroko; Shibato, Junko; Saito, Tomomi; Ogawa, Tetsuo; Rakwal, Randeep; Shioda, Seiji			Unraveling the Rat Intestine, Spleen and Liver Genome-Wide Transcriptome after the Oral Administration of Lavender Oil by a Two-Color Dye-Swap DNA Microarray Approach	PLOS ONE			English	Article							GENE-EXPRESSION; SIGNAL-TRANSDUCTION; PREPARATION SILEXAN; ANXIETY DISORDER; DOWN-REGULATION; ISCHEMIC BRAIN; MESSENGER-RNA; MOUSE MODEL; ER-ALPHA; LINALOOL	The use of lavender oil (LO) - a commonly, used oil in aromatherapy, with well-defined volatile components linalool and linalyl acetate - in non-traditional medicine is increasing globally. To understand and demonstrate the potential positive effects of LO on the body, we have established an animal model in this current study, investigating the orally administered LO effects genome wide in the rat small intestine, spleen, and liver. The rats were administered LO at 5 mg/kg (usual therapeutic dose in humans) followed by the screening of differentially expressed genes in the tissues, using a 4x44-K whole-genome rat chip (Agilent microarray platform; Agilent Technologies, Palo Alto, CA, USA) in conjunction with a dyeswap approach, a novelty of this study. Fourteen days after LO treatment and compared with a control group (sham), a total of 156 and 154 up (>= 1.5-fold)- and down (<= 0.75-fold)regulated genes, 174 and 66 up-(>= 1.5-fold)-and down (<= 0.75-fold)-regulated genes, and 222 and 322 up-(>= 1.5-fold)-and down (<= 0.75-fold)-regulated genes showed differential expression at the mRNA level in the small intestine, spleen and liver, respectively. The reverse transcription-polymerase chain reaction (RT-PCR) validation of highly up-and down-regulated genes confirmed the regulation of the Papd4, Lrp1b, Alb, Cyr61, Cyp2c, and Cxcl1 genes by LO as examples in these tissues. Using bioinformatics, including Ingenuity Pathway Analysis (IPA), differentially expressed genes were functionally categorized by their Gene Ontology (GO) and biological function and network analysis, revealing their diverse functions and potential roles in LO-mediated effects in rat. Further IPA analysis in particular unraveled the presence of novel genes, such as Papd4, Or8k5, Gprc5b, Taar5, Trpc6, Pld2 and Onecut3 (up-regulated top molecules) and Tnf, Slc45a4, Slc25a23 and Samt4 (down-regulated top molecules), to be influenced by LO treatment in the small intestine, spleen and liver, respectively. These results are the first such inventory of genes that are affected by lavender essential oil (LO) in an animal model, forming the basis for further in-depth bioinformatics and functional analyses and investigation.	[Kubo, Hiroko; Shibato, Junko; Saito, Tomomi; Ogawa, Tetsuo; Rakwal, Randeep; Shioda, Seiji] Showa Univ, Sch Med, Dept Anat 1, Shinagawa Ku, Tokyo 142, Japan; [Kubo, Hiroko] Oriental Aromatherapy Coll, Katsushika, Tokyo, Japan; [Shibato, Junko; Rakwal, Randeep; Shioda, Seiji] Hoshi Univ, Global Res Ctr Innovat Life Sci, Sch Pharm & Pharmaceut Sci, Peptide Drug Innovat,Shinagawa Ku, Tokyo 142, Japan; [Shibato, Junko] Univ Tsukuba, Inst Hlth & Sport Sci, Lab Exercise Biochem & Neuroendocrinol, Tsukuba, Ibaraki, Japan; [Ogawa, Tetsuo] Saitama Med Univ, Dept Physiol, Saitama, Japan; [Rakwal, Randeep] Univ Tsukuba, Org Educ Initiat, Tsukuba, Ibaraki, Japan; [Rakwal, Randeep] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan; [Rakwal, Randeep] Univ Tsukuba, Tsukuba Int Acad Sport Studies TIAS, Tsukuba, Ibaraki, Japan	Showa University; Hoshi University; University of Tsukuba; Saitama Medical University; University of Tsukuba; University of Tsukuba; University of Tsukuba	Rakwal, R (corresponding author), Showa Univ, Sch Med, Dept Anat 1, Shinagawa Ku, Tokyo 142, Japan.	plantproteomics@gmail.com; shioda@hoshi.ac.jp						Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Abdel-Aziz M, 2014, IRAN J ALLERGY ASTHM, V13, P324; Anderson M, 2014, J CELL PHYSIOL, V229, P434, DOI 10.1002/jcp.24461; [Anonymous], 1886, PHARMACOPOEA JAPONIC, Vviii, P292; [Anonymous], 2008, PRINC AR; [Anonymous], 2010, AR MON; [Anonymous], 2008, EUROPEAN PHARMACOPOE; Baker J, 2012, AM J PHYSIOL-GASTR L, V303, pG825, DOI 10.1152/ajpgi.00327.2011; Bandapalli OR, 2012, CYTOKINE, V57, P46, DOI 10.1016/j.cyto.2011.10.019; Beck M, 2008, PLOS ONE, V3, pe2343, DOI [10.1371/journal.pone.0002343, DOI 10.1371/JOURNAL.PONE.0002343]; Brum LFS, 2001, PHYTOTHER RES, V15, P422, DOI 10.1002/ptr.973; Buckle J, 2003, CLIN AROMATHERAPY ES, P236; CHADHA A, 1984, XENOBIOTICA, V14, P365, DOI 10.3109/00498258409151425; Clevenger CV, 1998, J ENDOCRINOL, V157, P187, DOI 10.1677/joe.0.1570187; Cooke B, 2000, BRIT J GEN PRACT, V50, P493; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Doroshyenko O, 2013, DRUG METAB DISPOS, V41, P987, DOI 10.1124/dmd.112.050203; Eder P, 2005, PFLUG ARCH EUR J PHY, V451, P99, DOI 10.1007/s00424-005-1434-2; Endo M, 2005, MOL ENDOCRINOL, V19, P1181, DOI 10.1210/me.2004-0063; Espana A, 2012, MOL CELL NEUROSCI, V50, P93, DOI 10.1016/j.mcn.2012.04.002; Estacion M, 2006, J PHYSIOL-LONDON, V572, P359, DOI 10.1113/jphysiol.2005.103143; Esworthy RS, 2003, BIOL CHEM, V384, P597, DOI 10.1515/BC.2003.067; Fang Y, 2014, PEPTIDES, V55, P47, DOI 10.1016/j.peptides.2014.01.019; Festing S, 1985, STORY LAVENDER; Fissler M, 2014, COMPLEMENT THER MED, V22, P63, DOI 10.1016/j.ctim.2013.11.008; Franchomme de P, 1990, AROMATHERAPIE EXACTE; Frasor J, 2001, MOL ENDOCRINOL, V15, P2172, DOI 10.1210/me.15.12.2172; Garcia-Martinez R, 2015, J HEPATOL, V62, P799, DOI 10.1016/j.jhep.2014.10.031; Gattefosse RM, 1993, AROMATHERAPY; Gimenez-Bastida JA, 2009, J AGR FOOD CHEM, V57, P9305, DOI 10.1021/jf901983g; Grieve M, 1971, MODERN HERBAL, V1-2; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Hori M, 2015, GENOM DATA, V3, P148, DOI 10.1016/j.gdata.2015.01.007; Hori Motohide, 2015, Microarrays (Basel), V4, P2, DOI 10.3390/microarrays4010002; Hori M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-256; Hori M, 2012, DIS MODEL MECH, V5, P270, DOI 10.1242/dmm.008276; Ito J, 2009, CELL TISSUE RES, V338, P257, DOI 10.1007/s00441-009-0859-x; JAGER W, 1992, J SOC COSMET CHEM, V43, P49; JIROVETZ L, 1990, FRESEN J ANAL CHEM, V338, P922, DOI 10.1007/BF00322039; Kainkaryam RM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-299; KALMOVARIN N, 1991, INFLAMMATION, V15, P369, DOI 10.1007/BF00917353; Kasper S, 2014, INT J NEUROPSYCHOPH, V17, P859, DOI 10.1017/S1461145714000017; Kasper S, 2010, WIEN MED WOCHENSCHR, V160, P547, DOI 10.1007/s10354-010-0845-7; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kendziorski CM, 2003, BIOSTATISTICS, V4, P465, DOI 10.1093/biostatistics/4.3.465; Kim YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003149; Kobayashi H, 2013, J ENDOCRINOL, V219, P39, DOI 10.1530/JOE-13-0156; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Lawless J, 1992, ENCY ESSENTIAL OILS; Lee MC, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12206; Lewith GT, 2005, J ALTERN COMPLEM MED, V11, P631, DOI 10.1089/acm.2005.11.631; Macintire K, 2014, REPROD FERT DEVELOP, V26, P351, DOI 10.1071/RD12384; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mattheisen M, 2015, MOL PSYCHIATR, V20, P337, DOI 10.1038/mp.2014.43; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Moss M, 2003, INT J NEUROSCI, V113, P15, DOI 10.1080/00207450390161903; National Center for Biotechnology Information, 2015, PUBCHEM COMP DAT; National Center for Biotechnology Information, 2015, PUBCHEM COMPOUND DAT; Ni SB, 2013, CANCER SCI, V104, P817, DOI 10.1111/cas.12157; Ogawa T, 2014, CONGENIT ANOM, V54, P195, DOI [10.1111/cga.12089, 10.1111/cga.12062]; Ogawa T, 2011, CONGENIT ANOM, V51, P110, DOI 10.1111/j.1741-4520.2011.00315.x; Patel V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087102; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Pierreux CE, 2004, J BIOL CHEM, V279, P51298, DOI 10.1074/jbc.M409038200; Politano VT, 2008, INT J TOXICOL, V27, P183, DOI 10.1080/10915810801977948; Qu DF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118933; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Sanchez J, 2009, ENDOCRINOLOGY, V150, P5341, DOI 10.1210/en.2009-0466; Schlndorff JS, 2006, SEMIN CELL DEV BIOL, V17, P667, DOI 10.1016/j.semcdb.2006.11.003; Schnaubelt K, 1999, MED AROMATHERAPY HEA, P296; Schuwald AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059998; Segen J. C., 1998, DICT ALTERNATIVE MED; Steiling H, 2003, ONCOGENE, V22, P4380, DOI 10.1038/sj.onc.1206499; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tanaka Y, 2004, INT J CANCER, V109, P336, DOI 10.1002/ijc.11700; Thangavel C, 2008, DRUG METAB DISPOS, V36, P1884, DOI 10.1124/dmd.108.021451; Vanhorenbeeck V, 2002, BIOCHEM BIOPH RES CO, V292, P848, DOI 10.1006/bbrc.2002.6760; Vickers KC, 2013, J LIPID RES, V54, P1182, DOI 10.1194/jlr.R034801; Visioli F, 1998, LIFE SCI, V62, P541, DOI 10.1016/S0024-3205(97)01150-8; Wallrabenstein I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054950; Wang J, 2009, J ENDOCRINOL, V202, P337, DOI 10.1677/JOE-09-0136; Wei K, 2013, NAT MED, V19, P1331, DOI 10.1038/nm.3295; Wheatley D, 2005, J PSYCHOPHARMACOL, V19, P414, DOI 10.1177/0269881105053309; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Yu GY, 2012, AM J RESP CRIT CARE, V186, P752, DOI 10.1164/rccm.201202-0302OC; Zhang XK, 2010, CELL CYCLE, V9, P4437, DOI 10.4161/cc.9.22.13887; Zheng H, 2014, SCI REP-UK, V4, DOI 10.1038/srep07046; Zhu Bo, 2011, Zhonghua Yi Xue Za Zhi, V91, P3134	90	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0129951	10.1371/journal.pone.0129951	http://dx.doi.org/10.1371/journal.pone.0129951			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161641	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300011
J	Lupo, KD; Schmitt, DN; Kiahtipes, CA; Ndanga, JP; Young, DC; Simiti, B				Lupo, Karen D.; Schmitt, Dave N.; Kiahtipes, Christopher A.; Ndanga, Jean-Paul; Young, D. Craig; Simiti, Bernard			On Intensive Late Holocene Iron Mining and Production in the Northern Congo Basin and the Environmental Consequences Associated with Metallurgy in Central Africa	PLOS ONE			English	Article							AGE CENTRAL-AFRICA; RAIN-FOREST; LAND-USE; SOUTHERN CAMEROON; EQUATORIAL AFRICA; HUMAN OCCUPATION; HUMAN IMPACTS; WEST-AFRICA; CLIMATE; GABON	An ongoing question in paleoenvironmental reconstructions of the central African rainforest concerns the role that prehistoric metallurgy played in shaping forest vegetation. Here we report evidence of intensive iron-ore mining and smelting in forested regions of the northern Congo Basin dating to the late Holocene. Volumetric estimates on extracted iron-ore and associated slag mounds from prehistoric sites in the southern Central African Republic suggest large-scale iron production on par with other archaeological and historically-known iron fabrication areas. These data document the first evidence of intensive iron mining and production spanning approximately 90 years prior to colonial occupation (circa AD 1889) and during an interval of time that is poorly represented in the archaeological record. Additional site areas pre-dating these remains by 3-4 centuries reflect an earlier period of iron production on a smaller scale. Microbotanical evidence from a sediment core collected from an adjacent riparian trap shows a reduction in shade-demanding trees in concert with an increase in light-demanding species spanning the time interval associated with iron intensification. This shift occurs during the same time interval when many portions of the Central African witnessed forest transgressions associated with a return to moister and more humid conditions beginning 500-100 years ago. Although data presented here do not demonstrate that iron smelting activities caused widespread vegetation change in Central Africa, we argue that intense mining and smelting can have localized and potentially regional impacts on vegetation communities. These data further demonstrate the high value of pairing archeological and paleoenvironmental analyses to reconstruct regional-scale forest histories.	[Lupo, Karen D.; Schmitt, Dave N.; Kiahtipes, Christopher A.] So Methodist Univ, Dept Anthropol, Dallas, TX 75275 USA; [Ndanga, Jean-Paul; Simiti, Bernard] Univ Bangui, Ctr Univ Rech & Documentat Hist & Archeol Centraf, Bangui, Cent Afr Republ; [Young, D. Craig] Far Western Anthropol Res Grp, Carson City, NV USA	Southern Methodist University	Lupo, KD (corresponding author), So Methodist Univ, Dept Anthropol, Dallas, TX 75275 USA.	klupo@smu.edu		Kiahtipes, Christopher/0000-0002-8758-4605	National Science Foundation [0924242]; Institute for the Study of Earth and Man (ISEM); Southern Methodist University; Dedman College, Southern Methodist University; Far Western Anthropological Research Group (FWAR)	National Science Foundation(National Science Foundation (NSF)); Institute for the Study of Earth and Man (ISEM); Southern Methodist University; Dedman College, Southern Methodist University; Far Western Anthropological Research Group (FWAR)	Most of the work was supported by a grant from the National Science Foundation (No. 0924242) to KL. The processing and dating of some of the core samples were supported by small grants from the Institute for the Study of Earth and Man (ISEM), Southern Methodist University and Dedman College, Southern Methodist University to CAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Far Western Anthropological Research Group (FWAR), provided indirect support in the form of salaries for one author (DCY). FWAR did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	[Anonymous], 1887, PROCEEDINGS OF THE R, V9, P440; Aremu DA, 2004, THE ORIGINS OF IRON, P149; Aubreville AMA, 1947, THE DISAPPEARANCE OF, V1; Bahuchet S, 1985, LES PYGMEES AKA ET L; Bahuchet S., 1982, POLITICS HIST BAND S, P189; Barton H, 2012, QUATERN INT, V249, P1, DOI 10.1016/j.quaint.2011.07.044; Bayon G, 2012, SCIENCE, V335, P1219, DOI 10.1126/science.1215400; Brncic TM, 2007, PHILOS T R SOC B, V362, P229, DOI 10.1098/rstb.2006.1982; Brncic TM, 2009, HOLOCENE, V19, P79, DOI 10.1177/0959683608098954; Clist B, 1989, NSI, V6, P79; Clist B, 1988, NSI LIBREVILLE, V2, P24; David N., 1977, W AFRICAN J ARCHAEOL, V7, P17; de Barros P., 1988, AFR ARCHAEOL REV, V69, P91, DOI DOI 10.1007/BF01117114; de Barros P, 1986, AFRICA LOND, V56, P152, DOI [10.1017/S0001972000041553, DOI 10.1017/S0001972000041553]; DE BARROS P, 2000, ANCIENT AFRICAN META, P147; de Maret P., 1996, HOW OLD IS IRON AGE, P29; de Maret P., 2004, ORIGINS IRON METALLU, P127; de Maret P., 1985, AFRICAN IRON WORKING, P73; deMenocal P, 2000, SCIENCE, V288, P2198, DOI 10.1126/science.288.5474.2198; DIGOMBE L, 1988, CURR ANTHROPOL, V29, P179, DOI 10.1086/203624; DIGOMBE L, 1985, CURR ANTHROPOL, V26, P516, DOI 10.1086/203317; Eggert M. K. H., 1993, ARCHAEOLOGY AFRICA F, P289; Elenga H, 1996, CR ACAD SCI II A, V323, P403; Essomba J-M., 2004, ORIGINS IRON METALLU, P135; Faegri K, 1989, TEXTBOOK OF POLLEN A; Fairhead J., 1998, REFRAMING DEFORESTAT; Fay JM, 1997, THESIS; Fluzin P., 2004, THE ORIGINS OF IRON, P65; Giles- Vernick T, 2002, CUTTING THE VINES OF; Giresse P, 2009, J PALEOLIMNOL, V41, P369, DOI 10.1007/s10933-008-9231-5; Gosling WD, 2013, REV PALAEOBOT PALYNO, V199, P1, DOI 10.1016/j.revpalbo.2013.01.003; Gotilogue S, 2000, STUDIES IN AFRICAN A, V7; GOUCHER CL, 1981, J AFR HIST, V22, P179, DOI 10.1017/S0021853700019393; GUYER JI, 1986, CAH ETUD AFR, V26, P577, DOI 10.3406/cea.1986.1685; Haaland R., 1985, AFRICAN IRON WORKING, P50; Hart TB, 1996, BIODIVERSITY OF AFRICAN PLANTS, P545; Holl A.F.C., 2000, ANCIENT AFRICAN META, P1; Holl AFC, 2009, J WORLD PREHIST, V22, P415, DOI 10.1007/s10963-009-9030-6; Itambi AC, 2010, J QUATERNARY SCI, V25, P267, DOI 10.1002/jqs.1306; Kiahtipes C., 2011, FARMING, V2011, P1, DOI DOI 10.3828/BFARM.2011.2.4; Killick D., 2004, J AFR ARCHAEOL, V2, P97, DOI [10.3213/1612-1651-10021, DOI 10.3213/1612-1651-10021]; Kliemann K, 1999, CHALLENGING ELUSIVEN, P261; L-M Maes-Diop, 2004, THE ORIGINS OF IRON, P189; Lezine AM, 2013, CR GEOSCI, V345, P327, DOI 10.1016/j.crte.2013.03.001; Lupo K.D., 2014, CONGO BASIN HUNTER G, P59; Lupo KD, 2013, J ARCHAEOL METHOD TH, V20, P420, DOI 10.1007/s10816-012-9159-y; MacEachern S., 1996, ASPECTS AFRICAN ARCH, P489; MALEY J, 1992, B SOC GEOL FR, V163, P363; Maley J, 2001, VEG HIST ARCHAEOBOT, V10, P117, DOI 10.1007/PL00006920; Maley J, 2012, SCIENCE, V337, DOI [10.1126/science.1221747, 10.1126/science.1221820]; Martinelli B, 2004, THE ORIGINS OF IRON, P165; Meister C, 2010, AFR ARCHAEOL REV, V27, P237, DOI 10.1007/s10437-010-9081-1; Meister C, 2008, J AFR ARCHAEOL, V6, P183, DOI 10.3213/1612-1651-10109; Miller D., 2004, J AFR ARCHAEOL, V2, P23, DOI DOI 10.3213/1612-1651-10017; Neumer M, 2008, PALAEOECOL AFR, V28, P121; Ngomanda A, 2005, HOLOCENE, V15, P1021, DOI 10.1191/0959683605hl875ra; Ngomanda A, 2009, CLIM PAST, V5, P647, DOI 10.5194/cp-5-647-2009; Oslisly R, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0304; Palmer PG, 1985, EAST AFRICAN GRASSES, VIII; Pendere-Sengue Simiti B., 2004, REVUE CENTRA FRICAIN, V1; Pole LM, 1985, AFRICAN IRON WORKING, P142; REID A, 1995, WORLD ARCHAEOL, V27, P144, DOI 10.1080/00438243.1995.9980298; Richards PW, 1952, THE TROPICAL RAIN FO; Runge J, 2002, CATENA, V48, P67, DOI 10.1016/S0341-8162(02)00010-3; Rupp S., 1998, RESOURCE USE TRINATI, P41; Salzmann U, 2005, HOLOCENE, V15, P190, DOI 10.1191/0959683605hl799rp; Sassen M, 2013, FOREST ECOL MANAG, V307, P206, DOI 10.1016/j.foreco.2013.07.010; Schmidt PR, 1996, THE CULTURE AND TECH; SCHWARTZ D, 1990, CR ACAD SCI II, V310, P1293; Shinnie P. L., 1985, AFRICAN IRON WORKING, P28; SOWUNMI M A, 1973, Grana, V13, P145, DOI 10.1080/00173137309429891; Sowunmi M. A, 2002, DROUGHTS FOOD CULTUR, P95; Spinage CA., 2012, AFRICAN ECOLOGY BENC; Sundstrom L, 1974, THE EXCHANGE ECONOMY; SWAINE MD, 1992, J VEG SCI, V3, P365, DOI 10.2307/3235762; Tinner W, 2003, HOLOCENE, V13, P499, DOI 10.1191/0959683603hl615rp; Tovar C, 2014, ECOGRAPHY, V37, P1139, DOI 10.1111/ecog.00697; van Gemerden BS, 2003, J BIOGEOGR, V30, P1381, DOI 10.1046/j.1365-2699.2003.00937.x; van Noten F, 1985, AFRICAN IRONWORKING, P102; VANSINA J, 1962, J AFR HIST, V3, P375, DOI 10.1017/S0021853700003303; Vansina J, 1990, PATHS IN THE RAINFOR; Vincens A, 1999, J BIOGEOGR, V26, P879, DOI 10.1046/j.1365-2699.1999.00333.x; Warnier J. -P., 2012, CAMEROON GRASSFIELDS; WARNIER JP, 1979, AFRICA, V49, P329, DOI 10.2307/1159222; White E, 1983, THE VEGETATION OF AF; White L. J. T., 2001, African rain forest ecology and conservation: an interdisciplinary perspective, P3; White LJT, 1999, GLOBAL ECOL BIOGEOGR, V8, P355, DOI 10.1046/j.1365-2699.1999.00149.x; White LJT., 2001, AFRICAN RAIN FOREST, P47; Willis KJ, 2004, SCIENCE, V304, P402, DOI 10.1126/science.1093991; ZANGATO E., 1999, CAMBRIDGE MONOGRAPHS, V46; Zangato E, 2007, LES ATELIERS DOBOUI	91	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132632	10.1371/journal.pone.0132632	http://dx.doi.org/10.1371/journal.pone.0132632			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161540	Green Submitted, gold, Green Published			2022-12-27	WOS:000358162300160
J	Mouchet, M; Levers, C; Zupan, L; Kuemmerle, T; Plutzar, C; Erb, K; Lavorel, S; Thuiller, W; Haberl, H				Mouchet, Maud; Levers, Christian; Zupan, Laure; Kuemmerle, Tobias; Plutzar, Christoph; Erb, Karlheinz; Lavorel, Sandra; Thuiller, Wilfried; Haberl, Helmut			Testing the Effectiveness of Environmental Variables to Explain European Terrestrial Vertebrate Species Richness across Biogeographical Scales	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; LAND-USE; LATITUDINAL GRADIENTS; BIOTIC INTERACTIONS; HUMAN APPROPRIATION; LANDSCAPE STRUCTURE; PLANT DIVERSITY; GLOBAL PATTERNS; CLIMATE; ENERGY	We compared the effectiveness of environmental variables, and in particular of land-use indicators, to explain species richness patterns across taxonomic groups and biogeographical scales (i.e. overall pan-Europe and ecoregions within pan-Europe). Using boosted regression trees that handle non-linear relationships, we compared the relative influence (as a measure of effectiveness) of environmental variables related to climate, landscape (or habitat heterogeneity), land-use intensity or energy availability to explain European vertebrate species richness (birds, amphibians, and mammals) at the continental and ecoregion scales. We found that dominant land cover and actual evapotranspiration that relate to energy availability were the main correlates of vertebrate species richness over Europe. At the ecoregion scale, we identified four distinct groups of ecoregions where species richness was essentially associated to (i) seasonality of temperature, (ii) actual evapotranspiration and/or mean annual temperature, (iii) seasonality of precipitation, actual evapotranspiration and land cover) and (iv) and an even combination of the environmental variables. This typology of ecoregions remained valid for total vertebrate richness and the three vertebrate groups taken separately. Despite the overwhelming influence of land cover and actual evapotranspiration to explain vertebrate species richness patterns at European scale, the ranking of the main correlates of species richness varied between regions. Interestingly, landscape and land-use indicators did not stand out at the continental scale but their influence greatly increased in southern ecoregions, revealing the long-lasting human footprint on land-use-land-cover changes. Our study provides one of the first multi-scale descriptions of the variability in the ranking of correlates across several taxa.	[Mouchet, Maud; Zupan, Laure; Lavorel, Sandra; Thuiller, Wilfried] Univ Grenoble Alpes, Lab Ecol Alpine LECA, F-38000 Grenoble, France; [Mouchet, Maud; Zupan, Laure; Lavorel, Sandra; Thuiller, Wilfried] CNRS, Lab Ecol Alpine LECA, F-38000 Grenoble, France; [Levers, Christian; Kuemmerle, Tobias] Humboldt Univ, Dept Geog, D-10099 Berlin, Germany; [Plutzar, Christoph; Erb, Karlheinz; Haberl, Helmut] Alpen Adria Univ Klagenfurt, Inst Social Ecol Vienna, A-1070 Vienna, Austria; [Kuemmerle, Tobias; Haberl, Helmut] Humboldt Univ, Integrat Res Inst Transformat Human Environm Syst, D-10099 Berlin, Germany	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Humboldt University of Berlin; University of Klagenfurt; Humboldt University of Berlin	Mouchet, M (corresponding author), MNHN, CESCO, UMR7204, 55 Rue Buffon, F-75005 Paris, France.	maud.mouchet@mnhn.fr	Levers, Christian/L-9204-2013; Mouchet, Maud A/D-4145-2013; Haberl, Helmut/G-3679-2013; Erb, Karlheinz/F-1282-2016; Plutzar, Christoph/J-6055-2015; Thuiller, Wilfried/G-3283-2010; Kuemmerle, Tobias/B-4340-2008	Levers, Christian/0000-0003-4810-9024; Mouchet, Maud A/0000-0001-5939-6802; Haberl, Helmut/0000-0003-2104-5446; Erb, Karlheinz/0000-0002-8335-4159; Plutzar, Christoph/0000-0003-2041-6399; Thuiller, Wilfried/0000-0002-5388-5274; Kuemmerle, Tobias/0000-0002-9775-142X	EU project VOLANTE (Visions of Land use Transitions in Europe) [FP7-ENV-2010-265104]; European Research Council grant ("LUISE") [ERC-2010-stg-263522]	EU project VOLANTE (Visions of Land use Transitions in Europe); European Research Council grant ("LUISE")	This research was funded by the EU project VOLANTE (Visions of Land use Transitions in Europe) FP7-ENV-2010-265104. Karlheinz Erb is supported by a European Research Council grant (ERC-2010-stg-263522 "LUISE").	Aggemyr E, 2012, J BIOGEOGR, V39, P1645, DOI 10.1111/j.1365-2699.2012.02733.x; Allen AP, 2006, ECOL LETT, V9, P947, DOI 10.1111/j.1461-0248.2006.00946.x; [Anonymous], 2001, PLANT STRATEGIES VEG; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Aronson MFJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3330; Atauri JA, 2001, LANDSCAPE ECOL, V16, P147, DOI 10.1023/A:1011115921050; BAZZAZ FA, 1975, ECOLOGY, V56, P485, DOI 10.2307/1934981; Belmaker J, 2011, GLOBAL ECOL BIOGEOGR, V20, P464, DOI 10.1111/j.1466-8238.2010.00615.x; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; BROWN JH, 1981, AM ZOOL, V21, P877; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Cusens J, 2012, ECOLOGY, V93, P2241, DOI 10.1890/11-1861.1; Davies RG, 2007, P ROY SOC B-BIOL SCI, V274, P1189, DOI 10.1098/rspb.2006.0061; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dullinger S, 2013, P NATL ACAD SCI USA, V110, P7342, DOI 10.1073/pnas.1216303110; Eglington SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030407; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Evans KL, 2005, P ROY SOC B-BIOL SCI, V272, P2155, DOI 10.1098/rspb.2005.3209; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Falcucci A, 2007, LANDSCAPE ECOL, V22, P617, DOI 10.1007/s10980-006-9056-4; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Flojgaard C, 2011, GLOBAL ECOL BIOGEOGR, V20, P218, DOI 10.1111/j.1466-8238.2010.00604.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gaston KJ, 2003, STRUCT DYNAMICS GEOG; Gerstner K, 2014, J APPL ECOL, V51, P1690, DOI 10.1111/1365-2664.12329; Gotelli NJ, 2010, P NATL ACAD SCI USA, V107, P5030, DOI 10.1073/pnas.0914089107; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Hagemeijer E.J.M., 1997, EBCC ATLAS EUROPEAN; Hastie TJ, 2011, ELEMENTS STAT LEARNI; Hawkins BA, 2005, AM NAT, V166, pE140, DOI 10.1086/491686; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Heikinheimo H, 2012, J BIOGEOGR, V39, P1633, DOI 10.1111/j.1365-2699.2012.02723.x; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Helm A, 2006, ECOL LETT, V9, P72, DOI 10.1111/j.1461-0248.2005.00841.x; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hortal J, 2008, J BIOGEOGR, V35, P1202, DOI 10.1111/j.1365-2699.2007.01850.x; Kerr JT, 1998, ECOSCIENCE, V5, P448, DOI 10.1080/11956860.1998.11682483; Kozak KH, 2012, ECOLOGY, V93, pS167, DOI 10.1890/11-0542.1; Krausmann F, 2013, P NATL ACAD SCI USA, V110, P10324, DOI 10.1073/pnas.1211349110; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Levers C, 2014, FOREST ECOL MANAG, V315, P160, DOI 10.1016/j.foreco.2013.12.030; Lindborg R, 2004, ECOLOGY, V85, P1840, DOI 10.1890/04-0367; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; MAC ARTHUR ROBERT H., 1967; Maiorano L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074989; Metzger MJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P549, DOI 10.1111/j.1466-822x.2005.00190.x; Mucher CA, 2009, LANDSCAPE URBAN PLAN, V92, P148, DOI 10.1016/j.landurbplan.2009.04.003; Muller D, 2013, AGR SYST, V117, P66, DOI 10.1016/j.agsy.2012.12.010; O'Brien EM, 1998, ECOGRAPHY, V21, P495, DOI 10.1111/j.1600-0587.1998.tb00441.x; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Pimm SL, 2004, SCIENCE, V304, P831, DOI 10.1126/science.1095332; Plutzar C, 2016, REG ENVIRON CHANGE, V16, P1225, DOI 10.1007/s10113-015-0820-3; R Development Core Team, 2012, R LANG ENV STAT COMP; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Riley S.J., 1999, INTERMOUNTAIN J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; Rodriguez MA, 2005, ACTA OECOL, V28, P65, DOI 10.1016/j.actao.2005.02.006; Sol D, 2014, ECOL LETT, V17, P942, DOI 10.1111/ele.12297; Spehn EM, 2011, PLANT ECOL DIVERS, V4, P301, DOI 10.1080/17550874.2012.698660; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2006, ECOGRAPHY, V29, P733, DOI 10.1111/j.0906-7590.2006.04674.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Whitton FJS, 2012, GLOBAL ECOL BIOGEOGR, V21, P179, DOI 10.1111/j.1466-8238.2011.00660.x; Yamaura Y, 2011, OIKOS, V120, P427, DOI 10.1111/j.1600-0706.2010.18764.x	72	18	19	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131924	10.1371/journal.pone.0131924	http://dx.doi.org/10.1371/journal.pone.0131924			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161981	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300074
J	Rambaud-Althaus, C; Shao, AF; Kahama-Maro, J; Genton, B; d'Acremont, V				Rambaud-Althaus, Clotilde; Shao, Amani Flexson; Kahama-Maro, Judith; Genton, Blaise; d'Acremont, Valerie			Managing the Sick Child in the Era of Declining Malaria Transmission: Development of ALMANACH, an Electronic Algorithm for Appropriate Use of Antimicrobials	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; RAPID DIAGNOSTIC-TESTS; ACUTE OTITIS-MEDIA; INTEGRATED MANAGEMENT; HEALTH-WORKERS; TYPHOID-FEVER; PLASMODIUM-FALCIPARUM; FEBRILE CHILDREN; RHEUMATIC-FEVER; WESTERN KENYA	Objective To review the available knowledge on epidemiology and diagnoses of acute infections in children aged 2 to 59 months in primary care setting and develop an electronic algorithm for the Integrated Management of Childhood Illness to reach optimal clinical outcome and rational use of medicines. Methods A structured literature review in Medline, Embase and the Cochrane Database of Systematic Review (CDRS) looked for available estimations of diseases prevalence in outpatients aged 2-59 months, and for available evidence on i) accuracy of clinical predictors, and ii) performance of point-of-care tests for targeted diseases. A new algorithm for the management of childhood illness (ALMANACH) was designed based on evidence retrieved and results of a study on etiologies of fever in Tanzanian children outpatients. Findings The major changes in ALMANACH compared to IMCI (2008 version) are the following: i) assessment of 10 danger signs, ii) classification of non-severe children into febrile and non-febrile illness, the latter receiving no antibiotics, iii) classification of pneumonia based on a respiratory rate threshold of 50 assessed twice for febrile children 12-59 months; iv) malaria rapid diagnostic test performed for all febrile children. In the absence of identified source of fever at the end of the assessment, v) urine dipstick performed for febrile children <2years to consider urinary tract infection, vi) classification of 'possible typhoid' for febrile children >2 years with abdominal tenderness; and lastly vii) classification of 'likely viral infection' in case of negative results. Conclusion This smartphone-run algorithm based on new evidence and two point-of-care tests should improve the quality of care of <5 year children and lead to more rational use of antimicrobials.	[Rambaud-Althaus, Clotilde; Shao, Amani Flexson; Genton, Blaise; d'Acremont, Valerie] Swiss Trop & Publ Hlth Inst, Epidemiol & Publ Hlth Dept, Basel, Switzerland; [Rambaud-Althaus, Clotilde; Shao, Amani Flexson; Genton, Blaise; d'Acremont, Valerie] Univ Basel, Basel, Switzerland; [Shao, Amani Flexson] Tukuyu Med Res Ctr, Natl Inst Med Res, Tukuyu, Tanzania; [Kahama-Maro, Judith] Dar Es Salaam City Council, City Med Off Hlth, Dar Es Salaam, Tanzania; [Genton, Blaise; d'Acremont, Valerie] Univ Hosp, Infect Dis Serv, Lausanne, Switzerland; [Genton, Blaise] Univ Hosp, Dept Ambulatory Care & Community Med, Lausanne, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Rambaud-Althaus, C (corresponding author), Swiss Trop & Publ Hlth Inst, Epidemiol & Publ Hlth Dept, Basel, Switzerland.	Clotilde.Rambaud@unibas.ch	Rambaud-Althaus, Clotilde/GLR-5703-2022	Rambaud-Althaus, Clotilde/0000-0002-0940-8833	Swiss National Science Foundation [IZ70Z0 - 124023]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was part of a larger project which aimed at improving the quality of health care and rational use of drugs for children in Tanzania (PeDiAtrick project), funded by the Swiss National Science Foundation (www.snf.ch; Grant Number IZ70Z0 - 124023). The funders played no role in study design, collection, analysis, interpretation of data, writing the report, or in the decision to submit the paper for publication. Pan Africa Clinical Trial registration number PACTR201011000262218.	Animut A, 2009, JPN J INFECT DIS, V62, P107; Baiden F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034073; Baiden F, 2011, TROP MED INT HEALTH, V16, P142, DOI 10.1111/j.1365-3156.2010.02692.x; Barat L, 1999, AM J TROP MED HYG, V60, P1024, DOI 10.4269/ajtmh.1999.60.1024; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Carapetis JR, 2000, EPIDEMIOL INFECT, V124, P239, DOI 10.1017/S0950268800003514; Chanda P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-49; Coker TR, 2010, JAMA-J AM MED ASSOC, V304, P2161, DOI 10.1001/jama.2010.1651; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; Davis TME, 1999, CLIN INFECT DIS, V28, P582, DOI 10.1086/515143; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Downs SH, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.4.e54; Factor SH, 2001, B WORLD HEALTH ORGAN, V79, P1096; Faucher JF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-104; Feikin DR, 2013, PEDIATR INFECT DIS J, V32, pE14, DOI 10.1097/INF.0b013e31826fd39b; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; Gorelick MH, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e54; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Hazir T, 2011, CLIN INFECT DIS, V52, P293, DOI 10.1093/cid/ciq142; HEALE WF, 1973, DRUGS, V6, P230, DOI 10.2165/00003495-197306030-00007; HEIKKINEN T, 1995, ARCH PEDIAT ADOL MED, V149, P26, DOI 10.1001/archpedi.1995.02170130028006; HOBERMAN A, 1993, J PEDIATR-US, V123, P17, DOI 10.1016/S0022-3476(05)81531-8; Hosoglu S, 2006, T ROY SOC TROP MED H, V100, P1068, DOI 10.1016/j.trstmh.2005.12.007; INGVARSSON L, 1982, ACTA PAEDIATR SCAND, V71, P705, DOI 10.1111/j.1651-2227.1982.tb09507.x; Kalter HD, 1997, B WORLD HEALTH ORGAN, V75, P65; Khallaf N, 1996, World Health Forum, V17, P297; Khan M, 1998, ACTA TROP, V69, P165, DOI 10.1016/S0001-706X(97)00139-3; Kolstad PR, 1997, B WORLD HEALTH ORGAN, V75, P77; KROBER MS, 1985, AM J DIS CHILD, V139, P889, DOI 10.1001/archpedi.1985.02140110043025; Kuvandik C, 2009, NEW MICROBIOL, V32, P25; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mayor S, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3234; Ministry of Health and Social Welfare (MoHSW), 2007, STAND TREATM GUID ST; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-290; Mubi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019753; Musa-Aisien AS, 2003, ANN TROP PAEDIATR, V23, P39, DOI 10.1179/000349803125002850; Neopane A, 2006, Kathmandu Univ Med J (KUMJ), V4, P307; NIEMELA M, 1994, PEDIATR INFECT DIS J, V13, P765, DOI 10.1097/00006454-199409000-00002; Njama-Meya D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-7; Paxton LA, 1996, B WORLD HEALTH ORGAN, V74, P613; Perkins BA, 1997, B WORLD HEALTH ORGAN, V75, P33; Rovers MM, 2006, LANCET, V368, P1429, DOI 10.1016/S0140-6736(06)69606-2; Rowe SY, 2007, TROP MED INT HEALTH, V12, P651, DOI 10.1111/j.1365-3156.2007.01824.x; Salaria Manju, 2003, Indian Journal of Pediatrics, V70, P621, DOI 10.1007/BF02724250; Sanders S, 1999, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000219.PUB2; Senn N, 2012, CLIN INFECT DIS, V54, P644, DOI 10.1093/cid/cir901; Shaikh N, 2008, PEDIATR INFECT DIS J, V27, P302, DOI 10.1097/INF.0b013e31815e4122; Shaikh N, 2007, JAMA-J AM MED ASSOC, V298, P2895, DOI 10.1001/jama.298.24.2895; Shaikh N, 2010, PEDIATRICS, V126, pE557, DOI 10.1542/peds.2009-2648; Shaw KN, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.2.e16; Simoes EAF, 1997, B WORLD HEALTH ORGAN, V75, P43; Subhi R, 2009, LANCET INFECT DIS, V9, P219, DOI 10.1016/S1473-3099(09)70071-4; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; Tibazarwa KB, 2008, HEART, V94, P1534, DOI 10.1136/hrt.2007.141309; UHARI M, 1995, ACTA PAEDIATR, V84, P90, DOI 10.1111/j.1651-2227.1995.tb13493.x; Ukwaja KN, 2010, ETHIOP J HEALTH SCI, V20, P179; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; Van Hemelrijck MJJ, 2009, TROP MED INT HEALTH, V14, P62, DOI 10.1111/j.1365-3156.2008.02184.x; Vollaard AM, 2005, T ROY SOC TROP MED H, V99, P440, DOI 10.1016/j.trstmh.2004.09.012; Weber MW, 1997, B WORLD HEALTH ORGAN, V75, P25; Whiting P., 2005, BMC PEDIATR, V5, P4, DOI DOI 10.1186/1471-2431-5-4; WHO, 2010, GUID TREATM MAL, DOI [10.1186/1475-2875-9-212, DOI 10.1186/1475-2875-9-212]; WHO Department of Child and Adolescent Health and Development, 2005, UR TRACT INF INF CHI; WHO UNICEF, 2008, INTEGRATED MANAGEMEN; Williams GJ, 2010, LANCET INFECT DIS, V10, P240, DOI 10.1016/S1473-3099(10)70031-1; Woods WA, 1999, PEDIATR EMERG CARE, V15, P338, DOI 10.1097/00006565-199910000-00011; World Health Organization, 2014, INTEGRATED MANAGEMEN; World Health Organization M, 2009, MED US PRIM CAR DEV	73	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0127674	10.1371/journal.pone.0127674	http://dx.doi.org/10.1371/journal.pone.0127674			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161753	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000358162300006
J	Calap-Quintana, P; Soriano, S; Llorens, JV; Al-Ramahi, I; Botas, J; Molto, MD; Martinez-Sebastian, MJ				Calap-Quintana, Pablo; Soriano, Sirena; Vicente Llorens, Jose; Al-Ramahi, Ismael; Botas, Juan; Dolores Molto, Maria; Jose Martinez-Sebastian, Maria			TORC1 Inhibition by Rapamycin Promotes Antioxidant Defences in a Drosophila Model of Friedreich's Ataxia	PLOS ONE			English	Article							OXIDATIVE STRESS-RESPONSE; EXTENDS LIFE-SPAN; FRATAXIN DEFICIENCY; IRON CHAPERONE; YEAST MODEL; PATHWAY; MECHANISMS; RESISTANCE; EXPRESSION; INCREASES	Friedreich's ataxia (FRDA), the most common inherited ataxia in the Caucasian population, is a multisystemic disease caused by a significant decrease in the frataxin level. To identify genes capable of modifying the severity of the symptoms of frataxin depletion, we performed a candidate genetic screen in a Drosophila RNAi-based model of FRDA. We found that genetic reduction in TOR Complex 1 (TORC1) signalling improves the impaired motor performance phenotype of FRDA model flies. Pharmacologic inhibition of TORC1 signalling by rapamycin also restored this phenotype and increased the lifespan and ATP levels. Furthermore, rapamycin reduced the altered levels of malondialdehyde + 4-hydroxyalkenals and total glutathione of the model flies. The rapamycin-mediated protection against oxidative stress is due in part to an increase in the transcription of antioxidant genes mediated by cap-n-collar (Drosophila ortholog of Nrf2). Our results suggest that autophagy is indeed necessary for the protective effect of rapamycin in hyperoxia. Rapamycin increased the survival and aconitase activity of model flies subjected to high oxidative insult, and this improvement was abolished by the autophagy inhibitor 3-methyladenine. These results point to the TORC1 pathway as a new potential therapeutic target for FRDA and as a guide to finding new promising molecules for disease treatment.	[Calap-Quintana, Pablo; Soriano, Sirena; Vicente Llorens, Jose; Dolores Molto, Maria; Jose Martinez-Sebastian, Maria] Univ Valencia, Dept Genet, Valencia, Spain; [Soriano, Sirena; Al-Ramahi, Ismael; Botas, Juan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dolores Molto, Maria] INCLIVA, CIBERSAM, Valencia, Spain	University of Valencia; Baylor College of Medicine; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Molto, MD (corresponding author), Univ Valencia, Dept Genet, Valencia, Spain.	dmolto@uv.es	Al-Ramahi, Ismael/B-4000-2017; VICENTE, LIERN/B-6112-2008	Al-Ramahi, Ismael/0000-0002-1275-1114; VICENTE, LIERN/0000-0001-5883-9640; Martinez-Sebastian, Maria-Jose/0000-0001-5549-7921; Llorens, Jose V./0000-0001-9823-6246; Soriano, Sirena/0000-0001-9967-7262; Molto, Maria Dolores/0000-0001-5219-2022	European Community's Seventh Framework Program [242193 EFACTS]; Fundacio la Marato TV3 of Spain [101932]; NIH [R01-NS42179]; La Fundacio la Marato TV3 of Spain; Ministerio de Ciencia e Innovacion of Spain; Prometeo Program from Generalitat Valenciana [PROMETEOII/2014/067]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042179] Funding Source: NIH RePORTER	European Community's Seventh Framework Program(European Commission); Fundacio la Marato TV3 of Spain; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); La Fundacio la Marato TV3 of Spain; Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Prometeo Program from Generalitat Valenciana; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the European Community's Seventh Framework Program FP7/2007-2013 [grant agreement no. 242193 EFACTS] and the Fundacio la Marato TV3 of Spain [exp 101932]. Work in the Botas laboratory was supported by the R01-NS42179 NIH grant. P.C.-Q. is a recipient of a research contract from La Fundacio la Marato TV3 of Spain; S.S. was a recipient of a fellowship from Ministerio de Ciencia e Innovacion of Spain; and J.V.L. was supported by a research contract from the European Community's Seventh Framework Program FP7/2007-2013 [grant agreement no. 242193 EFACTS]. This work was supported by a grant of the Prometeo Program from Generalitat Valenciana [PROMETEOII/2014/067].	Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Anderson PR, 2005, HUM MOL GENET, V14, P3397, DOI 10.1093/hmg/ddi367; Auchere F, 2008, HUM MOL GENET, V17, P2790, DOI 10.1093/hmg/ddn178; Barcelo H, 2002, GENESIS, V34, P83, DOI 10.1002/gene.10132; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Canizares J, 2000, GENE, V256, P35, DOI 10.1016/S0378-1119(00)00343-7; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Delatycki MB, 2012, J CHILD NEUROL, V27, P1133, DOI 10.1177/0883073812448230; Emond M, 2000, NEUROLOGY, V55, P1752, DOI 10.1212/WNL.55.11.1752; Gibson TJ, 1996, TRENDS NEUROSCI, V19, P465, DOI 10.1016/S0166-2236(96)20054-2; Gimenez-Cassina A, 2011, GENE THER, V18, P1015, DOI 10.1038/gt.2011.45; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Irazusta V, 2006, J BIOL CHEM, V281, P12227, DOI 10.1074/jbc.M511649200; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kaplan B, 2014, TRANSPLANT REV-ORLAN, V28, P126, DOI 10.1016/j.trre.2014.03.002; Katewa SD, 2011, EXP GERONTOL, V46, P382, DOI 10.1016/j.exger.2010.11.036; Kawasaki H, 2005, CYTOTECHNOLOGY, V49, P67, DOI 10.1007/s10616-005-5414-3; Kearney M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007791.pub3; Kofman AE, 2012, AGING-US, V4, P279, DOI 10.18632/aging.100451; Kondapalli KC, 2008, BIOCHEMISTRY-US, V47, P6917, DOI 10.1021/bi800366d; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Lefevre S, 2012, FEBS LETT, V586, P143, DOI 10.1016/j.febslet.2011.12.002; Llorens JV, 2007, FASEB J, V21, P333, DOI 10.1096/fj.05-5709com; Lodi R, 2001, ANN NEUROL, V49, P590; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lynch DR, 2002, MUSCLE NERVE, V25, P664, DOI 10.1002/mus.10077; Marobbio CMT, 2012, MITOCHONDRION, V12, P156, DOI 10.1016/j.mito.2011.07.001; Monros E, 1997, AM J HUM GENET, V61, P101, DOI 10.1086/513887; Napoli E, 2006, ANTIOXID REDOX SIGN, V8, P506, DOI 10.1089/ars.2006.8.506; Navarro JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021017; Navarro JA, 2010, HUM MOL GENET, V19, P2828, DOI 10.1093/hmg/ddq183; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Palau F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-47; Park J, 2013, NATURE, V498, P325, DOI 10.1038/nature12204; Pastore A, 2003, J BIOL CHEM, V278, P42588, DOI 10.1074/jbc.M301872200; Patel PH, 2006, J CELL SCI, V119, P4285, DOI 10.1242/jcs.03199; Paupe V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004253; Perdomini M, 2014, NAT MED, V20, P546, DOI 10.1038/nm.3510; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Runkoa AP, 2008, FEBS LETT, V582, P715, DOI 10.1016/j.febslet.2008.01.046; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Sarkar S, 2013, BIOCHEM SOC T, V41, P1103, DOI 10.1042/BST20130134; Schmucker S, 2010, HUM MOL GENET, V19, pR103, DOI 10.1093/hmg/ddq165; Shan YX, 2013, ANTIOXID REDOX SIGN, V19, P1481, DOI 10.1089/ars.2012.4537; Shidara Y, 2010, J NEUROSCI, V30, P11369, DOI 10.1523/JNEUROSCI.0529-10.2010; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Soragni E, 2012, J CHILD NEUROL, V27, P1164, DOI 10.1177/0883073812448533; Soriano S, 2013, GENE, V521, P274, DOI 10.1016/j.gene.2013.02.049; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; Tozzi G, 2002, ARCH DIS CHILD, V86, P376, DOI 10.1136/adc.86.5.376; Tricoire H, 2014, HUM MOL GENET, V23, P968, DOI 10.1093/hmg/ddt493; Turpaev KT, 2013, BIOCHEMISTRY-MOSCOW+, V78, P111, DOI 10.1134/S0006297913020016; Vazquez-Manrique RP, 2005, FASEB J, V19, P172, DOI 10.1096/fj.05-4212fje; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	64	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0132376	10.1371/journal.pone.0132376	http://dx.doi.org/10.1371/journal.pone.0132376			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158631	Green Published, gold, Green Submitted			2022-12-27	WOS:000358161200052
J	Fernandez-Gauna, B; Etxeberria-Agiriano, I; Grana, M				Fernandez-Gauna, Borja; Etxeberria-Agiriano, Ismael; Grana, Manuel			Learning Multirobot Hose Transportation and Deployment by Distributed Round-Robin Q-Learning	PLOS ONE			English	Article							REINFORCEMENT; SYSTEM; MDPS	Multi-Agent Reinforcement Learning (MARL) algorithms face two main difficulties: the curse of dimensionality, and environment non-stationarity due to the independent learning processes carried out by the agents concurrently. In this paper we formalize and prove the convergence of a Distributed Round Robin Q-learning (D-RR-QL) algorithm for cooperative systems. The computational complexity of this algorithm increases linearly with the number of agents. Moreover, it eliminates environment non sta tionarity by carrying a round-robin scheduling of the action selection and execution. That this learning scheme allows the implementation of Modular State-Action Vetoes (MSAV) in cooperative multi-agent systems, which speeds up learning convergence in over-constrained systems by vetoing state-action pairs which lead to undesired termination states (UTS) in the relevant state-action subspace. Each agent's local state-action value function learning is an independent process, including the MSAV policies. Coordination of locally optimal policies to obtain the global optimal joint policy is achieved by a greedy selection procedure using message passing. We show that D-RR-QL improves over state-of-the-art approaches, such as Distributed Q-Learning, Team Q-Learning and Coordinated Reinforcement Learning in a paradigmatic Linked Multi-Component Robotic System (L-MCRS) control problem: the hose transportation task. L-MCRS are over-constrained systems with many UTS induced by the interaction of the passive linking element and the active mobile robots.	[Fernandez-Gauna, Borja; Etxeberria-Agiriano, Ismael] Univ Basque Country UPV EHU, Polytech Inst, Vitoria, Spain; [Fernandez-Gauna, Borja] Univ Basque Country UPV EHU, Computat Intelligence Grp, Vitoria, Spain; [Grana, Manuel] Univ Basque Country UPV EHU, Computat Intelligence Grp, San Sebastian, Spain; [Grana, Manuel] Wroclaw Univ Technol WrUT, ENGINE Ctr, Wroclaw, Poland	University of Basque Country; University of Basque Country; University of Basque Country; Wroclaw University of Science & Technology	Grana, M (corresponding author), Univ Basque Country UPV EHU, Computat Intelligence Grp, San Sebastian, Spain.	manuel.grana@ehu.eus	Fernández-Gauna, Borja/D-8257-2013; Romay, Manuel M. Graña/L-1341-2014; Etxeberria-Agiriano, ismael/C-2576-2014; Fernandez-Gauna, Borja/AAI-9493-2020; Hernandez, María/GYU-3543-2022	Fernández-Gauna, Borja/0000-0001-9233-2333; Romay, Manuel M. Graña/0000-0001-7373-4097; Etxeberria-Agiriano, ismael/0000-0001-6146-3891; Fernandez-Gauna, Borja/0000-0001-9233-2333; Kudai, Bortx/0000-0002-6213-5096	EU [317947]; Ministerio de Ciencia e Innovacion of the Spanish Government (MINECO) [TIN2011-23823]; FEDER funds; EC [316097]; ENGINE European Research Centre of Network Intelligence for Innovation Enhancement;  [IT874-13]	EU(European Commission); Ministerio de Ciencia e Innovacion of the Spanish Government (MINECO); FEDER funds(European Commission); EC(European CommissionEuropean Commission Joint Research Centre); ENGINE European Research Centre of Network Intelligence for Innovation Enhancement; 	This research has been partially funded by EU through SandS project, grant agreement no 317947. This research has been partially funded by grant TIN2011-23823 of the Ministerio de Ciencia e Innovacion of the Spanish Government (MINECO), with FEDER funds. The GIC has been supported by grant IT874-13 as university research group category AMG was supported by EC under FP7, Coordination and Support Action, Grant Agreement Number 316097, ENGINE European Research Centre of Network Intelligence for Innovation Enhancement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbeel P, 2005, ICML ACM INT C PROCE, V119, P1, DOI 10.1145/1102351.1102352; AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; [Anonymous], [No title captured]; Bocicor MI, 2011, STUD INFORM CONTROL, V20, P221; Bowling Michael, 2002, BAAAI, P11; Boyan J. A., 1995, Advances in Neural Information Processing Systems 7, P369; Busoniu L, 2008, IEEE T SYST MAN CY C, V38, P156, DOI 10.1109/TSMCC.2007.913919; Cheng XB, 2007, LECT NOTES COMPUT SC, V4489, P90; Claus C., 1997, P 15 NAT C ART INT, P746; Crites RH, 1996, ADV NEUR IN, V8, P1017; Czibula G, 2011, J COMPUTER TECHNOLOG, P404; Dietterich T. G., 2000, Abstractions, Reformulation, and Approximation. 4th International Symposium, SARA 2000. Proceedings (Lecture Notes in Artificial Intelligence Vol.1864), P26; Duro RJ, 2010, INFORM SCIENCES, V180, P2635, DOI 10.1016/j.ins.2010.02.005; Echegoyen Z, 2010, ROBOT AUTON SYST, V58, P1292, DOI 10.1016/j.robot.2010.08.008; Fernandez-Gauna B., 2011, INT J ARTIF INTELL, V6, P183; Fernandez-Gauna B, 2014, INFORM SCI IN PRESS; Fernandez-Gauna B, 2013, ROBOT AUTON SYST, V61, P694, DOI 10.1016/j.robot.2012.07.020; Fernandez-Gauna B, 2013, INFORM SCIENCES, V232, P309, DOI 10.1016/j.ins.2012.12.021; Fernandez-Gauna B, 2010, NEURAL NETW WORLD, V20, P913; Gang Zhao, 2010, Proceedings 2010 Sixth International Conference on Natural Computation (ICNC 2010), P3830, DOI 10.1109/ICNC.2010.5582551; Geibel P, 2005, J ARTIF INTELL RES, V24, P81, DOI 10.1613/jair.1666; Geibel P., 2001, P 18 INT C MACH LEAR, P162; Geibel P, 2006, LECT NOTES COMPUT SC, V4212, P646; Guestrin C, 2002, ADV NEUR IN, V14, P1523; Guestrin C., 2002, ICML, P227; Hans A., 2008, ESANN, P143; Hengst B, 2004, LECT NOTES COMPUT SC, V3201, P144; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; Kapetanakis S, 2002, EIGHTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-02)/FOURTEENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE (IAAI-02), PROCEEDINGS, P326; Kok JR, 2006, J MACH LEARN RES, V7, P1789; Littman M. L., 2001, Cognitive Systems Research, V2, P55, DOI 10.1016/S1389-0417(01)00015-8; Mariano CE, 2000, MEMORIAS SEGUNDO ENC, P12; Matignon L, 2007, 2007 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-9, P64, DOI 10.1109/IROS.2007.4399095; Melo FS, 2010, AUTON AGENT MULTI-AG, V21, P321, DOI 10.1007/s10458-009-9104-y; Schneider J, 1999, MACHINE LEARNING, PROCEEDINGS, P371; Servin A, 2008, LECT NOTES ARTIF INT, V4865, P211, DOI 10.1007/978-3-540-77949-0_15; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Sutton RS, 1996, ADV NEUR IN, V8, P1038; Tadepalli P., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P471; Tamakoshi H., 2001, Artificial Life and Robotics, V5, P202, DOI 10.1007/BF02481502; Theetten A, 2008, COMPUT AIDED DESIGN, V40, P35, DOI 10.1016/j.cad.2007.05.008; Wang X., 2002, ADV NEURAL INFORM PR, P1603; Watkins C. J. C. H., 1989, PHD DISSERTATION; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Xiao HR, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON AUTOMATION AND LOGISTICS, VOLS 1-6, P2650, DOI 10.1109/ICAL.2007.4339028	46	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0127129	10.1371/journal.pone.0127129	http://dx.doi.org/10.1371/journal.pone.0127129			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158587	Green Submitted, Green Published, gold			2022-12-27	WOS:000358161200003
J	Junkes, MC; Fraiz, FC; Sardenberg, F; Lee, JY; Paiva, SM; Ferreira, FM				Junkes, Monica C.; Fraiz, Fabian C.; Sardenberg, Fernanda; Lee, Jessica Y.; Paiva, Saul M.; Ferreira, Fernanda M.			Validity and Reliability of the Brazilian Version of the Rapid Estimate of Adult Literacy in Dentistry - BREALD-30	PLOS ONE			English	Article							ORAL-HEALTH LITERACY; WORD RECOGNITION; OUTCOMES; IMPACT; INSTRUMENTS; EFFICACY; CARE	Objective The aim of the present study was to translate, perform the cross-cultural adaptation of the Rapid Estimate of Adult Literacy in Dentistry to Brazilian-Portuguese language and test the reliability and validity of this version. Methods After translation and cross-cultural adaptation, interviews were conducted with 258 parents/caregivers of children in treatment at the pediatric dentistry clinics and health units in Curitiba, Brazil. To test the instrument's validity, the scores of Brazilian Rapid Estimate of Adult Literacy in Dentistry (BREALD-30) were compared based on occupation, monthly household income, educational attainment, general literacy, use of dental services and three dental outcomes. Results The BREALD-30 demonstrated good internal reliability. Cronbach's alpha ranged from 0.88 to 0.89 when words were deleted individually. The analysis of test-retest reliability revealed excellent reproducibility (intraclass correlation coefficient = 0.983 and Kappa coefficient ranging from moderate to nearly perfect). In the bivariate analysis, BREALD-30 scores were significantly correlated with the level of general literacy (r(s) = 0.593) and income (r(s) = 0.327) and significantly associated with occupation, educational attainment, use of dental services, self-rated oral health and the respondent's perception regarding his/her child's oral health. However, only the association between the BREALD-30 score and the respondent's perception regarding his/her child's oral health remained significant in the multivariate analysis. Conclusion The BREALD-30 demonstrated satisfactory psychometric properties and is therefore applicable to adults in Brazil.	[Junkes, Monica C.; Fraiz, Fabian C.; Sardenberg, Fernanda; Ferreira, Fernanda M.] Univ Fed Parana, Dept Stomatol, BR-80060000 Curitiba, Parana, Brazil; [Lee, Jessica Y.; Ferreira, Fernanda M.] Univ N Carolina, Dept Pediat Dent, Chapel Hill, NC USA; [Paiva, Saul M.] Univ Fed Minas Gerais, Dept Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil	Universidade Federal do Parana; University of North Carolina; University of North Carolina Chapel Hill; Universidade Federal de Minas Gerais	Ferreira, FM (corresponding author), Univ Fed Parana, Dept Stomatol, BR-80060000 Curitiba, Parana, Brazil.	femoraisfe@gmail.com	Ferreira, Fernanda/AAE-3309-2019; Paiva, Saul Martins/H-5757-2012	Ferreira, Fernanda/0000-0001-9400-1167; Paiva, Saul Martins/0000-0002-3968-1638; Fraiz, Fabian/0000-0001-5290-7905	Brazilian Coordination of Higher Education (CAPES); State of Minas Gerais Research Foundation (FAPEMIG); National Council for Scientific and Technological Development (CNPq)	Brazilian Coordination of Higher Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); State of Minas Gerais Research Foundation (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Brazilian Coordination of Higher Education (CAPES-http://www.capes.gov.br/), State of Minas Gerais Research Foundation (FAPEMIG-http://www.fapemig.br/) and National Council for Scientific and Technological Development (CNPq-http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, NAT FUNCT LIT IND; Baker DW, 2006, J GEN INTERN MED, V21, P878, DOI 10.1111/j.1525-1497.2006.00540.x; Bennett IM, 2009, ANN FAM MED, V7, P204, DOI 10.1370/afm.940; Berkman Nancy D, 2011, Evid Rep Technol Assess (Full Rep), P1; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Brazil Ministry of Health, 2010, SB BRAZIL 2010 PROJE; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Davis T C, 1991, Fam Med, V23, P433; Dickson-Swift V, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-148; Gong DA, 2007, J PUBLIC HEALTH DENT, V67, P105, DOI 10.1111/j.1752-7325.2007.00023.x; Guo Y, 2014, AM J PUBLIC HEALTH, V104, pE85, DOI 10.2105/AJPH.2014.301930; HAMBLETON RK, 1986, APPL PSYCH MEAS, V10, P287, DOI 10.1177/014662168601000307; Herdman M, 1998, QUAL LIFE RES, V7, P323, DOI 10.1023/A:1024985930536; Jackson RD, 2010, J DENT EDUC, V74, P318; Jones M, 2007, J AM DENT ASSOC, V138, P1199, DOI 10.14219/jada.archive.2007.0344; KAISER HF, 1960, PSYCHOL REV, V67, P160, DOI 10.1037/h0047595; Khan K, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-135; Kutner ME, 2006, NATL CTR ED STAT PUB, V2006-483; Lee JY, 2007, J PUBLIC HEALTH DENT, V67, P94, DOI 10.1111/j.1752-7325.2007.00021.x; Lee JY, 2012, AM J PUBLIC HEALTH, V102, P923, DOI 10.2105/AJPH.2011.300291; Macek MD, 2010, J PUBLIC HEALTH DENT, V70, P197, DOI 10.1111/j.1752-7325.2010.00165.x; McDowell I., 1996, MEASURING HLTH GUIDE; Miller E, 2010, PEDIATRICS, V126, P107, DOI 10.1542/peds.2009-2887; National Institute of Dental and Craniofacial Research National Institute of Health U.S. Public Health Service Department of Health and Human Services, 2005, J Public Health Dent, V65, P174; Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR; Parker RM, 1999, JAMA-J AM MED ASSOC, V281, P552; Parker R, 2010, J HEALTH COMMUN, V15, P20, DOI 10.1080/10810730.2010.501094; Parthasarathy DS, 2014, ORAL HLTH PREV DENT, V12, P201, DOI 10.3290/j.ohpd.a32681; Penaranda E, 2012, SOUTH MED J, V105, P334, DOI 10.1097/SMJ.0b013e31825b2468; Slade GD, 1997, COMMUNITY DENT ORAL, V25, P284, DOI 10.1111/j.1600-0528.1997.tb00941.x; Stucky BD, 2011, COMMUNITY DENT ORAL, V39, P474, DOI 10.1111/j.1600-0528.2011.00619.x; Tadakamadla SK, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-120; Toci E, 2015, J PUBLIC HLTH OXF; Vann WF, 2010, J DENT RES, V89, P1395, DOI 10.1177/0022034510379601; WILLIAMS MV, 1995, JAMA-J AM MED ASSOC, V274, P1677; Wong HM, 2012, J INVESTIG CLIN DENT, V3, P118, DOI 10.1111/j.2041-1626.2012.00113.x	36	39	45	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131600	10.1371/journal.pone.0131600	http://dx.doi.org/10.1371/journal.pone.0131600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EW	26158724	Green Submitted, Green Published, gold			2022-12-27	WOS:000358161200033
J	Urin, V; Levin, D; Sharma, N; Harari, D; Schreiber, G				Urin, Victoria; Levin, Doron; Sharma, Nanaocha; Harari, Daniel; Schreiber, Gideon			Fine Tuning of a Type 1 Interferon Antagonist	PLOS ONE			English	Article							RECEPTOR-BINDING-SITE; I-INTERFERON; MULTIPLE-SCLEROSIS; EXPRESSION; INDUCTION; ALPHA	Type I interferons are multi-potent cytokines that serve as first line of defense against viruses and other pathogens, posses immunomudolatory functions and elicit a growth inhibitory response. In recent years it has been shown that interferons are also detrimental, for example in lupus, AIDS, tuberculosis and cognitive decline, highlighted the need to develop interferon antagonists. We have previously developed the antagonist IFN-1ant, with much reduced binding to the IFNAR1 receptor and enhanced binding to IFNAR2. Here, we further tune the IFN-1ant by producing three additional antagonists based on IFN-1ant but with altered activity profiles. We show that in all three cases the antiproliferative activity of interferons is blocked and the induction of gene transcription of immunomudolatory and antiproliferative associated genes are substantially decreased. Conversely, each of the new antagonists elicits a different degree of antiviral response, STAT phosphorylation and related gene induction. Two of the new antagonists promote decreased activity in relation to the original IFN-1ant, while one of them promotes increased activity. As we do not know the exact causes of the detrimental effects of IFNs, the four antagonists that were produced and analyzed provide the opportunity to investigate the extent of antagonistic and agonistic activity optimal for a given condition.	[Urin, Victoria; Levin, Doron; Sharma, Nanaocha; Harari, Daniel; Schreiber, Gideon] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Schreiber, G (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	gideon.schreiber@weizmann.ac.il			I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [1775/12]	I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation)	This research was supported by the I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation grant No 1775/12.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Brierley MM, 2002, J INTERF CYTOK RES, V22, P835, DOI 10.1089/107999002760274845; Cheon H, 2014, SEMIN ONCOL, V41, P156, DOI 10.1053/j.seminoncol.2014.02.002; Coelho LFL, 2005, P NATL ACAD SCI USA, V102, P11917, DOI 10.1073/pnas.0502188102; COHEN B, 1995, MOL CELL BIOL, V15, P4208; Cooksley WGE, 2003, J VIRAL HEPATITIS, V10, P298, DOI 10.1046/j.1365-2893.2003.00450.x; Goodin DS, 2002, NEUROLOGY, V58, P169, DOI 10.1212/WNL.58.2.169; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Harari D, 2014, J BIOL CHEM, V289, P29014, DOI 10.1074/jbc.M114.602474; Harari D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084259; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kalie E, 2007, J BIOL CHEM, V282, P11602, DOI 10.1074/jbc.M610115200; Komurov K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-282; Lavoie TB, 2011, CYTOKINE, V56, P282, DOI 10.1016/j.cyto.2011.07.019; Levin D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004998; Levin D, 2011, MOL CELL BIOL, V31, P3252, DOI 10.1128/MCB.05251-11; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Pan MJ, 2008, BIOCHEMISTRY-US, V47, P12018, DOI 10.1021/bi801588g; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Roisman LC, 2005, J MOL BIOL, V353, P271, DOI 10.1016/j.jmb.2005.08.042; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Sandling JK, 2011, EUR J HUM GENET, V19, P479, DOI 10.1038/ejhg.2010.197; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014	31	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130797	10.1371/journal.pone.0130797	http://dx.doi.org/10.1371/journal.pone.0130797			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158644	Green Submitted, gold, Green Published			2022-12-27	WOS:000358161200018
J	Patyka, M; Malamud, D; Weissman, D; Abrams, WR; Kurago, Z				Patyka, Mariia; Malamud, Daniel; Weissman, Drew; Abrams, William R.; Kurago, Zoya			Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DENDRITIC CELLS; GENITAL-TRACT; DC-SIGN; INFECTION; TRANSMISSION; RECEPTOR; EPITHELIUM; PROTEIN; TYPE-1	Studies have shown that the transmission of HIV is most likely to occur via rectal or vaginal routes, and rarely through oral exposure. However, the mechanisms of virus entry at mucosal surfaces remain incompletely understood. Prophylactic strategies against HIV infection may be attainable once gaps in current knowledge are filled. To address these gaps, we evaluated essentially normal epithelial surfaces and mapped the periluminal distribution of CD4(+) HIV target cells, including T cells and antigen-presenting cells, and an HIV-binding molecule gp340 that can be expressed by epithelial cells in secreted and cell-associated forms. Immunohistochemistry for CD4, CD16, CD3, CD1a and gp340 in human oral, rectal/sigmoid and cervical mucosal samples from HIV-negative subjects demonstrated that periluminal HIV target cells were more prevalent at rectal/sigmoid and endocervical surfaces lined by simple columnar epithelium, than at oral and ectocervical surfaces covered by multilayered stratified squamous epithelium (p<0.001). gp340 expression patterns at these sites were also distinct and strong in oral minor salivary gland acini and ducts, including ductal saliva, in individual rectum/sigmoid and endocervix periluminar columnar cells, and in ectocervix squamous cells. Only weak expression was noted in the oral non-ductal squamous epithelium. We conclude that periluminal HIV target cells, together with periluminal epithelial cell-associated gp340 appear to be most accessible for HIV transmission at rectal/sigmoid and endocervical surfaces. Our data help define vulnerable structural features of mucosal sites exposed to HIV.	[Patyka, Mariia] McGill Univ, Fac Med, Div Expt Med, Montreal, PQ, Canada; [Malamud, Daniel; Abrams, William R.] NYU, Coll Dent, Dept Basic Sci, HIV AIDS Res Program, New York, NY USA; [Malamud, Daniel] NYU, Sch Med, Infect Dis, New York, NY USA; [Weissman, Drew] Univ Penn, Med Infect Dis, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kurago, Zoya] Georgia Regents Univ, Coll Dent Med, Oral Hlth & Diagnost Sci, Augusta, GA 30912 USA	McGill University; New York University; New York University; University of Pennsylvania; Pennsylvania Medicine; University System of Georgia; Augusta University	Kurago, Z (corresponding author), Georgia Regents Univ, Coll Dent Med, Oral Hlth & Diagnost Sci, Augusta, GA 30912 USA.	zkurago@gru.edu	Abrams, William R/A-5782-2008	Malamud, Daniel/0000-0002-9094-4122	National Center for Research Resources, National Institutes of Health [UL1RR029893]; National Cancer Institute [5P30CA016087-32]; NYU Master's Program in Biology; Fulbright Graduate Student Program grant - United States Department of State, Bureau of Educational and Cultural Affairs; Department of Oral and Maxillofacial Pathology, Radiology and Medicine (NYUCD);  [U19DE018385];  [AI094599];  [AI082701]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094599, R21AI082701, R33AI082701, P30AI045008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U19DE018385] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NYU Master's Program in Biology; Fulbright Graduate Student Program grant - United States Department of State, Bureau of Educational and Cultural Affairs; Department of Oral and Maxillofacial Pathology, Radiology and Medicine (NYUCD); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The NYU BRC is supported in part by grant UL1RR029893 from the National Center for Research Resources, National Institutes of Health and grant 5P30CA016087-32 from the National Cancer Institute. The study was supported by U19DE018385, AI094599 and AI082701, as well as the NYU Master's Program in Biology, by the Fulbright Graduate Student Program grant, Sponsored by the United States Department of State, Bureau of Educational and Cultural Affairs (Mariia Patyka, Sep. 2010 - May 2012), and the Department of Oral and Maxillofacial Pathology, Radiology and Medicine (NYUCD).	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bergamaschi A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-31; Cannon G, 2008, J IMMUNOL, V181, P2065, DOI 10.4049/jimmunol.181.3.2065; Cavarelli M, 2013, EMBO MOL MED, V5, P776, DOI 10.1002/emmm.201202232; Collin M, 2013, IMMUNOLOGY, V140, P22, DOI 10.1111/imm.12117; Cummins JE, 2006, AIDS RES HUM RETROV, V22, P788, DOI 10.1089/aid.2006.22.788; de Witte L, 2007, P NATL ACAD SCI USA, V104, P19464, DOI 10.1073/pnas.0703747104; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Dimitrov DS, 1997, CELL, V91, P721, DOI 10.1016/S0092-8674(00)80460-2; Engering A, 2002, BLOOD, V100, P1780, DOI 10.1182/blood-2001-12-0179; Frappart L, 2004, INTRO ANATOMY UTERIN; Fukui H, 2011, INFLAMM BOWEL DIS, V17, P1177, DOI 10.1002/ibd.21473; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; GOLDACRE MJ, 1978, BRIT MED J, V1, P748, DOI 10.1136/bmj.1.6115.748; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Herzberg M C, 2011, Adv Dent Res, V23, P38, DOI 10.1177/0022034511399283; Hirbod T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025551; Jakobsen MR, 2010, FUTURE VIROL, V5, P219, DOI 10.2217/FVL.09.77; Jens Madsen JM, 2010, INNATE IMMUN, P1; Klijn AJ, 2004, J UROLOGY, V172, P1986, DOI 10.1097/01.ju.0000142686.09532.46; Kumar RB, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-25; Kurago ZB, 2008, HEAD NECK PATHOL, V2, P1, DOI 10.1007/s12105-007-0038-x; Ligtenberg AJM, 2010, INT J MOL SCI, V11, P5213, DOI 10.3390/ijms1112521; Malamud D, 2010, AIDS, V24, P5, DOI 10.1097/QAD.0b013e328333525f; Marlin R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005971; Matiluko AA, 2007, J FAM PLAN REPROD H, V33, P277, DOI 10.1783/147118907782101724; McElrath MJ, 2013, JAIDS-J ACQ IMM DEF, V63, P263, DOI 10.1097/QAI.0b013e3182898392; MOSS GB, 1991, J INFECT DIS, V164, P588, DOI 10.1093/infdis/164.3.588; Nagashunmugam T, 1998, J INFECT DIS, V178, P1635, DOI 10.1086/314511; Nazli A, 2013, J IMMUNOL, V191, P4246, DOI 10.4049/jimmunol.1301482; Page-Shafer K, 2006, Adv Dent Res, V19, P152; Page-Shafer K, 2002, AIDS, V16, P2350, DOI 10.1097/00002030-200211220-00022; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Romas LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100820; Schust DJ, 2012, CURR HIV RES, V10, P218, DOI 10.2174/157016212800618093; Sellors J.W., 2003, COLPOSCOPY AND TREAT; Shaw George M, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006965; Shugars DC, 2002, ORAL DIS, V8, P169, DOI 10.1034/j.1601-0825.8.s2.7.x; Sterjovski J, 2010, VIROLOGY, V404, P269, DOI 10.1016/j.virol.2010.05.006; Stoddard E, 2007, J IMMUNOL, V179, P3126, DOI 10.4049/jimmunol.179.5.3126; Stoddard E, 2009, J VIROL, V83, P8596, DOI 10.1128/JVI.00744-09; TAKANO K, 1991, ANAT REC, V230, P307, DOI 10.1002/ar.1092300303; TSOUKAS CM, 1988, J ACQ IMMUN DEF SYND, V1, P505; Wahl S M, 1997, Oral Dis, V3 Suppl 1, pS64; WALKER L, 1992, AIDS RES HUM RETROV, V8, P1083, DOI 10.1089/aid.1992.8.1083; WILEN CB, 2012, CSH PERSPECT MED, V2, P8191, DOI DOI 10.1101/CSHPERSPECT.A006866; Wood LF, 2013, IMMUNOL REV, V254, P34, DOI 10.1111/imr.12078; Wu ZW, 2004, AIDS RES HUM RETROV, V20, P600, DOI 10.1089/0889222041217400; Wu ZW, 2003, J INFECT DIS, V188, P1473, DOI 10.1086/379248; Yi TJ, 2013, AM J REPROD IMMUNOL, V69, P74, DOI 10.1111/aji.12035	53	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132942	10.1371/journal.pone.0132942	http://dx.doi.org/10.1371/journal.pone.0132942			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172445	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900105
J	Di, HY; Duan, Z; Luo, K; Zhang, DY; Wu, F; Zhang, JY; Liu, WX; Wang, YR				Di, Hongyan; Duan, Zhen; Luo, Kai; Zhang, Daiyu; Wu, Fan; Zhang, Jiyu; Liu, Wenxian; Wang, Yanrong			Interspecific Phylogenic Relationships within Genus Melilotus Based on Nuclear and Chloroplast DNA	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; ASTERACEAE; RDNA; AMPLIFICATION; PRIMERS; MODEL; MATK	Melilotus comprises 19 species, while the phylogenetic relationships between species remain unclear. In the present work, three chloroplast genes, rbcL, matK, tmL-F, and one nuclear region, ITS (internal transcribed spacer) belonging to 48 populations of 18 species of Melilotus were sequenced and phylogenetic trees were constructed to study their interspecific relationships. Based on the phylogenetic tree generated in this study using rbcL analysis, the Melilotusgenus is clearly monophyletic in the legume family. Both Bayesian and maximum-parsimony approaches were used to analyze the data. The nrDNA ITS provided more informative characteristics (9.8%) than cpDNA (3.0%). Melilotus contains two closely related groups, clade I and clade II. M. spicatus, M. indicusand M. segetalis have a close relationship. M. infestus, M. siculus and M. sulcatus are closely related. The comparing between molecular phylogeny and flower color classification in Melilotusshowed that the flower color is not much informative for phylogenetics of this genus.	[Di, Hongyan; Duan, Zhen; Luo, Kai; Zhang, Daiyu; Wu, Fan; Zhang, Jiyu; Liu, Wenxian; Wang, Yanrong] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China; [Di, Hongyan; Duan, Zhen; Luo, Kai; Zhang, Daiyu; Wu, Fan; Zhang, Jiyu; Liu, Wenxian; Wang, Yanrong] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University	Zhang, JY (corresponding author), Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China.	zhangjy@lzu.edu.cn	Zhang, Jiyu/AAG-3452-2021	Zhang, Jiyu/0000-0002-3642-373X	Ministry of Agriculture, China [20120304205]; Ministry of ST, China [31101759]; Department of Agriculture and Animal Husbandry, Gansu province [GNSW-2011-16]	Ministry of Agriculture, China(Ministry of Agriculture & Rural Affairs); Ministry of ST, China; Department of Agriculture and Animal Husbandry, Gansu province	This research was supported by grants from Ministry of Agriculture, China (20120304205), Ministry of S&T, China (31101759), the Department of Agriculture and Animal Husbandry, Gansu province (GNSW-2011-16).	Aboel-Atta AI, 2009, INT J PLANT SCI, V2, P113, DOI [10.1038/s41598-018-35947-7, DOI 10.1038/s41598-018-37737-7]; Al Sherif EA, 2009, FLORA, V204, P737, DOI 10.1016/j.flora.2008.10.004; ARNHEIM N, 1980, P NATL ACAD SCI-BIOL, V77, P7323, DOI 10.1073/pnas.77.12.7323; Bowman G, 1998, SUSTAINABLE AGR NETW, V15, P100; Brenner DM, 1970, NEWSLETTER, V141, P51; Cardoso D, 2013, AM J BOT, V100, P403, DOI 10.3732/ajb.1200276; Clarke A.E., 1934, NUMBER MORPHOLOGY CH; CLARKE ALFRED E., 1935, JOUR AMER SOC AGRON, V27, P492; Clevinger JA, 2000, AM J BOT, V87, P565, DOI 10.2307/2656600; Cong JM, 2012, J ANHUI AGR SCI, V5, P2962; Conn JS, 2011, ARCT ANTARCT ALP RES, V43, P343, DOI 10.1657/1938-4246-43.3.343; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Dong WP, 2014, MOL ECOL RESOUR, V14, P336, DOI 10.1111/1755-0998.12185; DOYLE JJ, 1992, SYST BOT, V17, P144, DOI 10.2307/2419070; Fior S, 2006, AM J BOT, V93, P399, DOI 10.3732/ajb.93.3.399; Fordyce JA, 2008, ANN ENTOMOL SOC AM, V101, P794, DOI 10.1603/0013-8746(2008)101[794:POGVBT]2.0.CO;2; Hamby RK, 1992, MOL SYSTEMATICS PLAN, DOI DOI 10.1086/661633; Hao JS, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/328049; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Isely D, 1969, P IOWA ACAD SCI, V61, P119; Jenks AA, 2013, J PLANT RES, V126, P483, DOI 10.1007/s10265-012-0543-1; Kass E, 1997, MOL PHYLOGENET EVOL, V8, P65, DOI 10.1006/mpev.1997.0410; KITA F., 1965, Journal of the Faculty of Agriculture, Hokkaido University, V54, P23; Klebesadel LJ, 1954, MORPHOLOGICAL PHYSL; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CS, 2012, J PLANT BIOL, V55, P165, DOI 10.1007/s12374-011-9201-8; Linder CR, 2000, MOL PHYLOGENET EVOL, V14, P285, DOI 10.1006/mpev.1999.0706; Lindner DL, 2011, MYCOLOGIA, V103, P731, DOI 10.3852/10-331; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mitsui Y, 2008, ANN BOT-LONDON, V101, P111, DOI 10.1093/aob/mcm267; Moussavi S. M., 2001, Rostaniha, V2, P57; Nuin P, 2005, MRMTGUI 10 VERSION 1; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reinhardt AC, 2008, APPL VEG SCI, V11, P131, DOI [10.3170/2007-7-18335, 10.1111/j.1654-109X.2008.tb00211.x]; Rogers ME, 2008, PLANT SOIL, V304, P89, DOI 10.1007/s11104-007-9523-y; Scarcelli N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019954; [单志 SHAN Zhi], 2011, [广东农业科学, Guangdong Agricultural Sciences], V38, P113; STEVENSO.GA, 1969, CAN J PLANT SCI, V49, P1, DOI 10.4141/cjps69-001; STEVENSON T. M., 1935, Scientific Agriculture, V15, P580; STICKLER F. C, 1959, AGRON JOUR, V51, P135; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Riper LC, 2009, PLANT ECOL, V200, P129, DOI 10.1007/s11258-008-9438-6; Yu J, 2011, J SYST EVOL, V49, P176, DOI 10.1111/j.1759-6831.2011.00134.x; Zhang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098133; Zimmer EA, 1991, P NATL ACAD SCI USA, V77, P2158	50	22	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132596	10.1371/journal.pone.0132596	http://dx.doi.org/10.1371/journal.pone.0132596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167689	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100058
J	Gundlapalli, AV; Nelson, RE; Haroldsen, C; Carter, ME; LaFleur, J				Gundlapalli, Adi V.; Nelson, Richard E.; Haroldsen, Candace; Carter, Marjorie E.; LaFleur, Joanne			Correlates of Initiation of Treatment for Chronic Hepatitis C Infection in United States Veterans, 2004-2009	PLOS ONE			English	Article							VIRUS-INFECTION; US VETERANS; PEGYLATED-INTERFERON; ANTIVIRAL THERAPY; HOMELESS ADULTS; PREVALENCE; ADHERENCE; PATIENT; PREDICTORS; RIBAVIRIN	We describe the rates and predictors of initiation of treatment for chronic hepatitis C (HCV) infection in a large cohort of HCV positive Veterans seen in U.S. Department of Veterans Affairs (VA) facilities between January 1, 2004 and December 31, 2009. In addition, we identify the relationship between homelessness among these Veterans and treatment initiation. Univariate and multivariable Cox Proportional Hazards regression models with time-varying covariates were used to identify predictors of initiation of treatment with pegylated interferon alpha plus ribavirin. Of the 101,444 HCV treatment-naive Veterans during the study period, rates of initiation of treatment among homeless and non-homeless Veterans with HCV were low and clinically similar (6.2% vs. 7.4%, p<0.0001). For all U.S. Veterans, being diagnosed with genotype 2 or 3, black or other/unknown race, having Medicare or other insurance increased the risk of treatment. Veterans with age >= 50 years, drug abuse, diabetes, and hemoglobin <10 g/dL showed lower rates of treatment. Initiation of treatment for HCV in homeless Veterans is low; similar factors predicted initiation of treatment. Additionally, exposure to treatment with medications for diabetes predicted lower rates of treatment. As newer therapies become available for HCV, these results may inform further studies and guide strategies to increase treatment rates in all U.S. Veterans and those who experience homelessness.	[Gundlapalli, Adi V.; Nelson, Richard E.; Haroldsen, Candace; Carter, Marjorie E.; LaFleur, Joanne] VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Surveillance IDEAS, Salt Lake City, UT 84108 USA; [Gundlapalli, Adi V.; Nelson, Richard E.; Haroldsen, Candace; Carter, Marjorie E.] Univ Utah, Sch Med, Salt Lake City, UT USA; [LaFleur, Joanne] Univ Utah, Coll Pharm, Salt Lake City, UT 84112 USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Gundlapalli, AV (corresponding author), VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Surveillance IDEAS, Salt Lake City, UT 84108 USA.	adi.gundlapalli@hsc.utah.edu			Genentech; U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development [HIR 10-002]; VA Salt Lake City Health Care System (IDEAS Center)	Genentech(Roche HoldingGenentech); U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development(US Department of Veterans Affairs); VA Salt Lake City Health Care System (IDEAS Center)	Funding for this project was provided by a grant from Genentech (PI: JL); additional funding was provided by U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development Project #HIR 10-002 (PI: AVG). Resources and administrative support were provided by the VA Salt Lake City Health Care System (IDEAS Center).	Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Backus LI, 2006, J VIRAL HEPATITIS, V13, P799, DOI 10.1111/j.1365-2893.2006.00751.x; Badiaga S, 2012, COMP IMMUNOL MICROB, V35, P39, DOI 10.1016/j.cimid.2011.09.008; Baggett TP, 2013, JAMA INTERN MED, V173, P189, DOI 10.1001/jamainternmed.2013.1604; Beste LA, 2015, EPIDEMIOL REV, V37, P131, DOI 10.1093/epirev/mxu002; Bini EJ, 2005, AM J GASTROENTEROL, V100, P1772, DOI 10.1111/j.1572-0241.2005.41860.x; Butt AA, 2007, GUT, V56, P385, DOI 10.1136/gut.2006.099150; Cacoub P, 2008, WORLD J GASTROENTERO, V14, P6195, DOI 10.3748/wjg.14.6195; Cawthorne CH, 2002, AM J GASTROENTEROL, V97, P149, DOI 10.1111/j.1572-0241.2002.05439.x; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; Cheung RC, 2002, J CLIN GASTROENTEROL, V34, P476, DOI 10.1097/00004836-200204000-00021; Clark BT, 2012, PATIENT PREFER ADHER, V6, P285, DOI 10.2147/PPA.S30111; Desai RA, 2003, SOC PSYCH PSYCH EPID, V38, P396, DOI 10.1007/s00127-003-0639-y; Dominitz JA, 2005, HEPATOLOGY, V41, P88, DOI 10.1002/hep.20502; Gelberg L, 2012, PUBLIC HEALTH REP, V127, P407, DOI 10.1177/003335491212700409; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gish RG, 2005, CLIN GASTROENTEROL H, V3, P311, DOI 10.1016/S1542-3565(04)00666-4; Groom H, 2008, J CLIN GASTROENTEROL, V42, P97, DOI 10.1097/MCG.0b013e31802dc56f; Hellard M, 2009, CLIN INFECT DIS, V49, P561, DOI 10.1086/600304; Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973; Hussein Mohamed, 2010, Qual Manag Health Care, V19, P25, DOI 10.1097/QMH.0b013e3181ccbc7a; Hwang EW, 2013, J CLIN GASTROENTEROL, V47, P264, DOI 10.1097/MCG.0b013e31827035cf; Hwang SW, 2014, LANCET, V384, P1541, DOI 10.1016/S0140-6736(14)61133-8; Kanwal F, 2007, HEPATOLOGY, V46, P1741, DOI 10.1002/hep.21927; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; LaFleur Joanne, 2014, BMC Res Notes, V7, P266, DOI 10.1186/1756-0500-7-266; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2002, GASTROENTEROLOGY, V123, P1061, DOI 10.1053/gast.2002.35950; Muir AJ, 2002, J CLIN GASTROENTEROL, V34, P268, DOI 10.1097/00004836-200203000-00015; Nelson RE, 2014, ANN PHARMACOTHER, V48, P826, DOI 10.1177/1060028014531724; Nelson RE, 2012, J RURAL HEALTH, V28, P192, DOI 10.1111/j.1748-0361.2011.00387.x; Sloan KL, 2004, J CLIN GASTROENTEROL, V38, P279, DOI 10.1097/00004836-200403000-00016; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Talal AH, 2013, ALIMENT PHARM THER, V37, P473, DOI 10.1111/apt.12200; U.S. Department of Veterans Affairs Office of Inspector Genial, 2012, HOM INC RISK FACT BE; U.S. Department ofVeteranAffairs, CHRON HEP C VIR HCV; US Department of Veterans Affairs, 2010, STAT CAR VET CHRON H; Webster DP, 2015, LANCET, V385, P1124, DOI [10.1016/S0140-6736(14)62401-6, 10.1016/S0140-6736(14)61932-2]; Weiss JJ, 2009, ALIMENT PHARM THER, V30, P14, DOI 10.1111/j.1365-2036.2009.04004.x	39	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132056	10.1371/journal.pone.0132056	http://dx.doi.org/10.1371/journal.pone.0132056			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167690	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100018
J	Svanes, O; Skorge, TD; Johannessen, A; Bertelsen, RJ; Bratveit, M; Forsberg, B; Gislason, T; Holm, M; Janson, C; Jogi, R; Macsali, F; Norback, D; Omenaas, ER; Real, FG; Schlunssen, V; Sigsgaard, T; Wieslander, G; Zock, JP; Aasen, T; Dratva, J; Svanes, C				Svanes, Oistein; Skorge, Trude Duelien; Johannessen, Ane; Bertelsen, Randi Jacobsen; Bratveit, Magne; Forsberg, Bertil; Gislason, Thorarin; Holm, Mathias; Janson, Christer; Joegi, Rain; Macsali, Ferenc; Norback, Dan; Omenaas, Ernst Reidar; Real, Francisco Gomez; Schlunssen, Vivi; Sigsgaard, Torben; Wieslander, Gunilla; Zock, Jan-Paul; Aasen, Tor; Dratva, Julia; Svanes, Cecilie			Respiratory Health in Cleaners in Northern Europe: Is Susceptibility Established in Early Life?	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION; OCCUPATIONAL EXPOSURES; CHRONIC-BRONCHITIS; ASTHMA; POPULATION; CHILDHOOD; SMOKING; WORK; COPD	Rationale There is some evidence that maternal smoking increases susceptibility to personal smoking's detrimental effects. One might question whether early life disadvantage might influence susceptibility to occupational exposure. Objectives In this cross-sectional study we investigated respiratory symptoms, asthma and self-reported chronic obstructive pulmonary disease (COPD) as related to working as a cleaner in Northern European populations, and whether early life factors influenced susceptibility to occupational cleaning's unhealthy effects. Methods The RHINE III questionnaire study assessed occupational cleaning in 13,499 participants. Associations with respiratory symptoms, asthma and self-reported COPD were analysed with multiple logistic regressions, adjusting for sex, age, smoking, educational level, parent's educational level, BMI and participating centre. Interaction of occupational cleaning with early life disadvantage (maternal smoking, severe respiratory infection < 5 years, born during winter months, maternal age at birth > 35 years) was investigated. Main Results Among 2138 ever-cleaners the risks of wheeze (OR 1.4, 95% CI 1.3-1.6), adult-onset asthma (1.5 [1.2-1.8]) and self-reported COPD (1.7 [1.3-2.2]) were increased. The risk increased with years in occupational cleaning (adult-onset asthma: <= 1 year 0.9 [0.7-1.3]; 1-4 years 1.5 [1.1-2.0]; >= 4 years 1.6 [1.2-2.1]). The association of wheeze with cleaning activity >= 4 years was significantly stronger for those with early life disadvantage than in those without (1.8 [1.5-2.3] vs. 1.3 [0.96-1.8]; pinteraction 0.035). Conclusions Occupational cleaners had increased risk of asthma and self-reported COPD. Respiratory symptom risk was particularly increased in persons with factors suggestive of early life disadvantage. We hypothesize that early life disadvantage may increase airway vulnerability to harmful exposure from cleaning agents later in life.	[Svanes, Oistein; Real, Francisco Gomez] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Svanes, Oistein] Haukeland Hosp, Dept Thorac Med, N-5021 Bergen, Norway; [Svanes, Oistein; Skorge, Trude Duelien; Bertelsen, Randi Jacobsen; Aasen, Tor; Svanes, Cecilie] Haukeland Hosp, Dept Occupat Med, N-5021 Bergen, Norway; [Johannessen, Ane; Omenaas, Ernst Reidar] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway; [Bratveit, Magne] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Forsberg, Bertil] Umea Univ, Occupat & Environm Med, Umea, Sweden; [Gislason, Thorarin] Natl Univ Hosp Iceland, Dept Resp Med & Sleep, Reykjavik, Iceland; [Holm, Mathias] Univ Gothenburg, Dept Occupat & Environm Med, Gothenburg, Sweden; [Janson, Christer; Norback, Dan; Wieslander, Gunilla] Uppsala Univ, Dept Med Sci Occupat & Environm Med, Uppsala, Sweden; [Joegi, Rain] Tartu Univ Hosp, Lung Clin, Tartu, Estonia; [Macsali, Ferenc; Real, Francisco Gomez] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [Schlunssen, Vivi; Sigsgaard, Torben] Aarhus Univ, Dept Publ Hlth, Sect Environm Occupat & Hlth, Aarhus, Denmark; [Zock, Jan-Paul] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Dratva, Julia] Univ Basel, Swiss Trop & Publ Hlth Inst SwissTPH, Basel, Switzerland; [Svanes, Cecilie] Univ Bergen, Ctr Int Hlth, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Umea University; Landspitali National University Hospital; University of Gothenburg; Uppsala University; University of Bergen; Haukeland University Hospital; Aarhus University; Pompeu Fabra University; University of Basel; Swiss Tropical & Public Health Institute; University of Bergen	Svanes, O (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	oistein.svanes@k2.uib.no	Bertelsen, Randi J/N-6917-2017; Sigsgaard, Torben/AAC-1292-2020; Zock, Jan-Paul/P-5034-2018; Svanes, Cecilie/N-7556-2017; Aasen, Tor/P-4452-2017	Bertelsen, Randi J/0000-0001-5319-525X; Sigsgaard, Torben/0000-0002-2043-7571; Zock, Jan-Paul/0000-0002-2941-6259; Svanes, Cecilie/0000-0001-8512-5192; Norback, Dan/0000-0002-5174-6668; Aasen, Tor/0000-0002-1043-5193; Schlunssen, Vivi/0000-0003-4915-1734; Johannessen, Ane/0000-0003-3269-8354; Gomez Real, Francisco/0000-0001-5407-3270	Norwegian Research Council [214123]; Bergen Medical Research Foundation; Western Norwegian Regional Health Authorities [911 892, 911 631]; Norwegian Labour Inspection; Norwegian Asthma and Allergy Association; Faculty of Health of Aarhus University [240008]; Wood Dust Foundation [444508795]; Danish Lung Association; Swedish Heart and Lung Foundation; Vardal Foundation for Health Care Science and Allergy Research; Swedish Council for Working Life and Social Research; Bror Hjerpstedt Foundation; Swedish Asthma and Allergy Association; Icelandic Research Council; Landspitali University Hospital Research Fund; University of Iceland; Estonian Science Foundation [4350]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Bergen Medical Research Foundation; Western Norwegian Regional Health Authorities; Norwegian Labour Inspection; Norwegian Asthma and Allergy Association; Faculty of Health of Aarhus University; Wood Dust Foundation; Danish Lung Association; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Vardal Foundation for Health Care Science and Allergy Research; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Bror Hjerpstedt Foundation; Swedish Asthma and Allergy Association; Icelandic Research Council; Landspitali University Hospital Research Fund; University of Iceland; Estonian Science Foundation	The RHINE III was supported financially by the Norwegian Research Council (Grant No. 214123), the Bergen Medical Research Foundation, the Western Norwegian Regional Health Authorities (Grant No. 911 892 and 911 631), the Norwegian Labour Inspection, the Norwegian Asthma and Allergy Association, the Faculty of Health of Aarhus University, (Project No. 240008), The Wood Dust Foundation (Project No. 444508795), the Danish Lung Association, the Swedish Heart and Lung Foundation, the Vardal Foundation for Health Care Science and Allergy Research, the Swedish Council for Working Life and Social Research, the Bror Hjerpstedt Foundation, the Swedish Asthma and Allergy Association, the Icelandic Research Council, the Landspitali University Hospital Research Fund, the University of Iceland and the Estonian Science Foundation (Grant No. 4350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameille J, 2006, REV MAL RESPIR, V23, P726, DOI 10.1016/S0761-8425(06)72085-X; Arif AA, 2003, AM J IND MED, V44, P368, DOI 10.1002/ajim.10291; Bello A, 2010, ENV HLTH, V9, P1; Blanc PD, 2009, EUR RESPIR J, V33, P298, DOI 10.1183/09031936.00118808; Blanc PD, 2012, J ASTHMA, V49, P2, DOI 10.3109/02770903.2011.611957; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dharmage SC, 2009, EUR RESPIR J, V33, P237, DOI 10.1183/09031936.00062907; Dumas O, 2013, OCCUP ENVIRON MED, V70, P603, DOI 10.1136/oemed-2013-101362; Guerra S, 2013, THORAX, V68, P1021, DOI 10.1136/thoraxjnl-2013-203538; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Holm M, 2012, INT J TUBERC LUNG D, V16, P553, DOI 10.5588/ijtld.11.0288; Jaakkola JJK, 2006, CURR OPIN ALLERGY CL, V6, P85, DOI 10.1097/01.all.0000216849.64828.55; Johannessen A, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-63; Kogevinas M, 1999, LANCET, V353, P1750, DOI 10.1016/S0140-6736(98)07397-8; Kogevinas M, 2007, LANCET, V370, P336, DOI 10.1016/S0140-6736(07)61164-7; Lemiere C, 1997, EUR RESPIR J, V10, P241, DOI 10.1183/09031936.97.10010241; LIBERATOS P, 1988, EPIDEMIOL REV, V10, P87, DOI 10.1093/oxfordjournals.epirev.a036030; Maestrelli P, 2009, J ALLERGY CLIN IMMUN, V123, P531, DOI 10.1016/j.jaci.2009.01.057; Makela R, 2011, OCCUP MED-OXFORD, V61, P121, DOI 10.1093/occmed/kqq192; Mehta AJ, 2012, AM J RESP CRIT CARE, V185, P1292, DOI 10.1164/rccm.201110-1917OC; Mirabelli MC, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-24; Pekkanen J, 2005, EUR RESPIR J, V26, P28, DOI 10.1183/09031936.05.00120104; Quirce S, 2010, J INVEST ALLERG CLIN, V20, P542; Santos R, 2014, PEDIAT CARDIOL; Siracusa A, 2013, ALLERGY, V68, P1532, DOI 10.1111/all.12279; Svanes C, 2008, INDOOR AIR, V18, P84, DOI 10.1111/j.1600-0668.2008.00523.x; Svanes C, 2004, THORAX, V59, P295, DOI 10.1136/thx.2003.009746; Svanes C, 2010, THORAX, V65, P14, DOI 10.1136/thx.2008.112136; van den Boom G, 1998, AM J RESP CRIT CARE, V158, P1730, DOI 10.1164/ajrccm.158.6.9709003; Waatevik M, 2013, RESP MED, V107, P1037, DOI 10.1016/j.rmed.2013.04.008; Zock JP, 2007, AM J RESP CRIT CARE, V176, P735, DOI 10.1164/rccm.200612-1793OC; Zock JP, 2010, CURR OPIN ALLERGY CL, V10, P114, DOI 10.1097/ACI.0b013e32833733fe; Zock JP, 2001, AM J RESP CRIT CARE, V163, P1572, DOI 10.1164/ajrccm.163.7.2004195	34	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131959	10.1371/journal.pone.0131959	http://dx.doi.org/10.1371/journal.pone.0131959			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168149	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000358193100016
J	Zhao, Y; Peng, L; Yang, LC; Xu, XD; Li, WJ; Luo, XM; Jin, X				Zhao, Yun; Peng, Lu; Yang, Li-chao; Xu, Xu-dong; Li, Wei-jie; Luo, Xiu-mei; Jin, Xin			Wedelolactone Regulates Lipid Metabolism and Improves Hepatic Steatosis Partly by AMPK Activation and Up-Regulation of Expression of PPAR alpha/LPL and LDLR	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; INDUCED HYPERLIPIDEMIC RATS; HIGH-FAT DIET; OXIDATIVE STRESS; TRITON WR-1339; PROTEIN-KINASE; MICE; ANTIOXIDANT; EXTRACT; LIVER	Hyperlipidemia is considered one of the greatest risk factors of cardiovascular diseases. We investigated the anti-hyperlipidemic effect and the underlying mechanism of wedelolactone, a plant-derived coumestan, in HepG2 cells and high-fat diet (HFD)-induced hyperlipidemic hamsters. We showed that in cultured HepG2 cells, wedelolactone up-regulated protein levels of adenosine monophosphate activated protein kinase (AMPK) and peroxisome proliferator-activated receptor-alpha (PPAR alpha) as well as the gene expression of AMPK, PPAR alpha, lipoprotein lipase (LPL), and the low-density lipoprotein receptor (LDLR). Meanwhile, administration of wedelolactone for 4 weeks decreased the lipid profiles of plasma and liver in HFD-induced hyperlipidemic hamsters, including total cholesterol (TC), triglycerides (TG), and low-density lipoprotein-cholesterol (LDL-C). The activation of AMPK and up-regulation of PPAR alpha was also observed with wedelolactone treatment. Furthermore, wedelolactone also increased the activities of superoxidase dismutase (SOD) and glutathione peroxidase (GSH-Px) and decreased the level of the lipid peroxidation product malondialdehyde (MDA) in the liver, therefore decreasing the activity of alanine aminotransferase (ALT). In conclusion, we provide novel experimental evidence that wedelolactone possesses lipid-lowering and steatosis-improving effects, and the underlying mechanism is, at least in part, mediated by the activation of AMPK and the up-regulation of PPAR alpha/LPL and LDLR.	[Zhao, Yun; Peng, Lu; Yang, Li-chao; Li, Wei-jie; Luo, Xiu-mei; Jin, Xin] Xiamen Univ, Coll Med, Dept Basic Med Sci, Xiamen, Fujian, Peoples R China; [Zhao, Yun; Peng, Lu; Yang, Li-chao; Li, Wei-jie; Jin, Xin] Xiamen Key Lab Chiral Drugs, Xiamen, Fujian, Peoples R China; [Xu, Xu-dong] Zhongshan Hosp, Dept Cardiol, Xiamen, Fujian, Peoples R China	Xiamen University	Jin, X (corresponding author), Xiamen Univ, Coll Med, Dept Basic Med Sci, Xiamen, Fujian, Peoples R China.	xinjin@xmu.edu.cn	li, wj/HGD-7322-2022; Yang, Lichao/HDM-6210-2022		Research Fund of Strait (Xiamen) Technology Platform in Traditional Chinese Medicine [3502Z20100006]	Research Fund of Strait (Xiamen) Technology Platform in Traditional Chinese Medicine	This study was supported by grants from the Research Fund of Strait (Xiamen) Technology Platform in Traditional Chinese Medicine (No. 3502Z20100006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barroso E, 2011, ENDOCRINOLOGY, V152, P1848, DOI 10.1210/en.2010-1468; Davies BSJ, 2012, CURR OPIN LIPIDOL, V23, P35, DOI 10.1097/MOL.0b013e32834d0b33; Do GM, 2011, BRIT J NUTR, V106, P1855, DOI 10.1017/S000711451100256X; Dyroy E, 2007, ARTERIOSCL THROM VAS, V27, P628, DOI 10.1161/01.ATV.0000255950.70774.d5; Ebrahimzadeh MA, 2010, PAK J PHARM SCI, V23, P29; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Fernandez-Alvarez A, 2011, J BIOL CHEM, V286, P21466, DOI 10.1074/jbc.M110.209973; Guo P, 2010, J PHARMACOL SCI, V113, P395, DOI 10.1254/jphs.10041FP; Harnafi H, 2007, J ETHNOPHARMACOL, V109, P156, DOI 10.1016/j.jep.2006.09.017; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hou XY, 2010, BIOCHEM BIOPH RES CO, V394, P653, DOI 10.1016/j.bbrc.2010.03.043; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Keating GM, 2011, AM J CARDIOVASC DRUG, V11, P227, DOI 10.2165/11207690-000000000-00000; Kim DI, 2008, NUTR RES, V28, P550, DOI 10.1016/j.nutres.2008.05.003; Kim DY, 2009, J AGR FOOD CHEM, V57, P1532, DOI 10.1021/jf802867b; Kobori M, 2004, CELL DEATH DIFFER, V11, P123, DOI 10.1038/sj.cdd.4401325; Kumar D, 2012, PHARMACOGN MAG, V8, P314, DOI 10.4103/0973-1296.103663; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lee W, 2012, AM J CHINESE MED, V40, P1217, DOI 10.1142/S0192415X12500905; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liu YQ, 2014, J ETHNOPHARMACOL, V157, P206, DOI 10.1016/j.jep.2014.09.033; Manvar D, 2012, J ETHNOPHARMACOL, V144, P545, DOI 10.1016/j.jep.2012.09.036; Peschel D, 2007, J NUTR BIOCHEM, V18, P113, DOI 10.1016/j.jnutbio.2006.03.007; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; Ricci D, 2005, J ETHNOPHARMACOL, V98, P195, DOI 10.1016/j.jep.2005.01.022; Rony KA, 2014, ENVIRON TOXICOL PHAR, V37, P482, DOI 10.1016/j.etap.2014.01.004; Rull A, 2014, J PROTEOME RES, V13, P1731, DOI 10.1021/pr401230s; Schafer HL, 2012, ACTA PHARMACOL SIN, V33, P82, DOI 10.1038/aps.2011.165; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Sharma N, 2009, INDIAN J BIOCHEM BIO, V46, P99; Slack C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047699; SPADY DK, 1986, P NATL ACAD SCI USA, V83, P1916, DOI 10.1073/pnas.83.6.1916; STAELS B, 1992, DEVELOPMENT, V115, P1035; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Werz O, 2007, PLANTA MED, V73, P1331, DOI 10.1055/s-2007-990242; Xia YZ, 2013, EUR J PHARMACOL, V714, P105, DOI 10.1016/j.ejphar.2013.06.012; Yan F, 2004, PLOS ONE, V9; Yao N, 2014, CHIN J INTEGR MED, V20, P31, DOI 10.1007/s11655-012-1243-3; Yashiro T, 2012, ATHEROSCLEROSIS, V220, P369, DOI 10.1016/j.atherosclerosis.2011.11.006; Yin JJ, 2014, J ETHNOPHARMACOL, V154, P229, DOI 10.1016/j.jep.2014.04.011; Yin SN, 2014, ENDOCR RES, V39, P67, DOI 10.3109/07435800.2013.828741; Youn JY, 2014, DIABETES, V63, P2344, DOI 10.2337/db13-0719; Zhang XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061922	43	28	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132720	10.1371/journal.pone.0132720	http://dx.doi.org/10.1371/journal.pone.0132720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168156	gold, Green Submitted, Green Published			2022-12-27	WOS:000358193100071
J	Fishwick, KJ; Rylett, RJ				Fishwick, Katherine J.; Rylett, R. Jane			Insulin Regulates the Activity of the High-Affinity Choline Transporter CHT	PLOS ONE			English	Article							GROWTH-FACTOR EXPRESSION; ALZHEIMERS-DISEASE; INTRANASAL INSULIN; FUNCTIONAL-CHARACTERIZATION; ACETYLCHOLINE SYNTHESIS; GENE-EXPRESSION; PROTEIN-KINASE; UPTAKE CARRIER; AMYLOID-BETA; ACTIVATION	Studies in humans and animal models show that neuronal insulin resistance increases the risk of developing Alzheimer's Disease (AD), and that insulin treatment may promote memory function. Cholinergic neurons play a critical role in cognitive and attentional processing and their dysfunction early in AD pathology may promote the progression of AD pathology. Synthesis and release of the neurotransmitter acetylcholine (ACh) is closely linked to the activity of the high-affinity choline transporter protein (CHT), but the impact of insulin receptor signaling and neuronal insulin resistance on these aspects of cholinergic function are unknown. In this study, we used differentiated SH-SY5Y cells stably-expressing CHT proteins to study the effect of insulin signaling on CHT activity and function. We find that choline uptake activity measured after acute addition of 20 nM insulin is significantly lower in cells that were grown for 24 h in media containing insulin compared to cells grown in the absence of insulin. This coincides with loss of ability to increase phospho-Protein Kinase B (PKB)/Akt levels in response to acute insulin stimulation in the chronic insulin-treated cells. Inhibition of phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3-kinase) in cells significantly lowers phospho-PKB/Akt levels and decreases choline uptake activity. We show total internal reflection microscopy (TIRF) imaging of the dynamic movement of CHT proteins in live cells in response to depolarization and drug treatments. These data show that acute exposure of depolarized cells to insulin is coupled to transiently increased levels of CHT proteins at the cell surface, and that this is attenuated by chronic insulin exposure. Moreover, prolonged inhibition of PI3-kinase results in enhanced levels of CHT proteins at the cell surface by decreasing their rate of internalization.	[Fishwick, Katherine J.; Rylett, R. Jane] Univ Western Ontario, Robarts Res Inst, Mol Med Res Grp, Schulich Sch Med & Dent, London, ON, Canada; [Fishwick, Katherine J.; Rylett, R. Jane] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Rylett, RJ (corresponding author), Univ Western Ontario, Robarts Res Inst, Mol Med Res Grp, Schulich Sch Med & Dent, London, ON, Canada.	jane.rylett@schulich.uwo.ca	Rylett, Rebecca Jane/K-3597-2013	Rylett, Rebecca Jane/0000-0002-9158-9599	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html, RJR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Rahman O, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-81; Apelt J, 2002, BRAIN RES, V953, P17, DOI 10.1016/S0006-8993(02)03262-6; Bales KR, 2006, J CLIN INVEST, V116, P825, DOI 10.1172/JCI27120; Black SAG, 2010, NEUROSCIENCE, V167, P765, DOI 10.1016/j.neuroscience.2010.02.026; Calvo-Ochoa E, 2014, J CEREBR BLOOD F MET, V34, P1001, DOI 10.1038/jcbfm.2014.48; Carvelli L, 2002, J NEUROCHEM, V81, P859, DOI 10.1046/j.1471-4159.2002.00892.x; CASADO M, 1991, J NEUROCHEM, V57, P1185, DOI 10.1111/j.1471-4159.1991.tb08278.x; Chua LM, 2012, J ALZHEIMERS DIS, V29, P783, DOI 10.3233/JAD-2012-111880; COLLIER B, 1974, J PHYSIOL-LONDON, V238, P639, DOI 10.1113/jphysiol.1974.sp010548; Cooke LJ, 1997, BRAIN RES, V751, P232, DOI 10.1016/S0006-8993(96)01183-3; Correia SC, 2011, AGEING RES REV, V10, P264, DOI 10.1016/j.arr.2011.01.001; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Cuddy LK, 2014, J NEUROCHEM, V128, P725, DOI 10.1111/jnc.12490; Cuddy LK, 2012, J NEUROSCI, V32, P5573, DOI 10.1523/JNEUROSCI.5235-11.2012; de la Monte SM, 2012, DRUGS, V72, P49, DOI 10.2165/11597760-000000000-00000; Francis GJ, 2008, BRAIN, V131, P3311, DOI 10.1093/brain/awn288; Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137; Freiherr J, 2013, CNS DRUGS, V27, P505, DOI 10.1007/s40263-013-0076-8; Frisardi V, 2010, AGEING RES REV, V9, P399, DOI 10.1016/j.arr.2010.04.007; Gates J, 2004, J PHARMACOL EXP THER, V310, P536, DOI 10.1124/jpet.104.066795; Hashemi SH, 2003, NEUROCHEM RES, V28, P449, DOI 10.1023/A:1022848718109; Hasselmo ME, 2006, J MOL NEUROSCI, V30, P133, DOI 10.1385/JMN:30:1:133; Ikonomovic MD, 2003, J ALZHEIMERS DIS, V5, P39, DOI 10.3233/JAD-2003-5106; Kar S, 1998, J NEUROCHEM, V70, P2179; Leibson CL, 1997, AM J EPIDEMIOL, V145, P301; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Lew M, 2007, BRIT J PHARMACOL, V152, P299, DOI 10.1038/sj.bjp.0707372; Li ZG, 2007, DIABETES, V56, P1817, DOI 10.2337/db07-0171; Madziar B, 2005, J NEUROCHEM, V92, P767, DOI 10.1111/j.1471-4159.2004.02908.x; Matsuo A, 2011, J BIOL CHEM, V286, P5836, DOI 10.1074/jbc.M110.147611; Mielke JG, 2005, J NEUROCHEM, V93, P1568, DOI 10.1111/j.1471-4159.2005.03155.x; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Nunes-Tavares N, 2012, J BIOL CHEM, V287, P19377, DOI 10.1074/jbc.M111.321448; Okuda T, 2000, FEBS LETT, V484, P92, DOI 10.1016/S0014-5793(00)02134-7; PASCUAL J, 1991, BRAIN RES, V552, P170, DOI 10.1016/0006-8993(91)90676-M; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; Pinthong M, 2008, MOL PHARMACOL, V73, P801, DOI 10.1124/mol.107.040881; Qian Y, 1997, J NEUROSCI, V17, P45, DOI 10.1523/JNEUROSCI.17-01-00045.1997; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; Ribeiro FM, 2007, EUR J NEUROSCI, V26, P3437, DOI 10.1111/j.1460-9568.2007.05967.x; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; RODRIGUEZPUERTAS R, 1994, J NEURAL TRANSM-PARK, V8, P161, DOI 10.1007/BF02260937; Ruggiero AM, 2012, ACS CHEM NEUROSCI, V3, P767, DOI 10.1021/cn3000718; RYLETT RJ, 1983, BRAIN RES, V289, P169, DOI 10.1016/0006-8993(83)90017-3; Schioth HB, 2012, MOL NEUROBIOL, V46, P4, DOI 10.1007/s12035-011-8229-6; SLOTKIN TA, 1990, P NATL ACAD SCI USA, V87, P2452, DOI 10.1073/pnas.87.7.2452; Speed NK, 2010, ACS CHEM NEUROSCI, V1, P476, DOI 10.1021/cn100031t; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Vogelsberg V, 1997, J NEUROCHEM, V68, P1062; Woolf NJ, 2011, BEHAV BRAIN RES, V221, P488, DOI 10.1016/j.bbr.2009.12.046; Xie L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0001.2002	53	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132934	10.1371/journal.pone.0132934	http://dx.doi.org/10.1371/journal.pone.0132934			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161852	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300181
J	Hashimoto, Y; Funamoto, S; Sasaki, S; Negishi, J; Honda, T; Hattori, S; Nam, K; Kimura, T; Mochizuki, M; Kobayashi, H; Kishida, A				Hashimoto, Yoshihide; Funamoto, Seiichi; Sasaki, Shuji; Negishi, Jun; Honda, Takako; Hattori, Shinya; Nam, Kwangwoo; Kimura, Tsuyoshi; Mochizuki, Manabu; Kobayashi, Hisatoshi; Kishida, Akio			Corneal Regeneration by Deep Anterior Lamellar Keratoplasty (DALK) Using Decellularized Corneal Matrix	PLOS ONE			English	Article							PENETRATING KERATOPLASTY; EXPRESSION; GRAFT; KERATOCONUS; SCAFFOLD; STROMA	The purpose of this study is to demonstrate the feasibility of DALK using a decellularized corneal matrix obtained by HHP methodology. Porcine corneas were hydrostatically pressurized at 980 MPa at 10 degrees C for 10 minutes to destroy the cells, followed by washing with EGM-2 medium to remove the cell debris. The HHP-treated corneas were stained with H-E to assess the efficacy of decellularization. The decellularized corneal matrix of 300 mu m thickness and 6.0 mm diameter was transplanted onto a 6.0 mm diameter keratectomy wound. The time course of regeneration on the decellularized corneal matrix was evaluated by haze grading score, fluorescein staining, and immunohistochemistry. H-E staining revealed that no cell nuclei were observed in the decellularized corneal matrix. The decellularized corneal matrices were opaque immediately after transplantation, but became completely transparent after 4 months. Fluorescein staining revealed that initial migration of epithelial cells over the grafts was slow, taking 3 months to completely cover the implant. Histological sections revealed that the implanted decellularized corneal matrix was completely integrated with the receptive rabbit cornea, and keratocytes infiltrated into the decellularized corneal matrix 6 months after transplantation. No inflammatory cells such as macrophages, or neovascularization, were observed during the implantation period. The decellularized corneal matrix improved corneal transparency, and remodelled the graft after being transplanted, demonstrating that the matrix obtained by HHP was a useful graft for corneal tissue regeneration.	[Funamoto, Seiichi; Negishi, Jun; Nam, Kwangwoo; Kimura, Tsuyoshi; Kishida, Akio] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan; [Sasaki, Shuji; Mochizuki, Manabu] Tokyo Med & Dent Univ, Dept Ophthalmol, Tokyo, Japan; [Honda, Takako; Hattori, Shinya; Kobayashi, Hisatoshi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Institute for Materials Science	Kobayashi, H (corresponding author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki, Japan.	KOBAYASHI.Hisatoshi@nims.go.jp; kishida.mbme@tmd.ac.jp	kobayashi, hisatoshi/H-2720-2011; HASHIMOTO, YOSHIHIDE/S-3056-2017	kobayashi, hisatoshi/0000-0001-9487-0725; HASHIMOTO, YOSHIHIDE/0000-0003-0537-8291	Research on Human Genome, Tissue Engineering from Ministry of Health, Labour, and Welfare [KHC1020]; Japan Society for the Promotion of Science (JSPS) [09J04930]	Research on Human Genome, Tissue Engineering from Ministry of Health, Labour, and Welfare; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was financially supported by the Research on Human Genome, Tissue Engineering from the Ministry of Health, Labour, and Welfare (No. KHC1020) to AK (http://www.mhlw.go.jp/english/index.html), and by a Grant-in-Aid for Scientific Research (No. 09J04930) to YH from the Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Torbak AA, 2006, CORNEA, V25, P408, DOI 10.1097/01.ico.0000220777.70981.46; Awan MA, 2010, BRIT J OPHTHALMOL, V94, P1300, DOI 10.1136/bjo.2009.169300; Borderie VM, 2011, AM J OPHTHALMOL, V151, P1024, DOI 10.1016/j.ajo.2011.01.007; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Du LQ, 2011, BRIT J OPHTHALMOL, V95, P410, DOI 10.1136/bjo.2008.142539; Echevarria TJ, 2011, STEM CELL REV REP, V7, P256, DOI 10.1007/s12015-010-9199-1; FANTES FE, 1990, ARCH OPHTHALMOL-CHIC, V108, P665, DOI 10.1001/archopht.1990.01070070051034; George AJT, 2004, AM J TRANSPLANT, V4, P678, DOI 10.1111/j.1600-6143.2004.00417.x; Hashimoto Y, 2010, BIOMATERIALS, V31, P3941, DOI 10.1016/j.biomaterials.2010.01.122; Karamichos D, 2011, J TISSUE ENG REGEN M, V5, pE228, DOI 10.1002/term.429; Kawashima M, 2006, AM J OPHTHALMOL, V142, P304, DOI 10.1016/j.ajo.2006.03.057; Lynch AP, 2013, EXP EYE RES, V108, P42, DOI 10.1016/j.exer.2012.12.012; Panda A, 1999, CORNEA, V18, P172, DOI 10.1097/00003226-199903000-00005; Park KA, 2007, CORNEA, V26, P1132, DOI 10.1097/ICO.0b013e318123765b; Parthasarathy A, 2007, CORNEA, V26, P1025, DOI 10.1097/ICO.0b013e31805771e3; Sasaki S, 2009, MOL VIS, V15, P2022; Sugita J, 1997, BRIT J OPHTHALMOL, V81, P184, DOI 10.1136/bjo.81.3.184; WESTMAYS JA, 1995, P NATL ACAD SCI USA, V92, P6768, DOI 10.1073/pnas.92.15.6768; Wilson SL, 2013, J FUNCT BIOMATER, V4, P114, DOI 10.3390/jfb4030114; Wilson SE, 1999, PROG RETIN EYE RES, V18, P293, DOI 10.1016/S1350-9462(98)00017-2; Wilson SE, 1996, EXP EYE RES, V62, P325, DOI 10.1006/exer.1996.0038; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Ye HQQ, 1998, INVEST OPHTH VIS SCI, V39, P913; Ye HQQ, 2000, INVEST OPHTH VIS SCI, V41, P2894; Zieske JD, 2001, EXP EYE RES, V72, P33, DOI 10.1006/exer.2000.0926	25	31	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131989	10.1371/journal.pone.0131989	http://dx.doi.org/10.1371/journal.pone.0131989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161854	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300079
J	Ligasova, A; Liboska, R; Rosenberg, I; Koberna, K				Ligasova, Anna; Liboska, Radek; Rosenberg, Ivan; Koberna, Karel			The Fingerprint of Anti-Bromodeoxyuridine Antibodies and Its Use for the Assessment of Their Affinity to 5-Bromo-2 '-Deoxyuridine in Cellular DNA under Various Conditions	PLOS ONE			English	Article							PANCREATIC DEOXYRIBONUCLEASE-A; DIFFERENT BIVALENT METALS; NUCLEAR-ORGANIZATION; REPLICATION SITES; IN-VIVO; MAMMALIAN-CELLS; CLICK CHEMISTRY; LIVING CELLS; EDU; PROLIFERATION	We have developed a simple system for the analysis of the affinity of anti-bromodeoxyuridine antibodies. The system is based on the anchored oligonucleotides containing 5-bromo-2'-deoxyuridine (BrdU) at three different positions. It allows a reliable estimation of the reactivity of particular clones of monoclonal anti-bromodeoxyuridine antibodies with BrdU in fixed and permeabilized cells. Using oligonucleotide probes and four different protocols for the detection of BrdU incorporated in cellular DNA, we identified two antibody clones that evinced sufficient reactivity to BrdU in all the tested protocols. One of these clones exhibited higher reactivity to 5-iodo-2'-deoxyuridine (IdU) than to BrdU. It allowed us to increase the sensitivity of the used protocols without a negative effect on the cell physiology as the cytotoxicity of IdU was comparable with BrdU and negligible when compared to 5-ethynyl-2'-deoxyuridine. The combination of IdU and the improved protocol for oxidative degradation of DNA provided a sensitive and reliable approach for the situations when the low degradation of DNA and high BrdU signal is a priority.	[Ligasova, Anna; Koberna, Karel] Palacky Univ, Fac Med, Inst Mol & Translat Med, CR-77147 Olomouc, Czech Republic; [Liboska, Radek; Rosenberg, Ivan] CAS, Inst Organ Chem & Biochem, Oligonucleotide Grp, Vvi, Prague, Czech Republic	Palacky University Olomouc; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Ligasova, A (corresponding author), Palacky Univ, Fac Med, Inst Mol & Translat Med, CR-77147 Olomouc, Czech Republic.	anna.ligasova@upol.cz	Ligasová, Anna/P-5460-2015; KOBERNA, Karel/G-5551-2019	Ligasová, Anna/0000-0002-1564-3768; KOBERNA, Karel/0000-0002-7375-4298	Technology Agency of the Czech Republic [TA03010598, TA03010719, TE02000058]; Ministry of Health of the Czech Republic [AZV 15-31604A]; Ministry of Education, Youth and Sports [LO1304]	Technology Agency of the Czech Republic; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Technology Agency of the Czech Republic [TA03010598, TA03010719 and TE02000058], the Ministry of Health of the Czech Republic [AZV 15-31604A] and the Ministry of Education, Youth and Sports [LO1304]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGENO M, 1969, BIOPHYS J, V9, P1281, DOI 10.1016/S0006-3495(69)86452-0; AHMADZADEH C, 1971, IMMUNOLOGY, V21, P1065; ATEN JA, 1992, HISTOCHEM J, V24, P251, DOI 10.1007/BF01046839; Barbie DA, 2004, MOL CELL BIOL, V24, P595, DOI 10.1128/MCB.24.2.595-607.2004; CAMPBELL VW, 1980, J BIOL CHEM, V255, P3726; Cristofoli WA, 2007, J MED CHEM, V50, P2851, DOI 10.1021/jm0701472; Diermeier-Daucher S, 2009, CYTOM PART A, V75A, P535, DOI 10.1002/cyto.a.20712; Dimitrova DS, 2002, J CELL SCI, V115, P4037, DOI 10.1242/jcs.00087; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Freshney RI, 2005, CULTURE ANIMAL CELLS, P365; Hong V, 2010, BIOCONJUGATE CHEM, V21, P1912, DOI 10.1021/bc100272z; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; JUNOWICZ E, 1973, BIOCHIM BIOPHYS ACTA, V312, P85, DOI 10.1016/0005-2787(73)90054-3; JUNOWICZ E, 1973, BIOCHIM BIOPHYS ACTA, V312, P72, DOI 10.1016/0005-2787(73)90053-1; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Koberna K, 1999, CHROMOSOMA, V108, P325, DOI 10.1007/s004120050384; Kohlmeier F, 2013, CHROMOSOME RES, V21, P87, DOI 10.1007/s10577-013-9340-5; Liboska R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051679; Ligasova A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117459; Ligasova A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066864; Ligasova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052584; Ligasova A, 2009, J STRUCT BIOL, V165, P204, DOI 10.1016/j.jsb.2008.11.004; Loschberger A, 2014, BIOTECHNOL J, V9, P693, DOI 10.1002/biot.201400026; Meneni S, 2007, BIOORGAN MED CHEM, V15, P3082, DOI 10.1016/j.bmc.2007.01.048; PEPPERKOK R, 1995, METHOD MOL CELL BIOL, V5, P112; Ross HH, 2011, J NEURO-ONCOL, V105, P485, DOI 10.1007/s11060-011-0621-6; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sokol AM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03277; Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3; Stanek D, 2001, CHROMOSOMA, V110, P460, DOI 10.1007/s00412-001-0172-2; Stanojcic S, 2008, MOL CELL BIOL, V28, P5265, DOI 10.1128/MCB.00181-08; Tang XB, 2007, J NEUROSCI, V27, P5837, DOI 10.1523/JNEUROSCI.5048-06.2007; Zhao H, 2013, CYTOM PART A, V83, P979, DOI 10.1002/cyto.a.22396; Zink D, 1998, HUM GENET, V102, P241, DOI 10.1007/s004390050686	35	5	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132393	10.1371/journal.pone.0132393	http://dx.doi.org/10.1371/journal.pone.0132393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161977	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300128
J	Manocha, GD; Puig, KL; Austin, SA; Seyb, K; Glicksman, MA; Combs, CK				Manocha, Gunjan D.; Puig, Kendra L.; Austin, Susan A.; Seyb, Kathleen; Glicksman, Marcie A.; Combs, Colin K.			Characterization of Novel Src Family Kinase Inhibitors to Attenuate Microgliosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; STIMULATED PROINFLAMMATORY RESPONSES; TYROSINE PHOSPHORYLATION SYSTEMS; NITRIC-OXIDE SYNTHASE; APPSW TRANSGENIC MICE; GLYCOPROTEIN HLA-DR; ALZHEIMERS-DISEASE; AMYLOID-BETA; INFLAMMATORY MECHANISMS; NEUROLOGICAL DISEASE	Microgliosis is a major hallmark of Alzheimer's disease (AD) brain pathology. A beta peptide is hypothesized to act as a stimulus for microglia leading to activation of non-receptor tyrosine kinases and subsequent secretion of pro-inflammatory cytokines. Therefore, the signaling pathways mediating microglial activation may be important therapeutic targets of anti-inflammatory therapy for AD. Four novel compounds were chosen after high throughput screening kinase activity assays determined them as potential Lyn kinase inhibitors. Their kinase inhibitory and anti-inflammatory effect on A beta-stimulated activation was assessed using the murine microglial cell line, BV2. Cells were treated with the compounds to determine effects on active, phosphorylated levels of Src family kinases, Src and Lyn, as well as MAP kinases ERK, JNK and p38. Only one compound, LDDN-0003499, produced a dose dependent decrease in basal levels of active, phosphorylated Src and Lyn in the BV2 cells. LDDN-0003499 treatment also attenuated the A beta-stimulated increase in active, phosphorylated levels of Lyn/Src and TNF alpha and IL-6 secretion. This study identifies a novel small molecule Src family tyrosine kinase inhibitor with anti-inflammatory effects in response to A beta stimulation of microglia. Further in vitro/in vivo characterization of LDDN-0003499 as well as structural modification may provide a new tool for attenuating microglial-mediated brain inflammatory conditions such as that occurring in AD.	[Manocha, Gunjan D.; Puig, Kendra L.; Combs, Colin K.] Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58203 USA; [Austin, Susan A.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Seyb, Kathleen; Glicksman, Marcie A.] Brigham & Womens Hosp, Harvard NeuroDiscovery Ctr, Lab Drug Discovery Neurodegenerat, Cambridge, MA 02139 USA	University of North Dakota Grand Forks; Mayo Clinic; Harvard University; Brigham & Women's Hospital	Combs, CK (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58203 USA.	colin.combs@med.und.edu	Manocha, Gunjan/AAF-2471-2020	Manocha, Gunjan/0000-0003-4488-6627	National Institutes of Health [RO1AG026330, R01AG042819]; National Science Foundation [EPS-0814442]; National Center for Drug Discovery in Neurodegeneration NIH/NINDS Cooperative Agreement Award [u24]; Harvard University; NATIONAL INSTITUTE ON AGING [R01AG042819, R01AG026330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Center for Drug Discovery in Neurodegeneration NIH/NINDS Cooperative Agreement Award; Harvard University; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institutes of Health RO1AG026330 and R01AG042819 to CKC, the National Science Foundation grant EPS-0814442 fellowship to GM, and the National Center for Drug Discovery in Neurodegeneration NIH/NINDS Cooperative Agreement Award (u24) with Harvard University to SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Bamberger ME, 2003, J NEUROSCI, V23, P2665; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BOLEN JB, 1992, FASEB J, V6, P3403, DOI 10.1096/fasebj.6.15.1281458; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown DR, 2001, MICROSC RES TECHNIQ, V54, P71, DOI 10.1002/jemt.1122; Combs CK, 2000, J NEUROSCI, V20, P558, DOI 10.1523/JNEUROSCI.20-02-00558.2000; Combs CK, 2001, NEUROCHEM INT, V39, P449, DOI 10.1016/S0197-0186(01)00052-3; Combs CK, 2001, J NEUROSCI, V21, P1179; Combs CK, 1999, J NEUROSCI, V19, P928; CRAS P, 1990, AM J PATHOL, V137, P241; Das J, 2006, J MED CHEM, V49, P6819, DOI 10.1021/jm060727j; Denny WA, 2001, FARMACO, V56, P51, DOI 10.1016/S0014-827X(01)01026-6; Dhawan G, 2012, NEUROBIOL AGING, V33, P2247, DOI 10.1016/j.neurobiolaging.2011.10.027; Dhawan G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-117; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002/glia.440070113; Floden AM, 2006, J NEUROSCI, V26, P4644, DOI 10.1523/JNEUROSCI.4822-05.2006; Frautschy SA, 1998, AM J PATHOL, V152, P307; Goodman PA, 1998, J BIOL CHEM, V273, P17742, DOI 10.1074/jbc.273.28.17742; Jara JH, 2007, J NEUROCHEM, V100, P1407, DOI 10.1111/j.1471-4159.2006.04330.x; KARP HL, 1994, GLIA, V11, P284, DOI 10.1002/glia.440110310; Kim HJ, 2007, ANN NY ACAD SCI, V1095, P473, DOI 10.1196/annals.1397.051; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; McDonald DR, 1997, J NEUROSCI, V17, P2284; McDonald DR, 1998, J NEUROSCI, V18, P4451; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; MCGEER PL, 1988, ACTA NEUROPATHOL, V76, P550, DOI 10.1007/BF00689592; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; PERRY VH, 1991, INT REV CYTOL, V125, P203, DOI 10.1016/S0074-7696(08)61220-6; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; RAINE CS, 1994, J NEUROPATH EXP NEUR, V53, P328, DOI 10.1097/00005072-199407000-00002; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; Rogers J, 2002, GLIA, V40, P260, DOI 10.1002/glia.10153; Sasaki A, 2002, VIRCHOWS ARCH, V441, P358, DOI 10.1007/s00428-002-0643-8; Schlachetzki JCM, 2009, CURR ALZHEIMER RES, V6, P554, DOI 10.2174/156720509790147179; Sondag CM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-1; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; STYREN SD, 1990, EXP NEUROL, V110, P93, DOI 10.1016/0014-4886(90)90054-V; TILLOTSON ML, 1989, GLIA, V2, P412; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009; Wegiel J, 2003, ACTA NEUROPATHOL, V105, P393, DOI 10.1007/s00401-002-0660-3; Wegiel J, 2001, NEUROBIOL AGING, V22, P49, DOI 10.1016/S0197-4580(00)00181-0; Weldon DT, 1998, J NEUROSCI, V18, P2161; WISNIEWSKI HM, 1992, ACTA NEUROPATHOL, V84, P117, DOI 10.1007/BF00311383; WOOD JG, 1991, NEUROSCI LETT, V121, P12, DOI 10.1016/0304-3940(91)90637-9; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; YAMANASHI Y, 1989, P NATL ACAD SCI USA, V86, P6538, DOI 10.1073/pnas.86.17.6538; Yates SL, 2000, J NEUROCHEM, V74, P1017, DOI 10.1046/j.1471-4159.2000.0741017.x	54	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132604	10.1371/journal.pone.0132604	http://dx.doi.org/10.1371/journal.pone.0132604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161952	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300158
J	Merino, S; Gonzalez, V; Tomas, JM				Merino, Susana; Gonzalez, Victor; Tomas, Juan M.			The Polymerization of Aeromonas hydrophila AH-3 O-Antigen LPS: Concerted Action of WecP and Wzy	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE; GENE; POLYSACCHARIDE; BIOSYNTHESIS; TRANSLOCATION; TEMPERATURE; CORE	The repeat units of heteropolymeric O antigen are synthesized at the cytosolic side of the inner bacterial membrane via the Wzx/Wzy-dependent assembly pathway. After being translocated across the membrane by Wzx, each repeat unit is polymerized by Wzy to form a glycan chain. In this study, we demonstrate the need of the corresponding enzyme transferring the initial HexNAc to undecaprenol phosphate (lipid carrier), together with the corresponding O-antigen polymerase (Wzy), to produce the Aeromonas hydrophila O:34-antigen. We suggest, the concerted action of WecA or P enzyme (UDP-HexNAc: polyprenol-P HexNAc-1-P transferase) and Wzy is involved in the mechanism responsible for the A. hydrophila O-antigen polymerization.	[Merino, Susana; Gonzalez, Victor; Tomas, Juan M.] Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona 08071, Spain	University of Barcelona	Tomas, JM (corresponding author), Univ Barcelona, Fac Biol, Dept Microbiol, Diagonal 643, Barcelona 08071, Spain.	jtomas@ub.edu	Tomas, Juan M/L-1398-2015; Merino, Susana/D-4342-2014	Tomas, Juan M/0000-0002-3575-7113; Merino, Susana/0000-0001-6040-4259	Plan Nacional de I + D + i (Ministerio de Educacion, Ciencia y Deporte and Ministerio de Sanidad, Spain); Generalitat de Catalunya (Centre de Referencia en Biotecnologia)	Plan Nacional de I + D + i (Ministerio de Educacion, Ciencia y Deporte and Ministerio de Sanidad, Spain); Generalitat de Catalunya (Centre de Referencia en Biotecnologia)(Generalitat de Catalunya)	This work was supported by Plan Nacional de I + D + i (Ministerio de Educacion, Ciencia y Deporte and Ministerio de Sanidad, Spain) and from Generalitat de Catalunya (Centre de Referencia en Biotecnologia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyrathne PD, 2005, J BACTERIOL, V187, P3002, DOI 10.1128/JB.187.9.3002-3012.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; BENEDI VJ, 1989, J CLIN MICROBIOL, V27, P82; Canals R, 2006, INFECT IMMUN, V74, P537, DOI 10.1128/IAI.74.1.537-548.2006; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hug I, 2011, GLYCOBIOLOGY, V21, P138, DOI 10.1093/glycob/cwq148; Islam ST, 2014, CAN J MICROBIOL, V60, P697, DOI 10.1139/cjm-2014-0595; Islam ST, 2013, SCI REP-UK, V3, DOI 10.1038/srep03441; Islam ST, 2013, MBIO, V4, DOI 10.1128/mBio.00678-13; Islam ST, 2013, ENVIRON MICROBIOL, V15, P1001, DOI 10.1111/j.1462-2920.2012.02890.x; Islam ST, 2012, MOL MICROBIOL, V84, P1165, DOI 10.1111/j.1365-2958.2012.08084.x; Islam ST, 2011, J BIOL CHEM, V286, P20600, DOI 10.1074/jbc.C110.204651; Islam ST, 2010, MBIO, V1, DOI 10.1128/mBio.00189-10; Jimenez N, 2008, J BACTERIOL, V190, P4198, DOI 10.1128/JB.00153-08; Jimenez N, 2008, J BACTERIOL, V190, P3176, DOI 10.1128/JB.01874-07; Jimenez N, 2009, J BIOL CHEM, V284, P32995, DOI 10.1074/jbc.M109.038828; Kalynych S, 2012, PROTEIN ENG DES SEL, V25, P797, DOI 10.1093/protein/gzs075; Knirel YA, 2004, CARBOHYD RES, V339, P787, DOI 10.1016/j.carres.2003.12.008; Knirel YA, 2002, CARBOHYD RES, V337, P1381, DOI 10.1016/S0008-6215(02)00136-2; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; MERINO S, 1992, INFECT IMMUN, V60, P4343, DOI 10.1128/IAI.60.10.4343-4349.1992; Merino S, 2011, J BACTERIOL, V193, P1943, DOI 10.1128/JB.01441-10; NIKAIDO H, 1996, ESCHERICHIA COLI SAL, P29; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rick PD, 2003, J BIOL CHEM, V278, P16534, DOI 10.1074/jbc.M301750200; Rush JS, 2010, J BIOL CHEM, V285, P1671, DOI 10.1074/jbc.M109.061630; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Valvano MA, 2003, FRONT BIOSCI-LANDMRK, V8, pS452, DOI 10.2741/1079; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030	36	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131905	10.1371/journal.pone.0131905	http://dx.doi.org/10.1371/journal.pone.0131905			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161781	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300072
J	Shao, AF; Rambaud-Althaus, C; Samaka, J; Faustine, AF; Perri-Moore, S; Swai, N; Kahama-Maro, J; Mitchell, M; Genton, B; D'Acremont, V				Shao, Amani Flexson; Rambaud-Althaus, Clotilde; Samaka, Josephine; Faustine, Allen Festo; Perri-Moore, Seneca; Swai, Ndeniria; Kahama-Maro, Judith; Mitchell, Marc; Genton, Blaise; D'Acremont, Valerie			New Algorithm for Managing Childhood Illness Using Mobile Technology (ALMANACH): A Controlled Non-Inferiority Study on Clinical Outcome and Antibiotic Use in Tanzania	PLOS ONE			English	Article							COMMUNITY CASE-MANAGEMENT; RAPID DIAGNOSTIC-TESTS; INTEGRATED MANAGEMENT; HEALTH-WORKERS; SEVERE PNEUMONIA; 1ST-LEVEL FACILITIES; ORAL AMOXICILLIN; CHILDREN; PERFORMANCE; MALARIA	Introduction The decline of malaria and scale-up of rapid diagnostic tests calls for a revision of IMCI. A new algorithm (ALMANACH) running on mobile technology was developed based on the latest evidence. The objective was to ensure that ALMANACH was safe, while keeping a low rate of antibiotic prescription. Methods Consecutive children aged 2-59 months with acute illness were managed using ALMANACH (2 intervention facilities), or standard practice (2 control facilities) in Tanzania. Primary outcomes were proportion of children cured at day 7 and who received antibiotics on day 0. Results 130/842 (15.4%) in ALMANACH and 241/623 (38.7%) in control arm were diagnosed with an infection in need for antibiotic, while 3.8% and 9.6% had malaria. 815/838 (97.3%; 97.3%;96.1-98.4%) were cured at D7 using ALMANACH versus 573/623 (92.0%; 89.8-94.1%) using standard practice (p<0.001). Of 23 children not cured at D7 using ALMANACH, 44% had skin problems, 30% pneumonia, 26% upper respiratory infection and 13% likely viral infection at DO. At DO, antibiotics were prescribed to 15.4% (12.9-17.9%) using ALMANACH versus 84.3% (81.4-87.1%) using standard practice (p<0.001). 2.3%(1.3-3.3) versus 3.2% (1.8-4.6%) received an antibiotic secondarily. Conclusion Management of children using ALMANACH improve clinical outcome and reduce antibiotic prescription by 80%. This was achieved through more accurate diagnoses and hence better identification of children in need of antibiotic treatment or not. The building on mobile technology allows easy access and rapid update of the decision chart.	[Shao, Amani Flexson; Rambaud-Althaus, Clotilde; Kahama-Maro, Judith; Genton, Blaise; D'Acremont, Valerie] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Shao, Amani Flexson; Rambaud-Althaus, Clotilde; Kahama-Maro, Judith; Genton, Blaise; D'Acremont, Valerie] Univ Basel, Basel, Switzerland; [Shao, Amani Flexson] Natl Inst Med Res, Tukuyu Med Res Ctr, Tukuyu, Tanzania; [Perri-Moore, Seneca] Univ Utah, Salt Lake City, UT USA; [Mitchell, Marc] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Swai, Ndeniria; Kahama-Maro, Judith] Dar Es Salaam City Council, City Med Off Hlth, Dar Es Salaam, Tanzania; [Genton, Blaise; D'Acremont, Valerie] Univ Lausanne Hosp, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Genton, Blaise] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland; [Samaka, Josephine] Amana Hosp, Dar Es Salaam, Tanzania; [Faustine, Allen Festo] Kilombero Dist Council, Morogoro, Tanzania	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Utah System of Higher Education; University of Utah; Harvard University; Harvard T.H. Chan School of Public Health; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Shao, AF (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	shaotz@gmail.com	Rambaud-Althaus, Clotilde/GLR-5703-2022	Rambaud-Althaus, Clotilde/0000-0002-0940-8833	Swiss National Science Foundation [IZ70Z0 - 124023]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was funded by Swiss National Science Foundation (Grant Number IZ70Z0 - 124023). The funder had no role in study design, collection, analysis, interpretation of the data, writing of the manuscript, or in the decision to submit the manuscript for publication.	Adam T, 2005, B WORLD HEALTH ORGAN, V83, P369; Batwala V, 2011, MALARIA J, V10, DOI [10.1186/1475-2875-10-377, 10.1186/1475-2875-10-373]; Bazin D., 2009, EC ANAL, V42, P7; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Bryan L, 2006, INVESTING TANZANIA H; Camara B, 2008, Med Trop (Mars), V68, P162; Chopra M, 2013, LANCET, V381, P1499, DOI 10.1016/S0140-6736(13)60319-0; Chowdhury EK, 2008, LANCET, V372, P822, DOI 10.1016/S0140-6736(08)61166-6; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; DeRenzi B, 2008, E IMCI IMPROVING PED; Dominic A, 2005, HUMAN RESOURCES HLTH; Gouws E, 2004, B WORLD HEALTH ORGAN, V82, P509; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Hamer DH, 2012, PATHOG GLOB HEALTH, V106, P32, DOI 10.1179/1364859411Y.0000000042; Hazir T, 2008, LANCET, V371, P49, DOI 10.1016/S0140-6736(08)60071-9; Huicho L, 2005, HEALTH POLICY PLANN, V20, P14, DOI 10.1093/heapol/czi002; Kelley E, 2001, INT J HEALTH PLAN M, V16, P195, DOI 10.1002/hpm.632; Maestad O, 2010, J HEALTH ECON, V29, P686, DOI 10.1016/j.jhealeco.2010.05.006; MoHSW WHO UNICEF, 2013, INT MAN CHILDH ILLN; Moyo SJ, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-19; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Mukanga D, 2012, AM J TROP MED HYG, V87, P21, DOI 10.4269/ajtmh.2012.11-0816; Munga MA, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-4; Nguyen DTK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066030; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; Simoes EAF, 1997, B WORLD HEALTH ORGAN, V75, P43; Soofi S, 2012, LANCET, V379, P729, DOI 10.1016/S0140-6736(11)61714-5; Temu M M, 2007, Tanzan Health Res Bull, V9, P186; WHO, 2003, HLTH FAC SURV TOOL E; World Health Organization, 2014, INTEGRATED MANAGEMEN; World Health Organization, 2013, WHO INFORMAL CONSULT	35	45	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132316	10.1371/journal.pone.0132316	http://dx.doi.org/10.1371/journal.pone.0132316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161535	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000358162300118
J	Zhang, JC; Gao, Y; Yu, MY; Wu, HB; Ai, ZY; Wu, YY; Liu, HL; Du, J; Guo, ZK; Zhang, Y				Zhang, Jingcheng; Gao, Yang; Yu, Mengying; Wu, Haibo; Ai, Zhiying; Wu, Yongyan; Liu, Hongliang; Du, Juan; Guo, Zekun; Zhang, Yong			Retinoic Acid Induces Embryonic Stem Cell Differentiation by Altering Both Encoding RNA and microRNA Expression	PLOS ONE			English	Article							ONE-CARBON METABOLISM; DNA-METHYLATION; HISTONE DEACETYLASES; MAMMALIAN DEVELOPMENT; MOUSE EMBRYOS; SELF-RENEWAL; VISCERAL ENDODERM; PROGENITOR CELLS; GENE-REGULATION; MESSENGER-RNA	Retinoic acid (RA) is a vitamin A metabolite that is essential for early embryonic development and promotes stem cell neural lineage specification; however, little is known regarding the impact of RA on mRNA transcription and microRNA levels on embryonic stem cell differentiation. Here, we present mRNA microarray and microRNA high-output sequencing to clarify how RA regulates gene expression. Using mRNA microarray analysis, we showed that RA repressed pluripotency-associated genes while activating ectoderm markers in mouse embryonic stem cells (mESCs). Moreover, RA modulated the DNA methylation of mESCs by altering the expression of epigenetic-associated genes such as Dnmt3b and Dnmt3l. Furthermore, H3K4me2, a pluripotent histone modification, was repressed by RA stimulation. From microRNA sequence data, we identified two downregulated microRNAs, namely, miR200b and miR-200c, which regulated the pluripotency of stem cells. We found that miR-200b or miR-200c deficiency suppressed the expression of pluripotent genes, including Oct4 and Nanog, and activated the expression of the ectodermal marker gene Nestin. These results demonstrate that retinoid induces mESCs to differentiate by regulating miR-200b/200c. Our findings provide the landscapes of mRNA and microRNA gene networks and indicate the crucial role of miR-200b/200c in the RA-induced differentiation of mESCs.	[Zhang, Jingcheng; Gao, Yang; Yu, Mengying; Wu, Haibo; Wu, Yongyan; Liu, Hongliang; Guo, Zekun; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Zhang, Jingcheng; Gao, Yang; Yu, Mengying; Wu, Haibo; Ai, Zhiying; Wu, Yongyan; Liu, Hongliang; Du, Juan; Guo, Zekun; Zhang, Yong] Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling 712100, Shaanxi, Peoples R China; [Ai, Zhiying; Du, Juan] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Zhang, Jingcheng] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China; China Agricultural University	Guo, ZK (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China.	gzk@nwsuaf.edu.cn; zhy1956@263.net	Wu, Yongyan/AAH-1471-2019; Zhang, Yong/K-7945-2016	Wu, Yongyan/0000-0003-1669-3860; Zhang, Yong/0000-0001-8642-4071	National High Technology Research and Development Program of China (863 Program) [2011AA100303]; National Natural Science Foundation of China [31172279]; Key Science and Technology Innovation Team in Shaanxi Province [2014KCT-26]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Innovation Team in Shaanxi Province	This work was supported by the National High Technology Research and Development Program of China (863 Program) (No. 2011AA100303) (http://www.863.gov.cn/), partly by a grant from the National Natural Science Foundation of China (No. 31172279) (http://www.nsfc.gov.cn/), and Key Science and Technology Innovation Team in Shaanxi Province (2014KCT-26) (http://www.sninfo.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ajamian F, 2003, NEUROSCI LETT, V346, P57, DOI 10.1016/S0304-3940(03)00545-7; Alison M, 2014, J BIOL CHEM; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Castelo-Branco G, 2014, STEM CELL REP, V3, P502, DOI 10.1016/j.stemcr.2014.07.008; Chen CC, 2012, J BIOL CHEM, V287, P33116, DOI 10.1074/jbc.C112.406975; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Choi I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065771; CONLON RA, 1995, TRENDS GENET, V11, P314, DOI 10.1016/S0168-9525(00)89089-7; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Friso S, 2005, CURR DRUG METAB, V6, P37, DOI 10.2174/1389200052997339; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Golebiewska A, 2009, STEM CELLS, V27, P1298, DOI 10.1002/stem.59; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; HO AM, 1994, J BIOL CHEM, V269, P28181; Holland LZ, 2007, NATURE, V447, P153, DOI 10.1038/447153a; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hough SR, 2006, STEM CELLS, V24, P1467, DOI 10.1634/stemcells.2005-0475; Howe EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049987; Huang HN, 2014, STEM CELL RES, V12, P338, DOI 10.1016/j.scr.2013.11.009; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kraushaar DC, 2012, J BIOL CHEM, V287, P22691, DOI 10.1074/jbc.M112.368241; Kuo LT, 2007, NEUROSCIENCE, V147, P491, DOI 10.1016/j.neuroscience.2007.04.023; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li TY, 2014, MITOCHONDR DNA, P1; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068990; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Neri F, 2013, CELL, V155, P121, DOI 10.1016/j.cell.2013.08.056; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Paterson EL, 2008, THESCIENTIFICWORLDJO, V8, P901, DOI 10.1100/tsw.2008.115; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Perea-Gomez A, 2001, DEVELOPMENT, V128, P753; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; RUBERTE E, 1991, DEVELOPMENT, V111, P45; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Semba RD, 1998, NUTR REV, V56, pS38, DOI 10.1111/j.1753-4887.1998.tb01643.x; Simandi Z, 2010, FEBS LETT, V584, P3123, DOI 10.1016/j.febslet.2010.05.052; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Spallotta F, 2010, STEM CELLS, V28, P431, DOI 10.1002/stem.300; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Terling C, 1995, INT J DEV BIOL, V39, P947; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wendling O, 2001, DEVELOPMENT, V128, P2031; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029043; Yang J, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0095-z; Yasuda S, 2006, GENES CELLS, V11, P1115, DOI 10.1111/j.1365-2443.2006.01000.x; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zhang J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S5	76	41	43	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132566	10.1371/journal.pone.0132566	http://dx.doi.org/10.1371/journal.pone.0132566			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162091	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300153
J	Albert, S; Aswani, S; Fisher, PL; Albert, J				Albert, Simon; Aswani, Shankar; Fisher, Paul L.; Albert, Joelle			Keeping Food on the Table: Human Responses and Changing Coastal Fisheries in Solomon Islands	PLOS ONE			English	Article							CORAL-REEF FISHERIES; GLOBAL FISHERIES; PACIFIC ISLANDS; SECURITY; MARINE; RESOURCES; RESILIENCE; DIVERSITY; PATTERNS; IMPACTS	Globally the majority of commercial fisheries have experienced dramatic declines in stock and catch. Likewise, projections for many subsistence fisheries in the tropics indicate a dramatic decline is looming in the coming decades. In the Pacific Islands coastal fisheries provide basic subsistence needs for millions of people. A decline in fish catch would therefore have profound impacts on the health and livelihoods of these coastal communities. Given the decrease in local catch rates reported for many coastal communities in the Pacific, it is important to understand if fishers have responded to ecological change (either by expanding their fishing range and/or increasing their fishing effort), and if so, to evaluate the costs or benefits of these responses. We compare data from fish catches in 1995 and 2011 from a rural coastal community in Solomon Islands to examine the potentially changing coastal reef fishery at these time points. In particular we found changes in preferred fishing locations, fishing methodology and catch composition between these data sets. The results indicate that despite changes in catch rates (catch per unit effort) between data collected in 2011 and 16 years previously, the study community was able to increase gross catches through visiting fishing sites further away, diversifying fishing methods and targeting pelagic species through trolling. Such insight into local-scale responses to changing resources and/or fisheries development will help scientists and policy makers throughout the Pacific region in managing the region's fisheries in the future.	[Albert, Simon; Fisher, Paul L.] Univ Queensland, Sch Civil Engn, Brisbane, Qld, Australia; [Aswani, Shankar] Rhodes Univ, Dept Anthropol, ZA-6140 Grahamstown, South Africa; [Aswani, Shankar] Rhodes Univ, Dept Ichthyol & Fisheries Sci, ZA-6140 Grahamstown, South Africa; [Albert, Joelle] WorldFish, Honiara, Solomon Islands	University of Queensland; Rhodes University; Rhodes University; CGIAR; Worldfish	Fisher, PL (corresponding author), Univ Queensland, Sch Civil Engn, Brisbane, Qld, Australia.	p.fisher@uq.edu.au	Albert, Simon/I-1104-2012	Albert, Simon/0000-0002-5947-7909; Fisher, Paul/0000-0003-1403-8563	Consultative Group on International Agricultural Research (CGIAR) Research Programs on Aquatic Agricultural Systems; Australian Centre for International Agricultural Research [FIS/2012/074]	Consultative Group on International Agricultural Research (CGIAR) Research Programs on Aquatic Agricultural Systems; Australian Centre for International Agricultural Research	This work was supported by the Consultative Group on International Agricultural Research (CGIAR) Research Programs on Aquatic Agricultural Systems (aas.cgiar.org) and an Australian Centre for International Agricultural Research (aciar.gov.au) grant (FIS/2012/074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TJH, 1996, 8 INT COR REEF S PAN; Albert JA, PLOS ONE IN PRESS; Albert S, 2012, 12 INT COR REEF S AU; [Anonymous], 2009, SOLOMON ISLAND POPUL; Aswani S, 1998, OCEAN COAST MANAGE, V40, P207, DOI 10.1016/S0964-5691(98)00047-7; Aswani S., 1997, CUSTOMARY SEA TENURE, P485; Aswani S, 2008, HUM ECOL, V36, P325, DOI 10.1007/s10745-007-9159-9; Aswani S, 2015, REV FISH BIOL FISHER, V25, P217, DOI 10.1007/s11160-014-9376-4; Aswani S, 2014, CONSERV BIOL, V28, P820, DOI 10.1111/cobi.12250; Aswani S, 2010, CONSERV BIOL, V24, P520, DOI 10.1111/j.1523-1739.2009.01377.x; Bell JD, 2015, MAR POLICY, V51, P584, DOI 10.1016/j.marpol.2014.10.005; Bell JD, 2013, NAT CLIM CHANGE, V3, P591, DOI 10.1038/NCLIMATE1838; Bell JD, 2013, CLIMATIC CHANGE, V119, P199, DOI 10.1007/s10584-012-0606-2; Bell JD, 2009, MAR POLICY, V33, P64, DOI 10.1016/j.marpol.2008.04.002; Brewer TD, 2012, GLOBAL ENVIRON CHANG, V22, P399, DOI 10.1016/j.gloenvcha.2012.01.006; Brewer TD, 2009, BIOL CONSERV, V142, P1797, DOI 10.1016/j.biocon.2009.03.021; Craig P, 2008, FISH RES, V89, P230, DOI 10.1016/j.fishres.2007.08.018; Dalzell P, 1996, OCEANOGR MAR BIOL, V34, P395; DALZELL P, 1996, 8 INT COR REEF S PAN; FAO, 2014, STAT WORLD FISH AQ; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gillett R., 2010, FUTURE PACIFIC ISLAN; Gillett R, 2009, FISHERIES EC PACIFIC; Grinham A, 2014, MAR POLLUT BULL, V88, P354, DOI 10.1016/j.marpolbul.2014.08.018; Hall SJ, 2013, P NATL ACAD SCI USA, V110, P8393, DOI 10.1073/pnas.1208067110; Halpern BS, 2013, CORAL REEFS, V32, P61, DOI 10.1007/s00338-012-0981-1; Harley S., 2014, W CENTRAL PACIFIC TU; Kuster C, 2005, FISH RES, V76, P221, DOI 10.1016/j.fishres.2005.06.011; Lauer M, 2013, GLOBAL ENVIRON CHANG, V23, P40, DOI 10.1016/j.gloenvcha.2012.10.011; Lauer M, 2010, ENVIRON MANAGE, V45, P985, DOI 10.1007/s00267-010-9471-9; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Pauly D, 2008, J BIOL RES-THESSALON, V9, P3; Pauly D, 2007, AMBIO, V36, P290, DOI 10.1579/0044-7447(2007)36[290:TSAUPD]2.0.CO;2; RICHARDS AH, 1994, MAR POLLUT BULL, V29, P90, DOI 10.1016/0025-326X(94)90431-6; Skewes T, 1990, MARINE RESOURCE PROF; SPC, 2013, STAT REP PAC ISL REE	36	30	32	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130800	10.1371/journal.pone.0130800	http://dx.doi.org/10.1371/journal.pone.0130800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EW	26158694	Green Submitted, Green Published, gold			2022-12-27	WOS:000358161200019
J	Doskey, CM; van't Erve, TJ; Wagner, BA; Buettner, GR				Doskey, Claire M.; van't Erve, Thomas J.; Wagner, Brett A.; Buettner, Garry R.			Moles of a Substance per Cell Is a Highly Informative Dosing Metric in Cell Culture	PLOS ONE			English	Article							NOMINAL EFFECTIVE CONCENTRATIONS; SUPEROXIDE-DISMUTASE ACTIVITY; COMPOUNDS IN-VITRO; HYDROGEN-PEROXIDE; INDUCED CYTOTOXICITY; ADDUCT FORMATION; DNA-DAMAGE; GLUTATHIONE; H2O2; TOXICITY	Background The biological consequences upon exposure of cells in culture to a dose of xenobiotic are not only dependent on biological variables, but also the physical aspects of experiments e.g. cell number and media volume. Dependence on physical aspects is often overlooked due to the unrecognized ambiguity in the dominant metric used to express exposure, i.e. initial concentration of xenobiotic delivered to the culture medium over the cells. We hypothesize that for many xenobiotics, specifying dose as moles per cell will reduce this ambiguity. Dose as moles per cell can also provide additional information not easily obtainable with traditional dosing metrics. Methods Here, 1,4-benzoquinone and oligomycin A are used as model compounds to investigate moles per cell as an informative dosing metric. Mechanistic insight into reactions with intracellular molecules, differences between sequential and bolus addition of xenobiotic and the influence of cell volume and protein content on toxicity are also investigated. Results When the dose of 1,4-benzoquinone or oligomycin A was specified as moles per cell, toxicity was independent of the physical conditions used (number of cells, volume of medium). When using moles per cell as a dose-metric, direct quantitative comparisons can be made between biochemical or biological endpoints and the dose of xenobiotic applied. For example, the toxicity of 1,4-benzoquinone correlated inversely with intracellular volume for all five cell lines exposed (C6, MDA-MB231, A549, MIA PaCa-2, and HepG2). Conclusions Moles per cell is a useful and informative dosing metric in cell culture. This dosing metric is a scalable parameter that: can reduce ambiguity between experiments having different physical conditions; provides additional mechanistic information; allows direct comparison between different cells; affords a more uniform platform for experimental design; addresses the important issue of repeatability of experimental results, and could increase the translatability of information gained from in vitro experiments.	[Doskey, Claire M.; van't Erve, Thomas J.; Buettner, Garry R.] Univ Iowa, Interdisciplinary Grad Program Human Toxicol, Iowa City, IA 52242 USA; [Wagner, Brett A.; Buettner, Garry R.] Univ Iowa, Dept Radiat Oncol, Free Radical & Radiat Biol Program, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Buettner, GR (corresponding author), Univ Iowa, Interdisciplinary Grad Program Human Toxicol, Iowa City, IA 52242 USA.	garry-buettner@uiowa.edu		Buettner, Garry/0000-0002-5594-1903; van 't Erve, Thomas/0000-0002-3260-6627	United States National Institutes of Health [R01 GM073929, R01 CA169046, P30 ES005605, P42 ES013661, NIH P30 CA086862]; NATIONAL CANCER INSTITUTE [P30CA086862, R01CA169046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605, P42ES013661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073929] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The United States National Institutes of Health Supported for this work with grants R01 GM073929 (GRB), R01 CA169046 (GRB), P30 ES005605 (GRB), P42 ES013661 (GRB, TJvE, CMD), NIH P30 CA086862 (GRB).	Abernethy DJ, 2004, TOXICOL SCI, V79, P82, DOI 10.1093/toxsci/kfh095; Aebi H, 1984, Methods Enzymol, V105, P121; Antunes F, 2001, FREE RADICAL BIO MED, V30, P1008, DOI 10.1016/S0891-5849(01)00493-2; Antunes F, 2000, FEBS LETT, V475, P121, DOI 10.1016/S0014-5793(00)01638-0; BANNISTER JV, 1973, FEBS LETT, V32, P303, DOI 10.1016/0014-5793(73)80859-2; Buettner GR, 2013, CELL BIOCHEM BIOPHYS, V67, P477, DOI 10.1007/s12013-011-9320-3; Codreanu SG, 2014, MOL CELL PROTEOMICS, V13, P849, DOI 10.1074/mcp.M113.032953; Coecke S, 2013, TOXICOL IN VITRO, V27, P1570, DOI 10.1016/j.tiv.2012.06.012; CUNNINGHAM CC, 1975, J BIOL CHEM, V250, P2036; ESMANN M, 1991, BIOCHIM BIOPHYS ACTA, V1064, P31, DOI 10.1016/0005-2736(91)90408-Z; Groothuis FA, 2015, TOXICOLOGY, V332, P30, DOI 10.1016/j.tox.2013.08.012; Gulden M, 2010, FREE RADICAL BIO MED, V49, P1298, DOI 10.1016/j.freeradbiomed.2010.07.015; Gulden M, 2005, AQUAT TOXICOL, V72, P327, DOI 10.1016/j.aquatox.2005.02.002; Gulden M, 2003, TOXICOLOGY, V189, P211, DOI 10.1016/S0300-483X(03)00146-X; Gulden M, 2002, TOXICOLOGY, V175, P201, DOI 10.1016/S0300-483X(02)00085-9; Gulden M, 2001, TOXICOL IN VITRO, V15, P233, DOI 10.1016/S0887-2333(01)00008-X; Halsey LG, 2015, NAT METHODS, V12, P179, DOI 10.1038/nmeth.3288; Johnson KM, 2006, ACS CHEM BIOL, V1, P304, DOI 10.1021/cb600143j; Lamore SD, 2010, CELL STRESS CHAPERON, V15, P309, DOI 10.1007/s12192-009-0145-6; Landar A, 2006, AM J PHYSIOL-HEART C, V290, pH1777, DOI 10.1152/ajpheart.01087.2005; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; LEA DE, 1946, BRIT MED BULL, V4, P24, DOI 10.1093/oxfordjournals.bmb.a072663; LEES MB, 1972, ANAL BIOCHEM, V47, P184, DOI 10.1016/0003-2697(72)90291-6; Monks Terrence J, 2002, Curr Drug Metab, V3, P425, DOI 10.2174/1389200023337388; Munshi A, 2005, METH MOLEC MED, V110, P21; Nakamura J, 2003, NUCLEIC ACIDS RES, V31, P1790, DOI 10.1093/nar/gkg263; OBERLEY LW, 1984, METHOD ENZYMOL, V105, P457; OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; Park HJ, 2010, ANAL BIOCHEM, V407, P151, DOI 10.1016/j.ab.2010.08.012; Rawal M, 2013, CANCER RES, V73, P5232, DOI 10.1158/0008-5472.CAN-13-0470; Riss TL, 2004, ASSAY DRUG DEV TECHN, V2, P51, DOI 10.1089/154065804322966315; RUSSELL W. M. S., 1959; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Seibert H, 2002, TOXICOL IN VITRO, V16, P289, DOI 10.1016/S0887-2333(02)00014-0; Sheridan AM, 1996, KIDNEY INT, V49, P88, DOI 10.1038/ki.1996.12; Sobotta MC, 2013, FREE RADICAL BIO MED, V60, P325, DOI 10.1016/j.freeradbiomed.2013.02.017; Song Y, 2010, FREE RADICAL BIO MED, V49, P919, DOI 10.1016/j.freeradbiomed.2010.05.009; Song Y, 2009, P NATL ACAD SCI USA, V106, P9725, DOI 10.1073/pnas.0810352106; SPITZ DR, 1990, ARCH BIOCHEM BIOPHYS, V279, P249, DOI 10.1016/0003-9861(90)90489-L; Stagg RB, 1997, BIOELECTROMAGNETICS, V18, P230, DOI 10.1002/(SICI)1521-186X(1997)18:3<230::AID-BEM5>3.0.CO;2-3; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Valdiglesias V, 2011, J ENVIRON MONITOR, V13, P1831, DOI 10.1039/c0em00771d; van 't Erve TJ, 2013, FREE RADICAL BIO MED, V65, P742, DOI 10.1016/j.freeradbiomed.2013.08.002; Wagner BA, 2013, REDOX BIOL, V1, P210, DOI 10.1016/j.redox.2013.01.011; Wagner BA, 2011, FREE RADICAL BIO MED, V51, P700, DOI 10.1016/j.freeradbiomed.2011.05.024; Wang XH, 2006, P NATL ACAD SCI USA, V103, P3604, DOI 10.1073/pnas.0510962103; Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254; Yang F, 2010, J TOXICOL ENV HEAL A, V73, P483, DOI 10.1080/15287390903523402	49	35	36	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132572	10.1371/journal.pone.0132572	http://dx.doi.org/10.1371/journal.pone.0132572			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172833	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900059
J	Kawashima-Goto, S; Imamura, T; Tomoyasu, C; Yano, M; Yoshida, H; Fujiki, A; Tamura, S; Osone, S; Ishida, H; Morimoto, A; Kuroda, H; Hosoi, H				Kawashima-Goto, Sachiko; Imamura, Toshihiko; Tomoyasu, Chihiro; Yano, Mio; Yoshida, Hideki; Fujiki, Atsushi; Tamura, Shinichi; Osone, Shinya; Ishida, Hiroyuki; Morimoto, Akira; Kuroda, Hiroshi; Hosoi, Hajime			BCL2 Inhibitor (ABT-737): A Restorer of Prednisolone Sensitivity in Early T-Cell Precursor-Acute Lymphoblastic Leukemia with High MEF2C Expression?	PLOS ONE			English	Article							PROGENITORS; MECHANISMS	Early T-cell precursor-acute lymphoblastic leukemia (ETP-ALL) has been identified as a high-risk subtype of pediatric T-cell acute lymphoblastic leukemia (T-ALL). Conventional chemotherapy is not fully effective for this subtype of leukemia; therefore, potential therapeutic targets need to be explored. Analysis of the gene expression patterns of the transcription factors in pediatric T-ALL revealed that MEF2C and FLT3 were expressed at higher levels in ETP-ALL than typical T-ALL. Using human T-ALL and BaF3 cell lines with high expression levels of MEF2C, the present study tested whether the BCL2 inhibitor (ABT-737) restores the sensitivity to prednisolone (PSL), because MEF2C causes PSL resistance, possibly by augmenting the anti-apoptotic activity of BCL2. Treatment with PSL and ABT-737 caused a significant reduction in the IC50 of PSL in the MEF2C-expressing LOUCY cells, in addition to the MEF2C-transduced BaF3 cells, but not in the non-MEF2C-expressing Jurkat cells. The combination treatment significantly accelerated the killing of primary leukemic blast cells of ETP-ALL with high expression levels of MEF2C, which were co-cultured with murine stromal cells. These findings suggest that BCL2 inhibitors may be a therapeutic candidate in vivo for patients with ETP-ALL with high expression levels of MEF2C.	[Imamura, Toshihiko] Kyoto Prefectural Univ Med, Dept Pediat, Grad Sch Med Sci, Kyoto 602, Japan; [Kawashima-Goto, Sachiko; Imamura, Toshihiko; Tomoyasu, Chihiro; Yano, Mio; Yoshida, Hideki; Osone, Shinya; Ishida, Hiroyuki; Hosoi, Hajime] Kyoto Prefectural Univ Med, Dept Pediat, Grad Sch Med Sci, Kyoto 602, Japan; [Fujiki, Atsushi; Ishida, Hiroyuki] Matsushita Mem Hosp, Dept Pediat, Moriguchi, Osaka, Japan; [Tamura, Shinichi; Kuroda, Hiroshi] Kyoto City Hosp, Dept Pediat, Kyoto, Japan; [Morimoto, Akira] Jichi Med Univ, Sch Med, Dept Pediat, Shimotuke, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto City Hospital; Jichi Medical University	Imamura, T (corresponding author), Kyoto Prefectural Univ Med, Dept Pediat, Grad Sch Med Sci, Kyoto 602, Japan.	imamura@koto.kpu-m.ac.jp			Japanese Ministry of Health, Labor, and Welfare; Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants for Clinical Cancer Research and Research on Measures for Intractable Diseases from the Japanese Ministry of Health, Labor, and Welfare, by grants-in-aid for scientific research from the Japanese Ministry of Education, Culture, Sports, Science and Technology, and by grants for the Japan Foundation for Pediatric Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Bonapace L, 2010, J CLIN INVEST, V120, P1310, DOI 10.1172/JCI39987; Buitenhuis M, 2005, BLOOD, V105, P4272, DOI 10.1182/blood-2004-12-4883; Cante-Barrett K, 2014, ONCOGENE, V33, P403, DOI 10.1038/onc.2013.56; CHEN ZX, 1994, CANCER RES, V54, P3494; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; ITOH K, 1989, EXP HEMATOL, V17, P145; Kikushige Y, 2008, J IMMUNOL, V180, P7358, DOI 10.4049/jimmunol.180.11.7358; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Lavau C, 2000, P NATL ACAD SCI USA, V97, P10984, DOI 10.1073/pnas.190167297; MCNIECE IK, 1982, CELL BIOL INT REP, V6, P243, DOI 10.1016/0309-1651(82)90076-5; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Moore VD, 2008, BLOOD, V111, P2300, DOI 10.1182/blood-2007-06-098012; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nagel S, 2008, LEUKEMIA, V22, P600, DOI 10.1038/sj.leu.2405067; Neumann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053190; Peirs S, 2014, BLOOD, V124, P3738, DOI 10.1182/blood-2014-05-574566; Schrappe M, 2011, BLOOD, V118, P2077, DOI 10.1182/blood-2011-03-338707; Stehling-Sun S, 2009, NAT IMMUNOL, V10, P289, DOI 10.1038/ni.1694; Wolfler A, 2010, BLOOD, V116, P4116, DOI 10.1182/blood-2010-03-275404; Yamaji K, 2010, PEDIATR BLOOD CANCER, V55, P1287, DOI 10.1002/pbc.22620; Zenatti PP, 2011, NAT GENET, V43, P932, DOI 10.1038/ng.924; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zuurbier L, 2014, HAEMATOLOGICA, V99, P94, DOI 10.3324/haematol.2013.090233	29	17	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132926	10.1371/journal.pone.0132926	http://dx.doi.org/10.1371/journal.pone.0132926			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172269	gold, Green Submitted, Green Published			2022-12-27	WOS:000358194900103
J	Ke, CC; Lin, CS; Yeh, CC; Chung, CL; Hung, CJ; Liao, CC; Chen, TL				Ke, Chi-Chen; Lin, Chao-Shun; Yeh, Chun-Chieh; Chung, Chi-Li; Hung, Chih-Jen; Liao, Chien-Chang; Chen, Ta-Liang			Adverse Outcomes after Non-Chest Surgeries in Patients with Pulmonary Tuberculosis: A Nationwide Study	PLOS ONE			English	Article							NONCARDIAC SURGERY; UNITED-STATES; POSTOPERATIVE OUTCOMES; RETROSPECTIVE COHORT; RISK-FACTORS; INFECTION; FAILURE; EPIDEMICS; MORTALITY; CARE	Background The association between pulmonary tuberculosis (TB) and postoperative outcomes remains unknown. This study investigated outcomes following non-chest surgeries in patients with previous pulmonary TB. Methods Using Taiwan's National Health Insurance Research Database, we analyzed 6911 patients (aged >= 20 years) with preoperative diagnosis of pulmonary TB and 6911 propensity score-matched controls receiving non-chest surgeries in 2008-2010. Postoperative outcomes were compared between patients with or without pulmonary TB by calculating adjusted odds ratios (ORs) and 95% confidence intervals (CIs) in the multivariate logistic regressions. Results Surgical patients with pulmonary TB had a significantly higher postoperative complication rates than controls, including septicemia, pneumonia, acute renal failure, deep wound infection, overall complications, and 30-day postoperative mortality (OR 1.41; 95% CI 1.07-1.86). The ORs of patients with low-income status were as high as 2.27 (95% CI 1.03-5.03). Preoperative use of TB drugs and TB-related medical expenditure also associated with higher postoperative mortality among surgical patients with pulmonary TB. Conclusions Surgical patients with pulmonary TB have significantly increased risks of postoperative complications and mortality after non-chest surgeries. This study suggests the need to improve postoperative care for surgical patients with pulmonary TB.	[Ke, Chi-Chen; Hung, Chih-Jen] Taichung Vet Gen Hosp, Dept Anesthesiol, Taichung, Taiwan; [Lin, Chao-Shun; Liao, Chien-Chang; Chen, Ta-Liang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Lin, Chao-Shun; Liao, Chien-Chang; Chen, Ta-Liang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei, Taiwan; [Lin, Chao-Shun; Liao, Chien-Chang; Chen, Ta-Liang] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Yeh, Chun-Chieh] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Chung, Chi-Li] Taipei Med Univ Hosp, Div Pulm Med, Dept Internal Med, Taipei, Taiwan; [Liao, Chien-Chang] China Med Univ, Sch Chinese Med, Taichung, Taiwan	Taichung Veterans General Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Taipei Medical University; Taipei Medical University Hospital; China Medical University Taiwan	Chen, TL (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan.	tlc@tmu.edu.tw	Yeh, Chun Chieh/I-4893-2019	Yeh, Chun Chieh/0000-0001-6753-7564; Hozbor, Daniela/0000-0001-6379-0482	Taiwan's Ministry of Science and Technology [NSC102-2314-B-038-021-MY3]	Taiwan's Ministry of Science and Technology	This study was supported by a grant (NSC102-2314-B-038-021-MY3) from Taiwan's Ministry of Science and Technology. Disclaimer: The funders were not involved with study design, data analysis, or manuscript preparation. The contents of the manuscript are solely the responsibility of the authors.	Ascuntar JM, 2010, INT J TUBERC LUNG D, V14, P1323; Boccia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020824; Boelaert JR, 2002, LANCET, V360, P1102, DOI 10.1016/S0140-6736(02)11169-X; Cantwell MF, 1998, AM J RESP CRIT CARE, V157, P1016, DOI 10.1164/ajrccm.157.4.9704036; Dobler CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029563; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Farmer PE, 2013, NEW ENGL J MED, V369, P2424, DOI 10.1056/NEJMsa1310472; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Hansel NN, 2004, CHEST, V126, P1079, DOI 10.1378/chest.126.4.1079; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Hernandez AF, 2004, J AM COLL CARDIOL, V44, P1446, DOI 10.1016/j.jacc.2004.06.059; Kempker RR, 2012, LANCET INFECT DIS, V12, P157, DOI 10.1016/S1473-3099(11)70244-4; Kethireddy S, 2013, CHEST, V144, P474, DOI 10.1378/chest.12-1286; Kim YJ, 2008, EUR RESPIR J, V32, P1625, DOI 10.1183/09031936.00070907; Kwara A, 2008, CHEST, V133, P862, DOI 10.1378/chest.07-2024; Lai SW, 2014, CLIN MICROBIOL INFEC, V20, P764, DOI 10.1111/1469-0691.12516; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Leung CC, 2002, J AM GERIATR SOC, V50, P1219, DOI 10.1046/j.1532-5415.2002.50308.x; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Liao CC, 2013, ANN SURG, V257, P433, DOI 10.1097/SLA.0b013e31827b9b25; Lin CS, 2013, BRIT J SURG, V100, P1784, DOI 10.1002/bjs.9312; Lin CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063936; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; Meintjes G, 2012, AM J RESP CRIT CARE, V186, P369, DOI 10.1164/rccm.201201-0094OC; Morris MD, 2013, INT J TUBERC LUNG D, V17, P954, DOI 10.5588/ijtld.12.0480; Musallam KM, 2011, LANCET, V378, P1396, DOI 10.1016/S0140-6736(11)61381-0; Oeltmann JE, 2009, ARCH INTERN MED, V169, P189, DOI 10.1001/archinternmed.2008.535; Pasipanodya JG, 2007, CHEST, V131, P1817, DOI 10.1378/chest.06-2949; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Rabe KF, 2012, LANCET, V380, P623, DOI 10.1016/S0140-6736(12)61306-3; Robinson TN, 2012, J AM COLL SURGEONS, V215, P12, DOI 10.1016/j.jamcollsurg.2012.02.007; Sepkowitz KA, 2002, CLIN INFECT DIS, V34, P1098, DOI 10.1086/339548; Sheu JJ, 2010, STROKE, V41, P244, DOI 10.1161/STROKEAHA.109.567735; Sokolove PE, 2000, ACAD EMERG MED, V7, P1056, DOI 10.1111/j.1553-2712.2000.tb02100.x; Turrentine FE, 2006, J AM COLL SURGEONS, V203, P865, DOI 10.1016/j.jamcollsurg.2006.08.026; Vento S, 2011, LANCET ONCOL, V12, P520, DOI 10.1016/S1470-2045(11)70105-X; Chung WS, 2007, INT J TUBERC LUNG D, V11, P59; Wu YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118929; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC; Yeh CC, 2013, DIABETES CARE, V36, P3216, DOI 10.2337/dc13-0770; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133064	10.1371/journal.pone.0133064	http://dx.doi.org/10.1371/journal.pone.0133064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172153	Green Submitted, gold, Green Published			2022-12-27	WOS:000358194900118
J	Mao, K; Wang, L; Li, YY; Wu, RL				Mao, Ke; Wang, Lina; Li, Yuan-Yuan; Wu, Rongling			Molecular Cloning and Functional Analysis of UV RESISTANCE LOCUS 8 (PeUVR8) from Populus euphratica	PLOS ONE			English	Article							B-INDUCED PHOTOMORPHOGENESIS; BLUE-LIGHT RECEPTORS; PHOTORECEPTOR; COP1; PERCEPTION; GROWTH; ELONGATION; TRYPTOPHAN; EXPRESSION; RADIATION	Ultraviolet-B (UV-B; 280-315 nm) light, which is an integral part of the solar radiation reaching the surface of the Earth, induces a broad range of physiological responses in plants. The UV RESISTANCE LOCUS 8 (UVR8) protein is the first and only light photoreceptor characterized to date that is specific for UV-B light and it regulates various aspects of plant growth and development in response to UV-B light. Despite its involvement in the control of important plant traits, most studies on UV-B photoreceptors have focused on Arabidopsis and no data on UVR8 function are available for forest trees. In this study, we isolated a homologue of the UV receptor UVR8 of Arabidopsis, PeUVR8, from Populus euphratica (Euphrates poplar) and analyzed its structure and function in detail. The deduced PeUVR8 amino acid sequence contained nine well-conserved regulator of chromosome condensation 1 (RCC1) repeats and the region 27 amino acids from the C terminus (C27) that interact with COP1 (CONSTITUTIVELY PHOTOMORPHOGENIC1). Secondary and tertiary structure analysis showed that PeUVR8 shares high similarity with the AtUVR8 protein from Arabidopsis thaliana. Using heterologous expression in Arabidopsis, we showed that PeUVR8 overexpression rescued the uvr8 mutant phenotype. In addition, PeUVR8 overexpression in wild-type background seedlings grown under UV-B light inhibited hypocotyl elongation and enhanced anthocyanin accumulation. Furthermore, we examined the interaction between PeUVR8 and AtCOP1 using a bimolecular fluorescence complementation (BiFC) assay. Our data provide evidence that PeUVR8 plays important roles in the control of photomorphogenesis in planta.	[Mao, Ke; Wang, Lina; Wu, Rongling] Beijing Forestry Univ, Coll Biol Sci & Technol, Ctr Computat Biol, Beijing 100083, Peoples R China; [Li, Yuan-Yuan] Shandong Agr Univ, Coll Hort Sci & Engn, Tai An 271018, Shandong, Peoples R China; [Wu, Rongling] Penn State Univ, Ctr Stat Genet, Hershey, PA 17033 USA	Beijing Forestry University; Shandong Agricultural University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Wu, RL (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Ctr Computat Biol, Beijing 100083, Peoples R China.	rwu@bjfu.edu.cn			Special Fund for Forest Scientific Research in the Public Welfare [201404102]; Foundation for Outstanding Young Scientist in Shandong Province [BS2013NY001]; National Natural Science Foundation of China [31301763]; "Thousand-Person Plan" Award	Special Fund for Forest Scientific Research in the Public Welfare; Foundation for Outstanding Young Scientist in Shandong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Thousand-Person Plan" Award(Chinese Academy of Sciences)	This work is supported by the Special Fund for Forest Scientific Research in the Public Welfare (201404102), the "Thousand-Person Plan" Award, the Foundation for Outstanding Young Scientist in Shandong Province (BS2013NY001), and the National Natural Science Foundation of China (31301763).	Boccalandro HE, 2001, PLANT PHYSIOL, V126, P780, DOI 10.1104/pp.126.2.780; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Brown BA, 2005, P NATL ACAD SCI USA, V102, P18225, DOI 10.1073/pnas.0507187102; Canamero RC, 2006, PLANTA, V224, P995, DOI 10.1007/s00425-006-0280-6; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Christie JM, 2012, SCIENCE, V335, P1492, DOI 10.1126/science.1218091; Cloix C, 2012, P NATL ACAD SCI USA, V109, P16366, DOI 10.1073/pnas.1210898109; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coleman RS, 2004, PHYSIOL PLANTARUM, V122, P362, DOI 10.1111/j.1399-3054.2004.00411.x; Conte M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-112; Correll MJ, 2005, PLANT CELL PHYSIOL, V46, P317, DOI 10.1093/pcp/pci038; CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P537; Eisinger WR, 2003, AM J BOT, V90, P1560, DOI 10.3732/ajb.90.11.1560; Favory JJ, 2009, EMBO J, V28, P591, DOI 10.1038/emboj.2009.4; Folta KM, 2003, PLANT J, V36, P203, DOI 10.1046/j.1365-313X.2003.01870.x; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; GEOURJON C, 1994, PROTEIN ENG, V7, P157, DOI 10.1093/protein/7.2.157; Heijde M, 2012, TRENDS PLANT SCI, V17, P230, DOI 10.1016/j.tplants.2012.01.007; Jenkins GI, 2014, CURR OPIN STRUC BIOL, V29, P52, DOI 10.1016/j.sbi.2014.09.004; Kaiserli E, 2007, PLANT CELL, V19, P2662, DOI 10.1105/tpc.107.053330; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kim BC, 1998, PLANT J, V15, P667, DOI 10.1046/j.1365-313x.1998.00246.x; Kliebenstein DJ, 2002, PLANT PHYSIOL, V130, P234, DOI 10.1104/pp.005041; Kucera B, 2003, PLANT PHYSIOL, V133, P1445, DOI 10.1104/pp.103.029520; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leasure CD, 2011, MOL PLANT, V4, P759, DOI 10.1093/mp/ssr033; LEE HS, 1991, J FOOD SCI, V56, P466, DOI 10.1111/j.1365-2621.1991.tb05305.x; Li YY, 2013, PLANT CELL REP, V32, P555, DOI 10.1007/s00299-013-1387-4; Lin CT, 2002, PLANT CELL, V14, pS207, DOI 10.1105/tpc.000646; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; McKenzie RL, 2007, PHOTOCH PHOTOBIO SCI, V6, P218, DOI 10.1039/b700017k; Morelli G, 2002, TRENDS PLANT SCI, V7, P399, DOI 10.1016/S1360-1385(02)02314-2; O'Hara A, 2012, PLANT CELL, V24, P3755, DOI 10.1105/tpc.112.101451; Oravecz A, 2006, PLANT CELL, V18, P1975, DOI 10.1105/tpc.105.040097; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Quaggiotti S, 2004, PLANT SCI, V167, P107, DOI 10.1016/j.plantsci.2004.03.005; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Rozema J, 1997, TRENDS ECOL EVOL, V12, P22, DOI 10.1016/S0169-5347(96)10062-8; Shinkle JR, 2004, PHYSIOL PLANTARUM, V120, P240, DOI 10.1111/j.0031-9317.2004.0237.x; Sorce C, 2008, J PLANT PHYSIOL, V165, P482, DOI 10.1016/j.jplph.2007.03.012; Suesslin C, 2003, PLANT J, V33, P591, DOI 10.1046/j.1365-313X.2003.01649.x; Sullivan JA, 2003, DEV BIOL, V260, P289, DOI 10.1016/S0012-1606(03)00212-4; SULLIVAN JH, 1988, AM J BOT, V75, P225, DOI 10.2307/2443888; TEVINI M, 1989, PHOTOCHEM PHOTOBIOL, V50, P479, DOI 10.1111/j.1751-1097.1989.tb05552.x; Tong HY, 2008, P NATL ACAD SCI USA, V105, P21039, DOI 10.1073/pnas.0809942106; Ulm R, 2004, P NATL ACAD SCI USA, V101, P1397, DOI 10.1073/pnas.0308044100; Wargent JJ, 2009, NEW PHYTOL, V183, P315, DOI 10.1111/j.1469-8137.2009.02855.x; Wu D, 2012, NATURE, V484, P214, DOI [10.1038/nature10931, 10.1038/nature11685]; Xie XB, 2012, PLANT CELL ENVIRON, V35, P1884, DOI 10.1111/j.1365-3040.2012.02523.x; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yin RH, 2015, PLANT CELL, V27, P202, DOI 10.1105/tpc.114.133868	52	16	20	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132390	10.1371/journal.pone.0132390	http://dx.doi.org/10.1371/journal.pone.0132390			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171608	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900049
J	Schumann, J; Stanko, K; Schliesser, U; Appelt, C; Sawitzki, B				Schumann, Julia; Stanko, Katarina; Schliesser, Ulrike; Appelt, Christine; Sawitzki, Birgit			Differences in CD44 Surface Expression Levels and Function Discriminates IL-17 and IFN-gamma Producing Helper T Cells	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TYROSINE KINASES; DENDRITIC CELLS; IMMUNE-CELLS; ANTIGEN; ACTIVATION; RECEPTOR; TH2; DIFFERENTIATION; LYMPHOCYTES	CD44 is a prominent activation marker which distinguishes memory and effector T cells from their naive counterparts. It also plays a role in early T cell signaling events as it is bound to the lymphocyte-specific protein kinase and thereby enhances T cell receptor signalling. Here, we investigated whether IFN-gamma and IL-17 producing T helper cells differ in their CD44 expression and their dependence of CD44 for differentiation. Stimulation of CD4(+) T cells with allogeneic dendritic cells resulted in the formation of three distinguishable populations: CD44(+), CD44(++) and CD44(+++). In vitro and in vivo generated allo-reactive IL-17 producing T helper cells were mainly CD44(+++) as compared to IFN-gamma(+) T helper cells, which were CD44(++). This effect was enhanced under polarizing conditions. T helper 17 polarization led to a shift towards the CD44(+++) population, whereas T helper 1 polarization diminished this population. Furthermore, blocking CD44 decreased IL-17 secretion, while IFN-gamma was barely affected. Titration experiments revealed that low T cell receptor and CD28 stimulation supported T helper 17 rather than T helper 1 development. Under these conditions CD44 could act as a co-stimulatory molecule and replace CD28. Indeed, rested CD44(+++) CD4(+) T cells contained already more total and especially phosphorylated zeta-chain-associated protein kinase 70 as compared to CD44(++) cells. Our results support the notion, that CD44 enhances T cell receptor signaling strength by delivering lymphocyte-specific protein kinase, which is required for induction of IL-17 producing T helper cells.	[Schumann, Julia; Stanko, Katarina; Schliesser, Ulrike; Appelt, Christine; Sawitzki, Birgit] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Sawitzki, Birgit] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sawitzki, B (corresponding author), Charite, Inst Med Immunol, D-13353 Berlin, Germany.	birgit.sawitzki@charite.de	Sawitzki, Birgit S/S-2307-2016	Sawitzki, Birgit/0000-0001-8166-8579	German Research Foundation (DFG) [Transregio 52 (TR52)]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the grant Transregio 52 (TR52), from the German Research Foundation (DFG) to B.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Baaten BJG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00023; Baaten BJG, 2010, IMMUNITY, V32, P104, DOI 10.1016/j.immuni.2009.10.011; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; BIRKELAND ML, 1989, P NATL ACAD SCI USA, V86, P6734, DOI 10.1073/pnas.86.17.6734; Bouguermouh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005087; BUDD RC, 1987, J IMMUNOL, V138, P3120; Chen HY, 2009, TRANSPL IMMUNOL, V21, P155, DOI 10.1016/j.trim.2009.03.006; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Do Y, 2004, J IMMUNOTHER, V27, P1, DOI 10.1097/00002371-200401000-00001; Ehnis T, 1996, EXP CELL RES, V229, P388, DOI 10.1006/excr.1996.0384; Flynn KM, 2013, AM J PATHOL, V182, P1322, DOI 10.1016/j.ajpath.2013.01.003; Foger N, 2000, EUR J IMMUNOL, V30, P2888; Galicia G, 2009, J CLIN IMMUNOL, V29, P426, DOI 10.1007/s10875-009-9287-7; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Grimbert P, 2011, NEPHROL DIAL TRANSPL, V26, P1087, DOI 10.1093/ndt/gfq453; Guan HB, 2011, J IMMUNOL, V186, P6955, DOI 10.4049/jimmunol.1004043; Guan HB, 2009, J IMMUNOL, V183, P172, DOI 10.4049/jimmunol.0802325; Guo Y, 1996, J EXP MED, V184, P955, DOI 10.1084/jem.184.3.955; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hegde VL, 2008, J LEUKOCYTE BIOL, V84, P134, DOI 10.1189/jlb.1107752; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Iezzi G, 2009, P NATL ACAD SCI USA, V106, P876, DOI 10.1073/pnas.0810769106; Ilangumaran S, 1998, BLOOD, V91, P3901; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Katoh S, 2011, EUR J IMMUNOL, V41, P3198, DOI 10.1002/eji.201141521; Koenders MI, 2012, ARTHRITIS RHEUM-US, V64, P1762, DOI 10.1002/art.34352; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lefebvre DC, 2010, MOL IMMUNOL, V47, P1882, DOI 10.1016/j.molimm.2010.03.018; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; Li RH, 2001, J BIOL CHEM, V276, P28767, DOI 10.1074/jbc.M100158200; Liu ZM, 2013, IMMUNOL REV, V252, P183, DOI 10.1111/imr.12038; Mosmann TR, 2005, J IMMUNOL, V175, P5; Mummert ME, 2002, J IMMUNOL, V169, P4322, DOI 10.4049/jimmunol.169.8.4322; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Purvis HA, 2010, BLOOD, V116, P4829, DOI 10.1182/blood-2010-03-272153; RACKE MK, 1995, J CLIN INVEST, V96, P2195, DOI 10.1172/JCI118274; Saeki K, 2009, J IMMUNOL, V182, P5929, DOI 10.4049/jimmunol.0802672; Saini M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000702; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Taher TEI, 1996, J BIOL CHEM, V271, P2863, DOI 10.1074/jbc.271.5.2863; TAMMI R, 1988, J INVEST DERMATOL, V90, P412, DOI 10.1111/1523-1747.ep12456530; Tao X, 1997, J IMMUNOL, V159, P5956; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Vincenti F, 2010, AM J TRANSPLANT, V10, P535, DOI 10.1111/j.1600-6143.2009.03005.x; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	56	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132479	10.1371/journal.pone.0132479	http://dx.doi.org/10.1371/journal.pone.0132479			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172046	Green Submitted, gold, Green Published			2022-12-27	WOS:000358194900053
J	Tavernier, E; Giraudeau, B				Tavernier, Elsa; Giraudeau, Bruno			Sample Size Calculation: Inaccurate A Priori Assumptions for Nuisance Parameters Can Greatly Affect the Power of a Randomized Controlled Trial	PLOS ONE			English	Article							CLINICAL-TRIALS; REESTIMATION; ETHICS	We aimed to examine the extent to which inaccurate assumptions for nuisance parameters used to calculate sample size can affect the power of a randomized controlled trial (RCT). In a simulation study, we separately considered an RCT with continuous, dichotomous or time-to-event outcomes, with associated nuisance parameters of standard deviation, success rate in the control group and survival rate in the control group at some time point, respectively. For each type of outcome, we calculated a required sample size N for a hypothesized treatment effect, an assumed nuisance parameter and a nominal power of 80%. We then assumed a nuisance parameter associated with a relative error at the design stage. For each type of outcome, we randomly drew 10,000 relative errors of the associated nuisance parameter (from empirical distributions derived from a previously published review). Then, retro-fitting the sample size formula, we derived, for the pre-calculated sample size N, the real power of the RCT, taking into account the relative error for the nuisance parameter. In total, 23%, 0% and 18% of RCTs with continuous, binary and time-to-event outcomes, respectively, were underpowered (i.e., the real power was < 60%, as compared with the 80% nominal power); 41%, 16% and 6%, respectively, were overpowered (i.e., with real power > 90%). Even with proper calculation of sample size, a substantial number of trials are underpowered or overpowered because of imprecise knowledge of nuisance parameters. Such findings raise questions about how sample size for RCTs should be determined.	[Tavernier, Elsa; Giraudeau, Bruno] INSERM, U1153, Paris, France; [Tavernier, Elsa; Giraudeau, Bruno] CHRU, Tours, France; [Tavernier, Elsa; Giraudeau, Bruno] INSERM CIC 1415, Tours, France; [Giraudeau, Bruno] Univ Tours, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Tavernier, E (corresponding author), INSERM, U1153, Paris, France.	elsa.tavernier@univ-tours.fr	Giraudeau, Bruno/L-9003-2015	Giraudeau, Bruno/0000-0003-3031-8258; Tavernier, Elsa/0000-0003-0798-1182				Bacchetti P, 2005, AM J EPIDEMIOL, V161, P105, DOI 10.1093/aje/kwi014; Bacchetti P, 2008, BIOMETRICS, V64, P577, DOI [10.1111/j.1541-0420.2008.01004.x, 10.1111/j.1541-0420.2008.01004_1.x]; Bacchetti P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001628; Bacchetti P, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-17; Charles P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1732; Clark T, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1135; Edwards SJL, 1997, LANCET, V350, P804, DOI 10.1016/S0140-6736(97)02290-3; Gad S. C., 2009, CLIN TRIALS HDB; Gardner CD, 2005, ANN INTERN MED, V142, P725, DOI 10.7326/0003-4819-142-9-200505030-00007; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gould AL, 2001, STAT MED, V20, P2625, DOI 10.1002/sim.733; Guyatt GH, 2008, PLOS MED, V5, P3, DOI 10.1371/journal.pmed.0050004; Halpern SD, 2002, JAMA-J AM MED ASSOC, V288, P358, DOI 10.1001/jama.288.3.358; Julious SA, 2004, PHARM STAT, V3, P261, DOI 10.1002/pst.139; Julious SA, 2006, PHARM STAT, V5, P29, DOI 10.1002/pst.197; Julious SA, 2011, STAT METHODS MED RES, V20, P595, DOI 10.1177/0962280210378945; MacHin D, 2008, SAMPLE SIZE TABLES C, V3rd; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Norman G, 2012, BMJ-BRIT MED J, V345, pe5278; Proschan MA, 2005, J BIOPHARM STAT, V15, P559, DOI 10.1081/BIP-200062852; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; Sully BGO, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-166; Vickers AJ, 2003, J CLIN EPIDEMIOL, V56, P717, DOI 10.1016/S0895-4356(03)00141-0; Wittes J, 2002, EPIDEMIOL REV, V24, P39, DOI 10.1093/epirev/24.1.39; WITTES J, 1990, STAT MED, V9, P65, DOI 10.1002/sim.4780090113	25	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132578	10.1371/journal.pone.0132578	http://dx.doi.org/10.1371/journal.pone.0132578			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173007	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900061
J	Fjaere, E; Andersen, C; Myrmel, LS; Petersen, RK; Hansen, JB; Tastesen, HS; Mandrup-Poulsen, T; Brunner, N; Kristiansen, K; Madsen, L; Romer, MU				Fjaere, Even; Andersen, Charlotte; Myrmel, Lene Secher; Petersen, Rasmus Koefoed; Hansen, Jakob Bondo; Tastesen, Hanne Sorup; Mandrup-Poulsen, Thomas; Brunner, Nils; Kristiansen, Karsten; Madsen, Lise; Romer, Maria Unni			Tissue Inhibitor Of Matrix Metalloproteinase-1 Is Required for High-Fat Diet-Induced Glucose Intolerance and Hepatic Steatosis in Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; INDUCED OBESITY; INSULIN; TIMP-1; DYSFUNCTION; PROGRESSION; DEFICIENCY; EXPRESSION; TUMOR	Background Plasma levels of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) are elevated in obesity and obesity-related disorders, such as steatosis, but the metabolic role of TIMP-1 is unclear. Here we investigated how the presence or absence of TIMP-1 affected the development of diet-induced glucose intolerance and hepatic steatosis using the Timp1 null mice. Methods Timp1 knockout (TKO) and wild type (TWT) mice were fed chow, high-fat diet (HFD) or intermediate fat and sucrose diet (IFSD). We determined body weight, body composition, lipid content of the liver, energy intake, energy expenditure, oral glucose tolerance, as well as insulin tolerance. In addition, the histology of liver and adipose tissues was examined and expression of selected genes involved in lipid metabolism and inflammation in liver and adipose tissues was determined by RT-qPCR. Results TKO mice gained less weight and had lower energy efficiency than TWT mice when fed HFD, but not when fed chow or IFSD. Importantly, TKO mice were protected from development of HFD- as well as IFSD-induced glucose intolerance, hepatic steatosis, and altered expression of genes involved in hepatic lipid metabolism and inflammation. Conclusion Collectively, our results indicate that TIMP-1 contributes to the development of diet-induced hepatic steatosis and glucose intolerance and may be a potential therapeutic target.	[Fjaere, Even; Myrmel, Lene Secher; Petersen, Rasmus Koefoed; Tastesen, Hanne Sorup; Kristiansen, Karsten; Madsen, Lise] Univ Copenhagen, Fac Sci, Dept Biol, Copenhagen, Denmark; [Fjaere, Even; Myrmel, Lene Secher; Madsen, Lise] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Andersen, Charlotte; Hansen, Jakob Bondo; Brunner, Nils; Romer, Maria Unni] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Hansen, Jakob Bondo; Mandrup-Poulsen, Thomas] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark; [Mandrup-Poulsen, Thomas] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Romer, Maria Unni] Univ Copenhagen, Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Karolinska Institutet; Rigshospitalet; University of Copenhagen	Madsen, L (corresponding author), Univ Copenhagen, Fac Sci, Dept Biol, Copenhagen, Denmark.	lmad@nifes.no; maria.unni.romer@gmail.com	Kristiansen, Karsten/J-5148-2014; Madsen, Lise/C-6246-2012	Kristiansen, Karsten/0000-0002-6024-0917; Madsen, Lise/0000-0003-4468-1947; Hansen, Jakob Bondo/0000-0002-6837-0919; Mandrup-Poulsen, Thomas/0000-0002-3215-9273	Danish Natural Science Research Council; Novo Nordisk Foundation; Carlsberg Foundation; Novo Nordisk; Synergy in Human and Animal Research (SHARE LIFE) Initiative; Strategic Research Counsel	Danish Natural Science Research Council(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); Novo Nordisk(Novo Nordisk); Synergy in Human and Animal Research (SHARE LIFE) Initiative; Strategic Research Counsel	The work was supported by grants to Karsten Kristiansen from the Danish Natural Science Research Council, the Novo Nordisk Foundation, and the Carlsberg Foundation, to Thomas Mandrup-Poulsen from Novo Nordisk and the Novo Nordisk Foundation, to Jakob Bondo Hansen from the Synergy in Human and Animal Research (SHARE LIFE) Initiative and Novo Nordisk and to Nils Brunner from The Strategic Research Counsel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaueux JL, 2003, ATHEROSCLEROSIS, V169, P139, DOI 10.1016/S0021-9150(03)00149-7; Boden G, 2008, AM J PHYSIOL-ENDOC M, V295, pE692, DOI 10.1152/ajpendo.90370.2008; Bouloumie A, 2001, DIABETES, V50, P2080, DOI 10.2337/diabetes.50.9.2080; Buler M, 2012, J BIOL CHEM, V287, P1847, DOI 10.1074/jbc.M111.302356; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Derosa G, 2009, CLIN INVEST MED, V32, pE124, DOI 10.25011/cim.v32i2.6030; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; Fearnside JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001668; Feng F, 2008, ENDOCRINOLOGY, V149, P1505, DOI 10.1210/en.2007-1119; Gerin I, 2009, ENDOCRINOLOGY, V150, P1697, DOI 10.1210/en.2008-1409; Gustafson B, 2010, J ATHEROSCLER THROMB, V17, P332, DOI 10.5551/jat.3939; Han X, 2001, DIABETES, V50, P1047, DOI 10.2337/diabetes.50.5.1047; Hansen JB, 2012, CELL METAB, V16, P449, DOI 10.1016/j.cmet.2012.09.001; Harslund J, 2007, AM J PHYSIOL-REG I, V293, pR1630, DOI 10.1152/ajpregu.00380.2007; Jiang HW, 2011, CHINESE MED J-PEKING, V124, P258, DOI 10.3760/cma.j.issn.0366-6999.2011.02.020; KEKOW J, 1988, DIABETES, V37, P321, DOI 10.2337/diabetes.37.3.321; Kralisch S, 2007, EUR J ENDOCRINOL, V156, P257, DOI 10.1530/eje.1.02328; Lee SW, 2005, DIABETES RES CLIN PR, V69, P175, DOI 10.1016/j.diabres.2004.12.010; Lijnen HR, 2003, THROMB HAEMOSTASIS, V89, P249; Lijnen HR, 2002, THROMB HAEMOSTASIS, V87, P530; Lo L, 2011, J HEPATOL, V55, P435, DOI 10.1016/j.jhep.2010.10.039; Malik J, 2005, INT ANGIOL, V24, P300; Maquoi E, 2003, THROMB HAEMOSTASIS, V89, P696, DOI 10.1055/s-0037-1613586; Maury E, 2010, OBESITY, V18, P1503, DOI 10.1038/oby.2009.464; Meissburger B, 2011, DIABETOLOGIA, V54, P1468, DOI 10.1007/s00125-011-2093-9; Miele L, 2009, TRANSL RES, V154, P194, DOI 10.1016/j.trsl.2009.06.007; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Papazoglou D, 2010, EXP CLIN ENDOCR DIAB, V118, P730, DOI 10.1055/s-0030-1249671; Pendas AM, 2004, MOL CELL BIOL, V24, P5304, DOI 10.1128/MCB.24.12.5304-5313.2004; Smith BW, 2011, CRIT REV CL LAB SCI, V48, P97, DOI 10.3109/10408363.2011.596521; Soloway PD, 1996, ONCOGENE, V13, P2307; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Weiss TW, 2011, INT J CLIN PRACT, V65, P939, DOI 10.1111/j.1742-1241.2011.02717.x; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Younossi ZM, 2011, OBES SURG, V21, P431, DOI 10.1007/s11695-010-0204-1	37	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132910	10.1371/journal.pone.0132910	http://dx.doi.org/10.1371/journal.pone.0132910			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168159	Green Submitted, Green Published, gold			2022-12-27	WOS:000358193100096
J	Lunny, C; Taylor, D; Hoang, LD; Wong, T; Gilbert, M; Lester, R; Krajden, M; Ogilvie, G				Lunny, Carole; Taylor, Darlene; Hoang, Linda; Wong, Tom; Gilbert, Mark; Lester, Richard; Krajden, Mel; Ogilvie, Gina			Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta-Analysis	PLOS ONE			English	Review							ACID AMPLIFICATION TESTS; LIGASE CHAIN-REACTION; SEXUALLY-TRANSMITTED INFECTIONS; NEISSERIA-GONORRHOEAE; TRACHOMATIS INFECTION; VAGINAL SWABS; DIAGNOSTIC-ACCURACY; RECTAL SPECIMENS; ASYMPTOMATIC MEN; CERVICAL SWABS	Background The increases in STI rates since the late 1990s in Canada have occurred despite widespread primary care and targeted public health programs and in the setting of universal health care. More innovative interventions are required that would eliminate barriers to STI testing such as internet-based or mail-in home and community service testing for patients that are hard to reach, who refuse to go for clinician-based testing, or who decline an examination. Jurisdictions such as New Zealand and some American states currently use self-collected sampling, but without the required evidence to determine whether self-collected specimens are as accurate as clinician-collected specimens in terms of chlamydia and gonorrhea diagnostic accuracy. The objective of the review is to compare self-collected vaginal, urine, pharyngeal and rectal samples to our reference standard - clinician-collected cervical, urethral, pharyngeal and rectal sampling techniques to identify a positive specimen using nucleic acid amplification test assays. Methods The hierarchical summary receiver operating characteristic and the fixed effect models were used to assess the accuracy of comparable specimens that were collected by patients compared to clinicians. Sensitivity and specificity estimates with 95% confidence intervals (CI) were reported as our main outcome measures. Findings We included 21 studies based on over 6100 paired samples. Fourteen included studies examined chlamydia only, 6 compared both gonorrhea and chlamydia separately in the same study, and one examined gonorrhea. The six chlamydia studies comparing self-collection by vaginal swab to a clinician-collected cervical swab had the highest sensitivity (92%, 95% CI 87-95) and specificity (98%, 95% CI 97-99), compared to other specimen-types (urine/urethra or urine/cervix). Six studies compared urine self-samples to urethra clinician-collected samples in males and produced a sensitivity of 88%(95% CI 83-93) and a specificity of 99% (95% CI 0.94-0.99). Taking into account that urine samples may be less sensitive than cervical samples, eight chlamydia studies that compared urine self-collected verses cliniciancollected cervical samples had a sensitivity of 87%(95% CI 81-91) and high specificity of 99%(95% CI 0.98-1.00). For gonorrhea testing, self-collected urine samples compared to clinician-collected urethra samples inmales produced a sensitivity of 92%(95% CI 83-97) and specificity of 99%(95% CI 0.98-1.00). Conclusion The sensitivity and specificity of vaginal self-collected swabs compared to swabs collected by clinicians supports the use of vaginal swab as the recommended specimen of choice in home-based screening for chlamydia and gonorrhea. Urine samples for gonorrhea collected by men had comparably high sensitivity and specificity, so could be recommended as they can be left at room temperature for several days, allowing for the possibility of mailin home-based testing. In populations that may not go for testing at all, do not have the option of clinical testing, or who refuse a clinical examination, self-collected screening would be a good alternative. We recommend that guidelines on how to self-collect gonorrhea and chlamydia urine, vaginal, rectal and pharyngeal specimens be published.	[Lunny, Carole; Taylor, Darlene; Hoang, Linda; Gilbert, Mark; Lester, Richard; Krajden, Mel; Ogilvie, Gina] BC Ctr Dis Control, Div STI HIV Prevent & Control, Vancouver, BC, Canada; [Lunny, Carole; Taylor, Darlene; Hoang, Linda; Gilbert, Mark; Lester, Richard; Krajden, Mel; Ogilvie, Gina] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Wong, Tom] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Hoang, Linda; Krajden, Mel] BC Publ Hlth Microbiol & Reference Lab, Vancouver, BC, Canada; [Lunny, Carole] Monash Univ, Australasian Cochrane Ctr, Melbourne, Vic 3004, Australia	University of British Columbia; Public Health Agency of Canada; Monash University	Lunny, C (corresponding author), BC Ctr Dis Control, Div STI HIV Prevent & Control, Vancouver, BC, Canada.	carole.lunny@monash.edu		Ogilvie, Gina/0000-0001-5783-4493; Lunny, Carole/0000-0002-7825-6765	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We thank the Canadian Institutes of Health Research (CIHR) for funding this research. The funding body had no role in the design of the study; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	Alberta Health Services, 2014, UR SAMPL COLL INSTR; Alexander S, 2008, SEX TRANSM INFECT, V84, P488, DOI 10.1136/sti.2008.031443; [Anonymous], 2015, CANADA POST; BC Centre for Disease Control, 2009, STI HIV PREV CONTR 2; BC Centre for Disease Control, 2011, STI BRIT COL 2011 AN; Beck-Sague CM, 1998, J ADOLESCENT HEALTH, V22, P197, DOI 10.1016/S1054-139X(97)00209-7; Berry SA, 2010, SEX TRANSM INFECT, V86, P481, DOI 10.1136/sti.2009.041541; Berwald N, 2009, ACAD EMERG MED, V16, P360, DOI 10.1111/j.1553-2712.2009.00359.x; Chan CH, 2012, SEX TRANSM INFECT, V88, P200, DOI 10.1136/sextrans-2011-050049; Chernesky MA, 2005, SEX TRANSM DIS, V32, P729, DOI 10.1097/01.olq.0000190057.61633.8d; Cook RL, 2005, ANN INTERN MED, V142, P914, DOI 10.7326/0003-4819-142-11-200506070-00010; Coutlee F, 2000, J CLIN MICROBIOL, V38, P2512; Darwin LH, 2002, SEX TRANSM DIS, V29, P576, DOI 10.1097/00007435-200210000-00003; Diagnostic Test Accuracy Working Group, 2011, HDB DTA REV; Domeika M, 1999, ACTA OBSTET GYN SCAN, V78, P131, DOI 10.1034/j.1600-0412.1999.780211.x; Falk L, 2010, INT J STD AIDS, V21, P283, DOI 10.1258/ijsa.2009.009440; Fisman DN, 2011, CAN J INFECT DIS MED, V22, P80, DOI 10.1155/2011/701906; Freeman AH, 2011, SEX TRANSM DIS, V38, P1036, DOI [10.1097/OLQ.0b013e3182275499, 10.1097/OLQ.0b013e318227713e]; Gaydos CA, 2010, J CLIN MICROBIOL, V48, P3236, DOI 10.1128/JCM.01019-10; Gaydos CA, 2005, INFECT DIS CLIN N AM, V19, P367, DOI 10.1016/j.idc.2005.03.006; Gaydos CA, 2004, J CLIN MICROBIOL, V42, P3041, DOI 10.1128/JCM.42.7.3041-3045.2004; Gaydos CA, 2003, J CLIN MICROBIOL, V41, P304, DOI 10.1128/JCM.41.1.304-309.2003; Gilbert M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2888; Harbord RM, 2008, J CLIN EPIDEMIOL, V61, P1095, DOI 10.1016/j.jclinepi.2007.09.013; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; Haugland S, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-9; Higgins SP, 1998, INT J STD AIDS, V9, P21, DOI 10.1258/0956462981920982; Hocking JS, 2013, FUTURE MICROBIOL, V8, P367, DOI [10.2217/FMB.13.3, 10.2217/fmb.13.3]; Hook EW, 1997, J CLIN MICROBIOL, V35, P2133, DOI 10.1128/JCM.35.8.2133-2135.1997; Hopkins John, 2015, I WANT KIT SELF COLL; Hosenfeld CB, 2009, SEX TRANSM DIS, V36, P478, DOI 10.1097/OLQ.0b013e3181a2a933; Hottes TS, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1948; Jenkins WD, 2011, SEX HEALTH, V8, P79, DOI 10.1071/SH10012; Keane FEA, 2007, INT J STD AIDS, V18, P98, DOI 10.1258/095646207779949619; Knox J, 2002, SEX TRANSM DIS, V29, P647, DOI 10.1097/00007435-200211000-00006; Koliopoulos G, 2007, GYNECOL ONCOL, V104, P232, DOI 10.1016/j.ygyno.2006.08.053; Levy V, 2012, METHODS MOL BIOL, V903, P407, DOI 10.1007/978-1-61779-937-2_28; Luu HN, 2013, CANCER MED-US, V2, P367, DOI 10.1002/cam4.83; Masek BJ, 2009, J CLIN MICROBIOL, V47, P1663, DOI 10.1128/JCM.02387-08; Mayaud P, 2001, BRIT MED BULL, V58, P129, DOI 10.1093/bmb/58.1.129; Michel CEC, 2007, J CLIN MICROBIOL, V45, P1395, DOI 10.1128/JCM.00100-07; Mimiaga MJ, 2009, AIDS PATIENT CARE ST, V23, P825, DOI 10.1089/apc.2009.0086; Moncada J, 2008, J CLIN MICROBIOL, V46, P1614, DOI 10.1128/JCM.02301-07; New Zealand Sexual Health Society, 2012, SEX HLTH CHECK MAN G; North Carolina STDPH, 2011, SELF COLL VAG SWABS; Odesanmi TY, 2013, SEX HEALTH, V10, P559, DOI 10.1071/SH13029; Ota KV, 2009, SEX TRANSM INFECT, V85, P182, DOI 10.1136/sti.2008.034140; Papp JR, 2014, MMWR RECOMM REP, V63, P1; Pogue J, 1998, LANCET, V351, P47, DOI 10.1016/S0140-6736(97)08461-4; Public Health Agency of Canada, 2010, CAN REP CAS RAT GON; Public Health Agency of Canada, 2010, REP CAS RAT CHLAM PR; Puolakkainen M, 1998, J CLIN MICROBIOL, V36, P1489, DOI 10.1128/JCM.36.6.1489-1493.1998; Quinn TC, 1996, J CLIN MICROBIOL, V34, P1401, DOI 10.1128/JCM.34.6.1401-1406.1996; Rank C, 2010, PREVALENCE RECTAL HU; Rekart ML, 2013, J INFECT DIS, V207, P30, DOI 10.1093/infdis/jis644; Roberts SW, 2011, OBSTET GYNECOL, V117, P883, DOI 10.1097/AOG.0b013e3182107d47; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Schachter J, 2005, J CLIN MICROBIOL, V43, P1372, DOI 10.1128/JCM.43.3.1372-1373.2005; Schachter J, 1999, CURR OPIN INFECT DIS, V12, P41, DOI 10.1097/00001432-199902000-00008; Schachter J, 2005, SEX TRANSM DIS, V32, P725, DOI 10.1097/01.olq.0000190092.59482.96; Schachter J, 2008, SEX TRANSM DIS, V35, P637, DOI 10.1097/OLQ.0b013e31817bdd7e; Skidmore S, 2008, SEX TRANSM INFECT, V84, P277, DOI 10.1136/sti.2007.029587; Stary A, 1997, J CLIN MICROBIOL, V35, P239, DOI 10.1128/JCM.35.1.239-242.1997; Stary A, 1997, J CLIN MICROBIOL, V35, P836, DOI 10.1128/JCM.35.4.836-838.1997; Stary A, 1998, J CLIN MICROBIOL, V36, P2666, DOI 10.1128/JCM.36.9.2666-2670.1998; StataCorp LP, 2009, STATA STAT SOFTWARE; Sugunendran H, 2001, SEX TRANSM INFECT, V77, P423, DOI 10.1136/sti.77.6.423; Tabrizi SN, 1997, J INFECT DIS, V176, P289, DOI 10.1086/517269; Taylor D, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-93; The Nordic Cochrane Collaboration Copenhagen, 2012, REV MAN REVMAN VERS; Toye B, 1996, J CLIN MICROBIOL, V34, P1396, DOI 10.1128/JCM.34.6.1396-1400.1996; van der Helm JJ, 2009, SEX TRANSM DIS, V36, P493, DOI 10.1097/OLQ.0b013e3181a44b8c; van Doornum GJJ, 2001, J CLIN MICROBIOL, V39, P829, DOI 10.1128/JCM.39.3.829-835.2001; Wade R, 2013, RES SYNTH METHODS, V4, P280, DOI 10.1002/jrsm.1080; Wayal S, 2009, SEX TRANSM INFECT, V85, P60, DOI 10.1136/sti.2008.032193; Wyoming Public Health Laboratory (N.D.), CHLAM GON COLL PROT; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	77	109	112	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132776	10.1371/journal.pone.0132776	http://dx.doi.org/10.1371/journal.pone.0132776			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168051	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100079
J	Tadesse, BT; Foster, BA; Berhan, Y				Tadesse, Birkneh Tilahun; Foster, Byron Alexander; Berhan, Yifru			Cross Sectional Characterization of Factors Associated with Pediatric HIV Status Disclosure in Southern Ethiopia	PLOS ONE			English	Article							CHILDREN; DIAGNOSIS; ADOLESCENTS	Background Disclosure of HIV positive status to children and adolescents is a complex process. However, disclosure has been found to be associated with improved outcomes. The objective of the current study was to identify the predictors that facilitate disclosure of HIV status to children and adolescents and to study the reasons for non-disclosure. Methods Interviews of caregivers and reviews of records were done to collect data on caregiver and child information and details regarding the disclosure status of children. Bivariate analysis was done to test the association between HIV status disclosure and different caregiver and child factors. To identify the independent predictors of disclosure, we did multivariable logistic regression. Results A total of 177 children attending an HIV clinic were included. The mean age of the participants was 10.1 years (SD = 2.8), and about half (50.8%) were female. Most caregivers, 137 (77.8%) stated that disclosure of HIV status to children is important and should be done. However, disclosure had only been made to 59 (33.3%) of the participants. Child age more than 10 years [AOR = 6.7; 95% CI: 1.73-26.01], duration of HIV diagnosis of 5 years or more [AOR = 4.4; 95% CI: 1.26-15.06] and taking a zidovudin (AZT) based regimen [AOR = 3.5; 95% CI: 1.31-9.53] predicted HIV positive status disclosure. Additionally, length of treatment of caregivers of more than 14 years [AOR = 3.9; 95% CI: 1.07-14.61], disclosure of caregiver's HIV status to children and/or others [AOR = 4.7; 95% CI: 1.19-18.74], and the child's inquiry about their condition [AOR = 4.5; 95% CI: 1.16-17.43] increased the odds of disclosure. Conclusion The rate of disclosure among HIV infected children in southern Ethiopia is low. Primarily time-based factors were associated with the probability of HIV positive status disclosure and a specific regimen which has not been found previously. Further qualitative research may elucidate more on these factors; educational strategies may address some of these determinants.	[Tadesse, Birkneh Tilahun; Berhan, Yifru] Hawassa Univ, Coll Hlth Sci, Dept Child Hlth, Hawassa, Ethiopia; [Foster, Byron Alexander] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA	Hawassa University; University of Texas System; University of Texas Health San Antonio	Foster, BA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA.	fosterba@uthscsa.edu		Tadesse, Birkneh Tilahun/0000-0003-4005-8605	NCATS NIH HHS [KL2 TR001118, UL1 TR001120] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001118, UL1TR001120] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Bachanas PJ, 2001, J PEDIATR PSYCHOL, V26, P343, DOI 10.1093/jpepsy/26.6.343; Bhattacharya M, 2011, J TROP PEDIATRICS, V57, P405, DOI 10.1093/tropej/fmq115; Biadgilign S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017572; Ferris M, 2007, AIDS CARE, V19, P1088, DOI 10.1080/09540120701367124; HARDY MS, 1994, J DEV BEHAV PEDIATR, V15, pS49; Heeren GA, 2012, VULNERABLE CHILD YOU, V7, P47, DOI 10.1080/17450128.2012.656733; Hejoaka F, 2009, SOC SCI MED, V69, P869, DOI 10.1016/j.socscimed.2009.05.041; Kallem S, 2011, AIDS BEHAV, V15, P1121, DOI 10.1007/s10461-010-9741-9; Kouyoumdjian FG, 2005, J TROP PEDIATRICS, V51, P285, DOI 10.1093/tropej/fmi014; Menon A, 2007, JAIDS-J ACQ IMM DEF, V46, P349, DOI 10.1097/QAI.0b013e3181565df0; Moodley K, 2006, SAMJ S AFR MED J, V96, pA201; Oberdorfer P, 2006, J PAEDIATR CHILD H, V42, P283, DOI 10.1111/j.1440-1754.2006.00855.x; Petersen I, 2010, AIDS CARE, V22, P970, DOI 10.1080/09540121003623693; UNAIDS, 2010, GLOB AIDS EP UPD REP; Vreeman RC, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18466; WHO, 2014, TREATM CHILDR HIV AI; WHO UNICEF, 2008, SCAL HIV REL PREV DI; Wiener L, 2007, J DEV BEHAV PEDIATR, V28, P155, DOI 10.1097/01.DBP.0000267570.87564.cd; Yang H, 2006, AIDS CARE, V18, P717, DOI 10.1080/09540120500303403	19	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132691	10.1371/journal.pone.0132691	http://dx.doi.org/10.1371/journal.pone.0132691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1PW	26167687	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100066
J	Yin, FF; Zhu, Z; Liu, XP; Hou, DH; Wang, J; Zhang, L; Wang, ML; Kou, Z; Wang, HL; Deng, F; Hu, ZH				Yin, Feifei; Zhu, Zheng; Liu, Xiaoping; Hou, Dianhai; Wang, Jun; Zhang, Lei; Wang, Manli; Kou, Zheng; Wang, Hualin; Deng, Fei; Hu, Zhihong			The Complete Genome of a New Betabaculovirus from Clostera anastomosis	PLOS ONE			English	Article							OS INFECTIVITY FACTOR; SEQUENCE-ANALYSIS; FUNCTIONAL-ANALYSIS; GRANULOSIS-VIRUS; F-PROTEINS; IN-VIVO; BACULOVIRUS; OCCLUSION; IDENTIFICATION; REPLICATION	Clostera anastomosis (Lepidoptera: Notodontidae) is a defoliating forest insect pest. Clostera anastomosis granulovirus-B (ClasGV-B) belonging to the genus Betabaculovirus of family Baculoviridae has been used for biological control of the pest. Here we reported the full genome sequence of ClasGV-B and compared it to other previously sequenced baculoviruses. The circular double-stranded DNA genome is 107,439 bp in length, with a G+C content of 37.8% and contains 123 open reading frames (ORFs) representing 93% of the genome. ClasGV-B contains 37 baculovirus core genes, 25 lepidopteran baculovirus specific genes, 19 betabaculovirus specific genes, 39 other genes with homologues to baculoviruses and 3 ORFs unique to ClasGV-B. Hrs appear to be absent from the ClasGV-B genome, however, two non-hr repeats were found. Phylogenetic tree based on 37 core genes from 73 baculovirus genomes placed ClasGV-B in the clade b of betabaculoviruses and was most closely related to Erinnyis ello GV (ErelGV). The gene arrangement of ClasGV-B also shared the strongest collinearity with ErelGV but differed from Clostera anachoreta GV (ClanGV), Clostera anastomosis GV-A (ClasGV-A, previously also called CaLGV) and Epinotia aporema GV (EpapGV) with a 20 kb inversion. ClasGV-B genome contains three copies of polyhedron envelope protein gene (pep) and phylogenetic tree divides the PEPs of betabaculoviruses into three major clades: PEP-1, PEP-2 and PEP/P10. ClasGV-B also contains three homologues of P10 which all harbor an N-terminal coiled-coli domain and a C-terminal basic sequence. ClasGV-B encodes three fibroblast growth factor (FGF) homologues which are conserved in all sequenced betabaculoviruses. Phylogenetic analysis placed these three FGFs into different groups and suggested that the FGFs were evolved at the early stage of the betabaculovirus expansion. ClasGV-B is different from previously reported ClasGV-A and ClanGV isolated from Notodontidae in sequence and gene arrangement, indicating the virus is a new notodontid betabaculovirus.	[Yin, Feifei; Zhu, Zheng; Liu, Xiaoping; Hou, Dianhai; Wang, Jun; Zhang, Lei; Wang, Manli; Kou, Zheng; Wang, Hualin; Deng, Fei; Hu, Zhihong] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China; [Yin, Feifei; Zhu, Zheng; Liu, Xiaoping; Hou, Dianhai; Wang, Jun; Zhang, Lei; Wang, Manli; Kou, Zheng; Wang, Hualin; Deng, Fei; Hu, Zhihong] Chinese Acad Sci, Wuhan Inst Virol, China Ctr Virus Culture Collect, Wuhan 430071, Peoples R China; [Yin, Feifei] Hainan Med Univ, Sch Trop & Lab Med, Haikou 571101, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Hainan Medical University	Hu, ZH (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.	huzh@wh.iov.cn	ZHU, ZHENG/P-2173-2016; Hu, Zhihong/AAS-2215-2020	ZHU, ZHENG/0000-0002-2035-0804; Hu, Zhihong/0000-0002-1560-0928; KOU, Zheng/0000-0003-4758-2872	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB11030400]; National Science Foundation of China [31321001, 31200124, 31460017]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported in part by the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDB11030400) and the National Science Foundation of China (31321001, 31200124, 31460017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens CH, 1997, VIROLOGY, V229, P381, DOI 10.1006/viro.1997.8448; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BLISSARD GW, 1992, J VIROL, V66, P6829, DOI 10.1128/JVI.66.11.6829-6835.1992; Detvisitsakun C, 2006, VIROLOGY, V346, P258, DOI 10.1016/j.virol.2006.01.016; Escasa SR, 2006, J GEN VIROL, V87, P1917, DOI 10.1099/vir.0.81792-0; Fang MG, 2009, J VIROL, V83, P12569, DOI 10.1128/JVI.01141-09; Federici B.A., 1997, BACULOVIRUSES VIRUSE, P33, DOI [10.1007/978-1-4899-1834-5_3, DOI 10.1007/978-1-4899-1834-5_3]; FEDERICI BA, 1990, J INVERTEBR PATHOL, V56, P401, DOI 10.1016/0022-2011(90)90128-S; Friesen PD, 1997, BACULOVIRUSES, P141, DOI [10.1007/978-1-4899-1834-5_6, DOI 10.1007/978-1-4899-1834-5_6]; Harrison RL, 2008, VIRUS GENES, V36, P565, DOI 10.1007/s11262-008-0218-0; Hashimoto Y, 2000, VIROLOGY, V275, P358, DOI 10.1006/viro.2000.0530; Hawtin RE, 1997, VIROLOGY, V238, P243, DOI 10.1006/viro.1997.8816; Hayakawa T, 1999, VIROLOGY, V262, P277, DOI 10.1006/viro.1999.9894; Hayakawa T, 2000, VIROLOGY, V278, P1, DOI 10.1006/viro.2000.0668; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Herniou EA, 2001, J VIROL, V75, P8117, DOI 10.1128/JVI.75.17.8117-8126.2001; Herniou EA, 2007, CURR DRUG TARGETS, V8, P1043, DOI 10.2174/138945007782151306; Hilton S, 2008, ARCH VIROL, V153, P1527, DOI 10.1007/s00705-008-0148-0; Hu ZH, 1998, J GEN VIROL, V79, P2841, DOI 10.1099/0022-1317-79-11-2841; IJkel WFJ, 2000, VIROLOGY, V275, P30, DOI 10.1006/viro.2000.0483; Ikeda M, 2004, VIROLOGY, V321, P359, DOI 10.1016/j.virol.2004.01.002; Ishimwe E, 2015, VIROLOGY, V479, P637, DOI 10.1016/j.virol.2015.01.027; Garavaglia MJ, 2012, J VIROL, V86, P12069, DOI 10.1128/JVI.01873-12; Jehle JA, 2006, VIROLOGY, V346, P180, DOI 10.1016/j.virol.2005.10.032; Jehle JA, 2002, J GEN VIROL, V83, P2025, DOI 10.1099/0022-1317-83-8-2025; Katsuma S, 2006, VIROLOGY, V355, P62, DOI 10.1016/j.virol.2006.07.008; Ko R, 2000, J VIROL, V74, P11240, DOI 10.1128/JVI.74.23.11240-11246.2000; Kuzio J, 1999, VIROLOGY, V253, P17, DOI 10.1006/viro.1998.9469; Lange M, 2003, VIROLOGY, V317, P220, DOI 10.1016/S0042-6822(03)00515-4; Lepore LS, 1996, J INVERTEBR PATHOL, V68, P131, DOI 10.1006/jipa.1996.0070; Ferrelli ML, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-548; Li Hai-xia, 2006, Journal of Forestry Research (Harbin), V17, P50, DOI 10.1007/s11676-006-0012-6; Liang ZP, 2013, ARCH VIROL, V158, P2109, DOI 10.1007/s00705-013-1710-y; Liang ZP, 2011, ARCH VIROL, V156, P1185, DOI 10.1007/s00705-011-0977-0; Lu H, 2014, PROT FORE SCI TECH, V126, P66; Lung O, 2002, J VIROL, V76, P5729, DOI 10.1128/JVI.76.11.5729-5736.2002; Luque T, 2001, J GEN VIROL, V82, P2531, DOI 10.1099/0022-1317-82-10-2531; Miele Solange Ana Belen, 2011, Int J Evol Biol, V2011, P379424, DOI 10.4061/2011/379424; Moscardi F, 2011, MICROBES AND MICROBIAL TECHNOLOGY: AGRICULTURAL AND ENVIRONMENTAL APPLICATIONS, P415, DOI 10.1007/978-1-4419-7931-5_16; Nie YC, 2012, J VIROL, V86, P3985, DOI 10.1128/JVI.06849-11; OReilly D.R., 1997, BACULOVIRUSES, P267, DOI DOI 10.1007/978-1-4899-1834-5_11; Passarelli AL, 2007, CURR DRUG TARGETS, V8, P1103, DOI 10.2174/138945007782151324; Pearson MN, 1998, J VIROL, V72, P9142, DOI 10.1128/JVI.72.11.9142-9149.1998; Peng K, 2010, J VIROL, V84, P9497, DOI 10.1128/JVI.00812-10; Ardisson-Araujo DMP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-856; Popovici C, 2005, BIOESSAYS, V27, P849, DOI 10.1002/bies.20261; Reichard P, 2002, ARCH BIOCHEM BIOPHYS, V397, P149, DOI 10.1006/abbi.2001.2637; SLACK JM, 1995, J GEN VIROL, V76, P1091, DOI 10.1099/0022-1317-76-5-1091; Solovyev VV, 1999, NUCLEIC ACIDS RES, V27, P248, DOI 10.1093/nar/27.1.248; Sparks WO, 2011, VIROLOGY, V409, P69, DOI 10.1016/j.virol.2010.09.027; Sun Xiulian, 1998, Virologica Sinica, V13, P83; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang X, 2004, J HUAZHONG AGR, V23, P616; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; van Oers MM, 2007, CURR DRUG TARGETS, V8, P1051, DOI 10.2174/138945007782151333; VanOers MM, 1997, J INVERTEBR PATHOL, V70, P1, DOI 10.1006/jipa.1997.4675; VANOERS MM, 1993, J GEN VIROL, V74, P563, DOI 10.1099/0022-1317-74-4-563; Vaux DL, 1996, P NATL ACAD SCI USA, V93, P2239, DOI 10.1073/pnas.93.6.2239; Wang P, 1997, P NATL ACAD SCI USA, V94, P6977, DOI 10.1073/pnas.94.13.6977; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; WINSTANLEY D, 1999, ENCY VIROLOGY, V1, P140; Wormleaton S, 2003, VIROLOGY, V311, P350, DOI 10.1016/S0042-6822(03)00149-1; Yin FF, 2008, J VIROL, V82, P8922, DOI 10.1128/JVI.00493-08; Yin FF, 2013, VIROLOGY, V436, P59, DOI 10.1016/j.virol.2012.10.017; Zheng M, 1987, GUIZHOU FORES SCI TE, V03, P78; Zhu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086450	66	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132792	10.1371/journal.pone.0132792	http://dx.doi.org/10.1371/journal.pone.0132792			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168260	Green Submitted, Green Published, gold			2022-12-27	WOS:000358193100081
J	El Anbari, M; Fadda, A; Ptitsyn, A				El Anbari, Mohammed; Fadda, Abeer; Ptitsyn, Andrey			Confidence in Phase Definition for Periodicity in Genes Expression Time Series	PLOS ONE			English	Article							CIRCADIAN CLOCKS; BOOTSTRAP; TISSUES; CYCLE	Circadian oscillation in baseline gene expression plays an important role in the regulation of multiple cellular processes. Most of the knowledge of circadian gene expression is based on studies measuring gene expression over time. Our ability to dissect molecular events in time is determined by the sampling frequency of such experiments. However, the real peaks of gene activity can be at any time on or between the time points at which samples are collected. Thus, some genes with a peak activity near the observation point have their phase of oscillation detected with better precision then those which peak between observation time points. Separating genes for which we can confidently identify peak activity from ambiguous genes can improve the analysis of time series gene expression. In this study we propose a new statistical method to quantify the phase confidence of circadian genes. The numerical performance of the proposed method has been tested using three real gene expression data sets.	[El Anbari, Mohammed; Fadda, Abeer; Ptitsyn, Andrey] Sidra Med & Res Ctr, Div Biomed Informat, Doha, Qatar	Sidra Medical & Research Center	El Anbari, M (corresponding author), Sidra Med & Res Ctr, Div Biomed Informat, Doha, Qatar.	melanbari@sidra.org		Ptitsyn, Andrey/0000-0003-1196-8757; Fadda, Abeer/0000-0002-8489-1335				Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Davison AC, 1997, BOOTSTRAP METHODS TH, V1; Efron B., 1979, ANS, V7, P1; Efron B., 1982, SIAM, V38; HALL P, 1986, ANN STAT, V14, P1431, DOI 10.1214/aos/1176350168; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Klevecz RR, 2008, FEBS J, V275, P2372, DOI 10.1111/j.1742-4658.2008.06399.x; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Ptitsyn AA, 2006, PLOS COMPUT BIOL, V2, P126, DOI 10.1371/journal.pcbi.0020016; Ptitsyn AA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-153; Ptitsyn AA, 2011, ANN MED, V43, P1, DOI 10.3109/07853890.2010.538078; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Vinod HD, 2009, J STAT SOFTW, V29, P1; Vinod HD, 2006, J ASIAN ECON, V17, P955, DOI 10.1016/j.asieco.2006.09.001; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	17	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131111	10.1371/journal.pone.0131111	http://dx.doi.org/10.1371/journal.pone.0131111			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161537	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300028
J	Imamaki, H; Ishii, A; Yokoi, H; Kasahara, M; Kuwabara, T; Mori, KP; Kato, Y; Kuwahara, T; Satoh, M; Nakatani, K; Saito, Y; Tomosugi, N; Sugawara, A; Nakao, K; Mukoyama, M; Yanagita, M; Mori, K				Imamaki, Hirotaka; Ishii, Akira; Yokoi, Hideki; Kasahara, Masato; Kuwabara, Takashige; Mori, Keita P.; Kato, Yukiko; Kuwahara, Takashi; Satoh, Masugi; Nakatani, Kimihiko; Saito, Yoshihiko; Tomosugi, Naohisa; Sugawara, Akira; Nakao, Kazuwa; Mukoyama, Masashi; Yanagita, Motoko; Mori, Kiyoshi			Low Serum Neutrophil Gelatinase-associated Lipocalin Level as a Marker of Malnutrition in Maintenance Hemodialysis Patients	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; ADULT CARDIAC-SURGERY; INSULIN-RESISTANCE; DIALYSIS PATIENTS; RENAL-FAILURE; REAL-TIME; IRON; NGAL; INFLAMMATION; RISK	Background Neutrophil gelatinase-associated lipocalin (NGAL or LCN2) is an iron-transporting factor which possesses various activities such as amelioration of kidney injury and host defense against pathogens. Its circulating concentrations are elevated in acute and chronic kidney diseases and show a positive correlation with poor renal outcome and mortality, but its clinical significance in maintenance hemodialysis (HD) patients remains elusive. Methods Serum NGAL levels were determined by enzyme-linked immunosorbent assay in outpatient, Japanese HD subjects. Their correlation to laboratory findings and morbidity (as development of severe infection or serum albumin reduction) was investigated using linear regression analysis and chi(2) test. Results Pre-dialysis serum NGAL levels in HD patients were elevated by 13-fold compared to healthy subjects (n=8, P<0.001). In a cross-sectional study of 139 cases, serum NGAL concentrations were determined independently by % creatinine generation rate (an indicator of muscle mass, standardized coefficient beta=0.40, P<0.001), peripheral blood neutrophil count (beta=0.38, P<0.001) and anion gap (which likely reflects dietary protein intake, beta=0.16, P<0.05). Iron administration to anemic HD patients caused marked elevation of peripheral blood hemoglobin, serum ferritin and iron-regulatory hormone hepcidin-25 levels, but NGAL levels were not affected. In a prospective study of 87 cases, increase in serum albumin levels a year later was positively associated to baseline NGAL levels by univariate analysis (r=0.36, P<0.01). Furthermore, within a year, patients with the lowest NGAL tertile showed significantly increased risk for marked decline in serum albumin levels (>= 0.4 g/dl; odds ratio 5.5, 95% confidence interval 1.5-20.3, P<0.05) and tendency of increased occurrence of severe infection requiring admission (odds ratio 3.1, not significant) compared to the middle and highest tertiles. Conclusion Low serum NGAL levels appear to be associated with current malnutrition and also its progressive worsening in maintenance HD patients.	[Imamaki, Hirotaka; Ishii, Akira; Yokoi, Hideki; Kuwabara, Takashige; Mori, Keita P.; Kato, Yukiko; Mukoyama, Masashi; Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan; [Kasahara, Masato] Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Kyoto 606, Japan; [Kuwahara, Takashi] Saiseikai Ibaraki Hosp, Dept Nephrol, Osaka, Japan; [Satoh, Masugi] Misugikai Satou Hosp, Osaka, Japan; [Nakatani, Kimihiko; Saito, Yoshihiko] Nara Med Univ, Dept Internal Med 1, Nara, Japan; [Tomosugi, Naohisa] Kanazawa Med Univ, Med Res Inst, Div Adv Med, Kanazawa, Ishikawa, Japan; [Sugawara, Akira] Osaka Red Cross Hosp, Dept Nephrol, Osaka, Japan; [Nakao, Kazuwa] Kyoto Univ, TK Project, Med Innovat Ctr, Grad Sch Med, Kyoto, Japan; [Kuwabara, Takashige; Mukoyama, Masashi] Kumamoto Univ, Grad Sch Med Sci, Dept Nephrol, Kumamoto, Japan; [Yanagita, Motoko; Mori, Kiyoshi] Kyoto Univ, TMK Project, Med Innovat Ctr, Grad Sch Med, Kyoto, Japan	Kyoto University; Kyoto University; Nara Medical University; Kanazawa Medical University; Osaka Red Cross Hospital; Kyoto University; Kumamoto University; Kyoto University	Mori, K (corresponding author), Kyoto Univ, TMK Project, Med Innovat Ctr, Grad Sch Med, Kyoto, Japan.	mori@tmk.med.kyoto-u.ac.jp	Yokoi, Hideki/R-1289-2016; Yokoi, Hideki/AAV-9038-2021; Mori, Kiyoshi/N-1267-2014; Yanagita, Motoko/AAJ-7731-2021	Yokoi, Hideki/0000-0001-8343-9737; Yokoi, Hideki/0000-0001-8343-9737; Mori, Kiyoshi/0000-0002-7285-8351; Kuwabara, Takashige/0000-0003-3507-4328; Yanagita, Motoko/0000-0002-0339-9008	JSPS KAKENHI [23390225, 26461224]; Ministry of Health, Labour and Welfare of Japan; Japan Kidney Foundation; Mitsubishi Tanabe Pharma Corporation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Kidney Foundation; Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation)	This work was supported in part by JSPS KAKENHI Grant Numbers 23390225 and 26461224 (KM and HI), Grant-in-Aid for Diabetic Nephropathy and Nephrosclerosis Research from the Ministry of Health, Labour and Welfare of Japan (KM), the Japan Kidney Foundation (KM), and research fund from Mitsubishi Tanabe Pharma Corporation (KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Barasch J, 2004, NATURE, V432, P811, DOI 10.1038/432811a; BERGSTROM J, 1995, J AM SOC NEPHROL, V6, P1329; Bolignano D, 2008, KIDNEY BLOOD PRESS R, V31, P255, DOI 10.1159/000143726; Bolignano D, 2010, CANCER LETT, V288, P10, DOI 10.1016/j.canlet.2009.05.027; Bolignano D, 2009, NEPHROL DIAL TRANSPL, V24, P3398, DOI 10.1093/ndt/gfp310; Bolignano D, 2009, CLIN J AM SOC NEPHRO, V4, P337, DOI 10.2215/CJN.03530708; BORAH MF, 1978, KIDNEY INT, V14, P491, DOI 10.1038/ki.1978.154; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777, DOI 10.1093/ajcn/82.4.777; Chan YR, 2009, J IMMUNOL, V182, P4947, DOI 10.4049/jimmunol.0803282; CHANDRA RK, 1983, LANCET, V1, P688; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Dent CL, 2007, CRIT CARE, V11, DOI 10.1186/cc6192; DRENICK EJ, 1971, AM J CLIN NUTR, V24, P859; Dumler F, 1999, ASAIO J, V45, P413, DOI 10.1097/00002480-199909000-00009; Fleischmann EH, 2001, ASAIO J, V47, P74, DOI 10.1097/00002480-200101000-00016; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Fluckinger M, 2004, ANTIMICROB AGENTS CH, V48, P3367, DOI 10.1128/AAC.48.9.3367-3372.2004; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Goldstein SL, 2006, CLIN J AM SOC NEPHRO, V1, P979, DOI 10.2215/CJN.02291205; Gupta A, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-16; Haase-Fielitz A, 2009, CRIT CARE MED, V37, P553, DOI 10.1097/CCM.0b013e318195846e; Hanai J, 2005, J BIOL CHEM, V280, P13641, DOI 10.1074/jbc.M413047200; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Hingorani S, 2009, AM J KIDNEY DIS, V53, P569, DOI 10.1053/j.ajkd.2009.01.002; Horl WH, 2002, J AM SOC NEPHROL, V13, pS62; Iwama H, 2006, J AM COLL CARDIOL, V47, P1559, DOI 10.1016/j.jacc.2005.11.064; Jiang W, 2008, BLOOD CELL MOL DIS, V41, P169, DOI 10.1016/j.bcmd.2008.04.006; Johnson ACM, 2010, AM J PHYSIOL-RENAL, V299, pF426, DOI 10.1152/ajprenal.00248.2010; Kalantar-Zadeh K, 2004, SEMIN DIALYSIS, V17, P455, DOI 10.1111/j.0894-0959.2004.17606.x; Kalantar-Zadeh K, 2004, J AM SOC NEPHROL, V15, P442, DOI 10.1097/01.ASN.0000107564.60018.51; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Kanda J, 2015, CLIN EXP NEPHROL, V19, P99, DOI 10.1007/s10157-014-0952-7; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Kuwabara T, 2009, KIDNEY INT, V75, P285, DOI 10.1038/ki.2008.499; LOCKRIDGE O, 1987, J BIOL CHEM, V262, P549; LOWRIE EG, 1990, AM J KIDNEY DIS, V15, P458, DOI 10.1016/S0272-6386(12)70364-5; Malyszko J, 2009, KIDNEY BLOOD PRESS R, V32, P464, DOI 10.1159/000274048; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Nakanishi T, 2012, CLIN EXP NEPHROL, V16, P819, DOI 10.1007/s10157-012-0694-3; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Paragas N, 2011, NAT MED, V17, P216, DOI 10.1038/nm.2290; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; Raj DSC, 2005, KIDNEY INT, V68, P2338, DOI 10.1111/j.1523-1755.2005.00695.x; Saiga H, 2008, J IMMUNOL, V181, P8521, DOI 10.4049/jimmunol.181.12.8521; SHINZATO T, 1994, NEPHRON, V67, P280, DOI 10.1159/000187980; Shinzato T, 1997, ARTIF ORGANS, V21, P864; Tomosugi N, 2006, BLOOD, V108, P1381, DOI 10.1182/blood-2005-10-4043; Wagener G, 2006, ANESTHESIOLOGY, V105, P485, DOI 10.1097/00000542-200609000-00011; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Wann JG, 2007, NEPHROL DIAL TRANSPL, V22, P2613, DOI 10.1093/ndt/gfm227; XU SY, 1995, SCAND J CLIN LAB INV, V55, P125, DOI 10.3109/00365519509089604; Yamada K, 2008, AM J CLIN NUTR, V87, P106, DOI 10.1093/ajcn/87.1.106; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zhang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096997	61	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132539	10.1371/journal.pone.0132539	http://dx.doi.org/10.1371/journal.pone.0132539			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161663	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300149
J	Kusama, K; Yoshie, M; Tamura, K; Imakawa, K; Isaka, K; Tachikawa, E				Kusama, Kazuya; Yoshie, Mikihiro; Tamura, Kazuhiro; Imakawa, Kazuhiko; Isaka, Keiichi; Tachikawa, Eiichi			Regulatory Action of Calcium Ion on Cyclic AMP-Enhanced Expression of Implantation-Related Factors in Human Endometrial Cells	PLOS ONE			English	Article							STROMAL CELLS; BINDING PROTEIN; DECIDUALIZATION; PROLACTIN; CA2+; PROLIFERATION; INVOLVEMENT; ACTIVATION; RECEPTORS; INCREASES	Decidualization of human endometrial stroma and gland development is mediated through cyclic AMP (cAMP), but the role of intracellular calcium ion (Ca2+) on cAMP mediated-signaling in human endometrial stroma and glandular epithelia has not been well-characterized. The present study was designed to investigate the role of intracellular Ca2+ on cAMP mediated-decidualization and gland maturation events, which can be identified by the up-regulation of prolactin and IGF-binding protein (IGFBP) 1 in human endometrial stromal cells (ESCs), and cyclooxygenase 2 (COX2) and prostaglandin E2 (PGE2) and glandular epithelial EM-1 cells. Increases in decidual prolactin and IGFBP-1 transcript levels, induced by cAMP-elevating agents forskolin or dibutyryl cyclic AMP, were inhibited by Ca2+ influx into ESCs with Ca2+ ionophores (alamethicin, ionomycin) in a dose-dependent manner. Conversely, inhibitors of Ca2+ influx through L-type voltage-dependent Ca2+ channel (VDCC), nifedipine and verapamil, enhanced the decidual gene expression. Furthermore, dantrolene, an inhibitor of Ca2+ release from the intracellular Ca2+ store, up-regulated prolactin and IGFBP-1 expression. Ca2+ ionophores decreased intracellular cAMP concentrations, whereas nifedipine, verapamil or dantrolene increased cAMP concentrations in ESCs. In glandular epithelial cells, similar responses in COX2 expression and PGE2 production were found when intracellular cAMP levels were up-regulated by decreases in Ca2+ concentrations. Thus, a marked decrease in cytosolic Ca2+ levels caused the elevation of cAMP concentrations, resulting in enhanced expression of implantation-related factors including decidual markers. These findings suggest that fluctuation in cytosolic Ca2+ concentrations alters intracellular cAMP levels, which then regulate differentiation of endometrial stromal and glandular epithelial cells.	[Kusama, Kazuya; Yoshie, Mikihiro; Tamura, Kazuhiro; Tachikawa, Eiichi] Tokyo Univ Pharm & Life Sci, Dept Endocrine & Neural Pharmacol, Hachioji, Tokyo 1920392, Japan; [Kusama, Kazuya; Imakawa, Kazuhiko] Univ Tokyo, Lab Theriogenol & Anim Breeding, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Isaka, Keiichi] Tokyo Med Univ, Dept Obstet & Gynecol, Tokyo 1600023, Japan	Tokyo University of Pharmacy & Life Sciences; University of Tokyo; Tokyo Medical University	Yoshie, M (corresponding author), Tokyo Univ Pharm & Life Sci, Dept Endocrine & Neural Pharmacol, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	yoshie@toyaku.ac.jp; hiro@toyaku.ac.jp	Kusama, Kazuya/K-9716-2018; Imakawa, Kazuhiko/AAD-3211-2022	Kusama, Kazuya/0000-0002-9120-0475; Yoshie, Mikihiro/0000-0001-5898-7950	education-research costs of institutional budget in Tokyo University of Pharmacy and Life Sciences; JSPS (Japan Society for the Promotion of Science) [25861511, 23590476]	education-research costs of institutional budget in Tokyo University of Pharmacy and Life Sciences; JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was mainly supported by education-research costs of institutional budget in Tokyo University of Pharmacy and Life Sciences, and in part by KAKENHI (Grant-in-Aid for Young Scientists B; 25861511 to MY, Grant-in-Aid for Scientific Research C; 23590476 to KT) from the JSPS (Japan Society for the Promotion of Science).	Abraham F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037750; Braileanu GT, 2002, REPROD FERT DEVELOP, V14, P199, DOI 10.1071/RD02003; Brar AK, 1997, ENDOCRINE, V6, P301, DOI 10.1007/BF02820507; Brosens JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03894; COUDERC B, 1995, PLACENTA, V16, P527, DOI 10.1016/S0143-4004(05)80004-9; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Dey SK, 2010, J CLIN INVEST, V120, P952, DOI 10.1172/JCI42380; Evans J, 2009, FASEB J, V23, P2165, DOI 10.1096/fj.08-124495; FRANK GR, 1994, ENDOCRINOLOGY, V134, P258, DOI 10.1210/en.134.1.258; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; GIUDICE LC, 1992, J CLIN ENDOCR METAB, V75, P1235, DOI 10.1210/jc.75.5.1235; Goraya TA, 2005, CELL SIGNAL, V17, P789, DOI 10.1016/j.cellsig.2004.12.017; Goraya TA, 2004, J BIOL CHEM, V279, P40494, DOI 10.1074/jbc.M313441200; Goraya TA, 2008, CELL SIGNAL, V20, P359, DOI 10.1016/j.cellsig.2007.10.024; Kawarabayashi Y, 2012, MOL ENDOCRINOL, V26, P846, DOI 10.1210/me.2011-1259; KUBOTA T, 1993, J ENDOCRINOL, V137, P335, DOI 10.1677/joe.0.1370335; Kusama K, 2013, PLACENTA, V34, P212, DOI 10.1016/j.placenta.2012.12.017; Kusama K, 2015, J MOL ENDOCRINOL, V54, P17, DOI 10.1530/JME-14-0162; Kusama K, 2014, REPRODUCTION, V147, P897, DOI 10.1530/REP-13-0654; Kusama K, 2014, ENDOCRINOLOGY, V155, P240, DOI 10.1210/en.2013-1478; Kutsukake M, 2007, MOL HUM REPROD, V13, P737, DOI 10.1093/molehr/gam058; Kyo S, 2003, AM J PATHOL, V163, P2259, DOI 10.1016/S0002-9440(10)63583-3; Liu XM, 2012, J CLIN ENDOCR METAB, V97, P3672, DOI 10.1210/jc.2012-2075; Macdonald LJ, 2011, MOL HUM REPROD, V17, P626, DOI 10.1093/molehr/gar031; Maldonado-Perez D, 2007, TRENDS ENDOCRIN MET, V18, P66, DOI 10.1016/j.tem.2006.12.002; Marions L, 1999, MOL HUM REPROD, V5, P961, DOI 10.1093/molehr/5.10.961; MASLAR IA, 1979, AM J OBSTET GYNECOL, V135, P751, DOI 10.1016/0002-9378(79)90386-7; Matsuoka A, 2010, J CLIN ENDOCR METAB, V95, pE291, DOI 10.1210/jc.2010-0619; Menezes-Rodrigues FS, 2013, EUR J PHARMACOL, V720, P326, DOI 10.1016/j.ejphar.2013.10.009; Milne SA, 2001, J CLIN ENDOCR METAB, V86, P4453, DOI 10.1210/jc.86.9.4453; Price SA, 2000, J ENDOCRINOL, V164, P21, DOI 10.1677/joe.0.1640021; Ruan YC, 2012, NAT MED, V18, P1112, DOI 10.1038/nm.2771; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Sonderegger S, 2010, PLACENTA, V31, P839, DOI 10.1016/j.placenta.2010.07.011; Sonderegger S, 2010, ENDOCRINOLOGY, V151, P211, DOI 10.1210/en.2009-0557; Stojilkovic SS, 2010, ENDOCR REV, V31, P845, DOI 10.1210/er.2010-0005; Strauss J F, 2009, YEN JAFFES REPROD EN, P191; Tamura K, 2007, J REPROD DEVELOP, V53, P525, DOI 10.1262/jrd.18129; Tang B, 1993, Acta Eur Fertil, V24, P221; TSENG L, 1992, BIOL REPROD, V47, P441, DOI 10.1095/biolreprod47.3.441; van der Horst PH, 2012, MOL CELL ENDOCRINOL, V358, P176, DOI 10.1016/j.mce.2011.06.010; von Hayn K, 2010, AM J PHYSIOL-CELL PH, V298, pC324, DOI 10.1152/ajpcell.00197.2009; Yuan Wei, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS10, DOI 10.1186/1471-2393-7-S1-S10; Zhou XL, 1999, J CLIN ENDOCR METAB, V84, P3364, DOI 10.1210/jc.84.9.3364	44	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132017	10.1371/journal.pone.0132017	http://dx.doi.org/10.1371/journal.pone.0132017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161798	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300084
J	Ren, ZH; Xu, JL; Fan, TF; Ji, T; Wu, HJ; Zhang, CP				Ren, Zhen-Hu; Xu, Jian-Lin; Fan, Teng-Fei; Ji, Tong; Wu, Han-Jiang; Zhang, Chen-Ping			The Harmonic Scalpel versus Conventional Hemostasis for Neck Dissection: A Meta-Analysis of the Randomized Controlled Trials	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TOTAL THYROIDECTOMY; SURGICAL OUTCOMES; SURGERY; CANCER; ELECTROCAUTERY; COMPLICATIONS; EFFICACY; LIGASURE; HEAD	Objective Neck dissection is the most definitive and effective treatment for head and neck cancer. This systematic review aims to compare the efficacy and surgical outcomes of neck dissection between the harmonic scalpel and conventional surgical techniques and conduct a quantitative meta-analysis of the randomized trials. Methods Randomized controlled trials (RCTs) were identified from the major electronic databases (MEDLINE, EMBASE and Cochrane Library) using the keywords "harmonic scalpel" and "neck dissection," and a quantitative meta-analysis was conducted. The operative time and intraoperative bleeding were the primary outcome measures, and other parameters assessed included the drainage fluid volume and length of hospital stay. Results Seven trials that met the inclusion criteria included 406 neck dissection cases (201 in the harmonic scalpel group). Compared with conventional surgical techniques, the HS group had an operative time that was significantly reduced by 29.3 minutes [mean difference: -29.29; 95% CI = (-44.26, -14.32); P = 0.0001], a reduction in intraoperative bleeding by 141.1 milliliters [mean difference: -141.13; 95% CI = (-314.99, 32.73); P = 0.11], and a reduction in drainage fluid volume by 64.9 milliliters [mean difference: -64.86; 95% CI = (-110.40, -19.32); P = 0.005], but it is not significant after removal of studies driving heterogeneity. There was no significant difference in the length of the hospital stay [mean difference: -0.21; 95% CI = (-0.48, 0.07); P = 0.14]. Conclusion This systematic review showed that using the harmonic scalpel for neck dissection significantly reduces the operative time and drainage fluid volume and that it is not associated with an increased length of hospital stay or perioperative complications. Therefore, the harmonic scalpel method is safe and effective for neck dissection. However, the statistical heterogeneity was high. Further studies are required to substantiate our findings.	[Ren, Zhen-Hu; Ji, Tong; Zhang, Chen-Ping] Shanghai Jiao Tong Univ, Dept Oral & Maxillofacial & Head & Neck Oncol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Xu, Jian-Lin] Shanghai Jiao Tong Univ, Dept Resp Med, Shanghai Chest Hosp, Sch Med, Shanghai 200030, Peoples R China; [Fan, Teng-Fei] Wuhan Univ, Hosp Stomatol, Dept Oral & Maxillofacial Surg, Wuhan 430072, Peoples R China; [Wu, Han-Jiang] Cent S Univ, Xiangya Hosp 2, Dept Oral & Maxillofacial Surg, Changsha, Hunan, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Wuhan University; Central South University	Zhang, CP (corresponding author), Shanghai Jiao Tong Univ, Dept Oral & Maxillofacial & Head & Neck Oncol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China.	zhangcp9th@hotmail.com			National Cancer Institute (NCI) [RO1 CA 123223]; Ministry of Science and Technology (Taiwan) [MOST 103-2320-B-016-022]; Department of Defense (Taiwan) [MAB-104-026]; NIH/NCI [P30-CA051008]; NATIONAL CANCER INSTITUTE [P30CA051008, R01CA123223] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan); Department of Defense (Taiwan)(United States Department of Defense); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute (NCI) Grant RO1 CA 123223 (to M. Johnson and C.-Y. Lin), and Ministry of Science and Technology (Taiwan) Grant MOST 103-2320-B-016-022 (to J.-K. Wang) and Department of Defense (Taiwan) Grant MAB-104-026 (to J.-K. Wang). The authors acknowledge the assistance provided by the Microscopy and Imaging, Tissue Culture, and other Shared Resources within the Lombardi Comprehensive Cancer Center which are partially supported by NIH/NCI grant P30-CA051008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BuSaba NY, 2007, LARYNGOSCOPE, V117, P1756, DOI 10.1097/MLG.0b013e3180de4d85; Cordon C, 2005, SURGERY, V137, P337, DOI 10.1016/j.surg.2004.09.011; Dean A, 2014, J CRANIO MAXILL SURG, V42, P84, DOI 10.1016/j.jcms.2013.02.007; Deo S, 2005, PLAST RECONSTR SURG, V115, P1006, DOI 10.1097/01.PRS.0000154209.21728.51; Dirix P, 2010, EXPERT REV ANTICANC, V10, P1461, DOI [10.1586/era.10.110, 10.1586/ERA.10.110]; Ferri E, 2013, INT J SURG ONCOL, V2013, DOI 10.1155/2013/369345; Gadepalli C, 2010, J LARYNGOL OTOL, V124, P936, DOI 10.1017/S0022215110000101; GALL AM, 1977, CANCER-AM CANCER SOC, V39, P624, DOI 10.1002/1097-0142(197702)39:2<624::AID-CNCR2820390238>3.0.CO;2-7; Girod A, 2010, ORAL ONCOL, V46, P190, DOI 10.1016/j.oraloncology.2009.12.002; Jackson LL, 2005, LARYNGOSCOPE, V115, P1070, DOI 10.1097/01.MLG.0000163336.37077.8F; Koh YW, 2008, ANN SURG, V247, P945, DOI 10.1097/SLA.0b013e31816bcd61; Kwak HY, 2014, J SURG RES, V187, P484, DOI 10.1016/j.jss.2013.11.1093; Lang BHH, 2013, ANN SURG ONCOL, V20, P1918, DOI 10.1245/s10434-012-2849-6; Matthews B, 2008, ARCH SURG-CHICAGO, V143, P592, DOI 10.1001/archsurg.143.6.592; Miccoli P, 2009, OTOLARYNG HEAD NECK, V140, P61, DOI 10.1016/j.otohns.2008.10.003; Miccoli P, 2006, ARCH OTOLARYNGOL, V132, P1069, DOI 10.1001/archotol.132.10.1069; Ren ZH, 2015, J ORAL MAXIL SURG, V73, P534, DOI 10.1016/j.joms.2014.09.021; Salami A, 2008, J OTOLARYNGOL-HEAD N, V37, P633, DOI 10.2310/7070.2008.0080; Shin YS, 2013, LARYNGOSCOPE, V123, P904, DOI 10.1002/lary.23704; Voutilainen PE, 2000, ANN SURG, V231, P322, DOI 10.1097/00000658-200003000-00004; Walen SG, 2011, OTOLARYNG HEAD NECK, V144, P894, DOI 10.1177/0194599811403874; Yener O, 2014, INDIAN J SURG, V76, P66, DOI 10.1007/s12262-012-0627-0	22	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132476	10.1371/journal.pone.0132476	http://dx.doi.org/10.1371/journal.pone.0132476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161897	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300139
J	Sacilotto, N; Castillo, J; Riffo-Campos, AL; Flores, JM; Hibbitt, O; Wade-Martins, R; Lopez, C; Rodrigo, MI; Franco, L; Lopez-Rodas, G				Sacilotto, Natalia; Castillo, Josefa; Riffo-Campos, Angela L.; Flores, Juana M.; Hibbitt, Olivia; Wade-Martins, Richard; Lopez, Carlos; Isabel Rodrigo, M.; Franco, Luis; Lopez-Rodas, Gerardo			Growth Arrest Specific 1 (Gas1) Gene Overexpression in Liver Reduces the In Vivo Progression of Murine Hepatocellular Carcinoma and Partially Restores Gene Expression Levels	PLOS ONE			English	Article							INHIBITS TUMOR-GROWTH; VENTRAL SPINAL-CORD; HEDGEHOG; CANCER; CELLS; PROLIFERATION; SHH; METASTASIS; TRANSPORT; PATHWAY	The prognosis of hepatocellular carcinoma patients is usually poor, the size of tumors being a limiting factor for surgical treatments. Present results suggest that the overexpression of Gas1 (growth arrest specific 1) gene reduces the size, proliferating activity and malignancy of liver tumors. Mice developing diethylnitrosamine-induced hepatocellular carcinoma were subjected to hydrodynamic gene delivery to overexpress Gas1 in liver. This treatment significantly (p < 0.05) reduced the number of large tumors, while the difference in the total number of lesions was not significant. Moreover, the number of carcinoma foci in the liver and the number of lung metastases were reduced. These results are related with the finding that overexpression of Gas1 in Hepa 1-6 cells arrests cell cycle before S phase, with a significant (p < 0.01) and concomitant reduction in the expression of cyclin E2 gene. In addition, a triangular analysis of microarray data shows that Gas1 overexpression restores the transcription levels of 150 genes whose expression was affected in the diethylnitrosamine-induced tumors, thirteen of which are involved in the hedgehog signaling pathway. Since the in vivo Gas1 gene delivery to livers of mice carrying hepatocellular carcinoma reduces the size and proliferating activity of tumors, partially restoring the transcriptional profile of the liver, the present study opens promising insights towards a therapeutic approach for hepatocellular carcinoma.	[Sacilotto, Natalia; Castillo, Josefa; Riffo-Campos, Angela L.; Isabel Rodrigo, M.; Franco, Luis; Lopez-Rodas, Gerardo] Univ Valencia, Dept Biochem & Mol Biol, Valencia, Spain; [Castillo, Josefa; Riffo-Campos, Angela L.; Isabel Rodrigo, M.; Franco, Luis] Inst Hlth Res INCLIVA, Valencia, Spain; [Flores, Juana M.] Univ Complutense, Dept Med & Anim Surg, E-28040 Madrid, Spain; [Hibbitt, Olivia; Wade-Martins, Richard] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Lopez, Carlos] Univ Valencia, Dept Cell Biol, Valencia, Spain	University of Valencia; Complutense University of Madrid; University of Oxford; University of Valencia	Franco, L (corresponding author), Univ Valencia, Dept Biochem & Mol Biol, Valencia, Spain.	luis.franco@uv.es	Riffo-Campos, Angela L./AAX-8637-2021; LOPEZ-RODAS, GERARDO/I-1349-2015	Riffo-Campos, Angela L./0000-0001-6300-3338; Wade-Martins, Richard/0000-0001-6691-580X; LOPEZ-RODAS, GERARDO/0000-0001-8367-653X; Castillo Aliaga, Josefa/0000-0002-4092-0085; Franco, Luis/0000-0001-9610-6448	Consolider-Ingenio program (Ministerio de Educacion, Spain); Generalitat Valenciana; Prometeo (Generalitat Valenciana)	Consolider-Ingenio program (Ministerio de Educacion, Spain); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Prometeo (Generalitat Valenciana)(Center for Forestry Research & Experimentation (CIEF))	This work was supported by Consolider-Ingenio program (Ministerio de Educacion, Spain) to G.L-R (http://www.mecd.gob.es/educacion-mecd/ACOM2010/133); Generalitat Valenciana to G.L.-R (http://www.cece.gva.es/es/); Prometeo 2013/2014 (Generalitat Valenciana) to L.F. (http://www.cece.gva.es/es/).	Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Annenkov A, 2009, MOL NEUROBIOL, V40, P195, DOI 10.1007/s12035-009-8081-0; Avanesov A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002503; Ayrault O, 2010, CANCER RES, V70, P5618, DOI 10.1158/0008-5472.CAN-09-3740; Benitez JA, 2007, CANCER GENE THER, V14, P836, DOI 10.1038/sj.cgt.7701076; Bhoori S, 2010, TRANSPL INT, V23, P712, DOI 10.1111/j.1432-2277.2010.01111.x; Bolstad B.M, 2001, PROBE LEVEL QUANTILE; Cabrera JR, 2006, J BIOL CHEM, V281, P14330, DOI 10.1074/jbc.M509572200; Chaya T, 2014, EMBO J, V33, P1227, DOI 10.1002/embj.201488175; Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002; Chenna V, 2012, MOL CANCER THER, V11, P165, DOI 10.1158/1535-7163.MCT-11-0341; Das SK, 2015, J CELL PHYSIOL, V230, P259, DOI 10.1002/jcp.24791; DELSAL G, 1994, P NATL ACAD SCI USA, V91, P1848, DOI 10.1073/pnas.91.5.1848; DELSAL G, 1992, CELL, V70, P595, DOI 10.1016/0092-8674(92)90429-G; DELSAL G, 1995, MOL CELL BIOL, V15, P7152; Dentice M, 2005, NAT CELL BIOL, V7, P698, DOI 10.1038/ncb1272; Evdokiou A, 1998, EXP CELL RES, V240, P359, DOI 10.1006/excr.1998.4011; EVDOKIOU A, 1993, GENOMICS, V18, P731, DOI 10.1016/S0888-7543(05)80388-X; Fan LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046472; Fernandez C, 2010, DEV NEUROSCI-BASEL, V32, P59, DOI 10.1159/000274458; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Genethliou N, 2009, BIOCHEM BIOPH RES CO, V382, P69, DOI 10.1016/j.bbrc.2009.02.134; Ghanipour A, 2009, CANCER EPIDEM BIOMAR, V18, P2949, DOI 10.1158/1055-9965.EPI-09-0456; Gialmanidis IP, 2013, LUNG, V191, P511, DOI 10.1007/s00408-013-9490-4; Gobeil S, 2008, GENE DEV, V22, P2932, DOI 10.1101/gad.1714608; Grossi M, 1998, ONCOGENE, V17, P1629, DOI 10.1038/sj.onc.1202090; Hager-Theodorides AL, 2009, J IMMUNOL, V183, P3023, DOI 10.4049/jimmunol.0900152; Izzi L, 2011, DEV CELL, V20, P788, DOI 10.1016/j.devcel.2011.04.017; Jiang Z, 2011, HUM PATHOL, V42, P361, DOI 10.1016/j.humpath.2010.03.009; Jimenez A, 2014, EXP CELL RES, V327, P307, DOI 10.1016/j.yexcr.2014.06.016; Justilien V, 2015, CLIN CANCER RES, V21, P505, DOI 10.1158/1078-0432.CCR-14-0507; Kawakubo T, 2007, CANCER RES, V67, P10869, DOI 10.1158/0008-5472.CAN-07-2048; KYRIAZIS AP, 1974, CANCER RES, V34, P2881; Lapouge G, 2005, CELL MOL LIFE SCI, V62, P53, DOI 10.1007/s00018-004-4329-z; Lee CS, 2001, P NATL ACAD SCI USA, V98, P11347, DOI 10.1073/pnas.201418298; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu JH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003884; Madhala-Levy D, 2012, J CELL PHYSIOL, V227, P1455, DOI 10.1002/jcp.22861; Moon H, 2014, P NATL ACAD SCI USA, V111, P8541, DOI 10.1073/pnas.1323161111; Ng RCL, 2014, CELL DEATH DIFFER, V21, P978, DOI 10.1038/cdd.2014.20; Nguyen AT, 2008, J SURG RES, V148, P60, DOI 10.1016/j.jss.2008.02.016; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Oishi N, 2014, LIVER CANCER, V3, P71, DOI 10.1159/000343863; Omenetti A, 2011, J HEPATOL, V54, P366, DOI 10.1016/j.jhep.2010.10.003; Pfaffl MW., 2004, REAL TIME PCR, P63; Pollard KS, 2005, STAT BIOL HEALTH, P249; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rizzi F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003617; Sala M, 2004, HEPATOLOGY, V40, P1352, DOI 10.1002/hep.20465; Sanchez-Arrones L, 2012, INT J BIOCHEM CELL B, V44, P698, DOI 10.1016/j.biocel.2012.01.019; Sanchez-Hernandez D, 2012, DEVELOPMENT, V139, P3849, DOI 10.1242/dev.080028; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Sebestyen MG, 2006, J GENE MED, V8, P852, DOI 10.1002/jgm.921; Stebel M, 2000, FEBS LETT, V481, P152, DOI 10.1016/S0014-5793(00)02004-4; Touahri Y, 2012, J NEUROSCI, V32, P18018, DOI 10.1523/JNEUROSCI.3553-12.2012; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van Roeyen CRC, 2013, KIDNEY INT, V83, P251, DOI 10.1038/ki.2012.400; Varas A, 2008, J LEUKOCYTE BIOL, V83, P1476, DOI 10.1189/jlb.1107792; VARNER JA, 1995, MOL BIOL CELL, V6, P725, DOI 10.1091/mbc.6.6.725; VESSELINOVITCH SD, 1983, CANCER RES, V43, P4253; Wang HH, 2012, FEBS J, V279, P3652, DOI 10.1111/j.1742-4658.2012.08726.x; Witt RM, 2013, J BIOL CHEM, V288, P26275, DOI 10.1074/jbc.M112.438937; Xu CR, 2009, MOL CANCER RES, V7, P1937, DOI 10.1158/1541-7786.MCR-09-0333; Zamorano A, 2004, NEUROBIOL DIS, V15, P483, DOI 10.1016/j.nbd.2003.11.022; Zamorano A, 2003, J NEUROSCI RES, V71, P256, DOI 10.1002/jnr.10461; Zarco N, 2012, APOPTOSIS, V17, P627, DOI 10.1007/s10495-011-0696-8	68	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132477	10.1371/journal.pone.0132477	http://dx.doi.org/10.1371/journal.pone.0132477			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161998	Green Submitted, gold, Green Published			2022-12-27	WOS:000358162300140
J	Thedja, MD; Muljono, DH; Ie, SI; Sidarta, E; Turyadi; Verhoef, J; Marzuki, S				Thedja, Meta Dewi; Muljono, David Handojo; Ie, Susan Irawati; Sidarta, Erick; Turyadi; Verhoef, Jan; Marzuki, Sangkot			Genogeography and Immune Epitope Characteristics of Hepatitis B Virus Genotype C Reveals Two Distinct Types: Asian and Papua-Pacific	PLOS ONE			English	Article							T-CELL EPITOPE; SURFACE-ANTIGEN; GENETIC DIVERSITY; PHYLOGENETIC RELATEDNESS; NUCLEOTIDE-SEQUENCE; BLOOD-DONORS; CORE GENE; SUBGENOTYPES; DISEASE; IDENTIFICATION	Distribution of hepatitis B virus (HBV) genotypes/subgenotypes is geographically and ethnologically specific. In the Indonesian archipelago, HBV genotype C (HBV/C) is prevalent with high genome variability, reflected by the presence of 13 of currently existing 16 subgenotypes. We investigated the association between HBV/C molecular characteristics with host ethnicity and geographical distribution by examining various subgenotypes of HBV/C isolates from the Asia and Pacific region, with further analysis on the immune epitope characteristics of the core and surface proteins. Phylogenetic tree was constructed based on complete HBV/C genome sequences from Asia and Pacific region, and genetic distance between isolates was also examined. HBV/C surface and core immune epitopes were analyzed and grouped by comparing the amino acid residue characteristics and geographical origins. Based on phylogenetic tree and geographical origins of isolates, two major groups of HBV/C isolates-East-Southeast Asia and Papua-Pacific-were identified. Analysis of core and surface immune epitopes supported these findings with several amino acid substitutions distinguishing the East-Southeast Asia isolates from the Papua-Pacific isolates. A west-to-east gradient of HBsAg subtype distribution was observed with adrq+ prominent in the East and Southeast Asia and adrq-in the Pacific, with several adrq-indeterminate subtypes observed in Papua and Papua New Guinea (PNG). This study indicates that HBV/C isolates can be classified into two types, the Asian and the Papua-Pacific, based on the virus genome diversity, immune epitope characteristics, and geographical distribution, with Papua and PNG as the molecular evolutionary admixture region in the switching from adrq+ to adrq-.	[Thedja, Meta Dewi; Muljono, David Handojo; Ie, Susan Irawati; Sidarta, Erick; Turyadi; Marzuki, Sangkot] Eijkman Inst Mol Biol, Jakarta, Indonesia; [Thedja, Meta Dewi; Verhoef, Jan] Univ Med Ctr UMC Utrecht, Eijkman Winkler Inst, Utrecht, Netherlands; [Muljono, David Handojo] Hasanuddin Univ, Fac Med, Makassar, Indonesia; [Muljono, David Handojo] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Marzuki, Sangkot] Monash Univ, Monash Med Ctr, Dept Med, Clayton, Vic, Australia	Eijkman Institute; Universitas Hasanuddin; University of Sydney; Monash University	Muljono, DH (corresponding author), Eijkman Inst Mol Biol, Jakarta, Indonesia.	davidhm@eijkman.go.id	Muljono, David Handojo/AAR-6270-2021; Muljono, David Handojo/H-5477-2019	Muljono, David Handojo/0000-0002-5542-106X; Ie, Susan Irawati/0000-0001-8469-932X; , Turyadi/0000-0002-1388-4920; Thedja, Meta Dewi/0000-0002-2948-4905				Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; BELLWOOD P, 1997, PREHISTORY INDOMALAY, P96; BERTOLETTI A, 1994, J EXP MED, V180, P933, DOI 10.1084/jem.180.3.933; Bertoletti A, 1997, HEPATOLOGY, V26, P1027, DOI 10.1002/hep.510260435; Carman WF, 1997, J INFECT DIS, V175, P1093, DOI 10.1086/516447; Carman WF, 2005, VIRAL HEPATITIS, 3RD EDITION, P225, DOI 10.1002/9780470987131.ch14; Cavinta L, 2009, J MED VIROL, V81, P983, DOI 10.1002/jmv.21475; Chan HLY, 2005, J INFECT DIS, V191, P2022, DOI 10.1086/430324; Chisari FV, 2000, AM J PATHOL, V156, P1117, DOI 10.1016/S0002-9440(10)64980-2; COUROUCEPAUTY AM, 1978, VOX SANG, V35, P304, DOI 10.1111/j.1423-0410.1978.tb02939.x; Deka R, 2001, GENETIC LINGUISTIC A, P135; EHATA T, 1992, J CLIN INVEST, V89, P332, DOI 10.1172/JCI115581; EHATA T, 1991, J GASTROEN HEPATOL, V6, P292, DOI 10.1111/j.1440-1746.1991.tb01481.x; FERRARI C, 1991, J CLIN INVEST, V88, P214, DOI 10.1172/JCI115280; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Huy TTT, 2008, VIRUS GENES, V36, P299, DOI 10.1007/s11262-008-0205-5; Huy TTT, 2004, J GEN VIROL, V85, P283, DOI 10.1099/vir.0.19633-0; Jazayeri M, 2004, J VIRAL HEPATITIS, V11, P488, DOI 10.1111/j.1365-2893.2004.00534.x; Jazayeri MS, 2004, J HEPATOL, V41, P139, DOI 10.1016/j.jhep.2004.03.025; Jazayeri SM, 2005, HEPAT MON, V5, P133; Kao JH, 2000, GASTROENTEROLOGY, V118, P554, DOI 10.1016/S0016-5085(00)70261-7; Kim HJ, 2007, LIVER INT, V27, P633, DOI 10.1111/j.1478-3231.2007.01481.x; Kramvis A, 2014, INTERVIROLOGY, V57, P141, DOI 10.1159/000360947; Kurbanov F, 2010, HEPATOL RES, V40, P14, DOI 10.1111/j.1872-034X.2009.00601.x; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Liu CJ, 2013, SEMIN LIVER DIS, V33, P97, DOI 10.1055/s-0033-1345716; Lusida MI, 2008, J CLIN MICROBIOL, V46, P2160, DOI 10.1128/JCM.01681-07; Marzuki S, 2003, ADV EXP MED BIOL, P5313; MCMAHON G, 1992, HEPATOLOGY, V15, P757, DOI 10.1002/hep.1840150503; Min WP, 1996, HUM IMMUNOL, V46, P93, DOI 10.1016/0198-8859(96)00009-2; Mohamadkhani A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-209; Mulyanto, 2012, VIRUS RES, V163, P129, DOI 10.1016/j.virusres.2011.09.002; Mulyanto, 2011, J MED VIROL, V83, P54, DOI 10.1002/jmv.21931; Mulyanto, 2010, ARCH VIROL, V155, P705, DOI 10.1007/s00705-010-0628-x; Mulyanto, 1997, ARCH VIROL, V142, P2121, DOI 10.1007/s007050050230; Mulyanto, 2009, ARCH VIROL, V154, P1047, DOI 10.1007/s00705-009-0406-9; NAYERSINA R, 1993, J IMMUNOL, V150, P4659; NORDER H, 1992, J GEN VIROL, V73, P3141, DOI 10.1099/0022-1317-73-12-3141; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; NORDER H, 1994, VIROLOGY, V198, P489, DOI 10.1006/viro.1994.1060; Nurainy N, 2008, ARCH VIROL, V153, P1057, DOI 10.1007/s00705-008-0092-z; OKAMOTO H, 1987, J VIROL, V61, P3030, DOI 10.1128/JVI.61.10.3030-3034.1987; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Okamoto H, 1992, NONB NONC NONG HEPAT; Orito E, 2001, HEPATOLOGY, V33, P218, DOI 10.1053/jhep.2001.20532; Pairan A, 2009, J VIROL, V83, P11616, DOI 10.1128/JVI.01178-09; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakamoto T, 2006, J GEN VIROL, V87, P1873, DOI 10.1099/vir.0.81714-0; SASTROSOEWIGNJO RI, 1991, J GASTROEN HEPATOL, V6, P491, DOI 10.1111/j.1440-1746.1991.tb00894.x; Sugauchi F, 2001, J GEN VIROL, V82, P883, DOI 10.1099/0022-1317-82-4-883; Tai PC, 1997, J VIROL, V71, P4852, DOI 10.1128/JVI.71.6.4852-4856.1997; Tan AT, 2008, J VIROL, V82, P10986, DOI 10.1128/JVI.01124-08; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Thedja MD, 2010, HEPATOL INT, V4, P608, DOI 10.1007/s12072-010-9203-5; Thedja MD, 2011, ARCH VIROL, V156, P855, DOI 10.1007/s00705-011-0926-y; Thursz M, 2011, SEMIN LIVER DIS, V31, P115, DOI 10.1055/s-0031-1276642; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; Tryon D. T., 1995, AUSTRONESIANS HIST C, P17; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Zeng G, 2005, J VIRAL HEPATITIS, V12, P609, DOI 10.1111/j.1365-2893.2005.00657.x	61	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132533	10.1371/journal.pone.0132533	http://dx.doi.org/10.1371/journal.pone.0132533			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162099	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300147
J	Zhang, Y; Cao, QS; Rubenstein, DI; Zang, S; Songer, M; Leimgruber, P; Chu, HJ; Cao, J; Li, K; Hu, DF				Zhang, Yongjun; Cao, Qing S.; Rubenstein, Daniel I.; Zang, Sen; Songer, Melissa; Leimgruber, Peter; Chu, Hongjun; Cao, Jie; Li, Kai; Hu, Defu			Water Use Patterns of Sympatric Przewalski's Horse and Khulan: Interspecific Comparison Reveals Niche Differences	PLOS ONE			English	Article							SOCIAL-ORGANIZATION; POPULATION; ECOLOGY; TAKHI	Acquiring water is essential for all animals, but doing so is most challenging for desert-living animals. Recently Przewalski's horse has been reintroduced to the desert area in China where the last wild surviving member of the species was seen before it vanished from China in the 1960s. Its reintroduction placed it within the range of a close evolutionary relative, the con-generic Khulan. Determining whether or not these two species experience competition and whether or not such competition was responsible for the extinction of Przewalski's horses in the wild over 50 years ago, requires identifying the fundamental and realized niches of both species. We remotely monitored the presence of both species at a variety of water points during the dry season in Kalamaili Nature Reserve, Xinjiang, China. Przewalski's horses drank twice per day mostly during daylight hours at low salinity water sources while Khulans drank mostly at night usually at high salinity water points or those far from human residences. Spatial and temporal differences in water use enables coexistence, but suggest that Przewalski's horses also restrict the actions of Khulan. Such differences in both the fundamental and realized niches were associated with differences in physiological tolerances for saline water and human activity as well as differences in aggression and dominance.	[Zhang, Yongjun; Zang, Sen; Chu, Hongjun; Li, Kai; Hu, Defu] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Cao, Qing S.; Rubenstein, Daniel I.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Cao, Qing S.; Songer, Melissa; Leimgruber, Peter] Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Chu, Hongjun] Altai Forestry Bur, Altai, Xinjiang, Peoples R China; [Cao, Jie] Xinjiang Forestry Dept, Wild Horse Breeding Ctr, Urumqi, Xinjiang, Peoples R China	Beijing Forestry University; Princeton University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Hu, DF (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	hudf@bjfu.edu.cn	Leimgruber, Peter/O-1304-2015	Leimgruber, Peter/0000-0002-3682-0153; Songer, Melissa/0000-0001-5536-6315	National Natural Science Foundation of China [30970545]; National Science Foundation [NSF-IIS-0705311]; Association of Zoos and Aquarium's Conservation Endowment Fund [11-1059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); Association of Zoos and Aquarium's Conservation Endowment Fund	National Natural Science Foundation of China (Grant No. 30970545); National Science Foundation (NSF-IIS-0705311); Association of Zoos and Aquarium's Conservation Endowment Fund (Grant No. 11-1059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban B, BOOK OF HAN ANNALS O, P111; Bartholomew G. A., 1968, P395; Berger J, 1986, WILD HORSES OF THE G; Bi J, 2007, STUDY STATUS ASIATIC; Bridges AS, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P57, DOI 10.1007/978-4-431-99495-4_5; Cain JW, 2006, WILDLIFE SOC B, V34, P570, DOI 10.2193/0091-7648(2006)34[570:MOTAWB]2.0.CO;2; Chen J, 2008, CHINA FISHERIES, P17; Chu G, 1985, CURRENT ZOOLOGY, V31, P173; Chu H, 2008, DIETS POPULATIONS AN; Chu H.J., 2009, BIODIVERS SCI, V17, P414; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; Cowles R. B., 1944, IGUANA, V83, P53; DELTHOMPSON V, 1989, ZOO BIOL, V8, P275, DOI 10.1002/zoo.1430080308; Deng Tao, 1999, Acta Theriologica Sinica, V19, P10; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Feh C., 2002, P62; Fryxell J, 2008, AFRICAN JOURNAL OF E, V26, P17; Gao X.Y., 2000, CHIN BIODIVERS, V8, P81; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; IUCN, 2004, IUCN RED LIST OF THR; JARMAN P J, 1977, Zoologica Africana, V12, P101; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Jinliang Chen, 2008, Journal of Equine Science, V19, P1, DOI 10.1294/jes.19.1; Jones M, 2001, ECOLOGY, V82, P2164, DOI 10.1890/0012-9658(2001)082[2164:COTPSM]2.0.CO;2; Kaczensky P, 2008, J APPL ECOL, V45, P1762, DOI 10.1111/j.1365-2664.2008.01565.x; King SRB, 2005, BIOL CONSERV, V124, P277, DOI 10.1016/j.biocon.2005.01.034; KLEIMAN DG, 1989, BIOSCIENCE, V39, P152, DOI 10.2307/1311025; LATTIMORE O, 1973, GEOGR J, V139, P233, DOI 10.2307/1796091; LEIMGRUBER P, 1994, J WILDLIFE MANAGE, V58, P254, DOI 10.2307/3809388; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; Macfarlane W, 1970, PHYSL DIGESTION META, P362; MBASSA GK, 1988, VET RES COMMUN, V12, P1, DOI 10.1007/BF00396399; Noy-Mein I., 1974, Annual Rev Ecol Syst, V5, P195, DOI 10.1146/annurev.es.05.110174.001211; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Paklina N., 1989, PRZEWALSKI HORSE, V24, P30; PARKER GA, 1981, ANIM BEHAV, V29, P221, DOI 10.1016/S0003-3472(81)80170-4; R Core Team, 2012, R A LANGUAGE AND ENV; Rubenstein D.I., 1986, P282; Rubenstein D.I., 2011, HDB MAMMALS WORLD, V2, P106; Rubenstein D.I., 1994, ANIMAL SOC INDIVIDUA, P13; RUBENSTEIN DI, 1989, J ARID ENVIRON, V17, P145, DOI 10.1016/S0140-1963(18)30901-7; Schmidt-Nielsen Knut, 1965, DESERT ANIMALS PHYSI; Shah N, 1993, RESEARCH PROJECT REP; Shannon G, 2008, J MAMMAL, V89, P467, DOI 10.1644/07-MAMM-A-132R.1; Stanley M.E., 1984, Zoo Biology, V3, P89, DOI 10.1002/zoo.1430030202; TAYLOR CR, 1969, SCI AM, V220, P89, DOI 10.1038/scientificamerican0169-88; VanDierendonck MC, 1996, CONSERV BIOL, V10, P728, DOI 10.1046/j.1523-1739.1996.10030728.x; vanSchaik CP, 1996, BIOTROPICA, V28, P105, DOI 10.2307/2388775; Wakefield Simon, 2002, P82; Xu WX, 2012, ITAL J ZOOL, V79, P92, DOI 10.1080/11250003.2011.620635; Yu X, 1981, CHINA NATURE, P91	53	20	21	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132094	10.1371/journal.pone.0132094	http://dx.doi.org/10.1371/journal.pone.0132094			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161909	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300091
J	Doubravsky, K; Dohnal, M				Doubravsky, Karel; Dohnal, Mirko			Reconciliation of Decision-Making Heuristics Based on Decision Trees Topologies and Incomplete Fuzzy Probabilities Sets	PLOS ONE			English	Article							UNCERTAINTY; EXTREMALITY; INFORMATION; SYSTEM; MODEL	Complex decision making tasks of different natures, e.g. economics, safety engineering, ecology and biology, are based on vague, sparse, partially inconsistent and subjective knowledge. Moreover, decision making economists / engineers are usually not willing to invest too much time into study of complex formal theories. They require such decisions which can be (re) checked by human like common sense reasoning. One important problem related to realistic decision making tasks are incomplete data sets required by the chosen decision making algorithm. This paper presents a relatively simple algorithm how some missing III (input information items) can be generated using mainly decision tree topologies and integrated into incomplete data sets. The algorithm is based on an easy to understand heuristics, e.g. a longer decision tree sub-path is less probable. This heuristic can solve decision problems under total ignorance, i.e. the decision tree topology is the only information available. But in a practice, isolated information items e.g. some vaguely known probabilities (e.g. fuzzy probabilities) are usually available. It means that a realistic problem is analysed under partial ignorance. The proposed algorithm reconciles topology related heuristics and additional fuzzy sets using fuzzy linear programming. The case study, represented by a tree with six lotteries and one fuzzy probability, is presented in details.	[Doubravsky, Karel] Brno Univ Technol, Fac Business & Management, Dept Informat, CS-61090 Brno, Czech Republic; [Dohnal, Mirko] Brno Univ Technol, Fac Business & Management, Dept Econ, CS-61090 Brno, Czech Republic	Brno University of Technology; Brno University of Technology	Doubravsky, K (corresponding author), Brno Univ Technol, Fac Business & Management, Dept Informat, CS-61090 Brno, Czech Republic.	doubravsky@fbm.vutbr.cz	Doubravský, Karel/GLR-2336-2022; Dohnal, Mirko/E-5778-2016	Doubravský, Karel/0000-0002-6882-1046; Dohnal, Mirko/0000-0001-9307-9528	"Economic Determinants of Competitiveness of Enterprises in Central and Eastern Europe" from Internal Grant Agency at Brno University of Technology [FP-S-15-2825]; "Effective Use of ICT and Quantitative Methods for Business Processes Optimization" from Internal Grant Agency at Brno University of Technology [FP-S-15-2787]; Internal Grant Agency at Brno University of Technology [FP-S-13-2148, FP-S-13-2052]	"Economic Determinants of Competitiveness of Enterprises in Central and Eastern Europe" from Internal Grant Agency at Brno University of Technology; "Effective Use of ICT and Quantitative Methods for Business Processes Optimization" from Internal Grant Agency at Brno University of Technology; Internal Grant Agency at Brno University of Technology	This paper was supported by grants FP-S-15-2825 "Economic Determinants of Competitiveness of Enterprises in Central and Eastern Europe" and FP-S-15-2787 "Effective Use of ICT and Quantitative Methods for Business Processes Optimization" from the Internal Grant Agency at Brno University of Technology." Support was also received from the Internal Grant Agency at Brno University of Technology Grant number: FP-S-13-2148 'The Application of ICT and Mathematical Methods in Business Management' Grant Recipient: Institute of Informatics, Faculty of Business and Management Resposnibility: Doc. RNDr. Bedrich Puze, CSc. Additional support was provided by the Internal Grant Agency at Brno University of Technology Grant number: FP-S-13-2052 'Microeconomic and macroeconomic principles and their impact on corporate behaviour Grant Recipient: Institute of Economics, Faculty of Business and Management Resposnibility: prof. Ing. Oldrich Rejnus, CSc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhaj-Dibo M, 2008, CONTROL ENG PRACT, V16, P159, DOI 10.1016/j.conengprac.2007.01.003; Basgalupp MP, 2014, INFORM SCIENCES, V258, P160, DOI 10.1016/j.ins.2013.07.025; Bertsekas Dimitri P., 2008, INTRO PROBABILITY; Bradshaw M, 2004, SSRN WORKING PAPER S, DOI [10.2139/ssrn.256438, DOI 10.2139/SSRN.256438]; Brooke A, 1988, GAMS USERS GUIDE, V821, P505; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Daniel K, 2002, J MONETARY ECON, V49, P139, DOI 10.1016/S0304-3932(01)00091-5; Dehmer M, 2013, MATCH-COMMUN MATH CO, V69, P785; Dehmer M, 2012, MATCH-COMMUN MATH CO, V68, P889; DOHNAL M, 1992, J LOSS PREVENT PROC, V5, P125, DOI 10.1016/0950-4230(92)80009-W; Dondi R, 2014, J DISCRET ALGORITHMS, V25, P51, DOI 10.1016/j.jda.2013.06.001; Dubois D, 2013, P 8 C EUR SOC FUZZ L; Dubois D, 2014, INT J APPROX REASON, V55, P1570, DOI 10.1016/j.ijar.2014.04.002; Eaton JW, 2009, GNU OCTAVE VERS 3 0; Fargier H., 2012, ARXIV12023718; FEDRIZZI M, 1991, LECT NOTES ECON MATH, V368, P15; Fitch Ernest C., 2004, HYDRAULIC COMPONENT; Guu SM, 1999, FUZZY SET SYST, V107, P191, DOI 10.1016/S0165-0114(97)00304-7; Hodouin D, 2011, J PROCESS CONTR, V21, P211, DOI 10.1016/j.jprocont.2010.10.016; HUANG GH, 1993, INT J SYST SCI, V24, P159, DOI 10.1080/00207729308949477; Janssens D, 2006, EUR J OPER RES, V175, P16, DOI 10.1016/j.ejor.2005.03.022; Jegadeesh N, 2004, J FINANC, V59, P1083, DOI 10.1111/j.1540-6261.2004.00657.x; Jung JJ, 2012, EXPERT SYST APPL, V39, P9002, DOI 10.1016/j.eswa.2012.02.035; Kashkoush M, 2013, PROC CIRP, V7, P169, DOI 10.1016/j.procir.2013.05.029; Kikuchi S, 2000, FUZZY SET SYST, V116, P3, DOI 10.1016/S0165-0114(99)00033-0; Kim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113131; Kraus V, 2013, MATCH-COMMUN MATH CO, V70, P885; Kuzilek J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098450; KYBURG HE, 1987, ARTIF INTELL, V31, P271, DOI 10.1016/0004-3702(87)90068-3; Lai Y.-J., 1992, FUZZY MATH PROGRAMMI; Lee YC, 2011, EXPERT SYST APPL, V38, P14407, DOI 10.1016/j.eswa.2011.04.088; Maroney C.O, 2008, BR ACCOUNT REV, V40, P103, DOI [10.1016/j.bar.2008.01.001, DOI 10.1016/J.BAR.2008.01.001]; Monekosso DN, 2013, EXPERT SYST APPL, V40, P3248, DOI 10.1016/j.eswa.2012.12.037; Mousavi S, 2014, J BUS RES, V67, P1671, DOI 10.1016/j.jbusres.2014.02.013; Narasimhan S, 1999, DATA RECONCILIATION; Nie GL, 2009, EXPERT SYST APPL, V36, P4589, DOI 10.1016/j.eswa.2008.05.014; PARSONS S, 1995, ENVIRON SOFTW, V10, P75, DOI 10.1016/0266-9838(95)00008-9; Pedrycz W, 2014, KNOWL-BASED SYST, V58, P3, DOI 10.1016/j.knosys.2013.07.022; Qin GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111769; Rokach L, 2013, WORLD SCI, V328; Rose L. M., 1976, ENG INVESTMENT DECIS; Rutkowski L, 2014, INFORM SCIENCES, V266, P1, DOI 10.1016/j.ins.2013.12.060; Sais F, 2014, KNOWL-BASED SYST, V67, P117, DOI 10.1016/j.knosys.2014.05.023; Schallehn E, 2004, DATA KNOWL ENG, V48, P361, DOI 10.1016/j.datak.2003.08.004; Stiglic G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033812; Sundar S, 2013, APPL SOFT COMPUT, V13, P4695, DOI 10.1016/j.asoc.2013.07.014; Tan RR, 2007, J CLEAN PROD, V15, P944, DOI 10.1016/j.jclepro.2005.09.001; TANAKA H, 1984, FUZZY SET SYST, V13, P1, DOI 10.1016/0165-0114(84)90022-8; Thipwiwatpotjana P, 2014, FUZZY OPTIM DECIS MA, V13, P151, DOI 10.1007/s10700-013-9171-z; Ubando AT, 2014, CLEAN TECHNOL ENVIR, V16, P1537, DOI 10.1007/s10098-014-0721-z; Vandaele N, 2012, P 6 INT C MAN INN TE, DOI [10.1109/ICMIT.2012.6225779, DOI 10.1109/ICMIT.2012.6225779]; Vasebi A, 2012, ANNU REV CONTROL, V36, P235, DOI 10.1016/j.arcontrol.2012.09.005; Vats S, 2014, APPL SOFT COMPUT, V21, P444, DOI 10.1016/j.asoc.2014.04.006; Wang P, 2004, ARTIF INTELL, V158, P97, DOI 10.1016/j.artint.2003.09.003; WATSON SR, 1994, RELIAB ENG SYST SAFE, V45, P261, DOI 10.1016/0951-8320(94)90142-2; Xia CY, 2009, INT J MOD PHYS B, V23, P2203, DOI 10.1142/S021797920905211X; Xia CY, 2012, NONLINEAR DYNAM, V69, P927, DOI 10.1007/s11071-011-0313-y; Yuan WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091012; Zeinalkhani M, 2014, INFORM SCIENCES, V278, P715, DOI 10.1016/j.ins.2014.03.087; Zhang ZJ, 2010, COMPUT CHEM ENG, V34, P154, DOI 10.1016/j.compchemeng.2009.09.007	60	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131590	10.1371/journal.pone.0131590	http://dx.doi.org/10.1371/journal.pone.0131590			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EW	26158662	Green Published, gold			2022-12-27	WOS:000358161200032
J	Li, MY; Fang, QY; Li, JZ; Zheng, X; Tao, J; Yan, XH; Lin, Q; Lan, XL; Chen, B; Zheng, GH; Chen, LD				Li, Moyi; Fang, Qianying; Li, Junzhe; Zheng, Xin; Tao, Jing; Yan, Xinghui; Lin, Qiu; Lan, Xiulu; Chen, Bai; Zheng, Guohua; Chen, Lidian			The Effect of Chinese Traditional Exercise-Baduanjin on Physical and Psychological Well-Being of College Students: A Randomized Controlled Trial	PLOS ONE			English	Article							METABOLIC SYNDROME; MENTAL-HEALTH; US; DISTRESS; QUALITY; FITNESS	Background The physical and mental health of college students tends to continuously decline around the world, therefore, it is important to improve their health during college period. Baduanjin, a traditional Chinese exercise which combines movements with breath and mind, may be one of the selectable effective exercises. However, the effect of Baduanjin exercise on college students has not been established. In this study, we systematically assessed the effectiveness and safety of Baduanjin exercise on physical and mental health of college students by a rigorous randomized, parallel-controlled design. Methods A total of 222 college students from Fujian University of Traditional Chinese Medicine were recruited and randomly allocated at an equal ratio into control or Baduanjin training. Participants in control group were informed to maintain their original activity habit, and those in Baduanjin exercise group received a 12-week Baduanjin exercise training with a frequency of 1 hour per day and 5 days per week on the basis of their original activity habit. The physical and psychological outcomes, including lumbar muscle strength, lower limb proprioception function, physical fitness, as well as self-reported symptom intensity, stress, self-esteem, mood, quality of life, quality of sleep, and adverse events, were evaluated at baseline, 13 weeks (at the end of 12-week intervention), and 25 weeks (after the 12-week follow-up period). Intention-to-treat analysis was performed for the above outcomes. Results Compared with controls, significant improvements in Baduanjin exercise group at the end of 12-week intervention period were found on lower limb proprioception function (the rate of average trace error on right lower limb (%): control 23.50 +/- 5.50, Baduanjin 21.92 +/- 6.54, P=0.004; the rate of average trace error on left lower limb (%): control 22.32 +/- 6.62, Baduanjin 20.63 +/- 4.62, P=0.046), cardiorespiratory endurance (step test index: control 47.66 +/- 5.94, Baduanjin 50.07 +/- 9.30, P=0.025), flexibility (control 14.35 +/- 7.26cm, Baduanjin 15.39 +/- 6.43cm, P=0.009) and explosive force of lower limb (standing long jump test (m): control 1.77 +/- 0.24, Baduanjin 1.79 +/- 0.22, P=0.005 for adjustment baseline) in physical outcomes, and attention (Schulte Grid test (second): control 210.4 +/- 51.15, Baduanjin 192.4 +/- 47.14, P=0.034) in mental outcome. Lumbar muscle strength in Baduanjin group had been moderately enhanced but no significant difference compared to controls. No significant changes in other physical and mental outcomes, including vital capacity, blood pressure, heart rate, hand grip force, self-symptom intensity, stress, self-efficacy, quality of life, and quality of sleep, were found between groups. No adverse event was reported during the study period. Conclusion Regular Baduanjin exercise had an advantage for college students on improvement of lower limb proprioception, enhance of cardiorespiratory endurance, flexibility, explosive force of lower limb and attention, compared with usual exercise.	[Li, Moyi; Fang, Qianying; Li, Junzhe; Zheng, Xin; Tao, Jing; Lan, Xiulu; Chen, Bai; Zheng, Guohua] Fujian Univ Tradit Chinese Med, Coll Rehabil Med, Fuzhou, Fujian, Peoples R China; [Yan, Xinghui; Lin, Qiu] Fujian Univ Tradit Chinese Med, Dept Phys Educ, Fuzhou, Fujian, Peoples R China; [Chen, Lidian] Fujian Univ Tradit Chinese Med, Fuzhou, Fujian, Peoples R China	Fujian University of Traditional Chinese Medicine; Fujian University of Traditional Chinese Medicine; Fujian University of Traditional Chinese Medicine	Zheng, GH (corresponding author), Fujian Univ Tradit Chinese Med, Coll Rehabil Med, Fuzhou, Fujian, Peoples R China.	zhgh_1969@aliyun.com; lidianchen87@163.com	, Jaaing/ABA-4467-2020	Tao, Jing/0000-0001-9751-5294; Chen, Lidian/0000-0002-6454-7932	Rehabilitation Technology of Collaborative Innovation Center, FJTCM [X2012002-Collaboration]; Special Scientific Research Fund of Public Welfare Profession of China [201307004]; Ministry of Science and Technology; Ministry of Finance of the People's Republic of China	Rehabilitation Technology of Collaborative Innovation Center, FJTCM; Special Scientific Research Fund of Public Welfare Profession of China; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Finance of the People's Republic of China	This study is funded by the Rehabilitation Technology of Collaborative Innovation Center, FJTCM (Grant No. X2012002-Collaboration), the Special Scientific Research Fund of Public Welfare Profession of China (Grant No. 201307004), Ministry of Science and Technology (http://www.most.gov.cn) and Ministry of Finance of the People's Republic of China (http://www.mof.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College Health Association. American College Health Association National College Health Assessment (ACHA-NCHA), 2006, J AM COLL HEALTH, V55, P5; An BC, 2013, CHIN J INTEGR MED, V19, P143, DOI 10.1007/s11655-012-1211-y; [Anonymous], 2002, NAT COLL HLTH ASS WE; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Chen HH, 2006, AM J CHINESE MED, V34, P741, DOI 10.1142/S0192415X06004259; Chen MC, 2012, INT J NURS STUD, V49, P265, DOI 10.1016/j.ijnurstu.2011.09.009; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Fox KR, 1999, PUBLIC HEALTH NUTR, V2, P411, DOI 10.1017/S1368980099000567; Geng YuanQing, 2008, China Journal of Traditional Chinese Medicine and Pharmacy, V23, P348; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Ha CH, 2012, IRAN J PUBLIC HEALTH, V41, P20; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Health Qigong Management Center of General Administration of Sport of China, 2003, HLTH QIG BAD; Hsu MC, 2008, AM J CHINESE MED, V36, P815, DOI 10.1142/S0192415X08006260; Hunt J, 2010, J ADOLESCENT HEALTH, V46, P3, DOI 10.1016/j.jadohealth.2009.08.008; Jiang X, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/942384; Kang J, 2014, PREV MED, V64, P121, DOI 10.1016/j.ypmed.2014.03.023; KOH TC, 1982, AM J CHINESE MED, V10, P14, DOI 10.1142/S0192415X8200004X; Lepp A, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-79; Li S, 2012, J JILIN I PHYS ED, V28, P13; Lin Q, 2010, J FUJIAN U TRADIT CH, V20, P55; Liu HF, 2008, J WUHAN I PHYS ED, V42, P54; Liu HF, 2007, J BEIJING SPORT U S, P149; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Mei LJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/282131; Miller KE, 2009, SOCIOL SPORT J, V26, P335, DOI 10.1123/ssj.26.2.335; Mo GN, 2013, WUSHU SCI, V10, P81; Morrell JS, 2013, METAB SYNDR RELAT D, V11, P370, DOI 10.1089/met.2013.0011; Nakamura T, 2008, ASIA PAC J CLIN NUTR, V17, P349; Nelson Toben F, 2007, J Phys Act Health, V4, P495; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Paluska SA, 2000, SPORTS MED, V29, P167, DOI 10.2165/00007256-200029030-00003; Peng LY, 2012, SPORT RES, V2, P115; Qu XF, 2014, LIAONING SPORT SCI T, V36, P45; Sagatun A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-155; Stallman HM, 2008, AUST FAM PHYSICIAN, V37, P673; Storrie K, 2010, INT J NURS PRACT, V16, P1, DOI 10.1111/j.1440-172X.2009.01813.x; Ullrich-French S, 2011, PSYCHOL HEALTH, V26, P1063, DOI 10.1080/08870446.2010.530123; Van Dyck D, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0120475, 10.1371/journal.pone.0122522]; Wang Y., 2011, J BEIJING SPORT U, V34, P102; Wang Z., 1984, SYMPTOM CHECKLIST SC, V2, P68, DOI DOI 10.32388/SG7B5L]; Werch CE, 2007, J ADOLESCENT HEALTH, V41, P577, DOI 10.1016/j.jadohealth.2007.06.003; World Health Organization, 2008, GLOB BURD DIS 2004 U; Xue ZH, 2012, J ANHUI SPORT SCI, V33, P46; Yamazaki Fumio, 2013, Journal of UOEH, V35, P51; Yang HG, 2013, J XIAN PHYS ED U, V30, P315; Yang HJ, 2011, SPORT RES ED, V26, P198; Yang TZ, 2003, J CHIN EPIDEMIOL, V24, P760; Yu GB, 1995, CHINESE QIGONG ILLUS; ZHANG JX, 1995, PSYCHOLOGIA, V38, P174; Zhang X, 2011, CHIN MED MOD DISTANC, V9, P105; Zheng GH, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-422; Zhou XQ, 2007, BEIJING TI YU DA XUE, V30, P795	54	59	66	13	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130544	10.1371/journal.pone.0130544	http://dx.doi.org/10.1371/journal.pone.0130544			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EW	26158769	gold, Green Published			2022-12-27	WOS:000358161200013
J	Rong, Y; Bazan, JG; Sekhon, A; Haglund, K; Xu-Welliver, M; Williams, T				Rong, Yi; Bazan, Jose G.; Sekhon, Ashley; Haglund, Karl; Xu-Welliver, Meng; Williams, Terence			Minimal Inter-Fractional Fiducial Migration during Image-Guided Lung Stereotactic Body Radiotherapy Using SuperLock Nitinol Coil Fiducial Markers	PLOS ONE			English	Article							TIME TUMOR-TRACKING; ABLATIVE RADIOTHERAPY; RADIATION-THERAPY; CANCER; MOVEMENT; PLACEMENT; LIVER; COMPLICATIONS; EMBOLIZATION; BRONCHOSCOPY	Objectives Stereotactic body radiotherapy (SBRT) is being increasingly used for the treatment of patients with lung cancer or lung metastasis who are medically unfit to undergo resection. In order to improve accuracy and confidence in targeting tumors, many centers rely on fiducial implantation. We evaluated the migration of a novel fiducial marker specifically designed for lung tissue implanted via electromagnetic navigation bronchoscopy (ENB). Methods We retrospectively quantified the individual and group migrations of SuperLock nitinol coil fiducials for 15 patients receiving lung stereotactic body radiotherapy (SBRT), in order to evaluate the reliability of using these fiducials as a target surrogate for cases where tumors cannot be clearly delineated on cone beam CTs (CBCTs). For each fraction, we compared the individual and group migrations of the fiducials between the planning CT and the acquired CBCT. The group migration was defined as the distance between the centroids of the fiducial group and GTV. Results A total of 16 lung targets were included in our study for these 15 patients (one patient with two targets). Of 55 fiducials placed, we observed a 100% retention rate. The mean individual migration was 1.87 mm (range, 0.63-5.25 mm) with a standard deviation of 1.26 mm. The mean group migration was 1.94 mm (range, 0.03-6.19 mm) with a standard deviation of 1.45 mm. Overall, there was minimal change in the relative locations of the markers with respect to each other, as well as to the target. Conclusions We found that the SuperLock nitinol coil fiducial marker positions are stable throughout the radiation treatment, and can be used as a reliable surrogate to target, and to avoid geometric misses during gated treatments.	[Rong, Yi] Univ Calif Davis, Dept Radiat Oncol, Ctr Comprehens Canc, Sacramento, CA 95817 USA; [Bazan, Jose G.; Sekhon, Ashley; Haglund, Karl; Xu-Welliver, Meng; Williams, Terence] Ohio State Univ, Dept Radiat Oncol, Wexner Med Ctr, Columbus, OH 43210 USA	University of California System; University of California Davis; University System of Ohio; Ohio State University	Rong, Y (corresponding author), Univ Calif Davis, Dept Radiat Oncol, Ctr Comprehens Canc, Sacramento, CA 95817 USA.	yrong@ucdavis.edu; terence.williams@osumc.edu	Williams, Terence M/I-9614-2014					Balter JM, 2001, INT J RADIAT ONCOL, V51, P267, DOI 10.1016/S0360-3016(01)01649-2; Bhagat N, 2010, CARDIOVASC INTER RAD, V33, P1186, DOI 10.1007/s00270-010-9949-0; BRYAN PJ, 1984, J ULTRAS MED, V3, P317; Crabtree T, 2013, J THORAC CARDIOV SUR, V145, P692, DOI 10.1016/j.jtcvs.2012.10.038; D'Souza WD, 2007, MED DOSIM, V32, P92, DOI 10.1016/j.meddos.2007.01.006; Farkas EA, 2012, ANN THORAC SURG, V93, P1715, DOI 10.1016/j.athoracsur.2011.08.057; Gildea TR, 2006, AM J RESP CRIT CARE, V174, P982, DOI 10.1164/rccm.200603-344OC; Giraud P, 2001, INT J RADIAT ONCOL, V51, P1081, DOI 10.1016/S0360-3016(01)01766-7; Glide-Hurst CK, 2014, J THORAC DIS, V6, P303, DOI 10.3978/j.issn.2072-1439.2013.11.10; Hennessey Hooman, 2009, J Med Case Rep, V3, P140, DOI 10.1186/1752-1947-3-140; Hong JC, 2013, J APPL CLIN MED PHYS, V14, P77, DOI 10.1120/jacmp.v14i2.4046; Hong JC, 2011, INT J RADIAT ONCOL, V81, P85, DOI 10.1016/j.ijrobp.2010.04.037; Imura M, 2005, INT J RADIAT ONCOL, V63, P1442, DOI 10.1016/j.ijrobp.2005.04.024; Iyengar P, 2013, SEMIN RESP CRIT CARE, V34, P845, DOI 10.1055/s-0033-1358554; Iyengar P, 2012, J NATL COMPR CANC NE, V10, P1514, DOI 10.6004/jnccn.2012.0157; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kelly P, 2010, INT J RADIAT ONCOL, V78, P1387, DOI 10.1016/j.ijrobp.2009.09.070; Kitamura K, 2003, INT J RADIAT ONCOL, V56, P221, DOI 10.1016/S0360-3016(03)00082-8; Kudchadker RJ, 2009, INT J RADIAT ONCOL, V74, P1283, DOI 10.1016/j.ijrobp.2009.02.033; Kupelian PA, 2007, INT J RADIAT ONCOL, V69, P777, DOI 10.1016/j.ijrobp.2007.03.040; Lagerwaard FJ, 2008, INT J RADIAT ONCOL, V70, P685, DOI 10.1016/j.ijrobp.2007.10.053; MUHM JR, 1983, RADIOLOGY, V148, P609, DOI 10.1148/radiology.148.3.6308709; Nabavizadeh N, 2014, J BRONCHOL INTERN PU, V21, P123, DOI 10.1097/LBR.0000000000000065; Nielsen MH, 2013, ACTA ONCOL, V52, P703, DOI 10.3109/0284186X.2013.765064; Nyman J, 2006, LUNG CANCER-J IASLC, V51, P97, DOI 10.1016/j.lungcan.2005.08.011; Ohta K, 2013, J RADIAT RES, V54, P957, DOI 10.1093/jrr/rrt020; Reyngold M, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-99; Ricardi U, 2010, LUNG CANCER, V68, P72, DOI 10.1016/j.lungcan.2009.05.007; Shimizu S, 2001, INT J RADIAT ONCOL, V51, P304, DOI 10.1016/S0360-3016(01)01641-8; Shirato H, 2003, INT J RADIAT ONCOL, V56, P240, DOI 10.1016/S0360-3016(03)00076-2; Shirato H, 1999, LANCET, V353, P1331, DOI 10.1016/S0140-6736(99)00700-X; Stevens CW, 2001, INT J RADIAT ONCOL, V51, P62, DOI 10.1016/S0360-3016(01)01621-2; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Trovo M, 2014, INT J RADIAT ONCOL, V88, P1114, DOI 10.1016/j.ijrobp.2014.01.012; Valentine K, 2014, TECHNOL CANCER RES T, V13, P253, DOI 10.7785/tcrt.2012.500378; van Zyp NCV, 2011, INT J RADIAT ONCOL, V81, pE75, DOI 10.1016/j.ijrobp.2010.12.026; Yousefi S, 2007, CLIN LUNG CANCER, V8, P252, DOI 10.3816/CLC.2007.n.002	37	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131945	10.1371/journal.pone.0131945	http://dx.doi.org/10.1371/journal.pone.0131945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158847	gold, Green Published, Green Submitted			2022-12-27	WOS:000358161200041
J	Olkkola, S; Kovanen, S; Roine, J; Hanninen, ML; Hielm-Bjorkman, A; Kivisto, R				Olkkola, Satu; Kovanen, Sara; Roine, Johanna; Hanninen, Marja-Liisa; Hielm-Bjorkman, Anna; Kivisto, Rauni			Population Genetics and Antimicrobial Susceptibility of Canine Campylobacter Isolates Collected before and after a Raw Feeding Experiment	PLOS ONE			English	Article							SEQUENCE TYPING SYSTEM; THERMOPHILIC CAMPYLOBACTER; RISK-FACTORS; RPSL GENE; PET DOGS; MYCOBACTERIUM-TUBERCULOSIS; STREPTOMYCIN RESISTANCE; PCR ASSAY; C. COLI; JEJUNI	In recent years, increasing numbers of consumers have become interested in feeding raw food for their pet dogs as opposed to commercial dry food, in the belief of health advantages. However, raw meat and internal organs, possibly contaminated by pathogens such as Campylobacter spp., may pose a risk of transmission of zoonoses to the pet owners. Campylobacter jejuni is the leading cause of bacterial gastroenteritis in humans but C. upsaliensis has also been associated with human disease. In this study we investigated the effect of different feeding strategies on the prevalence of Campylobacter spp. in Finnish dogs. We further characterized the isolates using multilocus sequence typing (MLST), whole-genome (wg) MLST and antimicrobial susceptibility testing. Dogs were sampled before and after a feeding period consisting of commercial raw feed or dry pellet feed. Altogether 56% (20/36) of the dogs yielded at least one Campylobacter-positive fecal sample. C. upsaliensis was the major species detected from 39% of the dogs before and 30% after the feeding period. Two C. jejuni isolates were recovered, both from raw-fed dogs after the dietary regimen. The isolates represented the same genotype (ST-1326), suggesting a common infection source. However, no statistically significant correlation was found between the feeding strategies and Campylobacter spp. carriage. The global genealogy of MLST types of dog and human C. upsaliensis isolates revealed weakly clonal population structure as most STs were widely dispersed. Major antimicrobial resistance among C. upsaliensis isolates was against streptomycin (STR MIC > 4mg/l). Apart from that, all isolates were highly susceptible against the antimicrobials tested. Mutations were found in the genes rpsL or rpsL and rsmG in streptomycin resistant isolates. In conclusion, increasing trend to feed dogs with raw meat warrants more studies to evaluate the risk associated with raw feeding of pets in transmission of zoonoses to humans.	[Olkkola, Satu; Kovanen, Sara; Hanninen, Marja-Liisa; Kivisto, Rauni] Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland; [Roine, Johanna; Hielm-Bjorkman, Anna] Univ Helsinki, Fac Vet Med, Dept Equine & Small Anim Med, Helsinki, Finland	University of Helsinki; University of Helsinki	Olkkola, S (corresponding author), Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland.	satu.olkkola@helsinki.fi		Kivisto, Rauni/0000-0001-9533-2259; Hielm-Bjorkman, Anna/0000-0003-1343-3473; Olkkola, Satu/0000-0001-6966-7151	Finnish Foundation of Veterinary Research	Finnish Foundation of Veterinary Research	SO received funding from the Finnish Foundation of Veterinary Research (no specific grant number) for conducting this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2001, VET RES, V32, P311, DOI 10.1051/vetres:2001127; Acke E, 2009, FOODBORNE PATHOG DIS, V6, P705, DOI 10.1089/fpd.2008.0225; Amar C, 2014, VET MICROBIOL, V168, P124, DOI 10.1016/j.vetmic.2013.10.006; Baily JL, 2015, MOL ECOL, V24, P208, DOI 10.1111/mec.13001; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Benford D, 2014, EFSA J, V12, DOI [10.2903/j.efsa.2014.3802, 10.2903/j.efsa.2015.4260]; Benitez-Paez A, 2014, BIOMEDICA, V34, P41, DOI [10.7705/biomedica.v34i0.1702, 10.1590/S0120-41572014000500006]; Billinghurst I., 2001, BARF DIET RAW FEEDIN; Blaser MJ, 2008, CAMPYLOBACTER, 3RD EDITION, P99; Carbonero A, 2012, COMP IMMUNOL MICROB, V35, P505, DOI 10.1016/j.cimid.2012.05.002; Chaban B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-73; Couturier BA, 2012, J CLIN MICROBIOL, V50, P3792, DOI 10.1128/JCM.01807-12; Denis M, 1999, LETT APPL MICROBIOL, V29, P406, DOI 10.1046/j.1472-765X.1999.00658.x; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Edwards DS, 2014, EPIDEMIOL INFECT, V142, P352, DOI 10.1017/S0950268813001222; Engvall EO, 2003, SCAND J INFECT DIS, V35, P713, DOI 10.1080/00365540310014558; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Fukuda M, 1999, J ANTIMICROB CHEMOTH, V43, P281, DOI 10.1093/jac/43.2.281; FUNATSU G, 1972, J MOL BIOL, V68, P547, DOI 10.1016/0022-2836(72)90108-8; GOOSSENS H, 1995, J INFECT DIS, V172, P1298, DOI 10.1093/infdis/172.5.1298; Gras LM, 2013, EPIDEMIOL INFECT, V141, P2526, DOI 10.1017/S0950268813000356; Hald B, 2004, J CLIN MICROBIOL, V42, P2003, DOI 10.1128/JCM.42.5.2003-2012.2004; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jesse TW, 2006, J APPL MICROBIOL, V100, P682, DOI 10.1111/j.1365-2672.2005.02796.x; KAPPERUD G, 1992, J CLIN MICROBIOL, V30, P3117, DOI 10.1128/JCM.30.12.3117-3121.1992; Katzav M, 2008, FOOD MICROBIOL, V25, P908, DOI 10.1016/j.fm.2008.05.010; Kittl S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081796; Kivisto RI, 2014, GENOME BIOL EVOL, V6, P2424, DOI 10.1093/gbe/evu194; Lawson AJ, 1997, J APPL MICROBIOL, V83, P375, DOI 10.1046/j.1365-2672.1997.00240.x; Lenz J, 2009, CAN VET J, V50, P637; Llarena AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116585; Luo N, 2003, ANTIMICROB AGENTS CH, V47, P390, DOI 10.1128/AAC.47.1.390-394.2003; Meier A, 1996, ANTIMICROB AGENTS CH, V40, P2452, DOI 10.1128/AAC.40.11.2452; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Nirdnoy W, 2005, ANTIMICROB AGENTS CH, V49, P2454, DOI 10.1128/AAC.49.6.2454-2459.2005; Nishimura K, 2007, J BACTERIOL, V189, P6068, DOI 10.1128/JB.00558-07; Noormohamed A, 2013, INT J ENV RES PUB HE, V10, P2058, DOI 10.3390/ijerph10052058; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Olkkola S, 2010, MICROB DRUG RESIST, V16, P105, DOI 10.1089/mdr.2009.0128; Parsons BN, 2012, VET MICROBIOL, V157, P391, DOI 10.1016/j.vetmic.2011.12.035; Parsons BN, 2010, VET J, V184, P66, DOI 10.1016/j.tvjl.2009.01.009; Parsons BN, 2009, J CLIN MICROBIOL, V47, P3466, DOI 10.1128/JCM.01046-09; Procter TD, 2014, ZOONOSES PUBLIC HLTH, V61, P208, DOI 10.1111/zph.12062; Qin SS, 2012, ANTIMICROB AGENTS CH, V56, P5332, DOI 10.1128/AAC.00809-12; Revez J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-768; Rossi M, 2008, VET MICROBIOL, V129, P304, DOI 10.1016/j.vetmic.2007.11.014; Sandberg M, 2002, PREV VET MED, V55, P241, DOI 10.1016/S0167-5877(02)00095-8; Sasaki Y, 2013, JPN J INFECT DIS, V66, P161, DOI 10.7883/yoken.66.161; Shimizu Y, 2012, CASE REP NEPHROL DIA, V2, P145, DOI 10.1159/000343499; Strohmeyer RA, 2006, JAVMA-J AM VET MED A, V228, P537, DOI 10.2460/javma.228.4.537; Torii N, 2003, MUTAT RES-GEN TOX EN, V535, P141, DOI 10.1016/S1383-5718(02)00292-9; Trokhymchuk A, 2014, J FOOD PROTECT, V77, P2106, DOI 10.4315/0362-028X.JFP-14-247; Tsai HJ, 2007, VET RES COMMUN, V31, P931, DOI 10.1007/s11259-007-0009-4; Vandenberg O, 2006, J ANTIMICROB CHEMOTH, V57, P908, DOI 10.1093/jac/dkl080; WANG Y, 1993, ANTIMICROB AGENTS CH, V37, P457, DOI 10.1128/AAC.37.3.457; Weese JS, 2005, CAN VET J, V46, P513; Workman SN, 2005, J CLIN MICROBIOL, V43, P2642, DOI 10.1128/JCM.43.6.2642-2650.2005; Zanoni RG, 2007, INT J FOOD MICROBIOL, V116, P168, DOI 10.1016/j.ijfoodmicro.2006.12.007; Zhang J, 2015, J CLIN MICROBIOL, V53, P1765, DOI 10.1128/JCM.00051-15	63	15	15	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132660	10.1371/journal.pone.0132660	http://dx.doi.org/10.1371/journal.pone.0132660			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172151	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900070
J	Tzeng, YM; Kao, LT; Lin, HC; Huang, CY				Tzeng, Ya-Mei; Kao, Li-Ting; Lin, Herng-Ching; Huang, Chao-Yuan			A Population-Based Study on the Association between Benign Prostatic Enlargement and Rheumatoid Arthritis	PLOS ONE			English	Article							INFLAMMATION; CYTOKINES; HYPERPLASIA; DISEASES	Benign prostatic hyperplasia is one of the chronic inflammatory conditions in ageing male populations. Rheumatoid arthritis (RA) is a major autoimmune disease and is also regarded as a chronic inflammatory disorder. Although RA and benign prostatic enlargement (BPE) may share the same underlying etiologies, almost no study has ever attempted to explore the relationship between RA and BPE. The aim of this study was to explore the relationship between RA and BPE using a population-based dataset. This case-control study used data retrieved from the Taiwan Longitudinal Health Insurance Database 2005. This study comprised 18,716 patients with BPE and 18,716 age-matched patients without BPE. Conditional logistic regression analyses were performed to calculate the odds ratio (OR) for having been previously diagnosed with RA between patients with BPE and comparison patients. In total, 485 of the 37,432 sampled patients (1.3%) had received a prior RA diagnosis. There was a significant difference in the prevalence of prior RA between cases and controls (1.6% vs. 1.0%, p<0.001). After adjusting for patient's urbanization level, monthly income, geographic region, and obesity, the adjusted OR was 1.54 (95% CI = 1.28 similar to 1.85) for patients with BPE compared to comparison patients. In addition, the sensitivity analysis showed that BPE was consistently and significantly associated with a prior RA diagnosis even after excluding subjects diagnosed with RA within 1, 2, or 3 years prior to the index date (the adjusted ORs were 1.46, 1.50, and 1.42, respectively). We concluded that there was a significant association between prior RA and BPE. Further large-scale longitudinal studies are suggested to clarify the causal relationship between RA and BPE.	[Tzeng, Ya-Mei] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Tzeng, Ya-Mei; Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Kao, Li-Ting] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Huang, Chao-Yuan] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Urol, Coll Med, Taipei 10764, Taiwan; [Huang, Chao-Yuan] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; Taipei Medical University; Taipei Medical University Hospital; National Defense Medical Center; National Taiwan University; National Taiwan University Hospital; Taipei Medical University	Huang, CY (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Urol, Coll Med, Taipei 10764, Taiwan.	cyh540909@yahoo.com.tw	Kao, Li-Ting/W-9287-2018	Kao, Li-Ting/0000-0003-0692-7408; HUANG, CHAO-YUAN/0000-0002-9322-6062				Abdollah F, 2011, KOREAN J UROL, V52, P507, DOI 10.4111/kju.2011.52.8.507; Al-Shukaili AK, 2006, SAUDI MED J, V27, P1642; Berhane N, 2012, MOL BIOL REP, V39, P11125, DOI 10.1007/s11033-012-2020-2; Briganti A, 2010, EUR UROL, V57, P551, DOI 10.1016/j.eururo.2009.12.023; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Ficarra V, 2013, EUR UROL SUPPL, V12, P110, DOI 10.1016/j.eursup.2013.08.002; Filkova M, 2015, CYTOKINE, V73, P36, DOI 10.1016/j.cyto.2015.01.019; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Koskimaki J, 2001, SCAND J UROL NEPHROL, V35, P377; Kramer G, 2006, CURR OPIN UROL, V16, P25; Kramer G, 2002, PROSTATE, V52, P43, DOI 10.1002/pros.10084; Nickel JC, 2008, UROL CLIN N AM, V35, P109, DOI 10.1016/j.ucl.2007.09.012; Siebert S, 2015, PHARMACOL REV, V67, P280, DOI 10.1124/pr.114.009639	13	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133013	10.1371/journal.pone.0133013	http://dx.doi.org/10.1371/journal.pone.0133013			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172054	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900117
J	Ren, GR; Hauser, F; Rewitz, KF; Kondo, S; Engelbrecht, AF; Didriksen, AK; Schjott, SR; Sembach, FE; Li, SZ; Sogaard, KC; Sondergaard, L; Grimmelikhuijzen, CJP				Ren, Guilin R.; Hauser, Frank; Rewitz, Kim F.; Kondo, Shu; Engelbrecht, Alexander F.; Didriksen, Anders K.; Schjott, Suzanne R.; Sembach, Frederikke E.; Li, Shizhong; Sogaard, Karen C.; Sondergaard, Leif; Grimmelikhuijzen, Cornelis J. P.			CCHamide-2 Is an Orexigenic Brain-Gut Peptide in Drosophila	PLOS ONE			English	Article							FOOD-INTAKE; DEVELOPMENTAL CONTROL; NEUROPEPTIDES; BEHAVIOR; NEURONS; GENOME; GROWTH; CELLS	The neuroendocrine peptides CCHamide-1 and -2, encoded by the genes ccha1 and -2, are produced by endocrine cells in the midgut and by neurons in the brain of Drosophila melanogaster. Here, we used the CRISPR/Cas9 technique to disrupt the ccha1 and -2 genes and identify mutant phenotypes with a focus on ccha-2 mutants. We found that both larval and adult ccha2 mutants showed a significantly reduced food intake as measured in adult flies by the Capillary Feeding (CAFE) assay (up to 72% reduced food intake compared to wild-type). Locomotion tests in adult flies showed that ccha2 mutants had a significantly reduced locomotor activity especially around 8 a.m. and 8 p.m., where adult Drosophila normally feeds (up to 70% reduced locomotor activity compared to wild-type). Reduced larval feeding is normally coupled to a delayed larval development, a process that is mediated by insulin. Accordingly, we found that the ccha2 mutants had a remarkably delayed development, showing pupariation 70 hours after the pupariation time point of the wild-type. In contrast, the ccha-1 mutants were not developmentally delayed. We also found that the ccha2 mutants had up to 80% reduced mRNA concentrations coding for the Drosophila insulin-like-peptides-2 and -3, while these concentrations were unchanged for the ccha1 mutants. From these experiments we conclude that CCHamide-2 is an orexigenic peptide and an important factor for controlling developmental timing in Drosophila.	[Ren, Guilin R.; Hauser, Frank; Engelbrecht, Alexander F.; Didriksen, Anders K.; Schjott, Suzanne R.; Sembach, Frederikke E.; Li, Shizhong; Sogaard, Karen C.; Sondergaard, Leif; Grimmelikhuijzen, Cornelis J. P.] Univ Copenhagen, Ctr Funct & Comparat Insect Genom, Dept Biol, Copenhagen, Denmark; [Ren, Guilin R.; Hauser, Frank; Rewitz, Kim F.; Engelbrecht, Alexander F.; Didriksen, Anders K.; Schjott, Suzanne R.; Sembach, Frederikke E.; Li, Shizhong; Sogaard, Karen C.; Sondergaard, Leif; Grimmelikhuijzen, Cornelis J. P.] Univ Copenhagen, Dept Biol, Sect Cell & Neurobiol, DK-2100 Copenhagen, Denmark; [Kondo, Shu] Natl Inst Genet, Genet Strains Res Ctr, Mishima, Shizuoka 411, Japan	University of Copenhagen; University of Copenhagen; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Grimmelikhuijzen, CJP (corresponding author), Univ Copenhagen, Ctr Funct & Comparat Insect Genom, Dept Biol, Copenhagen, Denmark.	cgrimmelikhuijzen@bio.ku.dk	Hauser, Frank/M-2952-2014; Rewitz, Kim F/M-6012-2014; Kondo, Shu/AAH-8921-2020	Hauser, Frank/0000-0001-5563-2345; Rewitz, Kim F/0000-0002-4409-9941; Kondo, Shu/0000-0002-4625-8379; Grimmelikhuijzen, Cornelis Johannes Pieter/0000-0001-6486-2046	Lundbeck Foundation; Lundbeck Foundation [R83-2011-7610] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0010929] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Lundbeck Foundation to CJPG: (http://www.lundbeckfoundation.com/About-the-Foundation.25.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chipman AD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002005; Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; Christie AE, 2015, GEN COMP ENDOCR, V210, P63, DOI 10.1016/j.ygcen.2014.10.005; Christie AE, 2014, GEN COMP ENDOCR, V206, P235, DOI 10.1016/j.ygcen.2014.04.015; Deshpande SA, 2014, NAT METHODS, V11, P535, DOI [10.1038/NMETH.2899, 10.1038/nmeth.2899]; Dircksen H, 2011, J PROTEOME RES, V10, P4478, DOI 10.1021/pr200284e; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; Erion R, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00353; Galagovsky D, 2014, MOL BIOL CELL, V25, P916, DOI 10.1091/mbc.E13-04-0213; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Hansen KK, 2011, BIOCHEM BIOPH RES CO, V404, P184, DOI 10.1016/j.bbrc.2010.11.089; Hergarden AC, 2012, P NATL ACAD SCI USA, V109, P3967, DOI 10.1073/pnas.1200778109; Ida Takanori, 2012, Front Endocrinol (Lausanne), V3, P177, DOI 10.3389/fendo.2012.00177; Kondo S, 2014, GENES GENET SYST, V89, P3, DOI 10.1266/ggs.89.3; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Li SZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076131; Mirth Christen Kerry, 2012, Front Endocrinol (Lausanne), V3, P49, DOI 10.3389/fendo.2012.00049; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Nijhout HF, 2014, WIRES DEV BIOL, V3, P113, DOI 10.1002/wdev.124; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Park S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004555; Parker J, 2011, EVOL DEV, V13, P304, DOI 10.1111/j.1525-142X.2011.00481.x; Poulsen M, 2014, P NATL ACAD SCI USA, V111, P14500, DOI 10.1073/pnas.1319718111; Reiher W, 2011, J PROTEOME RES, V10, P1881, DOI 10.1021/pr101116g; Ro J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101107; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sano H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005209; Schoofs A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001893; Soderberg Jeannette A E, 2012, Front Endocrinol (Lausanne), V3, P109, DOI 10.3389/fendo.2012.00109; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veenstra JA, 2014, CELL TISSUE RES, V357, P607, DOI 10.1007/s00441-014-1880-2; Veenstra JA, 2009, CELL TISSUE RES, V336, P309, DOI 10.1007/s00441-009-0769-y; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Zdarek J, 2000, J INSECT PHYSIOL, V46, P213, DOI 10.1016/S0022-1910(99)00114-6; Zoephel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041543	38	65	67	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0133017	10.1371/journal.pone.0133017	http://dx.doi.org/10.1371/journal.pone.0133017			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168160	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100103
J	Gruen, ME; Griffith, EH; Thomson, AE; Simpson, W; Lascelles, BDX				Gruen, Margaret E.; Griffith, Emily H.; Thomson, Andrea E.; Simpson, Wendy; Lascelles, B. Duncan X.			Criterion Validation Testing of Clinical Metrology Instruments for Measuring Degenerative Joint Disease Associated Mobility Impairment in Cats	PLOS ONE			English	Article							ENRICHED ENROLLMENT; OUTCOME MEASURES; PAIN; MELOXICAM; DOGS; OSTEOARTHRITIS; DESIGN; ANALGESICS; EFFICACY	Introduction Degenerative joint disease and associated pain are common in cats, particularly in older cats. There is a need for treatment options, however evaluation of putative therapies is limited by a lack of suitable, validated outcome measures that can be used in the target population of client owned cats. The objectives of this study were to evaluate low-dose daily meloxicam for the treatment of pain associated with degenerative joint disease in cats, and further validate two clinical metrology instruments, the Feline Musculoskeletal Pain Index (FMPI) and the Client Specific Outcome Measures (CSOM). Methods Sixty-six client owned cats with degenerative joint disease and owner-reported impairments in mobility were screened and enrolled into a double-masked, placebo-controlled, randomized clinical trial. Following a run-in baseline period, cats were given either placebo or meloxicam for 21 days, then in a masked washout, cats were all given placebo for 21 days. Subsequently, cats were given the opposite treatment, placebo or meloxicam, for 21 days. Cats wore activity monitors throughout the study, owners completed clinical metrology instruments following each period. Results Activity counts were increased in cats during treatment with daily meloxicam (p<0.0001) compared to baseline. The FMPI results and activity count data offer concurrent validation for the FMPI, though the relationship between baseline activity counts and FMPI scores at baseline was poor (R-2=0.034). The CSOM did not show responsiveness for improvement in this study, and the relationship between baseline activity counts and CSOM scores at baseline was similarly poor (R-2=0.042). Conclusions Refinements to the FMPI, including abbreviation of the instrument and scoring as percent of possible score are recommended. This study offered further validation of the FMPI as a clinical metrology instrument for use in detecting therapeutic efficacy in cats with degenerative joint disease.	[Gruen, Margaret E.; Thomson, Andrea E.; Lascelles, B. Duncan X.] N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Comparat Pain Res Lab, Raleigh, NC 27695 USA; [Griffith, Emily H.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Simpson, Wendy] Morrisville Cat Hosp, Morrisville, NC USA; [Lascelles, B. Duncan X.] N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Dept Clin Sci, Raleigh, NC USA; [Lascelles, B. Duncan X.] Univ N Carolina, Sch Med, Ctr Pain Res & Innovat, Chapel Hill, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Lascelles, BDX (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Comparat Pain Res Lab, Raleigh, NC 27695 USA.	Duncan_lascelles@ncsu.edu		Gruen, Margaret/0000-0002-6036-8849; /0000-0002-6712-0352; Lascelles, B. Duncan X./0000-0002-2950-9009	Boehringer-Ingelheim Vetmedica, Inc. [45079]; National Institutes of Health Ruth L. Kirschstein National Research Service Award [T32OD011130]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011130] Funding Source: NIH RePORTER	Boehringer-Ingelheim Vetmedica, Inc.(Boehringer Ingelheim); National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for the study was provided by a grant (45079) from Boehringer-Ingelheim Vetmedica, Inc. (http://www.bi-vetmedica.com/). The study sponsor had a collaborative role in the study design, and monitored the data collection, though the sponsor was not directly involved in data collection, analysis, decision to publish or manuscript content. The sponsor was given the opportunity to review the manuscript and comment. MEG receives funding support from the National Institutes of Health Ruth L. Kirschstein National Research Service Award (T32OD011130).	Benito J, 2013, VET J, V196, P368, DOI 10.1016/j.tvjl.2012.12.015; Benito J, 2013, J VET INTERN MED, V27, P474, DOI 10.1111/jvim.12077; Benito J, 2012, J FELINE MED SURG, V14, P863, DOI 10.1177/1098612X12453904; Bennett D, 2009, J FELINE MED SURG, V11, P997, DOI 10.1016/j.jfms.2009.09.016; Clarke SP, 2006, J SMALL ANIM PRACT, V47, P439, DOI 10.1111/j.1748-5827.2006.00143.x; Conzemius MG, 2012, JAVMA-J AM VET MED A, V241, P1314, DOI 10.2460/javma.241.10.1314; Freire M, 2011, VET RADIOL ULTRASOUN, V52, P239, DOI 10.1111/j.1740-8261.2011.01803.x; Gao XM, 2013, J FELINE MED SURG, V15, P466, DOI 10.1177/1098612X12470652; Gingerich DA, 2003, VET THER, V4, P56; Gowan RA, 2011, J FELINE MED SURG, V13, P752, DOI 10.1016/j.jfms.2011.06.008; Gruen ME, 2014, J VET INTERN MED, V28, P346, DOI 10.1111/jvim.12312; Guillot M, 2013, VET J, V196, P360, DOI 10.1016/j.tvjl.2013.01.009; Guillot M, 2012, VET SURG, V41, P328, DOI 10.1111/j.1532-950X.2012.00976.x; Gunew MN, 2008, J FELINE MED SURG, V10, P235, DOI 10.1016/j.jfms.2007.10.007; Innes J, 2010, IN PRACTICE, V32, P126, DOI 10.1136/inp.c1436; Katz N, 2009, CLIN J PAIN, V25, P797, DOI 10.1097/AJP.0b013e3181b12dec; Klinck MP, 2012, CAN VET J, V53, P1181; Lascelles BDX, 2007, VET REC, V160, P512, DOI 10.1136/vr.160.15.512; Lascelles BDX, 2010, J VET INTERN MED, V24, P487, DOI 10.1111/j.1939-1676.2010.0495.x; Lascelles BDX, 2008, VET ANAESTH ANALG, V35, P173, DOI 10.1111/j.1467-2995.2007.00367.x; Lascelles BDX, 2007, J VET INTERN MED, V21, P410, DOI 10.1892/0891-6640(2007)21[410:EOCOMA]2.0.CO;2; Lascelles BDX, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-10; Lascelles BDX, 2010, VET SURG, V39, P535, DOI 10.1111/j.1532-950X.2010.00708.x; Lascelles BDX, 2010, VET SURG, V39, P2, DOI 10.1111/j.1532-950X.2009.00597.x; Marino CL, 2014, J FELINE MED SURG, V16, P465, DOI 10.1177/1098612X13511446; Mathews KA, 2000, VET CLIN N AM-SMALL, V30, P783, DOI 10.1016/S0195-5616(08)70007-X; McQuay HJ, 2008, PAIN, V135, P217, DOI 10.1016/j.pain.2008.01.014; Moore RA, 2013, BRIT J ANAESTH, V111, P38, DOI 10.1093/bja/aet126; Piccione G, 2013, J VET BEHAV, V8, P189, DOI 10.1016/j.jveb.2012.09.004; Slingerland LI, 2011, VET J, V187, P304, DOI 10.1016/j.tvjl.2009.12.014; Surdyk KK, 2013, AM J VET RES, V74, P648, DOI 10.2460/ajvr.74.4.648; Wernham BGJ, 2011, J VET INTERN MED, V25, P1298, DOI 10.1111/j.1939-1676.2011.00825.x; Zamprogno H, 2010, AM J VET RES, V71, P1417, DOI 10.2460/ajvr.71.12.1417	33	51	51	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131839	10.1371/journal.pone.0131839	http://dx.doi.org/10.1371/journal.pone.0131839			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162101	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300063
J	Leitan, ND; Williams, B; Murray, G				Leitan, N. D.; Williams, B.; Murray, G.			Look Up for Healing: Embodiment of the Heal Concept in Looking Upward	PLOS ONE			English	Article							DIFFUSION-MODEL; READING FLUENCY; VERTICAL SPACE; FMRI EVIDENCE; REPRESENTATION; KNOWLEDGE; COGNITION; MEMORY; POWER; ACTIVATION	Objective Conceptual processing may not be restricted to the mind. The heal concept has been metaphorically associated with an "up" bodily posture. Perceptual Symbol Systems (PSS) theory suggests that this association is underpinned by bodily states which occur during learning and become instantiated as the concept. Thus the aim of this study was to examine whether processing related to the heal concept is promoted by priming the bodily state of looking upwards. Method We used a mixed 2x2 priming paradigm in which 58 participants were asked to evaluate words as either related to the heal concept or not after being primed to trigger the concept of looking up versus down (Direction - within subjects). A possible dose-response effect of priming was investigated via allocating participants to two 'strengths' of prime, observing an image of someone whose gaze was upward/downward (low strength) and observing an image of someone whose gaze was upward/downward while physically tilting their head upwards or downwards in accord with the image (high strength) (Strength - between subjects). Results Participants responded to words related to heal faster than words unrelated to heal across both "Strength" conditions. There was no evidence that priming was stronger in the high strength condition. Conclusion The present study found that, consistent with a PSS view of cognition, the heal concept is embodied in looking upward, which has important implications for cognition, general health, health psychology, health promotion and therapy.	[Leitan, N. D.; Williams, B.; Murray, G.] Swinburne Univ Technol, Fac Hlth Arts & Design, Melbourne, Vic, Australia	Swinburne University of Technology	Leitan, ND (corresponding author), Swinburne Univ Technol, Fac Hlth Arts & Design, Melbourne, Vic, Australia.	nleitan@swin.edu.au	Murray, Greg/N-8933-2017	Murray, Greg/0000-0001-7208-5603				[Anonymous], 2014, SENSORIA J MIND BRAI; Barsalou Lawrence, 2005, HDB CATEGORIZATION C, P620; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Barsalou LW, 2003, PSYCHOL LEARN MOTIV, V43, P43, DOI 10.1016/S0079-7421(03)01011-9; Burns MK, 2011, PSYCHOL SCHOOLS, V48, P124, DOI 10.1002/pits.20531; Chandler J, 2009, J EXP SOC PSYCHOL, V45, P123, DOI 10.1016/j.jesp.2008.06.012; Chang ACS, 2013, READ FOREIGN LANG, V25, P126; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Crawford LE, 2006, COGNITION EMOTION, V20, P1153, DOI 10.1080/02699930500347794; Crawford LE, 2009, EMOT REV, V1, P129, DOI 10.1177/1754073908100438; Ernst MO, 2002, J VISION, V2, DOI [10.1167/2.10.126, DOI 10.1167/2.10.126]; Faw B, 2009, J CONSCIOUSNESS STUD, V16, P45; Fodor J. A., 1975, LANGUAGE THOUGHT; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Gangi C, 2011, PSYCHOL HEALTH, V26, P1006, DOI 10.1080/08870446.2010.520714; Ghane A, 2013, HEALTH PSYCHOL REV, V7, pS159, DOI 10.1080/17437199.2012.706988; Harris J, 2003, WORDCOUNT2003; Henning J, 2010, BASIC ENGLISH WORD L; Howell D.C., 2010, STAT METHODS PSYCHOL, V7; Hung IW, 2011, J CONSUM RES, V37, P1046, DOI 10.1086/657240; Jostmann NB, 2009, PSYCHOL SCI, V20, P1169, DOI 10.1111/j.1467-9280.2009.02426.x; Kan IP, 2003, COGN NEUROPSYCHOL, V20, P525, DOI 10.1080/02643290244000257; Kellenbach ML, 2001, COGN AFFECT BEHAV NE, V1, P207, DOI 10.3758/CABN.1.3.207; Kirmayer LJ, 2008, TRANSCULT PSYCHIATRY, V45, P318, DOI 10.1177/1363461508089769; Lakens D, 2011, SOC PSYCHOL-GERMANY, V42, P205, DOI 10.1027/1864-9335/a000064; Lakoff George, 2003, METAPHOR WE LIVE BY; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Lavidor M, 2001, COGNITIVE BRAIN RES, V12, P265, DOI 10.1016/S0926-6410(01)00056-8; Marques JF, 2006, MEM COGNITION, V34, P60, DOI 10.3758/BF03193386; McClelland J. L., 1986, PARALLEL DISTRIBUTED, V2; Meier BP, 2006, J RES PERS, V40, P451, DOI 10.1016/j.jrp.2005.03.001; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Meier BP, 2007, J PERS SOC PSYCHOL, V93, P699, DOI 10.1037/0022-3514.93.5.699; Michalak J, 2014, CLIN PSYCHOL PSYCHOT, V21, P519, DOI 10.1002/cpp.1890; Michalak J, 2009, PSYCHOSOM MED, V71, P580, DOI 10.1097/PSY.0b013e3181a2515c; Monsell S., 1991, BASIC PROCESSES READ, P148; Nation ISP, 2005, PASAA, V36, P21; Pecher D, 2004, PSYCHON B REV, V11, P164, DOI 10.3758/BF03206477; Pecher D, 2003, PSYCHOL SCI, V14, P119, DOI 10.1111/1467-9280.t01-1-01429; PEPER E, 2012, BIOFEEDBACK, V40, P125, DOI DOI 10.5298/1081-5937-40.3.01; Pylyshyn Z., 1984, COMPUTATION COGNITIO; Ratcliff R, 2002, PSYCHON B REV, V9, P438, DOI 10.3758/BF03196302; Scheffe H., 1999, ANAL VARIANCE; Schubert TW, 2009, J EXP SOC PSYCHOL, V45, P828, DOI 10.1016/j.jesp.2009.02.003; Schubert TW, 2005, J PERS SOC PSYCHOL, V89, P1, DOI 10.1037/0022-3514.89.1.1; Schubert TW, 2004, PERS SOC PSYCHOL B, V30, P757, DOI 10.1177/0146167204263780; Shapiro L, 2007, PHILOS COMPASS, V2, P338, DOI 10.1111/j.1747-9991.2007.00064.x; Sherman DK, 2010, J EXP SOC PSYCHOL, V46, P461, DOI 10.1016/j.jesp.2009.12.008; Simmons WK, 2008, J PHYSIOL-PARIS, V102, P106, DOI 10.1016/j.jphysparis.2008.03.014; Simmons WK, 2003, COGN NEUROPSYCHOL, V20, P451, DOI 10.1080/02643290342000032; Slocomb D, 2009, J PSYCHOLINGUIST RES, V38, P43, DOI 10.1007/s10936-008-9082-2; Stage SA, 2001, SCHOOL PSYCHOL REV, V30, P407; TEASDALE JD, 1993, BEHAV RES THER, V31, P339, DOI 10.1016/0005-7967(93)90092-9; Vacharkulksemsuk T, 2012, J EXP SOC PSYCHOL, V48, P399, DOI 10.1016/j.jesp.2011.07.015; Wagenmakers EJ, 2008, J MEM LANG, V58, P140, DOI 10.1016/j.jml.2007.04.006; Wells AJ, 1998, COGNITIVE SCI, V22, P269, DOI 10.1207/s15516709cog2203_1; White C, 2009, COGNITION EMOTION, V23, P181, DOI 10.1080/02699930801976770; Wilson-Mendenhall CD, 2013, J COGNITIVE NEUROSCI, V25, P920, DOI 10.1162/jocn_a_00361; Wu LL, 2009, ACTA PSYCHOL, V132, P173, DOI 10.1016/j.actpsy.2009.02.002	60	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132427	10.1371/journal.pone.0132427	http://dx.doi.org/10.1371/journal.pone.0132427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161967	Green Published, gold			2022-12-27	WOS:000358162300134
J	Moeskops, P; Benders, MJNL; Kersbergen, KJ; Groenendaal, F; de Vries, LS; Viergever, MA; Isgum, I				Moeskops, Pim; Benders, Manon J. N. L.; Kersbergen, Karina J.; Groenendaal, Floris; de Vries, Linda S.; Viergever, Max A.; Isgum, Ivana			Development of Cortical Morphology Evaluated with Longitudinal MR Brain Images of Preterm Infants	PLOS ONE			English	Article							PRIMATE CEREBRAL-CORTEX; CENTRAL-NERVOUS-SYSTEM; PREMATURE-INFANTS; DIFFUSION TENSOR; MATTER VOLUME; BIRTH; AGE; THICKNESS; INJURY; TERM	Introduction The cerebral cortex develops rapidly in the last trimester of pregnancy. In preterm infants, brain development is very vulnerable because of their often complicated extra-uterine conditions. The aim of this study was to quantitatively describe cortical development in a cohort of 85 preterm infants with and without brain injury imaged at 30 and 40 weeks post-menstrual age (PMA). Methods In the acquired T2-weighted MR images, unmyelinated white matter (UWM), cortical grey matter (CoGM), and cerebrospinal fluid in the extracerebral space (CSF) were automatically segmented. Based on these segmentations, cortical descriptors evaluating volume, surface area, thickness, gyrification index, and global mean curvature were computed at both time points, for the whole brain, as well as for the frontal, temporal, parietal, and occipital lobes separately. Additionally, visual scoring of brain abnormality was performed using a conventional scoring system at 40 weeks PMA. Results The evaluated descriptors showed larger change in the occipital lobes than in the other lobes. Moreover, the cortical descriptors showed an association with the abnormality scores: gyrification index and global mean curvature decreased, whereas, interestingly, median cortical thickness increased with increasing abnormality score. This was more pronounced at 40 weeks PMA than at 30 weeks PMA, suggesting that the period between 30 and 40 weeks PMA might provide a window of opportunity for intervention to prevent delay in cortical development.	[Moeskops, Pim; Viergever, Max A.; Isgum, Ivana] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Moeskops, Pim; Benders, Manon J. N. L.; Kersbergen, Karina J.; Groenendaal, Floris; de Vries, Linda S.] Univ Med Ctr Utrecht, Dept Neonatol, Utrecht, Netherlands; [Benders, Manon J. N. L.] Kings Coll London, Dept Perinatal Imaging & Hlth, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England; [Benders, Manon J. N. L.; Groenendaal, Floris; de Vries, Linda S.; Isgum, Ivana] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of London; King's College London; Utrecht University; Utrecht University Medical Center	Moeskops, P (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands.	p.moeskops@umcutrecht.nl	de Vries, Linda S/AAB-6454-2021; Moeskops, Pim/K-6728-2017; Viergever, Max A/J-1215-2014; Groenendaal, Floris/P-6872-2019; Isgum, Ivana/H-8659-2014	Moeskops, Pim/0000-0002-8733-6716; Groenendaal, Floris/0000-0002-9284-1637; Isgum, Ivana/0000-0003-1869-5034	Wilhelmina Research Fund [10-427]	Wilhelmina Research Fund	This study included infants participating in the Neobrain study (LSHM-CT-2006-036534) and infants from a study funded by the Wilhelmina Research Fund (10-427).	Ajayi-Obe M, 2000, LANCET, V356, P1162, DOI 10.1016/S0140-6736(00)02761-6; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Awate SP, 2010, NEUROIMAGE, V53, P450, DOI 10.1016/j.neuroimage.2010.06.072; Back SA, 2014, ANN NEUROL, V75, P469, DOI 10.1002/ana.24132; Ball G, 2012, CEREB CORTEX, V22, P1016, DOI 10.1093/cercor/bhr176; Benders MJ, 2015, CEREB CORTEX, V25, P3014, DOI 10.1093/cercor/bhu097; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; CHI JG, 1977, ARCH NEUROL-CHICAGO, V34, P346, DOI 10.1001/archneur.1977.00500180040008; Chugani HT, 1998, PREV MED, V27, P184, DOI 10.1006/pmed.1998.0274; Clouchoux C, 2012, BRAIN STRUCT FUNCT, V217, P127, DOI 10.1007/s00429-011-0325-x; Connolly CJ, 1950, EXTERNAL MORPHOLOGY; De Vis JB, 2013, EUR J RADIOL, V82, P538, DOI 10.1016/j.ejrad.2012.10.013; Dean JM, 2014, PEDIATR RES, V75, P227, DOI 10.1038/pr.2013.189; Dean JM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004669; deIpolyi AR, 2005, NEUROIMAGE, V27, P579, DOI 10.1016/j.neuroimage.2005.04.027; Doesburg SM, 2013, PAIN, V154, P1946, DOI 10.1016/j.pain.2013.04.009; Dubois J, 2008, CEREB CORTEX, V18, P1444, DOI 10.1093/cercor/bhm180; Dubois J, 2008, BRAIN, V131, P2028, DOI 10.1093/brain/awn137; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldman-Rakic PSRP, 1984, CEREBRAL DOMINANCE B, P179; Hilgetag CC, 2005, ANAT EMBRYOL, V210, P411, DOI 10.1007/s00429-005-0041-5; Hilgetag CC, 2006, PLOS COMPUT BIOL, V2, P146, DOI 10.1371/journal.pcbi.0020022; Hill J, 2010, J NEUROSCI, V30, P2268, DOI 10.1523/JNEUROSCI.4682-09.2010; Hogstrom LJ, 2013, CEREB CORTEX, V23, P2521, DOI 10.1093/cercor/bhs231; Hu HH, 2009, EUR J NEUROSCI, V29, P1560, DOI 10.1111/j.1460-9568.2009.06707.x; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; Isgum I, 2015, MED IMAGE ANAL, V20, P135, DOI 10.1016/j.media.2014.11.001; Jones SE, 2000, HUM BRAIN MAPP, V11, P12, DOI 10.1002/1097-0193(200009)11:1<12::AID-HBM20>3.0.CO;2-K; Kapellou O, 2006, PLOS MED, V3, P1382, DOI 10.1371/journal.pmed.0030265; Kidokoro H, 2013, AM J NEURORADIOL, V34, P2208, DOI 10.3174/ajnr.A3521; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; Kostovic I, 2014, BRAIN STRUCT FUNCT, V219, P231, DOI 10.1007/s00429-012-0496-0; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; Kostovic I, 2009, SEMIN PERINATOL, V33, P220, DOI 10.1053/j.semperi.2009.04.003; Le Provost JB, 2003, BRIT J PSYCHIAT, V182, P228, DOI 10.1192/bjp.182.3.228; Lee JD, 2011, BRAIN, V134, P1199, DOI 10.1093/brain/awr021; Li G, 2014, J NEUROSCI, V34, P4228, DOI 10.1523/JNEUROSCI.3976-13.2014; Li G, 2013, CEREB CORTEX, V23, P2724, DOI 10.1093/cercor/bhs265; Lyall AE, 2015, CEREB CORTEX, V25, P2204, DOI 10.1093/cercor/bhu027; Mangin JF, 2010, CURR OPIN NEUROL, V23, P359, DOI 10.1097/WCO.0b013e32833a0afc; Moeskops P, 2015, NEUROIMAGE, V118, P628, DOI 10.1016/j.neuroimage.2015.06.007; Moeskops P, 2013, PROC SPIE, V8670, DOI 10.1117/12.2007829; Molko N, 2003, NEURON, V40, P847, DOI 10.1016/S0896-6273(03)00670-6; Murner-Lavanchy I, 2014, EARLY HUM DEV, V90, P443, DOI 10.1016/j.earlhumdev.2014.05.013; Nagy Z, 2011, CEREB CORTEX, V21, P300, DOI 10.1093/cercor/bhq095; Narberhaus A, 2009, NEUROIMAGE, V47, P1884, DOI 10.1016/j.neuroimage.2009.04.036; Neal J, 2007, J ANAT, V210, P66, DOI 10.1111/j.1469-7580.2006.00674.x; Nie JX, 2012, CEREB CORTEX, V22, P2272, DOI 10.1093/cercor/bhr293; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Nossin-Manor R, 2013, NEUROIMAGE, V64, P505, DOI 10.1016/j.neuroimage.2012.08.086; Padilla N, 2015, CEREB CORTEX, V25, P1897, DOI 10.1093/cercor/bht431; Peterson BS, 2003, PEDIATRICS, V111, P939, DOI 10.1542/peds.111.5.939; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Pienaar R, 2008, INT J IMAG SYST TECH, V18, P42, DOI 10.1002/ima.20138; Rakic P, 2004, SCIENCE, V303, P1983, DOI 10.1126/science.1096414; Rathbone R, 2011, NEUROLOGY, V77, P1510, DOI 10.1212/WNL.0b013e318233b215; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Rees S, 1997, DEV BRAIN RES, V103, P103, DOI 10.1016/S0165-3806(97)81787-7; RICHMAN DP, 1975, SCIENCE, V189, P18, DOI 10.1126/science.1135626; Rodriguez-Carranza CE, 2008, NEUROIMAGE, V41, P462, DOI 10.1016/j.neuroimage.2008.01.008; Rose J, 2014, NEUROIMAGE, V86, P244, DOI 10.1016/j.neuroimage.2013.09.053; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Thambisetty M, 2010, NEUROIMAGE, V52, P1215, DOI 10.1016/j.neuroimage.2010.04.258; Tich SNT, 2009, AM J NEURORADIOL, V30, P125, DOI 10.3174/ajnr.A1309; Toro R, 2005, CEREB CORTEX, V15, P1900, DOI 10.1093/cercor/bhi068; Tzarouchi LC, 2009, NEUROIMAGE, V47, P1148, DOI 10.1016/j.neuroimage.2009.03.072; Van Essen DC, 2006, J NEUROSCI, V26, P5470, DOI 10.1523/JNEUROSCI.4154-05.2006; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Volpe JV, 2008, NEUROLOGY OF THE NEW; Welker W., 1990, Cerebral Cortex, V8B, P3; Windreich G, 2003, PATTERN RECOGN, V36, P2531, DOI 10.1016/S0031-3203(03)00173-0; Wright R, 2014, NEUROIMAGE, V91, P21, DOI 10.1016/j.neuroimage.2014.01.034; Xue H, 2007, NEUROIMAGE, V38, P461, DOI 10.1016/j.neuroimage.2007.07.030; ZILLES K, 1988, ANAT EMBRYOL, V179, P173, DOI 10.1007/BF00304699; Zubiaurre-Elorza L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042148	80	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131552	10.1371/journal.pone.0131552	http://dx.doi.org/10.1371/journal.pone.0131552			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161536	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300046
J	Ni, SQ; Lv, JC; Cheng, ZH; Li, M				Ni, Shengqiao; Lv, Jiancheng; Cheng, Zhehao; Li, Mao			Novel Online Dimensionality Reduction Method with Improved Topology Representing and Radial Basis Function Networks	PLOS ONE			English	Article							LEARNING ALGORITHM	This paper presents improvements to the conventional Topology Representing Network to build more appropriate topology relationships. Based on this improved Topology Representing Network, we propose a novel method for online dimensionality reduction that integrates the improved Topology Representing Network and Radial Basis Function Network. This method can find meaningful low-dimensional feature structures embedded in high-dimensional original data space, process nonlinear embedded manifolds, and map the new data online. Furthermore, this method can deal with large datasets for the benefit of improved Topology Representing Network. Experiments illustrate the effectiveness of the proposed method.	[Ni, Shengqiao; Lv, Jiancheng; Cheng, Zhehao; Li, Mao] Sichuan Univ, Coll Comp Sci, Machine Intelligence Lab, Chengdu 610065, Peoples R China	Sichuan University	Lv, JC (corresponding author), Sichuan Univ, Coll Comp Sci, Machine Intelligence Lab, Chengdu 610065, Peoples R China.	lvjiancheng@scu.edu.cn			National Science Foundation of China [61375065, 61432014]; National Program on Key Basic 307 Research Project (973 Program) [2011CB302201]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic 307 Research Project (973 Program)(National Basic Research Program of China)	This work was supported by National Science Foundation of China (http://www.nsfc.gov.cn/) under grant 61375065 and 61432014 and National Program on Key Basic 307 Research Project (973 Program) (http://program.most.gov.cn/) under grant 2011CB302201.	Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Bharti KK, 2015, EXPERT SYST APPL, V42, P3105, DOI 10.1016/j.eswa.2014.11.038; Bollen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006022; Borg I, 2005, MODERN MUTLIDIMENSIO, V40; Boutsidis C, 2015, IEEE T INFORM THEORY, V61, P1045, DOI 10.1109/TIT.2014.2375327; Cattaert T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010304; Dai XJ, 2015, OPT COMMUN, V338, P348, DOI 10.1016/j.optcom.2014.10.055; Dominguez M, 2015, INFORM SCIENCES, V294, P553, DOI 10.1016/j.ins.2014.06.029; Espezua S, 2015, NEUROCOMPUTING, V149, P767, DOI 10.1016/j.neucom.2014.07.057; Estevez PA, 2006, NEURAL NETWORKS, V19, P923, DOI 10.1016/j.neunet.2006.05.024; Estevez PA, 2006, LECT NOTES COMPUT SC, V4131, P464; Fasshauer GE, 1999, ADV COMPUT MATH, V11, P139, DOI 10.1023/A:1018919824891; Fritzke B., 1995, Advances in Neural Information Processing Systems 7, P625; Gan M, 2015, IEEE SIGNAL PROC LET, V22, P809, DOI 10.1109/LSP.2014.2369415; Gisbrecht A, 2015, NEUROCOMPUTING, V147, P71, DOI 10.1016/j.neucom.2013.11.045; Graham D.B., 1998, CHARACTERISING VIRTU; Haykin S., 1998, NEURAL NETWORKS; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Ingram S, 2015, NEUROCOMPUTING, V150, P557, DOI 10.1016/j.neucom.2014.07.073; Jolliffe IT, 2002, SPRINGER SERIES IN S, V87, P41; Kaski S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-48; Li B, 2015, NEUROCOMPUTING, V152, P121, DOI 10.1016/j.neucom.2014.11.012; Lu JN, 2015, NEUROCOMPUTING, V152, P305, DOI 10.1016/j.neucom.2014.10.065; Lv JC, 2007, IEEE T NEURAL NETWOR, V18, P1557, DOI 10.1109/TNN.2007.895824; Lv JC, 2010, IEEE T FUZZY SYST, V18, P217, DOI 10.1109/TFUZZ.2009.2038711; Ma JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040115; MARTINETZ T, 1994, NEURAL NETWORKS, V7, P507, DOI 10.1016/0893-6080(94)90109-0; Martinetz T., 1991, Artificial Neural Networks. Proceedings of the 1991 International Conference. ICANN-91, P397; Pagliosa P, 2015, NEUROCOMPUTING, V150, P599, DOI 10.1016/j.neucom.2014.07.072; Park J, 1991, NEURAL COMPUT, V3, P246, DOI 10.1162/neco.1991.3.2.246; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Shang LF, 2006, NEUROCOMPUTING, V69, P1717, DOI 10.1016/j.neucom.2006.01.007; Shen HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084096; Silva VD, 2003, ADVANCES IN NEURAL I, V15; Tang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096944; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tokunaga K, 2014, APPL SOFT COMPUT, V22, P311, DOI 10.1016/j.asoc.2014.04.028; Tomenko V, 2011, NEURAL NETWORKS, V24, P501, DOI 10.1016/j.neunet.2011.02.007; Torgerson WS, 1958, BIOMETRIKA; Venna J, 2005, LOCAL MULTIDIMENSION; Wei MZ, 2015, IEEE SENS J, V15, DOI 10.1109/JSEN.2014.2366035; Xu HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108103; Ye M, 2005, NEURAL COMPUT APPL, V14, P18, DOI 10.1007/s00521-004-0435-y	44	1	1	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131631	10.1371/journal.pone.0131631	http://dx.doi.org/10.1371/journal.pone.0131631			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161960	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300050
J	Ruggeri, J; Longo, AV; Gaiarsa, MP; Alencar, LRV; Lambertini, C; Leite, DS; Carvalho-e-Silva, SP; Zamudio, KR; Toledo, LF; Martins, M				Ruggeri, Joice; Longo, Ana V.; Gaiarsa, Marilia P.; Alencar, Laura R. V.; Lambertini, Carolina; Leite, Domingos S.; Carvalho-e-Silva, Sergio P.; Zamudio, Kelly R.; Toledo, Luis Felipe; Martins, Marcio			Seasonal Variation in Population Abundance and Chytrid Infection in Stream-Dwelling Frogs of the Brazilian Atlantic Forest	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; AMPHIBIAN CHYTRIDIOMYCOSIS; HIGH PREVALENCE; HOST DEFENSES; DISEASE; FUNGUS; PATHOGEN; DECLINES; HISTORY; DYNAMICS	Enigmatic amphibian declines were first reported in southern and southeastern Brazil in the late 1980s and included several species of stream-dwelling anurans (families Hylodidae and Cycloramphidae). At that time, we were unaware of the amphibian-killing fungus Batrachochytrium dendrobatidis (Bd); therefore, pollution, habitat loss, fragmentation and unusual climatic events were hypothesized as primary causes of these declines. We now know that multiple lineages of Bd have infected amphibians of the Brazilian Atlantic forest for over a century, yet declines have not been associated specifically with Bd outbreaks. Because stream-dwelling anurans occupy an environmental hotspot ideal for disease transmission, we investigated temporal variation in population and infection dynamics of three stream-adapted species (Hylodes asper, H. phyllodes, and Cycloramphus boraceiensis) on the northern coast of Sao Paulo state, Brazil. We surveyed standardized transects along streams for four years, and show that fluctuations in the number of frogs correlate with specific climatic variables that also increase the likelihood of Bd infections. In addition, we found that Bd infection probability in C. boraceiensis, a nocturnal species, was significantly higher than in Hylodes spp., which are diurnal, suggesting that the nocturnal activity may either facilitate Bd zoospore transmission or increase susceptibility of hosts. Our findings indicate that, despite long-term persistence of Bd in Brazil, some hosts persist with seasonally variable infections, and thus future persistence in the face of climate change will depend on the relative effect of those changes on frog recruitment and pathogen proliferation.	[Ruggeri, Joice; Carvalho-e-Silva, Sergio P.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, RJ, Brazil; [Longo, Ana V.; Zamudio, Kelly R.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Gaiarsa, Marilia P.; Alencar, Laura R. V.; Martins, Marcio] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil; [Lambertini, Carolina; Toledo, Luis Felipe] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, LaHNAB, Campinas, SP, Brazil; [Leite, Domingos S.] Univ Estadual Campinas, Inst Biol, Dept Genet Evolucao & Bioagentes, Lab Antigenos Bacterianos, Campinas, SP, Brazil	Universidade Federal do Rio de Janeiro; Cornell University; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Ruggeri, J (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, RJ, Brazil.	joice.ruggeri@gmail.com	Martins, Marcio/C-1150-2011; Leite, Domingos S/D-4365-2012; Leite, Domingos/L-4531-2013; Toledo, Luís Felipe/I-4017-2012; Alencar, Laura R V/E-2030-2013; Longo, Ana V./AAH-1522-2020; Lambertini, Carolina/GNH-2000-2022; Ruggeri, Joice/F-7745-2015; Lambertini, Carolina/J-5192-2014; Gaiarsa, Marilia P/B-1211-2013	Martins, Marcio/0000-0001-8108-6309; Leite, Domingos/0000-0002-0946-4165; Toledo, Luís Felipe/0000-0002-4929-9598; Alencar, Laura R V/0000-0002-6805-7682; Longo, Ana V./0000-0002-5112-1246; Ruggeri, Joice/0000-0001-8307-6067; Lambertini, Carolina/0000-0002-6036-3079; Zamudio, Kelly/0000-0001-5107-6206; Da Silva Leite, Domingos/0000-0003-4737-7852	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2006/58011-4, 2007/51478-7, 2008/52847-9, 2008/50325-5, 2010/50146-3, 2011/51694-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [301128/2009-0, 302953/2012-4, 405285/20132, 302589/2013-9, 200352/2014-8]; National Science Foundation [OISE-1159513]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Science Foundation(National Science Foundation (NSF))	This work was supported by 2006/58011-4, 2007/51478-7, 2008/52847-9, 2008/50325-5, 2010/50146-3, and 2011/51694-7 Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br) (MM); 301128/2009-0, 302953/2012-4, 405285/20132, 302589/2013-9, 200352/2014-8 Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br) (LFT); 311156/2013-4 Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br) (SPCS); and OISE-1159513, National Science Foundation (www.nsf.gov) (KZ).	Almeida-Gomes M, 2014, CONSERV BIOL, V28, P616, DOI 10.1111/cobi.12196; [Anonymous], 2002, AGR SIST MON AGR; Becker CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048205; Becker CG, 2011, P NATL ACAD SCI USA, V108, P9893, DOI 10.1073/pnas.1014497108; Becker CG, 2015, P R SOC B, V281; Boltana S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1381; Catenazzi A, 2013, BIOL CONSERV, V159, P413, DOI 10.1016/j.biocon.2012.11.023; Cleveland R.B., 1990, J OFF STAT, V6, P3; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Corn P. S., 2005, Animal Biodiversity and Conservation, V28, P59; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Edenhofer O., 2014, CONTRIBUTION WORKING; Ellison AR, 2014, G3-GENES GENOM GENET, V4, P1275, DOI 10.1534/g3.114.010744; Eterovick PC, 2005, BIOTROPICA, V37, P166, DOI 10.1111/j.1744-7429.2005.00024.x; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Grundler MC, 2012, DIS AQUAT ORGAN, V97, P173, DOI 10.3354/dao02413; Guix Juan C., 1998, Herpetological Natural History, V6, P1; HADDAD C.F.B., 2013, GUIA ANFIBIOS MATA A; Hartmann MT, 2010, IHERINGIA SER ZOOL, V100, P207, DOI 10.1590/S0073-47212010000300004; HEYER WR, 1988, BIOTROPICA, V20, P230, DOI 10.2307/2388238; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Kriger KM, 2008, AUSTRAL ECOL, V33, P1022, DOI 10.1111/j.1442-9993.2008.01872.x; Kriger KM, 2006, DIS AQUAT ORGAN, V71, P149, DOI 10.3354/dao071149; Lambertini Carolina, 2013, Herpetologia Brasileira, V2, P12; Lamirande EW, 2002, P 6 INT S PATH REPT, P3; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longo AV, 2014, INTEGR COMP BIOL, V54, P427, DOI 10.1093/icb/icu073; Longo AV, 2013, J WILDLIFE DIS, V49, P197, DOI 10.7589/2012-05-129; Longo AV, 2010, DIS AQUAT ORGAN, V92, P253, DOI 10.3354/dao02054; McDonald K, 1999, DECLINES DISAPPEARAN, P14; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; Patto CEG, 2001, J HERPETOL, V35, P684, DOI 10.2307/1565913; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Puschendorf R, 2006, BIOL CONSERV, V132, P136, DOI 10.1016/j.biocon.2006.03.010; Puschendorf R, 2011, CONSERV BIOL, V25, P956, DOI 10.1111/j.1523-1739.2011.01728.x; R Development Core Team RDC, 2013, R A LANGUAGE AND ENV; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Richards-Zawacki CL, 2010, P ROY SOC B-BIOL SCI, V277, P519, DOI 10.1098/rspb.2009.1656; Rodriguez D, 2014, MOL ECOL, V23, P774, DOI 10.1111/mec.12615; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Rowley JJL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01515; Scheele BC, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00108.1; Scheele B, 2014, BIOL CONSERV, V170, P86, DOI 10.1016/j.biocon.2013.12.034; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Skerratt LF, 2008, DIS AQUAT ORGAN, V80, P85, DOI 10.3354/dao01923; Toledo L. F., 2006, Amphibian & Reptile Conservation, V4, P17, DOI 10.1514/journal.arc.0040017; Toledo LF, 2014, BIOL CONSERV, V179, P54, DOI 10.1016/j.biocon.2014.08.012; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Walls Susan C., 2013, Biology - Basel, V2, P399, DOI 10.3390/biology2010399; Welsh HH, 1998, ECOL APPL, V8, P1118; WEYGOLDT P, 1989, STUD NEOTROP FAUNA E, V24, P249, DOI 10.1080/01650528909360795; Whitfield SM, 2012, BIOTROPICA, V44, P779, DOI 10.1111/j.1744-7429.2012.00872.x; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1	57	32	33	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130554	10.1371/journal.pone.0130554	http://dx.doi.org/10.1371/journal.pone.0130554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161777	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300018
J	Viana, CTR; Castro, PR; Marques, S; Lopes, MTP; Goncalves, R; Campos, PP; Andrade, SP				Rodrigues Viana, Celso Tarso; Castro, Pollyana Ribeiro; Marques, SuzaneMotta; Paz Lopes, Miriam Teresa; Goncalves, Ricardo; Campos, Paula Peixoto; Andrade, Silvia Passos			Differential Contribution of Acute and Chronic Inflammation to the Development of Murine Mammary 4T1 Tumors	PLOS ONE			English	Article							CANCER-RELATED INFLAMMATION; NITRIC-OXIDE SYNTHASE; BREAST-CANCER; ANGIOGENESIS; MICE; CELLS; PROGRESSION; CARCINOMA; GROWTH; FIBROSARCOMA	Based on the notion that inflammation favors tumorigenesis, our experiments comparatively assessed the influence of acute and chronic inflammation on the development of a murine mammary tumor (4T1). In addition, we characterized angiogenic and inflammatory markers in the tumor tissue and systemically. Subcutaneous implantation of polyether-polyurethane sponge discs in Balb/c mice was used to host 4T1 tumor cells (1x10(6)), which were inoculated intraimplant 24h or 10 days post implantation. Flow cytometric analysis of enzyme-digested implants revealed that, after 24 hours, the population of leukocytes was primarily characterized by neutrophils (42.53%+/-8.45) andmonocytes (37.53%+/-7.48), with some lymphocytes (16.27%+/-4.0) and a few dendritic cells (1.82%+/-0.36). At 10 days, macrophages were predominant (37.10%+/-4.54), followed by lymphocytes (28.1%+/-4.77), and monocytes (22.33%+/-3.05), with some dendritic cells (13.60%+/-0.55) and neutrophils (11.07%+/-2.27). A mammary tumor grown in a chronic inflammatory environment was 2-fold when compared with one grown in acute inflammation and 5-fold when compared with tumor alone. The levels of pro-angiogenic cytokine (VEGF-Vascular Endothelial Growth Factor) were higher in implant-bearing tumor when 4T1 cells were grown in 10-day old implants as compared to the VEGF levels of the two other groups. Overall, the levels of the inflammatory markers evaluated (NAG -N-acetylglucosaminidase, TNF-alpha-Tumor Necrosis Factor-alpha) were higher in both groups of implant-bearing tumors and in serumfromthose animals when compared with the tumor alone levels. This inflammation-related difference in tumor growth may provide new insights into the contribution of different inflammatory cell populations to cancer progression.	[Rodrigues Viana, Celso Tarso; Castro, Pollyana Ribeiro; Marques, SuzaneMotta; Andrade, Silvia Passos] Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil; [Paz Lopes, Miriam Teresa] Univ Fed Minas Gerais, Inst Biol Sci, Dept Pharmacol, Belo Horizonte, MG, Brazil; [Goncalves, Ricardo; Campos, Paula Peixoto] Univ Fed Minas Gerais, Inst Biol Sci, Dept Gen Pathol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Campos, PP (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Gen Pathol, Belo Horizonte, MG, Brazil.	paulapc@icb.ufmg.br	CAMPOS, PAULA PEIXOTO/N-9004-2019; Goncalves, Ricardo/I-2411-2018; Lopes, Miriam T P/A-7732-2015; Castro, Pollyana R/E-3969-2019	CAMPOS, PAULA PEIXOTO/0000-0003-2016-2210; Lopes, Miriam T P/0000-0001-9980-3169; Castro, Pollyana R/0000-0002-1404-6873	CAPES-Brazil	CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The author Celso Tarso received funding as a (PhD scholarship) from CAPES-Brazil for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2012, NAT REV CLIN ONCOL, V9, P498, DOI 10.1038/nrclinonc.2012.120; ANDRADE SP, 1992, BRIT J PHARMACOL, V107, P1092, DOI 10.1111/j.1476-5381.1992.tb13412.x; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; BRAND I, 1977, J NATL CANCER I, V58, P1443; BRAND KG, 1975, J NATL CANCER I, V55, P319; BUTTERY LDK, 1993, J PATHOL, V171, P311, DOI 10.1002/path.1711710412; Campos PP, 2006, HISTOL HISTOPATHOL, V21, P1263, DOI 10.14670/HH-21.1263; Candido J, 2013, J CLIN IMMUNOL, V33, pS79, DOI 10.1007/s10875-012-9847-0; Castro PR, 2012, MICROVASC RES, V84, P9, DOI 10.1016/j.mvr.2012.04.003; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DEXTER DL, 1978, CANCER RES, V38, P3174; DRABKIN DL, 1946, J BIOL CHEM, V164, P703; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; Dupre SA, 2008, EXP MOL PATHOL, V85, P174, DOI 10.1016/j.yexmp.2008.05.002; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Germano MP, 2008, J ETHNOPHARMACOL, V115, P271, DOI 10.1016/j.jep.2007.10.001; Ghoneum M, 2008, INT J ONCOL, V33, P533, DOI 10.3892/ijo_00000037; Heppner GH, 2000, BREAST CANCER RES, V2, P331; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; ISHIKAWA M, 1987, INT J CANCER, V39, P338, DOI 10.1002/ijc.2910390312; Kirkpatrick CJ, 2000, AM J PATHOL, V156, P1455, DOI 10.1016/S0002-9440(10)65014-6; Kuper HE, 2000, CANCER CAUSE CONTROL, V11, P171, DOI 10.1023/A:1008951901148; Lage AP, 2000, MICROVASC RES, V59, P278, DOI 10.1006/mvre.1999.2217; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marques SM, 2011, MICROVASC RES, V82, P246, DOI 10.1016/j.mvr.2011.08.011; OKADA F, 1992, BRIT J CANCER, V66, P635, DOI 10.1038/bjc.1992.329; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rymaszewski AL, 2014, CANCERS, V6, P1111, DOI 10.3390/cancers6021111; Tazawa H, 2003, AM J PATHOL, V163, P2221, DOI 10.1016/S0002-9440(10)63580-8; Tazawa H, 2007, CARCINOGENESIS, V28, P191, DOI 10.1093/carcin/bgl128; Viana CTR, 2013, MICROVASC RES, V86, P44, DOI 10.1016/j.mvr.2012.12.002; WEITZMAN SA, 1985, SCIENCE, V227, P1231, DOI 10.1126/science.3975611; Yoshimura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058791	39	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130809	10.1371/journal.pone.0130809	http://dx.doi.org/10.1371/journal.pone.0130809			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158775	Green Published, Green Submitted, gold			2022-12-27	WOS:000358161200020
J	Kovell, LC; Juraschek, SP; Russell, SD				Kovell, Lara C.; Juraschek, Stephen P.; Russell, Stuart D.			Stage A Heart Failure Is Not Adequately Recognized in US Adults: Analysis of the National Health and Nutrition Examination Surveys, 2007-2010	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; HIGH-RISK; DISEASE; HYPERTENSION; MORBIDITY; MORTALITY; CORONARY; UPDATE	Background Stage A heart failure (HF) is defined as people without HF symptoms or structural heart disease, but with predisposing conditions for HF. This classification is used to identify high risk patients to prevent progression to symptomatic HF. While guidelines exist for managing HF risk factors, achievement of treatment goals in the United States (US) population is unknown. Methods We examined all adults with Stage A HF (>= 20 years, N = 4,470) in the National Health and Nutrition Examination Surveys (NHANES) 2007-2010, a nationally representative sample. Stage A HF was defined by coronary heart disease (CHD), hypertension, diabetes mellitus, or chronic kidney disease. We evaluated whether nationally accepted guidelines for risk factor control were achieved in Stage A patients, including sodium intake, body mass index, hemoglobin A1c (HbA1c), cholesterol, and blood pressure (BP). Pharmacologic interventions and socioeconomic factors associated with guideline compliance were also assessed. Results Over 75 million people, or 1 in 3 US adults, have Stage A HF. The mean age of the Stage A population was 56.9 years and 51.5% were women. Seventy-two percent consume >= 2g sodium/day and 49.2% are obese. Of those with CHD, 58.6% were on a statin and 51.8% were on a beta-blocker. In people with diabetes, 43.6% had HbA1c >= 7%, with Mexican Americans more likely to have HbA1c >= 7%. Of those with hypertension, 30.8% had a systolic BP >= 140 or diastolic BP >= 90 mm Hg. Having health insurance was associated with controlled blood pressure, both in those with hypertension and diabetes. In CHD patients, income >=$20,000/year and health insurance were inversely associated with LDL >= 100mg/dL with prevalence ratio (PR) of 0.58 (P=0.03) and 0.56 (P=0.03), respectively. Conclusions One-third of the US adult population has Stage A HF. Prevention efforts should focus on those with poorly controlled comorbid disease.	[Kovell, Lara C.; Russell, Stuart D.] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Juraschek, Stephen P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kovell, LC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.	lkovell1@jhmi.edu		Juraschek, Stephen/0000-0003-4168-2696; Chamberlain, Alanna/0000-0003-1888-9584; Kovell, Lara C/0000-0002-7919-2361	NIH/NHLBI [T32HL007024]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SPJ is supported by a NIH/NHLBI T32HL007024 Cardiovascular Epidemiology Training Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; AMBROSIONI E, 1995, NEW ENGL J MED, V332, P80, DOI 10.1056/NEJM199501123320203; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Arnold JMO, 2003, CIRCULATION, V107, P1284, DOI 10.1161/01.CIR.0000054165.93055.42; Behrens T, 2004, METHOD INFORM MED, V43, P505; Blair AS, 2002, J FAM PRACTICE, V51, P169; Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Centers for Disease Control, 2010, NHANES NHANES 1999 2; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Colucci WS, 2007, CIRCULATION, V116, P49, DOI 10.1161/CIRCULATIONAHA.106.666016; Djousse L, 2009, JAMA-J AM MED ASSOC, V302, P394, DOI 10.1001/jama.2009.1062; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hawkins NM, 2012, EUR J HEART FAIL, V14, P138, DOI 10.1093/eurjhf/hfr168; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Ho JE, 2013, CIRC-HEART FAIL, V6, P279, DOI 10.1161/CIRCHEARTFAILURE.112.972828; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Iribarren C, 2001, CIRCULATION, V103, P2668; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kjekshus J, 1997, J Card Fail, V3, P249, DOI 10.1016/S1071-9164(97)90022-1; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Masoudi FA, 2007, AM J CARDIOL, V99, p113B, DOI 10.1016/j.amjcard.2006.11.013; National Kidney Foundation, 2004, AM J KIDNEY DIS S, V43, pS1, DOI [DOI 10.1053/J.AJKD.2004.03.003, 10.1053/j.ajkd.2004.03.003]; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Quatromoni J, 2008, INT J CLIN PRACT, V62, P1910, DOI 10.1111/j.1742-1241.2008.01943.x; Salomaa V, 2001, J EPIDEMIOL COMMUN H, V55, P475, DOI 10.1136/jech.55.7.475; Shepherd J, 2008, J AM COLL CARDIOL, V51, P1448, DOI 10.1016/j.jacc.2007.11.072; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Toto RD, 2005, SEMIN NEPHROL, V25, P435, DOI 10.1016/j.semnephrol.2005.05.016; Tsai J, 2012, ADDICT BEHAV, V37, P78, DOI 10.1016/j.addbeh.2011.09.002; Vaur L, 2003, DIABETES CARE, V26, P855, DOI 10.2337/diacare.26.3.855; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	42	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132228	10.1371/journal.pone.0132228	http://dx.doi.org/10.1371/journal.pone.0132228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171960	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900036
J	Kubler, JE; Dudgeon, SR				Kuebler, Janet E.; Dudgeon, Steven R.			Predicting Effects of Ocean Acidification and Warming on Algae Lacking Carbon Concentrating Mechanisms	PLOS ONE			English	Article							INORGANIC CARBON; CHONDRUS-CRISPUS; RED MACROALGA; OXYGEN-UPTAKE; ULVA-RIGIDA; CO2; LIGHT; PHOTOSYNTHESIS; ACQUISITION; TEMPERATURE	Seaweeds that lack carbon-concentrating mechanisms are potentially inorganic carbon-limited under current air equilibrium conditions. To estimate effects of increased atmospheric carbon dioxide concentration and ocean acidification on photosynthetic rates, we modeled rates of photosynthesis in response to pCO(2), temperature, and their interaction under limiting and saturating photon flux densities. We synthesized the available data for photosynthetic responses of red seaweeds lacking carbon-concentrating mechanisms to light and temperature. The model was parameterized with published data and known carbonate system dynamics. The model predicts that direction and magnitude of response to pCO(2) and temperature, depend on photon flux density. At sub-saturating light intensities, photosynthetic rates are predicted to be low and respond positively to increasing pCO(2), and negatively to increasing temperature. Consequently, pCO(2) and temperature are predicted to interact antagonistically to influence photosynthetic rates at low PFD. The model predicts that pCO(2) will have a much larger effect than temperature at sub-saturating light intensities. However, photosynthetic rates under low light will not increase proportionately as pCO(2) in seawater continues to rise. In the range of light saturation (I-k), both CO2 and temperature have positive effects on photosynthetic rate and correspondingly strong predicted synergistic effects. At saturating light intensities, the response of photosynthetic rates to increasing pCO(2) approaches linearity, but the model also predicts increased importance of thermal over pCO(2) effects, with effects acting additively. Increasing boundary layer thickness decreased the effect of added pCO(2) and, for very thick boundary layers, overwhelmed the effect of temperature on photosynthetic rates. The maximum photosynthetic rates of strictly CO2-using algae are low, so even large percentage increases in rates with climate change will not contribute much to changing primary production in the habitats where they commonly live.	[Kuebler, Janet E.; Dudgeon, Steven R.] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA	California State University System; California State University Northridge	Kubler, JE (corresponding author), Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA.	janet.kubler@csun.edu	/AAL-3738-2021		National Science Foundation Ocean Sciences Program [OCE-1316198]	National Science Foundation Ocean Sciences Program	This work was supported by the National Science Foundation Ocean Sciences Program, OCE-1316198 to JE Kubler and SR Dudgeon.	Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; BRECHIGNAC F, 1985, PLANT PHYSIOL, V78, P545, DOI 10.1104/pp.78.3.545; BRECHIGNAC F, 1984, PLANT PHYSIOL, V75, P919, DOI 10.1104/pp.75.4.919; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Comeau S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2374; Cornwall CE, 2015, PHOTOSYNTH RES, V124, P181, DOI 10.1007/s11120-015-0114-0; Cornwall CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097235; DAVISON IR, 1991, J PHYCOL, V27, P2, DOI 10.1111/j.0022-3646.1991.00002.x; Dickson AG, 2007, CARBON DIOXIDE ANAL; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Gordillo FJL, 2003, PLANTA, V218, P315, DOI 10.1007/s00425-003-1087-3; Gordillo FJL, 2001, PLANTA, V213, P64, DOI 10.1007/s004250000468; Hendriks IE, 2010, ESTUAR COAST SHELF S, V86, P157, DOI 10.1016/j.ecss.2009.11.022; Hill R, 1955, WHITTINGHAM CP PHOTO; Hurd CL, 2014, SEAWEED ECOLOGY AND PHYSIOLOGY, 2ND EDITION, P1, DOI 10.1017/CBO9781139192637; JOHNSTON AM, 1992, OECOLOGIA, V92, P317, DOI 10.1007/BF00317457; JOHNSTON AM, 1986, J PHYCOL, V22, P78, DOI 10.1111/j.1529-8817.1986.tb02518.x; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kroeker KJ, 2010, ECOL LETT, V11, P1304; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; KUBLER JE, 1994, MAR ECOL PROG SER, V110, P203, DOI 10.3354/meps110203; Kubler JE, 1996, HYDROBIOLOGIA, V327, P401; KUBLER JE, 1993, MAR BIOL, V117, P327, DOI 10.1007/BF00345678; KUBLER JE, 1995, EUR J PHYCOL, V30, P189, DOI 10.1080/09670269500650971; Kubler JE, 1999, PLANT CELL ENVIRON, V22, P1303, DOI 10.1046/j.1365-3040.1999.00492.x; KUBLER JE, 1995, J PHYCOL, V31, P369, DOI 10.1111/j.0022-3646.1995.00369.x; KUEBLER JE, 1991, BRIT PHYCOL J, V26, P9, DOI 10.1080/00071619100650021; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; MABERLY SC, 1992, OECOLOGIA, V91, P481, DOI 10.1007/BF00650320; MACFARLANE JJ, 1985, J EXP BOT, V36, P610, DOI 10.1093/jxb/36.4.610; MACFARLANE JJ, 1989, J EXP BOT, V40, P321, DOI 10.1093/jxb/40.3.321; MACFARLANE JJ, 1990, PLANT CELL ENVIRON, V13, P1, DOI 10.1111/j.1365-3040.1990.tb01294.x; Mazerolle M. J., 2013, MODEL SELECTION MULT; MILLHOUSE J, 1986, J EXP BOT, V37, P965, DOI 10.1093/jxb/37.7.965; MOOK WG, 1974, EARTH PLANET SC LETT, V22, P169, DOI 10.1016/0012-821X(74)90078-8; Morel F, 2010, NATL STRATEGY MEET C; Olischlager M, 2013, J EXP BOT, V64, P5587, DOI 10.1093/jxb/ert329; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; R Core Development Team, 2013, R LANG ENV STAT COMP; Raven J, 2005, OCEAN ACIDIFICATION; Raven JA, 1997, ADV BOT RES, V27, P85; Raven JA, 2005, CAN J BOT, V83, P879, DOI 10.1139/B05-074; Raven JA, 2002, ANN BOT-LONDON, V90, P525, DOI 10.1093/aob/mcf171; Raven JA, 2002, FUNCT PLANT BIOL, V29, P355, DOI 10.1071/PP01201; Raven JA, 1987, PLANT LIFE AQUATIC A; Robbins L.L., 2010, CO2CALC USER FRIENDL, DOI 10.3133/ofr20101280; Sarker MY, 2013, BOT MAR, V56, P63, DOI 10.1515/bot-2012-0143; Sett S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088308; Sherlock JA, 2001, BOT J SCOTLAND, V113, P301; Uemura K, 1997, BIOCHEM BIOPH RES CO, V233, P568, DOI 10.1006/bbrc.1997.6497; WIENCKE C, 1990, MAR ECOL PROG SER, V65, P283, DOI 10.3354/meps065283; Zeebe RE, 2011, GEOCHIM COSMOCHIM AC, V75, P2483, DOI 10.1016/j.gca.2011.02.010	52	25	25	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132806	10.1371/journal.pone.0132806	http://dx.doi.org/10.1371/journal.pone.0132806			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172263	Green Submitted, gold, Green Published			2022-12-27	WOS:000358194900087
J	Sills, EO; Herrera, D; Kirkpatrick, AJ; Brandao, A; Dickson, R; Hall, S; Pattanayak, S; Shoch, D; Vedoveto, M; Young, L; Pfaff, A				Sills, Erin O.; Herrera, Diego; Kirkpatrick, A. Justin; Brandao, Amintas, Jr.; Dickson, Rebecca; Hall, Simon; Pattanayak, Subhrendu; Shoch, David; Vedoveto, Mariana; Young, Luisa; Pfaff, Alexander			Estimating the Impacts of Local Policy Innovation: The Synthetic Control Method Applied to Tropical Deforestation	PLOS ONE			English	Article							LAND-USE; REDUCE	Quasi-experimental methods increasingly are used to evaluate the impacts of conservation interventions by generating credible estimates of counterfactual baselines. These methods generally require large samples for statistical comparisons, presenting a challenge for evaluating innovative policies implemented within a few pioneering jurisdictions. Single jurisdictions often are studied using comparative methods, which rely on analysts' selection of best case comparisons. The synthetic control method (SCM) offers one systematic and transparent way to select cases for comparison, from a sizeable pool, by focusing upon similarity in outcomes before the intervention. We explain SCM, then apply it to one local initiative to limit deforestation in the Brazilian Amazon. The municipality of Paragominas launched a multi-pronged local initiative in 2008 to maintain low deforestation while restoring economic production. This was a response to having been placed, due to high deforestation, on a federal "blacklist" that increased enforcement of forest regulations and restricted access to credit and output markets. The local initiative included mapping and monitoring of rural land plus promotion of economic alternatives compatible with low deforestation. The key motivation for the program may have been to reduce the costs of blacklisting. However its stated purpose was to limit deforestation, and thus we apply SCM to estimate what deforestation would have been in a (counterfactual) scenario of no local initiative. We obtain a plausible estimate, in that deforestation patterns before the intervention were similar in Paragominas and the synthetic control, which suggests that after several years, the initiative did lower deforestation (significantly below the synthetic control in 2012). This demonstrates that SCM can yield helpful land-use counterfactuals for single units, with opportunities to integrate local and expert knowledge and to test innovations and permutations on policies that are implemented in just a few locations.	[Sills, Erin O.] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Herrera, Diego; Kirkpatrick, A. Justin; Pattanayak, Subhrendu; Pfaff, Alexander] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA; [Sills, Erin O.; Brandao, Amintas, Jr.] Amazon Inst People & Environm, IMAZON, Belem, Para, Brazil; [Dickson, Rebecca; Shoch, David] TerraCarbon LLC, Charlottesville, VA USA; [Hall, Simon] Natl Wildlife Federat, Washington, DC USA; [Vedoveto, Mariana] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Young, Luisa] Clark Univ, Dept Geog, Worcester, MA 01610 USA	University of North Carolina; North Carolina State University; Duke University; Yale University; Clark University	Sills, EO (corresponding author), N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA.	sills@ncsu.edu; alex.pfaff@duke.edu		Sills, Erin/0000-0001-8289-0489	American people through the United States Agency for International Development (USAID); Duke University's Graduate School	American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Duke University's Graduate School	This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. Funding was also provided by Duke University's Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie A, 2003, AM ECON REV, V93, P113, DOI 10.1257/000282803321455188; Abadie A, 2015, AM J POLIT SCI, V59, P495, DOI 10.1111/ajps.12116; Abadie A, 2011, J STAT SOFTW, V42, P1; Abadie A, 2010, J AM STAT ASSOC, V105, P493, DOI 10.1198/jasa.2009.ap08746; Arima EY, 2014, LAND USE POLICY, V41, P465, DOI 10.1016/j.landusepol.2014.06.026; Arima EY, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024010; AssuncAo J, 2014, GETTING GREENER GOIN; Billmeier A, 2013, REV ECON STAT, V95, P983, DOI 10.1162/REST_a_00324; Bohn S, 2014, REV ECON STAT, V96, P258, DOI 10.1162/REST_a_00429; Brito B., 2010, EVERYTHING IS CONNEC, P29; Campos NF, 2014, IZA DISCUSSION PAPER; Cavallo E, 2013, REV ECON STAT, V95, P1549, DOI 10.1162/REST_a_00413; Coffman M, 2012, ENVIRON DEV ECON, V17, P187, DOI 10.1017/S1355770X11000350; Collier D, 1993, POLITICAL SCI STATE, P105; Dorsett R, 2013, EUR J POLIT ECON, V29, P119, DOI 10.1016/j.ejpoleco.2012.10.003; Dube A, POOLED SYNT IN PRESS; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Heim BT, 2014, SMALL BUS ECON, V43, P917, DOI 10.1007/s11187-014-9572-6; Instituto Nacional de Pesquisas Espaciais (INPE) Database, PROJ PROD MON FLOR A; Keele L, 2013, LEGIS STUD QUART, V38, P291, DOI 10.1111/lsq.12016; Kirkpatrick AJ, 2014, J ENVIRON ECON MANAG, V68, P357, DOI 10.1016/j.jeem.2014.05.001; Lapola DM, 2010, P NATL ACAD SCI USA, V107, P3388, DOI 10.1073/pnas.0907318107; LIJPHART A, 1971, AM POLIT SCI REV, V65, P682, DOI 10.2307/1955513; Mooney CZ, 1993, QUANTITATIVE APPL SO; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Neves Estela Maria Souza Costa, 2012, Estud. av., V26, P137, DOI 10.1590/S0103-40142012000100010; Ostrom E, 2010, GLOBAL ENVIRON CHANG, V20, P550, DOI 10.1016/j.gloenvcha.2010.07.004; Sampaio B, 2014, TRANSPORTMETRICA A, V10, P1, DOI 10.1080/18128602.2012.688073; Sanso-Navarro M, 2011, JCMS-J COMMON MARK S, V49, P463, DOI 10.1111/j.1468-5965.2010.02124.x; Seawright J, 2008, POLIT RES QUART, V61, P294, DOI 10.1177/1065912907313077; Trandafir M, 2014, DEMOGRAPHY, V51, P317, DOI 10.1007/s13524-013-0248-7; Verissimo A, 2002, EXPANSAO MADEIREIRA, V2nd; Villela M, 2010, PARAGOMINAS AINDA PO	35	57	57	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132590	10.1371/journal.pone.0132590	http://dx.doi.org/10.1371/journal.pone.0132590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26173108	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900063
J	Spear, GT; McKenna, M; Landay, AL; Makinde, H; Hamaker, B; French, AL; Lee, BH				Spear, Greg T.; McKenna, Mary; Landay, Alan L.; Makinde, Hadijat; Hamaker, Bruce; French, Audrey L.; Lee, Byung-Hoo			Effect of pH on Cleavage of Glycogen by Vaginal Enzymes	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; LACTOBACILLI; FLUID; FLORA; RISK	Glycogen expressed by the lower genital tract epithelium is believed to support Lactobacillus growth in vivo, although most genital isolates of Lactobacillus are not able to use glycogen as an energy source in vitro. We recently reported that alpha-amylase is present in the genital fluid of women and that it breaks down glycogen into small carbohydrates that support growth of lactobacilli. Since the pH of the lower genital tract can be very low, we determined how low pH affects glycogen processing by alpha-amylase. alpha-amylase in saliva degraded glycogen similarly at pH 6 and 7, but activity was reduced by 52% at pH 4. The glycogen degrading activity in nine genital samples from seven women showed a similar profile with an average reduction of more than 50% at pH 4. However, two samples collected from one woman at different times had a strikingly different pH profile with increased glycogen degradation at pH 4, 5 and 6 compared to pH 7. This second pH profile did not correlate with levels of human alpha-acid glucosidase or human intestinal maltase glucoamylase. High-performance anion-exchange chromatography showed that mostly maltose was produced from glycogen by samples with the second pH profile in contrast to genital a-amylase that yielded maltose, maltotriose and maltotetraose. These studies show that at low pH, alpha-amylase activity is reduced to low but detectable levels, which we speculate helps maintain Lactobacillus growth at a limited but sustained rate. Additionally, some women have a genital enzyme distinct from alpha-amylase with higher activity at low pH. Further studies are needed to determine the identity and distribution of this second enzyme, and whether its presence influences the makeup of genital microbiota.	[Spear, Greg T.; McKenna, Mary; Landay, Alan L.; Makinde, Hadijat] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Hamaker, Bruce] Purdue Univ, Dept Food Sci, Whistler Ctr Carbohydrate Res, W Lafayette, IN 47907 USA; [French, Audrey L.] Rush Univ, Med Ctr, Dept Med, CORE Ctr Cook Cty Hlth & Hosp Syst, Chicago, IL 60612 USA; [Lee, Byung-Hoo] Gachon Univ, Coll BioNano Technol, Dept Food Sci & Biotechnol, Songnam, South Korea	Rush University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Rush University; Gachon University	Spear, GT (corresponding author), Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA.	gspear@rush.edu	Yoo, Sang-Ho/AAI-4446-2020	Makinde, Hadijat-Kubura/0000-0001-8492-4187	NIH [AI082971]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034993, P01AI082971] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by NIH grant AI082971.	Aframian DJ, 2006, ORAL DIS, V12, P420, DOI 10.1111/j.1601-0825.2005.01217.x; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Birse KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079505; Boskey ER, 1999, INFECT IMMUN, V67, P5170, DOI 10.1128/IAI.67.10.5170-5175.1999; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Cruickshank R SA, 1934, J OBSTET GYN BR COMM, V41, P208, DOI DOI 10.1111/J.1471-0528; FOX CA, 1973, J REPROD FERTIL, V33, P69; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Hillier SL, 1998, AIDS RES HUM RETROV, V14, pS17; Lee CK, 2008, J AGR FOOD CHEM, V56, P126, DOI 10.1021/jf072508s; Ma LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070716; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Martin R, 2009, INT MICROBIOL, V11, P261, DOI 10.2436/20.1501.01.70; MIRMONSEF P, 2014, MENOPAUSE, V22, P1, DOI DOI 10.1097/GME.0000000000000397; Mirmonsef P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102467; Mirmonsef P, 2014, AM J REPROD IMMUNOL, V71, P531, DOI 10.1111/aji.12232; MORRIS DL, 1946, J BIOL CHEM, V166, P199; O'Hanlon DE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-120; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Spear GT, 2014, J INFECT DIS, V210, P1019, DOI 10.1093/infdis/jiu231; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; STEWARTT.DE, 1964, AM J OBSTET GYNECOL, V88, P676, DOI 10.1016/0002-9378(64)90898-1; WYLIE JG, 1969, J MED MICROBIOL, V2, P363, DOI 10.1099/00222615-2-3-363	23	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132646	10.1371/journal.pone.0132646	http://dx.doi.org/10.1371/journal.pone.0132646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171967	gold, Green Submitted, Green Published			2022-12-27	WOS:000358194900068
J	Wang, TC; Lin, CC; Lin, CD; Chung, HK; Wang, CY; Tsai, MH; Kao, CH				Wang, Tang-Chuan; Lin, Che-Chen; Lin, Chia-Der; Chung, Hsiung-Kwang; Wang, Ching-Yuang; Tsai, Ming-Hsui; Kao, Chia-Hung			Increased Acquired Cholesteatoma Risk in Patients with Osteoporosis: A Retrospective Cohort Study	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MIDDLE-EAR CHOLESTEATOMA; CHRONIC OTITIS-MEDIA; BONE-RESORPTION; FACTOR-ALPHA; OSTEOCLAST; INTERLEUKIN-1-ALPHA; DIAGNOSIS; PRESSURE; BIOLOGY	Objective Clinically, we found the increased incidence of acquired colesteatoma in the patients with osteoporosis. In this study, we used a retrospective cohort to examine this association and to investigate the possible mechanism. Methods We conducted a population-based retrospective cohort study by using the National Health Insurance Research Database (NHIRD). We identified an osteoporosis cohort comprising 37 124 patients newly diagnosed with osteoporosis aged 20 years or older. Patients in the comparison cohort had no history of osteoporosis and were frequency matched with the patients in the osteoporosis cohort according to sex, age, and index year. Results The acquired cholesteatoma incidence rates for the osteoporosis and comparison cohorts were 1.12 and 0.83 per 1000 person-years, respectively. After we adjusted for confounding factors, the osteoporosis cohort exhibited a 1.32-fold increased acquired cholesteatoma risk relative to the comparison cohort (hazard ratio [HR] = 1.32, 95% confidence interval [CI] = 1.11-1.57). In addition, patients with no history of otitis media (HR = 1.33, 95% CI = 1.11-1.59), cancer (HR = 1.34, 95% CI = 1.12-1.60), or COPD (HR = 1.26, 95% CI = 1.05-1.52) in the osteoporosis cohort exhibited an increased risk of subsequent acquired cholesteatoma relative to those in the comparison cohort. Conclusions Our cohort study indicated that patients with osteoporosis had a 1.31-fold increased acquired cholesteatoma risk relative to the comparison cohort. This risk was further increased in patients with comorbid otitis media. Hence, we recommend that otolaryngologists evaluate the condition of the middle ear of patients with osteoporosis.	[Wang, Tang-Chuan; Lin, Chia-Der; Chung, Hsiung-Kwang; Wang, Ching-Yuang; Tsai, Ming-Hsui] China Med Univ Hosp, Dept Otolaryngol Head & Neck Surg, Taichung, Taiwan; [Wang, Tang-Chuan] Univ Iowa Hosp, Dept Otolaryngol Head & Neck Surg, Iowa City, IA USA; [Lin, Che-Chen] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Che-Chen] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Iowa; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.	d10040@mail.cmuh.org.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039-006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002); China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092); NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan, and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akimoto R, 2000, ORL J OTO-RHINO-LARY, V62, P257, DOI 10.1159/000027756; Albino AP, 1998, AM J OTOL, V19, P7; Albino AP, 1998, AM J OTOL, V19, P266; Amar MS, 1996, J LARYNGOL OTOL, V110, P534, DOI 10.1017/S002221510013419X; Bujia J, 1996, EUR ARCH OTO-RHINO-L, V253, P152, DOI 10.1007/BF00615113; Bujia J, 1996, EUR ARCH OTO-RHINO-L, V253, P252; CHESHIRE IM, 1991, LANCET, V338, P1041, DOI 10.1016/0140-6736(91)91902-7; Chole RA, 1997, ANN NY ACAD SCI, V830, P95, DOI 10.1111/j.1749-6632.1997.tb51882.x; CHOLE RA, 1984, LARYNGOSCOPE, V94, P76, DOI 10.1002/lary.5540940117; CHOLE RA, 1985, ANN OTO RHINOL LARYN, V94, P165, DOI 10.1177/000348948509400214; Hamzei M, 2003, LARYNGOSCOPE, V113, P436, DOI 10.1097/00005537-200303000-00009; Ho KY, 2013, INT J MOL SCI, V14, P14439, DOI 10.3390/ijms140714439; IINO Y, 1990, ACTA OTO-LARYNGOL, V110, P410, DOI 10.3109/00016489009107462; Jung JY, 2002, ORL-J OTO-RHIN-LARYN, V64, P95, DOI 10.1159/000057787; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Karmody CS, 2012, OTOL NEUROTOL, V33, P42, DOI 10.1097/MAO.0b013e31823c919c; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; ORISEK BS, 1987, ARCH OTOLARYNGOL, V113, P386; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Spears M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071460; Spilsbury K, 2010, LARYNGOSCOPE, V120, P625, DOI 10.1002/lary.20765; Tanaka Y, 1999, LARYNGOSCOPE, V109, P1102, DOI 10.1097/00005537-199907000-00017; Thorsteinsson AL, 2014, OSTEOPOROSIS INT, V25, P1937, DOI 10.1007/s00198-014-2684-7; Tsai LT, 2010, NEURORADIOL J, V23, P307, DOI 10.1177/197140091002300308; Warriner AH, 2013, ORTHOP CLIN N AM, V44, P125, DOI 10.1016/j.ocl.2013.01.005; WOLFMAN DE, 1986, ARCH OTOLARYNGOL, V112, P1037; YAN SD, 1991, AM J OTOLARYNG, V12, P83, DOI 10.1016/0196-0709(91)90041-D; Yetiser S, 2002, OTOL NEUROTOL, V23, P647, DOI 10.1097/00129492-200209000-00007	28	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132447	10.1371/journal.pone.0132447	http://dx.doi.org/10.1371/journal.pone.0132447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171780	gold, Green Published, Green Submitted			2022-12-27	WOS:000358194900050
J	Han, SY; Tsou, MH; Clarke, KC				Han, Su Yeon; Tsou, Ming-Hsiang; Clarke, Keith C.			Do Global Cities Enable Global Views? Using Twitter to Quantify the Level of Geographical Awareness of US Cities	PLOS ONE			English	Article								Dynamic social media content, such as Twitter messages, can be used to examine individuals' beliefs and perceptions. By analyzing Twitter messages, this study examines how Twitter users exchanged and recognized toponyms (city names) for different cities in the United States. The frequency and variety of city names found in their online conversations were used to identify the unique spatiotemporal patterns of "geographical awareness" for Twitter users. A new analytic method, Knowledge Discovery in Cyberspace for Geographical Awareness (KDCGA), is introduced to help identify the dynamic spatiotemporal patterns of geographic awareness among social media conversations. Twitter data were collected across 50 U.S. cities. Thousands of city names around the world were extracted from a large volume of Twitter messages (over 5 million tweets) by using the Twitter Application Programming Interface (APIs) and Python language computer programs. The percentages of distant city names (cities located in distant states or other countries far away from the locations of Twitter users) were used to estimate the level of global geographical awareness for Twitter users in each U.S. city. A Global awareness index (GAI) was developed to quantify the level of geographical awareness of Twitter users from within the same city. Our findings are that: (1) the level of geographical awareness varies depending on when and where Twitter messages are posted, yet Twitter users from big cities are more aware of the names of international cities or distant US cities than users from mid-size cities; (2) Twitter users have an increased awareness of other city names far away from their home city during holiday seasons; and (3) Twitter users are more aware of nearby city names than distant city names, and more aware of big city names rather than small city names.	[Han, Su Yeon; Tsou, Ming-Hsiang] San Diego State Univ, Dept Geog, San Diego, CA 92182 USA; [Han, Su Yeon; Clarke, Keith C.] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA	California State University System; San Diego State University; University of California System; University of California Santa Barbara	Tsou, MH (corresponding author), San Diego State Univ, Dept Geog, San Diego, CA 92182 USA.	mtsou@mail.sdsu.edu	Clarke, Keith/L-8641-2019; Clarke, Keith C/E-1863-2011; Tsou, Ming-Hsiang/B-2357-2015	Clarke, Keith/0000-0001-5805-6056; Clarke, Keith C/0000-0001-5805-6056; Tsou, Ming-Hsiang/0000-0003-3421-486X	National Science Foundation [1028177, 1416509]; Division Of Computer and Network Systems [1028177] Funding Source: National Science Foundation; SBE Off Of Multidisciplinary Activities [1416509] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); SBE Off Of Multidisciplinary Activities(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This material is based upon work supported by the National Science Foundation under Grant No. 1028177, project titled "CDI-Type II: Mapping Cyberspace to Realspace: Visualizing and Understanding the Spatiotemporal Dynamics of Global Diffusion of Ideas and the Semantic Web" and Grant No. 1416509, project titled, "Spatiotemporal Modeling of Human Dynamics Across Social Media and Social Networks". Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.	[Anonymous], 2001, FOREIGN POLICY, P56; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Aslam AA, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3532; BEATTY WW, 1987, SEX ROLES, V16, P565, DOI 10.1007/BF00300374; Bo Pang, 2008, Foundations and Trends in Information Retrieval, V2, P1, DOI 10.1561/1500000001; Brunn SD, 1991, COLLAPSING SPACE TIM; Cairncross F., 2001, DEATH DISTANCE COMMU; CHIODO JJ, 1993, J GEOGR, V92, P110, DOI 10.1080/00221349308979633; Clarke KC, 2015, MAPS WEB MAPPING; Downs RM, 1970, PROGR GEOGRAPHY, V2, P65; Dreher A, 2006, APPL ECON, V38, P1091, DOI 10.1080/00036840500392078; Fellmann JD, 2007, HUMAN GEOGRAPHY, P66; Ford CM., 2011, TWITTER FACEBOOK 10; Ghosh D, 2013, CARTOGR GEOGR INF SC, V40, P90, DOI 10.1080/15230406.2013.776210; Huberman BA, 2008, P INT C COMP SUPP CO; Kamvar Sepandar D., 2011, P 4 ACM INT C WEB SE; Lerman K, 2010, ICWSM, V10, P90, DOI DOI 10.1146/ANNUREV.AN.03.100174.001431; Leskovec J., 2008, INT C WORLD WIDE WEB, DOI DOI 10.1145/1367497.1367620; Li LN, 2013, CARTOGR GEOGR INF SC, V40, P61, DOI 10.1080/15230406.2013.777139; Maceachren A.M., 2011, 25 INT CART C; Manovich Lev, 2011, TRENDING PROMISES CH, P460; Martens P, 2009, INTEGRATED ASSESSMEN, V9; Martens P., 2014, GLOBALIZATIONS, V12, P1; Mislove A, 2011, P INT AAAI C WEB SOC; Montello D. R., 2009, INT ENCY HUMAN GEOGR, P160, DOI DOI 10.1016/B978-008044910-4.00668-4; Nader, 2012, USING SOCIAL MEDIA G; Nagel AC, 2013, J MED INTERNET RES, V15, P263, DOI 10.2196/jmir.2705; OConnor B., 2010, ICWSM, P122; Padmanabhan A., 2013, P C EXTR SCI ENG DIS; Randolph J, 2001, G INDEX GLOBALISATIO; Ressler S., 2006, HOMELAND SECURITY AF, V2, P1; Rodrigue JP., 2013, GEOGRAPHY TRANSPORT, DOI DOI 10.4324/9781315618159-2; Sakaki T., 2010, P 19 INT C WORLD WID; Shook E, 2012, E SCI E SCI 2012 IEE; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Spitzberg B. H., 2013, STUDIES MEDIA COMMUN, V1, P101, DOI 10.11114/smc.v1i1.64; Thelwall M, 2011, J AM SOC INF SCI TEC, V62, P406, DOI 10.1002/asi.21462; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Tsou M-H, 2013, GOLDEN OPPORTUNITY M; Tsou MH, 2013, CARTOGR GEOGR INF SC, V40, P337, DOI 10.1080/15230406.2013.799738; Tsou MH, 2013, CARTOGR GEOGR INF SC, V40, P55, DOI 10.1080/15230406.2013.776754; Wallace R, 1997, SOC SCI MED, V44, P935, DOI 10.1016/S0277-9536(96)00197-9; Wang W, 2012, PRIV SEC RISK TRUST; Wong DWS, 2005, STAT ANAL GEOGRAPHIC; Xu C, 2013, CARTOGR GEOGR INF SC, V40, P103, DOI 10.1080/15230406.2013.776212; Zywietz D., 2006, J INT DEV, V18, P331, DOI DOI 10.1002/JID.1223	46	19	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132464	10.1371/journal.pone.0132464	http://dx.doi.org/10.1371/journal.pone.0132464			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1PW	26167942	gold, Green Published, Green Submitted			2022-12-27	WOS:000358193100045
J	Choi, HL; Suh, CI; Park, SW; Jin, JY; Cho, HG; Paik, SY				Choi, Hye Lim; Suh, Chang-Il; Park, Seung-Won; Jin, Ji-Young; Cho, Han-Gil; Paik, Soon-Young			Whole-Genome Sequencing Analysis of Sapovirus Detected in South Korea	PLOS ONE			English	Article							HUMAN ENTERIC CALICIVIRUSES; MOLECULAR CHARACTERIZATION; GASTROENTERITIS OUTBREAKS; GENETIC DIVERSITY; PHYLOGENETIC ANALYSIS; FAMILY CALICIVIRIDAE; GENOTYPE ANALYSIS; SAPPORO VIRUS; EPIDEMIOLOGY; RECOMBINATION	Sapovirus (SaV), a virus residing in the intestines, is one of the important causes of gastroenteritis in human beings. Human SaV genomes are classified into various genogroups and genotypes. Whole-genome analysis and phylogenetic analysis of ROK62, the SaV isolated in South Korea, were carried out. The ROK62 genome of 7429 nucleotides contains 3 open-reading frames (ORF). The genotype of ROK62 is SaV GI-1, and 94% of its nucleotide sequence is identical with other SaVs, namely Manchester and Mc114. Recently, SaV infection has been on the rise throughout the world, particularly in countries neighboring South Korea; however, very few academic studies have been done nationally. As the first whole-genome sequence analysis of SaV in South Korea, this research will help provide reference for the detection of recombination, tracking of epidemic spread, and development of diagnosis methods for SaV.	[Choi, Hye Lim; Jin, Ji-Young; Paik, Soon-Young] Catholic Univ Korea, Dept Microbiol, Seoul 137701, South Korea; [Suh, Chang-Il] Dankook Univ, Dept Med Consilience, Yongin 448701, Gyeonggi Do, South Korea; [Park, Seung-Won] Catholic Univ Daegu, Div Biotechnol, Daegu 712702, South Korea; [Cho, Han-Gil] Gyeonggi Prov Inst Hlth & Environm, Div Publ Hlth Res, Suwon, South Korea	Catholic University of Korea; Dankook University; Catholic University of Daegu	Paik, SY (corresponding author), Catholic Univ Korea, Dept Microbiol, 222 Banpo Daero, Seoul 137701, South Korea.	paik@catholic.ac.kr			National Research Foundation of Korea [NRF-2012R1A2A2A01045078]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by the National Research Foundation of Korea (NRF-2012R1A2A2A01045078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bank-Wolf BR, 2010, VET MICROBIOL, V140, P204, DOI 10.1016/j.vetmic.2009.08.021; Chanit W, 2009, EMERG INFECT DIS, V15, P1084, DOI 10.3201/eid1507.090153; CHIBA S, 1979, J MED VIROL, V4, P249, DOI 10.1002/jmv.1890040402; Clarke IN, 2000, J INFECT DIS, V181, pS309, DOI 10.1086/315575; Dey SK, 2012, EPIDEMIOL INFECT, V140, P74, DOI 10.1017/S0950268811000240; Farkas T, 2004, ARCH VIROL, V149, P1309, DOI 10.1007/s00705-004-0296-9; Guo M, 1999, J VIROL, V73, P9625, DOI 10.1128/JVI.73.11.9625-9631.1999; Hansman GS, 2007, REV MED VIROL, V17, P133, DOI 10.1002/rmv.533; Hansman GS, 2005, EMERG INFECT DIS, V11, P1916; Hansman GS, 2004, J CLIN MICROBIOL, V42, P1305, DOI 10.1128/JCM.42.3.1305-1307.2004; Harada S, 2013, JPN J INFECT DIS, V66, P454, DOI 10.7883/yoken.66.454; Harada S, 2012, ARCH VIROL, V157, P1999, DOI 10.1007/s00705-012-1387-7; Harada S, 2009, J MED VIROL, V81, P1117, DOI 10.1002/jmv.21454; Honma S, 2001, J MED VIROL, V65, P413, DOI 10.1002/jmv.2050; Iritani N, 2014, J MED VIROL, V86, P2019, DOI 10.1002/jmv.23883; Jiang X, 1997, ARCH VIROL, V142, P1813, DOI 10.1007/s007050050199; Johansson PJH, 2005, SCAND J INFECT DIS, V37, P200, DOI 10.1080/00365540410020974; Koopmans M, 2001, NOVART FDN SYMP, V238, P197; Lee LE, 2012, EMERG INFECT DIS, V18, P873, DOI 10.3201/eid1805.111843; LIU BL, 1995, ARCH VIROL, V140, P1345, DOI 10.1007/BF01322662; Liu BL, 1997, VIRUS GENES, V15, P25, DOI 10.1023/A:1007946628253; MATSON DO, 1995, J MED VIROL, V45, P215, DOI 10.1002/jmv.1890450218; Nakanishi K, 2011, MICROBIOL IMMUNOL, V55, P657, DOI 10.1111/j.1348-0421.2011.00358.x; Nakata S, 2000, J INFECT DIS, V181, P2029, DOI 10.1086/315500; Numata K, 1997, ARCH VIROL, V142, P1537, DOI 10.1007/s007050050178; Oka T, 2015, CLIN MICROBIOL REV, V28, P32, DOI 10.1128/CMR.00011-14; Oka T, 2012, ARCH VIROL, V157, P349, DOI 10.1007/s00705-011-1161-2; Okada M, 2002, ARCH VIROL, V147, P1445, DOI 10.1007/s00705-002-0821-7; Pang XLL, 2009, J INFECT DIS, V199, P547, DOI 10.1086/596210; Park SH, 2011, CLIN LAB, V57, P59; Park S, 2012, CLIN LAB, V58, P1219, DOI 10.7754/Clin.Lab.2012.120118; Robinson S, 2002, J MED VIROL, V67, P282, DOI 10.1002/jmv.2219; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Svraka S, 2010, J CLIN MICROBIOL, V48, P2191, DOI 10.1128/JCM.02427-09; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vinje J, 2000, J CLIN MICROBIOL, V38, P530	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132328	10.1371/journal.pone.0132328	http://dx.doi.org/10.1371/journal.pone.0132328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161646	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300119
J	Day, RJ; Mason, MJ; Thomas, C; Poon, WW; Rohn, TT				Day, Ryan J.; Mason, Maria J.; Thomas, Chloe; Poon, Wayne W.; Rohn, Troy T.			Caspase-Cleaved Tau Co-Localizes with Early Tangle Markers in the Human Vascular Dementia Brain	PLOS ONE			English	Article							CORPORA-AMYLACEA; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; PROTEINS; RISK; ACTIVATION; PATHOLOGY; EPITOPES; AD	Vascular dementia (VaD) is the second most common form of dementia in the United States and is characterized as a cerebral vessel vascular disease that leads to ischemic episodes. Whereas the relationship between caspase-cleaved tau and neurofibrillary tangles (NFTs) in Alzheimer's disease (AD) has been previously described, whether caspase activation and cleavage of tau occurs in VaD is presently unknown. To investigate a potential role for caspase-cleaved tau in VaD, we analyzed seven confirmed cases of VaD by immunohistochemistry utilizing a well-characterized antibody that specifically detects caspase-cleaved tau truncated at Asp(421). Application of this antibody (TauC3) revealed consistent labeling within NFTs, dystrophic neurites within plaque-rich regions and corpora amylacea (CA) in the human VaD brain. Labeling of CA by the TauC3 antibody was widespread throughout the hippocampus proper, was significantly higher compared to age matched controls, and co-localized with ubiquitin. Staining of the TauC3 antibody co-localized with MC-1, AT8, and PHF-1 within NFTs. Quantitative analysis indicated that roughly 90% of PHF-1-labeled NFTs contained caspase-cleaved tau. In addition, we documented the presence of active caspase-3 within plaques, blood vessels and pretangle neurons that co-localized with TauC3. Collectively, these data support a role for the activation of caspase-3 and proteolytic cleavage of TauC3 in VaD providing further support for the involvement of this family of proteases in NFT pathology.	[Day, Ryan J.; Rohn, Troy T.] Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA; [Mason, Maria J.; Thomas, Chloe; Poon, Wayne W.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92697 USA	Idaho; Boise State University; University of California System; University of California Irvine	Rohn, TT (corresponding author), Boise State Univ, Dept Biol Sci, Sci Bldg,Room 228, Boise, ID 83725 USA.	trohn@boisestate.edu		Poon, Wayne/0000-0003-0625-3968	National Institutes of Health [1R15AG042781-01A1, AG016573]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R15AG042781, P50AG016573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this manuscript was supported by National Institutes of Health Grant 1R15AG042781-01A1 to TTR and AG016573 to WWP. http://grants.nih.gov/grants/oer.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal NT, 2007, SEMIN NEUROL, V27, P66, DOI 10.1055/s-2006-956757; Ahtiluoto S, 2010, NEUROLOGY, V75, P1195, DOI 10.1212/WNL.0b013e3181f4d7f8; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cavanagh JB, 1999, BRAIN RES REV, V29, P265, DOI 10.1016/S0165-0173(99)00003-X; CISSE S, 1993, ACTA NEUROPATHOL, V85, P233; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Geroldi C, 2005, ARCH NEUROL-CHICAGO, V62, P1067, DOI 10.1001/archneur.62.7.1067; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; Grinberg LT, 2010, J NEUROL SCI, V299, P136, DOI 10.1016/j.jns.2010.08.055; Guillozet-Bongaarts AL, 2005, NEUROBIOL AGING, V26, P1015, DOI 10.1016/j.neurobiolaging.2004.09.019; Jellinger KA, 2007, ACTA NEUROPATHOL, V113, P349, DOI 10.1007/s00401-006-0185-2; Jellinger KA, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00017; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kalaria RN, 2003, NEUROL RES, V25, P661, DOI 10.1179/016164103101201968; Knopman DS, 2003, ARCH NEUROL-CHICAGO, V60, P569, DOI 10.1001/archneur.60.4.569; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Kuller LH, 2005, NEUROLOGY, V64, P1548, DOI 10.1212/01.WNL.0000160115.55756.DE; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; LOEFFLER KU, 1993, INVEST OPHTH VIS SCI, V34, P2600; Meng H, 2009, NEUROPATHOLOGY, V29, P664, DOI 10.1111/j.1440-1789.2009.01024.x; Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588; Posner HB, 2002, NEUROLOGY, V58, P1175, DOI 10.1212/WNL.58.8.1175; Reitz C, 2004, ARCH NEUROL-CHICAGO, V61, P705, DOI 10.1001/archneur.61.5.705; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Rohn TT, 2014, INT J CLIN EXP PATHO, V7, P3504; Rohn TT, 2014, INT J CLIN EXP PATHO, V7, P938; Rohn TT, 2013, INT J CLIN EXP PATHO, V6, P41; Rohn TT, 2010, APOPTOSIS, V15, P1403, DOI 10.1007/s10495-010-0463-2; Rohn TT, 2009, HISTOL HISTOPATHOL, V24, P1081, DOI 10.14670/HH-24.1081; Rohn TT, 2008, REV NEUROSCIENCE, V19, P383; Ross GW, 1999, NEUROLOGY, V53, P337, DOI 10.1212/WNL.53.2.337; SINGHRAO SK, 1993, NEUROPATH APPL NEURO, V19, P269, DOI 10.1111/j.1365-2990.1993.tb00437.x; SINGHRAO SK, 1994, NEUROPATH APPL NEURO, V20, P66, DOI 10.1111/j.1365-2990.1994.tb00958.x; Spires-Jones TL, 2008, J NEUROSCI, V28, P862, DOI 10.1523/JNEUROSCI.3072-08.2008; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Staekenborg SS, 2008, STROKE, V39, P317, DOI 10.1161/STROKEAHA.107.493353; Staekenborg SS, 2010, J NEUROL NEUROSUR PS, V81, P547, DOI 10.1136/jnnp.2009.187500; STAM FC, 1973, ACTA NEUROPATHOL, V25, P95, DOI 10.1007/BF00687554; Sui RB, 2012, MED HYPOTHESES, V78, P162, DOI 10.1016/j.mehy.2011.10.017; Uchihara T, 2014, NEUROPATHOLOGY, V34, P571, DOI 10.1111/neup.12108; van Oijen M, 2007, ANN NEUROL, V61, P403, DOI 10.1002/ana.21073; Veld BAI, 2001, NEUROBIOL AGING, V22, P407, DOI 10.1016/S0197-4580(00)00241-4; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Wilhelmus MMM, 2011, NEUROBIOL AGING, V32, P845, DOI 10.1016/j.neurobiolaging.2009.04.019; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; WOODFORD B, 1980, AM J OPHTHALMOL, V90, P492, DOI 10.1016/S0002-9394(14)75018-4	49	24	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132637	10.1371/journal.pone.0132637	http://dx.doi.org/10.1371/journal.pone.0132637			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161867	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300163
J	Liao, RY; Liu, QH; Zheng, ZH; Fan, JJ; Peng, WX; Kong, QY; He, HJ; Yang, SC; Chen, WF; Tang, XQ; Yu, XQ				Liao, Ruyi; Liu, Qinghua; Zheng, Zhihua; Fan, Jinjin; Peng, Wenxing; Kong, Qingyu; He, Huijuan; Yang, Shicong; Chen, Wenfang; Tang, Xueqing; Yu, Xueqing			Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CYCLOSPORINE-A; DIRECT TARGET; LPR MICE; EXPRESSION; FK506; IMMUNOSUPPRESSANT; SYNAPTOPODIN; MECHANISMS; DISEASE	Objective Several studies have reported that tacrolimus (TAC) significantly reduced proteinuria in lupus nephritis (LN) patients and mouse models. However, the mechanism for this effect remains undetermined. This study explored the mechanism of how TAC protects podocytes from injury to identify new targets for protecting renal function. Methods MRL/lpr mice were given TAC at a dosage of 0.1 mg/kg per day by intragastric administration for 8 weeks. Urine and blood samples were collected. Kidney sections (2 mu m) were stained with hematoxylin-eosin (HE), periodic acid-Schiff base (PAS) and Masson's trichrome stain. Mouse podocyte cells (MPC5) were treated with TAC and/or TGF-beta(1) for 48h. The mRNA levels and protein expression of synaptopodin and Wilms' tumor 1 (WT1) were determined by real-time PCR, Western blotting and/or immunofluorescence, respectively. Flow cytometry was used to detect cell apoptosis with annexin V. Podocyte foot processes were observed under transmission electron microscopy. IgG and C3 deposition were assessed with immunofluorescence assays and confocal microscopy. Results Synaptopodin expression significantly decreased in MRL/lpr disease control mice, accompanied by increases in 24-h proteinuria, blood urea nitrogen, and serum creatinine. TAC, however, reduced proteinuria, improved renal function, attenuated renal pathology, restored synaptopodin expression and preserved podocyte numbers. In MPC5 cells, TGF-beta(1) enhanced F-actin damage in podocytes and TAC stabilized it. TAC also decreased TGF-beta(1)-induced podocyte apoptosis in vitro and inhibited foot process fusion in MRL/lpr mice. In addition, our results also showed TAC inhibited glomerular deposition of IgG and C3. Conclusion This study demonstrated that TAC reduced proteinuria and preserved renal function in LN through protecting podocytes from injury partly by stabilizing podocyte actin cytoskeleton and inhibiting podocyte apoptosis.	[Liao, Ruyi; Liu, Qinghua; Zheng, Zhihua; Fan, Jinjin; Peng, Wenxing; Kong, Qingyu; He, Huijuan; Tang, Xueqing; Yu, Xueqing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou 510275, Guangdong, Peoples R China; [Liao, Ruyi; Liu, Qinghua; Zheng, Zhihua; Fan, Jinjin; Peng, Wenxing; Kong, Qingyu; He, Huijuan; Tang, Xueqing; Yu, Xueqing] Guangdong Prov Key Lab Nephrol, Guangzhou, Guangdong, Peoples R China; [Liao, Ruyi; Liu, Qinghua; Zheng, Zhihua; Fan, Jinjin; Peng, Wenxing; Kong, Qingyu; He, Huijuan; Tang, Xueqing; Yu, Xueqing] Minist Hlth, Key Lab Nephrol, Guangzhou, Guangdong, Peoples R China; [Yang, Shicong; Chen, Wenfang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Yu, XQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou 510275, Guangdong, Peoples R China.	yuxq@mail.sysu.edu.cn			National Key Technology Research and Development Program of the Ministry of Science and Technology, China [2011BAI10B05]; Department of Science and Technology, Guangzhou City, China [2010U1-E00831]; 5010 clinical Program of Sun Yat-sen University [2007007]; National Natural Science Foundation of China [81370863]; Fundamental Research Funds for the Central Universities [13YKPY17]; Research Fund for PhD Program, Ministry of Education, China [20100171120067]; Natural Science Foundation of Guangdong Province [10451008901005957]	National Key Technology Research and Development Program of the Ministry of Science and Technology, China; Department of Science and Technology, Guangzhou City, China(Department of Science & Technology (DOST), Philippines); 5010 clinical Program of Sun Yat-sen University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Fund for PhD Program, Ministry of Education, China; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from National Key Technology Research and Development Program of the Ministry of Science and Technology, China (No. 2011BAI10B05), Department of Science and Technology, Guangzhou City, China (No. 2010U1-E00831), and 5010 clinical Program of Sun Yat-sen University (No. 2007007) to Xueqing Yu. Qinghua Liu was supported by grants from National Natural Science Foundation of China (No. 81370863), The Fundamental Research Funds for the Central Universities (No. 13YKPY17), Research Fund for PhD Program, Ministry of Education, China (No. 20100171120067) and Natural Science Foundation of Guangdong Province (No. 10451008901005957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Astellas Pharmaceuticals supplied the tacrolimus used in this study, but it played no role in the design and conduct of this study as well as in the analysis and the interpretation of results. Writing and publication of the manuscript were not contingent on the approval of Astellas Pharmaceuticals.	Chen W, 2011, AM J KIDNEY DIS, V57, P235, DOI 10.1053/j.ajkd.2010.08.036; Das R, 2014, AM J PHYSIOL-RENAL, V306, pF155, DOI 10.1152/ajprenal.00438.2013; ENTANI C, 1993, NEPHRON, V64, P471, DOI 10.1159/000187375; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Fornoni A, 2001, AM J PATHOL, V158, P275, DOI 10.1016/S0002-9440(10)63966-1; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; He FF, 2011, CELL BIOL INT, V35, P827, DOI 10.1042/CBI20100411; Herman-Edelstein M, 2013, CURR OPIN NEPHROL HY, V22, P93, DOI 10.1097/MNH.0b013e32835b4870; Kanemoto K, 2003, PATHOL INT, V53, P596, DOI 10.1046/j.1440-1827.2003.01526.x; KINO T, 1987, J ANTIBIOT, V40, P1256, DOI 10.7164/antibiotics.40.1256; Kitamura N, 2009, J INT MED RES, V37, P892, DOI 10.1177/147323000903700335; Li XY, 2009, AM J KIDNEY DIS, V54, P51, DOI 10.1053/j.ajkd.2009.02.018; Lotem J, 1998, P NATL ACAD SCI USA, V95, P4601, DOI 10.1073/pnas.95.8.4601; Mannoor K, 2012, J IMMUNOL, V188, P3628, DOI 10.4049/jimmunol.1102859; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; Mundel P, 2010, KIDNEY INT, V77, P571, DOI 10.1038/ki.2009.424; Olin AI, 2014, ARTHRITIS RHEUMATOL, V66, P397, DOI 10.1002/art.38250; Perysinaki GS, 2011, LUPUS, V20, P781, DOI 10.1177/0961203310397412; QUINN DG, 1991, IMMUNOLOGY, V72, P550; Schonenberger E, 2011, NEPHROL DIAL TRANSPL, V26, P18, DOI 10.1093/ndt/gfq617; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Srivastava T, 2001, KIDNEY INT, V59, P118, DOI 10.1046/j.1523-1755.2001.00472.x; Su J, 2010, DIABETES RES CLIN PR, V87, P167, DOI 10.1016/j.diabres.2009.10.022; SUZUKI N, 1990, CLIN EXP IMMUNOL, V79, P240; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Walter DH, 1998, CIRCULATION, V98, P1153, DOI 10.1161/01.CIR.98.12.1153; White KE, 2004, KIDNEY INT, V66, P663, DOI 10.1111/j.1523-1755.2004.00787.x; Yamamoto K, 2000, LAB INVEST, V80, P1561, DOI 10.1038/labinvest.3780166; Yamamoto T, 1996, KIDNEY INT, V49, P461, DOI 10.1038/ki.1996.65; Yoon KH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/686480; Zhao ZG, 2005, ARTHRITIS RHEUM-US, V52, P522, DOI 10.1002/art.20862	32	48	54	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132724	10.1371/journal.pone.0132724	http://dx.doi.org/10.1371/journal.pone.0132724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161538	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300172
J	Reeb, PD; Bramardi, SJ; Steibel, JP				Reeb, Pablo D.; Bramardi, Sergio J.; Steibel, Juan P.			Assessing Dissimilarity Measures for Sample-Based Hierarchical Clustering of RNA Sequencing Data Using Plasmode Datasets	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; STATISTICAL-METHODS; SEQ; GENE; VALIDATION; NORMALIZATION; TOPHAT	Sample-and gene-based hierarchical cluster analyses have been widely adopted as tools for exploring gene expression data in high-throughput experiments. Gene expression values (read counts) generated by RNA sequencing technology (RNA-seq) are discrete variables with special statistical properties, such as over-dispersion and right-skewness. Additionally, read counts are subject to technology artifacts as differences in sequencing depth. This possesses a challenge to finding distance measures suitable for hierarchical clustering. Normalization and transformation procedures have been proposed to favor the use of Euclidean and correlation based distances. Additionally, novel model-based dissimilarities that account for RNA-seq data characteristics have also been proposed. Adequacy of dissimilarity measures has been assessed using parametric simulations or exemplar datasets that may limit the scope of the conclusions. Here, we propose the simulation of realistic conditions through creation of plasmode datasets, to assess the adequacy of dissimilarity measures for sample-based hierarchical clustering of RNA-seq data. Consistent results were obtained using plasmode datasets based on RNA-seq experiments conducted under widely different conditions. Dissimilarity measures based on Euclidean distance that only considered data normalization or data standardization were not reliable to represent the expected hierarchical structure. Conversely, using either a Poisson-based dissimilarity or a rank correlation based dissimilarity or an appropriate data transformation, resulted in dendrograms that resemble the expected hierarchical structure. Plasmode datasets can be generated for a wide range of scenarios upon which dissimilarity measures can be evaluated for sample-based hierarchical clustering analysis. We showed different ways of generating such plasmodes and applied them to the problem of selecting a suitable dissimilarity measure. We report several measures that are satisfactory and the choice of a particular measure may rely on the availability on the software pipeline of preference.	[Reeb, Pablo D.; Steibel, Juan P.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Reeb, Pablo D.; Bramardi, Sergio J.] Univ Nacl Comahue, Dept Stat, Cinco Saltos, Rio Negro, Argentina; [Bramardi, Sergio J.] Univ Nacl La Plata, Coll Agr & Forest Sci, La Plata, Buenos Aires, Argentina; [Steibel, Juan P.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA	Michigan State University; Universidad Nacional del Comahue; National University of La Plata; Michigan State University	Steibel, JP (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	steibelj@msu.edu	Bramardi, Sergio/AAQ-8533-2020		Agriculture and Food Research Initiative Competitive Grant from USDA National Institute of Food and Agriculture [2010-65205-20342]	Agriculture and Food Research Initiative Competitive Grant from USDA National Institute of Food and Agriculture	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2010-65205-20342 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bottomly D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017820; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cattell RB, 1967, MULTIVARIATE BEHAV R, P57; Dalton L, 2009, CURR GENOMICS, V10, P430, DOI 10.2174/138920209789177601; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Frazee AC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-449; Gadbury GL, 2009, METHODS MOL BIOL, V553, P181, DOI 10.1007/978-1-60327-563-7_9; Gadbury GL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000098; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; Hastie T., 2009, UNSUPERVISED LEARNIN; Izenman AJ, 2008, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-78189-1_1; Jiang DX, 2004, IEEE T KNOWL DATA EN, V16, P1370, DOI 10.1109/TKDE.2004.68; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liu P, 2014, FRONT PROBAB STAT SC, P191, DOI 10.1007/978-3-319-07212-8_10; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma C, 2012, PLANT PHYSIOL, V160, P192, DOI 10.1104/pp.112.201962; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mehta T, 2004, NAT GENET, V36, P943, DOI 10.1038/ng1422; Mehta TS, 2006, PHYSIOL GENOMICS, V28, P24, DOI 10.1152/physiolgenomics.00095.2006; Pachter L, 2011, 11043889 ARXIV, P1; R Development Core Team, 2014, R LANG ENV STAT COMP; Rau A, 2015, BIOINFORMATICS, V31, P1420, DOI 10.1093/bioinformatics/btu845; Rau A, 2013, BIOINFORMATICS, V29, P2146, DOI 10.1093/bioinformatics/btt350; Reeb Pablo D., 2013, Frontiers in Genetics, V4, P178, DOI 10.3389/fgene.2013.00178; RICHARD A. J., 2002, APPL MULTIVARIATE ST; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Si YQ, 2014, BIOINFORMATICS, V30, P197, DOI 10.1093/bioinformatics/btt632; Sloutsky R, 2013, BRIEF BIOINFORM, V14, P423, DOI 10.1093/bib/bbs057; SOKAL ROBERT R., 1962, TAXON, V11, P33, DOI 10.2307/1217208; Steibel JP, 2014, 10 WCGALP VANC CAN; Steibel JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016766; Steibel JP, 2009, GENOMICS, V94, P146, DOI 10.1016/j.ygeno.2009.04.008; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Iterson M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-450; Vaughan LK, 2009, COMPUT STAT DATA AN, V53, P1755, DOI 10.1016/j.csda.2008.02.032; Waller NG, 2010, MULTIVARIATE BEHAV M, P37; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Witten DM, 2011, ANN APPL STAT, V5, P2493, DOI 10.1214/11-AOAS493; Xiong H., 2013, CLUSTERING VALIDATIO; Zhou XB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku310	48	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132310	10.1371/journal.pone.0132310	http://dx.doi.org/10.1371/journal.pone.0132310			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162080	Green Published, gold			2022-12-27	WOS:000358162300117
J	Wen, QY; Wang, WY; Chu, SZ; Luo, JD; Chen, LJ; Xie, GY; Xu, LN; Li, MR; Fan, SQ				Wen, Qiuyuan; Wang, Weiyuan; Chu, Shuzhou; Luo, Jiadi; Chen, Lingjiao; Xie, Guiyuan; Xu, Lina; Li, Meirong; Fan, Songqing			Flot-2 Expression Correlates with EGFR Levels and Poor Prognosis in Surgically Resected Non-Small Cell Lung Cancer	PLOS ONE			English	Article							FLOTILLIN-2; REGGIE-1/FLOTILLIN-2; PROGRESSION; MEMBRANE; SURVIVAL; OLIGOMERIZATION; OVEREXPRESSION; IDENTIFICATION; ASSOCIATION; CARCINOMA	We previously reported that expression of Flotillin 2 (Flot-2), a protein isolated from caveolae/lipid raft domains, increased significantly in nasopharyngeal carcinoma (NPC) compared with normal tissues. Signal transduction through epidermal growth factor receptors (EGFR) and Flot-2 play an important role in cancer development, but their precise role in lung cancer has not been investigated. In this study, we have investigated the correlation between the expression of Flot-2 and EGFR, which increase significantly in non-small cell lung cancer (NSCLC) patients (n=352) compared with non-cancer tissues. Additionally, patients with advanced stages of NSCLC had higher positive expression of Flot-2 and EGFR than patients with early stages. NSCLC patients with increased expression of Flot-2 and EGFR had significantly less overall survival rates than patients with less expression of Flot-2 and EGFR. Taken together, our data suggest that increased expression of Flot-2 and EGFR in NSCLC patients is inversely proportional to the disease prognosis and that increased expression of Flot-2 associated with increased EGFR may serve as a biomarker to predict poor disease prognosis.	[Wen, Qiuyuan; Wang, Weiyuan; Chu, Shuzhou; Luo, Jiadi; Chen, Lingjiao; Xu, Lina; Li, Meirong; Fan, Songqing] Cent S Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China; [Xie, Guiyuan] Cent S Univ, Xiangya Hosp 2, Dept Oncol, Changsha, Hunan, Peoples R China	Central South University; Central South University	Fan, SQ (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China.	songqingfan2000@yahoo.com	xu, li/GNH-3667-2022		National Natural Sciences Foundations of China [81272566, 81472773]	National Natural Sciences Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from The National Natural Sciences Foundations of China (No: 81272566; 81472773) (http://isis.nsfc.gov.cn/).	Al Zobair AA, 2013, ONCOL REP, V29, P1524, DOI 10.3892/or.2013.2254; Amaddii M, 2012, J BIOL CHEM, V287, P7265, DOI 10.1074/jbc.M111.287599; Arkhipova KA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-100; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Banning Antje, 2014, Cells, V3, P129, DOI 10.3390/cells3010129; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; Doherty SD, 2006, MELANOMA RES, V16, P461, DOI 10.1097/01.cmr.0000222592.75858.20; Gately K, 2014, CLIN LUNG CANCER, V15, P58, DOI 10.1016/j.cllc.2013.08.005; Goffin JR, 2013, CLIN THER, V35, P1282, DOI 10.1016/j.clinthera.2013.08.007; Hazarika P, 2004, CANCER RES, V64, P7361, DOI 10.1158/0008-5472.CAN-04-0823; Jiang AG, 2013, ONCOL LETT, V6, P375, DOI 10.3892/ol.2013.1368; Liang ZY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-376; Little AG, 2007, LUNG CANCER, V57, P253, DOI 10.1016/j.lungcan.2007.03.012; Liu YQ, 2015, INT J CLIN EXP PATHO, V8, P622; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Sasaki Y, 2008, MOL CANCER RES, V6, P395, DOI 10.1158/1541-7786.MCR-07-0108; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Solis GP, 2012, MOL BIOL CELL, V23, P1812, DOI 10.1091/mbc.E11-12-1006; Wang X, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-190; Wang YL, 2015, INT J CLIN EXP PATHO, V8, P601; Wen QY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101676; Yang XY, 2005, CELL ONCOL, V27, P215; Zhu Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062365	26	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132190	10.1371/journal.pone.0132190	http://dx.doi.org/10.1371/journal.pone.0132190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161893	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300103
J	Xia, JH; Zhang, YY; Xin, LL; Kong, SY; Chen, YX; Yang, SL; Li, K				Xia, Jihan; Zhang, Yuanyuan; Xin, Leilei; Kong, Siyuan; Chen, Yaoxing; Yang, Shulin; Li, Kui			Global Transcriptomic Profiling of Cardiac Hypertrophy and Fatty Heart Induced by Long-Term High-Energy Diet in Bama Miniature Pigs	PLOS ONE			English	Article							MYOCARDIAL SUBSTRATE METABOLISM; FACTOR-KAPPA-B; GENE-EXPRESSION; FAILURE; CARDIOMYOPATHY; OBESITY; MECHANISMS; MUTATIONS; RISK; CELL	A long-term high-energy diet affects human health and leads to obesity and metabolic syndrome in addition to cardiac steatosis and hypertrophy. Ectopic fat accumulation in the heart has been demonstrated to be a risk factor for heart disorders, but the molecular mechanism of heart disease remains largely unknown. Bama miniature pigs were fed a high-fat, high-sucrose diet (HFHSD) for 23 months. These pigs developed symptoms of metabolic syndrome and showed cardiac steatosis and hypertrophy with a greatly increased body weight (2.73-fold, P < 0.01), insulin level (4.60-fold, P < 0.01), heart weight (1.82-fold, P < 0.05) and heart volume (1.60-fold, P < 0.05) compared with the control pigs. To understand the molecular mechanisms of cardiac steatosis and hypertrophy, nine pig heart cRNA samples were hybridized to porcine GeneChips. Microarray analyses revealed that 1,022 genes were significantly differentially expressed (P < 0.05, >= 1.5-fold change), including 591 up-regulated and 431 down-regulated genes in the HFHSD group relative to the control group. KEGG analysis indicated that the observed heart disorder involved the signal transduction-related MAPK, cytokine, and PPAR signaling pathways, energy metabolism-related fatty acid and oxidative phosphorylation signaling pathways, heart function signaling-related focal adhesion, axon guidance, hypertrophic cardiomyopathy and actin cytoskeleton signaling pathways, inflammation and apoptosis pathways, and others. Quantitative RT-PCR assays identified several important differentially expressed heart-related genes, including STAT3, ACSL4, ATF4, FADD, PPP3CA, CD74, SLA-8, VCL, ACTN2 and FGFR1, which may be targets of further research. This study shows that a long-term, high-energy diet induces obesity, cardiac steatosis, and hypertrophy and provides insights into the molecular mechanisms of hypertrophy and fatty heart to facilitate further research.	[Xia, Jihan; Xin, Leilei; Kong, Siyuan; Yang, Shulin; Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Zhang, Yuanyuan; Chen, Yaoxing] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Li, Kui] CAAS, Agr Genomes Inst Shenzhen, Shenzhen 518120, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; China Agricultural University; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS	Yang, SL (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.	yangshulin@caas.cn	zhang, yuanyuan/GYA-4428-2022; Xia, Jihan/GLQ-5273-2022	Xia, Jihan/0000-0002-0035-0727	National Natural Science Foundation of China [31372276]; National Key Technology Support Program [2012BAI39B04]; National Basic Research Program [2011CBA01005]; National Science and Technology Major Project [2014ZX08010-003]; Development Program of China [2012AA020603]; Agricultural Science and Technology Innovation Program [ASTIP-IAS05, ASTIP-IAS-TS-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Support Program(National Key Technology R&D Program); National Basic Research Program(National Basic Research Program of China); National Science and Technology Major Project; Development Program of China; Agricultural Science and Technology Innovation Program	This research was supported by the National Natural Science Foundation of China (31372276), National Key Technology Support Program (2012BAI39B04), The National Basic Research Program (2011CBA01005), National Science and Technology Major Project (2014ZX08010-003), Development Program of China (2012AA020603) and The Agricultural Science and Technology Innovation Program (ASTIP-IAS05, ASTIP-IAS-TS-4).	Abdulsid A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071127; Barbisan F, 2009, IMMUNOGENETICS, V61, P145, DOI 10.1007/s00251-008-0339-6; Baumgarten G, 2002, CIRCULATION, V105, P2192, DOI 10.1161/01.CIR.0000015608.37608.18; Bays JL, 2014, J CELL BIOL, V205, P251, DOI 10.1083/jcb.201309092; Bell DSH, 2007, CARDIOL CLIN, V25, P523, DOI 10.1016/j.ccl.2007.08.003; Berenji K, 2005, AM J PHYSIOL-HEART C, V289, pH8, DOI 10.1152/ajpheart.01303.2004; Brindley DN, 2010, AM J PHYSIOL-ENDOC M, V298, pE897, DOI 10.1152/ajpendo.00509.2009; Chan CP, 2013, BBA-MOL CELL RES, V1833, P2165, DOI 10.1016/j.bbamcr.2013.05.002; Chess DJ, 2008, CARDIOVASC RES, V79, P269, DOI 10.1093/cvr/cvn074; Chiu C, 2010, J AM COLL CARDIOL, V55, P1127, DOI 10.1016/j.jacc.2009.11.016; Franchini KG, 2009, BRAZ J MED BIOL RES, V42, P44, DOI 10.1590/S0100-879X2009000100008; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Graner M, 2013, J CLIN ENDOCR METAB, V98, P1189, DOI 10.1210/jc.2012-3190; Gupta S, 2007, ANTIOXID REDOX SIGN, V9, P623, DOI 10.1089/ars.2007.1474; Guzzardi Maria A, 2011, Rev Diabet Stud, V8, P403, DOI 10.1900/RDS.2011.8.403; Hsia HC, 2014, J SURG RES, V191, P268, DOI 10.1016/j.jss.2014.05.084; Iozzo P, 2011, DIABETES CARE, V34, pS371, DOI 10.2337/dc11-s250; Kim HJ, 2014, J BIOL CHEM, V289, P1429, DOI 10.1074/jbc.M113.520130; Kusza S, 2011, ANIM GENET, V42, P510, DOI 10.1111/j.1365-2052.2010.02170.x; Madsen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062503; Malchers F, 2014, CANCER DISCOV, V4, P246, DOI 10.1158/2159-8290.CD-13-0323; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Ong RW, 2014, J NEUROL NEUROSUR PS, V85, P1058, DOI 10.1136/jnnp-2014-307608; Osterholt M, 2013, HEART FAIL REV, V18, P645, DOI 10.1007/s10741-012-9346-7; Peterson LR, 2004, CIRCULATION, V109, P2191, DOI 10.1161/01.CIR.0000127959.28627.F8; Richard AF, 2011, DEV BIOL, V359, P303, DOI 10.1016/j.ydbio.2011.08.010; Rodrigues B, 1998, MOL CELL BIOCHEM, V180, P53, DOI 10.1023/A:1006882805197; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shim J, 2013, MOL REPROD DEV, V80, P570, DOI 10.1002/mrd.22192; Shimabukuro M, 2009, CIRC J, V73, P27, DOI 10.1253/circj.CJ-08-1012; Song G, 2010, BIOL REPROD, V82, P854, DOI 10.1095/biolreprod.109.080929; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Weterman MAJ, 2013, BRAIN, V136, P282, DOI 10.1093/brain/aws293; Xia JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113724; Xia JH, 2014, MOL BIOL REP, V41, P3211, DOI 10.1007/s11033-014-3182-x; Xiao L, 2014, DIABETES, V63, P1366, DOI 10.2337/db13-1412; Yue LX, 2011, CARDIOVASC RES, V89, P744, DOI 10.1093/cvr/cvq329; Zhang HL, 2013, ARCH VIROL, V158, P2285, DOI 10.1007/s00705-013-1750-3	40	15	17	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132420	10.1371/journal.pone.0132420	http://dx.doi.org/10.1371/journal.pone.0132420			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161779	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300132
J	Hester, SE; Goodfield, LL; Park, J; Feaga, HA; Ivanov, YV; Bendor, L; Taylor, DL; Harvill, ET				Hester, Sara E.; Goodfield, Laura L.; Park, Jihye; Feaga, Heather A.; Ivanov, Yury V.; Bendor, Liron; Taylor, Dawn L.; Harvill, Eric T.			Host Specificity of Ovine Bordetella parapertussis and the Role of Complement	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; O-ANTIGEN; NEISSERIA-MENINGITIDIS; LISTERIA-MONOCYTOGENES; E-CADHERIN; PERTUSSIS; BRONCHISEPTICA; BIOSYNTHESIS; PNEUMONIA; DIVERSITY	The classical bordetellae are comprised of three subspecies that differ from broad to very limited host specificity. Although several lineages appear to have specialized to particular host species, most retain the ability to colonize and grow in mice, providing a powerful common experimental model to study their differences. One of the subspecies, Bordetella parapertussis, is composed of two distinct clades that have specialized to different hosts: one to humans (Bpp(hu)), and the other to sheep (Bpp(ov)). While Bpp(hu) and the other classical bordetellae can efficiently colonize mice, Bppov strains are severely defective in their ability to colonize the murine respiratory tract. Bpp(ov) genomic analysis did not reveal the loss of adherence genes, but substantial mutations and deletions of multiple genes involved in the production of O-antigen, which is required to prevent complement deposition on B. bronchiseptica and Bpphu strains. Bpp(ov) lacks O-antigen and, like O-antigen mutants of other bordetellae, is highly sensitive to murine complement-mediated killing in vitro. Based on these results, we hypothesized that Bpp(ov) failed to colonize mice because of its sensitivity to murine complement. Consistent with this, the Bpp(ov) defect in the colonization of wild type mice was not observed in mice lacking the central complement component C3. Furthermore, Bpp(ov) strains were highly susceptible to killing by murine complement, but not by sheep complement. These data demonstrate that the failure of Bpp(ov) to colonize mice is due to sensitivity to murine, but not sheep, complement, providing a mechanistic example of how specialization that accompanies expansion in one host can limit host range.	[Hester, Sara E.; Goodfield, Laura L.; Park, Jihye; Feaga, Heather A.; Ivanov, Yury V.; Bendor, Liron; Taylor, Dawn L.; Harvill, Eric T.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Hester, Sara E.; Feaga, Heather A.] Penn State Univ, Grad Program Biochem Microbiol & Mol Biol, University Pk, PA 16802 USA; [Goodfield, Laura L.] Penn State Univ, Grad Program Immunol & Infect Dis, University Pk, PA 16802 USA; [Park, Jihye] Penn State Univ, Grad Program Bioinformat & Genom, University Pk, PA 16802 USA; [Bendor, Liron] Penn State Univ, Grad Program Genet, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Harvill, ET (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	Harvill@psu.edu		Harvill, Eric/0000-0001-8893-2133	National Institutes of Health [GM083113]; United States Department of Agriculture National Institute of Food and Agriculture [2010-65110-20488]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM083113 to ETH (www.nih.gov/) and by the Agriculture and Food Research Initiative Competitive Grants Program Grant no. 2010-65110-20488 from the United States Department of Agriculture National Institute of Food and Agriculture to SEH, JP, HAF (www.csrees.usda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A, 1996, MOL MICROBIOL, V19, P37, DOI 10.1046/j.1365-2958.1996.354877.x; Berggard K, 1997, INFECT IMMUN, V65, P3638; Bjornstad ON, 2005, TRENDS MICROBIOL, V13, P355, DOI 10.1016/j.tim.2005.06.007; Brinig MM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r81; Burns VC, 2003, INFECT IMMUN, V71, P86, DOI 10.1128/IAI.71.1.86-94.2003; CHEN WX, 1988, NEW ZEAL VET J, V36, P138, DOI 10.1080/00480169.1988.35509; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; FERNANDEZ RC, 1994, INFECT IMMUN, V62, P4727, DOI 10.1128/IAI.62.11.4727-4738.1994; Goebel EM, 2008, INFECT IMMUN, V76, P1774, DOI 10.1128/IAI.01629-07; Goebel EM, 2008, INFECT IMMUN; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Harvill ET, 2000, INFECT IMMUN, V68, P6720, DOI 10.1128/IAI.68.12.6720-6728.2000; Heininger U, 2002, INFECT IMMUN, V70, P3777, DOI 10.1128/IAI.70.7.3777-3784.2002; IMAIZUMI A, 1983, J CLIN MICROBIOL, V17, P781, DOI 10.1128/JCM.17.5.781-786.1983; Lecuit M, 2004, P NATL ACAD SCI USA, V101, P6152, DOI 10.1073/pnas.0401434101; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Marr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020585; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; MUSSER JM, 1987, J BACTERIOL, V169, P2793, DOI 10.1128/jb.169.6.2793-2803.1987; MUSSER JM, 1986, J BACTERIOL, V166, P230, DOI 10.1128/jb.166.1.230-237.1986; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; PORTER JF, 1995, J COMP PATHOL, V112, P381, DOI 10.1016/S0021-9975(05)80019-2; PORTER JF, 1994, MICROBIOL-SGM, V140, P255, DOI 10.1099/13500872-140-2-255; Preston A, 1999, INFECT IMMUN, V67, P3763, DOI 10.1128/IAI.67.8.3763-3767.1999; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130964	10.1371/journal.pone.0130964	http://dx.doi.org/10.1371/journal.pone.0130964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158540	Green Published, Green Submitted, gold			2022-12-27	WOS:000358161200023
J	Zhang, L; Wei, PF; Shen, XD; Zhang, YW; Xu, B; Zhou, J; Fan, S; Hao, ZY; Shi, HQ; Zhang, XS; Kong, R; Xu, LF; Gao, JJ; Zou, DH; Liang, CZ				Zhang, Li; Wei, Pengfei; Shen, Xudong; Zhang, Yuanwei; Xu, Bo; Zhou, Jun; Fan, Song; Hao, Zongyao; Shi, Haoqiang; Zhang, Xiansheng; Kong, Rui; Xu, Lingfan; Gao, Jingjing; Zou, Duohong; Liang, Chaozhao			MicroRNA Expression Profile in Penile Cancer Revealed by Next-Generation Small RNA Sequencing	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; DOWN-REGULATION; NONCODING RNAS; CELL CARCINOMA; PROGRESSION; METHYLATION; DISCOVERY; APOPTOSIS; ONCOGENE	Penile cancer (PeCa) is a relatively rare tumor entity but possesses higher morbidity and mortality rates especially in developing countries. To date, the concrete pathogenic signaling pathways and core machineries involved in tumorigenesis and progression of PeCa remain to be elucidated. Several studies suggested miRNAs, which modulate gene expression at posttranscriptional level, were frequently mis-regulated and aberrantly expressed in human cancers. However, the miRNA profile in human PeCa has not been reported before. In this present study, the miRNA profile was obtained from 10 fresh penile cancerous tissues and matched adjacent non-cancerous tissues via next-generation sequencing. As a result, a total of 751 and 806 annotated miRNAs were identified in normal and cancerous penile tissues, respectively. Among which, 56 miRNAs with significantly different expression levels between paired tissues were identified. Subsequently, several annotated miRNAs were selected randomly and validated using quantitative real-time PCR. Compared with the previous publications regarding to the altered miRNAs expression in various cancers and especially genitourinary (prostate, bladder, kidney, testis) cancers, the most majority of deregulated miRNAs showed the similar expression pattern in penile cancer. Moreover, the bioinformatics analyses suggested that the putative target genes of differentially expressed miRNAs between cancerous and matched normal penile tissues were tightly associated with cell junction, proliferation, growth as well as genomic instability and so on, by modulating Wnt, MAPK, p53, PI3K-Akt, Notch and TGF-beta signaling pathways, which were all well-established to participate in cancer initiation and progression. Our work presents a global view of the differentially expressed miRNAs and potentially regulatory networks of their target genes for clarifying the pathogenic transformation of normal penis to PeCa, which research resource also provides new insights into future investigations aimed to explore the in-depth mechanisms of miRNAs and other small RNAs including piRNAs in penile carcinogenesis regulation and effective target-specific theragnosis.	[Zhang, Li; Shen, Xudong; Zhou, Jun; Fan, Song; Hao, Zongyao; Shi, Haoqiang; Zhang, Xiansheng; Kong, Rui; Xu, Lingfan; Gao, Jingjing; Liang, Chaozhao] Anhui Med Univ, Affiliated Hosp 1, Dept Urol, Hefei, Anhui, Peoples R China; [Zhang, Li; Shen, Xudong; Zhou, Jun; Fan, Song; Hao, Zongyao; Shi, Haoqiang; Zhang, Xiansheng; Kong, Rui; Xu, Lingfan; Gao, Jingjing; Liang, Chaozhao] Anhui Med Univ, Inst Urol, Hefei, Anhui, Peoples R China; [Wei, Pengfei; Zhang, Yuanwei] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Xu, Bo] Anhui Med Univ, Anhui Prov Hosp, Ctr Reprod Med, Hefei, Anhui, Peoples R China; [Zou, Duohong] Anhui Med Univ, Stomatol Coll, Key Lab Oral Dis Res Anhui Prov, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Anhui Medical University	Zou, DH (corresponding author), Anhui Med Univ, Stomatol Coll, Key Lab Oral Dis Res Anhui Prov, Hefei, Anhui, Peoples R China.	zouduohongyy@126.com; liang_chaozhao@163.com	Wei, Pengfei/J-1264-2016; zhang, xian/GYA-0290-2022; Zhang, Yuanwei/C-7695-2016	Wei, Pengfei/0000-0002-5786-6580; Zhang, Yuanwei/0000-0002-2814-8061; Zhang, Li/0000-0003-2599-952X; xu, lingfan/0000-0003-2465-241X	National Natural Science Foundation of China [81401518, 31430028, 81170698, 81370856, 31370983]; Anhui Provincial Natural Science Foundation [1408085QH180]; Clinical Key Subjects Program of the Ministry of Public Health of China; cultivation project for NSFC at Anhui Medical University [2013KJ14]; Key Project of the Chinese Ministry of Education [212080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Clinical Key Subjects Program of the Ministry of Public Health of China; cultivation project for NSFC at Anhui Medical University; Key Project of the Chinese Ministry of Education(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (No. 81401518, No. 31430028, http://www.nsfc.gov.cn/) (LZ); the National Natural Science Foundation of China (No. 81170698, No. 81370856, http://www.nsfc.gov.cn/) (CZL); the National Natural Science Foundation of China (No. 31370983, http://www.nsfc.gov.cn/) (DHZ); Anhui Provincial Natural Science Foundation (No. 1408085QH180, http://www.ahkjt.gov.cn/) (LZ), the Clinical Key Subjects Program of the Ministry of Public Health of China (Urology, http://www.nhfpc.gov.cn/) (CZL), the cultivation project for NSFC at Anhui Medical University (No. 2013KJ14, http://www.ayfy.com) (LZ) and the Key Project of the Chinese Ministry of Education (No. 212080, http://www.moe.edu.cn/) (DHZ). The funders had no roles in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Andersson P, 2008, J UROLOGY, V179, P2030, DOI 10.1016/j.juro.2007.12.040; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Avila JL, 2013, TRENDS MOL MED, V19, P320, DOI 10.1016/j.molmed.2013.03.003; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bleeker MCG, 2009, WORLD J UROL, V27, P141, DOI 10.1007/s00345-008-0302-z; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calmon MF, 2011, THESCIENTIFICWORLDJO, V11, P269, DOI 10.1100/tsw.2011.24; Calmon MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053260; Calore F, 2013, INT J MOL SCI, V14, P17085, DOI 10.3390/ijms140817085; Chen HY, 2012, CANCER RES, V72, P3631, DOI 10.1158/0008-5472.CAN-12-0667; Chen L, 2013, BIOCHEM BIOPH RES CO, V435, P745, DOI 10.1016/j.bbrc.2013.05.056; Cheng J, 2011, CLIN CHIM ACTA, V412, P1621, DOI 10.1016/j.cca.2011.05.015; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Dong HF, 2013, CHEM REV, V113, P6207, DOI 10.1021/cr300362f; Elgamal OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076402; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; He XJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-218; Henry VJ, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau069; Hirata H, 2013, BRIT J CANCER, V108, P2070, DOI 10.1038/bjc.2013.173; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Li N, 2013, NUCLEIC ACIDS RES, V41, P3619, DOI 10.1093/nar/gkt072; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; Li XH, 2011, J CELL MOL MED, V15, P1887, DOI 10.1111/j.1582-4934.2010.01194.x; Lim SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099687; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Majid S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067686; Majid S, 2012, CANCER RES, V72, P6435, DOI 10.1158/0008-5472.CAN-12-2181; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Meng FX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034394; Misra S, 2004, LANCET ONCOL, V5, P240, DOI 10.1016/S1470-2045(04)01427-5; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Olar A, 2014, HUM PATHOL, V45, P1358, DOI 10.1016/j.humpath.2014.02.009; Osanto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038298; Patterson Erin E, 2011, Cancer, V117, P1630, DOI 10.1002/cncr.25724; Protzel C, 2013, INT J MOL SCI, V14, P19494, DOI 10.3390/ijms141019494; Rogenhofer S, 2013, J UROLOGY, V189, P1117, DOI 10.1016/j.juro.2012.08.221; Schaefer A, 2010, NAT REV UROL, V7, P286, DOI 10.1038/nrurol.2010.45; Schee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066165; Shang C, 2014, MOL BIOL REP, V41, P2521, DOI 10.1007/s11033-014-3110-0; Shi S, 2014, CURR MOL MED, V14, P316, DOI 10.2174/1566524014666140228120014; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Stegh AH, 2012, EXPERT OPIN THER TAR, V16, P67, DOI 10.1517/14728222.2011.643299; Streppel MM, 2013, CLIN CANCER RES, V19, P4067, DOI 10.1158/1078-0432.CCR-13-0601; Sturm M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-292; Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443; Tong XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106706; Torres A, 2013, INT J CANCER, V132, P1633, DOI 10.1002/ijc.27840; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wang BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101306; Wang D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013067; Wang JW, 2022, FEBS LETT, DOI 10.1016/j.febslet.2013.04.029; Watahiki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024950; Weinberg RA., 2002, NEW ENGL J MED, V347, P1593, DOI [DOI 10.1056/NEJMRA021902, 10.1056/NEJMra021902]; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Wu JY, 2013, RNA BIOL, V10, P1087, DOI 10.4161/rna.25193; Wu KM, 2013, PATHOL ONCOL RES, V19, P739, DOI 10.1007/s12253-013-9637-x; Xi YM, 2014, CANCER LETT, V353, P8, DOI 10.1016/j.canlet.2014.07.010; Xu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087920; Xu Y, 2012, BRIT J CANCER, V106, P553, DOI 10.1038/bjc.2011.568; Yamashita AS, 2013, TRANSL ONCOL, V6, P197, DOI 10.1593/tlo.12442; Yanagawa N, 2008, PATHOL INT, V58, P477, DOI 10.1111/j.1440-1827.2008.02259.x; Yang QL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066809; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050203; Zhai QN, 2012, BIOCHEM BIOPH RES CO, V419, P621, DOI 10.1016/j.bbrc.2012.02.060; Zhang P, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau110; Zhao HC, 2014, CARCINOGENESIS, V35, P886, DOI 10.1093/carcin/bgt378	87	29	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131336	10.1371/journal.pone.0131336	http://dx.doi.org/10.1371/journal.pone.0131336			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158897	gold, Green Published, Green Submitted			2022-12-27	WOS:000358161200027
J	Das Gupta, M; Chan, SKS; Monteiro, A				Das Gupta, Mainak; Chan, Sam Kok Sim; Monteiro, Antonia			Natural Loss of eyeless/Pax6 Expression in Eyes of Bicyclus anynana Adult Butterflies Likely Leads to Exponential Decrease of Eye Fluorescence in Transgenics	PLOS ONE			English	Article							MARKER; TRANSFORMATION; DROSOPHILA; PROTEIN; MORPHOGENESIS; PATTERNS; REPORTER; PAX6; GFP	Commonly used visible markers for transgenesis use fluorescent proteins expressed at the surface of the body, such as in eyes. One commonly used marker is the 3xP3-EGFP cassette containing synthetic binding sites for the eyeless/Pax6 conserved transcription factor. This marker cassette leads to fluorescent eyes in a variety of animals tested so far. Here we show that upon reaching adulthood, transgenic Bicyclus anynana butterflies containing this marker cassette exponentially loose fluorescence in their eyes. After 12 days, transgenic individuals are no longer distinguishable from wild type individuals. The decreased eye fluorescence is likely due to significantly decreased or halted eyeless/Pax6 expression observed in wild type animals upon adult emergence. Implications from these findings include care in screening transgenic animals before these reach adulthood, or shortly thereafter, and in using adult animals of the same age for quantitative screening of likely homozygote and heterozygote individuals.	[Das Gupta, Mainak; Monteiro, Antonia] Natl Univ Singapore, Biol Sci, Singapore 117548, Singapore; [Chan, Sam Kok Sim] Univ Tunku Abdul Rahman, Biol Sci, Kampar, Perak, Malaysia; [Monteiro, Antonia] Yale NUS Coll, Singapore, Singapore	National University of Singapore; Universiti Tunku Abdul Rahman (UTAR); Yale NUS College	Monteiro, A (corresponding author), Natl Univ Singapore, Biol Sci, Singapore 117548, Singapore.	antonia.monteiro@nus.edu.sg	Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X; CHAN, KOK SIM/0000-0003-3458-1897	Singapore Ministry of Education [R-154-000-602-112]	Singapore Ministry of Education(Ministry of Education, Singapore)	This research was funded by the Singapore Ministry of Education grant R-154-000-602-112. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463; Chen B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018659; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Cornett JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029486; Fic W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000253; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Gonzalez-Estevez C, 2003, P NATL ACAD SCI USA, V100, P14046, DOI 10.1073/pnas.2335980100; IKAWA M, 1995, DEV GROWTH DIFFER, V37, P455, DOI 10.1046/j.1440-169X.1995.t01-2-00012.x; Kokoza V, 2001, INSECT BIOCHEM MOLEC, V31, P1137, DOI 10.1016/S0965-1748(01)00120-5; Kriventseva EV, 2015, NUCLEIC ACIDS RES, V43, pD250, DOI 10.1093/nar/gku1220; Marcus JM, 2004, P ROY SOC B-BIOL SCI, V271, pS263, DOI 10.1098/rsbl.2004.0175; Mishra M, 2010, DEVELOPMENT, V137, P2895, DOI 10.1242/dev.051722; Monteiro A, 2013, J EXP ZOOL PART B, V320B, P321, DOI 10.1002/jez.b.22503; Papatsenko D, 2001, MECH DEVELOP, V101, P143, DOI 10.1016/S0925-4773(00)00581-5; Pavlopoulos A, 2005, P NATL ACAD SCI USA, V102, P7888, DOI 10.1073/pnas.0501101102; Ramos DM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-55; Sheng GJ, 1997, GENE DEV, V11, P1122, DOI 10.1101/gad.11.9.1122; Thomas JL, 2002, INSECT BIOCHEM MOLEC, V32, P247, DOI 10.1016/S0965-1748(01)00150-3; Tong XL, 2014, DEV BIOL, V394, P357, DOI 10.1016/j.ydbio.2014.08.020; Warren IA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-86; Yang Y, 2006, EMBO J, V25, P2107, DOI 10.1038/sj.emboj.7601114; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036	23	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132882	10.1371/journal.pone.0132882	http://dx.doi.org/10.1371/journal.pone.0132882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173066	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900094
J	Lu, XH; Zang, RG; Huang, JH				Lu, XingHui; Zang, RunGuo; Huang, JiHong			Relationships between Community Level Functional Traits of Trees and Seedlings during Secondary Succession in a Tropical Lowland Rainforest	PLOS ONE			English	Article							LEAF TRAITS; GROWTH-RESPONSES; SHADE TOLERANCE; WOODY-PLANTS; ADULT TREES; LIGHT; PATTERNS; SAPLINGS; NITROGEN; RATES	Most of the previous studies on functional traits focus exclusively on either seedlings or trees. Little knowledge exists on the relationships between community level functional traits of trees and seedlings during succession. Here, we examine variations of the community-level functional traits for trees and seedlings and their correlations along a secondary successional and environmental gradient in a tropical lowland rainforest after shifting cultivation. The results showed that the dynamic patterns in community level functional traits of seedlings were generally consistent with those of the trees during secondary succession. Compared with seedlings, community level traits for trees were less affected by abiotic factors during secondary succession. Correlations between community level functional traits of trees and seedlings were significant for: leaf dry matter content and leaf nitrogen concentration in the 18-year-old fallow; leaf chlorophyll content in the 30-year-old fallow; specific leaf area, leaf dry matter content and leaf nitrogen concentration in the 60-year-old fallow; and leaf nitrogen concentration in old growth. However, these traits except specific leaf area for the tree and seedling communities were all significantly correlated if all the successional stages were combined. Our results suggest that the correlations between community level functional traits of trees and those of seedlings depend on the actual traits and the successional stages examined. However, if all the four successional stages are combined, then four out of five of the community level functional traits for trees could be well predicted by those of the seedlings in the tropical lowland rain forest.	[Lu, XingHui; Zang, RunGuo; Huang, JiHong] Chinese Acad Forestry, Key Lab Forest Ecol & Environm, Inst Forest Ecol, State Forestry Adm, Beijing, Peoples R China; [Lu, XingHui; Zang, RunGuo; Huang, JiHong] Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Nanjing Forestry University	Zang, RG (corresponding author), Chinese Acad Forestry, Key Lab Forest Ecol & Environm, Inst Forest Ecol, State Forestry Adm, Beijing, Peoples R China.	zangrung@caf.ac.cn	Huang, Jihong/I-8860-2019	Huang, Jihong/0000-0001-7668-3010	Special Fund for Forest Scientific Research in the Public Welfare [201304308]; National natural science foundation of China [30430570]	Special Fund for Forest Scientific Research in the Public Welfare; National natural science foundation of China(National Natural Science Foundation of China (NSFC))	Special Fund for Forest Scientific Research in the Public Welfare (201304308), Runguo Zang, http://www.hymof.net.cn/SystemFrame/wdt_login.aspx; National natural science foundation of China (30430570), Runguo Zang, http://isisn.nsfc.gov.cn/egrantweb/project/rptcompletion/index. The funder played an important role in the study design and preparation of the manuscript.	Adler PB, 2014, P NATL ACAD SCI USA, V111, P740, DOI 10.1073/pnas.1315179111; Adler PB, 2013, ECOL LETT, V16, P1294, DOI 10.1111/ele.12157; Beckage B, 2005, J ECOL, V93, P1177, DOI 10.1111/j.1365-2745.2005.01053.x; Campetella G, 2011, AGR ECOSYST ENVIRON, V145, P38, DOI 10.1016/j.agee.2011.06.025; Cavender-Bares J, 2000, OECOLOGIA, V124, P8, DOI 10.1007/PL00008865; Chen YH, 2013, ECOGRAPHY, V36, P178, DOI 10.1111/j.1600-0587.2011.06833.x; Comita LS, 2008, BIOTROPICA, V40, P251, DOI 10.1111/j.1744-7429.2007.00337.x; Comita LS, 2007, J VEG SCI, V18, P163, DOI 10.1658/1100-9233(2007)18[163:POWPSA]2.0.CO;2; Cornelissen JHC, 2003, J VEG SCI, V14, P311, DOI 10.1111/j.1654-1103.2003.tb02157.x; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Dray S, 2014, ECOLOGY, V95, P14, DOI 10.1890/13-0196.1; Ellsworth DS, 1996, ECOLOGY, V77, P581, DOI 10.2307/2265632; Fortunel C, 2014, J ECOL, V102, P145, DOI 10.1111/1365-2745.12160; Gonzalez MA, 2010, J ECOL, V98, P137, DOI 10.1111/j.1365-2745.2009.01607.x; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; Holscher D, 2004, BASIC APPL ECOL, V5, P163, DOI 10.1078/1439-1791-00218; Holste EK, 2011, ECOLOGY, V92, P1828, DOI 10.1890/10-1697.1; Jackson BG, 2013, J ECOL, V101, P1409, DOI 10.1111/1365-2745.12155; Kitajima K, 2010, NEW PHYTOL, V186, P708, DOI 10.1111/j.1469-8137.2010.03212.x; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Lu XH, 2014, BIOTROPICA, V46, P404, DOI 10.1111/btp.12125; Lusk CH, 2004, FUNCT ECOL, V18, P820, DOI 10.1111/j.0269-8463.2004.00897.x; Norden N, 2009, ECOL LETT, V12, P385, DOI 10.1111/j.1461-0248.2009.01292.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Poorter L, 2004, PLANT BIOLOGY, V6, P746, DOI 10.1055/s-2004-821269; Poorter L, 1999, FUNCT ECOL, V13, P396, DOI 10.1046/j.1365-2435.1999.00332.x; Poorter L, 2008, BIOTROPICA, V40, P321, DOI 10.1111/j.1744-7429.2007.00380.x; Rijkers T, 2000, FUNCT ECOL, V14, P77, DOI 10.1046/j.1365-2435.2000.00395.x; Roscher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036760; Saura-Mas S, 2009, FUNCT ECOL, V23, P103, DOI 10.1111/j.1365-2435.2008.01474.x; Thomas SC, 2002, TREE PHYSIOL, V22, P117, DOI 10.1093/treephys/22.2-3.117	33	2	3	10	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132849	10.1371/journal.pone.0132849	http://dx.doi.org/10.1371/journal.pone.0132849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172543	Green Published, gold			2022-12-27	WOS:000358194900090
J	Theilacker, C; Diederich, AK; Otto, A; Sava, IG; Wobser, D; Bao, YY; Hese, K; Broszat, M; Henneke, P; Becher, D; Huebner, J				Theilacker, Christian; Diederich, Ann-Kristin; Otto, Andreas; Sava, Irina G.; Wobser, Dominique; Bao, Yinyin; Hese, Katrin; Broszat, Melanie; Henneke, Philipp; Becher, Doerte; Huebner, Johannes			Enterococcus faecalis Glycolipids Modulate Lipoprotein-Content of the Bacterial Cell Membrane and Host Immune Response	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; QUANTITATIVE-ANALYSIS; LIPOTEICHOIC ACID; PROTEOME; FAECIUM; RECOGNITION; EXPRESSION; TLR2; CONTRIBUTES; CLEARANCE	In this study, we investigated the impact of the cell membrane composition of E. faecalis on its recognition by the host immune system. To this end, we employed an E. faecalis deletion mutant (Delta bgsA) that does not synthesize the major cell membrane glycolipid diglycosyl-diacylglycerol (DGlcDAG). Proteomic analysis revealed that 13 of a total of 21 upregulated surface-associated proteins of E. faecalis Delta bgsA were lipoproteins. This led to a total lipoprotein content in the cell membrane of 35.8% in Delta bgsA compared to only 9.4% in wildtype bacteria. Increased lipoprotein content strongly affected the recognition of Delta bgsA by mouse macrophages in vitro with an increased stimulation of TNF-alpha production by heat-fixed bacteria and secreted antigens. Inactivation of the prolipoprotein diacylglycerol transferase (lgt) in Delta bgsA abrogated TNF-alpha induction by a Delta bgsA_lgt double mutant indicating that lipoproteins mediate increased activation of mouse macrophages by Delta bgsA. Heatfixed Delta bgsA bacteria, culture supernatant, or cell membrane lipid extract activated transfected HEK cells in a TLR2-dependent fashion; the same was not true of wild-type bacteria. In mice infected intraperitoneally with a sublethal dose of E. faecalis we observed a 70% greater mortality in mice infected with Delta bgsA compared with wild-type-infected mice. Increased mortality due to Delta bgsA infection was associated with elevated plasma levels of the inflammatory cytokines TNF-alpha, IL-6 and MIP-2. In summary, our results provide evidence that an E. faecalis mutant lacking its major bilayer forming glycolipid DGlcDAG upregulates lipoprotein expression leading to increased activation of the host innate immune system and virulence in vivo.	[Theilacker, Christian; Hese, Katrin; Henneke, Philipp] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany; [Theilacker, Christian; Diederich, Ann-Kristin; Wobser, Dominique; Bao, Yinyin; Broszat, Melanie; Huebner, Johannes] Univ Med Ctr Freiburg, Ctr Infect Dis & Travel Med, Freiburg, Germany; [Diederich, Ann-Kristin; Huebner, Johannes] Univ Munich, Dr von Hauner Childrens Hosp, Div Pediat Infect Dis, Munich, Germany; [Otto, Andreas; Becher, Doerte] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Dept Microbial Physiol, Greifswald, Germany; [Henneke, Philipp] Univ Med Ctr Freiburg, Ctr Paediat & Adolescent Med, Freiburg, Germany; [Diederich, Ann-Kristin] Univ Freiburg, Dept Microbiol, Fac Biol, D-79106 Freiburg, Germany; [Sava, Irina G.] Tech Univ Munich, Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany	University of Freiburg; University of Freiburg; University of Munich; Ernst Moritz Arndt Universitat Greifswald; University of Freiburg; University of Freiburg; Technical University of Munich	Theilacker, C (corresponding author), Univ Basel Hosp, Div Infect Dis, Petersgraben 4, CH-4031 Basel, Switzerland.	christian.theilacker@usb.ch	; Becher, Dorte/B-4454-2015	Huebner, Johannes/0000-0003-1232-4646; Theilacker, Christian/0000-0003-0821-9202; Becher, Dorte/0000-0002-9630-5735	German Federal Ministry of Education and Research [BMBF 01 EO 0803]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (BMBF 01 EO 0803).	Becher D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008176; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; BRUSCA JS, 1994, METHOD ENZYMOL, V228, P182; Bychowska A, 2011, CARBOHYD RES, V346, P2816, DOI 10.1016/j.carres.2011.09.026; Callegan MC, 1999, INFECT IMMUN, V67, P3357, DOI 10.1128/IAI.67.7.3357-3366.1999; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; Diederich AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096295; Dreisbach A, 2008, PROTEOMICS, V8, P2062, DOI 10.1002/pmic.200701081; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; Gurung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027958; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Henneke P, 2005, J IMMUNOL, V174, P6449, DOI 10.4049/jimmunol.174.10.6449; Henneke P, 2008, J IMMUNOL, V180, P6149, DOI 10.4049/jimmunol.180.9.6149; Hilmi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096416; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Jones CL, 2012, CELL MICROBIOL, V14, P1531, DOI 10.1111/j.1462-5822.2012.01816.x; Jouhet J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00494; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Knapp S, 2004, J IMMUNOL, V172, P3132, DOI 10.4049/jimmunol.172.5.3132; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leendertse M, 2008, J IMMUNOL, V180, P4865, DOI 10.4049/jimmunol.180.7.4865; Leendertse Masja, 2009, Innate Immun, V15, P3, DOI 10.1177/1753425908100238; Leendertse M, 2010, J INFECT DIS, V201, P544, DOI 10.1086/650341; Leendertse M, 2009, INFECT IMMUN, V77, P485, DOI 10.1128/IAI.00863-08; Lind J, 2007, BIOCHEMISTRY-US, V46, P5664, DOI 10.1021/bi700042x; MacCoss MJ, 2003, ANAL CHEM, V75, P6912, DOI 10.1021/ac034790h; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; Meiers M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-12; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Ness TL, 2003, J IMMUNOL, V171, P3775, DOI 10.4049/jimmunol.171.7.3775; Otto A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1137; Paoletti LC, 1996, INFECT IMMUN, V64, P1220, DOI 10.1128/IAI.64.4.1220-1226.1996; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Prados-Rosales R, 2011, J CLIN INVEST, V121, P1471, DOI 10.1172/JCI44261; Reffuveille F, 2012, MICROBIOL-SGM, V158, P816, DOI 10.1099/mic.0.055319-0; Reffuveille F, 2011, MICROBIOL-SGM, V157, P3001, DOI 10.1099/mic.0.053314-0; Sievers S, 2010, PROTEOMICS, V10, P1685, DOI 10.1002/pmic.200900772; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Theilacker C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-67; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; Walley KR, 1997, INFECT IMMUN, V65, P3847, DOI 10.1128/IAI.65.9.3847-3851.1997; Wardenburg JB, 2006, P NATL ACAD SCI USA, V103, P13831, DOI 10.1073/pnas.0603072103; Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648; Wikstrom M, 2004, J BIOL CHEM, V279, P10484, DOI 10.1074/jbc.M310183200; Yimin, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074287; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	55	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132949	10.1371/journal.pone.0132949	http://dx.doi.org/10.1371/journal.pone.0132949			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172831	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900107
J	Woo, SJ; Ahn, J; Morrison, MA; Ahn, SY; Lee, J; Kim, KW; DeAngelis, MM; Park, KH				Woo, Se Joon; Ahn, Jeeyun; Morrison, Margaux A.; Ahn, So Yeon; Lee, Jaebong; Kim, Ki Woong; DeAngelis, Margaret M.; Park, Kyu Hyung			Analysis of Genetic and Environmental Risk Factors and Their Interactions in Korean Patients with Age-Related Macular Degeneration	PLOS ONE			English	Article							POLYPOIDAL CHOROIDAL VASCULOPATHY; FACTOR-H GENE; CIGARETTE-SMOKING; LOC387715/HTRA1 POLYMORPHISMS; ASSOCIATION; SUSCEPTIBILITY; POPULATION; PREVALENCE; JAPANESE; CFH	Purpose To investigate the association of genetic and environmental factors, and their interactions in Korean patients with exudative age-related macular degeneration (AMD). Methods A total of 314 robustly characterized exudative AMD patients, including 111 PCV (polypoidal choroidal vasculopathy) and 154 typical choroidal neovascularization (CNV), and 395 control subjects without any evidence of AMD were enrolled. Full ophthalmologic examinations including fluorescein angiography (FA), indocyanine green angiography (ICG) and optical coherence tomography (OCT) were done, according to which patients were divided into either PCV or typical CNV. Standardized questionnaires were used to collect information regarding underlying systemic diseases, dietary habits, smoking history and body mass index (BMI). A total of 86 SNPs from 31 candidate genes were analyzed. Genotype association and logistic regression analyses were done and stepwise regression models to best predict disease for each AMD subtype were constructed. Results Age, spherical equivalent, myopia, and ever smoking were associated with exudative AMD. Age, hypertension, hyperlipidemia, spherical equivalent, and myopia were risk factors for typical CNV, while increased education and ever smoking were significantly associated with PCV (p<.05 for all). Four SNPs, ARMS2/HTRA1 rs10490924, rs11200638, and rs2736911, and CFH rs800292, showed association with exudative AMD. Two of these SNPs, ARMS2/HTRA1 rs10490924 and rs11200638, showed significant association with typical CNV and PCV specifically. There were no significant interactions between environmental and genetic factors. The most predictive disease model for exudative AMD included age, spherical equivalent, smoking, CFH rs800292, and ARMS2 rs10490924 while that for typical CNV included age, hyperlipidemia, spherical equivalent, and ARMS2 rs10490924. Smoking, spherical equivalent, and ARMS2 rs10490924 were the most predictive variables for PCV. When comparing PCV cases to CNV cases, age, BMI, and education were the most predictive risk factors of PCV. Conclusions Only one locus, the ARMS2/HTRA1 was a significant genetic risk factor for Korean exudative AMD, including its subtypes, PCV and typical CNV. Stepwise regression revealed that CFH was important to risk of exudative AMD in general but not to any specific subtype. While increased education was a unique risk factor to PCV when compared to CNV, this association was independent of refractive error in this homogenous population from South Korea. No significant interactions between environmental and genetic risk factors were observed.	[Woo, Se Joon; Ahn, Jeeyun; Park, Kyu Hyung] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Woo, Se Joon; Park, Kyu Hyung] Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Songnam, South Korea; [Ahn, Jeeyun] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Morrison, Margaux A.; DeAngelis, Margaret M.] Univ Utah, Dept Ophthalmol & Visual Sci, John A Moran Eye Ctr, Salt Lake City, UT 84112 USA; [Ahn, So Yeon; Lee, Jaebong] Seoul Natl Univ, Bundang Hosp, Med Res Collaborating Ctr, Songnam, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Utah System of Higher Education; University of Utah; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	DeAngelis, MM (corresponding author), Univ Utah, Dept Ophthalmol & Visual Sci, John A Moran Eye Ctr, Salt Lake City, UT 84112 USA.	Margaret.DeAngelis@utah.edu; jiani4@snu.ac.kr	DeAngelis, e/J-7863-2015	Ahn, Jeeyun/0000-0001-9017-1652	Seoul National University Bundang Hospital Research Fund [03-2009-008]; National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2009-0072603, 2012R1A1A2008943]; Research to Prevent Blindness; ALSAM Foundation	Seoul National University Bundang Hospital Research Fund; National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ALSAM Foundation	This study was supported by the Seoul National University Bundang Hospital Research Fund (Grant No. 03-2009-008), National Research Foundation of Korea (NRF) grants funded by the Ministry of Education, Science, and Technology (2009-0072603, 2012R1A1A2008943), an unrestricted grant from Research to Prevent Blindness (http://www.rpbusa.org/rpb/) to the Department of Ophthalmology and Visual Sciences - Moran Eye Center, and the ALSAM Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Arakawa S, 2011, NAT GENET, V43, P1001, DOI 10.1038/ng.938; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Chen HY, 2012, MOL VIS, V18, P816; Chen LJ, 2006, MOL VIS, V12, P1536; Conley YP, 2006, HUM MOL GENET, V15, P3206, DOI 10.1093/hmg/ddl396; DeAngelis MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P49, DOI 10.1001/archopht.125.1.49; DeAngelis MM, 2011, SEMIN OPHTHALMOL, V26, P77, DOI 10.3109/08820538.2011.577129; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Gorin MB, 2012, MOL ASPECTS MED, V33, P467, DOI 10.1016/j.mam.2012.04.004; Gotoh N, 2006, HUM GENET, V120, P139, DOI 10.1007/s00439-006-0187-0; Gotoh N, 2009, AM J OPHTHALMOL, V147, P1037, DOI 10.1016/j.ajo.2008.12.036; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Imamura Y, 2010, SURV OPHTHALMOL, V55, P501, DOI 10.1016/j.survophthal.2010.03.004; Jhoo JH, 2008, DEMENT GERIATR COGN, V26, P270, DOI 10.1159/000160960; Kabasawa S, 2011, OPHTHALMOLOGY, V118, P1082, DOI 10.1016/j.ophtha.2010.10.012; Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006; Kim NR, 2008, INVEST OPHTH VIS SCI, V49, P2071, DOI 10.1167/iovs.07-1195; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein Ronald, 2003, Ophthalmology, V110, P1273, DOI 10.1016/S0161-6420(03)00599-2; Kondo N, 2011, OPHTHALMOLOGY, V118, P339, DOI 10.1016/j.ophtha.2010.06.040; Kondo N, 2009, OPHTHALMOLOGY, V116, P304, DOI 10.1016/j.ophtha.2008.11.011; KyuHyung Park，, 2010, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V51, P516; Lee SJ, 2010, CLIN EXP OPHTHALMOL, V38, P698, DOI 10.1111/j.1442-9071.2010.02316.x; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Liu Y, 2007, GRAEF ARCH CLIN EXP, V245, P1441, DOI 10.1007/s00417-007-0575-8; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Mori K, 2010, OPHTHALMOLOGY, V117, P928, DOI 10.1016/j.ophtha.2009.10.001; Nakanishi H, 2010, INVEST OPHTH VIS SCI, V51, P6183, DOI 10.1167/iovs.09-4948; Park SJ, 2014, OPHTHALMOLOGY, V121, P1756, DOI 10.1016/j.ophtha.2014.03.022; Ristau T, 2014, INVEST OPHTH VIS SCI, V55, P5228, DOI 10.1167/iovs.14-14299; Sakurada Y, 2013, RETINA-J RET VIT DIS, V33, P841, DOI 10.1097/IAE.0b013e31826ffe9d; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P2044, DOI 10.1167/iovs.08-3064; Singerman Lawrence J, 2005, Retina, V25, pS1; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Tan JSL, 2007, OPHTHALMOLOGY, V114, P1143, DOI 10.1016/j.ophtha.2006.09.033; Thakkinstian A, 2006, HUM MOL GENET, V15, P2784, DOI 10.1093/hmg/ddl220; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; Ueta T, 2009, OPHTHALMOLOGY, V116, P2400, DOI 10.1016/j.ophtha.2009.06.013	42	32	34	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132771	10.1371/journal.pone.0132771	http://dx.doi.org/10.1371/journal.pone.0132771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171855	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900083
J	Yu, YM; Shin, WG; Lee, JY; Choi, SA; Jo, YH; Youn, SJ; Lee, MS; Choi, KH				Yu, Yun Mi; Shin, Wan Gyoon; Lee, Ju-Yeun; Choi, Soo An; Jo, Yun Hee; Youn, So Jung; Lee, Mo Se; Choi, Kwang Hoon			Patterns of Adverse Drug Reactions in Different Age Groups: Analysis of Spontaneous Reports by Community Pharmacists	PLOS ONE			English	Article							AMBULATORY-CARE; GENDER-DIFFERENCES; EVENTS; PREVALENCE; DIZZINESS; MEDICINE	Purpose To evaluate the clinical manifestations and causative drugs associated with adverse drug reactions (ADRs) spontaneously reported by community pharmacists and to compare the ADRs by age. Methods ADRs reported to the Regional Pharmacovigilance Center of the Korean Pharmaceutical Association by community pharmacists from January 2013 to June 2014 were included. Causality was assessed using the WHO-Uppsala Monitoring Centre system. The patient population was classified into three age groups. We analyzed 31,398 (74.9%) ADRs from 9,705 patients, identified as having a causal relationship, from a total pool of 41,930 ADRs from 9,873 patients. Median patient age was 58.0 years; 66.9% were female. Results Gastrointestinal system (34.4%), nervous system (14.4%), and psychiatric (12.1%) disorders were the most frequent symptoms. Prevalent causative drugs were those for acid-related disorders (11.4%), anti-inflammatory products (10.5%), analgesics (7.2%), and anti-bacterials (7.1%). Comparisons by age revealed diarrhea and antibacterials to be most commonly associated with ADRs in children (p < 0.001), whereas dizziness was prevalent in the elderly (p < 0.001). Anaphylactic reaction was the most frequent serious event (19.7%), mainly associated with cephalosporins and non-steroidal anti-inflammatory drugs. Among 612 ADRs caused by nonprescription drugs, the leading symptoms and causative drugs were skin disorders (29.6%) and non-steroidal anti-inflammatory drugs (16.2%), respectively. Conclusions According to the community pharmacist reports, the leading clinical manifestations and causative drugs associated with ADRs in outpatients differed among age groups.	[Yu, Yun Mi; Shin, Wan Gyoon; Choi, Soo An; Jo, Yun Hee] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Yu, Yun Mi; Shin, Wan Gyoon; Choi, Soo An; Jo, Yun Hee] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Lee, Ju-Yeun] Hanyang Univ, Inst Pharmaceut Sci & Technol, Coll Pharm, Ansan, South Korea; [Youn, So Jung; Lee, Mo Se; Choi, Kwang Hoon] Korean Pharmaceut Assoc, Reg Pharmacovigilance Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Hanyang University	Shin, WG (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.	wgshin@snu.ac.kr		Yu, Yun Mi/0000-0002-8267-9453	Ministry of Food and Drug Safety to operation of the regional pharmacovigilance center [20140114-000012]	Ministry of Food and Drug Safety to operation of the regional pharmacovigilance center(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This research was supported by a grant from Ministry of Food and Drug Safety (http://www.mfds.go.kr/index.do) to operation of the regional pharmacovigilance center in 2014 (20140114-000012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hamid A, 2014, BRIT J CLIN PHARMACO, V78, P202, DOI 10.1111/bcp.12293; Bourgeois FT, 2010, PHARMACOEPIDEM DR S, V19, P901, DOI 10.1002/pds.1984; Byrt T, 1996, EPIDEMIOLOGY, V7, P561, DOI 10.1097/00001648-199609000-00030; Capuano A, 2009, EUR J CLIN PHARMACOL, V65, P721, DOI 10.1007/s00228-009-0641-8; Conforti A, 2012, PHARMACOEPIDEM DR S, V21, P597, DOI 10.1002/pds.3225; D'Incau P, 2014, FUND CLIN PHARMACOL, V28, P342, DOI 10.1111/fcp.12032; Drici MD, 2001, DRUG SAFETY, V24, P575, DOI 10.2165/00002018-200124080-00002; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Inman WHW, 1996, BRIT J CLIN PHARMACO, V41, P434; Kaushal R, 2007, AMBUL PEDIATR, V7, P383, DOI 10.1016/j.ambp.2007.05.005; Kongkaew C, 2013, PHARMACOTHERAPY, V33, P827, DOI 10.1002/phar.1287; Korea Institute of Drug Safefy & Risk Management, 2014, TRENDS DRUG SAF INF; Ladwig KH, 2000, EUR J EPIDEMIOL, V16, P511, DOI 10.1023/A:1007629920752; Lagnaoui R, 2000, EUR J CLIN PHARMACOL, V56, P181, DOI 10.1007/s002280050738; Leone R, 2013, DRUG SAFETY, V36, P267, DOI 10.1007/s40264-013-0028-8; Maarsingh OR, 2010, ANN FAM MED, V8, P196, DOI 10.1370/afm.1116; Mazzitello C, 2013, J PHARMACOL PHARMACO, V4, pS20, DOI 10.4103/0976-500X.120942; McLernon DJ, 2010, DRUG SAFETY, V33, P775, DOI 10.2165/11536510-000000000-00000; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Perraudin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063894; Ribeiro-Vaz I, 2013, EUR J CLIN PHARMACOL, V69, P673, DOI 10.1007/s00228-012-1376-5; Schmiedl S, 2014, DRUG SAFETY, V37, P225, DOI 10.1007/s40264-014-0141-3; Shin YS, 2009, PHARMACOEPIDEM DR S, V18, P910, DOI 10.1002/pds.1796; Sloane PD, 2001, ANN INTERN MED, V134, P823, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00005; Smyth RMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024061; Statistics Korea, 2014, STAT DAT KOR STAT IN, VAvailable; Tache SV, 2011, ANN PHARMACOTHER, V45, P977, DOI 10.1345/aph.1P627; Thomsen LA, 2007, ANN PHARMACOTHER, V41, P1411, DOI 10.1345/aph.1H658; Tran C, 1998, J CLIN PHARMACOL, V38, P1003, DOI 10.1177/009127009803801103; van Grootheest A C, 2005, Res Social Adm Pharm, V1, P126, DOI 10.1016/j.sapharm.2004.12.009; van Grootheest K, 2004, PHARMACOEPIDEM DR S, V13, P457, DOI 10.1002/pds.897; Vidaver RM, 2000, J WOMEN HEALTH GEN-B, V9, P495, DOI 10.1089/15246090050073576; Willis A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091157; Wistrom J, 2001, J ANTIMICROB CHEMOTH, V47, P43, DOI 10.1093/jac/47.1.43; World Health Oganization, 2013, AN THER CHEM ATC CLA; World Health Oganization, 2005, WHO ADV REACT TERM W; World Health Organization, 2012, WHO UMC CAUS ASS; World Health Organization, 1972, WHO TECH REP SER, V488, P1	39	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132916	10.1371/journal.pone.0132916	http://dx.doi.org/10.1371/journal.pone.0132916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172050	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900101
J	Ortiz-Matamoros, MF; Islas-Flores, T; Voigt, B; Menzel, D; Baluska, F; Villanueva, MA				Fernando Ortiz-Matamoros, Mario; Islas-Flores, Tania; Voigt, Boris; Menzel, Diedrik; Baluska, Frantisek; Villanueva, Marco A.			Heterologous DNA Uptake in Cultured Symbiodinium spp. Aided by Agrobacterium tumefaciens	PLOS ONE			English	Article							MEDIATED TRANSFORMATION; GENETIC-TRANSFORMATION; ARABIDOPSIS-THALIANA; T-DNA; CHLAMYDOMONAS-REINHARDTII; NUCLEAR TRANSFORMATION; PLANT TRANSFORMATION; SYMBIOSIS; EXPRESSION; CELLS	Plant-targeted pCB302 plasmids containing sequences encoding gfp fusions with a microtubule-binding domain; gfp with the fimbrin actin-binding domain 2; and gfp with AtRACK1C from Arabidopsis thaliana, all harbored in Agrobacterium tumefaciens, were used to assay heterologous expression on three different clades of the photosynthetic dinoflagellate, Symbiodinium. Accessibility to the resistant cell wall and through the plasma membrane of these dinoflagellates was gained after brief but vigorous shaking in the presence of glass beads and polyethylene glycol. A resistance gene to the herbicide Basta allowed appropriate selection of the cells expressing the hybrid proteins, which showed a characteristic green fluorescence, although they appeared to lose their photosynthetic pigments and did not further divide. Cell GFP expression frequency measured as green fluorescence emission yielded 839 per every 10(6) cells for Symbiodinium kawagutii, followed by 640 and 460 per every 10(6) cells for Symbiodinium microadriaticum and Symbiodinium sp. Mf11, respectively. Genomic PCR with specific primers amplified the AtRACK1C and gfp sequences after selection in all clades, thus revealing their presence in the cells. RT-PCR from RNA of S. kawagutii co-incubated with A. tumefaciens harboring each of the three vectors with their respective constructs, amplified products corresponding to the heterologous gfp sequence while no products were obtained from three distinct negative controls. The reported procedure shows that mild abrasion followed by co-incubation with A. tumefaciens harboring heterologous plasmids with CaMV35S and nos promoters can lead to expression of the encoded proteins into the Symbiodinium cells in culture. Despite the obvious drawbacks of the procedure, this is an important first step towards a stable transformation of Symbiodinium.	[Fernando Ortiz-Matamoros, Mario; Islas-Flores, Tania; Villanueva, Marco A.] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales, Puerto Morelos 77580, Quintana Roo, Mexico; [Fernando Ortiz-Matamoros, Mario] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Posgrado Ciencias Mar & Limnol, Delegacion Coyoacan 04510, DF, Mexico; [Voigt, Boris; Menzel, Diedrik; Baluska, Frantisek] Univ Bonn, Inst Zellular & Mol Bot, D-53115 Bonn, Germany	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Bonn	Villanueva, MA (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales, Prol Ave Ninos Heroes S-N, Puerto Morelos 77580, Quintana Roo, Mexico.	marco@cmarl.unam.mx	Islas, Tania/AAN-7790-2020; Baluska, Frantisek/AAQ-1358-2021; Villanueva, Marco A/A-7153-2013	Villanueva, Marco/0000-0001-5369-1026; Islas, Tania/0000-0003-0073-7734	DGAPA-UNAM [PAPIIT IN210514]; National Council of Science and Technology-Mexico (CONACyT) [175951]; CONACyT [131280]	DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); National Council of Science and Technology-Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants PAPIIT IN210514 from DGAPA-UNAM and 175951 from the National Council of Science and Technology-Mexico (CONACyT) to MAV. MFO was supported by a PhD scholarship (No. 131280) from CONACyT. TIF was supported by a postdoctoral fellowship from DGAPA-UNAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAMA K, 1995, PLANT CELL REP, V14, P450, DOI 10.1007/BF00234053; Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; BUNDOCK P, 1995, EMBO J, V14, P3206, DOI 10.1002/j.1460-2075.1995.tb07323.x; Castillo-Medina RE, 2013, PHOTOSYNTH RES, V115, P167, DOI 10.1007/s11120-013-9856-8; Chen MC, 2005, BIOCHEM BIOPH RES CO, V338, P1607, DOI 10.1016/j.bbrc.2005.10.133; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; Dunahay Terri G., 1997, V62, P503; Elliott AR, 1998, AUST J PLANT PHYSIOL, V25, P739, DOI 10.1071/PP98066; Ortiz-Matamoros MF, 2015, CIENC MAR, V41, P21, DOI 10.7773/cm.v41i1.2449; Foret S, 2007, CORAL REEFS, V26, P475, DOI 10.1007/s00338-007-0206-1; Franklin DJ, 2004, MAR ECOL PROG SER, V272, P117, DOI 10.3354/meps272117; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; GODWIN I, 1991, PLANT CELL REP, V9, P671, DOI 10.1007/BF00235354; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HOOYKAAS PJJ, 1992, PLANT MOL BIOL, V19, P15, DOI 10.1007/BF00015604; Ishida Y, 1996, NAT BIOTECHNOL, V14, P745, DOI 10.1038/nbt0696-745; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kumar SV, 2004, PLANT SCI, V166, P731, DOI 10.1016/j.plantsci.2003.11.012; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; Kuo J, 2004, BIOCHEM BIOPH RES CO, V318, P176, DOI 10.1016/j.bbrc.2004.03.191; Lacroix B, 2006, TRENDS GENET, V22, P29, DOI 10.1016/j.tig.2005.10.004; Leggat W, 2007, J PHYCOL, V43, P1010, DOI 10.1111/j.1529-8817.2007.00387.x; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Loram JE, 2007, MOL ECOL, V16, P4849, DOI 10.1111/j.1365-294X.2007.03491.x; Marc J, 1998, PLANT CELL, V10, P1927, DOI 10.1105/tpc.10.11.1927; Mikosch TSP, 2001, CURR GENET, V39, P35, DOI 10.1007/s002940000178; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Newell CA, 2000, MOL BIOTECHNOL, V16, P53, DOI 10.1385/MB:16:1:53; Rodriguez-Lanetty M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-23; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-97; Shoguchi E, 2013, CURR BIOL, V23, P1399, DOI 10.1016/j.cub.2013.05.062; Soffer N., 2008, P 11 INT COR REEF S, P159; ten Lohuis MR, 1998, PLANT J, V13, P427; TRENCH RK, 1993, ENDOCYTOBIOSIS CELL, V9, P135; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; Voigt B, 2005, EUR J CELL BIOL, V84, P595, DOI 10.1016/j.ejcb.2004.11.011; Voolstra CR, 2009, MOL ECOL, V18, P1823, DOI 10.1111/j.1365-294X.2009.04167.x; Wakefield TS, 2001, BIOL BULL-US, V200, P127, DOI 10.2307/1543306; Wild A, 1990, PESTIC SCI, V30, P22; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593	44	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132693	10.1371/journal.pone.0132693	http://dx.doi.org/10.1371/journal.pone.0132693			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167858	Green Submitted, Green Published, gold			2022-12-27	WOS:000358193100067
J	Rapoport, SI; Primiani, CT; Chen, CT; Ahn, K; Ryan, VH				Rapoport, Stanley I.; Primiani, Christopher T.; Chen, Chuck T.; Ahn, Kwangmi; Ryan, Veronica H.			Coordinated Expression of Phosphoinositide Metabolic Genes during Development and Aging of Human Dorsolateral Prefrontal Cortex	PLOS ONE			English	Article							INOSITOL TRISPHOSPHATE RECEPTOR; HUMAN BRAIN; ALZHEIMERS-DISEASE; MESSENGER-RNA; PROTEIN; AGE; TRANSCRIPTION; MYOINOSITOL; ACID; PHOSPHATIDYLINOSITOL	Background Phosphoinositides, lipid-signaling molecules, participate in diverse brain processes within a wide metabolic cascade. Hypothesis Gene transcriptional networks coordinately regulate the phosphoinositide cascade during human brain Development and Aging. Methods We used the public BrainCloud database for human dorsolateral prefrontal cortex to examine age-related expression levels of 49 phosphoinositide metabolic genes during Development (0 to 20+ years) and Aging (21+ years). Results We identified three groups of partially overlapping genes in each of the two intervals, with similar intergroup correlations despite marked phenotypic differences between Aging and Development. In each interval, ITPKB, PLCD1, PIK3R3, ISYNA1, IMPA2, INPPL1, PI4KB, and AKT1 are in Group 1, PIK3CB, PTEN, PIK3CA, and IMPA1 in Group 2, and SACM1L, PI3KR4, INPP5A, SYNJ1, and PLCB1 in Group 3. Ten of the genes change expression non-linearly during Development, suggesting involvement in rapidly changing neuronal, glial and myelination events. Correlated transcription for some gene pairs likely is facilitated by colocalization on the same chromosome band. Conclusions Stable coordinated gene transcriptional networks regulate brain phosphoinositide metabolic pathways during human Development and Aging.	[Rapoport, Stanley I.; Primiani, Christopher T.; Ryan, Veronica H.] NIA, Brain Physiol & Metab Sect, Neurosci Lab, NIH, Bethesda, MD 20892 USA; [Chen, Chuck T.] NIAAA, Sect Nutr Neurosci, NIH, Bethesda, MD USA; [Ahn, Kwangmi] NIMH, Child Psychiat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Rapoport, SI (corresponding author), NIA, Brain Physiol & Metab Sect, Neurosci Lab, NIH, Bethesda, MD 20892 USA.	sir@nih.gov	Ahn, Kwangmi/GLV-4077-2022	Chen, Chuck/0000-0002-1099-4198; Ryan, Veronica/0000-0001-5121-4672	Intramural Research Programs of the National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Institute of Mental Health; NATIONAL INSTITUTE ON AGING [ZIAAG000428] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Institute of Mental Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Intramural Research Programs of the National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Institute of Mental Health supported this research.	Arai Y, 2001, DEV BRAIN RES, V129, P1, DOI 10.1016/S0165-3806(01)00140-7; BENJAMIN J, 1995, PSYCHOPHARMACOL BULL, V31, P167; BERRIDGE MJ, 1989, JAMA-J AM MED ASSOC, V262, P1834; Carver JD, 2001, BRAIN RES BULL, V56, P79, DOI 10.1016/S0361-9230(01)00551-2; CHUGANI HT, 1991, J NUCL MED, V32, P23; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Cooper J., 2003, BIOCH BASIS NEUROPHA; Cunnane SC, 2014, J HUM EVOL, V77, P88, DOI 10.1016/j.jhevol.2014.05.001; Dai ZM, 2012, NUCLEIC ACIDS RES, V40, P27, DOI 10.1093/nar/gkr689; Dall'Armi C, 2013, CURR BIOL, V23, pR33, DOI 10.1016/j.cub.2012.10.041; Dawson AP, 2003, BIOCHEM J, V370, P621, DOI 10.1042/BJ20021289; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Delgado-Esteban M, 2007, J NEUROCHEM, V102, P194, DOI 10.1111/j.1471-4159.2007.04450.x; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Eisen M, 1998, CLUSTER 3 0 MANUAL; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; FURTH EE, 1988, J BIOL CHEM, V263, P15951; George AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084394; Grachev ID, 2001, J NEUROCHEM, V77, P292, DOI 10.1046/j.1471-4159.2001.00238.x; GREENWOOD AF, 1995, NEUROSCIENCE, V69, P125, DOI 10.1016/0306-4522(95)00220-D; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; HAUSER G, 1963, J BIOL CHEM, V238, P3224; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Heffron TP, 2012, J MED CHEM, V55, P8007, DOI 10.1021/jm300867c; Hu LH, 2008, BIOPHYS J, V95, P1151, DOI 10.1529/biophysj.108.129825; Huang W, 1999, AM J PSYCHIAT, V156, P1879; HUTTENLOCHER PR, 1984, AM J MENT DEF, V88, P488; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P586, DOI 10.1038/nrm1152; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; JOLLES J, 1993, DEMENTIA, V4, P81, DOI 10.1159/000107301; Kantarci K, 2000, NEUROLOGY, V55, P210, DOI 10.1212/WNL.55.2.210; Kim S, 2011, CELL METAB, V13, P215, DOI 10.1016/j.cmet.2011.01.007; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; LAPOSATA M, 1987, METHOD ENZYMOL, V141, P350; Law AJ, 2012, P NATL ACAD SCI USA, V109, P12165, DOI 10.1073/pnas.1206118109; Lee JY, 2012, ANN NY ACAD SCI, V1271, P68, DOI 10.1111/j.1749-6632.2012.06725.x; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Ma KZ, 2006, NEUROCHEM RES, V31, P759, DOI 10.1007/s11064-006-9080-4; MIYAZAKI S, 1995, CURR OPIN CELL BIOL, V7, P190, DOI 10.1016/0955-0674(95)80027-1; NEUFELD EJ, 1985, J CELL BIOL, V101, P573, DOI 10.1083/jcb.101.2.573; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; O' Neill C, 2013, EXP GERONTOL, V48, P647, DOI 10.1016/j.exger.2013.02.025; Ohno S., 1970, EVOLUTION GENE DUPLI; Pacheco MA, 1996, PROG NEUROBIOL, V50, P255, DOI 10.1016/S0301-0082(96)00035-4; Persengiev S, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00032; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Pouwels PJW, 1999, PEDIATR RES, V46, P474, DOI 10.1203/00006450-199910000-00019; Primiani CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110972; Purdon A.D., 2007, HDB NEUROCHEMISTRY M, P401; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; RAPOPORT SI, 1990, BRAIN RES REV, V15, P267, DOI 10.1016/0165-0173(90)90004-8; Rapoport SI, 2008, PROSTAG LEUKOTR ESS, V79, P153, DOI 10.1016/j.plefa.2008.09.010; Ryan VH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100858; Saetre P, 2011, SYNAPSE, V65, P971, DOI 10.1002/syn.20933; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Serretti A, 2009, CURR MED CHEM, V16, P1917, DOI 10.2174/092986709788186101; Shankar SK, 2010, INDIAN J PATHOL MICR, V53, P595, DOI 10.4103/0377-4929.71995; SHETTY HU, 1995, J CLIN INVEST, V95, P542, DOI 10.1172/JCI117696; Shetty HU, 1996, BIOCHEM J, V313, P31, DOI 10.1042/bj3130031; Sjoholt G, 2004, MOL PSYCHIATR, V9, P621, DOI 10.1038/sj.mp.4001460; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Tamarkin-Ben-Harush A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-688; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; Voronov SV, 2008, P NATL ACAD SCI USA, V105, P9415, DOI 10.1073/pnas.0803756105; Wang DZ, 2013, ANNU REV MED, V64, P131, DOI 10.1146/annurev-med-112211-154330; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3	74	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132675	10.1371/journal.pone.0132675	http://dx.doi.org/10.1371/journal.pone.0132675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168237	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100065
J	Virgone, C; Lalli, E; Bisogno, G; Lazzari, E; Roma, J; Zin, A; Poli, E; Cecchetto, G; Dall'Igna, P; Alaggio, R				Virgone, Calogero; Lalli, Enzo; Bisogno, Gianni; Lazzari, Elena; Roma, Josep; Zin, Angelica; Poli, Elena; Cecchetto, Giovanni; Dall'Igna, Patrizia; Alaggio, Rita			DAX-1 Expression in Pediatric Rhabdomyosarcomas: Another Immunohistochemical Marker Useful in the Diagnosis of Translocation Positive Alveolar Rhabdomyosarcoma	PLOS ONE			English	Article							NUCLEAR RECEPTOR DAX1; EMBRYONIC STEM-CELLS; FUSION STATUS; INFANTILE RHABDOMYOFIBROSARCOMA; EPITHELIOID RHABDOMYOSARCOMA; INTERGROUP RHABDOMYOSARCOMA; EWS/FLI1 ONCOPROTEIN; WILMS-TUMOR; GENE; CLASSIFICATION	Objectives The aim of this study was to investigate the expression of DAX-1 in a series of pediatric rhabdomyosarcomas (RMS) with known translocation and compare it to Ap2 beta, known to be selectively expressed in ARMS. Design We revised a series of 71 alveolar rhabdomyosarcomas (ARMS), enrolled in the Italian Protocols RMS 79 and 96, and 23 embryonal rhabdomyosarcomas (ERMS) as controls. Before investigating Ap2 beta and DAX-1, ARMS were reviewed and reclassified as 48 ARMS and 23 non-ARMS. Results Translocation positive ARMS showed a characteristic Ap2 beta/DAX-1+ staining pattern in 78% of cases, while 76% of classic ERMS were negative for both. Ap2 beta alone was positive in 3.9% of RMS lacking translocation, whereas DAX-1 alone was positive in 25.4%. Conversely, 9% and 6% of translocation positive ARMS were positive only for DAX-1 or Ap2 beta, respectively. The 23 non-ARMS shared the same phenotype as ERMS but had a higher frequency of DAX-1 expression. Conclusions DAX-1 is less specific than Ap2 beta, however it is a sensitive marker for translocation positive ARMS and can be helpful in their diagnosis if used in combination with Ap2 beta.	[Virgone, Calogero; Cecchetto, Giovanni; Dall'Igna, Patrizia] Univ Hosp Padua, Pediat Surg, Dept Womens & Childrens Hlth, Padua, Italy; [Lalli, Enzo] CNRS, Inst Pharmacol Mol & Cellulaire, Unite Mixte Rech 7275, F-06560 Valbonne, France; [Lalli, Enzo] Univ Nice Sophia Antipolis, Valbonne, France; [Bisogno, Gianni] Univ Hosp Padua, Hematol Oncol, Dept Womens & Childrens Hlth, Padua, Italy; [Lazzari, Elena] San Bortolo Hosp, Pathol Unit, Vicenza, Italy; [Roma, Josep] Univ Autonoma Barcelona, Lab Translat Res Pediat Canc, Vall dHebron Res Inst, E-08193 Barcelona, Spain; [Zin, Angelica; Poli, Elena] Ist Ric Pediat Citta della Speranza, Lab Biol Tumori Solidi, Padua, Italy; [Alaggio, Rita] Univ Padua, Dept Med & Diagnost Sci & Special Therapies, Pathol Unit, Padua, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; University of Padua; Azienda Ospedaliera - Universita di Padova; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Fondazione Citta della Speranza; University of Padua	Virgone, C (corresponding author), Univ Hosp Padua, Pediat Surg, Dept Womens & Childrens Hlth, Padua, Italy.	calogero.virgone@unipd.it	Virgone, Calogero/ABB-7432-2020; alaggio, rita/AAC-2348-2019; Lalli, Enzo/F-7052-2013; Bisogno, Gianni/K-9282-2016	alaggio, rita/0000-0003-3915-3816; Lalli, Enzo/0000-0002-0584-5681; Virgone, Calogero/0000-0002-3651-9416; Dall'Igna, Patrizia/0000-0002-3822-3272; Bisogno, Gianni/0000-0003-4462-5523; Roma, Josep/0000-0001-7692-6123				Barr FG, 2006, J MOL DIAGN, V8, P202, DOI 10.2353/jmoldx.2006.050124; BARR FG, 1991, GENE CHROMOSOME CANC, V3, P153, DOI 10.1002/gcc.2870030212; Barr FG, 2009, GENE CHROMOSOME CANC, V48, P661, DOI 10.1002/gcc.20673; Battista MC, 2005, J CLIN ENDOCR METAB, V90, P5426, DOI 10.1210/jc.2005-0666; Boman F, 1996, PEDIATR PATHOL LAB M, V16, P951, DOI 10.1080/15513819609168718; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; Davicioni E, 2009, AM J PATHOL, V174, P550, DOI 10.2353/ajpath.2009.080631; Doghman M, 2007, MOL ENDOCRINOL, V21, P2968, DOI 10.1210/me.2007-0120; Faria P, 1996, AM J SURG PATHOL, V20, P909, DOI 10.1097/00000478-199608000-00001; Fletcher C, 2013, WHO CLASSIFICATION O; Folpe AL, 2002, AM J SURG PATHOL, V26, P1175, DOI 10.1097/00000478-200209000-00008; Garcia-Aragoncillo E, 2008, ONCOGENE, V27, P6034, DOI 10.1038/onc.2008.203; GURNEY JG, 1995, CANCER, V75, P2186, DOI 10.1002/1097-0142(19950415)75:8<2186::AID-CNCR2820750825>3.0.CO;2-F; Jo VY, 2011, AM J SURG PATHOL, V35, P1523, DOI 10.1097/PAS.0b013e31822e0907; Kelly VR, 2011, MOL CELL ENDOCRINOL, V332, P116, DOI 10.1016/j.mce.2010.10.003; Khalfallah O, 2009, STEM CELLS, V27, P1529, DOI 10.1002/stem.78; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; KODET R, 1991, AM J SURG PATHOL, V15, P257, DOI 10.1097/00000478-199103000-00006; Lalli E, 2010, EXPERT OPIN THER TAR, V14, P169, DOI 10.1517/14728220903531454; LUNDGREN L, 1993, HUM PATHOL, V24, P785, DOI 10.1016/0046-8177(93)90017-B; Mendiola M, 2006, INT J CANCER, V118, P1381, DOI 10.1002/ijc.21578; Mentzel T, 2000, VIRCHOWS ARCH, V436, P305, DOI 10.1007/s004280050451; Miki H, 1999, HUM PATHOL, V30, P1519, DOI 10.1016/S0046-8177(99)90177-6; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; NEWTON WA, 1995, CANCER-AM CANCER SOC, V76, P1073, DOI 10.1002/1097-0142(19950915)76:6<1073::AID-CNCR2820760624>3.0.CO;2-L; Niakan KK, 2006, MOL GENET METAB, V88, P261, DOI 10.1016/j.ymgme.2005.12.010; Oda T, 2009, AM J PATHOL, V175, P1235, DOI 10.2353/ajpath.2009.090010; Parham DM, 2007, AM J SURG PATHOL, V31, P895, DOI 10.1097/01.pas.0000213436.99492.51; Parham DM, 2013, ADV ANAT PATHOL, V20, P387, DOI 10.1097/PAP.0b013e3182a92d0d; Qualman SJ, 1998, PEDIATR DEVEL PATHOL, V1, P550, DOI 10.1007/s100249900076; Rudzinski ER, 2014, AM J SURG PATHOL, V38, P654, DOI 10.1097/PAS.0000000000000195; Rudzinski Erin R, 2013, Am Soc Clin Oncol Educ Book, P425, DOI 10.1200/EdBook_AM.2013.33.425; Skapek SX, 2013, PEDIATR BLOOD CANCER, V60, P1411, DOI 10.1002/pbc.24532; Tamai KT, 1996, MOL ENDOCRINOL, V10, P1561, DOI 10.1210/me.10.12.1561; Wachtel M, 2006, J CLIN ONCOL, V24, P816, DOI 10.1200/JCO.2005.03.4934; Wachtel M, 2004, CANCER RES, V64, P5539, DOI 10.1158/0008-5472.CAN-04-0844; Wexler Leonard H., 1997, P799; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814; Xia SJJ, 2002, CANCER BIOL THER, V1, P97, DOI 10.4161/cbt.51; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0; Zin A, 2014, AM J SURG PATHOL, V38, P273, DOI 10.1097/PAS.0000000000000105; ZUPPAN CW, 1991, ULTRASTRUCT PATHOL, V15, P353, DOI 10.3109/01913129109016244; ZUPPAN CW, 1988, HUM PATHOL, V19, P1199, DOI 10.1016/S0046-8177(88)80152-7	43	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0133019	10.1371/journal.pone.0133019	http://dx.doi.org/10.1371/journal.pone.0133019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168243	gold, Green Published, Green Submitted			2022-12-27	WOS:000358193100104
J	Wang, LY; Wang, N; Le, F; Li, L; Lou, HY; Liu, XZ; Zheng, YM; Qian, YQ; Chen, YL; Jiang, XH; Huang, HF; Jin, F				Wang, Li-Ya; Wang, Ning; Le, Fang; Li, Lei; Lou, Hang-Ying; Liu, Xiao-Zhen; Zheng, Ying-Ming; Qian, Ye-Qing; Chen, Yun-Long; Jiang, Xin-Hang; Huang, He-Feng; Jin, Fan			Superovulation Induced Changes of Lipid Metabolism in Ovaries and Embryos and Its Probable Mechanism	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; ELEMENT-BINDING PROTEIN-1A; LOW-BIRTH-WEIGHT; GRANULOSA-CELLS; FATTY-ACIDS; POSTMENOPAUSAL WOMEN; REPLACEMENT THERAPY; RECEPTOR EXPRESSION; FETAL DEVELOPMENT; HORMONE RECEPTOR	This research was intended to investigate the fetal origins of changed birth weight of the offspring born through assisted reproductive technology (ART). The association between hormone and lipid metabolism or body weight has been generally accepted, and as the basic and specific treatment in ART procedure, gonadotropin stimulation might have potential effects on intrauterine lipid metabolism. In our studies, the mice were superovulated with two doses of gonadotropin. The cholesterol metabolism in ovaries and the triglyceride metabolism in embryos were analyzed. The results showed gonadotropin probably accelerated luteinization and induced a longer time follicle development and ovulation, which resulted in histological and morphological alteration of ovary, and increased the cholesterol content and the expressions of steroidogenesis-related genes. In embryos, gonadotropin increased lipid accumulation and decreased fatty acid synthesis in a dose-dependent manner. Moreover, the changes of fatty acid composition were also shown in superovulation groups. Our studies firstly provided the evidence that the superovulation might affect the maternal and fetal lipid metabolism. These variations of lipid metabolism in our results may be associated with birth weight of ART infants.	[Wang, Li-Ya; Wang, Ning; Le, Fang; Lou, Hang-Ying; Liu, Xiao-Zhen; Zheng, Ying-Ming; Qian, Ye-Qing; Jin, Fan] Zhejiang Univ, Sch Med, Womens Hosp, Ctr Reprod Med, Hangzhou 310006, Zhejiang, Peoples R China; [Wang, Li-Ya; Wang, Ning; Le, Fang; Lou, Hang-Ying; Liu, Xiao-Zhen; Zheng, Ying-Ming; Qian, Ye-Qing; Huang, He-Feng; Jin, Fan] Minist Hlth, Key Lab Reprod Genet Zhejiang, Hangzhou 310006, Zhejiang, Peoples R China; [Li, Lei] Henan Canc Hosp, Dept Gynecol Oncol, Zhengzhou 450003, Peoples R China; [Chen, Yun-Long; Jiang, Xin-Hang] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Huang, He-Feng] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai 200030, Peoples R China	Zhejiang University; Zhengzhou University; Zhejiang University; Shanghai Jiao Tong University	Jin, F (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Ctr Reprod Med, Hangzhou 310006, Zhejiang, Peoples R China.	jinfan@zju.edu.cn	Huang, He-Feng/AAN-7985-2020; Huang, Hefeng/AAR-7184-2021; Huang, Hefeng/ABF-1117-2020	Huang, He-Feng/0000-0003-4344-8019; Wang, Li-Ya/0000-0002-1100-3704	National Basic Research Program of China [2014CB943302, 2012CB944901]; National Science Foundation of China [81370760, 81300532]; Zhejiang Province Natural Science Foundation Projects of China [LZ13H040001]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Natural Science Foundation Projects of China	This work was supported by the National Basic Research Program of China (grant numbers 2014CB943302 and 2012CB944901), the National Science Foundation of China (grant numbers 81370760 and 81300532), and the Zhejiang Province Natural Science Foundation Projects of China (grant number LZ13H040001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2009, AM J CLIN NUTR, V89, P1383, DOI 10.3945/ajcn.2008.27139; Andric N, 2010, MOL ENDOCRINOL, V24, P552, DOI 10.1210/me.2009-0450; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Beltrand J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005343; Berfield AK, 2002, KIDNEY INT, V62, P1229, DOI 10.1111/j.1523-1755.2002.kid578.x; BROOKE OG, 1989, BRIT MED J, V298, P795, DOI 10.1136/bmj.298.6676.795; Christenson LK, 2001, ENDOCRINOLOGY, V142, P28, DOI 10.1210/endo.142.1.7867; Drouineaud V, 2007, MOL HUM REPROD, V13, P373, DOI 10.1093/molehr/gam019; Dunning KR, 2010, BIOL REPROD, V83, P909, DOI 10.1095/biolreprod.110.084145; Farhat A, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-3; Gambacciani M, 1997, J CLIN ENDOCR METAB, V82, P414, DOI 10.1210/jc.82.2.414; GREENWALD GS, 1976, J REPROD FERTIL, V48, P313, DOI 10.1530/jrf.0.0480313; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; HERVEY E, 1967, J ENDOCRINOL, V37, P361, DOI 10.1677/joe.0.0370361; HORROBIN DF, 1980, MED HYPOTHESES, V6, P785, DOI 10.1016/0306-9877(80)90003-1; Huynh K, 2004, BIOL REPROD, V70, P1263, DOI 10.1095/biolreprod.103.022111; JOHNSON MR, 1995, EUR J OBSTET GYN R B, V59, P193, DOI 10.1016/0028-2243(95)02040-Y; Kortelainen ML, 2004, INT J OBESITY, V28, P623, DOI 10.1038/sj.ijo.0802522; KRONE W, 1988, J LIPID RES, V29, P1663; Kuroda H, 2001, INT J CANCER, V91, P309, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1060>3.0.CO;2-0; LAPOLT PS, 1990, ENDOCRINOLOGY, V126, P3277, DOI 10.1210/endo-126-6-3277; Lawson JS, 2001, BREAST CANCER RES, V3, P342, DOI 10.1186/bcr318; Lindsay RS, 2008, INT J EPIDEMIOL, V37, P192, DOI 10.1093/ije/dym256; Lindsay RS, 2007, CLIN ENDOCRINOL, V66, P322, DOI 10.1111/j.1365-2265.2006.02719.x; Liu JY, 1998, BIOL REPROD, V58, P648, DOI 10.1095/biolreprod58.3.648; Liu ZL, 2009, MOL ENDOCRINOL, V23, P649, DOI 10.1210/me.2008-0412; Lopez D, 1999, ENDOCRINOLOGY, V140, P5669, DOI 10.1210/en.140.12.5669; MATTHEWS KA, 1989, NEW ENGL J MED, V321, P641, DOI 10.1056/NEJM198909073211004; Miles EA, 2002, CYTOKINE, V20, P215, DOI 10.1006/cyto.2002.2007; Mzayek F, 2007, AM J EPIDEMIOL, V166, P413, DOI 10.1093/aje/kwm098; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Sriraman V, 2000, MOL CELL ENDOCRINOL, V162, P113, DOI 10.1016/S0303-7207(00)00201-X; Sturmey RG, 2009, REPROD DOMEST ANIM, V44, P50, DOI 10.1111/j.1439-0531.2009.01402.x; Van der Auwera I, 2001, HUM REPROD, V16, P1237, DOI 10.1093/humrep/16.6.1237; Wang DH, 2010, AQUAC RES, V41, P1140, DOI 10.1111/j.1365-2109.2009.02401.x; Wang L, 2007, MOL ENDOCRINOL, V21, P2233, DOI 10.1210/me.2007-0102; Wang YA, 2005, FERTIL STERIL, V83, P1650, DOI 10.1016/j.fertnstert.2004.12.033; Watanabe T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-38; WATERMAN RA, 1988, BIOL REPROD, V38, P605, DOI 10.1095/biolreprod38.3.605; Wilhelms KW, 2006, ENVIRON TOXICOL CHEM, V25, P233, DOI 10.1897/05-039R.1; WU TCJ, 1992, MOL REPROD DEV, V33, P407, DOI 10.1002/mrd.1080330406; Yamashita S, 2005, MOL ENDOCRINOL, V19, P2099, DOI 10.1210/me.2005-0049; Yu Y, 2009, MOL CELL PROTEOMICS, V8, P1490, DOI 10.1074/mcp.M800273-MCP200	45	148	148	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132638	10.1371/journal.pone.0132638	http://dx.doi.org/10.1371/journal.pone.0132638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167919	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100061
J	Munoz-Reyes, JA; Iglesias-Julios, M; Pita, M; Turiegano, E				Antonio Munoz-Reyes, Jose; Iglesias-Julios, Marta; Pita, Miguel; Turiegano, Enrique			Facial Features: What Women Perceive as Attractive and What Men Consider Attractive	PLOS ONE			English	Article							BODY-MASS-INDEX; CROSS-CULTURAL EVIDENCE; PHYSICAL ATTRACTIVENESS; FLUCTUATING ASYMMETRY; SEXUAL-DIMORPHISM; DIGIT RATIO; DEVELOPMENTAL INSTABILITY; GEOMETRIC MORPHOMETRICS; VISUAL CUES; HIP-RATIO	Attractiveness plays an important role in social exchange and in the ability to attract potential mates, especially for women. Several facial traits have been described as reliable indicators of attractiveness in women, but very few studies consider the influence of several measurements simultaneously. In addition, most studies consider just one of two assessments to directly measure attractiveness: either self-evaluation or men's ratings. We explored the relationship between these two estimators of attractiveness and a set of facial traits in a sample of 266 young Spanish women. These traits are: facial fluctuating asymmetry, facial averageness, facial sexual dimorphism, and facial maturity. We made use of the advantage of having recently developed methodologies that enabled us to measure these variables in real faces. We also controlled for three other widely used variables: age, body mass index and waist-to-hip ratio. The inclusion of many different variables allowed us to detect any possible interaction between the features described that could affect attractiveness perception. Our results show that facial fluctuating asymmetry is related both to self-perceived and male-rated attractiveness. Other facial traits are related only to one direct attractiveness measurement: facial averageness and facial maturity only affect men's ratings. Unmodified faces are closer to natural stimuli than are manipulated photographs, and therefore our results support the importance of employing unmodified faces to analyse the factors affecting attractiveness. We also discuss the relatively low equivalence between self-perceived and male-rated attractiveness and how various anthropometric traits are relevant to them in different ways. Finally, we highlight the need to perform integrated-variable studies to fully understand female attractiveness.	[Antonio Munoz-Reyes, Jose] Univ Playa Ancha, Ctr Estudios Avanzados, Vina Del Mar, Chile; [Iglesias-Julios, Marta; Pita, Miguel; Turiegano, Enrique] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Iglesias-Julios, Marta] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal	Universidad de Playa Ancha; Autonomous University of Madrid; Fundacao Champalimaud	Turiegano, E (corresponding author), Univ Autonoma Madrid, Dept Biol, Madrid, Spain.	enrique.turiegano@uam.es	Pita, Miguel/AAA-6505-2019; Turiegano, Enrique/M-8679-2013; Pita, Miguel/L-2466-2013; Muñoz-Reyes, José Antonio/D-2822-2012	Pita, Miguel/0000-0001-5106-5566; Turiegano, Enrique/0000-0003-4620-7894; Pita, Miguel/0000-0001-5106-5566; Muñoz-Reyes, José Antonio/0000-0001-6275-8456; Iglesias-Julios, Marta/0000-0002-1271-6597	Spanish MICINN [BFU2010-10981-E]; Chilean FONDECYT [11130028]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Chilean FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The research was supported by funds from the grants BFU2010-10981-E of the Spanish MICINN and "FONDECYT Iniciacion" #11130028 of the Chilean FONDECYT.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Munoz-Reyes JA, 2012, PERS INDIV DIFFER, V53, P857, DOI 10.1016/j.paid.2012.06.012; Apicella CL, 2007, PERCEPTION, V36, P1813, DOI 10.1068/p5601; Baudouin JY, 2004, ACTA PSYCHOL, V117, P313, DOI 10.1016/j.actpsy.2004.07.002; Beall Anne E, 2007, Dent Clin North Am, V51, P289, DOI 10.1016/j.cden.2007.02.002; Belsley D. A., 1991, CONDITIONING DIAGNOS; Benzeval M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063975; Bisson M, 2004, ANGLE ORTHOD, V74, P162; Brand RJ, 2012, COMPUT HUM BEHAV, V28, P166, DOI 10.1016/j.chb.2011.08.023; Brown WM, 2008, P NATL ACAD SCI USA, V105, P12938, DOI 10.1073/pnas.0710420105; Buggio L, 2012, GYNECOL ENDOCRINOL, V28, P753, DOI 10.3109/09513590.2012.662545; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Campbell A, 2004, J SEX RES, V41, P16, DOI 10.1080/00224490409552210; Clark AP, 2004, EVOL HUM BEHAV, V25, P113, DOI 10.1016/S1090-5138(03)00085-0; Coetzee V, 2010, PERCEPTION, V39, P51, DOI 10.1068/p6560; Cornwell RE, 2006, PHILOS T R SOC B, V361, P2143, DOI 10.1098/rstb.2006.1936; CUNNINGHAM MR, 1990, J PERS SOC PSYCHOL, V59, P61, DOI 10.1037/0022-3514.59.1.61; CUNNINGHAM MR, 1995, J PERS SOC PSYCHOL, V68, P261, DOI 10.1037/0022-3514.68.2.261; Currie TE, 2009, EVOL HUM BEHAV, V30, P409, DOI 10.1016/j.evolhumbehav.2009.06.005; DeBruine LM, 2007, J EXP PSYCHOL HUMAN, V33, P1420, DOI 10.1037/0096-1523.33.6.1420; DION K, 1972, J PERS SOC PSYCHOL, V24, P285, DOI 10.1037/h0033731; Edler R J, 2001, J Orthod, V28, P159, DOI 10.1093/ortho/28.2.159; Etcoff N., 1999, SURVIVAL PRETTIEST S; Farmer H, 2014, PSYCHOL SCI, V25, P290, DOI 10.1177/0956797613494852; Feinberg DR, 2005, EVOL HUM BEHAV, V26, P398, DOI 10.1016/j.evolhumbehav.2005.04.001; FEINGOLD A, 1992, PSYCHOL BULL, V111, P304, DOI 10.1037/0033-2909.111.2.304; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; Fink B, 2006, AM J HUM BIOL, V18, P776, DOI 10.1002/ajhb.20549; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Furnham Adrian, 2006, Psychol Health Med, V11, P129, DOI 10.1080/13548500500155982; GABRIEL MT, 1994, J PERS, V62, P143, DOI 10.1111/j.1467-6494.1994.tb00798.x; Gangestad SW, 2005, ANNU REV ANTHROPOL, V34, P523, DOI 10.1146/annurev.anthro.33.070203.143733; Ghirlanda S, 2002, HUM NATURE-INT BIOS, V13, P383, DOI 10.1007/s12110-002-1021-6; Griffey JAF, 2014, EXP PSYCHOL, V61, P301, DOI 10.1027/1618-3169/a000248; Halberstadt J, 2000, PSYCHOL SCI, V11, P285, DOI 10.1111/1467-9280.00257; Halberstadt J, 2003, PSYCHON B REV, V10, P149, DOI 10.3758/BF03196479; Holliday IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027255; Holtzman NS, 2011, J RES PERS, V45, P687, DOI 10.1016/j.jrp.2011.08.003; Hope D, 2013, ECON HUM BIOL, V11, P236, DOI 10.1016/j.ehb.2011.06.006; Jansson L, 2002, ANIM BEHAV, V63, P617, DOI 10.1006/anbe.2001.1936; Jasienska G, 2004, P ROY SOC B-BIOL SCI, V271, P1213, DOI 10.1098/rspb.2004.2712; JOHNSTON VS, 1993, ETHOL SOCIOBIOL, V14, P183, DOI 10.1016/0162-3095(93)90005-3; JONES D, 1995, CURR ANTHROPOL, V36, P723, DOI 10.1086/204427; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Kocinski K., 2007, ANTHROPOL REV, V70, P45, DOI [10.2478/V10044-008-0001-9, DOI 10.2478/V10044-008-0001-9]; Koehler N, 2004, P ROY SOC B-BIOL SCI, V271, pS233, DOI 10.1098/rsbl.2003.0146; Komori M, 2009, ACTA PSYCHOL, V131, P136, DOI 10.1016/j.actpsy.2009.03.008; Koscinski K, 2013, BEHAV ECOL, V24, P914, DOI 10.1093/beheco/art016; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Lake JK, 1997, INT J OBESITY, V21, P432, DOI 10.1038/sj.ijo.0800424; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Lie HC, 2008, EVOLUTION, V62, P2473, DOI 10.1111/j.1558-5646.2008.00478.x; Little AC, 2003, P ROY SOC B-BIOL SCI, V270, P1759, DOI 10.1098/rspb.2003.2445; Little AC, 2001, P ROY SOC B-BIOL SCI, V268, P39, DOI 10.1098/rspb.2000.1327; Little AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002106; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Lorenzo GL, 2010, PSYCHOL SCI, V21, P1777, DOI 10.1177/0956797610388048; Lynn M, 2009, ARCH SEX BEHAV, V38, P737, DOI 10.1007/s10508-008-9379-0; Manning JT, 1999, NATURE, V399, P214, DOI 10.1038/20341; Marcus DK, 2003, PERS SOC PSYCHOL B, V29, P325, DOI 10.1177/0146167202250193; MATHES EW, 1985, J SOC PSYCHOL, V125, P157, DOI 10.1080/00224545.1985.9922868; MAZZELLA R, 1994, J APPL SOC PSYCHOL, V24, P1315, DOI 10.1111/j.1559-1816.1994.tb01552.x; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; MITTON JB, 1984, ANNU REV ECOL SYST, V15, P479; Moller AP, 2006, INFECT GENET EVOL, V6, P133, DOI 10.1016/j.meegid.2005.03.005; Moller AP, 1998, AM NAT, V151, P174, DOI 10.1086/286110; Moller AP, 1997, ASYMMETRY DEV STABIL; Moore FR, 2011, PERS INDIV DIFFER, V50, P1068, DOI 10.1016/j.paid.2011.01.026; Mulford M, 1998, AM J SOCIOL, V103, P1565, DOI 10.1086/231401; Munoz-Reyes JA, 2014, EVOL HUM BEHAV, V35, P118, DOI 10.1016/j.evolhumbehav.2013.11.005; Munoz-Reyes JA, 2014, ESTUD PSICOL-MADRID, V35, P319, DOI 10.1080/02109395.2014.922259; Pawlowski B, 2005, HUM NATURE-INT BIOS, V16, P164, DOI 10.1007/s12110-005-1002-7; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Perrett DI, 1999, EVOL HUM BEHAV, V20, P295, DOI 10.1016/S1090-5138(99)00014-8; Peters Jay, 2002, Violence Vict, V17, P255, DOI 10.1891/vivi.17.2.255.33644; Peters M, 2007, ANIM BEHAV, V73, P937, DOI 10.1016/j.anbehav.2006.07.012; Pisanski K, 2013, CROSS-CULT RES, V47, P162, DOI 10.1177/1069397112471806; Platek SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009042; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Rantala MJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0255; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Reither EN, 2009, DEMOGRAPHY, V46, P27, DOI 10.1353/dem.0.0037; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2005, EVOL HUM BEHAV, V26, P186, DOI 10.1016/j.evolhumbehav.2004.08.014; Rhodes G, 2001, EVOL HUM BEHAV, V22, P31, DOI 10.1016/S1090-5138(00)00060-X; Ritz BW, 2006, J NUTR, V136, P1141, DOI 10.1093/jn/136.5.1141; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 2003, J HUM EVOL, V44, P665, DOI 10.1016/S0047-2484(03)00047-2; Rohlf FJ, 2000, AM J PHYS ANTHROPOL, V111, P463, DOI 10.1002/(SICI)1096-8644(200004)111:4<463::AID-AJPA3>3.0.CO;2-B; Rosenblum GD, 1999, CHILD DEV, V70, P50, DOI 10.1111/1467-8624.00005; Sanchez-Pages S, 2013, BEHAVIOUR, V150, P713, DOI 10.1163/1568539X-00003077; Sanchez-Pages S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112157; Sanchez-Pages S, 2010, PHYSIOL BEHAV, V99, P355, DOI 10.1016/j.physbeh.2009.11.013; Santayana G, 1955, THE SENSE OF BEAUTY; Saxton T.K., 2009, J EVOL PSYCHOL, V7, P23, DOI [10.1556/JEP.7.2009.1.4, DOI 10.1556/JEP.7.2009.1.4]; Schaefer K., 2006, PSYCHOL SCI, V48, P187; Scheyd GJ, 2008, FDN EVOLUTIONARY PSY, P239; Schwarz S, 2012, HUM NATURE-INT BIOS, V23, P447, DOI 10.1007/s12110-012-9152-x; Scott IML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013585; Sell A, 2009, P NATL ACAD SCI USA, V106, P15073, DOI 10.1073/pnas.0904312106; Singh D, 2004, J SEX RES, V41, P43, DOI 10.1080/00224490409552212; SINGH D, 1993, J PERS SOC PSYCHOL, V65, P293, DOI 10.1037/0022-3514.65.2.293; Singh Devendra, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P81; Singh D, 2010, EVOL HUM BEHAV, V31, P176, DOI 10.1016/j.evolhumbehav.2009.09.001; Slice DE, 2007, ANNU REV ANTHROPOL, V36, P261, DOI 10.1146/annurev.anthro.34.081804.120613; SWADDLE JP, 1995, P ROY SOC B-BIOL SCI, V261, P111, DOI 10.1098/rspb.1995.0124; Thornhill R, 1998, EVOL HUM BEHAV, V202, P105; Tinlin RM, 2013, BRIT J PSYCHOL, V104, P235, DOI 10.1111/j.2044-8295.2012.02117.x; Tovee MJ, 1999, P ROY SOC B-BIOL SCI, V266, P211, DOI 10.1098/rspb.1999.0624; Tovee MJ, 1998, LANCET, V352, P548, DOI 10.1016/S0140-6736(05)79257-6; Van Dongen S, 2014, ANN HUM BIOL, V41, P205, DOI 10.3109/03014460.2013.847120; Van Dongen S, 2012, ARCH SEX BEHAV, V41, P1453, DOI 10.1007/s10508-012-9917-7; Van Dongen S, 2011, EVOL HUM BEHAV, V32, P380, DOI 10.1016/j.evolhumbehav.2011.03.002; VANVALEN L, 1962, EVOLUTION, V16, P125; Viscosi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025630; Vukovic J, 2008, PERS INDIV DIFFER, V45, P451, DOI 10.1016/j.paid.2008.05.013; Weeden J, 2007, ARCH SEX BEHAV, V36, P79, DOI 10.1007/s10508-006-9075-x; Wilson JM, 1996, J HUM EVOL, V30, P529, DOI 10.1006/jhev.1996.0041; Winkielman P, 2006, PSYCHOL SCI, V17, P799, DOI 10.1111/j.1467-9280.2006.01785.x; Wood J. W., 1994, DYNAMICS HUMAN REPRO; ZAADSTRA BM, 1993, BRIT MED J, V306, P484, DOI 10.1136/bmj.306.6876.484; Zar, 2011, BIOSTAT ANAL; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	129	20	20	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132979	10.1371/journal.pone.0132979	http://dx.doi.org/10.1371/journal.pone.0132979			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161954	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300182
J	Casetti, R; De Simone, G; Sacchi, A; Rinaldi, A; Viola, D; Agrati, C; Bordoni, V; Cimini, E; Tumino, N; Besi, F; Martini, F				Casetti, Rita; De Simone, Gabriele; Sacchi, Alessandra; Rinaldi, Alessandra; Viola, Domenico; Agrati, Chiara; Bordoni, Veronica; Cimini, Eleonora; Tumino, Nicola; Besi, Francesca; Martini, Federico			V gamma V delta 2 T-Cell Polyfunctionality Is Differently Modulated in HAART-Treated HIV Patients according to CD4 T-Cell Count	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; MYCOBACTERIAL ANTIGENS; INFECTED PERSONS; REPLICATION; LYMPHOCYTE; RESPONSES; ASSOCIATION; SUPPRESSION; REPERTOIRE	Alteration of gamma delta T-cell distribution and function in peripheral blood is among the earliest defects during HIV-infection. We asked whether the polyfunctional response could also be affected, and how this impairment could be associated to CD4 T-cell count. To this aim, we performed a cross-sectional study on HIV-infected individuals. In order to evaluate the poly-functional- V gamma 9V delta 2 T-cell response after phosphoantigen-stimulation, we assessed the cytokine/chemokine production and cytotoxicity by flow-cytometry in HAART-treated-HIV+ persons and healthy-donors. During HIV-infection V gamma 9V delta 2-polyfunctional response quality is affected, since several V gamma 9V delta 2 T-cell subsets resulted significantly lower in HIV+ patients in respect to healthy donors. Interestingly, we found a weak positive correlation between V gamma 9V delta 2 T-cell-response and CD4 T-cell counts. By dividing the HIV+ patients according to CD4 T-cell count, we found that Low-CD4 patients expressed a lower number of two V gamma 9V delta 2 T-cell subsets expressing MIP-1 beta in different combinations with other molecules (CD107a/IFN gamma.) in respect to High-CD4 individuals. Our results show that the V gamma 9V delta 2 T-cell- response quality in Low-CD4 patients is specifically affected, suggesting a direct link between innate V gamma 9V delta 2 T-cells and CD4 T-cell count. These findings suggest that V gamma 9V delta 2 T-cell quality may be indirectly influenced by HAART therapy and could be included in a new therapeutical strategy which would perform an important role in fighting HIV infection.	[Casetti, Rita; De Simone, Gabriele; Sacchi, Alessandra; Rinaldi, Alessandra; Viola, Domenico; Agrati, Chiara; Bordoni, Veronica; Cimini, Eleonora; Tumino, Nicola; Besi, Francesca; Martini, Federico] IRCCS, Lazzaro Spallanzani Natl Inst Infect Dis, Cellular Immunol Lab, Rome, Italy	IRCCS Lazzaro Spallanzani	Casetti, R (corresponding author), IRCCS, Lazzaro Spallanzani Natl Inst Infect Dis, Cellular Immunol Lab, Rome, Italy.	rita.casetti@inmi.it	Tumino, Nicola/Y-4761-2019; Besi, Francesca/AAH-9352-2019; bordoni, veronica/K-8614-2016; Sacchi, Alessandra/K-7782-2016; Cimini, Eleonora/K-8878-2016; Casetti, Rita/K-8631-2016; Agrati, Chiara/K-8806-2016	Tumino, Nicola/0000-0003-3773-8829; Besi, Francesca/0000-0002-9401-300X; bordoni, veronica/0000-0002-1747-2245; Sacchi, Alessandra/0000-0003-4964-386X; Cimini, Eleonora/0000-0002-2659-0868; Casetti, Rita/0000-0002-7574-8780; Agrati, Chiara/0000-0002-5252-0927	Italian Ministry of Health "Ricerca Corrente" fund	Italian Ministry of Health "Ricerca Corrente" fund	Funding provided by Italian Ministry of Health "Ricerca Corrente" fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Agrati C, 2011, AIDS REV, V13, P3; AUTRAN B, 1989, CLIN EXP IMMUNOL, V75, P206; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bordon J, 2004, J INFECT DIS, V189, P1482, DOI 10.1086/382961; Casetti R, 2014, INT J IMMUNOPATH PH, V27, P291, DOI 10.1177/039463201402700218; Garcia VE, 1997, J IMMUNOL, V159, P1328; Gong GM, 2009, BLOOD, V113, P837, DOI 10.1182/blood-2008-06-162792; Hebbeler AM, 2008, CLIN IMMUNOL, V128, P349, DOI 10.1016/j.clim.2008.04.008; Kosub DA, 2008, J VIROL, V82, P1155, DOI 10.1128/JVI.01275-07; Li HS, 2008, CLIN INFECT DIS, V46, P1466, DOI 10.1086/587107; Lopez M, 2008, EUR J IMMUNOL, V38, P1548, DOI 10.1002/eji.200738054; Martini F, 2000, IMMUNOLOGY, V100, P481, DOI 10.1046/j.1365-2567.2000.00068.x; Migueles SA, 2009, J VIROL, V83, P11876, DOI 10.1128/JVI.01153-09; Poccia F, 1999, J INFECT DIS, V180, P858, DOI 10.1086/314925; Poccia F, 1996, J IMMUNOL, V157, P449; Poccia F, 2009, AIDS, V23, P555, DOI 10.1097/QAD.0b013e3283244619; Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413; Rehr M, 2008, J VIROL, V82, P3391, DOI 10.1128/JVI.02383-07; Restrepo C, 2013, J MED VIROL, V85, P200, DOI 10.1002/jmv.23447; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Ryan-Payseur B, 2012, J IMMUNOL, V189, P1285, DOI 10.4049/jimmunol.1200641; Sciammas R, 1999, MICROBES INFECT, V1, P203, DOI 10.1016/S1286-4579(99)80035-5; Wallace M, 1997, MOL MED, V3, P60, DOI 10.1007/BF03401668	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132291	10.1371/journal.pone.0132291	http://dx.doi.org/10.1371/journal.pone.0132291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161861	gold, Green Submitted, Green Published			2022-12-27	WOS:000358162300115
J	Janssen, CP; Brumby, DP				Janssen, Christian P.; Brumby, Duncan P.			Strategic Adaptation to Task Characteristics, Incentives, and Individual Differences in Dual-Tasking	PLOS ONE			English	Article							RATIONAL ANALYSIS; ATTENTION ALLOCATION; SOFT CONSTRAINTS; DECISION-MAKING; PERFORMANCE; MULTITASKING; CHOICE; BEHAVIOR; UTILITY; SKILL	We investigate how good people are at multitasking by comparing behavior to a prediction of the optimal strategy for dividing attention between two concurrent tasks. In our experiment, 24 participants had to interleave entering digits on a keyboard with controlling a randomly moving cursor with a joystick. The difficulty of the tracking task was systematically varied as a within-subjects factor. Participants were also exposed to different explicit reward functions that varied the relative importance of the tracking task relative to the typing task (between-subjects). Results demonstrate that these changes in task characteristics and monetary incentives, together with individual differences in typing ability, influenced how participants choose to interleave tasks. This change in strategy then affected their performance on each task. A computational cognitive model was used to predict performance for a wide set of alternative strategies for how participants might have possibly interleaved tasks. This allowed for predictions of optimal performance to be derived, given the constraints placed on performance by the task and cognition. A comparison of human behavior with the predicted optimal strategy shows that participants behaved near optimally. Our findings have implications for the design and evaluation of technology for multitasking situations, as consideration should be given to the characteristics of the task, but also to how different users might use technology depending on their individual characteristics and their priorities.	[Janssen, Christian P.; Brumby, Duncan P.] UCL, UCL Interact Ctr, London, England; [Janssen, Christian P.] Univ Utrecht, Helmholtz Inst, Dept Expt Psychol, Utrecht, Netherlands	University of London; University College London; Utrecht University	Janssen, CP (corresponding author), UCL, UCL Interact Ctr, London, England.	c.p.janssen@uu.nl			Engineering and Physical Sciences Research Council [EP/G043507/1]; UCL's open access fund; Engineering and Physical Sciences Research Council [EP/G059063/1] Funding Source: researchfish; EPSRC [EP/G059063/1, EP/G043507/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UCL's open access fund; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	CPJ and DPB were funded by the Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk/) grant EP/G043507/1 awarded to DPB. Publication costs were supported by UCL's open access fund (http://www.ucl.ac.uk/library/open-access). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 2002, COGNITIVE SCI, V26, P85, DOI 10.1207/s15516709cog2601_3; Back J., 2012, P SIGCHI C HUM FACT, P1651, DOI DOI 10.1145/2207676.2208289; Ballas J. A., 1992, CHI '92 Conference Proceedings. ACM Conference on Human Factors in Computing Systems. Striking a Balance, P127, DOI 10.1145/142750.142770; Boot WR, 2010, ACTA PSYCHOL, V135, P349, DOI 10.1016/j.actpsy.2010.09.005; Botvinick MM, 2008, TRENDS COGN SCI, V12, P201, DOI 10.1016/j.tics.2008.02.009; Brumby DP, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P473; Brumby DP, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1629; Card S. K., 1983, PSYCHOL HUMAN COMPUT; Dabbish L, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P3127; Diels C., 2009, DRIVERS ATTITUDES DI; Duggan GB, 2001, J EXP PSYCHOL-APPL, V7, P297, DOI 10.1037//1076-898X.7.4.297; Duggan GB, 2013, INT J HUM-COMPUT ST, V71, P533, DOI 10.1016/j.ijhcs.2013.01.001; Emerson R. M., 1992, Proceedings of the Human Factors Society 36th Annual Meeting. Innovations for Interactions, P1408; Erev I, 1999, ATTENTION PERFORM, V17, P343; Farmer G. D., 2011, P 33 ANN M COGN SCI, P862; GOPHER D, 1993, ATTENTION PERFORM, V14, P299; GOPHER D, 1982, J EXP PSYCHOL HUMAN, V8, P146, DOI 10.1037/0096-1523.8.1.146; Gould Sandy JJ, 2015, P SIGCHI C HUM FACT, P1785; Gray WD, 2006, PSYCHOL REV, V113, P461, DOI 10.1037/0033-295X.113.3.461; Gray WD, 2000, J EXP PSYCHOL-APPL, V6, P322, DOI 10.1037//1076-898X.6.4.322; Gureckis TM, 2009, COGNITION, V113, P293, DOI 10.1016/j.cognition.2009.03.013; Hahn U, 2014, TOP COGN SCI, V6, P229, DOI 10.1111/tops.12083; Hill L, 2015, TRAFFIC INJ PREV, V16, P362, DOI 10.1080/15389588.2014.949340; Hornof AJ, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P2103; Horrey WJ, 2006, J EXP PSYCHOL-APPL, V12, P67, DOI 10.1037/1076-898X.12.2.67; Howes A, 2015, COGNITIVE S IN PRESS; Howes A, 2014, TOP COGN SCI, V6, P198, DOI 10.1111/tops.12089; Howes A, 2009, PSYCHOL REV, V116, P717, DOI 10.1037/a0017187; Janssen CP, 2015, INT J HUM-COMPUT ST, V79, P1, DOI 10.1016/j.ijhcs.2015.03.002; Janssen CP, 2012, J COGN ENG DECIS MAK, V6, P5, DOI 10.1177/1555343411432339; Janssen CP, 2012, COGNITIVE SCI, V36, P333, DOI 10.1111/j.1551-6709.2011.01222.x; Janssen CP, 2011, TOP COGN SCI, V3, P123, DOI 10.1111/j.1756-8765.2010.01125.x; Janssen CP, 2010, COGNITIVE SCI, V34, P1548, DOI 10.1111/j.1551-6709.2010.01124.x; Janssen CP, 2012, THESIS U COLL LONDON; Jin J, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1799; JOHNSONLAIRD PN, 1970, COGNITIVE PSYCHOL, V1, P134, DOI 10.1016/0010-0285(70)90009-5; Kieras D, 2012, HUM FACTORS ERGON, P1299; Kieras DE, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P681; Kieras DE, 2000, EXP RES APPL, P237; Klauer SG, 2014, NEW ENGL J MED, V370, P54, DOI 10.1056/NEJMsa1204142; Kool W, 2014, J EXP PSYCHOL GEN, V143, P131, DOI 10.1037/a0031048; Kool W, 2010, J EXP PSYCHOL GEN, V139, P665, DOI 10.1037/a0020198; Levy J, 2008, APPL COGNITIVE PSYCH, V22, P507, DOI 10.1002/acp.1378; Lewis RL, 2014, TOP COGN SCI, V6, P279, DOI 10.1111/tops.12086; Lieder F., 2012, ADV NEURAL INFORM PR, P2690; MacLean A., 1985, PEOPLE COMPUTERS DES, P172; Mark G, 2004, P SIGCHI C HUMAN FAC, P113, DOI DOI 10.1145/985692.985707; Marr D., 1982, VISION COMPUTATIONAL; Maynard DC, 1997, HUM PERFORM, V10, P303, DOI 10.1207/s15327043hup1004_1; MORAY N, 1991, HUM FACTORS, V33, P607, DOI 10.1177/001872089103300602; Morgan PL, 2009, J EXP PSYCHOL-APPL, V15, P291, DOI 10.1037/a0018008; Newell A., 1990, UNIFIED THEORIES COG; Nijboer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079583; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; OAKSFORD M, 1994, PSYCHOL REV, V101, P608, DOI 10.1037/0033-295X.101.4.608; Oaksford M, 1998, RATIONAL MODELS COGN, P373; Ophir E, 2009, P NATL ACAD SCI USA, V106, P15583, DOI 10.1073/pnas.0903620106; Pashler HE, 1998, PSYCHOL ATTENTION; Payne S. J., 2013, ADAPTIVE INTERACTION, DOI [10.2200/S00479ED1V01Y201302HCI016, DOI 10.2200/S00479ED1V01Y201302HCI016, 10. 2200/s00479ed1v01y201302hci016]; Payne SJ, 2007, J EXP PSYCHOL GEN, V136, P370, DOI 10.1037/0096-3445.136.3.370; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Rice S, 2012, J GEN PSYCHOL, V139, P1, DOI 10.1080/00221309.2011.619223; SALTHOUSE TA, 1984, J EXP PSYCHOL GEN, V113, P345, DOI 10.1037/0096-3445.113.3.345; SALTHOUSE TA, 1987, J APPL PSYCHOL, V72, P187, DOI 10.1037/0021-9010.72.2.187; Salvucci D.D., 2011, MULTITASKING MIND, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Salvucci DD, 2008, PSYCHOL REV, V115, P101, DOI 10.1037/0033-295X.115.1.101; Salvucci DD, 2005, COGNITIVE SCI, V29, P457, DOI 10.1207/s15516709cog0000_19; Schumacher EH, 1999, J EXP PSYCHOL HUMAN, V25, P791, DOI 10.1037/0096-1523.25.3.791; Siegler RS, 1997, J EXP PSYCHOL GEN, V126, P71, DOI 10.1037/0096-3445.126.1.71; SIMON HA, 1956, PSYCHOL REV, V63, P129, DOI 10.1037/h0042769; Sims CR, 2013, PSYCHOL REV, V120, P139, DOI 10.1037/a0030850; Stoet G., 2013, BMC PSYCHOL, V1, DOI [10.1186/2050-7283-1-18, DOI 10.1186/2050-7283-1-18]; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; Sullivan BT, 2012, J VISION, V12, DOI 10.1167/12.13.19; Taatgen NA, 2010, P 2010 INT C COGN MO, P247; Taatgen NA, 2013, PSYCHOL REV, V120, P439, DOI 10.1037/a0033138; Tseng YC, 2015, INT J HUM-COMPUT ST, V80, P45, DOI 10.1016/j.ijhcs.2015.03.005; Vlaev I, 2011, TRENDS COGN SCI, V15, P546, DOI 10.1016/j.tics.2011.09.008; Waldron SM, 2007, COMPUT J, V50, P694, DOI 10.1093/comjnl/bxm064; Walsh MM, 2009, COGNITIVE PSYCHOL, V58, P416, DOI 10.1016/j.cogpsych.2008.09.003; Wang DYD, 2007, HUM FACTORS, V49, P995, DOI 10.1518/001872007X249866; Wang DD, 2009, BEHAV RES METHODS, V41, P705, DOI 10.3758/BRM.41.3.705; Wason P.C., 1966, NEW HORIZONS PSYCHOL, DOI DOI 10.1080/14640746808400161; Watson JM, 2010, PSYCHON B REV, V17, P479, DOI 10.3758/PBR.17.4.479; Wickens C. D., 2002, THEORETICAL ISSUES E, V3, P159, DOI [10.1080/14639220210123806, DOI 10.1080/14639220210123806]; Wickens CD, 2008, HUM FACTORS, V50, P397, DOI 10.1518/001872008X288420; Wickens CD, 2015, INT J HUM-COMPUT ST, V79, P79, DOI 10.1016/j.ijhcs.2015.01.002; Zhang YF, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P3885, DOI 10.1145/2556288.2557351	88	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130009	10.1371/journal.pone.0130009	http://dx.doi.org/10.1371/journal.pone.0130009			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161851	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300013
J	Kolhe, NV; Staples, D; Reilly, T; Merrison, D; Mcintyre, CW; Fluck, RJ; Selby, NM; Taal, MW				Kolhe, Nitin V.; Staples, David; Reilly, Timothy; Merrison, Daniel; Mcintyre, Christopher W.; Fluck, Richard J.; Selby, Nicholas M.; Taal, Maarten W.			Impact of Compliance with a Care Bundle on Acute Kidney Injury Outcomes: A Prospective Observational Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; ELECTRONIC ALERT; SEVERE SEPSIS; MORTALITY; IMPLEMENTATION; INTERVENTION; MANAGEMENT	Background A recent report has highlighted suboptimal standards of care for acute kidney injury (AKI) patients in England. The objective of this study was to ascertain if improvement in basic standard of care by implementing a care bundle (CB) with interruptive alert improved outcomes in patients with AKI. Methods An AKI CB linked to electronic recognition of AKI, coupled with an interruptive alert, was introduced to improve basic care delivered to patients with AKI. Outcomes were compared in patients who had the CB completed within 24 hours (early CB group) versus those who didn't have the CB completed or had it completed after 24 hours. Results In the 11-month period, 2297 patients had 2500 AKI episodes, with 1209 and 1291 episodes occurring before and after implementation of the AKI CB with interruptive alert, respectively. The CB was completed within 24 hours in 306 (12.2%) of AKI episodes. Inhospital case-fatality was significantly lower in the early CB group (18% versus 23.1%, p 0.046). Progression to higher AKI stages was lower in the early CB group (3.9% vs. 8.1%, p 0.01). In multivariate analysis, patients in the early CB group had lower odds of death at discharge (0.641; 95% CI 0.46, 0.891), 30 days (0.707; 95% CI 0.527, 0.950), 60 days (0.704; 95% CI 0.526, 0.941) and after a median of 134 days (0.771; 95% CI 0.62, 0.958). Conclusions Compliance with AKI CB was associated with a decrease in case-fatality and reduced progression to higher AKI stage. Further interventions are required to improve utilization of the CB.	[Kolhe, Nitin V.; Mcintyre, Christopher W.; Fluck, Richard J.; Selby, Nicholas M.; Taal, Maarten W.] Royal Derby Hosp, Dept Renal Med, Derby DE22 3NE, England; [Staples, David] Royal Derby Hosp, Dept Acute Med, Derby DE22 3NE, England; [Reilly, Timothy; Merrison, Daniel] Dept Informat Management & Technol, Derby DE22 3NE, England; [Mcintyre, Christopher W.; Selby, Nicholas M.; Taal, Maarten W.] Univ Nottingham, Div Med Sci & Grad Entry Med, Derby DE22 3NE, England	University of Nottingham; University of Nottingham; University of Nottingham	Kolhe, NV (corresponding author), Royal Derby Hosp, Dept Renal Med, Uttoxeter Rd, Derby DE22 3NE, England.	nitin.kolhe@nhs.net	Selby, Nicholas/T-6759-2019; McIntyre, Christopher W/O-8927-2014	Kolhe, Nitin/0000-0003-2528-4436; Selby, Nicholas/0000-0003-0351-8326; Taal, Maarten/0000-0002-9065-212X				Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Cho A, 2012, AM J KIDNEY DIS, V60, P74, DOI 10.1053/j.ajkd.2012.02.331; Colpaert K, 2007, ACTA CLIN BELG, V62, P322, DOI 10.1179/acb.2007.073; Colpaert K, 2012, CRIT CARE MED, V40, P1164, DOI 10.1097/CCM.0b013e3182387a6b; Endre ZH, 2010, KIDNEY INT, V77, P1020, DOI 10.1038/ki.2010.25; Furuya EY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015452; Gao F, 2005, CRIT CARE, V9, pR764, DOI 10.1186/cc3909; Handler SM, 2014, NEPHROL DIAL TRANSPL, V29, P1802, DOI 10.1093/ndt/gfu211; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Kellum JA, 2001, CRIT CARE MED, V29, P1526, DOI 10.1097/00003246-200108000-00005; McCoy AB, 2012, J AM MED INFORM ASSN, V19, P346, DOI 10.1136/amiajnl-2011-000185; Nguyen HB, 2007, CRIT CARE MED, V35, P1105, DOI 10.1097/01.CCM.0000259463.33848.3D; Porter CJ, 2014, NEPHROL DIAL TRANSPL, V29, P1888, DOI 10.1093/ndt/gfu082; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; Selby NM, 2012, CLIN J AM SOC NEPHRO, V7, P533, DOI 10.2215/CJN.08970911; Stewart JAD, 2009, BRIT J HOSP MED, V70, P372, DOI 10.12968/hmed.2009.70.7.43116; Thomas M, 2011, NEPHROL DIAL TRANSPL, V26, P2161, DOI 10.1093/ndt/gfq710; Uchino S, 2004, CRIT CARE MED, V32, P1669, DOI 10.1097/01.CCM.0000132892.51063.2F; Van Hoecke S, 2008, METHOD INFORM MED, V47, P364, DOI 10.3414/ME0480; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Wallace K, 2014, CLIN MED, V14, P22, DOI 10.7861/clinmedicine.14-1-22; Xu G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004388; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Zambon M, 2008, J CRIT CARE, V23, P455, DOI 10.1016/j.jcrc.2007.08.003	25	80	84	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132279	10.1371/journal.pone.0132279	http://dx.doi.org/10.1371/journal.pone.0132279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161979	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300110
J	Nieuwenhuizen, RPJ; Nahidiazar, L; Manders, EMM; Jalink, K; Stallinga, S; Rieger, B				Nieuwenhuizen, Robert P. J.; Nahidiazar, Leila; Manders, Erik M. M.; Jalink, Kees; Stallinga, Sjoerd; Rieger, Bernd			Co-Orientation: Quantifying Simultaneous Co-Localization and Orientational Alignment of Filaments in Light Microscopy	PLOS ONE			English	Article							SINGLE-MOLECULE LOCALIZATION; FLUORESCENCE MICROSCOPY; RESOLUTION	Co-localization analysis is a widely used tool to seek evidence for functional interactions between molecules in different color channels in microscopic images. Here we extend the basic co-localization analysis by including the orientations of the structures on which the molecules reside. We refer to the combination of co-localization of molecules and orientational alignment of the structures on which they reside as co-orientation. Because the orientation varies with the length scale at which it is evaluated, we consider this scale as a separate informative dimension in the analysis. Additionally we introduce a data driven method for testing the statistical significance of the co-orientation and provide a method for visualizing the local co-orientation strength in images. We demonstrate our methods on simulated localization microscopy data of filamentous structures, as well as experimental images of similar structures acquired with localization microscopy in different color channels. We also show that in cultured primary HUVEC endothelial cells, filaments of the intermediate filament vimentin run close to and parallel with microtubuli. In contrast, no coorientation was found between keratin and actin filaments. Co-orientation between vimentin and tubulin was also observed in an endothelial cell line, albeit to a lesser extent, but not in 3T3 fibroblasts. These data therefore suggest that microtubuli functionally interact with the vimentin network in a cell-type specific manner.	[Nieuwenhuizen, Robert P. J.; Stallinga, Sjoerd; Rieger, Bernd] Delft Univ Technol, Dept Imaging Phys, Quantitat Imaging Grp, Delft, Netherlands; [Nahidiazar, Leila; Jalink, Kees] Netherlands Canc Inst, Dept Cell Biol, Cell Biophys Grp, Amsterdam, Netherlands; [Manders, Erik M. M.] Univ Amsterdam, Van Leeuwenhoek Ctr Adv Microscopy Mol Cytol, Swammerdam Inst Life Sci, Amsterdam, Netherlands	Delft University of Technology; Netherlands Cancer Institute; University of Amsterdam	Jalink, K (corresponding author), Netherlands Canc Inst, Dept Cell Biol, Cell Biophys Grp, Amsterdam, Netherlands.	k.jalink@nki.nl; s.stallinga@tudelft.nl; b.rieger@tudelft.nl		Jalink, Kees/0000-0001-7019-3440; Nieuwenhuizen, Robert/0000-0003-0243-1173	Dutch Technology Foundation STW; Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs, Agriculture and Innovation	Dutch Technology Foundation STW(Technologiestichting STW); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Ministry of Economic Affairs, Agriculture and Innovation	R.P.J.N. and L.N. are supported by the Dutch Technology Foundation STW (http://www.stw.nl/), which is part of the Netherlands Organisation for Scientific Research (NWO) and which is partly funded by the Ministry of Economic Affairs, Agriculture and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2013, ESSENTIAL CELL BIOL; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Faas FGA, 2003, LECT NOTES COMPUT SC, V2749, P36; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; FONTIJN R, 1995, EXP CELL RES, V216, P199, DOI 10.1006/excr.1995.1025; GOLDMAN AE, 1992, J CELL BIOL, V119, P725, DOI 10.1083/jcb.119.4.725; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hookway C, 2015, MOL BIOL CELL, V26, P1675, DOI 10.1091/mbc.E14-09-1398; Huang F, 2011, BIOMED OPT EXPRESS, V2, P1377, DOI 10.1364/BOE.2.001377; Ketema M, 2015, MOL BIOL CELL, V26, P2402, DOI 10.1091/mbc.E15-01-0043; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; Lachmanovich E, 2003, J MICROSC-OXFORD, V212, P122, DOI 10.1046/j.1365-2818.2003.01239.x; Lagache T, 2013, I S BIOMED IMAGING, P896; Malkusch S, 2012, HISTOCHEM CELL BIOL, V137, P1, DOI 10.1007/s00418-011-0880-5; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MANDERS EMM, 1992, J CELL SCI, V103, P857; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mlodzianoski MJ, 2011, OPT EXPRESS, V19, P15009, DOI 10.1364/OE.19.015009; Nieuwenhuizen RPJ, 2015, CELL MEMBRANE NANODOMAINS: FROM BIOCHEMISTRY TO NANOSCOPY, P409; Nieuwenhuizen RPJ, 2013, NAT METHODS, V10, P557, DOI [10.1038/nmeth.2448, 10.1038/NMETH.2448]; Rieger B, 2014, CHEMPHYSCHEM, V15, P664, DOI 10.1002/cphc.201300711; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sakamoto Y, 2013, J CELL BIOL, V200, P249, DOI 10.1083/jcb.201206010; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Shivanandan A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-349; SIBSON R, 1979, J ROY STAT SOC B MET, V41, P217; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Stallinga S., 2012, IEEE INT SYMP BIOMED, P988; Stallinga S, 2010, OPT EXPRESS, V18, P24461, DOI 10.1364/OE.18.024461; van Ginkel M., 2002, THESIS DELFT U TECHN; vanSteensel B, 1996, J CELL SCI, V109, P787; WALTERS D, 1987, COMPUT VISION GRAPH, V37, P261, DOI 10.1016/S0734-189X(87)80005-1	35	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131756	10.1371/journal.pone.0131756	http://dx.doi.org/10.1371/journal.pone.0131756			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161965	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300056
J	Puttachary, S; Sharma, S; Tse, K; Beamer, E; Sexton, A; Crutison, J; Thippeswamy, T				Puttachary, Sreekanth; Sharma, Shaunik; Tse, Karen; Beamer, Edward; Sexton, Abby; Crutison, Joseph; Thippeswamy, Thimmasettappa			Immediate Epileptogenesis after Kainate-Induced Status Epilepticus in C57BL/6J Mice: Evidence from Long Term Continuous Video-EEG Telemetry	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; UNILATERAL INTRAHIPPOCAMPAL INJECTION; SPONTANEOUS RECURRENT SEIZURES; KAINIC ACID; MOUSE MODEL; PILOCARPINE MODEL; ANIMAL-MODELS; HIPPOCAMPAL SCLEROSIS; RAT MODEL; NEURODEGENERATION	The C57BL/6J mouse as a model of seizure/epilepsy is challenging due to high mortality and huge variability in response to kainate. We have recently demonstrated that repeated administration of a low dose of kainate by intraperitoneal route can induce severe status epilepticus (SE) with 94% survival rate. In the present study, based on continuous video-EEG recording for 4-18 weeks from epidurally implanted electrodes on the cortex, we demonstrate that this method also induces immediate epileptogenesis (<1-5 days post-SE). This finding was based on identification of two types of spontaneous recurrent seizures; behavioral convulsive seizures (CS) and electrographic nonconvulsive seizures (NCS). The identification of the spontaneous CS, stage 3-5 types, was based on the behaviors (video) that were associated with the EEG characteristics (stage 3-5 epileptiform spikes), the power spectrum, and the activity counts. The electrographic NCS identification was based on the stage 1-2 epileptiform spike clusters on the EEG and their associated power spectrum. Severe SE induced immediate epileptogenesis in all the mice. The maximum numbers of spontaneous CS were observed during the first 4-6 weeks of the SE and they decreased thereafter. Mild SE also induced immediate epileptogenesis in some mice but the CS were less frequent. In both the severe and the mild SE groups, the spontaneous electrographic NCS persisted throughout the 18 weeks observation period, and therefore this could serve as a chronic model for complex seizures. However, unlike rat kainate models, the C57BL/6J mouse kainate model is a unique regressive CS model of epilepsy. Further studies are required to understand the mechanism of recovery from spontaneous CS in this model, which could reveal novel therapeutic targets for epilepsy.	[Puttachary, Sreekanth; Sharma, Shaunik; Sexton, Abby; Crutison, Joseph; Thippeswamy, Thimmasettappa] Iowa State Univ, Coll Vet Med, Dept Biomed Sci, Ames, IA 50011 USA; [Tse, Karen; Beamer, Edward] Univ Liverpool, Inst Aging & Chron Dis, Liverpool L69 3GA, Merseyside, England	Iowa State University; University of Liverpool	Thippeswamy, T (corresponding author), Iowa State Univ, Coll Vet Med, Dept Biomed Sci, Ames, IA 50011 USA.	tswamy@iastate.edu	Puttachary, Sreekanth/S-3639-2019; Sharma, Shaunik/AAT-4234-2021	Puttachary, Sreekanth/0000-0002-4071-7896; Sharma, Shaunik/0000-0002-3352-6397; Beamer, Edward/0000-0003-1947-7346	Iowa State University (ISU); Seed Grant from the College of Veterinary Medicine, ISU, USA [290-05-02-00-0075, 701-05-07-15-0100, 701-05-07-00-0075]; BBSRC, UK; University of Liverpool, UK; Undergraduate Research Assistantship from ISU; TT's startup funds	Iowa State University (ISU); Seed Grant from the College of Veterinary Medicine, ISU, USA; BBSRC, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Liverpool, UK; Undergraduate Research Assistantship from ISU; TT's startup funds	SP and SS are supported by the start-up funds provided to TT by the Iowa State University (ISU) and the Seed Grant from the College of Veterinary Medicine, ISU, USA. (Grant numbers-290-05-02-00-0075, 701-05-07-15-0100, and 701-05-07-00-0075) http://vetmed.iastate.edu/). KT and EB (PhD students) were supervised by TT during his employment at the University of Liverpool. Funding support for KT and EB was from the BBSRC, UK and the University of Liverpool, UK. AS and JC were supported by the Undergraduate Research Assistantship from ISU and part-funded by TT's startup funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arabadzisz D, 2005, EXP NEUROL, V194, P76, DOI 10.1016/j.expneurol.2005.01.029; Arcieri S, 2014, EPILEPSIA, V55, P1978, DOI 10.1111/epi.12850; Bankstahl M, 2012, BEHAV BRAIN RES, V230, P182, DOI 10.1016/j.bbr.2012.02.004; Barth D, 2014, AM EP SO ANN M SEATT; Bastlund JF, 2004, J NEUROSCI METH, V138, P65, DOI 10.1016/j.jneumeth.2004.03.004; Beamer E, 2012, EUR J NEUROSCI, V36, P3194, DOI 10.1111/j.1460-9568.2012.08234.x; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Ben-Ari Y, 2012, KAINATE TEMPORAL LOB; Benkovic SA, 2006, BRAIN RES, V1070, P215, DOI 10.1016/j.brainres.2005.11.065; Benkovic SA, 2004, BRAIN RES, V1024, P59, DOI 10.1016/j.brainres.2004.07.021; Biagini G, 2006, EXP NEUROL, V201, P519, DOI 10.1016/j.expneurol.2006.04.029; Bortel A, 2010, NEUROBIOL DIS, V40, P478, DOI 10.1016/j.nbd.2010.07.015; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Buckmaster PS, 2004, COMPARATIVE MED, V54, P473; Bumanglag AV, 2008, J COMP NEUROL, V510, P561, DOI 10.1002/cne.21801; Carriero G, 2012, EPILEPSIA, V53, P1917, DOI 10.1111/j.1528-1167.2012.03669.x; Chen ZG, 2002, BRAIN RES, V931, P135, DOI 10.1016/S0006-8993(02)02268-0; Csernansky JG, 1998, BIOL PSYCHIAT, V44, P1143, DOI 10.1016/S0006-3223(98)00019-5; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; Dudek FE, 2011, NEUROSCI LETT, V497, P240, DOI 10.1016/j.neulet.2011.03.071; Fuquay JM, 2012, TOXICOLOGY, V294, P36, DOI 10.1016/j.tox.2012.01.012; Galanopoulou AS, 2013, EPILEPSIA, V54, P13, DOI 10.1111/epi.12295; Goffin K, 2007, EXP NEUROL, V205, P501, DOI 10.1016/j.expneurol.2007.03.008; Heinrich C, 2011, NEUROBIOL DIS, V42, P35, DOI 10.1016/j.nbd.2011.01.001; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Hirshler Y, 2010, EXP NEUROL, V222, P42, DOI 10.1016/j.expneurol.2009.12.006; Huneau C, 2013, EPILEPSIA, V54, P2219, DOI 10.1111/epi.12406; Huneau C, 2010, IEEE ENG MED BIO, P6007, DOI 10.1109/IEMBS.2010.5627592; Jung S, 2007, J NEUROSCI, V27, P13012, DOI 10.1523/JNEUROSCI.3605-07.2007; Kadam SD, 2010, J NEUROSCI, V30, P404, DOI 10.1523/JNEUROSCI.4093-09.2010; KESSLER J, 1983, EXPERIENTIA, V39, P922, DOI 10.1007/BF01990440; Klitgaard H, 2002, EPILEPSY RES, V51, P93, DOI 10.1016/S0920-1211(02)00099-2; Knuesel I, 2002, EUR J NEUROSCI, V15, P1474, DOI 10.1046/j.1460-9568.2002.01980.x; Le Duigou C, 2008, J PHYSIOL-LONDON, V586, P4891, DOI 10.1113/jphysiol.2008.156281; Levesque M, 2013, NEUROSCI BIOBEHAV R, V37, P2887, DOI 10.1016/j.neubiorev.2013.10.011; Lowenstein DH, 1999, EPILEPSIA, V40, P120, DOI 10.1111/j.1528-1157.1999.tb02000.x; Mazzuferi M, 2012, EXP NEUROL, V238, P156, DOI 10.1016/j.expneurol.2012.08.022; McCord MC, 2008, NEUROSCIENCE, V154, P1143, DOI 10.1016/j.neuroscience.2008.03.082; McKhann GM, 2003, NEUROSCIENCE, V122, P551, DOI 10.1016/S0306-4522(03)00562-1; McLin JP, 2006, EUR J NEUROSCI, V24, P3134, DOI 10.1111/j.1460-9568.2006.05198.x; McLin JP, 2006, EUR J NEUROSCI, V24, P2191, DOI 10.1111/j.1460-9568.2006.05111.x; Melo T, 2010, J NEUROCHEM, V115, P1445, DOI 10.1111/j.1471-4159.2010.07048.x; Michalak Z, 2013, EPILEPSY RES, V103, P167, DOI 10.1016/j.eplepsyres.2012.10.006; Minicucci F, 2006, EPILEPSIA, V47, P9, DOI 10.1111/j.1528-1167.2006.00870.x; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Mouri G, 2008, BRAIN RES, V1213, P140, DOI 10.1016/j.brainres.2008.03.061; Pan JC, 1996, NEUROSCI LETT, V209, P121, DOI 10.1016/0304-3940(96)12615-X; Pearce PS, 2014, EPILEPSY BEHAV, V32, P121, DOI 10.1016/j.yebeh.2014.01.004; Pernot F, 2011, EPILEPSIA, V52, P2315, DOI 10.1111/j.1528-1167.2011.03273.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raedt R, 2009, ACTA NEUROL SCAND, V119, P293, DOI 10.1111/j.1600-0404.2008.01108.x; Rao MS, 2006, J NEUROSCI RES, V83, P1088, DOI 10.1002/jnr.20802; Raol YH, 2012, PROG MOL BIOL TRANSL, V105, P57, DOI 10.1016/B978-0-12-394596-9.00003-2; Raol YH, 2006, J NEUROSCI, V26, P11342, DOI 10.1523/JNEUROSCI.3329-06.2006; Rattka M, 2013, EPILEPSY RES, V103, P135, DOI 10.1016/j.eplepsyres.2012.09.015; Reddy DS, 2013, INT J MOL SCI, V14, P18284, DOI 10.3390/ijms140918284; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Scharfman HE, 2007, CURR NEUROL NEUROSCI, V7, P348, DOI 10.1007/s11910-007-0053-z; Schauwecker PE, 2011, GENES BRAIN BEHAV, V10, P100, DOI 10.1111/j.1601-183X.2010.00644.x; Schauwecker PE, 2011, EPILEPSY RES, V97, P1, DOI 10.1016/j.eplepsyres.2011.09.005; Schauwecker PE, 2003, EPILEPSY RES, V55, P201, DOI 10.1016/S0920-1211(03)00115-3; Schauwecker PE, 2002, EXP NEUROL, V178, P219, DOI 10.1006/exnr.2002.8038; Sloviter RS, 2008, EPILEPSIA, V49, P85, DOI 10.1111/j.1528-1167.2008.01931.x; Tan HO, 2007, P NATL ACAD SCI USA, V104, P17536, DOI 10.1073/pnas.0708440104; Tang XD, 2007, SLEEP, V30, P1057, DOI 10.1093/sleep/30.8.1057; Tse K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096622; TURSKI WA, 1984, BRAIN RES, V321, P237, DOI 10.1016/0006-8993(84)90177-X; White A, 2010, EPILEPSIA, V51, P371, DOI 10.1111/j.1528-1167.2009.02339.x; Williams PA, 2007, EPILEPSIA, V48, P157, DOI 10.1111/j.1528-1167.2007.01304.x; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Yang J, 2005, NEUROSCIENCE, V131, P853, DOI 10.1016/j.neuroscience.2004.09.064; Zheng XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/457079	73	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131705	10.1371/journal.pone.0131705	http://dx.doi.org/10.1371/journal.pone.0131705			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161754	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300054
J	Siegert, S; Wolf, A; Cooper, DN; Krawczak, M; Nothnagel, M				Siegert, Sabine; Wolf, Andreas; Cooper, David N.; Krawczak, Michael; Nothnagel, Michael			Mutations Causing Complex Disease May under Certain Circumstances Be Protective in an Epidemiological Sense	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MISSING HERITABILITY; MACULAR DEGENERATION; SUSCEPTIBILITY LOCI; COMMON DISEASES; RARE VARIANTS; BREAST-CANCER; STRATEGIES; AFRICAN; TRAITS	Guided by the practice of classical epidemiology, research into the genetic basis of complex disease has usually taken for granted the dictum that causative mutations are invariably over-represented among clinically affected as compared to unaffected individuals. However, we show that this supposition is not true and that a mutation contributing to the etiology of a complex disease can, under certain circumstances, be depleted among patients. Populations with defined disease prevalence were repeatedly simulated under a Wright-Fisher model, assuming various types of population history and genotype-phenotype relationship. For each simulation, the resulting mutation-specific population frequencies and odds ratios (ORs) were evaluated. In addition, the relationship between mutation frequency and OR was studied using real data from the NIH GWAS catalogue of reported phenotype associations of single-nucleotide polymorphisms (SNPs). While rare diseases (prevalence <1%) were found to be consistently caused by rare mutations with ORs>1, up to 20% of mutations causing a pandemic disease (prevalence 10-20%) had ORs<1, and their population frequency ranged from 0% to 100%. Moreover, simulation-based ORs exhibited a wide distribution, irrespective of mutation frequency. In conclusion, a substantial proportion of mutations causing common complex diseases may appear 'protective' in genetic epidemiological studies and hence would normally tend to be excluded, albeit erroneously, from further study. This apparently paradoxical result is explicable in terms of mutual confounding of the respective genotype-phenotype relationships due to a negative correlation between causal mutations induced by their common gene genealogy. As would be predicted by our findings, a significant negative correlation became apparent in published genome-wide association studies between the OR of genetic variants associated with a particular disease and the prevalence of that disease.	[Siegert, Sabine; Nothnagel, Michael] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Siegert, Sabine] Univ Kiel, Inst Epidemiol, Kiel, Germany; [Wolf, Andreas; Krawczak, Michael; Nothnagel, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany; [Cooper, David N.] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff CF10 3AX, S Glam, Wales	University of Cologne; University of Kiel; University of Kiel; Cardiff University	Nothnagel, M (corresponding author), Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany.	michael.nothnagel@uni-koeln.de	Nothnagel, Michael/L-7187-2019; Krawczak, Michael/A-8964-2010; Wolf, Andreas/M-2518-2016; Cooper, David N/H-4384-2011; Nothnagel, Michael/G-6545-2014	Nothnagel, Michael/0000-0001-8305-7114; Krawczak, Michael/0000-0003-2603-1502; Cooper, David N/0000-0002-8943-8484; 	National Genome Research Network (NGFNplus) [01GS0809]; DFG Excellence Cluster 'Inflammation at Interfaces' (EXC) [306, 306/2]	National Genome Research Network (NGFNplus); DFG Excellence Cluster 'Inflammation at Interfaces' (EXC)	This study was supported by the National Genome Research Network (NGFNplus 01GS0809) and the DFG Excellence Cluster 'Inflammation at Interfaces' (EXC 306 and 306/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2011, AM J RESP CRIT CARE, V184, P633, DOI 10.1164/rccm.201103-0446ED; Anderson CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000580; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Bhatia G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000954; Brookfield JFY, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-41; Clarke AJ, 2010, EUR J HUM GENET, V18, P859, DOI 10.1038/ejhg.2010.35; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Diez O, 2010, FAM CANCER, V9, P187, DOI 10.1007/s10689-009-9301-5; Durrett R, 2008, PROBAB APPL SER, P1, DOI 10.1007/978-0-387-78168-6_1; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Evangelou E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000196; Falconer D. S., 1996, INTRO QUANTITATIVE G; Ferla R, 2007, ANN ONCOL, V18, P93, DOI 10.1093/annonc/mdm234; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Hein J., 2005, GENE GENEALOGIES VAR; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; HUDSON R, 1990, GENE GENEALOGIES COA; Huo DZ, 2012, CARCINOGENESIS, V33, P835, DOI 10.1093/carcin/bgs093; Hutter CM, 2011, CANCER EPIDEM BIOMAR, V20, P1950, DOI 10.1158/1055-9965.EPI-11-0524; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Kathiresan S, 2012, CELL, V148, P1242, DOI 10.1016/j.cell.2012.03.001; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kupfer SS, 2010, GASTROENTEROLOGY, V139, P1677, DOI 10.1053/j.gastro.2010.07.038; Lewis Cathryn M, 2012, Cold Spring Harb Protoc, V2012, P297, DOI 10.1101/pdb.top068163; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nordborg M., 2007, HDB STAT GENETICS, P843; Platt A, 2010, GENETICS, V186, P1045, DOI 10.1534/genetics.110.121665; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; R Development Core Team, 2012, R LANG ENV STAT COMP; RISCH N, 1990, AM J HUM GENET, V46, P222; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Rothman K., 1998, MODERN EPIDEMIOLOGY; Simons YB, 2014, NAT GENET, V46, P220, DOI 10.1038/ng.2896; Thornton KR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003258; Tremblay J, 2013, METABOLISM, V62, pS2, DOI 10.1016/j.metabol.2012.08.023; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	49	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132150	10.1371/journal.pone.0132150	http://dx.doi.org/10.1371/journal.pone.0132150			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161957	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000358162300098
J	Thibodeau, A; Fravalo, P; Yergeau, E; Arsenault, J; Lahaye, L; Letellier, A				Thibodeau, Alexandre; Fravalo, Philippe; Yergeau, Etienne; Arsenault, Julie; Lahaye, Ludovic; Letellier, Ann			Chicken Caecal Microbiome Modifications Induced by Campylobacter jejuni Colonization and by a Non-Antibiotic Feed Additive	PLOS ONE			English	Article							BROILER-CHICKENS; CLOSTRIDIUM-PERFRINGENS; QUANTITATIVE PCR; GUT MICROBIOTA; ESSENTIAL OILS; POULTRY; PERFORMANCE; MICROFLORA; BACTERIA; QUANTIFICATION	Campylobacter jejuni is an important zoonotic foodborne pathogen causing acute gastroenteritis in humans. Chickens are often colonized at very high numbers by C. jejuni, up to 10(9) CFU per gram of caecal content, with no detrimental effects on their health. Farm control strategies are being developed to lower the C. jejuni contamination of chicken food products in an effort to reduce human campylobacteriosis incidence. It is believed that intestinal microbiome composition may affect gut colonization by such undesirable bacteria but, although the chicken microbiome is being increasingly characterized, information is lacking on the factors affecting its modulation, especially by foodborne pathogens. This study monitored the effects of C. jejuni chicken caecal colonization on the chicken microbiome in healthy chickens. It also evaluated the capacity of a feed additive to affect caecal bacterial populations and to lower C. jejuni colonization. From day-0, chickens received or not a microencapsulated feed additive and were inoculated or not with C. jejuni at 14 days of age. Fresh caecal content was harvested at 35 days of age. The caecal microbiome was characterized by real time quantitative PCR and Ion Torrent sequencing. We observed that the feed additive lowered C. jejuni caecal count by 0.7 log (p<0.05). Alpha-diversity of the caecal microbiome was not affected by C. jejuni colonization or by the feed additive. C. jejuni colonization modified the caecal beta-diversity while the feed additive did not. We observed that C. jejuni colonization was associated with an increase of Bifidobacterium and affected Clostridia and Mollicutes relative abundances. The feed additive was associated with a lower Streptococcus relative abundance. The caecal microbiome remained relatively unchanged despite high C. jejuni colonization. The feed additive was efficient in lowering C. jejuni colonization while not disturbing the caecal microbiome.	[Thibodeau, Alexandre; Fravalo, Philippe; Letellier, Ann] Univ Montreal, Fac Med Vet, NSERC Ind Res Chair Meat Safety CRSV, St Hyacinthe, PQ J2S 7C6, Canada; [Thibodeau, Alexandre; Fravalo, Philippe; Arsenault, Julie; Letellier, Ann] Univ Montreal, Fac Med Vet, Swine & Avian Infect Dis Res Ctr CRIPA, St Hyacinthe, PQ J2S 7C6, Canada; [Thibodeau, Alexandre; Fravalo, Philippe; Arsenault, Julie; Letellier, Ann] Univ Montreal, Fac Med Vet, GRESA, St Hyacinthe, PQ J2S 7C6, Canada; [Yergeau, Etienne] Natl Res Council Canada, Montreal, PQ, Canada; [Lahaye, Ludovic] Jefo Nutr Inc, St Hyacinthe, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; National Research Council Canada	Thibodeau, A (corresponding author), Univ Montreal, Fac Med Vet, NSERC Ind Res Chair Meat Safety CRSV, St Hyacinthe, PQ J2S 7C6, Canada.	alexandre.thibodeau@live.ca; ann.letellier@umontreal.ca	Arsenault, Julie/D-5077-2015; Yergeau, Etienne/B-5344-2008; Yergeau, Etienne/AAZ-6145-2020	Arsenault, Julie/0000-0001-8382-7326; Yergeau, Etienne/0000-0002-7112-3425	Ministere de l'Agriculture et des Peches du Quebec (MAPAQ); Centre de Recherche en Infectiologie Porcine et Aviaire (CRIPA); Natural Sciences and Engineering Research Council of Canada (NSERC) [130565330]	Ministere de l'Agriculture et des Peches du Quebec (MAPAQ); Centre de Recherche en Infectiologie Porcine et Aviaire (CRIPA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors received funding from: Ministere de l'Agriculture et des Peches du Quebec (MAPAQ), the Centre de Recherche en Infectiologie Porcine et Aviaire (CRIPA), Natural Sciences and Engineering Research Council of Canada (NSERC grant no: 130565330); for the NSERC Industrial Research Chair in Meat Safety and Jefo Nutrition Inc.	Boroojeni FG, 2014, POULTRY SCI, V93, P1440, DOI 10.3382/ps.2013-03763; Castillo M, 2006, VET MICROBIOL, V114, P165, DOI 10.1016/j.vetmic.2005.11.055; Cean A, 2015, FOODBORNE PATHOG DIS, V12, P122, DOI 10.1089/fpd.2014.1849; Clifford RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048558; Cross DE, 2007, BRIT POULTRY SCI, V48, P496, DOI 10.1080/00071660701463221; Ding W, 2005, J FOOD PROTECT, V68, P2295, DOI 10.4315/0362-028X-68.11.2295; Duncan SH, 2004, BRIT J NUTR, V91, P915, DOI 10.1079/BJN20041150; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Giannenas I, 2012, VET PARASITOL, V188, P31, DOI 10.1016/j.vetpar.2012.02.017; Gras LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042599; Grilli E, 2013, J APPL MICROBIOL, V114, P308, DOI 10.1111/jam.12053; Hansen AK, 2014, WORLD J GASTROENTERO, V20, P17727, DOI 10.3748/wjg.v20.i47.17727; Hermans D, 2012, VECTOR-BORNE ZOONOT, V12, P89, DOI 10.1089/vbz.2011.0676; Hermans D, 2012, CRIT REV MICROBIOL, V38, P17, DOI 10.3109/1040841X.2011.615298; Hermans D, 2011, J FOOD PROTECT, V74, P1729, DOI 10.4315/0362-028X.JFP-10-487; Hermans D, 2011, VET MICROBIOL, V152, P219, DOI 10.1016/j.vetmic.2011.03.010; Hermans D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-82; Humphrey S, 2014, MBIO, V5, DOI 10.1128/mBio.01364-14; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; HUTCHINSON DN, 1984, J CLIN PATHOL, V37, P956, DOI 10.1136/jcp.37.8.956-b; Johansen CH, 2006, POULTRY SCI, V85, P579, DOI 10.1093/ps/85.4.579; Juteau P, 2004, APPL MICROBIOL BIOT, V66, P115, DOI 10.1007/s00253-004-1692-5; Kaakoush NO, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-18; Laisney MJ, 2004, BRIT POULTRY SCI, V45, P49, DOI 10.1080/00071660410001668851; Line JE, 2010, J MICROBIOL METH, V80, P198, DOI 10.1016/j.mimet.2009.12.011; Luber P, 2006, APPL ENVIRON MICROB, V72, P66, DOI 10.1128/AEM.72.1.66-70.2006; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; MESSIER S, 1993, AVIAN DIS, V37, P839, DOI 10.2307/1592039; Molatova Z, 2011, J ANIM PHYSIOL AN N, V95, P701, DOI 10.1111/j.1439-0396.2010.01100.x; Mookiah S, 2014, J SCI FOOD AGR, V94, P341, DOI 10.1002/jsfa.6365; Morotomi M, 2012, INT J SYST EVOL MICR, V62, P144, DOI 10.1099/ijs.0.026989-0; Newell DG, 2011, APPL ENVIRON MICROB, V77, P8605, DOI 10.1128/AEM.01090-10; Oakley BB, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0282-8; Oakley BB, 2014, FEMS MICROBIOL LETT, V360, P100, DOI 10.1111/1574-6968.12608; Oh MH, 2009, J FOOD PROTECT, V72, P1262, DOI 10.4315/0362-028X-72.6.1262; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Rosenquist H, 2003, INT J FOOD MICROBIOL, V83, P87, DOI 10.1016/S0168-1605(02)00317-3; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Sanschagrin S, 2014, JOVE-J VIS EXP, DOI 10.3791/51709; Santini C, 2010, INT J FOOD MICROBIOL, V141, pS98, DOI 10.1016/j.ijfoodmicro.2010.03.039; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sergeant MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091941; Singh P, 2013, POULTRY SCI, V92, P272, DOI 10.3382/ps.2012-02603; Skanseng B, 2006, MOL CELL PROBE, V20, P269, DOI 10.1016/j.mcp.2006.02.001; Smith CK, 2008, FEMS IMMUNOL MED MIC, V54, P114, DOI 10.1111/j.1574-695X.2008.00458.x; Sofka D, 2015, BERL MUNCH TIERARZTL, V128, P104, DOI 10.2376/0005-9366-128-104; Stanley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104739; Stanley D, 2012, VET MICROBIOL, V159, P155, DOI 10.1016/j.vetmic.2012.03.032; Sylvester FA, 1996, INFECT IMMUN, V64; Thibodeau A, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0433-5; Thibodeau A, 2013, FOODBORNE PATHOG DIS, V10, P382, DOI 10.1089/fpd.2012.1271; Thibodeau A, 2011, CAN J VET RES, V75, P298; Tiihonen K, 2010, BRIT POULTRY SCI, V51, P381, DOI 10.1080/00071668.2010.496446; Van Deun K, 2008, BRIT J NUTR, V100, P480, DOI 10.1017/S0007114508921693; Van Deun K, 2008, VET MICROBIOL, V130, P285, DOI 10.1016/j.vetmic.2007.11.027; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-140; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-30; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61; Yergeau E, 2012, APPL ENVIRON MICROB, V78, P7626, DOI 10.1128/AEM.02036-12	60	82	83	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131978	10.1371/journal.pone.0131978	http://dx.doi.org/10.1371/journal.pone.0131978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161743	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300078
J	Li, H; Tong, P; Gallegos, J; Dimmer, E; Cai, G; Molldrem, JJ; Liang, SD				Li, Hua; Tong, Pan; Gallegos, Juan; Dimmer, Emily; Cai, Guoshuai; Molldrem, Jeffrey J.; Liang, Shoudan			PAND: A Distribution to Identify Functional Linkage from Networks with Preferential Attachment Property	PLOS ONE			English	Article							PROTEIN FUNCTION; PREDICTION; MEDIATOR	Technology advances have immensely accelerated large-scale mapping of biological networks, which necessitates the development of accurate and powerful network-based algorithms to make functional inferences. A prevailing approach is to leverage functions of neighboring nodes to predict unknown molecular function. However, existing neighbor-based algorithms have ignored the scale-free property hidden in many biological networks. By assuming that neighbor sharing is constrained by the preferential attachment property, we developed a Preferential Attachment based common Neighbor Distribution (PAND) to calculate the probability of the neighbor-sharing event between any two nodes in scale-free networks, which nearly perfectly matched the observed probability in simulations. By applying PAND to a human protein-protein interaction (PPI) network, we showed that smaller probabilities represented closer functional linkages between proteins. With the PAND-derive linkages, we were able to build new networks where the links are more functionally reliable than those of the human PPI network. We then applied simple annotation schemes to a PAND-derived network to make reliable functional predictions for proteins. We also developed an R package called PANDA (PAND-derived functional Associations) to implement the methods proposed in this study. In conclusion, PAND is a useful distribution to calculate the probability of the neighbor-sharing events in scale-free networks. With PAND, we are able to extract reliable functional linkages from real biological networks and builds new networks that are better bases for further functional inference.	[Li, Hua; Liang, Shoudan] Shanghai Jiao Tong Univ, Sch Biomed Engn, BioiD Ctr, Shanghai 200240, Peoples R China; [Li, Hua; Molldrem, Jeffrey J.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Tong, Pan; Cai, Guoshuai; Liang, Shoudan] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Gallegos, Juan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dimmer, Emily] EMBL Outstn European Bioinformat Inst, Cambridge CB10 1SD, England	Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; European Molecular Biology Laboratory (EMBL)	Li, H (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, BioiD Ctr, Shanghai 200240, Peoples R China.	kaikaixinxin@sjtu.edu.cn; shoudanl@gmail.com	Tong, Pan/O-6097-2015	LI, HUA/0000-0003-2153-2500	Keck Center for Quantitative Biomedical Sciences of the Gulf Coast Consortia; Cancer Prevention & Research Institute of Texas (CPRIT) [RP101489]; National Natural Science Foundation of China [91129000, 11374207, 91229108]; K.C. Wong Education Foundation; Scientific Research Foundation; State Education Ministry; NATIONAL CANCER INSTITUTE [P50CA100632] Funding Source: NIH RePORTER	Keck Center for Quantitative Biomedical Sciences of the Gulf Coast Consortia; Cancer Prevention & Research Institute of Texas (CPRIT); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); K.C. Wong Education Foundation; Scientific Research Foundation; State Education Ministry; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a training fellowship from the Keck Center for Quantitative Biomedical Sciences of the Gulf Coast Consortia, on the Computational Cancer Biology Training Program from the Cancer Prevention & Research Institute of Texas (CPRIT No. RP101489). This research was also supported by National Natural Science Foundation of China (91129000, 11374207, 91229108), K.C. Wong Education Foundation (H.K.) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2007, PLANT CELL, V19, P3327, DOI 10.1105/tpc.107.054700; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brun Christine, 2003, Genome Biol, V5, pR6, DOI 10.1186/gb-2003-5-1-r6; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006410; Llewellyn R, 2008, P NATL ACAD SCI USA, V105, P17700, DOI 10.1073/pnas.0809583105; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Samanta MP, 2003, P NATL ACAD SCI USA, V100, P12579, DOI 10.1073/pnas.2132527100; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853	25	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0127968	10.1371/journal.pone.0127968	http://dx.doi.org/10.1371/journal.pone.0127968			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158709	Green Published, Green Submitted, gold			2022-12-27	WOS:000358161200005
J	Chen, Z; Wu, WL; Shao, XM; Li, L; Guo, YB; Ding, GC				Chen, Zhu; Wu, Wenliang; Shao, Xiaoming; Li, Li; Guo, Yanbin; Ding, Guochun			Shifts in Abundance and Diversity of Soil Ammonia-Oxidizing Bacteria and Archaea Associated with Land Restoration in a Semi-Arid Ecosystem	PLOS ONE			English	Article							LONG-TERM FERTILIZATION; COMMUNITY STRUCTURE; NITROGEN; NITRIFICATION; RHIZOSPHERE; RESPONSES; POLICIES	The Grain to Green Project (GGP) is an unprecedented land restoration action in China. The project converted large areas (ca 10 million ha) of steep-sloped/degraded farmland and barren land into forest and grassland resulting in ecological benefits such as a reduction in severe soil erosion. It may also affect soil microorganisms involved in ammonia oxidization, which is a key step in the global nitrogen cycle. The methods for restoration that are typically adopted in semi-arid regions include abandoning farmland and growing drought tolerant grass (Lolium perenne L.) or shrubs (Caragana korshinskii Kom.). In the present study, the effects of these methods on the abundance and diversity of ammonia-oxidizing bacteria (AOB) and ammonia-oxidizing archaea (AOA) were evaluated via quantitative real-time PCR, terminal restriction fragment length polymorphism and clone library analysis of amoA genes. Comparisons were made between soil samples from three restored lands and the adjacent farmland in Inner Mongolia. Both the abundance and community composition of AOB were significantly different between the restored lands and the adjacent control. Significantly lower nitrification activity was observed for the restored land. Clone library analysis revealed that all AOB amoA gene sequences were affiliated with Nitrosospira. Abundance of the populations that were associated with Nitrosospira sp. Nv6 which had possibly adapted to high concentrations of inorganic nitrogen, decreased on the restored land. Only a slight difference in the AOB communities was observed between the restored land with and without the shrub (Caragana korshinskii Kom.). A minor effect of land restoration on AOA was observed. In summary, land restoration negatively affected the abundance of AOB and soil nitrification activities, suggesting the potential role of GGP in the leaching of nitrates, and in the emission of N2O in related terrestrial ecosystems.	[Chen, Zhu; Shao, Xiaoming] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Wu, Wenliang; Li, Li; Guo, Yanbin; Ding, Guochun] China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China; [Wu, Wenliang; Li, Li; Guo, Yanbin; Ding, Guochun] China Agr Univ, Beijing Key Lab Biodivers & Organ Farming, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University; China Agricultural University	Guo, YB (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China.	guoyb@cau.edu.cn; gc_ding@cau.edu.cn		ding, guo-chun/0000-0002-5468-5979	National Natural Science Foundation of China [31170489, 31400095]; Funds for International Cooperation and Exchange of the National Natural Science Foundation of China [31261140367]; Funds for Science and Technology Bureau of Tibet Autonomous Region [Z2013C02N02]; Chinese Universities Scientific Fund [2015ZH005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funds for International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funds for Science and Technology Bureau of Tibet Autonomous Region; Chinese Universities Scientific Fund	This work was supported by the National Natural Science Foundation of China (Grant No. 31170489), the Funds for International Cooperation and Exchange of the National Natural Science Foundation of China (Grant No. 31261140367), the Funds for Science and Technology Bureau of Tibet Autonomous Region (Project no. Z2013C02N02), National Natural Science Foundation of China (Grant No. 31400095), Chinese Universities Scientific Fund (Project no. 2015ZH005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai C, 2013, SOIL BIOL BIOCHEM, V57, P30, DOI 10.1016/j.soilbio.2012.08.003; ALLISON SM, 1991, SOIL BIOL BIOCHEM, V23, P45, DOI 10.1016/0038-0717(91)90161-C; [安萍莉 An Pingli], 2002, [资源科学, Resources science], V24, P35; Babic KH, 2008, ENVIRON MICROBIOL, V10, P2922, DOI 10.1111/j.1462-2920.2008.01762.x; Bissett A, 2011, APPL SOIL ECOL, V51, P66, DOI 10.1016/j.apsoil.2011.08.010; Boyle-Yarwood SA, 2008, ENVIRON MICROBIOL, V10, P2956, DOI 10.1111/j.1462-2920.2008.01600.x; Chen YL, 2013, APPL SOIL ECOL, V68, P36, DOI 10.1016/j.apsoil.2013.03.006; Chu HY, 2007, APPL ENVIRON MICROB, V73, P485, DOI 10.1128/AEM.01536-06; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Deng L, 2012, INT J SEDIMENT RES, V27, P120, DOI 10.1016/S1001-6279(12)60021-3; Di HJ, 2009, NAT GEOSCI, V2, P621, DOI 10.1038/NGEO613; Ding GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059497; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Hu HW, 2015, ENVIRON MICROBIOL, V17, P444, DOI 10.1111/1462-2920.12481; Jia GM, 2010, EUR J SOIL BIOL, V46, P6, DOI 10.1016/j.ejsobi.2009.10.002; Khademi S, 2006, PHYSIOLOGY, V21, P419, DOI 10.1152/physiol.00051.2005; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kowalchuk GA, 2000, ENVIRON MICROBIOL, V2, P99, DOI 10.1046/j.1462-2920.2000.00080.x; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Kurola J, 2005, FEMS MICROBIOL LETT, V250, P33, DOI 10.1016/j.femsle.2005.06.057; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Lu L, 2012, ISME J, V6, P1978, DOI 10.1038/ismej.2012.45; McLean E., 1983, METHODS SOIL ANAL PA, V9, P199, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C12; Murty D, 2002, GLOBAL CHANGE BIOL, V8, P105, DOI 10.1046/j.1354-1013.2001.00459.x; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Offre P, 2014, TRENDS MICROBIOL, V22, P665, DOI 10.1016/j.tim.2014.07.007; Olsen SR, 1965, METHODS SOIL ANAL, V9, P920, DOI DOI 10.2134/AGRONMONOGR9.2.C22; Placella SA, 2013, APPL ENVIRON MICROB, V79, P3294, DOI 10.1128/AEM.00404-13; PROSSER JI, 1989, ADV MICROB PHYSIOL, V30, P125; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shen JP, 2008, ENVIRON MICROBIOL, V10, P1601, DOI 10.1111/j.1462-2920.2008.01578.x; Sheng R, 2013, J SOIL SEDIMENT, V13, P1246, DOI 10.1007/s11368-013-0713-3; Song XZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04460; Stempfhuber B, 2015, MICROB ECOL, V69, P879, DOI 10.1007/s00248-014-0548-5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Verhamme DT, 2011, ISME J, V5, P1067, DOI 10.1038/ismej.2010.191; Wang LiWei, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P224; Webster G, 2005, ENVIRON MICROBIOL, V7, P676, DOI 10.1111/j.1462-2920.2005.00740.x; Young IM, 2004, SCIENCE, V304, P1634, DOI 10.1126/science.1097394; Zhang JL, 2013, 2012 CHINA FORESTRY; Zhang LM, 2012, ISME J, V6, P1032, DOI 10.1038/ismej.2011.168; Zhao CX, 2006, ARID LAND RES MANAG, V20, P233, DOI 10.1080/15324980600705735	49	10	13	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132879	10.1371/journal.pone.0132879	http://dx.doi.org/10.1371/journal.pone.0132879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172994	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900093
J	Huang, X; Park, H; Greene, J; Pao, J; Mulvey, E; Zhou, SX; Albert, CM; Moy, F; Sachdev, D; Yee, D; Rader, C; Hamby, CV; Loeb, DM; Cairo, MS; Zhou, XZ				Huang, Xin; Park, Haein; Greene, Joseph; Pao, James; Mulvey, Erin; Zhou, Sophia X.; Albert, Catherine M.; Moy, Fred; Sachdev, Deepali; Yee, Douglas; Rader, Christoph; Hamby, Carl V.; Loeb, David M.; Cairo, Mitchell S.; Zhou, Xianzheng			IGF1R-and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CHIMERIC ANTIGEN RECEPTOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; REFRACTORY EWING SARCOMA; FACTOR-I RECEPTOR; BREAST-CANCER; SOLID TUMORS; HEMATOLOGIC MALIGNANCIES; MONOCLONAL-ANTIBODY; IGF-IR	Patients with metastatic or recurrent and refractory sarcomas have a dismal prognosis. Therefore, new targeted therapies are urgently needed. This study was designed to evaluate chimeric antigen receptor (CAR) T cells targeting the type I insulin-like growth factor receptor (IGF1R) or tyrosine kinase-like orphan receptor 1 (ROR1) molecules for their therapeutic potential against sarcomas. Here, we report that IGF1R (15/15) and ROR1 (11/15) were highly expressed in sarcoma cell lines including Ewing sarcoma, osteosarcoma, alveolar or embryonal rhabdomyosarcoma, and fibrosarcoma. IGF1R and ROR1 CAR T cells derived from eight healthy donors using the Sleeping Beauty (SB) transposon system were cytotoxic against sarcoma cells and produced high levels of IFN-gamma, TNF-alpha and IL-13 in an antigen-specific manner. IGF1R and ROR1 CAR T cells generated from three sarcoma patients released significant amounts of IFN-gamma in response to sarcoma stimulation. The adoptive transfer of IGF1R and ROR1 CAR T cells derived from a sarcoma patient significantly reduced tumor growth in pre-established, systemically disseminated and localized osteosarcoma xenograft models in NSG mice. Infusion of IGF1R and ROR1 CAR T cells also prolonged animal survival in a localized sarcoma model using NOD/scid mice. Our data indicate that both IGF1R and ROR1 can be effectively targeted by SB modified CAR T cells and that such CAR T cells may be useful in the treatment of high risk sarcoma patients.	[Huang, Xin; Park, Haein; Cairo, Mitchell S.; Zhou, Xianzheng] New York Med Coll, Dept Pediat, Div Hematol Oncol & Stem Cell Transplantat, Valhalla, NY 10595 USA; [Greene, Joseph] Univ Minnesota, Coll Biol Sci, Minneapolis, MN USA; [Pao, James; Mulvey, Erin] New York Med Coll, Sch Med, Valhalla, NY 10595 USA; [Zhou, Sophia X.; Sachdev, Deepali; Yee, Douglas] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Albert, Catherine M.; Loeb, David M.] Johns Hopkins Univ, Div Pediat Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Moy, Fred; Cairo, Mitchell S.] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA; [Rader, Christoph] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Rader, Christoph] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; [Hamby, Carl V.; Cairo, Mitchell S.; Zhou, Xianzheng] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Cairo, Mitchell S.; Zhou, Xianzheng] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Cairo, Mitchell S.] New York Med Coll, Dept Med, Valhalla, NY 10595 USA	New York Medical College; University of Minnesota System; University of Minnesota Twin Cities; New York Medical College; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; Johns Hopkins Medicine; New York Medical College; Scripps Research Institute; Scripps Research Institute; New York Medical College; New York Medical College; New York Medical College	Zhou, XZ (corresponding author), New York Med Coll, Dept Pediat, Div Hematol Oncol & Stem Cell Transplantat, Valhalla, NY 10595 USA.	xianzheng_zhou@nymc.edu		Rader, Christoph/0000-0001-9955-3454; Yee, Douglas/0000-0002-3387-4009; Greene, Joseph/0000-0003-3482-0958	Karen Wyckoff Rein in Sarcoma Foundation; National Institutes of Health [AI092220]; Pediatric Cancer Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092220] Funding Source: NIH RePORTER	Karen Wyckoff Rein in Sarcoma Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Cancer Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Karen Wyckoff Rein in Sarcoma Foundation (XZ), National Institutes of Health AI092220 (XZ) and Pediatric Cancer Research Foundation (MSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2015, J CLIN ONCOL, V33, P1688, DOI 10.1200/JCO.2014.58.0225; Ahmed N, 2009, MOL THER, V17, P1779, DOI 10.1038/mt.2009.133; Anders K, 2013, CLIN CANCER RES, V19, P320, DOI 10.1158/1078-0432.CCR-12-3017; Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Baskar S, 2012, MABS-AUSTIN, V4, P349, DOI 10.4161/mabs.19870; Berger C, 2015, CANCER IMMUNOL RES, V3, P206, DOI 10.1158/2326-6066.CIR-14-0163; Bicocca VT, 2012, CANCER CELL, V22, P656, DOI 10.1016/j.ccr.2012.08.027; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Broome HE, 2011, LEUKEMIA RES, V35, P1390, DOI 10.1016/j.leukres.2011.06.021; Cecil DL, 2013, BREAST CANCER RES TR, V139, P657, DOI 10.1007/s10549-013-2577-z; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Cui B, 2013, CANCER RES, V73, P3649, DOI 10.1158/0008-5472.CAN-12-3832; Dave H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052655; Disis ML, 2013, CANCER PREV RES, V6, P1273, DOI 10.1158/1940-6207.CAPR-13-0182; Fedorov VD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006597; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gattenlohner S, 2006, CANCER RES, V66, P24, DOI 10.1158/0008-5472.CAN-05-0542; Hojjat-Farsangi M, 2014, SEMIN CANCER BIOL, V29, P21, DOI 10.1016/j.semcancer.2014.07.005; Huang GX, 2012, CANCER RES, V72, P271, DOI 10.1158/0008-5472.CAN-11-2778; Huang X, 2008, MOL THER, V16, P580, DOI 10.1038/sj.mt.6300404; Hudecek M, 2013, CLIN CANCER RES, V19, P3153, DOI 10.1158/1078-0432.CCR-13-0330; Hudecek M, 2010, BLOOD, V116, P4532, DOI 10.1182/blood-2010-05-283309; Juergens H, 2011, J CLIN ONCOL, V29, P4534, DOI 10.1200/JCO.2010.33.0670; June CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3643; Kailayangiri S, 2012, BRIT J CANCER, V106, P1123, DOI 10.1038/bjc.2012.57; Kakarla S, 2014, CANCER J, V20, P151, DOI 10.1097/PPO.0000000000000032; Kusada Y, 2008, J BIOCHEM, V143, P9, DOI 10.1093/jb/mvm192; Langer CJ, 2014, J CLIN ONCOL, V32, P2059, DOI 10.1200/JCO.2013.54.4932; Luo W, 2009, ONCOGENE, V28, P4126, DOI 10.1038/onc.2009.262; Malempati S, 2012, J CLIN ONCOL, V30, P256, DOI 10.1200/JCO.2011.37.4355; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Maus MV, 2014, BLOOD, V123, P2625, DOI 10.1182/blood-2013-11-492231; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Owen LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001965; Pappo AS, 2011, J CLIN ONCOL, V29, P4541, DOI 10.1200/JCO.2010.34.0000; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Sachdev D, 2006, CANCER RES, V66, P2391, DOI 10.1158/0008-5472.CAN-05-3126; Sachdev D, 2003, CANCER RES, V63, P627; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Tammana S, 2010, HUM GENE THER, V21, P75, DOI 10.1089/hum.2009.122; Wagner MJ, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00009; Xue XK, 2009, BLOOD, V114, P1319, DOI 10.1182/blood-2009-03-210005; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021018; YEE D, 1990, J CLIN INVEST, V86, P1806, DOI 10.1172/JCI114910; Yee D, 2012, JNCI-J NATL CANCER I, V104, P975, DOI 10.1093/jnci/djs258; Zhang SP, 2014, P NATL ACAD SCI USA, V111, P17266, DOI 10.1073/pnas.1419599111; Zhang SP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031127, 10.1371/journal.pone.0046853]; Zhou XZ, 2005, CANCER RES, V65, P1079	53	58	62	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133152	10.1371/journal.pone.0133152	http://dx.doi.org/10.1371/journal.pone.0133152			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173023	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900141
J	Lai, YJJ; Chang, HHD; Lai, HY; Xu, Y; Shiao, F; Huang, NX; Li, LP; Lee, MS; Johnson, MD; Wang, JK; Lin, CY				Lai, Ying-Jung J.; Chang, Hsiang-Hua D.; Lai, Hongyu; Xu, Yuan; Shiao, Frank; Huang, Nanxi; Li, Linpei; Lee, Ming-Shyue; Johnson, Michael D.; Wang, Jehng-Kang; Lin, Chen-Yong			N-Glycan Branching Affects the Subcellular Distribution of and Inhibition of Matriptase by HAI-2/Placental Bikunin	PLOS ONE			English	Article							GROWTH-FACTOR ACTIVATOR; SERINE-PROTEASE INHIBITOR; SQUAMOUS-CELL CARCINOMA; ZYMOGEN; CLONING; LINES; HEAD; NECK	The gene product of SPINT 2, that encodes a transmembrane, Kunitz-type serine protease inhibitor independently designated as HAI-2 or placenta bikunin (PB), is involved in regulation of sodium absorption in human gastrointestinal track. Here, we show that SPINT 2 is expressed as two species of different size (30-40-versus 25-kDa) due to different N-glycans on Asn-57. The N-glycan on 25-kDa HAI-2 appears to be of the oligomannose type and that on 30-40-kDa HAI-2 to be of complex type with extensive terminal N-acetylglucosamine branching. The two different types of N-glycan differentially mask two epitopes on HAI-2 polypeptide, recognized by two different HAI-2 mAbs. The 30-40-kDa form may be mature HAI-2, and is primarily localized in vesicles/granules. The 25-kDa form is likely immature HAI-2, that remains in the endoplasmic reticulum (ER) in the perinuclear regions of mammary epithelial cells. The two different N-glycans could, therefore, represent different maturation stages of N-glycosylation with the 25-kDa likely a precursor of the 30-40-kDa HAI-2, with the ratio of their levels roughly similar among a variety of cells. In breast cancer cells, a significant amount of the 30-40-kDa HAI-2 can translocate to and inhibit matriptase on the cell surface, followed by shedding of the matriptase-HAI-2 complex. The 25-kDa HAI-2 appears to have also exited the ER/Golgi, being localized at the cytoplasmic face of the plasma membrane of breast cancer cells. While the 25-kDa HAI-2 was also detected at the extracellular face of plasma membrane at very low levels it appears to have no role in matriptase inhibition probably due to its paucity on the cell surface. Our study reveals that N-glycan branching regulates HAI-2 through different subcellular distribution and subsequently access to different target proteases.	[Lai, Ying-Jung J.; Chang, Hsiang-Hua D.; Lai, Hongyu; Xu, Yuan; Shiao, Frank; Huang, Nanxi; Li, Linpei; Johnson, Michael D.; Lin, Chen-Yong] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Chang, Hsiang-Hua D.; Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; [Li, Linpei] Hunan Tradit Chinese Med Res Inst, Affiliated Hosp, Changsha, Hunan, Peoples R China; [Lee, Ming-Shyue] Natl Taiwan Univ, Coll Med, Grad Inst Biochem & Mol Biol, Taipei 10764, Taiwan	Georgetown University; National Defense Medical Center; National Taiwan University	Lin, CY (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA.	jkwang@ndmctsgh.edu.tw; lincy@georgetown.edu	Lin, Chen/GRR-2799-2022	Shiao, Frank/0000-0001-9258-0396; LEE, MING-SHYUE/0000-0002-8673-5088; johnson, Michael/0000-0001-6260-7586; LEE, MING-SHYUE/0000-0002-5884-4535	National Cancer Institute (NCI) Grant [RO1 CA 123223]; Ministry of Science and Technology (Taiwan) Grant [MOST 103-2320-B-016-022]; Department of Defense (Taiwan) Grant [MAB-104-026]; NIH/NCI grant [P30-CA051008]; NATIONAL CANCER INSTITUTE [P30CA051008, R01CA123223] Funding Source: NIH RePORTER	National Cancer Institute (NCI) Grant; Ministry of Science and Technology (Taiwan) Grant; Department of Defense (Taiwan) Grant; NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a National Cancer Institute (NCI) Grant RO1 CA 123223 (to M. Johnson and C.-Y. Lin), and a Ministry of Science and Technology (Taiwan) Grant MOST 103-2320-B-016-022 (to J.-K. Wang) and a Department of Defense (Taiwan) Grant MAB-104-026 (to J.-K. Wang). The authors acknowledge the assistance provided by the Microscopy and Imaging, Tissue Culture, and other Shared Resources within the Lombardi Comprehensive Cancer Center which are partially supported by NIH/NCI grant P30-CA051008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, CLIN DYSMORPHOL; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Chang HH, 2015, PLOS ONE, V9; Enghild JJ, 1999, BIOCHEMISTRY-US, V38, P11804, DOI 10.1021/bi9908540; Faller N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094267; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Heinz-Erian P, 2009, AM J HUM GENET, V84, P188, DOI 10.1016/j.ajhg.2009.01.004; HEO DS, 1989, CANCER RES, V49, P5167; Kataoka H, 2000, CANCER LETT, V148, P127, DOI 10.1016/S0304-3835(99)00322-5; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Larsen BR, 2013, EXP CELL RES, V319, P918, DOI 10.1016/j.yexcr.2013.01.008; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Marlor CW, 1997, J BIOL CHEM, V272, P12202, DOI 10.1074/jbc.272.18.12202; Muller T, 2000, GASTROENTEROLOGY, V119, P1506, DOI 10.1053/gast.2000.20514; Okajima A, 1997, HEPATOLOGY, V25, P97, DOI 10.1002/hep.510250118; SHIMOMURA T, 1993, J BIOL CHEM, V268, P22927; Stampfer MR, P NATL ACAD SCI US, V198, P2394; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; TEICHER BA, 1987, CANCER RES, V47, P388; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Xu H, 2012, AM J PHYSIOL-CELL PH, V302, pC453, DOI 10.1152/ajpcell.00344.2011; Xu ZH, 2011, J MED CHEM, V54, P7567, DOI 10.1021/jm200920s; YASUMURA S, 1993, CANCER RES, V53, P1461	25	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132163	10.1371/journal.pone.0132163	http://dx.doi.org/10.1371/journal.pone.0132163			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171609	gold, Green Published, Green Submitted			2022-12-27	WOS:000358194900033
J	Lei, HM; Chen, Y; Li, RQ; He, DL; Zhang, J				Lei, Hongmei; Chen, Ying; Li, Ruiqi; He, Deli; Zhang, Jiang			Maximum Entropy for the International Division of Labor	PLOS ONE			English	Article							MONOPOLISTIC COMPETITION; INCREASING RETURNS; PRODUCT; SPECIALIZATION	As a result of the international division of labor, the trade value distribution on different products substantiated by international trade flows can be regarded as one country's strategy for competition. According to the empirical data of trade flows, countries may spend a large fraction of export values on ubiquitous and competitive products. Meanwhile, countries may also diversify their exports share on different types of products to reduce the risk. In this paper, we report that the export share distribution curves can be derived by maximizing the entropy of shares on different products under the product's complexity constraint once the international market structure (the country-product bipartite network) is given. Therefore, a maximum entropy model provides a good fit to empirical data. The empirical data is consistent with maximum entropy subject to a constraint on the expected value of the product complexity for each country. One country's strategy is mainly determined by the types of products this country can export. In addition, our model is able to fit the empirical export share distribution curves of nearly every country very well by tuning only one parameter.	[Lei, Hongmei; Chen, Ying; Li, Ruiqi; He, Deli; Zhang, Jiang] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China	Beijing Normal University	Zhang, J (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	zhangjiang@bnu.edu.cn	Li, Ruiqi/AAD-2689-2019	Li, Ruiqi/0000-0002-3290-9476	Beijing Higher Education Young Elite Teacher Project [YETP0291]	Beijing Higher Education Young Elite Teacher Project	This work was supported by Beijing Higher Education Young Elite Teacher Project under Grant No. YETP0291 (http://www.bjedu.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, WORLD EC MILLENNIAL; Cover T. M., 1991, ELEMENTS INFORM THEO; DIXIT AK, 1977, AM ECON REV, V67, P297; Golan A., 1996, MAXIMUM ENTROPY ECON; Harte J, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199593415.001.0001; Hausmann R, 2010, HKS FACULTY RES WORK; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; HOUTHAKKER HS, 1956, KYKLOS, V9, P181, DOI 10.1111/j.1467-6435.1956.tb02717.x; Hu LC, 2012, PHYSICA A, V391, P731, DOI 10.1016/j.physa.2011.08.048; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; KRUGMAN P, 1980, AM ECON REV, V70, P950; KRUGMAN PR, 1979, J INT ECON, V9, P469, DOI 10.1016/0022-1996(79)90017-5; Lei HM, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/68003; Pritchett L, 1997, J ECON PERSPECT, V11, P3, DOI 10.1257/jep.11.3.3; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Smith A., 1976, INQUIRY NATURE CAUSE; Stigler GJ, 1951, J POLIT ECON, V59, P185, DOI 10.1086/257075; YANG XK, 1991, J POLIT ECON, V99, P460, DOI 10.1086/261762; YANG XK, 1992, AM ECON REV, V82, P392; Young AA, 1928, ECON J, V38, P527, DOI 10.2307/2224097	21	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0129955	10.1371/journal.pone.0129955	http://dx.doi.org/10.1371/journal.pone.0129955			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26172052	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900005
J	Luinstra, M; Rutgers, AWF; Dijkstra, H; Grasmeijer, F; Hagedoorn, P; Vogelzang, JMJ; Frijlink, HW; de Boer, AH				Luinstra, M.; Rutgers, A. W. F.; Dijkstra, H.; Grasmeijer, F.; Hagedoorn, P.; Vogelzang, J. M. J.; Frijlink, H. W.; de Boer, A. H.			Can Patients with Parkinson's Disease Use Dry Powder Inhalers during Off Periods?	PLOS ONE			English	Article							INHALATION; DEPOSITION; ABSORPTION; PARTICLES	Because of its rapid onset of action, pulmonary administration of levodopa is an interesting alternative to oral administration for the rescue treatment of Parkinson's disease patients in an off period. We studied the ability of Parkinson's disease patients to operate a dry powder inhaler (DPI) correctly during an off period. We used an instrumented test inhaler with three different resistances to air flow to record flow curves and computed various inhalation parameters. We observed that all (13) patients were able to generate pressure drops > 2 kPa over the highest resistance and 10 out of 13 patients achieved at least 4 kPa. Inhaled volumes (all resistances) varied from 1.2 L to 3.5 L. Total inhalation time and the time to peak inspiratory flow rate both decreased with decreasing inhaler resistance. Twelve out of thirteen patients could hold their breath for at least five seconds after inhalation and nine could extend this time to ten seconds. The data from this study indicate that patients with Parkinson's disease will indeed be able to use a dry powder inhaler during an off period and they provide an adequate starting point for the development of a levodopa powder inhaler to treat this particular patient group.	[Luinstra, M.; Vogelzang, J. M. J.] Martini Hosp, Dept Clin Pharm, Groningen, Netherlands; [Luinstra, M.; Dijkstra, H.; Grasmeijer, F.; Hagedoorn, P.; Frijlink, H. W.; de Boer, A. H.] Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands; [Rutgers, A. W. F.] Martini Hosp, Dept Neurol & Clin Neurophysiol, Groningen, Netherlands	Martini Hospital; University of Groningen; Martini Hospital	Luinstra, M (corresponding author), Martini Hosp, Dept Clin Pharm, Groningen, Netherlands.	m.luinstra@mzh.nl	Frijlink, Henderik Willem/AAD-7382-2020	Frijlink, Henderik Willem/0000-0001-7901-8198				Azouz W, 2012, PRIM CARE RESP J, V21, P208, DOI 10.4104/pcrj.2012.00010; Bartus RT, 2004, J PHARMACOL EXP THER, V310, P828, DOI 10.1124/jpet.103.064121; Cenci MA, 2011, CNS NEUROL DISORD-DR, V10, P670; de Koning JP, 2001, THESIS U GRONINGEN G, P43; Demoly P, 2014, RESP MED; Doi H, 2012, J NEUROL SCI, V319, P86, DOI 10.1016/j.jns.2012.05.010; Factor SA, 2000, AM J EMERG MED, V18, P209, DOI 10.1016/S0735-6757(00)90023-8; Frijlink H W, 2004, Expert Opin Drug Deliv, V1, P67, DOI 10.1517/17425247.1.1.67; Guedes LU, 2012, ARQ NEURO-PSIQUIAT, V70, P847, DOI 10.1590/S0004-282X2012001100005; Hoppentocht M., 2014, ADV DRUG DELIV REV; Hoppentocht M, 2015, EUROPEAN J PHARM BIO; Khajeh-Hosseini-Dalasm N, 2015, J AEROSOL SCI, V79, P15, DOI 10.1016/j.jaerosci.2014.09.003; Laube BL, 2011, EUR RESPIR J, V37, P1308, DOI 10.1183/09031936.00166410; Laube Beth L, 2005, Respir Care, V50, P1161; Nyholm D, 2008, EXPERT OPIN DRUG MET, V4, P193, DOI 10.1517/17425255.4.2.193; Pal G, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00054; Pappert EJ, 1996, MOVEMENT DISORD, V11, P24, DOI 10.1002/mds.870110106; Pedrosa DJ, 2013, NEUROPSYCH DIS TREAT, V9, P321, DOI [10.2147/NDT.S32302, 10.2147/NDT.532302]; Sakagami M, 2006, ADV DRUG DELIVER REV, V58, P1030, DOI 10.1016/j.addr.2006.07.012; Tavares ALT, 2005, MOVEMENT DISORD, V20, P1286, DOI 10.1002/mds.20556; Usmani OS, 2005, AM J RESP CRIT CARE, V172, P1497, DOI 10.1164/rccm.200410-1414OC; Weers J, 2013, J AEROSOL MED PULM D, V26, P56, DOI 10.1089/jamp.2012.0973	22	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132714	10.1371/journal.pone.0132714	http://dx.doi.org/10.1371/journal.pone.0132714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173114	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900079
J	Mork-Jansson, A; Bue, AK; Gargano, D; Furnes, C; Reisinger, V; Arnold, J; Kmiec, K; Eichacker, LA				Mork-Jansson, Astrid; Bue, Ann Kristin; Gargano, Daniela; Furnes, Clemens; Reisinger, Veronika; Arnold, Janine; Kmiec, Karol; Eichacker, Lutz Andreas			Lil3 Assembles with Proteins Regulating Chlorophyll Synthesis in Barley	PLOS ONE			English	Article							II REACTION-CENTER; SYNECHOCYSTIS SP PCC-6803; PHOTOSYSTEM-II; PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; HOMOGENTISATE PHYTYLTRANSFERASE; GERANYLGERANYL REDUCTASE; ARABIDOPSIS-THALIANA; ETIOPLAST MEMBRANES; COMPLEX; BIOSYNTHESIS	The light-harvesting-like (LIL) proteins are a family of membrane proteins that share a chlorophyll a/b-binding motif with the major light-harvesting antenna proteins of oxygenic photoautotrophs. LIL proteins have been associated with the regulation of tetrapyrrol biosynthesis, and plant responses to light-stress. Here, it was found in a native PAGE approach that chlorophyllide, and chlorophyllide plus geranylgeraniolpyrophosphate trigger assembly of Lil3 in three chlorine binding fluorescent protein bands, termed F1, F2, and F3. It is shown that light and chlorophyllide trigger accumulation of protochlorophyllide-oxidoreductase, and chlorophyll synthase in band F3. Chlorophyllide and chlorophyll esterified to geranylgeraniol were identified as basis of fluorescence recorded from band F3. A direct interaction between Lil3, CHS and POR was confirmed in a split ubiquitin assay. In the presence of light or chlorophyllide, geranylgeraniolpyrophosphate was shown to trigger a loss of the F3 band and accumulation of Lil3 and geranylgeranyl reductase in F1 and F2. No direct interaction between Lil3 and geranylgeraniolreductase was identified in a split ubiquitin assay; however, accumulation of chlorophyll esterified to phytol in F1 and F2 corroborated the enzymes assembly. Chlorophyll esterified to phytol and the reaction center protein psbD of photosystem II were identified to accumulate together with psb29, and APX in the fluorescent band F2. Data show that Lil3 assembles with proteins regulating chlorophyll synthesis in etioplasts from barley (Hordeum vulgare L.).	[Mork-Jansson, Astrid; Bue, Ann Kristin; Gargano, Daniela; Furnes, Clemens; Reisinger, Veronika; Arnold, Janine; Kmiec, Karol; Eichacker, Lutz Andreas] Univ Stavanger, Ctr Organelle Res, Stavanger, Norway	Universitetet i Stavanger	Eichacker, LA (corresponding author), Univ Stavanger, Ctr Organelle Res, Stavanger, Norway.	lutz.eichacker@uis.no	Vatland, Ann Kristin/ABC-5758-2021	Vatland, Ann Kristin/0000-0002-3296-6120; Mork-Jansson, Astrid Elisabeth/0000-0003-1525-2270	Forskingsradet [192436, 197119]	Forskingsradet	192436, http://www.forskningsradet.no/no/Forsiden/1173185591033, Forskingsradet, DG, VR; 197119, http://www.forskningsradet.no/no/Forsiden/1173185591033, Forskingsradet, JA, AMJ, CF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra AN, 1998, PHOTOCHEM PHOTOBIOL, V68, P852; ARMSTRONG GA, 1995, PLANT PHYSIOL, V108, P1505, DOI 10.1104/pp.108.4.1505; Barthelemy X, 2000, PHOTOSYNTH RES, V64, P63, DOI 10.1023/A:1026576319029; Chidgey JW, 2014, PLANT CELL, V26, P1267, DOI 10.1105/tpc.114.124495; Collakova E, 2001, PLANT PHYSIOL, V127, P1113, DOI 10.1104/pp.010421; Domanskii VP, 2001, PHOTOSYNTH RES, V68, P131, DOI 10.1023/A:1011817531801; EICHACKER LA, 1990, J BIOL CHEM, V265, P13566; Eichacker LA, 1996, J BIOL CHEM; Granvogl B, 2006, PROTEOMICS, V6, P3681, DOI 10.1002/pmic.200500924; GRIFFITHS WT, 1978, BIOCHEM J, V174, P681, DOI 10.1042/bj1740681; Grzyb JM, 2013, J PLANT PHYSIOL, V170, P1217, DOI 10.1016/j.jplph.2013.04.017; HELFRICH M, 1994, EUR J BIOCHEM, V219, P267, DOI 10.1111/j.1432-1033.1994.tb19938.x; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Keller Y, 1998, EUR J BIOCHEM, V251, P413, DOI 10.1046/j.1432-1327.1998.2510413.x; Keren N, 2005, PLANT CELL, V17, P2768, DOI 10.1105/tpc.105.035048; KIM S, 1992, FEBS LETT, V314, P67, DOI 10.1016/0014-5793(92)81463-V; Knoppova J, 2014, PLANT CELL, V26, P1200, DOI 10.1105/tpc.114.123919; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Muller B, 1999, PLANT CELL, V11, P2365, DOI 10.1105/tpc.11.12.2365; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; Reisinger V, 2008, FEBS LETT, V582, P1547, DOI 10.1016/j.febslet.2008.03.042; Reisinger V, 2008, FEBS J, V275, P1018, DOI 10.1111/j.1742-4658.2008.06268.x; RUDIGER W, 1980, EUR J BIOCHEM, V109, P193, DOI 10.1111/j.1432-1033.1980.tb04784.x; Savidge B, 2002, PLANT PHYSIOL, V129, P321, DOI 10.1104/pp.010747; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schoefs B, 2008, PHOTOSYNTH RES, V96, P15, DOI 10.1007/s11120-007-9274-x; Seo J, 2006, BIOINFORMATICS, V22, P808, DOI 10.1093/bioinformatics/btk052; Seo J, 2004, UNDERSTANDING CLUSTE; Shpilyov AV, 2013, PLANT J, V73, P336, DOI 10.1111/tpj.12044; SOLL J, 1987, METHOD ENZYMOL, V148, P383; Solymosi K, 2010, PHOTOSYNTH RES, V105, P143, DOI 10.1007/s11120-010-9568-2; Takahashi K, 2014, J BIOL CHEM, V289, P987, DOI 10.1074/jbc.M113.525428; Tanaka R, 1999, PLANT PHYSIOL, V120, P695, DOI 10.1104/pp.120.3.695; Tanaka R, 2010, P NATL ACAD SCI USA, V107, P16721, DOI 10.1073/pnas.1004699107; Towbin H, 1992, Biotechnology, V24, P145; TROST P, 1995, EUR J BIOCHEM, V234, P452, DOI 10.1111/j.1432-1033.1995.452_b.x; Vinti G, 2005, PLANT MOL BIOL, V57, P343, DOI 10.1007/s11103-004-7867-8; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075299	40	19	19	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133145	10.1371/journal.pone.0133145	http://dx.doi.org/10.1371/journal.pone.0133145			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172838	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900139
J	Skinner, DZ				Skinner, Daniel Z.			Genes Upregulated in Winter Wheat (Triticum aestivum L.) during Mild Freezing and Subsequent Thawing Suggest Sequential Activation of Multiple Response Mechanisms	PLOS ONE			English	Article							QUANTITATIVE EXPRESSION ANALYSIS; PLANT COLD-ACCLIMATION; LOW-TEMPERATURE; TOLERANCE; PATHWAY; GLYCOSYLTRANSFERASES; SALINITY; ONTOLOGY; EXPOSURE	Exposing fully cold-acclimated wheat plants to a mild freeze-thaw cycle of -3 degrees C for 24h followed by +3 degrees C for 24 or 48h results in dramatically improved tolerance of subsequent exposure to sub-freezing temperatures. Gene enrichment analysis of crown tissue from plants collected before or after the -3 degrees C freeze or after thawing at +3 degrees C for 24 or 48h revealed that many biological processes and molecular functions were activated during the freeze-thaw cycle in an increasing cascade of responses such that over 150 processes or functions were significantly enhanced by the end of the 48 h, post-freeze thaw. Nearly 2,000 individual genes were upregulated more than 2-fold over the 72 h course of freezing and thawing, but more than 70% of these genes were upregulated during only one of the time periods examined, suggesting a series of genes and gene functions were involved in activation of the processes that led to enhanced freezing tolerance. This series of functions appeared to include extensive cell signaling, activation of stress response mechanisms and the phenylpropanoid biosynthetic pathway, extensive modification of secondary metabolites, and physical restructuring of cell membranes. By identifying plant lines that are especially able to activate these multiple mechanisms it may be possible to develop lines with enhanced winterhardiness.	[Skinner, Daniel Z.] USDA ARS, 209 Johnson Hall, Pullman, WA 99164 USA; [Skinner, Daniel Z.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); Washington State University	Skinner, DZ (corresponding author), USDA ARS, 209 Johnson Hall, Pullman, WA 99164 USA.	dan.skinner@ars.usda.gov			US Department of Agriculture intramural project [5348-21000-030-00D]	US Department of Agriculture intramural project	This research was supported by US Department of Agriculture intramural project number 5348-21000-030-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Cheynier V, 2011, PLANT PHYSIOL BIOCH, V72, P1; Clark N.R., 2014, PLANT PHYSIOL, V15, P79, DOI DOI 10.1104/PP.107.109561; Clark NR, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-79; Day-Richter J, 2007, BIOINFORMATICS, V23, P2198, DOI 10.1093/bioinformatics/btm112; Demiral T, 2011, ADV BOT RES, V57, P293, DOI 10.1016/B978-0-12-387692-8.00008-4; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Eckardt NA, 2008, PLANT CELL, V20, P499, DOI [10.1105/tpc.108.200311, 10.1105/tpc.108.059485]; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Ganeshan S, 2008, J EXP BOT, V59, P2393, DOI 10.1093/jxb/ern112; Ganeshan S, 2011, PLANT MOL BIOL, V75, P379, DOI 10.1007/s11103-011-9734-8; Ganeshan S, 2009, ENVIRON EXP BOT, V66, P46, DOI 10.1016/j.envexpbot.2008.12.013; Grace SC, 2000, PHILOS T R SOC B, V355, P1499, DOI 10.1098/rstb.2000.0710; Gulick PJ, 2005, GENOME, V48, P913, DOI 10.1139/g05-039; Harper JE, 2004, ANNU REV PLANT BIOL, V55, P263, DOI 10.1146/annurev.arplant.55.031903.141627; Hartung W, 2002, J EXP BOT, V53, P27, DOI 10.1093/jexbot/53.366.27; Herman EM, 2006, J EXP BOT, V57, P3601, DOI 10.1093/jxb/erl111; Jacoby RP, 2011, TRENDS PLANT SCI, V16, P614, DOI 10.1016/j.tplants.2011.08.002; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KISHA TJ, 1992, CROP SCI, V32, P1292, DOI 10.2135/cropsci1992.0011183X003200050049x; Laudencia-Chingcuanco D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-299; Le MQ, 2015, PLANT MOL BIOL, V87, P1, DOI 10.1007/s11103-014-0256-z; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050785; Monroy AF, 2007, PLANT MOL BIOL, V64, P409, DOI 10.1007/s11103-007-9161-z; Naika M, 2013, MOL BIOSYST, V9, P1888, DOI 10.1039/c3mb70072k; NIEMAN RICHARD H., 1962, BOT GAZ, V123, P279, DOI 10.1086/336163; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Saulescu N. N., 2001, APPL PHYSL WHEAT BRE, P111; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Skinner DZ, 2014, METHODS MOL BIOL, V1166, P7, DOI 10.1007/978-1-4939-0844-8_2; Skinner DZ, 2010, PLANT SOIL, V332, P289, DOI 10.1007/s11104-010-0293-6; Skinner DZ, 2009, FUNCT INTEGR GENOMIC, V9, P513, DOI 10.1007/s10142-009-0126-y; Skinner DZ, 2005, CROP SCI, V45, P1858, DOI 10.2135/cropsci2004.0721; Sun YH, 2013, ZOOKEYS, P85, DOI 10.3897/zookeys.258.4108; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogt T, 2000, TRENDS PLANT SCI, V5, P380, DOI 10.1016/S1360-1385(00)01720-9; Winfield MO, 2010, PLANT BIOTECHNOL J, V8, P749, DOI 10.1111/j.1467-7652.2010.00536.x; Winfield MO, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-55; Yonekura-Sakakibara K, 2011, PLANT J, V66, P182, DOI 10.1111/j.1365-313X.2011.04493.x; Yoo H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3833	50	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133166	10.1371/journal.pone.0133166	http://dx.doi.org/10.1371/journal.pone.0133166			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173115	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900143
J	Wan, GJ; Wang, WJ; Xu, JJ; Yang, QF; Dai, MJ; Zhang, FJ; Sword, GA; Pan, WD; Chen, FJ				Wan, Gui-Jun; Wang, Wen-Jing; Xu, Jing-Jing; Yang, Quan-Feng; Dai, Ming-Jiang; Zhang, Feng-Jiao; Sword, Gregory A.; Pan, Wei-Dong; Chen, Fa-Jun			Cryptochromes and Hormone Signal Transduction under Near-Zero Magnetic Fields: New Clues to Magnetic Field Effects in a Rice Planthopper	PLOS ONE			English	Article							JUVENILE-HORMONE; BROWN PLANTHOPPER; CIRCADIAN CLOCK; GEOMAGNETIC-FIELD; WING DIMORPHISM; GENES; LONGEVITY; MECHANISM; RHYTHMS; DENSITY	Although there are considerable reports of magnetic field effects (MFE) on organisms, very little is known so far about the MFE-related signal transduction pathways. Here we establish a manipulative near-zero magnetic field (NZMF) to investigate the potential signal transduction pathways involved in MFE. We show that exposure of migratory white-backed planthopper, Sogatella furcifera, to the NZMF results in delayed egg and nymphal development, increased frequency of brachypterous females, and reduced longevity of macropterous female adults. To understand the changes in gene expression underlying these phenotypes, we examined the temporal patterns of gene expression of (i) CRY1 and CRY2 as putative magnetosensors, (ii) JHAMT, FAMeT and JHEH in the juvenile hormone pathway, (iii) CYP307A1 in the ecdysone pathway, and (iv) reproduction-related Vitellogenin (Vg). The significantly altered gene expression of CRY1 and CRY2 under the NZMF suggest their developmental stage-specific patterns and potential upstream location in magnetic response. Gene expression patterns of JHAMT, JHEH and CYP307A1 were consistent with the NZMF-triggered delay in nymphal development, higher proportion of brachypterous female adults, and the shortened longevity of macropterous female adults, which show feasible links between hormone signal transduction and phenotypic MFE. By conducting manipulative NZMF experiments, our study suggests an important role of the geomagnetic field (GMF) in modulating development and physiology of insects, provides new insights into the complexity of MFE-magnetosensitivity interactions, and represents an initial but crucial step forward in understanding the molecular basis of cryptochromes and hormone signal transduction involved in MFE.	[Wan, Gui-Jun; Wang, Wen-Jing; Yang, Quan-Feng; Dai, Ming-Jiang; Zhang, Feng-Jiao; Chen, Fa-Jun] Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China; [Xu, Jing-Jing; Pan, Wei-Dong] Chinese Acad Sci, Inst Elect Engn, Beijing Key Lab Bioelectromaget, Beijing, Peoples R China; [Sword, Gregory A.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Nanjing Agricultural University; Chinese Academy of Sciences; Institute of Electrical Engineering, CAS; Texas A&M University System; Texas A&M University College Station	Chen, FJ (corresponding author), Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China.	panwd@mail.iee.ac.cn; fajunchen@njau.edu.cn	DAI, M/GPS-8291-2022		National Basic Research Program of China "973" grant [2010CB126200]; National Nature Science Foundations of China [31470454, 31272051, 31170362, 31070755]; Fok Ying Tung Education Foundation [122033]; Qing Lan Project; Jiangsu Province [KYLX_0576]	National Basic Research Program of China "973" grant(National Basic Research Program of China); National Nature Science Foundations of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Qing Lan Project(Jiangsu Polytech Institute); Jiangsu Province	FJC was funded by the National Basic Research Program of China "973" grant no. 2010CB126200, the National Nature Science Foundations of China grants no. 31470454 and 31272051, the Fok Ying Tung Education Foundation grant no. 122033 and the Qing Lan Project. WDP was funded by the National Nature Science Foundations of China grant no. 31170362 and 31070755. GJW was funded by the Research Grant from the Innovation Project for Graduate Student of Jiangsu Province grant no. KYLX_0576. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Bajgar A, 2013, P NATL ACAD SCI USA, V110, P4416, DOI 10.1073/pnas.1217060110; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; BERG BN, 1960, J NUTR, V71, P255; BLISS VL, 1976, NATURE, V261, P411, DOI 10.1038/261411a0; Bree RT, 2002, BIOGERONTOLOGY, V3, P195, DOI 10.1023/A:1016299812327; Burger T, 2010, J R SOC INTERFACE, V7, P1275, DOI 10.1098/rsif.2009.0551; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Close J, 2012, P ROY SOC B-BIOL SCI, V279, P2081, DOI 10.1098/rspb.2012.0324; CZEISLER CA, 1986, SCIENCE, V233, P667, DOI 10.1126/science.3726555; De Loof A, 2008, GEN COMP ENDOCR, V155, P3, DOI 10.1016/j.ygcen.2007.07.001; De Santis A, 2007, PHYS EARTH PLANET IN, V162, P217, DOI 10.1016/j.pepi.2007.04.011; Dodson CA, 2013, TRENDS BIOCHEM SCI, V38, P435, DOI 10.1016/j.tibs.2013.07.002; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Fedele G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004804; Flatt T, 2013, Q REV BIOL, V88, P185, DOI 10.1086/671484; Foley LE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1364; Gegear RJ, 2010, NATURE, V463, P804, DOI 10.1038/nature08719; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Gould JL, 2010, CURR BIOL, V20, pR431, DOI 10.1016/j.cub.2010.03.045; Guerra PA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5164; Henrich VC, 1999, VITAM HORM, V55, P73; Hoffmann KH, 1999, EUR J ENTOMOL, V96, P255; IWANAGA K, 1986, J INSECT PHYSIOL, V32, P585, DOI 10.1016/0022-1910(86)90076-4; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; KAWAKAMI A, 1990, SCIENCE, V247, P1333, DOI 10.1126/science.2315701; Lee AA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1063; Lohmann KJ, 2010, NATURE, V464, P1140, DOI 10.1038/4641140a; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; Maeda K, 2012, P NATL ACAD SCI USA, V109, P4774, DOI 10.1073/pnas.1118959109; Maffei ME, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00445; Mallis MM, 2005, AVIAT SPACE ENVIR MD, V76, pB94; Marley R, 2014, SCI REP-UK, V4, DOI 10.1038/srep05799; Matsumura M, 1996, HEREDITY, V76, P229, DOI 10.1038/hdy.1996.36; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Meelkop E, 2011, PROG NEUROBIOL, V93, P125, DOI 10.1016/j.pneurobio.2010.10.004; Mo WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054775; Mo WC, 2014, SCI CHINA LIFE SCI, V57, P448, DOI 10.1007/s11427-014-4644-z; Monk TH, 2001, PSYCHOSOM MED, V63, P881, DOI 10.1097/00006842-200111000-00005; NISHIO T, 1979, PHYSIOL BEHAV, V23, P763, DOI 10.1016/0031-9384(79)90172-0; Reppert SM, 2006, CELL, V124, P233, DOI 10.1016/j.cell.2006.01.009; Sakai T, 2001, P NATL ACAD SCI USA, V98, P9221, DOI 10.1073/pnas.151443298; Sandrelli F, 2008, INSECT MOL BIOL, V17, P447, DOI 10.1111/j.1365-2583.2008.00832.x; Sehadova H, 2004, J BIOL RHYTHM, V19, P466, DOI 10.1177/0748730404269153; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Sneed A, 2014, SCI AM, V311, P29, DOI 10.1038/scientificamerican1014-29; Stay B, 2000, INSECT BIOCHEM MOLEC, V30, P653, DOI 10.1016/S0965-1748(00)00036-9; Tomioka K, 2010, CELL MOL LIFE SCI, V67, P1397, DOI 10.1007/s00018-009-0232-y; Tufail M, 2014, ENTOMOL SCI, V17, P269, DOI 10.1111/ens.12086; Van Ekert E, 2014, J INSECT PHYSIOL, V70, P143, DOI 10.1016/j.jinsphys.2014.08.001; WALKER MM, 1989, J EXP BIOL, V145, P489; Wan GJ, 2014, J INSECT PHYSIOL, V68, P7, DOI 10.1016/j.jinsphys.2014.06.016; Wiltschko R, 2014, BIOSENSORS-BASEL, V4, P221, DOI 10.3390/bios4030221; Yamanaka N, 2013, SCIENCE, V341, P1113, DOI 10.1126/science.1241210; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Yoshii T, 2009, PLOS BIOL, V7, P813, DOI 10.1371/journal.pbio.1000086; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zamoshchina T A, 2012, Aviakosm Ekolog Med, V46, P17; Zhai YF, 2013, J PROTEOME RES, V12, P5199, DOI 10.1021/pr400561c; Zhou GH, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00270	61	15	22	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132966	10.1371/journal.pone.0132966	http://dx.doi.org/10.1371/journal.pone.0132966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173003	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900109
J	Devi, SG; Fathima, AA; Radha, S; Arunraj, R; Curtis, WR; Ramya, M				Devi, Selvaraju Gayathri; Fathima, Anwar Aliya; Radha, Sudhakar; Arunraj, Rex; Curtis, Wayne R.; Ramya, Mohandass			A Rapid and Economical Method for Efficient DNA Extraction from Diverse Soils Suitable for Metagenomic Applications	PLOS ONE			English	Article							SEDIMENT SAMPLES; PURIFICATION PROCEDURES; MOLECULAR DIVERSITY; BACTERIAL DIVERSITY; COASTAL GUJARAT; SALINE HABITATS; NUCLEIC-ACIDS; GLASS POWDER; PCR; ENVIRONMENT	A rapid, cost effective method of metagenomic DNA extraction from soil is a useful tool for environmental microbiology. The present work describes an improved method of DNA extraction namely "powdered glass method" from diverse soils. The method involves the use of sterile glass powder for cell lysis followed by addition of 1% powdered activated charcoal (PAC) as purifying agent to remove humic substances. The method yielded substantial DNA (5.87 +/- 0.04 mu g/g of soil) with high purity (A(260/280): 1.76 +/- 0.05) and reduced humic substances (A(340): 0.047 +/- 0.03). The quality of the extracted DNA was compared against five different methods based on 16S rDNA PCR amplification, BamHI digestion and validated using quantitative PCR. The digested DNA was used for a metagenomic library construction with the transformation efficiency of 4 X 10(6) CFU mL(-1). Besides providing rapid, efficient and economical extraction of metgenomic DNA from diverse soils, this method's applicability is also demonstrated for cultivated organisms (Gram positive B. subtilis NRRL-B-201, Gram negative E. coli MTCC40, and a microalgae C. sorokiniana UTEX#1666).	[Devi, Selvaraju Gayathri; Fathima, Anwar Aliya; Radha, Sudhakar; Arunraj, Rex; Ramya, Mohandass] SRM Univ, Dept Genet Engn, Kattankulathur, Tamil Nadu, India; [Curtis, Wayne R.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA	SRM Institute of Science & Technology Chennai; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Ramya, M (corresponding author), SRM Univ, Dept Genet Engn, Kattankulathur, Tamil Nadu, India.	ramya.mohandass@gmail.com	Arunraj, Rex/AAS-9159-2020; Wolverton, Christopher/B-7542-2009; Mohandass, Ramya/Q-4185-2016; Selvaraju, Gayathri Devi/ADI-9612-2022; Anwar, Aliya Fathima/AAJ-6312-2021	Mohandass, Ramya/0000-0003-4448-920X; Selvaraju, Gayathri Devi/0000-0001-7500-6181; Curtis, Wayne/0000-0001-6976-0890; Arunraj, Rex/0000-0002-2739-8325				American Public Health Association (APHA), 2005, STANDARD METHODS EXA; ATTAL J, 1995, TRANSGENIC RES, V4, P149, DOI 10.1007/BF01969417; Aziz A, 2007, ANN BIOMED ENG, V35, P2108, DOI 10.1007/s10439-007-9387-6; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Burgmann H, 2001, J MICROBIOL METH, V45, P7, DOI 10.1016/S0167-7012(01)00213-5; Buscot F., 2005, MICROORGANISMS SOILS, P19; Cottrell MT, 2005, ENVIRON MICROBIOL, V7, P1883, DOI 10.1111/j.1462-2920.2005.00762.x; CURTIS WR, 1993, BIOTECHNOL BIOENG, V42, P520, DOI 10.1002/bit.260420416; Doebler RW, 2009, JALA-J LAB AUTOM, V14, P119, DOI 10.1016/j.jala.2009.02.010; Frostegard A, 1999, APPL ENVIRON MICROB, V65, P5409; Gray JP, 1996, APPL ENVIRON MICROB, V62, P4049, DOI 10.1128/AEM.62.11.4049-4059.1996; Harry M, 1999, ANALUSIS, V27, P439, DOI 10.1051/analusis:1999270439; Hussain T, 2014, SAUDI J BIOL SCI, V21, P380, DOI 10.1016/j.sjbs.2013.09.012; JACOBSEN CS, 1992, APPL ENVIRON MICROB, V58, P2458, DOI 10.1128/AEM.58.8.2458-2462.1992; JOHNSTON CG, 1994, APPL ENVIRON MICROB, V60, P2350, DOI 10.1128/AEM.60.7.2350-2354.1994; Kauffmann IM, 2004, APPL MICROBIOL BIOT, V64, P665, DOI 10.1007/s00253-003-1528-8; LaMontagne MG, 2002, J MICROBIOL METH, V49, P255, DOI 10.1016/S0167-7012(01)00377-3; Lee SY, 1996, APPL ENVIRON MICROB, V62, P3787, DOI 10.1128/AEM.62.10.3787-3793.1996; Li L, 2015, J VIROL METHODS, V213, P139, DOI 10.1016/j.jviromet.2014.12.002; LIESACK W, 1992, J BACTERIOL, V174, P5072, DOI 10.1128/JB.174.15.5072-5078.1992; MARKO MA, 1982, ANAL BIOCHEM, V121, P382, DOI 10.1016/0003-2697(82)90497-3; Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715; Nair Harisree P, 2014, Biotechnol Rep (Amst), V4, P134, DOI 10.1016/j.btre.2014.09.008; Poeckh T, 2008, ANAL BIOCHEM, V373, P253, DOI 10.1016/j.ab.2007.10.026; Punekar N.S., 2003, FUNGAL GENET REP, V50, P15; Purohit MK, 2009, LETT APPL MICROBIOL, V49, P338, DOI 10.1111/j.1472-765X.2009.02663.x; Radha S, 2013, J APPL PHYCOL, V25, P609, DOI 10.1007/s10811-012-9895-0; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Rojas-Herrera R, 2008, MOL BIOTECHNOL, V40, P13, DOI 10.1007/s12033-008-9061-8; Roose-Amsaleg CL, 2001, APPL SOIL ECOL, V18, P47, DOI 10.1016/S0929-1393(01)00149-4; Sagar K, 2014, J MICROBIOL METH, V97, P68, DOI 10.1016/j.mimet.2013.11.008; Seo GT, 2001, WATER SCI TECHNOL, V43, P67, DOI 10.2166/wst.2001.0668; Sharma PK, 2007, MOL BIOTECHNOL, V36, P61, DOI 10.1007/s12033-007-0015-3; Sharma S, 2014, J APPL MICROBIOL, V116, P923, DOI 10.1111/jam.12420; Siddhapura PK, 2010, INT J BIOL MACROMOL, V47, P375, DOI 10.1016/j.ijbiomac.2010.06.004; Tiedje JM, 1999, APPL SOIL ECOL, V13, P109, DOI 10.1016/S0929-1393(99)00026-8; TSAI YL, 1991, APPL ENVIRON MICROB, V57, P1070, DOI 10.1128/AEM.57.4.1070-1074.1991; Verma D, 2011, APPL BIOCHEM BIOTECH, V165, P454, DOI 10.1007/s12010-011-9264-5; Wise MG, 1997, APPL ENVIRON MICROB, V63, P1505, DOI 10.1128/AEM.63.4.1505-1514.1997; Yeates C, 1998, Biol Proced Online, V1, P40, DOI 10.1251/bpo6; Zhang D, 2004, ANAL BIOANAL CHEM, V379, P1025, DOI 10.1007/s00216-004-2653-7; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	42	32	34	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132441	10.1371/journal.pone.0132441	http://dx.doi.org/10.1371/journal.pone.0132441			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167854	gold, Green Submitted, Green Published			2022-12-27	WOS:000358193100043
J	Salerno, L; Cosentino, C; Morrone, G; Amato, F				Salerno, Luca; Cosentino, Carlo; Morrone, Giovanni; Amato, Francesco			Computational Modeling of a Transcriptional Switch Underlying B-Lymphocyte Lineage Commitment of Hematopoietic Multipotent Cells	PLOS ONE			English	Article							FINGER PROTEIN 521; STEM-CELLS; TERMINAL DIFFERENTIATION; INTERLEUKIN-7 RECEPTOR; PROGENITOR CELLS; GENE-EXPRESSION; PU.1; SPECIFICATION; SYSTEMS; ZFP521	Despite progresses in identifying the cellular mechanisms at the basis of the differentiation of hematopoietic stem/progenitor cells, little is known about the regulatory circuitry at the basis of lineage commitment of hematopoietic multipotent progenitors. To address this issue, we propose a computational approach to give further insights in the comprehension of this genetic mechanism. Differently from T lymphopoiesis, however, there is at present no mathematical model describing lineage restriction of multipotent progenitors to early B-cell precursors. Here, we provide a first model-constructed on the basis of current experimental evidence from literature and of publicly available microarray datasets-of the genetic regulatory network driving the cellular fate determination at the stage of lymphoid lineage commitment, with particular regard to the multipotent-B-cell progenitor transition. By applying multistability analysis methods, we are able to assess the capability of the model to capture the experimentally observed switch-like commitment behavior. These methods allow us to confirm the central role of zinc finger protein 521 (ZNF521) in this process, that we had previously reported, and to identify a novel putative functional interaction for ZNF521, which is essential to realize such characteristic behavior. Moreover, using the devised model, we are able to rigorously analyze the mechanisms underpinning irreversibility of the physiological commitment step and to devise a possible reprogramming strategy, based on the combined modification of the expression of ZNF521 and EBF1.	[Salerno, Luca; Cosentino, Carlo; Amato, Francesco] Magna Graecia Univ Catanzaro, Lab Biomechatron, Dept Expt & Clin Med, Catanzaro, Italy; [Morrone, Giovanni] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Lab Mol Haematopoiesis & Stem Cell Biol, Catanzaro, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro	Cosentino, C (corresponding author), Magna Graecia Univ Catanzaro, Lab Biomechatron, Dept Expt & Clin Med, Catanzaro, Italy.	carlo.cosentino@unicz.it	Amato, Francesco/E-8757-2013; Morrone, Giovanni/A-7202-2008; Cosentino, Carlo/C-5677-2011; Salerno, Luca/ABF-9467-2022	Amato, Francesco/0000-0002-9053-3139; Morrone, Giovanni/0000-0002-1978-340X; Cosentino, Carlo/0000-0001-5768-1829; Salerno, Luca/0000-0003-4221-3533	Italian PON project "STAYWELL" [PON04a2_00003]	Italian PON project "STAYWELL"	The post-doc fellowship of L.S. was funded under the Italian PON project "STAYWELL" - PON04a2_00003. The other authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; Bates DG, 2011, IET SYST BIOL, V5, P229, DOI 10.1049/iet-syb.2010.0072; Bond HM, 2008, INT J BIOCHEM CELL B, V40, P848, DOI 10.1016/j.biocel.2007.04.006; Bond HM, 2004, BLOOD, V103, P2062, DOI 10.1182/blood-2003-07-2388; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Chickarmane V, 2005, BIOINFORMATICS, V21, P3688, DOI 10.1093/bioinformatics/bti603; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Corfe SA, 2012, SEMIN IMMUNOL, V24, P198, DOI 10.1016/j.smim.2012.02.001; Correa D, 2010, DEV CELL, V19, P533, DOI 10.1016/j.devcel.2010.09.008; Cosentino C., 2011, FEEDBACK CONTROL SYS; Cross MA, 1997, CURR OPIN GENET DEV, V7, P609, DOI 10.1016/S0959-437X(97)80007-X; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; Dhooge A, 2004, LECT NOTES COMPUT SC, V3037, P42; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Fuxa M, 2007, J IMMUNOL, V178, P8221, DOI 10.4049/jimmunol.178.12.8221-a; Gerrits A, 2011, THESIS U LIB GRONING; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Grosschedl R, 2013, COLD SPRING HARB SYM, V157, P549; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hesse E, 2010, J CELL BIOL, V191, P1271, DOI 10.1083/jcb.201009107; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang S, 2009, ENCY COMPLEXITY SYST, P1180; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000380; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Kirk P, 2013, CURR OPIN BIOTECH, V24, P767, DOI 10.1016/j.copbio.2013.03.012; Kirstetter P, 2002, EUR J IMMUNOL, V32, P720, DOI 10.1002/1521-4141(200203)32:3<720::AID-IMMU720>3.0.CO;2-P; Kiviranta R, 2013, J EXP MED, V210, P969, DOI 10.1084/jem.20121187; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Laurent M, 1999, TRENDS BIOCHEM SCI, V24, P418, DOI 10.1016/S0968-0004(99)01473-5; Loose M, 2007, CURR OPIN HEMATOL, V14, P307, DOI 10.1097/MOH.0b013e3281900eee; Loose M, 2006, CURR OPIN HEMATOL, V13, P229, DOI 10.1097/01.moh.0000231419.15654.7f; Lukin K, 2008, SEMIN IMMUNOL, V20, P221, DOI 10.1016/j.smim.2008.07.004; Martinez MR, 2012, P NATL ACAD SCI USA, V109, P2672, DOI 10.1073/pnas.1113019109; Matsubara E, 2009, J BIOL CHEM, V284, P3480, DOI 10.1074/jbc.M805874200; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Mega T, 2011, CELL CYCLE, V10, P2129, DOI 10.4161/cc.10.13.16045; Mesuraca M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/318793; Miller JP, 2002, J EXP MED, V196, P705, DOI 10.1084/jem.20020784; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Nodland SE, 2011, BLOOD, V118, P2116, DOI 10.1182/blood-2010-08-302513; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Roeder I, 2006, J THEOR BIOL, V241, P852, DOI 10.1016/j.jtbi.2006.01.021; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; Schwickert TA, 2014, NAT IMMUNOL, V15, P283, DOI 10.1038/ni.2828; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; Spina R, 2013, ONCOTARGET, V4, P1280, DOI 10.18632/oncotarget.1176; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Strogatz SH., 1994, NONLINEAR DYNAMICS C, V1; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; van Zelm MC, 2005, J IMMUNOL, V175, P5912, DOI 10.4049/jimmunol.175.9.5912; Yamasaki N, 2010, ONCOGENE, V29, P1963, DOI 10.1038/onc.2009.475; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zhang Q, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-40; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	64	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132208	10.1371/journal.pone.0132208	http://dx.doi.org/10.1371/journal.pone.0132208			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167861	Green Submitted, gold, Green Published			2022-12-27	WOS:000358193100027
J	Schmidt, AE; Dybala, KE; Botsford, LW; Eadie, JM; Bradley, RW; Jahncke, J				Schmidt, Annie E.; Dybala, Kristen E.; Botsford, Louis W.; Eadie, John M.; Bradley, Russell W.; Jahncke, Jaime			Shifting Effects of Ocean Conditions on Survival and Breeding Probability of a Long-Lived Seabird	PLOS ONE			English	Article							CLIMATE-CHANGE; POPULATION-DYNAMICS; EL-NINO; REPRODUCTIVE SUCCESS; PACIFIC; VARIABILITY; CALIFORNIA; COSTS; AGE; HYPOTHESES	With a rapidly changing climate, there is an increasing need to predict how species will respond to changes in the physical environment. One approach is to use historic data to estimate the past influence of environmental variation on important demographic parameters and then use these relationships to project the abundance of a population or species under future climate scenarios. However, as novel climate conditions emerge, novel species responses may also appear. In some systems, environmental conditions beyond the range of those observed during the course of most long-term ecological studies are already evident. Yet little attention has been given to how these novel conditions may be influencing previously established environment-species relationships. Here, we model the relationships between ocean conditions and the demography of a long-lived seabird, Brandt's cormorant (Phalacrocorax penicillatusI), in central California and show that these relationships have changed in recent years. Beginning in 2007/2008, the response of Brandt's cormorant, an upper trophic level predator, to ocean conditions shifted, resulting in lower than predicted survival and breeding probability. Survival was generally less variable than breeding probability and was initially best predicted by the basin-scale forcing of the El Nino Southern Oscillation rather than local ocean conditions. The shifting response of Brandt's cormorant to ocean conditions may be just a proximate indication of altered dynamics in the food web and that important forage fish are not responding to the physical ocean environment as expected. These changing relationships have important implications for our ability to project the effects of future climate change for species and communities.	[Schmidt, Annie E.; Dybala, Kristen E.; Botsford, Louis W.; Eadie, John M.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Schmidt, Annie E.; Bradley, Russell W.; Jahncke, Jaime] Point Blue Conservat Sci, Petaluma, CA 94954 USA	University of California System; University of California Davis	Schmidt, AE (corresponding author), Point Blue Conservat Sci, Petaluma, CA 94954 USA.	aschmidt@ucdavis.edu	Dybala, Kristen/P-4629-2015	Dybala, Kristen/0000-0002-2787-4600; Schmidt, Annie/0000-0001-6144-9950; Eadie, John/0000-0001-9573-2703	National Science Foundation Graduate Research Fellowship [1148897]; University of California, Davis, Graduate Group in Ecology fellowship; Jastro Shields research fellowship; Selma Herr Fund for Ornithological Research; Baker Trust; Marisla Foundation; Campini Foundation; Kimball Foundation; Mead Foundation	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); University of California, Davis, Graduate Group in Ecology fellowship; Jastro Shields research fellowship; Selma Herr Fund for Ornithological Research; Baker Trust; Marisla Foundation; Campini Foundation; Kimball Foundation; Mead Foundation	AES was supported by a National Science Foundation Graduate Research Fellowship (grant No. 1148897), a University of California, Davis, Graduate Group in Ecology fellowship, a Jastro Shields research fellowship, and a grant from the Selma Herr Fund for Ornithological Research. No other authors received specific funding for this work. The continued operation of Point Blue's Farallon Research Program is supported by the Baker Trust, Marisla Foundation, Campini Foundation, Kimball Foundation, Mead Foundation, and individual donors. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham CL, 2004, MAR ECOL PROG SER, V274, P235, DOI 10.3354/meps274235; AINLEY DG, 1995, MAR ECOL PROG SER, V118, P69, DOI 10.3354/meps118069; Barbraud C, 2005, ECOLOGY, V86, P682, DOI 10.1890/04-0075; Beaugrand G, 2012, MAR ECOL PROG SER, V445, P293, DOI 10.3354/meps09493; Black BA, 2011, GLOBAL CHANGE BIOL, V17, P2536, DOI 10.1111/j.1365-2486.2011.02422.x; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; BOEKELHEIDE RJ, 1989, AUK, V106, P389; BRIGGS KT, 1987, STUD AVIAN BIOL, V11, P1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chenillat F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049966; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Di Lorenzo E, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038261; Durant JM, 2009, CLIM RES, V39, P115, DOI 10.3354/cr00798; Dybala KE, 2013, GLOBAL CHANGE BIOL, V19, P2688, DOI 10.1111/gcb.12228; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Garcia-Reyes M, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007629; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Hatch SA, 2013, MAR ECOL PROG SER, V477, P271, DOI 10.3354/meps10161; Hidalgo M, 2012, P ROY SOC B-BIOL SCI, V279, P275, DOI 10.1098/rspb.2011.0750; Jenouvrier S, 2005, OIKOS, V108, P511, DOI 10.1111/j.0030-1299.2005.13351.x; Jenouvrier S, 2012, GLOBAL CHANGE BIOL, V18, P2756, DOI 10.1111/j.1365-2486.2012.02744.x; Jones NM, 2008, WATERBIRDS, V31, P505; Kao HY, 2009, J CLIMATE, V22, P615, DOI 10.1175/2008JCLI2309.1; Kirby RR, 2009, P ROY SOC B-BIOL SCI, V276, P4095, DOI 10.1098/rspb.2009.1320; Laake J. L., 2013, 201301 AFSC; LARGIER JL, 1993, J GEOPHYS RES-OCEANS, V98, P18147, DOI 10.1029/93JC01074; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Litzow MA, 2014, PROG OCEANOGR, V120, P110, DOI 10.1016/j.pocean.2013.08.003; Mann KH, 2006, DYNAMICS MARINE ECOS; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Marinovic BB, 2002, PROG OCEANOGR, V54, P265, DOI 10.1016/S0079-6611(02)00053-8; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; McPhaden MJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051826; Nevoux M, 2010, ECOLOGY, V91, P2416, DOI 10.1890/09-0143.1; NICHOLS JD, 1994, ECOLOGY, V75, P2052, DOI 10.2307/1941610; Nur N, 1999, BIRD STUDY, V46, P92; Oro D, 2010, ECOLOGY, V91, P1205, DOI 10.1890/09-0939.1; Pardo D, 2013, ECOLOGY, V94, P208, DOI 10.1890/12-0215.1; Piatt JF, 2007, MAR ECOL PROG SER, V352, P221, DOI 10.3354/meps07078; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Robert A, 2012, ECOLOGY, V93, P1944, DOI 10.1890/11-1840.1; Schmidt AE, 2014, MAR ECOL PROG SER, V499, P249, DOI 10.3354/meps10629; SCHREIBER RW, 1984, SCIENCE, V225, P713, DOI 10.1126/science.225.4663.713; Skalski JR, 1996, CAN J FISH AQUAT SCI, V53, P196, DOI 10.1139/cjfas-53-1-196; Sydeman WJ, 2014, SCIENCE, V345, P77, DOI [10.1126/science.1251635, 10.1126/science.1250830]; Sydeman WJ, 2013, GLOBAL CHANGE BIOL, V19, P1662, DOI 10.1111/gcb.12165; van de Pol M, 2010, ECOLOGY, V91, P1192, DOI 10.1890/09-0410.1; Warzybok PM, 2012, POPULATION SIZE REPR; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336; Yeh SW, 2009, NATURE, V461, P511, DOI 10.1038/nature08316; Yokomizo H, 2010, THEOR ECOL-NETH, V3, P53, DOI 10.1007/s12080-009-0053-5; [No title captured]; [No title captured]	57	10	10	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132372	10.1371/journal.pone.0132372	http://dx.doi.org/10.1371/journal.pone.0132372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168050	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100038
J	Tzeng, TD; Pao, YY; Chen, PC; Weng, FCH; Jean, WD; Wang, D				Tzeng, Tzong-Der; Pao, Yueh-Yang; Chen, Po-Cheng; Weng, Francis Cheng-Hsuan; Jean, Wen Dar; Wang, Daryi			Effects of Host Phylogeny and Habitats on Gut Microbiomes of Oriental River Prawn (Macrobrachium nipponense)	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; COMMUNITIES; SHRIMP; DISEASE; TRACT; FISH; CHIMPANZEES; EXPRESSION; PROBIOTICS; DIVERSITY	The gut microbial community is one of the richest and most complex ecosystems on earth, and the intestinal microbes play an important role in host development and health. Next generation sequencing approaches, which rapidly produce millions of short reads that enable the investigation on a culture independent basis, are now popular for exploring microbial community. Currently, the gut microbiome in fresh water shrimp is unexplored. To explore gut microbiomes of the oriental river prawn (Macrobrachium nipponense) and investigate the effects of host genetics and habitats on the microbial composition, 454 pyrosequencing based on the 16S rRNA gene were performed. We collected six groups of samples, including M. nipponense shrimp from two populations, rivers and lakes, and one sister species (M. asperulum) as an out group. We found that Proteobacteria is the major phylum in oriental river prawn, followed by Firmicutes and Actinobacteria. Compositional analysis showed microbial divergence between the two shrimp species is higher than that between the two populations of one shrimp species collected from river and lake. Hierarchical clustering also showed that host genetics had a greater impact on the divergence of gut microbiome than host habitats. This finding was also congruent with the functional prediction from the metagenomic data implying that the two shrimp species still shared the same type of biological functions, reflecting a similar metabolic profile in their gut environments. In conclusion, this study provides the first investigation of the gut microbiome of fresh water shrimp, and supports the hypothesis of host species-specific signatures of bacterial community composition.	[Tzeng, Tzong-Der] Shu Te Univ, Dept Leisure & Tourism Management, Kaohsiung 824, Taiwan; [Pao, Yueh-Yang; Weng, Francis Cheng-Hsuan; Jean, Wen Dar; Wang, Daryi] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Chen, Po-Cheng] Natl Taiwan Univ, Coll Life Sci, Inst Fisheries Sci, Taipei 106, Taiwan; [Weng, Francis Cheng-Hsuan; Wang, Daryi] Acad Sinica, Taiwan Int Grad Program, Biodivers Program, Taipei 115, Taiwan; [Weng, Francis Cheng-Hsuan; Wang, Daryi] Natl Taiwan Normal Univ, Dept Life Sci, Taipei 116, Taiwan	Shu-Te University; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan; National Taiwan Normal University	Jean, WD (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	aredarj001@gmail.com; dywang@gate.sinica.edu.tw			National Science Council of Taiwan [MOST 103-2313-B-001-004]; Sustainability Science Research Project, Academia Sinica	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Sustainability Science Research Project, Academia Sinica	This work was supported by the National Science Council of Taiwan (Grant No: MOST 103-2313-B-001-004), and Sustainability Science Research Project, Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Balcazar JL, 2006, VET MICROBIOL, V114, P173, DOI 10.1016/j.vetmic.2006.01.009; Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165; Blaser MJ, 2008, CANCER PREV RES, V1, P15, DOI 10.1158/1940-6207.CAPR-08-0024; Cai Y, 2006, RAFFLES B ZOOL, V54, P25; Chaiyapechara S, 2012, MICROB ECOL, V63, P938, DOI 10.1007/s00248-011-9936-2; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Degnan PH, 2012, P NATL ACAD SCI USA, V109, P13034, DOI 10.1073/pnas.1110994109; Delsuc F, 2014, MOL ECOL, V23, P1301, DOI 10.1111/mec.12501; DG S., 2006, AQUAT INVASIONS, V1, P5; Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ezenwa VO, 2012, SCIENCE, V338, P198, DOI 10.1126/science.1227412; Flegel TW, 2012, J INVERTEBR PATHOL, V110, P166, DOI 10.1016/j.jip.2012.03.004; Franzenburg S, 2013, P NATL ACAD SCI USA, V110, pE3730, DOI 10.1073/pnas.1304960110; Gomez GD, 2008, FEMS IMMUNOL MED MIC, V52, P145, DOI 10.1111/j.1574-695X.2007.00343.x; Hamdan LJ, 2008, FEMS MICROBIOL ECOL, V65, P15, DOI 10.1111/j.1574-6941.2008.00507.x; HARRIS JM, 1993, MICROB ECOL, V25, P195, DOI 10.1007/BF00171889; He YD, 2014, J VIROL, V88, P1104, DOI 10.1128/JVI.02455-13; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Ilmberger N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106707; Kongnum K, 2012, FISH SHELLFISH IMMUN, V32, P170, DOI 10.1016/j.fsi.2011.11.008; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063139; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Li XM, 2012, J MICROBIOL, V50, P29, DOI 10.1007/s12275-012-1340-1; Linnenbrink M, 2013, MOL ECOL, V22, P1904, DOI 10.1111/mec.12206; Luz-Agostinho KDG, 2006, NEOTROP ICHTHYOL, V4, P61, DOI 10.1590/S1679-62252006000100005; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mashiko K, 2000, J CRUSTACEAN BIOL, V20, P118, DOI 10.1651/0278-0372(2000)020[0118:DOPWDS]2.0.CO;2; Mashiko K, 2008, J CRUSTACEAN BIOL, V28, P370, DOI 10.1651/0278-0372(2008)028[0370:DOFMAS]2.0.CO;2; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Moeller AH, 2013, GENOME RES, V23, P1715, DOI 10.1101/gr.154773.113; Ninawe AS, 2009, CRIT REV MICROBIOL, V35, P43, DOI 10.1080/10408410802667202; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Park SJ, 2014, ANAEROBE, V28, P157, DOI 10.1016/j.anaerobe.2014.06.002; Perez T, 2010, MUCOSAL IMMUNOL, V3, P355, DOI 10.1038/mi.2010.12; Qin CB, 2014, FISH SHELLFISH IMMUN, V40, P267, DOI 10.1016/j.fsi.2014.07.010; Quinn RA, 2013, CAN J MICROBIOL, V59, P380, DOI 10.1139/cjm-2012-0679; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rungrassamee W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091853; Rungrassamee W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060802; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekar R, 2006, APPL ENVIRON MICROB, V72, P5963, DOI 10.1128/AEM.00843-06; Shy JY, 1987, J FISH SOC TAIWAN, V14, P14; Stanley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084290; Sullam KE, 2015, ISME J, V9, P1508, DOI 10.1038/ismej.2014.231; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Wong ACN, 2013, ISME J, V7, P1922, DOI 10.1038/ismej.2013.86; Wong JTY, 1994, AQUACULTURE, V88, P5; Wu HM, 2010, COMPUTATIONAL STAT D, V54, P12; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; Xing MX, 2013, FEMS MICROBIOL ECOL, V86, P432, DOI 10.1111/1574-6941.12174; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Ye L, 2014, ISME J, V8, P541, DOI 10.1038/ismej.2013.181	60	45	51	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132860	10.1371/journal.pone.0132860	http://dx.doi.org/10.1371/journal.pone.0132860			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168244	gold, Green Published, Green Submitted			2022-12-27	WOS:000358193100088
J	Ware, EB; Riehle, E; Smith, JA; Zhao, W; Turner, ST; Kardia, SLR; Lieske, JC				Ware, Erin B.; Riehle, Ellen; Smith, Jennifer A.; Zhao, Wei; Turner, Stephen T.; Kardia, Sharon L. R.; Lieske, John C.			SLC2A9 Genotype Is Associated with SLC2A9 Gene Expression and Urinary Uric Acid Concentration	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RENAL HYPOURICEMIA TYPE-2; CALCIUM STONE DISEASE; UNITED-STATES; KIDNEY-STONES; RISK-FACTORS; URATE; NEPHROLITHIASIS; FREQUENCY; POPULATION	Objectives SLC2A9 gene variants have been associated with urinary uric acid (UA) concentration, but little is known about the functional mechanism linking these gene variants with UA. SLC2A9 encodes a UA transporter present in the proximal tubule of the kidney, and gene expression levels of SLC2A9 and other genes in the uricosuric pathway (ABCG2, SLC17A1, SLC17A3, and SLC22A12) could potentially mediate the relationship between SLC2A9 gene variants and urinary UA excretion. Methods The association between urinary UA concentrations and single nucleotide polymorphisms (SNPs) within the SLC2A9 gene region, expression levels of genes in the uricosuric pathway, and dietary protein intake were analyzed for a sample of non-Hispanic white participants from the Genetic Epidemiology Network of Arteriopathy (GENOA) cohort. The SLC2A9 SNP most significantly associated with urinary UA concentration was then tested for associations with gene expression levels from uric acid absorption/secretion associated genes. Models including interactions between dietary protein (total, animal, and vegetable) and genetic factors were also assessed. Results The most significant SLC2A9 SNP associated with urinary UA (rs12509955, corrected p = 0.001) was also associated with SLC2A9 gene expression levels (corrected p = 0.0084); however, SLC2A9 gene expression levels were not significantly associated with urinary UA concentrations (p = 0.509). The interactions between rs12509955 and total dietary protein, and SLC2A9 gene-level gene expression and dietary vegetable protein on the outcome of urinary UA were marginally significant (p = 0.11 and p = 0.07, respectively). Gene expression level of one SLC2A9 transcript had a significant interaction with dietary animal protein (SLC2A9-001 ENST00000506583, p = 0.01) and a marginally significant interaction with total dietary protein (p = 0.07) on urinary UA. Conclusion Our results illustrate that SNPs in the SLC2A9 gene influence SLC2A9 gene expression as well as urinary UA excretion. Evidence is also suggestive that gene-by-diet interactions may disproportionately increase urinary UA in genetically susceptible individuals that consume higher amounts of protein.	[Ware, Erin B.; Riehle, Ellen; Smith, Jennifer A.; Zhao, Wei; Kardia, Sharon L. R.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Ware, Erin B.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Turner, Stephen T.; Lieske, John C.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Lieske, John C.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Mayo Clinic; Mayo Clinic	Kardia, SLR (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	skardia@umich.edu	Turner, Stephen/GXM-4654-2022; Lieske, John/ABA-4829-2020	Ware, Erin/0000-0003-4731-8158; Smith, Jennifer Ann/0000-0002-3575-5468	Mayo Clinic O'Brien Urology Research Center from the National Center for Advancing Translational Sciences (NCATS) [U54 DK100227, UL1 TR000135]; National Institutes of Health;  [R01 DK077950];  [R01 DK073537];  [U01 HL054457];  [R01 HL087660];  [R01 HL119443]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119443, U01HL054457, R01HL087660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK100227, R01DK077950, R01DK073537] Funding Source: NIH RePORTER	Mayo Clinic O'Brien Urology Research Center from the National Center for Advancing Translational Sciences (NCATS); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01 DK077950, R01 DK073537, U01 HL054457, R01 HL087660, R01 HL119443, and the Mayo Clinic O'Brien Urology Research Center U54 DK100227, and Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), all funded by the National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, BAS SAS R CAR; Anzai N, 2012, CLIN EXP NEPHROL, V16, P89, DOI 10.1007/s10157-011-0532-z; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; COE FL, 1978, KIDNEY INT, V13, P418, DOI 10.1038/ki.1978.60; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Curhan GC, 1997, J AM SOC NEPHROL, V8, P1568; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Dinour D, 2012, NEPHROL DIAL TRANSPL, V27, P1035, DOI 10.1093/ndt/gfr419; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gault MH, 2000, J UROLOGY, V164, P302, DOI 10.1016/S0022-5347(05)67345-4; Giannini S, 1999, AM J CLIN NUTR, V69, P267; Griffin DG, 2004, J CLIN PATHOL, V57, P793, DOI 10.1136/jcp.2003.014886; GROVER PK, 1993, CLIN SCI, V85, P303, DOI 10.1042/cs0850303; GUTMAN AB, 1968, AM J MED, V45, P756, DOI 10.1016/0002-9343(68)90209-X; Hamajima N, 2011, MOL GENET METAB, V103, P378, DOI 10.1016/j.ymgme.2011.04.001; Heilberg IP, 2013, ADV CHRONIC KIDNEY D, V20, P165, DOI 10.1053/j.ackd.2012.12.001; Kawamura Y, 2011, NUCLEOS NUCLEOT NUCL, V30, P1105, DOI 10.1080/15257770.2011.623685; Khitan Z, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/682673; Kirejczyk JK, 2014, J PEDIATR UROL, V10, P130, DOI 10.1016/j.jpurol.2013.07.010; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Kuo CF, 2015, ANN RHEUM DIS, V74, P369, DOI 10.1136/annrheumdis-2013-204067; Leonetti F, 1998, NEPHROL DIAL TRANSPL, V13, P617, DOI 10.1093/ndt/13.3.617; Lieske JC, 2014, CLIN J AM SOC NEPHRO, V9, P943, DOI 10.2215/CJN.08210813; Lipkowitz MS, 2012, CURR RHEUMATOL REP, V14, DOI 10.1007/s11926-012-0240-z; MANDEL NS, 1989, J UROLOGY, V142, P1513, DOI 10.1016/S0022-5347(17)39144-9; MCGEOWN MG, 1960, CLIN SCI, V19, P465; Mosli HA, 2013, RES REP UROL, V5, P11, DOI 10.2147/RRU.S39581; Pais VM, 2007, J ENDOUROL, V21, P232, DOI 10.1089/end.2007.2218; PAK CYC, 1977, J CLIN INVEST, V59, P426, DOI 10.1172/JCI108656; Park C, 2010, KOREAN J UROL, V51, P50, DOI 10.4111/kju.2010.51.1.50; Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6; Polasek O, 2010, CROAT MED J, V51, P48, DOI 10.3325/cmj.2010.51.48; Preitner F, 2013, AM J PHYSIOL-RENAL, V305, pF786, DOI 10.1152/ajprenal.00083.2013; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Reddy ST, 2002, AM J KIDNEY DIS, V40, P265, DOI 10.1053/ajkd.2002.34504; Reginato AM, 2012, NAT REV RHEUMATOL, V8, P610, DOI 10.1038/nrrheum.2012.144; RESNICK M, 1968, NEW ENGL J MED, V278, P1313, DOI 10.1056/NEJM196806132782403; ROBERTSON WG, 1978, BRIT J UROL, V50, P449, DOI 10.1111/j.1464-410X.1978.tb06189.x; Roch-Ramel F, 1999, NEWS PHYSIOL SCI, V14, P80; Rule AD, 2011, RHEUMATOLOGY, V50, P871, DOI 10.1093/rheumatology/keq425; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; SIERAKOWSKI R, 1978, INVEST UROL, V15, P438; Stiburkova B, 2011, MOL GENET METAB, V102, P430, DOI 10.1016/j.ymgme.2010.12.016; Sull JW, 2013, RHEUMATOL INT, V33, P19, DOI 10.1007/s00296-011-2303-2; Tracy CR, 2014, J UROLOGY, V192, P137, DOI 10.1016/j.juro.2014.01.093; TRINCHIERI A, 1988, J UROLOGY, V139, P478, DOI 10.1016/S0022-5347(17)42497-9; Voruganti VS, 2014, EUR J HUM GENET, V22, P938, DOI 10.1038/ejhg.2013.264; Voruganti Venkata Saroja, 2013, Frontiers in Genetics, V4, P279, DOI 10.3389/fgene.2013.00279; Witkowska K, 2012, AM J PHYSIOL-RENAL, V303, pF527, DOI 10.1152/ajprenal.00134.2012; Wright AF, 2010, KIDNEY INT, V78, P446, DOI 10.1038/ki.2010.206	52	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0128593	10.1371/journal.pone.0128593	http://dx.doi.org/10.1371/journal.pone.0128593			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167684	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100002
J	Gonzalez-Wevar, CA; Salinas, P; Hune, M; Segovia, NI; Vargas-Chacoff, L; Astorga, M; Canete, JI; Poulin, E				Gonzalez-Wevar, Claudio A.; Salinas, Pilar; Huene, Mathias; Segovia, Nicolas I.; Vargas-Chacoff, Luis; Astorga, Marcela; Canete, Juan I.; Poulin, Elie			Phylogeography in Galaxias maculatus (Jenyns, 1848) along Two Biogeographical Provinces in the Chilean Coast	PLOS ONE			English	Article							LAST GLACIAL MAXIMUM; CLIMATE-CHANGE; GENETIC CONSEQUENCES; EVOLUTIONARY HISTORY; DIVERGENCE; PATAGONIA; DISPERSAL; MIGRATION; ATLANTIC; PATTERNS	Major geologic and climatic changes during the Quaternary exerted a major role in shaping past and contemporary distribution of genetic diversity and structure of aquatic organisms in southern South America. In fact, the northern glacial limit along the Pacific coast, an area of major environmental changes in terms of topography, currents, and water salinity, represents a major biogeographic transition for marine and freshwater species. We used mitochondrial DNA sequences (D-loop) to investigate the consequences of Quaternary glacial cycles over the pattern of genetic diversity and structure of G. maculatus (Pisces: Galaxiidae) along two biogeographical provinces in the Chilean coast. Extreme levels of genetic diversity and strong phylogeographic structure characterize the species suggesting a low amount of influence of the last glacial cycle over its demography. However, we recognized contrasting patterns of genetic diversity and structure between main biogeographical areas here analyzed. Along the Intermediate Area (38 degrees-41 degrees S) each estuarine population constitutes a different unit. In contrast, Magellanic populations (43 degrees-53 degrees S) exhibited low levels of genetic differentiation. Contrasting patterns of genetic diversity and structure recorded in the species between the analyzed biogeographic areas are consistent with the marked differences in abiotic factors (i.e., different coastal configurations, Quaternary glacial histories, and oceanographic regimes) and to inherent characteristics of the species (i.e., salt-tolerance, physiology, and reproductive behavior).	[Gonzalez-Wevar, Claudio A.] Univ Magallanes, GAIA Antartica, Punta Arenas, Chile; [Gonzalez-Wevar, Claudio A.; Salinas, Pilar; Huene, Mathias; Segovia, Nicolas I.; Poulin, Elie] Univ Chile, Fac Ciencias, Inst Ecol Biodiversidad, Dept Ciencias Ecol,Lab Ecol Mol, Santiago, Chile; [Huene, Mathias] Fdn Ictiol, Santiago, Chile; [Vargas-Chacoff, Luis] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Astorga, Marcela] Univ Austral Chile, CIEN Austral Puerto Montt, Inst Acuicultura, Puerto Montt, Chile; [Canete, Juan I.] Univ Magallanes, Dept Recursos Nat, Punta Arenas, Chile	Universidad de Magallanes; Universidad de Chile; Universidad Austral de Chile; Universidad Austral de Chile; Universidad de Magallanes	Gonzalez-Wevar, CA (corresponding author), Univ Magallanes, GAIA Antartica, Punta Arenas, Chile.	omeuno01@hotmail.com	Hüne, Mathias/ABE-6000-2020; Astorga, Marcela/AAA-8115-2019; González-Wevar, Claudio Alejandro/AAD-6513-2021; Poulin, Elie/C-2654-2012; Vargas-Chacoff, Luis LVCh/A-5855-2012; Canete, Juan/GRS-4620-2022	Poulin, Elie/0000-0001-7736-0969; Vargas-Chacoff, Luis/0000-0002-0497-2582; Astorga, Marcela/0000-0002-9364-2365	post-doctorate fellowship (Fondecyt) [3120075]; Insituto de Ecologia y Biodiversidad IEB, Universidad de Chile [P05-002 ICM, PFB 023]; project Fondecyt [1110798]	post-doctorate fellowship (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Insituto de Ecologia y Biodiversidad IEB, Universidad de Chile; project Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was supported by a post-doctorate fellowship (Fondecyt 3120075) to CAG-W. All the specimens were captured under the Chilean legislation (Technical Memorandum P.INV No 427/2011 SUBPESCA). At the same time, this research was supported by the Projects P05-002 ICM and PFB 023 (Insituto de Ecologia y Biodiversidad IEB, Universidad de Chile), to EP and CG-W and project Fondecyt 1110798 to LV-C.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Alo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071577; Barriga JP, 2002, NEW ZEAL J MAR FRESH, V36, P345, DOI 10.1080/00288330.2002.9517092; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Burridge CP, 2012, J BIOGEOGR, V39, P306, DOI 10.1111/j.1365-2699.2011.02600.x; Bustos CA, 2011, CONT SHELF RES, V31, P293, DOI 10.1016/j.csr.2010.03.013; Camus PA, 2001, REV CHIL HIST NAT, V74, P587, DOI 10.4067/S0716-078X2001000300008; Ceballos SG, 2012, MAR BIOL, V159, P499, DOI 10.1007/s00227-011-1830-4; Clapperton CM, 1993, QUATERNARY GEOLOGY G; Cussac V, 2004, J BIOGEOGR, V31, P103, DOI 10.1046/j.0305-0270.2003.01000.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Aranzamendi MC, 2011, MAR BIOL, V158, P2405, DOI 10.1007/s00227-011-1742-3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dyer Brian S., 2000, Estudios Oceanologicos, V19, P77; Palma RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032206; Escribano Rubén, 2003, Gayana (Concepc.), V67, P190; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Filatov DA, 2009, BIOINFORMATICS, V25, P3189, DOI 10.1093/bioinformatics/btp572; Fraser CI, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-203; Gersonde R, 2005, QUATERNARY SCI REV, V24, P869, DOI 10.1016/j.quascirev.2004.07.015; Goldstien SJ, 2006, MOL ECOL, V15, P3259, DOI 10.1111/j.1365-294X.2006.02977.x; Gonzalez-Wevar CA, 2011, MOL ECOL, V20, P1936, DOI 10.1111/j.1365-294X.2011.05065.x; Gonzalez-Wevar C, 2015, J HERED, V106, P439, DOI 10.1093/jhered/esv005; Gonzalez-Wevar CA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-139; Haye PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088613; Hein AS, 2010, QUATERNARY SCI REV, V29, P1212, DOI 10.1016/j.quascirev.2010.01.020; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Himes CMT, 2008, J BIOGEOGR, V35, P1415, DOI 10.1111/j.1365-2699.2008.01895.x; Hudson RR, 2000, GENETICS, V155, P2011; Hune M, 2015, POLAR BIOL, V38, P607, DOI 10.1007/s00300-014-1623-6; Hulton NRJ, 2002, QUATERNARY SCI REV, V21, P233, DOI 10.1016/S0277-3791(01)00103-2; Jakob SS, 2009, MOL BIOL EVOL, V26, P907, DOI 10.1093/molbev/msp012; Jolly MT, 2005, HEREDITY, V94, P23, DOI 10.1038/sj.hdy.6800543; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kemp AES, 2010, QUATERNARY SCI REV, V29, P1993, DOI 10.1016/j.quascirev.2010.04.027; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lessa EP, 2010, MOL ECOL, V19, P3031, DOI 10.1111/j.1365-294X.2010.04734.x; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Macaya EC, 2010, MAR ECOL PROG SER, V420, P103, DOI 10.3354/meps08893; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Marko PB, 2004, MOL ECOL, V13, P597, DOI 10.1046/j.1365-294X.2004.02096.x; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; McCulloch RD, 2000, J QUATERNARY SCI, V15, P409, DOI 10.1002/1099-1417(200005)15:4<409::AID-JQS539>3.0.CO;2-#; MCDOWALL R M, 1970, Bulletin of the Museum of Comparative Zoology, V139, P341; MCDOWALL R M, 1975, New Zealand Journal of Marine and Freshwater Research, V9, P1; MCDOWALL RM, 1978, SYST ZOOL, V27, P88, DOI 10.2307/2412819; McMahon SM, 2011, TRENDS ECOL EVOL, V26, P249, DOI 10.1016/j.tree.2011.02.012; Near TJ, 2012, P NATL ACAD SCI USA, V109, P3434, DOI 10.1073/pnas.1115169109; Nielsen R, 2001, GENETICS, V158, P885; Nunez JJ, 2011, MOL PHYLOGENET EVOL, V58, P343, DOI 10.1016/j.ympev.2010.11.026; Pardinas UFJ, 2011, BIOL J LINN SOC, V103, P495, DOI 10.1111/j.1095-8312.2011.01679.x; PARMESAN C, 2006, ANNU REV ECOL EVOL, V37, P1, DOI DOI 10.1146/annurev.ecolsys.37.091305.110035; Pastorino MJ, 2002, J BIOGEOGR, V29, P1167, DOI 10.1046/j.1365-2699.2002.00731.x; Pons O, 1996, GENETICS, V144, P1237; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Rabassa J, 2005, J S AM EARTH SCI, V20, P81, DOI 10.1016/j.jsames.2005.07.004; Rabassa J, 2011, BIOL J LINN SOC, V103, P316, DOI 10.1111/j.1095-8312.2011.01681.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; ROSEN DE, 1978, SYST ZOOL, V27, P159, DOI 10.2307/2412970; Ruzzante DE, 2008, MOL ECOL, V17, P2234, DOI 10.1111/j.1365-294X.2008.03738.x; Ruzzante DE, 2006, MOL ECOL, V15, P2949, DOI 10.1111/j.1365-294X.2006.03010.x; Salinas MP., 2011, THESIS U CHILE SANTI, P56; Sersic AN, 2011, BIOL J LINN SOC, V103, P475, DOI 10.1111/j.1095-8312.2011.01656.x; SLATKIN M, 1995, GENETICS, V139, P457; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Taylor MS, 2006, MOL ECOL, V15, P695, DOI 10.1111/j.1365-294X.2006.02820.x; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Unmack PJ, 2012, MOL ECOL, V21, P942, DOI 10.1111/j.1365-294X.2011.05408.x; Unmack PJ, 2009, BIOL J LINN SOC, V97, P876, DOI 10.1111/j.1095-8312.2009.01224.x; Valdenegro Alexander, 2003, Ciencia y Tecnologia del Mar, V26, P19; Valdovinos C, 2003, ECOGRAPHY, V26, P139, DOI 10.1034/j.1600-0587.2003.03349.x; Vavrek MJ, 2011, PALAEONTOL ELECTRON, V14; Vianna JA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-53; Victoriano PF, 2008, MOL ECOL, V17, P2397, DOI 10.1111/j.1365-294X.2008.03741.x; Waters JM, 2000, SYST BIOL, V49, P777, DOI 10.1080/106351500750049824; Waters JM, 2000, MOL ECOL, V9, P1815, DOI 10.1046/j.1365-294x.2000.01082.x; Waters JM, 1999, MOL PHYLOGENET EVOL, V11, P1, DOI 10.1006/mpev.1998.0554; Waters JM, 2004, SYST BIOL, V53, P18, DOI 10.1080/10635150490264671; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xu JW, 2009, MOL ECOL, V18, P904, DOI 10.1111/j.1365-294X.2008.04070.x; Zattara EE, 2005, J BIOGEOGR, V32, P5, DOI 10.1111/j.1365-2699.2004.01164.x; Zemlak TS, 2011, MOL ECOL, V20, P5280, DOI 10.1111/j.1365-294X.2011.05352.x; Zemlak TS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-67; Zemlak TS, 2008, MOL ECOL, V17, P5049, DOI 10.1111/j.1365-294X.2008.03987.x	90	25	25	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131289	10.1371/journal.pone.0131289	http://dx.doi.org/10.1371/journal.pone.0131289			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161896	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300031
J	Liang, J; Xu, GR; Xie, J; Lee, I; Xiang, L; Wang, HZ; Zhang, GY; Xie, LP; Zhang, RQ				Liang, Jian; Xu, Guangrui; Xie, Jun; Lee, Ilsun; Xiang, Liang; Wang, Hongzhong; Zhang, Guiyou; Xie, Liping; Zhang, Rongqing			Dual Roles of the Lysine-Rich Matrix Protein (KRMP)-3 in Shell Formation of Pearl Oyster, Pinctada fucata	PLOS ONE			English	Article							PRISMATIC LAYER; FRAMEWORK FORMATION; CARBONIC-ANHYDRASE; NACRE; BIOMINERALIZATION; GENE; IDENTIFICATION; MANTLE; CALCIFICATION; PRISMALIN-14	Matrix proteins play important roles in shell formation. Our group firstly isolated three cDNAs encoding lysine-rich matrix protein from Pinctada fucata in 2006. However, the functions of KRMPs are not fully understood. In addition, KRMPs contain two functional domains, the basic domain and the Gly/Tyr domain respectively. Based on the modular organization, the roles of their two domains were poorly characterized. Furthermore, KRMPs were then reported in other two species, P. maxima and P. margaritifera, which indicated that KRMPs might be very important for shell formation. In this study, the characterization and function of KRMP-3 and its two functional domains were studied in vitro through purification of recombinant glutathione S-transferase tagged KRMP-3 and two KRMP-3 deletion mutants. Western blot and immunofluorescence revealed that native KRMP-3 existed in the EDTA-insoluble matrix of the prismatic layer and was located in the organic sheet and the prismatic sheath. Recombinant KRMP-3 (rKRMP-3) bound tightly to chitin and this binding capacity was duo to the Gly/Tyr-rich region. rKRMP-3 inhibited the precipitation of CaCO3, affected the crystal morphology of calcite and inhibited the growth of aragonite in vitro, which was almost entirely attributed to the lysine-rich region. The results present direct evidence of the roles of KRMP-3 in shell biomineralization. The functional rBR region was found to participate in the growth control of crystals and the rGYR region was responsible to bind to chitin.	[Liang, Jian; Xu, Guangrui; Xie, Jun; Lee, Ilsun; Xiang, Liang; Wang, Hongzhong; Zhang, Guiyou; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Sch Life Sci, Collaborat Innovat Ctr Deep Sea Biol, Inst Marine Biotechnol, Beijing 100084, Peoples R China; [Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Xie, LP (corresponding author), Tsinghua Univ, Sch Life Sci, Collaborat Innovat Ctr Deep Sea Biol, Inst Marine Biotechnol, Beijing 100084, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Natural Science Foundation of China [31372502, 31172382]; Independent Research Projects of Tsinghua University [20111080964]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Research Projects of Tsinghua University	This work was supported by the National Natural Science Foundation of China Grants 31372502, 31172382 and Independent Research Projects of Tsinghua University Grant 20111080964.	Aizenberg J, 2003, SCIENCE, V299, P1205, DOI 10.1126/science.1079204; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Belton D, 2004, J MATER CHEM, V14, P2231, DOI 10.1039/b401882f; Berland S, 2011, CHEMBIOCHEM, V12, P950, DOI 10.1002/cbic.201000667; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; Currey JD, 1999, J EXP BIOL, V202, P3285; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Fan XX, 2004, PLANT PHYSIOL, V136, P3979, DOI 10.1104/pp.104.046326; Fang D, 2012, J BIOL CHEM, V287, P15776, DOI 10.1074/jbc.M112.341594; Farre B, 2009, COMP BIOCHEM PHYS B, V152, P103, DOI 10.1016/j.cbpb.2008.10.003; Freer A, 2014, MAR BIOTECHNOL, V16, P34, DOI 10.1007/s10126-013-9516-1; Fu G, 2005, BIOMACROMOLECULES, V6, P1289, DOI 10.1021/bm049314v; Gardner LD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-455; Ghatak AS, 2013, INT J MOL SCI, V14, P11842, DOI 10.3390/ijms140611842; Inoue H, 2001, BIOSCI BIOTECH BIOCH, V65, P1840, DOI 10.1271/bbb.65.1840; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Liu HL, 2007, BIOCHEMISTRY-US, V46, P844, DOI 10.1021/bi061881a; Lowenstam HA, 1989, BIOMINERALIZATION; Marin F, 2005, MAT SCI ENG C-BIO S, V25, P105, DOI 10.1016/j.msec.2005.01.003; Marin F, 2000, J BIOL CHEM, V275, P20667, DOI 10.1074/jbc.M003006200; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; McDougall C, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0041; Miyamoto H, 2005, ZOOL SCI, V22, P311, DOI 10.2108/zsj.22.311; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Patwardhan SV, 2005, CHEM COMMUN, P1113, DOI 10.1039/b416926c; Ramanathan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017707; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Shechter A, 2008, P NATL ACAD SCI USA, V105, P7129, DOI 10.1073/pnas.0800193105; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; Simkiss K, 1989, BIOMINERALIZATION CE; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2007, FEBS J, V274, P5158, DOI 10.1111/j.1742-4658.2007.06036.x; Suzuki M, 2007, BIOSCI BIOTECH BIOCH, V71, P1735, DOI 10.1271/bbb.70140; Suzuki M, 2013, CAN J ZOOL, V91, P349, DOI 10.1139/cjz-2012-0333; Takeuchi T, 2008, FEBS LETT, V582, P591, DOI 10.1016/j.febslet.2008.01.026; Watabe N., 1988, P69; Yan ZG, 2007, BIOMACROMOLECULES, V8, P3597, DOI 10.1021/bm0701494; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Zhang C, 2006, MAR BIOTECHNOL, V8, P624, DOI 10.1007/s10126-006-6037-1; Zhang C, 2006, BIOCHEM BIOPH RES CO, V344, P735, DOI 10.1016/j.bbrc.2006.03.179; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6	44	31	36	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131868	10.1371/journal.pone.0131868	http://dx.doi.org/10.1371/journal.pone.0131868			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161976	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300068
J	Wang, CS; Oshima, M; Sashida, G; Tomioka, T; Hasegawa, N; Mochizuki-Kashio, M; Nakajima-Takagi, Y; Kusunoki, Y; Kyoizumi, S; Imai, K; Nakachi, K; Iwama, A				Wang, Changshan; Oshima, Motohiko; Sashida, Goro; Tomioka, Takahisa; Hasegawa, Nagisa; Mochizuki-Kashio, Makiko; Nakajima-Takagi, Yaeko; Kusunoki, Yoichiro; Kyoizumi, Seishi; Imai, Kazue; Nakachi, Kei; Iwama, Atsushi			Non-Lethal Ionizing Radiation Promotes Aging-Like Phenotypic Changes of Human Hematopoietic Stem and Progenitor Cells in Humanized Mice	PLOS ONE			English	Article							EXPRESSION; HALLMARKS; SUBTYPES; REPAIR; MOUSE; IL-7	Precise understanding of radiation effects is critical to develop new modalities for the prevention and treatment of radiation-induced damage. We previously reported that non-lethal doses of X-ray irradiation induce DNA damage in human hematopoietic stem and progenitor cells (HSPCs) reconstituted in NOD/Shi-scid IL2r gamma(null) (NOG) immunodeficient mice and severely compromise their repopulating capacity. In this study, we analyzed in detail the functional changes in human HSPCs in NOG mice following non-lethal radiation. We transplanted cord blood CD34(+) HSPCs into NOG mice. At 12 weeks post-transplantation, the recipients were irradiated with 0, 0.5, or 1.0 Gy. At 2 weeks post-irradiation, human CD34(+) HSPCs recovered from the primary recipient mice were transplanted into secondary recipients. CD34(+) HSPCs from irradiated mice showed severely impaired reconstitution capacity in the secondary recipient mice. Of interest, non-lethal radiation compromised contribution of HSPCs to the peripheral blood cells, particularly to CD19(+) B lymphocytes, which resulted in myeloid-biased repopulation. Co-culture of limiting numbers of CD34(+) HSPCs with stromal cells revealed that the frequency of B cell-producing CD34(+) HSPCs at 2 weeks post-irradiation was reduced more than 10-fold. Furthermore, the key B-cell regulator genes such as IL-7R and EBF1 were downregulated in HSPCs upon 0.5 Gy irradiation. Given that compromised repopulating capacity and myeloid-biased differentiation are representative phenotypes of aged HSCs, our findings indicate that non-lethal ionizing radiation is one of the critical external stresses that promote aging of human HSPCs in the bone marrow niche.	[Wang, Changshan; Oshima, Motohiko; Sashida, Goro; Tomioka, Takahisa; Hasegawa, Nagisa; Mochizuki-Kashio, Makiko; Nakajima-Takagi, Yaeko; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba 2608670, Japan; [Wang, Changshan] Inner Mongolia Univ, Coll Life Sci, Hohhot 010021, Peoples R China; [Sashida, Goro] Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto 8600811, Japan; [Hasegawa, Nagisa] Chiba Univ Hosp, Dept Hematol, Chiba 2608670, Japan; [Kusunoki, Yoichiro; Kyoizumi, Seishi; Imai, Kazue; Nakachi, Kei] Radiat Effects Res Fdn, Dept Radiobiol Mol Epidemiol, Hiroshima 7320815, Japan	Chiba University; Inner Mongolia University; Kumamoto University; Chiba University; Radiation Effects Research Foundation - Japan	Iwama, A (corresponding author), Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba 2608670, Japan.	aiwama@faculty.chiba-u.jp	Sashida, Goro/N-5259-2014	Sashida, Goro/0000-0003-2318-5987	Japanese Ministry of Health, Labor, and Welfare (MHLW); U.S. Department of Energy (DOE); RERF Research Protocol [5-09]; U.S. National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200900059C]; Grants-in-Aid for Scientific Research [14J40024] Funding Source: KAKEN	Japanese Ministry of Health, Labor, and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); RERF Research Protocol; U.S. National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Radiation Effects Research Foundation (RERF), Hiroshima and Nagasaki, Japan, is a public interest foundation funded by the Japanese Ministry of Health, Labor, and Welfare (MHLW) and the U.S. Department of Energy (DOE). This publication was supported by RERF Research Protocol 5-09 and by the U.S. National Institute of Allergy and Infectious Diseases (NIAID Contract HHSN272200900059C). The views of the authors do not necessarily reflect those of the two governments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attema JL, 2009, ONCOGENE, V28, P2238, DOI 10.1038/onc.2009.94; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Ema H, 2014, EXP HEMATOL, V42, P74, DOI 10.1016/j.exphem.2013.11.004; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kuranda K, 2011, AGING CELL, V10, P542, DOI 10.1111/j.1474-9726.2011.00675.x; Lawrence HJ, 2005, BLOOD, V106, P3988, DOI 10.1182/blood-2005-05-2003; Lescale C, 2010, AGING CELL, V9, P410, DOI 10.1111/j.1474-9726.2010.00566.x; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Masuda K, 2005, EMBO J, V24, P4052, DOI 10.1038/sj.emboj.7600878; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Muller-Sieburg CE, 2004, BLOOD, V103, P4111, DOI 10.1182/blood-2003-10-3448; Nakachi K, 2008, MUTAT RES-REV MUTAT, V659, P109, DOI 10.1016/j.mrrev.2008.02.001; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Oshima M, 2014, INT J HEMATOL, V100, P326, DOI 10.1007/s12185-014-1647-2; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Ramirez J, 2010, CURR OPIN IMMUNOL, V22, P177, DOI 10.1016/j.coi.2010.02.003; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Shao LJ, 2014, BLOOD, V123, P3105, DOI 10.1182/blood-2013-07-515619; Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Unnisa Z, 2012, BLOOD, V120, P4973, DOI 10.1182/blood-2012-06-435800; Van Zant G, 2003, EXP HEMATOL, V31, P659, DOI 10.1016/S0301-472X(03)00088-2; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wang CS, 2013, INT J RADIAT BIOL, V89, P132, DOI 10.3109/09553002.2013.734947; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	38	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132041	10.1371/journal.pone.0132041	http://dx.doi.org/10.1371/journal.pone.0132041			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161905	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300085
J	Xia, L; Sun, LH; Wang, XL; Yao, ML; Xu, FL; Cheng, GM; Wang, XY; Zhu, CL				Xia, Lei; Sun, Lihuan; Wang, Xingling; Yao, Meiling; Xu, Falin; Cheng, Guomei; Wang, Xiaoyang; Zhu, Changlian			Changes in the Incidence of Congenital Anomalies in Henan Province, China, from 1997 to 2011	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; BIRTH-DEFECTS; MATERNAL AGE; FOLIC-ACID; INFANT-MORTALITY; UNITED-STATES; RISK-FACTOR; PREVALENCE; ASSOCIATION; PREVENTION	Aim To investigate changes in incidence and characteristics of congenital anomalies in infants in Henan Province of China over a period of 15 years. Methods Population-based surveillance in Henan Province was conducted from 1997 to 2011 in 75 hospitals (40 urban districts and 35 rural counties, comprising about 20% of the total births). Basic population information was obtained from the healthcare network. All live births, intrauterine deaths after 28 weeks, and stillbirths were included. Congenital anomalies were diagnosed and reported to Henan Provincial Maternal and Pediatric Healthcare Hospital. Results Of 1,815,920 births from 1997 to 2011, 15,660 cases of congenital anomalies were identified, resulting in an average incidence of 86.2 cases per 10,000 births. The incidence of congenital anomalies showed a significant downward trend (p < 0.0001) in rural areas and the whole province (p < 0.0001), but an increase in urban areas (p = 0.003). The incidence was much higher in rural than in urban areas in 1997, but this discrepancy decreased rapidly and no difference was seen between rural and urban areas in 2003. The incidence in females was higher than in males in 1997-1999 but decreased to a similar level as that in males in 2000. Maternal age exceeding 35 years was associated with a higher incidence of congenital anomalies. Among the 23 types of congenital anomalies recorded, neural tube defects were the most common; the incidence declined from 39.3 cases per 10,000 births in 1997 to 6.1 cases per 10,000 births in 2011. Conclusion The incidence of congenital anomalies has decreased in Henan Province over the past 15 years due to significant reductions in rural areas and among girls. This decrease was partly related to a reduction in neural tube defects that was likely the result of a folic acid intervention in the province.	[Xia, Lei; Xu, Falin; Wang, Xiaoyang; Zhu, Changlian] Zhengzhou Univ, Affiliated Hosp 3, Dept Pediat, Zhengzhou 450052, Peoples R China; [Sun, Lihuan; Yao, Meiling] Zhengzhou Univ, Affiliated Hosp 3, Dept Women & Childrens Healthcare, Zhengzhou 450052, Peoples R China; [Wang, Xingling] Zhengzhou Univ, Affiliated Hosp 3, Reprod Ctr, Zhengzhou 450052, Peoples R China; [Cheng, Guomei] Zhengzhou Univ, Affiliated Hosp 3, Perinatal Ctr, Zhengzhou 450052, Peoples R China; [Wang, Xiaoyang] Univ Gothenburg, Sahlgrenska Acad, Perinatal Ctr, Gothenburg, Sweden; [Zhu, Changlian] Univ Gothenburg, Sahlgrenska Acad, Ctr Brain Repair & Rehabil, Gothenburg, Sweden	Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University; University of Gothenburg; University of Gothenburg	Sun, LH (corresponding author), Zhengzhou Univ, Affiliated Hosp 3, Dept Women & Childrens Healthcare, Zhengzhou 450052, Peoples R China.	sunlihuanw@163.com; changlian.zhu@neuro.gu.se	Zhu, Changlian/AAN-6205-2020	Zhu, Changlian/0000-0002-5029-6730; Wang, Xiaoyang/0000-0001-9717-8160	Science and Technology Bureau of Zhengzhou [131PCXTD621]; Department of Education [2011B320020]; Department of Health [201201002]; Department of Science and Technology of Henan Province, China [134200510023]	Science and Technology Bureau of Zhengzhou; Department of Education(US Department of Education); Department of Health; Department of Science and Technology of Henan Province, China	This study was supported by the Science and Technology Bureau of Zhengzhou (131PCXTD621), the Department of Education (2011B320020), the Department of Health (201201002) and the Department of Science and Technology of Henan Province (134200510023), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agay-Shay K, 2012, BIRTH DEFECTS RES A, V94, P438, DOI 10.1002/bdra.23010; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Bestwick JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089354; Cheng N, 2003, ANN TROP PAEDIATR, V23, P25, DOI 10.1179/000349803125002823; Copp AJ, 2013, LANCET NEUROL, V12, P799, DOI 10.1016/S1474-4422(13)70110-8; Correa A, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.018; Dai L, 2011, WORLD J PEDIATR, V7, P302, DOI 10.1007/s12519-011-0326-0; Dan S, 2012, PRENATAL DIAG, V32, P1225, DOI 10.1002/pd.4002; Deak KL, 2008, BIRTH DEFECTS RES A, V82, P662, DOI 10.1002/bdra.20511; Deng XX, 2014, NAT REV GENET, V15, P367, DOI 10.1038/nrg3687; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Fan LC, 2013, BIRTH DEFECTS RES A, V97, P750, DOI 10.1002/bdra.23148; Gill SK, 2012, BIRTH DEFECTS RES A, V94, P1010, DOI 10.1002/bdra.23049; Houghton LA, 2011, AM J CLIN NUTR, V94, P136, DOI 10.3945/ajcn.110.004549; Huo KM, 2010, PAEDIATR PERINAT EP, V24, P343, DOI 10.1111/j.1365-3016.2010.01126.x; Jahromi BN, 2008, TAIWAN J OBSTET GYNE, V47, P318, DOI 10.1016/S1028-4559(08)60131-X; Lee K, 2001, OBSTET GYNECOL, V98, P620, DOI 10.1016/S0029-7844(01)01507-1; Li XH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-161; Liu JF, 2015, PUBLIC HEALTH NUTR, V18, P582, DOI 10.1017/S1368980014000950; Luke B, 2007, HUM REPROD, V22, P1264, DOI 10.1093/humrep/del522; Natsume N, 2000, BRIT J ORAL MAX SURG, V38, P23, DOI 10.1054/bjom.1999.0133; Ooki S, 2013, INT J WOMENS HEALTH, V5, P65, DOI 10.2147/IJWH.S32296; Reefhuis J, 2004, BIRTH DEFECTS RES A, V70, P572, DOI 10.1002/bdra.20065; Ren AG, 2011, P NATL ACAD SCI USA, V108, P12770, DOI 10.1073/pnas.1105209108; Rosano A, 2000, J EPIDEMIOL COMMUN H, V54, P660, DOI 10.1136/jech.54.9.660; Rosano A, 2000, AM J MED GENET, V93, P110, DOI 10.1002/1096-8628(20000717)93:2<110::AID-AJMG6>3.0.CO;2-9; Rossi AC, 2013, OBSTET GYNECOL, V122, P1160, DOI 10.1097/AOG.0000000000000015; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Sokal R, 2014, BIRTH DEFECTS RES A, V100, P79, DOI 10.1002/bdra.23218; Tang KF, 2015, SCI REP-UK, V5, DOI 10.1038/srep08510; Wang ZP, 2012, J MATERN-FETAL NEO M, V25, P389, DOI 10.3109/14767058.2011.580800; Yang JH, 2004, J KOREAN MED SCI, V19, P509, DOI 10.3346/jkms.2004.19.4.509; Yang WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053429; Yaniv SS, 2011, ARCH GYNECOL OBSTET, V283, P755, DOI 10.1007/s00404-010-1459-4; Zeng ZQ, 2011, PUBLIC HEALTH NUTR, V14, P1142, DOI 10.1017/S1368980011000097; Zhang XH, 2011, BIRTH DEFECTS RES A, V91, P34, DOI 10.1002/bdra.20725; Zhang XG, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-125; Zhu L, 2008, FOOD NUTR BULL, V29, pS196, DOI 10.1177/15648265080292S123	38	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131874	10.1371/journal.pone.0131874	http://dx.doi.org/10.1371/journal.pone.0131874			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161554	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300070
J	Sun, M; Bloom, AB; Zaman, MH				Sun, Meng; Bloom, Alexander B.; Zaman, Muhammad H.			Rapid Quantification of 3D Collagen Fiber Alignment and Fiber Intersection Correlations with High Sensitivity	PLOS ONE			English	Article							CROSS-LINKING; MECHANICAL-PROPERTIES; CONTACT GUIDANCE; CELL MOTILITY; I COLLAGEN; GELS; ORIENTATION; TISSUE; DYNAMICS; MATRIX	Metastatic cancers aggressively reorganize collagen in their microenvironment. For example, radially orientated collagen fibers have been observed surrounding tumor cell clusters in vivo. The degree of fiber alignment, as a consequence of this remodeling, has often been difficult to quantify. In this paper, we present an easy to implement algorithm for accurate detection of collagen fiber orientation in a rapid pixel-wise manner. This algorithm quantifies the alignment of both computer generated and actual collagen fiber networks of varying degrees of alignment within 5(oo). We also present an alternative easy method to calculate the alignment index directly from the standard deviation of fiber orientation. Using this quantitative method for determining collagen alignment, we demonstrate that the number of collagen fiber intersections has a negative correlation with the degree of fiber alignment. This decrease in intersections of aligned fibers could explain why cells move more rapidly along aligned fibers than unaligned fibers, as previously reported. Overall, our paper provides an easier, more quantitative and quicker way to quantify fiber orientation and alignment, and presents a platform in studying effects of matrix and cellular properties on fiber alignment in complex 3D environments.	[Sun, Meng; Zaman, Muhammad H.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Bloom, Alexander B.] Boston Univ, Dept Mol Biol Cellular Biol & Biochem, Boston, MA 02215 USA; [Zaman, Muhammad H.] Howard Hughes Med Inst, Boston, MA 02115 USA	Boston University; Boston University; Howard Hughes Medical Institute	Zaman, MH (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	zaman@bu.edu			National Institutes of Health [U01-CA177799]; National Science Foundation [DMR-1206335]; NATIONAL CANCER INSTITUTE [U01CA177799] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL120839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this work came from National Institutes of Health (U01-CA177799): http://www.nih.gov/, and National Science Foundation (DMR-1206335): http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilash AS, 2014, BIOPHYS J, V107, P1829, DOI 10.1016/j.bpj.2014.08.029; Bassereau P, 2014, ADV COLLOID INTERFAC, V208, P47, DOI 10.1016/j.cis.2014.02.002; Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2; Brabrand A, 2015, APMIS, V123, P1, DOI 10.1111/apm.12298; Bredfeldt JS, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016007; Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879; Candes E, 2006, MULTISCALE MODEL SIM, V5, P861, DOI 10.1137/05064182X; Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Daniels F, 2007, IFMBE PROC, V15, P282; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; ELICEIRI K, 2014, J PATHOL INFORM, V5, P28, DOI DOI 10.4103/2153-3539.139707; Enderling H, 2008, BIOPHYS J, V95, P2203, DOI 10.1529/biophysj.108.133199; Erikson A, 2008, BIOPOLYMERS, V89, P135, DOI 10.1002/bip.20874; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; FRENKEL D, 1985, PHYS REV A, V31, P1776, DOI 10.1103/PhysRevA.31.1776; Friedl P, 2004, HISTOCHEM CELL BIOL, V122, P183, DOI 10.1007/s00418-004-0682-0; Fujiwara S, 1998, PHYS REV LETT, V80, P991, DOI 10.1103/PhysRevLett.80.991; GALE M, 1995, BIOPHYS J, V68, P2124, DOI 10.1016/S0006-3495(95)80393-0; GUIDO S, 1993, J CELL SCI, V105, P317; Haralock R. M., 1991, COMPUTER ROBOT VISIO; Harjanto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024891; Hong L, 1998, IEEE T PATTERN ANAL, V20, P777, DOI 10.1109/34.709565; Karlon WJ, 1999, ANN BIOMED ENG, V27, P712, DOI 10.1114/1.226; KASS M, 1987, COMPUT VISION GRAPH, V37, P362, DOI 10.1016/0734-189X(87)90043-0; KATZ MJ, 1980, CELL MOTIL CYTOSKEL, V1, P141, DOI 10.1002/cm.970010111; Kaunas R, 2009, J THEOR BIOL, V257, P320, DOI 10.1016/j.jtbi.2008.11.024; Kim A, 2006, EXP CELL RES, V312, P3683, DOI 10.1016/j.yexcr.2006.08.009; Kong T.Y., 1996, TOPOLOGICAL ALGORITH; Kovesi P. D., 2000, MATLAB OCTAVE FUNCTI; Krok JL, 2014, CANCER EPIDEM BIOMAR, V23, P563, DOI 10.1158/1055-9965.EPI-14-0066; Lackie J.M., 1986, CELL MOVEMENT CELL B, P253, DOI [10.1007/978-94-009-4071-0_10, DOI 10.1007/978-94-009-4071-0_10]; Lai VK, 2012, ACTA BIOMATER, V8, P4031, DOI 10.1016/j.actbio.2012.07.010; LAM L, 1992, IEEE T PATTERN ANAL, V14, P869, DOI 10.1109/34.161346; Lanfer B, 2008, BIOMATERIALS, V29, P3888, DOI 10.1016/j.biomaterials.2008.06.016; Liang HC, 2004, BIOMATERIALS, V25, P3541, DOI 10.1016/j.biomaterials.2003.09.109; Liu Y, 2015, CURVEALIGN; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Nawroth JC, 2012, NAT BIOTECHNOL, V30, P792, DOI 10.1038/nbt.2269; Ng CP, 2006, ANN BIOMED ENG, V34, P446, DOI 10.1007/s10439-005-9067-3; Pang YG, 2011, BIOMATERIALS, V32, P3776, DOI 10.1016/j.biomaterials.2011.02.003; Pang YG, 2009, BIOMATERIALS, V30, P2023, DOI 10.1016/j.biomaterials.2008.12.064; Pawitan Y, 2001, ALL LIKELIHOOD STAT; Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4; Pratt W, 1991, DIGITAL IMAGE PROCES; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; R Core Team, 2013, R LANGUAGE ENV STAT; Rao AR, 2012, TAXONOMY TEXTURE DES; Riching KM, 2014, BIOPHYS J, V107, P2546, DOI 10.1016/j.bpj.2014.10.035; Russ J.C., 2006, IMAGE PROCESSING HDB, VFifth; Sander LM, 2014, CANCER RES, V74, P4588, DOI 10.1158/0008-5472.CAN-13-3294; Shahsavari A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011923; Sheetz MP, 1996, TRENDS CELL BIOL, V6, P85, DOI 10.1016/0962-8924(96)80993-7; Shih F.Y., 2010, IMAGE PROCESSING PAT; Sisson K, 2009, BIOMACROMOLECULES, V10, P1675, DOI 10.1021/bm900036s; Stein AM, 2011, COMPLEXITY, V16, P22, DOI 10.1002/cplx.20332; Stein AM, 2008, J MICROSC-OXFORD, V232, P463, DOI 10.1111/j.1365-2818.2008.02141.x; STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8; Stylianopoulos T, 2008, J MECH BEHAV BIOMED, V1, P326, DOI 10.1016/j.jmbbm.2008.01.003; Sundararaghavan HG, 2009, BIOTECHNOL BIOENG, V102, P632, DOI 10.1002/bit.22074; Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902; Wang WG, 2007, CANCER RES, V67, P3505, DOI 10.1158/0008-5472.CAN-06-3714; Wasserman L., 2004, ALL STAT CONCISE COU, V26; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035	65	20	20	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131814	10.1371/journal.pone.0131814	http://dx.doi.org/10.1371/journal.pone.0131814			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158674	gold, Green Published			2022-12-27	WOS:000358161200039
J	Gradidge, PJL; Norris, SA; Micklesfield, LK; Crowther, NJ				Gradidge, Philippe Jean-Luc; Norris, Shane A.; Micklesfield, Lisa K.; Crowther, Nigel J.			The Role of Lifestyle and Psycho-Social Factors in Predicting Changes in Body Composition in Black South African Women	PLOS ONE			English	Article							NORTH-WEST PROVINCE; PHYSICAL-ACTIVITY; MASS INDEX; HEALTH; DRINKING; OBESITY; IMAGE; WEIGHT; PERCEPTIONS; TRANSITION	Background This study aimed to determine whether lifestyle and psycho-social factors determine changes in body composition over 10 years in a population of black African females with a high prevalence of obesity. Materials and Methods Data were collected from 430 women at baseline and 10-year follow-up. Dual energy x-ray absorptiometry-derived body fat mass and fat free soft tissue mass, and simple anthropometric measures were taken at both time points. Data on physical activity (PA), diet, smoking, and alcohol intake were collected at baseline. Body size dissatisfaction and body size discrepancy were determined at baseline using the feel minus ideal (FID) index and the perceived minus actual weight status discrepancy score (PAD), respectively. Results All body composition measurements increased over 10 years (p<0.0005). Two distinct groups of overweight/obese females were identified using PAD and FID: one that was content with their body size and one that wished to be leaner. Vigorous PA at baseline was inversely associated with absolute changes in all measures of adiposity. In subjects who underestimated their body size at baseline (74.0% of the study population) changes in total and peripheral levels of body fat were less than in subjects who correctly identified their body size. In the group that underestimated body size, more women wanted to be leaner than in the group who knew their body size (60.1% vs 47.5%, p<0.05). Conclusions Underestimation of body size is common and is associated with a lower gain in total body adiposity and a prevalent desire to lose weight.	[Gradidge, Philippe Jean-Luc] Univ Witwatersrand, Ctr Exercise Sci & Sports Med, Fac Hlth Sci, Johannesburg, South Africa; [Gradidge, Philippe Jean-Luc; Norris, Shane A.; Micklesfield, Lisa K.] Univ Witwatersrand, Wits Dev Pathways Hlth Res Unit, MRC, Fac Hlth Sci, Johannesburg, South Africa; [Crowther, Nigel J.] Univ Witwatersrand, Dept Chem Pathol, Natl Hlth Lab Serv, Fac Hlth Sci, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand	Gradidge, PJL (corresponding author), Univ Witwatersrand, Ctr Exercise Sci & Sports Med, Fac Hlth Sci, Johannesburg, South Africa.	philippe.gradidge@wits.ac.za	Gradidge, Philippe/ABE-4070-2020; Gradidge, Philippe/R-5183-2017; Norris, Shane/C-4664-2014; Micklesfield, Lisa/AAR-8262-2021	Gradidge, Philippe/0000-0001-5225-1184; Gradidge, Philippe/0000-0001-5225-1184; Norris, Shane/0000-0001-7124-3788; Micklesfield, Lisa/0000-0002-4994-0779; Crowther, Nigel/0000-0002-5766-1745	Wellcome Trust (UK)	Wellcome Trust (UK)(Wellcome Trust)	This research was supported financially by the Wellcome Trust (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2010, ACSMS GUID EX TEST P; [Anonymous], STATISTICA; [Anonymous], 2014, J PSYCHIAT, DOI DOI 10.4172/1994-8220.1000101; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; CHESLER JULIA, 1961, S AFRICAN MED JOUR, V35, P129; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Cook I, 2012, J PHYS ACT HEALTH, V9, P300, DOI 10.1123/jpah.9.2.300; Crowther NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048883; Dorn JM, 2003, J NUTR, V133, P2655, DOI 10.1093/jn/133.8.2655; Fitzgibbon ML, 2000, OBES RES, V8, P582, DOI 10.1038/oby.2000.75; Gitau TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109709; Griffiths PL, 2008, ARCH DIS CHILD, V93, P862, DOI 10.1136/adc.2006.112649; Guthold R, 2008, AM J PREV MED, V34, P486, DOI 10.1016/j.amepre.2008.02.013; Guthold R, 2011, AM J PREV MED, V41, P52, DOI 10.1016/j.amepre.2011.03.008; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Irving BA, 2008, MED SCI SPORT EXER, V40, P1863, DOI 10.1249/MSS.0b013e3181801d40; Kruger H Salome, 2003, Cardiovasc J S Afr, V14, P16; Kruger HS, 2001, BRIT J NUTR, V86, P733, DOI 10.1079/BJN2001469; Letamo G, 2011, J BIOSOC SCI, V43, P75, DOI 10.1017/S0021932010000519; MacIntyre UE, 2002, NUTR RES, V22, P239, DOI 10.1016/S0271-5317(01)00392-X; Malyutina S, 2002, LANCET, V360, P1448, DOI 10.1016/S0140-6736(02)11470-X; Matoti-Mvalo T, 2011, S AFR J CLIN NUTR, V24, P40; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mchiza ZJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-433; Mciza Z, 2005, PUBLIC HEALTH NUTR, V8, P509, DOI [10.1097/PHN2005814, 10.1079/PHN2005814]; Mfenyana K, 2006, SAMJ S AFR MED J, V96, P323; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Mvo Z, 1999, Curationis, V22, P27; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Peer N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043336; Philipsen A, 2015, MED SCI SPORT EXER, V47, P983, DOI 10.1249/MSS.0000000000000504; Puoane T, 2005, S AFR J CLIN NUTR, V18, P6; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Puoane T, 2010, ETHNIC DIS, V20, P29; Richter LM, 2004, PAEDIATR PERINAT EP, V18, P290, DOI 10.1111/j.1365-3016.2004.00572.x; Senekal M, 2003, ETHNIC DIS, V13, P109; Shisana O, 2013, S AFRICAN NATL HLTH; Skelton DA, 2008, ADV SPORTS EXERCISE; Steyn NP, 2011, SCAND J PUBLIC HEALT, V39, P88, DOI 10.1177/1403494810384426; Stunkard A J, 1983, Res Publ Assoc Res Nerv Ment Dis, V60, P115; Tolstrup JS, 2008, AM J CLIN NUTR, V87, P957, DOI 10.1093/ajcn/87.4.957; Tolstrup JS, 2005, INT J OBESITY, V29, P490, DOI 10.1038/sj.ijo.0802874; Zaccagni L, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-42	43	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132914	10.1371/journal.pone.0132914	http://dx.doi.org/10.1371/journal.pone.0132914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171972	gold, Green Published, Green Submitted			2022-12-27	WOS:000358194900100
J	Dumpala, PR; Peterson, BC; Lawrence, ML; Karsi, A				Dumpala, Pradeep R.; Peterson, Brian C.; Lawrence, Mark L.; Karsi, Attila			Identification of Differentially Abundant Proteins of Edwardsiella ictaluri during Iron Restriction	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; ESCHERICHIA-COLI; CHANNEL CATFISH; PSEUDOMONAS-AERUGINOSA; VIBRIO-CHOLERAE; SMALL RNA; EXTRACELLULAR PRODUCTS; PUNCTATUS RAFINESQUE; PATHOGENIC BACTERIA; ENTERIC SEPTICEMIA	Edwardsiella ictaluri is a Gram-negative facultative anaerobe intracellular bacterium that causes enteric septicemia in channel catfish. Iron is an essential inorganic nutrient of bacteria and is crucial for bacterial invasion. Reduced availability of iron by the host may cause significant stress for bacterial pathogens and is considered a signal that leads to significant alteration in virulence gene expression. However, the precise effect of iron-restriction on E. ictaluri protein abundance is unknown. The purpose of this study was to identify differentially abundant proteins of E. ictaluri during in vitro iron-restricted conditions. We applied two-dimensional difference in gel electrophoresis (2D-DIGE) for determining differentially abundant proteins and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI TOF/TOF MS) for protein identification. Gene ontology and pathway-based functional modeling of differentially abundant proteins was also conducted. A total of 50 unique differentially abundant proteins at a minimum of 2-fold (p <= 0.05) difference in abundance due to iron-restriction were detected. The numbers of up-and down-regulated proteins were 37 and 13, respectively. We noted several proteins, including EsrB, LamB, MalM, MalE, FdaA, and TonB-dependent heme/hemoglobin receptor family proteins responded to iron restriction in E. ictaluri.	[Dumpala, Pradeep R.] Rogosin Inst, Xenia Div, Xenia, OH USA; [Peterson, Brian C.] USDA ARS, Warmwater Aquaculture Res Unit, Thad Cochran Natl Warmwater Aquaculture Ctr, Stoneville, MS 38776 USA; [Lawrence, Mark L.; Karsi, Attila] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA	United States Department of Agriculture (USDA); Mississippi State University	Karsi, A (corresponding author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.	a.karsi@msstate.edu	Karsi, Attila/AAG-5046-2019	Karsi, Attila/0000-0001-6845-3346	United States Department of Agriculture; College of Veterinary Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	United States Department of Agriculture(United States Department of Agriculture (USDA)); College of Veterinary Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the United States Department of Agriculture and College of Veterinary Medicine for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamed H, 2013, VET MICROBIOL, V162, P858, DOI 10.1016/j.vetmic.2012.11.006; AINSWORTH AJ, 1990, DEV COMP IMMUNOL, V14, P201, DOI 10.1016/0145-305X(90)90091-R; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Antiabong JF, 2015, GENE, V563, P94, DOI 10.1016/j.gene.2015.03.017; Arias CR, 2003, J FISH DIS, V26, P415, DOI 10.1046/j.1365-2761.2003.00475.x; Bader JA, 2004, FISH SHELLFISH IMMUN, V16, P415, DOI 10.1016/j.fsi.2003.07.003; Baldwin Thomas J., 1993, Journal of Aquatic Animal Health, V5, P189, DOI 10.1577/1548-8667(1993)005&lt;0189:POESOC&gt;2.3.CO;2; BINDEREIF A, 1985, J BACTERIOL, V162, P1039, DOI 10.1128/JB.162.3.1039-1046.1985; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; BJORN MJ, 1978, INFECT IMMUN, V19, P785, DOI 10.1128/IAI.19.3.785-791.1978; BJORN MJ, 1979, J BACTERIOL, V138, P193, DOI 10.1128/JB.138.1.193-200.1979; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; CALDERWOOD SB, 1987, J BACTERIOL, V169, P4759, DOI 10.1128/jb.169.10.4759-4764.1987; Chaudhary A, 2007, TOXICOL APPL PHARM, V220, P197, DOI 10.1016/j.taap.2006.12.030; Cooper Richard K. Ii, 1996, Journal of Aquatic Animal Health, V8, P319, DOI 10.1577/1548-8667(1996)008&lt;0319:UOAMTT&gt;2.3.CO;2; DAVIES RL, 1992, J GEN MICROBIOL, V138, P909, DOI 10.1099/00221287-138-5-909; DUBOS RJ, 1946, J EXP MED, V84, P143, DOI 10.1084/jem.84.2.143; Dumpala PR, 2009, PROTEOMICS, V9, P1353, DOI 10.1002/pmic.200800652; DYER DW, 1988, INFECT IMMUN, V56, P977, DOI 10.1128/IAI.56.4.977-983.1988; Ernst FD, 2005, J BACTERIOL, V187, P3687, DOI 10.1128/JB.187.11.3687-3692.2005; Ferguson AD, 2007, P NATL ACAD SCI USA, V104, P513, DOI 10.1073/pnas.0609887104; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; GOLDBERG MB, 1990, INFECT IMMUN, V58, P55, DOI 10.1128/IAI.58.1.55-60.1990; Griffiths E, 1999, IRON REGULATORY SIGN; HAWKE JP, 1981, INT J SYST BACTERIOL, V31, P396, DOI 10.1099/00207713-31-4-396; Jacobsen I, 2005, INFECT IMMUN, V73, P226, DOI 10.1128/IAI.73.1.226-234.2005; Jung YS, 2008, CURR MICROBIOL, V57, P593, DOI 10.1007/s00284-008-9248-z; Kaplan J, 2006, BBA-MOL CELL RES, V1763, P646, DOI 10.1016/j.bbamcr.2006.03.008; Kneidinger B, 2002, J BACTERIOL, V184, P363, DOI 10.1128/JB.184.2.363-369.2002; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lawrence ML, 2003, MICROBIOL-SGM, V149, P1409, DOI 10.1099/mic.0.26138-0; Lawrence ML, 2001, J AQUAT ANIM HEALTH, V13, P291, DOI 10.1577/1548-8667(2001)013&lt;0291:PAVOAT&gt;2.0.CO;2; Lawrence ML, 1997, INFECT IMMUN, V65, P4642, DOI 10.1128/IAI.65.11.4642-4651.1997; Lee Y, 2009, FEMS MICROBIOL LETT, V297, P38, DOI 10.1111/j.1574-6968.2009.01650.x; Lenco J, 2007, FEMS MICROBIOL LETT, V269, P11, DOI 10.1111/j.1574-6968.2006.00595.x; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137, DOI 10.1128/CMR.6.2.137-149.1993; Madsen ML, 2006, MICROBIOL-SGM, V152, P937, DOI 10.1099/mic.0.28674-0; Masse E, 2005, TRENDS BIOCHEM SCI, V30, P462, DOI 10.1016/j.tibs.2005.06.005; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Mey AR, 2005, INFECT IMMUN, V73, P8167, DOI 10.1128/IAI.73.12.8167-8178.2005; MIYAZAKI T, 1985, J FISH DIS, V8, P389, DOI 10.1111/j.1365-2761.1985.tb00961.x; Moore MM, 2002, DIS AQUAT ORGAN, V52, P93, DOI 10.3354/dao052093; NEWTON JC, 1989, J FISH DIS, V12, P335, DOI 10.1111/j.1365-2761.1989.tb00322.x; NEWTON JC, 1990, AM J VET RES, V51, P211; Newton Joseph C., 1993, Journal of Aquatic Animal Health, V5, P246, DOI 10.1577/1548-8667(1993)005&lt;0246:EAICOL&gt;2.3.CO;2; Payne Shelley M., 1993, Trends in Microbiology, V1, P66, DOI 10.1016/0966-842X(93)90036-Q; POOLE K, 1993, J BACTERIOL, V175, P4597, DOI 10.1128/JB.175.15.4597-4604.1993; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Sabri M, 2006, MICROBIOL-SGM, V152, P745, DOI 10.1099/mic.0.28682-0; Santander J, 2012, INFECT IMMUN, V80, P2689, DOI 10.1128/IAI.00013-12; SCIORTINO CV, 1983, INFECT IMMUN, V42, P990, DOI 10.1128/IAI.42.3.990-996.1983; Sheldon JR, 2014, MOL MICROBIOL, V92, P824, DOI 10.1111/mmi.12593; SHOTTS EB, 1986, CAN J FISH AQUAT SCI, V43, P36, DOI 10.1139/f86-005; SIGEL SP, 1982, J BACTERIOL, V150, P148, DOI 10.1128/JB.150.1.148-155.1982; Skirpstunas RT, 2003, J AQUAT ANIM HEALTH, V15, P92, DOI 10.1577/1548-8667(2003)015&lt;0092:AAASOM&gt;2.0.CO;2; Stanley L. A., 1994, Journal of Aquatic Animal Health, V6, P36, DOI 10.1577/1548-8667(1994)006&lt;0036:EPAWVA&gt;2.3.CO;2; STOEBNER JA, 1988, INFECT IMMUN, V56, P2891, DOI 10.1128/IAI.56.11.2891-2895.1988; Subramanian K, 2008, J APPL MICROBIOL, V105, P715, DOI 10.1111/j.1365-2672.2008.03800.x; Timms P, 2009, J MICROBIOL IMMUNOL, V42, P27; Vasil ML, 2007, BIOMETALS, V20, P587, DOI 10.1007/s10534-006-9067-2; Vassinova N, 2000, MICROBIOL-SGM, V146, P3171, DOI 10.1099/00221287-146-12-3171; VINITNANTHARAT S, 1993, FISH SHELLFISH IMMUN, V3, P401, DOI 10.1006/fsim.1993.1040; WALTMAN WD, 1986, APPL ENVIRON MICROB, V51, P101, DOI 10.1128/AEM.51.1.101-104.1986; Wang QY, 2008, ARCH MICROBIOL, V190, P595, DOI 10.1007/s00203-008-0407-1; Wang X, 2009, FISH SHELLFISH IMMUN, V27, P469, DOI 10.1016/j.fsi.2009.06.013; Wang YF, 1997, J MOL BIOL, V272, P56, DOI 10.1006/jmbi.1997.1224; WEETE JD, 1988, CAN J MICROBIOL, V34, P1224, DOI 10.1139/m88-215; WEINBERG ED, 1993, PERSPECT BIOL MED, V36, P215; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Williams ML, 2005, VET MICROBIOL, V108, P281, DOI 10.1016/j.vetmic.2005.04.017; Williams ML, 2003, J AQUAT ANIM HEALTH, V15, P264, DOI 10.1577/H03-051.1; YOUNG CC, 1991, J BACTERIOL, V173, P3096, DOI 10.1128/JB.173.10.3096-3100.1991; YU F, 1986, J BIOL CHEM, V261, P2284; Yu J, 1999, MICROBES INFECT, V1, P1221, DOI 10.1016/S1286-4579(99)00239-7; Zhang DF, 2008, INT J ANTIMICROB AG, V32, P315, DOI 10.1016/j.ijantimicag.2008.04.015	81	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132504	10.1371/journal.pone.0132504	http://dx.doi.org/10.1371/journal.pone.0132504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168192	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100047
J	Bino, G; Kingsford, RT; Porter, J				Bino, Gilad; Kingsford, Richard T.; Porter, John			Prioritizing Wetlands for Waterbirds in a Boom and Bust System: Waterbird Refugia and Breeding in the Murray-Darling Basin	PLOS ONE			English	Article							COLONIALLY-NESTING WATERBIRDS; MACQUARIE MARSHES; ARID AUSTRALIA; DRYLAND RIVERS; SOUTHERN-OSCILLATION; RESOURCE DEVELOPMENT; ECOLOGICAL IMPACTS; EASTERN AUSTRALIA; FLOW VARIABILITY; PROTECTED AREAS	Dryland rivers have considerable flow variability, producing complex ecosystems, processes, and communities of organisms that vary over space and time. They are also among the more vulnerable of the world's ecosystems. A key strategy for conservation of dryland rivers is identifying and maintaining key sites for biodiversity conservation, particularly protecting the quantity and quality of flow and flooding regimes. Extreme variability considerably challenges freshwater conservation planning. We systematically prioritised wetlands for waterbirds (simultaneously for 52 species), across about 13.5% of the Murray-Darling Basin (1,061,469 km2), using a 30-year record of systematic aerial surveys of waterbird populations. Nine key wetlands in this area, primarily lakes, floodplains, and swamps, consistently contributed to a representation target (80%) of total abundances of all 52 waterbird species. The long temporal span of our data included dramatic availability (i.e., booms) and scarcity (i.e., busts) of water, providing a unique opportunity to test prioritisation at extremes of variation. These extremes represented periods when waterbirds were breeding or concentrating on refugia, varying wetland prioritisation. In dry years, important wetlands for waterbirds were riverine and lacustrine (12 wetlands) but this changed in wet years to lacustrine and palustrine (8 wetlands). Such variation in ecosystem condition substantially changes the relative importance of individual wetlands for waterbirds during boom and bust phases. Incorporating this variability is necessary for effective conservation of Murray-Darling Basin waterbirds, with considerable generality for other similarly variable systems around the world.	[Bino, Gilad; Kingsford, Richard T.; Porter, John] Univ New S Wales, Sch Biol Earth & Environm Sci, Ctr Ecosyst Sci, Sydney, NSW, Australia; [Porter, John] NSW Off Environm & Heritage, Ecosyst Management Sci, Sydney, NSW, Australia	University of New South Wales Sydney; Office of Environment & Heritage - New South Wales	Bino, G (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Ctr Ecosyst Sci, Sydney, NSW, Australia.	gilad.bino@unsw.edu.au	Porter, John L/C-4073-2008	Bino, Gilad/0000-0002-9265-4057; Porter, John/0000-0003-1444-9215; Kingsford, Richard/0000-0001-6565-4134	Murray-Darling Basin Authority [RG134148]; ARC Linkage [LP0884160]	Murray-Darling Basin Authority; ARC Linkage(Australian Research Council)	This study was funded by the Murray-Darling Basin Authority (RG134148; http://www.mdba.gov.au) and ARC Linkage (LP0884160; http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, EC HUM WELL BEING WE; Arthington A.H, 2012, ENV FLOWS SAVING RIV; Arthington AH, 2003, RIVER RES APPL, V19, P377, DOI 10.1002/rra.745; Arthington AH, 2006, ECOL APPL, V16, P1311, DOI 10.1890/1051-0761(2006)016[1311:TCOPEF]2.0.CO;2; Arthington AH, 2011, ECOHYDROLOGY, V4, P708, DOI 10.1002/eco.221; Arthington AH, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02340.x; Arthur AD, 2012, WETLANDS, V32, P257, DOI 10.1007/s13157-011-0235-y; Balcombe SR, 2005, J FISH BIOL, V67, P1552, DOI 10.1111/j.1095-8649.2005.00858.x; Ball I., 2000, MARXAN V1 8 2 MARINE; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Bellio MG, 2009, BIOL CONSERV, V142, P3076, DOI 10.1016/j.biocon.2009.08.007; Bino G, 2014, SETTING WATERBIRD OB, P128; Bino G, 2014, ECOL APPL, V24, P142, DOI 10.1890/13-0202.1; Bomford M, 2002, EMU, V102, P29, DOI 10.1071/MU01028; Bonnot TW, 2013, BIOL CONSERV, V165, P104, DOI 10.1016/j.biocon.2013.05.010; Boulton AJ, 2006, AUST J BOT, V54, P133, DOI 10.1071/BT05074; Boulton AJ, 2003, FRESHWATER BIOL, V48, P1173, DOI 10.1046/j.1365-2427.2003.01084.x; BRAITHWAITE LW, 1986, AUST WILDLIFE RES, V13, P213; Brock MA, 2006, ECOLOGY OF DESERT RIVERS, P100; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Bunn SE, 2006, RIVER RES APPL, V22, P179, DOI 10.1002/rra.904; Bureau of Meteorology, 2014, WEATH CLIM DAT; Capon SJ, 2007, WETLANDS, V27, P904, DOI 10.1672/0277-5212(2007)27[904:EOFOSE]2.0.CO;2; Collares-Pereira MJ, 2000, FISHERIES MANAG ECOL, V7, P167, DOI 10.1046/j.1365-2400.2000.00202.x; Cowx IG, 2004, FISHERIES MANAG ECOL, V11, P243, DOI 10.1111/j.1365-2400.2004.00410.x; Datry T, 2014, BIOSCIENCE, V64, P229, DOI 10.1093/biosci/bit027; De la Cruz SEW, 2014, BIOL CONSERV, V169, P68, DOI 10.1016/j.biocon.2013.10.021; EFRON B, 1978, J AM STAT ASSOC, V73, P113, DOI 10.2307/2286531; Fellows CS, 2009, FRESHWATER BIOL, V54, P236, DOI 10.1111/j.1365-2427.2008.02104.x; Ferrier S, 2000, BIOL CONSERV, V93, P303, DOI 10.1016/S0006-3207(99)00149-4; Gibbs HM, 2011, EMU, V111, P283, DOI 10.1071/MU10083; Halse SA, 2005, EMU, V105, P115, DOI 10.1071/MU04021; Hermoso V, 2011, FRESHWATER BIOL, V56, P57, DOI 10.1111/j.1365-2427.2009.02390.x; Hermoso V, 2012, DIVERS DISTRIB, V18, P448, DOI 10.1111/j.1472-4642.2011.00879.x; Humphries P, 2003, FRESHWATER BIOL, V48, P1141, DOI 10.1046/j.1365-2427.2003.01092.x; Jenkins KM, 2003, ECOLOGY, V84, P2708, DOI 10.1890/02-0326; Kennard MJ, 2010, FRESHWATER BIOL, V55, P171, DOI 10.1111/j.1365-2427.2009.02307.x; Khoury M, 2011, FRESHWATER BIOL, V56, P162, DOI 10.1111/j.1365-2427.2010.02468.x; Kingsford RT, 2006, ECOLOGY OF DESERT RIVERS, P203; Kingsford RT, 2010, MAR FRESHWATER RES, V61, P875, DOI 10.1071/MF09088; Kingsford RT, 2006, ECOLOGY OF DESERT RIVERS, P154; Kingsford RT, 2009, WILDLIFE RES, V36, P29, DOI 10.1071/WR08034; Kingsford R, 2006, ECOLOGY OF DESERT RIVERS, pXI; Kingsford RT, 2011, BIOL CONSERV, V144, P1194, DOI 10.1016/j.biocon.2010.09.022; Kingsford RT, 2011, MAR FRESHWATER RES, V62, P255, DOI 10.1071/MF09315; Kingsford RT, 2000, AUSTRAL ECOL, V25, P109, DOI 10.1111/j.1442-9993.2000.tb00012.x; Kingsford RT, 1999, FRESHWATER BIOL, V41, P425, DOI 10.1046/j.1365-2427.1999.00440.x; KINGSFORD RT, 1995, ENVIRON MANAGE, V19, P867, DOI 10.1007/BF02471938; Kingsford RT, 2005, RIVER RES APPL, V21, P187, DOI 10.1002/rra.840; Kingsford RT, 2004, ECOLOGY, V85, P2478, DOI 10.1890/03-0470; Kingsford RT, 2004, MAR FRESHWATER RES, V55, P17, DOI 10.1071/MF03075; Kingsford RT, 2002, EMU, V102, P47, DOI 10.1071/MU01030; Kingsford RT, 1999, WILDLIFE RES, V26, P351, DOI 10.1071/WR96062; KINGSFORD RT, 1994, BIOL CONSERV, V69, P219, DOI 10.1016/0006-3207(94)90063-9; Kingsford RT, 1998, COLON WATERBIRD, V21, P159, DOI 10.2307/1521903; Kingsford RT, 1999, BIOL CONSERV, V88, P231, DOI 10.1016/S0006-3207(98)00098-6; Kingsford RT, 1995, ECOLOGICAL EFFECTS R; Kingsford RT, 1994, WATERBIRDS WETLANDS; Kingsford RT., 2013, WATERBIRD COMMUNITIE; Kutner M. H., 2004, APPL LINEAR REGRESSI; Lake PS, 2007, FRESHWATER BIOL, V52, P597, DOI 10.1111/j.1365-2427.2006.01709.x; Lake PS, 2003, FRESHWATER BIOL, V48, P1161, DOI 10.1046/j.1365-2427.2003.01086.x; Larned ST, 2010, FRESHWATER BIOL, V55, P717, DOI 10.1111/j.1365-2427.2009.02322.x; Leigh C, 2008, RIVER RES APPL, V24, P1251, DOI 10.1002/rra.1125; Leigh C, 2010, MAR FRESHWATER RES, V61, P896, DOI 10.1071/MF10106; Lemly AD, 2000, ENVIRON MANAGE, V25, P485, DOI 10.1007/s002679910039; Leslie DJ, 2001, REGUL RIVER, V17, P21, DOI 10.1002/1099-1646(200101/02)17:1&lt;21::AID-RRR589&gt;3.0.CO;2-V; Linke S, 2012, J APPL ECOL, V49, P1036, DOI 10.1111/j.1365-2664.2012.02177.x; Linke S, 2011, FRESHWATER BIOL, V56, P6, DOI 10.1111/j.1365-2427.2010.02456.x; Lovejoy TE, 2006, TRENDS ECOL EVOL, V21, P329, DOI 10.1016/j.tree.2006.04.005; Magalhaes MF, 2007, FRESHWATER BIOL, V52, P1494, DOI 10.1111/j.1365-2427.2007.01781.x; Magoulick DD, 2003, FRESHWATER BIOL, V48, P1186, DOI 10.1046/j.1365-2427.2003.01089.x; Maher MT., 1992, RANGEL J, V14, P128, DOI [10.1071/RJ9920128, 10.1071/rj9920128, DOI 10.1071/RJ9920128]; Marshall JC, 2006, MAR FRESHWATER RES, V57, P61, DOI 10.1071/MF05021; MDBA, 2012, BAS PLAN; MDBA (Murray Darling Basin Authority), 2010, GUID PROP BAS PLAN T; Moilanen A, 2008, FRESHWATER BIOL, V53, P577, DOI 10.1111/j.1365-2427.2007.01906.x; Murray CG, 2012, EMU, V112, P209, DOI 10.1071/MU11070; Nel JL, 2011, FRESHWATER BIOL, V56, P106, DOI 10.1111/j.1365-2427.2010.02437.x; NORMAN FI, 1991, AUST J ECOL, V16, P485, DOI 10.1111/j.1442-9993.1991.tb01077.x; Okumura YM, 2010, J CLIMATE, V23, P5826, DOI 10.1175/2010JCLI3592.1; Paillex A, 2009, J APPL ECOL, V46, P250, DOI 10.1111/j.1365-2664.2008.01593.x; Peel MC, 2001, J HYDROL, V250, P224, DOI 10.1016/S0022-1694(01)00438-3; Piechota TC, 1998, WATER RESOUR RES, V34, P3035, DOI 10.1029/98WR02406; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Popescu VD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079330; Possingham H. P., 2006, PRINCIPLES CONSERVAT, V3rd, P507, DOI DOI 10.1023/A:1006601319528; Puckridge JT, 2000, REGUL RIVER, V16, P385, DOI 10.1002/1099-1646(200009/10)16:5<385::AID-RRR592>3.3.CO;2-N; Puckridge JT, 1998, MAR FRESHWATER RES, V49, P55, DOI 10.1071/MF94161; R Core Team, 2014, LANG ENV STAT COMP; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Raftery AE, 2011, BMA BAYESIAN MODEL A; Rood SB, 2005, FRONT ECOL ENVIRON, V3, P193, DOI 10.1890/1540-9295(2005)003[0193:MRFTRF]2.0.CO;2; Roshier DA, 2001, LANDSCAPE ECOL, V16, P547, DOI 10.1023/A:1013184512541; Roshier D, 2008, IBIS, V150, P474, DOI 10.1111/j.1474-919X.2008.00806.x; Roshier DA, 2008, OECOLOGIA, V156, P465, DOI 10.1007/s00442-008-0987-0; RUELLO NV, 1976, AUST J MAR FRESH RES, V27, P667; Segan DB, 2010, BIOL CONSERV, V143, P2, DOI 10.1016/j.biocon.2009.09.014; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Shaw P.A., 2011, ARID ZONE GEOMORPHOL, V3rd, P611; Sheldon F, 2010, MAR FRESHWATER RES, V61, P885, DOI 10.1071/MF09239; SIMPSON HJ, 1993, WATER RESOUR RES, V29, P3671, DOI 10.1029/93WR01492; Stanley EH, 1997, BIOSCIENCE, V47, P427, DOI 10.2307/1313058; Tooth S, 2000, EARTH-SCI REV, V51, P67, DOI 10.1016/S0012-8252(00)00014-3; Turak E, 2011, MAR FRESHWATER RES, V62, P300, DOI 10.1071/MF09297; Turak E, 2011, FRESHWATER BIOL, V56, P1, DOI 10.1111/j.1365-2427.2010.02515.x; Valett HM, 2005, ECOLOGY, V86, P220, DOI 10.1890/03-4091; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Ward JV, 1999, REGUL RIVER, V15, P125, DOI 10.1002/(SICI)1099-1646(199901/06)15:1/3&lt;125::AID-RRR523&gt;3.0.CO;2-E; Wilson KA, 2009, ANN NY ACAD SCI, V1162, P237, DOI 10.1111/j.1749-6632.2009.04149.x; Wintle BA, 2003, CONSERV BIOL, V17, P1579, DOI 10.1111/j.1523-1739.2003.00614.x; Wishart MJ, 2006, ECOLOGY OF DESERT RIVERS, P315	113	17	18	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132682	10.1371/journal.pone.0132682	http://dx.doi.org/10.1371/journal.pone.0132682			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161652	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300167
J	Driebe, EM; Sahl, JW; Roe, C; Bowers, JR; Schupp, JM; Gillece, JD; Kelley, E; Price, LB; Pearson, TR; Hepp, CM; Brzoska, PM; Cummings, CA; Furtado, MR; Andersen, PS; Stegger, M; Engelthaler, DM; Keim, PS				Driebe, Elizabeth M.; Sahl, Jason W.; Roe, Chandler; Bowers, Jolene R.; Schupp, James M.; Gillece, John D.; Kelley, Erin; Price, Lance B.; Pearson, Talima R.; Hepp, Crystal M.; Brzoska, Pius M.; Cummings, Craig A.; Furtado, Manohar R.; Andersen, Paal S.; Stegger, Marc; Engelthaler, David M.; Keim, Paul S.			Using Whole Genome Analysis to Examine Recombination across Diverse Sequence Types of Staphylococcus aureus	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; HORIZONTAL GENE-TRANSFER; MOLECULAR CLOCK; UNITED-STATES; COMMUNITY; VIRULENCE; EVOLUTION; EMERGENCE; PREVALENCE; SOFTWARE	Staphylococcus aureus is an important clinical pathogen worldwide and understanding this organism's phylogeny and, in particular, the role of recombination, is important both to understand the overall spread of virulent lineages and to characterize outbreaks. To further elucidate the phylogeny of S. aureus, 35 diverse strains were sequenced using whole genome sequencing. In addition, 29 publicly available whole genome sequences were included to create a single nucleotide polymorphism (SNP)-based phylogenetic tree encompassing 11 distinct lineages. All strains of a particular sequence type fell into the same clade with clear groupings of the major clonal complexes of CC8, CC5, CC30, CC45 and CC1. Using a novel analysis method, we plotted the homoplasy density and SNP density across the whole genome and found evidence of recombination throughout the entire chromosome, but when we examined individual clonal lineages we found very little recombination. However, when we analyzed three branches of multiple lineages, we saw intermediate and differing levels of recombination between them. These data demonstrate that in S. aureus, recombination occurs across major lineages that subsequently expand in a clonal manner. Estimated mutation rates for the CC8 and CC5 lineages were different from each other. While the CC8 lineage rate was similar to previous studies, the CC5 lineage was 100-fold greater. Fifty known virulence genes were screened in all genomes in silico to determine their distribution across major clades. Thirty-three genes were present variably across clades, most of which were not constrained by ancestry, indicating horizontal gene transfer or gene loss.	[Driebe, Elizabeth M.; Sahl, Jason W.; Roe, Chandler; Bowers, Jolene R.; Schupp, James M.; Gillece, John D.; Kelley, Erin; Price, Lance B.; Engelthaler, David M.; Keim, Paul S.] Translat Genom Res Inst, Pathogen Genom Div, Flagstaff, AZ 85004 USA; [Pearson, Talima R.; Hepp, Crystal M.; Keim, Paul S.] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Brzoska, Pius M.; Cummings, Craig A.; Furtado, Manohar R.] Thermo Fisher Sci, San Francisco, CA USA; [Andersen, Paal S.; Stegger, Marc] Statens Serum Inst, Microbiol & Infect Control, DK-2300 Copenhagen, Denmark	Translational Genomics Research Institute; Northern Arizona University; Thermo Fisher Scientific; Statens Serum Institut	Driebe, EM (corresponding author), Translat Genom Res Inst, Pathogen Genom Div, Flagstaff, AZ 85004 USA.	edriebe@tgen.org	Pearson, Talima/O-7840-2019; Andersen, Paal Skytt/H-2087-2015	Pearson, Talima/0000-0003-3696-041X; Andersen, Paal Skytt/0000-0001-5656-0427; , Jason/0000-0002-2497-0138; Stegger, Marc/0000-0003-0321-1180; Furtado, Manohar/0000-0001-6016-1357	NIH R01 [R01AI090782]; NIH U01 [AI066581]; Thermo Fisher Scientific (Life Technologies); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101371, R01AI090782, U01AI066581] Funding Source: NIH RePORTER	NIH R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH U01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thermo Fisher Scientific (Life Technologies); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was provided in part by NIH R01 grant R01AI090782 and NIH U01 grant AI066581, http://www.niaid.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Thermo Fisher Scientific (Life Technologies) provided support in the form of salaries for authors PMB, CAC and MRF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1961, BMJ-BRIT MED J, V1, P113; [Anonymous], 2014, TRACER V1 6; Bae IG, 2009, J CLIN MICROBIOL, V47, P3952, DOI 10.1128/JCM.01643-09; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Brauner J, 2013, EUR J CLIN MICROBIOL, V32, P613, DOI 10.1007/s10096-012-1784-6; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chua K, 2010, J BACTERIOL, V192, P5556, DOI 10.1128/JB.00878-10; Chua KYL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025887; Coombs GW, 2009, COMMUN DIS INTELL, V33, P10; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Everitt RG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4956; Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Gelman A, 1998, STAT SCI, V13, P163; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Gray RR, 2011, MOL BIOL EVOL, V28, P1593, DOI 10.1093/molbev/msq319; Hanssen AM, 2005, J CLIN MICROBIOL, V43, P2118, DOI 10.1128/JCM.43.5.2118-2124.2005; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Holden MTG, 2010, J BACTERIOL, V192, P888, DOI 10.1128/JB.01255-09; Holt DC, 2011, GENOME BIOL EVOL, V3, P881, DOI 10.1093/gbe/evr078; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Jackson CR, 2013, J CLIN MICROBIOL, V51, P1199, DOI 10.1128/JCM.03166-12; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Larsen AR, 2008, CLIN MICROBIOL INFEC, V14, P611, DOI 10.1111/j.1469-0691.2008.01995.x; Lattar SM, 2012, EUR J CLIN MICROBIOL, V31, P2559, DOI 10.1007/s10096-012-1596-8; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7; Long SW, 2014, MBIO, V5, DOI 10.1128/mBio.01692-14; McCarthy AJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00006; McCarthy AJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-104; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Moore CL, 2010, J CLIN MICROBIOL, V48, P2307, DOI 10.1128/JCM.00409-10; Moore PCL, 2001, J CLIN MICROBIOL, V39, P2760, DOI 10.1128/JCM.39.8.2760-2767.2001; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Pasquale TR, 2013, INT J INFECT DIS, V17, pE398, DOI 10.1016/j.ijid.2012.12.013; Pearson T, 2013, SYST BIOL, V62, P752, DOI 10.1093/sysbio/syt038; Rasko DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-2; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sahl JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054287; Sanderson MJ, 1996, HOMOPLASY RECURRENCE, Vxxv; Sanguinetti L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002668; Stam-Bolink EM, 2007, EUR J CLIN MICROBIOL, V26, P723, DOI 10.1007/s10096-007-0352-y; Sung JML, 2007, ANTIMICROB AGENTS CH, V51, P2189, DOI 10.1128/AAC.01442-06; Takuno S, 2012, MOL BIOL EVOL, V29, P797, DOI 10.1093/molbev/msr249; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tenover FC, 2012, ANTIMICROB AGENTS CH, V56, P1324, DOI 10.1128/AAC.05804-11; Tenover FC, 2009, J CLIN MICROBIOL, V47, P2452, DOI 10.1128/JCM.00476-09; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Varshney AK, 2009, APPL ENVIRON MICROB, V75, P6839, DOI 10.1128/AEM.00272-09; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Witte W, 2005, EUR J CLIN MICROBIOL, V24, P1, DOI 10.1007/s10096-004-1262-x; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	71	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130955	10.1371/journal.pone.0130955	http://dx.doi.org/10.1371/journal.pone.0130955			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161978	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300026
J	Katrinardottir, B; Alves, JA; Sigurjonsdottir, H; Hersteinsson, P; Gunnarsson, TG				Katrinardottir, Borgny; Alves, Jose A.; Sigurjonsdottir, Hrefna; Hersteinsson, Pall; Gunnarsson, Tomas G.			The Effects of Habitat Type and Volcanic Eruptions on the Breeding Demography of Icelandic Whimbrels Numenius phaeopus	PLOS ONE			English	Article							TERRITORY SIZE; HATCHING SUCCESS; NATAL PHILOPATRY; RIVER REGULATION; NESTING SUCCESS; MAYFIELD METHOD; SITE-FIDELITY; PREDATION; BIRDS; FOOD	Distinct preference of species for habitats is most often driven by long term differences in demographic rates between habitats. Estimating variation in those rates is key for developing successful conservation strategies. Stochastic events can interact with underlying variation in habitat quality in regulating demography but the opportunities to explore such interactions are rare. Whimbrels in Iceland show a strong preference for sparsely vegetated riverplains. Such habitats in Iceland face various threats, e.g., climate change, river regulation and spread of alien plant species. In this study we compared demographic parameters of breeding Whimbrels between riverplains and other habitats before, during and after volcanic eruption events to estimate the importance of the habitats for the species and the effect of ash deposit on breeding success. We found that an estimated minimum of 23% of the Icelandic population of Whimbrels and c. 10% of the world population of the species breed in riverplain habitats in Iceland. Whimbrels bred consistently at much higher densities in riverplain habitats than in other habitats and riverplains also had higher densities of pairs with fledglings although the proportion of successful breeders was similar between habitats. Predation by livestock may have had a considerable negative effect on breeding success on our study sites. Breeding was negatively affected by the volcanic activity, probably through the effects of ash on the invertebrate food supply, with breeding success being gradually worse closer to the eruption. Breeding success was equally affected by volcanism across habitats which differed in underlying habitat quality. This study gives an example of how populations can be regulated by factors which operate at different spatial scales, such as local variation in habitat quality and stochastic events which impact larger areas.	[Katrinardottir, Borgny] Iceland Inst Nat Hist, Dept Ecol, Gardabaer, Iceland; [Katrinardottir, Borgny; Alves, Jose A.; Gunnarsson, Tomas G.] Univ Iceland, South Iceland Res Ctr, Selfoss Gunnarsholt, Iceland; [Alves, Jose A.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Sigurjonsdottir, Hrefna; Hersteinsson, Pall] Univ Iceland, Dept Life & Environm Sci, Reykjavik, Iceland	University of Iceland; Universidade de Aveiro; University of Iceland	Katrinardottir, B (corresponding author), Iceland Inst Nat Hist, Dept Ecol, Gardabaer, Iceland.	borgny@ni.is	Gunnarsson, Tomas G/L-9783-2015; Sigurjonsdottir, Hrefna/N-8252-2019; Sigurjónsdóttir, Hrefna/M-2380-2015; Alves, José A./U-4674-2018	Sigurjonsdottir, Hrefna/0000-0002-4052-1324; Alves, José A./0000-0001-7182-0936; Gunnarsson, Tomas Gretar/0000-0001-7692-0637	University of Iceland Research Fund; Icelandic Research Fund for Graduate Students; Palmi Jonsson's Conservation Fund (Natturuverndarsjodur Palma Jonssonar)	University of Iceland Research Fund; Icelandic Research Fund for Graduate Students; Palmi Jonsson's Conservation Fund (Natturuverndarsjodur Palma Jonssonar)	The work was supported by the following: 2010 - University of Iceland Research Fund, http://www.sjodir.hi.is/english, TGG - 900.000 ISK; 2010 - Icelandic Research Fund for Graduate Students (has now been joined with another fund), http://www.rannis.is/, BK 840.000 ISK; and 2009 - Palmi Jonsson's Conservation Fund (Natturuverndarsjodur Palma Jonssonar), http://www.natturuverndarsjodur.is/, BK - 850.000 ISK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKRE R D, 1981, Melanderia, V37, P1; [Anonymous], 2011, RESULTS OF THE 2 PHA; ARNALDS A, 1987, ARCTIC ALPINE RES, V19, P508, DOI 10.2307/1551417; Arnalds O, 2014, BIOGEOSCIENCES, V11, P6623, DOI 10.5194/bg-11-6623-2014; Arnalds O, 2013, ADV AGRON, V121, P331, DOI 10.1016/B978-0-12-407685-3.00006-2; Arnalds O, 2013, SCI REP-UK, V3, DOI 10.1038/srep01257; Arnalds O, 2010, ICELAND AGR SCI, V23, P3; Ballantyne K, 2011, WATERBIRDS, V34, P151, DOI 10.1675/063.034.0203; BROWN J J, 1981, Melanderia, V37, P30; CODY ML, 1972, CONDOR, V74, P473, DOI 10.2307/1365901; Colwell MA, 2010, SHOREBIRD ECOLOGY, CONSERVATION, AND MANAGEMENT, P1; Conklin J.R., 2014, PRIORITIZING MIGRATO; Dalsgaard B, 2007, IBIS, V149, P298, DOI 10.1111/j.1474-919X.2006.00631.x; Daviosdottir B, 2010, PROUN AOFEROA VIO VO; Delany S, 2009, AN ATLAS OF WADER PO; ENOKSSON B, 1983, J ANIM ECOL, V52, P927, DOI 10.2307/4464; Evans P.R., 1984, Behavior of Marine Animals, V5, P83; Fuller RJ, 2012, BIRDS AND HABITATS R; FURNESS RW, 1988, BIRD STUDY, V35, P199, DOI 10.1080/00063658809476989; GARDARSSON A, 1994, HYDROBIOLOGIA, V279, P15, DOI 10.1007/BF00027837; GORANSSON G, 1975, OIKOS, V26, P117, DOI 10.2307/3543700; GRANT MC, 1991, BIRD STUDY, V38, P160, DOI 10.1080/00063659109477085; Grant MC, 2000, BIRD STUDY, V47, P41, DOI 10.1080/00063650009461159; Gregory Cory J., 2011, Wader Study Group Bulletin, V118, P109; Gudmundsson Magnus T., 2010, EOS T AM GEOPHYS UN, V91, P190, DOI DOI 10.1029/2010EO210002; Gunnarsson TG, 2006, BIOL CONSERV, V128, P265, DOI 10.1016/j.biocon.2005.09.034; Gunnarsson TG, 2005, J ANIM ECOL, V74, P965, DOI 10.1111/j.1365-2656.2005.00994.x; Gunnarsson TG, 2000, STOFNVISTFRAEODI SPO; Gunnarsson TG, 2015, ECOL EVOL, V5, P2386, DOI 10.1002/ece3.1523; Gunnarsson TG, 2012, P ROY SOC B-BIOL SCI, V279, P411, DOI 10.1098/rspb.2011.0939; Gunnarsson Tomas Gretar, 2010, Wader Study Group Bulletin, V117, P46; Gunnarsson Tomas Gretar, 2010, Natturufraedingurinn, V79, P75; HAYWARD JL, 1982, AUK, V99, P623; HENSLER GL, 1981, WILSON BULL, V93, P42; International Wader Study Group, 2003, WADER STUDY GROUP B, V101/102, P8; JACKSON DB, 1994, IBIS, V136, P463, DOI 10.1111/j.1474-919X.1994.tb01123.x; JEHL JR, 1970, ECOLOGY, V52, P169; Johannesdottir L, 2014, BIRD STUDY, V61, P544, DOI 10.1080/00063657.2014.962481; JOHANSEN C A, 1981, Melanderia, V37, P20; JOHNSON DH, 1979, AUK, V96, P651; Jonsson JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067093; Jonsson Jon Einar, 2010, Wader Study Group Bulletin, V117, P145; Katrinardottir Borgny, 2013, Ringing & Migration, V28, P43, DOI 10.1080/03078698.2013.811160; KREBS J R, 1971, Ecology (Washington D C), V52, P2, DOI 10.2307/1934734; Liebezeit JR, 2007, CONDOR, V109, P32, DOI 10.1650/0010-5422(2007)109[32:ATDOSE]2.0.CO;2; Lopez-Sepulcre A, 2010, P ROY SOC B-BIOL SCI, V277, P3477, DOI 10.1098/rspb.2010.0819; MacDonald MA, 2008, IBIS, V150, P54, DOI 10.1111/j.1474-919X.2008.00869.x; Magnusson B, 2001, GROOURFRAMVINDA IUPI; Marske KA, 2007, ENVIRON ENTOMOL, V36, P817, DOI 10.1603/0046-225X(2007)36[817:EOVAOT]2.0.CO;2; MAYFIELD HAROLD, 1961, WILSON BULL, V73, P255; MAYFIELD HF, 1975, WILSON BULL, V87, P456; MCCAFFERY BJ, 1996, INT WADER STUD, V8, P28; Meltofte H, 2008, ADV ECOL RES, V40, P325, DOI 10.1016/S0065-2504(07)00014-1; Merritt DM, 2000, REGUL RIVER, V16, P543, DOI 10.1002/1099-1646(200011/12)16:6&lt;543::AID-RRR590&gt;3.0.CO;2-N; MILLER GR, 1978, J ANIM ECOL, V47, P293, DOI 10.2307/3937; NEWTON I, 1977, J ANIM ECOL, V46, P425, DOI 10.2307/3821; NILSSON C, 1994, REGUL RIVER, V9, P45, DOI 10.1002/rrr.3450090105; Overpeck J, 1997, SCIENCE, V278, P1251, DOI 10.1126/science.278.5341.1251; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; PAGE GW, 1983, AUK, V100, P13, DOI 10.1093/auk/100.1.13; Palsdottir K, 1992, BLIKI, V12, P55; Perkins A, 2014, DETERMINING THE CAUS; PULLIAINEN E, 1993, ORNIS FENNICA, V70, P110; REDMOND RL, 1986, OIKOS, V46, P330, DOI 10.2307/3565831; REDMOND RL, 1982, BEHAV ECOL SOCIOBIOL, V10, P277, DOI 10.1007/BF00302817; Schmidt KA, 1999, OIKOS, V87, P65, DOI 10.2307/3546997; SEASTEDT TR, 1979, AUK, V96, P131; SHANKS C H JR, 1981, Melanderia, V37, P63; SKEEL MA, 1983, CAN J ZOOL, V61, P218, DOI 10.1139/z83-027; Smart J, 2006, J APPL ECOL, V43, P454, DOI 10.1111/j.1365-2664.2006.01166.x; Sutherland WJ, 2012, IBIS, V154, P663, DOI 10.1111/j.1474-919X.2012.01261.x; SUTHERLAND WJ, 1996, FROM INDIVIDUAL BEHA; THOMPSON PS, 1989, IBIS, V131, P214, DOI 10.1111/j.1474-919X.1989.tb02764.x; Thorup O, 2006, BREEDING WADERS IN E, P60; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Williams JC, 2010, ARCT ANTARCT ALP RES, V42, P306, DOI 10.1657/1938-4246-42.3.306; [No title captured]	77	8	12	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131395	10.1371/journal.pone.0131395	http://dx.doi.org/10.1371/journal.pone.0131395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161860	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300037
J	Lioy, VS; Volante, A; Soberon, NE; Lurz, R; Ayora, S; Alonso, JC				Lioy, Virginia S.; Volante, Andrea; Soberon, Nora E.; Lurz, Rudi; Ayora, Silvia; Alonso, Juan C.			ParAB Partition Dynamics in Firmicutes: Nucleoid Bound ParA Captures and Tethers ParB-Plasmid Complexes	PLOS ONE			English	Article							BACTERIAL CHROMOSOME SEGREGATION; BACILLUS-SUBTILIS; DNA-SEGREGATION; F-PLASMID; P1 PARA; PSM19035; PROTEIN; ATP; MECHANISM; TRANSPORT	In Firmicutes, small homodimeric ParA-like (delta(2)) and ParB-like (omega(2)) proteins, in concert with cis-acting plasmid-borne parS and the host chromosome, secure stable plasmid inheritance in a growing bacterial population. This study shows that (omega:YFP)(2) binding to parSfacilitates plasmid clustering in the cytosol. (delta:GFP)(2) requires ATP binding but not hydrolysis to localize onto the cell's nucleoid as a fluorescent cloud. The interaction of (delta:CFP)(2) or delta(2) bound to the nucleoid with (omega:YFP)(2) foci facilitates plasmid capture, from a very broad distribution, towards the nucleoid and plasmid pairing. parS-bound omega(2) promotes redistribution of (delta:GFP)(2), leading to the dynamic release of (delta:GFP)(2) from the nucleoid, in a process favored by ATP hydrolysis and protein-protein interaction. (delta D60A:GFP)(2), which binds but cannot hydrolyze ATP, also forms unstable complexes on the nucleoid. In the presence of omega(2), (delta D60A:GFP)(2) accumulates foci or patched structures on the nucleoid. We propose that (delta:GFP)(2) binding to different nucleoid regions and to omega(2)-parS might generate (delta:GFP)(2) gradients that could direct plasmid movement. The iterative pairing and unpairing cycles may tether plasmids equidistantly on the nucleoid to ensure faithful plasmid segregation by a mechanism compatible with the diffusion-ratchet mechanism as proposed from in vitro reconstituted systems.	[Lioy, Virginia S.; Volante, Andrea; Soberon, Nora E.; Ayora, Silvia; Alonso, Juan C.] CSIC, CNB, Dept Microbial Biotechnol, E-28049 Madrid, Spain; [Lurz, Rudi] Max Planck Inst Mol Genet, D-1000 Berlin, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Max Planck Society	Alonso, JC (corresponding author), CSIC, CNB, Dept Microbial Biotechnol, Darwin Str 3, E-28049 Madrid, Spain.	jcalonso@cnb.csic.es	Ayora, Silvia/D-2552-2009; Lioy, Vicky/AAE-4039-2022; Alonso, Juan Carlos/D-2595-2009; Lioy, Vicky S./AAL-9782-2021	Ayora, Silvia/0000-0003-3121-1786; Lioy, Vicky/0000-0002-5366-0462; Alonso, Juan Carlos/0000-0002-5178-7179; Lioy, Vicky S./0000-0002-5366-0462; Volante, Andrea/0000-0002-3290-0148	Ministerio de Economia y Competitividad, Direccion General de Investigacion [BFU2012-39879-C02-01, BFU2012-39879-C02-02]; Comunidad de Madrid grant [S2009MAT-1507, BIO0260-2006]	Ministerio de Economia y Competitividad, Direccion General de Investigacion; Comunidad de Madrid grant(Comunidad de Madrid)	This work was supported in part by the Ministerio de Economia y Competitividad, Direccion General de Investigacion grants BFU2012-39879-C02-01 to J.C.A. and BFU2012-39879-C02-02 to S.A., and by the Comunidad de Madrid grant S2009MAT-1507 to J.C.A, and BIO0260-2006 to S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Seng Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003956; Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Cardenas PP, 2009, NUCLEIC ACIDS RES, V37, P4157, DOI 10.1093/nar/gkp314; Carrasco B, 2005, NUCLEIC ACIDS RES, V33, P3942, DOI 10.1093/nar/gki713; CEGLOWSKI P, 1993, MOL GEN GENET, V241, P579, DOI 10.1007/BF00279900; DAVEY MJ, 1994, J BIOL CHEM, V269, P29908; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; de la Hoz AB, 2004, NUCLEIC ACIDS RES, V32, P3136, DOI 10.1093/nar/gkh633; Dunham TD, 2009, EMBO J, V28, P1792, DOI 10.1038/emboj.2009.120; Ebersbach G, 2006, MOL MICROBIOL, V61, P1428, DOI 10.1111/j.1365-2958.2006.05322.x; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Graham TGW, 2014, GENE DEV, V28, P1228, DOI 10.1101/gad.242206.114; Hatano T, 2010, MOL MICROBIOL, V78, P1182, DOI 10.1111/j.1365-2958.2010.07398.x; Havey JC, 2012, NUCLEIC ACIDS RES, V40, P801, DOI 10.1093/nar/gkr747; Hwang LC, 2013, EMBO J, V32, P1238, DOI 10.1038/emboj.2013.34; Lemon KP, 2000, MOL CELL, V6, P1321, DOI 10.1016/S1097-2765(00)00130-1; Lim HC, 2014, ELIFE, V3, DOI 10.7554/eLife.02758; Lioy VS, 2010, PLASMID, V64, P1, DOI 10.1016/j.plasmid.2010.04.002; LYNCH AS, 1995, P NATL ACAD SCI USA, V92, P1896, DOI 10.1073/pnas.92.6.1896; Murayama K, 2001, J MOL BIOL, V314, P789, DOI 10.1006/jmbi.2001.5157; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Pratto F, 2007, ANAL SISTEMA PARTICI; Pratto F, 2008, NUCLEIC ACIDS RES, V36, P3676, DOI 10.1093/nar/gkn170; Pratto F, 2009, J BIOL CHEM, V284, P30298, DOI 10.1074/jbc.M109.035410; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Reyes-Lamothe R, 2012, ANNU REV GENET, V46, P121, DOI 10.1146/annurev-genet-110711-155421; Ringgaard S, 2009, P NATL ACAD SCI USA, V106, P19369, DOI 10.1073/pnas.0908347106; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Schofield WB, 2010, EMBO J, V29, P3068, DOI 10.1038/emboj.2010.207; Schumacher MA, 2005, NATURE, V438, P516, DOI 10.1038/nature04149; Schumacher MA, 2012, J BIOL CHEM, V287, P26146, DOI 10.1074/jbc.M112.373696; Sengupta M, 2010, J BACTERIOL, V192, P1175, DOI 10.1128/JB.01245-09; Soberon NE, 2011, NUCLEIC ACIDS RES, V39, P2624, DOI 10.1093/nar/gkq1245; Szardenings F, 2011, CURR OPIN MICROBIOL, V14, P712, DOI 10.1016/j.mib.2011.09.008; Vecchiarelli AG, 2014, P NATL ACAD SCI USA, V111, P4880, DOI 10.1073/pnas.1401025111; Vecchiarelli AG, 2013, P NATL ACAD SCI USA, V110, pE1390, DOI 10.1073/pnas.1302745110; Vecchiarelli AG, 2012, MOL MICROBIOL, V86, P513, DOI 10.1111/mmi.12017; Vecchiarelli AG, 2010, MOL MICROBIOL, V78, P78, DOI 10.1111/j.1365-2958.2010.07314.x; Wang JD, 2004, J BACTERIOL, V186, P7084, DOI 10.1128/JB.186.21.7084-7090.2004; Wang XD, 2013, NAT REV GENET, V14, P191, DOI 10.1038/nrg3375; Weihofen WA, 2006, NUCLEIC ACIDS RES, V34, P1450, DOI 10.1093/nar/gkl015; Welfle K, 2005, BIOL CHEM, V386, P881, DOI 10.1515/BC.2005.103	42	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131943	10.1371/journal.pone.0131943	http://dx.doi.org/10.1371/journal.pone.0131943			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161642	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300077
J	Liu, RC; Leung, RKK; Chen, TM; Zhang, XX; Chen, FM; Chen, SL; Zhao, J				Liu, Ruchun; Leung, Ross Ka-kit; Chen, Tianmu; Zhang, Xixing; Chen, Faming; Chen, Shuilian; Zhao, Jin			The Effectiveness of Age-Specific Isolation Policies on Epidemics of Influenza A (H1N1) in a Large City in Central South China	PLOS ONE			English	Article							PANDEMIC INFLUENZA; MODELS; TRANSMISSIBILITY; STRATEGIES; INSIGHTS; FUTURE	During the early stage of a pandemic, isolation is the most effective means of controlling transmission. However, the effectiveness of age-specific isolation policies is not clear; especially little information is available concerning their effectiveness in China. Epidemiological and serological survey data in the city of Changsha were employed to estimate key model parameters. The average infectious period (date of recovery - date of symptom onset) of influenza A (H1N1) was 5.2 days. Of all infected persons, 45.93% were asymptomatic. The basic reproduction number of the influenza A (H1N1) pandemic was 1.82. Based on the natural history of influenza A (H1N1), we built an extended susceptible-exposed-infectious/asymptomatic-removed model, taking age groups: 0-5, 6-14, 15-24, 25-59, and >= 60 years into consideration for isolation. Without interventions, the total attack rates (TARs) in each age group were 42.73%, 41.95%, 20.51%, 45.03%, and 37.49%, respectively. Although the isolation of 25-59 years-old persons was the most effective, the TAR of individuals of aged 0-5 and 6-14 could not be reduced. Paradoxically, isolating individuals >= 60 year olds was not predicted to be an effective way of reducing the TAR in this group but isolating the age-group 25-59 did, which implies inter-age-group transmission from the latter to the former is significant. Isolating multiple age groups increased effectiveness. The most effective combined isolation target groups were of 6-14 + 25-59 year olds, 6-14 + 15-24 + 25-59 year olds, and 0-5 + 6-14 + 25-59 + >= 60 year olds. The last of these isolation schemas reduced the TAR of the total population from 39.64% to 0.006%, which was exceptionally close to the effectiveness of isolating all five age groups (TAR = 0.004%).	[Liu, Ruchun; Leung, Ross Ka-kit; Chen, Tianmu; Zhang, Xixing; Chen, Faming; Chen, Shuilian; Zhao, Jin] Changsha Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, Changsha, Hunan, Peoples R China; [Leung, Ross Ka-kit] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Chen, TM (corresponding author), Changsha Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, Changsha, Hunan, Peoples R China.	13698665@qq.com			Scientific Research Program of Health Department of Hunan Province [B2012-138]; Scientific Research Program of Changsha Science and Technology Bureau [K1205028-31]	Scientific Research Program of Health Department of Hunan Province; Scientific Research Program of Changsha Science and Technology Bureau	This work was partially supported by the Scientific Research Program of Health Department of Hunan Province (B2012-138, url: http://www.21hospital.com/) and by the Scientific Research Program of Changsha Science and Technology Bureau (K1205028-31, url: http://www.cssti.cn/html/cskjw/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arino J, 2006, J R SOC INTERFACE, V3, P453, DOI 10.1098/rsif.2006.0112; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Chen SC, 2008, EPIDEMIOL INFECT, V136, P1035, DOI 10.1017/S0950268807009284; Chen TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095006; CHEN TM, 2011, ZHONGHUA LIU XING BI, V32, P723; Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30; Cruz-Pacheco G, 2009, EUROSURVEILLANCE, V14, P1; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Lee VJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-76; Liu DongHui, 2010, Chinese Preventive Medicine, V11, P109; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mikolajczyk R, 2009, DTSCH ARZTEBL INT, V106, P777, DOI 10.3238/arztebl.2009.0777; National Health and Family Planning Commission of the People's Republic of China, 2011, DIAGN TREATM GUID IN; National Health and Family Planning Commission of the People's Republic of China, 2010, INFL SURV PROGR CHIN; National Health and Family Planning Commission of the People's Republic of China, 2009, DIAGN TREATM PROGR I; National Health and Family Planning Commission of the People's Republic of China, 2012, GUID DISP INFL LIK I; Russell CJ, 2005, CELL, V123, P368, DOI 10.1016/j.cell.2005.10.019; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tracht SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009018; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; WHO, 2009, SIT UPD PAND H1N1 20; WHO, PAND H1N1 2009 UPD 1; Wu JT, 2011, EXP BIOL MED, V236, P955, DOI 10.1258/ebm.2010.010271; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zhang SG, 2010, INFLUENZA OTHER RESP, V4, P27, DOI 10.1111/j.1750-2659.2009.00117.x	27	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132588	10.1371/journal.pone.0132588	http://dx.doi.org/10.1371/journal.pone.0132588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161740	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300156
J	Khajeh-Alijani, A; Urbanczik, R; Senn, W				Khajeh-Alijani, Azadeh; Urbanczik, Robert; Senn, Walter			Scale-Free Navigational Planning by Neuronal Traveling Waves	PLOS ONE			English	Article							WEAKLY COUPLED OSCILLATORS; THETA-OSCILLATIONS; SPATIAL NAVIGATION; DYNAMICS; SYSTEM; HIPPOCAMPUS; DISCHARGES; SYNCHRONY; SEQUENCES; BEHAVIOR	Spatial navigation and planning is assumed to involve a cognitive map for evaluating trajectories towards a goal. How such a map is realized in neuronal terms, however, remains elusive. Here we describe a simple and noise-robust neuronal implementation of a path finding algorithm in complex environments. We consider a neuronal map of the environment that supports a traveling wave spreading out from the goal location opposite to direction of the physical movement. At each position of the map, the smallest firing phase between adjacent neurons indicate the shortest direction towards the goal. In contrast to diffusion or single-wave-fronts, local phase differences build up in time at arbitrary distances from the goal, providing a minimal and robust directional information throughout the map. The time needed to reach the steady state represents an estimate of an agent's waiting time before it heads off to the goal. Given typical waiting times we estimate the minimal number of neurons involved in the cognitive map. In the context of the planning model, forward and backward spread of neuronal activity, oscillatory waves, and phase precession get a functional interpretation, allowing for speculations about the biological counterpart.	[Khajeh-Alijani, Azadeh; Urbanczik, Robert; Senn, Walter] Univ Bern, Dept Physiol, CH-3012 Bern, Switzerland	University of Bern	Senn, W (corresponding author), Univ Bern, Dept Physiol, Buhlpl 5, CH-3012 Bern, Switzerland.	senn@pyl.unibe.ch	Senn, Walter/D-6308-2014	Senn, Walter/0000-0003-3622-0497	Swiss National Science Foundation [31003A_133094]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a personal grant of the Swiss National Science Foundation (for WS, grant no 31003A_133094).	Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bressloff PC, 1999, PHYSICA D, V130, P232, DOI 10.1016/S0167-2789(99)00013-5; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Clopath Claudia, 2010, Front Synaptic Neurosci, V2, P25, DOI 10.3389/fnsyn.2010.00025; Dehaene S, 1997, P NATL ACAD SCI USA, V94, P13293, DOI 10.1073/pnas.94.24.13293; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; ERMENTROUT GB, 1984, SIAM J MATH ANAL, V15, P215, DOI 10.1137/0515019; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Ermentrout GB, 1997, J COMPUT NEUROSCI, V5, P191, DOI [10.1023/A:1008822117809, DOI 10.1023/A:1008822117809]; Gaussier P, 2002, BIOL CYBERN, V86, P15, DOI 10.1007/s004220100269; Glasius R, 1996, BIOL CYBERN, V74, P511, DOI 10.1007/BF00209422; Goel P, 2002, PHYSICA D, V163, P191, DOI 10.1016/S0167-2789(01)00374-8; Golomb D, 1997, J NEUROPHYSIOL, V78, P1199, DOI 10.1152/jn.1997.78.3.1199; Gorchetchnikov A, 2005, CONNECT SCI, V17, P145, DOI 10.1080/09540090500140925; GRANON S, 1995, BEHAV NEUROSCI, V109, P474, DOI 10.1037/0735-7044.109.3.474; HANSEL D, 1995, NEURAL COMPUT, V7, P307, DOI 10.1162/neco.1995.7.2.307; Hasselmo ME, 2005, J COGNITIVE NEUROSCI, V17, P1115, DOI 10.1162/0898929054475190; Hebb DO, 1946, J GEN PSYCHOL, V34, P59, DOI 10.1080/00221309.1946.10544520; Hirel J, 2013, NEURAL NETWORKS, V43, P8, DOI 10.1016/j.neunet.2013.01.023; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; KOPELL N, 1986, COMMUN PUR APPL MATH, V39, P623, DOI 10.1002/cpa.3160390504; Kubie J L, 1991, Hippocampus, V1, P240, DOI 10.1002/hipo.450010305; LaValle S.M., 2006, PLANNING ALGORITHMS, P1007; Lewis TJ, 2003, J COMPUT NEUROSCI, V14, P283, DOI 10.1023/A:1023265027714; Martinet LE, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002045; NAKAYAMA K, 1986, NATURE, V320, P264, DOI 10.1038/320264a0; Nikolic D, 2013, TRENDS COGN SCI, V17, P54, DOI 10.1016/j.tics.2012.12.003; O'Keefe J, 1978, THE HIPPOCAMPUS AS A; Ponulak F, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00098; Poucet B, 2004, REV NEUROSCIENCE, V15, P89; Rauch A, 2003, J NEUROPHYSIOL, V90, P1598, DOI 10.1152/jn.00293.2003; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Rhodes BJ, 2004, HUM MOVEMENT SCI, V23, P699, DOI 10.1016/j.humov.2004.10.008; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; SOMPOLINSKY H, 1991, PHYS REV A, V43, P6990, DOI 10.1103/PhysRevA.43.6990; Spiers HJ, 2007, HIPPOCAMPUS, V17, P618, DOI 10.1002/hipo.20298; Toussaint M, 2006, NEURAL COMPUT, V18, P1132, DOI 10.1162/neco.2006.18.5.1132; TRAUB RD, 1993, J PHYSIOL-LONDON, V472, P267, DOI 10.1113/jphysiol.1993.sp019946; Viard A, 2011, J NEUROSCI, V31, P4613, DOI 10.1523/JNEUROSCI.4640-10.2011	41	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0127269	10.1371/journal.pone.0127269	http://dx.doi.org/10.1371/journal.pone.0127269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EW	26158660	Green Published, Green Submitted, gold			2022-12-27	WOS:000358161200004
J	Tiwari, V; Chaturvedi, AK; Mishra, A; Jha, B				Tiwari, Vivekanand; Chaturvedi, Amit Kumar; Mishra, Avinash; Jha, Bhavanath			Introgression of the SbASR-1 Gene Cloned from a Halophyte Salicornia braciata Enhances Salinity and Drought Endurance in Transgenic Groundnut (Arachis hypogaea) and Acts as a Transcription Factor	PLOS ONE			English	Article							GAMMA-KAFIRIN PROMOTER; HMW GLUTENIN GENE(S); EXTREME HALOPHYTE; STRESS TOLERANCE; SALT TOLERANCE; GRAPE ASR; HETEROLOGOUS EXPRESSION; PLANT-REGENERATION; OVER-EXPRESSION; DNA-BINDING	The SbASR-1 gene, cloned from a halophyte Salicornia brachiata, encodes a plant-specific hydrophilic and stress responsive protein. The genome of S. brachiata has two paralogs of the SbASR-1 gene (2549 bp), which is comprised of a single intron of 1611 bp, the largest intron of the abscisic acid stress ripening [ASR] gene family yet reported. In silico analysis of the 843-bp putative promoter revealed the presence of ABA, biotic stress, dehydration, phytohormone, salinity, and sugar responsive cis-regulatory motifs. The SbASR-1 protein belongs to Group 7 LEA protein family with different amino acid composition compared to their glycophytic homologs. Bipartite Nuclear Localization Signal (NLS) was found on the C-terminal end of protein and localization study confirmed that SbASR-1 is a nuclear protein. Furthermore, transgenic groundnut (Arachis hypogaea) plants over-expressing the SbASR-1 gene constitutively showed enhanced salinity and drought stress tolerance in the T1 generation. Leaves of transgenic lines exhibited higher chlorophyll and relative water contents and lower electrolyte leakage, malondialdehyde content, proline, sugars, and starch accumulation under stress treatments than wild-type (Wt) plants. Also, lower accumulation of H2O2 and O-2(.-) radicals was detected in transgenic lines compared to Wt plants under stress conditions. Transcript expression of APX (ascorbate peroxidase) and CAT (catalase) genes were higher in Wt plants, whereas the SOD (superoxide dismutase) transcripts were higher in transgenic lines under stress. Electrophoretic mobility shift assay (EMSA) confirmed that the SbASR-1 protein binds at the consensus sequence (C/G/A)(G/T) CC(C/G)(C/G/A)(A/T). Based on results of the present study, it may be concluded that SbASR-1 enhances the salinity and drought stress tolerance in transgenic groundnut by functioning as a LEA (late embryogenesis abundant) protein and a transcription factor.	[Tiwari, Vivekanand; Chaturvedi, Amit Kumar; Mishra, Avinash; Jha, Bhavanath] CSIR Cent Salt & Marine Chem Res Inst, Marine Biotechnol & Ecol Div, Bhavnagar, Gujarat, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI)	Mishra, A (corresponding author), CSIR Cent Salt & Marine Chem Res Inst, Marine Biotechnol & Ecol Div, Bhavnagar, Gujarat, India.	avinash@csmcri.org; bjha@csmcri.org	Mishra, Avinash/AAG-2961-2019; TIWARI, VIVEKANAND/AAD-9738-2020; Mishra, Avinash/C-3210-2009; Chaturvedi, Amit k/J-5187-2012	Mishra, Avinash/0000-0003-0342-010X; TIWARI, VIVEKANAND/0000-0002-0464-6031; Mishra, Avinash/0000-0003-0342-010X; 	Council of Scientific and Industrial Research (CSIR)Government of India, New Delhi [BSC0109-SIMPLE, BSC0117-PMSI]	Council of Scientific and Industrial Research (CSIR)Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by the Council of Scientific and Industrial Research (CSIR, www.csir.res.in), Government of India, New Delhi (BSC0109-SIMPLE; BSC0117-PMSI, Senior Research Fellowship to AKC and VT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambede Jane Gayalwa, 2012, Braz. J. Plant Physiol., V24, P151, DOI 10.1590/S1677-04202012000300002; Arenhart RA, 2014, MOL PLANT, V7, P709, DOI 10.1093/mp/sst160; Banjara M, 2012, PLANT BIOTECHNOL REP, V6, P59, DOI 10.1007/s11816-011-0200-5; Bansal S, 2008, J CEREAL SCI, V48, P808, DOI 10.1016/j.jcs.2008.06.004; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Cakir B, 2003, PLANT CELL, V15, P2165, DOI 10.1105/tpc.013854; CHAMOVITZ D, 1993, J BIOL CHEM, V268, P17348; Chaturvedi AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111379; Chaturvedi AK, 2012, GENE, V499, P280, DOI 10.1016/j.gene.2012.03.001; Dai JR, 2011, PLANT CELL REP, V30, P1219, DOI 10.1007/s00299-011-1030-1; de Jonge H R, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.63.pe1; Demidchik V, 2014, J EXP BOT, V65, P1259, DOI 10.1093/jxb/eru004; Dita MA, 2006, EUPHYTICA, V147, P1, DOI 10.1007/s10681-006-6156-9; FAOSTAT, 2014, FAO STAT DIV; Flowers TJ, 2015, ANN BOT-LONDON, V115, P419, DOI 10.1093/aob/mcu217; Frankel N, 2006, GENE, V378, P74, DOI 10.1016/j.gene.2006.05.010; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Goldgur Y, 2007, PLANT PHYSIOL, V143, P617, DOI 10.1104/pp.106.092965; Gonzalez RM, 2014, PLANTA, V239, P941, DOI 10.1007/s00425-014-2039-9; Dominguez PG, 2013, PLANT PHYSIOL, V161, P1486, DOI 10.1104/pp.112.208199; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Henry IM, 2011, PLANTA, V234, P785, DOI 10.1007/s00425-011-1421-0; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hu W, 2013, PLANT CELL ENVIRON, V36, P1449, DOI 10.1111/pce.12074; Hu YX, 2014, GENE, V549, P243, DOI 10.1016/j.gene.2014.07.071; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Ishitani M, 2000, PLANT CELL, V12, P1667, DOI 10.1105/tpc.12.9.1667; IUSEM ND, 1993, PLANT PHYSIOL, V102, P1353, DOI 10.1104/pp.102.4.1353; Jha B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071136; Jha B, 2012, MAR BIOTECHNOL, V14, P782, DOI 10.1007/s10126-012-9442-7; Jha B, 2012, J AGR FOOD CHEM, V60, P4320, DOI 10.1021/jf203632v; Jha B, 2011, MOL BIOL REP, V38, P4823, DOI 10.1007/s11033-010-0625-x; Joseph Deepu, 2013, J FOOD NUTR RES, V1, P97, DOI [10.12691/jfnr-1-5-4, DOI 10.12691/JFNR-1-5-4]; Joshi M, 2012, IND CROP PROD, V35, P313, DOI 10.1016/j.indcrop.2011.06.024; Joshi M, 2011, IND CROP PROD, V33, P67, DOI 10.1016/j.indcrop.2010.09.002; Kalifa Y, 2004, PLANT CELL ENVIRON, V27, P1459, DOI 10.1111/j.1365-3040.2004.01251.x; Kalifa Y, 2004, BIOCHEM J, V381, P373, DOI 10.1042/BJ20031800; Kim IS, 2012, MOL CELLS, V33, P285, DOI 10.1007/s10059-012-2253-x; Konrad Z, 2008, PLANTA, V227, P1213, DOI 10.1007/s00425-008-0693-5; Kosova K, 2013, FUNCT PLANT BIOL, V40, P775, DOI 10.1071/FP12375; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Kumari A, 2012, BIOINFORMATION, V8, P1211, DOI 10.6026/97320630081211; Li RH, 2013, BIOSCI BIOTECH BIOCH, V77, P475, DOI 10.1271/bbb.120666; Liu JH, 2013, PLANTA, V237, P1025, DOI 10.1007/s00425-012-1820-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manjulatha M, 2014, MOL BIOTECHNOL, V56, P111, DOI 10.1007/s12033-013-9687-z; Mishra Avinash, 2008, Acta Biologica Szegediensis, V52, P277; Mishra A, 2008, MOL BIOL REP, V35, P81, DOI 10.1007/s11033-007-9056-8; Mishra A, 2015, J FUNCT FOODS, V13, P21, DOI 10.1016/j.jff.2014.12.027; Mishra A, 2013, CARBOHYD POLYM, V92, P1942, DOI 10.1016/j.carbpol.2012.11.055; Mishra Avinash, 2009, Acta Biologica Szegediensis, V53, P9; Moore K, 1998, FREE RADICAL RES, V28, P659, DOI 10.3109/10715769809065821; Ozgur R, 2013, FUNCT PLANT BIOL, V40, P832, DOI 10.1071/FP12389; Pandey MK, 2012, BIOTECHNOL ADV, V30, P639, DOI 10.1016/j.biotechadv.2011.11.001; Pandey R, 2008, MOL BIOL REP, V35, P153, DOI 10.1007/s11033-007-9065-7; Pandey S, 2013, APPL BIOCHEM BIOTECH, V171, P1, DOI 10.1007/s12010-013-0349-1; Patil M, 2014, PLANT BIOTECHNOL REP, V8, P161, DOI 10.1007/s11816-013-0305-0; Philippe R, 2010, THEOR APPL GENET, V121, P769, DOI 10.1007/s00122-010-1348-z; Qin H, 2013, PLANT BIOTECHNOL REP, V7, P345, DOI 10.1007/s11816-012-0269-5; Qin H, 2011, PLANT CELL PHYSIOL, V52, P1904, DOI 10.1093/pcp/pcr125; Ramel F, 2012, PLANT PHYSIOL, V158, P1267, DOI 10.1104/pp.111.182394; Ricardi MM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-29; Rom S, 2006, BIOCHIMIE, V88, P621, DOI 10.1016/j.biochi.2005.11.008; Saumonneau A, 2008, FEBS LETT, V582, P3281, DOI 10.1016/j.febslet.2008.09.015; Saumonneau A, 2012, J EXP BOT, V63, P1495, DOI 10.1093/jxb/err391; Sharma K. K., 2002, JIRCAS Working Report, P61; Singh N, 2014, GENE, V547, P119, DOI 10.1016/j.gene.2014.06.037; Singh N, 2014, MAR BIOTECHNOL, V16, P321, DOI 10.1007/s10126-013-9548-6; Singh N, 2010, PLANT CELL TISS ORG, V103, P1, DOI 10.1007/s11240-010-9746-0; Tiwari V, 2015, APPL BIOCHEM BIOTECH, V175, P436, DOI 10.1007/s12010-014-1286-3; Tiwari V, 2014, PLANT CELL PHYSIOL, V55, P201, DOI 10.1093/pcp/pct172; Udawat P, 2014, GENE, V536, P163, DOI 10.1016/j.gene.2013.11.020; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Virlouvet L, 2011, PLANT PHYSIOL, V157, P917, DOI 10.1104/pp.111.176818; Yang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071214; Yem EW, 1954, BIOCHEM J, V57, P769	80	29	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131567	10.1371/journal.pone.0131567	http://dx.doi.org/10.1371/journal.pone.0131567			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158616	Green Submitted, Green Published, gold			2022-12-27	WOS:000358161200031
J	Maher, M; Churchill, NW; Manoel, ALD; Graham, SJ; Macdonald, RL; Schweizer, TA				Maher, Monica; Churchill, Nathan W.; Manoel, Airton Leonardo de Oliveira; Graham, Simon J.; Macdonald, R. Loch; Schweizer, Tom A.			Altered Resting-State Connectivity within Executive Networks after Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							QUALITY-OF-LIFE; SORTING TEST-PERFORMANCE; VERBAL FLUENCY; COGNITIVE DYSFUNCTION; DEPRESSION; STROKE; IMPAIRMENT; VALIDITY; DISEASE; LESIONS	Aneurysmal subarachnoid hemorrhage (aSAH) is associated with significant mortality rates, and most survivors experience significant cognitive deficits across multiple domains, including executive function. It is critical to determine the neural basis for executive deficits in aSAH, in order to better understand and improve patient outcomes. This study is the first examination of resting-state functional Magnetic Resonance Imaging in a group of aSAH patients, used to characterize changes in functional connectivity of the frontoparietal network. We scanned 14 aSAH patients and 14 healthy controls, and divided patients into "impaired" and "unimpaired" groups based on a composite executive function score. Impaired patients exhibited significantly lower quality of life and neuropsychological impairment relative to controls, across multiple domains. Seed-based functional connectivity analysis demonstrated that unimpaired patients were not significantly different from controls, but impaired patients had increased frontoparietal connectivity. Patients evidenced increased frontoparietal connectivity as a function of decreased executive function and decreased mood (i.e. quality of life). In addition, T1 morphometric analysis demonstrated that these changes are not attributable to local cortical atrophy among aSAH patients. These results establish significant, reliable changes in the endogenous brain dynamics of aSAH patients, that are related to cognitive and mood outcomes.	[Maher, Monica] Univ Toronto, Fac Med, Toronto, ON, Canada; [Churchill, Nathan W.; Manoel, Airton Leonardo de Oliveira] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Li Ka Shing Knowledge Inst, Neurosci Res Program, Toronto, ON M5B 1W8, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Graham, Simon J.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Macdonald, R. Loch; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Macdonald, R. Loch; Schweizer, Tom A.] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Macdonald, R. Loch; Schweizer, Tom A.] Univ Toronto, Dept Neurosurg, Div Neurosurg, Toronto, ON, Canada	University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Schweizer, TA (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	SchweizerT@smh.ca	de Oliveira Manoel, Airton Leonardo/C-4724-2018	de Oliveira Manoel, Airton Leonardo/0000-0002-9593-1013	Heart and Stroke Foundation of Canada [G-13-0002824]; Heart and Stroke Foundation of Ontario; Ontario Ministry of Research and Innovation; Brain Aneurysm Foundation; Canadian Institutes for Health Research; Heart and Stroke Foundation of Canada; Edge Therapeutics, Inc.	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Brain Aneurysm Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Edge Therapeutics, Inc.	This work was supported by a Personnel Award from the Heart and Stroke Foundation of Canada, Operating Award from the Heart and Stroke Foundation of Ontario and an Early Researcher Award from the Ontario Ministry of Research and Innovation to TAS. It was also supported in part by grant G-13-0002824 awarded from the Heart and Stroke Foundation of Canada to SJG. RLM receives grant support from the Physicians Services Incorporated Foundation, Brain Aneurysm Foundation, Canadian Institutes for Health Research, and the Heart and Stroke Foundation of Canada. Edge Therapeutics, Inc. supplied support in the form of salary to R. Loch Macdonald, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Armitage SG, 1946, PSYCHOL MONOGR, V60, P1; Barch D., 2013, AM J GERIATRIC PSYCH, V20, P682; Baune BT, 2014, PSYCHIAT RES, V219, P25, DOI 10.1016/j.psychres.2014.05.013; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Brodtmann A. P. H. L. Q. L. R. O. L. C. T., 2012, J NEUROLOGICAL SCI, V322; Cannon R., 2014, CLIN EEG NEUROSCI, V45, P1; Chung C. P. A., 2012, HEALTH; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Davidson PSR, 2008, J CLIN EXP NEUROPSYC, V30, P18, DOI 10.1080/13803390601161166; Dean PJ S, 2009, BRAIN BEHAV, V5; Delnooz CCS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062877; Di Pellegrino G. C. E. L. E., 2007, J COGNITIVE NEUROSCI, V19; Dobkin RD, 2007, MOVEMENT DISORD, V22, P946, DOI 10.1002/mds.21455; Doolittle ND, 2013, NEUROLOGY, V81, P84, DOI 10.1212/WNL.0b013e318297eeba; Dumas R, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-87; Egge A, 2005, ACTA NEUROL SCAND, V112, P76, DOI 10.1111/j.1600-0404.2005.00449.x; Ellmore TM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00179; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Frontera J., 2013, J NEUROLOGY, P2014; Hackett ML, 2000, NEUROLOGY, V55, P658, DOI 10.1212/WNL.55.5.658; Hadeishi H, 2002, NEUROSURGERY, V50, P741, DOI 10.1097/00006123-200204000-00010; He Y. E. A., 2010, CURRENT OPINION NEUR, V23; Hillis AE, 2000, J NEUROL NEUROSUR PS, V69, P608, DOI 10.1136/jnnp.69.5.608; Hollender KD, 2014, J NEUROSCI NURS, V46, P135, DOI 10.1097/JNN.0000000000000047; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Kraemer M. S. T. H. G. Q. B. W. O. S. R., 2004, J NEUROIMAGING, V14; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Mikell CB, 2015, STROKE, V46, P49, DOI 10.1161/STROKEAHA.114.007645; ODONNELL WE, 1993, J CLIN PSYCHOL, V49, P372, DOI 10.1002/1097-4679(199305)49:3<372::AID-JCLP2270490311>3.0.CO;2-K; Ovadia-Caro S, 2014, STROKE, V45, P2818, DOI 10.1161/STROKEAHA.114.003689; Possin KL, 2014, J INT NEUROPSYCH SOC, V20, P20, DOI 10.1017/S1355617713000611; Pugh KG, 2003, J AM GERIATR SOC, V51, P1439, DOI 10.1046/j.1532-5415.2003.51463.x; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Sato K, 2010, J CEREBR BLOOD F MET, V30, P1110, DOI 10.1038/jcbfm.2009.264; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Smith AB, 2004, HUM BRAIN MAPP, V21, P247, DOI 10.1002/hbm.20007; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stebbins G. N. D. W. C. C. J. F. S. B. K. e. a., 2008, STROKE, V39; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Thiel A, 2015, STROKE, V46, P296, DOI 10.1161/STROKEAHA.114.006307; TIDSWELL P, 1995, NEUROLOGY, V45, P875; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Weschler D, 1997, WESCHLER ADULT INTEL; Williams LS, 1999, STROKE, V30, P1362, DOI 10.1161/01.STR.30.7.1362	52	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0130483	10.1371/journal.pone.0130483	http://dx.doi.org/10.1371/journal.pone.0130483			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172281	Green Submitted, Green Published, gold			2022-12-27	WOS:000358194900007
J	Nishimura, Y; Takahashi, K; Mase, A; Kotani, M; Ami, K; Maeda, M; Shirahama, T; Lee, S; Matsuzaki, H; Kumagai-Takei, N; Yoshitome, K; Otsuki, T				Nishimura, Yasumitsu; Takahashi, Kazuaki; Mase, Akinori; Kotani, Muneo; Ami, Kazuhisa; Maeda, Megumi; Shirahama, Takashi; Lee, Suni; Matsuzaki, Hidenori; Kumagai-Takei, Naoko; Yoshitome, Kei; Otsuki, Takemi			Enhancement of NK Cell Cytotoxicity Induced by Long-Term Living in Negatively Charged-Particle Dominant Indoor Air-Conditions	PLOS ONE			English	Article							NATURAL-KILLER ACTIVITY; EGF RECEPTOR; EXPRESSION; CANCER; FOREST	Investigation of house conditions that promote health revealed that negatively charged-particle dominant indoor air-conditions (NCPDIAC) induced immune stimulation. Negatively charged air-conditions were established using a fine charcoal powder on walls and ceilings and utilizing forced negatively charged particles (approximate diameter: 20 nm) dominant in indoor air-conditions created by applying an electric voltage (72 V) between the backside of the walls and the ground. We reported previously that these conditions induced a slight and significant increase of interleukin-2 during a 2.5-h stay and an increase of NK cell cytotoxicity when examining human subjects after a two-week night stay under these conditions. In the present study, seven healthy volunteers had a device installed to create NCPDIAC in the living or sleeping rooms of their own homes. Every three months the volunteers then turned the NCPDIAC device on or off. A total of 16 ON and 13 OFF trials were conducted and their biological effects were analyzed. NK activity increased during ON trials and decreased during OFF trials, although no other adverse effects were found. In addition, there were slight increases of epidermal growth factor (EGF) during ON trials. Furthermore, a comparison of the cytokine status between ON and OFF trials showed that basic immune status was stimulated slightly during ON trials under NCPIADC. Our overall findings indicate that the NCPDIAC device caused activation of NK activity and stimulated immune status, particularly only on NK activity, and therefore could be set in the home or office buildings.	[Nishimura, Yasumitsu; Lee, Suni; Matsuzaki, Hidenori; Kumagai-Takei, Naoko; Yoshitome, Kei; Otsuki, Takemi] Kawasaki Med Sch, Dept Hyg, Kurashiki, Okayama 7010192, Japan; [Takahashi, Kazuaki; Mase, Akinori; Kotani, Muneo; Ami, Kazuhisa] SEKISUI HOUSE Ltd, Comprehens Housing R&D Inst, Kyoto 6190224, Japan; [Kotani, Muneo] Sumitomo Riko Co Ltd, Komaki, Aichi 4858550, Japan; [Ami, Kazuhisa] Yamada SXL Home Co Ltd, Kita Ku, Osaka 5300043, Japan; [Maeda, Megumi] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biofunct Chem, Div Biosci, Okayama 7000082, Japan; [Shirahama, Takashi] Artech Kohboh Co Ltd, Nagasaki 8593922, Japan	Kawasaki Medical School; Okayama University	Otsuki, T (corresponding author), Kawasaki Med Sch, Dept Hyg, 577 Mastushima, Kurashiki, Okayama 7010192, Japan.	takemi@med.kawasaki-m.ac.jp	Nishimura, Yasumitsu/AAI-1790-2021		KAKENHI grant from The Ministry of Education, Culture, Sports, Science and Technology, Japan [21659161]; Kawasaki Medical School Project [23B14, 24B9, 25B3, 26B6]	KAKENHI grant from The Ministry of Education, Culture, Sports, Science and Technology, Japan; Kawasaki Medical School Project	This study was supported by KAKENHI grant (21659161) from The Ministry of Education, Culture, Sports, Science and Technology, Japan, and Kawasaki Medical School Project Grants (23B14, 24B9, 25B3 and 26B6). Takashi Shirahama is employed by Artech Kohboh Ltd. Kazuhisa Ami is employed by Yamada SXL Home Co. Ltd., and SEKISUI HOUSE, Ltd. Kazuaki Takahashi is employed by SEKISUI HOUSE, Ltd., and Muneo Kotani is employed by SEKISUI HOUSE, Ltd. and Sumitomo Riko Co. Ltd. These companies provided support in the form of salaries for these authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALLEN G, 1984, INT J COSMETIC SCI, V6, P61, DOI 10.1111/j.1467-2494.1984.tb00360.x; [Anonymous], 2010, CHEMILESS NECESSITY; BENSCHOP RJ, 1993, LIFE SCI, V52, P1825, DOI 10.1016/0024-3205(93)90002-K; Bornschein S, 2001, J INTERN MED, V250, P309, DOI 10.1046/j.1365-2796.2001.00870.x; Burk T, 2013, J ENVIRON HEALTH, V75, P36; BURRELL R, 1991, ENVIRON HEALTH PERSP, V95, P29, DOI 10.2307/3431102; GIRDLER NM, 1995, AM J CLIN ONCOL-CANC, V18, P403, DOI 10.1097/00000421-199510000-00009; Hardwicke J, 2008, SURG-J R COLL SURG E, V6, P172, DOI 10.1016/S1479-666X(08)80114-X; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Hirose Y, 2006, J NUTR, V136, P3069, DOI 10.1093/jn/136.12.3069; HODGSON M, 1995, OCCUP MED, V10, P167; HODGSON MJ, 1989, OCCUP MED, V4, P593; Hojo S, 2003, TOXICOL IND HEALTH, V19, P41, DOI 10.1191/0748233703th180oa; Husman T, 1996, SCAND J WORK ENV HEA, V22, P5, DOI 10.5271/sjweh.103; Johnston JB, 2006, CURR MED CHEM, V13, P3483, DOI 10.2174/092986706779026174; Kasza A, 2013, CYTOKINE, V62, P22, DOI 10.1016/j.cyto.2013.02.007; Kawada S, 2010, J STRENGTH COND RES, V24, P846, DOI 10.1519/JSC.0b013e3181c7c299; Li Q, 2008, J BIOL REG HOMEOS AG, V22, P45; Li Q, 2008, INT J IMMUNOPATH PH, V21, P117, DOI 10.1177/039463200802100113; Luttrell LM, 2002, CAN J PHYSIOL PHARM, V80, P375, DOI 10.1139/Y02-045; Mitchell CS, 2007, ENVIRON HEALTH PERSP, V115, P958, DOI 10.1289/ehp.8987; Mori Chisato, 2009, Environmental Health and Preventive Medicine, V14, P1, DOI 10.1007/s12199-008-0051-z; Nishimura Y, 2013, ENVIRON HEALTH PREV, V18, P198, DOI 10.1007/s12199-013-0333-y; NORBACK D, 1990, BRIT J IND MED, V47, P733; Nordin S, 2010, INT ARCH OCC ENV HEA, V83, P95, DOI 10.1007/s00420-009-0427-4; Roy M, 2013, J SURG RES, V185, P6, DOI 10.1016/j.jss.2013.06.046; STAMPFER MR, 1993, CANCER SURV, V18, P7; Sunesson AL, 2006, INDOOR AIR, V16, P383, DOI 10.1111/j.1600-0668.2006.00450.x; Takahashi, 1997, Int J Occup Environ Health, V3, P111; Takahashi K, 2009, INT J IMMUNOPATH PH, V22, P333, DOI 10.1177/039463200902200210; Takahashi K, 2008, ENVIRON INT, V34, P765, DOI 10.1016/j.envint.2008.01.003; Takeuchi K, 2010, FEBS J, V277, P316, DOI 10.1111/j.1742-4658.2009.07450.x; Tiaka Elisavet K, 2012, Perspect Vasc Surg Endovasc Ther, V24, P37, DOI 10.1177/1531003512442093; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010; Xian CJ, 2004, FRONT BIOSCI-LANDMRK, V9, P85, DOI 10.2741/1210	36	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132373	10.1371/journal.pone.0132373	http://dx.doi.org/10.1371/journal.pone.0132373			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173062	Green Submitted, gold, Green Published			2022-12-27	WOS:000358194900046
J	Steketee, RME; Mutsaerts, HJMM; Bron, EE; van Osch, MJP; Majoie, CBLM; van der Lugt, A; Nederveen, AJ; Smits, M				Steketee, Rebecca M. E.; Mutsaerts, Henri J. M. M.; Bron, Esther E.; van Osch, Matthias J. P.; Majoie, Charles B. L. M.; van der Lugt, Aad; Nederveen, Aart J.; Smits, Marion			Quantitative Functional Arterial Spin Labeling (fASL) MRI - Sensitivity and Reproducibility of Regional CBF Changes Using Pseudo-Continuous ASL Product Sequences	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; PERFUSION MRI; MOTOR ACTIVATION; WHOLE-BRAIN; BOLD; TIME; RELIABILITY; PRECISION; LOCALIZATION; EFFICIENCY	Arterial spin labeling (ASL) magnetic resonance imaging is increasingly used to quantify task-related brain activation. This study assessed functional ASL (fASL) using pseudo-continuous ASL (pCASL) product sequences from two vendors. By scanning healthy participants twice with each sequence while they performed a motor task, this study assessed functional ASL for 1) its sensitivity to detect task-related cerebral blood flow (CBF) changes, and 2) its reproducibility of resting CBF and absolute CBF changes (delta CBF) in the motor cortex. Whole-brain voxel-wise analyses showed that sensitivity for motor activation was sufficient with each sequence, and comparable between sequences. Reproducibility was assessed with within-subject coefficients of variation (wsCV) and intraclass correlation coefficients (ICC). Reproducibility of resting CBF was reasonably good within (wsCV: 14.1-15.7%; ICC: 0.69-0.77) and between sequences (wsCV: 15.1%; ICC: 0.69). Reproducibility of delta CBF was relatively low, both within (wsCV: 182-297%; ICC: 0.04-0.32) and between sequences (wsCV: 185%; ICC: 0.45), while inter-session variation was low. This may be due to delta CBF's small mean effect (0.77-1.32 mL/100g gray matter/min). In conclusion, fASL seems sufficiently sensitive to detect task-related changes on a group level, with acceptable inter-sequence differences. Resting CBF may provide a consistent baseline to compare task-related activation to, but absolute regional CBF changes are more variable, and should be interpreted cautiously when acquired with two pCASL product sequences.	[Steketee, Rebecca M. E.; Bron, Esther E.; van der Lugt, Aad; Smits, Marion] Erasmus MC Univ Med Ctr Rotterdam, Dept Radiol, Rotterdam, Netherlands; [Mutsaerts, Henri J. M. M.; Majoie, Charles B. L. M.; Nederveen, Aart J.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Bron, Esther E.] Erasmus MC Univ Med Ctr Rotterdam, Dept Med Informat, Biomed Imaging Grp Rotterdam, Rotterdam, Netherlands; [van Osch, Matthias J. P.] Leiden Univ, Med Ctr, CJ Gorter Ctr High Field MRI, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Smits, M (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Radiol, Rotterdam, Netherlands.	marion.smits@erasmusmc.nl	Smits, Marion/E-4795-2011; Smits, Marion/AAB-3985-2019; Steketee, Rebecca/AAA-4081-2020; Mutsaerts, Henk JMM/T-8656-2017; Van Osch, Matthias/AAV-3876-2021	Smits, Marion/0000-0001-5563-2871; Mutsaerts, Henk JMM/0000-0003-0894-0307; Van Osch, Matthias/0000-0001-7034-8959; Steketee, Rebecca/0000-0003-2689-5490; Bron, Esther/0000-0002-5778-9263; Nederveen, Aart/0000-0002-5477-973X	Dutch non-governmental organization 'Stichting Coolsingel' (Rotterdam, NL);  [179]	Dutch non-governmental organization 'Stichting Coolsingel' (Rotterdam, NL); 	This project was financially supported by the Dutch non-governmental organization 'Stichting Coolsingel' (Rotterdam, NL). The funder had no role in the study design; data collection, analysis or interpretation; writing of the report; or decision to submit the article for publication (grant no. 179, received by MS; http://www.stichtingcoolsingel.nl/).	Aguirre GK, 2002, NEUROIMAGE, V15, P488, DOI 10.1006/nimg.2001.0990; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Alsop DC, 1996, J CEREBR BLOOD F MET, V16, P1236, DOI 10.1097/00004647-199611000-00019; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Bron EE, 2014, HUM BRAIN MAPP, V35, P4916, DOI 10.1002/hbm.22522; Cavusoglu M, 2012, NEUROIMAGE, V59, P4044, DOI 10.1016/j.neuroimage.2011.10.056; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Demeter E, 2011, NEUROIMAGE, V54, P1518, DOI 10.1016/j.neuroimage.2010.09.026; Fernandez-Seara MA, 2007, HUM BRAIN MAPP, V28, P1391, DOI 10.1002/hbm.20366; Floyd TF, 2003, J MAGN RESON IMAGING, V18, P649, DOI 10.1002/jmri.10416; Garcia DM, 2005, MAGN RESON MED, V54, P366, DOI 10.1002/mrm.20556; Gaxiola-Valdez I, 2012, MAGN RESON IMAGING, V30, P1394, DOI 10.1016/j.mri.2012.05.002; Gevers S, 2009, AM J NEURORADIOL, V30, P968, DOI 10.3174/ajnr.A1454; Gevers S, 2011, J CEREBR BLOOD F MET, V31, P1706, DOI 10.1038/jcbfm.2011.10; Gonzalez-At JB, 2000, MAGNET RESON MED, V43, P739, DOI 10.1002/(SICI)1522-2594(200005)43:5<739::AID-MRM17>3.0.CO;2-2; Gousias IS, 2008, NEUROIMAGE, V40, P672, DOI 10.1016/j.neuroimage.2007.11.034; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Heijtel DFR, 2014, NEUROIMAGE, V92, P182, DOI 10.1016/j.neuroimage.2014.02.011; Hermes M, 2007, MAGN RESON MATER PHY, V20, P103, DOI 10.1007/s10334-007-0073-3; Hu Y, 2007, MAGN RESON MED, V58, P947, DOI 10.1002/mrm.21328; Jahng GH, 2005, RADIOLOGY, V234, P909, DOI 10.1148/radiol.2343031499; Kemeny S, 2005, HUM BRAIN MAPP, V24, P173, DOI 10.1002/hbm.20078; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Klomp A, 2012, NEUROIMAGE, V63, P1695, DOI 10.1016/j.neuroimage.2012.07.038; Lawrence KSS, 2005, MAGN RESON MED, V53, P425, DOI 10.1002/mrm.20364; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Mildner T, 2003, MAGNET RESON MED, V49, P791, DOI 10.1002/mrm.10438; Mutsaerts HJMM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104108; Obata T, 2004, NEUROIMAGE, V21, P144, DOI 10.1016/j.neuroimage.2003.08.040; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; Pfefferbaum A, 2010, PSYCHIAT RES-NEUROIM, V182, P266, DOI 10.1016/j.pscychresns.2010.02.010; Pimentel MAF, 2013, HUM BRAIN MAPP, V34, P96, DOI 10.1002/hbm.21418; Raoult H, 2012, J MAGN RESON IMAGING, V36, P1435, DOI 10.1002/jmri.23782; Raoult H, 2011, NEUROIMAGE, V58, P157, DOI 10.1016/j.neuroimage.2011.06.011; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Tjandra T, 2005, NEUROIMAGE, V27, P393, DOI 10.1016/j.neuroimage.2005.04.021; van Osch MJP, 2007, J MAGN RESON IMAGING, V25, P215, DOI 10.1002/jmri.20823; Vidorreta M, 2013, NEUROIMAGE, V66, P662, DOI 10.1016/j.neuroimage.2012.10.087; Wang JJ, 2003, MAGN RESON MED, V49, P796, DOI 10.1002/mrm.10437; Wang Y, 2011, NEUROIMAGE, V54, P1188, DOI 10.1016/j.neuroimage.2010.08.043; Wu B, 2014, J MAGN RESON IMAGING, V39, P402, DOI 10.1002/jmri.24175; Wu WC, 2011, NEUROIMAGE, V56, P1244, DOI 10.1016/j.neuroimage.2011.02.080; Xu GF, 2010, NMR BIOMED, V23, P286, DOI 10.1002/nbm.1462; Ye FQ, 1999, MAGNET RESON MED, V42, P404, DOI 10.1002/(SICI)1522-2594(199908)42:2<404::AID-MRM23>3.0.CO;2-0; Yen YF, 2002, MAGNET RESON MED, V47, P921, DOI 10.1002/mrm.10140; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	49	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132929	10.1371/journal.pone.0132929	http://dx.doi.org/10.1371/journal.pone.0132929			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172381	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900104
J	Troegeler, A; Lugo-Villarino, G; Hansen, S; Rasolofo, V; Henriksen, ML; Mori, K; Ohtani, K; Duval, C; Mercier, I; Benard, A; Nigou, J; Hudrisier, D; Wakamiya, N; Neyrolles, O				Troegeler, Anthony; Lugo-Villarino, Geanncarlo; Hansen, Soren; Rasolofo, Voahangy; Henriksen, Maiken Lumby; Mori, Kenichiro; Ohtani, Katsuki; Duval, Carine; Mercier, Ingrid; Benard, Alan; Nigou, Jerome; Hudrisier, Denis; Wakamiya, Nobutaka; Neyrolles, Olivier			Collectin CL-LK Is a Novel Soluble Pattern Recognition Receptor for Mycobacterium tuberculosis	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; 11 CL-11; COMPLEMENT-SYSTEM; DC-SIGN; CL-K1; BINDING; LECTIN; LIPOARABINOMANNAN; PHAGOCYTOSIS; MACROPHAGES	Understanding the molecular components of immune recognition of the tuberculosis ( TB) bacillus, Mycobacterium tuberculosis, can help designing novel strategies to combat TB. Here, we identify collectin CL-LK as a novel soluble C-type lectin able to bind M. tuberculosis, and characterize mycobacterial mannose-capped lipoarabinomannan as a primary ligand for CL-LK. Mice deficient in CL-K1, one of the CL-LK subunits, do not display altered susceptibility to M. tuberculosis. However, we found that the amount of CL-LK in the serum of patients with active TB is reduced, compared to that in controls, and correlates inversely to the magnitude of the immune response to the pathogen. These findings indicate that CL-LK might be of interest for future diagnostic and treatment monitoring purposes.	[Troegeler, Anthony; Lugo-Villarino, Geanncarlo; Duval, Carine; Mercier, Ingrid; Benard, Alan; Nigou, Jerome; Hudrisier, Denis; Neyrolles, Olivier] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Troegeler, Anthony; Lugo-Villarino, Geanncarlo; Duval, Carine; Mercier, Ingrid; Benard, Alan; Nigou, Jerome; Hudrisier, Denis; Neyrolles, Olivier] Univ Toulouse 3, Inst Pharmacol & Biol Struct, F-31062 Toulouse, France; [Hansen, Soren] Univ Southern Denmark, Inst Mol Med, Dept Canc & Inflammat Res, Odense, Denmark; [Rasolofo, Voahangy] Pasteur Inst Antananarivo, Mycobacteria Unit, Antananarivo, Madagascar; [Mori, Kenichiro; Ohtani, Katsuki; Wakamiya, Nobutaka] Asahikawa Med Univ, Dept Microbiol & Immunochem, Asahikawa, Hokkaido, Japan	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Southern Denmark; Asahikawa Medical College	Neyrolles, O (corresponding author), CNRS, Inst Pharmacol & Biol Struct, Toulouse, France.	olivier.neyrolles@ipbs.fr	Lugo, Geanncarlo/H-4674-2019; Neyrolles, Olivier/AAG-3692-2019; Nigou, Jérôme/D-6802-2019	Lugo, Geanncarlo/0000-0003-4620-8491; Neyrolles, Olivier/0000-0003-0047-5885; Nigou, Jérôme/0000-0002-6233-2487; Hudrisier, Denis/0000-0002-3631-9561; Hansen, Soren/0000-0002-8186-4630	Fondation pour la Recherche Medicale (FRM); European Union (NEWTBVAC project) [241745]; Fondation Bettencourt-Schueller; Centre National de la Recherche Scientifique (CNRS); University of Toulouse; Agence Nationale de la Recherche (ANR)/Programme d'Investissements d'Avenir (PIA grant) [ANR-11-EQUIPEX-0003]; French Ministry of Higher Education and Research [ANR-12-BSV3-0002 B-TB]	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Union (NEWTBVAC project); Fondation Bettencourt-Schueller; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Toulouse; Agence Nationale de la Recherche (ANR)/Programme d'Investissements d'Avenir (PIA grant)(French National Research Agency (ANR)); French Ministry of Higher Education and Research	This work was supported by Centre National de la Recherche Scientifique (CNRS), University of Toulouse, Agence Nationale de la Recherche (ANR)/Programme d'Investissements d'Avenir (PIA grant number ANR-11-EQUIPEX-0003) and ANR-12-BSV3-0002 B-TB grant, French Ministry of Higher Education and Research (fellowship to A. T.), Fondation pour la Recherche Medicale (FRM fellowships to G.L.V., A.B. and C.D.), European Union (NEWTBVAC project, project no 241745), and Fondation Bettencourt-Schueller. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Degn SE, 2011, AM J HUM GENET, V88, P689, DOI 10.1016/j.ajhg.2011.05.011; Doherty TM, 2005, J IMMUNOL METHODS, V298, P129, DOI 10.1016/j.jim.2005.01.013; Ferguson JS, 2004, INFECT IMMUN, V72, P2564, DOI 10.1128/IAI.72.5.2564-2573.2004; Ferguson JS, 1999, J IMMUNOL, V163, P312; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Gouzy A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003928; Gupta A, 2012, IMMUNOBIOLOGY, V217, P363, DOI 10.1016/j.imbio.2011.07.008; Hakansson K, 2000, PROTEIN SCI, V9, P1607, DOI 10.1110/ps.9.9.1607; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Henriksen ML, 2014, J IMMUNOL METHODS, V413, P25, DOI 10.1016/j.jim.2014.07.006; Henriksen ML, 2013, J IMMUNOL, V191, P6117, DOI 10.4049/jimmunol.1302121; Henriksen ML, 2013, MOL IMMUNOL, V56, P757, DOI 10.1016/j.molimm.2013.07.011; Keshi H, 2006, MICROBIOL IMMUNOL, V50, P1001, DOI 10.1111/j.1348-0421.2006.tb03868.x; Lemos MP, 2011, INFECT IMMUN, V79, P1077, DOI 10.1128/IAI.00286-10; Motomura W, 2008, J HISTOCHEM CYTOCHEM, V56, P243, DOI 10.1369/jhc.7A7312.2007; Nigou J, 2001, J IMMUNOL, V166, P7477, DOI 10.4049/jimmunol.166.12.7477; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Rakotosamimanana N, 2010, CLIN VACCINE IMMUNOL, V17, P1094, DOI 10.1128/CVI.00049-10; SCHLESINGER LS, 1994, J IMMUNOL, V152, P4070; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Selman L, 2012, J IMMUNOL METHODS, V375, P182, DOI 10.1016/j.jim.2011.10.010; Selman L, 2012, IMMUNOBIOLOGY, V217, P851, DOI 10.1016/j.imbio.2011.12.008; Sidobre S, 2000, J BIOL CHEM, V275, P2415, DOI 10.1074/jbc.275.4.2415; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Torrelles JB, 2008, CURR DRUG TARGETS, V9, P102; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yoshizaki T, 2012, J BIOCHEM, V151, P57, DOI 10.1093/jb/mvr114; Zumla A, 2013, LANCET, V382, P1765, DOI 10.1016/S0140-6736(13)62078-4	28	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132692	10.1371/journal.pone.0132692	http://dx.doi.org/10.1371/journal.pone.0132692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173080	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900078
J	Guariguata, L; de Beer, I; Hough, R; Mulongeni, P; Feeley, FG; de Wit, TFR				Guariguata, Leonor; de Beer, Ingrid; Hough, Rina; Mulongeni, Pancho; Feeley, Frank G.; de Wit, Tobias F. Rinke			Prevalence and Knowledge Assessment of HIV and Non-Communicable Disease Risk Factors among Formal Sector Employees in Namibia	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; DIABETES-MELLITUS; HEALTH CONDITIONS; BLOOD-PRESSURE; LIFE-STYLES; HYPERTENSION; AWARENESS; PROGRAM; POPULATION; PERCEPTION	Introduction The burden of non-communicable diseases (NCDs) is growing in sub-Saharan Africa combined with an already high prevalence of infectious disease, like HIV. Engaging the formal employment sector may present a viable strategy for addressing both HIV and NCDs in people of working age. This study assesses the presence of three of the most significant threats to health in Namibia among employees in the formal sector: elevated blood pressure, elevated blood glucose, and HIV and assesses the knowledge and self-perceived risk of employees for these conditions. Methods A health and wellness screening survey of employees working in 13 industries in the formal sector of Namibia was conducted including 11,192 participants in the Bophelo! Project in Namibia, from January 2009 to October 2010. The survey combined a medical screening for HIV, blood glucose and blood pressure with an employee-completed survey on knowledge and risk behaviors for those conditions. We estimated the prevalence of the three conditions and compared to self-reported employee knowledge and risk behaviors and possible determinants. Results 25.8% of participants had elevated blood pressure, 8.3% of participants had an elevated random blood glucose measurement, and 8.9% of participants tested positive for HIV. Most participants were not smokers (80%), reported not drinking alcohol regularly (81.2%), and had regular condom use (66%). Most participants could not correctly identify risk factors for hypertension (57.2%), diabetes (57.3%), or high-risk behaviors for HIV infection (59.5%). In multivariate analysis, having insurance (OR: 1.15, 95% CI: 1.03 - 1.28) and a managerial position (OR: 1.29, 95% CI: 1.13 - 1.47) were associated with better odds of knowledge of diabetes. Conclusion The prevalence of elevated blood pressure, elevated blood glucose, and HIV among employees of the Namibian formal sector is high, while risk awareness is low. Attention must be paid to improving the knowledge of health-related risk factors as well as providing care to those with chronic conditions in the formal sector through programs such as work-place wellness.	[Guariguata, Leonor; de Wit, Tobias F. Rinke] PharmAccess Fdn, Amsterdam, Netherlands; [de Beer, Ingrid; Hough, Rina; Mulongeni, Pancho] PharmAccess Fdn, Windhoek, Namibia; [Feeley, Frank G.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [de Wit, Tobias F. Rinke] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands	Boston University; University of Amsterdam; Academic Medical Center Amsterdam	Guariguata, L (corresponding author), PharmAccess Fdn, Amsterdam, Netherlands.	leonor.guariguata@gmail.com		Guariguata, Leonor/0000-0003-1682-7160	Namibia Global Fund Program; Dutch Foreign Ministry; Ministry of Health and Social Services; Dutch Postcode Loterij; Dutch Aidsfonds; Stop AIDS Now!; HIVOS; Global Fund	Namibia Global Fund Program; Dutch Foreign Ministry; Ministry of Health and Social Services; Dutch Postcode Loterij; Dutch Aidsfonds; Stop AIDS Now!; HIVOS; Global Fund	The Namibia Global Fund Program provided funding for the HIV screening of the Bophelo! program. The funding for the Bophelo! is provided by The Dutch Foreign Ministry. The Bophelo! Project is a partnership between the PharmAccess Foundation, the Namibian Business Coalition on AIDS, and the Namibian Institute of Pathology, supported by the Ministry of Health and Social Services. The project was initially created using funds from the Dutch Postcode Loterij, through the Dutch Aidsfonds, Stop AIDS Now!, HIVOS and the Global Fund to fight AIDS, TB and Malaria. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakari AR, 2013, INT J GEN MED, V6, P617, DOI 10.2147/IJGM.S46649; Akwara PA, 2003, J BIOSOC SCI, V35, P385, DOI 10.1017/S0021932003003857; Albarracin D, 2005, PSYCHOL BULL, V131, P856, DOI 10.1037/0033-2909.131.6.856; Archer W Roodly, 2011, Am J Health Promot, V25, pe12, DOI 10.4278/ajhp.090421-QUAN-144; Clark MJ, 2000, PUBLIC HEALTH NURS, V17, P452, DOI 10.1046/j.1525-1446.2000.00452.x; Collins JJ, 2005, J OCCUP ENVIRON MED, V47, P547, DOI 10.1097/01.jom.0000166864.58664.29; Commodore-Mensah Y, 2014, J HYPERTENS, V32, P464, DOI 10.1097/HJH.0000000000000061; Cooper M, 2012, ETHNIC HEALTH, V17, P597, DOI 10.1080/13557858.2012.740003; Dzudie A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001217; Fenton KA, 2002, SEX TRANSM INFECT, V78, P241, DOI 10.1136/sti.78.4.241; Fisher HH, 2011, AIDS BEHAV, V15, P1691, DOI 10.1007/s10461-011-9961-7; Freak-Poli R, 2010, J OCCUP ENVIRON MED, V52, P1132, DOI 10.1097/JOM.0b013e3181f8da77; Green EC, 2006, AIDS BEHAV, V10, P335, DOI 10.1007/s10461-006-9073-y; Guariguata L, 2013, DIABETES RES CLIN PR; Guariguata L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-44; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Huang SQ, 2011, HYPERTENS RES, V34, P503, DOI 10.1038/hr.2010.265; Kirigia JM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-6; Kolbe-Alexander T, 2014, J OCCUP ENVIRON MED, V56, P1094, DOI 10.1097/JOM.0000000000000236; Lee LL, 2010, INT J NURS STUD, V47, P1545, DOI 10.1016/j.ijnurstu.2010.08.008; Lindstrom J, 2003, J AM SOC NEPHROL, V14, pS108, DOI 10.1097/01.ASN.0000070157.96264.13; Loeppke R, 2008, POPUL HEALTH MANAG, V11, P287, DOI 10.1089/pop.2008.0006; Loprinzi PD, 2015, PREV MED, V73, P37, DOI 10.1016/j.ypmed.2015.01.002; Marseille E, 2006, AIDS, V20, P907, DOI 10.1097/01.aids.0000218556.36661.47; Mayega RW, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-864; Milani RV, 2009, AM J CARDIOL, V104, P1389, DOI 10.1016/j.amjcard.2009.07.007; Namibia Statistics Agency, 2013, NAM LAB WORKF SURV 2; Pegus C, 2002, J OCCUP ENVIRON MED, V44, P228, DOI 10.1097/00043764-200203000-00010; Perez AP, 2009, PREV CHRONIC DIS, V6; Prabhakaran D, 2005, NATL MED J INDIA, V18, P59; Prata N, 2006, INT FAM PLAN PERSPEC, V32, P192, DOI 10.1363/3219206; Rosen S, 2004, AIDS, V18, P317, DOI 10.1097/00002030-200401230-00023; Rula EY, 2010, AM J HEALTH BEHAV, V34, P532; Sarafidis PA, 2004, J HUM HYPERTENS, V18, P623, DOI 10.1038/sj.jhh.1001724; Totsikas C, 2011, J HYPERTENS, V29, P1220, DOI 10.1097/HJH.0b013e3283469910; UNAIDS, NAM COUNTR REP	36	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131737	10.1371/journal.pone.0131737	http://dx.doi.org/10.1371/journal.pone.0131737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1PW	26167926	Green Published, Green Submitted, gold			2022-12-27	WOS:000358193100014
J	Kunutsor, SK; Bakker, SJL; Kootstra-Ros, JE; Gansevoort, RT; Gregson, J; Dullaart, RPF				Kunutsor, Setor K.; Bakker, Stephan J. L.; Kootstra-Ros, Jenny E.; Gansevoort, Ronald T.; Gregson, John; Dullaart, Robin P. F.			Serum Alkaline Phosphatase and Risk of Incident Cardiovascular Disease: Interrelationship with High Sensitivity C-Reactive Protein	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; GENERAL-POPULATION; VASCULAR CALCIFICATION; LIVER-ENZYMES; VITAMIN-D; ASSOCIATION; MORTALITY; HEALTH; PREDICTION; FRAMINGHAM	Background Alkaline phosphatase (ALP) has been suggested to be associated with cardiovascular disease (CVD) risk, however, important aspects of the association, such as shape and independence from established risk factors, have yet to be characterized in detail. We assessed the association of ALP with CVD risk and determined its utility for CVD risk prediction. Methods Alkaline phosphatase activity was measured at baseline in the PREVEND prospective cohort involving 6,974 participants aged 28-75 years without pre-existing CVD. Hazard ratios (95% confidence intervals [ CI]) and measures of risk discrimination and reclassification were assessed. Results During a median follow-up of 10.5 years, 737 participants developed CVD. Serum ALP was correlated with several risk markers for CVD, with strongest correlations for age (r = 0.30; P < 0.001), gamma-glutamyltransferase (r = 0.26; P < 0.001), and C-reactive protein (CRP) (r = 0.25; P < 0.001). There was a non-linear "J-shaped" relationship between ALP and CVD risk. In analyses adjusted for conventional risk factors, the hazard ratio (95% CI) for CVD in a comparison of the top quintile versus bottom quintiles 1-4 of ALP values was 1.34 (1.14 to 1.56; P< 0.001), which persisted after additional adjustment for potential confounders 1.33 (1.13 to 1.55; P< 0.001). However, the association was somewhat attenuated after adjustment for CRP 1.24 (1.05 to 1.45; P= 0.009). Addition of information on ALP to a CVD risk prediction model containing established risk factors did not improve the C-index or net reclassification. Conclusions Available evidence suggests a non-linear association between ALP activity and CVD risk, which is partly dependent on CRP. Taking account of conventional	[Kunutsor, Setor K.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Kunutsor, Setor K.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Bakker, Stephan J. L.; Gansevoort, Ronald T.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Bakker, Stephan J. L.] Top Inst Food & Nutr, Wageningen, Netherlands; [Kootstra-Ros, Jenny E.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Chem, Groningen, Netherlands; [Gregson, John] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Dullaart, Robin P. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands	University of Cambridge; University of Bristol; University of Groningen; Top Institute Food & Nutrition; University of Groningen; University of London; London School of Hygiene & Tropical Medicine; University of Groningen	Kunutsor, SK (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.	skk31@cantab.net	Kunutsor, Setor K/H-9807-2019	Kunutsor, Setor K/0000-0002-2625-0273	Dutch Kidney Foundation [E.033]; Dutch Heart Foundation [2001-005]	Dutch Kidney Foundation; Dutch Heart Foundation(Netherlands Heart Foundation)	The Dutch Kidney Foundation supported the infrastructure of the PREVEND program from 1997 to 2003 (Grant E.033). The University Medical Center Groningen supported the infrastructure from 2003 to 2006 and from 2007 to 2011. Dade Behring, Ausam, Roche, and Abbott financed laboratory equipment and reagents by which various laboratory determinations could be performed. The Dutch Heart Foundation supported studies on lipid metabolism (Grant 2001-005). These sources had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Abbasi A, 2013, J CLIN ENDOCR METAB, V98, pE1352, DOI 10.1210/jc.2013-1680; Abramowitz M, 2010, CLIN J AM SOC NEPHRO, V5, P1064, DOI 10.2215/CJN.08621209; Ali AT, 2006, ANN CLIN BIOCHEM, V43, P207, DOI 10.1258/000456306776865179; Belozeroff V, 2009, CLIN J AM SOC NEPHRO, V4, P673, DOI 10.2215/CJN.03790808; Borggreve SE, 2007, EUR HEART J, V28, P1012, DOI 10.1093/eurheartj/ehm062; Cheung BMY, 2008, CLIN CHEM LAB MED, V46, P523, DOI 10.1515/CCLM.2008.111; Cook NR, 2012, CIRCULATION, V125, P1748, DOI 10.1161/CIRCULATIONAHA.111.075929; COX DR, 1972, J R STAT SOC B, V34, P187; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Damera S, 2011, KIDNEY INT, V79, P228, DOI 10.1038/ki.2010.356; Detrano RC, 2000, CURR PROB CARDIOLOGY, V25, P374, DOI 10.1067/mcd.2000.104848; Dullaart RPF, 2010, ATHEROSCLEROSIS, V208, P537, DOI 10.1016/j.atherosclerosis.2009.07.042; Durup D, 2015, J CLIN ENDOCR METAB, V100, P2339, DOI 10.1210/jc.2014-4551; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Germano G, 2012, EUR HEART J, V33, P137; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heeringa SG, 2017, APPL SURVEY DATA ANA, VSecond, DOI DOI 10.1201/9781315153278; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kalantar-Zadeh K, 2009, CLIN J AM SOC NEPHRO, V4, P1529, DOI 10.2215/CJN.02140309; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kerner A, 2005, ARTERIOSCL THROM VAS, V25, P193, DOI 10.1161/01.ATV.0000148324.63685.6a; Kunutsor SK, 2014, ATHEROSCLEROSIS, V236, P7, DOI 10.1016/j.atherosclerosis.2014.06.006; Lambers Heerspink HJ, 2008, AM J EPIDEMIOL, V168, P897, DOI 10.1093/aje/kwn209; Lazo M, 2008, ANN INTERN MED, V148, P348, DOI 10.7326/0003-4819-148-5-200803040-00005; Maldonado O, 1998, J CLIN GASTROENTEROL, V27, P342, DOI 10.1097/00004836-199812000-00013; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Narisawa S, 2007, J BONE MINER RES, V22, P1700, DOI 10.1359/JBMR.070714; O'Neill WC, 2006, CIRC RES, V99, pE2, DOI 10.1161/01.RES.0000234909.24367.a9; Soler EP, 2010, CURR CARDIOL REV, V6, P138, DOI 10.2174/157340310791658785; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; PRISMANT, 2002, INV REL NAT MED REG; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Ryu WS, 2010, NEUROLOGY, V75, P1995, DOI 10.1212/WNL.0b013e3181ff966a; Schoppet M, 2008, KIDNEY INT, V73, P989, DOI 10.1038/ki.2008.104; Schumann G, 2011, CLIN CHEM LAB MED, V49, P1439, DOI 10.1515/CCLM.2011.621; Shimizu Y, 2013, J STROKE CEREBROVASC, V22, P1046, DOI 10.1016/j.jstrokecerebrovasdis.2012.06.009; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Stricker B H Ch, 2006, Ned Tijdschr Geneeskd, V150, P1916; Tang FT, 2006, CALCIFIED TISSUE INT, V79, P326, DOI 10.1007/s00223-006-0004-8; Therneau T.M., 2000, MODELING SURVIVAL DA; Tonelli M, 2009, CIRCULATION, V120, P1784, DOI 10.1161/CIRCULATIONAHA.109.851873; Wannamethee SG, 2013, ARTERIOSCL THROM VAS, V33, P1070, DOI 10.1161/ATVBAHA.112.300826; Webber M, 2010, CLIN CHEM LAB MED, V48, P167, DOI 10.1515/CCLM.2010.052; WILKINSO.JH, 1970, CLIN CHEM, V16, P733	48	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132822	10.1371/journal.pone.0132822	http://dx.doi.org/10.1371/journal.pone.0132822			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167920	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000358193100084
J	Potter, AS; Potter, SS				Potter, Andrew S.; Potter, S. Steven			Molecular Anatomy of Palate Development	PLOS ONE			English	Article							CLEFT-PALATE; GENE-EXPRESSION; PALATOGENESIS; GROWTH; MICE; MORPHOGENESIS; MODULATION; MECHANISMS; TGFBR2; LIP	The NIH FACEBASE consortium was established in part to create a central resource for craniofacial researchers. One purpose is to provide a molecular anatomy of craniofacial development. To this end we have used a combination of laser capture microdissection and RNA-Seq to define the gene expression programs driving development of the murine palate. We focused on the E14.5 palate, soon after medial fusion of the two palatal shelves. The palate was divided into multiple compartments, including both medial and lateral, as well as oral and nasal, for both the anterior and posterior domains. A total of 25 RNA-Seq datasets were generated. The results provide a comprehensive view of the region specific expression of all transcription factors, growth factors and receptors. Paracrine interactions can be inferred from flanking compartment growth factor/receptor expression patterns. The results are validated primarily through very high concordance with extensive previously published gene expression data for the developing palate. In addition selected immunostain validations were carried out. In conclusion, this report provides an RNA-Seq based atlas of gene expression patterns driving palate development at microanatomic resolution. This FACEBASE resource is designed to promote discovery by the craniofacial research community.	[Potter, Andrew S.; Potter, S. Steven] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Potter, SS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Steve.Potter@cchmc.org			United States National Institutes of Health [5UO1DE20049]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE020049] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the United States National Institutes of Health grant 5UO1DE20049.	Brown NL, 2003, DEV GROWTH DIFFER, V45, P153; Brunskill EW, 2014, DEV BIOL, V391, P133, DOI 10.1016/j.ydbio.2014.04.016; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; d'Amaro R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00377; Feng WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008066; Han J, 2009, DEVELOPMENT, V136, P4225, DOI 10.1242/dev.036723; He FL, 2011, DEV BIOL, V350, P511, DOI 10.1016/j.ydbio.2010.12.021; Hochheiser H, 2011, DEV BIOL, V355, P175, DOI 10.1016/j.ydbio.2011.02.033; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Iwata J, 2012, J CLIN INVEST, V122, P873, DOI 10.1172/JCI61498; Liu H, 2013, P NATL ACAD SCI USA, V110, P18555, DOI 10.1073/pnas.1306495110; Liu WJ, 2008, DEVELOPMENT, V135, P3959, DOI 10.1242/dev.025304; Marazita ML, 2012, ANNU REV GENOM HUM G, V13, P263, DOI 10.1146/annurev-genom-090711-163729; Meng L, 2009, J DENT RES, V88, P22, DOI 10.1177/0022034508327868; Mossey P, 2007, ORTHOD CRANIOFAC RES, V10, P114, DOI 10.1111/j.1601-6343.2007.00398.x; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Nie XG, 2006, ACTA ODONTOL SCAND, V64, P97, DOI 10.1080/00016350500420089; Parada C, 2013, MOL CELL BIOL, V33, P3482, DOI 10.1128/MCB.00615-13; Pelikan RC, 2013, J CELL BIOCHEM, V114, P796, DOI 10.1002/jcb.24417; Yamada T, 2014, J CRANIO MAXILL SURG, V42, P1, DOI 10.1016/j.jcms.2013.01.024; Zhang L, 1999, J DENT RES, V78, P1417, DOI 10.1177/00220345990780080701	23	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132662	10.1371/journal.pone.0132662	http://dx.doi.org/10.1371/journal.pone.0132662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168040	Green Submitted, Green Published, gold			2022-12-27	WOS:000358193100063
J	Wei, F; Shang, WJ; Yang, JR; Hu, XP; Xu, XM				Wei, Feng; Shang, Wenjing; Yang, Jiarong; Hu, Xiaoping; Xu, Xiangming			Spatial Pattern of Verticillium dahliae Microsclerotia and Cotton Plants with Wilt Symptoms in Commercial Plantations	PLOS ONE			English	Article							SPORE DISPERSAL GRADIENT; POTATO FIELD SOILS; DISEASE EPIDEMICS; INOCULUM DENSITY; SOUTHERN SPAIN; QUADRAT SIZE; POPULATION; PROPAGULES; TIME; CAULIFLOWER	Spatial patterns of pathogen inoculum in field soils and the resulting patterns of disease may reflect the underlying mechanisms of pathogen dispersal. This knowledge can be used to design more efficient sampling schemes for assessing diseases. Spatial patterns of Verticillium dahliae microsclerotia were characterized in commercial cotton fields through quadrat and point sampling in 1994 and 2013, respectively. Furthermore, cotton plants with wilt symptoms, caused by V. dahliae, were assessed in six commercial cotton fields in 2013. Soil samples were assayed for the density of microsclerotia (expressed as CFU g(-1) of soil) using a wet-sieving plating method and a real-time quantitative PCR method for the 1994 and 2013 study, respectively. The estimated inoculum threshold for causing wilt development on individual plants varied with the three fields: ca. 1.6 CFU g(-1) of soil for one field, and 7.2 CFU g(-1) of soil for the other two. Both quadrat and point sampling spatial analyses showed that aggregation of V. dahliae inoculum in soils was usually not detected beyond 1.0 m. Similarly, the spatial patterns of wilted cotton plants indicated that spatial aggregation of diseased plants were only observed below the scale of 1.0 m in six commercial cotton plantations. Therefore, spatial aggregation of both V. dahliae inoculum and cotton plants with wilt symptoms is not likely to be detected above the scale of 1.0 m for most commercial cotton plantations. When designing schemes for assessing wilt inoculum and wilt development, this scale needs to be taken into consideration.	[Wei, Feng; Shang, Wenjing; Yang, Jiarong; Hu, Xiaoping; Xu, Xiangming] Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China; [Xu, Xiangming] East Malling Res, East Malling, Kent, England	Northwest A&F University - China	Hu, XP (corresponding author), Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China.	xphu@nwsuaf.edu.cn; Xiangming.Xu@emr.ac.uk	FANG, DAVID/AAV-5774-2020; Xu, Xiangming/I-3050-2014	FANG, DAVID/0000-0003-0036-5459; Xu, Xiangming/0000-0002-4567-7117; Wei, Feng/0000-0002-4579-3732	National Natural Science Foundation of China [31371888]; State Key Laboratory of Cotton Biology Open Fund of China [CB2013A20]; Programme of Introducing Talents of Discipline to Universities of China [B07049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Cotton Biology Open Fund of China; Programme of Introducing Talents of Discipline to Universities of China(Ministry of Education, China - 111 Project)	The study was sponsored by National Natural Science Foundation of China (No. 31371888), and partially by State Key Laboratory of Cotton Biology Open Fund of China (No. CB2013A20) and by the Programme of Introducing Talents of Discipline to Universities of China (No. B07049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth JLJ, 1979, PHYTOPATHOLOGY, V69, P483; Banno S, 2011, J GEN PLANT PATHOL, V77, P282, DOI 10.1007/s10327-011-0335-9; Bilodeau GJ, 2012, PHYTOPATHOLOGY, V102, P331, DOI 10.1094/PHYTO-05-11-0130; Debode J, 2011, PLANT DIS, V95, P1571, DOI 10.1094/PDIS-04-11-0267; Dhanasekaran S, 2010, J IMMUNOL METHODS, V354, P34, DOI 10.1016/j.jim.2010.01.004; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; EASTON GD, 1969, PHYTOPATHOLOGY, V59, P1171; EVANS G, 1980, ANN APPL BIOL, V95, P177, DOI 10.1111/j.1744-7348.1980.tb04736.x; EVANS G, 1967, PHYTOPATHOLOGY, V57, P1250; Franca SC, 2013, CROP PROT, V54, P134, DOI 10.1016/j.cropro.2013.08.008; Garcia-Cabello S, 2012, EUR J PLANT PATHOL, V133, P877, DOI 10.1007/s10658-012-0011-8; GRIFFITHS DA, 1970, ARCH MIKROBIOL, V74, P207, DOI 10.1007/BF00408881; Harris DC, 1996, PLANT PATHOL, V45, P106, DOI 10.1046/j.1365-3059.1996.d01-96.x; HARRIS DC, 1993, PLANT PATHOL, V42, P238, DOI 10.1111/j.1365-3059.1993.tb01496.x; Johnson DA, 2006, PLANT DIS, V90, P789, DOI 10.1094/PD-90-0789; JOHNSON KB, 1988, PLANT DIS, V72, P484, DOI 10.1094/PD-72-0484; KOROLEVA NS, 1986, MIKOL FITOPATOL, V20, P509; Madden L.V., 2007, STUDY PLANT DIS EPID; Mol L, 1996, PLANT PATHOL, V45, P205, DOI 10.1046/j.1365-3059.1996.d01-125.x; Navas-Cortes JA, 2008, PHYTOPATHOLOGY, V98, P167, DOI 10.1094/PHYTO-98-2-0167; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; PULLMAN GS, 1982, PHYTOPATHOLOGY, V72, P549, DOI 10.1094/Phyto-72-549; Sivaganesan M, 2010, WATER RES, V44, P4726, DOI 10.1016/j.watres.2010.07.066; SMITH VL, 1984, PHYTOPATHOLOGY, V74, P553, DOI 10.1094/Phyto-74-553; Wang YL, 2013, PLANT DIS, V97, P1645, DOI 10.1094/PDIS-04-13-0406-RE; Wei F, 2015, PHYTOPATHOLOGY, V105, P220, DOI 10.1094/PHYTO-05-14-0139-R; Wheeler TA, 2000, PLANT DIS, V84, P961, DOI 10.1094/PDIS.2000.84.9.961; WHEELER TA, 1994, PHYTOPATHOLOGY, V84, P843, DOI 10.1094/Phyto-84-843; Xiao CL, 1997, PHYTOPATHOLOGY, V87, P325, DOI 10.1094/PHYTO.1997.87.3.325; Xiao CL, 1998, PHYTOPATHOLOGY, V88, P1108, DOI 10.1094/PHYTO.1998.88.10.1108; Xu XM, 2000, PHYTOPATHOLOGY, V90, P738, DOI 10.1094/PHYTO.2000.90.7.738; Xu XM, 1998, PHYTOPATHOLOGY, V88, P1000, DOI 10.1094/PHYTO.1998.88.10.1000; Zhang WW, 2013, EUR J PLANT PATHOL, V135, P867, DOI 10.1007/s10658-012-0131-1	33	3	3	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132812	10.1371/journal.pone.0132812	http://dx.doi.org/10.1371/journal.pone.0132812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167868	Green Submitted, Green Published, gold			2022-12-27	WOS:000358193100083
J	Bach, S; Binder, A; Montavon, G; Klauschen, F; Muller, KR; Samek, W				Bach, Sebastian; Binder, Alexander; Montavon, Gregoire; Klauschen, Frederick; Mueller, Klaus-Robert; Samek, Wojciech			On Pixel-Wise Explanations for Non-Linear Classifier Decisions by Layer-Wise Relevance Propagation	PLOS ONE			English	Article							NEURAL-NETWORKS; IMAGE; FEATURES; MODEL	Understanding and interpreting classification decisions of automated image classification systems is of high value in many applications, as it allows to verify the reasoning of the system and provides additional information to the human expert. Although machine learning methods are solving very successfully a plethora of tasks, they have in most cases the disadvantage of acting as a black box, not providing any information about what made them arrive at a particular decision. This work proposes a general solution to the problem of understanding classification decisions by pixel-wise decomposition of nonlinear classifiers. We introduce a methodology that allows to visualize the contributions of single pixels to predictions for kernel-based classifiers over Bag of Words features and for multilayered neural networks. These pixel contributions can be visualized as heatmaps and are provided to a human expert who can intuitively not only verify the validity of the classification decision, but also focus further analysis on regions of potential interest. We evaluate our method for classifiers trained on PASCAL VOC 2009 images, synthetic image data containing geometric shapes, the MNIST handwritten digits data set and for the pre-trained ImageNet model available as part of the Caffe open source package.	[Bach, Sebastian; Samek, Wojciech] Fraunhofer Heinrich Hertz Inst, Machine Learning Grp, Berlin, Germany; [Bach, Sebastian; Binder, Alexander; Montavon, Gregoire; Mueller, Klaus-Robert; Samek, Wojciech] Tech Univ Berlin, Machine Learning Grp, Berlin, Germany; [Klauschen, Frederick] Charite, Berlin, Germany; [Mueller, Klaus-Robert] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Binder, Alexander] SUTD, ISTD Pillar, Singapore, Singapore	Fraunhofer Gesellschaft; Technical University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Korea University; Singapore University of Technology & Design	Bach, S (corresponding author), Fraunhofer Heinrich Hertz Inst, Machine Learning Grp, Berlin, Germany.	sebastian.bach@hhi.fraunhofer.de; klaus-robert.mueller@tu-berlin.de; wojciech.samek@hhi.fraunhofer.de	Montavon, Grégoire/Q-1836-2016; Samek, Wojciech/AAZ-2165-2021; Mueller, Klaus-Robert/Y-3547-2019; Samek, Wojciech/AAZ-2156-2021; Klauschen, Frederick/C-5637-2015	Samek, Wojciech/0000-0002-6283-3265; Mueller, Klaus-Robert/0000-0002-3861-7685; Samek, Wojciech/0000-0002-6283-3265; Klauschen, Frederick/0000-0002-9131-2389; Binder, Alexander/0000-0001-9605-6209; Lapuschkin, Sebastian/0000-0002-0762-7258	PROSEC project [16BY1145]; BK21 program of the National Research Foundation of Korea in the Brain Korea 21 program; German Ministry for Education and Research as Berlin Big Data Center BBDC [01IS14013A]; Machine Learning Group of the TU Berlin; Human Frontier Science Program [RGY0077/2011]; Federal Ministry of Education and Research (BMBF) [01GQ1115];  [01MQ07018]	PROSEC project; BK21 program of the National Research Foundation of Korea in the Brain Korea 21 program(National Research Foundation of Korea); German Ministry for Education and Research as Berlin Big Data Center BBDC; Machine Learning Group of the TU Berlin; Human Frontier Science Program(Human Frontier Science Program); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); 	SB was funded by the PROSEC project (http://www.prosec-project.org/index.html, grant no. 16BY1145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AB and KRM were partially funded by http://www.bmwi.de/EN/root.html (grant no. 01MQ07018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KRM was partially funded by the BK21 program of the National Research Foundation of Korea in the Brain Korea 21 program (http://www.nrf.re.kr/nrf eng cms/, - no grant number available), and partially funded by the German Ministry for Education and Research as Berlin Big Data Center BBDC, funding mark 01IS14013A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GM is funded as an employee of the Machine Learning Group of the TU Berlin, http://www.ml.tu-berlin.de/ (research/teaching), http://www.tu-berlin.de/ (no grant number available). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FK is funded by the Human Frontier Science Program (http://www.hfsp.org/, grant no. RGY0077/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. WS was funded by the Federal Ministry of Education and Research (BMBF, http://www.bmbf.de/) under the project Adaptive BCI, grant no. 01GQ1115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach F. R., 2004, P 21 INT C MACH LEAR, P41, DOI 10.1145/ 1015330.1015424; Baehrens D, 2010, J MACH LEARN RES, V11, P1803; Binder A, 2013, COMPUT VIS IMAGE UND, V117, P466, DOI 10.1016/j.cviu.2012.09.006; Binder A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038897; Binder A, 2012, INT J COMPUT VISION, V99, P281, DOI 10.1007/s11263-010-0417-8; Bishop C.M., 1995, NEURAL NETWORKS PATT; Blaschko Matthew B., 2013, Machine Learning and Knowledge Discovery in Databases. European Conference (ECML PKDD 2013). Proceedings: LNCS 8189, P304, DOI 10.1007/978-3-642-40991-2_20; Cao LL, 2009, IEEE I CONF COMP VIS, P1095, DOI 10.1109/ICCV.2009.5459401; Chalupka K, 2014, CORR; Christian Szegedy, 2014, Arxiv, DOI arXiv:1312.6199; Csurka G., 2004, WORKSHOP STAT LEARNI, P1, DOI DOI 10.1234/12345678; Dahlkamp H., 2006, ROBOTICS SCI SYSTEMS, P1; Deng Jia, 2012, IMAGENET LARGE SCALE, P41; Erhan D, 2009, VISUALIZING HIGHER L, P1341; Everingham M., PASCAL VISUAL OBJECT; Everingham M, 2009, PASCAL VISUAL OBJECT; Fei-Fei L, 2005, PROC CVPR IEEE, P524; Gevrey M, 2003, ECOL MODEL, V160, P249, DOI 10.1016/S0304-3800(02)00257-0; Goodfellow IJ, 2014, ADV NEUR IN, V27, P2672, DOI 10.1145/3422622; Hansch R, 2010, REMOTE SENS DIGIT IM, V15, P109, DOI 10.1007/978-90-481-3751-0_5; Hansen K, 2011, MOL INFORM, V30, P817, DOI 10.1002/minf.201100059; Hwang SJ, 2012, ADV NEURAL INFORM PR; Jia Y., 2013, CAFFE OPEN SOURCE CO; Kloft M, 2011, J MACH LEARN RES, V12, P953; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lanckriet GRG, 2004, J MACH LEARN RES, V5, P27; Le QV, 2013, INT CONF ACOUST SPEE, P8595, DOI 10.1109/ICASSP.2013.6639343; Lecun Y., 1998, MNIST DATABASE HANDW; LeCun Y, 2010, IEEE INT SYMP CIRC S, P253, DOI 10.1109/ISCAS.2010.5537907; Liu LQ, 2012, PROC CVPR IEEE, P3586, DOI 10.1109/CVPR.2012.6248103; Liu LQ, 2011, IEEE I CONF COMP VIS, P2486, DOI 10.1109/ICCV.2011.6126534; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Marius K., 2009, NIPS, P997; Montavon G., 2012, LECT NOTES COMPUTER, V7700; Moosmann F, 2008, IEEE T PATTERN ANAL, V30, P1632, DOI 10.1109/TPAMI.2007.70822; Muller H, 2010, INFORM RETRIEVAL SER, V32, P1, DOI 10.1007/978-3-642-15181-1; Nowak S, 2011, CLEF 2011 LABS WORKS; Olden JD, 2004, ECOL MODEL, V178, P389, DOI 10.1016/j.ecolmodel.2004.03.013; Perronnin F, 2010, LECT NOTES COMPUT SC, V6314, P143, DOI 10.1007/978-3-642-15561-1_11; Pinto N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040027; Rasmussen PM, 2011, NEUROIMAGE, V55, P1120, DOI 10.1016/j.neuroimage.2010.12.035; Rasmussen PM, 2012, BIOSIGNALS, P254; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Sanchez J, 2013, INT J COMPUT VISION, V105, P222, DOI 10.1007/s11263-013-0636-x; Setiono R, 1995, INT JOINT CONF ARTIF, P480; Simonyan K., 2013, DEEP INSIDE CONVOLUT; Uijlings JRR, 2012, INT J COMPUT VISION, V96, P46, DOI 10.1007/s11263-011-0443-1; van de Sande KEA, 2010, IEEE T PATTERN ANAL, V32, P1582, DOI 10.1109/TPAMI.2009.154; van Gemert JC, 2008, LECT NOTES COMPUT SC, V5304, P696; van Gemert JC, 2010, IEEE T PATTERN ANAL, V32, P1271, DOI 10.1109/TPAMI.2009.132; Vedaldi A, 2009, IEEE I CONF COMP VIS, P606, DOI 10.1109/ICCV.2009.5459183; Walker R, 1994, AUSTRALIAN NEW ZEALA; Wang J., 2010, COMPUTER VISION PATT, DOI DOI 10.1109/CVPR.2010.5540018; Yang Jun, 2009, Proceedings of the 2009 2nd International Congress on Image and Signal Processing (CISP), DOI 10.1109/CISP.2009.5304123; Yu Kai, 2009, ADV NEURAL INFORM PR, P2223; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zeiler MD, 2011, IEEE I CONF COMP VIS, P2018, DOI 10.1109/ICCV.2011.6126474; Zhang J, 2007, INT J COMPUT VISION, V73, P213, DOI 10.1007/s11263-006-9794-4	58	1274	1306	32	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130140	10.1371/journal.pone.0130140	http://dx.doi.org/10.1371/journal.pone.0130140			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161953	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300014
J	Dietz, SM; Tacke, CEA; Hutten, BA; Kuijpers, TW				Dietz, Sanne M.; Tacke, Carline E. A.; Hutten, Barbara A.; Kuijpers, Taco W.			Peripheral Endothelial (Dys)Function, Arterial Stiffness and Carotid Intima-Media Thickness in Patients after Kawasaki Disease: A Systematic Review and Meta-Analyses	PLOS ONE			English	Review							CARDIOVASCULAR RISK-FACTORS; C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; PULSE-WAVE VELOCITY; BRACHIAL-ARTERY; STATIN THERAPY; TASK-FORCE; CHILDREN; ATHEROSCLEROSIS; ADOLESCENTS	Background Kawasaki disease (KD) is a systemic pediatric vasculitis. Its main complication is the development of coronary arterial aneurysms (CAA), causing an increased risk for ischemia and myocardial infarction. It is unclear whether KD patients, apart from the presence of CAA, have an increased cardiovascular disease (CVD) risk due to the previous systemic vasculitis. The aim of this study was to systematically review and meta-analyse the literature regarding surrogate markers for CVD risk in KD patients. Methods Medline and Embase were searched for articles comparing endothelial dysfunction (flow-mediated dilation, nitroglycerin-mediated dilation and peripheral arterial tonometry), vascular stiffness (stiffness index, pulse wave velocity) and carotid intima-media thickness (cIMT) between patients and controls. Two investigators assessed the articles for eligibility and evaluated quality. Results Thirty studies were included. For all outcomes, moderate to high heterogeneity between studies was found. Most studies reported a decreased flow-mediated dilation in the whole KD- and CAA-positive group compared to controls, while data on CAA-negative patients were conflicting. The stiffness index was increased in the majority of studies evaluating the whole KD- and CAA-positive group, but not in most studies on CAA-negative patients. Mean cIMT was neither significantly increased in the whole KD-group nor in the CAA-positive group nor in most studies studying CAA-negative patients. Studies measuring maximum cIMT were conflicting. Conclusion Literature suggests that surrogate markers for CVD risk in KD patients are increased in CAA-positive but not in CAA-negative patients. This may indicate that CAA-positive patients should be monitored for CVD in later life. The results of this review have to be interpreted with care due to substantial heterogeneity between studies and methodological limitations, as well as the lack of long-term follow-up studies.	[Dietz, Sanne M.; Tacke, Carline E. A.; Kuijpers, Taco W.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Hematol Immunol & Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [Hutten, Barbara A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Dietz, SM (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Hematol Immunol & Infect Dis, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.m.dietz@amc.uva.nl	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	Stinafo Foundation (The Hague, The Netherlands)	Stinafo Foundation (The Hague, The Netherlands)(Netherlands Government)	This work was supported by the Stinafo Foundation (The Hague, The Netherlands). The sponsor had no role in the study design, the data collection and analysis, the writing of the report, or the decision to submit the manuscript for publication.	Borzutzky A, 2008, CLIN RHEUMATOL, V27, P845, DOI 10.1007/s10067-007-0808-6; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Cheung YF, 2007, ARCH DIS CHILD, V92, P43, DOI 10.1136/adc.2006.096628; Cheung YF, 2004, J AM COLL CARDIOL, V43, P120, DOI 10.1016/j.jacc.2003.08.030; Cheung YF, 2004, HEART, V90, P1281, DOI 10.1136/hrt.2003.018507; Cheung YF, 2004, PEDIATR RES, V56, P591, DOI 10.1203/01.PDR.0000139406.22305.A4; Cheung YF, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-20; Cho Hyun Jeong, 2014, Korean J Pediatr, V57, P217, DOI 10.3345/kjp.2014.57.5.217; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Dawson JD, 2009, J AM COLL CARDIOL, V53, P2273, DOI 10.1016/j.jacc.2009.03.026; de Jongh S, 2002, J AM COLL CARDIOL, V40, P2117, DOI 10.1016/S0735-1097(02)02593-7; Deng YB, 2002, CIRC J, V66, P908, DOI 10.1253/circj.66.908; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhillon R, 1996, CIRCULATION, V94, P2103, DOI 10.1161/01.CIR.94.9.2103; Duan C, 2014, WORLD J PEDIATR, V10, P232, DOI 10.1007/s12519-014-0498-5; Duan Chao, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P373; Green DJ, 2014, HYPERTENSION, V63, P376, DOI 10.1161/HYPERTENSIONAHA.113.02044; Gupta-Malhotra M, 2009, J PEDIATR-US, V155, P572, DOI 10.1016/j.jpeds.2009.04.054; Hamburg NM, 2011, HYPERTENSION, V57, P390, DOI 10.1161/HYPERTENSIONAHA.110.160812; Han JY, 2013, AM J MED SCI, V346, P92, DOI 10.1097/MAJ.0b013e318268c05a; Hedetoft M, 2014, NITRIC OXIDE-BIOL CH, V42, P1, DOI 10.1016/j.niox.2014.07.003; HIRAI T, 1989, CIRCULATION, V80, P78, DOI 10.1161/01.CIR.80.1.78; Huang SM, 2008, CIRC J, V72, P1583, DOI 10.1253/circj.CJ-08-0121; Ikemoto Y, 2005, PEDIATR CARDIOL, V26, P782, DOI 10.1007/s00246-005-0921-8; Im JA, 2007, J PEDIATR-US, V150, P247, DOI 10.1016/j.jpeds.2006.11.038; Ishikawa T, 2013, J PEDIATR-US, V163, P1117, DOI 10.1016/j.jpeds.2013.04.046; Kadono T, 2005, PEDIATR CARDIOL, V26, P385, DOI 10.1007/s00246-004-0755-9; Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2; Lamotte C, 2013, ATHEROSCLEROSIS, V228, P460, DOI 10.1016/j.atherosclerosis.2013.03.007; Laurito M, 2014, ANGIOLOGY, V65, P716, DOI 10.1177/0003319713502392; Lee Soo Jin, 2009, Korean Circ J, V39, P264, DOI 10.4070/kcj.2009.39.7.264; Liu XQ, 2009, ACTA PAEDIATR, V98, P1355, DOI 10.1111/j.1651-2227.2009.01334.x; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Manlhiot C, 2010, PEDIATR CARDIOL, V31, P242, DOI 10.1007/s00246-009-9599-7; Maruhashi T, 2013, ARTERIOSCL THROM VAS, V33, P1401, DOI 10.1161/ATVBAHA.112.300934; Mccrindle BW, 2007, J PEDIATR-US, V151, P244, DOI 10.1016/j.jpeds.2007.03.056; Meena RS, 2014, RHEUMATOL INT, V34, P1117, DOI 10.1007/s00296-013-2820-2; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Niboshi A, 2008, EUR J PEDIATR, V167, P189, DOI 10.1007/s00431-007-0452-9; Noto N, 2001, PEDIATRICS, V107, P1095, DOI 10.1542/peds.107.5.1095; Noto N, 2012, ATHEROSCLEROSIS, V222, P106, DOI 10.1016/j.atherosclerosis.2012.01.049; Noto N, 2009, PEDIATR CARDIOL, V30, P262, DOI 10.1007/s00246-008-9329-6; Nunez F, 2010, REV ESP CARDIOL, V63, P1253, DOI 10.1016/S0300-8932(10)70295-5; O'Rourke MF, 2002, AM J HYPERTENS, V15, P426, DOI 10.1016/S0895-7061(01)02319-6; Ogawa S, 2010, CIRC J, V74, P1989, DOI 10.1253/circj.CJ-10-74-0903; Oguri M, 2014, CARDIOL YOUNG, V24, P87, DOI 10.1017/S1047951112002302; Pahkala K, 2011, CIRCULATION, V124, P1956, DOI 10.1161/CIRCULATIONAHA.111.043851; Pinto FF, 2013, CARDIOL YOUNG, V23, P517, DOI 10.1017/S1047951112001357; Ras RT, 2013, INT J CARDIOL, V168, P344, DOI 10.1016/j.ijcard.2012.09.047; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rubinshtein R, 2010, EUR HEART J, V31, P1142, DOI 10.1093/eurheartj/ehq010; Silva AAEE, 2001, J PEDIATR-US, V138, P400, DOI 10.1067/mpd.2001.111430; Suzuki A, 2000, CIRCULATION, V101, P2935, DOI 10.1161/01.CIR.101.25.2935; Tierney ESS, 2013, J AM COLL CARDIOL, V62, P1114, DOI 10.1016/j.jacc.2013.04.090; Tobayama H, 2013, J CARDIOL, V61, P330, DOI 10.1016/j.jjcc.2012.12.007; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061	59	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130913	10.1371/journal.pone.0130913	http://dx.doi.org/10.1371/journal.pone.0130913			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161871	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300025
J	Erdos, PL; Kiss, SZ; Miklos, I; Soukup, L				Erdos, Peter L.; Kiss, Sandor Z.; Miklos, Istvan; Soukup, Lajos			Approximate Counting of Graphical Realizations	PLOS ONE			English	Article							ALGORITHM	In 1999 Kannan, Tetali and Vempala proposed a MCMC method to uniformly sample all possible realizations of a given graphical degree sequence and conjectured its rapidly mixing nature. Recently their conjecture was proved affirmative for regular graphs (by Cooper, Dyer and Greenhill, 2007), for regular directed graphs (by Greenhill, 2011) and for half-regular bipartite graphs (by Miklos, Erdos and Soukup, 2013). Several heuristics on counting the number of possible realizations exist (via sampling processes), and while they work well in practice, so far no approximation guarantees exist for such an approach. This paper is the first to develop a method for counting realizations with provable approximation guarantee. In fact, we solve a slightly more general problem; besides the graphical degree sequence a small set of forbidden edges is also given. We show that for the general problem (which contains the Greenhill problem and the Miklos, Erdos and Soukup problem as special cases) the derived MCMC process is rapidly mixing. Further, we show that this new problem is self-reducible therefore it provides a fully polynomial randomized approximation scheme (a.k.a. FPRAS) for counting of all realizations.	[Erdos, Peter L.; Miklos, Istvan; Soukup, Lajos] Hungarian Acad Sci, Alfred Renyi Inst Math, Budapest, Hungary; [Kiss, Sandor Z.; Miklos, Istvan] Hungarian Acad Sci, Inst Comp Sci & Control, Budapest, Hungary; [Kiss, Sandor Z.] Univ Technol & Econ, Dept Algebra, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Alfred Renyi Institute of Mathematics; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute for Computer Science & Control; Budapest University of Technology & Economics	Erdos, PL (corresponding author), Realtanoda U 13-5, H-1053 Budapest, Hungary.	erdos.peter@renyi.mta.hu			U.S. Air Force Office of Scientific Research (AFOSR) [FA9550-12-1-0405]; Defense Advanced Research Projects Agency (DARPA); Alexander von Humboldt-Foundation; Hungarian NSF [K77476, NK105645, PD84297, NK 83726]	U.S. Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation); Hungarian NSF(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	PLE and IM acknowledge financial support from grant #FA9550-12-1-0405 from the U.S. Air Force Office of Scientific Research (AFOSR) and the Defense Advanced Research Projects Agency (DARPA). PLE was partly supported by the Alexander von Humboldt-Foundation, when this author visited Universitat Hamburg in Fall of 2014. SZK was partly supported by Hungarian NSF, under contract K77476 and NK105645. IM was partly supported by Hungarian NSF, under contract PD84297. LS was partly supported by Hungarian NSF, under contract NK 83726. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper C, 2007, COMB PROBAB COMPUT, V16, P557, DOI 10.1017/S0963548306007978; Erdos PL, 2013, COMB PROBAB COMPUT, V22, P366, DOI 10.1017/S0963548313000096; Erdos PL, 2010, ELECTRON J COMB, V17; Gale D., 1957, PAC J MATH, V7, P1073, DOI [10.2140/pjm.1957.7.1073, DOI 10.2140/PJM.1957.7.1073]; Greenhill C., 2011, ELECTRON J COMB, V18, P234; HAKIMI SL, 1962, J SOC IND APPL MATH, V10, P496, DOI 10.1137/0110037; Havel V., 1955, CASOPIS PROPESTOV MA, V80, P477, DOI DOI 10.21136/CPM.1955.108220; Jerrum M, 2004, J ACM, V51, P671, DOI 10.1145/1008731.1008738; JERRUM MR, 1986, THEOR COMPUT SCI, V43, P169, DOI 10.1016/0304-3975(86)90174-X; Kannan R, 1999, RANDOM STRUCT ALGOR, V14, P293, DOI 10.1002/(SICI)1098-2418(199907)14:4<293::AID-RSA1>3.0.CO;2-G; Kim H, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/39/392001; Kleitman D. J., 1973, Discrete Mathematics, V6, P79, DOI 10.1016/0012-365X(73)90037-X; Miklos I., 2013, ELECRON J COMBIN, V20, P1; Newman M, 2010, NETWORKS INTRO, DOI 10.1093/acprof:oso/9780199206650.001.0001; Newman MEJ, 2006, STRUCTURE DYNAMICS N, P624; Petersen J., 1891, ACTA MATH, P193, DOI DOI 10.1007/BF02392606; Ryser HJ., 1957, CAN J MATH, V9, P371, DOI [10.4153/CJM-1957-044-3, DOI 10.4153/CJM-1957-044-3]; Sinclair A., 1992, COMBINATORICS PROBAB, V1, P351, DOI DOI 10.1017/S0963548300000390; TUTTE WT, 1952, CAN J MATH, V4, P314, DOI 10.4153/CJM-1952-028-2	19	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131300	10.1371/journal.pone.0131300	http://dx.doi.org/10.1371/journal.pone.0131300			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161994	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000358162300032
J	Jiang, BH; Yang, KJ; Cao, SY				Jiang, Beihan; Yang, Kejun; Cao, Shuyou			An Analytical Model for the Distributions of Velocity and Discharge in Compound Channels with Submerged Vegetation	PLOS ONE			English	Article							2-DIMENSIONAL ANALYTICAL SOLUTION; DEPTH-AVERAGED VELOCITY; MOMENTUM-TRANSFER; FLOW RESISTANCE; EMERGENT; FORMULAS; STRESS; DRAG	Based on the momentum transfer theory, an analytical model is proposed for the velocity and discharge distributions in compound channels with submerged vegetation on the flood-plain. The partially vegetated channel was divided into three sub-regions, i.e. the main channel region, the floodplain region with submerged vegetation and the floodplain region without vegetation. For each region, the force balance relationship was established, and the momentum transfer between different regions was presented. Verification by the experimental data and comparison with the traditional method shows that the proposed method is capable of predicting for the velocity and discharge distributions in compound channels with submerged vegetation and is superior to the conventional method. The results also show that when the momentum transfer between different regions is ignored, the computed discharge will be much lager than the measured data, and the error increases with the discharge, especially in the floodplain region.	[Jiang, Beihan] Fuzhou Univ, Coll Civil Engn, Fuzhou 350002, Fujian, Peoples R China; [Jiang, Beihan; Yang, Kejun; Cao, Shuyou] Sichuan Univ, State Key Lab Hydraul & Mt River Engn, Chengdu 610064, Sichuan, Peoples R China	Fuzhou University; Sichuan University	Yang, KJ (corresponding author), Sichuan Univ, State Key Lab Hydraul & Mt River Engn, Chengdu 610064, Sichuan, Peoples R China.	yangkejun@scu.edu.cn			National Natural Scientific Foundation of China [51479128, 51279117]; Program for New Century Excellent Talents in University of China [NCET-13-0393]; Excellent Youth Foundation of Sichuan University [2014SCU04B03]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); Excellent Youth Foundation of Sichuan University	The National Natural Scientific Foundation of China (Nos. 51479128 and 51279117), the Program for New Century Excellent Talents in University of China (No.: NCET-13-0393) and the Excellent Youth Foundation of Sichuan University (No.: 2014SCU04B03) supported this study.	ACKERS P, 1992, P I CIVIL ENG-WATER, V96, P247, DOI 10.1680/iwtme.1992.21674; ACKERS P, 1993, J HYDRAUL RES, V31, P509, DOI 10.1080/00221689309498874; Ackers P., 1993, WATER ENV MANAGE, V7, P52, DOI DOI 10.1111/j.1747-6593.1993.tb00810.x; Choi SU, 2004, J HYDRAUL RES, V42, P3, DOI 10.1080/00221686.2004.9641178; Einstein H.A., 1950, EOS T AM GEOPHYS UN, V31, P603, DOI [DOI 10.1029/TR031I004P00603, 10.1029/TR031i004p00603]; Fischer-Antze T, 2001, J HYDRAUL RES, V39, P303, DOI 10.1080/00221680109499833; Huai WX, 2010, ADV WATER RESOUR, V33, P635, DOI 10.1016/j.advwatres.2010.03.006; Huai WX, 2008, APPL MATH MECH-ENGL, V29, P1077, DOI 10.1007/s10483-008-0811-y; Huai WX, 2011, APPL MATH MECH-ENGL, V32, P459, DOI 10.1007/s10483-011-1430-6; Huai WX, 2009, APPL MATH MECH-ENGL, V30, P1121, DOI 10.1007/s10483-009-0906-z; Huai WX, 2009, APPL MATH MECH-ENGL, V30, P343, DOI 10.1007/s10483-009-0308-1; Huai WX, 2014, ADV WATER RESOUR, V69, P106, DOI 10.1016/j.advwatres.2014.04.001; Huai WX, 2013, J HYDRAUL RES, V51, P708, DOI 10.1080/00221686.2013.818585; Huai WX, 2012, ADV WATER RESOUR, V49, P56, DOI 10.1016/j.advwatres.2012.07.001; Huang B., 2002, J HYDRODYNAM SERB, V14, P23; KNIGHT DW, 1983, J HYDRAUL ENG-ASCE, V109, P1073, DOI 10.1061/(ASCE)0733-9429(1983)109:8(1073); Krishnamurthy M., 1972, J HYDRAUL DIV, V98, P2257; Liao HS, 2007, ADV WATER RESOUR, V30, P2283, DOI 10.1016/j.advwatres.2007.05.002; Liu C, 2013, ADV WATER RESOUR, V60, P148, DOI 10.1016/j.advwatres.2013.08.002; Liu P.Q., 1995, J YANGTZE RIVER SCI, V3, P61; Lotter G.K., 1933, T ALL UNION SCI RES, V9, P238; Mohaghegh A, 2008, J HYDRODYN, V20, P81, DOI 10.1016/S1001-6058(08)60031-1; MYERS WRC, 1990, J HYDRAUL RES, V28, P141, DOI 10.1080/00221689009499083; MYERS WRC, 1978, J HYDRAUL RES, V16, P139, DOI 10.1080/00221687809499626; Nepf HM, 1999, WATER RESOUR RES, V35, P479, DOI 10.1029/1998WR900069; Nepf HM, 2000, J GEOPHYS RES-OCEANS, V105, P28547, DOI 10.1029/2000JC900145; Pavlovskii N. N., 1931, T ALL UNION SCI RES, V3, P157; POSEY CJ, 1967, CIVIL ENG, V37, P63; PRINOS P, 1984, ADV WATER RESOUR, V7, P180, DOI 10.1016/0309-1708(84)90016-2; Righetti M, 2002, J HYDROL, V269, P55, DOI 10.1016/S0022-1694(02)00194-4; Schlichting H., 1961, BOUNDARY LAYER THEOR, V121; SHIONO K, 1991, J FLUID MECH, V222, P617, DOI 10.1017/S0022112091001246; Sun X, 2006, THESIS LOUGHBOROUGH; Sun X, 2009, ADV WATER RESOUR, V32, P430, DOI 10.1016/j.advwatres.2008.12.004; Tang X, 2008, ADV WATER RESOUR, V31, P846, DOI 10.1016/j.advwatres.2008.02.002; Tang XN, 2009, SCI CHINA SER E, V52, P3357, DOI 10.1007/s11431-009-0342-7; Tang XN, 1999, J HYDRAUL RES, V37, P591, DOI 10.1080/00221689909498519; Tang XN, 2011, J ENG COMPUTATION ME, V164, P1; Tanino Y, 2008, J HYDRAUL ENG-ASCE, V134, P34, DOI 10.1061/(ASCE)0733-9429(2008)134:1(34); Wang H, 2007, J HYDRODYN, V19, P225, DOI 10.1016/S1001-6058(07)60052-3; Wang W, 1998, J HYDRODYNAMICS B, V10, P31; WORMLEATON PR, 1982, J HYDR ENG DIV-ASCE, V108, P975; Wu CG, 1982, BOOK 2 HYDRAULICS; [吴福生 WU Fusheng], 2007, [水利学报, Journal of Hydraulic Engineering], V38, P1301; Yang KJ, 2007, J HYDRAUL ENG-ASCE, V133, P148, DOI 10.1061/(ASCE)0733-9429(2007)133:2(148); [杨克君 Yang Kejun], 2005, [水利学报, Journal of Hydraulic Engineering], V36, P563	46	7	7	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130841	10.1371/journal.pone.0130841	http://dx.doi.org/10.1371/journal.pone.0130841			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161661	gold, Green Published, Green Submitted			2022-12-27	WOS:000358162300023
J	Kim, GS; Jung, HE; Kim, JS; Lee, YC				Kim, Gwang Sik; Jung, Ha-Eun; Kim, Jeong-Sun; Lee, Young Chul			Mutagenesis Study Reveals the Rim of Catalytic Entry Site of HDAC4 and-5 as the Major Binding Surface of SMRT Corepressor	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; NUCLEAR RECEPTOR COREPRESSOR; THYROID-HORMONE RECEPTOR; PLUS 2-HYBRID SYSTEM; VITAMIN-D-RECEPTOR; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTIONAL REPRESSION; MOLECULAR DETERMINANTS; LXR/RXR HETERODIMERS; CARDIAC-HYPERTROPHY	Histone deacetylases (HDACs) play a pivotal role in eukaryotic gene expression by modulating the levels of acetylation of chromatin and related transcription factors. In contrast to class I HDACs (HDAC1, -2, -3 and -8), the class IIa HDACs (HDAC4, -5, -7 and -9) harbor cryptic deacetylases activity and recruit the SMRT-HDAC3 complex to repress target genes in vivo. In this regard, the specific interaction between the HDAC domain of class IIa HDACs and the C-terminal region of SMRT repression domain 3 (SRD3c) is known to be critical, but the molecular basis of this interaction has not yet been addressed. Here, we used an extensive mutant screening system, named the "partitioned one-plus two-hybrid system", to isolate SRD3c interaction-defective (SRID) mutants over the entire catalytic domains of HDAC4 (HDAC4c) and -5. The surface presentation of the SRID mutations on the HDAC4c structure revealed that most of the mutations were mapped to the rim surface of the catalytic entry site, strongly suggesting this mutational hot-spot region as the major binding surface of SRD3c. Notably, among the HDAC4c surface residues required for SRD3c binding, some residues (C667, C669, C751, D759, T760 and F871) are present only in class IIa HDACs, providing the molecular basis for the specific interactions between SRD3c and class IIa enzymes. To investigate the functional consequence of SRID mutation, the in vitro HDAC activities of HDAC4 mutants immuno-purified from HEK293 cells were measured. The levels of HDAC activity of the HDAC4c mutants were substantially decreased compared to wild-type. Consistent with this, SRID mutations of HDAC4c prevented the association of HDAC4c with the SMRT-HDAC3 complex in vivo. Our findings may provide structural insight into the binding interface of HDAC4 and -5 with SRD3c, as a novel target to design modulators specific to these enzymes.	[Kim, Gwang Sik; Jung, Ha-Eun; Lee, Young Chul] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea; [Kim, Jeong-Sun] Chonnam Natl Univ, Dept Chem, Kwangju 500757, South Korea; [Kim, Jeong-Sun] Chonnam Natl Univ, Inst Basic Sci, Kwangju 500757, South Korea	Chonnam National University; Chonnam National University; Chonnam National University	Lee, YC (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea.	yclee@jnu.ac.kr			National Research Foundation of Korea (NRF) - Korean Government [NRF 2011-0029484]	National Research Foundation of Korea (NRF) - Korean Government	This work was supported by a grant from the National Research Foundation of Korea (NRF), funded by the Korean Government (NRF 2011-0029484).	Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; Burli RW, 2013, J MED CHEM, V56, P9934, DOI 10.1021/jm4011884; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Clocchiatti A, 2011, J CELL MOL MED, V15, P1833, DOI 10.1111/j.1582-4934.2011.01321.x; Di Gennaro E, 2004, AMINO ACIDS, V26, P435, DOI 10.1007/s00726-004-0087-3; Downes M, 2000, P NATL ACAD SCI USA, V97, P10330, DOI 10.1073/pnas.97.19.10330; Eom GH, 2014, PHARMACOL THERAPEUT, V143, P168, DOI 10.1016/j.pharmthera.2014.02.012; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Granger A, 2008, FASEB J, V22, P3549, DOI 10.1096/fj.08-108548; Haberland M, 2009, P NATL ACAD SCI USA, V106, P7751, DOI 10.1073/pnas.0903139106; Hancock WW, 2012, ANN RHEUM DIS, V71, P46, DOI 10.1136/annrheumdis-2011-200593; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Huang EY, 2000, GENE DEV, V14, P45; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ishizuka T, 2005, MOL ENDOCRINOL, V19, P1443, DOI 10.1210/me.2005-0009; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim JY, 2007, MOL CELL PROTEOMICS, V6, P1727, DOI 10.1074/mcp.M700079-MCP200; Kim JY, 2012, METHODS MOL BIOL, V812, P209, DOI 10.1007/978-1-61779-455-1_12; Kim JY, 2010, J MOL BIOL, V396, P747, DOI 10.1016/j.jmb.2009.12.008; Kim JY, 2009, BIOCHEM BIOPH RES CO, V379, P780, DOI [10.1016/j.bbrc.2008.12.156, 10.1016/j.bbrc.2008.12.155]; Kim JY, 2009, MOL ENDOCRINOL, V23, P251, DOI 10.1210/me.2008-0426; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Mielcarek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080849; Mielcarek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027746; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Miller TA, 2003, J MED CHEM, V46, P5097, DOI 10.1021/jm0303094; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Park EJ, 1999, P NATL ACAD SCI USA, V96, P3519, DOI 10.1073/pnas.96.7.3519; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Slingerland M, 2014, ANTI-CANCER DRUG, V25, P140, DOI 10.1097/CAD.0000000000000040; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Son YL, 2008, BIOCHEM J, V410, P319, DOI 10.1042/BJ20070837; Son YL, 2012, MOL BIOL REP, V39, P177, DOI 10.1007/s11033-011-0723-4; Son YL, 2010, FEBS LETT, V584, P3862, DOI 10.1016/j.febslet.2010.07.056; Son YL, 2009, BIOCHEM BIOPH RES CO, V384, P389, DOI 10.1016/j.bbrc.2009.04.131; Sun Z, 2013, MOL CELL, V52, P769, DOI 10.1016/j.molcel.2013.10.022; Sung YM, 2013, EXP NEUROL, V239, P192, DOI 10.1016/j.expneurol.2012.10.005; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wardell SE, 2009, MOL ENDOCRINOL, V23, P388, DOI 10.1210/me.2008-0179; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yin Lei, 2010, Nucl Recept Signal, V8, pe001, DOI 10.1621/nrs.08001; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1	62	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132680	10.1371/journal.pone.0132680	http://dx.doi.org/10.1371/journal.pone.0132680			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161557	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300166
J	Sanli, C; Lambiotte, R				Sanli, Ceyda; Lambiotte, Renaud			Local Variation of Hashtag Spike Trains and Popularity in Twitter	PLOS ONE			English	Article							HEAVY TAILS; COMPETITION; DIFFUSION; DYNAMICS; NETWORK; MEMES; MODEL	We draw a parallel between hashtag time series and neuron spike trains. In each case, the process presents complex dynamic patterns including temporal correlations, burstiness, and all other types of nonstationarity. We propose the adoption of the so-called local variation in order to uncover salient dynamical properties, while properly detrending for the time-dependent features of a signal. The methodology is tested on both real and randomized hashtag spike trains, and identifies that popular hashtags present regular and so less bursty behavior, suggesting its potential use for predicting online popularity in social media.	[Sanli, Ceyda; Lambiotte, Renaud] Univ Namur, NaXys, Dept Math, CompleX & Networks, Namur, Belgium	University of Namur	Sanli, C (corresponding author), Univ Namur, NaXys, Dept Math, CompleX & Networks, Namur, Belgium.	cedaysan@gmail.com	Lambiotte, Renaud/HDO-4530-2022	Lambiotte, Renaud/0000-0002-0583-4595	EU 7th Framework OptimizR Project [48909A2 CE OPTIMIZR];  [F.N.R.S MIS F4527.12 48888F3]	EU 7th Framework OptimizR Project; 	This work was supported by grant number F.N.R.S MIS F4527.12 48888F3 (grant holder: RL, funding receiver: CS, http://www.fnrs.be/), the EU 7th Framework OptimizR Project: 48909A2 CE OPTIMIZR (grant holder: RL, funding receiver: CS, http://optimizr.eu/), and the National Institute of Informatics Tokyo (http://www.nii.ac.jp/en/) for partial traveling support. This funder had a role in preparation of the manuscript (visit for scientific exchange of ideas), but did not have a further role in	[Anonymous], 2013, NONLINEAR MICROSCALE; Backlund VP, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.062815; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Borge-Holthoefer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023883; Cetin U, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032801; Cheng J, 2014, WWW'14: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P925, DOI 10.1145/2566486.2567997; Coscia M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06477; Deschatres F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016112; DOMENICO MD, 2013, SCI REP, V3, DOI DOI 10.1038/SREP02980; Franca U, 2014, ARXIV E PRINTS; Gleeson JP, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.048701; Gleeson JP, 2015, ARXIV E PRINTS; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; Jo HH, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/013055; Jo HH, 2015, ARXIV E PRINTS; Jovanovic S, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.042802; Karimi F, 2013, PHYSICA A, V392, P3476, DOI 10.1016/j.physa.2013.03.050; Karsai M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00397; Kawamoto T, 2013, PHYSICA A, V392, P3470, DOI 10.1016/j.physa.2013.03.048; Kenett DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102001; Koyama S, 2005, J PHYS A-MATH GEN, V38, pL531, DOI 10.1088/0305-4470/38/29/L04; Lambiotte R, 2007, J INFORMETR, V1, P277, DOI 10.1016/j.joi.2007.07.001; Lambiotte R, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40456-9; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; Miotto JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111506; Miura K, 2006, NEURAL COMPUT, V18, P2359, DOI 10.1162/neco.2006.18.10.2359; Mollgaard A, 2015, ARXIV E PRINTS; Myers S, 2014, WWW'14: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P913, DOI 10.1145/2566486.2568043; Myers SA, 2012, IEEE DATA MINING, P539, DOI 10.1109/ICDM.2012.159; Omi T, 2011, NEURAL COMPUT, V23, P3125, DOI 10.1162/NECO_a_00213; Onaga T, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.042817; Ratkiewicz J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158701; Rodriguez MG, 2014, NETW SCI, V2, P26, DOI 10.1017/nws.2014.3; Sasahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061823; Shimazaki H, 2007, NEURAL COMPUT, V19, P1503, DOI 10.1162/neco.2007.19.6.1503; Shinomoto S, 2003, NEURAL COMPUT, V15, P2823, DOI 10.1162/089976603322518759; Shinomoto S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000433; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Szabolcs V, 2013, NEW J PHYS, V15, DOI [10.1088/1367-2630/15/10/103023, DOI 10.1088/1367-2630/15/10/103023]; Takaguchi T, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036115; Tuckwell H. C., 1988, INTRO THEORETICAL NE, V2; Vestergaard CL, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042805; Weng L, 2012, SCI REP-UK, V2, P1, DOI 10.1038/srep00335; Weng LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02522	44	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131704	10.1371/journal.pone.0131704	http://dx.doi.org/10.1371/journal.pone.0131704			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161650	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300053
J	van Wijk, DF; Strang, AC; Duivenvoorden, R; Enklaar, DJF; Zwinderman, AH; van der Geest, RJ; Kastelein, JJP; de Groot, E; Stroes, ESG; Nederveen, AJ				van Wijk, Diederik F.; Strang, Aart C.; Duivenvoorden, Raphael; Enklaar, Dirk-Jan F.; Zwinderman, Aeilko H.; van der Geest, Rob J.; Kastelein, John J. P.; de Groot, Eric; Stroes, Erik S. G.; Nederveen, Aart J.			Increasing the Spatial Resolution of 3T Carotid MRI Has No Beneficial Effect for Plaque Component Measurement Reproducibility	PLOS ONE			English	Article							IN-VIVO; FIBROUS-CAP; ATHEROSCLEROTIC LESIONS; SCAN-RESCAN; 1.5 T; THICKNESS; VALIDATION; HEMORRHAGE; ACCURACY; CONTRAST	Purpose Different in-plane resolutions have been used for carotid 3T MRI. We compared the reproducibility, as well as the within-and between reader variability of high and routinely used spatial resolution in scans of patients with atherosclerotic carotid artery disease. Since no consensus exists about the optimal segmentation method, we analysed all imaging data using two different segmentation methods. Materials and Methods In 31 patient with carotid atherosclerosis a high (0.25 x 0.25 mm(2); HR) and routinely used (0.50 x 0.50 mm(2); LR) spatial resolution carotid MRI scan were performed within one month. A fully blinded closed and a simultaneously open segmentation were used to quantify the lipid rich necrotic core (LRNC), calcified and loose matrix (LM) plaque area and the fibrous cap (FC) thickness. Results No significant differences were observed between scan-rescan reproducibility for HR versus LR measurements, nor did we find any significant difference between the within-reader and between-reader reproducibility. The same applies for differences between the open and closed reads. All intraclass correlation coefficients between scans and rescans for the LRNC, calcified and LM plaque area, as well as the FC thickness measurements with the open segmentation method were excellent (all above 0.75). Conclusions Increasing the spatial resolution at the expense of the contrast-to-noise ratio does not improve carotid plaque component scan-rescan reproducibility in patients with atherosclerotic carotid disease, nor does using a different segmentation method.	[van Wijk, Diederik F.; Strang, Aart C.; Duivenvoorden, Raphael; Enklaar, Dirk-Jan F.; Kastelein, John J. P.; de Groot, Eric; Stroes, Erik S. G.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; [van der Geest, Rob J.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Nederveen, Aart J.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	van Wijk, DF (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	D.F.vanWijk@amc.uva.nl	Duivenvoorden, Raphaël/B-5154-2019; Kastelein, John/AAF-7950-2020; van der Geest, Rob J/J-8193-2015	Duivenvoorden, Raphaël/0000-0003-1446-8336; van der Geest, Rob J/0000-0002-9084-5597; Nederveen, Aart/0000-0002-5477-973X	Merck, United States of America	Merck, United States of America	This study was supported by an educational research grant of Merck, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame IM, 2006, J MAGN RESON IMAGING, V24, P595, DOI 10.1002/jmri.20662; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Balu N, 2009, J MAGN RESON IMAGING, V30, P1209, DOI 10.1002/jmri.21890; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; Cappendijk VC, 2004, J MAGN RESON IMAGING, V20, P105, DOI 10.1002/jmri.20060; Corti R, 2002, CIRCULATION, V106, P2884, DOI 10.1161/01.CIR.0000041255.88750.F0; Hatsukami TS, 2000, CIRCULATION, V102, P959, DOI 10.1161/01.CIR.102.9.959; Keenan NG, 2010, J MAGN RESON IMAGING, V31, P935, DOI 10.1002/jmri.22109; Kobayashi M, 2008, NEUROL MED-CHIR, V48, P211, DOI 10.2176/nmc.48.211; Koktzoglou I, 2006, J MAGN RESON IMAGING, V23, P699, DOI 10.1002/jmri.20563; Koning W, 2013, MAGN RESON MED, V69, P1186, DOI 10.1002/mrm.24345; Kwee RM, 2009, STROKE, V40, P3017, DOI 10.1161/STROKEAHA.109.555052; Li FY, 2010, J MAGN RESON IMAGING, V31, P168, DOI 10.1002/jmri.22014; Meissner OA, 2003, J VASC INTERV RADIOL, V14, P227, DOI 10.1097/01.RVI.0000058325.82956.63; Rosner B, 2010, FUNDAMENTALS BIOSTAT; Saam T, 2005, J CARDIOVASC MAGN R, V7, P799, DOI 10.1080/10976640500287703; Saam T, 2005, ARTERIOSCL THROM VAS, V25, P234, DOI 10.1161/01.ATV.0000149867.61851.31; Saam T, 2008, J AM COLL CARDIOL, V51, P1014, DOI 10.1016/j.jacc.2007.10.054; Shinnar M, 1999, ARTERIOSCL THROM VAS, V19, P2756, DOI 10.1161/01.ATV.19.11.2756; TOUSSAINT JF, 1995, ARTERIOSCL THROM VAS, V15, P1533; Trivedi RA, 2004, NEURORADIOLOGY, V46, P738, DOI 10.1007/s00234-004-1247-6; Underhill HR, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2007.11.018; Van Wijk DF, 2013, INCREASING SPATIAL R; Vidal A, 2008, PHYS MED BIOL, V53, P6821, DOI 10.1088/0031-9155/53/23/011; Winn WB, 1998, AM J NEURORADIOL, V19, P129; Wong SK, 2014, WORLD J RADIOL, V6, P192, DOI 10.4329/wjr.v6.i5.192; Yarnykh VL, 2006, J MAGN RESON IMAGING, V23, P691, DOI 10.1002/jmri.20562; Yuan C, 2001, CIRCULATION, V104, P2051, DOI 10.1161/hc4201.097839; Zhao XH, 2011, STROKE, V42, P347, DOI 10.1161/STROKEAHA.110.597328; Zhao XQ, 2011, JACC-CARDIOVASC IMAG, V4, P977, DOI 10.1016/j.jcmg.2011.06.013	30	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130878	10.1371/journal.pone.0130878	http://dx.doi.org/10.1371/journal.pone.0130878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161783	gold, Green Submitted, Green Published			2022-12-27	WOS:000358162300024
J	Wang, Q; Li, KY; Zhang, DX; Li, JY; Xu, GY; Zheng, JX; Yang, N; Qu, LJ				Wang, Qiong; Li, Kaiyang; Zhang, Daixi; Li, Junying; Xu, Guiyun; Zheng, Jiangxia; Yang, Ning; Qu, Lujiang			Next-Generation Sequencing Techniques Reveal that Genomic Imprinting Is Absent in Day-Old Gallus gallus domesticus Brains	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; ORIGIN ALLELIC EXPRESSION; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; MOUSE-BRAIN; RNA-SEQ; TRANSCRIPTS; ALIGNMENT; CHICKEN; MAIZE	Genomic imprinting is a phenomenon characterized by parent-of-origin-specific gene expression. While widely documented in viviparous mammals and plants, imprinting in oviparous birds remains controversial. Because genomic imprinting is temporal-and tissue-specific, we investigated this phenomenon only in the brain tissues of 1-day-old chickens (Gallus gallus). We used next-generation sequencing technology to compare four transcrip-tomes pooled from 11 chickens, generated from reciprocally crossed families, to the DNA sequences of their parents. Candidate imprinted genes were then selected from these sequence alignments and subjected to verification experiments that excluded all but one SNP. Subsequent experiments performed with two new sets of reciprocally crossed families resulted in the exclusion of that candidate SNP as well. Attempts to find evidence of genomic imprinting from long non-coding RNAs yielded negative results. We therefore conclude that genomic imprinting is absent in the brains of 1-day-old chickens. However, due to the temporal and tissue specificity of imprinting, our results cannot be extended to all growth stages and tissue types.	[Wang, Qiong; Li, Kaiyang; Zhang, Daixi; Li, Junying; Xu, Guiyun; Zheng, Jiangxia; Yang, Ning; Qu, Lujiang] China Agr Univ, Dept Anim Genet & Breeding, Natl Engn Lab Anim Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	China Agricultural University	Qu, LJ (corresponding author), China Agr Univ, Dept Anim Genet & Breeding, Natl Engn Lab Anim Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	quluj@cau.edu.cn	Wang, Qiong/HDO-3975-2022	Wang, Qiong/0000-0001-7798-1554; Yang, Ning/0000-0001-5772-3320	National Scientific Supporting Projects of China [2012BAD39B04, 2011BAD28B03]	National Scientific Supporting Projects of China	Beijing innovation team attached to poultry industry technology system (CARS-PSTP) and National Scientific Supporting Projects of China (2011BAD28B03) received by LQ support the sequencing and data analysis; National Scientific Supporting Projects of China (2012BAD39B04) received by LQ play role in verification experiment and preparation of the manuscript.	BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Coolon JD, 2012, CELL REP, V2, P69, DOI 10.1016/j.celrep.2012.06.013; Davies W, 2005, NEUROSCI BIOBEHAV R, V29, P421, DOI 10.1016/j.neubiorev.2004.11.007; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; Fresard L, 2014, NUCLEIC ACIDS RES, V42, P3768, DOI 10.1093/nar/gkt1390; Fresard L, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-16; Gibson G, 2004, GENETICS, V167, P1791, DOI 10.1534/genetics.104.026583; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; KERMICLE JL, 1970, GENETICS, V66, P69; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Korir PK, 2014, METHODS MOL BIOL, V1112, P49, DOI 10.1007/978-1-62703-773-0_4; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Munshi Anjana, 2007, Journal of Genetics and Genomics, V34, P93, DOI 10.1016/S1673-8527(07)60010-1; Nadeau C, 2012, NAT METHODS, P9; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; Oakey RJ, 2002, TRENDS GENET, V18, P359, DOI 10.1016/S0168-9525(02)02708-7; Pask Andrew, 2012, Methods Mol Biol, V925, P263, DOI 10.1007/978-1-62703-011-3_18; Raissig MT, 2011, PLANT CELL, V23, P16, DOI 10.1105/tpc.110.081018; Ramirez-Gonzalez Ricardo H, 2013, F1000Res, V2, P248, DOI 10.12688/f1000research.2-248.v1; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Sauder JM, 2000, PROTEINS, V40, P6, DOI 10.1002/(SICI)1097-0134(20000701)40:1<6::AID-PROT30>3.0.CO;2-7; Smits G, 2008, NAT GENET, V40, P971, DOI 10.1038/ng.168; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuiskula-Haavisto M, 2007, CYTOGENET GENOME RES, V117, P305, DOI 10.1159/000103192; Wang ZP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003183; Weaver JR, 2009, MAMM GENOME, V20, P532, DOI 10.1007/s00335-009-9225-2; Yona G, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P395; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102; Zhang M, 2011, P NATL ACAD SCI USA, V108, P20042, DOI 10.1073/pnas.1112186108	39	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132345	10.1371/journal.pone.0132345	http://dx.doi.org/10.1371/journal.pone.0132345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161857	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300121
J	Mahjoub, Y; Malaquin, S; Mourier, G; Lorne, E; Abou Arab, O; Massy, ZA; Dupont, H; Ducancel, F				Mahjoub, Yazine; Malaquin, Stephanie; Mourier, Gilles; Lorne, Emmanuel; Abou Arab, Osama; Massy, Ziad A.; Dupont, Herve; Ducancel, Frederic			Short- versus Long-Sarafotoxins: Two Structurally Related Snake Toxins with Very Different in vivo Haemodynamic Effects	PLOS ONE			English	Article							ENDOTHELIN-LIKE PEPTIDES; LEFT-VENTRICULAR RELAXATION; ATRACTASPIS-ENGADDENSIS; BURROWING ASP; ISOLATED RAT; PRESSURE; RECEPTOR; LUNG; POLYPEPTIDE; PERFORMANCE	Sarafotoxin-m (24 amino acids) from the venom of Atractaspis microlepidota microlepidota was the first long-sarafotoxin to be identified, while sarafotoxin-b (21 aa) is a short-sarafotoxin from Atractaspis engaddensis. Despite the presence of three additional C-terminus residues in sarafotoxin-m, these two peptides display a high sequence homology and share similar three-dimensional structures. However, unlike sarafotoxin-b, sarafotoxin-m shows a very low in vitro affinity for endothelin receptors, but still has a very high in vivo toxicity in mammals, similar to that of sarafotoxin-b. We have previously demonstrated, in vitro, the crucial role of the C-terminus extension in terms of pharmacological profiles and receptor affinities of long-versus short-sarafotoxins. One possible hypothesis to explain the high in vivo toxicity of sarafotoxin-m could be that its C-terminus extension is processed in vivo, resulting in short-like sarafotoxin. To address this possibility, we investigated, in the present study, the in vivo cardiovascular effects of sarafotoxin-b, sarafotoxin-m and sarafotoxin-m -Cter (sarafotoxin-m without the C -terminus extension). Male Wistar rats were anaesthetised and mechanically ventilated. Invasive haemodynamic measurements and echocardiographic measurements of left and right ventricular function were performed. The rats were divided into four groups that respectively received intravenous injections of: saline, sarafotoxin-b (one LD50), sarafotoxin-m (one LD50) or sarafotoxin-m -Cter (one LD50). All measurements were performed at baseline, at 1 minute (+1) and at 6 minutes (+6) after injection. Results: Sarafotoxin-b and sarafotoxin-m-Cter decreased cardiac output and impaired left ventricle systolic and diastolic function, whilst sarafotoxin-m decreased cardiac output, increased airway pressures and led to acute right ventricular dilatation associated with a decreased tricuspid annulus peak systolic velocity. Sarafotoxin-b and sarafotoxin-m -Cter appear to exert toxic effects via impairment of left ventricular function, whilst sarafotoxin-m increases airway pressures and impairs right ventricular function. These results do not support the hypothesis of an in vivo processing of long sarafotoxins.	[Mahjoub, Yazine; Malaquin, Stephanie; Lorne, Emmanuel; Abou Arab, Osama; Dupont, Herve; Ducancel, Frederic] CHU Amiens, Pole Anesthesie Reanimat & Med Urgence, Amiens, France; [Mahjoub, Yazine; Malaquin, Stephanie; Lorne, Emmanuel; Abou Arab, Osama; Massy, Ziad A.; Dupont, Herve] Unite INSERM U1088, Amiens, France; [Ducancel, Frederic] CEA Fontenay aux Roses, Serv Immuno Virol, CEA, iMETI, F-92265 Fontenay Aux Roses, France; [Mourier, Gilles] CEA Saclay, CEA, iBiTec S, Serv Ingn Mol Prot SIMOPRO, F-91191 Gif Sur Yvette, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Mahjoub, Y (corresponding author), CHU Amiens, Pole Anesthesie Reanimat & Med Urgence, Amiens, France.	mahjoub.yazine@chu-amiens.fr	Mahjoub, Yazine/AAR-8585-2020; arab, osama abou/J-3073-2019; Dupont, Herve/D-1259-2010	arab, osama abou/0000-0003-3766-716X; 	CHU Amiens; INSERM [U1088]	CHU Amiens; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was funded by institutional funds from CHU Amiens and INSERM U1088 with no specific grant. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alam M, 2000, AM HEART J, V139, P710, DOI 10.1016/S0002-8703(00)90053-X; ATKINS AR, 1995, BIOCHEMISTRY-US, V34, P2026, DOI 10.1021/bi00006a024; Barton M, 2008, CAN J PHYSIOL PHARM, V86, P485, DOI 10.1139/Y08-059; BDOLAH A, 1989, BIOCHEM PHARMACOL, V38, P3145, DOI 10.1016/0006-2952(89)90606-0; D'Orleans-Juste P, 2002, PHARMACOL THERAPEUT, V95, P221, DOI 10.1016/S0163-7258(02)00235-8; Ducancel F, 2005, CELL MOL LIFE SCI, V62, P2828, DOI 10.1007/s00018-005-5286-x; Ducancel F, 2002, TOXICON, V40, P1541, DOI 10.1016/S0041-0101(02)00159-9; FILEP JG, 1991, BRIT J PHARMACOL, V103, P1633, DOI 10.1111/j.1476-5381.1991.tb09840.x; Fougeres E, 2010, CRIT CARE MED, V38, P802, DOI 10.1097/CCM.0b013e3181c587fd; GLOWER DD, 1985, CIRCULATION, V71, P994, DOI 10.1161/01.CIR.71.5.994; Granstrom B, 2004, ACTA PHYSIOL SCAND, V181, P259, DOI 10.1111/j.1365-201X.2004.01275.x; HAN SP, 1990, LIFE SCI, V46, P767, DOI 10.1016/0024-3205(90)90064-X; Hayashi MAF, 2004, PEPTIDES, V25, P1243, DOI 10.1016/j.peptides.2004.05.010; Jacques D, 2005, PEPTIDES, V26, P1427, DOI 10.1016/j.peptides.2005.03.048; Janosi T, 2008, EXP PHYSIOL, V93, P1210, DOI 10.1113/expphysiol.2008.042481; Jardin F, 1997, CHEST, V111, P209, DOI 10.1378/chest.111.1.209; JARDIN F, 1987, CHEST, V92, P789, DOI 10.1378/chest.92.5.789; KASS DA, 1988, CIRCULATION, V77, P1203, DOI 10.1161/01.CIR.77.6.1203; Khimji AK, 2010, CELL SIGNAL, V22, P1615, DOI 10.1016/j.cellsig.2010.05.002; Kiely DG, 1997, CARDIOVASC RES, V33, P378, DOI 10.1016/S0008-6363(96)00219-2; Konrad D, 2005, AM J PHYSIOL-HEART C, V289, pH1702, DOI 10.1152/ajpheart.00892.2004; Kurnik D, 1999, TOXICON, V37, P223, DOI 10.1016/S0041-0101(98)00166-4; LAL H, 1995, BRIT J PHARMACOL, V115, P653, DOI 10.1111/j.1476-5381.1995.tb14982.x; LOUIE EK, 1995, CIRCULATION, V92, P819, DOI 10.1161/01.CIR.92.4.819; Mahjoub Y, 2012, BRIT J ANAESTH, V108, P211, DOI 10.1093/bja/aer382; Mahjoub Y, 2009, CRIT CARE MED, V37, P2570, DOI 10.1097/CCM.0b013e3181a380a3; Meluzin J, 2001, EUR HEART J, V22, P340, DOI 10.1053/euhj.2000.2296; Mourier G, 2003, MOL PHARMACOL, V63, P26, DOI 10.1124/mol.63.1.26; Mourier G, 2012, BIOCHIMIE, V94, P461, DOI 10.1016/j.biochi.2011.08.014; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Slama M, 2005, AM J PHYSIOL-HEART C, V289, pH1131, DOI 10.1152/ajpheart.00345.2004; Slama M, 2003, AM J PHYSIOL-HEART C, V284, pH691, DOI 10.1152/ajpheart.00653.2002; SOKOLOVSKY M, 1991, TRENDS BIOCHEM SCI, V16, P261, DOI 10.1016/0968-0004(91)90100-A; TEERLINK JR, 1994, CIRC RES, V74, P105, DOI 10.1161/01.RES.74.1.105; Tei C, 1997, J AM SOC ECHOCARDIOG, V10, P169, DOI 10.1016/S0894-7317(97)70090-7; Vieillard-Baron A, 1999, J APPL PHYSIOL, V87, P1644, DOI 10.1152/jappl.1999.87.5.1644; WEISS JL, 1976, J CLIN INVEST, V58, P751, DOI 10.1172/JCI108522; WOLLBERG Z, 1988, TOXICON, V26, P525, DOI 10.1016/0041-0101(88)90232-2; Xu XL, 2015, CURR TOP MED CHEM, V15, P658, DOI 10.2174/1568026615666150217113835; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	40	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132864	10.1371/journal.pone.0132864	http://dx.doi.org/10.1371/journal.pone.0132864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176218	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600170
J	Birungi, J; Min, JE; Muldoon, KA; Kaleebu, P; King, R; Khanakwa, S; Nyonyintono, M; Chen, YL; Mills, EJ; Lyagoba, F; Ragonnet-Cronin, M; Wangisi, J; Lourenco, L; Moore, DM				Birungi, Josephine; Min, Jeong Eun; Muldoon, Katherine A.; Kaleebu, Pontiano; King, Rachel; Khanakwa, Sarah; Nyonyintono, Maureen; Chen, YaLin; Mills, Edward J.; Lyagoba, Fred; Ragonnet-Cronin, Manon; Wangisi, Jonathan; Lourenco, Lillian; Moore, David M.			Lack of Effectiveness of Antiretroviral Therapy in Preventing HIV Infection in Serodiscordant Couples in Uganda: An Observational Study	PLOS ONE			English	Article							HETEROSEXUAL TRANSMISSION; AFRICA; ACCESS	Background We examined the real-world effectiveness of ART as an HIV prevention tool among HIV serodiscordant couples in a programmatic setting in a low-income country. Methods We enrolled individuals from HIV serodiscordant couples aged >= 18 years of age in Jinja, Uganda from June 2009 - June 2011. In one group of couples the HIV positive partner was receiving ART as they met clinical eligibility criteria (a CD4 cell count <250 cells/mu L or WHO Stage III/IV disease). In the second group the infected partner was not yet ART-eligible. We measured HIV incidence by testing the uninfected partner every three months. We conducted genetic linkage studies to determine the source of new infections in seroconverting participants. Results A total of 586 couples were enrolled of which 249 (42%) of the HIV positive participants were receiving ART at enrollment, and an additional 99 (17%) initiated ART during the study. The median duration of follow-up was 1.5 years. We found 9 new infections among partners of participants who had been receiving ART for at least three months and 8 new infections in partners of participants who had not received ART or received it for less than three months, for incidence rates of 2.09 per 100 person-years (PYRs) and 2.30 per 100 PYRs, respectively. The incidence rate ratio for ART-use was 0.91 (95% confidence interval 0.31-2.70; p=0.999). The hazard ratio for HIV seroconversion associated with ART-use by the positive partner was 1.07 (95% CI 0.41-2.80). A total of 5/7 (71%) of the transmissions on ART and 6/7 (86%) of those not on ART were genetically linked. Conclusion Overall HIV incidence was low in comparison to previous studies of serodiscordant couples. However, ART-use was not associated with a reduced risk of HIV transmission in this study.	[Birungi, Josephine; Khanakwa, Sarah; Nyonyintono, Maureen; Wangisi, Jonathan] AIDS Support Org, Kampala, Uganda; [Min, Jeong Eun; Muldoon, Katherine A.; Chen, YaLin; Lourenco, Lillian; Moore, David M.] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Muldoon, Katherine A.; Moore, David M.] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Kaleebu, Pontiano; Lyagoba, Fred] Med Res Council UK, Uganda Virus Res Inst Res Unit AIDS, Entebbe, Uganda; [Kaleebu, Pontiano] London Sch Hyg & Trop Med, London WC1, England; [King, Rachel] Univ Calif San Francisco, Kampala, Uganda; [Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada; [Ragonnet-Cronin, Manon] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of London; London School of Hygiene & Tropical Medicine; University of Ottawa; University of Edinburgh	Moore, DM (corresponding author), BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	dmoore@cfenet.ubc.ca	Ragonnet-Cronin, Manon/L-5394-2019; Muldoon, Katherine/AAC-4703-2021	Muldoon, Katherine/0000-0002-0766-4294; Ragonnet-Cronin, Manon/0000-0002-4879-2209	Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research; CIHR - Canadian Association for HIV/AIDS Research (CANFAR); CIHR Canada Research Chair; CIHR [MOP-8970, HBF-112308, MHI-I26391]; CANFAR [023 502]; Biotechnology and Biological Sciences Research Council [1098048] Funding Source: researchfish; Medical Research Council [MC_UP_1204/1] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); CIHR - Canadian Association for HIV/AIDS Research (CANFAR); CIHR Canada Research Chair(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); CANFAR; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DMM was supported by a New Investigator Award from the Canadian Institutes of Health Research (CIHR) and a Scholar Award from the Michael Smith Foundation for Health Research. KAM is supported by a CIHR Doctoral Award funded by the Canadian Association for HIV/AIDS Research (CANFAR). Edward Mills is supported from a CIHR Canada Research Chair. The study was funded by CIHR (Grant numbers MOP-8970, HBF-112308 and MHI-I26391) and CANFAR (Grant number 023 502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglemyer A, 2013, COCHRANE DB SYST REV, V4; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Cohen MS, N ENGL J MED, V365, P493; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; Donnell D, LANCET, V375, P2092; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hirschhorn Lisa R, 2006, Hum Resour Health, V4, P1, DOI 10.1186/1478-4491-4-1; Jean K, 2013, J INFECT DIS; Jia Z, 2012, LANCET; Katabira E, 2008, NAT ANT TREATM CAR G, V2nd; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Nakanjako D, 2009, AIDS REV, V11, P179; Ngolobe M, 2011, 5 INT AIDS SOC C HIV; Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Schneider H, 2006, REPROD HEALTH MATTER, V14, P12, DOI 10.1016/S0968-8080(06)27232-X; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; TM Therneau., 2000, MODELING SURVIVAL DA, DOI DOI 10.1007/978; Vermund SH, 2013, LANCET, V382, P1159, DOI 10.1016/S0140-6736(12)62005-4	22	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132182	10.1371/journal.pone.0132182	http://dx.doi.org/10.1371/journal.pone.0132182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171777	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000358194900034
J	Chiu, SC; Lin, YJ; Huang, SY; Lien, CF; Chen, SP; Pang, CY; Lin, JH; Yang, KT				Chiu, Sheng-Chun; Lin, Yu-Jou; Huang, Sung-Ying; Lien, Chih-Feng; Chen, Shee-Ping; Pang, Cheng-Yoong; Lin, Jian-Hong; Yang, Kun-Ta			The Role of Intermittent Hypoxia on the Proliferative Inhibition of Rat Cerebellar Astrocytes	PLOS ONE			English	Article							ASTROGLIAL CELL-PROLIFERATION; SLEEP-APNEA; POLY(ADP-RIBOSE) POLYMERASE; OXIDATIVE STRESS; REACTIVE OXYGEN; EXPRESSION; BRAIN; GLUTATHIONE; DEATH; DIFFERENTIATION	Sleep apnea syndrome, characterized by intermittent hypoxia (IH), is linked with increased oxidative stress. This study investigates the mechanisms underlying IH and the effects of IH-induced oxidative stress on cerebellar astrocytes. Rat primary cerebellar astrocytes were kept in an incubator with an oscillating O-2 concentration between 20% and 5% every 30 min for 1-4 days. Although the cell loss increased with the duration, the IH incubation didn't induce apoptosis or necrosis, but rather a G0/G1 cell cycle arrest of cerebellar astrocytes was noted. ROS accumulation was associated with cell loss during IH. PARP activation, resulting in p21 activation and cyclin D1 degradation was associated with cell cycle G0/G1 arrest of IH-treated cerebellar astrocytes. Our results suggest that IH induces cell loss by enhancing oxidative stress, PARP activation and cell cycle G0/G1 arrest in rat primary cerebellar astrocytes.	[Chiu, Sheng-Chun] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Res, Taichung, Taiwan; [Lin, Yu-Jou; Yang, Kun-Ta] Tzu Chi Univ, Sch Med, Physiol & Anat Med, Hualien, Taiwan; [Huang, Sung-Ying] Mackay Mem Hosp, Dept Ophthalmol, Hsinchu, Taiwan; [Lien, Chih-Feng; Pang, Cheng-Yoong] Tzu Chi Univ, Sch Med, Inst Med Sci, Hualien, Taiwan; [Chen, Shee-Ping] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Tzu Chi Stem Cells Ctr, Hualien, Taiwan; [Pang, Cheng-Yoong] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Med Res, Hualien, Taiwan; [Lin, Jian-Hong] Tzu Chi Univ, PhD Program Pharmacol & Toxicol, Hualien, Taiwan; [Yang, Kun-Ta] Tzu Chi Univ, Sch Med, Dept Physiol, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; Mackay Memorial Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Tzu Chi University	Yang, KT (corresponding author), Tzu Chi Univ, Sch Med, Physiol & Anat Med, Hualien, Taiwan.	ktyang@mail.tcu.edu.tw	Pang, Cheng-Yoong/AFO-1562-2022; Pang, Cheng-Yoong/R-4990-2019; Chiu, Sheng-Chun/F-9493-2015; Lin, Jian-Hong/AAX-9667-2021	Pang, Cheng-Yoong/0000-0002-9063-2858; Lin, Jian-Hong/0000-0002-3011-8259; Chiu, Sheng-Chun/0000-0002-5927-8088	Tzu Chi University, Taiwan, ROC [TCRPP100007, TCIRP98002-1, TCIRP 95004-05]	Tzu Chi University, Taiwan, ROC	This research was supported by grants TCRPP100007, TCIRP98002-1 and TCIRP 95004-05 from Tzu Chi University, Taiwan, ROC.	Albrecht PJ, 2002, EXP NEUROL, V173, P46, DOI 10.1006/exnr.2001.7834; Bramanti V, 2015, J NEUROSCI RES, V93, P521, DOI 10.1002/jnr.23506; Bramanti V, 2012, NEUROCHEM RES, V37, P2795, DOI 10.1007/s11064-012-0873-3; Burch PM, 2005, ANTIOXID REDOX SIGN, V7, P741, DOI 10.1089/ars.2005.7.741; Carnevale D., 2007, CNS & Neurological Disorders-Drug Targets, V6, P388; Chiu SC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-29; Douglas RM, 2010, AM J PHYSIOL-CELL PH, V298, pC1594, DOI 10.1152/ajpcell.00298.2009; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dringen R, 1998, GLIA, V23, P139, DOI 10.1002/(SICI)1098-1136(199806)23:2<139::AID-GLIA5>3.0.CO;2-1; Fasanaro P, 2006, FASEB J, V20, P1242, DOI 10.1096/fj.05-4695fje; Gao C, 2014, NEUROCHEM RES, V39, P2160, DOI 10.1007/s11064-014-1411-2; Grasso S, 2014, J NEUROSCI RES, V92, P86, DOI 10.1002/jnr.23289; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Kussmaul L, 1999, J NEUROCHEM, V73, P1246, DOI 10.1046/j.1471-4159.1999.0731246.x; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Martin-Oliva D, 2006, CANCER RES, V66, P5744, DOI 10.1158/0008-5472.CAN-05-3050; MAYFIELD KP, 1994, AM J PHYSIOL, V266, pR1615, DOI 10.1152/ajpregu.1994.266.5.R1615; NAEGELE B, 1995, SLEEP, V18, P43; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Neubauer JA, 2001, J APPL PHYSIOL, V90, P1593, DOI 10.1152/jappl.2001.90.4.1593; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; O'Brien LM, 2004, PEDIATR CLIN N AM, V51, P187, DOI 10.1016/S0031-3955(03)00184-6; Pellerin L, 2002, DIABETES NUTR METAB, V15, P268; Rosafio K, 2014, GLIA, V62, P477, DOI 10.1002/glia.22618; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Tsai KL, 1997, J PHYSIOL-LONDON, V502, P161, DOI 10.1111/j.1469-7793.1997.161bl.x; van Wijk SJL, 2005, FREE RADICAL BIO MED, V39, P81, DOI 10.1016/j.freeadbiomed.2005.03.021; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wilson JX, 1997, CAN J PHYSIOL PHARM, V75, P1149, DOI 10.1139/cjpp-75-10-11-1149; Wu ML, 1999, J NEUROCHEM, V73, P1318; Xu W, 2004, NEUROSCIENCE, V126, P313, DOI 10.1016/j.neuroscience.2004.03.055	34	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132263	10.1371/journal.pone.0132263	http://dx.doi.org/10.1371/journal.pone.0132263			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172116	Green Published, gold, Green Submitted			2022-12-27	WOS:000358194900038
J	Grendelmeier, A; Arlettaz, R; Gerber, M; Pasinelli, G				Grendelmeier, Alex; Arlettaz, Raphael; Gerber, Michael; Pasinelli, Gilberto			Reproductive Performance of a Declining Forest Passerine in Relation to Environmental and Social Factors: Implications for Species Conservation	PLOS ONE			English	Article							WARBLER PHYLLOSCOPUS-SIBILATRIX; AKAIKES-INFORMATION-CRITERION; GROUND-NESTING BIRDS; TITS PARUS-MAJOR; CLUTCH SIZE; SITE SELECTION; RECREATIONAL TRAILS; SEASONAL DECLINE; BREEDING SUCCESS; PREDATION RATES	Identifying factors influencing a species' ecological niche and demography is a prerequisite for species conservation. However, our understanding of the interplay between demographic rates and biotic/abiotic factors is still poor for most species of conservation concern. We evaluated relevance of eight hypotheses relating to timing of breeding, temporal nest exposure, nest concealment, topography, tree structure, predation risk and disturbance, density dependence and weather for explaining variation in reproductive performance of the declining wood warbler Phylloscopus sibilatrix in northern Switzerland. Reproductive performance was monitored with cameras at 136 nests from 2010 to 2012 and was associated to temporal exposure, timing of breeding and concealment of nests. Daily nest survival was positively related to the number of grass and sedge tussocks, nest concealment and nest age. Clutch size and number of fledglings decreased, the later in the season a nest was initiated. Nest survival over an average nesting period of 31 days was 46.9 +/- 0.07% (mean +/- SE), daily nest survival rate was 0.976 +/- 0.002. As for many ground-breeding birds, nest predation was the principal cause of nest failure, accounting for 79% of all nest losses. Conservation measures should aim at increasing the area of relatively homogenous forest stands featuring suitable habitats characterized by abundant and accessible grass and sedge tussocks. In managed forests, such conditions can be found in stands of middle age (i.e. pole wood) with little to no shrub layer.	[Grendelmeier, Alex; Pasinelli, Gilberto] Swiss Ornithol Inst, Sempach, Switzerland; [Grendelmeier, Alex; Arlettaz, Raphael] Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland; [Gerber, Michael] BirdLife Schweiz, Schweizer Vogelschutz SVS, Zurich, Switzerland	Swiss Ornithological Institute; University of Bern	Grendelmeier, A (corresponding author), Swiss Ornithol Inst, Sempach, Switzerland.	alex.grendelmeier@vogelwarte.ch	Arlettaz, Raphaël/O-2182-2016	Arlettaz, Raphaël/0000-0001-6360-5339	Swiss National Science Foundation [31003A_143879/1]; Hilfsfonds fur die Schweizerische Vogelwarte Sempach; Styner-Stiftung; Stotzer-Kastli-Stiftung; Lotteriefonds des Kantons Solothurn	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Hilfsfonds fur die Schweizerische Vogelwarte Sempach; Styner-Stiftung; Stotzer-Kastli-Stiftung; Lotteriefonds des Kantons Solothurn	Swiss National Science Foundation (grant no. 31003A_143879/1) www.snf.ch, recipient: GP; Hilfsfonds fur die Schweizerische Vogelwarte Sempach, recipient: GP; Styner-Stiftung, recipient: GP; Stotzer-Kastli-Stiftung, recipient: GP; Lotteriefonds des Kantons Solothurn, https://www.so.ch/verwaltung/departement-des-innern/amt-fuersoziale-sicherheit/non-profit-organisationen/lotterie-sportfonds/lotteriefonds/, recipient: GP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlering MA, 2010, CONDOR, V112, P252, DOI 10.1525/cond.2010.090239; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arlettaz R, 2007, P R SOC B, V274, P1219, DOI 10.1098/rspb.2006.0434; Arlettaz R, 2010, J ORNITHOL, V151, P889, DOI 10.1007/s10336-010-0527-7; Arlettaz R, 2010, J ORNITHOL, V151, P553, DOI 10.1007/s10336-009-0485-0; Bakermans MH, 2012, J WILDLIFE MANAGE, V76, P1225, DOI 10.1002/jwmg.349; Bates D. M., 2010, LME4 MIXED EFFECTS M; BAXTER GS, 1994, COLON WATERBIRD, V17, P120, DOI 10.2307/1521290; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; BEST LB, 1978, AUK, V95, P9, DOI 10.2307/4085491; Betts MG, 2008, P ROY SOC B-BIOL SCI, V275, P2257, DOI 10.1098/rspb.2008.0217; BirdLifeInternational, 2014, SPEC FACTSH PHYLL SI; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; BOYLE SA, 1985, WILDLIFE SOC B, V13, P110; Brown CR, 1999, AUK, V116, P467, DOI 10.2307/4089380; Buchanan KL, 1997, P ROY SOC B-BIOL SCI, V264, P521, DOI 10.1098/rspb.1997.0074; Burhans DE, 2002, J WILDLIFE MANAGE, V66, P240, DOI 10.2307/3802890; Burke DM, 2000, ECOL APPL, V10, P1749, DOI 10.1890/1051-0761(2000)010[1749:LAFSEO]2.0.CO;2; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burton NHK, 2006, J AVIAN BIOL, V37, P312, DOI 10.1111/j.2006.0908-8857.03822.x; Christians JK, 2001, J ANIM ECOL, V70, P1080, DOI 10.1046/j.0021-8790.2001.00566.x; Coch T., 2005, Schweizerische Zeitschrift fur Forstwesen, V156, P59, DOI 10.3188/szf.2005.0059; Courchamp F., 2008, ALLEE EFFECTS ECOLOG, DOI DOI 10.1017/S0376892909005384; de Heij ME, 2006, P ROY SOC B-BIOL SCI, V273, P2353, DOI 10.1098/rspb.2006.3584; DIXON CL, 1978, AUK, V95, P235; Emmering QC, 2011, J ANIM ECOL, V80, P1305, DOI 10.1111/j.1365-2656.2011.01869.x; Flade Martin, 2004, Vogelwelt, V125, P177; Gelman A., 2011, ARM DATA ANAL USING; Gerber M, 2011, THESIS U ZURICH; Glutz von Blotzheim U., 1991, HDB VOGEL MITTELEURO; Grant TA, 2005, AUK, V122, P661, DOI 10.1642/0004-8038(2005)122[0661:TVIPNS]2.0.CO;2; Haff TM, 2011, BIOL LETTERS, V7, P493, DOI 10.1098/rsbl.2010.1125; Haley MP, 2004, BEHAVIOUR, V141, P391, DOI 10.1163/156853904323066702; Hansson B, 2000, ECOLOGY, V81, P319, DOI 10.2307/177429; Hatchwell BJ, 1996, IBIS, V138, P256, DOI 10.1111/j.1474-919X.1996.tb04337.x; Heltzel JM, 2006, CONDOR, V108, P842, DOI 10.1650/0010-5422(2006)108[842:FINSOS]2.0.CO;2; HERREMANS M, 1993, BIRD STUDY, V40, P12, DOI 10.1080/00063659309477124; Hillig F, 2009, VERURSACHEN VERANDER; Hobson KA, 2014, ACTA ORNITHOL, V49, P57, DOI 10.3161/000164514X682896; Holzinger J, 1999, SINGVOGEL; Howlett JS, 1997, WILSON BULL, V109, P643; Huber N, 2013, THESIS U ZURICH; Ibanez-Alamo JD, 2012, IBIS, V154, P5, DOI 10.1111/j.1474-919X.2011.01186.x; Jetz W, 2008, PLOS BIOL, V6, P2650, DOI 10.1371/journal.pbio.0060303; Keller V., 2010, Ornithologische Beobachter, V107, P265; Kirkpatrick C, 2010, WILSON J ORNITHOL, V122, P614, DOI 10.1676/09-166.1; Kruger O, 2002, OECOLOGIA, V133, P474, DOI 10.1007/s00442-002-1053-y; Lack D., 1954, P343; LaHaye WS, 1997, WILSON BULL, V109, P42; Langgemach Torsten, 2005, Vogelwelt, V126, P259; Lippek Wolfgang, 2009, Vogelwelt, V130, P165; Maguire GS, 2006, J AVIAN BIOL, V37, P579, DOI 10.1111/j.2006.0908-8857.03757.x; Mallord JW, 2012, BIRD STUDY, V59, P286, DOI 10.1080/00063657.2012.669359; Marti Jakob, 2007, Ornithologische Beobachter, V104, P45; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MARTIN TE, 1993, AM NAT, V141, P897, DOI 10.1086/285515; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Maumary L., 2007, OISEAUX SUISSE; MAYFIELD HAROLD, 1961, WILSON BULL, V73, P255; Mazerolle M. J., 2010, AICCMODAVG MODEL SEL; Mazerolle MJ, 2006, AMPHIBIA-REPTILIA, V27, P169, DOI 10.1163/156853806777239922; Maziarz M, 2010, BIRD STUDY, V57, P540, DOI 10.1080/00063657.2010.512954; MILDENBERGER H., 1940, JOUR ORNITHOL, V88, P537, DOI 10.1007/BF01670583; Miller JR, 2000, LANDSCAPE URBAN PLAN, V50, P227, DOI 10.1016/S0169-2046(00)00091-8; Miller SG, 1998, ECOL APPL, V8, P162, DOI 10.1890/1051-0761(1998)008[0162:IORTOB]2.0.CO;2; Mills L. S., 2012, CONSERVATION WILDLIF; Monaghan P, 1997, TRENDS ECOL EVOL, V12, P270, DOI 10.1016/S0169-5347(97)01094-X; Moreau Gaston, 2001, Alauda, V69, P103; Morrison SA, 2002, OECOLOGIA, V133, P315, DOI 10.1007/s00442-002-1040-3; Muller M, 2005, OECOLOGIA, V143, P37, DOI 10.1007/s00442-004-1770-5; MURPHY MT, 1983, AUK, V100, P326, DOI 10.1093/auk/100.2.326; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; Naef-Daenzer L, 2000, J AVIAN BIOL, V31, P206, DOI 10.1034/j.1600-048X.2000.310212.x; Newell FL, 2011, FOREST ECOL MANAG, V262, P739, DOI 10.1016/j.foreco.2011.05.006; Pasinelli G, 2002, ECOLOGY, V83, P2229, DOI 10.1890/0012-9658(2002)083[2229:SAEFAN]2.0.CO;2; Pasinelli G, 2006, ECOGRAPHY, V29, P721, DOI 10.1111/j.2006.0906-7590.04728.x; Patthey P, 2008, J APPL ECOL, V45, P1704, DOI 10.1111/j.1365-2664.2008.01547.x; Peak RG, 2007, CONDOR, V109, P628, DOI 10.1650/8274.1; Pietz PJ, 2000, J WILDLIFE MANAGE, V64, P71, DOI 10.2307/3802976; R Core Team, 2018, R LANG ENV STAT COMP; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; Rodriguez C, 2003, J ANIM ECOL, V72, P793, DOI 10.1046/j.1365-2656.2003.00757.x; Roper JJ, 1997, J AVIAN BIOL, V28, P111, DOI 10.2307/3677304; Sanders MD, 2002, BIOL CONSERV, V106, P225, DOI 10.1016/S0006-3207(01)00248-8; Schaub M, 2012, OECOLOGIA, V168, P97, DOI 10.1007/s00442-011-2070-5; Schmidt KA, 2008, ECOLOGY, V89, P635, DOI 10.1890/07-0199.1; Shaffer TL, 2004, AUK, V121, P526, DOI 10.1642/0004-8038(2004)121[0526:AUATAN]2.0.CO;2; Signorell N, 2010, WILDLIFE BIOL, V16, P249, DOI 10.2981/09-028; Skorpilova J, 2007, WOOD WARBLER POPULAT; SLAGSVOLD T, 1984, J ANIM ECOL, V53, P945, DOI 10.2307/4669; Smith JI, 2005, J FIELD ORNITHOL, V76, P383, DOI 10.1648/0273-8570-76.4.383; Spaar R, 2012, ELEMENTE ARTENFORDER; Steven R, 2011, J ENVIRON MANAGE, V92, P2287, DOI 10.1016/j.jenvman.2011.05.005; Storch I, 2005, LANDSCAPE ECOL, V20, P927, DOI 10.1007/s10980-005-7005-2; STRESEMANN ERWIN, 1955, JOUR ORNITHOL, V96, P153, DOI 10.1007/BF01975010; SUAREZ F, 1992, ORNIS SCAND, V23, P24, DOI 10.2307/3676423; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Tarof SA, 2004, AUK, V121, P877, DOI 10.1642/0004-8038(2004)121[0877:HCANPD]2.0.CO;2; VERBEEK NAM, 1981, ORNIS SCAND, V12, P37, DOI 10.2307/3675902; VERHULST S, 1995, ECOLOGY, V76, P2392, DOI 10.2307/2265815; Walankiewicz Wieslaw, 2002, Acta Ornithologica (Warsaw), V37, P21; Weidinger K, 2002, J ANIM ECOL, V71, P424, DOI 10.1046/j.1365-2656.2002.00611.x; WESOLOWSKI T, 1985, ORNIS SCAND, V16, P49, DOI 10.2307/3676575; Wesolowski T, 2005, J AVIAN BIOL, V36, P361, DOI 10.1111/j.0908-8857.2005.03570.x; Wesolowski T, 2009, ACTA ORNITHOL, V44, P69, DOI 10.3161/000164509X464902; Wesolowski T, 2009, BIRD STUDY, V56, P26, DOI 10.1080/00063650802681540; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Yanes M, 1995, ECOGRAPHY, V18, P423, DOI 10.1111/j.1600-0587.1995.tb00145.x; YOUNG HOWARD, 1963, AUK, V80, P145; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908	111	25	26	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0130954	10.1371/journal.pone.0130954	http://dx.doi.org/10.1371/journal.pone.0130954			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172954	gold, Green Published			2022-12-27	WOS:000358194900012
J	Kwan, CK; Sanford, E; Long, J				Kwan, Christopher Kent; Sanford, Eric; Long, Jeremy			Copper Pollution Increases the Relative Importance of Predation Risk in an Aquatic Food Web	PLOS ONE			English	Article							DENSITY-DEPENDENT MORTALITY; JUVENILE COHO SALMON; SAN-FRANCISCO BAY; CONSPECIFIC DENSITY; CHEMICAL SIGNALS; MARINE; MECHANISMS; ECOLOGY; INSECTICIDES; CONTAMINANTS	Although the cascading impact of predators depends critically on the relative role of lethal predation and predation risk, we lack an understanding of how human-caused stressors may shift this balance. Emergent evidence suggests that pollution may increase the importance of predator consumptive effects by weakening the effects of fear perceived by prey. However, this oversimplification ignores the possibility that pollution may also alter predator consumptive effects. In particular, contaminants may impair the consumptive effects of predators by altering density-dependent interactions among prey conspecifics. No study has directly compared predator consumptive and non-consumptive effects in polluted versus non-polluted settings. We addressed this issue by using laboratory mesocosms to examine the impact of sublethal doses of copper on tri-trophic interactions among estuarine predator crabs Cancer productus, carnivorous whelk prey Urosalpinx cinerea, and the basal resource barnacles Balanus glandula. We investigated crab consumptive effects (whelks culled without crab chemical cues), non-consumptive effects (whelks not culled with crab chemical cues), and total effects (whelks culled with crab chemical cues) on whelks in copper polluted and non-polluted waters. Realistic copper concentrations suppressed the effects of simulated crab lethal predation (whelk culling) by removing density-dependent feeding by whelks. Specifically, reductions in conspecific density occurring in elevated copper levels did not trigger the normal increase in whelk consumption rates of barnacles. Weakened effects of fear were only observed at extremely high copper levels, suggesting consumptive effects were more sensitive to pollution. Thus, pollution may shape communities by altering the roles of predators and interactions among prey.	[Kwan, Christopher Kent; Long, Jeremy] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Kwan, Christopher Kent; Long, Jeremy] San Diego State Univ, Coastal & Marine Inst Lab, San Diego, CA 92182 USA; [Kwan, Christopher Kent; Sanford, Eric] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA USA; [Kwan, Christopher Kent; Sanford, Eric] Univ Calif Davis, Dept Ecol & Evolut, Bodega Bay, CA USA	California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California Davis; University of California System; University of California Davis	Long, J (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	jlong@mail.sdsu.edu			National Science Foundation Coastal, Atmospheric, and Marine Environmental Observing Studies Fellowship; California State University Council on Ocean Affairs, Science and Technology Award	National Science Foundation Coastal, Atmospheric, and Marine Environmental Observing Studies Fellowship; California State University Council on Ocean Affairs, Science and Technology Award	This work was supported by National Science Foundation Coastal, Atmospheric, and Marine Environmental Observing Studies Fellowship to CK and the California State University Council on Ocean Affairs, Science and Technology Award to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TW, 2001, ECOLOGY, V82, P245; Blake AC, 2004, ESTUARIES, V27, P437, DOI 10.1007/BF02803536; BROWN KM, 1994, MAR ECOL PROG SER, V112, P97, DOI 10.3354/meps112097; Brown RJ, 2004, AQUAT TOXICOL, V66, P267, DOI 10.1016/j.aquatox.2003.10.001; BRYAN GW, 1992, ENVIRON POLLUT, V76, P89, DOI 10.1016/0269-7491(92)90099-V; Carlton JT, 1999, MALACOLOGIA, V41, P439; Dew WA, 2012, ENVIRON SCI TECHNOL, V46, P9019, DOI 10.1021/es300670p; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Fernandez-Juricic E, 2004, BEHAV ECOL, V15, P371, DOI 10.1093/beheco/arh017; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Flegal AR, 2005, ECOTOXICOLOGY, V14, P645, DOI 10.1007/s10646-005-0016-6; Frid A, 2008, OIKOS, V117, P191, DOI 10.1111/j.2007.0030-1299.16134.x; Griffin CAM, 2006, ECOL LETT, V9, P335, DOI 10.1111/j.1461-0248.2005.00880.x; GROSHOLZ ED, 1995, MAR BIOL, V122, P239; Hanazato T, 1999, ENVIRON POLLUT, V105, P137, DOI 10.1016/S0269-7491(98)00203-6; Hawlena D, 2012, SCIENCE, V336, P1434, DOI 10.1126/science.1220097; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Hixon MA, 2005, ECOLOGY, V86, P2847, DOI 10.1890/04-1455; Hughes AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044839; Kimbro DL, 2009, OECOLOGIA, V160, P563, DOI 10.1007/s00442-009-1322-0; Letelier ME, 2005, CHEM-BIOL INTERACT, V151, P71, DOI 10.1016/j.cbi.2004.12.004; Linder MC, 1996, AM J CLIN NUTR, V63, P797; Lurling M, 2007, TRENDS ECOL EVOL, V22, P374, DOI 10.1016/j.tree.2007.04.002; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Mccoy MW, 2007, OECOLOGIA, V153, P871, DOI 10.1007/s00442-007-0795-y; McIntyre JK, 2008, ENVIRON SCI TECHNOL, V42, P1352, DOI 10.1021/es071603e; McIntyre JK, 2012, ECOL APPL, V22, P1460, DOI 10.1890/11-2001.1; McPherson CA, 2000, MAR POLLUT BULL, V40, P656, DOI 10.1016/S0025-326X(00)00043-6; MEADOR JP, 1993, ECOL APPL, V3, P139, DOI 10.2307/1941797; MIAO SL, 1991, ECOLOGY, V72, P1634, DOI 10.2307/1940963; Miller LP, 2014, GLOBAL CHANGE BIOL, V20, P3834, DOI 10.1111/gcb.12639; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Neff JM, 1977, POLLUTANT EFFECTS MA, P155; Peacor SD, 2004, ECOLOGY, V85, P2754, DOI 10.1890/03-0662; Peacor SD, 2003, OIKOS, V100, P409, DOI 10.1034/j.1600-0706.2003.12043.x; Peacor SD, 2001, P NATL ACAD SCI USA, V98, P3904, DOI 10.1073/pnas.071061998; PRATT DM, 1974, MAR BIOL, V27, P37, DOI 10.1007/BF00394758; PRATT DM, 1976, J EXP MAR BIOL ECOL, V21, P7, DOI 10.1016/0022-0981(76)90066-6; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Rainbow PS, 2002, ENVIRON POLLUT, V120, P497, DOI 10.1016/S0269-7491(02)00238-5; Relyea RA, 2005, ECOL APPL, V15, P618, DOI 10.1890/03-5342; Relyea R, 2006, ECOL LETT, V9, P1157, DOI 10.1111/j.1461-0248.2006.00966.x; Rice A, 2007, J CRUSTACEAN BIOL, V27, P74, DOI 10.1651/S-2668.1; Rohr JR, 2006, TRENDS ECOL EVOL, V21, P606, DOI 10.1016/j.tree.2006.07.002; S-ROZSA K, 1990, Environmental Monitoring and Assessment, V14, P363, DOI 10.1007/BF00677928; Schiff K, 2004, MAR POLLUT BULL, V48, P371, DOI 10.1016/j.marpolbul.2003.08.016; Singhasemanon N., 2009, EH0805 CAL ENV PROT; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Trussell GC, 2008, ECOLOGY, V89, P2798, DOI 10.1890/08-0250.1; Trussell GC, 2006, ECOL LETT, V9, P1245, DOI 10.1111/j.1461-0248.2006.00981.x; Weis JS, 2001, BIOSCIENCE, V51, P209, DOI 10.1641/0006-3568(2001)051[0209:EOCOBB]2.0.CO;2; WEISSBURG MJ, 1993, ECOLOGY, V74, P1428, DOI 10.2307/1940072; Woin P, 1998, ECOTOX ENVIRON SAFE, V41, P137, DOI 10.1006/eesa.1998.1694; Wojdak JM, 2005, OIKOS, V111, P592, DOI 10.1111/j.0030-1299.2005.13869.x; Zimmer RK, 1999, ECOLOGY, V80, P1432, DOI 10.1890/0012-9658(1999)080[1432:REOECS]2.0.CO;2	55	12	12	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133329	10.1371/journal.pone.0133329	http://dx.doi.org/10.1371/journal.pone.0133329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172044	Green Submitted, gold, Green Published			2022-12-27	WOS:000358194900149
J	Lu, K; Guo, WJ; Lu, JX; Yu, H; Qu, CM; Tang, ZL; Li, JN; Chai, YR; Liang, Y				Lu, Kun; Guo, Wenjin; Lu, Junxing; Yu, Hao; Qu, Cunmin; Tang, Zhanglin; Li, Jiana; Chai, Yourong; Liang, Ying			Genome-Wide Survey and Expression Profile Analysis of the Mitogen-Activated Protein Kinase (MAPK) Gene Family in Brassica rapa	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; SALT STRESS; CASCADE; MPK4; CYTOKINESIS; RESISTANCE; IMMUNITY; DATABASE; DEFENSE; CLONING	Mitogen-activated protein kinase (MAPK) cascades are fundamental signal transduction modules in plants, controlling cell division, development, hormone signaling, and biotic and abiotic stress responses. Although MAPKs have been investigated in several plant species, a comprehensive analysis of the MAPK gene family has hitherto not been performed in Brassica rapa. In this study, we identified 32 MAPKs in the B. rapa genome by conducting BLASTP and syntenic block analyses, and screening for the essential signature motif (TDY or TEY) of plant MAPK proteins. Of the 32 BraMAPK genes retrieved from the Brassica Database, 13 exhibited exon splicing errors, excessive splicing of the 5' sequence, excessive retention of the 5' sequence, and sequencing errors of the 3' end. Phylogenetic trees of the 32 corrected MAPKs from B. rapa and of MAPKs from other plants generated by the neighbor-joining and maximum likelihood methods suggested that BraMAPKs could be divided into four groups (groups A, B, C, and D). Gene number expansion was observed for BraMAPK genes in groups A and D, which may have been caused by the tandem duplication and genome triplication of the ancestral genome of the Brassica progenitor. Except for five members of the BraMAPK10 subfamily, the identified BraMAPKs were expressed in most of the tissues examined, including callus, root, stem, leaf, flower, and silique. Quantitative real-time PCR demonstrated that at least six and five BraMAPKs were induced or repressed by various abiotic stresses and hormone treatments, respectively, suggesting their potential roles in the abiotic stress response and various hormone signal transduction pathways in B. rapa. This study provides valuable insight into the putative physiological and biochemical functions of MAPK genes in B. rapa.	[Lu, Kun; Guo, Wenjin; Lu, Junxing; Yu, Hao; Qu, Cunmin; Tang, Zhanglin; Li, Jiana; Chai, Yourong; Liang, Ying] Southwest Univ, Coll Agron & Biotechnol, Chongqing 400715, Peoples R China; [Lu, Kun; Qu, Cunmin; Tang, Zhanglin; Li, Jiana; Chai, Yourong; Liang, Ying] Southwest Univ, Chongqing Rapeseed Engn Res Ctr, Chongqing 400715, Peoples R China; [Lu, Kun; Qu, Cunmin; Tang, Zhanglin; Li, Jiana; Chai, Yourong; Liang, Ying] Southwest Univ, Minist Educ, Engn Res Ctr South Upland Agr, Chongqing 400715, Peoples R China; [Lu, Junxing] Chongqing Normal Univ, Coll Life Sci, Chongqing 401331, Peoples R China	Southwest University - China; Southwest University - China; Southwest University - China; Chongqing Normal University	Lu, K (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Chongqing 400715, Peoples R China.	drlukun@swu.edu.cn; yliang@swu.edu.cn	Lu, Kun/C-2597-2008; Lu, Junxing/GZH-2188-2022	Lu, Kun/0000-0003-1370-8633; Lu, Junxing/0000-0002-1447-2768; Qu, Cunmin/0000-0003-2413-2350	863 Project [2013AA102602]; National Science Foundation of China [31271756, 31171619]; 111 Project [B12006]; 973 Project [2015CB250100]; Chongqing Project of Main Crop Variety Innovation [cstc2012ggB80008]; Fundamental Research Funds for the Central Universities [XDJK2012A009, XDJK2013C031]	863 Project(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); 973 Project(National Basic Research Program of China); Chongqing Project of Main Crop Variety Innovation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the 863 Project [2013AA102602, www.most.gov.cn], the National Science Foundation of China [31271756 and 31171619, http://www.nsfc.gov.cn], the 111 Project [B12006, http://www.moe.edu.cn], the 973 Project [2015CB250100, www.most.gov.cn], the Chongqing Project of Main Crop Variety Innovation [cstc2012ggB80008, http://www.cstc.gov.cn], and the Fundamental Research Funds for the Central Universities [XDJK2012A009 and XDJK2013C031, http://www.moe.edu.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2003, BIOCHEM BIOPH RES CO, V302, P171, DOI 10.1016/S0006-291X(03)00174-8; Ahmed NU, 2013, SCI HORTIC-AMSTERDAM, V152, P26, DOI 10.1016/j.scienta.2013.01.007; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreasson E, 2005, EMBO J, V24, P2579, DOI 10.1038/sj.emboj.7600737; Arasan SKT, 2013, PLANT PHYSIOL BIOCH, V67, P144, DOI 10.1016/j.plaphy.2013.02.030; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Asif MH, 2014, FUNCT INTEGR GENOMIC, V14, P161, DOI 10.1007/s10142-013-0349-9; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Berriri S, 2012, PLANT CELL, V24, P4281, DOI 10.1105/tpc.112.101253; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046744; Cheng F, 2013, PLANT CELL, V25, P1541, DOI 10.1105/tpc.113.110486; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; DRUMMOND AJ, 2009, GENEIOUS V4 8; Fang L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00261; Gao MH, 2008, CELL RES, V18, P1190, DOI 10.1038/cr.2008.300; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Hulskamp M, 1997, DEV BIOL, V187, P114, DOI 10.1006/dbio.1997.8554; Hyun TK, 2010, GENES GENOM, V32, P275, DOI 10.1007/s13258-010-0010-0; Ichimura K, 2000, PLANT J, V24, P655, DOI 10.1046/j.1365-313x.2000.00913.x; Ichimura K, 2006, J BIOL CHEM, V281, P36969, DOI 10.1074/jbc.M605319200; Jammes F, 2009, P NATL ACAD SCI USA, V106, P20520, DOI 10.1073/pnas.0907205106; Jeong MJ, 2006, PLANT CELL TISS ORG, V85, P151, DOI 10.1007/s11240-005-9064-0; Jiang JJ, 2013, MOL GENET GENOMICS, V288, P601, DOI 10.1007/s00438-013-0775-3; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Kong FL, 2012, GENE, V499, P108, DOI 10.1016/j.gene.2012.01.048; Kong Q, 2012, PLANT CELL, V24, P2225, DOI 10.1105/tpc.112.097253; Kosetsu K, 2010, PLANT CELL, V22, P3778, DOI 10.1105/tpc.110.077164; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Larade K, 2006, COMP BIOCHEM PHYS B, V143, P85, DOI 10.1016/j.cbpb.2005.10.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SK, 2011, J BIOSCIENCES, V36, P139, DOI 10.1007/s12038-011-9002-8; Lei B, 2013, MOL BIOL REP, V40, P345, DOI 10.1007/s11033-012-2067-0; Lian WW, 2012, J INTEGR AGR, V11, P1227, DOI 10.1016/S2095-3119(12)60119-1; Liu YK, 2013, PLANT MOL BIOL REP, V31, P1446, DOI 10.1007/s11105-013-0623-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu K, 2008, THEOR APPL GENET, V117, P963, DOI 10.1007/s00122-008-0836-x; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Mizoguchi T, 1996, P NATL ACAD SCI USA, V93, P765, DOI 10.1073/pnas.93.2.765; Moustafa K, 2014, PLANT CELL REP, V33, P1217, DOI 10.1007/s00299-014-1629-0; Ohyanagi H, 2006, NUCLEIC ACIDS RES, V34, pD741, DOI 10.1093/nar/gkj094; Ovecka Miroslav, 2009, P51, DOI 10.1007/978-3-540-89228-1_3; Pan JW, 2012, PLANTA, V235, P661, DOI 10.1007/s00425-011-1510-0; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Qi JN, 2010, PLANT MOL BIOL REP, V28, P597, DOI 10.1007/s11105-010-0185-1; Ramchiary N, 2011, PLANT GENET GENOMICS, V9, P215, DOI 10.1007/978-1-4419-7118-0_8; Rao KP, 2010, DNA RES, V17, P139, DOI 10.1093/dnares/dsq011; Reyna NS, 2006, MOL PLANT MICROBE IN, V19, P530, DOI 10.1094/MPMI-19-0530; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Rohila JS, 2007, J INTEGR PLANT BIOL, V49, P751, DOI 10.1111/j.1744-7909.2007.00501.x; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Shi J, 2010, PLANT MOL BIOL, V74, P1, DOI 10.1007/s11103-010-9661-0; Song D, 2006, PLANT BIOLOGY, V8, P587, DOI 10.1055/s-2006-924149; Song FM, 2002, PLANTA, V215, P997, DOI 10.1007/s00425-002-0794-5; Soyano T, 2003, GENE DEV, V17, P1055, DOI 10.1101/gad.1071103; Takahashi Y, 2010, PLANT CELL PHYSIOL, V51, P1766, DOI 10.1093/pcp/pcq135; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Tong CB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-689; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; U. N., 1935, Japanese Journal of Botany, V7, P389; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang JX, 2010, J INTEGR PLANT BIOL, V52, P442, DOI 10.1111/j.1744-7909.2010.00906.x; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Z, 2014, MOL GENET GENOMICS, V289, P1023, DOI 10.1007/s00438-014-0853-1; Wang Z, 2009, MOL PLANT MICROBE IN, V22, P235, DOI 10.1094/MPMI-22-3-0235; Wei CJ, 2014, PLANT PHYSIOL BIOCH, V77, P108, DOI 10.1016/j.plaphy.2014.02.002; Wu J, 2012, MOL GENET GENOMICS, V287, P295, DOI 10.1007/s00438-012-0675-y; Xing Y, 2008, PLANT J, V54, P440, DOI 10.1111/j.1365-313X.2008.03433.x; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Zeng QN, 2011, PLANT SIGNAL BEHAV, V6, P1436, DOI 10.4161/psb.6.10.17089; Zeng QN, 2011, PLANT J, V67, P895, DOI 10.1111/j.1365-313X.2011.04642.x; Zhang A, 2010, J EXP BOT, V61, P4399, DOI 10.1093/jxb/erq243; Zhang SZ, 2013, GENE, V531, P377, DOI 10.1016/j.gene.2013.07.107; Zhang XT, 2013, MOL BIOL REP, V40, P1407, DOI 10.1007/s11033-012-2184-9; Zhang ZB, 2012, CELL HOST MICROBE, V11, P253, DOI 10.1016/j.chom.2012.01.015; Zhou CJ, 2009, PLANT PHYSIOL, V150, P167, DOI 10.1104/pp.108.133439	87	39	40	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132051	10.1371/journal.pone.0132051	http://dx.doi.org/10.1371/journal.pone.0132051			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173020	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900029
J	Takamatsu, T; Uehara, K; Sasaki, Y; Hidekazu, M; Matsumura, Y; Iwasawa, A; Ito, N; Kohno, M; Azuma, T; Okino, A				Takamatsu, Toshihiro; Uehara, Kodai; Sasaki, Yota; Hidekazu, Miyahara; Matsumura, Yuriko; Iwasawa, Atsuo; Ito, Norihiko; Kohno, Masahiro; Azuma, Takeshi; Okino, Akitoshi			Microbial Inactivation in the Liquid Phase Induced by Multigas Plasma Jet	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE PLASMA; SINGLET OXYGEN; HELIUM; DAMAGE	Various gas atmospheric nonthermal plasmas were generated using a multigas plasma jet to treat microbial suspensions. Results indicated that carbon dioxide and nitrogen plasma had high sterilization effects. Carbon dioxide plasma, which generated the greatest amount of singlet oxygen than other gas plasmas, killed general bacteria and some fungi. On the other hand, nitrogen plasma, which generated the largest amount of OH radical, killed >= 6 log of 11 species of microorganisms, including general bacteria, fungi, acid-fast bacteria, spores, and viruses in 1-15 min. To identify reactive species responsible for bacterial inactivation, antioxidants were added to bacterial suspensions, which revealed that singlet oxygen and OH radicals had greatest inactivation effects.	[Takamatsu, Toshihiro; Azuma, Takeshi] Kobe Univ, Dept Gastroenterol, Kobe, Hyogo 657, Japan; [Takamatsu, Toshihiro; Uehara, Kodai; Sasaki, Yota; Hidekazu, Miyahara; Okino, Akitoshi] Tokyo Inst Technol, Dept Energy Sci, Yokohama, Kanagawa 227, Japan; [Matsumura, Yuriko; Iwasawa, Atsuo; Kohno, Masahiro] Tokyo Inst Technol, Dept Bioengn, Yokohama, Kanagawa 227, Japan; [Ito, Norihiko] Tottori Univ, Ctr Vet Med, Tottori 680, Japan	Kobe University; Tokyo Institute of Technology; Tokyo Institute of Technology; Tottori University	Takamatsu, T (corresponding author), Kobe Univ, Dept Gastroenterol, Kobe, Hyogo 657, Japan.	tplasma@med.kobe-u.ac.jp	Okino, Akitoshi/O-1804-2013; Ito, Norihiko/ABD-3147-2021	Okino, Akitoshi/0000-0002-8949-294X; 	 [26886009];  [26670382]	; 	This work was supported by Grant-in-Aid for Research Activity Start-up Grant Number 26886009 and Grant-in-Aid for Challenging Exploratory Research Grant Number 26670382. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buonocore G, 2010, SEMIN FETAL NEONAT M, V15, P186, DOI 10.1016/j.siny.2010.04.003; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; Ehlbeck J, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/1/013002; Ionin AA, 2007, J PHYS D APPL PHYS, V40, pR25, DOI 10.1088/0022-3727/40/2/R01; Iwai T, 2014, J ANAL ATOM SPECTROM, V29, P464, DOI 10.1039/c3ja50321f; Iwasawa A, 2012, BIOCONTROL SCI, V17, P45, DOI 10.4265/bio.17.45; KONG MG, 2009, NEW J PHYS, V11, DOI DOI 10.1088/1367-2630/11/11/115012; Kongmany S, 2013, J PHYS CONF SER, V441, DOI 10.1088/1742-6596/441/1/012006; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Lee K, 2006, J MICROBIOL, V44, P269; Matsumura Y, 2013, CHEM LETT, V42, P1291, DOI 10.1246/cl.130618; Nakamura K, 2012, MICROBIOL IMMUNOL, V56, P48, DOI 10.1111/j.1348-0421.2011.00400.x; Oehmigen K, 2010, PLASMA PROCESS POLYM, V7, P250, DOI 10.1002/ppap.200900077; Oshita T, 2015, IEEE T PLASMA SCI, V43, P1987, DOI 10.1109/TPS.2015.2428696; Surowsky B, 2015, FOOD ENG REV, V7, P82, DOI 10.1007/s12393-014-9088-5; Takamatsu T., 2012, PLASMA MED, V2, P237, DOI DOI 10.1615/PLASMAMED.2014010792; Takamatsu T, 2014, RSC ADV, V4, P39901, DOI 10.1039/c4ra05936k; Takamatsu T, 2014, J TOXICOL SCI, V39, P281, DOI 10.2131/jts.39.281; Takamatsu T, 2013, IEEE T PLASMA SCI, V41, P119, DOI 10.1109/TPS.2012.2227459; Tomaru A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085569; Vakrat-Haglili Y, 2005, J AM CHEM SOC, V127, P6487, DOI 10.1021/ja046210j; van Gils CAJ, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/17/175203; Ziuzina D, 2013, J APPL MICROBIOL, V114, P778, DOI 10.1111/jam.12087	23	48	48	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132381	10.1371/journal.pone.0132381	http://dx.doi.org/10.1371/journal.pone.0132381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173107	gold, Green Published			2022-12-27	WOS:000358194900047
J	Zhang, HS; Zhu, MX; Zheng, Y; Li, GL				Zhang, Haoshi; Zhu, Mingxing; Zheng, Yue; Li, Guanglin			Toward Capturing Momentary Changes of Heart Rate Variability by a Dynamic Analysis Method	PLOS ONE			English	Article							TIME-FREQUENCY	The analysis of heart rate variability (HRV) has been performed on long-term electrocardiography (ECG) recordings (12 similar to 24 hours) and short-term recordings (2 similar to 5 minutes), which may not capture momentary change of HRV. In this study, we present a new method to analyze the momentary HRV (mHRV). The ECG recordings were segmented into a series of overlapped HRV analysis windows with a window length of 5 minutes and different time increments. The performance of the proposed method in delineating the dynamics of momentary HRV measurement was evaluated with four commonly used time courses of HRV measures on both synthetic time series and real ECG recordings from human subjects and dogs. Our results showed that a smaller time increment could capture more dynamical information on transient changes. Considering a too short increment such as 10 s would cause the indented time courses of the four measures, a 1-min time increment (4-min overlapping) was suggested in the analysis of mHRV in the study. ECG recordings from human subjects and dogs were used to further assess the effectiveness of the proposed method. The pilot study demonstrated that the proposed analysis of mHRV could provide more accurate assessment of the dynamical changes in cardiac activity than the conventional measures of HRV (without time overlapping). The proposed method may provide an efficient means in delineating the dynamics of momentary HRV and it would be worthy performing more investigations.	[Zhang, Haoshi; Zhu, Mingxing; Zheng, Yue; Li, Guanglin] Chinese Acad Sci, Key Lab Human Machine Intelligence Synergy Syst, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Li, GL (corresponding author), Chinese Acad Sci, Key Lab Human Machine Intelligence Synergy Syst, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China.	gl.li@siat.ac.cn		Li, Guanglin/0000-0001-9016-2617	National Key Basic Research Program of China [2013CB329505]; National Natural Science Foundation of China [61135004]; Shenzhen Governmental Basic Research Grant [JCYJ20130402113127532]; Guangdong Innovation Research Team Fund for Low-cost Healthcare Technologies	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Governmental Basic Research Grant; Guangdong Innovation Research Team Fund for Low-cost Healthcare Technologies	This work was partly supported by the National Key Basic Research Program of China (#2013CB329505), the National Natural Science Foundation of China under grants (#61135004), the Shenzhen Governmental Basic Research Grant (#JCYJ20130402113127532), and the Guangdong Innovation Research Team Fund for Low-cost Healthcare Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Bar KJ, 2007, CLIN NEUROPHYSIOL, V118, P2009, DOI 10.1016/j.clinph.2007.06.012; Bahoura M, 1997, COMPUT METH PROG BIO, V52, P35, DOI 10.1016/S0169-2607(97)01780-X; Bailon R, 2007, P ANN INT IEEE EMBS, P6675; Bernardi L, 2000, J AM COLL CARDIOL, V35, P1462, DOI 10.1016/S0735-1097(00)00595-7; Camm AJ, 1996, CIRCULATION, V93, P1043; CHOI HI, 1989, IEEE T ACOUST SPEECH, V37, P862, DOI 10.1109/ASSP.1989.28057; FRIESEN GM, 1990, IEEE T BIO-MED ENG, V37, P85, DOI 10.1109/10.43620; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Gorman Jack M., 2000, American Heart Journal, V140, pS77; Li HL, 2011, IEEE ACM T COMPUT BI, V8, P1557, DOI 10.1109/TCBB.2011.43; Mainardi LT, 2009, PHILOS T R SOC A, V367, P255, DOI 10.1098/rsta.2008.0188; Peng CK, 1999, INT J CARDIOL, V70, P101, DOI 10.1016/S0167-5273(99)00066-2; Pola S, 1996, IEEE T BIO-MED ENG, V43, P46, DOI 10.1109/10.477700; Toledo E, 2003, AM J PHYSIOL-REG I, V284, pR1079, DOI 10.1152/ajpregu.00287.2002; Vila J, 1997, IEEE ENG MED BIOL, V16, P119, DOI 10.1109/51.620503; Wiklund U, 1997, IEEE ENG MED BIOL, V16, P113, DOI 10.1109/51.620502; Zhong YR, 2004, IEEE T BIO-MED ENG, V51, P255, DOI 10.1109/TBME.2003.820401	18	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133148	10.1371/journal.pone.0133148	http://dx.doi.org/10.1371/journal.pone.0133148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172953	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900140
J	Brand, HK; Ahout, IML; de Ridder, D; van Diepen, A; Li, Y; Zaalberg, M; Andeweg, A; Roeleveld, N; de Groot, R; Warris, A; Hermans, PWM; Ferwerda, G; Staal, FJT				Brand, H. K.; Ahout, I. M. L.; de Ridder, D.; van Diepen, A.; Li, Y.; Zaalberg, M.; Andeweg, A.; Roeleveld, N.; de Groot, R.; Warris, A.; Hermans, P. W. M.; Ferwerda, G.; Staal, F. J. T.			Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; PROSPECTIVE MULTICENTER; EMERGENCY-DEPARTMENT; HELICOBACTER-PYLORI; BRONCHIOLITIS; CHILDREN; MICROARRAYS; HOSPITALIZATIONS; DIAGNOSTICS; ADMISSION	Background Respiratory viral infections follow an unpredictable clinical course in young children ranging from a common cold to respiratory failure. The transition from mild to severe disease occurs rapidly and is difficult to predict. The pathophysiology underlying disease severity has remained elusive. There is an urgent need to better understand the immune response in this disease to come up with biomarkers that may aid clinical decision making. Methods In a prospective study, flow cytometric and genome-wide gene expression analyses were performed on blood samples of 26 children with a diagnosis of severe, moderate or mild Respiratory Syncytial Virus (RSV) infection. Differentially expressed genes were validated using Q-PCR in a second cohort of 80 children during three consecutive winter seasons. FACS analyses were also performed in the second cohort and on recovery samples of severe cases in the first cohort. Results Severe RSV infection was associated with a transient but marked decrease in CD4+ T, CD8+ T, and NK cells in peripheral blood. Gene expression analyses in both cohorts identified Olfactomedin4 (OLFM4) as a fully discriminative marker between children with mild and severe RSV infection, giving a PAM cross-validation error of 0%. Patients with an OLFM4 gene expression level above -7.5 were 6 times more likely to develop severe disease, after correction for age at hospitalization and gestational age. Conclusion By combining genome-wide expression profiling of blood cell subsets with clinically well-annotated samples, OLFM4 was identified as a biomarker for severity of pediatric RSV infection.	[Brand, H. K.; Ahout, I. M. L.; van Diepen, A.; Zaalberg, M.; Roeleveld, N.; de Groot, R.; Warris, A.; Hermans, P. W. M.; Ferwerda, G.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Brand, H. K.; Ahout, I. M. L.; van Diepen, A.; de Groot, R.; Warris, A.; Hermans, P. W. M.; Ferwerda, G.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [de Ridder, D.] Delft Univ Technol, Delft Bioinformat Lab, Fac Elect Engn Math & Comp Sci, Delft, Netherlands; [Li, Y.] Erasmus Univ, Med Ctr, Dept Bioinformat, Rotterdam, Netherlands; [Andeweg, A.] Erasmus Univ, Med Ctr, Dept Virol, Rotterdam, Netherlands; [Roeleveld, N.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6525 ED Nijmegen, Netherlands; [Staal, F. J. T.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Staal, F. J. T.] Erasmus Univ, Med Ctr, Dept Immunol, Rotterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Delft University of Technology; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Ferwerda, G (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands.	Gerben.ferwerda@radboudumc.nl	Ferwerda, J.G./L-4305-2015; Warris, A./L-4745-2015; de Groot, R./H-8039-2014; Roeleveld, Nel/B-4242-2008; Hermans, Peter W.M./H-8042-2014; de Ridder, Dick/F-3169-2010; Ahout, Inge ML/P-8666-2015	Roeleveld, Nel/0000-0002-3390-4466; de Ridder, Dick/0000-0002-4944-4310; Warris, Adilia/0000-0001-6586-3358	VIRGO consortium; Dutch Government [BSIK 03012]	VIRGO consortium; Dutch Government	Statement of financial support: The study was financially supported by the VIRGO consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative and partially funded by the Dutch Government (BSIK 03012). The authors have indicated they have no personal financial relationships relevant to this article to disclose.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Berger TM, 2009, INFECTION, V37, P109, DOI 10.1007/s15010-008-8130-z; Black Craig Patrick, 2003, Respir Care, V48, P209; Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Brand HK, 2010, ADV EXP MED BIOL, V659, P19, DOI 10.1007/978-1-4419-0981-7_2; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gersemann M, 2012, J CROHNS COLITIS, V6, P425, DOI 10.1016/j.crohns.2011.09.013; Grover PK, 2010, CANCER METAST REV, V29, P761, DOI 10.1007/s10555-010-9262-z; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Hoggatt J, 2011, MOL DIAGN THER, V15, P53, DOI 10.2165/11534880-000000000-00000; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Kim Brand H, 2012, PEDIAT RES; Liu WL, 2012, J IMMUNOL, V189, P2460, DOI 10.4049/jimmunol.1103179; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; Lopez Guinea A, 2007, An Pediatr (Barc), V67, P116; Mannick EE, 2004, SCAND J GASTROENTERO, V39, P1192, DOI 10.1080/00365520410003588; Mansbach JM, 2008, PEDIATRICS, V121, P680, DOI 10.1542/peds.2007-1418; Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549; Norwood A, 2010, ACAD EMERG MED, V17, P376, DOI 10.1111/j.1553-2712.2010.00699.x; Openshaw PJM, 2005, CLIN MICROBIOL REV, V18, P541, DOI 10.1128/CMR.18.3.541-555.2005; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Prais D, 2005, CHEST, V128, P2765, DOI 10.1378/chest.128.4.2765; Quinn B, 2010, CLIN PHARMACOL THER, V88, P751, DOI 10.1038/clpt.2010.234; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Roback MG, 1997, PEDIATR EMERG CARE, V13, P9, DOI 10.1097/00006565-199702000-00003; Robbins AS, 2002, ANN EPIDEMIOL, V12, P452, DOI 10.1016/S1047-2797(01)00278-2; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Staal FJT, 2010, LEUKEMIA, V24, P491, DOI 10.1038/leu.2009.286; Staal FJT, 2004, J IMMUNOL, V172, P1099, DOI 10.4049/jimmunol.172.2.1099; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; WANG EEL, 1995, J PEDIATR-US, V126, P212, DOI 10.1016/S0022-3476(95)70547-3; Wang YH, 2007, J VIROL, V81, P3904, DOI 10.1128/JVI.01887-06; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; Zhang JC, 2002, GENE, V283, P83, DOI 10.1016/S0378-1119(01)00763-6; Zilliox MJ, 2007, CLIN VACCINE IMMUNOL, V14, P918, DOI 10.1128/CVI.00031-07	42	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131927	10.1371/journal.pone.0131927	http://dx.doi.org/10.1371/journal.pone.0131927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162090	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300075
J	Gardner, CJ; Raxworthy, CJ; Metcalfe, K; Raselimanana, AP; Smith, RJ; Davies, ZG				Gardner, Charlie J.; Raxworthy, Christopher J.; Metcalfe, Kristian; Raselimanana, Achille P.; Smith, Robert J.; Davies, Zoe G.			Comparing Methods for Prioritising Protected Areas for Investment: A Case Study Using Madagascar's Dry Forest Reptiles	PLOS ONE			English	Article							CONSERVATION PRIORITIES; BIODIVERSITY; DIVERSITY; DEFORESTATION; EXPERIENCES; SECONDARY; EXPANSION; MANAGERS; RADIATA; RETURN	There are insufficient resources available to manage the world's existing protected area portfolio effectively, so the most important sites should be prioritised in investment decision-making. Sophisticated conservation planning and assessment tools developed to identify locations for new protected areas can provide an evidence base for such prioritisations, yet decision-makers in many countries lack the institutional support and necessary capacity to use the associated software. As such, simple heuristic approaches such as species richness or number of threatened species are generally adopted to inform prioritisation decisions. However, their performance has never been tested. Using the reptile fauna of Madagascar's dry forests as a case study, we evaluate the performance of four site prioritisation protocols used to rank the conservation value of 22 established and candidate protected areas. We compare the results to a benchmark produced by the widely-used systematic conservation planning software Zonation. The four indices scored sites on the basis of: i) species richness; ii) an index based on species' Red List status; iii) irreplaceability (a key metric in systematic conservation planning); and, iv) a novel Conservation Value Index (CVI), which incorporates species-level information on endemism, representation in the protected area system, tolerance of habitat degradation and hunting/collection pressure. Rankings produced by the four protocols were positively correlated to the results of Zonation, particularly amongst high-scoring sites, but CVI and Irreplaceability performed better than Species Richness and the Red List Index. Given the technological capacity constraints experienced by decision-makers in the developing world, our findings suggest that heuristic metrics can represent a useful alternative to more sophisticated analyses, especially when they integrate species-specific information related to extinction risk. However, this can require access to, and understanding of, more complex species data.	[Gardner, Charlie J.; Metcalfe, Kristian; Smith, Robert J.; Davies, Zoe G.] Univ Kent, Sch Anthropol & Conservat, DICE, Canterbury, Kent, England; [Gardner, Charlie J.] WWF Madagascar & Western Indian Ocean Programme O, Antananarivo 101, Madagascar; [Raxworthy, Christopher J.] Amer Museum Nat Hist, Dept Herpetol, New York, NY 10024 USA; [Metcalfe, Kristian] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Metcalfe, Kristian] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Raselimanana, Achille P.] Assoc Vahatra, Antananarivo 101, Madagascar; [Raselimanana, Achille P.] Univ Antananarivo, Fac Sci, Dept Biol Anim, Antananarivo 101, Madagascar	University of Kent; World Wildlife Fund; American Museum of Natural History (AMNH); University of Exeter; University of Exeter; University Antananarivo	Gardner, CJ (corresponding author), Univ Kent, Sch Anthropol & Conservat, DICE, Canterbury, Kent, England.	cg399@kent.ac.uk	Smith, Robert J/D-9660-2011; Metcalfe, Kristian/A-2297-2015	Smith, Robert J/0000-0003-1599-9171; Raselimanana, Achille Philippe/0000-0003-1610-7307; Gardner, Charlie/0000-0002-2750-3690; Metcalfe, Kristian/0000-0002-7662-5379	National Science Foundation [DEB-0641023, 0423286, 9984496]; National Geographic Society; Conservation International; Earthwatch	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Conservation International; Earthwatch	The authors received no specific funding for this work. Some material used in the analysis was collected by CJR and funded by National Science Foundation (DEB-0641023, 0423286, 9984496) (www.nsf.gov/), National Geographic Society (www.nationalgeographic.com), Conservation International (www.conservation.org) and Earthwatch (www.earthwatch.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRECO, 2012, AN COUTS SOURC FIN S; Allnutt TF, 2013, TROP CONSERV SCI, V6, P1, DOI 10.1177/194008291300600101; Auerbach NA, 2014, ECOL APPL, V24, P1357, DOI 10.1890/13-0711.1; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Barr LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024707; Benayas JMR, 2003, BIOL CONSERV, V114, P357, DOI 10.1016/S0006-3207(03)00064-8; Beresford AE, 2011, ANIM CONSERV, V14, P99, DOI 10.1111/j.1469-1795.2010.00398.x; Bertzky B., 2012, PROTECTED PLANET REP; Bora P, 2010, HERPETOL CONSERV BIO, V5, P111; Bottrill MC, 2012, CONSERV LETT, V5, P407, DOI 10.1111/j.1755-263X.2012.00268.x; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Brandon K., 1998, PARKS PERIL PEOPLE P; Brooks T, 2004, CONSERV BIOL, V18, P1682, DOI 10.1111/j.1523-1739.2004.00457.x; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brooks TM, 2009, CONSERV BIOL, V23, P1448, DOI 10.1111/j.1523-1739.2009.01334.x; Brooks TM, 2004, BIOSCIENCE, V54, P1081, DOI 10.1641/0006-3568(2004)054[1081:CPBTGP]2.0.CO;2; Brugiere D, 2013, J NAT CONSERV, V21, P286, DOI 10.1016/j.jnc.2013.02.004; Bruner AG, 2004, BIOSCIENCE, V54, P1119, DOI 10.1641/0006-3568(2004)054[1119:FCASOM]2.0.CO;2; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Butler R, 2010, MADAGASCARS POLITICA; Cadle John E., 2008, Herpetological Review, V39, P285; Carwardine J, 2010, CONSERV BIOL, V24, P1529, DOI 10.1111/j.1523-1739.2010.01535.x; Cook CN, 2012, J ENVIRON MANAGE, V113, P341, DOI 10.1016/j.jenvman.2012.09.002; Cook CN, 2010, FRONT ECOL ENVIRON, V8, P181, DOI 10.1890/090020; Cornet A., 1974, NOTICE EXPLICATIVE, V55, P1; Corson C, 2014, EARTH CONSERV DEV, P193; Cowling RM, 2010, CONSERV BIOL, V24, P633, DOI 10.1111/j.1523-1739.2009.01342.x; Daily GC, 2001, NATURE, V411, P245, DOI 10.1038/35077178; Diniz JAF, 2004, CONSERV BIOL, V18, P698; Fischer J, 2006, FRONT ECOL ENVIRON, V4, P80, DOI 10.1890/1540-9295(2006)004[0080:BEFART]2.0.CO;2; Fuller RA, 2010, NATURE, V466, P365, DOI 10.1038/nature09180; Game ET, 2013, CONSERV BIOL, V27, P480, DOI 10.1111/cobi.12051; Gardner Charlie, 2009, Herpetology Notes, V2, P239; Gardner CJ, 2011, ORYX, V45, P336, DOI 10.1017/S0030605310001808; Gardner CJ, 2013, J APPL ECOL, V50, P1289, DOI 10.1111/1365-2664.12164; GARDNER CJ, 2009, MALAGASY NATURE, V2, P2; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gaston KJ, 2008, ANN NY ACAD SCI, V1134, P97, DOI 10.1196/annals.1439.006; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Glaw F, 2007, FIELD GUIDE AMPHIBIA; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Grantham HS, 2008, CONSERV LETT, V1, P190, DOI 10.1111/j.1755-263X.2008.00029.x; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Harris GM, 2004, CONSERV BIOL, V18, P1607, DOI 10.1111/j.1523-1739.2004.00157.x; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; IUCN, 2012, IUCN RED LIST THREAT; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Jenkins RKB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100173; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Knight A. T., 2010, TRADE OFFS CONSERVAT, P273, DOI DOI 10.1002/9781444324907.CH15; Knight AT, 2008, CONSERV BIOL, V22, P610, DOI 10.1111/j.1523-1739.2008.00914.x; Knight AT, 2011, BIOL CONSERV, V144, P202, DOI 10.1016/j.biocon.2010.08.017; Knight AT, 2010, SCIENCE, V329, P141, DOI 10.1126/science.329.5988.141-a; Knight AT, 2006, CONSERV BIOL, V20, P408, DOI 10.1111/j.1523-1739.2006.00305.x; Kohler G, 2009, HERPETOLOGICA, V65, P419; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Leuteritz TEJ, 2005, BIOL CONSERV, V124, P451, DOI 10.1016/j.biocon.2005.02.003; Leuteritz TEJ, 2013, CHELON RES MONOGR, V6, P33; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marris E, 2007, NATURE, V450, P152, DOI 10.1038/450152a; Milner-Gulland EJ, 2012, J APPL ECOL, V49, P1, DOI 10.1111/j.1365-2664.2011.02102.x; Moilanen A, 2012, ZONATION V3 1 SPATIA; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; Nagy Zoltan T, 2012, PLoS One, V7, pe34506, DOI 10.1371/journal.pone.0034506; Nagy ZT, 2010, ZOOL SCR, V39, P426, DOI 10.1111/j.1463-6409.2010.00435.x; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; ONE DGF FTM MNP CI, 2013, EV COUV FOR NAT MAD; Owens IPF, 2000, CONSERV BIOL, V14, P1014, DOI 10.1046/j.1523-1739.2000.98509.x; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; PRESSEY RL, 1994, CONSERV BIOL, V8, P662, DOI 10.1046/j.1523-1739.1994.08030662.x; Pullin AS, 2005, CONSERV BIOL, V19, P1989, DOI 10.1111/j.1523-1739.2005.00287.x; Pullin AS, 2004, BIOL CONSERV, V119, P245, DOI 10.1016/j.biocon.2003.11.007; PULLIN AS, 2013, KEY TOPICS CONSERVAT, P3, DOI DOI 10.1002/9781118520178.CH1; Raik D., 2011, MADAGASCAR CONSERVAT, V2, P5, DOI [10.4314/mcd.v2i1.44123, DOI 10.4314/MCD.V2I1.44123]; Rakotondravony HA, 2011, HERPETOL CONSERV BIO, V6, P297; Randriamalala H., 2010, Madagascar Conservation and Development, V5, P11; Randrianandianina B.N., 2003, P1423; Rasoavahiny L., 2008, PARKS, V17, P12; Raxworthy C.J., 2003, P934; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Raxworthy Christopher J., 2000, Amphibian and Reptile Conservation, V2, P15; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Scheiner SM, 2012, OIKOS, V121, P1191, DOI 10.1111/j.1600-0706.2012.20607.x; Schwitzer C, 2014, SCIENCE, V343, P842, DOI 10.1126/science.1245783; Schwitzer C., 2013, LEMURS MADAGASCAR ST, P146; Smith RJ, 2012, CONSERV LETT, V5, P205, DOI 10.1111/j.1755-263X.2012.00229.x; Smith RJ, 2009, NATURE, V462, P280, DOI 10.1038/462280a; SOULE ME, 1985, BIOSCIENCE, V35, P727, DOI 10.2307/1310054; Tang LN, 2010, BIOL CONSERV, V143, P1295, DOI 10.1016/j.biocon.2010.01.024; Veloz SD, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00341.1; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Virah-Sawmy M, 2014, EARTH CONSERV DEV, P216; Waldron A, 2013, P NATL ACAD SCI USA, V110, P12144, DOI 10.1073/pnas.1221370110; Walker R.C.J., 2013, CHELONIAN RES MONOGR, V6, P135; Walker RCJ, 2012, CHELONIAN CONSERV BI, V11, P223, DOI 10.2744/CCB-0968.1; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Whitehurst AS, 2009, ORYX, V43, P275, DOI 10.1017/S0030605309001756; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Wilson RS, 2008, CONSERV BIOL, V22, P1452, DOI 10.1111/j.1523-1739.2008.01016.x	108	5	5	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132803	10.1371/journal.pone.0132803	http://dx.doi.org/10.1371/journal.pone.0132803			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162073	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300177
J	Jiang, J; Wu, HB; Huang, MY; Wu, Y; Wang, QS; Zhao, JQ; Yang, W; Chen, WF; Feng, QJ				Jiang, Jun; Wu, Hubing; Huang, Meiyan; Wu, Yao; Wang, Quanshi; Zhao, Jianqi; Yang, Wei; Chen, Wufan; Feng, Qianjin			Variability of Gross Tumor Volume in Nasopharyngeal Carcinoma Using C-11-Choline and F-18-FDG PET/CT	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SEGMENTATION; DELINEATION; CANCER; RADIOTHERAPY; IMPACT; IMAGES; TARGET; CT	This study was conducted to evaluate the variability of gross tumor volume (GTV) using C-11-Choline and F-18-FDG PET/CT images for nasopharyngeal carcinomas boundary definition. Assessment consisted of inter-observer and inter-modality variation analysis. Four radiation oncologists were invited to manually contour GTV by using PET/CT fusion obtained from a cohort of 12 patients with nasopharyngeal carcinoma (NPC) and who underwent both C-11-Choline and F-18-FDG scans. Student's paired-sample t-test was performed for analyzing inter-observer and inter-modality variability. Semi-automatic segmentation methods, including thresholding and region growing, were also validated against the manual contouring of the two types of PET images. We observed no significant variation in the results obtained by different oncologists in terms of the same type of PET/CT volumes. Choline fusion volumes were significantly larger than the FDG volumes (p < 0.0001, mean +/- SD = 18.21 +/- 8.19). While significantly consistent results were obtained between the oncologists and the standard references in Choline volumes compared with those in FDG volumes (p = 0.0025). Simple semi-automatic delineation methods indicated that C-11-Choline PET images could provide better results than FDG volumes (p = 0.076, CI = [-0.29, 0.025]). C-11-Choline PET/CT may be more advantageous in GTV delineation for the radiotherapy of NPC than F-18-FDG. Phantom simulations and clinical trials should be conducted to prove the possible improvement of the treatment outcome.	[Jiang, Jun; Huang, Meiyan; Wu, Yao; Zhao, Jianqi; Yang, Wei; Chen, Wufan; Feng, Qianjin] Southern Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China; [Wu, Hubing; Wang, Quanshi] Nanfang Hosp, Dept PET Ctr, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Feng, QJ (corresponding author), Southern Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China.	qianjinfeng08@gmail.com	feng, qianjin/GNM-7856-2022; Feng, Qianjin/Y-5438-2019	feng, qianjin/0000-0002-3830-5120; Jiang, Jun/0000-0003-1147-3666	National Basic Research Program of China (973 Program) [2010CB732505]; National Science & Technology Pillar Program of China [2012BAI14B02]; Ministry of Science special fund for major instrument [2011YQ030114]; National High-tech R&D Program of China (863 Program) [2012AA02A616]; National Natural Science Funds of China (NSFC) [81101109]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science & Technology Pillar Program of China; Ministry of Science special fund for major instrument; National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Funds of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Basic Research Program of China (973 Program) (No. 2010CB732505), National Science & Technology Pillar Program of China (No. 2012BAI14B02), Ministry of Science special fund for major instrument (No. 2011YQ030114), National High-tech R&D Program of China (863 Program) (No. 2012AA02A616) and National Natural Science Funds of China (NSFC, No. 81101109). The authors would also like to thank Ye Dong and Shaobo Wang from the Department of PET Center, Nanfang Hospital for their great support of GTV evaluation.	Ashamalla H, 2007, INT J RADIAT ONCOL, V68, P388, DOI 10.1016/j.ijrobp.2006.12.029; Bagci U, 2012, LECT NOTES COMPUT SC, V7512, P459, DOI 10.1007/978-3-642-33454-2_57; Bassi MC, 2008, INT J RADIAT ONCOL, V70, P1423, DOI 10.1016/j.ijrobp.2007.08.043; Black QC, 2004, INT J RADIAT ONCOL, V60, P1272, DOI 10.1016/j.ijrobp.2004.06.254; Chanapai W, 2012, INT J COMPUT ASS RAD, V7, P413, DOI 10.1007/s11548-011-0629-6; Day E, 2009, MED PHYS, V36, P4349, DOI 10.1118/1.3213099; Devic S, 2010, INT J RADIAT ONCOL, V78, P1555, DOI 10.1016/j.ijrobp.2010.02.015; Erdi YE, 1997, CANCER, V80, P2505, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2505::AID-CNCR24>3.3.CO;2-B; Houweling AC, 2013, RADIOTHERAPY ONCOLOG; Kato T, 2008, AM J NEURORADIOL, V29, P1176, DOI 10.3174/ajnr.A1008; King AD, 2008, BRIT J RADIOL, V81, P291, DOI 10.1259/bjr/73751469; Li H, 2008, MED PHYS, V35, P3711, DOI 10.1118/1.2956713; Masa-Ah P., 2010, INT J MATH MODELS ME, V4, P291; Nestle U, 1999, INT J RADIAT ONCOL, V44, P593, DOI 10.1016/S0360-3016(99)00061-9; Potesil V., 2007, P SPIE INT S MED IM, V6514; Riegel AC, 2006, INT J RADIAT ONCOL, V65, P726, DOI 10.1016/j.ijrobp.2006.01.014; Troost EGC, 2010, RADIOTHER ONCOL, V96, P328, DOI 10.1016/j.radonc.2010.07.017; Wu HB, 2011, J NUCL MED, V52, P341, DOI 10.2967/jnumed.110.081190; Xia Y, 2012, COMPUT MED IMAG GRAP, V36, P47, DOI 10.1016/j.compmedimag.2011.06.004; Zaidi H, 2010, EUR J NUCL MED MOL I, V37, P2165, DOI 10.1007/s00259-010-1423-3	20	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131801	10.1371/journal.pone.0131801	http://dx.doi.org/10.1371/journal.pone.0131801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161910	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300061
J	Kirkland, T; Gruber, J; Cunningham, WA				Kirkland, Tabitha; Gruber, June; Cunningham, William A.			Comparing Happiness and Hypomania Risk: A Study of Extraversion and Neuroticism Aspects	PLOS ONE			English	Article							PERSONALITY-TRAITS; 5-FACTOR MODEL; HAPPY; MANIA; SATISFACTION; VALIDATION; DOMAINS; FACETS; SCALE; TOO	Positive affect has long been considered a hallmark of subjective happiness. Yet, high levels of positive affect have also been linked with hypomania risk: a set of cognitive, affective, and behavioral characteristics that constitute a dispositional risk for future episodes of hypomania and mania. At a personality level, two powerful predictors of affective experience are extraversion and neuroticism: extraversion has been linked to positive affect, and neuroticism to negative affect. As such, a single personality trait - extraversion - has been linked to both beneficial and harmful outcomes associated with positivity. It is clear that positive affect, in different forms, has divergent consequences for well-being, but previous research has struggled to articulate the nature of these differences. We suggest that the relationship between affect and well-being needs to be situated within the psychological context of the individual - both in terms of more specific forms of extraversion and neuroticism, but also in terms of interactions among personality aspects. Consistent with this idea, we found that two aspects of extraversion (enthusiasm and assertiveness) differentially predicted subjective happiness from hypomania risk and two aspects of neuroticism (volatility and withdrawal) interacted to predict hypomania risk: the highest levels of hypomania risk were associated with the combination of high volatility and low withdrawal. These findings underscore the importance of examining personality at the right level of resolution to understand well-being and dysfunction.	[Kirkland, Tabitha; Cunningham, William A.] Bellevue Coll, Dept Psychol, Bellevue, WA USA; [Kirkland, Tabitha; Cunningham, William A.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Gruber, June] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Cunningham, William A.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Cunningham, William A.] Univ Toronto, Dept Mkt, Toronto, ON, Canada	University System of Ohio; Ohio State University; University of Colorado System; University of Colorado Boulder; University of Toronto; University of Toronto	Cunningham, WA (corresponding author), Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA.	cunningham@psych.utoronto.ca						Altman EG, 1997, BIOL PSYCHIAT, V42, P948, DOI 10.1016/S0006-3223(96)00548-3; Andrews F. M., 1976, SOCIAL INDICATORS WE; BECK AT, 1974, PSYCHOL REP, V34, P1184; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cacioppo J T, 1997, Pers Soc Psychol Rev, V1, P3, DOI 10.1207/s15327957pspr0101_2; Campos B, 2013, COGNITION EMOTION, V27, P37, DOI 10.1080/02699931.2012.683852; Carpenter S, 2012, SCIENCE, V335, P1558, DOI 10.1126/science.335.6076.1558; Clark L.A., 2008, HDB PERSONALITY THEO, P265; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohn MA, 2009, EMOTION, V9, P361, DOI 10.1037/a0015952; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; COSTA PT, 1992, J PERS DISORD, V6, P343, DOI 10.1521/pedi.1992.6.4.343; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; DeYoung CG, 2007, J PERS SOC PSYCHOL, V93, P880, DOI 10.1037/0022-3514.93.5.880; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x; Diener E, 2009, SOC INDIC RES SER, V39, P213, DOI 10.1007/978-90-481-2354-4_10; ECKBLAD M, 1986, J ABNORM PSYCHOL, V95, P214, DOI 10.1037/0021-843X.95.3.214; Fredrickson Barbara L, 1998, Rev Gen Psychol, V2, P300; Fredrickson BL, 2002, PSYCHOL SCI, V13, P172, DOI 10.1111/1467-9280.00431; Freedman J., 1978, HAPPY PEOPLE WHAT HA; GRAY JA, 1982, BEHAV BRAIN SCI, V5, P469, DOI 10.1017/S0140525X00013066; Gruber J., 2014, POSITIVE EMOTION INT; Gruber J, 2008, EMOTION, V8, P23, DOI 10.1037/1528-3542.8.1.23; Gruber J, 2011, CURR DIR PSYCHOL SCI, V20, P217, DOI 10.1177/0963721411414632; Gruber J, 2011, PERSPECT PSYCHOL SCI, V6, P222, DOI 10.1177/1745691611406927; Hofmann BU, 2006, BRIT J CLIN PSYCHOL, V45, P105, DOI 10.1348/014466505X35317; Jang KL, 2002, PERS INDIV DIFFER, V33, P83, DOI 10.1016/S0191-8869(01)00137-4; Johnson SL, 2005, CLIN PSYCHOL REV, V25, P241, DOI 10.1016/j.cpr.2004.11.002; Klein DN, 1996, J AFFECT DISORDERS, V38, P135, DOI 10.1016/0165-0327(96)00005-5; Kwapil TR, 2000, J ABNORM PSYCHOL, V109, P222, DOI 10.1037/0021-843X.109.2.222; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Meyer B, 2001, J PSYCHOPATHOL BEHAV, V23, P133, DOI 10.1023/A:1010929402770; Meyer TD, 2009, J INDIVID DIFFER, V30, P169, DOI 10.1027/1614-0001.30.3.169; Parker G, 2014, PSYCHIAT RES, V220, P654, DOI 10.1016/j.psychres.2014.07.040; Quilty LC, 2013, J AFFECT DISORDERS, V147, P247, DOI 10.1016/j.jad.2012.11.012; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Schalet BD, 2011, PSYCHOL ASSESSMENT, V23, P504, DOI 10.1037/a0022301; Schimmack U, 2012, PSYCHOL METHODS, V17, P551, DOI 10.1037/a0029487; Shiota M.N., 2006, J POSIT PSYCHOL, V1, P61, DOI [10.1080/17439760500510833, DOI 10.1080/17439760500510833]; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watson D, 1999, J PERS SOC PSYCHOL, V76, P820, DOI 10.1037/0022-3514.76.5.820	49	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132438	10.1371/journal.pone.0132438	http://dx.doi.org/10.1371/journal.pone.0132438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161562	Green Published, Green Submitted, gold			2022-12-27	WOS:000358162300136
J	Kogashiwa, Y; Sakurai, H; Akimoto, Y; Sato, D; Ikeda, T; Matsumoto, Y; Moro, Y; Kimura, T; Hamanoue, Y; Nakamura, T; Yamauchi, K; Saito, K; Sugasawa, M; Kohno, N				Kogashiwa, Yasunao; Sakurai, Hiroyuki; Akimoto, Yoshihiro; Sato, Dai; Ikeda, Tetsuya; Matsumoto, Yoshifumi; Moro, Yorihisa; Kimura, Toru; Hamanoue, Yasuhiro; Nakamura, Takehiro; Yamauchi, Koichi; Saito, Koichiro; Sugasawa, Masashi; Kohno, Naoyuki			Sentinel Node Biopsy for the Head and Neck Using Contrast-Enhanced Ultrasonography Combined with Indocyanine Green Fluorescence in Animal Models: A Feasibility Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LYMPH-NODE; MELANOMA; METASTASES; DISSECTION; CANCER	Background Sentinel node navigation surgery is gaining popularity in oral cancer. We assessed application of sentinel lymph node navigation surgery to pharyngeal and laryngeal cancers by evaluating the combination of contrast-enhanced ultrasonography and indocyanine green fluorescence in animal models. Methods This was a prospective, nonrandomized, experimental study in rabbit and swine animal models. A mixture of indocyanine green and Sonazoid was used as the tracer. The tracer mixture was injected into the tongue, larynx, or pharynx. The sentinel lymph nodes were identified transcutaneously by infra-red camera and contrast-enhanced ultrasonography. Detection time and extraction time of the sentinel lymph nodes were measured. The safety of the tracer mixture in terms of mucosal reaction was evaluated macroscopically and microscopically. Results Sentinel lymph nodes were detected transcutaneously by contrast-enhanced ultrasonography alone. The number of sentinel lymph nodes detected was one or two. Despite observation of contrast enhancement of Sonazoid for at least 90 minutes, the number of sentinel lymph nodes detected did not change. The average extraction time of sentinel lymph nodes was 4.8 minutes. Indocyanine green fluorescence offered visual information during lymph node biopsy. The safety of the tracer was confirmed by absence of laryngeal edema both macro and microscopically. Conclusions The combination method of indocyanine green fluorescence and contrast-enhanced ultrasonography for detecting sentinel lymph nodes during surgery for head and neck cancer seems promising, especially for pharyngeal and laryngeal cancer. Further clinical studies to confirm this are warranted.	[Kogashiwa, Yasunao; Sugasawa, Masashi] Saitama Med Univ, Int Med Ctr, Dept Head & Neck Surg, Otolaryngol, Hidaka, Saitama, Japan; [Kogashiwa, Yasunao; Sato, Dai; Ikeda, Tetsuya; Matsumoto, Yoshifumi; Moro, Yorihisa; Hamanoue, Yasuhiro; Nakamura, Takehiro; Yamauchi, Koichi; Saito, Koichiro; Kohno, Naoyuki] Kyorin Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Mitaka, Tokyo 181, Japan; [Sakurai, Hiroyuki; Kimura, Toru] Kyorin Univ, Sch Med, Dept Pharmacol & Toxycol, Mitaka, Tokyo 181, Japan; [Akimoto, Yoshihiro] Kyorin Univ, Sch Med, Dept Anat, Mitaka, Tokyo 181, Japan	Saitama Medical University; Kyorin University; Kyorin University; Kyorin University	Kogashiwa, Y (corresponding author), Saitama Med Univ, Int Med Ctr, Dept Head & Neck Surg, Otolaryngol, Hidaka, Saitama, Japan.	y_koga@saitama-med.ac.jp		Saito, Koichiro/0000-0002-8107-2967	Setsuro Fujii Memorial The Osaka Foundation for Promotion of Fundamental Medical Research	Setsuro Fujii Memorial The Osaka Foundation for Promotion of Fundamental Medical Research	The research was partly supported by grant from Setsuro Fujii Memorial The Osaka Foundation for Promotion of Fundamental Medical Research (NK and YK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CASTELIJNS JA, 1993, MAGN RESON QUART, V9, P113; Curry JM, 2007, OTOLARYNG HEAD NECK, V137, P735, DOI 10.1016/j.otohns.2007.07.019; Goldberg BB, 2004, RADIOLOGY, V230, P727, DOI 10.1148/radiol.2303021440; Hayashi T, 2010, INT J CLIN ONCOL, V15, P504, DOI 10.1007/s10147-010-0063-8; Higashi H, 2004, J SURG RES, V121, P1, DOI 10.1016/j.jss.2004.02.011; Jansen L, 2000, HEAD NECK-J SCI SPEC, V22, P27, DOI 10.1002/(SICI)1097-0347(200001)22:1<27::AID-HED5>3.0.CO;2-Z; Japan Society for Head and Neck Cancer Registry Committee, 2003, REP HEAD NECK CANC R; Japan Society for Head and Neck Cancer Registry Committee, 2001, REP HEAD NECK CANC R; Japan Society for Head and Neck Cancer Registry Committee, 2002, REP HEAD NECK CANC R; Katada C, 2007, LARYNGOSCOPE, V117, P1596, DOI 10.1097/MLG.0b013e318093ed70; LEEMANS CR, 1993, CANCER, V71, P452, DOI 10.1002/1097-0142(19930115)71:2<452::AID-CNCR2820710228>3.0.CO;2-B; Mayland MK, 2005, LARYNGOSCOPE, V115, P629, DOI 10.1097/01.mlg.0000161338.54515.b1; Nakayama M, 2013, JPN J CLIN ONCOL, V43, P782, DOI 10.1093/jjco/hyt081; Norling R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090360; Omoto K, 2006, J CLIN ULTRASOUND, V34, P317, DOI 10.1002/jcu.20241; Piazza C, 2008, ACTA OTORHINOLARYNGO, V28, P49; Righi PD, 1997, HEAD NECK-J SCI SPEC, V19, P604, DOI 10.1002/(SICI)1097-0347(199710)19:7<604::AID-HED7>3.3.CO;2-K; Shiotani A, 2011, OTOLARYNG HEAD NECK, V144, P288, DOI 10.1177/0194599810392148; Stoeckh SJ, 2007, LARYNGOSCOPE, V117, P1539, DOI 10.1097/MLG.0b013e318093ee67; Tanis PJ, 2008, HEAD NECK-J SCI SPEC, V30, P380, DOI 10.1002/hed.20749; van Leeuwen AC, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3528027; Watanabe A, 2009, EUR ARCH OTO-RHINO-L, V266, P1017, DOI 10.1007/s00405-008-0835-1; Yamauchi K, 2011, ANN SURG ONCOL, V18, P2042, DOI 10.1245/s10434-010-1499-9; Yamazaki Y, 2008, ANN NUCL MED, V22, P177, DOI 10.1007/s12149-007-0097-9	24	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132511	10.1371/journal.pone.0132511	http://dx.doi.org/10.1371/journal.pone.0132511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161800	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300144
J	Quintana, HK; Vikstrom, M; Andersson, T; Hallqvist, J; Leander, K				Quintana, Hedley Knewjen; Vikstrom, Max; Andersson, Tomas; Hallqvist, Johan; Leander, Karin			Agreement between Myocardial Infarction Patients and Their Spouses on Reporting of Data on 82 Cardiovascular Risk Exposures	PLOS ONE			English	Article							PROXY RESPONDENTS; INFORMATION; RELIABILITY	Background The validity of exposure data collected from proxy respondents of myocardial infarction patients has scarcely been studied. We assessed the level of disagreement between myocardial infarction patients and their spouses with respect to the reporting of the patient's cardiovascular risk exposures. Methods Within the frame of the Stockholm Heart Epidemiology Program (SHEEP), a case-control study of risk factors of myocardial infarction performed in Stockholm county 1992-1994, a subset of 327 first time myocardial infarction cases aged 45-70 who survived >28 days after the event and who co-habited with a spouse or common-law spouse (proxy) were identified between 1993-04-05 and 1993-12-31. Among these, 243 cases participated along with their respective proxy in the present study. Control individuals, matched to cases by age, sex and residential area were also included (n = 243). Data were collected using questionnaires. Using conditional logistic regression we calculated for each of 82 exposures the odds ratio based on information collected from 1) myocardial infarction cases and controls [odds ratio A] and 2) proxies and the same set of controls [odds ratio B]. Disagreement was measured by calculating the ratio between odds ratio B and odds ratio A with 95% confidence intervals (CI) calculated using resampling bootstrap. Results For the vast majority of the exposures considered including diet, smoking, education, work-related stress, and family history of CVD, there was no statistically significant disagreement between myocardial infarction patients and proxies (n = 243 pairs). However, leisure time physical inactivity (proxy bias = 1.59, 95% CI 1.05-3.57) was overestimated by spouses compared to myocardial infarction patients. A few other exposures including some sleep-related problems and work-related issues also showed disagreement. Conclusions Myocardial infarction patients and their spouses similarly reported data on a wide range of exposures including the majority of the traditional cardiovascular risk factors, leisure time physical inactivity being an exception.	[Quintana, Hedley Knewjen; Vikstrom, Max; Andersson, Tomas; Leander, Karin] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Andersson, Tomas] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden; [Hallqvist, Johan] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden	Karolinska Institutet; Stockholm County Council; Uppsala University	Quintana, HK (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	hedley.quintana@ki.se	Quintana, Hedley/J-6562-2019; Leander, Karin/C-7261-2017	Quintana, Hedley/0000-0002-5929-8791; Leander, Karin/0000-0002-1404-9222	Swedish Council for Work Life and Social Research; Stockholm County Council; ERACOL an Erasmus Mundus Target 2 program	Swedish Council for Work Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Stockholm County Council(Stockholm County Council); ERACOL an Erasmus Mundus Target 2 program	This study was supported by grants from the Swedish Council for Work Life and Social Research (http://www.forte.se/en/) and the Stockholm County Council (http://www.sll.se/om-landstinget/Information-in-English1/). In addition, a grant from the ERACOL (http://erasmus-columbus.eu/about/) an Erasmus Mundus Target 2 program, was awarded to HKQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capelle LG, 2011, ACTA NEUROL SCAND, V123, P160, DOI 10.1111/j.1600-0404.2010.01389.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; ENTERLINE PE, 1959, AM J PUBLIC HEALTH N, V49, P205, DOI 10.2105/AJPH.49.2.205; GRAHAM P, 1993, AM J EPIDEMIOL, V138, P443, DOI 10.1093/oxfordjournals.aje.a116876; Hallqvist J, 1998, SOC SCI MED, V46, P1405, DOI 10.1016/S0277-9536(97)10084-3; Hansen J, 1997, INT J EPIDEMIOL, V26, P1009, DOI 10.1093/ije/26.5.1009; Kirwood BR, 2003, ESSENTIAL MED STAT, P351; Kottner J, 2011, INT J NURS STUD, V48, P659, DOI 10.1016/j.ijnurstu.2011.01.017; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MCLAUGHLIN JK, 1987, AM J EPIDEMIOL, V126, P144, DOI 10.1093/oxfordjournals.aje.a114647; NELSON LM, 1994, EPIDEMIOLOGY, V5, P204, DOI 10.1097/00001648-199403000-00011; Reuterwall C, 1999, J INTERN MED, V246, P161, DOI 10.1046/j.1365-2796.1999.00554.x; TEPPER A, 1993, J CLIN EPIDEMIOL, V46, P1243, DOI 10.1016/0895-4356(93)90088-I; The National Board of Health and Welfare, 2012, MYOC INF SWED; WIGGINS CL, 1990, SLEEP, V13, P245, DOI 10.1093/sleep/13.3.245	15	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132601	10.1371/journal.pone.0132601	http://dx.doi.org/10.1371/journal.pone.0132601			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161850	Green Submitted, Green Published, gold			2022-12-27	WOS:000358162300157
J	Buscema, M; Grossi, E; Montanini, L; Street, ME				Buscema, Massimo; Grossi, Enzo; Montanini, Luisa; Street, Maria E.			Data Mining of Determinants of Intrauterine Growth Retardation Revisited Using Novel Algorithms Generating Semantic Maps and Prototypical Discriminating Variable Profiles	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; HUMAN PLACENTA; TNF-ALPHA; FACTOR-II; INTERLEUKIN-6; IGF; EXPRESSION; SYSTEM; RESTRICTION	Objectives Intra-uterine growth retardation is often of unknown origin, and is of great interest as a "Fetal Origin of Adult Disease" has been now well recognized. We built a benchmark based upon a previously analysed data set related to Intrauterine Growth Retardation with 46 subjects described by 14 variables, related with the insulin-like growth factor system and pro-inflammatory cytokines, namely interleukin -6 and tumor necrosis factor -alpha. Design and Methods We used new algorithms for optimal information sorting based on the combination of two neural network algorithms: Auto-contractive Map and Activation and Competition System. Auto-Contractive Map spatializes the relationships among variables or records by constructing a suitable embedding space where 'closeness' among variables or records reflects accurately their associations. The Activation and Competition System algorithm instead works as a dynamic non linear associative memory on the weight matrices of other algorithms, and is able to produce a prototypical variable profile of a given target. Results Classical statistical analysis, proved to be unable to distinguish intrauterine growth retardation from appropriate-for-gestational age (AGA) subjects due to the high non-linearity of underlying functions. Auto-contractive map succeeded in clustering and differentiating completely the conditions under study, while Activation and Competition System allowed to develop the profile of variables which discriminated the two conditions under study better than any other previous form of attempt. In particular, Activation and Competition System showed that ppropriateness for gestational age was explained by IGF-2 relative gene expression, and by IGFBP-2 and TNF-alpha placental contents. IUGR instead was explained by IGF-I, IGFBP-1, IGFBP-2 and IL-6 gene expression in placenta. Conclusion This further analysis provided further insight into the placental key-players of fetal growth within the insulin-like growth factor and cytokine systems. Our previous published analysis could identify only which variables were predictive of fetal growth in general, and identified only some relationships.	[Buscema, Massimo; Grossi, Enzo] Semeion Res Ctr Sci Commun, Rome, Italy; [Buscema, Massimo] Univ Colorado, Dept Math & Stat Sci, Ctr Math & Computat Biol, Denver, CO 80202 USA; [Grossi, Enzo] Villa Santa Maria Inst, Tavernerio, Italy; [Montanini, Luisa] Univ Hosp, Dept Pediat, Parma, Italy; [Street, Maria E.] IRCCS Arcisped S Maria Nuova, Dept Pediat, Reggio Emilia, Italy	University of Colorado System; University of Colorado Denver; University of Parma; University Hospital of Parma	Street, ME (corresponding author), IRCCS Arcisped S Maria Nuova, Dept Pediat, Reggio Emilia, Italy.	MariaElisabeth.Street@asmn.re.it	Street, Maria E/B-7099-2011; Grossi, Enzo/AAF-7765-2020	Street, Maria E/0000-0001-8427-8971; Buscema, Paolo Massimo/0000-0003-4356-0510				Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Buscema M, 2014, CHEMOMETR INTELL LAB, V138, P110, DOI 10.1016/j.chemolab.2014.06.013; Buscema M, 2008, P N AM FUZZ INF PRC; Buscema M, 2010, P N AM FUZZ INF PRC; Buscema M, 2007, 32 SEM; Buscema M, 2007, P IEEE INT C SYST MA; Buscema M., 2010, DATA MINING APPL USI, P1, DOI DOI 10.1007/978-1-4614-4223-3_1; Buscema M, 2008, CURR ALZHEIMER RES, V5, P481, DOI 10.2174/156720508785908928; Buscema M, 2008, INT J DATA MIN BIOIN, V2, P362, DOI 10.1504/IJDMB.2008.022159; Crossey PA, 2002, J CLIN INVEST, V110, P411, DOI 10.1172/JCI200210077; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Foltran F, 2011, J BIOL REG HOMEOS AG, V25, P269; GAGLIARDI L, 1999, RIV ITAL PED, V25, P159; Gironi M, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-1; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; GROSSBERG S, 1976, BIOL CYBERN, V23, P121, DOI 10.1007/BF00344744; GROSSBERG S, 1980, PSYCHOL REV, V87, P1, DOI 10.1037/0033-295X.87.1.1; Grossberg S, 1978, FORMAL THEORIES VISU; Han VKM, 1996, J CLIN ENDOCR METAB, V81, P2680, DOI 10.1210/jc.81.7.2680; Hashimoto R, 2010, ENDOCR J, V57, P193, DOI 10.1507/endocrj.K09E-189; Hedbacker K, 2010, CELL METAB, V11, P11, DOI 10.1016/j.cmet.2009.11.007; Hess AP, 2007, BIOL REPROD, V76, P102, DOI 10.1095/biolreprod.106.054791; HEYBORNE KD, 1992, AM J OBSTET GYNECOL, V167, P920, DOI 10.1016/S0002-9378(12)80012-3; Hinton G. E., 1989, PARALLEL MODELS ASS; Holcberg G, 2001, EUR J OBSTET GYN R B, V94, P69, DOI 10.1016/S0301-2115(00)00321-3; Kajimura S, 2005, P NATL ACAD SCI USA, V102, P1240, DOI 10.1073/pnas.0407443102; KARLBERG J, 1995, PEDIATR RES, V38, P733, DOI 10.1203/00006450-199511000-00017; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Li YC, 2010, J CELL BIOCHEM, V110, P248, DOI 10.1002/jcb.22532; Licastro F, 2010, NEUROBIOL AGING, V31, P257, DOI 10.1016/j.neurobiolaging.2008.03.019; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Massini G, 2007, TREES VISUALIZER VER; McClelland J. L., 1988, EXPLORATIONS PARALLE; Meisser A, 1999, MOL HUM REPROD, V5, P1055, DOI 10.1093/molehr/5.11.1055; OHLSSON R, 1989, EMBO J, V8, P1993, DOI 10.1002/j.1460-2075.1989.tb03606.x; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Resnik R, 2002, OBSTET GYNECOL, V99, P490, DOI 10.1016/S0029-7844(01)01780-X; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; SHEN SJ, 1986, P NATL ACAD SCI USA, V83, P9179, DOI 10.1073/pnas.83.23.9179; Smerieri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029562; Street ME, 2006, GROWTH HORM IGF RES, V16, P365, DOI 10.1016/j.ghir.2006.09.007; Street ME, 2008, CLIN ENDOCRINOL, V68, P22, DOI 10.1111/j.1365-2265.2007.02992.x; Street ME, 2006, EUR J ENDOCRINOL, V155, P567, DOI 10.1530/eje.1.02251; Street ME, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-24; Street ME, 2006, EUR J ENDOCRINOL, V154, P47, DOI 10.1530/eje.1.02064; Street ME, 2004, HORM RES, V61, P159, DOI 10.1159/000075699; WANG CY, 1988, MOL ENDOCRINOL, V2, P217, DOI 10.1210/mend-2-3-217; Wheatcroft SB, 2009, TRENDS ENDOCRIN MET, V20, P153, DOI 10.1016/j.tem.2009.01.002; Zollers WG, 2001, BIOL REPROD, V65, P1208, DOI 10.1095/biolreprod65.4.1208	51	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0126020	10.1371/journal.pone.0126020	http://dx.doi.org/10.1371/journal.pone.0126020			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158499	gold, Green Published, Green Submitted			2022-12-27	WOS:000358161200002
J	Corral, A; Boleda, G; Ferrer-I-Cancho, R				Corral, Alvaro; Boleda, Gemma; Ferrer-i-Cancho, Ramon			Zipf's Law for Word Frequencies: Word Forms versus Lemmas in Long Texts	PLOS ONE			English	Article							DISTRIBUTIONS; EVOLUTION	Zipf's law is a fundamental paradigm in the statistics of written and spoken natural language as well as in other communication systems. We raise the question of the elementary units for which Zipf's law should hold in the most natural way, studying its validity for plain word forms and for the corresponding lemma forms. We analyze several long literary texts comprising four languages, with different levels of morphological complexity. In all cases Zipf's law is fulfilled, in the sense that a power-law distribution of word or lemma frequencies is valid for several orders of magnitude. We investigate the extent to which the word-lemma transformation preserves two parameters of Zipf's law: the exponent and the low-frequency cut-off. We are not able to demonstrate a strict invariance of the tail, as for a few texts both exponents deviate significantly, but we conclude that the exponents are very similar, despite the remarkavble transformation that going from words to lemmas represents, considerably affecting all ranges of frequencies. In contrast, the low-frequency cut-offs are less stable, tending to increase substantially after the transformation.	[Corral, Alvaro] Ctr Recerca Matemat, Barcelona, Spain; [Corral, Alvaro] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Boleda, Gemma] Univ Pompeu Fabra, Dept Translat & Language Sci, Barcelona, Spain; [Ferrer-i-Cancho, Ramon] Univ Politecn Cataluna, Dept Ciencies Computacio, Complex & Quantitat Linguist Lab, Barcelona, Spain	Centre de Recerca Matematica (CRM); Autonomous University of Barcelona; Pompeu Fabra University; Universitat Politecnica de Catalunya	Corral, A (corresponding author), Ctr Recerca Matemat, Barcelona, Spain.	acorral@crm.cat	Ferrer-i-Cancho, Ramon/A-5424-2011; Corral, Alvaro/I-5590-2015	Ferrer-i-Cancho, Ramon/0000-0002-7820-923X; Corral, Alvaro/0000-0002-5280-2692	former Spanish Ministerio de Ciencia e Innovacion [FIS2009-09508]; Spanish Ministerio de Economia y Competitividad [FIS2012-31324]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [2009SGR-164, 2014SGR-1307]; Beatriu de Pinos from Agencia de Gestio d'Ajuts Universitaris i de Recerca [2010 BP-A 00070, 2010 BP-A2 00015]; BASMATI, from the former Spanish Ministerio de Ciencia e Innovacion [TIN2011-27479-C04-03, OpenMT-2, TIN2009-14675-C03]; grant Iniciacio i reincorporacio a la recerca from Universitat Politecnica de Catalunya	former Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)); Spanish Ministerio de Economia y Competitividad(Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Beatriu de Pinos from Agencia de Gestio d'Ajuts Universitaris i de Recerca; BASMATI, from the former Spanish Ministerio de Ciencia e Innovacion; grant Iniciacio i reincorporacio a la recerca from Universitat Politecnica de Catalunya	This work was supported by FIS2009-09508 from the former Spanish Ministerio de Ciencia e Innovacion (www.micinn.es, AC); FIS2012-31324 from the Spanish Ministerio de Economia y Competitividad (www.mineco.gob.es, AC); 2009SGR-164, 2014SGR-1307 from the Agencia de Gestio d'Ajuts Universitaris i de Recerca (www.gencat.cat/agaur, AC); Beatriu de Pinos grants 2010 BP-A 00070 and 2010 BP-A2 00015 from Agencia de Gestio d'Ajuts Universitaris i de Recerca (www.gencat.cat/agaur of the Generalitat de Catalunya, GB); BASMATI, TIN2011-27479-C04-03 and OpenMT-2, TIN2009-14675-C03 from the former Spanish Ministerio de Ciencia e Innovacion (www.micinn.es, RFiC); and grant Iniciacio i reincorporacio a la recerca from Universitat Politecnica de Catalunya (www.upc.edu, RFiC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Baayen Harald, 2001, WORD FREQUENCY DISTR; Baixeries J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053227; Baroni M, 2009, HANDB SPRACH KOMMUN, V29, P803; Bentz C, 2014, CORPUS LINGUIST LING, V10, P175, DOI 10.1515/cllt-2014-0009; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Cancho RFI., 2001, J QUANT LINGUIST, V8, P165, DOI [10.1076/jqul.8.3.165.4101, DOI 10.1076/JQUL.8.3.165.4101]; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Conrad B, 2004, IEEE T INFORM THEORY, V50, P1403, DOI 10.1109/TIT.2004.830752; Corral A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.028501; Corral A, 2012, ARXIV 1209 1270; Corral A, 2015, CHAOS SOLITON FRACT, V74, P99, DOI 10.1016/j.chaos.2015.01.011; Corral A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066103; Corral A, 2010, NAT PHYS, V6, P693, DOI 10.1038/NPHYS1725; Deluca A, 2013, ACTA GEOPHYS, V61, P1351, DOI 10.2478/s11600-013-0154-9; Egghe L, 2000, MATH COMPUT MODEL, V31, P35, DOI 10.1016/S0895-7177(00)00058-3; Cancho RFI, 2005, GLOTTOMETRICS, V11, P1; Ferrer-i-Cancho R., 2012, J STAT MECH-THEORY E; Ferrer-i-Cancho R, 2014, STAT APPL GENET MOL, V13, P633, DOI 10.1515/sagmb-2013-0034; Ferrer-i-Cancho R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009411; Ferrer-I-Cancho R, 2009, J AM SOC INF SCI TEC, V60, P837, DOI 10.1002/asi.21033; Font-Clos F, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/9/093033; Gerlach M, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021006; Hatzigeorgiu N., 2001, J QUANT LINGUIST, V8, P175, DOI [10.1076/jqul.8.3.175.4096, DOI 10.1076/JQUL.8.3.175.4096]; Hernandez-Fernandez A, 2013, ANU PSICOL, V43, P67; Jayaram BD, 2008, J QUANT LINGUIST, V15, P293, DOI 10.1080/09296170802326640; Jiang B, 2014, INT J GEOGR INF SCI; Jiang B, 2011, INT J GEOGR INF SCI, V25, P1269, DOI 10.1080/13658816.2010.510801; Kolmogorov AN., 1956, FOUNDATIONS OF THE T; KRUSKAL WH, 1958, J AM STAT ASSOC, V53, P814, DOI 10.2307/2281954; Kwapien J, 2012, PHYS REP, V515, P115, DOI 10.1016/j.physrep.2012.01.007; Li WT, 2010, ENTROPY-SWITZ, V12, P1743, DOI 10.3390/e12071743; LI WT, 1992, IEEE T INFORM THEORY, V38, P1842, DOI 10.1109/18.165464; MACARTHUR RH, 1957, P NATL ACAD SCI USA, V43, P293, DOI 10.1073/pnas.43.3.293; Malevergne Y, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036111; MANTEGNA RN, 1995, PHYS REV E, V52, P2939, DOI 10.1103/PhysRevE.52.2939; McCowan B, 2005, ANIM BEHAV, V69, P1, DOI DOI 10.1016/J.ANBEHAV.2004.09.002; Miller GA, 1968, THE PSYCHO BIOLOGY O, pv; NARANAN S, 1993, J SCI IND RES INDIA, V52, P728; Peters O, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/11/P11030; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00943; Piotrowski R.G., 2007, EXACT METHODS STUDY, P545; Poirier DJ, 1995, INTERMEDIATE STATIST; Popescu II, 2006, GLOTTOMETRICS, V13, P23; SCHMID LA, 1994, INT CONF ACOUST SPEE, P41; Serra J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00521; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; Suzuki R., 2005, ANIM BEHAV, V69, pF9, DOI DOI 10.1016/J.ANBEHAV.2004.08.004; Taylor JR, 1997, THE STUDY OF UNCERTA; Tuzzi A, 2009, J QUANT LINGUIST, V16, P354, DOI 10.1080/09296170903211519; Van Egmond M, 2011, THESIS; Zanette D, 2014, ARXIV 1412 3336; Zipf GK, 1972, AN INTRODUCTION TO H; Zou KH, 2003, RADIOLOGY, V227, P617, DOI 10.1148/radiol.2273011499; [No title captured]	57	40	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0129031	10.1371/journal.pone.0129031	http://dx.doi.org/10.1371/journal.pone.0129031			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158787	Green Published, gold, Green Submitted			2022-12-27	WOS:000358161200006
J	Levin, LA; Mendoza, GF; Grupe, BM; Gonzalez, JP; Jellison, B; Rouse, G; Thurber, AR; Waren, A				Levin, Lisa A.; Mendoza, Guillermo F.; Grupe, Benjamin M.; Gonzalez, Jennifer P.; Jellison, Brittany; Rouse, Greg; Thurber, Andrew R.; Waren, Anders			Biodiversity on the Rocks: Macrofauna Inhabiting Authigenic Carbonate at Costa Rica Methane Seeps	PLOS ONE			English	Article							SEA HYDROTHERMAL VENTS; STABLE-ISOTOPE RATIOS; EEL RIVER-BASIN; DEEP-SEA; COMMUNITY STRUCTURE; MUSSEL BEDS; COLD-SEEPS; BIOLOGICAL COMMUNITIES; ANAEROBIC OXIDATION; FLORIDA ESCARPMENT	Carbonate communities: The activity of anaerobic methane oxidizing microbes facilitates precipitation of vast quantities of authigenic carbonate at methane seeps. Here we demonstrate the significant role of carbonate rocks in promoting diversity by providing unique habitat and food resources for macrofaunal assemblages at seeps on the Costa Rica margin (400-1850 m). The attendant fauna is surprisingly similar to that in rocky intertidal shores, with numerous grazing gastropods (limpets and snails) as dominant taxa. However, the community feeds upon seep-associated microbes. Macrofaunal density, composition, and diversity on carbonates vary as a function of seepage activity, biogenic habitat and location. The macrofaunal community of carbonates at non-seeping (inactive) sites is strongly related to the hydrography (depth, temperature, O-2) of overlying water, whereas the fauna at sites of active seepage is not. Densities are highest on active rocks from tubeworm bushes and mussel beds, particularly at the Mound 12 location (1000 m). Species diversity is higher on rocks exposed to active seepage, with multiple species of gastropods and polychaetes dominant, while crustaceans, cnidarians, and ophiuroids were better represented on rocks at inactive sites. Macro-infauna (larger than 0.3 mm) from tube cores taken in nearby seep sediments at comparable depths exhibited densities similar to those on carbonate rocks, but had lower diversity and different taxonomic composition. Seep sediments had higher densities of ampharetid, dorvilleid, hesionid, cirratulid and lacydoniid polychaetes, whereas carbonates had more gastropods, as well as syllid, chrysopetalid and polynoid polychaetes. Stable isotope signatures and metrics: The stable isotope signatures of carbonates were heterogeneous, as were the food sources and nutrition used by the animals. Carbonate delta C-13(inorg) values (mean = -26.98 parts per thousand) ranged from -53.3 parts per thousand to + 10.0 parts per thousand, and were significantly heavier than carbonate delta C-13(org) (mean = -33.83 parts per thousand), which ranged from -74.4% to -20.6%. Invertebrates on carbonates had average delta C-13 (per rock) = -31.0% (range -18.5% to -46.5%) and delta N-15 = 5.7%(range -4.5% to + 13.4%). Average delta C-13 values did not differ between active and inactive sites; carbonate fauna from both settings depend on chemosynthesis-based nutrition. Community metrics reflecting trophic diversity (SEAc, total Hull Area, ranges of delta C-13 and delta N-15) and species packing (mean distance to centroid, nearest neighbor distance) also did not vary as a function of seepage activity or site. However, distinct isotopic signatures were observed among related, co-occurring species of gastropods and polychaetes, reflecting intense microbial resource partitioning. Overall, the substrate and nutritional heterogeneity introduced by authigenic seep carbonates act to promote diverse, uniquely adapted assemblages, even after seepage ceases. The macrofauna in these ecosystems remain largely overlooked in most surveys, but are major contributors to biodiversity of chemosynthetic ecosystems and the deep sea in general.	[Levin, Lisa A.; Mendoza, Guillermo F.; Grupe, Benjamin M.; Gonzalez, Jennifer P.; Jellison, Brittany] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA; [Levin, Lisa A.; Rouse, Greg] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Thurber, Andrew R.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Waren, Anders] Swedish Museum Nat Hist, S-10405 Stockholm, Sweden	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography; Oregon State University; Swedish Museum of Natural History	Levin, LA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA.	llevin@ucsd.edu	Grupe, Benjamin/D-1436-2010; Rouse, Greg W/F-2611-2010; Rouse, Gregory/AAW-1494-2021	Grupe, Benjamin/0000-0002-5421-7278; Rouse, Greg W/0000-0001-9036-9263; Rouse, Gregory/0000-0001-9036-9263; Levin, Lisa/0000-0002-2858-8622; Jellison, Brittany/0000-0001-9118-5132	National Science Foundation (NSF) [OCE 0826254, OCE 0939557]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by the National Science Foundation (NSF grants OCE 0826254 and OCE 0939557). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi G, 2002, EARTH PLANET SC LETT, V203, P195, DOI 10.1016/S0012-821X(02)00878-6; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2005, PERMANOVA FORTRAN CO; Baco AR, 2003, MAR ECOL PROG SER, V260, P109, DOI 10.3354/meps260109; Bahr A, 2009, INT J EARTH SCI, V98, P677, DOI 10.1007/s00531-007-0264-1; Beaulieu SE, 2001, MAR BIOL, V138, P803, DOI 10.1007/s002270000500; Bergquist DC, 2003, J EXP MAR BIOL ECOL, V289, P197, DOI 10.1016/S0022-0981(03)00046-7; Bernardino AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033515; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Bohrmann G, 1998, GEOLOGY, V26, P647, DOI 10.1130/0091-7613(1998)026<0647:ACFTCS>2.3.CO;2; Bohrmann G, 2002, TERRA NOVA, V14, P69, DOI 10.1046/j.1365-3121.2002.00400.x; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Campbell KA, 2006, PALAEOGEOGR PALAEOCL, V232, P362, DOI 10.1016/j.palaeo.2005.06.018; CARPENTER JAMES H., 1965, LIMNOL OCEANOGR, V10, P135; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Coates M, 1998, GLOBAL ECOL BIOGEOGR, V7, P115, DOI 10.2307/2997814; Cordes EE, 2005, MAR ECOL PROG SER, V305, P17, DOI 10.3354/meps305017; Cunha MR, 2013, BIOGEOSCIENCES, V10, P2553, DOI 10.5194/bg-10-2553-2013; Cunha MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076688; Dando PR, 2010, TOP GEOBIOL, V33, P333, DOI 10.1007/978-90-481-9572-5_11; DANDO PR, 1991, MAR ECOL PROG SER, V70, P49, DOI 10.3354/meps070049; DEAN RL, 1987, J EXP MAR BIOL ECOL, V109, P217, DOI 10.1016/0022-0981(87)90056-6; Feng D, 2013, DEEP-SEA RES PT I, V75, P110, DOI 10.1016/j.dsr.2013.02.002; Furi E, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002810; Gaudron SM, 2010, MAR ENVIRON RES, V70, P1, DOI 10.1016/j.marenvres.2010.02.002; Genio L, 2013, BIOGEOSCIENCES, V10, P5159, DOI 10.5194/bg-10-5159-2013; Gieskes J, 2005, CHEM GEOL, V220, P329, DOI 10.1016/j.chemgeo.2005.04.002; GITTINGS SR, 1984, CONTRIB MAR SCI, V27, P105; Gorley C.K., 2006, GETTING STARTED PRIM; Govenar B, 2008, EOS, V89, P53, DOI [10.1016/j.pt.2003.09.013, DOI 10.1016/J.PT.2003.09.013]; Grupe BM, 2015, MAR ECOL-EVOL PERSP, V36, P91, DOI 10.1111/maec.12243; Han XQ, 2004, INT J EARTH SCI, V93, P596, DOI 10.1007/s00531-004-0402-y; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; JENSEN P, 1992, MAR ECOL PROG SER, V83, P103, DOI 10.3354/meps083103; Kimura G, 1997, P OCEAN DRILLING PRO, V170, P458, DOI DOI 10.2973/ODP.PROC.IR.170.1997; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Levin LA, 2005, OCEANOGR MAR BIOL, V43, P1, DOI 10.1201/9781420037449.ch1; Levin LA, 2002, LIMNOL OCEANOGR, V47, P1336, DOI 10.4319/lo.2002.47.5.1336; Levin LA, 2000, MAR ECOL PROG SER, V208, P21, DOI 10.3354/meps208021; Levin LA, 2007, MAR ECOL-EVOL PERSP, V28, P131, DOI 10.1111/j.1439-0485.2006.00131.x; Levin LA, 2013, DEEP-SEA RES PT II, V92, P214, DOI 10.1016/j.dsr2.2013.02.006; Levin LA, 2012, P ROY SOC B-BIOL SCI, V279, P2580, DOI 10.1098/rspb.2012.0205; Lizzaralde D, 2010, NATURE GEOSC, DOI [10.1038/NGEO1006, DOI 10.1038/NGEO_1006]; Lundsten L, 2009, MAR ECOL PROG SER, V374, P23, DOI 10.3354/meps07745; Marlow JJ, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00044; Marlow JJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6094; Mau S, 2006, MAR GEOL, V225, P129, DOI 10.1016/j.margeo.2005.09.007; Mau S, 2014, INT J EARTH SCI, V103, P1801, DOI 10.1007/s00531-012-0822-z; McAdoo BG, 1996, GEOPHYS RES LETT, V23, P883, DOI 10.1029/96GL00731; McCarthy S. A., 1998, Pacific Science, V52, P141; Menot L., 2010, LIFE WORLDS OCEANS D; Michaelis W, 2002, SCIENCE, V297, P1013, DOI 10.1126/science.1072502; MULLINEAUX LS, 1987, DEEP-SEA RES, V34, P165, DOI 10.1016/0198-0149(87)90080-X; Naehr TH, 2007, DEEP-SEA RES PT II, V54, P1268, DOI 10.1016/j.dsr2.2007.04.010; Ohara Y, 2012, P NATL ACAD SCI USA, V109, P2831, DOI 10.1073/pnas.1112005109; Orphan VJ, 2004, CHEM GEOL, V205, P265, DOI 10.1016/j.chemgeo.2003.12.035; PAULL CK, 1984, SCIENCE, V226, P965, DOI 10.1126/science.226.4677.965; Rex M.A., 2010, BIOSCIENCE; Ritt B, 2011, MAR BIOL, V158, P1187, DOI 10.1007/s00227-011-1679-6; Ritt B, 2010, DEEP-SEA RES PT I, V57, P1120, DOI 10.1016/j.dsr.2010.05.011; Sahling H, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001978; Schmidt M, 2005, MAR GEOL, V216, P83, DOI 10.1016/j.margeo.2005.01.001; Schrag DP, 2013, SCIENCE, V339, P540, DOI 10.1126/science.1229578; Sellanes J, 2004, J MAR BIOL ASSOC UK, V84, P1065, DOI 10.1017/S0025315404010422h; Shapiro RS, 2004, ASTROBIOLOGY, V4, P438; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Stakes DS, 1999, MAR GEOL, V159, P93, DOI 10.1016/S0025-3227(98)00200-X; Suess E, 2002, 4 INT C GAS HYDR YOK, P740; Sun XL, 2014, NAT GEOSCI, V7, P201, DOI [10.1038/ngeo2070, 10.1038/NGEO2070]; Taylor RB, 1998, MAR ECOL PROG SER, V172, P37, DOI 10.3354/meps172037; Teichert BMA, 2005, PALAEOGEOGR PALAEOCL, V227, P67, DOI 10.1016/j.palaeo.2005.04.029; Thurber AR, 2012, ISME J, V6, P1602, DOI 10.1038/ismej.2012.16; Tryon MD, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002818; Turner TF, 2010, ECOLOGY, V91, P2227, DOI 10.1890/09-1454.1; Turnipseed M, 2003, ECOL LETT, V6, P518, DOI 10.1046/j.1461-0248.2003.00465.x; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 2000, MAR ECOL PROG SER, V195, P169, DOI 10.3354/meps195169; Van Dover CL, 2003, MAR ECOL PROG SER, V253, P55, DOI 10.3354/meps253055; Van Dover CL, 2002, MAR ECOL PROG SER, V230, P137, DOI 10.3354/meps230137	80	40	41	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131080	10.1371/journal.pone.0131080	http://dx.doi.org/10.1371/journal.pone.0131080			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158723	Green Published, gold			2022-12-27	WOS:000358161200025
J	Bruffaerts, N; Pedersen, LE; Vandermeulen, G; Preat, V; Stockhofe-Zurwieden, N; Huygen, K; Romano, M				Bruffaerts, Nicolas; Pedersen, Lasse E.; Vandermeulen, Gaelle; Preat, Veronique; Stockhofe-Zurwieden, Norbert; Huygen, Kris; Romano, Marta			Increased B and T Cell Responses in M-bovis Bacille Calmette-Guerin Vaccinated Pigs Co-Immunized with Plasmid DNA Encoding a Prototype Tuberculosis Antigen	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; PRIME-BOOST VACCINATION; MYCOBACTERIUM-TUBERCULOSIS; PROTECTIVE EFFICACY; PEPTIDE-BINDING; HLA-A; BCG; IMMUNOGENICITY; EPITOPES; SWINE	The only tuberculosis vaccine currently available, bacille Calmette-Guerin (BCG) is a poor inducer of CD8(+) T cells, which are particularly important for the control of latent tuberculosis and protection against reactivation. As the induction of strong CD8(+) T cell responses is a hallmark of DNA vaccines, a combination of BCG with plasmid DNA encoding a prototype TB antigen (Ag85A) was tested. As an alternative animal model, pigs were primed with BCG mixed with empty vector or codon-optimized pAg85A by the intradermal route and boosted with plasmid delivered by intramuscular electroporation. Control pigs received unformulated BCG. The BCG-pAg85A combination stimulated robust and sustained Ag85A specific antibody, lymphoproliferative, IL-6, IL-10 and IFN-gamma responses. IgG1/IgG2 antibody isotype ratio reflected the Th1 helper type biased response. T lymphocyte responses against purified protein derivative of tuberculin (PPD) were induced in all (BCG) vaccinated animals, but responses were much stronger in BCG-pAg85A vaccinated pigs. Finally, Ag85A-specific IFN-gamma producing CD8(+) T cells were detected by intracellular cytokine staining and a synthetic peptide, spanning Ag85A131-150 and encompassing two regions with strong predicted SLA-1*0401/SLA-1*0801 binding affinity, was promiscuously recognized by 6/6 animals vaccinated with the BCG-pAg85A combination. Our study provides a proof of concept in a large mammalian species, for a new Th1 and CD8(+) targeting tuberculosis vaccine, based on BCG-plasmid DNA co-administration.	[Bruffaerts, Nicolas; Huygen, Kris; Romano, Marta] Sci Inst Publ Hlth, Serv Immunol, Brussels, Belgium; [Pedersen, Lasse E.] Tech Univ Denmark, Sect Immunol & Vaccinol, Bulowsvej Frederiksberg C, Denmark; [Vandermeulen, Gaelle; Preat, Veronique] Catholic Univ Louvain, Louvain Drug Res Inst, Pharmaceut & Drug Delivery, B-1200 Brussels, Belgium; [Stockhofe-Zurwieden, Norbert] Cent Vet Inst, Div Infect Biol, Lelystad, Netherlands	Technical University of Denmark; Universite Catholique Louvain; Wageningen University & Research	Huygen, K (corresponding author), Sci Inst Publ Hlth, Serv Immunol, WIV ISP Site Ukkel, Brussels, Belgium.	kris.huygen@wiv-isp.be	Vandermeulen, Gaëlle/A-4074-2011; ROMANO, Marta/ABD-9517-2021; Bruffaerts, Nicolas/AAQ-2647-2020	Vandermeulen, Gaëlle/0000-0002-8696-9642; ROMANO, Marta/0000-0001-8996-7899; Bruffaerts, Nicolas/0000-0001-6310-9140; Pedersen, Lasse Eggers/0000-0002-9159-5585; Huygen, Kris/0000-0001-7808-0512	FWO-Vlaanderen; EDCTP [MVA85A IP.2007.32080.002]; EU (FP7 NEWTBVAC);  [TRANSVAC-TNA1204-6]	FWO-Vlaanderen(FWO); EDCTP; EU (FP7 NEWTBVAC); 	Gaelle Vandermeulen is a postdoctoral researcher of the Fonds de la Recherche Scientifique-FNRS. This work was partially supported by FWO-Vlaanderen, EDCTP (MVA85A IP.2007.32080.002), EU (FP7 NEWTBVAC) and TRANSVAC-TNA1204-6.	Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Baldwin SL, 1998, INFECT IMMUN, V66, P2951, DOI 10.1128/IAI.66.6.2951-2959.1998; Barandiaran S, 2015, EPIDEMIOL INFECT, V143, P966, DOI 10.1017/S095026881400332X; Bloom Barry R., 1994, P531; Bolin CA, 1997, J INFECT DIS, V176, P1559, DOI 10.1086/514155; Brennan MJ, 2012, VACCINE, V30, P2811, DOI 10.1016/j.vaccine.2012.02.036; Brennan MJ, 2012, TUBERCULOSIS, V92, pS6, DOI 10.1016/S1472-9792(12)70005-7; BRODSKY FM, 1979, EUR J IMMUNOL, V9, P536, DOI 10.1002/eji.1830090709; Bruffaerts N, 2014, VACCINES, V2, P181, DOI 10.3390/vaccines2010181; Bruffaerts N, 2014, EXPERT OPIN BIOL TH, V14, P1801, DOI 10.1517/14712598.2014.951630; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Cai H, 2006, DNA CELL BIOL, V25, P438, DOI 10.1089/dna.2006.25.438; Cardoso-Toset F, 2015, VET J, V204, P232, DOI 10.1016/j.tvjl.2015.01.022; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; de Brito C, 2011, J IMMUNOL, V186, P1503, DOI 10.4049/jimmunol.1001022; Denis O, 1998, INFECT IMMUN, V66, P1527, DOI 10.1128/IAI.66.4.1527-1533.1998; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Dou J, 2012, INT J IMMUNOGENET, V39, P183, DOI 10.1111/j.1744-313X.2011.01066.x; Feng CG, 2001, INFECT IMMUN, V69, P4174, DOI 10.1128/IAI.69.6.4174-4176.2001; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Gartner T, 2007, IMMUNOL LETT, V111, P26, DOI 10.1016/j.imlet.2007.04.010; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Hengge UR, 1996, J CLIN INVEST, V97, P2911, DOI 10.1172/JCI118750; HENGGE UR, 1995, NAT GENET, V10, P161, DOI 10.1038/ng0695-161; Ho CS, 2009, ANIM GENET, V40, P468, DOI 10.1111/j.1365-2052.2009.01860.x; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Huygen K, 1996, NAT MED, V2, P893, DOI 10.1038/nm0896-893; HUYGEN K, 1994, INFECT IMMUN, V62, P363, DOI 10.1128/IAI.62.2.363-370.1994; Huygen K, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00321; KAST WM, 1994, J IMMUNOL, V152, P3904; Kibuuka H, 2015, LANCET, V385, P1545, DOI 10.1016/S0140-6736(14)62385-0; Launois P, 2010, CLIN DEV IMMUNOL, V2011; Lee J, 2004, INFECT IMMUN, V72, P1504, DOI 10.1128/IAI.72.3.1504-1511.2004; Lin MY, 2007, INFECT IMMUN, V75, P3523, DOI 10.1128/IAI.01999-06; Liu MA, 2003, J INTERN MED, V253, P402, DOI 10.1046/j.1365-2796.2003.01140.x; Luckay A, 2007, J VIROL, V81, P5257, DOI 10.1128/JVI.00055-07; Lundegaard C, 2011, J IMMUNOL METHODS, V374, P26, DOI 10.1016/j.jim.2010.10.011; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Montgomery DL, 1997, CELL MOL BIOL, V43, P285; Ndiaye BP, 2015, LANCET RESP MED, V3, P190, DOI 10.1016/S2213-2600(15)00037-5; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Olin MR, 2005, J IMMUNOL METHODS, V297, P1, DOI 10.1016/j.jim.2004.10.002; Panas MW, 2014, INFECT IMMUN, V82, P5317, DOI 10.1128/IAI.02100-14; Pedersen LE, 2014, VET IMMUNOL IMMUNOP, V162, P108, DOI 10.1016/j.vetimm.2014.10.007; Pedersen LE, 2011, IMMUNOGENETICS, V63, P821, DOI 10.1007/s00251-011-0555-3; Rahman S, 2012, MOL MED, V18, P647, DOI 10.2119/molmed.2011.00222; Romano M, 2006, VACCINE, V24, P3353, DOI 10.1016/j.vaccine.2005.12.066; Romano M, 2014, ART SCI TUBERCULOSIS, P741; Romano M, 2008, VACCINE, V26, P6053, DOI 10.1016/j.vaccine.2008.09.025; Romano M, 2012, EXPERT OPIN BIOL TH, V12, P1601, DOI 10.1517/14712598.2012.721768; Rosseels V, 2006, INFECT IMMUN, V74, P202, DOI 10.1128/IAI.74.1.202-212.2006; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Roupie V, 2012, VET IMMUNOL IMMUNOP, V145, P74, DOI 10.1016/j.vetimm.2011.10.012; Ryan AA, 2009, J IMMUNOL, V182, P7172, DOI 10.4049/jimmunol.0801694; Saade F, 2012, EXPERT REV VACCINES, V11, P189, DOI [10.1586/erv.11.188, 10.1586/ERV.11.188]; Skinner MA, 2003, INFECT IMMUN, V71, P4901, DOI 10.1128/IAI.71.9.4901-4907.2003; Smith DM, 2005, TISSUE ANTIGENS, V65, P136, DOI 10.1111/j.1399-0039.2005.00337.x; Sylvester-Hvid C, 2002, TISSUE ANTIGENS, V59, P251, DOI 10.1034/j.1399-0039.2002.590402.x; Tameris M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087340; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Tollefsen S, 2003, SCAND J IMMUNOL, V57, P229, DOI 10.1046/j.1365-3083.2003.01218.x; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992	63	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132288	10.1371/journal.pone.0132288	http://dx.doi.org/10.1371/journal.pone.0132288			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172261	gold, Green Published, Green Submitted			2022-12-27	WOS:000358194900039
J	Chan, CYS; Chiu, JMY				Chan, Christine Ying Shan; Chiu, Jill Man Ying			Chronic Effects of Coated Silver Nanoparticles on Marine Invertebrate Larvae: A Proof of Concept Study	PLOS ONE			English	Article							CRASSOSTREA-VIRGINICA; AQUATIC ORGANISMS; RAINBOW-TROUT; IONIC AG; TOXICITY; RESPONSES; EXPOSURE; GROWTH; FOOD; BIOAVAILABILITY	Silver nanoparticles (AgNPs), owing to their unique physical and chemical properties, have become increasingly popular in consumer products. However, data on their potential biological effects on marine organisms, especially invertebrates, remain very limited. This proof of principle study reports the chronic sub-lethal toxicity of two coated AgNPs (oleic acid coated AgNPs and polyvinylpyrrolidone coated AgNPs) on marine benthic invertebrate larvae across three phyla (i.e., the barnacle Balanus Amphitrite, the slipper-limpet Crepidula onyx, and the polychaete Hydroides elegans) in terms of growth, development, and metamorphosis. Bioaccumulation and biodistribution of silver were also investigated. Larvae were also exposed to silver nitrate (AgNO3) in parallel to distinguish the toxic effects derived from nano-silver and the aqueous form of silver. The sub-lethal effect of chronic exposure to coated AgNPs resulted in a significant retardation in growth and development, and reduction of larval settlement rate. The larval settlement rate of H. elegans was significantly lower in the coated AgNP treatment than the AgNO3 treatment, suggesting that the toxicity of coated AgNPs might not be solely evoked by the release of silver ions (Ag+) in the test medium. The three species accumulated silver effectively from coated AgNPs as well as AgNO3, and coated AgNPs were observed in the vacuoles of epithelial cell in the digestive tract of C. onyx. Types of surface coatings did not affect the sub-lethal toxicity of AgNPs. This study demonstrated that coated AgNPs exerted toxic effects in a species-specific manner, and their exposure might allow bioaccumulation of silver, and affect growth, development, and settlement of marine invertebrate larvae. This study also highlighted the possibility that coated AgNPs could be taken up through diet and the toxicity of coated AgNPs might be mediated through toxic Ag+ as well as the novel modalities of coated AgNPs.	[Chan, Christine Ying Shan; Chiu, Jill Man Ying] Hong Kong Baptist Univ, Dept Biol, Kowloon, Hong Kong, Peoples R China	Hong Kong Baptist University	Chiu, JMY (corresponding author), Hong Kong Baptist Univ, Dept Biol, Kowloon, Hong Kong, Peoples R China.	jillchiu@hkbu.edu.hk			Hong Kong Baptist University [FRG 2/12-13/084]	Hong Kong Baptist University	The work described in this paper was fully supported by grants from Hong Kong Baptist University (FRG 2/12-13/084) to JMYC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn GA, 2004, J COMP PHYSIOL B, V174, P439, DOI 10.1007/s00360-004-0438-0; Al-Sid-Cheikh M, 2013, MAR ENVIRON RES, V86, P21, DOI 10.1016/j.marenvres.2013.02.003; [Anonymous], 2007, NAN WHIT PAP; Baker TJ, 2014, ENVIRON POLLUT, V186, P257, DOI 10.1016/j.envpol.2013.11.014; Brix KV, 2012, ARCH ENVIRON CON TOX, V63, P95, DOI 10.1007/s00244-012-9757-4; Buffet PE, 2013, ECOTOX ENVIRON SAFE, V89, P117, DOI 10.1016/j.ecoenv.2012.11.019; Burchardt AD, 2012, ENVIRON SCI TECHNOL, V46, P11336, DOI 10.1021/es300989e; Canesi L, 2012, MAR ENVIRON RES, V76, P16, DOI 10.1016/j.marenvres.2011.06.005; Chiu JMY, 2008, MAR ECOL PROG SER, V358, P41, DOI 10.3354/meps07310; Chiu JMY, 2007, MAR ECOL PROG SER, V343, P173, DOI 10.3354/meps06928; Chiu JMY, 2012, ENVIRON SCI TECHNOL, V46, P7772, DOI 10.1021/es300261c; Choi O, 2008, ENVIRON SCI TECHNOL, V42, P4583, DOI 10.1021/es703238h; Croteau MN, 2011, ENVIRON SCI TECHNOL, V45, P6600, DOI 10.1021/es200880c; Dutta S, 2011, LANGMUIR, V27, P5000, DOI 10.1021/la104903z; Engel D. W., 1981, BIOL MONITORING MARI, P127; Erickson RJ, 1998, ENVIRON TOXICOL CHEM, V17, P572, DOI 10.1002/etc.5620170407; Fabrega J, 2011, ENVIRON INT, V37, P517, DOI 10.1016/j.envint.2010.10.012; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g; Farkas J, 2011, AQUAT TOXICOL, V101, P117, DOI 10.1016/j.aquatox.2010.09.010; Farre M, 2009, ANAL BIOANAL CHEM, V393, P81, DOI 10.1007/s00216-008-2458-1; French RA, 2009, ENVIRON SCI TECHNOL, V43, P1354, DOI 10.1021/es802628n; Gao J, 2009, ENVIRON SCI TECHNOL, V43, P3322, DOI 10.1021/es803315v; Garcia-Alonso J, 2014, SCI TOTAL ENVIRON, V476, P688, DOI 10.1016/j.scitotenv.2014.01.039; Garcia-Aonso J, 2011, ENVIRON SCI TECHNOL, V45, P4630, DOI 10.1021/es2005122; Gomes T, 2013, AQUAT TOXICOL, V136, P79, DOI 10.1016/j.aquatox.2013.03.021; Griffitt RJ, 2012, ENVIRON TOXICOL CHEM, V31, P160, DOI 10.1002/etc.709; Groh KJ, 2015, NANOTOXICOLOGY, V9, P81, DOI 10.3109/17435390.2014.893379; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3., 10.1007/978-1-4615-8714-9_3]; Haase A, 2012, TOXICOL SCI, V126, P457, DOI 10.1093/toxsci/kfs003; He D, 2012, ENVIRON SCI TECHNOL, V46, P8731, DOI 10.1021/es300588a; Hwang ET, 2008, SMALL, V4, P765, DOI [10.1002/smll.200700580, DOI 10.1002/SMLL.200700580]; Iversen TG, 2011, NANO TODAY, V6, P176, DOI 10.1016/j.nantod.2011.02.003; Kim KT, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/11/115101; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Kvitek L, 2009, J PHYS CHEM C, V113, P4296, DOI 10.1021/jp808645e; Kwok KWH, 2012, AQUAT TOXICOL, V120, P59, DOI 10.1016/j.aquatox.2012.04.012; Luoma S. N., SILVER NANOTECHNOLOG SILVER NANOTECHNOLOG; Ma XM, 2010, SCI TOTAL ENVIRON, V408, P3053, DOI 10.1016/j.scitotenv.2010.03.031; Macken A, 2012, ECOTOX ENVIRON SAFE, V86, P101, DOI 10.1016/j.ecoenv.2012.08.025; MATILE P, 1978, ANNU REV PLANT PHYS, V29, P193, DOI 10.1146/annurev.pp.29.060178.001205; McCarthy MP, 2013, AQUAT TOXICOL, V138, P123, DOI 10.1016/j.aquatox.2013.04.015; Menge BA, 2001, MARINE COMMUNITY ECOLOGY, P221; Meyer JN, 2010, AQUAT TOXICOL, V100, P140, DOI 10.1016/j.aquatox.2010.07.016; Miao AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015196; Miao AJ, 2009, ENVIRON POLLUT, V157, P3034, DOI 10.1016/j.envpol.2009.05.047; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Oukarroum A, 2013, ENVIRON TOXICOL CHEM, V32, P902, DOI 10.1002/etc.2131; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; Powers CM, 2011, NEUROTOXICOL TERATOL, V33, P708, DOI 10.1016/j.ntt.2011.02.002; Qiu JW, 1997, J EXP MAR BIOL ECOL, V217, P47, DOI 10.1016/S0022-0981(97)00037-3; Quik JTK, 2011, ENVIRON INT, V37, P1068, DOI 10.1016/j.envint.2011.01.015; Reinfelder JR, 1999, ENVIRON SCI TECHNOL, V33, P1860, DOI 10.1021/es980896w; Ringwood AH, 2010, MAR ENVIRON RES, V69, pS49, DOI 10.1016/j.marenvres.2009.10.011; Scown TM, 2010, TOXICOL SCI, V115, P521, DOI 10.1093/toxsci/kfq076; Shapiro SS, 1965, BIOMETRIKA, V52, P59; Shikuma N., 2005, BIOFILMS, V2, P231, DOI [10.1017/s1479050506002018, DOI 10.1017/S1479050506002018, 10.1017/S1479050506002018]; Shoults-Wilson WA, 2011, NANOTOXICOLOGY, V5, P432, DOI 10.3109/17435390.2010.537382; Siller L, 2013, ENVIRON POLLUT, V178, P498, DOI 10.1016/j.envpol.2013.03.010; Stumpp M, 2013, NAT CLIM CHANGE, V3, P1044, DOI 10.1038/NCLIMATE2028; Turner A, 2012, ECOTOXICOLOGY, V21, P148, DOI 10.1007/s10646-011-0774-2; Underwood AJ, 2001, MARINE COMMUNITY ECOLOGY, P183; US Environmental Protection Agency, 1992, SW 846 REF METH METH; Ward JE, 2009, MAR ENVIRON RES, V68, P137, DOI 10.1016/j.marenvres.2009.05.002; WARD JE, 1993, LIMNOL OCEANOGR, V38, P265, DOI 10.4319/lo.1993.38.2.0265; WARD JE, 1994, BIOL BULL, V186, P221, DOI 10.2307/1542056; Wong SWY, 2010, ANAL BIOANAL CHEM, V396, P609, DOI 10.1007/s00216-009-3249-z; WoodrowWilson International Center for Scholars, 2011, PROJ EM NAN; Yang XY, 2012, ENVIRON SCI TECHNOL, V46, P1119, DOI 10.1021/es202417t; Yu SJ, 2013, ENVIRON SCI TECHNOL, V47, P3268, DOI 10.1021/es304346p; Zar JH, 1999, BIOSTATISTICAL ANAL; Zuykov M, 2011, MAR ENVIRON RES, V71, P17, DOI 10.1016/j.marenvres.2010.09.004	71	30	30	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132457	10.1371/journal.pone.0132457	http://dx.doi.org/10.1371/journal.pone.0132457			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171857	Green Published, Green Submitted, gold			2022-12-27	WOS:000358194900051
J	Ferguson, AA; Bilonick, RA; Buchanich, JM; Marsh, GM; Fisher, AL				Ferguson, Annabel A.; Bilonick, Richard A.; Buchanich, Jeanine M.; Marsh, Gary M.; Fisher, Alfred L.			How Well Do Raters Agree on the Development Stage of Caenorhabditis elegans?	PLOS ONE			English	Article							INTERRATER AGREEMENT	The assessment of inter-rater reliability is a topic that is infrequently addressed in Caenorhabditis elegans research, despite the existence of sophisticated statistical methods and the strong interest in the field in obtaining reliable and accurate data. This study applies statistical modeling as a robust means of analyzing the performance of worm researchers measuring the stage of worm development in terms of the two independent factors that comprise "agreement", which are (1) accuracy, representing trueness, a lack of systematic differences, or lack of bias, and (2) precision, representing reliability or the extent to which random differences are small. In our study, multiple raters assessed the same sample of worms to determine the developmental stage of each animal, and we collected data linking each scorer with their assessment for each worm. To describe the agreement of the raters, we developed a structural equation model with latent variables and thresholds, which assumes that all the raters are jointly scoring each worm. This common factor model separately quantifies the two aspects of agreement. The stage-specific thresholds examine accuracy and characterize the relative biases of each rater during the scoring process. The factor loadings for each rater examine the precision and characterizes the random error of the rater. Within our group, we found that the overall agreement was good, while certain adjustments in particular raters would have decreased systematic differences. Hence, the use of developmental stage as an experimental outcome can be both accurate and precise.	[Ferguson, Annabel A.; Bilonick, Richard A.; Buchanich, Jeanine M.; Marsh, Gary M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Bilonick, Richard A.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [Bilonick, Richard A.] Univ Pittsburgh, Sch Dent Med, Dept Orthodont, Pittsburgh, PA USA; [Buchanich, Jeanine M.; Marsh, Gary M.] Univ Pittsburgh, Grad Sch Publ Hlth, Ctr Occupat Biostat & Epidemiol, Pittsburgh, PA USA; [Fisher, Alfred L.] UTHSCSA, Dept Med, Div Geriatr Gerontol & Palliat Med, San Antonio, TX 78229 USA; [Fisher, Alfred L.] UTHSCSA, Ctr Hlth Aging, San Antonio, TX USA; [Fisher, Alfred L.] STVAHCS, San Antonio GRECC, San Antonio, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Fisher, AL (corresponding author), UTHSCSA, Dept Med, Div Geriatr Gerontol & Palliat Med, San Antonio, TX 78229 USA.	fishera2@uthscsa.edu		Fisher, Alfred/0000-0001-6451-2644	South Texas Veteran's Affairs Healthcare System; National Institutes of Health [ES017761, AG044768, AG013319]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG044768, P30AG013319] Funding Source: NIH RePORTER	South Texas Veteran's Affairs Healthcare System; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from the South Texas Veteran's Affairs Healthcare System (ALF) as well as National Institutes of Health grants ES017761, AG044768, and AG013319 to ALF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahante JE, 1998, GENETICS, V149, P1335; Ambros V., 1997, C ELEGANS; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boker S.M., 2012, OPENMX 1 3 USER GUID; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Ferguson AA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004020; Gisev N, 2013, RES SOC ADMIN PHARM, V9, P330, DOI 10.1016/j.sapharm.2012.04.004; Moore BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057142; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; UEBERSAX JS, 1990, STAT MED, V9, P559, DOI 10.1002/sim.4780090509; UEBERSAX JS, 1992, INVEST RADIOL, V27, P738, DOI 10.1097/00004424-199209000-00017; UEBERSAX JS, 1993, BIOMETRICS, V49, P823, DOI 10.2307/2532202; UEBERSAX JS, 1987, PSYCHOL BULL, V101, P140, DOI 10.1037/0033-2909.101.1.140	16	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132365	10.1371/journal.pone.0132365	http://dx.doi.org/10.1371/journal.pone.0132365			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172989	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000358194900045
J	Hernandez-Rodriguez, M; Correa-Basurto, J; Nicolas-Vazquez, MI; Miranda-Ruvalcaba, R; Benitez-Cardoza, CG; Resendiz-Albor, AA; Mendez-Mendez, JV; Rosales-Hernandez, MC				Hernandez-Rodriguez, Maricarmen; Correa-Basurto, Jose; Ines Nicolas-Vazquez, Maria; Miranda-Ruvalcaba, Rene; Guadalupe Benitez-Cardoza, Claudia; Arturo Resendiz-Albor, Aldo; Vicente Mendez-Mendez, Juan; Rosales-Hernandez, Martha C.			Virtual and In Vitro Screens Reveal a Potential Pharmacophore that Avoids the Fibrillization of A beta(1-42)	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; ALZHEIMERS-DISEASE; SECONDARY STRUCTURE; AGGREGATION; INHIBITORS; OLIGOMERS; IDENTIFICATION; NUCLEATION; PEPTIDES; DESIGN	Among the multiple factors that induce Alzheimer's disease, aggregation of the amyloid beta peptide (A beta) is considered the most important due to the ability of the 42-amino acid A beta peptides (A beta(1-42)) to form oligomers and fibrils, which constitute A beta pathological aggregates. For this reason, the development of inhibitors of A beta 1-42 pathological aggregation represents a field of research interest. Several A beta(1-42) fibrillization inhibitors possess tertiary amine and aromatic moieties. In the present study, we selected 26 compounds containing tertiary amine and aromatic moieties with or without substituents and performed theoretical studies that allowed us to select four compounds according to their free energy values for A beta(1-42) in alpha-helix (A beta-alpha), random coil (A beta-RC) and beta-sheet (A beta-beta) conformations. Docking studies revealed that compound 5 had a higher affinity for A beta-alpha and A beta-RC than the other compounds. In vitro, this compound was able to abolish Thioflavin T fluorescence and favored an RC conformation of A beta(1-42) in circular dichroism studies, resulting in the formation of amorphous aggregates as shown by atomic force microscopy. The results obtained from quantum studies allowed us to identify a possible pharmacophore that can be used to design A beta(1-42) aggregation inhibitors. In conclusion, compounds with higher affinity for A beta-alpha and A beta-RC prevented the formation of oligomeric species.	[Hernandez-Rodriguez, Maricarmen; Correa-Basurto, Jose] Inst Politecn Nacl, Escuela Super Med, Lab Modelado Mol & Diseno Farm, Mexico City, DF, Mexico; [Hernandez-Rodriguez, Maricarmen; Rosales-Hernandez, Martha C.] Inst Politecn Nacl, Escuela Super Med, Lab Biofis & Biocatalisis, Mexico City, DF, Mexico; [Ines Nicolas-Vazquez, Maria; Miranda-Ruvalcaba, Rene] Univ Nacl Autonoma Mexico, Dept Ciencias Quim, Fac Estudios Super Cuautitlan Campo 1, Quim Inorgan Organ, Cuautitlan, Estado De Mexic, Mexico; [Guadalupe Benitez-Cardoza, Claudia] Inst Politecn Nacl, Escuela Nacl Med & Homeopatia, Lab Invest Bioquim, Secc Estudios Posgrad & Invest, Mexico City, DF, Mexico; [Arturo Resendiz-Albor, Aldo] Inst Politecn Nacl, Escuela Super Med, Lab Invest Inmunol, Mexico City, DF, Mexico; [Vicente Mendez-Mendez, Juan] Inst Politecn Nacl, Ctr Nanociencias & Micro & Nanotecnol, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico	Correa-Basurto, J (corresponding author), Inst Politecn Nacl, Escuela Super Med, Lab Modelado Mol & Diseno Farm, Plan San Luis & Diaz Miron S-N, Mexico City, DF, Mexico.	corrjose@gmail.com; marcrh2002@yahoo.com.mx	hernendez, Martha Cecilia rosales/AAD-3536-2021; Mendez Mendez, Juan Vicente/R-2225-2018	Mendez Mendez, Juan Vicente/0000-0002-1227-8072; Hernandez, Maricarmen/0000-0001-9371-1095; Resendiz Albor, Aldo Arturo/0000-0003-1415-5524; RODRIGUEZ-CORTES, OCTAVIO/0000-0002-7380-5665; Benitez Cardoza, Claudia Guadalupe/0000-0002-7841-5711	Instituto de Ciencia y Tecnologia del Distrito Federal [1276/2011, 42/2012]; Consejo Nacional de Ciencia y Tecnologia [84119, 132353, 356817]; PIFI-SIPCOFAA-IPN [SIP20150944]	Instituto de Ciencia y Tecnologia del Distrito Federal; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PIFI-SIPCOFAA-IPN	This work was supported by grants from Instituto de Ciencia y Tecnologia del Distrito Federal/1276/2011 and 42/2012 JCB, Consejo Nacional de Ciencia y Tecnologia 84119 MCRH and 132353 JCB, PIFI-SIPCOFAA-IPN, SIP20150944 and scholarships from Consejo Nacional de Ciencia y Tecnologia to study PhD 356817 to HMR. The funders played no role in data collection and analysis, decision to publish and preparation of the manuscript.	Aloisi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068159; Bansode SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105196; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021660; Chebaro Y, 2012, J PHYS CHEM B, V116, P8412, DOI 10.1021/jp2118778; Chen WT, 2011, J BIOL CHEM, V286, P9646, DOI 10.1074/jbc.M110.177246; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cui LL, 2013, J ALZHEIMERS DIS, V37, P19, DOI 10.3233/JAD-130164; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Doig AJ, 2015, CURR OPIN STRUC BIOL, V30, P50, DOI 10.1016/j.sbi.2014.12.004; Esteras-Chopo A, 2008, J MOL BIOL, V383, P266, DOI 10.1016/j.jmb.2008.07.076; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; FUKUI K, 1982, SCIENCE, V218, P747, DOI 10.1126/science.218.4574.747; Glenner G G, 1984, Appl Pathol, V2, P357; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hehre W.J., 1998, MOL MODELING WORKBOO; Hernandez-Rodriguez M, 2013, PROTEIN SCI, V22, P1320, DOI 10.1002/pro.2319; Hunter CA, 2004, ANGEW CHEM INT EDIT, V43, P5310, DOI 10.1002/anie.200301739; Ito M, 2011, PLOS ONE, V3, P1; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Landau M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001080; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Levine H, 2007, AMYLOID, V14, P185, DOI 10.1080/13506120701461020; Li J, 2013, NEUROCHEM RES, V38, P443, DOI 10.1007/s11064-012-0939-2; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Mason JM, 2003, CURR OPIN STRUC BIOL, V13, P526, DOI 10.1016/S0959-440X(03)00100-3; Matharu B, 2009, J NEUROL SCI, V280, P49, DOI 10.1016/j.jns.2009.01.024; Matsubara E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/984041; MERLINI G, 1995, P NATL ACAD SCI USA, V92, P2959, DOI 10.1073/pnas.92.7.2959; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nasica-Labouze J, 2015, CHEM REV, V115, P3518, DOI 10.1021/cr500638n; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Nguyent P, 2014, ACCOUNTS CHEM RES, V47, P603, DOI 10.1021/ar4002075; Novick PA, 2012, J MED CHEM, V55, P3002, DOI 10.1021/jm201332p; Orlando RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031869; Pappolla M, 1998, J BIOL CHEM, V273, P7185, DOI 10.1074/jbc.273.13.7185; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Pohl G, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4811712; POLITZER P, 1985, ENVIRON HEALTH PERSP, V61, P191, DOI 10.2307/3430072; Salomon AR, 1996, BIOCHEMISTRY-US, V35, P13568, DOI 10.1021/bi9617264; Sciarretta KL, 2005, BIOCHEMISTRY-US, V44, P6003, DOI 10.1021/bi0474867; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shaw JE, 2012, ACS CHEM NEUROSCI, V3, P167, DOI 10.1021/cn2000926; Singh SK, 2014, NEUROTOX RES, V26, P331, DOI 10.1007/s12640-014-9466-z; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Tarus B, 2015, EUR J MED CHEM, V91, P43, DOI 10.1016/j.ejmech.2014.07.002; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wheeler SE, 2009, J CHEM THEORY COMPUT, V5, P2301, DOI 10.1021/ct900344g; Xie Q, 2008, J MED CHEM, V51, P2027, DOI 10.1021/jm070154q; Yadav A, 2009, EUR J MED CHEM, V44, P3866, DOI 10.1016/j.ejmech.2009.04.013; Zhang T, 2014, ACS CHEM NEUROSCI, V5, P148, DOI 10.1021/cn400197x	58	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0130263	10.1371/journal.pone.0130263	http://dx.doi.org/10.1371/journal.pone.0130263			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172152	Green Submitted, gold, Green Published			2022-12-27	WOS:000358194900006
J	Ayyappan, V; Kalavacharla, V; Thimmapuram, J; Bhide, KP; Sripathi, VR; Smolinski, TG; Manoharan, M; Thurston, Y; Todd, A; Kingham, B				Ayyappan, Vasudevan; Kalavacharla, Venu; Thimmapuram, Jyothi; Bhide, Ketaki P.; Sripathi, Venkateswara R.; Smolinski, Tomasz G.; Manoharan, Muthusamy; Thurston, Yaqoob; Todd, Antonette; Kingham, Bruce			Genome-Wide Profiling of Histone Modifications (H3K9(me2) and H4K12(ac)) and Gene Expression in Rust (Uromyces appendiculatus) Inoculated Common Bean (Phaseolus vulgaris L.)	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; DISEASE RESISTANCE; STRESS RESPONSES; ARABIDOPSIS; PATHOGEN; PROTEIN; IDENTIFICATION; RNA; VIRULENCE; CROSSTALK	Histone modifications such as methylation and acetylation play a significant role in controlling gene expression in unstressed and stressed plants. Genome-wide analysis of such stress-responsive modifications and genes in non-model crops is limited. We report the genome-wide profiling of histone methylation (H3K9(me2)) and acetylation (H4K12(ac)) in common bean (Phaseolus vulgaris L.) under rust (Uromyces appendiculatus) stress using two high-throughput approaches, chromatin immunoprecipitation sequencing (ChIP-Seq) and RNA sequencing (RNA-Seq). ChIP-Seq analysis revealed 1,235 and 556 histone methylation and acetylation responsive genes from common bean leaves treated with the rust pathogen at 0, 12 and 84 hour-after-inoculation (hai), while RNA-Seq analysis identified 145 and 1,763 genes differentially expressed between mock-inoculated and inoculated plants. The combined ChIP-Seq and RNA-Seq analyses identified some key defense responsive genes (calmodulin, cytochrome p450, chitinase, DNA Pol II, and LRR) and transcription factors (WRKY, bZIP, MYB, HSFB3, GRAS, NAC, and NMRA) in bean-rust interaction. Differential methylation and acetylation affected a large proportion of stress-responsive genes including resistant (R) proteins, detoxifying enzymes, and genes involved in ion flux and cell death. The genes identified were functionally classified using Gene Ontology (GO) and EuKaryotic Orthologous Groups (KOGs). The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis identified a putative pathway with ten key genes involved in plant-pathogen interactions. This first report of an integrated analysis of histone modifications and gene expression involved in the bean-rust interaction as reported here provides a comprehensive resource for other epigenomic regulation studies in non-model species under stress.	[Ayyappan, Vasudevan; Kalavacharla, Venu; Sripathi, Venkateswara R.; Thurston, Yaqoob; Todd, Antonette] Delaware State Univ, Mol Genet & Epigen Lab, Dover, DE 19901 USA; [Kalavacharla, Venu] Delaware State Univ, Ctr Integrated Biol & Environm Res, Dover, DE USA; [Thimmapuram, Jyothi; Bhide, Ketaki P.] Purdue Univ, Bioinformat Core, W Lafayette, IN 47907 USA; [Smolinski, Tomasz G.] Delaware State Univ, Computat Intelligence & Biol Informat Lab CIBiL, Dover, DE USA; [Manoharan, Muthusamy] Univ Arkansas, Dept Agr, Pine Bluff, AR USA; [Kingham, Bruce] Delaware Biotechnol Inst, Sequencing & Genotyping Ctr, Newark, DE USA	Delaware State University; Delaware State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Delaware State University; University of Arkansas System; University of Arkansas Fayetteville	Kalavacharla, V (corresponding author), Delaware State Univ, Mol Genet & Epigen Lab, Dover, DE 19901 USA.	vkalavacharla@desu.edu			USDA Capacity Building Grant [2008-38814-04735, 2010-38821-21540]; National Science Foundation Grant [EPS-0814251]; State of Delaware; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446] Funding Source: NIH RePORTER; Office Of The Director [1003970] Funding Source: National Science Foundation	USDA Capacity Building Grant; National Science Foundation Grant(National Science Foundation (NSF)); State of Delaware; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by USDA Capacity Building Grant 2008-38814-04735 to VK, USDA Capacity Building Grant 2010-38821-21540 to MM and VK and Delaware EPSCoR grant from the National Science Foundation Grant EPS-0814251 and the State of Delaware in part to VK.	AbuQamar S, 2009, PLANT J, V58, P347, DOI 10.1111/j.1365-313X.2008.03783.x; Acevedo M, 2013, PLANT DIS, V97, P652, DOI 10.1094/PDIS-02-12-0169-RE; Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Alves MS, 2013, INT J MOL SCI, V14, P7815, DOI 10.3390/ijms14047815; Blair MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049488; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Chan ZL, 2012, GENOMICS, V100, P110, DOI 10.1016/j.ygeno.2012.06.004; Cortes AJ, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-58; Costas C, 2011, NAT STRUCT MOL BIOL, V18, P395, DOI 10.1038/nsmb.1988; Diener AC, 2001, PLANT CELL, V13, P1625, DOI 10.1105/tpc.13.7.1625; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; Foerster AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002331; Gaude N, 2012, PLANT J, V69, P510, DOI 10.1111/j.1365-313X.2011.04810.x; Gayacharan, 2013, PHYSIOL MOL BIOL PLA, V19, P379, DOI 10.1007/s12298-013-0176-4; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Guo N, 2011, GENOME, V54, P954, DOI [10.1139/g11-050, 10.1139/G11-050]; Gutzat R, 2012, CURR OPIN PLANT BIOL, V15, P568, DOI 10.1016/j.pbi.2012.08.007; Hahne F, 2008, USE R, P207, DOI 10.1007/978-0-387-77240-0_14; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu YF, 2012, P NATL ACAD SCI USA, V109, P5773, DOI 10.1073/pnas.1203148109; Huang Shengxiong, 2013, Chinese Journal of Applied and Environmental Biology, V19, P205, DOI 10.3724/SP.J.1145.2013.00205; Jang IC, 2011, PLANT CELL, V23, P459, DOI 10.1105/tpc.110.080481; Jaskiewicz M, 2011, EMBO REP, V12, P50, DOI 10.1038/embor.2010.186; Jochua C, 2008, PLANT DIS, V92, P401, DOI 10.1094/PDIS-92-3-0401; Kalavacharla V, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-135; Kang YJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-139; Kapazoglou A, 2011, ABIOTIC STRESS IN PLANTS - MECHANISMS AND ADAPTATIONS, P395; Kim KC, 2006, PLANT PHYSIOL, V142, P1180, DOI 10.1104/pp.106.082487; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Leba LJ, 2012, PLANT J, V71, P976, DOI 10.1111/j.1365-313X.2012.05045.x; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Li Y, 2013, PLANT PATHOLOGY J, V29, P168, DOI 10.5423/PPJ.SI.08.2012.0125; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo CY, 2014, METHODS MOL BIOL, V1112, P177, DOI 10.1007/978-1-62703-773-0_12; Luo CY, 2013, PLANT J, V73, P77, DOI 10.1111/tpj.12017; Luo M, 2005, PHYTOPATHOLOGY, V95, P381, DOI 10.1094/PHYTO-95-0381; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mmbaga MT, 1996, J PHYTOPATHOL, V144, P533, DOI 10.1111/j.1439-0434.1996.tb00295.x; Munoz-Bodnar A, 2014, PLANT CELL REP, V33, P1901, DOI 10.1007/s00299-014-1667-7; Narusaka Y, 2004, PLANT MOL BIOL, V55, P327, DOI 10.1007/s11103-004-0685-1; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; Okay S, 2014, MOL GENET GENOMICS, V289, P765, DOI 10.1007/s00438-014-0849-x; Paris S, 2003, BIOCHEM J, V372, P391, DOI 10.1042/BJ20030047; Pecinka A, 2012, PLANT CELL PHYSIOL, V53, P801, DOI 10.1093/pcp/pcs044; Perez-Clemente RM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/654120; Porch TG, 2013, AGRONOMY-BASEL, V3, P433, DOI 10.3390/agronomy3020433; PUNJA ZK, 1993, J NEMATOL, V25, P526; Qiao Weihua, 2011, [Frontiers in Biology, 生物学前沿], V6, P477; Ramegowda V, 2015, J PLANT PHYSIOL, V176, P47, DOI 10.1016/j.jplph.2014.11.008; Roudier F, 2009, TRENDS GENET, V25, P511, DOI 10.1016/j.tig.2009.09.013; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sandlin CM, 1999, PLANT DIS, V83, P108, DOI 10.1094/PDIS.1999.83.2.108; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shamimuzzaman M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-477; Sharma R, 2013, MOL PLANT, V6, P250, DOI 10.1093/mp/sss147; Shen HS, 2012, PLANT CELL, V24, P875, DOI 10.1105/tpc.111.094870; Singh P, 2014, PLANT CELL, V26, P2676, DOI 10.1105/tpc.114.123356; Soar A, 2014, MOL BIOL REP, V41, P7683, DOI [10.1007/s11033-014-3661-0, DOI 10.1007/S11033-014-3661-0]; Sridha S, 2006, PLANT J, V46, P124, DOI 10.1111/j.1365-313X.2006.02678.x; Stokes TL, 2002, P NATL ACAD SCI USA, V99, P7792, DOI 10.1073/pnas.112040999; Stracke R, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0249-8; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Torres-Martin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065868; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Turra D, 2014, ANNU REV PHYTOPATHOL, V52, P267, DOI 10.1146/annurev-phyto-102313-050143; van Ooijen G, 2008, J EXP BOT, P1, DOI [10.1093/jxb/em045, DOI 10.1093/JXB/EM045]; Wakasa Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-101; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhang Guo-Bin, 2013, Yichuan, V35, P971, DOI 10.3724/SP.J.1005.2013.00971; Zhao JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044968; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462; Zhuang XF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-668	86	25	25	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132176	10.1371/journal.pone.0132176	http://dx.doi.org/10.1371/journal.pone.0132176			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167691	gold, Green Published, Green Submitted			2022-12-27	WOS:000358193100026
J	Pennacchio, A; Varriale, A; Esposito, MG; Scala, A; Marzullo, VM; Staiano, M; D'Auria, S				Pennacchio, Anna; Varriale, Antonio; Esposito, Maria Grazia; Scala, Andrea; Marzullo, Vincenzo Manuel; Staiano, Maria; D'Auria, Sabato			A Rapid and Sensitive Assay for the Detection of Benzylpenicillin (PenG) in Milk	PLOS ONE			English	Article							RESONANCE-BASED BIOCHIP; (DIHYDRO)STREPTOMYCIN RESIDUES; ANTIBIOTIC-RESIDUES; PATULIN TOXIN; BIOSENSOR; DIHYDROSTREPTOMYCIN; IMMUNOASSAYS; STREPTOMYCIN; INHIBITORS; PENICILLIN	Antibiotics, such as benzyl-penicillin (PenG) and cephalosporin, are the most common compounds used in animal therapy. Their massive and illegal use in animal therapy and prophylaxis inevitably causes the presence of traces in foods of animal origin (milk and meat), which creates several problems for human health. With the aim to prevent the negative impact of beta-lactam and, in particular, PenG residues present in the milk on customer health, many countries have established maximum residue limits (MRLs). To cope with this problem here, we propose an effective alternative, compared to the analytical methods actually employed, to quantify the presence of penicillin G using the surface plasmon resonance (SPR) method. In particular, the PenG molecule was conjugated to a protein carrier to immunize a rabbit and produce polyclonal antibodies (anti-PenG). The produced antibodies were used as molecular recognition elements for the design of a competitive immune-assay for the detection of PenG by SPR experiments. The detection limit of the developed assay was found to be 8.0 pM, a value much lower than the MRL of the EU regulation limit that is fixed at 12 nM. Thus, our results clearly show that this system could be successfully suitable for the accurate and easy determination of PenG.	[Pennacchio, Anna; Varriale, Antonio; Esposito, Maria Grazia; Scala, Andrea; Marzullo, Vincenzo Manuel; Staiano, Maria] CNR, IBP, Lab Mol Sensing, I-80125 Naples, Italy; [Varriale, Antonio; Scala, Andrea; Staiano, Maria; D'Auria, Sabato] CNR, Inst Food Sci, ISA, Avellino, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Varriale, A (corresponding author), CNR, IBP, Lab Mol Sensing, I-80125 Naples, Italy.	a.varriale@ibp.cnr.it; sabato.dauria@cnr.it	Varriale, Antonio/AAL-1439-2020; STAIANO, MARIA/B-9584-2015; Marzullo, Vincenzo Manuel/ABG-8416-2020	STAIANO, MARIA/0000-0003-0223-1825; Marzullo, Vincenzo Manuel/0000-0001-8746-1296	project "SAFE & SMART-Nuove tecnologie abilitanti per la food safety e l'integrita delle filiere agro-alimentari in uno scenario globale" [CTN01_00230_240864]; CNR project "Conoscenze integrate per sostenibilita ed innovazione del Made in Italy agro-alimentare (CISIA)"	project "SAFE & SMART-Nuove tecnologie abilitanti per la food safety e l'integrita delle filiere agro-alimentari in uno scenario globale"; CNR project "Conoscenze integrate per sostenibilita ed innovazione del Made in Italy agro-alimentare (CISIA)"	This project was realized in the frame of the CNR Commessa "Progettazione e Sviluppo di Biochip per la Sicurezza Alimentare e Salute Umana (SD; MS; AV)". This Project was partially funded by the project CTN01_00230_240864 "SAFE & SMART-Nuove tecnologie abilitanti per la food safety e l'integrita delle filiere agro-alimentari in uno scenario globale", and it was also partially funded by the CNR project "Conoscenze integrate per sostenibilita ed innovazione del Made in Italy agro-alimentare (CISIA)".	Abbasi H, 1998, ANALYST, V123, P2725, DOI 10.1039/a804910f; Abuknesha RA, 2005, ANALYST, V130, P964, DOI 10.1039/b418107g; ADETUNJI VO, 2002, NAT SCI, V10, P60; Baxter GA, 2001, J AGR FOOD CHEM, V49, P3204, DOI 10.1021/jf001484l; Bencini R, 1997, AUST J EXP AGR, V37, P485, DOI 10.1071/EA96014; Caldow M, 2005, J AGR FOOD CHEM, V53, P7367, DOI 10.1021/jf050725s; de Champdore M, 2007, ANAL CHEM, V79, P751, DOI 10.1021/ac0618526; Epstein JB, 2000, J AM DENT ASSOC, V131, P1600, DOI 10.14219/jada.archive.2000.0090; Fejzic N, 2014, BOSNIAN J BASIC MED, V14, P155, DOI 10.17305/bjbms.2014.3.109; Ferrini AM, 2008, J AGR FOOD CHEM, V56, P784, DOI 10.1021/jf071479i; Haasnoot W, 1999, ANALYST, V124, P301, DOI 10.1039/a807846g; Haasnoot W, 2002, FOOD AGR IMMUNOL, V14, P15, DOI 10.1080/09540100220137637; Heinrich-Balard L, 2015, MOL CELL ENDOCRINOL, V399, P201, DOI 10.1016/j.mce.2014.10.002; Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d; Kuck LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109616; LEVINE BB, 1962, J MED PHARMACEUT CH, V5, P1025, DOI 10.1021/jm01240a016; Li MJ, 2014, ANTIMICROB AGENTS CH, V58, P4495, DOI 10.1128/AAC.02806-14; MCEWEN SA, 1991, J FOOD PROTECT, V54, P454, DOI 10.4315/0362-028X-54.6.454; Payne MA, 2006, EXTRA LABEL USE PENI; Pennacchio A, 2014, OPT MATER, V36, P1670, DOI 10.1016/j.optmat.2013.12.045; Preu M, 1999, J CHROMATOGR A, V840, P81, DOI 10.1016/S0021-9673(99)00163-6; Pry, 2008, CLIN BIOCHEM REV, V29, pS49; Raz SR, 2009, ANAL CHEM, V81, P7743, DOI 10.1021/ac901230v; Shepherd CA, 2014, PROGR BIOPHYSICS MOL, VXXX, P1; Staiano M, 2005, BIOCHEMISTRY-US, V44, P5625, DOI 10.1021/bi0478300; Varriale A, 2012, ANAL METHODS-UK, V4, P1940, DOI 10.1039/c2ay25231g; Verheijen R, 2000, FOOD AGR IMMUNOL, V12, P31, DOI 10.1080/09540100099607; Zacco E, 2007, BIOSENS BIOELECTRON, V22, P2184, DOI 10.1016/j.bios.2006.10.014	28	12	13	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132396	10.1371/journal.pone.0132396	http://dx.doi.org/10.1371/journal.pone.0132396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168259	Green Submitted, gold, Green Published			2022-12-27	WOS:000358193100040
J	Stefani, V; Pires, TL; Torezan-Silingardi, HM; Del-Claro, K				Stefani, Vanessa; Pires, Tayna Lopes; Torezan-Silingardi, Helena Maura; Del-Claro, Kleber			Beneficial Effects of Ants and Spiders on the Reproductive Value of Eriotheca gracilipes (Malvaceae) in a Tropical Savanna	PLOS ONE			English	Article							EXTRAFLORAL NECTARIES; HERBIVORE INTERACTIONS; PLANT INTERACTIONS; FRUIT-SET; POLLINATORS; SYSTEMS; COST	Predators affect plant fitness when they forage on them and reduce the action of herbivores. Our study evaluates the complementary effects of spiders and ants that visit the extrafloral nectaries of Eriotheca gracilipes(Malvaceae) on the production of fruits and viable seeds of these savanna trees. Four experimental groups were established: control group - with free access of spiders and ants; exclusion group - spiders and ants excluded; ant group absence of spiders; and spider group - absence of ants. The presence of ants reduced the spider richness; however, the presence of spiders did not affect the ant richness. A significantly higher number of fruits per buds were found in the presence of spiders alone or spiders and ants together (control group) compared with the absence of both predators (exclusion group). The number of seeds per fruits and seed viability were higher in the control group. This is the first study showing that spiders and ants may exert a positive and complementary effect on the reproductive value of an extrafloral nectaried plant. Mostly the impact of ants and/or spiders on herbivores is considered, whereas our study reinforces the importance of evaluating the effect of multiple predators simultaneously, exploring how the interactions among predators with distinct skills may affect the herbivores and the plants on which they forage.	[Stefani, Vanessa; Pires, Tayna Lopes; Torezan-Silingardi, Helena Maura; Del-Claro, Kleber] Univ Fed Uberlandia, Inst Biol, Programa Posgrad Ecol & Conservacao Recursos Nat, Lab Ecol Comportamental & Interacoes, BR-38400 Uberlandia, MG, Brazil	Universidade Federal de Uberlandia	Del-Claro, K (corresponding author), Univ Fed Uberlandia, Inst Biol, Programa Posgrad Ecol & Conservacao Recursos Nat, Lab Ecol Comportamental & Interacoes, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	delclaro@ufu.br	Torezan-Silingardi, Helena Maura/AAH-2880-2019; Del-Claro, K/C-5570-2013; Del-Claro, Kleber/N-3700-2019	Torezan-Silingardi, Helena Maura/0000-0002-0393-869X; Del-Claro, K/0000-0001-8886-9568; Stefani, Vanessa/0000-0002-8659-9194	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CNPq [473055/2012, 72046/2011, 301248/2009]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Plano Nacional de Pos-Doutorado, CAPES-PNPD [2556/2011]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Plano Nacional de Pos-Doutorado, CAPES-PNPD	The authors (HMTS and KDC) had financial support of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CNPq - Grant numbers 473055/2012; 72046/2011; 301248/2009. VS thanks the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Plano Nacional de Pos-Doutorado, CAPES-PNPD, number 2556/2011). The authors ensure that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Silva E, 2013, NATURWISSENSCHAFTEN, V100, P525, DOI 10.1007/s00114-013-1048-z; Assuncao MA, 2014, FLORA, V209, P244, DOI 10.1016/j.flora.2014.03.003; Bronstein JL, 2009, J ECOL, V97, P1160, DOI 10.1111/j.1365-2745.2009.01566.x; Byk J, 2011, POPUL ECOL, V53, P327, DOI 10.1007/s10144-010-0240-7; Christianini AV, 2004, ENTOMOL EXP APPL, V112, P81, DOI 10.1111/j.0013-8703.2004.00188.x; COSTA NP, 1994, INFORM ABRATES, V4, P53; Dattilo W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099838; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; de Souza ALT, 2004, J ARACHNOL, V32, P345; de Souza AUT, 2005, BIOTROPICA, V37, P416, DOI 10.1111/j.1744-7429.2005.00055.x; Del-Claro K, 2013, SOCIOBIOLOGY, V60, P217; Del-Claro K, 2009, NEOTROP ENTOMOL, V38, P159, DOI 10.1590/S1519-566X2009000200001; Del-Claro Stefani V, 2005, NEOTROP ENTOMOL, V34, P881; DelClaro K, 1996, J TROP ECOL, V12, P887, DOI 10.1017/S0266467400010142; Delouche J.C., 1976, TESTE TETRAZOLIO VIA, P103; DICKE M, 1990, J CHEM ECOL, V16, P3091, DOI 10.1007/BF00979614; Diniz Suzana, 2012, Psyche (Cambridge), P791395, DOI 10.1155/2012/791395; Durigan Giselda, 2002, Acta Bot. Bras., V16, P251, DOI 10.1590/S0102-33062002000300002; Ferreira CA, 2013, SOCIOBIOLOGY, V60, P323; Foelix R, 2010, BIOL SPIDERS; FRANCA-NETO J.B., 1988, METODOLOGIA TESTE TE; Goncalves-Souza T, 2008, ECOLOGY, V89, P2407, DOI 10.1890/07-1881.1; Halaj J, 2001, AM NAT, V157, P262, DOI 10.1086/319190; Heikkinen MW, 2004, J ARACHNOL, V32, P313, DOI 10.1636/M02-1; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Hofer H., 2001, ANDRIAS, V15, P99; Lange D, 2013, ECOL ENTOMOL, V38, P463, DOI 10.1111/een.12036; LOUDA SM, 1982, OECOLOGIA, V55, P185, DOI 10.1007/BF00384486; Machado SR, 2008, PLANT BIOLOGY, V10, P660, DOI 10.1111/j.1438-8677.2008.00068.x; Nahas L, 2012, BIOTROPICA, V44, P498, DOI 10.1111/j.1744-7429.2011.00850.x; Nascimento EA, 2010, FLORA, V205, P754, DOI 10.1016/j.flora.2009.12.040; Nelson XJ, 2013, CHEMOECOLOGY, V23, P149, DOI 10.1007/s00049-013-0130-5; OLIVEIRA PE, 1992, PLANT SYST EVOL, V179, P207, DOI 10.1007/BF00937597; Oliveira PS, 2002, CERRADOS BRAZIL ECOL; Price P.W., 2011, INSECT ECOLOGY BEHAV; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Romero G. Q., 2007, ECOLOGIA COMPORTAMEN, P277; Romero GQ, 2004, ECOLOGY, V85, P446, DOI 10.1890/02-0327; Rosa C, 2008, LIVRO CURSO CAMPO EC; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Ruhren S, 1999, OECOLOGIA, V119, P227, DOI 10.1007/s004420050780; Sanders D, 2008, BASIC APPL ECOL, V9, P152, DOI 10.1016/j.baae.2007.01.003; Sanders D, 2011, OIKOS, V120, P418, DOI 10.1111/j.1600-0706.2010.18924.x; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; SILBERBAUERGOTTSBERGER I, 1987, PHYTON-ANN REI BOT A, V27, P55; Terborgh J., 2010, TROPHIC CASCADES PRE; THOMAS CD, 1989, OIKOS, V55, P291, DOI 10.2307/3565587; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson John N., 1997, P285; Torezan-Silingardi HM, 2011, SOCIOBIOLOGY, V57, P181; Torres-Hernandez Leonel, 2000, Acta Zoologica Mexicana Nueva Serie, P13; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Vilela AA, 2014, FLORA, V209, P359, DOI 10.1016/j.flora.2014.04.004	53	22	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131843	10.1371/journal.pone.0131843	http://dx.doi.org/10.1371/journal.pone.0131843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168036	gold, Green Published, Green Submitted			2022-12-27	WOS:000358193100015
J	Wang, XM; Kindzierski, W; Kaul, P				Wang, Xiaoming; Kindzierski, Warren; Kaul, Padma			Air Pollution and Acute Myocardial Infarction Hospital Admission in Alberta, Canada: A Three-Step Procedure Case-Crossover Study	PLOS ONE			English	Article							POTENTIALLY SENSITIVE GROUPS; PARTICULATE MATTER; EMERGENCY ADMISSIONS; REFERENT SELECTION; FINE PARTICLES; MINAP DATABASE; TIME-SERIES; EXPOSURE; RISK; MORTALITY	Adverse associations between air pollution and myocardial infarction (MI) are widely reported in medical literature. However, inconsistency and sensitivity of the findings are still big concerns. An exploratory investigation was undertaken to examine associations between air pollutants and risk of acute MI (AMI) hospitalization in Alberta, Canada. A time stratified case-crossover design was used to assess the transient effect of five air pollutants (carbon monoxide (CO), nitrogen dioxide (NO2), nitric oxide (NO), ozone (O-3) and particulate matter with an aerodynamic diameter <= 2.5 (PM2.5)) on the risk of AMI hospitalization over the period 1999-2009. Subgroups were predefined to see if any susceptible group of individuals existed. A three-step procedure, including univariate analysis, multivariate analysis, and bootstrap model averaging, was used. The multivariate analysis was used in an effort to address adjustment uncertainty; whereas the bootstrap technique was used as a way to account for regression model uncertainty. There were 25,894 AMI hospital admissions during the 11-year period. Estimating health effects that are properly adjusted for all possible confounding factors and accounting for model uncertainty are important for making interpretations of air pollution-health effect associations. The most robust findings included: (1) only 1-day lag NO2 concentrations (6-, 12- or 24-hour average), but not those of CO, NO, O-3 or PM2.5, were associated with an elevated risk of AMI hospitalization; (2) evidence was suggested for an effect of elevated risk of hospitalization for NSTEMI (Non-ST Segment Elevation Myocardial Infarction), but not for STEMI (ST segment elevation myocardial infarction); and (3) susceptible subgroups included elders (age >= 65) and elders with hypertension. As this was only an exploratory study there is a need to replicate these findings with other methodologies and datasets.	[Wang, Xiaoming; Kindzierski, Warren] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Kaul, Padma] Univ Alberta, Dept Med, Canadian Vigour Ctr, Edmonton, AB, Canada	University of Alberta; University of Alberta	Kindzierski, W (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	warrenk@ualberta.ca		Kaul, Padma/0000-0003-2239-3944	Alberta Public Health Information Network Project	Alberta Public Health Information Network Project	This study was funded by the Alberta Public Health Information Network Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100307; Barnett AG, 2006, ENVIRON HEALTH PERSP, V114, P1018, DOI 10.1289/ehp.8674; Bateson TF, 2004, EPIDEMIOLOGY, V15, P143, DOI 10.1097/01.ede.0000112210.68754.fa; Berglind N, 2010, INT J ENV RES PUB HE, V7, P1486, DOI 10.3390/ijerph7041486; Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018; Bhaskaran K, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5531; Cadum E, 2009, EPIDEMIOL PREV, V33, P113; Cheng MF, 2009, J TOXICOL ENV HEAL A, V72, P1135, DOI 10.1080/15287390903091756; Clyde M, 2000, ENVIRONMETRICS, V11, P745, DOI 10.1002/1099-095X(200011/12)11:6<745::AID-ENV431>3.0.CO;2-N; D'Ippoliti D, 2003, EPIDEMIOLOGY, V14, P528, DOI 10.1097/01.ede.0000082046.22919.72; Dominici F, 2004, J AM STAT ASSOC, V99, P938, DOI 10.1198/016214504000000656; Dominici F, 2008, EPIDEMIOLOGY, V19, P558, DOI 10.1097/EDE.0b013e31817307dc; Dominici F, 2014, SCIENCE, V344, P257, DOI 10.1126/science.1247348; Environment Canada, 2013, NAT AIR POLL SURV NA; Gardner B, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-1; Hastie T., 2009, UNSUPERVISED LEARNIN; Hodas N, 2013, J EXPO SCI ENV EPID, V23, P573, DOI 10.1038/jes.2013.24; Hsieh YL, 2010, J TOXICOL ENV HEAL A, V73, P757, DOI 10.1080/15287391003684789; Janes H, 2005, STAT MED, V24, P285, DOI 10.1002/sim.1889; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Kioumourtzoglou MA, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-68; Koop G, 2010, ENVIRON MODELL SOFTW, V25, P873, DOI 10.1016/j.envsoft.2010.01.010; Levinsson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099043; Levy D, 2001, EPIDEMIOLOGY, V12, P186, DOI 10.1097/00001648-200103000-00010; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Milojevic A, 2014, HEART, V100, P1093, DOI 10.1136/heartjnl-2013-304963; Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126; National Oceanic and Atmospheric Administration (NOAA), 2013, LAND BAS STAT DAT; Nuvolone D, 2011, AM J EPIDEMIOL, V174, P63, DOI 10.1093/aje/kwr046; Peel JL, 2007, AM J EPIDEMIOL, V165, P625, DOI 10.1093/aje/kwk051; Peters A, 2001, CIRCULATION, V103, P2810; Poloniecki JD, 1997, OCCUP ENVIRON MED, V54, P535, DOI 10.1136/oem.54.8.535; Rich DQ, 2013, ENVIRON SCI TECHNOL, V47, P9414, DOI 10.1021/es4027248; Rich DQ, 2010, ENVIRON HEALTH PERSP, V118, P1229, DOI 10.1289/ehp.0901624; Rosenthal FS, 2013, J EXPO SCI ENV EPID, V23, P281, DOI 10.1038/jes.2012.121; Ruidavets JB, 2005, CIRCULATION, V111, P563, DOI 10.1161/01.CIR.0000154546.32135.6E; Schwartz Joel, 1991, Public Health Reviews, V19, P39; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Stylianou M, 2009, ENVIRON POLLUT, V157, P2216, DOI 10.1016/j.envpol.2009.04.011; Sullivan J, 2005, EPIDEMIOLOGY, V16, P41, DOI 10.1097/01.ede.0000147116.34813.56; Tsai SS, 2012, J TOXICOL ENV HEAL A, V75, P242, DOI 10.1080/15287394.2012.641202; Turin TC, 2012, NEUROEPIDEMIOLOGY, V38, P84, DOI 10.1159/000335654; von Klot S, 2011, PROG CARDIOVASC DIS, V53, P361, DOI 10.1016/j.pcad.2011.01.002; Wichmann J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062059; Wichmann J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053684; Wichmann J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-19; Zanobetti A, 2000, ENVIRON HEALTH PERSP, V108, P841, DOI 10.2307/3434991; Zanobetti A, 2005, ENVIRON HEALTH PERSP, V113, P978, DOI 10.1289/ehp.7550; Zanobetti A, 2006, J EPIDEMIOL COMMUN H, V60, P890, DOI 10.1136/jech.2005.039834	49	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132769	10.1371/journal.pone.0132769	http://dx.doi.org/10.1371/journal.pone.0132769			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167938	Green Published, gold, Green Submitted			2022-12-27	WOS:000358193100078
J	Antunes, F; Zindoga, P; Gomes, P; Augusto, O; Mahumane, I; Veloso, L; Valadas, E; Camacho, R				Antunes, Francisco; Zindoga, Pereira; Gomes, Perpetua; Augusto, Orvalho; Mahumane, Isabel; Veloso, Luis; Valadas, Emilia; Camacho, Ricardo			Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique	PLOS ONE			English	Article							SINGLE-DOSE NEVIRAPINE; IMMUNODEFICIENCY-VIRUS TYPE-1; DRUG-RESISTANCE; ANTIRETROVIRAL TREATMENT; VERTICAL TRANSMISSION; GENOTYPING SYSTEM; INFECTED INFANTS; NVP RESISTANCE; BREAST-MILK; SUBTYPE-C	Background Single-dose nevirapine (sd-NVP) has been the main option for prevention of mother-to-child transmission (PMTCT) of HIV-1 in low-resource settings. However, sd-NVP can induce the selection of HIV-1 resistant mutations in mothers and infants. In Mozambique, there are limited data regarding the profile of NVP resistance associated mutations (RAM) in the context of PMTCT. Objectives To assess the prevalence and the factors associated with NVP RAM among children born to HIV-1 infected mothers enrolled in the PMTCT programme adopted in Mozambique. Methods One hundred and fifty seven children aged 6 to 48 weeks were sequentially included (July 2011 to March 2012) at four centres in Maputo. Genotyping of RAM was performed in samples with HIV-1 RNA >= 100 copies/mu L (Viroseq). Sequencing was performed with ABI 3100 (Applied Biosystems). Logistic regression modelling was undertaken to identify the factors associated with NVP RAM. Results Seventy-nine children had their samples genotyped. Their median age was 7.0 (3-12) months and 92.4% received prophylaxis with sd-NVP at birth plus daily NVP. 35.4% of mothers received antiretrovirals (ARVs) for PMTCT. ARV RAM were detected in 43 (54.4%) of the children. 45.6% of these children had at least one NVP RAM. The most common mutations associated with NVP resistance were K103N (n = 16) and Y181C (n = 15). NVP RAM was significantly associated with mother exposure to PMTCT (crude odds ratio [OR] 30.3, 95% CI 4.93-186.34) and with mother's CD4 count < 350 cells/mm(3) (crude OR 3.08, 95% CI 1.02-9.32). In the multivariable analysis the mother's exposure to PMTCT was the only variable significantly associated with NVP RAM (adjusted OR 48.65, 95% CI 9.33-253.66). Conclusions We found a high prevalence of NVP RAM among children who were exposed to the drug regimen for PMTCT in Mozambique. The mothers' exposure to PMTCT significantly increased the risk of NVP RAM.	[Antunes, Francisco] Univ Lisbon, Inst Saude Ambiental ISAMB, Fac Med, P-1699 Lisbon, Portugal; [Zindoga, Pereira] Hosp Cent Maputo, Inst Nacl Saude, Dept Med, Maputo, Mozambique; [Gomes, Perpetua] Ctr Hosp Lisboa Ocidental, Serv Patol Clin, Lab Microbiol Clin & Biol Mol, Lisbon, Portugal; [Augusto, Orvalho] Univ Eduardo Mondlane, Saude Comunidade, Fac Med, Maputo, Mozambique; [Mahumane, Isabel] Inst Nacl Saude, Plataforma Virol Mol, Plataformas Tecnol, Maputo, Mozambique; [Veloso, Luis] Eurotrials Sci Consultants, Clin Data Unit, Lisbon, Portugal; [Valadas, Emilia] Fac Med Lisbon, Clin Univ Doencas Infecciosas & Parasitarias, Lisbon, Portugal; [Camacho, Ricardo] Rega Inst Med Res, Dept Microbiol & Immunol, Leuven, Belgium	Universidade de Lisboa; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade de Lisboa; Eduardo Mondlane University; Universidade de Lisboa; KU Leuven	Antunes, F (corresponding author), Univ Lisbon, Inst Saude Ambiental ISAMB, Fac Med, P-1699 Lisbon, Portugal.	fantunes@medicina.ulisboa.pt	Augusto, Orvalho/J-8767-2019; Gomes, Perpetua/I-5652-2012	Augusto, Orvalho/0000-0002-0005-3968; Gomes, Perpetua/0000-0003-3271-8255; Valadas, Emilia/0000-0001-5213-1473; Zindoga, Pereira/0000-0002-0348-574X	Associacao para a Investigacao e Desenvolvimento da Faculdade de Medicina (AIDFM)	Associacao para a Investigacao e Desenvolvimento da Faculdade de Medicina (AIDFM)	This study was funded by the Associacao para a Investigacao e Desenvolvimento da Faculdade de Medicina (AIDFM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adje-Toure C, 2008, AIDS RES HUM RETROV, V24, P911, DOI 10.1089/aid.2007.0264; Bila DCA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068213; [Anonymous], 2020, HIGH POSS COST COVID; [Anonymous], 2017, 2013 UNAIDS REP GLOB; Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104; Church JD, 2008, J INFECT DIS, V198, P1075, DOI 10.1086/591503; Cunningham S, 2001, J CLIN MICROBIOL, V39, P1254, DOI 10.1128/JCM.39.4.1254-1257.2001; Dagnra AY, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-30; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Eshleman SH, 2005, AIDS, V19, P2167, DOI 10.1097/01.aids.0000194800.43799.94; Eshleman SH, 2005, J INFECT DIS, V192, P30, DOI 10.1086/430764; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Flys T, 2005, J INFECT DIS, V192, P24, DOI 10.1086/430742; Fogel J, 2011, AIDS, V25, P911, DOI 10.1097/QAD.0b013e328344fedc; Frank M, 2011, ANTIMICROB AGENTS CH, V55, P5529, DOI 10.1128/AAC.00741-11; Gantt S, 2012, J PEDIATR INFECT DIS, V1, P244, DOI [10.1093/jpids/pis065, 10.1093/JPIDS/PIS065]; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hunt GM, 2011, AIDS, V25, P1461, DOI 10.1097/QAD.0b013e3283492180; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Kamoto K, 2008, ANTIVIR THER, V13, P83; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Maiga AI, 2013, AIDS RES HUM RETROV, V29, P182, DOI [10.1089/AID.2012.0118, 10.1089/aid.2012.0118]; Martinson NA, 2007, JAIDS-J ACQ IMM DEF, V44, P148, DOI 10.1097/QAI.0b013e31802b920e; McMahon DK, 2013, CLIN INFECT DIS, V56, P1044, DOI 10.1093/cid/cis1219; Micek MA, 2014, J INFECT DIS, V210, P641, DOI 10.1093/infdis/jiu130; Micek MA, 2010, CLIN INFECT DIS, V50, P1405, DOI 10.1086/652151; MISAU, 2009, B EP DO MIN SAUD MOC; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; Moorthy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004096; Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Shao ER, 2014, J ANTIMICROB CHEMOTH, V69, P1928, DOI 10.1093/jac/dku087; UNAIDS, 2011, OUTL REP 30 YEARS AI; UNAIDS, 2011, WORLD AIDS DAY REP 2; Van Dyke RB, 2012, CLIN INFECT DIS, V54, P285, DOI 10.1093/cid/cir798; Vaz P, 2012, CLIN INFECT DIS, V54, pS369, DOI 10.1093/cid/cis006; Vaz Paula, 2009, Pediatr Infect Dis J, V28, pe283, DOI 10.1097/INF.0b013e3181ba6c92; Whitson D, 2008, ANAL HIV PREVENTION, P11; WHO, 2010, RAP ADV US ANT DRUGS	40	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131994	10.1371/journal.pone.0131994	http://dx.doi.org/10.1371/journal.pone.0131994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161559	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300082
J	Cai, LM; Huang, P; Luo, QL; Huang, H; Mo, L				Cai, Liman; Huang, Ping; Luo, Qiuling; Huang, Hong; Mo, Lei			Iconic Meaning in Music: An Event-Related Potential Study	PLOS ONE			English	Article							CORTICAL REPRESENTATION; NEURAL BASIS; BRAIN; LANGUAGE; CONTEXT; SOUNDS	Although there has been extensive research on the processing of the emotional meaning of music, little is known about other aspects of listeners' experience of music. The present study investigated the neural correlates of the iconic meaning of music. Event-related potentials (ERP) were recorded while a group of 20 music majors and a group of 20 non-music majors performed a lexical decision task in the context of implicit musical iconic meaning priming. ERP analysis revealed a significant N400 effect of congruency in time window 260-510 ms following the onset of the target word only in the group of music majors. Time-course analysis using 50 ms windows indicated significant N400 effects both within the time window 410-460 ms and 460-510 ms for music majors, whereas only a partial N400 effect during time window 410-460 ms was observed for non-music majors. There was also a trend for the N400 effects in the music major group to be stronger than those in the non-major group in the sub-windows of 310-360ms and 410-460ms. Especially in the sub-window of 410-460 ms, the topographical map of the difference waveforms between congruent and incongruent conditions revealed different N400 distribution between groups; the effect was concentrated in bilateral frontal areas for music majors, but in central-parietal areas for non-music majors. These results imply probable neural mechanism differences underlying automatic iconic meaning priming of music. Our findings suggest that processing of the iconic meaning of music can be accomplished automatically and that musical training may facilitate the understanding of the iconic meaning of music.	[Cai, Liman; Huang, Ping; Luo, Qiuling; Mo, Lei] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou 510631, Guangdong, Peoples R China; [Cai, Liman] S China Normal Univ, Coll Educ Sci, Guangzhou 510631, Guangdong, Peoples R China; [Huang, Hong] Xinghai Conservatory Mus, Dept Mus, Guangzhou 510500, Guangdong, Peoples R China	South China Normal University; South China Normal University; Xinghai Conservatory of Music	Mo, L (corresponding author), S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou 510631, Guangdong, Peoples R China.	molei@scnu.edu.cn			National Natural Science Foundation of China [31170997]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China(31170997), http://www.nsfc.gov.cn/, (LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenmuller EO, 2001, ANN NY ACAD SCI, V930, P273, DOI 10.1111/j.1749-6632.2001.tb05738.x; Anderson T. W., 1958, INTRO MULTIVARIATE S; [蔡黎曼 Cai Liman], 2013, [心理科学, Journal of Psychological Science], V36, P547; Cidian X., 1986, MODERN CHINESE FREQU; Coulson S, 1998, LANG COGNITIVE PROC, V13, P21, DOI 10.1080/016909698386582; Daltrozzo J, 2009, BRAIN RES, V1270, P88, DOI 10.1016/j.brainres.2009.03.019; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Friederici AD, 1996, J EXP PSYCHOL LEARN, V22, P1219, DOI 10.1037//0278-7393.22.5.1219; Goerlich KS, 2012, J COGNITIVE NEUROSCI, V24, P1725, DOI 10.1162/jocn_a_00213; Hodges D. A., 1996, HDB MUSIC PSYCHOL, V2nd; Hoenig K, 2011, NEUROIMAGE, V56, P1714, DOI 10.1016/j.neuroimage.2011.02.065; Jednorog K, 2010, NEUROPSYCHOLOGIA, V48, P2447, DOI 10.1016/j.neuropsychologia.2010.04.017; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2005, TRENDS COGN SCI, V9, P578, DOI 10.1016/j.tics.2005.10.001; Koelsch S, 2004, NAT NEUROSCI, V7, P302, DOI 10.1038/nn1197; Koelsch S, 2002, PSYCHOPHYSIOLOGY, V39, P38, DOI 10.1017/S004857720102011X; Koelsch S, 2002, PSYCHOPHYSIOLOGY, V39, P657, DOI 10.1017/S0048577202010508; Koelsch S, 2011, PHYS LIFE REV, V8, P89, DOI 10.1016/j.plrev.2011.04.004; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Krumhansl CL, 1996, MUSIC PERCEPT, V13, P401; Loui P, 2005, COGNITIVE BRAIN RES, V25, P678, DOI 10.1016/j.cogbrainres.2005.08.019; Meyer L., 1956, EMOTION MEANING MUSI; Miranda RA, 2007, NEUROIMAGE, V38, P331, DOI 10.1016/j.neuroimage.2007.07.034; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; Painter JG, 2011, PSYCHOPHYSIOLOGY, V48, P645, DOI 10.1111/j.1469-8986.2010.01134.x; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Sollberger B, 2003, MUSIC PERCEPT, V20, P263, DOI 10.1525/mp.2003.20.3.263; Steinbeis N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002226; Steinbeis N, 2011, J COGNITIVE NEUROSCI, V23, P604, DOI 10.1162/jocn.2009.21383; Warne RT, 2014, PRACTICAL ASSESSMENT, V19, P2; Wu YJ, 2011, CEREB CORTEX; Zhao JJ, 2011, NEUROPSYCHOLOGIA, V49, P1761, DOI 10.1016/j.neuropsychologia.2011.02.054	33	1	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132169	10.1371/journal.pone.0132169	http://dx.doi.org/10.1371/journal.pone.0132169			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161561	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300100
J	Seiler, C; Gebhart, N; Zhang, Y; Shinton, SA; Li, YS; Ross, NL; Liu, XJ; Li, Q; Bilbee, AN; Varshney, GK; LaFave, MC; Burgess, SM; Balciuniene, J; Balciunas, D; Hardy, RR; Kappes, DJ; Wiest, DL; Rhodes, J				Seiler, Christoph; Gebhart, Nichole; Zhang, Yong; Shinton, Susan A.; Li, Yue-sheng; Ross, Nicola L.; Liu, Xingjun; Li, Qin; Bilbee, Alison N.; Varshney, Gaurav K.; LaFave, Matthew C.; Burgess, Shawn M.; Balciuniene, Jorune; Balciunas, Darius; Hardy, Richard R.; Kappes, Dietmar J.; Wiest, David L.; Rhodes, Jennifer			Mutagenesis Screen Identifies agtpbp1 and eps15L1 as Essential for T lymphocyte Development in Zebrafish	PLOS ONE			English	Article							PURKINJE-CELL DEGENERATION; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; TRANSGENIC ZEBRAFISH; MUTANT ZEBRAFISH; IMMUNE-SYSTEM; DANIO-RERIO; GENOME-WIDE; TRANSPOSON; PROTEIN	Genetic screens are a powerful tool to discover genes that are important in immune cell development and function. The evolutionarily conserved development of lymphoid cells paired with the genetic tractability of zebrafish make this a powerful model system for this purpose. We used a Tol2-based gene-breaking transposon to induce mutations in the zebrafish (Danio rerio, AB strain) genome, which served the dual purpose of fluorescently tagging cells and tissues that express the disrupted gene and provided a means of identifying the disrupted gene. We identified 12 lines in which hematopoietic tissues expressed green fluorescent protein (GFP) during embryonic development, as detected by microscopy. Subsequent analysis of young adult fish, using a novel approach in which single cell suspensions of whole fish were analyzed by flow cytometry, revealed that 8 of these lines also exhibited GFP expression in young adult cells. An additional 15 lines that did not have embryonic GFP(+) hematopoietic tissue by microscopy, nevertheless exhibited GFP(+) cells in young adults. RT-PCR analysis of purified GFP(+) populations for expression of T and B cell-specific markers identified 18 lines in which T and/or B cells were fluorescently tagged at 6 weeks of age. As transposon insertion is expected to cause gene disruption, these lines can be used to assess the requirement for the disrupted genes in immune cell development. Focusing on the lines with embryonic GFP(+) hematopoietic tissue, we identified three lines in which homozygous mutants exhibited impaired T cell development at 6 days of age. In two of the lines we identified the disrupted genes, agtpbp1 and eps15L1. Morpholino-mediated knockdown of these genes mimicked the T cell defects in the corresponding mutant embryos, demonstrating the previously unrecognized, essential roles of agtpbp1 and eps15L1 in T cell development.	[Seiler, Christoph; Gebhart, Nichole; Zhang, Yong; Shinton, Susan A.; Li, Yue-sheng; Ross, Nicola L.; Liu, Xingjun; Li, Qin; Bilbee, Alison N.; Hardy, Richard R.; Kappes, Dietmar J.; Wiest, David L.; Rhodes, Jennifer] Temple Univ Hlth Syst, Fox Chase Canc Ctr, Blood Cell Dev & Funct Program, Philadelphia, PA 19129 USA; [Varshney, Gaurav K.; LaFave, Matthew C.; Burgess, Shawn M.] NHGRI, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA; [Balciuniene, Jorune; Balciunas, Darius] Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA	Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Rhodes, J (corresponding author), Temple Univ Hlth Syst, Fox Chase Canc Ctr, Blood Cell Dev & Funct Program, Philadelphia, PA 19129 USA.	jennifer.rhodes@fccc.edu	LI, Yue/GRS-8071-2022; Balciunas, Darius/AAD-1420-2019	Wiest, David/0000-0002-0792-3188; Varshney, Gaurav K./0000-0002-0429-1904; LaFave, Matthew/0000-0001-9165-041X; Burgess, Shawn/0000-0003-1147-0596	Gabrielle's Angel Foundation [3261601]; National Institutes of Health [HD061749]; Fox Chase Cancer Center Keystone Blood Cell Development and Disease; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061749] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000183] Funding Source: NIH RePORTER	Gabrielle's Angel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fox Chase Cancer Center Keystone Blood Cell Development and Disease; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by (JR) Gabrielle's Angel Foundation 3261601; (DB) National Institutes of Health HD061749; (DLW and RRH) Fox Chase Cancer Center Keystone Blood Cell Development and Disease funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitake CM, 2011, DEV BIOL, V352, P191, DOI 10.1016/j.ydbio.2011.01.002; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Balciuniene J, 2013, JOVE-J VIS EXP, DOI 10.3791/50113; Balciuniene J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-619; Boatman S, 2013, BLOOD CELL MOL DIS, V51, P271, DOI 10.1016/j.bcmd.2013.07.009; Burns CE, 2009, BLOOD, V113, P5776, DOI 10.1182/blood-2008-12-193607; Callery EM, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120060; Carbone R, 1997, CANCER RES, V57, P5498; Carroll KJ, 2014, EXP HEMATOL, V42, P684, DOI 10.1016/j.exphem.2014.05.002; Clark KJ, 2011, NAT METHODS, V8, P506, DOI [10.1038/NMETH.1606, 10.1038/nmeth.1606]; Dai Zhao-xia, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1230; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Eckfeldt CE, 2005, PLOS BIOL, V3, P1449, DOI 10.1371/journal.pbio.0030254; English MA, 2012, DEV DYNAM, V241, P879, DOI 10.1002/dvdy.23774; Frazer JK, 2009, LEUKEMIA, V23, P1825, DOI 10.1038/leu.2009.116; Goll MG, 2009, GENETICS, V182, P747, DOI 10.1534/genetics.109.102079; GREER CA, 1982, BRAIN RES, V235, P156, DOI 10.1016/0006-8993(82)90206-2; Haffter P, 1996, DEVELOPMENT, V123, P1; Harris A, 2000, MOL CELL NEUROSCI, V16, P578, DOI 10.1006/mcne.2000.0900; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hermanson S, 2004, METHOD CELL BIOL, V77, P349; Ikawa T, 2014, CURR TOP MICROBIOL, V381, P1, DOI 10.1007/82_2014_370; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; Kawahara A, 2012, BIOCHEM BIOPH RES CO, V421, P367, DOI 10.1016/j.bbrc.2012.04.019; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Kondrychyn I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-418; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; LaFave MC, 2014, NUCLEIC ACIDS RES, V42, P4257, DOI 10.1093/nar/gkt1399; Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4; Lam SH, 2002, DEV DYNAM, V225, P87, DOI 10.1002/dvdy.10127; LANDIS SC, 1978, J COMP NEUROL, V177, P125, DOI 10.1002/cne.901770109; Langenau DM, 2004, P NATL ACAD SCI USA, V101, P7369, DOI 10.1073/pnas.0402248101; Malhotra N, 2013, IMMUNOLOGY, V139, P1, DOI 10.1111/imm.12076; MULLEN RJ, 1975, NATURE, V258, P528, DOI 10.1038/258528a0; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Page DM, 2013, BLOOD, V122, pE1, DOI 10.1182/blood-2012-12-471029; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Payne EM, 2011, BLOOD, V118, P903, DOI 10.1182/blood-2010-11-318022; Petzold AM, 2009, P NATL ACAD SCI USA, V106, P18662, DOI 10.1073/pnas.0908247106; Poupon V, 2002, J BIOL CHEM, V277, P8941, DOI 10.1074/jbc.M108385200; Ransom DG, 1996, DEVELOPMENT, V123, P311; Rehn K, 2011, INT J DEV BIOL, V55, P613, DOI 10.1387/ijdb.103249kp; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Seiler C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001386; Sivasubbu S, 2006, MECH DEVELOP, V123, P513, DOI 10.1016/j.mod.2006.06.002; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Taylor AM, 2012, EXP HEMATOL, V40, P228, DOI [10.1016/j.exphem.2011.11.007, 10.1016/j.exphem.2011.11.007.]; Trede NS, 2008, DEV DYNAM, V237, P2575, DOI 10.1002/dvdy.21683; Varshney GK, 2013, GENOME RES, V23, P727, DOI 10.1101/gr.151464.112; WEST RW, 1984, MOL CELL BIOL, V4, P2467, DOI 10.1128/MCB.4.11.2467; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Xiong JW, 2008, CIRC RES, V102, P1057, DOI 10.1161/CIRCRESAHA.107.163907; Zhang Y, 2013, DEV CELL, V24, P411, DOI 10.1016/j.devcel.2013.01.018	60	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131908	10.1371/journal.pone.0131908	http://dx.doi.org/10.1371/journal.pone.0131908			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161877	Green Published, gold, Green Submitted			2022-12-27	WOS:000358162300073
J	Zhang, Y; Xiao, RR; Yin, TL; Zou, W; Tang, Y; Ding, JL; Yang, J				Zhang, Yi; Xiao, Rong-Rong; Yin, Tailang; Zou, Wei; Tang, Yun; Ding, Jinli; Yang, Jing			Generation of Gradients on a Microfluidic Device: Toward a High-Throughput Investigation of Spermatozoa Chemotaxis	PLOS ONE			English	Article							SPERM CHEMOTAXIS; MAMMALIAN SPERM; PROGESTERONE; CHEMOATTRACTANT; CAPACITATION; MECHANISMS; MIGRATION; AXON	Various research tools have been used for in vitro detection of sperm chemotaxis. However, they are typically poor in maintenance of gradient stability, not to mention their low efficiency. Microfluidic device offers a new experimental platform for better control over chemical concentration gradient than traditional ones. In the present study, an easy-handle diffusion-based microfluidic chip was established. This device allowed for conduction of three parallel experiments on the same chip, and improved the performance of sperm chemotaxis research. In such a chip, there were six channels surrounding a hexagonal pool. The channels are connected to the hexagon by microchannels. Firstly, the fluid flow in the system was characterized; secondly, fluorescein solution was used to calibrate gradient profiles formed in the central hexagon; thirdly, sperm behavior was observed under two concentration gradients of progesterone (100 pM and 1 mM, respectively) as a validation of the device. Significant differences in chemotactic parameters were recognized between experimental and control groups (p < 0.05). Compared with control group, sperm motility was greatly enhanced in 1 mM group (p < 0.05), but no significant difference was found in 100 pM group. In conclusion, we proposed a microfluidic device for the study of sperm chemotaxis that was capable of generating multi-channel gradients on a chip and would help reduce experimental errors and save time in experiment.	[Zhang, Yi; Yin, Tailang; Ding, Jinli; Yang, Jing] Wuhan Univ, Renmin Hosp, Reprod Med Ctr, Wuhan 430072, Hubei Province, Peoples R China; [Xiao, Rong-Rong; Zou, Wei; Tang, Yun] Wuhan Univ, Key Lab Analyt Chem Biol & Med, Minist Educ, Coll Chem & Mol Sci, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Yang, J (corresponding author), Wuhan Univ, Renmin Hosp, Reprod Med Ctr, Wuhan 430072, Hubei Province, Peoples R China.	dryangjing607@gmail.com			National Natural Science Foundation of China [81370767]; Health and Family Planning Commission of Hubei Province [JS-2011001]; Public Welfare of Hubei Province [2013BCB005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health and Family Planning Commission of Hubei Province; Public Welfare of Hubei Province	Funding: This research was supported by National Natural Science Foundation of China (81370767, grant recipient JY), Health and Family Planning Commission of Hubei Province (JS-2011001, grant recipient JY) and Public Welfare of Hubei Province (2013BCB005, grant recipient JY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi E, 2009, MOL CELL ENDOCRINOL, V308, P39, DOI 10.1016/j.mce.2009.02.006; Calogero AE, 2000, HUM REPROD, V15, P28, DOI 10.1093/humrep/15.suppl_1.28; Chang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060587; Cheng SY, 2007, LAB CHIP, V7, P763, DOI 10.1039/b618463d; COHENDAYAG A, 1995, P NATL ACAD SCI USA, V92, P11039, DOI 10.1073/pnas.92.24.11039; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Eisenbach M, 1999, REV REPROD, V4, P56, DOI 10.1530/revreprod/4.1.56; Eisenbach M, 1999, DEV GENET, V25, P87, DOI 10.1002/(SICI)1520-6408(1999)25:2&lt;87::AID-DVG2&gt;3.0.CO;2-4; Fabro G, 2002, BIOL REPROD, V67, P1565, DOI 10.1095/biolreprod.102.006395; Gakamsky A, 2009, HUM REPROD, V24, P1152, DOI 10.1093/humrep/den409; Gatica LV, 2013, MOL HUM REPROD, V19, P559, DOI 10.1093/molehr/gat037; Henkel Ralf R, 2003, Reprod Biol Endocrinol, V1, P108, DOI 10.1186/1477-7827-1-108; Kaupp UB, 2012, J GEN PHYSIOL, V140, P583, DOI 10.1085/jgp.201210902; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Kim BJ, 2012, ANN BIOMED ENG, V40, P1316, DOI 10.1007/s10439-011-0489-9; Li J, 2011, TRENDS CELL BIOL, V21, P489, DOI 10.1016/j.tcb.2011.05.002; Lopez-Garcia MDC, 2008, BIOMED MICRODEVICES, V10, P709, DOI 10.1007/s10544-008-9182-7; Miki K, 2013, CURR BIOL, V23, P443, DOI 10.1016/j.cub.2013.02.007; Oren-Benaroya R, 2008, HUM REPROD, V23, P2339, DOI 10.1093/humrep/den265; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Sagare-Patil V, 2012, INT J ANDROL, V35, P633, DOI 10.1111/j.1365-2605.2012.01291.x; Srinivasan P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099640; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Sugiyama Hitoshi, 2004, Methods Mol Biol, V253, P27; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; Teves ME, 2006, FERTIL STERIL, V86, P745, DOI 10.1016/j.fertnstert.2006.02.080; Tung CK, 2014, LAB CHIP, V14, P1348, DOI 10.1039/c3lc51297e; WHO, 2001, ANN I SUPER SANITA, V37, pI; WILLIAMS M, 1993, HUM REPROD, V8, P2019, DOI 10.1093/oxfordjournals.humrep.a137975; Xiao RR, 2014, ANAL CHEM, V86, P11649, DOI 10.1021/ac504159g; Xiao RR, 2013, ANAL CHEM, V85, P7842, DOI 10.1021/ac4022055; Zou YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061593	32	149	154	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142555	10.1371/journal.pone.0142555	http://dx.doi.org/10.1371/journal.pone.0142555			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26171860	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700127
